PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kaeser, PS; Deng, LB; Wang, Y; Dulubova, I; Liu, XR; Rizo, J; Sudhof, TC				Kaeser, Pascal S.; Deng, Lunbin; Wang, Yun; Dulubova, Irina; Liu, Xinran; Rizo, Josep; Suedhof, Thomas C.			RIM Proteins Tether Ca2+ Channels to Presynaptic Active Zones via a Direct PDZ-Domain Interaction	CELL			English	Article							CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; RAB3 EFFECTOR; RIM1-ALPHA; COMPLEX; BINDING; CALYX; DELETION; FAMILY	At a synapse, fast synchronous neurotransmitter release requires localization of Ca2+ channels to presynaptic active zones. How Ca2+ channels are recruited to active zones, however, remains unknown. Using unbiased yeast two-hybrid screens, we here identify a direct interaction of the central PDZ domain of the active-zone protein RIM with the C termini of presynaptic N- and P/Q-type Ca2+ channels but not L-type Ca2+ channels. To test the physiological significance of this interaction, we generated conditional knockout mice lacking all multidomain RIM isoforms. Deletion of RIM proteins ablated most neurotransmitter release by simultaneously impairing the priming of synaptic vesicles and by decreasing the presynaptic localization of Ca2+ channels. Strikingly, rescue of the decreased Ca2+-channel localization required the RIM PDZ domain, whereas rescue of vesicle priming required the RIM N terminus. We propose that RIMs tether N- and P/Q-type Ca2+ channels to presynaptic active zones via a direct PDZ-domain-mediated interaction, thereby enabling fast, synchronous triggering of neurotransmitter release at a synapse.	[Kaeser, Pascal S.; Deng, Lunbin; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kaeser, Pascal S.; Deng, Lunbin; Wang, Yun; Liu, Xinran; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Dulubova, Irina; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Lorry Lokey Bldg,265 Campus Dr, Stanford, CA 94305 USA.	tcs1@stanford.edu			NIH [NINDS 33564, NS37200, DA029044]; Swiss National Science Foundation; NARSAD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA029044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NARSAD(NARSAD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank E. Borowicz, I. Kornblum, L. Fan, J. Mitchell, H. Ly, and I. Huryeva for technical assistance, Dr. R.E. Hammer for blastocyst injections, Dr. N. Brose for Munc 13-1 antibodies, Dr. C. Acuna-Goycolea for advice on Ca<SUP>2+</SUP>-imaging experiments, Dr. Z. Ma for assistance with yeast two-hybrid screening, Drs. Z. Pang, T. Bacaj, and C. Foldy for help with data analysis, and Dr. R. Schneggenburger for comments. This work was supported by grants from the NIH (NINDS 33564 to T.C.S., NS37200 to J.R., DA029044 to P.S.K.), a Swiss National Science Foundation Postdoctoral Fellowship (to P.S.K.), and a NARSAD Young Investigator Award (to P.S.K.).	Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; DENG L, 2011, NEURON IN PRESS, V69, DOI DOI 10.1016/J.NEURON.2011.01.005; Dietrich D, 2003, NEURON, V39, P483, DOI 10.1016/S0896-6273(03)00430-6; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Gracheva EO, 2008, NEUROSCI LETT, V444, P137, DOI 10.1016/j.neulet.2008.08.026; HAN Y, 2011, NEURON IN PRESS, V69, DOI DOI 10.1016/J.NEURON.2010.12.014; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Kaeser PS, 2009, NEURON, V64, P227, DOI 10.1016/j.neuron.2009.09.019; Kaeser PS, 2008, J NEUROSCI, V28, P13435, DOI 10.1523/JNEUROSCI.3235-08.2008; Katz B., 1969, RELEASE NEURAL TRANS; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Lu J, 2005, J MOL BIOL, V352, P455, DOI 10.1016/j.jmb.2005.07.047; LUEBKE JI, 1993, NEURON, V11, P895, DOI 10.1016/0896-6273(93)90119-C; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mittelstaedt T, 2010, BIOL CHEM, V391, P599, DOI 10.1515/BC.2010.064; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Qian J, 2000, J NEUROSCI, V20, P163, DOI 10.1523/JNEUROSCI.20-01-00163.2000; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Wu LG, 1999, J NEUROSCI, V19, P726	42	375	383	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					282	295		10.1016/j.cell.2010.12.029	http://dx.doi.org/10.1016/j.cell.2010.12.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241895	Bronze, Green Accepted			2022-12-28	WOS:000286459900012
J	Huang, PY; Ruiz-Vargas, CS; van der Zande, AM; Whitney, WS; Levendorf, MP; Kevek, JW; Garg, S; Alden, JS; Hustedt, CJ; Zhu, Y; Park, J; McEuen, PL; Muller, DA				Huang, Pinshane Y.; Ruiz-Vargas, Carlos S.; van der Zande, Arend M.; Whitney, William S.; Levendorf, Mark P.; Kevek, Joshua W.; Garg, Shivank; Alden, Jonathan S.; Hustedt, Caleb J.; Zhu, Ye; Park, Jiwoong; McEuen, Paul L.; Muller, David A.			Grains and grain boundaries in single-layer graphene atomic patchwork quilts	NATURE			English	Article							CHEMICAL-VAPOR-DEPOSITION; ELECTRONIC TRANSPORT; CARBON NANOTUBES; LARGE-AREA; DEFECTS; FILMS; MICROSCOPY; STRENGTH; GROWTH; FOILS	The properties of polycrystalline materials are often dominated by the size of their grains and by the atomic structure of their grain boundaries. These effects should be especially pronounced in two-dimensional materials, where even a line defect can divide and disrupt a crystal. These issues take on practical significance in graphene, which is a hexagonal, two-dimensional crystal of carbon atoms. Single-atom-thick graphene sheets can now be produced by chemical vapour deposition(1-3) on scales of up to metres(4), making their polycrystallinity almost unavoidable. Theoretically, graphene grain boundaries are predicted to have distinct electronic(5-8), magnetic(9), chemical(10) and mechanical(11-13) properties that strongly depend on their atomic arrangement. Yet because of the five-order-of-magnitude size difference between grains and the atoms at grain boundaries, few experiments have fully explored the graphene grain structure. Here we use a combination of old and new transmission electron microscopy techniques to bridge these length scales. Using atomic-resolution imaging, we determine the location and identity of every atom at a grain boundary and find that different grains stitch together predominantly through pentagon-heptagon pairs. Rather than individually imaging the several billion atoms in each grain, we use diffraction-filtered imaging(14) to rapidly map the location, orientation and shape of several hundred grains and boundaries, where only a handful have been previously reported(15-19). The resulting images reveal an unexpectedly small and intricate patchwork of grains connected by tilt boundaries. By correlating grain imaging with scanning probe and transport measurements, we show that these grain boundaries severely weaken the mechanical strength of graphene membranes but do not as drastically alter their electrical properties. These techniques open a new window for studies on the structure, properties and control of grains and grain boundaries in graphene and other two-dimensional materials.	[Huang, Pinshane Y.; Ruiz-Vargas, Carlos S.; Alden, Jonathan S.; Zhu, Ye; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [van der Zande, Arend M.; Whitney, William S.; McEuen, Paul L.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Levendorf, Mark P.; Garg, Shivank; Park, Jiwoong] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Kevek, Joshua W.] Oregon State Univ, Dept Phys, Corvallis, OR 97331 USA; [Hustedt, Caleb J.] Brigham Young Univ, Dept Phys & Astron, Provo, UT 84602 USA; [Park, Jiwoong; McEuen, Paul L.; Muller, David A.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Oregon State University; Brigham Young University	Muller, DA (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	david.a.muller@cornell.edu	Park, Jiwoong/C-2327-2013; Zhu, Ye/U-3836-2019; van der Zande, Arend M/C-1989-2016; Muller, David/A-7745-2010; Zhu, Ye/A-1844-2011	Zhu, Ye/0000-0002-5217-493X; van der Zande, Arend M/0000-0001-5104-9646; Muller, David/0000-0003-4129-0473; Zhu, Ye/0000-0002-5217-493X; Huang, Pinshane/0000-0002-1095-1833	National Science Foundation through the Cornell Center for Materials Research; Nanoscale Science and Engineering Initiative of the National Science Foundation [EEC-0117770, 064654]; NSF	National Science Foundation through the Cornell Center for Materials Research; Nanoscale Science and Engineering Initiative of the National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	The authors acknowledge discussions with M. Blees, J. Cha, S. Gerbode, J. Grazul, E. Kirkland, L. Fitting-Kourkoutis, O. Krivanek, S. Shi, S. Wang and H. Zhuang. This work was supported in part by the National Science Foundation through the Cornell Center for Materials Research and the Nanoscale Science and Engineering Initiative of the National Science Foundation under NSF Award EEC-0117770, 064654. Additional support was provided by the Army Research Office, CONACYT-Mexico, the Air Force Office of Scientific Research, DARPA-MTO and the MARCO Focused Research Center on Materials, Structures, and Devices. Sample fabrication was performed at the Cornell node of the National Nanofabrication Infrastructure Network, funded by the NSF. Additional facilities support was provided by the Cornell Center for Materials Research (NSF DMR-0520404 and IMR-0417392) and NYSTAR.	Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Cervenka J, 2009, NAT PHYS, V5, P840, DOI 10.1038/NPHYS1399; Cervenka J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195429; Cockayne E., 2010, ROTATIONAL GRAIN BOU; de Villeneuve VWA, 2005, J PHYS-CONDENS MAT, V17, pS3371, DOI 10.1088/0953-8984/17/45/024; Gao L, 2010, NANO LETT, V10, P3512, DOI 10.1021/nl1016706; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Grantab R, 2010, SCIENCE, V330, P946, DOI 10.1126/science.1196893; Hashimoto A, 2004, NATURE, V430, P870, DOI 10.1038/nature02817; Hirsch P., 1965, ELECT MICROSCOPY THI; Jiao LY, 2008, J AM CHEM SOC, V130, P12612, DOI 10.1021/ja805070b; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Li XS, 2010, NANO LETT, V10, P4328, DOI 10.1021/nl101629g; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liu YY, 2010, NANO LETT, V10, P2178, DOI 10.1021/nl100988r; Malola S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165447; Mesaros A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205119; Meyer J. C., 2009, MC2009, V3, P347; Meyer JC, 2008, NANO LETT, V8, P3582, DOI 10.1021/nl801386m; Park HJ, 2010, CARBON, V48, P1088, DOI 10.1016/j.carbon.2009.11.030; Park S, 2010, CARBON, V48, P797, DOI 10.1016/j.carbon.2009.10.030; Peres NMR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125411; Regan W, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3337091; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Suenaga K, 2007, NAT NANOTECHNOL, V2, P358, DOI 10.1038/nnano.2007.141; Thiel S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046809; van der Zande AM, 2010, NANO LETT, V10, P4869, DOI 10.1021/nl102713c; Wofford JM, 2010, NANO LETT, V10, P4890, DOI 10.1021/nl102788f; Yazyev OV, 2010, NAT MATER, V9, P806, DOI [10.1038/nmat2830, 10.1038/NMAT2830]; Yazyev OV, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195420; Zhao L., 2010, ATOMIC SCALE GROWTH	33	1589	1624	28	1247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					389	+		10.1038/nature09718	http://dx.doi.org/10.1038/nature09718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21209615	Green Submitted			2022-12-28	WOS:000286385600050
J	Freeman, EW; Guthrie, KA; Caan, B; Sternfeld, B; Cohen, LS; Joffe, H; Carpenter, JS; Anderson, GL; Larson, JC; Ensrud, KE; Reed, SD; Newton, KM; Sherman, S; Sammel, MD; LaCroix, AZ				Freeman, Ellen W.; Guthrie, Katherine A.; Caan, Bette; Sternfeld, Barbara; Cohen, Lee S.; Joffe, Hadine; Carpenter, Janet S.; Anderson, Garnet L.; Larson, Joseph C.; Ensrud, Kristine E.; Reed, Susan D.; Newton, Katherine M.; Sherman, Sheryl; Sammel, Mary D.; LaCroix, Andrea Z.			Efficacy of Escitalopram for Hot Flashes in Healthy Menopausal Women A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VASOMOTOR SYMPTOMS; NEWER ANTIDEPRESSANTS; HORMONE-THERAPY; DOUBLE-BLIND; PLACEBO; CITALOPRAM; DEPRESSION; GABAPENTIN; SEROTONIN; ESTROGEN	Context Concerns regarding the risks associated with estrogen and progesterone to manage menopausal symptoms have resulted in its declining use and increased interest in nonhormonal treatments with demonstrated efficacy for hot flashes. Objective To determine the efficacy and tolerability of 10 to 20 mg/d escitalopram, a selective serotonin reuptake inhibitor, in alleviating the frequency, severity, and bother of menopausal hot flashes. Design, Setting, and Patients A multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel group trial that enrolled 205 women (95 African American; 102 white; 8 other) between July 2009 and June 2010. Intervention Women received 10 to 20 mg/d of escitalopram or a matching placebo for 8 weeks. Main Outcome Measures Primary outcomes were the frequency and severity of hot flashes assessed by prospective daily diaries at weeks 4 and 8. Secondary outcomes were hot flash bother, recorded on daily diaries, and clinical improvement (defined as hot flash frequency >= 50% decrease from baseline). Results Mean (SD) daily hot flash frequency was 9.78 (5.60) at baseline. In a modified intent-to-treat analysis that included all randomized participants who provided hot flash diary data, the mean difference in hot flash frequency reduction was 1.41 (95% CI, 0.13-2.69) fewer hot flashes per day at week 8 among women taking escitalopram (P<.001), with mean reductions of 4.60 (95% CI, 3.74-5.47) and 3.20 (95% CI, 2.24-4.15) hot flashes per day in the escitalopram and placebo groups, respectively. Fifty-five percent of women in the escitalopram group vs 36% in the placebo group reported a decrease of at least 50% in hot flash frequency (P=.009) at the 8-week follow-up. Reductions in hot flash severity scores were significantly greater in the escitalopram group (-0.52; 95% CI, -0.64 to -0.40 vs -0.30; 95% CI, -0.42 to -0.17 for placebo; P<.001). Race did not significantly modify the treatment effect (P=.62). Overall discontinuation due to adverse events was 4% (7 in the active group, 2 in the placebo group). Three weeks after treatment ended, women in the escitalopram group reported a mean 1.59 (95% CI, 0.55-2.63; P=.02) more hot flashes per day than women in the placebo group. Conclusion Among healthy women, the use of escitalopram (10-20 mg/d) compared with placebo resulted in fewer and less severe menopausal hot flashes at 8 weeks of follow-up.	[Freeman, Ellen W.] Univ Penn, Sch Med, Dept Obstet, Philadelphia, PA 19104 USA; [Freeman, Ellen W.] Univ Penn, Sch Med, Dept Gynecol & Psychiat, Philadelphia, PA 19104 USA; [Sammel, Mary D.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Stat, Philadelphia, PA 19104 USA; [Guthrie, Katherine A.; Anderson, Garnet L.; Larson, Joseph C.; LaCroix, Andrea Z.] Fred Hutchinson Canc Res Ctr, Data Coordinating Ctr, Seattle, WA 98104 USA; [Reed, Susan D.] Univ Washington, Sch Med, Seattle, WA USA; [Newton, Katherine M.] Grp Hlth Res Inst, Seattle, WA USA; [Caan, Bette; Sternfeld, Barbara] Kaiser Permanente, Div Res, Oakland, CA USA; [Cohen, Lee S.; Joffe, Hadine] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Carpenter, Janet S.] Indiana Univ, Sch Nursing, Indianapolis, IN 46204 USA; [Ensrud, Kristine E.] Univ Minnesota, VA Med Ctr, Minneapolis, MN USA; [Sherman, Sheryl] NIA, US Natl Inst Hlth, Bethesda, MD 20892 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Kaiser Permanente; Harvard University; Massachusetts General Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Freeman, EW (corresponding author), 3701 Market St,Ste 820 Mudd, Philadelphia, PA 19104 USA.	freemane@mail.med.upenn.edu	Joffe, Hadine/T-6062-2019	Caan, Bette/0000-0002-5803-310X; Ensrud, Kristine/0000-0002-9069-3036; Reed, Susan/0000-0001-7532-3785; Sammel, Mary/0000-0003-1248-4199	Forest Laboratories, Inc; Wyeth; Pfizer; Xanodyne Pharmaceuticals; National Alliance for Research on Schizophrenia and Depression; Astra-Zeneca Pharmaceuticals; Sepracor, Inc; Bayer HealthCare; Bristol-Myers; Stanley Foundation; Ortho-McNeill Jansen; Pfizer, Inc.; Eli Lilly; GlaxoSmithKline; Sanofi-Events; Wyeth-Ayerst Pharmaceuticals; National Institute of Aging [U01 AG032656, U01AG032659, U01AG032669, U01AG032682, U01AG032699, U01AG032700]; Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD); National Center for Complementary and Alternative Medicine (NCCAM); Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Research Resources [UL1 RR025761]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG032700, U01AG032669, U01AG032656, U01AG032659, U01AG032699, U01AG032682] Funding Source: NIH RePORTER	Forest Laboratories, Inc; Wyeth(Wyeth); Pfizer(Pfizer); Xanodyne Pharmaceuticals; National Alliance for Research on Schizophrenia and Depression(NARSAD); Astra-Zeneca Pharmaceuticals(AstraZeneca); Sepracor, Inc; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Bristol-Myers(Bristol-Myers Squibb); Stanley Foundation; Ortho-McNeill Jansen; Pfizer, Inc.(Pfizer); Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Sanofi-Events; Wyeth-Ayerst Pharmaceuticals(Canadian Institutes of Health Research (CIHR)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Freeman reported research support from Forest Laboratories, Inc, Wyeth, Pfizer and Xanodyne Pharmaceuticals; honoraria for consulting and presentations from Wyeth, Forest Laboratories, Inc, Pherin Pharmaceuticals and Bayer Health Care. Dr Cohen reported research support from National Alliance for Research on Schizophrenia and Depression; Astra-Zeneca Pharmaceuticals; Sepracor, Inc; Bayer HealthCare; Bristol-Myers; Stanley Foundation; Ortho-McNeill Jansen; Pfizer, Inc. Advisory/Consulting: Eli Lilly; GlaxoSmithKline; JDS/Noven Pharmaceuticals; Wyeth-Ayerst Pharmaceuticals; Honoraria, Eli Lilly, Forest Laboratories, Inc; GlaxosmithKline; Pfizer, Inc, and Wyeth-Ayerst Pharmaceuticals. Dr Joffe reported research support from AstraZeneca Pharmaceuticals, Bayer HealthCare, Eli Lilly, Forest Laboratories, Inc, GlaxoSmithKline, Sanofi-Events (product support only), Sepracor, Inc, and Wyeth-Ayerst Pharmaceuticals; speaking honoraria, Eli Lilly, GlaxoSmithKline; Advisory/Consulting, Abbott Laboratories, Eli Lilly, Forest Laboratories, Inc, JDS-Noven Pharmaceuticals, Sanofi-Events, Sepracor Inc, and Wyeth-Ayerst Pharmaceuticals. No other authors reported having a financial conflict of interest.; The study was supported by a cooperative agreement issued by the National Institute of Aging (NIA), in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD), the National Center for Complementary and Alternative Medicine (NCCAM) and the Office of Research and Women's Health (ORWH), and grants U01 AG032656, U01AG032659, U01AG032669, U01AG032682, U01AG032699, U01AG032700 from the NIA. At the Indiana University site, the project was funded in part with support from the Indiana Clinical and Translational Sciences Institute, funded in part by grant UL1 RR025761 from the National Institutes of Health, National Center for Research Resources, Clinical and Translational Sciences Award. Escitalopram and matching placebo pills were provided by Forest Research Institute.	Appling S, 2007, J WOMENS HEALTH, V16, P1130, DOI 10.1089/jwh.2006.0033; Archer DF, 2009, AM J OBSTET GYNECOL, V200, p172e1; Barton DL, 2010, J CLIN ONCOL, V28, P3278, DOI 10.1200/JCO.2009.26.6379; Berendsen HHG, 2000, MATURITAS, V36, P155, DOI 10.1016/S0378-5122(00)00151-1; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Dobkin RD, 2009, ANN CLIN PSYCHIATRY, V21, P70; Gold EB, 2006, AM J PUBLIC HEALTH, V96, P1226, DOI 10.2105/AJPH.2005.066936; Grady D, 2007, OBSTET GYNECOL, V109, P823, DOI 10.1097/01.AOG.0000258278.73505.fa; Guttuso T, 2010, J WOMENS HEALTH, V19, P699, DOI 10.1089/jwh.2009.1610; Haas JS, 2004, ANN INTERN MED, V140, P184, DOI 10.7326/0003-4819-140-3-200402030-00009; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Kalay AE, 2007, MENOPAUSE, V14, P223, DOI 10.1097/01.gme.0000243571.55699.4a; Kerr EA, 2005, ANN INTERN MED, V142, P154, DOI 10.7326/0003-4819-142-2-200501180-00021; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Loprinzi CL, 2009, MENOPAUSE, V16, P883, DOI 10.1097/gme.0b013e31819c46c7; Loprinzi CL, 2009, J CLIN ONCOL, V27, P2831, DOI 10.1200/JCO.2008.19.6253; Michelson D, 2000, BRIT J PSYCHIAT, V176, P363, DOI 10.1192/bjp.176.4.363; Nedrow A, 2006, ARCH INTERN MED, V166, P1453, DOI 10.1001/archinte.166.14.1453; Nelson HD, 2004, JAMA-J AM MED ASSOC, V291, P1610, DOI 10.1001/jama.291.13.1610; Nelson HD, 2006, JAMA-J AM MED ASSOC, V295, P2057, DOI 10.1001/jama.295.17.2057; Newton KM, 2006, ANN INTERN MED, V145, P869, DOI 10.7326/0003-4819-145-12-200612190-00003; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Simpkins JW, 2009, MATURITAS, V63, P341, DOI 10.1016/j.maturitas.2009.06.002; Soares CN, 2006, MENOPAUSE, V13, P780, DOI 10.1097/01.gme.0000240633.46300.fa; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stearns V, 2005, J CLIN ONCOL, V23, P6919, DOI 10.1200/JCO.2005.10.081; Suvanto-Luukkonen E, 2005, MENOPAUSE, V12, P18, DOI 10.1097/00042192-200512010-00006; Whiteman MK, 2003, OBSTET GYNECOL, V101, P264, DOI 10.1016/S0029-7844(02)02593-0; Wyrwich KW, 2008, MENOPAUSE, V15, P698, DOI 10.1097/gme.0b013e31815f892d	29	151	161	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					267	274		10.1001/jama.2010.2016	http://dx.doi.org/10.1001/jama.2010.2016			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707YY	21245182	Green Accepted, Bronze			2022-12-28	WOS:000286328700022
J	Kavalier, F				Kavalier, Fred			Personal View Why do pharmacists sell homoeopathic remedies?	BRITISH MEDICAL JOURNAL			English	Editorial Material												kavalier@btinternet.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2011	342								d349	10.1136/bmj.d349	http://dx.doi.org/10.1136/bmj.d349			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OX	21248013				2022-12-28	WOS:000286602400025
J	Mor, V; Besdine, RW				Mor, Vincent; Besdine, Richard W.			Policy Options to Improve Discharge Planning and Reduce Rehospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CONTROLLED-TRIAL; CARE; HOSPITALISTS		[Mor, Vincent; Besdine, Richard W.] Brown Univ, Sch Med, Dept Community Hlth, Providence, RI 02912 USA; [Mor, Vincent; Besdine, Richard W.] Brown Univ, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA; [Besdine, Richard W.] Brown Univ, Sch Med, Dept Med, Div Geriatr, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Mor, V (corresponding author), Brown Univ, Sch Med, Dept Community Hlth, Box G-S121, Providence, RI 02912 USA.	vincent_mor@brown.edu			NIA NIH HHS [P0-1 AG027296, P01 AG027296] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG027296] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; *COMM MP, 2008, DAT BOOK HEALTHC SPE; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; Hamel MB, 2009, NEW ENGL J MED, V360, P1141, DOI 10.1056/NEJMe0900796; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kane RL, 2011, JAMA-J AM MED ASSOC, V305, P284, DOI 10.1001/jama.2010.2015; Mor V, 2010, HEALTH AFFAIR, V29, P57, DOI 10.1377/hlthaff.2009.0629; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Peterson MC, 2009, MAYO CLIN PROC, V84, P248, DOI 10.1016/S0025-6196(11)61142-7	9	28	28	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					302	303		10.1001/jama.2010.2006	http://dx.doi.org/10.1001/jama.2010.2006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707YY	21245187	Green Accepted			2022-12-28	WOS:000286328700029
J	Forbes, GM				Forbes, Geoffrey M.			Review: Fecal calprotectin is accurate for screening for suspected IBD in adults but less so in children	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Forbes, Geoffrey M.] Royal Perth Hosp, Perth, WA, Australia; [Forbes, Geoffrey M.] Univ Western Australia, Perth, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia	Forbes, GM (corresponding author), Royal Perth Hosp, Perth, WA, Australia.							Caccaro R, 2010, EXPERT REV CLIN IMMU, V6, P551, DOI 10.1586/ECI.10.26	1	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-12	10.7326/0003-4819-154-2-201101180-02012	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242354				2022-12-28	WOS:000286223500038
J	Giuliano, AR; Nyitray, AG; Albero, G				Giuliano, Anna R.; Nyitray, Alan G.; Albero, Ginesa			Male circumcision and HPV transmission to female partners	LANCET			English	Editorial Material							RISK HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; MEN; ACQUISITION; INFECTIONS; PREVENTION; PREVALENCE; TRIAL		[Giuliano, Anna R.; Nyitray, Alan G.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol & Genet, Tampa, FL 33612 USA; [Albero, Ginesa] Catalan Inst Oncol, IDIBELL, Barcelona, Spain; [Albero, Ginesa] CIBER Epidemiol & Salud Publ, Barcelona, Spain	H Lee Moffitt Cancer Center & Research Institute; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Giuliano, AR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol & Genet, Tampa, FL 33612 USA.	anna.giuliano@moffitt.org	Albero, Ginesa/G-7248-2015	Albero, Ginesa/0000-0002-9400-1914				Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bosch FX, 2009, J FAM PLAN REPROD H, V35, P5, DOI 10.1783/147118909787072270; BOYD JT, 1964, BRIT J CANCER, V18, P419, DOI 10.1038/bjc.1964.49; Braithwaite J., 1901, LANCET, V158, P1578, DOI [10.1016/S0140-6736(00)44674-X, DOI 10.1016/S0140-6736(00)44674-X]; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Centers for Disease Control and Prevention, 2010, TRENDS CIRC NEWB; Drain PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-172; Gray RH, 2010, J INFECT DIS, V201, P1455, DOI 10.1086/652184; Tobian AAR, 2010, ARCH PEDIAT ADOL MED, V164, P78, DOI 10.1001/archpediatrics.2009.232; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Wawer MJ, 2011, LANCET, V377, P209, DOI 10.1016/S0140-6736(10)61967-8; Xu F, 2007, SEX TRANSM DIS, V34, P479, DOI 10.1097/01.olq.0000253335.41841.04	12	6	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					183	184		10.1016/S0140-6736(10)62273-8	http://dx.doi.org/10.1016/S0140-6736(10)62273-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712WG	21216001				2022-12-28	WOS:000286696400005
J	Rasmussen, SGF; Choi, HJ; Fung, JJ; Pardon, E; Casarosa, P; Chae, PS; DeVree, BT; Rosenbaum, DM; Thian, FS; Kobilka, TS; Schnapp, A; Konetzki, I; Sunahara, RK; Gellman, SH; Pautsch, A; Steyaert, J; Weis, WI; Kobilka, BK				Rasmussen, Soren G. F.; Choi, Hee-Jung; Fung, Juan Jose; Pardon, Els; Casarosa, Paola; Chae, Pil Seok; DeVree, Brian T.; Rosenbaum, Daniel M.; Thian, Foon Sun; Kobilka, Tong Sun; Schnapp, Andreas; Konetzki, Ingo; Sunahara, Roger K.; Gellman, Samuel H.; Pautsch, Alexander; Steyaert, Jan; Weis, William I.; Kobilka, Brian K.			Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor	NATURE			English	Article							CRYSTAL-STRUCTURE; LIGAND-BINDING; PROTEIN; RHODOPSIN; CONFORMATIONS; ACTIVATION	G protein coupled receptors (GPCRs) exhibit a spectrum of functional behaviours in response to natural and synthetic ligands. Recent crystal structures provide insights into inactive states of several GPCRs. Efforts to obtain an agonist-bound active-state GPCR structure have proven difficult due to the inherent instability of this state in the absence of a G protein. We generated a camelid antibody fragment (nanobody) to the human beta(2) adrenergic receptor (beta(2)AR) that exhibits G protein-like behaviour, and obtained an agonist-bound, active-state crystal structure of the receptor-nanobody complex. Comparison with the inactive beta(2)AR structure reveals subtle changes in the binding pocket; however, these small changes are associated with an 11 angstrom outward movement of the cytoplasmic end of transmembrane segment 6, and rearrangements of transmembrane segments 5 and 7 that are remarkably similar to those observed in opsin, an active form of rhodopsin. This structure provides insights into the process of agonist binding and activation.	[Rasmussen, Soren G. F.; Choi, Hee-Jung; Fung, Juan Jose; Rosenbaum, Daniel M.; Thian, Foon Sun; Kobilka, Tong Sun; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Rasmussen, Soren G. F.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Choi, Hee-Jung; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, Vlaams Inst Biotechnol, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Casarosa, Paola; Schnapp, Andreas; Konetzki, Ingo; Pautsch, Alexander] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Chae, Pil Seok; Gellman, Samuel H.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [DeVree, Brian T.; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	Stanford University; University of Copenhagen; Stanford University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Boehringer Ingelheim; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	bill.weis@stanford.edu; kobilka@stanford.edu	DeVree, Brian T/F-6205-2011; Steyaert, Jan/H-4662-2011; steyaert, jan/GQP-7811-2022; Weis, William I/G-1437-2011; Sunahara, Roger/AAJ-8667-2020	Steyaert, Jan/0000-0002-3825-874X; Weis, William I/0000-0002-5583-6150; Choi, Hee-Jung/0000-0002-1167-1526; DeVree, Brian/0000-0003-0582-8125; Rasmussen, Soren/0000-0002-1853-1841; Kobilka, Brian/0000-0001-5958-3990; Pardon, Els/0000-0002-2466-0172	National Institutes of Health [NS028471, GM083118, GM56169, P01 GM75913, P60DK-20572]; Mathers Foundation; Lundbeck Foundation; University of Michigan; Fund for Scientific Research of Flanders (FWO-Vlaanderen); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169, P01GM075913, R01GM068603, R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Lundbeck Foundation(Lundbeckfonden); University of Michigan(University of Michigan System); Fund for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health Grants NS028471 and GM083118 (B. K. K.), GM56169 (W. I. W.), P01 GM75913 (S. H. G), and P60DK-20572 (R. K. S.), the Mathers Foundation (B. K. K. and W. I. W.), the Lundbeck Foundation (Junior Group Leader Fellowship, S. G. F. R.), the University of Michigan Biomedical Sciences Scholars Program (R. K. S.), the Fund for Scientific Research of Flanders (FWO-Vlaanderen) and the Institute for the encouragement of Scientific Research and Innovation of Brussels (ISRIB) (E.P. and J.S.).	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Pellissier LP, 2009, MOL PHARMACOL, V75, P982, DOI 10.1124/mol.108.053686; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	31	1247	1287	10	398	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					175	180		10.1038/nature09648	http://dx.doi.org/10.1038/nature09648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228869	Green Published, Green Accepted			2022-12-28	WOS:000286143400030
J	De Pontieu, B; McIntosh, SW; Carlsson, M; Hansteen, VH; Tarbell, TD; Boerner, P; Martinez-Sykora, J; Schrijver, CJ; Title, AM				De Pontieu, B.; McIntosh, S. W.; Carlsson, M.; Hansteen, V. H.; Tarbell, T. D.; Boerner, P.; Martinez-Sykora, J.; Schrijver, C. J.; Title, A. M.			The Origins of Hot Plasma in the Solar Corona	SCIENCE			English	Article							TRANSITION REGION; SPICULES; MISSION; MODEL	Sun's outer atmosphere, or corona, is heated to millions of degrees, considerably hotter than its surface or photosphere. Explanations for this enigma typically invoke the deposition in the corona of nonthermal energy generated by magnetoconvection. However, the coronal heating mechanism remains unknown. We used observations from the Solar Dynamics Observatory and the Hinode solar physics mission to reveal a ubiquitous coronal mass supply in which chromospheric plasma in fountainlike jets or spicules is accelerated upward into the corona, with much of the plasma heated to temperatures between similar to 0.02 and 0.1 million kelvin (MK) and a small but sufficient fraction to temperatures above 1 MK. These observations provide constraints on the coronal heating mechanism(s) and highlight the importance of the interface region between photosphere and corona.	[De Pontieu, B.; Hansteen, V. H.; Tarbell, T. D.; Boerner, P.; Martinez-Sykora, J.; Schrijver, C. J.; Title, A. M.] Org ADBS, Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA; [McIntosh, S. W.] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; [Carlsson, M.; Hansteen, V. H.; Martinez-Sykora, J.] Univ Oslo, Inst Theoret Astrophys, N-0315 Oslo, Norway	Lockheed Martin; National Center Atmospheric Research (NCAR) - USA; University of Oslo	De Pontieu, B (corresponding author), Org ADBS, Lockheed Martin Solar & Astrophys Lab, 3251 Hanover St,Bldg 252, Palo Alto, CA 94304 USA.	bdp@lmsal.com		Schrijver, Carolus/0000-0002-6010-8182	NASA [NNX08AL22G, NNX08BA99G, NNM07AA01C, NNG04EA00C]; Research Council of Norway; NSF; Div Atmospheric & Geospace Sciences [0925177] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); Research Council of Norway(Research Council of Norway); NSF(National Science Foundation (NSF)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is supported by NASA grants NNX08AL22G and NNX08BA99G (to B.D.P. and S.W.M.), NASA contracts NNM07AA01C (Hinode) and NNG04EA00C (AIA), and the Research Council of Norway (M.C. and V.H.H.). The National Center for Atmospheric Research is sponsored by NSF. Hinode is a Japanese mission developed by the Institute of Space and Astronautical Science/Japan Aerospace Exploration Agency, with the National Astronomical Observatory of Japan as domestic partner and NASA and Science and Technology Facilities Council (UK) as international partners. It is operated in cooperation with the European Space Agency and the Norwegian Space Centre (Norway).	Anzer U, 2005, ASTROPHYS J, V622, P714, DOI 10.1086/427817; Aschwanden MJ, 2007, ASTROPHYS J, V656, P577, DOI 10.1086/510232; ATHAY RG, 1982, ASTROPHYS J, V255, P743, DOI 10.1086/159873; Banerjee D, 2009, ASTRON ASTROPHYS, V499, pL29, DOI 10.1051/0004-6361/200912059; Culhane JL, 2007, SOL PHYS, V243, P19, DOI 10.1007/s01007-007-0293-1; De Pontieu B, 2007, PUBL ASTRON SOC JPN, V59, pS655, DOI 10.1093/pasj/59.sp3.S655; De Pontieu B, 2009, ASTROPHYS J LETT, V701, pL1, DOI 10.1088/0004-637X/701/1/L1; DERE KP, 1989, SOL PHYS, V123, P41, DOI 10.1007/BF00150011; Edlen B, 1942, Z ASTROPHYS, V22, P30; Gudiksen BV, 2005, ASTROPHYS J, V618, P1031, DOI 10.1086/426064; Hansteen VH, 2010, ASTROPHYS J, V718, P1070, DOI 10.1088/0004-637X/718/2/1070; Hara H, 2008, ASTROPHYS J LETT, V678, pL67, DOI 10.1086/588252; Klimchuk JA, 2006, SOL PHYS, V234, P41, DOI 10.1007/s11207-006-0055-z; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Langangen O, 2008, ASTROPHYS J LETT, V679, pL167, DOI 10.1086/589442; Mariska J. T., 1992, CAMBRIDGE ASTROPHYSI, V23; McIntosh SW, 2010, ASTRON ASTROPHYS, V510, DOI 10.1051/0004-6361/200913699; McIntosh SW, 2009, ASTROPHYS J, V707, P524, DOI 10.1088/0004-637X/707/1/524; PARKER EN, 1990, GEOPHYS ASTRO FLUID, V50, P229, DOI 10.1080/03091929008204106; Patsourakos S, 2006, ASTROPHYS J, V647, P1452, DOI 10.1086/505517; PNEUMAN GW, 1978, SOL PHYS, V57, P49, DOI 10.1007/BF00152043; Priest E. R, 1982, SOLAR MAGNETOHYDRODY; Priest ER, 2002, ASTROPHYS J, V576, P533, DOI 10.1086/341539; Rutten RJ, 2006, ASTR SOC P, V354, P276; Schrijver CJ, 2004, ASTROPHYS J, V615, P512, DOI 10.1086/424028; Sterling AC, 2000, SOL PHYS, V196, P79, DOI 10.1023/A:1005213923962; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; van der Voort LR, 2009, ASTROPHYS J, V705, P272, DOI 10.1088/0004-637X/705/1/272; WITHBROE GL, 1983, ASTROPHYS J, V267, P825, DOI 10.1086/160917	29	281	282	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					55	58		10.1126/science.1197738	http://dx.doi.org/10.1126/science.1197738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212351				2022-12-28	WOS:000285974000032
J	Durieux, J; Wolff, S; Dillin, A				Durieux, Jenni; Wolff, Suzanne; Dillin, Andrew			The Cell-Non-Autonomous Nature of Electron Transport Chain-Mediated Longevity	CELL			English	Article							ELEGANS LIFE-SPAN; GENE-EXPRESSION; ENDOCRINE REGULATION; OXIDATIVE STRESS; DROSOPHILA; IDENTIFICATION; REQUIREMENTS; DETERMINANT; MUTANTS; DAF-16	The life span of C. elegans can be increased via reduced function of the mitochondria; however, the extent to which mitochondrial alteration in a single, distinct tissue may influence aging in the whole organism remains unknown. We addressed this question by asking whether manipulations to ETC function can modulate aging in a cell-non-autonomous fashion. We report that the alteration of mitochondrial function in key tissues is essential for establishing and maintaining a prolongevity cue. We find that regulators of mitochondrial stress responses are essential and specific genetic requirements for the electron transport chain (ETC) longevity pathway. Strikingly, we find that mitochondrial perturbation in one tissue is perceived and acted upon by the mitochondrial stress response pathway in a distal tissue. These results suggest that mitochondria may establish and perpetuate the rate of aging for the whole organism independent of cell-autonomous functions.	[Durieux, Jenni; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, La Jolla, CA 92037 USA; [Wolff, Suzanne] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Scripps Research Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Wolff, Suzanne/A-2839-2012		NIA [R01 AG024365]; NIH; HHMI; NATIONAL INSTITUTE ON AGING [R01AG024365] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. W. Mair, S. Panowski, M. Raices, P. Douglas, and N. Baird for thoughtful editing and scientific insight. We thank Z. Liu for cloning and strain integration. We are grateful to Drs. C. Hunter, C. Haynes, D. Ron, and K. Shen for strains and reagents; and anonymous reviewers for their insight. This work was supported by NIA R01 AG024365, NIH Developmental Biology Training Grant, and HHMI. A.D. is cofounder of Proteostasis Therapeutics, Inc. and declares no financial interest related to this work.	AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Burglin TR, 2002, INT J DEV BIOL, V46, P115; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; COPELAND JM, 2009, CURRENT BIOL; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Gems David, 2008, P81, DOI 10.1007/978-1-59745-420-9_6; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jose AM, 2009, P NATL ACAD SCI USA, V106, P2283, DOI 10.1073/pnas.0809760106; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kirchman PA, 1999, GENETICS, V152, P179; LAPOINTE J, 2009, J BIOL CHEM, pM109; LARSEN PL, 1995, GENETICS, V139, P1567; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Liu XF, 2005, FASEB J, V19, pA1391; MADURO M, 1995, GENETICS, V141, P977; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; Nonet ML, 1997, J NEUROSCI, V17, P8061; OKKEMA PG, 1993, GENETICS, V135, P385; PEARL R, 2007, GENE, V400, P166; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubner M, 1908, PROBLEM LEBENSDAUER; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; VANRAAMSDONK JM, 2009, PLOS GENET, P5; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	54	682	694	5	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					79	91		10.1016/j.cell.2010.12.016	http://dx.doi.org/10.1016/j.cell.2010.12.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215371	Green Accepted, Bronze			2022-12-28	WOS:000285993600009
J	Kruta, I; Landman, N; Rouget, I; Cecca, F; Tafforeau, P				Kruta, Isabelle; Landman, Neil; Rouget, Isabelle; Cecca, Fabrizio; Tafforeau, Paul			The Role of Ammonites in the Mesozoic Marine Food Web Revealed by Jaw Preservation	SCIENCE			English	Article							ZOOPLANKTON; CEPHALOPODA; BEHAVIOR	Ammonites are prominent in macroevolutionary studies because of their abundance and diversity in the fossil record, but their paleobiology and position in the marine food web are not well understood due to the lack of preserved soft tissue. We present three-dimensional reconstructions of the buccal apparatus in the Mesozoic ammonite Baculites with the use of synchrotron x-ray microtomography. Buccal mass morphology, combined with the coexistence of food remains found in the buccal mass, suggests that these ammonites fed on plankton. This diet may have extended to all aptychophoran ammonites, which share the same buccal mass morphology. Understanding the role of these ammonites in the Mesozoic food web provides insights into their radiation in the Early Jurassic, as well as their extinction at the end of the Cretaceous/early Paleogene.	[Kruta, Isabelle] Museum Natl Hist Nat, Dept Hist Terre, CNRS, UMR 7207, F-75231 Paris 05, France; [Landman, Neil] Amer Museum Nat Hist, Dept Paleontol Invertebrates, New York, NY 10024 USA; [Rouget, Isabelle; Cecca, Fabrizio] Univ Paris 06, CNRS, UMR 7207, F-75252 Paris 05, France; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; American Museum of Natural History (AMNH); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; European Synchrotron Radiation Facility (ESRF)	Kruta, I (corresponding author), Museum Natl Hist Nat, Dept Hist Terre, CNRS, UMR 7207, 47 Rue Cuvier, F-75231 Paris 05, France.	kruta@mnhn.fr		Tafforeau, Paul/0000-0002-5962-1683	ESRF; UMR CNRS [7207]; Annette Kade Fellowship (AMNH)	ESRF; UMR CNRS(Centre National de la Recherche Scientifique (CNRS)); Annette Kade Fellowship (AMNH)	This work was supported by ESRF, UMR CNRS 7207, its 3D platform, and the Annette Kade Fellowship (AMNH). P. Janvier and C. Klug reviewed an earlier draft of the manuscript; A. Lethiers helped produce the figures and movie; N. Larson and K. Cochran helped in field work; and D. Defaye, N. Bruce, R. Feldmann, and K. Bandel helped in the identification of non-ammonite material. Data are available at the ESRF database http://paleo.esrf.eu.	ALLDREDGE AL, 1985, MAR BIOL, V84, P253, DOI 10.1007/BF00392494; Arkell W. J., 1957, MOLLUSCA, pL80; CASTRO JJ, 1995, SCI MAR, V59, P347; Cecca F, 1997, CR ACAD SCI II A, V325, P629, DOI 10.1016/S1251-8050(97)89465-7; Doguzhaeva Larisa A., 1992, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V223, P167; Engeser T, 2002, LETHAIA, V35, P79, DOI 10.1080/002411602317345894; Huber BT, 2002, GEOL SOC AM SPEC PAP, V356, P277; Jacobs D. K., 1996, AMMONOID PALEOBIOLOG, P169; JACOBS DK, 1993, LETHAIA, V26, P101, DOI 10.1111/j.1502-3931.1993.tb01799.x; Jager M, 1997, PALAEONTOLOGY, V40, P557; Kennedy William J., 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P113; Korn D, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P57, DOI 10.1007/978-1-4020-6806-5_3; Lalli C.M., 1989, PELAGIC SNAILS BIOL; Landman NH, 2007, CEPHALOPODS PRESENT AND PAST: NEW INSIGHTS AND FRESH PERSPECTIVES, P257, DOI 10.1007/978-1-4020-6806-5_13; Lehmann U., 1981, AMMONITES THEIR LIFE; Machalski M, 2005, B GEOL SOC DENMARK, V52, P97; MILLER AK, 1949, EVOLUTION, V3, P231, DOI 10.2307/2405560; NIXON M, 1995, J ZOOL, V236, P73, DOI 10.1111/j.1469-7998.1995.tb01785.x; Nixon M., 2003, BRAINS LIVES CEPHALO; Owen G., 1966, PHYSL MOLLUSCA, V2, P1; Rigby S, 2000, ANNU REV ECOL SYST, V31, P293, DOI 10.1146/annurev.ecolsys.31.1.293; Runham N. W., 1997, Scientia Marina, V61, P67; Tanabe Kazushige, 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P157; Tanabe Kazushige, 1999, P245; Thore S., 1949, Dana Reports, VNo. 33, P1; Ward P. D., 1987, NATURAL HIST NAUTILU; Westermann GEG, 1996, AMMONOID PALEOBIOLOG, P607; Wright C. W., 1996, TREATISE INVERTEBR L, P1	28	118	124	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					70	72		10.1126/science.1198793	http://dx.doi.org/10.1126/science.1198793			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212354				2022-12-28	WOS:000285974000037
J	Miller, AL; Schissel, S; Levy, BD; Loscalzo, J				Miller, Amy Leigh; Schissel, Scott; Levy, Bruce D.; Loscalzo, Joseph			A Crazy Cause of Dyspnea.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY ALVEOLAR PROTEINOSIS	An 18-year-old black woman with a history of asthma presented with fever, ear pain, and dull discomfort on the right side of her chest that was unchanged with movement or inspiration. She had no other symptoms and had been well until the morning of presentation. On examination, her temperature was 38.8 degrees C, and her right tympanic membrane was inflamed. Although the lungs were clear on auscultation, radiography revealed air-space opacities in both lower lobes. Azithromycin was prescribed. Her symptoms resolved within 24 hours, and repeat radiography performed 1 week later showed that the opacities, although still present, had diminished.	[Levy, Bruce D.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Dept Med, Harvard Inst Med Bldg,Ave Pasteur HIM855, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021					Frazier AA, 2008, RADIOGRAPHICS, V28, P883, DOI 10.1148/rg.283075219; Ioachimescu O C, 2006, Chron Respir Dis, V3, P149, DOI 10.1191/1479972306cd101rs; Irwin RS, 2006, CHEST, V129, P1, DOI 10.1378/chest.129.1.1; Parker LA, 1997, CHEST, V111, P1457, DOI 10.1378/chest.111.5.1457; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Suzuki T, 2008, J EXP MED, V205, P2703, DOI 10.1084/jem.20080990; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Uchida K, 2007, NEW ENGL J MED, V356, P567, DOI 10.1056/NEJMoa062505; Venkateshiah SB, 2006, CHEST, V130, P227, DOI 10.1378/chest.130.1.227	9	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					72	77		10.1056/NEJMcps0901689	http://dx.doi.org/10.1056/NEJMcps0901689			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UY	21208111				2022-12-28	WOS:000285922600014
J	Bhutta, ZA; Soofi, S; Cousens, S; Mohammad, S; Memon, ZA; Ali, I; Feroze, A; Raza, F; Khan, A; Wall, S; Martines, J				Bhutta, Zulfiqar A.; Soofi, Sajid; Cousens, Simon; Mohammad, Shah; Memon, Zahid A.; Ali, Imran; Feroze, Asher; Raza, Farrukh; Khan, Amanullah; Wall, Steve; Martines, Jose			Improvement of perinatal and newborn care in rural Pakistan through community-based strategies: a cluster-randomised effectiveness trial	LANCET			English	Article							NEONATAL DEATHS; DEVELOPING-COUNTRIES; MORTALITY; INDIA; INTERVENTIONS; STILLBIRTHS; MANAGEMENT; PROGRAM; IMPACT	Background Newborn deaths account for 57% of deaths in children younger than 5 years in Pakistan. Although a large programme of trained lady health workers (LHWs) exists, the effectiveness of this training on newborn outcomes has not been studied. We aimed to evaluate the effectiveness of a community-based intervention package, principally delivered through LHWs working with traditional birth attendants and community health committees, for reduction of perinatal and neonatal mortality in a rural district of Pakistan. Methods We undertook a cluster randomised trial between February, 2006, and March, 2008, in Hala and Matiari subdistricts, Pakistan. Catchment areas of primary care facilities and all affiliated LHWs were used to define clusters, which were allocated to intervention and control groups by restricted, stratified randomisation. The intervention package delivered by LHWs through group sessions consisted of promotion of antenatal care and maternal health education, use of clean delivery kits, facility births, immediate newborn care, identification of danger signs, and promotion of careseeking; control clusters received routine care. Independent data collectors undertook quarterly household surveillance to capture data for births, deaths, and household practices related to maternal and newborn care. Data collectors were masked to cluster allocation; those analysing data were not. The primary outcome was perinatal and all-cause neonatal mortality. Analysis was by intention to treat. This trial is registered, ISRCTN16247511. Findings 16 clusters were assigned to intervention (23 353 households, 12 391 total births) and control groups (23 768 households, 11 443 total births). LHWs in the intervention clusters were able to undertake 4428 (63%) of 7084 planned group sessions, but were only able to visit 2943 neonates (24%) of a total 12 028 livebirths in their catchment villages. Stillbirths were reduced in intervention clusters (39.1 stillbirths per 1000 total births) compared with control (48.7 per 1000; risk ratio [RR] 0.79, 95% CI 0.68-0.92; p=0.006). The neonatal mortality rate was 43.0 deaths per 1000 livebirths in intervention clusters compared with 49.1 per 1000 in control groups (RR 0.85, 0.76-0.96; p=0.02). Interpretation Our results support the scale-up of preventive and promotive maternal and newborn interventions through community health workers and emphasise the need for attention to issues of programme management and coverage for such initiatives to achieve maximum potential.	[Bhutta, Zulfiqar A.; Soofi, Sajid; Mohammad, Shah; Memon, Zahid A.; Ali, Imran; Feroze, Asher; Raza, Farrukh] Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan; [Cousens, Simon] London Sch Hyg & Trop Med, London WC1, England; [Khan, Amanullah; Wall, Steve] Save Children USA, Saving Newborn Lives, Washington, DC USA; [Martines, Jose] WHO, Dept Child & Adolescent Hlth, CH-1211 Geneva, Switzerland	Aga Khan University; University of London; London School of Hygiene & Tropical Medicine; Save the Children; World Health Organization	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu	Memon, Zahid Ali/GRE-8118-2022	Memon, Zahid Ali/0000-0002-5321-8885	WHO; Bill & Melinda Gates Foundation	WHO(World Health Organization); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The Hala trial was funded by grants from WHO and the Saving Newborn Lives programme funded by the Bill & Melinda Gates Foundation. We thank Department of Health, Sindh Government, and the National Program for Family Planning and Primary Health Care for their encouragement and support towards undertaking this trial, all staff of the Hala project office for their hard work and support, and notably, the excellent support provided by Usman Chachar, the district coordinating officer, and Hasan Murad Shah, the executive district officer for health for Matiari district.	[Anonymous], NAT PROGR FAM PLANN; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2006, Bull World Health Organ, V84, P706, DOI 10.2471/BLT.05.026443; Baqui AH, 2008, HEALTH POLICY PLANN, V23, P234, DOI 10.1093/heapol/czn012; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2004, MATERNAL CHILD HLTH, V1st; Bhutta ZA, 2008, PAKISTAN DEMOGRAPHIC; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bhutta ZA, 2010, LANCET, V375, P1142, DOI 10.1016/S0140-6736(10)60324-8; Carlo WA, 2010, NEW ENGL J MED, V362, P614, DOI 10.1056/NEJMsa0806033; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Douthwaite M, 2005, HEALTH POLICY PLANN, V20, P117, DOI 10.1093/heapol/czi014; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Haq Zaeem, 2008, Int J Ment Health Syst, V2, P15, DOI 10.1186/1752-4458-2-15; Hayes RJ, 2009, INTERD STAT, P3; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Jafarey S N, 1981, J Pak Med Assoc, V31, P288; Kalter HD, 2008, PAEDIATR PERINAT EP, V22, P321, DOI 10.1111/j.1365-3016.2008.00943.x; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lassi ZS, 2010, COMMUNITY BASED INTE; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lewin S, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004015.PUB3; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Mavalankar D, 2009, INT J GYNECOL OBSTET, V107, P271, DOI 10.1016/j.ijgo.2009.09.008; Midhet F, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-30; Moulton Lawrence H, 2004, Clin Trials, V1, P297, DOI 10.1191/1740774504cn024oa; Oxford Policy Management, 2003, EV PRIM MIN LAD HLTH; Oxford Policy Management, 2009, EXT EV LAD HLTH WORK; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; Tugwell P, 2006, BMJ-BRIT MED J, V332, P358, DOI 10.1136/bmj.332.7537.358; World Health Organization, 2003, STAND NEON VERB AUT	39	185	188	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2011	377	9763					403	412		10.1016/S0140-6736(10)62274-X	http://dx.doi.org/10.1016/S0140-6736(10)62274-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721ES	21239052	Green Accepted			2022-12-28	WOS:000287337000030
J	Petherick, A				Petherick, Anna			Mother's milk: A rich opportunity	NATURE			English	Editorial Material							LARGE RANDOMIZED-TRIAL											Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Chapkin RS, 2010, AM J PHYSIOL-GASTR L, V298, pG582, DOI 10.1152/ajpgi.00004.2010; Koletzko B, 2009, ADV EXP MED BIOL, V646, P15, DOI 10.1007/978-1-4020-9173-5_2; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; KRAMER MS, 2007, BRIT MED J; LEFEVRE CM, 2010, GENOMICS HUMAN GENET, V11, P219; Powe CE, 2010, AM J HUM BIOL, V22, P50, DOI 10.1002/ajhb.20941; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sullivan EC, 2011, DEV PSYCHOBIOL, V53, P96, DOI 10.1002/dev.20483; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05	11	63	70	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S5	S7		10.1038/468S5a	http://dx.doi.org/10.1038/468S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179083	Bronze			2022-12-28	WOS:000285553800002
J	Sillanpaa, M; Shinnar, S				Sillanpaa, Matti; Shinnar, Shlomo			Long-Term Mortality in Childhood-Onset Epilepsy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUDDEN UNEXPECTED DEATH; UNEXPLAINED DEATH; RISK-FACTORS; CHILDREN; SEIZURE; PROGNOSIS; COHORT; TERMINOLOGY; DUTCH	Background: There are few studies on long-term mortality in prospectively followed, well-characterized cohorts of children with epilepsy. We report on long-term mortality in a Finnish cohort of subjects with a diagnosis of epilepsy in childhood. Methods: We assessed seizure outcomes and mortality in a population-based cohort of 245 children with a diagnosis of epilepsy in 1964; this cohort was prospectively followed for 40 years. Rates of sudden, unexplained death were estimated. The very high autopsy rate in the cohort allowed for a specific diagnosis in almost all subjects. Results: Sixty subjects died (24%); this rate is three times as high as the expected age- and sex-adjusted mortality in the general population. The subjects who died included 51 of 107 subjects (48%) who were not in 5-year terminal remission (i.e., greater/equal 5 years seizure-free at the time of death or last follow-up). A remote symptomatic cause of epilepsy (i.e., a major neurologic impairment or insult) was also associated with an increased risk of death as compared with an idiopathic or cryptogenic cause (37% vs. 12%, P<0.001). Of the 60 deaths, 33 (55%) were related to epilepsy, including sudden, unexplained death in 18 subjects (30%), definite or probable seizure in 9 (15%), and accidental drowning in 6 (10%). The deaths that were not related to epilepsy occurred primarily in subjects with remote symptomatic epilepsy. The cumulative risk of sudden, unexplained death was 7% at 40 years overall and 12% in an analysis that was limited to subjects who were not in long-term remission and not receiving medication. Among subjects with idiopathic or cryptogenic epilepsy, there were no sudden, unexplained deaths in subjects younger than 14 years of age. Conclusions: Childhood-onset epilepsy was associated with a substantial risk of epilepsy-related death, including sudden, unexplained death. The risk was especially high among children who were not in remission. (Funded by the Finnish Epilepsy Research Foundation.) N Engl J Med 2010;363:2522-9.	[Shinnar, Shlomo] Albert Einstein Coll Med, Montefiore Med Ctr, Comprehens Epilepsy Management Ctr, Bronx, NY 10467 USA; [Sillanpaa, Matti] Univ Turku, Dept Pediat Neurol, Turku, Finland; [Sillanpaa, Matti] Univ Turku, Dept Publ Hlth, Turku, Finland; [Sillanpaa, Matti] Turku Univ Hosp, FIN-20520 Turku, Finland; [Shinnar, Shlomo] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Neurol Pediat & Epidemiol, Bronx, NY 10467 USA; [Shinnar, Shlomo] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Populat Hlth, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Turku; University of Turku; University of Turku; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Shinnar, S (corresponding author), Albert Einstein Coll Med, Montefiore Med Ctr, Comprehens Epilepsy Management Ctr, 111 E 210th St, Bronx, NY 10467 USA.	sshinnar@montefiore.org	Sillanpaa, Matti L/G-4708-2015	Sillanpaa, Matti L/0000-0003-4190-3698; Sillanpaa, Matti/0000-0002-1521-3602	Finnish Epilepsy Research Foundation	Finnish Epilepsy Research Foundation	Supported by a grant from the Finnish Epilepsy Research Foundation.	Annegers JF, 1997, EPILEPSIA, V38, pS9, DOI 10.1111/j.1528-1157.1997.tb06137.x; [Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berg AT, 2004, ARCH PEDIAT ADOL MED, V158, P1147, DOI 10.1001/archpedi.158.12.1147; BRORSON LO, 1987, EPILEPSIA, V28, P324, DOI 10.1111/j.1528-1157.1987.tb03651.x; Callenbach PMC, 2001, PEDIATRICS, V107, P1259, DOI 10.1542/peds.107.6.1259; Camfield CS, 2002, LANCET, V359, P1891, DOI 10.1016/S0140-6736(02)08779-2; Central Statistical Office of Finland, 2003, STAT YB FINL; Cockerell OC, 1997, EPILEPSIA, V38, P31, DOI 10.1111/j.1528-1157.1997.tb01075.x; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; COX DR, 1972, J R STAT SOC B, V34, P187; Derby LE, 1996, EPILEPSIA, V37, P931, DOI 10.1111/j.1528-1157.1996.tb00529.x; Donner EJ, 2001, NEUROLOGY, V57, P430, DOI 10.1212/WNL.57.3.430; Elandt-Johnson RC, 1980, SURVIVAL MODELS DATA, P150; Ficker DM, 1998, NEUROLOGY, V51, P1270, DOI 10.1212/WNL.51.5.1270; Fleiss J, 2003, STAT METHODS RATES P, P638; Foreman AJ, 2003, SAS STAT USERS GUIDE; HAUSER WA, 1980, EPILEPSIA, V21, P399, DOI 10.1111/j.1528-1157.1980.tb04088.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LEESTMA JE, 1989, ANN NEUROL, V26, P195, DOI 10.1002/ana.410260203; Lhatoo SD, 2001, ANN NEUROL, V49, P336; NASHEF L, 1995, EPILEPSIA, V36, P1187, DOI 10.1111/j.1528-1157.1995.tb01061.x; Nashef L, 1997, EPILEPSIA, V38, pS6, DOI 10.1111/j.1528-1157.1997.tb06130.x; Nilsson L, 1999, LANCET, V353, P888, DOI 10.1016/S0140-6736(98)05114-9; Shackleton DP, 1999, J NEUROL NEUROSUR PS, V66, P636, DOI 10.1136/jnnp.66.5.636; Shinnar S, 2005, NEUROLOGY, V64, P880, DOI 10.1212/01.WNL.0000152893.72146.92; Sillanpaa M, 1999, PEDIATR NEUROL, V21, P533, DOI 10.1016/S0887-8994(99)00031-4; Sillanpaa M, 2002, ANN NEUROL, V52, P303, DOI 10.1002/ana.10286; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Sperling MR, 1999, ANN NEUROL, V46, P45, DOI 10.1002/1531-8249(199907)46:1<45::AID-ANA8>3.0.CO;2-I; TENNIS P, 1995, EPILEPSIA, V36, P29, DOI 10.1111/j.1528-1157.1995.tb01661.x; Tomson T, 2005, EPILEPSIA, V46, P54, DOI 10.1111/j.1528-1167.2005.00411.x; Walczak TS, 2001, NEUROLOGY, V56, P519, DOI 10.1212/WNL.56.4.519; ZIELINSKI JJ, 1974, EPILEPSIA, V15, P191, DOI 10.1111/j.1528-1157.1974.tb04941.x	36	250	255	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2522	2529		10.1056/NEJMoa0911610	http://dx.doi.org/10.1056/NEJMoa0911610			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697YL	21175314				2022-12-28	WOS:000285555600007
J	Taelman, VF; Dobrowolski, R; Plouhinec, JL; Fuentealba, LC; Vorwald, PP; Gumper, I; Sabatini, DD; De Robertis, EM				Taelman, Vincent F.; Dobrowolski, Radoslaw; Plouhinec, Jean-Louis; Fuentealba, Luis C.; Vorwald, Peggy P.; Gumper, Iwona; Sabatini, David D.; De Robertis, Edward M.			Wnt Signaling Requires Sequestration of Glycogen Synthase Kinase 3 inside Multivesicular Endosomes	CELL			English	Article							ENDOCYTIC TRAFFICKING; DESTRUCTION COMPLEX; BODY BIOGENESIS; RECEPTOR; LRP6; WINGLESS; INTERNALIZATION; MECHANISM; PATHWAY; TARGETS	Canonical Wnt signaling requires inhibition of Glycogen Synthase Kinase 3 (GSK3) activity, but the molecular mechanism by which this is achieved remains unclear. Here, we report that Wnt signaling triggers the sequestration of GSK3 from the cytosol into multivesicular bodies (MVBs), so that this enzyme becomes separated from its many cytosolic substrates. Endocytosed Wnt colocalized with GSK3 in acidic vesicles positive for endosomal markers. After Wnt addition, endogenous GSK3 activity decreased in the cytosol, and GSK3 became protected from protease treatment inside membrane-bounded organelles. Cryoimmunoelectron microscopy showed that these corresponded to MVBs. Two proteins essential for MVB formation, HRS/Vps27 and Vps4, were required for Wnt signaling. The sequestration of GSK3 extended the half-life of many other proteins in addition to beta-Catenin, including an artificial Wnt-regulated reporter protein containing GSK3 phosphorylation sites. We conclude that multivesicular endosomes are essential components of the Wnt signal-transduction pathway.	[Taelman, Vincent F.; Dobrowolski, Radoslaw; Plouhinec, Jean-Louis; Fuentealba, Luis C.; Vorwald, Peggy P.; De Robertis, Edward M.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Taelman, Vincent F.; Dobrowolski, Radoslaw; Plouhinec, Jean-Louis; Fuentealba, Luis C.; Vorwald, Peggy P.; De Robertis, Edward M.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Gumper, Iwona; Sabatini, David D.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New York University	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ederobertis@mednet.ucla.edu		Dobrowolski, Radek/0000-0002-1805-5806; De Robertis, Edward/0000-0002-7843-1869	Deutsche Forschungsgemeinschaft [DO1429/1-1]; NIH [HD21502-24]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502, R01HD021502] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Drs. R. Moon for beta-Catenin-GFP and SuperTopFlash reporter, X. He for CA-LRP6, B. van Deurs for dog Rab7-GFP, S. Sokol for Myc-xDvl, M. Bienz for DIX > Ctail-GFP, M. Taira for xWnt8-Venus, P. Woodman for Vps4-EQ-GFP, R. Pagano for Rab5-DsRed-WT, P. De Camilli for DN-Dynamin-GFP, H. Stenmark for FYVE-GFP, H. Clevers for DN-xTcf3, O. Wessely for beta-Catenin-DN-xTcf3, P. Lemaire for Siamois, and R. Nusse for Wnt3a-producing L cells. We thank three anonymous referees and members of our laboratories for improving the manuscript, H. Snitkin for her help in processing cultured cells for electron microscopy, U. Lendahl for suggesting the HRS depletion experiments, the Deutsche Forschungsgemeinschaft for supporting R. D. (DO1429/1-1), and the NIH (HD21502-24) for funding. E. M. D. R. is an Investigator of the Howard Hughes Medical Institute.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; DUNN LA, 1983, J BIOL CHEM, V258, P4989; Falguieres T, 2009, EXP CELL RES, V315, P1567, DOI 10.1016/j.yexcr.2008.12.006; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MCKANNA JA, 1979, P NATL ACAD SCI USA, V76, P5689, DOI 10.1073/pnas.76.11.5689; Metcalfe C, 2010, J CELL SCI, V123, P1588, DOI 10.1242/jcs.067546; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Ryves WJ, 1998, ANAL BIOCHEM, V264, P124, DOI 10.1006/abio.1998.2832; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	42	497	504	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1136	1148		10.1016/j.cell.2010.11.034	http://dx.doi.org/10.1016/j.cell.2010.11.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183076	Bronze, Green Accepted			2022-12-28	WOS:000285625400011
J	Relman, AS				Relman, Arnold S.			Could Physicians Take the Lead in Health Reform?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Relman, AS (corresponding author), Brigham & Womens Hosp, Dept Med, 181 Longwood Ave, Boston, MA 02115 USA.	arelman@rics.bwh.harvard.edu						ENTHOVEN A, 2004, 21 CENTURY HLTH SYST; Oberlander J, 2010, NEW YORK REV BOOKS, V57, P61; Relman AS, 2009, NEW ENGL J MED, V361, P1225, DOI 10.1056/NEJMp0907925; Relman AS, 2010, 2 OPINION RESCUING A; Tollen L., 2008, PHYS ORG RELATION QU; Weeks WB, 2010, HEALTH AFFAIR, V29, P991, DOI 10.1377/hlthaff.2009.0388	6	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2740	2741		10.1001/jama.2010.1872	http://dx.doi.org/10.1001/jama.2010.1872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177510				2022-12-28	WOS:000285518000020
J	McLernon, DJ; Harrild, K; Bergh, C; Davies, MJ; de Neubourg, D; Dumoulin, JCM; Gerris, J; Kremer, JAM; Martikainen, H; Mol, BW; Norman, RJ; Thurin-Kjellberg, A; Tiitinen, A; van Montfoort, APA; van Peperstraten, AM; Van Royen, E; Bhattacharya, S				McLernon, D. J.; Harrild, K.; Bergh, C.; Davies, M. J.; de Neubourg, D.; Dumoulin, J. C. M.; Gerris, J.; Kremer, J. A. M.; Martikainen, H.; Mol, B. W.; Norman, R. J.; Thurin-Kjellberg, A.; Tiitinen, A.; van Montfoort, A. P. A.; van Peperstraten, A. M.; Van Royen, E.; Bhattacharya, S.			Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IN-VITRO FERTILIZATION; BLASTOCYST TRANSFER; CLEAVAGE STAGE; MULTIPLE BIRTH; LIVE BIRTH; PREGNANCY; IVF; GESTATION; IMPACT; RATES	Objective To compare the effectiveness of elective single embryo transfer versus double embryo transfer on the outcomes of live birth, multiple live birth, miscarriage, preterm birth, term singleton birth, and low birth weight after fresh embryo transfer, and on the outcomes of cumulative live birth and multiple live birth after fresh and frozen embryo transfers. Design One stage meta-analysis of individual patient data. Data sources A systematic review of English and non-English articles from Medline, Embase, and the Cochrane Central Register of Controlled Trials (up to 2008). Additional studies were identified by contact with clinical experts and searches of bibliographies of all relevant primary articles. Search terms included embryo transfer, randomised controlled trial, controlled clinical trial, single embryo transfer, and double embryo transfer. Review methods Comparisons of the clinical effectiveness of cleavage stage (day 2 or 3) elective single versus double embryo transfer after fresh or frozen in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) treatments were included. Trials were included if the intervention differed only in terms of the intended number of embryos to be transferred. Trials that involved only blastocyst (day five) transfers were excluded. Results Individual patient data were received for every patient recruited to all eight eligible trials (n=1367). A total of 683 and 684 women randomised to the single and double embryo transfer arms, respectively, were included in the analysis. Baseline characteristics in the two groups were comparable. The overall live birth rate in a fresh IVF cycle was lower after single (181/683, 27%) than double embryo transfer (285/683, 42%) (adjusted odds ratio 0.50, 95% confidence interval 0.39 to 0.63), as was the multiple birth rate (3/181 (2%) v 84/285 (29%)) (0.04, 0.01 to 0.12). An additional frozen single embryo transfer, however, resulted in a cumulative live birth rate not significantly lower than the rate after one fresh double embryo transfer (132/350 (38%) v 149/353 (42%) (0.85, 0.62 to 1.15), with a minimal cumulative risk of multiple birth (1/132 (1%) v 47/149 (32%)). The odds of a term singleton birth (that is, over 37 weeks) after elective single embryo transfer was almost five times higher than the odds after double embryo transfer (4.93, 2.98 to 8.18). Conclusions Elective single embryo transfer results in a higher chance of delivering a term singleton live birth compared with double embryo transfer. Although this strategy yields a lower pregnancy rate than a double embryo transfer in a fresh IVF cycle, this difference is almost completely overcome by an additional frozen single embryo transfer cycle. The multiple pregnancy rate after elective single embryo transfer is comparable with that observed in spontaneous pregnancies.	[McLernon, D. J.; Harrild, K.] Univ Aberdeen, Sect Populat Hlth, Med Stat Team, Aberdeen AB25 2ZD, Scotland; [Bergh, C.; Thurin-Kjellberg, A.] Sahlgrens Univ Hosp, Inst Clin Sci, Dept Obstet & Gynaecol, Gothenburg, Sweden; [Davies, M. J.] Univ Adelaide, Discipline Obstet & Gynaecol, Robinson Inst, Adelaide, SA 5005, Australia; [de Neubourg, D.; Van Royen, E.] ZNA Middelheim Hosp, Ctr Reprod Med, Antwerp, Belgium; [Gerris, J.] Ghent Univ Hosp, Dept Obstet & Gynaecol, Ctr Reprod Med, Sector Man Women & Child, B-9000 Ghent, Belgium; [Kremer, J. A. M.; van Peperstraten, A. M.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Martikainen, H.] Univ Oulu, Dept Obstet & Gynaecol, Div Reprod Endocrinol & Infertil, Oulu, Finland; [Mol, B. W.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Tiitinen, A.] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; [Dumoulin, J. C. M.; van Montfoort, A. P. A.] Maastricht Univ, Med Ctr, Dept Obstet & Gynaecol, IVF Lab, Maastricht, Netherlands; [Bhattacharya, S.] Univ Aberdeen, Aberdeen Matern Hosp, Sch Med & Dent, Div Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; Sahlgrenska University Hospital; Robinson Research Institute; University of Adelaide; ZNA Middelheim Hospital; Ghent University; Ghent University Hospital; Radboud University Nijmegen; University of Oulu; University of Amsterdam; Academic Medical Center Amsterdam; University of Helsinki; Helsinki University Central Hospital; Maastricht University; University of Aberdeen	McLernon, DJ (corresponding author), Univ Aberdeen, Sect Populat Hlth, Med Stat Team, Aberdeen AB25 2ZD, Scotland.	d.mclernon@abdn.ac.uk	Davies, Michael John/Y-3542-2018; Mol, Ben/I-4526-2012; Norman, Robert J/A-1155-2007; McLernon, David/D-5167-2012; Davies, Michael/GWV-2527-2022; Gundavarapu, Venkata Nagesh Kumar/H-5111-2016; De Neubourg, Diane/D-8159-2016; Kremer, J.A.M./H-8063-2014	Davies, Michael John/0000-0003-1526-0801; Norman, Robert J/0000-0002-3118-3896; McLernon, David/0000-0001-8905-2429; Gundavarapu, Venkata Nagesh Kumar/0000-0002-9298-7708; De Neubourg, Diane/0000-0002-9159-5083; Kremer, J.A.M./0000-0002-0495-0201; Bhattacharya, Siladitya/0000-0002-4588-356X	Wellcome Trust; National Health and Medical Research Council; Schering-Plough	Wellcome Trust(Wellcome Trust); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Schering-Plough(Merck & CompanySchering Plough Corporation)	This review was funded by the Wellcome Trust (Research Leave award for SB). The study funder did not participate in study design; in the collection, analysis or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. All researchers were independent from the funder.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work apart from the funding from the Wellcome Trust (mentioned above); MJD received a research grant from the National Health and Medical Research Council, DdeN is secretary of the VWRG (Reproductive Medicine subgroup of the Flemish Gynaecological society) and received travel and accommodation sponsored by Schering-Plough for the 6th world congress on ovulation induction; with the exception of DJM, KH, BWM, and AMvanP, all authors were involved in the conduct of the primary randomised trials included in this systematic review.	Bergh C, 2005, HUM REPROD, V20, P323, DOI 10.1093/humrep/deh744; Bhattacharya S, 2006, EFFICACY COST EFFECT; Blake DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002118.pub3; Borenstein M., 2009, INTRO METAANALYSIS; de Mouzon J, 2010, HUM REPROD, V25, P1851, DOI 10.1093/humrep/deq124; El-Toukhy T, 2006, AM J OBSTET GYNECOL, V194, P322, DOI 10.1016/j.ajog.2005.05.018; Gardner DK, 2004, FERTIL STERIL, V81, P551, DOI 10.1016/j.fertnstert.2003.07.023; Gelbaya TA, 2010, FERTIL STERIL, V94, P936, DOI 10.1016/j.fertnstert.2009.04.003; Gerris J, 1999, HUM REPROD, V14, P2581, DOI 10.1093/humrep/14.10.2581; Gerris JMR, 2005, HUM REPROD UPDATE, V11, P105, DOI 10.1093/humupd/dmh049; Heijnen EMEW, 2007, LANCET, V369, P743, DOI 10.1016/S0140-6736(07)60360-2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holte J, 2007, HUM REPROD, V22, P548, DOI 10.1093/humrep/del403; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Human Fertility and Embryology Authority, 2009, MULT BIRTHS SINGL EM; Kallen B, 2010, FERTIL STERIL, V94, P1680, DOI 10.1016/j.fertnstert.2009.12.027; Karlstrom PO, 2007, HUM REPROD, V22, P2202, DOI 10.1093/humrep/dem120; Kjellberg AT, 2006, HUM REPROD, V21, P210, DOI 10.1093/humrep/dei298; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lukassen HGM, 2005, HUM REPROD, V20, P702, DOI 10.1093/humrep/deh672; Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maheshwari A, 2010, HUM REPROD UPDA 0715; Martikainen H, 2001, HUM REPROD, V16, P1900, DOI 10.1093/humrep/16.9.1900; Min JK, 2004, HUM REPROD, V19, P3, DOI 10.1093/humrep/deh028; Min JK, 2008, INT J GYNECOL OBSTET, V102, P203, DOI DOI 10.1016/J.IJGO.2008.01.007; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moustafa MK, 2008, REPROD BIOMED ONLINE, V17, P82, DOI 10.1016/S1472-6483(10)60297-0; Murray S, 2004, HUM REPROD, V19, P911, DOI 10.1093/humrep/deh176; Pandian Z., 2009, COCHRANE DB SYST REV, V2; Papanikolaou EG, 2006, REPROD BIOMED ONLINE, V12, P60, DOI 10.1016/S1472-6483(10)60981-9; Porter M, 2005, HUM REPROD, V20, P2523, DOI 10.1093/humrep/dei094; Roberts SA, 2009, HUM REPROD, V24, P122, DOI 10.1093/humrep/den355; Ryan GL, 2007, FERTIL STERIL, V88, P354, DOI 10.1016/j.fertnstert.2007.03.001; Ryan GL, 2004, FERTIL STERIL, V81, P500, DOI 10.1016/j.fertnstert.2003.05.035; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Templeton A, 2000, HUM REPROD, V15, P1662, DOI 10.1093/humrep/15.8.1662; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032; Thurin A, 2005, THESIS GOTHENBURG U; van Montfoort APA, 2006, HUM REPROD, V21, P338, DOI 10.1093/humrep/dei359; Van Royen E, 2001, HUM REPROD, V16, P326, DOI 10.1093/humrep/16.2.326; Veleva Z, 2009, HUM REPROD, V24, P1632, DOI 10.1093/humrep/dep042; Vilska S, 1999, HUM REPROD, V14, P2392, DOI 10.1093/humrep/14.9.2392	45	206	220	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2010	341								c6945	10.1136/bmj.c6945	http://dx.doi.org/10.1136/bmj.c6945			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700DV	21177530	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000285716600005
J	Brown, MJ; McInnes, GT; Papst, CC; Zhang, J; MacDonald, TM				Brown, Morris J.; McInnes, Gordon T.; Papst, Cheraz Cherif; Zhang, Jack; MacDonald, Thomas M.			Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial	LANCET			English	Article							BLOOD-PRESSURE; DOUBLE-BLIND; CARDIOVASCULAR EVENTS; ANKLE EDEMA; RENIN; MONOTHERAPY; VALSARTAN; EFFICACY; METAANALYSIS; MULTICENTER	Background Short-term studies have suggested that the use of initial combination therapy for the control of blood pressure improves early effectiveness. We tested whether a combination of aliskiren and amlodipine is superior to each monotherapy in early control of blood pressure without excess of adverse events, and if initial control by monotherapy impairs subsequent control by combination therapy. Methods: We did a double-blind, randomised, parallel-group, superiority trial at 146 primary and secondary care sites in ten countries, with enrolment from Nov 28, 2008, to July 15, 2009. Patients eligible for enrolment had essential hypertension, were aged 18 years or older, and had systolic blood pressure between 150 and 180 mm Hg. Patients were randomly assigned (1:1:2) to treatment with 150 mg aliskiren plus placebo, 5 mg amlodipine plus placebo, or 150 mg aliskiren plus 5 mg amlodipine. Random assignment was through a central interactive voice response system and treatment allocation was masked from the patients. From 16-32 weeks, all patients received combination therapy with 300 mg aliskiren plus 10 mg amlodipine. Our primary endpoints, assessed on an intention-to-treat basis (ie, in patients who received the allocated treatment), were the adjusted mean reduction in systolic blood pressure from baseline over 8 to 24 weeks, and then the final reduction at 24 weeks. This trial is registered with ClinicalTrials.gov, number NCT00797862. Findings 318 patients were randomly assigned to aliskiren, 316 to amlodipine, and 620 to aliskiren plus amlodipine. 315 patients initially allocated to aliskiren, 315 allocated to amlodipine, and 617 allocated to aliskiren plus amlodipine were available for analysis. Patients given initial combination therapy had a 6.5 mm Hg (95% CI 5.3 to 7.7) greater reduction in mean systolic blood pressure than the monotherapy groups (p<0.0001). At 24 weeks, when all patients were on combination treatment, the difference was 1.4 mm Hg (95% CI 0-05 to 2.9; p=0.059). Adverse events caused withdrawal of 85 patients (14%) from the initial aliskiren plus amlodipine group, 45 (14%) from the aliskiren group, and 58 (18%) from the amlodipine group. Adverse events were peripheral oedema, hypotension, or orthostatic hypotension. Interpretation We believe that routine initial reduction in blood pressure (>150 mm Hg) with a combination such as aliskiren plus amlodipine can be recommended.	[Brown, Morris J.] Univ Cambridge, Dept Med, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Brown, Morris J.; McInnes, Gordon T.; MacDonald, Thomas M.] British Hypertens Soc, London, England; [McInnes, Gordon T.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Papst, Cheraz Cherif; Zhang, Jack] Novartis Pharma AG, Basel, Switzerland; [MacDonald, Thomas M.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland	University of Cambridge; University of Glasgow; Novartis; University of Dundee	Brown, MJ (corresponding author), Addenbrookes Hosp, Addenbrookes Ctr Clin Invest, Clin Pharmacol Unit, Level 6,Box 110,Hills Rd, Cambridge CB2 2QQ, England.	m.j.brown@cai.cam.ac.uk		MacDonald, Thomas/0000-0001-5189-6669	Novartis; Novartis Pharma AG	Novartis(Novartis); Novartis Pharma AG	MJB has served on an advisory board for and received an honorarium, travel expenses, and lecture fees from Novartis. GTM has received consultancy fees, lecture fees, and travel expenses from Novartis. TMM has received an honorarium, consultancy fees, and travel expenses from Novartis. JZ and CCP are employees of Novartis.; Funding Novartis Pharma AG.	Bakris George L, 2003, J Clin Hypertens (Greenwich), V5, P202, DOI 10.1111/j.1524-6175.2002.2041.x; BRAUNDULLAEUS RC, 2010, J CLIN HYPERTENS S1, V12, pA27; BROWN MJ, 1995, J HYPERTENS, V13, P701, DOI 10.1097/00004872-199506000-00018; Brown MJ, 2008, CIRCULATION, V118, P773, DOI 10.1161/CIRCULATIONAHA.108.787630; Brown MJ, 2007, HEART, V93, P1026, DOI 10.1136/hrt.2006.107706; Brown MJ, 2010, AM J HYPERTENS, V23, P926, DOI 10.1038/ajh.2010.139; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chrysant SG, 2008, CLIN THER, V30, P587, DOI 10.1016/j.clinthera.2008.04.002; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Feldman RD, 2009, HYPERTENSION, V53, P646, DOI 10.1161/HYPERTENSIONAHA.108.123455; Fogari R, 2007, J HUM HYPERTENS, V21, P220, DOI 10.1038/sj.jhh.1002140; Fogari R, 2007, CLIN THER, V29, P413, DOI 10.1016/S0149-2918(07)80079-8; Hood SJ, 2007, CIRCULATION, V116, P268, DOI 10.1161/CIRCULATIONAHA.107.690396; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; KAPLAN NM, 1976, ANN INTERN MED, V84, P639, DOI 10.7326/0003-4819-84-6-639; LARAGH JH, 1979, JAMA-J AM MED ASSOC, V241, P151, DOI 10.1001/jama.241.2.151; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Messerli FH, 2000, AM J CARDIOL, V86, P1182, DOI 10.1016/S0002-9149(00)01199-1; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; NICE, 2017, HYP IMPR BLOOD PRESS; Philipp T, 2007, CLIN THER, V29, P563, DOI 10.1016/j.clinthera.2007.03.018; Primatesta P, 2006, J HYPERTENS, V24, P1187, DOI 10.1097/01.hjh.0000226210.95936.bc; Turnbull F, 2003, LANCET, V362, P1527; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038; Zappe DH, 2010, J HUM HYPERTENS, V24, P483, DOI 10.1038/jhh.2009.90	29	124	133	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2011	377	9762					312	320		10.1016/S0140-6736(10)62003-X	http://dx.doi.org/10.1016/S0140-6736(10)62003-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714ZO	21236483				2022-12-28	WOS:000286850400028
J	van de Velde, CJH; Rea, D; Seynaeve, C; Putter, H; Hasenburg, A; Vannetzel, JM; Paridaens, R; Markopoulos, C; Hozumi, Y; Hille, ETM; Kieback, DG; Asmar, L; Smeets, J; Nortier, JWR; Hadji, P; Bartlett, JMS; Jones, SE				van de Velde, Cornelis J. H.; Rea, Daniel; Seynaeve, Caroline; Putter, Hein; Hasenburg, Annette; Vannetzel, Jean-Michel; Paridaens, Robert; Markopoulos, Christos; Hozumi, Yasuo; Hille, Elysee T. M.; Kieback, Dirk G.; Asmar, Lina; Smeets, Jan; Nortier, Johan W. R.; Hadji, Peyman; Bartlett, John M. S.; Jones, Stephen E.			Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial	LANCET			English	Article							POSTMENOPAUSAL WOMEN; 1ST-LINE THERAPY; LETROZOLE; EXPRESSION; ESTROGEN; UPDATE	Background Aromatase inhibitors improved disease-free survival compared with tamoxifen when given as an initial adjuvant treatment or after 2-3 years of tamcodfen to postmenopausal women with hormone-receptor-positive breast cancer. We therefore compared the long-term effects of exemestane monotherapy with sequential treatment (tamoxifen followed by exemestane). Methods The Tamoxifen Exemestane Adjuvant Multinational (TEAM) phase 3 trial was conducted in hospitals in nine countries. Postmenopausal women (median age 64 years, range 35-96) with hormone-receptor-positive breast cancer were randomly assigned in a 1:1 ratio to open-label exemestane (25 mg once a day, orally) alone or following tamoxifen (20 mg once a day, orally) for 5 years. Randomisation was by use of a computer-generated random permuted block method. The primary endpoint was disease-free survival (DFS) at 5 years. Main analyses were by intention to treat. The trial is registered with ClinicalTrials.gov, NCT00279448, NCT00032136, and NCT00036270; NTR 267; Ethics Commis;ion Trial 27/2001; and UMIN, C000000057. Findings 9779 patients were assigned to sequential treatment (n=4875) or exemestane alone (n=4904), and 4868 and 4898 were analysed by intention to treat, respectively. 4154 (85%) patients in the sequential group and 4186 (86%) in the exemestane alone group were disease free at 5 years (hazard ratio 0.97, 95% CI 0.88-1.08; p=0.60). In the safety analysis, sequential treatment was associated with a higher incidence of gynaecological symptoms (942[20%] of 4814 vs 523 [11%] of 4852), venous thrombosis (99 [2%] vs 47 [1%]), and endometrial abnormalities (191 [4%] vs 19 [<1%]) than was exemestane alone. Musculoskeletal adverse events (2448 [50%] vs 2133 [44%]), hypertension (303 [6%] vs 219 [5%]), and hyperlipidaemia (230 [5%] vs 136 [3%]) were reported more frequently with exemestane alone. Interpretation Treatment regimens of exemestane alone or after tamoxifen might be judged to be appropriate options for postmenopausal women with hormone-receptor-positive early breast cancer.	[van de Velde, Cornelis J. H.] Leiden Univ, Med Ctr, Dept Surg, NL-2300 RC Leiden, Netherlands; [Rea, Daniel] Univ Birmingham, Birmingham, W Midlands, England; [Seynaeve, Caroline] Erasmus MC Daniel Den Hoed, Rotterdam, Netherlands; [Hasenburg, Annette] Univ Hosp Freiburg, Freiburg, Germany; [Vannetzel, Jean-Michel] Inst Sein Henri Hartmann, Neuilly Sur Seine, France; [Paridaens, Robert] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium; [Markopoulos, Christos] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Hozumi, Yasuo] Jichi Med Univ, Shimotsuke, Japan; [Kieback, Dirk G.] Elblandkliniken, Riesa, Germany; [Asmar, Lina; Jones, Stephen E.] US Oncol Res, Houston, TX USA; [Smeets, Jan] Pfizer Oncol, New York, NY USA; [Hadji, Peyman] Univ Marburg, Marburg, Germany; [Bartlett, John M. S.] Univ Edinburgh, Dept Pathol, Endocrine Canc Grp, Edinburgh, Midlothian, Scotland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Birmingham; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Freiburg; KU Leuven; University Hospital Leuven; Athens Medical School; National & Kapodistrian University of Athens; Jichi Medical University; US Oncology Network; Pfizer; Philipps University Marburg; University of Edinburgh	van de Velde, CJH (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.	c.j.h.van_de_velde@lumc.nl	Putter, Hein/C-2244-2018; van de Velde, Cornelis/AAY-8360-2020; Markopoulos, Christos/AAD-8501-2019	Putter, Hein/0000-0001-5395-1422; Markopoulos, Christos/0000-0002-5072-6390	Pfizer; Roche; GlaxoSmithKline; Sanofi Pasteur; AstraZeneca; Medconcept	Pfizer(Pfizer); Roche(Roche Holding); GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur; AstraZeneca(AstraZeneca); Medconcept	CS has received support for travel expenses from Pfizer, and consultancy honoraria from Sanofi-Aventis. JMSB has received honoraria for presentation and discussion of trial results at national and international meetings from Pfizer, and travel grants from Pfizer and Roche for attendance at national and international meetings. PH received travel grants for study meetings and lecture fees from Pfizer. AH has received payment for consultancy from Pfizer, and for lecture honoraria and travel expenses from Pfizer, GlaxoSmithKline, Sanofi Pasteur, AstraZeneca, and Medconcept. SEJ is an adviser and member of Pfizer USA's speaker's bureau. DGK is a member of Pfizer's speaker's board and has received research funding, honoraria for consultancy, and support for travel from Pfizer. CM has received past educational grants and honoraria for lectures from AstraZeneca, Novartis, and Pfizer. RP received investigator fees paid to the hospital for participation in the trial. DR received payment for consultancy and honoraria from Pfizer, Novartis, and AstraZeneca; support for travel to meetings from Pfizer and Novartis; and expenses covered or reimbursed for steering committee meetings from Pfizer. JS is an employee of Pfizer. The other authors declare that they have no conflicts of interest.	Bartlett WS, 2008, 31 ANN SAN ANT BREAS; Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Clarke M, 1998, LANCET, V351, P1451; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Dowsett M, 2008, J CLIN ONCOL, V26, P1059, DOI 10.1200/JCO.2007.12.9437; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Hadji P, 2009, ANN ONCOL, V20, P1203, DOI 10.1093/annonc/mdn762; Hughes-Davies L, 2009, BRIT J CANCER, V101, P875, DOI 10.1038/sj.bjc.6605231; Jakesz R, 2008, 31 ANN SAN ANT BREAS; Jones SE, 2008, 31 ANN SAN ANT BREAS; Jones S, 2008, CLIN BREAST CANCER, V8, P527, DOI 10.3816/CBC.2008.n.065; Jones SE, 2007, J CLIN ONCOL, V25, P4765, DOI 10.1200/JCO.2007.10.8274; Kieback DG, 2010, GYNECOL ONCOL, V119, P500, DOI 10.1016/j.ygyno.2010.08.006; Markopoulos C, 2009, ANN ONCOL, V20, P49, DOI 10.1093/annonc/mdn545; Markopoulos C, 2005, BREAST CANCER RES TR, V93, P61, DOI 10.1007/s10549-005-3783-0; MedDRA, 2009, MAINT SUPP ORG INTR; Mouridsen H, 2003, J CLIN ONCOL, V21, P2101, DOI 10.1200/JCO.2003.04.194; Mouridsen H, 2009, NEW ENGL J MED, V361, P766, DOI 10.1056/NEJMoa0810818; *NAT CANC I, COMM TOX CRIT VERS 2; NCCN, 2010, NCCN CLIN PRACT GUID; Paridaens RJ, 2008, J CLIN ONCOL, V26, P4883, DOI 10.1200/JCO.2007.14.4659; POCOCK SJ, 1987, BIOMETRICS, V43, P487, DOI 10.2307/2531989; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Schilder CM, 2010, J CLIN ONCOL, V28, P1294, DOI 10.1200/JCO.2008.21.3553; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; van Nes JGH, 2010, BRIT J SURG, V97, P671, DOI 10.1002/bjs.6962; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	32	248	249	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2011	377	9762					321	331		10.1016/S0140-6736(10)62312-4	http://dx.doi.org/10.1016/S0140-6736(10)62312-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714ZO	21247627				2022-12-28	WOS:000286850400029
J	Levine, B; Mizushima, N; Virgin, HW				Levine, Beth; Mizushima, Noboru; Virgin, Herbert W.			Autophagy in immunity and inflammation	NATURE			English	Review							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENE ATG16L1; CELL-DEATH; INNATE; PROTEIN; ANTIGEN; STRESS; VIRUS; PATHWAY	Autophagy is an essential, homeostatic process by which cells break down their own components. Perhaps the most primordial function of this lysosomal degradation pathway is adaptation to nutrient deprivation. However, in complex multicellular organisms, the core molecular machinery of autophagy - the 'autophagy proteins' - orchestrates diverse aspects of cellular and organismal responses to other dangerous stimuli such as infection. Recent developments reveal a crucial role for the autophagy pathway and proteins in immunity and inflammation. They balance the beneficial and detrimental effects of immunity and inflammation, and thereby may protect against infectious, autoimmune and inflammatory diseases.	[Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, Tokyo 1138519, Japan; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Virgin, Herbert W.] Midw Reg Ctr Excellence Biodef & Emerging Infect, St Louis, MO 63110 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tokyo Medical & Dental University (TMDU); Washington University (WUSTL)	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu; virgin@wustl.edu	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; Virgin, Herbert/0000-0001-8580-7628	National Institutes of Health (NIH) [RO1 CA109618, U54 AI057156, RO1 AI054483, U54 AI057160, RO1 AI084887, RO1 CA096511]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation; Broad Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA096511, R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084887, R01AI054483, U54AI057156, U54AI057160] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Broad Medical Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work in the authors' laboratories was supported by National Institutes of Health (NIH) grants RO1 CA109618 and U54 AI057156 (B.L.); by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Takeda Science Foundation (N.M.); and by NIH grants RO1 AI054483, U54 AI057160, RO1 AI084887 and RO1 CA096511 and the Broad Medical Foundation (H.W.V.). We thank T. Stappenbeck for discussions, and A. Diehl and M. Harstein for scientific illustration. We apologize to those authors whose work could not be cited owing to space limitations.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Brain O, 2010, AUTOPHAGY, V6, P412, DOI 10.4161/auto.6.3.11389; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; E.X, 2009, PLOS PATHOGENS, V5; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fujita N, 2009, J BIOL CHEM, V284, P32602, DOI 10.1074/jbc.M109.037671; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Guillemain A., 1954, CARYOLOGIA S, P1211; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980; Leib DA, 2009, J VIROL, V83, P12164, DOI 10.1128/JVI.01676-09; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Low DHP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006260; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2010, CELL MICROBIOL, V12, P1108, DOI 10.1111/j.1462-5822.2010.01456.x; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Munz C, 2010, CURR OPIN IMMUNOL, V22, P89, DOI 10.1016/j.coi.2010.01.016; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Reggiori F, 2010, CELL HOST MICROBE, V7, P500, DOI 10.1016/j.chom.2010.05.013; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Sumpter R, 2010, SEMIN CELL DEV BIOL, V21, P699, DOI 10.1016/j.semcdb.2010.04.003; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Yamaguchi H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000670; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	100	2283	2414	17	695	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					323	335		10.1038/nature09782	http://dx.doi.org/10.1038/nature09782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248839	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000286385600039
J	Johnson, S; Rondina, M				Johnson, Stacy; Rondina, Matthew			Local INR control had some effect on the benefits of dabigatran over warfarin for major bleeding in atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Johnson, Stacy; Rondina, Matthew] Univ Utah, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Johnson, S (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.			Rondina, Matthew/0000-0003-3455-3730	NHLBI NIH HHS [K23 HL092161] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092161] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Food and Drug Administration, LAB APPR HIST PRAD; White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-6	10.7326/0003-4819-154-2-201101180-02006	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242360				2022-12-28	WOS:000286223500032
J	von Dadelszen, P; Payne, B; Li, J; Ansermino, JM; Pipkin, FB; Cote, AM; Douglas, MJ; Gruslin, A; Hutcheon, JA; Joseph, KS; Kyle, PM; Lee, T; Loughna, P; Menzies, JM; Merialdi, M; Millman, AL; Moore, MP; Moutquin, JM; Ouellet, AB; Smith, GN; Walker, JJ; Walley, KR; Walters, BN; Widmer, M; Lee, SK; Russell, JA; Magee, LA				von Dadelszen, Peter; Payne, Beth; Li, Jing; Ansermino, J. Mark; Pipkin, Fiona Broughton; Cote, Anne-Marie; Douglas, M. Joanne; Gruslin, Andree; Hutcheon, Jennifer A.; Joseph, K. S.; Kyle, Phillipa M.; Lee, Tang; Loughna, Pamela; Menzies, Jennifer M.; Merialdi, Mario; Millman, Alexandra L.; Moore, M. Peter; Moutquin, Jean-Marie; Ouellet, Annie B.; Smith, Graeme N.; Walker, James J.; Walley, Keith R.; Walters, Barry N.; Widmer, Mariana; Lee, Shoo K.; Russell, James A.; Magee, Laura A.		PIERS Study Grp	Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model	LANCET			English	Article							HYPERTENSIVE DISORDERS; MORTALITY; MANAGEMENT; PREGNANCY; CONSENSUS; ECLAMPSIA; CRITERIA; WEIGHT	Background Pre-eclampsia is a leading cause of maternal deaths. These deaths mainly result from eclampsia, uncontrolled hypertension, or systemic inflammation. We developed and validated the fullPIERS model with the aim of identifying the risk of fatal or life-threatening complications in women with pre-eclampsia within 48 h of hospital admission for the disorder. Methods We developed and internally validated the fullPIERS model in a prospective, multicentre study in women who were admitted to tertiary obstetric centres with pre-eclampsia or who developed pre-eclampsia after admission. The outcome of interest was maternal mortality or other serious complications of pre-eclampsia. Routinely reported and informative variables were included in a stepwise backward elimination regression model to predict the adverse maternal outcome. We assessed performance using the area under the curve (AUC) of the receiver operating characteristic (ROC). Standard bootstrapping techniques were used to assess potential overfitting. Findings 261 of 2023 women with pre-eclampsia had adverse outcomes at any time after hospital admission (106 [5%] within 48 h of admission). Predictors of adverse maternal outcome included gestational age, chest pain or dyspnoea, oxygen saturation, platelet count, and creatinine and aspartate transaminase concentrations. The fullPIERS model predicted adverse maternal outcomes within 48 h of study eligibility (AUC ROC 0.88, 95% CI 0.84-0.92). There was no significant overfitting. fullPIERS performed well (AUC ROC >0.7) up to 7 days after eligibility. Interpretation The fullPIERS model identifies women at increased risk of adverse outcomes up to 7 days before complications arise and can thereby modify direct patient care (eg, timing of delivery, place of care), improve the design of clinical trials, and inform biomedical investigations related to pre-eclampsia.	[von Dadelszen, Peter; Payne, Beth; Li, Jing; Hutcheon, Jennifer A.; Joseph, K. S.; Lee, Tang; Menzies, Jennifer M.; Millman, Alexandra L.; Magee, Laura A.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [von Dadelszen, Peter; Joseph, K. S.; Magee, Laura A.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Ansermino, J. Mark; Douglas, M. Joanne] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Walley, Keith R.; Russell, James A.; Magee, Laura A.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [von Dadelszen, Peter; Payne, Beth; Li, Jing; Ansermino, J. Mark; Hutcheon, Jennifer A.; Joseph, K. S.; Lee, Tang; Menzies, Jennifer M.; Magee, Laura A.] Univ British Columbia, CFRI Reprod & Healthy Pregnancy Cluster, Vancouver, BC V5Z 1M9, Canada; [Gruslin, Andree] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON, Canada; [Cote, Anne-Marie] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Moutquin, Jean-Marie; Ouellet, Annie B.] Univ Sherbrooke, Dept Obstet & Gynecol, Sherbrooke, PQ J1K 2R1, Canada; [Smith, Graeme N.] Queens Univ, Dept Obstet & Gynaecol, Kingston, ON, Canada; [Lee, Shoo K.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Kyle, Phillipa M.] Univ Otago, Dept Obstet & Gynaecol, Christchurch, New Zealand; [Moore, M. Peter] Univ Otago, Dept Med, Christchurch, New Zealand; [Pipkin, Fiona Broughton; Loughna, Pamela] Univ Nottingham, Dept Obstet & Gynaecol, Nottingham NG7 2RD, England; [Walker, James J.] Univ Leeds, Dept Obstet & Gynaecol, Leeds, W Yorkshire, England; [Walters, Barry N.] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia; [Merialdi, Mario; Widmer, Mariana] UNDP UNFPA WHO World Bank Special Programme Res D, Dept Reprod Hlth & Res, Geneva, Switzerland	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of Ottawa; University of Sherbrooke; University of Sherbrooke; Queens University - Canada; University of Toronto; University of Otago; University of Otago; University of Nottingham; University of Leeds; University of Western Australia; United Nations Population Fund; World Health Organization	von Dadelszen, P (corresponding author), 2H30-4500 Oak St, Vancouver, BC V6H 3N1, Canada.	pvd@cw.bc.ca	von Dadelszen, Peter/AAP-7480-2021; Lee, Shoo K/P-3016-2015; Smith, Graeme Neil/ABB-6863-2021	Smith, Graeme Neil/0000-0002-3128-4523; Hutcheon, Jennifer/0000-0002-6618-6018; Joseph, K.S./0000-0003-2317-5607; Ansermino, J Mark/0000-0001-8427-2035	Canadian Institutes of Health Research; UNDP/UNFPA/WHO/World Bank; Preeclampsia Foundation; International Federation of Obstetricians and Gynecologists; Michael Smith Foundation for Health Research; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UNDP/UNFPA/WHO/World Bank(World Health Organization); Preeclampsia Foundation; International Federation of Obstetricians and Gynecologists; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Child and Family Research Institute	Canadian Institutes of Health Research; UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development, and Research Training in Human Reproduction; Preeclampsia Foundation; International Federation of Obstetricians and Gynecologists; Michael Smith Foundation for Health Research; and Child and Family Research Institute.; We acknowledge the funding support of the Canadian Institutes for Health Research (CIHR; operating grants, salary: SKL, PvD; post-doctoral fellowship: JAH), UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development & Research Training in Human Reproduction, Preeclampsia Foundation, International Federation of Obstetricians and Gynecologists, Michael Smith Foundation for Health Research (salary: JMA, LAM, PvD, JAH), and Child and Family Research Institute (salary award: JMA, PvD, KSJ).	Altman DG, 1998, BREAST CANCER RES TR, V52, P289, DOI 10.1023/A:1006193704132; Audibert F, 1996, AM J OBSTET GYNECOL, V175, P460, DOI 10.1016/S0002-9378(96)70162-X; Bellomo R, 2007, INTENS CARE MED, V33, P409, DOI 10.1007/s00134-006-0478-x; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P139, DOI 10.1111/j.1479-828X.2000.tb01137.x; DULEY L, 2003, COCHRANE DB SYST REV, V2; Efron B., 1994, MONOGRAPHS STAT APPL; Ganzevoort W, 2006, AM J OBSTET GYNECOL, V195, P495, DOI 10.1016/j.ajog.2006.02.012; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Homer CSE, 2008, J HYPERTENS, V26, P295, DOI 10.1097/HJH.0b013e3282f1a953; Horton R, 2009, LANCET, V374, P1400, DOI 10.1016/S0140-6736(09)61669-X; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Knuiman MW, 1997, J EPIDEMIOL COMMUN H, V51, P515, DOI 10.1136/jech.51.5.515; Koopmans C, 2008, HYPERTENS PREGNANCY, V27, P421, DOI 10.1080/10253890802519881; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Langer A, 2008, LANCET, V371, P705, DOI 10.1016/S0140-6736(08)60321-9; Lessoway VA, 1998, J CLIN ULTRASOUND, V26, P433; Leushuis E, 2009, HUM REPROD UPDATE, V15, P537, DOI 10.1093/humupd/dmp013; Lewis G., 2004, WHY MOTHERS DIE 2000; Lindheimer MD, 2010, OBSTET GYNECOL, V115, P365, DOI 10.1097/AOG.0b013e3181cb9644; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Martin JN, 2005, OBSTET GYNECOL, V105, P246, DOI 10.1097/01.AOG.0000151116.84113.56; Menzies J, 2007, HYPERTENS PREGNANCY, V26, P447, DOI 10.1080/10641950701521742; Menzies J, 2007, OBSTET GYNECOL, V110, P121, DOI 10.1097/01.AOG.0000266977.26311.f0; MILHOLLAND AV, 1973, NEW ENGL J MED, V288, P1272, DOI 10.1056/NEJM197306142882405; Molenberghs G, 2007, J ROY STAT SOC A STA, V170, P861, DOI 10.1111/j.1467-985X.2007.00504.x; Novara G, 2005, CURR OPIN UROL, V15, P256, DOI 10.1097/01.mou.0000172399.47019.e9; PILL J, 1971, SOCIO ECON PLAN SCI, V5, P57, DOI 10.1016/0038-0121(71)90041-3; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; Royal College of Obstetricians and Gynaecologists, US EL FET MON; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stoger S, 2008, HYPERTENS PREGNAN S1, V21, P48; Thangaratinam Shakila, 2008, BMC Pregnancy Childbirth, V8, P38, DOI 10.1186/1471-2393-8-38; von Dadelszen P, 2002, CRIT CARE MED, V30, P1883, DOI 10.1097/00003246-200208000-00035; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Williams AJ, 1998, BRIT MED J, V317, P1213, DOI 10.1136/bmj.317.7167.1213; YOUNG GA, 1990, BIOMETRIKA, V77, P179, DOI 10.1093/biomet/77.1.179; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	41	321	327	1	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					219	227		10.1016/S0140-6736(10)61351-7	http://dx.doi.org/10.1016/S0140-6736(10)61351-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712WG	21185591	Green Accepted			2022-12-28	WOS:000286696400029
J	Sarnthein, M				Sarnthein, Michael			Northern Meltwater Pulses, CO2, and Changes in Atlantic Convection	SCIENCE			English	Editorial Material							DEEP; VENTILATION; OCEAN; RISE		Univ Kiel, Inst Geosci, D-24098 Kiel, Germany	University of Kiel	Sarnthein, M (corresponding author), Univ Kiel, Inst Geosci, Olshaussenstr 40, D-24098 Kiel, Germany.	ms@gpi.uni-kiel.de						Adkins JF, 1997, PALEOCEANOGRAPHY, V12, P337, DOI 10.1029/97PA00379; Barker S., 2010, NAT GEOSCI; Broecker W, 2004, SCIENCE, V306, P1169, DOI 10.1126/science.1102293; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Gebhardt H, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001513; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Matsumoto K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004095; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Sarnthein M., 2000, NO N ATLANTIC CHANGI, P365; Sarnthein M., 2011, EARTH PLANET SCI LET; SARNTHEIN M, 2007, GEOPHYS MONOGR SER, V173, P175, DOI DOI 10.1029/173GM13; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Thornalley DJR, 2011, SCIENCE, V331, P202, DOI 10.1126/science.1196812; Wunsch C, 2010, QUATERNARY SCI REV, V29, P1960, DOI 10.1016/j.quascirev.2010.05.020; Yu JM, 2010, SCIENCE, V330, P1084, DOI 10.1126/science.1193221	19	8	8	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					156	158		10.1126/science.1201144	http://dx.doi.org/10.1126/science.1201144			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233374				2022-12-28	WOS:000286433100027
J	Gordon, LM; Joester, D				Gordon, Lyle M.; Joester, Derk			Nanoscale chemical tomography of buried organic-inorganic interfaces in the chiton tooth	NATURE			English	Article							SPECIMEN PREPARATION; RADULA TEETH; PROTEIN; MATRIX; BIOMINERALIZATION; CRYSTALS; BONE	Biological organisms possess an unparalleled ability to control the structure and properties of mineralized tissues. They are able, for example, to guide the formation of smoothly curving single crystals or tough, lightweight, self-repairing skeletal elements(1). In many biominerals, an organic matrix interacts with the mineral as it forms, controls its morphology and polymorph, and is occluded during mineralization(2-4). The remarkable functional properties of the resulting composites-such as outstanding fracture toughness and wear resistance-can be attributed to buried organic-inorganic interfaces at multiple hierarchical levels(5). Analysing and controlling such interfaces at the nanometre length scale is critical also in emerging organic electronic and photovoltaic hybrid materials(6). However, elucidating the structural and chemical complexity of buried organic-inorganic interfaces presents a challenge to state-of-the-art imaging techniques. Here we show that pulsed-laser atom-probe tomography reveals three-dimensional chemical maps of organic fibres with a diameter of 5-10 nm in the surrounding nano-crystalline magnetite (Fe3O4) mineral in the tooth of a marine mollusc, the chiton Chaetopleura apiculata. Remarkably, most fibres co-localize with either sodium or magnesium. Furthermore, clustering of these cations in the fibre indicates a structural level of hierarchy previously undetected. Our results demonstrate that in the chiton tooth, individual organic fibres have different chemical compositions, and therefore probably different functional roles in controlling fibre formation and matrix-mineral interactions. Atom-probe tomography is able to detect this chemical/structural heterogeneity by virtue of its high three-dimensional spatial resolution and sensitivity across the periodic table. We anticipate that the quantitative analysis and visualization of nanometre-scale interfaces by laser-pulsed atom-probe tomography will contribute greatly to our understanding not only of biominerals (such as bone, dentine and enamel), but also of synthetic organic-inorganic composites.	[Gordon, Lyle M.; Joester, Derk] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University	Joester, D (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.	d-joester@northwestern.edu	Joester, Derk/B-7525-2009	Gordon, Lyle/0000-0001-8335-0126	Canadian National Sciences and Engineering Research Council; US National Science Foundation [DMR-0805313]; NSF-NSEC; NSF-MRSEC; Keck Foundation; State of Illinois; Northwestern University; NSF-MRI [DMR-0420532]; ONR-DURIP [N00014-0400798, N00014-0610539, N00014-0910781]; Division Of Materials Research [0805313] Funding Source: National Science Foundation	Canadian National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Science Foundation(National Science Foundation (NSF)); NSF-NSEC(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Keck Foundation(W.M. Keck Foundation); State of Illinois; Northwestern University; NSF-MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); ONR-DURIP(Office of Naval Research); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by the Canadian National Sciences and Engineering Research Council and the US National Science Foundation (DMR-0805313). FIB, SEM and (S) TEM work was performed in the Northwestern University Atomic and Nanoscale Characterization and Experimental Center (NUANCE) supported by NSF-NSEC, NSF-MRSEC, the Keck Foundation, the State of Illinois, and Northwestern University. APT measurements were performed at the Northwestern University Center for Atom Probe Tomography (NUCAPT) supported by NSF-MRI (DMR-0420532) and ONR-DURIP (N00014-0400798, N00014-0610539, N00014-0910781). We thank A. Tayi for help in preparing chitin thin film samples; B. Myers (NUANCE) for help with FIB; D. Isheim (NUCAPT), and D. Lawrence, R. Ulfig, T. Prosa and M. Greene (Cameca) for their assistance with APT; and D. Seidman for discussions.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Aizenberg J, 2006, Nanomechanics of Materials and Structures, P99, DOI 10.1007/1-4020-3951-4_10; BAS P, 1995, APPL SURF SCI, V87-8, P298, DOI 10.1016/0169-4332(94)00561-3; Chen YM, 2009, SCRIPTA MATER, V61, P693, DOI 10.1016/j.scriptamat.2009.05.043; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; EVANS LA, 1991, MAR BIOL, V109, P281, DOI 10.1007/BF01319396; EVANS LA, 1990, PHILOS T ROY SOC B, V329, P87, DOI 10.1098/rstb.1990.0153; Falini G, 2004, TISSUE ENG, V10, P1, DOI 10.1089/107632704322791646; Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428; FLEET ME, 1981, ACTA CRYSTALLOGR B, V37, P917, DOI 10.1107/S0567740881004597; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Giannuzzi LA, 1999, MICRON, V30, P197, DOI 10.1016/S0968-4328(99)00005-0; Gotliv BA, 2005, CHEMBIOCHEM, V6, P304, DOI 10.1002/cbic.200400221; Hellman OC, 2000, MICROSC MICROANAL, V6, P437, DOI 10.1007/s100050010051; Kelly TF, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2709758; Koch N, 2007, CHEMPHYSCHEM, V8, P1438, DOI 10.1002/cphc.200700177; Kuhlman KR, 2001, ULTRAMICROSCOPY, V89, P169, DOI 10.1016/S0304-3991(01)00116-4; Larson DJ., 2008, MICROSC MICROANAL, V14, P1254, DOI DOI 10.1017/S1431927608083657; Law NA, 1999, ADV INORG CHEM, V46, P305; LEHN JM, 1994, P INDIAN AS-CHEM SCI, V106, P915; Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583; Li J, 1997, J APPL POLYM SCI, V65, P373; Lowenstam HA, 1989, BIOMINERALIZATION; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Miller M. K., 2000, ATOM PROBE TOMOGRAPH, P139; Miller MK, 2007, MICROSC MICROANAL, V13, P428, DOI 10.1017/S1431927607070845; Miller MK, 2005, ULTRAMICROSCOPY, V102, P287, DOI 10.1016/J.ULTRAMIC.2004.10.011; Omelon SJ, 2008, CHEM REV, V108, P4694, DOI 10.1021/cr0782527; Seidman D., 2009, MAT RES SOC B, V34, P717; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e; Tao JH, 2009, P NATL ACAD SCI USA, V106, P22096, DOI 10.1073/pnas.0909040106; Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008; Tsai GJ, 2002, FISHERIES SCI, V68, P170, DOI 10.1046/j.1444-2906.2002.00404.x; van der Wal P, 2000, MAT SCI ENG C-BIO S, V7, P129, DOI 10.1016/S0928-4931(99)00129-0; Wang DB, 2009, P NATL ACAD SCI USA, V106, P21511, DOI 10.1073/pnas.0906741106; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001	40	182	185	8	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					194	197		10.1038/nature09686	http://dx.doi.org/10.1038/nature09686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228873				2022-12-28	WOS:000286143400034
J	Saraux, C; Le Bohec, C; Durant, JM; Viblanc, VA; Gauthier-Clerc, M; Beaune, D; Park, YH; Yoccoz, NG; Stenseth, NC; Le Maho, Y				Saraux, Claire; Le Bohec, Celine; Durant, Joel M.; Viblanc, Vincent A.; Gauthier-Clerc, Michel; Beaune, David; Park, Young-Hyang; Yoccoz, Nigel G.; Stenseth, Nils C.; Le Maho, Yvon			Reliability of flipper-banded penguins as indicators of climate change	NATURE			English	Article							POPULATION-DYNAMICS; KING PENGUIN; REPRODUCTION; SURVIVAL; BEHAVIOR	In 2007, the Intergovernmental Panel on Climate Change highlighted an urgent need to assess the responses of marine ecosystems to climate change(1). Because they lie in a high-latitude region, the Southern Ocean ecosystems are expected to be strongly affected by global warming. Using top predators of this highly productive ocean(2) (such as penguins) as integrative indicators may help us assess the impacts of climate change on marine ecosystems(3,4). Yet most available information on penguin population dynamics is based on the controversial use of flipper banding. Although some reports have found the effects of flipper bands to be deleterious(5-8), some short-term (one-year) studies have concluded otherwise(9-11), resulting in the continuation of extensive banding schemes and the use of data sets thus collected to predict climate impact on natural populations(12,13). Here we show that banding of free-ranging king penguins (Aptenodytes patagonicus) impairs both survival and reproduction, ultimately affecting population growth rate. Over the course of a 10-year longitudinal study, banded birds produced 39% fewer chicks and had a survival rate 16% lower than non-banded birds, demonstrating a massive long-term impact of banding and thus refuting the assumption that birds will ultimately adapt to being banded(6,12). Indeed, banded birds still arrived later for breeding at the study site and had longer foraging trips even after 10 years. One of our major findings is that responses of flipper-banded penguins to climate variability (that is, changes in sea surface temperature and in the Southern Oscillation index) differ from those of non-banded birds. We show that only long-term investigations may allow an evaluation of the impact of flipper bands and that every major life-history trait can be affected, calling into question the banding schemes still going on. In addition, our understanding of the effects of climate change on marine ecosystems based on flipper-band data should be reconsidered.	[Saraux, Claire; Le Bohec, Celine; Viblanc, Vincent A.; Beaune, David; Le Maho, Yvon] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, F-67087 Strasbourg, France; [Saraux, Claire; Le Bohec, Celine; Viblanc, Vincent A.; Beaune, David; Le Maho, Yvon] CNRS, UMR7178, F-67037 Strasbourg, France; [Saraux, Claire; Le Bohec, Celine; Durant, Joel M.; Stenseth, Nils C.] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; [Saraux, Claire] ENGREF, AgroParisTech, F-75732 Paris, France; [Gauthier-Clerc, Michel] Ctr Rech Tour Valat, F-13200 Arles, France; [Park, Young-Hyang] Museum Natl Hist Nat, USM LOCEAN 0402, Dept Milieux & Peuplements Aquat, F-75231 Paris, France; [Yoccoz, Nigel G.] Univ Tromso, Dept Arctic & Marine Biol, N-9037 Tromso, Norway; [Stenseth, Nils C.] Inst Marine Res, Flodevigen Marine Res Stn, N-4817 His, Norway	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oslo; AgroParisTech; Museum National d'Histoire Naturelle (MNHN); UiT The Arctic University of Tromso; Institute of Marine Research - Norway	Saraux, C (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, 23 Rue Becquerel, F-67087 Strasbourg, France.	claire.saraux@c-strasbourg.fr; yvon.lemaho@iphc.cnrs.fr	saraux, claire/AAX-8709-2020; Yoccoz, Nigel/C-8561-2014; LE BOHEC, CELINE/AAD-3589-2022; Durant, Joël/D-3821-2013; Stenseth, Nils Christian/G-5212-2016	saraux, claire/0000-0001-5061-4009; Yoccoz, Nigel/0000-0003-2192-1039; Durant, Joël/0000-0002-1129-525X; LE BOHEC, Celine/0000-0003-0149-6477; Beaune, David/0000-0002-2329-1598; Viblanc, Vincent/0000-0002-4953-659X; Stenseth, Nils Christian/0000-0002-1591-5399	Institut Polaire Francais-Paul-Emile Victor; Fondation Bettencourt-Schueller; Fondation des Treilles; Centre National de la Recherche Scientifique; European Commission; Norwegian Research Council; YGGDRASIL programme	Institut Polaire Francais-Paul-Emile Victor; Fondation Bettencourt-Schueller; Fondation des Treilles; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Commission(European CommissionEuropean Commission Joint Research Centre); Norwegian Research Council(Research Council of NorwayEuropean Commission); YGGDRASIL programme	We thank P. Trathan for his comments on the paper. We are grateful to C. Salmon for his help in pre-analysing data. We thank M. Ballesteros, C. Bricaud, N. Chatelain, G. Conan, S. Descamps, J. Dutel, C. Gilbert, S. Gravier, A. Hergott, G. Kuntz, N. Lambert, T. Lebard, N. Lecomte, J. Legrand, S. Mangin, V. Mosch, S. Quemeneur, A. Simon, E. Taquet and C. Villemin, for their help with field work. We also thank I. Durant for her help with chlorophyll data. This work was supported by the Institut Polaire Francais-Paul-Emile Victor, the Fondation Bettencourt-Schueller, the Fondation des Treilles and the Centre National de la Recherche Scientifique (Programme Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique), and grants from the European Commission (Marie Curie, to C. L. B.), the Norwegian Research Council through the Match/Mismatch and Ecosystem project (to J. M. D.) and the YGGDRASIL programme (to C.S.).	Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Barrat A, 1976, COM NAT FR RECH ANTA, V40, P9, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2014.12.010; Bates D., 2009, CRAN PACKAGE LME4; Boersma PD, 2010, J FIELD ORNITHOL, V81, P195, DOI 10.1111/j.1557-9263.2010.00277.x; Boersma PD, 2009, J FIELD ORNITHOL, V80, P408, DOI 10.1111/j.1557-9263.2009.00248.x; Boulinier T, 2008, BIOL LETTERS, V4, P538, DOI 10.1098/rsbl.2008.0291; Caswell H., 2001, MATRIX POPULATION MO, P72; Croxall J.P., 1988, P261; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; Descamps Sebastien, 2002, Avian Science, V2, P87; DESER C, 1987, J GEOPHYS RES-OCEANS, V92, P14189, DOI 10.1029/JC092iC13p14189; Dugger KM, 2006, AUK, V123, P858, DOI 10.1642/0004-8038(2006)123[858:EOFBOF]2.0.CO;2; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Fallow PM, 2009, J WILDLIFE MANAGE, V73, P1348, DOI 10.2193/2008-146; Froget G, 1998, POLAR BIOL, V20, P409, DOI 10.1007/s003000050322; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Gendner JP, 2005, J FIELD ORNITHOL, V76, P138, DOI 10.1648/0273-8570-76.2.138; Groscolas R, 2001, COMP BIOCHEM PHYS A, V128, P645, DOI 10.1016/S1095-6433(00)00341-X; Hindell MA, 1996, IBIS, V138, P557, DOI 10.1111/j.1474-919X.1996.tb08080.x; Jackson S, 2002, FUNCT ECOL, V16, P141, DOI 10.1046/j.0269-8463.2001.00606.x; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; KOZLOV AN, 1989, J ICHTHYOL, V29, P160; Le Bohec C, 2008, P NATL ACAD SCI USA, V105, P2493, DOI 10.1073/pnas.0712031105; Lebreton J.-D., 1991, BIRD POPULATION STUD, P105; LEMAHO Y, 1993, MAR ECOL PROG SER, V95, P1, DOI 10.3354/meps095001; May RM, 2004, NATURE, V431, P403, DOI 10.1038/431403a; Nicolaus M, 2008, ARDEA, V96, P286, DOI 10.5253/078.096.0215; Olsson O, 1996, J AVIAN BIOL, V27, P7, DOI 10.2307/3676955; Pfister CA, 1998, P NATL ACAD SCI USA, V95, P213, DOI 10.1073/pnas.95.1.213; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Stearns S.C., 1992, pi; Stonehouse B, 1960, SCI REPT FALKLAND IS, V23, P1; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; Wolfaardt Anton C., 2003, P18	36	145	147	1	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					203	206		10.1038/nature09630	http://dx.doi.org/10.1038/nature09630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228875				2022-12-28	WOS:000286143400036
J	Taitsman, JK				Taitsman, Julie K.			Educating Physicians to Prevent Fraud, Waste, and Abuse	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*OFF INSP GEN DEP, ROADM NEW PHYS AV ME; Office of Inspector General Office of Evaluation and Inspections, 2010, MED MED FRAUD AB TRA	2	12	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					102	103		10.1056/NEJMp1012609	http://dx.doi.org/10.1056/NEJMp1012609			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	705NJ	21226574				2022-12-28	WOS:000286142900003
J	Morris, K				Morris, Kelly			Alan Guttmacher-a visionary leader of developmental research Profile	LANCET			English	Biographical-Item												kellyvitalwriter@gmail.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 8	2011	377	9760					117	117		10.1016/S0140-6736(11)60008-1	http://dx.doi.org/10.1016/S0140-6736(11)60008-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21215874				2022-12-28	WOS:000286292800014
J	Gardner, CJ; Richardson, P; Wong, C; Polavarapu, N; Kemp, GJ; Cuthbertson, DJ				Gardner, C. J.; Richardson, P.; Wong, C.; Polavarapu, N.; Kemp, G. J.; Cuthbertson, D. J.			Lesson of the Week Hypothyroidism in a patient with non-alcoholic fatty liver disease	BRITISH MEDICAL JOURNAL			English	Article							THYROID-HORMONE RECEPTOR; HEPATIC STEATOSIS; METABOLIC SYNDROME; UNITED-STATES; STEATOHEPATITIS; PREVALENCE; PATHWAYS; AGONIST; RATS					daniel.cuthbertson@liverpool.ac.uk	Kemp, Graham J/A-7540-2008	Kemp, Graham J/0000-0002-8324-9666; Cuthbertson, Daniel/0000-0002-6128-0822				Bhala N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2474; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cable EE, 2009, HEPATOLOGY, V49, P407, DOI 10.1002/hep.22572; Chidakel A, 2005, THYROID, V15, P899, DOI 10.1089/thy.2005.15.899; ERICKSON AR, 1994, AM J MED, V97, P231, DOI 10.1016/0002-9343(94)90005-1; Erion MD, 2007, P NATL ACAD SCI USA, V104, P15490, DOI 10.1073/pnas.0702759104; Hashimoto K, 2006, J BIOL CHEM, V281, P295, DOI 10.1074/jbc.M507877200; Hassan MM, 2009, HEPATOLOGY, V49, P1563, DOI 10.1002/hep.22793; Ichikawa T, 2003, GUT, V52, P914, DOI 10.1136/gut.52.6.914; Liangpunsakul S, 2003, J CLIN GASTROENTEROL, V37, P340, DOI 10.1097/00004836-200310000-00014; Lonardo A, 2002, AM J GASTROENTEROL, V97, P1071; Loria P, 2009, NAT REV GASTRO HEPAT, V6, P236, DOI 10.1038/nrgastro.2009.33; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Nyenwe EA, 2009, AM J MED SCI, V338, P190, DOI 10.1097/MAJ.0b013e3181a84bde; Perra A, 2008, FASEB J, V22, P2981, DOI 10.1096/fj.08-108464; Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566; VUPPALANCHI R, NONALCOHOLIC FATTY L; Yatsuji Satoru, 2006, Nihon Rinsho, V64, P1173	19	13	13	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 6	2011	342								c7199	10.1136/bmj.c7199	http://dx.doi.org/10.1136/bmj.c7199			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NK	21212123				2022-12-28	WOS:000286143000004
J	Yee, HF				Yee, Hal F., Jr.			The Patient-Centered Medical Home Neighbor: A Subspecialty Physician's View	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PRIMARY-CARE; ACCOUNTABLE CARE; SPECIALISTS; REFORM	To achieve the benefits of the patient-centered medical home (PCMH) model, the American College of Physicians has issued a policy paper addressing the relationship between specialist and subspecialist physicians and PCMH practices. This paper represents a significant step toward improving care coordination and quality by demonstrating that this model is supported by numerous specialties and subspecialties, recognizing the importance of building a strong medical neighborhood, and providing a framework that will foster improvements in care at the interface of PCMHs and PCMH neighbors (PCMH-Ns). Construction of a well-functioning medical neighborhood will, however, require some refinements. First, the proposed interaction typology between PCMHs and PCMH-Ns must be expanded to include innovative forms of interaction that do not depend on traditional office visits, but for which there are clear incentives. Second, the recommended care coordination agreements must be better standardized for the sake of practicality. Finally, genuine dialogue between PCMH and PCMH-N practices needs to be realized.	[Yee, Hal F., Jr.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; [Yee, Hal F., Jr.] Ctr Trauma, San Francisco, CA USA; [Yee, Hal F., Jr.] Ctr Innovat Access & Qual, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Yee, HF (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, 1001 Potrero Ave,NH 3D7,Box 0862, San Francisco, CA 94110 USA.	hyee@medsfgh.ucsf.edu						*AM AC FAM PHYS AM, 2007, JOINT PRINC PAT CTR; American College of Physicians, 2010, PAT CTR MED HOM NEIG; Bashshur RL, 2009, TELEMED J E-HEALTH, V15, P600, DOI 10.1089/tmj.2009.9960; Chen AH, 2010, HEALTH AFFAIR, V29, P969, DOI 10.1377/hlthaff.2010.0027; Chen AH, 2009, ARCH INTERN MED, V169, P1024, DOI 10.1001/archinternmed.2009.140; Fisher ES, 2008, NEW ENGL J MED, V359, P1202, DOI 10.1056/NEJMp0806233; Forrest CB, 2009, ARCH INTERN MED, V169, P1062, DOI 10.1001/archinternmed.2009.114; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194; National Academy of State Health Policy, 2008, RES STAT MED HOM SCA; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Rittenhouse DR, 2009, NEW ENGL J MED, V361, P2301, DOI 10.1056/NEJMp0909327; Surjadi M, 2010, DIG DIS SCI	12	29	30	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					63	64		10.7326/0003-4819-154-1-201101040-00011	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200042				2022-12-28	WOS:000285830900010
J	Lotta, LA; Peyvandi, F				Lotta, Luca A.; Peyvandi, Flora			Addressing the complexity of cardiovascular disease by design	LANCET			English	Editorial Material							HUMAN GENOME; MAP		[Lotta, Luca A.; Peyvandi, Flora] Univ Milan, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy; [Lotta, Luca A.; Peyvandi, Flora] Univ Milan, Osped Maggiore Policlin, Luigi Villa Fdn, I-20122 Milan, Italy; [Lotta, Luca A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Baylor College of Medicine	Lotta, LA (corresponding author), Univ Milan, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy.	luca.lotta@unimi.it	Peyvandi, Flora/AAK-7437-2020	Peyvandi, Flora/0000-0001-7423-9864; Lotta, Luca Andrea/0000-0002-2619-5956				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Hindorff LA, CATALOG PUBLISHED GE; Lotta LA, 2010, EUR J INTERN MED, V21, P74, DOI 10.1016/j.ejim.2009.11.003; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; REILLY MP, 2011, LANCET          0115, DOI DOI 10.1016/50140-6736(10)61996-4; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	7	9	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2011	377	9763					356	358		10.1016/S0140-6736(10)62240-4	http://dx.doi.org/10.1016/S0140-6736(10)62240-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721ES	21239053				2022-12-28	WOS:000287337000005
J	Kuhns, DB; Alvord, WG; Heller, T; Feld, JJ; Pike, KM; Marciano, BE; Uzel, G; DeRavin, SS; Priel, DAL; Soule, BP; Zarember, KA; Malech, HL; Holland, SM; Gallin, JI				Kuhns, Douglas B.; Alvord, W. Gregory; Heller, Theo; Feld, Jordan J.; Pike, Kristen M.; Marciano, Beatriz E.; Uzel, Gulbu; DeRavin, Suk See; Priel, Debra A. Long; Soule, Benjamin P.; Zarember, Kol A.; Malech, Harry L.; Holland, Steven M.; Gallin, John I.			Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMATOLOGICALLY IMPORTANT MUTATIONS; MARROW-TRANSPLANTATION; RESPIRATORY-BURST; INVOLVEMENT; DEFICIENCY; GP91-PHOX; DOMAIN; RISK	Background: Failure to generate phagocyte-derived superoxide and related reactive oxygen intermediates (ROIs) is the major defect in chronic granulomatous disease, causing recurrent infections and granulomatous complications. Chronic granulomatous disease is caused by missense, nonsense, frameshift, splice, or deletion mutations in the genes for p22(sup phox), p40(sup phox), p47(sup phox), p67(sup phox) (autosomal chronic granulomatous disease), or gp91(sup phox) (X-linked chronic granulomatous disease), which result in variable production of neutrophil-derived ROIs. We hypothesized that residual ROI production might be linked to survival in patients with chronic granulomatous disease. Methods: We assessed the risks of illness and death among 287 patients with chronic granulomatous disease from 244 kindreds. Residual ROI production was measured with the use of superoxide-dependent ferricytochrome c reduction and flow cytometry with dihydrorhodamine oxidation assays. Expression of NADPH oxidase component protein was detected by means of immunoblotting, and the affected genes were sequenced to identify causal mutations. Results: Survival of patients with chronic granulomatous disease was strongly associated with residual ROI production as a continuous variable, independently of the specific gene affected. Patients with mutations in p47(sup phox) and most missense mutations in gp91(sup phox) (with the exception of missense mutations in the nucleotide-binding and heme-binding domains) had more residual ROI production than patients with nonsense, frameshift, splice, or deletion mutations in gp91(sup phox). After adolescence, mortality curves diverged according to the extent of residual ROI production. Conclusions: Patients with chronic granulomatous disease and modest residual production of ROI have significantly less severe illness and a greater likelihood of long-term survival than patients with little residual ROI production. The production of residual ROI is predicted by the specific NADPH oxidase mutation, regardless of the specific gene affected, and it is a predictor of survival in patients with chronic granulomatous disease. (Funded by the National Institutes of Health.) N Engl J Med 2010;363:2600-10.	[DeRavin, Suk See; Soule, Benjamin P.; Zarember, Kol A.; Malech, Harry L.; Gallin, John I.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Kuhns, Douglas B.; Priel, Debra A. Long] SAIC Frederick, Clin Serv Program, Frederick, MD USA; [Pike, Kristen M.] SAIC Frederick, Lab Mol Technol, Frederick, MD USA; [Alvord, W. Gregory] NCI Frederick, Biostat Consulting Div, Data Management Serv, Frederick, MD USA; [Heller, Theo] NIDDKD, Liver Dis Branch, Bethesda, MD USA; [Marciano, Beatriz E.; Uzel, Gulbu; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [DeRavin, Suk See; Soule, Benjamin P.; Zarember, Kol A.; Malech, Harry L.; Gallin, John I.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Feld, Jordan J.] Univ Toronto, Toronto Western Hosp, McLaughlin Rotman Ctr Global Hlth, Ctr Liver, Toronto, ON M5T 2S8, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Science Applications International Corporation (SAIC); SAIC-Frederick; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gallin, JI (corresponding author), NIAID, Host Def Lab, NIH, Bldg 10,Rm 6-2551, Bethesda, MD 20892 USA.	jgallin@cc.nih.gov	Feld, Jordan/AAH-5628-2020	Feld, Jordan/0000-0003-2640-2211; Heller, Theo/0000-0002-2643-6289; Malech, Harry/0000-0001-5874-5775; De Ravin, Suk See/0000-0002-9800-774X; Zarember, Kol/0000-0002-9624-7096	National Institute of Allergy and Infectious Diseases [Z01-AI-000155, Z01-AI-000645, Z01-AI-00646-06]; National Institute of Diabetes and Digestive and Kidney Diseases [ZIA DK075008-04 LDB]; National Cancer Institute [HH-SN261200800001E]; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000646, Z01AI000646, ZIAAI000645, ZIAAI000155, Z01AI000155, Z01AI000645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075008] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by intramural grants from the National Institute of Allergy and Infectious Diseases (Z01-AI-000155, Z01-AI-000645, and Z01-AI-00646-06), a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (ZIA DK075008-04 LDB), and a contract from the National Cancer Institute (HH-SN261200800001E).; Funded by the National Institutes of Health	Anderson-Cohen M, 2003, CLIN IMMUNOL, V109, P308, DOI 10.1016/j.clim.2003.08.002; BERENDES H, 1957, Minn Med, V40, P309; Cale CM, 2000, CLIN EXP IMMUNOL, V120, P351, DOI 10.1046/j.1365-2249.2000.01234.x; Carnide EG, 2005, PEDIATR ALLERGY IMMU, V16, P5, DOI 10.1111/j.1399-3038.2005.00225.x; Collett D, 1994, MODELLING SURVIVAL D; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COOPER MR, 1972, J CLIN INVEST, V51, P769, DOI 10.1172/JCI106871; Cross AR, 1996, BLOOD CELL MOL DIS, V22, P268, DOI 10.1006/bcmd.1996.0109; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; Feld JJ, 2008, GASTROENTEROLOGY, V134, P1917, DOI 10.1053/j.gastro.2008.02.081; Foster CB, 1998, J CLIN INVEST, V102, P2146, DOI 10.1172/JCI5084; FREY D, 1988, BLOOD, V71, P252; Gallin JI, 2003, NEW ENGL J MED, V348, P2416, DOI 10.1056/NEJMoa021931; Guide SV, 2003, J INFECT DIS, V187, P845, DOI 10.1086/368388; Han CH, 2001, J BIOCHEM-TOKYO, V129, P513, DOI 10.1093/oxfordjournals.jbchem.a002885; Heyworth PG, 2001, BLOOD CELL MOL DIS, V27, P16, DOI 10.1006/bcmd.2000.0347; Jirapongsananuruk O, 2003, J ALLERGY CLIN IMMUN, V111, P374, DOI 10.1067/mai.2003.58; Kang EM, 2009, IMMUNOL RES, V43, P77, DOI 10.1007/s12026-008-8051-z; Kasahara Y, 1997, BLOOD, V89, P1748, DOI 10.1182/blood.V89.5.1748.1748_1748_1753; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lekstrom-Himes JA, 2005, J IMMUNOL, V174, P411, DOI 10.4049/jimmunol.174.1.411; LUCARELLI G, 1993, NEW ENGL J MED, V329, P840, DOI 10.1056/NEJM199309163291204; Marciano BE, 2004, CLIN INFECT DIS, V39, P692, DOI 10.1086/422993; Marciano BE, 2004, PEDIATRICS, V114, P462, DOI 10.1542/peds.114.2.462; MARGOLIS DM, 1990, J INFECT DIS, V162, P723, DOI 10.1093/infdis/162.3.723; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Mauch L, 2007, CLIN CHEM, V53, P890, DOI 10.1373/clinchem.2006.083444; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Rae J, 1998, AM J HUM GENET, V62, P1320, DOI 10.1086/301874; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; SCHAPIRO BL, 1991, NEW ENGL J MED, V325, P1786, DOI 10.1056/NEJM199112193252506; Sodani P, 2004, BLOOD, V104, P1201, DOI 10.1182/blood-2003-08-2800; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; VOLPP BD, 1993, J CLIN INVEST, V91, P201, DOI 10.1172/JCI116171; Weening RS, 2000, CLIN EXP IMMUNOL, V122, P410, DOI 10.1046/j.1365-2249.2000.01405.x; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Yoshida LS, 1998, J BIOL CHEM, V273, P27879, DOI 10.1074/jbc.273.43.27879	40	358	371	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2600	2610		10.1056/NEJMoa1007097	http://dx.doi.org/10.1056/NEJMoa1007097			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190454	Green Accepted			2022-12-28	WOS:000285763700005
J	Eisenstein, M				Eisenstein, Michael			The first supper	NATURE			English	Editorial Material																		Braun DR, 2010, P NATL ACAD SCI USA, V107, P10002, DOI 10.1073/pnas.1002181107; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504	3	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S8	S9		10.1038/468S8a	http://dx.doi.org/10.1038/468S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179084	Bronze			2022-12-28	WOS:000285553800003
J	Fiumara, F; Fioriti, L; Kandel, ER; Hendrickson, WA				Fiumara, Ferdinando; Fioriti, Luana; Kandel, Eric R.; Hendrickson, Wayne A.			Essential Role of Coiled Coils for Aggregation and Activity of Q/N-Rich Prions and PolyQ Proteins	CELL			English	Article							CRYSTAL-STRUCTURE; SECONDARY STRUCTURE; TERMINAL DOMAIN; GLUTAMINE-RICH; APLYSIA CPEB; YEAST; SEQUENCE; PEPTIDES; ANGSTROM; FIBRILS	The functional switch of glutamine/asparagine (Q/N)-rich prions and the neurotoxicity of polyQ-expanded proteins involve complex aggregation-prone structural transitions, commonly presumed to be forming beta sheets. By analyzing sequences of interaction partners of these proteins, we discovered a recurrent presence of coiled-coil domains both in the partners and in segments that flank or overlap Q/N-rich and polyQ domains. Since coiled coils can mediate protein interactions and multimerization, we studied their possible involvement in Q/N-rich and polyQ aggregations. Using circular dichroism and chemical crosslinking, we found that Q/N-rich and polyQ peptides form alpha-helical coiled coils in vitro and assemble into multimers. Using structure-guided mutagenesis, we found that coiled-coil domains modulate in vivo properties of two Q/N-rich prions and polyQ-expanded huntingtin. Mutations that disrupt coiled coils impair aggregation and activity, whereas mutations that enhance coiled-coil propensity promote aggregation. These findings support a coiled-coil model for the functional switch of Q/N-rich prions and for the pathogenesis of polyQ-expansion diseases.	[Fiumara, Ferdinando; Fioriti, Luana; Kandel, Eric R.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Fioriti, Luana; Kandel, Eric R.; Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Fiumara, Ferdinando] Univ Turin, Dept Neurosci, I-10124 Turin, Italy	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University; Columbia University; University of Turin	Kandel, ER (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	erk5@columbia.edu; wayne@convex.hhmi.columbia.edu	Fiumara, Ferdinando/AAE-3074-2022; Fioriti, Luana/AAN-7207-2021	fioriti, luana/0000-0003-2429-8967; FIUMARA, Ferdinando/0000-0003-0715-7863	HHMI; Mathers Foundation; Broitman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060762] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Mathers Foundation; Broitman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Emi Ling for technical support; Francisco Monje, Burkhard Rost, and Ann McDermott for helpful discussions and suggestions; and Craig Bailey, Christoph Kellendonk, and Radegonda Mazzitelli for critical reading of the manuscript. This work was supported by grants from HHMI, Mathers Foundation, and Broitman Foundation.	Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Chang DK, 1999, J STRUCT BIOL, V128, P270, DOI 10.1006/jsbi.1999.4182; COLLOCH N, 1991, J MOL BIOL, V221, P603, DOI 10.1016/0022-2836(91)80075-6; Davies P, 2008, J MOL ENDOCRINOL, V41, P301, DOI 10.1677/JME-08-0042; Deng YQ, 2007, PROTEIN SCI, V16, P323, DOI 10.1110/ps.062590807; Frost DWH, 2005, BIOPOLYMERS, V80, P26, DOI 10.1002/bip.20188; Gazi AD, 2008, J BIOL CHEM, V283, P34062, DOI 10.1074/jbc.M803408200; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1002, DOI 10.1038/nsb1296-1002; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; Harada N, 2010, J STEROID BIOCHEM, V118, P77, DOI 10.1016/j.jsbmb.2009.10.003; Hicks MR, 2002, J STRUCT BIOL, V137, P73, DOI 10.1006/jsbi.2002.4462; Kelley NW, 2009, J MOL BIOL, V388, P919, DOI 10.1016/j.jmb.2009.01.032; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Krammer C, 2009, P NATL ACAD SCI USA, V106, P462, DOI 10.1073/pnas.0811571106; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; Lathrop R H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P105; Leitgeb B, 2007, J MOL MODEL, V13, P1141, DOI 10.1007/s00894-007-0241-4; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martin J, 2004, TRENDS BIOCHEM SCI, V29, P455, DOI 10.1016/j.tibs.2004.07.004; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Narayanan S, 2006, CHEMBIOCHEM, V7, P757, DOI 10.1002/cbic.200500382; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Niu Q, 2008, J MOL BIOL, V375, P1197, DOI 10.1016/j.jmb.2007.11.036; Odgren PR, 1996, PROTEINS, V24, P467, DOI 10.1002/(SICI)1097-0134(199604)24:4<467::AID-PROT6>3.0.CO;2-B; Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404; Ono BI, 2008, PRION, V2, P37, DOI 10.4161/pri.2.1.6436; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Potekhin SA, 2001, CHEM BIOL, V8, P1025, DOI 10.1016/S1074-5521(01)00073-4; PRUSINER SB, 1987, ANNU REV MED, V38, P381, DOI 10.1146/annurev.me.38.020187.002121; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Schwalbe M, 2010, PROTEINS, V78, P2433, DOI 10.1002/prot.22752; Shin DH, 2006, PROTEIN SCI, V15, P921, DOI 10.1110/ps.051993506; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; SODEK J, 1972, P NATL ACAD SCI USA, V69, P3800, DOI 10.1073/pnas.69.12.3800; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Xu SH, 2007, AMYLOID, V14, P119, DOI 10.1080/13506120701260059; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153; Yang ZN, 1999, J STRUCT BIOL, V126, P131, DOI 10.1006/jsbi.1999.4116	53	171	171	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1121	1135		10.1016/j.cell.2010.11.042	http://dx.doi.org/10.1016/j.cell.2010.11.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183075	Green Accepted, Bronze			2022-12-28	WOS:000285625400010
J	Timmins, S; Hibbert, M				Timmins, Sophie; Hibbert, Michael			Metastatic Pulmonary Calcification.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Timmins, Sophie; Hibbert, Michael] Royal N Shore Hosp, Sydney, NSW, Australia	Royal North Shore Hospital; University of Sydney	Timmins, S (corresponding author), Royal N Shore Hosp, Sydney, NSW, Australia.	stimmins@med.usyd.edu.au							0	3	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2547	2547		10.1056/NEJMicm1003051	http://dx.doi.org/10.1056/NEJMicm1003051			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697YL	21175317				2022-12-28	WOS:000285555600010
J	Spence, D				Spence, Des			From the Frontline Overweening on weaning	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2011	342								d334	10.1136/bmj.d334	http://dx.doi.org/10.1136/bmj.d334			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OX	21248011				2022-12-28	WOS:000286602400016
J	Bohannon, J				Bohannon, John			The Science Hall of Fame	SCIENCE			English	Editorial Material																			0	13	13	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2011	331	6014					143	143		10.1126/science.331.6014.143-c	http://dx.doi.org/10.1126/science.331.6014.143-c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233362				2022-12-28	WOS:000286433100047
J	Vergeer, M; Korporaal, SJA; Franssen, R; Meurs, I; Out, R; Hovingh, GK; Hoekstra, M; Sierts, JA; Dallinga-Thie, GM; Motazacker, MM; Holleboom, AG; Van Berkel, TJC; Kastelein, JJP; Van Eck, M; Kuivenhoven, JA				Vergeer, Menno; Korporaal, Suzanne J. A.; Franssen, Remco; Meurs, Illiana; Out, Ruud; Hovingh, G. Kees; Hoekstra, Menno; Sierts, Jeroen A.; Dallinga-Thie, Geesje M.; Motazacker, Mohammad Mahdi; Holleboom, Adriaan G.; Van Berkel, Theo J. C.; Kastelein, John J. P.; Van Eck, Miranda; Kuivenhoven, Jan Albert			Genetic Variant of the Scavenger Receptor BI in Humans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-DENSITY-LIPOPROTEIN; MARROW-DERIVED CELLS; TRANSPORT IN-VIVO; SR-BI; CHOLESTEROL EFFLUX; FAMILIAL HYPERCHOLESTEROLEMIA; LIPID-METABOLISM; TRANSFER PROTEIN; RAISING HDL; DEFICIENCY	BACKGROUND In mice, the scavenger receptor class B type I (SR-BI) is essential for the delivery of high-density lipoprotein (HDL) cholesterol to the liver and steroidogenic organs. Paradoxically, elevated HDL cholesterol levels are associated with increased atherosclerosis in SR-BI-knockout mice. It is unclear what role SR-BI plays in human metabolism. METHODS We sequenced the gene encoding SR-BI in persons with elevated HDL cholesterol levels and identified a family with a new missense mutation (P297S). The functional effects of the P297S mutation on HDL binding, cellular cholesterol uptake and efflux, atherosclerosis, platelet function, and adrenal function were studied. RESULTS Cholesterol uptake from HDL by primary murine hepatocytes that expressed mutant SR-BI was reduced to half of that of hepatocytes expressing wild-type SR-BI. Carriers of the P297S mutation had increased HDL cholesterol levels (70.4 mg per deciliter [1.8 mmol per liter], vs. 53.4 mg per deciliter [1.4 mmol per liter] in noncarriers; P<0.001) and a reduced capacity for efflux of cholesterol from macrophages, but the carotid artery intima-media thickness was similar in carriers and in family noncarriers. Platelets from carriers had increased unesterified cholesterol content and impaired function. In carriers, adrenal steroidogenesis was attenuated, as evidenced by decreased urinary excretion of sterol metabolites, a decreased response to corticotropin stimulation, and symptoms of diminished adrenal function. CONCLUSIONS We identified a family with a functional mutation in SR-BI. The mutation carriers had increased HDL cholesterol levels and a reduction in cholesterol efflux from macrophages but no significant increase in atherosclerosis. Reduced SR-BI function was associated with altered platelet function and decreased adrenal steroidogenesis.	[Vergeer, Menno; Franssen, Remco; Hovingh, G. Kees; Sierts, Jeroen A.; Dallinga-Thie, Geesje M.; Motazacker, Mohammad Mahdi; Holleboom, Adriaan G.; Kastelein, John J. P.; Kuivenhoven, Jan Albert] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Korporaal, Suzanne J. A.; Meurs, Illiana; Out, Ruud; Hoekstra, Menno; Van Berkel, Theo J. C.; Van Eck, Miranda] Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC	Kuivenhoven, JA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9,G1-113, NL-1105 AZ Amsterdam, Netherlands.	j.a.kuivenhoven@amc.uva.nl	Van Berkel, Theo/ABD-7677-2021; Kastelein, John/AAF-7950-2020	Holleboom, A.G. (Onno)/0000-0002-2911-2917; Hoekstra, Menno/0000-0001-7463-2893; dallinga-thie, geesje/0000-0001-5412-5923; van Eck, Miranda/0000-0003-3936-3194	European Community [037631]; Netherlands Heart Foundation [2006B107, 2007T056, 2008T070, 2009B027]; Netherlands Organization for Scientific Research [021.001.035, 917.66.301]	European Community(European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Supported by grants from the European Community (FP6-2005-LifeSciHealth-6; STREP contract number 037631), the Netherlands Heart Foundation (2006B107, 2007T056, 2008T070, and 2009B027), and the Netherlands Organization for Scientific Research (project numbers 021.001.035 and 917.66.301).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Acton S, 1999, ARTERIOSCL THROM VAS, V19, P1734, DOI 10.1161/01.ATV.19.7.1734; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Covey SD, 2003, ARTERIOSCL THROM VAS, V23, P1589, DOI 10.1161/01.ATV.0000083343.19940.A0; Covey SD, 2003, ARTERIOSCLER THROMB, V23, P1950; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dole VS, 2008, ARTERIOSCL THROM VAS, V28, P1111, DOI 10.1161/ATVBAHA.108.162347; Duong M, 2006, ARTERIOSCL THROM VAS, V26, P541, DOI 10.1161/01.ATV.0000203515.25574.19; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; Hsu LA, 2003, ARTERIOSCL THROM VAS, V23, P1869, DOI 10.1161/01.ATV.0000082525.84814.A9; ILLINGWORTH DR, 1984, J CLIN ENDOCR METAB, V58, P206, DOI 10.1210/jcem-58-1-206; ILLINGWORTH DR, 1983, METABOLISM, V32, P1045, DOI 10.1016/0026-0495(83)90075-6; Imachi H, 2003, ARTERIOSCL THROM VAS, V23, P898, DOI 10.1161/01.ATV.0000067429.46333.7B; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Joy T, 2008, NAT REV DRUG DISCOV, V7, P143, DOI 10.1038/nrd2489; Lange K, 2001, AM J HUM GENET, V69, P504; Masson D, 2009, ARTERIOSCL THROM VAS, V29, P2054, DOI 10.1161/ATVBAHA.109.191320; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; NORUM KR, 1967, SCAND J CLIN LAB INV, V20, P231, DOI 10.3109/00365516709076948; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; Out R, 2004, J LIPID RES, V45, P2088, DOI 10.1194/jlr.M400191-JLR200; Pirillo A, 2006, BBA-MOL CELL BIOL L, V1761, P292, DOI 10.1016/j.bbalip.2006.03.009; Rader DJ, 2009, CIRCULATION, V120, P549, DOI 10.1161/CIRCULATIONAHA.109.881979; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84; Van Eck M, 2004, AM J PATHOL, V165, P785, DOI 10.1016/S0002-9440(10)63341-X; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; West M, 2009, J CLIN ENDOCR METAB, V94, P1451, DOI 10.1210/jc.2008-1223; Wild S, 2008, HEART, V94, P692, DOI 10.1136/hrt.2007.126326; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	39	246	253	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					136	145		10.1056/NEJMoa0907687	http://dx.doi.org/10.1056/NEJMoa0907687			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226579	Bronze			2022-12-28	WOS:000286142900007
J	Berkes, P; Orban, G; Lengyel, M; Fiser, J				Berkes, Pietro; Orban, Gergo; Lengyel, Mate; Fiser, Jozsef			Spontaneous Cortical Activity Reveals Hallmarks of an Optimal Internal Model of the Environment	SCIENCE			English	Article							BAYESIAN-INFERENCE; NATURAL SCENES; VISUAL-CORTEX; POPULATION; PERCEPTION; EMERGENCE	The brain maintains internal models of its environment to interpret sensory inputs and to prepare actions. Although behavioral studies have demonstrated that these internal models are optimally adapted to the statistics of the environment, the neural underpinning of this adaptation is unknown. Using a Bayesian model of sensory cortical processing, we related stimulus-evoked and spontaneous neural activities to inferences and prior expectations in an internal model and predicted that they should match if the model is statistically optimal. To test this prediction, we analyzed visual cortical activity of awake ferrets during development. Similarity between spontaneous and evoked activities increased with age and was specific to responses evoked by natural scenes. This demonstrates the progressive adaptation of internal models to the statistics of natural stimuli at the neural level.	[Berkes, Pietro; Orban, Gergo; Fiser, Jozsef] Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA; [Orban, Gergo] Hungarian Acad Sci, Res Inst Particle & Nucl Phys, Dept Biophys, H-1121 Budapest, Hungary; [Orban, Gergo; Lengyel, Mate] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Fiser, Jozsef] Brandeis Univ, Dept Psychol, Waltham, MA 02454 USA; [Fiser, Jozsef] Brandeis Univ, Neurosci Program, Waltham, MA 02454 USA; [Fiser, Jozsef] Coll Budapest Inst Adv Study, H-1014 Budapest, Hungary	Brandeis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; University of Cambridge; Brandeis University; Brandeis University	Berkes, P (corresponding author), Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA.	berkes@brandeis.edu	Lengyel, Mate/A-6665-2013	Lengyel, Mate/0000-0001-7266-0049; Orban, Gergo/0000-0002-2406-5912; Fiser, Jozsef/0000-0002-7064-0690; Berkes, Pietro/0000-0002-2827-3911	Swartz Foundation; Swiss National Science Foundation; EU; Wellcome Trust; NIH; NATIONAL EYE INSTITUTE [R01EY018196] Funding Source: NIH RePORTER	Swartz Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Wolpert and D. Katz for suggestions on the manuscript, C. Chiu and M. Weliky for help with the data collection, and D. Lisitsyn for technical help. This work was supported by the Swartz Foundation (J.F., G.O., and P.B.), the Swiss National Science Foundation (P.B.), an EU-FP7 Marie Curie Intra-European Fellowship (G.O.), the Wellcome Trust (M.L.), and NIH (J.F.).	Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Blaisdell AP, 2006, SCIENCE, V311, P1020, DOI 10.1126/science.1121872; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Dayan P., 1999, THEORETICAL NEUROSCI; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Goldberg JA, 2004, NEURON, V42, P489, DOI 10.1016/S0896-6273(04)00197-7; Hoyer P., 2003, ADV NEURAL INFORM PR, V16, P293; Jaynes E.T., 2003, PROBABILITY THEORY L; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; Sobel DM, 2004, COGNITIVE SCI, V28, P303, DOI 10.1016/j.cogsci.2003.11.001; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Teh YW, 2004, J MACH LEARN RES, V4, P1235; Trommershauser J, 2008, TRENDS COGN SCI, V12, P291, DOI 10.1016/j.tics.2008.04.010; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	22	399	400	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					83	87		10.1126/science.1195870	http://dx.doi.org/10.1126/science.1195870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212356	Green Accepted			2022-12-28	WOS:000285974000041
J	Badri, T; Ben Jennet, S				Badri, Talel; Ben Jennet, Salima			Rash Associated with Secondary Syphilis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Badri, Talel; Ben Jennet, Salima] Univ Tunis El Manar, Habib Thameur Hosp, Tunis, Tunisia	Universite de Tunis-El-Manar; Hopital Habib Thameur	Badri, T (corresponding author), Univ Tunis El Manar, Habib Thameur Hosp, Tunis, Tunisia.	talel_badri@yahoo.fr							0	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					71	71		10.1056/NEJMicm1005345	http://dx.doi.org/10.1056/NEJMicm1005345			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UY	21208110				2022-12-28	WOS:000285922600012
J	Patel, V; Chatterji, S; Chisholm, D; Ebrahim, S; Gopalakrishna, G; Mathers, C; Mohan, V; Prabhakaran, D; Ravindran, RD; Reddy, KS				Patel, Vikram; Chatterji, Somnath; Chisholm, Dan; Ebrahim, Shah; Gopalakrishna, Gururaj; Mathers, Colin; Mohan, Viswanathan; Prabhakaran, Dorairaj; Ravindran, Ravilla D.; Reddy, K. Srinath			India: Towards Universal Health Coverage 3 Chronic diseases and injuries in India	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; COST-EFFECTIVENESS; MYOCARDIAL-INFARCTION; GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; EDUCATIONAL STATUS; HEART-DISEASE; RISK-FACTORS; TOBACCO USE; ALCOHOL-USE	Chronic diseases (eg, cardiovascular diseases, mental health disorders, diabetes, and cancer) and injuries are the leading causes of death and disability in India, and we project pronounced increases in their contribution to the burden of disease during the next 25 years. Most chronic diseases are equally prevalent in poor and rural populations and often occur together. Although a wide range of cost-effective primary and secondary prevention strategies are available, their coverage is generally low, especially in poor and rural populations. Much of the care for chronic diseases and injuries is provided in the private sector and can be very expensive. Sufficient evidence exists to warrant immediate action to scale up interventions for chronic diseases and injuries through private and public sectors; improved public health and primary health-care systems are essential for the implementation of cost-effective interventions. We strongly advocate the need to strengthen social and policy frameworks to enable the implementation of interventions such as taxation on bidis (small hand-rolled cigarettes), smokeless tobacco, and locally brewed alcohols. We also advocate the integration of national programmes for various chronic diseases and injuries with one another and with national health agendas. India has already passed the early stages of a chronic disease and injury epidemic; in view of the implications for future disease burden and the demographic transition that is in progress in India, the rate at which effective prevention and control is implemented should be substantially increased. The emerging agenda of chronic diseases and injuries should be a political priority and central to national consciousness, if universal health care is to be achieved.	[Patel, Vikram; Ebrahim, Shah] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Patel, Vikram] Sangath, Porvorim, Goa, India; [Chisholm, Dan] WHO, Dept Hlth Syst Financing, CH-1211 Geneva, Switzerland; [Ebrahim, Shah; Prabhakaran, Dorairaj; Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Gopalakrishna, Gururaj] WHO Collaborating Ctr Injury Prevent & Safety Pro, Natl Inst Mental Hlth & Neurosci, Dept Epidemiol, Bengaluru, India; [Mohan, Viswanathan] Dr Mohans Diabet Special Ctr, Madras, Tamil Nadu, India; [Mohan, Viswanathan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control India, New Delhi, India; [Ravindran, Ravilla D.] Aravind Eye Care Syst, Madurai, Tamil Nadu, India	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Public Health Foundation of India; National Institute of Mental Health & Neurosciences - India; Madras Diabetes Research Foundation	Patel, V (corresponding author), Sangath Ctr, Alto Porvorim 403521, Goa, India.	vikram.patel@lshtm.ac.uk	Prabhakaran, Dorairaj/B-4147-2011; CHATTERJI, Somnath/ABE-6832-2020	Prabhakaran, Dorairaj/0000-0002-3172-834X; Patel, Vikram/0000-0003-1066-8584; Reddy, K Srinath/0000-0003-3416-3548; Mathers, Colin/0000-0002-0617-6731	Wellcome Trust; John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	VP is supported by a Wellcome Trust Senior Clinical Research Fellowship in Tropical Medicine. We acknowledge the contribution of Krishna Rao who collated economic data for the cost-effectiveness estimates; the India World Health Survey team (P Arokiasamy) for doing the survey; and Emese Verdes for assisting with the World Health Survey analysis. The views expressed in this report are solely the responsibility of the named authors and do not necessarily reflect the decisions or stated policy of the WHO or its member states. The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; [Anonymous], 2000, TOB IND IND EC AN; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Baltussen R, 2009, INT J AUDIOL, V48, P144, DOI 10.1080/14992020802538081; Baltussen R, 2009, HEALTH POLICY, V89, P201, DOI 10.1016/j.healthpol.2008.06.003; Bang A, 1995, HLTH ACTION, V11, P2; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Bidi Smoking and Public Health, 2008, BIDI SMOKING PUBLIC; BRILLIANT GE, 1991, ARCH OPHTHALMOL-CHIC, V109, P584, DOI 10.1001/archopht.1991.01080040152048; Cecchini M, 2010, LANCET          1111, DOI [10.1016/S0140-6736(10)61514-0, DOI 10.1016/50140-6736(10)61514-0]; Chang DF, 2005, BRIT J OPHTHALMOL, V89, P1073, DOI 10.1136/bjo.2005.068213; Chatterjee S, 2003, BRIT J PSYCHIAT, V182, P57, DOI 10.1192/bjp.182.1.57; Chatterji S, 2008, HEALTH AFFAIR, V27, P1052, DOI 10.1377/hlthaff.27.4.1052; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Chisholm D, 2004, BRIT J PSYCHIAT, V184, P393, DOI 10.1192/bjp.184.5.393; Chisholm D, 2008, ROAD TRAFFIC INJURY, P4; Chisholm D, 2008, B WORLD HEALTH ORGAN, V86, P542, DOI 10.2471/BLT.07.045377; Chow J, 2007, COST EFFECTIVENESS D; Crime National Records, 2007, ACC DEATHS SUIC IND, V11; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Duc AH, 2011, HEALTH POLICY PLANN, V26, P210, DOI 10.1093/heapol/czq045; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; Ferguson B., 2003, HLTH SYSTEMS PERFORM, P747; Gajalakshmi V, 2007, INT J EPIDEMIOL, V36, P203, DOI 10.1093/ije/dyl308; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Gill A, 2006, EC POLIT WKLY, V26, P27662; Ginsberg Gary M, 2010, Cost Eff Resour Alloc, V8, P2, DOI 10.1186/1478-7547-8-2; Ginsberg GM, 2009, VACCINE, V27, P6060, DOI 10.1016/j.vaccine.2009.07.026; Go R, 2005, STRIKING RIGHT BALAN; Gonzalez-Pier E, 2006, LANCET, V368, P1608, DOI 10.1016/S0140-6736(06)69567-6; Groot MT, 2006, BREAST J, V12, pS81, DOI 10.1111/j.1075-122X.2006.00206.x; Grover A, 2011, LANCET, V377, P976, DOI 10.1016/S0140-6736(10)62042-9; Gupta P. C., 2008, BIDI SMOKING PUBLIC; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Gupta R, 2006, INDIAN J MED RES, V124, P15; Gururaj G., 2006, ROAD TRAFFIC INJURY; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; John R, EC TOBACCO TOBACCO T; John RM, 2008, HEALTH POLICY PLANN, V23, P200, DOI 10.1093/heapol/czn007; John TJ, 2011, LANCET          0112, DOI [10.1016/S0140-6736(10)61265-2, DOI 10.1016/50140-6736(10)61265-2]; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Jose R, 2008, COMMUNITY EYE HLTH, V21, ps103; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Kapur A, 2007, INDIAN J MED RES, V125, P473; Karthikeyan G, 2007, HEART, V93, P1334, DOI 10.1136/hrt.2007.131193; Kinra S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a605; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Leeder S, 2004, RACE TIME CHALLENGE; Levesque JF, 2007, INT J HEALTH PLAN M, V22, P159, DOI 10.1002/hpm.879; Levesque JF, 2006, FOR 9 M MUMB; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Maselko J, 2008, J EPIDEMIOL COMMUN H, V62, P817, DOI 10.1136/jech.2007.069351; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Ministry of Road Transport and Highways Government of India, 2007, REP COMM ROAD SAF TR; Ministry of Road Transport and Highways Government of India, 2007, NAT ROAD TRANSP POL; Ministry of Urban Development Government of India, NAT URB TRANSP POL; Mock C, 2003, J TRAUMA, V54, P1197, DOI 10.1097/01.TA.0000033492.48190.7A; Mock C., 2004, GUIDELINES ESSENTIAL; Mohan Dinesh, 2004, ROAD AHEAD TRAFFIC I; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Murray CJ, LANCET, V361, P717; Murthy RS, 2007, INDIAN J MED RES, V125, P707; Nagpal J, 2006, DIABETES CARE, V29, P2341, DOI 10.2337/dc06-0783; NATCHIAR G, 1994, ARCH OPHTHALMOL-CHIC, V112, P987, DOI 10.1001/archopht.1994.01090190135035; O'Heagarty M, 2008, BIDI SMOKING PUBLIC, P13; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016; Patel V, 2001, SOCIOECONOMIC FACTOR; Patel V, 2011, LANCET          1214; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2007, TROP MED INT HEALTH, V12, P130, DOI 10.1111/j.1365-3156.2006.01756.x; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Peden M., 2004, WORLD REPORT ROAD TR; Pednekar MS, 2008, BIDI SMOKING PUBLIC, P113; Planning Commission Government of India, 2007, 11 5 YEAR PLAN, VII; Prabhakaran Dorairaj, 2005, Indian Heart J, V57, P217; Purohit BC, 2001, HEALTH POLICY PLANN, V16, P87, DOI 10.1093/heapol/16.1.87; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2007, EPIDEMIOLOGY DIABETE; Ramachandran A, 2007, DIABETES CARE, V30, P2548, DOI 10.2337/dc07-0150; Rastogi T, 2005, TOB CONTROL, V14, P356, DOI 10.1136/tc.2005.011965; Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Reddy KS, 2006, LANCET, V367, P589, DOI 10.1016/S0140-6736(06)68225-1; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Rees K, 2004, COCHRANE DB SYST REV, V2; Rehm J, 1995, ALCOHOL CAPITA CONSU; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Sasser S, PREHOSPITAL TRAUMA C; Shastri SS, 2008, BIDI SMOKING PUBLIC, P143; Shibuya K, 2003, BMJ-BRIT MED J, V327, P154, DOI 10.1136/bmj.327.7407.154; Singh RB, 2005, ACTA CARDIOL, V60, P611, DOI 10.2143/AC.60.6.2004933; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub3; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Sunley E., 2008, INDIA TAX TREATMENT; Tan-Torres Edejer T, 2003, MAKING CHOICE HLTH W; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thomas A, 2004, INVOLVEMENT IMPACT R; UNAIDS, 2007, AIDS EP UPD DEC 2007; Unwin N., 2009, INT DIABETES FEDERAT, V4; Ustun TB., 2003, WORLD HLTH SURVEYS H; Vijayakumar L, 2005, CRISIS, V26, P120, DOI 10.1027/0227-5910.26.3.120; WHO, 2005, CHRON DIS HLTH PROM; WHO Global Infobase Team, 2005, 2 WHO SURF GLOB INF; World Bank, 2008, GLOBAL ECONOMIC PROSPECTS: TECHNOLOGY DIFFUSION IN THE DEVELOPING WORLD, P1, DOI 10.1596/978-0-8213-7365-1; World Health Organisation, 2008, CLOS GAP GEN; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization, GLOB HLTH RISKS MORT; World Health Organization, GUID TRAUM QUAL IMPR; World Health Organization, 2004, GLOB BURD DIS 2004 U; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	122	220	222	3	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2011	377	9763					413	428		10.1016/S0140-6736(10)61188-9	http://dx.doi.org/10.1016/S0140-6736(10)61188-9			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721ES	21227486				2022-12-28	WOS:000287337000031
J	Panosian, C				Panosian, Claire			Courting Danger While Doing Good -- Protecting Global Health Workers from Harm.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Panosian, Claire] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Program Global Hlth, Los Angeles, CA 90095 USA; [Panosian, Claire] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Panosian, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Program Global Hlth, Los Angeles, CA 90095 USA.							Dahlgren AL, 2009, J TRAVEL MED, V16, P382, DOI 10.1111/j.1708-8305.2009.00350.x; Division of Medical Education, 2009, GQ MED SCH GRAD QUES; Mohan S, 2010, J TRAVEL MED, V17, P264, DOI 10.1111/j.1708-8305.2010.00421.x; Panosian C, 2006, NEW ENGL J MED, V354, P1771, DOI 10.1056/NEJMp068035; Sleet DA, 2009, CDC HLTH INFORM INT, P209	5	5	6	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2484	2485		10.1056/NEJMp1011407	http://dx.doi.org/10.1056/NEJMp1011407			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697YL	21175310				2022-12-28	WOS:000285555600003
J	Richly, H; Rocha-Viegas, L; Ribeiro, JD; Demajo, S; Gundem, G; Lopez-Bigas, N; Nakagawa, T; Rospert, S; Ito, T; Di Croce, L				Richly, Holger; Rocha-Viegas, Luciana; Domingues Ribeiro, Joana; Demajo, Santiago; Gundem, Gunes; Lopez-Bigas, Nuria; Nakagawa, Tekeya; Rospert, Sabine; Ito, Takashi; Di Croce, Luciano			Transcriptional activation of polycomb-repressed genes by ZRF1	NATURE			English	Article							RNA-POLYMERASE-II; H2A UBIQUITINATION; HISTONE H2B; PROTEIN; CHROMATIN; DIFFERENTIATION; MONOUBIQUITINATION; DEMETHYLATION; INITIATION; LEUKEMIA	Covalent modification of histones is fundamental in orchestrating chromatin dynamics and transcription(1-3). One example of such an epigenetic mark is the mono-ubiquitination of histones, which mainly occurs at histone H2A and H2B(4-6). Ubiquitination of histone H2A has been implicated in polycomb-mediated transcriptional silencing(7-9). However, the precise role of the ubiquitin mark during silencing is still elusive. Here we show in human cell lines that ZRF1 (zuotin-related factor 1) is specifically recruited to histone H2A when it is ubiquitinated at Lys 119 by means of a novel ubiquitin-interacting domain that is located in the evolutionarily conserved zuotin domain. At the onset of differentiation, ZRF1 specifically displaces polycomb-repressive complex 1 (PRC1) from chromatin and facilitates transcriptional activation. A genome-wide mapping of ZRF1, RING1B and H2A-ubiquitin targets revealed its involvement in the regulation of a large set of polycomb target genes, emphasizing the key role ZRF1 has in cell fate decisions. We provide here a model of the molecular mechanism of switching polycomb-repressed genes to an active state.	[Richly, Holger; Rocha-Viegas, Luciana; Domingues Ribeiro, Joana; Demajo, Santiago; Di Croce, Luciano] UPF, CRG, Barcelona 08003, Spain; [Gundem, Gunes; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08003, Spain; [Nakagawa, Tekeya; Ito, Takashi] Nagasaki Univ, Sch Med, Nagasaki 8528523, Japan; [Rospert, Sabine] Univ Freiburg, Inst Biochem & Mol Biol ZBMZ, D-79104 Freiburg, Germany; [Di Croce, Luciano] PRBB, CRG, ICREA, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Nagasaki University; University of Freiburg; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Di Croce, L (corresponding author), UPF, CRG, Barcelona 08003, Spain.	luciano.dicroce@crg.es	Lopez-Bigas, Nuria/F-6193-2011; Ribeiro, Joana/K-3357-2014; Demajo, Santiago/AAB-1999-2021; Di Croce, Luciano/E-7759-2015	Lopez-Bigas, Nuria/0000-0003-4925-8988; Ribeiro, Joana/0000-0003-2221-4002; Di Croce, Luciano/0000-0003-3488-6228; Rospert, Sabine/0000-0002-3089-9614; Rocha-Viegas, Luciana/0000-0001-7857-0212; Demajo Meseguer, Santiago/0000-0003-3998-8784	Spanish "Ministerio de Educacion y Ciencia'' [BFU2007-63059]; Association for International Cancer Research [10-0177]; AGAUR; Consolider; FEBS fellowship; Fundacao para a Ciencia e Tecnologia; Juan de la Cierva Fellowship; PFIS fellowship;  [FOR967]; ICREA Funding Source: Custom	Spanish "Ministerio de Educacion y Ciencia''(Spanish Government); Association for International Cancer Research; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEBS fellowship; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Juan de la Cierva Fellowship; PFIS fellowship; ; ICREA(ICREA)	We are indebted to S. Jentsch, S. Berger, K. Helin, J. Hasskarl, R. Shiekattar, T. Zimmermann and V. Raker for antibodies and plasmids and for discussions; and to the CRG Microarray facility and Light Microscopy Facility. This work was supported by the Spanish "Ministerio de Educacion y Ciencia'' (BFU2007-63059), the Association for International Cancer Research (10-0177), by the AGAUR and Consolider to L. D. C., and by FOR967 to S. R.; H. R. was supported by a FEBS fellowship; J. R. by a fellowship from Fundacao para a Ciencia e Tecnologia; L. R.-V. by a Juan de la Cierva Fellowship; S. D. by a PFIS fellowship.	ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; ANDREWS PW, 1984, LAB INVEST, V50, P147; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Gibbons FD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r96; GOLDKNOPF IL, 1975, J BIOL CHEM, V250, P7182; Greiner J, 2003, INT J CANCER, V106, P224, DOI 10.1002/ijc.11200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue T, 1999, BIOCHEM BIOPH RES CO, V266, P147, DOI 10.1006/bbrc.1999.1779; Kallin EM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000506; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; LEVINGER L, 1982, CELL, V28, P375, DOI 10.1016/0092-8674(82)90355-5; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P958, DOI 10.1021/bi00429a006; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Resto VA, 2000, CANCER RES, V60, P5529; Saito S, 2008, INT J CANCER, V123, P633, DOI 10.1002/ijc.23490; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	33	103	105	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1124	U533		10.1038/nature09574	http://dx.doi.org/10.1038/nature09574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179169				2022-12-28	WOS:000285553800063
J	Verbrugge, I; Johnstone, RW; Smyth, MJ				Verbrugge, Inge; Johnstone, Ricky W.; Smyth, Mark J.			SnapShot: Extrinsic Apoptosis Pathways	CELL			English	Editorial Material							DEATH RECEPTORS; MITOCHONDRIA; INDUCTION; LIGAND; TRAIL		[Verbrugge, Inge; Johnstone, Ricky W.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia	Peter Maccallum Cancer Center	Verbrugge, I (corresponding author), Peter MacCallum Canc Ctr, Div Res, St Andrews Pl, Melbourne, Vic 3002, Australia.		Johnstone, Ricky w/H-3748-2014; Smyth, Mark J/H-8709-2014	Johnstone, Ricky w/0000-0001-7053-9237; Smyth, Mark J/0000-0001-7098-7240				ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386	10	50	53	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1192	+	1192.e1	10.1016/j.cell.2010.12.004	http://dx.doi.org/10.1016/j.cell.2010.12.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183080	Bronze			2022-12-28	WOS:000285625400016
J	Vavalle, JP; Newby, LK				Vavalle, John P.; Newby, L. Kristin			Review: Angiotensin-receptor blockers increase risk for cancer but not cancer-related death	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Vavalle, John P.; Newby, L. Kristin] Duke Univ, Med Ctr, Durham, NC 27706 USA	Duke University	Vavalle, JP (corresponding author), Duke Univ, Med Ctr, Durham, NC 27706 USA.							Bommer William J, 2008, Prev Cardiol, V11, P148; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Walther T, 2003, FASEB J, V17, P2061, DOI 10.1096/fj.03-0129com	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12							JC6-8	10.7326/0003-4819-153-12-201012210-02008	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173409				2022-12-28	WOS:000285453700025
J	Kesselheim, AS; Austad, KE				Kesselheim, Aaron S.; Austad, Kirsten E.			Residents: Workers or Students in the Eyes of the Law?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Aaron S.; Austad, Kirsten E.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.; Austad, Kirsten E.] Harvard Univ, Sch Med, Boston, MA USA; [Austad, Kirsten E.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Austad, Kirsten/ABC-7684-2021; Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Austad, Kirsten/0000-0001-5237-2955				MAY, DDD; *MAY FDN MED ED RE, 2010, BRIEF PET; Nuckols TK, 2009, NEW ENGL J MED, V360, P2202, DOI 10.1056/NEJMsa0810251; TK N, 2009, NEW ENGL J MED, V360, P2202	4	9	10	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					697	699		10.1056/NEJMp1100414	http://dx.doi.org/10.1056/NEJMp1100414			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725NP	21226569				2022-12-28	WOS:000287652500003
J	Gutierrez, NL; Hilborn, R; Defeo, O				Gutierrez, Nicolas L.; Hilborn, Ray; Defeo, Omar			Leadership, social capital and incentives promote successful fisheries	NATURE			English	Article							MANAGEMENT; COMANAGEMENT; PRINCIPLES; GOVERNANCE; QUOTAS	One billion people depend on seafood as their primary source of protein and 25% of the world's total animal protein comes from fisheries(1). Yet a third of fish stocks worldwide are overexploited or depleted(1,2). Using individual case studies, many have argued that community-based co-management(3) should prevent the tragedy of the commons(4) because cooperative management by fishers, managers and scientists often results in sustainable fisheries(3,5,6). However, general and multidisciplinary evaluations of co-management regimes and the conditions for social, economic and ecological success within such regimes are lacking. Here we examine 130 co-managed fisheries in a wide range of countries with different degrees of development, ecosystems, fishing sectors and type of resources. We identified strong leadership as the most important attribute contributing to success, followed by individual or community quotas, social cohesion and protected areas. Less important conditions included enforcement mechanisms, long-term management policies and life history of the resources. Fisheries were most successful when at least eight co-management attributes were present, showing a strong positive relationship between the number of these attributes and success, owing to redundancy in management regulations. Our results demonstrate the critical importance of prominent community leaders and robust social capital(7), combined with clear incentives through catch shares and conservation benefits derived from protected areas, for successfully managing aquatic resources and securing the livelihoods of communities depending on them. Our study offers hope that co-management, the only realistic solution for the majority of the world's fisheries, can solve many of the problems facing global fisheries.	[Gutierrez, Nicolas L.; Hilborn, Ray] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Defeo, Omar] Fac Ciencias, UNDECIMAR, Montevideo 11400, Uruguay	University of Washington; University of Washington Seattle; Universidad de la Republica, Uruguay	Gutierrez, NL (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	nicolasg@uw.edu	Gutierrez, Nicolas/D-4026-2009; Hilborn, Ray W/D-6332-2013	Defeo, Omar/0000-0001-8318-528X	National Science Foundation [0308440]; Fulbright-OAS Initiative in Ecology; Pew Charitable Trusts	National Science Foundation(National Science Foundation (NSF)); Fulbright-OAS Initiative in Ecology; Pew Charitable Trusts	N.L.G. was partially funded by the National Science Foundation (award 0308440) and a Fulbright-OAS Initiative in Ecology fellowship. O.D. acknowledges support by the Pew Charitable Trusts. We thank E. Ostrom, T. A. Branch, and X. Basurto for comments on the manuscript and A. E. Punt, W. N. Venables, R. Perera and S. Sethi for discussions on the methodological and statistical approach.	Basurto X., 2009, J NATURAL RESOURCES, V1, P255, DOI DOI 10.1080/19390450903040447; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Borrini-Feyerabend G., 2004, SHARING POWER LEARNI; Branch TA, 2009, FISH FISH, V10, P39, DOI 10.1111/j.1467-2979.2008.00294.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Castilla JC, 2005, SCIENCE, V309, P1324; Chetty RK, 2010, CLIN PHARMACOL THER, V88, P260, DOI 10.1038/clpt.2010.77; Costanza R, 1998, SCIENCE, V281, P198, DOI 10.1126/science.281.5374.198; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Defeo O, 2005, REV FISH BIOL FISHER, V15, P265, DOI 10.1007/s11160-005-4865-0; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Essington TE, 2010, P NATL ACAD SCI USA, V107, P754, DOI 10.1073/pnas.0907252107; Food and Agriculture Organization of the United Nations, 2009, FAO YB FISH AQ STAT; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hilborn R, 2007, FISH FISH, V8, P285, DOI 10.1111/j.1467-2979.2007.00263_2.x; Hilborn R, 2007, MAR POLICY, V31, P153, DOI 10.1016/j.marpol.2006.05.014; Levin S, 2010, PHILOS T R SOC B, V365, P13, DOI 10.1098/rstb.2009.0197; Olsson P, 2004, ECOL SOC, V9; Olsson P, 2004, ENVIRON MANAGE, V34, P75, DOI 10.1007/s00267-003-0101-7; Ostrom, 1990, GOVERNING COMMONS, DOI DOI 10.1017/CBO9780511807763; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pollnac R., 2010, P NATL ACAD SCI US; Pomeroy R.S., 1994, FISHERIES COMANAGEME; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Stefansson G, 2005, PHILOS T R SOC B, V360, P133, DOI 10.1098/rstb.2004.1579; United Nations Development Program, 2009, HUM DEV IND; Wilson J, 2007, P NATL ACAD SCI USA, V104, P15212, DOI 10.1073/pnas.0702241104; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	30	829	844	12	574	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					386	389		10.1038/nature09689	http://dx.doi.org/10.1038/nature09689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21209616				2022-12-28	WOS:000287409100040
J	Tavani, M; Bulgarelli, A; Vittorini, V; Pellizzoni, A; Striani, E; Caraveo, P; Weisskopf, MC; Tennant, A; Pucella, G; Trois, A; Costa, E; Evangelista, Y; Pittori, C; Verrecchia, F; Del Monte, E; Campana, R; Pilia, M; De Luca, A; Donnarumma, I; Horns, D; Ferrigno, C; Heinke, CO; Trifoglio, M; Gianotti, F; Vercellone, S; Argan, A; Barbiellini, G; Cattaneo, PW; Chen, AW; Contessi, T; D'Ammando, F; DeParis, G; Di Cocco, G; Di Persio, G; Feroci, M; Ferrari, A; Galli, M; Giuliani, A; Giusti, M; Labanti, C; Lapshov, I; Lazzarotto, F; Lipari, P; Longo, F; Fuschino, F; Marisaldi, M; Mereghetti, S; Morelli, E; Moretti, E; Morselli, A; Pacciani, L; Perotti, F; Piano, G; Picozza, P; Prest, M; Rapisarda, M; Rappoldi, A; Rubini, A; Sabatini, S; Soffitta, P; Vallazza, E; Zambra, A; Zanello, D; Lucarelli, F; Santolamazza, P; Giommi, P; Salotti, L; Bignami, GF				Tavani, M.; Bulgarelli, A.; Vittorini, V.; Pellizzoni, A.; Striani, E.; Caraveo, P.; Weisskopf, M. C.; Tennant, A.; Pucella, G.; Trois, A.; Costa, E.; Evangelista, Y.; Pittori, C.; Verrecchia, F.; Del Monte, E.; Campana, R.; Pilia, M.; De Luca, A.; Donnarumma, I.; Horns, D.; Ferrigno, C.; Heinke, C. O.; Trifoglio, M.; Gianotti, F.; Vercellone, S.; Argan, A.; Barbiellini, G.; Cattaneo, P. W.; Chen, A. W.; Contessi, T.; D'Ammando, F.; DeParis, G.; Di Cocco, G.; Di Persio, G.; Feroci, M.; Ferrari, A.; Galli, M.; Giuliani, A.; Giusti, M.; Labanti, C.; Lapshov, I.; Lazzarotto, F.; Lipari, P.; Longo, F.; Fuschino, F.; Marisaldi, M.; Mereghetti, S.; Morelli, E.; Moretti, E.; Morselli, A.; Pacciani, L.; Perotti, F.; Piano, G.; Picozza, P.; Prest, M.; Rapisarda, M.; Rappoldi, A.; Rubini, A.; Sabatini, S.; Soffitta, P.; Vallazza, E.; Zambra, A.; Zanello, D.; Lucarelli, F.; Santolamazza, P.; Giommi, P.; Salotti, L.; Bignami, G. F.			Discovery of Powerful Gamma-Ray Flares from the Crab Nebula	SCIENCE			English	Article							HIGH-ENERGY; TELESCOPE; EMISSION; PULSARS; SHOCKS; WISPS	The well-known Crab Nebula is at the center of the SN1054 supernova remnant. It consists of a rotationally powered pulsar interacting with a surrounding nebula through a relativistic particle wind. The emissions originating from the pulsar and nebula have been considered to be essentially stable. Here, we report the detection of strong gamma-ray (100 mega-electron volts to 10 giga-electron volts) flares observed by the AGILE satellite in September 2010 and October 2007. In both cases, the total gamma-ray flux increased by a factor of three compared with the non-flaring flux. The flare luminosity and short time scale favor an origin near the pulsar, and we discuss Chandra Observatory x-ray and Hubble Space Telescope optical follow-up observations of the nebula. Our observations challenge standard models of nebular emission and require power-law acceleration by shock-driven plasma wave turbulence within an approximately 1-day time scale.	[Tavani, M.; Vittorini, V.; Trois, A.; Costa, E.; Evangelista, Y.; Del Monte, E.; Campana, R.; Donnarumma, I.; Argan, A.; DeParis, G.; Di Persio, G.; Feroci, M.; Giusti, M.; Lazzarotto, F.; Pacciani, L.; Piano, G.; Picozza, P.; Rubini, A.; Sabatini, S.; Soffitta, P.] Ist Astrofis Spaziale & Fis Cosm INAF IASF Roma, Ist Nazl Astrofis, I-00133 Rome, Italy; [Tavani, M.; Striani, E.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Tavani, M.; Barbiellini, G.; Chen, A. W.; Ferrari, A.; Giusti, M.; Zambra, A.] CIFS, I-10133 Turin, Italy; [Tavani, M.; Striani, E.; Morselli, A.; Piano, G.; Picozza, P.; Sabatini, S.] Ist Nazl Fis Nucl Roma Tor Vergata, I-00133 Rome, Italy; [Bulgarelli, A.; Trifoglio, M.; Gianotti, F.; Di Cocco, G.; Labanti, C.; Fuschino, F.; Marisaldi, M.; Morelli, E.] INAF IASF Bologna, I-40129 Bologna, Italy; [Pucella, G.; Rapisarda, M.] Ente Nuove Tecnol Energia & Ambiente Frascati, I-00044 Frascati, RM, Italy; [Caraveo, P.; De Luca, A.; Chen, A. W.; Contessi, T.; Giuliani, A.; Mereghetti, S.; Perotti, F.; Zambra, A.] INAF IASF Milano, I-20133 Milan, Italy; [Barbiellini, G.; Longo, F.; Moretti, E.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.; Moretti, E.; Vallazza, E.] Ist Nazl Fis Nucl, I-34012 Trieste, Italy; [Cattaneo, P. W.; Rappoldi, A.] Ist Nazl Fis Nucl, I-27100 Pavia, Italy; [Ferrari, A.] Univ Turin, Dipartimento Fis Gen, I-10125 Turin, Italy; [Galli, M.] ENEA Bologna, I-40128 Bologna, Italy; [Lapshov, I.] Russian Acad Sci, Space Res Inst, Moscow 117997, Russia; [Lipari, P.; Zanello, D.] INFN Roma 1, I-00185 Rome, Italy; [Lipari, P.; Zanello, D.] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Pellizzoni, A.; Pilia, M.] INAF Osservatorio Astron Cagliari, I-09012 Capoterra, Italy; [Pilia, M.; Prest, M.] Univ Insubria, Dipartimento Fis, I-22100 Como, Italy; [Vercellone, S.; D'Ammando, F.] INAF IASF Palermo, I-90146 Palermo, Italy; [Pittori, C.; Verrecchia, F.; Lucarelli, F.; Santolamazza, P.; Giommi, P.] European Space Agcy, Earth Observat Ctr ESRIN, Sci Data Ctr, ASI, I-00044 Frascati, Italy; [Salotti, L.] ASI, Rome, Italy; [Weisskopf, M. C.; Tennant, A.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Horns, D.] Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany; [Ferrigno, C.] Univ Geneva, Integral Sci Data Ctr, CH-1290 Versoix, Switzerland; [Heinke, C. O.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2G7, Canada; [De Luca, A.; Bignami, G. F.] IUSS, I-27100 Pavia, Italy	Istituto Nazionale Astrofisica (INAF); University of Rome Tor Vergata; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); University of Turin; Italian National Agency New Technical Energy & Sustainable Economics Development; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Istituto Nazionale Astrofisica (INAF); University of Insubria; Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI); European Space Agency; Agenzia Spaziale Italiana (ASI); National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Hamburg; University of Geneva; University of Alberta; IUSS PAVIA	Tavani, M (corresponding author), Ist Astrofis Spaziale & Fis Cosm INAF IASF Roma, Ist Nazl Astrofis, Via Fosso del Cavaliere 100, I-00133 Rome, Italy.	pi.agile@iasf-roma.inaf.it	Horns, Dieter/ABE-9516-2020; cattaneo, Paolo/AAC-4200-2021; Cattaneo, Paolo Walter/AAG-9097-2020; Prest, Michela/V-1736-2017; ferrigno, cassio/D-8230-2012; Vallazza, Erik Silvio/V-1732-2017; Vercellone, Stefano/ABC-7250-2020; Soffitta, Paolo/AAA-7514-2021; Lazzarotto, Francesco/J-4670-2012; Ferrigno, Carlo/H-4139-2012; Caraveo, Patrizia/AAL-5708-2020; Lazzarotto, Francesco/R-4124-2019; Chen, Andrew/AAC-3979-2020; Trifoglio, Massimo/F-5302-2015; Campana, Riccardo/F-5272-2015; Pittori, Carlotta/C-7710-2016; Horns, Dieter/C-9727-2011; Morselli, Aldo/G-6769-2011; giommi, paolo/L-1006-2018	Horns, Dieter/0000-0003-1945-0119; Cattaneo, Paolo Walter/0000-0001-6877-6882; Prest, Michela/0000-0003-3161-4454; ferrigno, cassio/0000-0002-9805-989X; Vallazza, Erik Silvio/0000-0002-7465-7430; Vercellone, Stefano/0000-0003-1163-1396; Soffitta, Paolo/0000-0002-7781-4104; Lazzarotto, Francesco/0000-0003-4871-4072; Caraveo, Patrizia/0000-0003-2478-8018; Trifoglio, Massimo/0000-0002-2505-3630; Campana, Riccardo/0000-0002-4794-5453; Pittori, Carlotta/0000-0001-6661-9779; Morselli, Aldo/0000-0002-7704-9553; Costa, Enrico/0000-0003-4925-8523; Gianotti, Fulvio/0000-0003-4666-119X; Marisaldi, Martino/0000-0002-4000-3789; Feroci, Marco/0000-0002-7617-3421; Chen, Andrew/0000-0001-6425-5692; Giuliani, Andrea/0000-0002-4315-1699; Labanti, Claudio/0000-0002-5086-3619; Argan, Andrea/0000-0002-6230-665X; Heinke, Craig/0000-0003-3944-6109; Del Monte, Ettore/0000-0002-3013-6334; Pellizzoni, Alberto Paolo/0000-0002-4590-0040; Pacciani, Luigi/0000-0001-6897-5996; Tavani, Marco/0000-0003-2893-1459; Bignami, Giovanni/0000-0001-9582-2450; Evangelista, Yuri/0000-0001-6096-6710; Lucarelli, Fabrizio/0000-0002-6311-764X; Donnarumma, Immacolata/0000-0002-4700-4549; Piano, Giovanni/0000-0002-9332-5319; Giusti, Manuela/0000-0002-1434-7203; galli, marcello/0000-0002-9135-3228; Verrecchia, Francesco/0000-0003-3455-5082; Picozza, Piergiorgio/0000-0002-7986-3321; D'Ammando, Filippo/0000-0001-7618-7527; Moretti, Elena/0000-0001-5477-9097; Fuschino, Fabio/0000-0003-2139-3299; Pilia, Maura/0000-0001-7397-8091; De Luca, Andrea/0000-0001-6739-687X; Sabatini, Sabina/0000-0003-2076-5767; vittorini, valerio/0000-0002-1208-8818; MEREGHETTI, SANDRO/0000-0003-3259-7801; Bulgarelli, Andrea/0000-0001-6347-0649; giommi, paolo/0000-0002-2265-5003; trois, alessio/0000-0002-3180-6002; Rappoldi, Andrea/0000-0001-9702-7645	ASI [I/089/06/2]	ASI(Agenzia Spaziale Italiana (ASI))	We thank the Chandra Observatory Director H. Tananbaum; HST director M. Mountain; N. Gehrels; and the Swift team for their prompt response in carrying out the observations reported in this paper. Research partially supported by ASI grant I/089/06/2.	Abdo AA, 2010, ASTROPHYS J, V708, P1254, DOI 10.1088/0004-637X/708/2/1254; Abdo A. A., ARXIV10113855V1; Aielli G., 2010, ATEL, P2921; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2858; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2903; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2889; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2893; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2882; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2872; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2856; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2868; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2879; [Anonymous], 2010, ASTRONOMERS TELEGRAM; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2866; Arons J., 2008, NEUTRON STARS PULSAR, P1; Atoyan AM, 1996, MON NOT R ASTRON SOC, V278, P525, DOI 10.1093/mnras/278.2.525; Buehler R., 2010, ATEL, P2861; DEJAGER OC, 1992, ASTROPHYS J, V396, P161, DOI 10.1086/171706; deJager OC, 1996, ASTROPHYS J, V457, P253, DOI 10.1086/176726; DOBROWOLNY M, 1976, ASTRON ASTROPHYS, V47, P97; Espinoza C. M., 2010, ASTRONOMERS TELEGRAM, P2889; Fierro JM, 1998, ASTROPHYS J, V494, P734, DOI 10.1086/305219; GALLANT YA, 1994, ASTROPHYS J, V435, P230, DOI 10.1086/174810; Hays E., 2010, ASTRONOMERS TELEGRAM, P2879; Hester JJ, 2008, ANNU REV ASTRON ASTR, V46, P127, DOI 10.1146/annurev.astro.45.051806.110608; HESTER JJ, 1995, ASTROPHYS J, V448, P240, DOI 10.1086/175956; Hester JJ, 2002, ASTROPHYS J, V577, pL49, DOI 10.1086/344132; Keshet U, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.111102; Kirk JG, 2000, ASTROPHYS J, V542, P235, DOI 10.1086/309533; Meyer M, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/201014108; Pellizzoni A, 2009, ASTROPHYS J, V691, P1618, DOI 10.1088/0004-637X/691/2/1618; Pittori C, 2009, ASTRON ASTROPHYS, V506, P1563, DOI 10.1051/0004-6361/200911783; REES MF, 1974, MON NOT R ASTRON SOC, V167, P1; Reville B., 2010, ASTROPHYS J; SCARGLE JD, 1969, ASTROPHYS J, V156, P401, DOI 10.1086/149978; Spitkovsky A, 2004, ASTROPHYS J, V603, P669, DOI 10.1086/381568; Tavani M, 2009, ASTRON ASTROPHYS, V502, P995, DOI 10.1051/0004-6361/200810527; Tavani M., 2010, ATEL, P2855; Weisskopf MC, 2000, ASTROPHYS J, V536, pL81, DOI 10.1086/312733; Wilson-Hodge C. A., 2010, ARXIV10102679V1	40	257	262	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					736	739		10.1126/science.1200083	http://dx.doi.org/10.1126/science.1200083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21212318	Green Submitted			2022-12-28	WOS:000287205700061
J	Butler, S				Butler, Stuart			The Wyden-Brown Bill - Short on State Flexibility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Heritage Fdn, Ctr Policy Innovat, Washington, DC 20002 USA		Butler, S (corresponding author), Heritage Fdn, Ctr Policy Innovat, Washington, DC 20002 USA.							Aaron HJ, 2008, HEALTH AFFAIR, V27, P725, DOI 10.1377/hlthaff.27.3.725; AARON HJ, 2004, HLTH AFF MILLWOOD S; MCCANNE D, 2010, WILL WYDEN BROWN STA; 2010, KAISER HLTH NEW 1216	4	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					397	399		10.1056/NEJMp1013277	http://dx.doi.org/10.1056/NEJMp1013277			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715LL	21247307				2022-12-28	WOS:000286885900004
J	Engineer, ND; Riley, JR; Seale, JD; Vrana, WA; Shetake, JA; Sudanagunta, SP; Borland, MS; Kilgard, MP				Engineer, Navzer D.; Riley, Jonathan R.; Seale, Jonathan D.; Vrana, Will A.; Shetake, Jai A.; Sudanagunta, Sindhu P.; Borland, Michael S.; Kilgard, Michael P.			Reversing pathological neural activity using targeted plasticity	NATURE			English	Article							VAGUS NERVE-STIMULATION; CORTICAL MAP REORGANIZATION; PHANTOM-LIMB PAIN; AUDITORY-CORTEX; HEARING-LOSS; ASSESSING TINNITUS; TRAUMA; HYPERACTIVITY; SELECTIVITY; NUCLEUS	Brain changes in response to nerve damage or cochlear trauma can generate pathological neural activity that is believed to be responsible for many types of chronic pain and tinnitus(1-3). Several studies have reported that the severity of chronic pain and tinnitus is correlated with the degree of map reorganization in somatosensory and auditory cortex, respectively(1,4). Direct electrical or transcranial magnetic stimulation of sensory cortex can temporarily disrupt these phantom sensations(5). However, there is as yet no direct evidence for a causal role of plasticity in the generation of pain or tinnitus. Here we report evidence that reversing the brain changes responsible can eliminate the perceptual impairment in an animal model of noise-induced tinnitus. Exposure to intense noise degrades the frequency tuning of auditory cortex neurons and increases cortical synchronization. Repeatedly pairing tones with brief pulses of vagus nerve stimulation completely eliminated the physiological and behavioural correlates of tinnitus in noise-exposed rats. These improvements persisted for weeks after the end of therapy. This method for restoring neural activity to normal may be applicable to a variety of neurological disorders.	[Engineer, Navzer D.; Riley, Jonathan R.; Seale, Jonathan D.; Vrana, Will A.; Shetake, Jai A.; Sudanagunta, Sindhu P.; Borland, Michael S.; Kilgard, Michael P.] Univ Texas Dallas, Cort Plast Lab, Richardson, TX 75080 USA; [Engineer, Navzer D.] MicroTransponder Inc, Austin, TX 78738 USA	University of Texas System; University of Texas Dallas	Engineer, ND (corresponding author), Univ Texas Dallas, Cort Plast Lab, Richardson, TX 75080 USA.	navzer@utdallas.edu		Riley, Jonathan/0000-0003-0129-3071; Kilgard, Michael/0000-0002-6699-1818	James S. McDonnell Foundation; Texas Advanced Research Program; National Institute for Deafness and other Communication Disorders; MicroTransponder Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R43DC010084, R44DC010084] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Texas Advanced Research Program; National Institute for Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); MicroTransponder Inc.; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank A. Kuzu, J. Omana, D. Vuppala, H. Rasul, M. Fink, E. Hanacik, R. Miller and C. Walker for help with rat behavioural training. We would also like to thank J. Eggermont, A. Moller, C. Bauer, J. Fritz, H. Reed, C. Engineer, A. Reed, M. Brosch, R. Rennaker, R. Beitel, V. Miller, C. McIntyre, G. White, P. Pandya, R. Tyler and D. deRidder for suggestions about earlier versions of the manuscript. This work was supported by the James S. McDonnell Foundation, the Texas Advanced Research Program, the National Institute for Deafness and other Communication Disorders, and MicroTransponder Inc.	Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Bauer CA, 2007, J NEUROSCI RES, V85, P1489, DOI 10.1002/jnr.21259; Ben-Menachem E, 2001, J CLIN NEUROPHYSIOL, V18, P415, DOI 10.1097/00004691-200109000-00005; Bollinger J. J., 2006, THESIS U CALIFORNIA; BURNS EM, 1984, AUDIOLOGY, V23, P426; Clark KB, 1999, NAT NEUROSCI, V2, P94, DOI 10.1038/4600; DAUMAN R, 1989, ARCH OTO-RHINO-LARYN, V246, P252, DOI 10.1007/BF00463566; De Ridder D, 2007, PROG BRAIN RES, V166, P377, DOI 10.1016/S0079-6123(07)66036-1; Diesch E, 2010, NEUROSCIENCE, V167, P540, DOI 10.1016/j.neuroscience.2010.02.003; Dietrich V, 2001, HEARING RES, V158, P95, DOI 10.1016/S0378-5955(01)00282-9; Dorr AE, 2006, J PHARMACOL EXP THER, V318, P890, DOI 10.1124/jpet.106.104166; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2007, PROG BRAIN RES, V166, P19, DOI 10.1016/S0079-6123(07)66002-6; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Flor H, 2001, LANCET, V357, P1763, DOI 10.1016/S0140-6736(00)04890-X; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Kilgard MP, 2007, HEARING RES, V229, P171, DOI 10.1016/j.heares.2007.01.005; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Konig O, 2006, HEARING RES, V221, P59, DOI 10.1016/j.heares.2006.07.007; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Moller AR, 2007, PROG BRAIN RES, V166, P47, DOI 10.1016/S0079-6123(07)66004-X; Moore BCJ, 2010, HEARING RES, V261, P51, DOI 10.1016/j.heares.2010.01.003; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; MURPHY WJ, 2001, J ACOUST SOC AM, V109, P2373; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Ochi K, 2003, LARYNGOSCOPE, V113, P427, DOI 10.1097/00005537-200303000-00007; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013	34	403	442	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					101	U114		10.1038/nature09656	http://dx.doi.org/10.1038/nature09656			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21228773	Green Accepted			2022-12-28	WOS:000286886400042
J	Bodemann, BO; Orvedahl, A; Cheng, TL; Ram, RR; Ou, YH; Formstecher, E; Maiti, M; Hazelett, CC; Wauson, EM; Balakireva, M; Camonis, JH; Yeaman, C; Levine, B; White, MA				Bodemann, Brian O.; Orvedahl, Anthony; Cheng, Tzuling; Ram, Rosalyn R.; Ou, Yi-Hung; Formstecher, Etienne; Maiti, Mekhala; Hazelett, C. Clayton; Wauson, Eric M.; Balakireva, Maria; Camonis, Jacques H.; Yeaman, Charles; Levine, Beth; White, Michael A.			RalB and the Exocyst Mediate the Cellular Starvation Response by Direct Activation of Autophagosome Assembly	CELL			English	Article							PROTEIN CONJUGATION SYSTEM; PHOSPHATIDYLINOSITOL 3-KINASE; EFFECTOR COMPLEX; DISTINCT ROLES; BECLIN 1; MEMBRANE; KINASE; YEAST; GTPASES; MACROAUTOPHAGY	The study of macroautophagy in mammalian cells has described induction, vesicle nucleation, and membrane elongation complexes as key signaling intermediates driving autophagosome biogenesis. How these components are recruited to nascent autophagosomes is poorly understood, and although much is known about signaling mechanisms that restrain autophagy, the nature of positive inductive signals that can promote autophagy remain cryptic. We find that the Ras-like small G protein, RalB, is localized to nascent autophagosomes and is activated on nutrient deprivation. RalB and its effector Exo84 are required for nutrient starvation-induced autophagocytosis, and RalB activation is sufficient to promote autophagosome formation. Through direct binding to Exo84, RalB induces the assembly of catalytically active ULK1 and Beclin1-VPS34 complexes on the exocyst, which are required for isolation membrane formation and maturation. Thus, RalB signaling is a primary adaptive response to nutrient limitation that directly engages autophagocytosis through mobilization of the core vesicle nucleation machinery.	[Bodemann, Brian O.; Cheng, Tzuling; Ram, Rosalyn R.; Ou, Yi-Hung; Maiti, Mekhala; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Orvedahl, Anthony; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med & Microbiol, Dallas, TX 75390 USA; [Orvedahl, Anthony; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Wauson, Eric M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Formstecher, Etienne] Hybrigenics Inc, F-75014 Paris, France; [Hazelett, C. Clayton; Yeaman, Charles] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Balakireva, Maria; Camonis, Jacques H.] INSERM, Inst Curie, U548, F-75248 Paris, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	White, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Yeaman, Charles A/A-1624-2009	Yeaman, Charles/0000-0001-6149-628X; Ou, Yi-Hung/0000-0002-9909-7791; FORMSTECHER, Etienne/0000-0002-6410-4365	National Institutes of Health [CA71443, CA129451, CA84254, CA109618]; GenHomme Network [02490-6088]; Welch Foundation [I-1414]; DOD [W81XWH-06-1-0749]; CPRIT [RP101496];  [ARC4845];  [T32GM008203]; NATIONAL CANCER INSTITUTE [R01CA071443, R01CA084254, R56CA109618, R01CA129451, R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067002, T32GM008203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GenHomme Network; Welch Foundation(The Welch Foundation); DOD(United States Department of Defense); CPRIT; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Noboru Mishuzima for GFP-Atg5 and GFP-LC3, Zhenyu Yue for Flag-ATG14L and Flag-RUBICON, and Noriko Okazaki for HA-ULK1 and HA-ULK1(K46N). We thank members of the White and Levine labs for productive discussions. We thank Melanie Cobb for helpful discussion and assistance with kinase assays. This work was supported by grants from the National Institutes of Health (CA71443 and CA129451 to M.W. and CA84254 and CA109618 to B.L.), ARC4845 and GenHomme Network Grant 02490-6088 to J.C., and the Welch Foundation (I-1414 to M.W.). B.B. was supported by DOD Award Number W81XWH-06-1-0749. R.R. was supported by T32GM008203. Y.O. was supported by CPRIT RP101496.	Amar N, 2006, EMBO REP, V7, P635, DOI 10.1038/sj.embor.7400698; Balakireva M, 2006, MOL CELL BIOL, V26, P8953, DOI 10.1128/MCB.00506-06; Bhuvanakantham R, 2010, CELL MICROBIOL, V12, P453, DOI 10.1111/j.1462-5822.2009.01407.x; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Frische EW, 2007, EMBO J, V26, P5083, DOI 10.1038/sj.emboj.7601922; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; George MD, 2000, MOL BIOL CELL, V11, P969, DOI 10.1091/mbc.11.3.969; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Jung C, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/3/035607; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Lalli G, 2005, J CELL BIOL, V171, P857, DOI 10.1083/jcb.200507061; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Voss M, 1999, J BIOL CHEM, V274, P34691, DOI 10.1074/jbc.274.49.34691; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	61	232	242	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					253	267		10.1016/j.cell.2010.12.018	http://dx.doi.org/10.1016/j.cell.2010.12.018			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241894	Bronze, Green Accepted			2022-12-28	WOS:000286459900010
J	Teela, KC; Ferguson, RM; Donnay, FA; Darmstadt, GL				Teela, Katherine C.; Ferguson, Rebecca M.; Donnay, France A.; Darmstadt, Gary L.			The PIERS trial: hope for averting deaths from pre-eclampsia	LANCET			English	Editorial Material							PREGNANCY; MORTALITY		[Teela, Katherine C.; Ferguson, Rebecca M.; Donnay, France A.; Darmstadt, Gary L.] Bill & Melinda Gates Fdn, Global Hlth Program, Family Hlth Div, Seattle, WA 98102 USA	Bill & Melinda Gates Foundation	Darmstadt, GL (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Family Hlth Div, Seattle, WA 98102 USA.	gary.darmstadt@gatesfoundation.org	Darmstadt, Gary/AAU-7488-2020	Darmstadt, Gary/0000-0002-7522-5824				Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Danso KA, 2010, INT J GYNECOL OBSTET, V110, P78, DOI 10.1016/j.ijgo.2010.01.026; DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; HOFMEYR GJ, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001059.PUB2; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jim B, 2010, CARDIOL REV, V18, P178, DOI 10.1097/CRD.0b013e3181c60ca6; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Ronsmans C, BMC PUBLIC IN PRESS; The Magpie Trial Collaborative Group, 2002, LANCET, V360, P1331; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7	12	4	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					185	186		10.1016/S0140-6736(10)61463-8	http://dx.doi.org/10.1016/S0140-6736(10)61463-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	712WG	21185592				2022-12-28	WOS:000286696400006
J	Gelstein, S; Yeshurun, Y; Rozenkrantz, L; Shushan, S; Frumin, I; Roth, Y; Sobel, N				Gelstein, Shani; Yeshurun, Yaara; Rozenkrantz, Liron; Shushan, Sagit; Frumin, Idan; Roth, Yehudah; Sobel, Noam			Human Tears Contain a Chemosignal	SCIENCE			English	Article							PULSATILE SECRETION; CHEMOSENSORY CUES; HORMONE; WOMEN; MOOD	Emotional tearing is a poorly understood behavior that is considered uniquely human. In mice, tears serve as a chemosignal. We therefore hypothesized that human tears may similarly serve a chemosignaling function. We found that merely sniffing negative-emotion-related odorless tears obtained from women donors induced reductions in sexual appeal attributed by men to pictures of women's faces. Moreover, after sniffing such tears, men experienced reduced self-rated sexual arousal, reduced physiological measures of arousal, and reduced levels of testosterone. Finally, functional magnetic resonance imaging revealed that sniffing women's tears selectively reduced activity in brain substrates of sexual arousal in men.	[Gelstein, Shani; Yeshurun, Yaara; Rozenkrantz, Liron; Shushan, Sagit; Frumin, Idan; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Shushan, Sagit; Roth, Yehudah] Edith Wolfson Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, IL-58100 Holon, Israel	Weizmann Institute of Science	Sobel, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	noam.sobel@weizmann.ac.il	Frumin, Idan/N-7049-2014	Frumin, Idan/0000-0002-6293-1586; Sobel, Noam/0000-0002-3232-9391; Yeshurun, Yaara/0000-0002-0843-6998; Rozenkrantz, Liron/0000-0002-6496-4592	Minerva Stiftung Foundation	Minerva Stiftung Foundation	This work was supported by a grant from the Minerva Stiftung Foundation.	Bensafi M, 2003, BEHAV NEUROSCI, V117, P1125, DOI 10.1037/0735-7044.117.6.1125; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; FREY WH, 1981, AM J OPHTHALMOL, V92, P559, DOI 10.1016/0002-9394(81)90651-6; Frey William H., 1985, CRYING MYSTERY TEARS; Frijda N. H., 1986, EMOTIONS STUDIES EMO; GROSS JJ, 1994, PSYCHOPHYSIOLOGY, V31, P460, DOI 10.1111/j.1469-8986.1994.tb01049.x; Hendriks MCP, 2008, J SOC PSYCHOL, V148, P22, DOI 10.3200/SOCP.148.1.22-42; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; LEVENSON RW, 1990, PSYCHOPHYSIOLOGY, V27, P363, DOI 10.1111/j.1469-8986.1990.tb02330.x; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; McCarthy Susan, 1995, ELEPHANTS WEEP EMOTI; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; MONTAGU A, 1959, SCIENCE, V130, P1572, DOI 10.1126/science.130.3388.1572; Preti G, 2003, BIOL REPROD, V68, P2107, DOI 10.1095/biolreprod.102.008268; Provine RR, 2009, EVOL PSYCHOL, V7, P52, DOI 10.1177/147470490900700107; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; STOLERU SG, 1993, PSYCHONEUROENDOCRINO, V18, P205, DOI 10.1016/0306-4530(93)90005-6; Thompson RN, 2007, PHYSIOL BEHAV, V90, P797, DOI 10.1016/j.physbeh.2007.01.008; VANHAERINGEN NJ, 1981, SURV OPHTHALMOL, V26, P84, DOI 10.1016/0039-6257(81)90145-4; Vingerhoets A.J.J.M., 2000, REV GEN PSYRCHOLOGY, V4, P354, DOI [https://doi.org/10.1037/1089-2680.4.4.354, DOI 10.1037/1089-2680.4.4.354, 10.1037/1089-2680.4.4.354]; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Zhou W, 2008, J NEUROSCI, V28, P14416, DOI 10.1523/JNEUROSCI.3148-08.2008	30	136	139	1	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					226	230		10.1126/science.1198331	http://dx.doi.org/10.1126/science.1198331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21212322				2022-12-28	WOS:000286433100046
J	Herring, RA				Herring, Rodney Arthur			A New Twist for Electron Beams	SCIENCE			English	Editorial Material							ORBITAL ANGULAR-MOMENTUM		Univ Victoria, Victoria, BC V8W 3P6, Canada	University of Victoria	Herring, RA (corresponding author), Univ Victoria, Victoria, BC V8W 3P6, Canada.	rherring@uvic.ca						ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Bliokh KY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.190404; HE H, 1995, PHYS REV LETT, V75, P826, DOI 10.1103/PhysRevLett.75.826; Herring R.A., 1999, INTRO ELECT HOLOGRAP, P295; McMorran BJ, 2011, SCIENCE, V331, P192, DOI 10.1126/science.1198804; Uchida M, 2010, NATURE, V464, P737, DOI 10.1038/nature08904; Verbeeck J, 2010, NATURE, V467, P301, DOI 10.1038/nature09366	7	12	12	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					155	156		10.1126/science.1200643	http://dx.doi.org/10.1126/science.1200643			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233373				2022-12-28	WOS:000286433100026
J	Rust, MJ; Golden, SS; O'Shea, EK				Rust, Michael J.; Golden, Susan S.; O'Shea, Erin K.			Light-Driven Changes in Energy Metabolism Directly Entrain the Cyanobacterial Circadian Oscillator	SCIENCE			English	Article							SYNECHOCOCCUS-ELONGATUS; KAIC PHOSPHORYLATION; CLOCK PROTEIN; ATP LEVEL; RHYTHMS; INHIBITORS; FIXATION; LDPA; PH	Circadian clocks are self-sustained biological oscillators that can be entrained by environmental cues. Although this phenomenon has been studied in many organisms, the molecular mechanisms of entrainment remain unclear. Three cyanobacterial proteins and adenosine triphosphate (ATP) are sufficient to generate oscillations in phosphorylation in vitro. We show that changes in illumination that induce a phase shift in cultured cyanobacteria also cause changes in the ratio of ATP to adenosine diphosphate (ADP). When these nucleotide changes are simulated in the in vitro oscillator, they cause phase shifts similar to those observed in vivo. Physiological concentrations of ADP inhibit kinase activity in the oscillator, and a mathematical model constrained by data shows that this effect is sufficient to quantitatively explain entrainment of the cyanobacterial circadian clock.	[Rust, Michael J.; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Rust, Michael J.; O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Golden, Susan S.] Univ Calif San Diego, Div Biol Sci, Ctr Chronobiol, La Jolla, CA 92093 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; University of California System; University of California San Diego	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.	eoshea@mcb.harvard.edu			NIH [GM62419]; Helen Hay Whitney Foundation; Burroughs-Wellcome Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062419] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Burroughs-Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Dong for advice on culture conditions, and K. Cook, V. Denic, Q. Justman, J. Markson, A. Rizvi, and V. Vijayan for valuable discussions and comments on the manuscript. E.K.O. is an investigator of the Howard Hughes Medical Institute. Supported by NIH grant GM62419 (S. S. G.), a Helen Hay Whitney Foundation postdoctoral fellowship (M. J. R.), and a Burroughs-Wellcome Foundation Career Award at the Scientific Interface (M.J.R.).	Andersson CR, 2000, METHOD ENZYMOL, V305, P527; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; BORNEFELD T, 1974, PLANTA, V115, P309, DOI 10.1007/BF00388613; IHLENFELDT MJA, 1975, ARCH MICROBIOL, V102, P13, DOI 10.1007/BF00428339; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Ivleva NB, 2006, P NATL ACAD SCI USA, V103, P17468, DOI 10.1073/pnas.0606639103; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; KALLAS T, 1982, J BACTERIOL, V149, P229, DOI 10.1128/JB.149.1.229-236.1982; Katayama M, 2003, J BACTERIOL, V185, P1415, DOI 10.1128/JB.185.4.1415-1422.2003; Kiyohara YB, 2005, J BACTERIOL, V187, P2559, DOI 10.1128/JB.187.8.2559-2564.2005; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; LUBBERDING HJ, 1984, FEMS MICROBIOL LETT, V22, P93; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; SCHERER S, 1988, PHOTOSYNTH RES, V15, P95, DOI 10.1007/BF00035255; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Wood TL, 2010, P NATL ACAD SCI USA, V107, P5804, DOI 10.1073/pnas.0910141107; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101	27	140	140	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					220	223		10.1126/science.1197243	http://dx.doi.org/10.1126/science.1197243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233390	Green Accepted			2022-12-28	WOS:000286433100044
J	Hoberman, A; Paradise, JL; Rockette, HE; Shaikh, N; Wald, ER; Kearney, DH; Colborn, DK; Kurs-Lasky, M; Bhatnagar, S; Haralam, MA; Zoffel, LM; Jenkins, C; Pope, MA; Balentine, TL; Barbadora, KA				Hoberman, Alejandro; Paradise, Jack L.; Rockette, Howard E.; Shaikh, Nader; Wald, Ellen R.; Kearney, Diana H.; Colborn, D. Kathleen; Kurs-Lasky, Marcia; Bhatnagar, Sonika; Haralam, Mary Ann; Zoffel, Lisa M.; Jenkins, Carly; Pope, Marcia A.; Balentine, Tracy L.; Barbadora, Karen A.			Treatment of Acute Otitis Media in Children under 2 Years of Age	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							YOUNG-CHILDREN; MANAGEMENT; INFANTS; TRIALS	BACKGROUND Recommendations vary regarding immediate antimicrobial treatment versus watchful waiting for children younger than 2 years of age with acute otitis media. METHODS We randomly assigned 291 children 6 to 23 months of age, with acute otitis media diagnosed with the use of stringent criteria, to receive amoxicillin-clavulanate or placebo for 10 days. We measured symptomatic response and rates of clinical failure. RESULTS Among the children who received amoxicillin-clavulanate, 35% had initial resolution of symptoms by day 2, 61% by day 4, and 80% by day 7; among children who received placebo, 28% had initial resolution of symptoms by day 2, 54% by day 4, and 74% by day 7 (P = 0.14 for the overall comparison). For sustained resolution of symptoms, the corresponding values were 20%, 41%, and 67% with amoxicillin-clavulanate, as compared with 14%, 36%, and 53% with placebo (P = 0.04 for the overall comparison). Mean symptom scores over the first 7 days were lower for the children treated with amoxicillin-clavulanate than for those who received placebo (P = 0.02). The rate of clinical failure - defined as the persistence of signs of acute infection on otoscopic examination - was also lower among the children treated with amoxicillin-clavulanate than among those who received placebo: 4% versus 23% at or before the visit on day 4 or 5 (P<0.001) and 16% versus 51% at or before the visit on day 10 to 12 (P<0.001). Mastoiditis developed in one child who received placebo. Diarrhea and diaper-area dermatitis were more common among children who received amoxicillin-clavulanate. There were no significant changes in either group in the rates of nasopharyngeal colonization with nonsusceptible Streptococcus pneumoniae. CONCLUSIONS Among children 6 to 23 months of age with acute otitis media, treatment with amoxicillin-clavulanate for 10 days tended to reduce the time to resolution of symptoms and reduced the overall symptom burden and the rate of persistent signs of acute infection on otoscopic examination.	[Hoberman, Alejandro] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat,Div Gen Acad Pediat,Sch Med, Pittsburgh, PA 15224 USA; [Rockette, Howard E.; Kurs-Lasky, Marcia] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hoberman, A (corresponding author), Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat,Div Gen Acad Pediat,Sch Med, Childrens Hosp Off Bldg,3rd Fl,4401 Penn Ave, Pittsburgh, PA 15224 USA.	hoberman@chp.edu			National Institute of Allergy and Infectious Diseases [3U01AI066007-02S1]; Merck; GlaxoSmithKline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066007] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Merck(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by a grant (3U01AI066007-02S1) from the National Institute of Allergy and Infectious Diseases.; Dr. Hoberman reports receiving honoraria and travel-expense reimbursement from GlaxoSmithKline, and Dr. Wald, grant support from Merck and GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	APPELMAN CL, 1999, HUISARTS WET, V42, P362; Finkelstein JA, 2000, ARCH PEDIAT ADOL MED, V154, P395, DOI 10.1001/archpedi.154.4.395; *FOOD DRUG ADM CTR, 2008, GUID IND AC BACT OT; Forgie S, 2009, PAED CHILD HEALT-CAN, V14, P457, DOI 10.1093/pch/14.7.457; Freid V M, 1998, Vital Health Stat 13, P1; HAYDEN GF, 1985, AM J DIS CHILD, V139, P721, DOI 10.1001/archpedi.1985.02140090083037; Hoberman A, 1997, PEDIATR INFECT DIS J, V16, pS25, DOI 10.1097/00006454-199702001-00007; Hoberman A, 2005, PEDIATR INFECT DIS J, V24, P525, DOI 10.1097/01.inf.0000164794.50281.1a; KALEIDA PH, 1992, AM J DIS CHILD, V146, P433, DOI 10.1001/archpedi.1992.02160160053013; KALEIDA PH, 1991, PEDIATRICS, V87, P466; Laine MK, 2010, PEDIATRICS, V125, pE1154, DOI 10.1542/peds.2009-2689; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; NIEMELA M, 1994, PEDIATR INFECT DIS J, V13, P765, DOI 10.1097/00006454-199409000-00002; Paradise Jack L., 1993, Pediatric Research, V33, p121A; PARADISE JL, 1987, J PEDIATR-US, V111, P948, DOI 10.1016/S0022-3476(87)80226-3; Paradise JL, 1997, JAMA-J AM MED ASSOC, V278, P1640, DOI 10.1001/jama.278.20.1640; ROSENFELD RM, 1994, J PEDIATR-US, V124, P355, DOI 10.1016/S0022-3476(94)70356-6; *SCOTT INT GUID NE, 2003, DIAGN MAN CHILDH OT, V66; Shaikh N, 2009, PEDIATR INFECT DIS J, V28, P9, DOI 10.1097/INF.0b013e318185a3a0; Shaikh N, 2009, PEDIATR INFECT DIS J, V28, P5, DOI 10.1097/INF.0b013e318185a387	20	157	166	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					105	115		10.1056/NEJMoa0912254	http://dx.doi.org/10.1056/NEJMoa0912254			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226576	Green Accepted, Bronze			2022-12-28	WOS:000286142900004
J	Tahtinen, PA; Laine, MK; Huovinen, P; Jalava, J; Ruuskanen, O; Ruohola, A				Tahtinen, Paula A.; Laine, Miia K.; Huovinen, Pentti; Jalava, Jari; Ruuskanen, Olli; Ruohola, Aino			A Placebo-Controlled Trial of Antimicrobial Treatment for Acute Otitis Media	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; ANTIBIOTIC-TREATMENT; CLINICAL-TRIALS; CHILDREN; AMOXICILLIN; METAANALYSIS; MYRINGOTOMY; MICROBIOLOGY; DIAGNOSIS; THERAPY	BACKGROUND The efficacy of antimicrobial treatment in children with acute otitis media remains controversial. METHODS In this randomized, double-blind trial, children 6 to 35 months of age with acute otitis media, diagnosed with the use of strict criteria, received amoxicillin-clavulanate (161 children) or placebo (158 children) for 7 days. The primary outcome was the time to treatment failure from the first dose until the end-of-treatment visit on day 8. The definition of treatment failure was based on the overall condition of the child (including adverse events) and otoscopic signs of acute otitis media. RESULTS Treatment failure occurred in 18.6% of the children who received amoxicillin-clavulanate, as compared with 44.9% of the children who received placebo (P<0.001). The difference between the groups was already apparent at the first scheduled visit (day 3), at which time 13.7% of the children who received amoxicillin-clavulanate, as compared with 25.3% of those who received placebo, had treatment failure. Overall, amoxicillin-clavulanate reduced the progression to treatment failure by 62% (hazard ratio, 0.38; 95% confidence interval [CI], 0.25 to 0.59; P<0.001) and the need for rescue treatment by 81% (6.8% vs. 33.5%; hazard ratio, 0.19; 95% CI, 0.10 to 0.36; P<0.001). Analgesic or antipyretic agents were given to 84.2% and 85.9% of the children in the amoxicillin-clavulanate and placebo groups, respectively. Adverse events were significantly more common in the amoxicillin-clavulanate group than in the placebo group. A total of 47.8% of the children in the amoxicillin-clavulanate group had diarrhea, as compared with 26.6% in the placebo group (P<0.001); 8.7% and 3.2% of the children in the respective groups had eczema (P = 0.04). CONCLUSIONS Children with acute otitis media benefit from antimicrobial treatment as compared with placebo, although they have more side effects. Future studies should identify patients who may derive the greatest benefit, in order to minimize unnecessary antimicrobial treatment and the development of bacterial resistance. (Funded by the Foundation for Paediatric Research and others;	[Tahtinen, Paula A.; Laine, Miia K.; Ruuskanen, Olli; Ruohola, Aino] Turku Univ Hosp, Dept Pediat, FIN-20521 Turku, Finland; [Huovinen, Pentti; Jalava, Jari] Natl Inst Hlth & Welf, Div Hlth Protect, Turku, Finland; [Huovinen, Pentti] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland	University of Turku; Finland National Institute for Health & Welfare; University of Turku	Ruohola, A (corresponding author), Turku Univ Hosp, Dept Pediat, PL 52, FIN-20521 Turku, Finland.	aino.ruohola@utu.fi	Huovinen, Pentti/C-9121-2019	Huovinen, Pentti/0000-0003-0003-1539	European Society for Paediatric Infectious Diseases; Foundation for Paediatric Research; Specified Government Transfers; Jenny and Antti Wihuri Foundation; Paulo Foundation; Maud Kuistila Memorial Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation; Turku University Hospital Research Foundation; Finnish-Norwegian Medical Foundation	European Society for Paediatric Infectious Diseases; Foundation for Paediatric Research; Specified Government Transfers; Jenny and Antti Wihuri Foundation; Paulo Foundation; Maud Kuistila Memorial Foundation; Emil Aaltonen Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Turku University Hospital Research Foundation; Finnish-Norwegian Medical Foundation	Supported by the Fellowship Award of the European Society for Paediatric Infectious Diseases (to Dr. Ruohola) and by grants from the Foundation for Paediatric Research; Research Funds from Specified Government Transfers; the Jenny and Antti Wihuri Foundation; the Paulo Foundation; the Maud Kuistila Memorial Foundation; the Emil Aaltonen Foundation; the Finnish Cultural Foundation, Varsinais-Suomi Regional Fund; the Turku University Hospital Research Foundation; and the Finnish-Norwegian Medical Foundation.	APPELMAN CLM, 1991, BMJ-BRIT MED J, V303, P1450, DOI 10.1136/bmj.303.6815.1450; Appelman CLM, 1990, HUISARTS WET, V33, P242; Bain J, 2001, BRIT J GEN PRACT, V51, P132; Bain J, 2003, DIAGNOSIS MANAGEMENT; BURKE P, 1991, BRIT MED J, V303, P558, DOI 10.1136/bmj.303.6802.558; Coker TR, 2010, JAMA-J AM MED ASSOC, V304, P2161, DOI 10.1001/jama.2010.1651; Dagan R, 2002, PEDIATR INFECT DIS J, V21, P894, DOI 10.1097/00006454-200210000-00003; Damoiseaux RAMJ, 2000, BRIT MED J, V320, P350, DOI 10.1136/bmj.320.7231.350; DELBECCARO MA, 1992, J PEDIATR-US, V120, P81, DOI 10.1016/S0022-3476(05)80605-5; DelMar C, 1997, BRIT MED J, V314, P1526, DOI 10.1136/bmj.314.7093.1526; Dowell SF, 1998, PEDIATRICS, V101, P165; ENGELHARD D, 1989, LANCET, V2, P141; Forgie S, 2009, PAED CHILD HEALT-CAN, V14, P457, DOI 10.1093/pch/14.7.457; HALSTED C, 1968, AM J DIS CHILD, V115, P542, DOI 10.1001/archpedi.1968.02100010544003; Hendley JO, 2002, NEW ENGL J MED, V347, P1169, DOI 10.1056/NEJMcp010944; Johann-Liang R, 2003, PEDIATR INFECT DIS J, V22, P936, DOI 10.1097/01.inf.0000092637.66762.c6; Juven T, 2004, EUR J PEDIATR, V163, P140, DOI 10.1007/s00431-003-1397-2; KALEIDA PH, 1991, PEDIATRICS, V87, P466; Lahikainen E, 1953, ACTA OTO-LARYNGOL, V107, P1; Laine MK, 2010, PEDIATRICS, V125, pE1154, DOI 10.1542/peds.2009-2689; Le Saux N, 2005, CAN MED ASSOC J, V172, P335, DOI 10.1503/cmaj.1040771; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Marchant CD, 2002, PEDIATR INFECT DIS J, V21, P891, DOI 10.1097/00006454-200210000-00002; Marchisio P, 2010, INT J PEDIATR OTORHI, V74, P1209, DOI 10.1016/j.ijporl.2010.08.016; Marcy M, 2000, Evid Rep Technol Assess (Summ), P1; MYGIND N, 1981, CLIN OTOLARYNGOL, V6, P5, DOI 10.1111/j.1365-2273.1981.tb01781.x; Pichichero ME, 2008, PEDIATR INFECT DIS J, V27, P958, DOI 10.1097/INF.0b013e318179a2ac; Pichichero ME, 2008, INT J PEDIATR OTORHI, V72, P737, DOI 10.1016/j.ijporl.2008.02.020; Rautakorpi UM, 2001, SCAND J INFECT DIS, V33, P920, DOI 10.1080/00365540110077056; ROSENFELD RM, 1994, J PEDIATR-US, V124, P355, DOI 10.1016/S0022-3476(94)70356-6; Rovers MM, 2006, LANCET, V368, P1429, DOI 10.1016/S0140-6736(06)69606-2; Rovers MM, 2004, LANCET, V363, P1080; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; RUDBERG R. D., 1954, ACTA OTO LARYNGOL, V113, P1; Ruohola A, 2003, PEDIATRICS, V111, P1061, DOI 10.1542/peds.111.5.1061; Ruohola A, 2006, CLIN INFECT DIS, V43, P1417, DOI 10.1086/509332; Sanders S, 2010, COCHRANE DB SYST REV, V1; Schaad UB, 2004, PEDIATR INFECT DIS J, V23, pS101, DOI 10.1097/01.inf.0000112522.34408.cc; Shaikh N, 2010, NEW ENGL J MED, V362; Thalin A, 1985, P INT C AC SECR OT 1, P441; Toikka P, 1999, CLIN INFECT DIS, V29, P568, DOI 10.1086/598635; VANBUCHEM FL, 1981, LANCET, V2, P883; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Vouloumanou EK, 2009, J ANTIMICROB CHEMOTH, V64, P16, DOI 10.1093/jac/dkp166	44	132	137	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					116	126		10.1056/NEJMoa1007174	http://dx.doi.org/10.1056/NEJMoa1007174			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226577	Bronze			2022-12-28	WOS:000286142900005
J	Eklind-Cervenka, M; Benson, L; Dahlstrom, U; Edner, M; Rosenqvist, M; Lund, LH				Eklind-Cervenka, Maria; Benson, Lina; Dahlstrom, Ulf; Edner, Magnus; Rosenqvist, Marten; Lund, Lars H.			Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANGIOTENSIN-RECEPTOR BLOCKERS; VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME INHIBITORS; RANDOMIZED-TRIAL; BLOOD-PRESSURE; TASK-FORCE; DIAGNOSIS; GUIDELINES; MANAGEMENT; BINDING	Context Angiotensin II receptor blockers (ARBs) reduce combined mortality and hospitalization in patients with heart failure (HF) with reduced left ventricular ejection fraction. Different agents have different affinity for the AT(1) receptor and may have different clinical effects, but have not been tested against each other in HF. Objective To assess the association of candesartan vs losartan with all-cause mortality in patients with HF. Design, Setting, and Patients An HF registry (the Swedish Heart Failure Registry) of 30 254 unique patients registered from 62 hospitals and 60 outpatient clinics between 2000 and 2009. A total of 5139 patients (mean [SD] age, 74 [11] years; 39% women) were treated with candesartan (n=2639) or losartan (n=2500). Survival as of December 14, 2009, by ARB agent was analyzed by Kaplan-Meier method and predictors of survival determined by univariate and multivariate proportional hazard regression models, with and without adjustment for propensity scores and interactions. Stratified analyses and quantification of residual confounding were also performed. Main Outcome Measures All-cause mortality at 1 and 5 years. Results One-year survival was 90% (95% confidence interval [CI], 89%-91%) for patients receiving candesartan and 83% (95% CI, 81%-84%) for patients receiving losartan, and 5-year survival was 61% (95% CI, 54%-68%) and 44% (95% CI, 41%-48%), respectively (log-rank P<.001). In multivariate analysis with adjustment for propensity scores, the hazard ratio for mortality for losartan compared with candesartan was 1.43 (95% CI, 1.23-1.65; P<.001). The results persisted in stratified analyses. Conclusion In this registry of patients with HF, the use of candesartan compared with losartan was associated with a lower mortality risk. JAMA. 2011; 305(2): 175-182	[Lund, Lars H.] Karolinska Univ Hosp, Dept Cardiol, S-17176 Stockholm, Sweden; [Eklind-Cervenka, Maria; Rosenqvist, Marten] Soder Sjukhuset, Dept Cardiol, Stockholm, Sweden; [Eklind-Cervenka, Maria; Benson, Lina; Rosenqvist, Marten] Karolinska Inst, Dept Clin Sci & Educ, SoS, Stockholm, Sweden; [Dahlstrom, Ulf] Linkoping Univ Hosp, Dept Cardiol, S-58185 Linkoping, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Edner, Magnus] Danderyd Hosp, Div Cardiovasc Med, Stockholm, Sweden; [Edner, Magnus] Karolinska Inst, Dept Clin Sci, Stockholm, Sweden; [Lund, Lars H.] Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Sodersjukhuset Hospital; Karolinska Institutet; Linkoping University; Linkoping University; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet	Lund, LH (corresponding author), Karolinska Univ Hosp, Dept Cardiol, N305, S-17176 Stockholm, Sweden.	lars.lund@alumni.duke.edu		Benson, Lina/0000-0002-5393-0055	Astra-Zeneca; Linkoping University; Research Foundation SouthEastern Sweden; Swedish Heart-Lung Foundation; Merck Sharp and Dohme; Karolinska Institutet; Stockholm County Council; Medtronic; St Jude; Boston Scientific; Vinnova; Swedish Order of Free Mason; Sanofi-Aventis; Boehringer Ingelheim; Orion Pharma; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Roche; Merck; ResMed	Astra-Zeneca(AstraZeneca); Linkoping University; Research Foundation SouthEastern Sweden; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Merck Sharp and Dohme(Merck & Company); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Medtronic(Medtronic); St Jude(St. Jude Medical); Boston Scientific(Boston Scientific); Vinnova(Vinnova); Swedish Order of Free Mason; Sanofi-Aventis(Sanofi-Aventis); Boehringer Ingelheim(Boehringer Ingelheim); Orion Pharma; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Roche(Roche Holding); Merck(Merck & Company); ResMed	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Eklind-Cervenka reported receiving speaker's fees from Astra-Zeneca. Dr Dahlstrom reported receiving speaker's fees from Astra-Zeneca and research grants from Linkoping University, Research Foundation SouthEastern Sweden, and Swedish Heart-Lung Foundation. Dr Edner reported receiving speaker's fees from Merck Sharp and Dohme, and research grants from Karolinska Institutet, Stockholm County Council, Medtronic, St Jude, Boston Scientific, and Merck Sharp and Dohme. Dr Rosenqvist reported receiving consulting fees from Merck Sharp and Dohme, speaker's fees from Astra-Zeneca and Merck Sharp and Dohme, and research grants from Karolinska Institutet, Stockholm County Council, Swedish Heart-Lung Foundation, Vinnova, Swedish Order of Free Mason, Sanofi-Aventis, and Boehringer Ingelheim. Dr Lund reported receiving consulting fees and speaker's fees from Astra-Zeneca, and research grants from Karolinska Institutet, Stockholm County Council, Swedish Heart-Lung Foundation, Astra-Zeneca, and Orion Pharma. Ms Benson reported no financial disclosures.; This study received no specific funding. However, establishment of the Swedish Heart Failure Registry was supported by the Swedish National Board of Health and Welfare, the Swedish Association of Local Authorities and Regions, the Swedish Society of Cardiology, AstraZeneca, Roche, Merck, Orion Pharma, and ResMed.	Bhuiyan MA, 2009, LIFE SCI, V85, P136, DOI 10.1016/j.lfs.2009.05.001; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Fabiani ME, 2000, AM J HYPERTENS, V13, P1005, DOI 10.1016/S0895-7061(00)00286-7; Fierens F, 1999, EUR J PHARMACOL, V367, P413, DOI 10.1016/S0014-2999(98)00965-0; Fierens F L, 2000, J Renin Angiotensin Aldosterone Syst, V1, P283, DOI 10.3317/jraas.2000.044; Fridman KUB, 2002, BLOOD PRESSURE, V11, P244, DOI 10.1080/08037050213766; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Hudson M, 2007, PHARMACOTHERAPY, V27, P526, DOI 10.1592/phco.27.4.526; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Jonsson A, 2010, EUR J HEART FAIL, V12, P25, DOI 10.1093/eurjhf/hfp175; Kjeldsen SE, 2010, J HUM HYPERTENS, V24, P263, DOI 10.1038/jhh.2009.77; Koh KK, 2004, AM J CARDIOL, V93, P1432, DOI 10.1016/j.amjcard.2004.02.050; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lacourciere Y, 1999, AM J HYPERTENS, V12, P1181, DOI 10.1016/S0895-7061(99)00142-9; Lee VC, 2004, ANN INTERN MED, V141, P693, DOI 10.7326/0003-4819-141-9-200411020-00011; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2010, EUR J HEART FAIL, V12, P99, DOI 10.1093/eurjhf/hfp197; Meredith PA, 2010, J HUM HYPERTENS, V24, P525, DOI 10.1038/jhh.2009.99; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Van Liefde I, 2009, MOL CELL ENDOCRINOL, V302, P237, DOI 10.1016/j.mce.2008.06.006; Vanderheyden PML, 1999, BRIT J PHARMACOL, V126, P1057, DOI 10.1038/sj.bjp.0702398; Vauquelin G, 2006, J HYPERTENS, V24, pS23, DOI 10.1097/01.hjh.0000220403.61493.18; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	30	52	53	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					175	182		10.1001/jama.2010.1949	http://dx.doi.org/10.1001/jama.2010.1949			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224459	Bronze			2022-12-28	WOS:000286103400023
J	Iacopino, V; Allen, SA; Keller, AS				Iacopino, Vincent; Allen, Scott A.; Keller, Allen S.			Bad Science Used to Support Torture and Human Experimentation	SCIENCE			English	Editorial Material									[Iacopino, Vincent; Allen, Scott A.] Phys Human Rights, Cambridge, MA 02138 USA; [Iacopino, Vincent] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Iacopino, Vincent] Univ Calif Berkeley, Human Rights Ctr, Berkeley, CA 94720 USA; [Allen, Scott A.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Keller, Allen S.] Bellevue NYU Program Survivors Torture, New York, NY 10016 USA; [Keller, Allen S.] NYU, Sch Med, Dept Med, Div Gen Internal Med,Ctr Hlth & Human Rights, New York, NY 10016 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; Brown University; New York University	Allen, SA (corresponding author), Phys Human Rights, Cambridge, MA 02138 USA.	docallen1@me.com	Allen, Scott/D-2403-2015	Allen, Scott/0000-0001-8815-4714				Allen Scott., 2007, LEAVE NO MARKS ENHAN; [Anonymous], 2005, COMMUNICATION   0510; BYBEE JS, 2002, COMMUNICATION   0801; *CENTR INT AG OFF, 2004, COUNT DET INT SPEC R; Hashemian F, 2008, BROKEN LAWS BROKEN L; Human Rights Watch, 2004, END FREED AB US FORC; IACOPINO V, 2001, UN PUBLICATIONS; *JTF GTMO BSCT DOD, 2002, STAND OP PROC; *JTF GTMO BSCT DOD, 2004, STAND OP PROC; *JTF GTMO BSCT DOD, 2005, STAND OP PROC; Raymond N., 2010, EXPT TORTURE EVIDENC; *SASC, 2008, INQ TREATM DET; United States Senate, 2006, POSTW FIND IR WMD PR; World Medical Association, 1975, DECL TOK	14	7	7	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					34	35		10.1126/science.1194437	http://dx.doi.org/10.1126/science.1194437			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	703JK	21212341				2022-12-28	WOS:000285974000022
J	Isaksen, ISA; Dalsoren, SB				Isaksen, I. S. A.; Dalsoren, S. B.			Getting a Better Estimate of an Atmospheric Radical	SCIENCE			English	Editorial Material							INTERANNUAL VARIABILITY; METHYL CHLOROFORM; OH; HYDROXYL		[Isaksen, I. S. A.] Univ Oslo, Dept Geosci, N-0316 Oslo, Norway; [Isaksen, I. S. A.; Dalsoren, S. B.] CICERO, N-0349 Oslo, Norway	University of Oslo	Isaksen, ISA (corresponding author), Univ Oslo, Dept Geosci, N-0316 Oslo, Norway.	i.s.a.isaksen@geo.uio.no		Dalsoren, Stig/0000-0002-6752-4728				Bousquet P, 2005, ATMOS CHEM PHYS, V5, P2635, DOI 10.5194/acp-5-2635-2005; Dalsoren SB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027295; Dentener F, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002916; Dlugokencky EJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039780; Duncan BN, 2008, ATMOS CHEM PHYS, V8, P7389, DOI 10.5194/acp-8-7389-2008; Hoor P, 2009, ATMOS CHEM PHYS, V9, P3113, DOI 10.5194/acp-9-3113-2009; Krol M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002423; Krol MC, 2008, ATMOS CHEM PHYS, V8, P5033, DOI 10.5194/acp-8-5033-2008; Lelieveld J, 2006, ATMOS ENVIRON, V40, P5741, DOI 10.1016/j.atmosenv.2006.04.008; Manning MR, 2005, NATURE, V436, P1001, DOI 10.1038/nature03900; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Prinn RG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022228; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; Shindell D. T., 2006, J GEOPHYS RES, V111	14	33	33	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					38	39		10.1126/science.1199773	http://dx.doi.org/10.1126/science.1199773			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212344				2022-12-28	WOS:000285974000025
J	Reddy, MM; Wilson, R; Wilson, J; Connell, S; Gocke, A; Hynan, L; German, D; Kodadek, T				Reddy, M. Muralidhar; Wilson, Rosemary; Wilson, Johnnie; Connell, Steven; Gocke, Anne; Hynan, Linda; German, Dwight; Kodadek, Thomas			Identification of Candidate IgG Biomarkers for Alzheimer's Disease via Combinatorial Library Screening	CELL			English	Article							PROTEIN MICROARRAYS; MULTIPLE-SCLEROSIS; PEPTOID LIBRARIES; CANCER; AUTOIMMUNITY; DISCOVERY; LESSONS; ARRAY	The adaptive immune system is thought to be a rich source of protein biomarkers, but diagnostically useful antibodies remain unknown for a large number of diseases. This is, in part, because the antigens that trigger an immune response in many diseases remain unknown. We present here a general and unbiased approach to the identification of diagnostically useful antibodies that avoids the requirement for antigen identification. This method involves the comparative screening of combinatorial libraries of unnatural, synthetic molecules against serum samples obtained from cases and controls. Molecules that retain far more IgG antibodies from the case samples than the controls are identified and subsequently tested as capture agents for diagnostically useful antibodies. The utility of this method is demonstrated using a mouse model for multiple sclerosis and via the identification of two candidate IgG biomarkers for Alzheimer's disease.	[Reddy, M. Muralidhar; Kodadek, Thomas] Scripps Florida, Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Reddy, M. Muralidhar; Kodadek, Thomas] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Reddy, M. Muralidhar; Wilson, Rosemary; Wilson, Johnnie] Opko Hlth Labs, Jupiter, FL 33458 USA; [Connell, Steven; Gocke, Anne] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Translat Res, Dallas, TX 75390 USA; [Hynan, Linda] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [German, Dwight] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	Scripps Research Institute; State University System of Florida; University of Florida; Scripps Research Institute; State University System of Florida; University of Florida; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), Scripps Florida, Scripps Res Inst, Dept Chem, 130 Scripps Way,3A2, Jupiter, FL 33458 USA.	kodadek@scripps.edu	Hynan, Linda S/P-6473-2016	Hynan, Linda/0000-0002-4642-7769; Kodadek, Thomas/0000-0003-1930-4795	NIH [DP1OD000663, AG12300]; NHLBI Proteomics Initiative of the National Heart, Lung & Blood Institute, National Institutes of Health [NO1-HV-28185]; NATIONAL INSTITUTE ON AGING [P30AG012300] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Proteomics Initiative of the National Heart, Lung & Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Mike Racke, Amy Lovett-Racke, and Ward Wakeland for contributing EAE and SLE samples in the early phase of this project. We thank Kristin Martin-Cook of the UT Southwestern Medical Center's Alzheimer's Disease Center for selecting the normal and AD serum samples for analysis and Dr. Padraig O'Suilleabhain for diagnosis and collection of the PD serum samples. This work was supported by an NIH Director Pioneer Award to T.K. (DP1OD000663) and the NHLBI Proteomics Initiative of the National Heart, Lung & Blood Institute, National Institutes of Health (contract No. NO1-HV-28185). Human serum sample collection was supported by grant NIH grant AG12300.	Alluri PG, 2003, J AM CHEM SOC, V125, P13995, DOI 10.1021/ja036417x; Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Fathman CG, 2005, NATURE, V435, P605, DOI 10.1038/nature03726; Figliozzi GM, 1996, METHOD ENZYMOL, V267, P437; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Gibson DS, 2010, J PROTEOMICS, V73, P1045, DOI 10.1016/j.jprot.2009.11.013; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hauser SL, 2008, NEW ENGL J MED, V359, P1838, DOI 10.1056/NEJMe0806738; Hudson ME, 2007, P NATL ACAD SCI USA, V104, P17494, DOI 10.1073/pnas.0708572104; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; Knittelfelder R, 2009, EXPERT OPIN BIOL TH, V9, P493, DOI [10.1517/14712590902870386, 10.1517/14712590902870386 ]; Liu K, 2001, ADV EXP MED BIOL, V490, P1; Lueking A, 2003, MOL CELL PROTEOMICS, V2, P1342, DOI 10.1074/mcp.T300001-MCP200; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Olivos HJ, 2002, ORG LETT, V4, P4057, DOI 10.1021/ol0267578; Ransohoff DF, 2005, J NATL CANCER I, V97, P315, DOI 10.1093/jnci/dji054; Reddy MM, 2005, P NATL ACAD SCI USA, V102, P12672, DOI 10.1073/pnas.0501208102; Robinson WH, 2002, BIOTECHNIQUES, P66; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026; SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367; Steller S, 2005, PROTEOMICS, V5, P2048, DOI 10.1002/pmic.200401097; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3	28	165	183	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					132	142		10.1016/j.cell.2010.11.054	http://dx.doi.org/10.1016/j.cell.2010.11.054			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215375	Green Accepted, Bronze			2022-12-28	WOS:000285993600013
J	Friedberg, JW				Friedberg, Jonathan W.			Rituximab maintenance in follicular lymphoma: PRIMA	LANCET			English	Editorial Material							CYCLOPHOSPHAMIDE; VINCRISTINE; SURVIVAL		Univ Rochester, James P Wilmot Canc Ctr, Div Hematol & Oncol, Rochester, NY 14642 USA	University of Rochester	Friedberg, JW (corresponding author), Univ Rochester, James P Wilmot Canc Ctr, Div Hematol & Oncol, 601 Elmwood Ave, Rochester, NY 14642 USA.	jonathan_friedberg@urmc.rochester.edu						Anolik JH, 2007, CLIN IMMUNOL, V122, P139, DOI 10.1016/j.clim.2006.08.009; Fisher RI, 2005, J CLIN ONCOL, V23, P8447, DOI 10.1200/JCO.2005.03.1674; FRIEDBERG J, 2005, HEMATOLOGY, V1, P329; FRIEDBERG PN, 2009, CLIN ONCOL, V27, P1202; Hiddemann W, 2005, BLOOD, V106, P3725, DOI 10.1182/blood-2005-01-0016; Hochster H, 2009, J CLIN ONCOL, V27, P1607, DOI 10.1200/JCO.2008.17.1561; Kahl BS, 2006, CLIN LYMPHOMA MYELOM, V6, P423, DOI 10.3816/CLM.2006.n.024; Marcus R, 2005, BLOOD, V105, P1417, DOI 10.1182/blood-2004-08-3175; Martinelli G, 2010, J CLIN ONCOL, V28, P4480, DOI 10.1200/JCO.2010.28.4786; Salles G, 2011, LANCET, V377, P42, DOI 10.1016/S0140-6736(10)62175-7; Swenson WT, 2005, J CLIN ONCOL, V23, p595S	11	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 1	2011	377	9759					4	6		10.1016/S0140-6736(10)62272-6	http://dx.doi.org/10.1016/S0140-6736(10)62272-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709MQ	21176951				2022-12-28	WOS:000286445200005
J	Hiraga, T; Miyazaki, T; Tasaka, M; Yoshida, H				Hiraga, Takehiko; Miyazaki, Tomonori; Tasaka, Miki; Yoshida, Hidehiro			Mantle superplasticity and its self-made demise	NATURE			English	Article							EARTHS LOWER MANTLE; GRAIN-GROWTH; MGSIO3 PEROVSKITE; TRANSITION-ZONE; DEFORMATION; DIFFUSION; FLOW; CONSTRAINTS; FORSTERITE; FELDSPAR	The unusual capability of solid crystalline materials to deform plastically, known as superplasticity, has been found in metals and even in ceramics(1). Such superplastic behaviour has been speculated for decades to take place in geological materials, ranging from surface ice sheets to the Earth's lowermantle(2-8). In materials science, superplasticity is confirmed when the material deforms with large tensile strain without failure; however, no experimental studies have yet shown this characteristic in geomaterials. Here we show that polycrystalline forsterite + periclase (9:1) and forsterite 1 enstatite + diopside (7:2.5:0.5), which are good analogues for Earth's mantle, undergo homogeneous elongation of up to 500 per cent under subsolidus conditions. Such superplastic deformation is accompanied by strain hardening, which is well explained by the grain size sensitivity of superplasticity and grain growth under grain switching conditions (that is, grain boundary sliding); grain boundary sliding is the main deformation mechanism for superplasticity. We apply the observed strain-grain size-viscosity relationship to portions of the mantle where superplasticity has been presumed to take place, such as localized shear zones in the upper mantle and within subducting slabs penetrating into the transition zone and lower mantle after a phase transformation. Calculations show that superplastic flow in the mantle is inevitably accompanied by significant grain growth that can bring fine grained (<= 1 mu m) rocks to coarse-grained (1-10 mm) aggregates, resulting in increasing mantle viscosity and finally termination of superplastic flow.	[Hiraga, Takehiko; Miyazaki, Tomonori; Tasaka, Miki] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Yoshida, Hidehiro] Natl Inst Mat Sci, Nano Ceram Ctr, Tsukuba, Ibaraki 3050047, Japan	University of Tokyo; National Institute for Materials Science	Hiraga, T (corresponding author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	hiraga@eri.u-tokyo.ac.jp	YOSHIDA, Hidehiro/H-2529-2011	YOSHIDA, Hidehiro/0000-0002-0759-8258; Tasaka, Miki/0000-0002-5214-9849	JSPS [A 20684024]; Earthquake Research Institute;  [A 19686042];  [B 21360328];  [474-19053008]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Earthquake Research Institute; ; ; 	Technical support from S. Sano, N. Ohashi, S. Ohtsuka, K. Ibe, M. Uchida, H. Yoshida and A. Yasuda is appreciated. Scientific discussions with T. Kubo, S. Honda, T. Takei and D. L. Kohlstedt were valuable. Part of the synthesis of the specimens was supported by S. Sano, Ube Materials. Scientific and editorial comments from C. McCarthy were valuable. This research was supported by the JSPS through a Grant-in-Aid for Young Scientists (A 20684024), by the Earthquake Research Institute's cooperative research programme (to T. H.) and by a Grant-in-Aid for Young Scientists (A 19686042), a Grant-in-Aid for Scientific Research (B 21360328) and a Grant-in-Aid for Scientific Research on Priority Areas (474-19053008) (to H.Y.).	ARDELL AJ, 1972, ACTA METALL MATER, V20, P601, DOI 10.1016/0001-6160(72)90015-6; ASHBY MF, 1973, ACTA METALL MATER, V21, P149, DOI 10.1016/0001-6160(73)90057-6; BEHRMANN JH, 1987, TECTONOPHYSICS, V140, P297, DOI 10.1016/0040-1951(87)90236-8; BOULLIER AM, 1975, CONTRIB MINERAL PETR, V50, P93, DOI 10.1007/BF00373329; Farver JR, 2000, GEOPHYS RES LETT, V27, P2337, DOI 10.1029/2000GL008492; Goldsby DL, 2001, J GEOPHYS RES-SOL EA, V106, P11017, DOI 10.1029/2000JB900336; Hiraga K, 2005, J CERAM SOC JPN, V113, P191, DOI 10.2109/jcersj.113.191; Hiraga T, 2010, EARTH PLANET SC LETT, V291, P10, DOI 10.1016/j.epsl.2009.12.026; Hirth G., 2003, INSIDE SUBDUCTION FA, V138, P83, DOI [10.1029/138GM06, DOI 10.1029/138GM06]; HOLM K, 1977, ACTA METALL MATER, V25, P1191, DOI 10.1016/0001-6160(77)90207-3; Ishii K, 2007, J STRUCT GEOL, V29, P1083, DOI 10.1016/j.jsg.2007.02.008; ITO E, 1991, NATURE, V351, P140, DOI 10.1038/351140a0; Karato S, 1998, NATURE, V395, P266, DOI 10.1038/26206; KARATO S, 1995, SCIENCE, V270, P458, DOI 10.1126/science.270.5235.458; Karato SI, 2008, DEFORMATION OF EARTH MATERIALS: AN INTRODUCTION TO THE RHEOLOGY OF SOLID EARTH, P1, DOI 10.1017/CBO9780511804892; Koizumi S, 2010, PHYS CHEM MINER, V37, P505, DOI 10.1007/s00269-009-0350-y; Kubo T, 2009, EARTH PLANET SC LETT, V287, P12, DOI 10.1016/j.epsl.2009.07.028; NIEH TG, 1991, INT MATER REV, V36, P146, DOI 10.1179/095066091790150679; SATO E, 1988, SUPERPLASTICITY SUPE, P115; Shimojuku A, 2009, EARTH PLANET SC LETT, V284, P103, DOI 10.1016/j.epsl.2009.04.014; Solomatov VS, 2002, PHYS EARTH PLANET IN, V129, P265, DOI 10.1016/S0031-9201(01)00295-3; SPEIGHT MV, 1968, ACTA METALL MATER, V16, P133, DOI 10.1016/0001-6160(68)90081-3; Wakai F., 1986, ADV CERAM MATER, V1, P259, DOI DOI 10.1111/J.1551-2916.1986.TB00026.X; Warren JM, 2006, EARTH PLANET SC LETT, V248, P438, DOI 10.1016/j.epsl.2006.06.006; WILKINSON DS, 1984, ACTA METALL MATER, V32, P1335, DOI 10.1016/0001-6160(84)90079-8; Yamazaki D, 2000, PHYS EARTH PLANET IN, V119, P299, DOI 10.1016/S0031-9201(00)00135-7; Yamazaki D, 1996, SCIENCE, V274, P2052, DOI 10.1126/science.274.5295.2052; Yamazaki D, 2001, AM MINERAL, V86, P385	28	63	64	6	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1091	U490		10.1038/nature09685	http://dx.doi.org/10.1038/nature09685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179165				2022-12-28	WOS:000285553800056
J	Calonge, N; Bibbins-Domingo, K; Cantu, AG; Curry, S; Dietrich, AJ; Flores, G; Grossman, D; Isham, G; LeFevre, ML; Leipzig, RM; Melnikow, J; Melnyk, B; Nicholson, W; Reyes, C; Schwartz, JS; Wilt, T				Calonge, Ned; Bibbins-Domingo, Kirsten; Cantu, Adelita Gonzales; Curry, Susan; Dietrich, Allen J.; Flores, Glenn; Grossman, David; Isham, George; LeFevre, Michael L.; Leipzig, Rosanne M.; Melnikow, Joy; Melnyk, Bernadette; Nicholson, Wanda; Reyes, Carolina; Schwartz, J. Sanford; Wilt, Timothy		US Preventive Serv Task Force	Screening for Osteoporosis: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							ATRIAL-FIBRILLATION; BONE-DENSITY; WOMEN; RISK; MEN; ALENDRONATE; FRACTURES; METAANALYSIS; PREDICTION	Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for osteoporosis. Methods: The USPSTF evaluated evidence on the diagnostic accuracy of risk assessment instruments for osteoporosis and fractures, the performance of dual-energy x-ray absorptiometry and peripheral bone measurement tests in predicting fractures, the harms of screening for osteoporosis, and the benefits and harms of drug therapy for osteoporosis in women and men. Recommendations: The USPSTF recommends screening for osteoporosis in women aged 65 years or older and in younger women whose fracture risk is equal to or greater than that of a 65-year-old white woman who has no additional risk factors. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for osteoporosis in men. (I statement)	[Calonge, Ned] Colorado Trust, Denver, CO USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cantu, Adelita Gonzales] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Curry, Susan] Univ Iowa, Iowa City, IA USA; [Dietrich, Allen J.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; [Flores, Glenn] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Grossman, David] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [Isham, George] HealthPartners, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Leipzig, Rosanne M.] Mt Sinai Sch Med, New York, NY USA; [Melnikow, Joy] Univ Calif Davis, Sacramento, CA 95817 USA; Arizona State Univ W, Coll Nursing & Healthcare Innovat, Phoenix, AZ 85069 USA; [Nicholson, Wanda] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Reyes, Carolina] Univ So Calif, Los Angeles, CA USA; [Schwartz, J. Sanford] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Schwartz, J. Sanford] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Wilt, Timothy] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Wilt, Timothy] Minneapolis Veteran Affairs Med Ctr, Minneapolis, MN 55455 USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; University of Iowa; Dartmouth College; University of Texas System; University of Texas Southwestern Medical Center Dallas; Group Health Cooperative; University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; University of California System; University of California Davis; Arizona State University; Arizona State University-Downtown Phoenix; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Southern California; University of Pennsylvania; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities	Calonge, N (corresponding author), Colorado Trust, Denver, CO USA.		Melnyk, Bernadette J/E-9868-2013	Chou, Roger/0000-0001-9889-8610	USPSTF	USPSTF	Financial Support: The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	*AM COLL OBST GYN, 2004, OST, P18853; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Heckbert SR, 2008, ARCH INTERN MED, V168, P826, DOI 10.1001/archinte.168.8.826; Hillier TA, 2007, ARCH INTERN MED, V167, P155, DOI 10.1001/archinte.167.2.155; Johnell O, 2006, WHAT EV IS THER PREV; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; National Osteoporosis Foundation, 2008, CLIN GUID PREV TREAT; Nayak S, 2006, ANN INTERN MED, V144, P832, DOI 10.7326/0003-4819-144-11-200606060-00009; Nelson HD, 2010, AHRQ PUBLICATION; NELSON HD, 1926, ANN INTERN MED, V151, P703; Nelson HD, 2010, ANN INTERN MED, V153, P99, DOI 10.7326/0003-4819-153-2-201007200-00262; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Qaseem A, 2008, ANN INTERN MED, V148, P680, DOI 10.7326/0003-4819-148-9-200805060-00008; Sawka AM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-39; Sorensen HT, 2008, BMJ-BRIT MED J, V336, P813, DOI 10.1136/bmj.39507.551644.BE; U.S. Preventive Services Task Force, 2002, SCREEN OST POSTM WOM	17	316	318	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					356	+		10.7326/0003-4819-154-5-201103010-00307	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00307			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21242341				2022-12-28	WOS:000287799900008
J	Bredel, M; Scholtens, DM; Yadav, AK; Alvarez, AA; Renfrow, JJ; Chandler, JP; Yu, ILY; Carro, MS; Dai, FP; Tagge, MJ; Ferrarese, R; Bredel, C; Phillips, HS; Lukac, PJ; Robe, PA; Weyerbrock, A; Vogel, H; Dubner, S; Mobley, B; He, XL; Scheck, AC; Sikic, BI; Aldape, KD; Chakravarti, A; Harsh, GR				Bredel, Markus; Scholtens, Denise M.; Yadav, Ajay K.; Alvarez, Angel A.; Renfrow, Jaclyn J.; Chandler, James P.; Yu, Irene L. Y.; Carro, Maria S.; Dai, Fangping; Tagge, Michael J.; Ferrarese, Roberto; Bredel, Claudia; Phillips, Heidi S.; Lukac, Paul J.; Robe, Pierre A.; Weyerbrock, Astrid; Vogel, Hannes; Dubner, Steven; Mobley, Bret; He, Xiaolin; Scheck, Adrienne C.; Sikic, Branimir I.; Aldape, Kenneth D.; Chakravarti, Arnab; Harsh, Griffith R.			NFKBIA Deletion in Glioblastomas.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KAPPA-B-ALPHA; INTEGRATED GENOMIC ANALYSIS; HODGKIN LYMPHOMA; ADJUVANT TEMOZOLOMIDE; MULTIPLE-MYELOMA; STERNBERG CELLS; EGF RECEPTOR; GENE; MUTATIONS; GROWTH	Background: Amplification and activating mutations of the epidermal growth factor receptor (EGFR) oncogene are molecular hallmarks of glioblastomas. We hypothesized that deletion of NFKBIA (encoding nuclear factor of (kappa)-light polypeptide gene enhancer in B-cells inhibitor-(alpha)), an inhibitor of the EGFR-signaling pathway, promotes tumorigenesis in glioblastomas that do not have alterations of EGFR. Methods: We analyzed 790 human glioblastomas for deletions, mutations, or expression of NFKBIA and EGFR. We studied the tumor-suppressor activity of NFKBIA in tumor-cell culture. We compared the molecular results with the outcome of glioblastoma in 570 affected persons. Results: NFKBIA is often deleted but not mutated in glioblastomas; most deletions occur in nonclassical subtypes of the disease. Deletion of NFKBIA and amplification of EGFR show a pattern of mutual exclusivity. Restoration of the expression of NFKBIA attenuated the malignant phenotype and increased the vulnerability to chemotherapy of cells cultured from tumors with NFKBIA deletion; it also reduced the viability of cells with EGFR amplification but not of cells with normal gene dosages of both NFKBIA and EGFR. Deletion and low expression of NFKBIA were associated with unfavorable outcomes. Patients who had tumors with NFKBIA deletion had outcomes that were similar to those in patients with tumors harboring EGFR amplification. These outcomes were poor as compared with the outcomes in patients with tumors that had normal gene dosages of NFKBIA and EGFR. A two-gene model that was based on expression of NFKBIA and O(sup 6)-methylguanine DNA methyltransferase was strongly associated with the clinical course of the disease. Conclusions: Deletion of NFKBIA has an effect that is similar to the effect of EGFR amplification in the pathogenesis of glioblastoma and is associated with comparatively short survival. N Engl J Med 2011;364:627-37.	[Bredel, Markus; Yu, Irene L. Y.; Carro, Maria S.; Dai, Fangping; Ferrarese, Roberto; Bredel, Claudia; Weyerbrock, Astrid] Univ Freiburg, Dept Neurosurg, Neuroctr, Freiburg, Germany; [Bredel, Markus; Yu, Irene L. Y.; Carro, Maria S.; Dai, Fangping; Ferrarese, Roberto; Bredel, Claudia; Weyerbrock, Astrid] Univ Freiburg, Ctr Comprehens Canc, Freiburg, Germany; [Bredel, Markus; Alvarez, Angel A.] Univ Alabama, UAB Comprehens Canc Ctr, Dept Radiat Oncol, Birmingham, AL USA; [Bredel, Markus; Yadav, Ajay K.; Renfrow, Jaclyn J.; Chandler, James P.; Tagge, Michael J.; Lukac, Paul J.] Northwestern Univ, Feinberg Sch Med, Lurie Ctr Canc Genet Res, NW Brain Tumor Inst,Dept Neurol Surg, Chicago, IL 60611 USA; [Bredel, Markus; Yadav, Ajay K.; Renfrow, Jaclyn J.; Chandler, James P.; Tagge, Michael J.; Lukac, Paul J.] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [Scholtens, Denise M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Div Biostat, Chicago, IL 60611 USA; [Dubner, Steven] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [He, Xiaolin] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Bredel, Markus; Harsh, Griffith R.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Vogel, Hannes; Mobley, Bret] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Sikic, Branimir I.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Phillips, Heidi S.] Genentech Inc, San Francisco, CA 94080 USA; [Robe, Pierre A.] Univ Liege, Dept Neurosurg, Liege, Belgium; [Robe, Pierre A.] Univ Liege, Dept Human Genet, Liege, Belgium; [Robe, Pierre A.] Univ Utrecht, Dept Neurosurg, Utrecht, Netherlands; [Scheck, Adrienne C.] Barrow Neurol Inst, Ina Levine Brain Tumor Ctr, Phoenix, AZ 85013 USA; [Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Chakravarti, Arnab] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Dept Radiat Oncol, Columbus, OH 43210 USA; [Chakravarti, Arnab] Ohio State Univ, Richard L Solove Res Inst, Columbus, OH 43210 USA	University of Freiburg; University of Freiburg; University of Alabama System; University of Alabama Birmingham; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Stanford University; Stanford University; Stanford University; Roche Holding; Genentech; University of Liege; University of Liege; Utrecht University; Barrow Neurological Institute; University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Bredel, M (corresponding author), Univ Freiburg, Dept Neurosurg, Neuroctr, Freiburg, Germany.	markus.bredel@uniklinik-freiburg.de	Weyerbrock, Astrid/AAI-1731-2020; Stella, Maria Stella/GVS-1585-2022; Scheck, Adrienne/AAH-5040-2020; Ferrarese, Roberto/GSJ-3449-2022; Weyerbrock, Astrid/E-8493-2014; Lukac, Pavel/P-4068-2017	Weyerbrock, Astrid/0000-0001-9060-4462; Ferrarese, Roberto/0000-0003-0625-3319; Lukac, Pavel/0000-0001-8412-1931; Yadav, Ajay/0000-0003-3321-4198; Carro, Maria Stella/0000-0002-8570-7691; Vogel, Otto Hannes/0000-0002-0960-3508; Scheck, Adrienne/0000-0003-3497-1895	Accelerate Brain Cancer Cure; Mike Gardner/American Brain Tumor Association; German Cancer Aid [107714]; State of Illinois Excellence in Academic Medicine Program Award [211]; State of Alabama Investment Pool for Action (IMPACT); National Cancer Institute [RO1CA108633, RC2CA148190, P50CA127001, RTOG U10CA21661, CCOP U10CA37422]; Goldhirsh Brain Tumor Research Award; Leach Foundation; Brain Tumor Funders' Collaborative; Lou Malnati's Cancer Benefit Committee; Mazza Foundation; NATIONAL CANCER INSTITUTE [RC2CA148190, R01CA108633, U10CA037422, U10CA021661, P50CA127001] Funding Source: NIH RePORTER	Accelerate Brain Cancer Cure; Mike Gardner/American Brain Tumor Association; German Cancer Aid(Deutsche Krebshilfe); State of Illinois Excellence in Academic Medicine Program Award; State of Alabama Investment Pool for Action (IMPACT); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Goldhirsh Brain Tumor Research Award; Leach Foundation; Brain Tumor Funders' Collaborative; Lou Malnati's Cancer Benefit Committee; Mazza Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a Project Award of Accelerate Brain Cancer Cure, a Mike Gardner/American Brain Tumor Association Grant Award, a German Cancer Aid Grant Award (107714), a State of Illinois Excellence in Academic Medicine Program Award (211), State of Alabama Investment Pool for Action (IMPACT) funds, grants from the National Cancer Institute (RO1CA108633, RC2CA148190, P50CA127001, RTOG U10CA21661, and CCOP U10CA37422), a Goldhirsh Brain Tumor Research Award, a Leach Foundation Research Award, the Brain Tumor Funders' Collaborative, the Lou Malnati's Cancer Benefit Committee, and the Mazza Foundation.	Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bredel M, 2006, J CLIN ONCOL, V24, P274, DOI 10.1200/JCO.2005.02.9405; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Bu H, 2007, J CANCER RES CLIN, V133, P859, DOI 10.1007/s00432-007-0228-7; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Chakravarti A, 2002, CANCER RES, V62, P4307; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Emmerich F, 1999, BLOOD, V94, P3129, DOI 10.1182/blood.V94.9.3129.421k03_3129_3134; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Fulci G, 2000, ONCOGENE, V19, P3816, DOI 10.1038/sj.onc.1203700; Gao JF, 2007, SCAND J GASTROENTERO, V42, P345, DOI 10.1080/00365520600880856; Habib AA, 2001, J BIOL CHEM, V276, P8865, DOI 10.1074/jbc.M008458200; He YC, 2009, CARCINOGENESIS, V30, P1916, DOI 10.1093/carcin/bgp226; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Kapoor GS, 2004, MOL CELL BIOL, V24, P823, DOI 10.1128/MCB.24.2.823-836.2004; Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351; Lake A, 2009, INT J CANCER, V125, P1334, DOI 10.1002/ijc.24502; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Liu XJ, 2010, CANCER GENET CYTOGEN, V197, P152, DOI 10.1016/j.cancergencyto.2009.11.005; MIKESKA T, 1955, ANN HUM GENET, V19, P251; Nagai S, 2002, J NEUROSURG, V96, P909, DOI 10.3171/jns.2002.96.5.0909; Osborne J, 2005, INT J CANCER, V116, P646, DOI 10.1002/ijc.21036; Parker KM, 2002, CANCER GENET CYTOGEN, V137, P43, DOI 10.1016/S0165-4608(02)00541-1; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Raychaudhuri B, 2007, J NEURO-ONCOL, V85, P39, DOI 10.1007/s11060-007-9390-7; Sethi G, 2007, ONCOGENE, V26, P7324, DOI 10.1038/sj.onc.1210544; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Spink CF, 2007, CANCER LETT, V246, P92, DOI 10.1016/j.canlet.2006.02.001; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tsunoda Keishi, 2005, Brain Tumor Pathol, V22, P79, DOI 10.1007/s10014-005-0186-1; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wen PY, 2008, NEW ENGL J MED, V359, P877; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yadav AK, 2009, JAMA-J AM MED ASSOC, V302, P276, DOI 10.1001/jama.2009.1022; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	39	181	186	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					627	637		10.1056/NEJMoa1006312	http://dx.doi.org/10.1056/NEJMoa1006312			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21175304	Green Accepted			2022-12-28	WOS:000287406000008
J	Abdo, AA; Ackermann, M; Ajello, M; Allafort, A; Baldini, L; Ballet, J; Barbiellini, G; Bastieri, D; Bechtol, K; Bellazzini, R; Berenji, B; Blandford, RD; Bloom, ED; Bonamente, E; Borgland, AW; Bouvier, A; Brandt, TJ; Bregeon, J; Brez, A; Brigida, M; Bruel, P; Buehler, R; Buson, S; Caliandro, GA; Cameron, RA; Cannon, A; Caraveo, PA; Casandjian, JM; Celik, O; Charles, E; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cohen-Tanugi, J; Costamante, L; Cutini, S; D'Ammando, F; Dermer, CD; de Angelis, A; de Luca, A; de Palma, F; Digel, SW; Silva, EDE; Drell, PS; Drlica-Wagner, A; Dubois, R; Dumora, D; Favuzzi, C; Fegan, SJ; Ferrara, EC; Focke, WB; Fortin, P; Frailis, M; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Giglietto, N; Giordano, F; Giroletti, M; Glanzman, T; Godfrey, G; Grenier, IA; Grondin, MH; Grove, JE; Guiriec, S; Hadasch, D; Hanabata, Y; Harding, AK; Hayashi, K; Hayashida, M; Hays, E; Horan, D; Itoh, R; Johannesson, G; Johnson, AS; Johnson, TJ; Khangulyan, D; Kamae, T; Katagiri, H; Kataoka, J; Kerr, M; Knodlseder, J; Kuss, M; Lande, J; Latronico, L; Lee, SH; Lemoine-Goumard, M; Longo, F; Loparco, F; Lubrano, P; Madejski, GM; Makeev, A; Marelli, M; Mazziotta, MN; McEnery, JE; Michelson, PF; Mitthumsiri, W; Mizuno, T; Moiseev, AA; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nakamori, T; Naumann-Godo, M; Nolan, PL; Norris, JP; Nuss, E; Ohsugi, T; Okumura, A; Omodei, N; Ormes, JF; Ozaki, M; Paneque, D; Parent, D; Pelassa, V; Pepe, M; Pesce-Rollins, M; Pierbattista, M; Piron, F; Porter, TA; Raino, S; Rando, R; Ray, PS; Razzano, M; Reimer, A; Reimer, O; Reposeur, T; Ritz, S; Romani, RW; Sadrozinski, HFW; Sanchez, D; Parkinson, PMS; Scargle, JD; Schalk, TL; Sgro, C; Siskind, EJ; Smith, PD; Spandre, G; Spinelli, P; Strickman, MS; Suson, DJ; Takahashi, H; Takahashi, T; Tanaka, T; Thayer, JB; Thompson, DJ; Tibaldo, L; Torres, DF; Tosti, G; Tramacere, A; Troja, E; Uchiyama, Y; Vandenbroucke, J; Vasileiou, V; Vianello, G; Vitale, V; Wang, P; Wood, KS; Yang, Z; Ziegler, M				Abdo, A. A.; Ackermann, M.; Ajello, M.; Allafort, A.; Baldini, L.; Ballet, J.; Barbiellini, G.; Bastieri, D.; Bechtol, K.; Bellazzini, R.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bonamente, E.; Borgland, A. W.; Bouvier, A.; Brandt, T. J.; Bregeon, J.; Brez, A.; Brigida, M.; Bruel, P.; Buehler, R.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Cannon, A.; Caraveo, P. A.; Casandjian, J. M.; Celik, O.; Charles, E.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cohen-Tanugi, J.; Costamante, L.; Cutini, S.; D'Ammando, F.; Dermer, C. D.; de Angelis, A.; de Luca, A.; de Palma, F.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Drlica-Wagner, A.; Dubois, R.; Dumora, D.; Favuzzi, C.; Fegan, S. J.; Ferrara, E. C.; Focke, W. B.; Fortin, P.; Frailis, M.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Giglietto, N.; Giordano, F.; Giroletti, M.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grondin, M. -H.; Grove, J. E.; Guiriec, S.; Hadasch, D.; Hanabata, Y.; Harding, A. K.; Hayashi, K.; Hayashida, M.; Hays, E.; Horan, D.; Itoh, R.; Johannesson, G.; Johnson, A. S.; Johnson, T. J.; Khangulyan, D.; Kamae, T.; Katagiri, H.; Kataoka, J.; Kerr, M.; Knoedlseder, J.; Kuss, M.; Lande, J.; Latronico, L.; Lee, S. -H.; Lemoine-Goumard, M.; Longo, F.; Loparco, F.; Lubrano, P.; Madejski, G. M.; Makeev, A.; Marelli, M.; Mazziotta, M. N.; McEnery, J. E.; Michelson, P. F.; Mitthumsiri, W.; Mizuno, T.; Moiseev, A. A.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nakamori, T.; Naumann-Godo, M.; Nolan, P. L.; Norris, J. P.; Nuss, E.; Ohsugi, T.; Okumura, A.; Omodei, N.; Ormes, J. F.; Ozaki, M.; Paneque, D.; Parent, D.; Pelassa, V.; Pepe, M.; Pesce-Rollins, M.; Pierbattista, M.; Piron, F.; Porter, T. A.; Raino, S.; Rando, R.; Ray, P. S.; Razzano, M.; Reimer, A.; Reimer, O.; Reposeur, T.; Ritz, S.; Romani, R. W.; Sadrozinski, H. F. -W.; Sanchez, D.; Parkinson, P. M. Saz; Scargle, J. D.; Schalk, T. L.; Sgro, C.; Siskind, E. J.; Smith, P. D.; Spandre, G.; Spinelli, P.; Strickman, M. S.; Suson, D. J.; Takahashi, H.; Takahashi, T.; Tanaka, T.; Thayer, J. B.; Thompson, D. J.; Tibaldo, L.; Torres, D. F.; Tosti, G.; Tramacere, A.; Troja, E.; Uchiyama, Y.; Vandenbroucke, J.; Vasileiou, V.; Vianello, G.; Vitale, V.; Wang, P.; Wood, K. S.; Yang, Z.; Ziegler, M.			Gamma-Ray Flares from the Crab Nebula	SCIENCE			English	Article							PARTICLE-ACCELERATION; HIGH-ENERGY; PULSAR; SYNCHROTRON; EMISSION; POLARIZATION; TELESCOPE; COMPTEL; MODEL	A young and energetic pulsar powers the well-known Crab Nebula. Here, we describe two separate gamma-ray (photon energy greater than 100 mega-electron volts) flares from this source detected by the Large Area Telescope on board the Fermi Gamma-ray Space Telescope. The first flare occurred in February 2009 and lasted approximately 16 days. The second flare was detected in September 2010 and lasted approximately 4 days. During these outbursts, the gamma-ray flux from the nebula increased by factors of four and six, respectively. The brevity of the flares implies that the gamma rays were emitted via synchrotron radiation from peta-electron-volt (10(15) electron volts) electrons in a region smaller than 1.4 x 10(-2) parsecs. These are the highest-energy particles that can be associated with a discrete astronomical source, and they pose challenges to particle acceleration theory.	[Ackermann, M.; Ajello, M.; Allafort, A.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Bouvier, A.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Costamante, L.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Drlica-Wagner, A.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johnson, A. S.; Kamae, T.; Lande, J.; Lee, S. -H.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Omodei, N.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Romani, R. W.; Tanaka, T.; Thayer, J. B.; Tramacere, A.; Uchiyama, Y.; Vandenbroucke, J.; Vianello, G.; Wang, P.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Ackermann, M.; Ajello, M.; Allafort, A.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Bouvier, A.; Buehler, R.; Cameron, R. A.; Charles, E.; Chiang, J.; Claus, R.; Costamante, L.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Drlica-Wagner, A.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johnson, A. S.; Kamae, T.; Lande, J.; Lee, S. -H.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Moskalenko, I. V.; Murgia, S.; Nolan, P. L.; Omodei, N.; Paneque, D.; Porter, T. A.; Reimer, A.; Reimer, O.; Romani, R. W.; Tanaka, T.; Thayer, J. B.; Tramacere, A.; Uchiyama, Y.; Vandenbroucke, J.; Vianello, G.; Wang, P.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Abdo, A. A.; Cheung, C. C.] Natl Acad Sci, Natl Res Council, Washington, DC 20001 USA; [Abdo, A. A.; Cheung, C. C.] USN, Res Lab, Washington, DC 20375 USA; [Baldini, L.; Bellazzini, R.; Bregeon, J.; Brez, A.; Kuss, M.; Latronico, L.; Pesce-Rollins, M.; Razzano, M.; Spandre, G.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Grenier, I. A.; Naumann-Godo, M.; Pierbattista, M.; Tibaldo, L.] Univ Paris Diderot, CEA Saclay, Inst Res Fundamental Laws Universe, CNRS,CEA,Lab AIM,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Bastieri, D.; Buson, S.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Buson, S.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Bonamente, E.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brandt, T. J.; Knoedlseder, J.] UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; [Brandt, T. J.; Smith, P. D.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Brigida, M.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Fortin, P.; Horan, D.; Sanchez, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Caliandro, G. A.; Hadasch, D.; Torres, D. F.] CSIC, IEEC, Inst Ciencies Espai, Barcelona 08193, Spain; [Cannon, A.; Celik, O.; Ferrara, E. C.; Gehrels, N.; Harding, A. K.; Hays, E.; Johnson, T. J.; McEnery, J. E.; Moiseev, A. A.; Thompson, D. J.; Troja, E.; Vasileiou, V.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Cannon, A.] Univ Coll Dublin, Sch Phys, Dublin 4, Ireland; [Caraveo, P. A.; Marelli, M.] Ist Astrofis Spaziale & Fis Cosm, Ist Nazl Astrofis, I-20133 Milan, Italy; [Celik, O.; Moiseev, A. A.; Vasileiou, V.] CRESST, Greenbelt, MD 20771 USA; [Celik, O.; Vasileiou, V.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Celik, O.; Vasileiou, V.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA; [Chekhtman, A.; Makeev, A.; Parent, D.] George Mason Univ, Coll Sci, Fairfax, VA 22030 USA; [Cohen-Tanugi, J.; Nuss, E.; Pelassa, V.; Piron, F.] Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, Montpellier, France; [Cutini, S.; Gasparrini, D.] ASI, Sci Data Ctr, I-00044 Frascati, Roma, Italy; [D'Ammando, F.] IASF Palermo, I-90146 Palermo, Italy; [D'Ammando, F.] INAF IASF, I-00133 Rome, Italy; [Dermer, C. D.; Grove, J. E.; Ray, P. S.; Strickman, M. S.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [de Angelis, A.; Frailis, M.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.; Frailis, M.] Ist Nazl Fis Nucl, Sez Trieste, Grp Collegato Udine, I-33100 Udine, Italy; [de Luca, A.] IUSS, I-27100 Pavia, Italy; [Dumora, D.; Grondin, M. -H.; Lemoine-Goumard, M.; Reposeur, T.] Univ Bordeaux 1, CNRS, IN2P3, Ctr Etud Nucl Bordeaux Gradignan, F-33175 Gradignan, France; [Frailis, M.] Ist Nazl Astrofis, Osservatorio Astron Trieste, I-34143 Trieste, Italy; [Fukazawa, Y.; Hanabata, Y.; Hayashi, K.; Itoh, R.; Katagiri, H.; Mizuno, T.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Giroletti, M.] INAF Ist Radioastron, I-40129 Bologna, Italy; [Guiriec, S.] Univ Alabama, Ctr Space Plasma & Aeron Res, Huntsville, AL 35899 USA; [Johannesson, G.] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Johnson, T. J.; McEnery, J. E.; Moiseev, A. A.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Johnson, T. J.; McEnery, J. E.; Moiseev, A. A.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Kataoka, J.; Nakamori, T.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Kerr, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Ohsugi, T.; Takahashi, H.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Khangulyan, D.; Okumura, A.; Ozaki, M.; Takahashi, T.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Kanagawa 2525210, Japan; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Ritz, S.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Schalk, T. L.; Ziegler, M.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Ritz, S.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Schalk, T. L.; Ziegler, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB Real Time Comp, Lattingtown, NY 11560 USA; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Torres, D. F.] ICREA, Barcelona, Spain; [Tramacere, A.; Vianello, G.] CIFS, I-10133 Turin, Italy; [Tramacere, A.] INTEGRAL Sci Data Ctr, CH-1290 Versoix, Switzerland; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Yang, Z.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Yang, Z.] Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; National Academies of Sciences, Engineering & Medicine; United States Department of Defense; United States Navy; Naval Research Laboratory; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University System of Ohio; Ohio State University; Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University College Dublin; Istituto Nazionale Astrofisica (INAF); University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; George Mason University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Agenzia Spaziale Italiana (ASI); Istituto Nazionale Astrofisica (INAF); United States Department of Defense; United States Navy; Naval Research Laboratory; University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); IUSS PAVIA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Istituto Nazionale Astrofisica (INAF); Hiroshima University; Istituto Nazionale Astrofisica (INAF); University of Alabama System; University of Alabama Huntsville; University of Iceland; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Waseda University; University of Washington; University of Washington Seattle; Istituto Nazionale di Fisica Nucleare (INFN); University of Denver; Hiroshima University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Innsbruck; University of Innsbruck; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Purdue University System; Purdue University; ICREA; University of Geneva; University of Rome Tor Vergata; Stockholm University; Oskar Klein Centre	Blandford, RD (corresponding author), Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA.	rdb3@stanford.edu; buehler@stanford.edu; funk@slac.stanford.edu	Hays, Elizabeth/D-3257-2012; Troja, Eleonora/AAB-3604-2020; Morselli, Aldo/G-6769-2011; Gargano, Fabio/O-8934-2015; Okumura, Akira/I-2468-2014; McEnery, Julie E/D-6612-2012; Baldini, Luca/E-5396-2012; Ozaki, Masanobu/K-1165-2013; Harding, Alice K/D-3160-2012; Gargano, Fabio/AAD-5121-2021; Giglietto, Nicola/Y-2425-2019; Troja, Eleonora/I-5282-2017; Jóhannesson, Guðlaugur/ABC-7216-2020; Fukazawa, Yasushi/G-2081-2017; Tosti, Gino/E-9976-2013; Thompson, David J/D-2939-2012; Torres, Diego F./O-9422-2016; Rando, Riccardo/O-1302-2019; Takahashi, Hiromitsu H/T-2713-2017; Moskalenko, Igor V/A-1301-2007; cohen-tanugi, Johann/ABB-1481-2021; Caraveo, Patrizia/AAL-5708-2020; Loparco, Francesco/O-8847-2015; Cutini, Sara/ABB-1787-2020; Mazziotta, Mario N/O-8867-2015; Funk, Stefan/AAI-1568-2021; Reimer, Olaf/A-3117-2013; tramacere, andrea/B-9424-2012; Jóhannesson, Guðlaugur/O-8741-2015; giglietto, nicola/I-8951-2012; Rando, Riccardo/M-7179-2013; Torres, Diego F./AAF-7931-2019; Sgrò, Carmelo/K-3395-2016; Funk, Stefan/B-7629-2015; Torres, Diego F/ABD-7940-2020; Gasparrini, Dario/X-6699-2019; Khangulyan, Dmitry/AAH-1940-2019; Kuss, Michael W/H-8959-2012; Gehrels, Neil/D-2971-2012; Parkinson, Pablo Miguel Saz/I-7980-2013; Hadasch, Daniela/N-7819-2016; lubrano, pasquale/F-7269-2012; Bastieri, Denis/AAC-5917-2020; Reimer, Anita/K-5822-2015	Troja, Eleonora/0000-0002-1869-7817; Morselli, Aldo/0000-0002-7704-9553; Gargano, Fabio/0000-0002-5055-6395; Okumura, Akira/0000-0002-3055-7964; Gargano, Fabio/0000-0002-5055-6395; Giglietto, Nicola/0000-0002-9021-2888; Troja, Eleonora/0000-0002-1869-7817; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Fukazawa, Yasushi/0000-0002-0921-8837; Thompson, David J/0000-0001-5217-9135; Torres, Diego F./0000-0002-1522-9065; Rando, Riccardo/0000-0001-6992-818X; Takahashi, Hiromitsu H/0000-0001-6314-5897; Moskalenko, Igor V/0000-0001-6141-458X; cohen-tanugi, Johann/0000-0001-9022-4232; Caraveo, Patrizia/0000-0003-2478-8018; Loparco, Francesco/0000-0002-1173-5673; Cutini, Sara/0000-0002-1271-2924; Mazziotta, Mario N/0000-0001-9325-4672; Funk, Stefan/0000-0002-2012-0080; Reimer, Olaf/0000-0001-6953-1385; tramacere, andrea/0000-0002-8186-3793; Jóhannesson, Guðlaugur/0000-0003-1458-7036; giglietto, nicola/0000-0002-9021-2888; Torres, Diego F./0000-0002-1522-9065; Funk, Stefan/0000-0002-2012-0080; Gasparrini, Dario/0000-0002-5064-9495; Khangulyan, Dmitry/0000-0002-7576-7869; Hadasch, Daniela/0000-0001-8663-6461; lubrano, pasquale/0000-0003-0221-4806; Bastieri, Denis/0000-0002-6954-8862; Reimer, Anita/0000-0001-8604-7077; Lee, Shiu-Hang/0000-0002-2899-4241; Omodei, Nicola/0000-0002-5448-7577; Costamante, Luigi/0000-0002-8120-5272; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Ciprini, Stefano/0000-0002-0712-2479; Giroletti, Marcello/0000-0002-8657-8852; Johnson, Tyrel/0000-0002-2771-472X; de Palma, Francesco/0000-0001-5898-2834; Grenier, Isabelle/0000-0003-3274-674X; Porter, Troy/0000-0002-2621-4440; Frailis, Marco/0000-0002-7400-2135; D'Ammando, Filippo/0000-0001-7618-7527; Cheung, Chi (Teddy)/0000-0002-4377-0174; Fusco, Piergiorgio/0000-0002-9383-2425; Raino', Silvia/0000-0002-9181-0345; De Luca, Andrea/0000-0001-6739-687X; De Angelis, Alessandro/0000-0002-3288-2517; SANCHEZ, David/0000-0002-7210-4496; Spandre, Gloria/0000-0003-0802-3453; Kerr, Matthew/0000-0002-0893-4073; Berenji, Bijan/0000-0002-4551-772X; Cameron, Robert/0000-0003-0942-2747; Tanaka, Takaaki/0000-0002-4383-0368; Pepe, Monica/0000-0001-5624-4010; Baldini, Luca/0000-0002-9785-7726; Sgro', Carmelo/0000-0001-5676-6214; Vianello, Giacomo/0000-0002-2553-0839; Pesce-Rollins, Melissa/0000-0003-1790-8018; Ackermann, Markus/0000-0001-8952-588X; Tibaldo, Luigi/0000-0001-7523-570X; Buehler, Rolf/0000-0003-4425-6641; Buson, Sara/0000-0002-3308-324X; Ray, Paul/0000-0002-5297-5278; Ajello, Marco/0000-0002-6584-1703; Charles, Eric/0000-0002-3925-7802; Casandjian, Jean-Marc/0000-0003-1404-0524; Itoh, Ryosuke/0000-0002-1183-8955; Katagiri, Hideaki/0000-0003-2347-8819	NASA; U.S. Department of Energy in the United States; CEA/IRFU; IN2P3/CNRS in France; ASI; INFN in Italy; Ministry of Education, Culture, Sports, Science and Technology, High Energy Accelerator Research Organization (KEK); JAXA in Japan; K.A. Wallenberg Foundation; Swedish Research Council; National Space Board in Sweden; International Doctorate on Astroparticle Physics; ICREA Funding Source: Custom	NASA(National Aeronautics & Space Administration (NASA)); U.S. Department of Energy in the United States(United States Department of Energy (DOE)); CEA/IRFU(French Atomic Energy Commission); IN2P3/CNRS in France(Centre National de la Recherche Scientifique (CNRS)); ASI(Agenzia Spaziale Italiana (ASI)); INFN in Italy(Istituto Nazionale di Fisica Nucleare (INFN)); Ministry of Education, Culture, Sports, Science and Technology, High Energy Accelerator Research Organization (KEK)(High Energy Accelerator Research Organization (KEK)); JAXA in Japan; K.A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Space Board in Sweden; International Doctorate on Astroparticle Physics; ICREA(ICREA)	The Fermi LAT Collaboration acknowledges support from a number of agencies and institutes for both development and the operation of the LAT as well as scientific data analysis. These include NASA and the U.S. Department of Energy in the United States; CEA/IRFU and IN2P3/CNRS in France; ASI and INFN in Italy; the Ministry of Education, Culture, Sports, Science and Technology, High Energy Accelerator Research Organization (KEK), and JAXA in Japan; and the K.A. Wallenberg Foundation, the Swedish Research Council, and the National Space Board in Sweden. Additional support from INAF in Italy and CNES in France for science analysis during the operations phase is also gratefully acknowledged. L.T. was partially supported by the International Doctorate on Astroparticle Physics program.	Abdo AA, 2010, ASTROPHYS J, V708, P1254, DOI 10.1088/0004-637X/708/2/1254; Aharonian F, 2006, ASTRON ASTROPHYS, V457, P899, DOI 10.1051/0004-6361:20065351; Aharonian F, 2004, ASTROPHYS J, V614, P897, DOI 10.1086/423931; Ajello M, 2008, ASTROPHYS J, V673, P96, DOI 10.1086/524104; Albert J, 2008, ASTROPHYS J, V674, P1037, DOI 10.1086/525270; Amato E, 2006, ASTROPHYS J, V653, P325, DOI 10.1086/508050; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2903; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2855; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2893; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2882; [Anonymous], 2010, ASTRONOMERS TELEGRAM, P2872; [Anonymous], 2010, ASTRONOMERS TELEGRAM; Atoyan AM, 1996, ASTRON ASTROPHYS SUP, V120, pC453; Atoyan AM, 1996, MON NOT R ASTRON SOC, V278, P525, DOI 10.1093/mnras/278.2.525; Bucciantini N, 2011, MON NOT R ASTRON SOC, V410, P381, DOI 10.1111/j.1365-2966.2010.17449.x; COCKE WJ, 1970, NATURE, V227, P1327, DOI 10.1038/2271327a0; Dean AJ, 2008, SCIENCE, V321, P1183, DOI 10.1126/science.1149056; DEJAGER OC, 1992, ASTROPHYS J, V396, P161, DOI 10.1086/171706; deJager OC, 1996, ASTROPHYS J, V457, P253, DOI 10.1086/176726; Gallant YA, 2002, LECT NOTES PHYS, V589, P24; Gilfanov M., 2002, LIGHTHOUSES UNIVERSE; GOULD RJ, 1965, ANN ASTROPHYS, V28, P171; Hester JJ, 2008, ANNU REV ASTRON ASTR, V46, P127, DOI 10.1146/annurev.astro.45.051806.110608; HESTER JJ, 1995, ASTROPHYS J, V448, P240, DOI 10.1086/175956; Hester JJ, 2002, ASTROPHYS J, V577, pL49, DOI 10.1086/344132; KENNEL CF, 1984, ASTROPHYS J, V283, P710, DOI 10.1086/162357; Kuiper L, 2001, ASTRON ASTROPHYS, V378, P918, DOI 10.1051/0004-6361:20011256; Lyubarsky Y, 2008, ASTROPHYS J, V682, P1436, DOI 10.1086/589640; Lyutikov M, 2010, MON NOT R ASTRON SOC, V405, P1809, DOI 10.1111/j.1365-2966.2010.16553.x; MUCH R, 1995, ASTRON ASTROPHYS, V299, P435; NOVICK R, 1972, ASTROPHYS J, V174, pL1, DOI 10.1086/180938; REES MF, 1974, MON NOT R ASTRON SOC, V167, P1; SCARGLE JD, 1969, ASTROPHYS J, V156, P401, DOI 10.1086/149978; Sironi L, 2009, ASTROPHYS J, V698, P1523, DOI 10.1088/0004-637X/698/2/1523; Tavani M, 2011, SCIENCE, V331, P736, DOI 10.1126/science.1200083; TRIMBLE V, 1973, PUBL ASTRON SOC PAC, V85, P579, DOI 10.1086/129507; Volpi D, 2008, ASTRON ASTROPHYS, V485, P337, DOI 10.1051/0004-6361:200809424; Weisskopf MC, 2010, ASTROPHYS J, V713, P912, DOI 10.1088/0004-637X/713/2/912; Weisskopf MC, 2000, ASTROPHYS J, V536, pL81, DOI 10.1086/312733	39	266	269	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					739	742		10.1126/science.1199705	http://dx.doi.org/10.1126/science.1199705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21212321	Green Submitted			2022-12-28	WOS:000287205700062
J	Stramer, SL; Wend, U; Candotti, D; Foster, GA; Hollinger, FB; Dodd, RY; Allain, JP; Gerlich, W				Stramer, Susan L.; Wend, Ulrike; Candotti, Daniel; Foster, Gregory A.; Hollinger, F. Blaine; Dodd, Roger Y.; Allain, Jean-Pierre; Gerlich, Wolfram			Nucleic Acid Testing to Detect HBV Infection in Blood Donors.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-B-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSFUSION RECIPIENTS; SURFACE-ANTIGEN; UNITED-STATES; CORE ANTIGEN; HIV TRANSMISSION; SCREENED BLOOD; RESIDUAL RISK; C VIRUS	Background: The detection of hepatitis B virus (HBV) in blood donors is achieved by screening for hepatitis B surface antigen (HBsAg) and for antibodies against hepatitis B core antigen (anti-HBc). However, donors who are positive for HBV DNA are currently not identified during the window period before seroconversion. The current use of nucleic acid testing for detection of the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) RNA and HBV DNA in a single triplex assay may provide additional safety. Methods: We performed nucleic acid testing on 3.7 million blood donations and further evaluated those that were HBV DNA-positive but negative for HBsAg and anti-HBc. We determined the serologic, biochemical, and molecular features of samples that were found to contain only HBV DNA and performed similar analyses of follow-up samples and samples from sexual partners of infected donors. Seronegative HIV and HCV-positive donors were also studied. Results: We identified 9 donors who were positive for HBV DNA (1 in 410,540 donations), including 6 samples from donors who had received the HBV vaccine, in whom subclinical infection had developed and resolved. Of the HBV DNA-positive donors, 4 probably acquired HBV infection from a chronically infected sexual partner. Clinically significant liver injury developed in 2 unvaccinated donors. In 5 of the 6 vaccinated donors, a non-A genotype was identified as the dominant strain, whereas subgenotype A2 (represented in the HBV vaccine) was the dominant strain in unvaccinated donors. Of 75 reactive nucleic acid test results identified in seronegative blood donations, 26 (9 HBV, 15 HCV, and 2 HIV) were confirmed as positive. Conclusions: Triplex nucleic acid testing detected potentially infectious HBV, along with HIV and HCV, during the window period before seroconversion. HBV vaccination appeared to be protective, with a breakthrough subclinical infection occurring with non-A2 HBV subgenotypes and causing clinically inconsequential outcomes. (Funded by the American Red Cross and others.) N Engl J Med 2011;364:236-47.	[Stramer, Susan L.; Foster, Gregory A.] Amer Red Cross, Sci Support Off, Gaithersburg, MD 20877 USA; [Dodd, Roger Y.] Amer Red Cross, Holland Lab, Rockville, MD USA; [Wend, Ulrike; Gerlich, Wolfram] Univ Giessen, Inst Med Virol, Giessen, Germany; [Candotti, Daniel] Univ Cambridge, Natl Hlth Serv Blood & Transplant, Cambridge, England; [Allain, Jean-Pierre] Univ Cambridge, Dept Haematol, Cambridge, England; [Hollinger, F. Blaine] Baylor Coll Med, Eugene B Casey Hepatitis Res Ctr, Houston, TX 77030 USA	American Red Cross; American Red Cross; Justus Liebig University Giessen; NHS Blood & Transplant (NHSBT); University of Cambridge; University of Cambridge; Baylor College of Medicine	Stramer, SL (corresponding author), Amer Red Cross, Sci Support Off, 9315 Gaither Rd, Gaithersburg, MD 20877 USA.	stramers@usa.redcross.org	Hollinger, F Blaine/AAY-3323-2021		American Red Cross; Novartis Diagnostics; Gen-Probe; Eugene B. Casey Foundation; William and Sonya Carpenter Fund; Robert Koch Institute; U.K. National Health Service Blood and Transplant	American Red Cross; Novartis Diagnostics; Gen-Probe; Eugene B. Casey Foundation; William and Sonya Carpenter Fund; Robert Koch Institute; U.K. National Health Service Blood and Transplant	Supported by the American Red Cross, Novartis Diagnostics, and Gen-Probe and by grants from the Eugene B. Casey Foundation and the William and Sonya Carpenter Fund (to Dr. Hollinger), from the Robert Koch Institute (to Ms. Wend and Dr. Gerlich), and from the U.K. National Health Service Blood and Transplant (to Dr. Candotti). Abbott Laboratories and Bio-Rad Laboratories provided additional testing support.	AACH RD, 1974, LANCET, V2, P190; Bremer CM, 2009, TRANSFUSION, V49, P1621, DOI 10.1111/j.1537-2995.2009.02188.x; Center for Biologies Evaluation and Research, 2009, BLOOD PROD ADV COMM; Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1; Delwart EL, 2004, VOX SANG, V86, P171, DOI 10.1111/j.0042-9007.2004.00416.x; Dreier J, 2004, TRANSFUSION MED, V14, P97, DOI 10.1111/j.0958-7578.2004.0486.x; Gerlich WH, 2006, J CLIN VIROL, V36, pS18, DOI 10.1016/S1386-6532(06)80004-1; Hollinger FB, 2010, J VIRAL HEPATITIS, V17, P600, DOI 10.1111/j.1365-2893.2010.01344.x; Hollinger FB, 2010, J VIRAL HEPATITIS, V17, P1, DOI 10.1111/j.1365-2893.2009.01245.x; Hollinger FB, 2008, TRANSFUSION, V48, P1001, DOI 10.1111/j.1537-2995.2008.01701.x; HOOFNAGLE JH, 1978, NEW ENGL J MED, V298, P1379, DOI 10.1056/NEJM197806222982502; Jackson BR, 2003, TRANSFUSION, V43, P721, DOI 10.1046/j.1537-2995.2003.00392.x; Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x; Laffoon B., 2010, Morbidity and Mortality Weekly Report, V59, P1335; Levicnik-Stezinar S, 2008, J HEPATOL, V48, P1022, DOI 10.1016/j.jhep.2008.02.016; Linauts S, 2008, TRANSFUSION, V48, P1376, DOI 10.1111/j.1537-2995.2008.01698.x; Manzini P, 2009, TRANSFUSION, V49, P757, DOI 10.1111/j.1537-2995.2008.02041.x; Mosley JW, 1997, TRANSFUSION, V37, P109; MOSLEY JW, 1995, TRANSFUSION, V35, P5, DOI 10.1046/j.1537-2995.1995.35195090661.x; Mosley JW, 1996, TRANSFUSION, V36, P776, DOI 10.1046/j.1537-2995.1996.36996420752.x; O'Brien S, 2008, TRANSFUSION, V48, p62A; Phelps R, 2004, TRANSFUSION, V44, P929, DOI 10.1111/j.1537-2995.2004.03364.x; Phikulsod S, 2009, TRANSFUSION, V49, P1126, DOI 10.1111/j.1537-2995.2009.02176.x; Prince AM, 2001, TRANSFUSION, V41, P329, DOI 10.1046/j.1537-2995.2001.41030329.x; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Satake M, 2007, TRANSFUSION, V47, P1197, DOI 10.1111/j.1537-2995.2007.01276.x; STEVENS CE, 1984, ANN INTERN MED, V101, P733, DOI 10.7326/0003-4819-101-6-733; Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085; Stramer SL, 2003, TRANSFUSION, V43, p40A; Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x; Tabuchi A, 2008, J MED VIROL, V80, P2064, DOI 10.1002/jmv.21320; Taylor C, 2002, TRANSFUSION, V42, p9S; Yoshikawa A, 2007, TRANSFUSION, V47, P1162, DOI 10.1111/j.1537-2995.2007.01234.x; Zou SM, 2010, TRANSFUSION, V50, P1495, DOI 10.1111/j.1537-2995.2010.02622.x; Zou SM, 2009, TRANSFUSION, V49, P1609, DOI 10.1111/j.1537-2995.2009.02195.x	35	216	235	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					236	247		10.1056/NEJMoa1007644	http://dx.doi.org/10.1056/NEJMoa1007644			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21247314				2022-12-28	WOS:000286383900008
J	Tao, F; Salmeron, M				Tao, Franklin (Feng); Salmeron, Miquel			In Situ Studies of Chemistry and Structure of Materials in Reactive Environments	SCIENCE			English	Review							PHOTOELECTRON-SPECTROSCOPY; SURFACES; CATALYST; OXYGEN; MICROSCOPY; NANOSCALE; REDUCTION; OXIDATION; GROWTH; NANOPARTICLES	Most materials and devices typically operate under specific environmental conditions, many of them highly reactive. Heterogeneous catalysts, for example, work under high pressure of reactants or in acidic solutions. The relationship between surface structure and composition of materials during operation and their chemical properties needs to be established in order to understand the mechanisms at work and to enable the design of new and better materials. Although studies of the structure, composition, chemical state, and phase transformation under working conditions are challenging, progress has been made in recent years in the development of new techniques that operate under a variety of realistic environments. With them, new chemistry and new structures of materials that are only present under reaction conditions have been uncovered.	[Tao, Franklin (Feng)] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Salmeron, Miquel] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of Notre Dame; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tao, F (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	ftao@nd.edu; mbsalmeron@lbl.gov			Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy [DE-AC02-05CH11231]; Department of Chemistry and Biochemistry, College of Science, Sustainable Energy Initiative, Radiation Lab, and Office of Research at University of Notre Dame	Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy(United States Department of Energy (DOE)); Department of Chemistry and Biochemistry, College of Science, Sustainable Energy Initiative, Radiation Lab, and Office of Research at University of Notre Dame	This work was supported by the director, Office of Basic Energy Sciences, Materials Sciences Division of the U.S. Department of Energy under contract no. DE-AC02-05CH11231, and Department of Chemistry and Biochemistry, College of Science, Sustainable Energy Initiative, Radiation Lab, and Office of Research at University of Notre Dame. F. T. would like to acknowledge K. Davis of the University of Notre Dame for assistance with the animation movie.	Altman MS, 2010, SCIENCE, V327, P789, DOI 10.1126/science.1187483; Blume R, 2005, J PHYS CHEM B, V109, P14052, DOI 10.1021/jp044175x; Campbell CT, 2005, SCIENCE, V309, P713, DOI 10.1126/science.1113955; CHEN SJ, 1993, SURF SCI, V292, P289, DOI 10.1016/0039-6028(93)90334-G; de Smit E, 2008, NATURE, V456, P222, DOI 10.1038/nature07516; Dudin P, 2005, J PHYS CHEM B, V109, P13649, DOI 10.1021/jp0508002; Frenken J, 2007, MRS BULL, V32, P1015, DOI 10.1557/mrs2007.210; Gai PL, 2002, MICROSC MICROANAL, V8, P21, DOI 10.1017/S1431927601010054; GROZIER PA, 2008, ULTRAMICROSCOPY, V108, P1432; Hansen PL, 2002, SCIENCE, V295, P2053, DOI 10.1126/science.1069325; Helveg S, 2004, NATURE, V427, P426, DOI 10.1038/nature02278; Jeong HC, 1999, SURF SCI REP, V34, P171, DOI 10.1016/S0167-5729(98)00010-7; Ketteler G, 2005, J AM CHEM SOC, V127, P18269, DOI 10.1021/ja055754y; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; Liu CJ, 2010, ACS NANO, V4, P5517, DOI 10.1021/nn102420c; Liu K, 2010, J PHYS CHEM C, V114, P8533, DOI 10.1021/jp101697e; Longwitz SR, 2004, J PHYS CHEM B, V108, P14497, DOI 10.1021/jp0492218; Murray CB, 2009, SCIENCE, V324, P1276, DOI 10.1126/science.1174666; Quiros C, 2003, SURF SCI, V522, P161, DOI 10.1016/S0039-6028(02)02342-7; REISS H, 1951, J CHEM PHYS, V19, P482, DOI 10.1063/1.1748251; Rodriguez JA, 2007, SCIENCE, V318, P1757, DOI 10.1126/science.1150038; Russell AE, 2004, CHEM REV, V104, P4613, DOI 10.1021/cr020708r; Salmeron M, 2008, SURF SCI REP, V63, P169, DOI 10.1016/j.surfrep.2008.01.001; Somorjai G.A., 2010, INTRO SURFACE CHEM C; Stair PC, 2001, CURR OPIN SOLID ST M, V5, P365, DOI 10.1016/S1359-0286(01)00034-1; Tao F, 2008, SCIENCE, V322, P932, DOI 10.1126/science.1164170; Tao F, 2010, SCIENCE, V327, P850, DOI 10.1126/science.1182122; Tao F, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2960569; Thostrup P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.126102; Traa, 2008, HDB HETEROGENEOUS CA, DOI DOI 10.1002/9783527610044.HETCAT0130; Vestergaard EK, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.126101; Wachs IE, 2010, CHEM SOC REV, V39, P5002, DOI 10.1039/c0cs00145g; Wang W, 2008, ACCOUNTS CHEM RES, V41, P895, DOI 10.1021/ar700210f; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; Yang M, 2004, J AM CHEM SOC, V126, P7698, DOI 10.1021/ja0361446; Yu GB, 2010, J AM CHEM SOC, V132, P935, DOI 10.1021/ja906370b; Zhang CJ, 2010, NAT MATER, V9, P944, DOI 10.1038/nmat2851; Zhang J, 2007, SCIENCE, V315, P220, DOI 10.1126/science.1134569; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104	39	303	310	7	447	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2011	331	6014					171	174		10.1126/science.1197461	http://dx.doi.org/10.1126/science.1197461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233377				2022-12-28	WOS:000286433100030
J	Leibenluft, RF				Leibenluft, Robert F.			ACOs and the Enforcement of Fraud, Abuse, and Antitrust Laws	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hogan Lovells, Washington, DC USA		Leibenluft, RF (corresponding author), Hogan Lovells, Washington, DC USA.							LEIBENLUFT RF, 2009, HLTH LAW HDB, P251; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194	2	10	10	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					99	101		10.1056/NEJMp1011464	http://dx.doi.org/10.1056/NEJMp1011464			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	705NJ	21175308				2022-12-28	WOS:000286142900002
J	Tang, THC; Tsang, OTY				Tang, Tommy Hing Cheung; Tsang, Owen Tak Yin			Fungal Infection from Sweeping in the Wrong Place	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tang, Tommy Hing Cheung] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China; [Tsang, Owen Tak Yin] Princess Margaret Hosp, Hong Kong, Hong Kong, Peoples R China		Tang, THC (corresponding author), Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China.	thc061@gmail.com	Tang, Tommy HC/H-8621-2019	Tang, Tommy HC/0000-0002-6476-4697					0	8	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					E3	E3		10.1056/NEJMicm1007348	http://dx.doi.org/10.1056/NEJMicm1007348			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226571				2022-12-28	WOS:000286142900010
J	Cutter, WJ; Greenberg, K; Nicholson, TRJ; Cairns, R				Cutter, William J.; Greenberg, Karla; Nicholson, Timothy R. J.; Cairns, Ruth			Practice Pointer Identifying and managing deprivation of liberty in adults in England and Wales	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cutter, William J.] Hampshire Partnership NHS Fdn Trust, Directorate Older Peoples Mental Hlth, Gosport PO13 0GY, Hants, England; [Greenberg, Karla] St James Hosp, Langstone Ctr, Dept Older Persons Mental Hlth, Portsmouth, Hants, England; [Nicholson, Timothy R. J.] Kings Coll London, Inst Psychiat, Dept Psychol Med, Sect Cognit Neuropsychiat, London WC2R 2LS, England; [Cairns, Ruth] Kings Coll London, Inst Psychiat, Dept Psychol Med, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Cutter, WJ (corresponding author), Hampshire Partnership NHS Fdn Trust, Directorate Older Peoples Mental Hlth, Gosport PO13 0GY, Hants, England.	wjcutter@gmail.com		Nicholson, Timothy/0000-0002-2350-2332	National Institute for Health Research [CL-2009-17-006] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Allen N, 2010, MED LAW REV, V18, P78, DOI 10.1093/medlaw/fwq005; Nicholson TRJ, 2008, BRIT MED J, V336, P322, DOI 10.1136/bmj.39457.485347.80; Zigmond A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1888; [No title captured]	4	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 10	2011	342								c7323	10.1136/bmj.c7323	http://dx.doi.org/10.1136/bmj.c7323			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708RZ	21220387				2022-12-28	WOS:000286383300007
J	Kaiser, JT; Hu, YL; Wiig, JA; Rees, DC; Ribbe, MW				Kaiser, Jens T.; Hu, Yilin; Wiig, Jared A.; Rees, Douglas C.; Ribbe, Markus W.			Structure of Precursor-Bound NifEN: A Nitrogenase FeMo Cofactor Maturase/Insertase	SCIENCE			English	Article							IRON-MOLYBDENUM COFACTOR; MOFE-PROTEIN	NifEN plays an essential role in the biosynthesis of the nitrogenase iron-molybdenum (FeMo) cofactor (M cluster). It is an alpha(2)beta(2) tetramer that is homologous to the catalytic molybdenum-iron (MoFe) protein (NifDK) component of nitrogenase. NifEN serves as a scaffold for the conversion of an iron-only precursor to a matured form of the M cluster before delivering the latter to its target location within NifDK. Here, we present the structure of the precursor-bound NifEN of Azotobacter vinelandii at 2.6 angstrom resolution. From a structural comparison of NifEN with des-M-cluster NifDK and holo NifDK, we propose similar pathways of cluster insertion for the homologous NifEN and NifDK proteins.	[Kaiser, Jens T.; Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hu, Yilin; Wiig, Jared A.; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; University of California System; University of California Irvine; California Institute of Technology; Howard Hughes Medical Institute	Rees, DC (corresponding author), CALTECH, Div Chem & Chem Engn, Mail Code 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu; mribbe@uci.edu			NIH [GM-67626, GM-45162]; U.S. Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626, R01GM045162, R37GM045162] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM-67626 (M.W.R.) and GM-45162 (D.C.R.) D.C.R. is an investigator of the Howard Hughes Medical Institute. We acknowledge the Gordon and Betty Moore Foundation for support of the Molecular Observatory at California Institute of Technology. Operations at the Stanford Synchrotron Radiation Lightsource are supported by the U.S. Department of Energy and NIH. The coordinates and structure factors have been deposited with the Protein Data Bank (PDB), accession number 3PDI.	Brocker MJ, 2010, J BIOL CHEM, V285, P8268, DOI 10.1074/jbc.M109.087874; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Corbett MC, 2006, P NATL ACAD SCI USA, V103, P1238, DOI 10.1073/pnas.0507853103; Dos Santos PC, 2004, CHEM REV, V104, P1159, DOI 10.1021/cr020608l; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17119, DOI 10.1073/pnas.0602647103; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Hu YL, 2005, P NATL ACAD SCI USA, V102, P3236, DOI 10.1073/pnas.0409201102; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Lee CC, 2009, P NATL ACAD SCI USA, V106, P18474, DOI 10.1073/pnas.0909149106; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302	17	78	80	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					91	94		10.1126/science.1196954	http://dx.doi.org/10.1126/science.1196954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212358	Green Accepted			2022-12-28	WOS:000285974000043
J	Turck, F; Coupland, G				Turck, Franziska; Coupland, George			When Vernalization Makes Sense	SCIENCE			English	Editorial Material							ARABIDOPSIS-THALIANA; FLC; PROTEIN; REQUIRES; COMPLEX; GENE		[Turck, Franziska; Coupland, George] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Max Planck Society	Turck, F (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linn Weg 10, D-50829 Cologne, Germany.	coupland@mpipz.mpg.de	Coupland, George/AAP-8609-2020; Turck, Franziska/G-1240-2013	Coupland, George/0000-0001-6988-4172; Turck, Franziska/0000-0002-4982-5949				Aikawa S, 2010, P NATL ACAD SCI USA, V107, P11632, DOI 10.1073/pnas.0914293107; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103	15	13	17	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					36	37		10.1126/science.1200786	http://dx.doi.org/10.1126/science.1200786			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212342				2022-12-28	WOS:000285974000023
J	Maillet, F; Poinsot, V; Andre, O; Puech-Pages, V; Haouy, A; Gueunier, M; Cromer, L; Giraudet, D; Formey, D; Niebel, A; Martinez, EA; Driguez, H; Becard, G; Denarie, J				Maillet, Fabienne; Poinsot, Verena; Andre, Olivier; Puech-Pages, Virginie; Haouy, Alexandra; Gueunier, Monique; Cromer, Laurence; Giraudet, Delphine; Formey, Damien; Niebel, Andreas; Martinez, Eduardo Andres; Driguez, Hugues; Becard, Guillaume; Denarie, Jean			Fungal lipochitooligosaccharide symbiotic signals in arbuscular mycorrhiza	NATURE			English	Article							CHITOOLIGOSACCHARIDE NODULATION FACTORS; MEDICAGO-TRUNCATULA; NODULE DEVELOPMENT; DIFFUSIBLE FACTOR; ESCHERICHIA-COLI; RHIZOBIUM; GENES; LEGUMES; BACTERIAL; PROTEIN	Arbuscular mycorrhiza (AM) is a root endosymbiosis between plants and glomeromycete fungi. It is the most widespread terrestrial plant symbiosis, improving plant uptake of water and mineral nutrients. Yet, despite its crucial role in land ecosystems, molecular mechanisms leading to its formation are just beginning to be unravelled. Recent evidence suggests that AM fungi produce diffusible symbiotic signals. Here we show that Glomus intraradices secretes symbiotic signals that are a mixture of sulphated and non-sulphated simple lipochitooligosaccharides (LCOs), which stimulate formation of AM in plant species of diverse families (Fabaceae, Asteraceae and Umbelliferae). In the legume Medicago truncatula these signals stimulate root growth and branching by the symbiotic DMI signalling pathway. These findings provide a better understanding of the evolution of signalling mechanisms involved in plant root endosymbioses and will greatly facilitate their molecular dissection. They also open the way to using these natural and very active molecules in agriculture.	[Maillet, Fabienne; Andre, Olivier; Haouy, Alexandra; Gueunier, Monique; Cromer, Laurence; Giraudet, Delphine; Niebel, Andreas; Denarie, Jean] INRA, CNRS 2594, UMR 441, Lab Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France; [Poinsot, Verena] Univ Toulouse 3, CNRS, UMR 5623, Lab IMRCP, F-31062 Toulouse, France; [Puech-Pages, Virginie; Gueunier, Monique; Formey, Damien; Becard, Guillaume] Univ Toulouse, UPS, UMR 5546, F-31326 Castanet Tolosan, France; [Puech-Pages, Virginie; Gueunier, Monique; Formey, Damien; Becard, Guillaume] CNRS, UMR 5546, F-31326 Castanet Tolosan, France; [Martinez, Eduardo Andres; Driguez, Hugues] Univ Grenoble 1, CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble 9, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Denarie, J (corresponding author), INRA, CNRS 2594, UMR 441, Lab Interact Plantes Microorganismes, BP 52627, F-31326 Castanet Tolosan, France.	jean.denarie@toulouse.inra.fr	NIEBEL, Andreas/AAL-7687-2020; Poinsot, Verena/AAU-2614-2021; Formey, Damien/X-5542-2019; poinssot, benoit/B-2569-2009; cromer, Laurence/I-4814-2014	Formey, Damien/0000-0003-2852-4706; poinssot, benoit/0000-0001-5890-4318; Poinsot, Verena/0000-0002-9746-6768; Niebel, Andreas/0000-0002-3402-8381	EMD Crop BioScience; Charles-Leopold Mayer Prize; French Academy of Sciences; Institut National de la Recherche Agronomique	EMD Crop BioScience; Charles-Leopold Mayer Prize; French Academy of Sciences; Institut National de la Recherche Agronomique	This work was supported in part by a grant from EMD Crop BioScience and by the Charles-Leopold Mayer Prize (2005) attributed to J.D. by the French Academy of Sciences. M. G. was supported by an Institut National de la Recherche Agronomique fellowship. We are grateful to C. Gough and G. Oldroyd for providing seeds of M. truncatula mutants, and to S. Roy and J. Loubradou for providing sterile mycorrhized roots and spores of G. intraradices. The UPLC/QToF mass spectrometer was made available to us by the Institut des Technologies Avancees du Vivant and the QTRAP mass spectrometer by the Metabolomics and fluxomics platform (MetaToul). We thank S. Danoun for her help with UPLC/QToF mass spectrometry, F. Letisse for his advice and help in setting up experiments on the QTrap mass spectrometer, P. Lavedan for NMR measurements, C. Herve for her advice and help for quantitative PCR with reverse transcription experiments and C. Briere for his advice for statistical analysis. We thank C. Gough, J. Cullimore and G. Oldroyd for their comments on this manuscript.	Andriankaja A, 2007, PLANT CELL, V19, P2866, DOI 10.1105/tpc.107.052944; Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; ARDOUREL M, 1994, PLANT CELL, V6, P1357, DOI 10.1105/tpc.6.10.1357; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; CHABOT S, 1992, MYCOLOGIA, V84, P315, DOI 10.2307/3760183; Chen CY, 2008, NEW PHYTOL, V180, P311, DOI 10.1111/j.1469-8137.2008.02612.x; Chen CY, 2007, PLANT PHYSIOL, V145, P1619, DOI 10.1104/pp.107.109876; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; DEMONT N, 1993, J BIOL CHEM, V268, P20134; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gutjahr C, 2009, NEW PHYTOL, V183, P53, DOI 10.1111/j.1469-8137.2009.02871.x; Gutjahr C, 2009, NEW PHYTOL, V182, P829, DOI 10.1111/j.1469-8137.2009.02839.x; Harrison MJ, 2005, ANNU REV MICROBIOL, V59, P19, DOI 10.1146/annurev.micro.58.030603.123749; Hewitt E., 1966, SAND WATER CULTURE M, V187-237, P430; Hirsch S, 2009, PLANT CELL, V21, P545, DOI 10.1105/tpc.108.064501; Journet EP, 2001, MOL PLANT MICROBE IN, V14, P737, DOI 10.1094/MPMI.2001.14.6.737; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kosuta S, 2003, PLANT PHYSIOL, V131, P952, DOI 10.1104/pp.011882; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Kuhn H, 2010, NEW PHYTOL, V185, P716, DOI 10.1111/j.1469-8137.2009.03116.x; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Oldroyd GED, 2006, CURR OPIN PLANT BIOL, V9, P351, DOI 10.1016/j.pbi.2006.05.003; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Olsthoorn MMA, 1998, BIOCHEMISTRY-US, V37, P9024, DOI 10.1021/bi972937r; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Poinsot V, 2001, J BACTERIOL, V183, P3721, DOI 10.1128/JB.183.12.3721-3728.2001; PRICE NPJ, 1992, MOL MICROBIOL, V6, P3575, DOI 10.1111/j.1365-2958.1992.tb01793.x; R Core Team, 2020, R LANG ENV STAT COMP; Rasmussen MO, 2004, ORG BIOMOL CHEM, V2, P1908, DOI 10.1039/b403575e; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Riely BK, 2004, CURR OPIN PLANT BIOL, V7, P408, DOI 10.1016/j.pbi.2004.04.005; ROCHE P, 1991, J BIOL CHEM, V266, P10933; Samain E, 1999, J BIOTECHNOL, V72, P33, DOI 10.1016/S0168-1656(99)00048-6; Samain E, 1997, CARBOHYD RES, V302, P35, DOI 10.1016/S0008-6215(97)00107-9; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P145, DOI 10.1016/B978-012370526-6.50007-6; SPAINK HP, 1995, J BACTERIOL, V177, P6276, DOI 10.1128/jb.177.21.6276-6281.1995; SPAINK HP, 1994, MOL MICROBIOL, V13, P821, DOI 10.1111/j.1365-2958.1994.tb00474.x; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Stacey G, 2006, CURR OPIN PLANT BIOL, V9, P110, DOI 10.1016/j.pbi.2006.01.005; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797; Wang B, 2010, NEW PHYTOL, V186, P514, DOI 10.1111/j.1469-8137.2009.03137.x; Weidmann S, 2004, MOL PLANT MICROBE IN, V17, P1385, DOI 10.1094/MPMI.2004.17.12.1385	55	614	669	10	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					58	U1501		10.1038/nature09622	http://dx.doi.org/10.1038/nature09622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	702UO	21209659				2022-12-28	WOS:000285921600030
J	Carstairs, SD; Schneir, AB				Carstairs, Shaun D.; Schneir, Aaron B.			Opsoclonus Due to Diphenhydramine Poisoning.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Carstairs, Shaun D.] USN, Med Ctr, San Diego, CA 92152 USA; [Schneir, Aaron B.] Univ Calif San Diego, Ctr Med, San Diego, CA 92103 USA	United States Department of Defense; United States Navy; University of California System; University of California San Diego	Carstairs, SD (corresponding author), USN, Med Ctr, San Diego, CA 92152 USA.	shaunc@yahoo.com	Carstairs, Shaun/AAL-4645-2021	Carstairs, Shaun/0000-0003-4558-9704					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					E40	E40		10.1056/NEJMicm1002035	http://dx.doi.org/10.1056/NEJMicm1002035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190451				2022-12-28	WOS:000285763700011
J	Roess, AA; Galan, A; Kitces, E; Li, Y; Zhao, H; Paddock, CD; Adem, P; Goldsmith, CS; Miller, D; Reynolds, MG; Zaki, SR; Damon, IK				Roess, Amira A.; Galan, Anjela; Kitces, Edward; Li, Yu; Zhao, Hui; Paddock, Christopher D.; Adem, Patricia; Goldsmith, Cynthia S.; Miller, Debra; Reynolds, Mary G.; Zaki, Sherif R.; Damon, Inger K.			Brief Report: Novel Deer-Associated Parapoxvirus Infection in Deer Hunters.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORF-VIRUS-INFECTION; PCR ASSAYS; RED DEER; IMIQUIMOD; POXVIRUS; SEA	Parapoxviruses are a genus of the double-stranded DNA family of poxviruses that infect ruminants, and zoonotic transmission to humans often results from occupational exposures. Parapoxvirus infection in humans begins with an incubation period of 3 to 7 days, followed by the development of one or more erythematous maculopapular lesions that evolve over the course of several weeks into nodules. In 2009, parapoxvirus infection was diagnosed in two deer hunters in the eastern United States after the hunters had field-dressed white-tailed deer. We describe the clinical and pathological features of these infections and the phylogenetic relationship of a unique strain of parapoxvirus to other parapoxviruses. Deer populations continue to increase, leading to the possibility that there will be more deer-associated parapoxvirus infections.	[Roess, Amira A.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; [Roess, Amira A.; Li, Yu; Zhao, Hui; Paddock, Christopher D.; Adem, Patricia; Goldsmith, Cynthia S.; Reynolds, Mary G.; Zaki, Sherif R.; Damon, Inger K.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Galan, Anjela] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Galan, Anjela; Miller, Debra] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kitces, Edward] Richmond Dermatol & Laser Specialists, Richmond, VA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Yale University; Yale University	Damon, IK (corresponding author), Mailstop G-06,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	idamon@cdc.gov		Reynolds, Mary/0000-0001-7882-4614; Roess, Amira/0000-0003-2321-1575				BOWMAN KF, 1981, JAMA-J AM MED ASSOC, V246, P2813, DOI 10.1001/jama.246.24.2813; CHEVILLE NF, 1967, J AM VET MED ASSOC, V150, P855; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Erbagci Z, 2005, J DERMATOL TREAT, V16, P353, DOI 10.1080/09546630500375734; FRIEDMANKIEN AE, 1963, SCIENCE, V140, P1335, DOI 10.1126/science.140.3573.1335; GROVES RW, 1991, J AM ACAD DERMATOL, V25, P706, DOI 10.1016/0190-9622(91)70257-3; Hautaniemi M, 2010, J GEN VIROL, V91, P1560, DOI 10.1099/vir.0.018374-0; Hawary MB, 1997, J HAND SURG-BRIT EUR, V22B, P550, DOI 10.1016/S0266-7681(97)80291-4; HORNER GW, 1987, NEW ZEAL VET J, V35, P41, DOI 10.1080/00480169.1987.35376; Inoshima Y, 2001, EPIDEMIOL INFECT, V126, P153, DOI 10.1017/S0950268801005131; Kuhl JT, 2003, CUTIS, V71, P288; LEAVELL UW, 1968, J AMER MED ASSOC, V204, P657, DOI 10.1001/jama.1968.03140210011003; Lederman ER, 2007, CLIN INFECT DIS, V44, pE100, DOI 10.1086/517509; Lederman ER, 2007, PEDIATR INFECT DIS J, V26, P740, DOI 10.1097/INF.0b013e31806211bf; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Li Y, 2010, J CLIN MICROBIOL, V48, P268, DOI 10.1128/JCM.01697-09; Muller G, 2003, VET PATHOL, V40, P445, DOI 10.1354/vp.40-4-445; Nollens HH, 2006, J WILDLIFE DIS, V42, P23, DOI 10.7589/0090-3558-42.1.23; Paddock CD, 2007, CURR TOP MICROBIOL, V315, P289; ROBINSON AJ, 1995, VIROLOGY, V208, P812, DOI 10.1006/viro.1995.1217; SHELUKHINA E M, 1986, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V30, P411; SMITH KJ, 1991, ARCH DERMATOL, V127, P79, DOI 10.1001/archderm.127.1.79; TAN ST, 1991, BRIT J PLAST SURG, V44, P465, DOI 10.1016/0007-1226(91)90209-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tikkanen MK, 2004, BRIT J DERMATOL, V85, P1413	25	26	26	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2621	2627		10.1056/NEJMoa1007407	http://dx.doi.org/10.1056/NEJMoa1007407			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190456	Bronze			2022-12-28	WOS:000285763700007
J	Carone, BR; Fauquier, L; Habib, N; Shea, JM; Hart, CE; Li, RW; Bock, C; Li, CJ; Gu, HC; Zamore, PD; Meissner, A; Weng, ZP; Hofmann, HA; Friedman, N; Rando, OJ				Carone, Benjamin R.; Fauquier, Lucas; Habib, Naomi; Shea, Jeremy M.; Hart, Caroline E.; Li, Ruowang; Bock, Christoph; Li, Chengjian; Gu, Hongcang; Zamore, Phillip D.; Meissner, Alexander; Weng, Zhiping; Hofmann, Hans A.; Friedman, Nir; Rando, Oliver J.			Paternally Induced Transgenerational Environmental Reprogramming of Metabolic Gene Expression in Mammals	CELL			English	Article							DNA METHYLATION; EPIGENETIC INHERITANCE; HUMAN GENOME; MOUSE; MICE; DROSOPHILA; CHROMATIN; PROMOTER; ALLELE; CELLS	Epigenetic information can be inherited through the mammalian germline and represents a plausible transgenerational carrier of environmental information. To test whether transgenerational inheritance of environmental information occurs in mammals, we carried out an expression profiling screen for genes in mice that responded to paternal diet. Offspring of males fed a low-protein diet exhibited elevated hepatic expression of many genes involved in lipid and cholesterol biosynthesis and decreased levels of cholesterol esters, relative to the offspring of males fed a control diet. Epigenomic profiling of offspring livers revealed numerous modest (similar to 20%) changes in cytosine methylation depending on paternal diet, including reproducible changes in methylation over a likely enhancer for the key lipid regulator Ppara. These results, in conjunction with recent human epidemiological data, indicate that parental diet can affect cholesterol and lipid metabolism in offspring and define a model system to study environmental reprogramming of the heritable epigenome.	[Carone, Benjamin R.; Fauquier, Lucas; Shea, Jeremy M.; Hart, Caroline E.; Li, Chengjian; Zamore, Phillip D.; Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Li, Ruowang; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Habib, Naomi; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; [Habib, Naomi] Hebrew Univ Jerusalem, Dept Mol Genet & Biotechnol, Fac Med, IL-91120 Jerusalem, Israel; [Bock, Christoph; Gu, Hongcang; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Bock, Christoph; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hofmann, Hans A.] Univ Texas Austin, Inst Neurosci, Sect Integrat Biol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Friedman, Nir] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Texas System; University of Texas Austin; Hebrew University of Jerusalem	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu	Hofmann, Hans A/E-4538-2016; Zamore, Phillip D/A-8941-2013; Habib, Naomi/AAA-8937-2020; Friedman, Nir/H-9692-2012; Bock, Christoph/AAE-7618-2019	Hofmann, Hans A/0000-0002-3335-330X; Friedman, Nir/0000-0002-9678-3550; Bock, Christoph/0000-0001-6091-3088; Rando, Oliver/0000-0003-1516-9397; Gu, Hongcang/0000-0002-1439-7606; Zamore, Phillip/0000-0002-4505-9618; Carone, Benjamin/0000-0002-9822-4218	Burroughs Wellcome Fund; NIGMS [GM088618, GM62862, GM65236]; NIH; US-Israel Binational Science Foundation (BSF); NSF; Alfred P. Sloan Foundation; Meidan fellowship; Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862, R01GM065236, R01GM088618] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Meidan fellowship; Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Haig for initial discussions motivating this experiment and K. Ahmad, P. Kaufman, C. Meiklejohn, Y. Nahmias, and members of the Rando lab for critical reading of the manuscript. O.J.R. is supported in part by a Career Award in Biomedical Sciences from the Burroughs Wellcome Fund, by grant GM088618 from NIGMS, and by the Mathers Foundation and is a member of the UMass Diabetes Endocrinology Research Center (DK32520). N.F. is supported by grants from the NIH and the US-Israel Binational Science Foundation (BSF). H. A. H. is supported by NSF, an Alfred P. Sloan Foundation Fellowship and a Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology. P.D.Z. is supported by grants GM62862 and GM65236 from the NIGMS. N.H. is supported by the Meidan fellowship. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Arpanahi A, 2009, GENOME RES, V19, P1338, DOI 10.1101/gr.094953.109; Avital Eytan, 2000, ANIMAL TRADITIONS BE, DOI 10-1017/CBO9780511542251; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Champagne F, 2001, Prog Brain Res, V133, P287; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Horton TH, 2005, AM J HUM BIOL, V17, P34, DOI 10.1002/ajhb.20092; Jablonka E., 1995, EPIGENETIC INHERITAN; Jablonka E., 2005, EVOLUTION 4 DIMENSIO; Jacinto FV, 2008, BIOTECHNIQUES, V44, P35, DOI 10.2144/000112708; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Lumey LH, 2007, INT J EPIDEMIOL, V36, P1196, DOI 10.1093/ije/dym126; Madsen MA, 2004, BIOCHEM BIOPH RES CO, V318, P998, DOI 10.1016/j.bbrc.2004.04.126; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ooi SL, 2007, CURR OPIN CELL BIOL, V19, P257, DOI 10.1016/j.ceb.2007.04.015; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Torrisani J, 2007, CURR GENOMICS, V8, P229; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Yamaguchi R, 2010, HORM METAB RES, V42, P821, DOI 10.1055/s-0030-1261954; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	56	770	811	5	178	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1084	1096		10.1016/j.cell.2010.12.008	http://dx.doi.org/10.1016/j.cell.2010.12.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183072	Green Accepted, Bronze			2022-12-28	WOS:000285625400007
J	Carpi, F; Bauer, S; De Rossi, D				Carpi, Federico; Bauer, Siegfried; De Rossi, Danilo			Stretching Dielectric Elastomer Performance	SCIENCE			English	Editorial Material							ARTIFICIAL MUSCLES; ACTUATORS		[Carpi, Federico; De Rossi, Danilo] Univ Pisa, Sch Engn, Interdept Res Ctr E Piaggio, I-56100 Pisa, Italy; [Bauer, Siegfried] Univ Linz, Dept Soft Matter Phys, A-4040 Linz, Austria	University of Pisa; Johannes Kepler University Linz	Carpi, F (corresponding author), Univ Pisa, Sch Engn, Interdept Res Ctr E Piaggio, I-56100 Pisa, Italy.	f.carpi@centropiaggio.unipi.it	Carpi, Federico/D-2112-2013; Bauer, Siegfried/A-2354-2009	Carpi, Federico/0000-0001-8496-5085; Bauer, Siegfried/0000-0002-7770-9435	Austrian Science Fund (FWF) [P 20971] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Aschwanden M, 2006, OPT LETT, V31, P2610, DOI 10.1364/OL.31.002610; Brochu P, 2010, MACROMOL RAPID COMM, V31, P10, DOI 10.1002/marc.200900425; Carpi F, 2008, DIELECTRIC ELASTOMERS AS ELECTROMECHANICAL TRANSDUCERS: FUNDAMENTALS, MATERIALS, DEVICES, MODELS AND APPLICATIONS OF AN EMERGING ELECTROACTIVE POLYMER TECHNOLOGY, P1; Carpi F, 2010, IEEE-ASME T MECH, V15, P308, DOI 10.1109/TMECH.2009.2021651; Chiba S, 2008, PROC SPIE, V6927, DOI 10.1117/12.778345; Keplinger C, 2010, P NATL ACAD SCI USA, V107, P4505, DOI 10.1073/pnas.0913461107; Koh SJA, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3167773; Kovacs G, 2009, SENSOR ACTUAT A-PHYS, V155, P299, DOI 10.1016/j.sna.2009.08.027; Montanari GI, 1835, LETT INEDITE A VOLTA, P15; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Rontgen WC, 1880, ANN PHYS CHEM, V247, P771, DOI DOI 10.1002/ANDP.18802471304; Rosset S, 2009, ADV FUNCT MATER, V19, P470, DOI 10.1002/adfm.200801218; Stoyanov H, 2010, J MATER CHEM, V20, P7558, DOI 10.1039/c0jm00519c; 1782, SCELTA OPUSCOLI INTE, V2, P33	14	416	427	17	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1759	1761		10.1126/science.1194773	http://dx.doi.org/10.1126/science.1194773			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205659				2022-12-28	WOS:000285603700025
J	Eisenstein, M				Eisenstein, Michael			Of beans and genes	NATURE			English	Editorial Material																		Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Itan Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-36; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; QIN J, NATURE, V464, P59	4	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S13	S15		10.1038/468S13a	http://dx.doi.org/10.1038/468S13a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179077	Bronze			2022-12-28	WOS:000285553800005
J	Reich, D; Green, RE; Kircher, M; Krause, J; Patterson, N; Durand, EY; Viola, B; Briggs, AW; Stenzel, U; Johnson, PLF; Maricic, T; Good, JM; Marques-Bonet, T; Alkan, C; Fu, QM; Mallick, S; Li, H; Meyer, M; Eichler, EE; Stoneking, M; Richards, M; Talamo, S; Shunkov, MV; Derevianko, AP; Hublin, JJ; Kelso, J; Slatkin, M; Paabo, S				Reich, David; Green, Richard E.; Kircher, Martin; Krause, Johannes; Patterson, Nick; Durand, Eric Y.; Viola, Bence; Briggs, Adrian W.; Stenzel, Udo; Johnson, Philip L. F.; Maricic, Tomislav; Good, Jeffrey M.; Marques-Bonet, Tomas; Alkan, Can; Fu, Qiaomei; Mallick, Swapan; Li, Heng; Meyer, Matthias; Eichler, Evan E.; Stoneking, Mark; Richards, Michael; Talamo, Sahra; Shunkov, Michael V.; Derevianko, Anatoli P.; Hublin, Jean-Jacques; Kelso, Janet; Slatkin, Montgomery; Paeaebo, Svante			Genetic history of an archaic hominin group from Denisova Cave in Siberia	NATURE			English	Article							MITOCHONDRIAL-DNA; GENOME SEQUENCE; NEANDERTHAL; PATTERNS; FLORES; SIMA	Using DNA extracted from a finger bone found in Denisova Cave in southern Siberia, we have sequenced the genome of an archaic hominin to about 1.9-fold coverage. This individual is from a group that shares a common origin with Neanderthals. This population was not involved in the putative gene flow from Neanderthals into Eurasians; however, the data suggest that it contributed 4-6% of its genetic material to the genomes of present-day Melanesians. We designate this hominin population 'Denisovans' and suggest that it may have been widespread in Asia during the Late Pleistocene epoch. A tooth found in Denisova Cave carries a mitochondrial genome highly similar to that of the finger bone. This tooth shares no derived morphological features with Neanderthals or modern humans, further indicating that Denisovans have an evolutionary history distinct from Neanderthals and modern humans.	[Reich, David; Briggs, Adrian W.; Mallick, Swapan] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Reich, David; Patterson, Nick; Mallick, Swapan; Li, Heng] MIT, Broad Inst, Cambridge, MA 02142 USA; [Reich, David; Patterson, Nick; Mallick, Swapan; Li, Heng] Harvard Univ, Cambridge, MA 02142 USA; [Green, Richard E.; Kircher, Martin; Krause, Johannes; Viola, Bence; Briggs, Adrian W.; Stenzel, Udo; Maricic, Tomislav; Fu, Qiaomei; Meyer, Matthias; Stoneking, Mark; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Krause, Johannes] Univ Tubingen, Inst Nat Wissensch Archaol, D-72070 Tubingen, Germany; [Durand, Eric Y.; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Viola, Bence; Richards, Michael; Talamo, Sahra; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Johnson, Philip L. F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Good, Jeffrey M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Marques-Bonet, Tomas; Alkan, Can; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; [Marques-Bonet, Tomas] Inst Evolutionary Biol UPF CSIC, Barcelona 08003, Spain; [Fu, Qiaomei] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, CAS MPS Joint Lab Human Evolut & Archeometry, Beijing 100044, Peoples R China; [Richards, Michael] Univ British Columbia, Dept Anthropol, Vancouver, BC V6T 1Z1, Canada; [Shunkov, Michael V.; Derevianko, Anatoli P.] Russian Acad Sci, Inst Archaeol Ethnog, Siberian Branch, Palaeolith Dept, Novosibirsk 630090, Russia	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Max Planck Society; University of California System; University of California Santa Cruz; Eberhard Karls University of Tubingen; University of California System; University of California Berkeley; Max Planck Society; Emory University; University of Montana System; University of Montana; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of British Columbia; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu; bence.viola@eva.mpg.de; paabo@eva.mpg.de	Hug, Balthasar L./G-1568-2010; Talamo, Sahra/AAD-1774-2022; Richards, Michael/O-3717-2016; Marques-Bonet, Tomas/ABF-3734-2020; Alkan, Can/D-2982-2009; Kircher, Martin/H-6909-2019; Marques-Bonet, Tomas/I-4618-2014; Krause, Johannes/E-6640-2015; Richards, Michael/A-9374-2008; Viola, Bence/B-7390-2011; Krause, Johannes/AFP-2642-2022; Kelso, Janet/N-1812-2019; Shunkov, Mikhail V./Q-6576-2016; Li, Heng/D-9344-2011; Ganesh, Dunna Sai/AGX-5170-2022; Derevianko, Anatoly P./Q-5975-2016; Kircher, Martin/HDL-9392-2022	Talamo, Sahra/0000-0002-2406-3132; Richards, Michael/0000-0001-5274-8887; Marques-Bonet, Tomas/0000-0002-5597-3075; Alkan, Can/0000-0002-5443-0706; Kircher, Martin/0000-0001-9278-5471; Marques-Bonet, Tomas/0000-0002-5597-3075; Krause, Johannes/0000-0001-5475-4690; Richards, Michael/0000-0001-5274-8887; Krause, Johannes/0000-0001-9144-3920; Kelso, Janet/0000-0002-3618-322X; Shunkov, Mikhail V./0000-0003-1388-2308; Li, Heng/0000-0003-4874-2874; Derevianko, Anatoly P./0000-0003-1156-8331; Viola, Bence/0000-0001-8052-707X; Green, Richard/0000-0003-0516-5827	Max Planck Society; Krekeler Foundation; US National Institutes of Health [R01-GM40282]; National Science Foundation [OISE-0754461, 1032255]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER; Direct For Biological Sciences [0906041] Funding Source: National Science Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Krekeler Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. Bustamante, A. I. Krivoshapkin, M. Lachmann, R. Nielsen, K. Pruefer, A. Tsybankov, L. Vigilant and W. Zhai for comments; K. Finstermeier for graphics work; the MPI-EVA sequencing group, R. Schultz and S. Weihnachtsmann for technical support; and P. Fujita, A. Hinrichs and K. Learned for designing the UCSC genome browser portal to the Denisova data. The Presidential Innovation Fund of the Max Planck Society and the Krekeler Foundation provided financial support. M.S. was supported by a US National Institutes of Health grant (R01-GM40282). The National Science Foundation provided an International Postdoctoral Fellowship (OISE-0754461) to J.M.G., a Fellowship in Biological Informatics to P.L.F.J. and a HOMINID grant (1032255) to D.R.	Beauval C, 2005, P NATL ACAD SCI USA, V102, P7085, DOI 10.1073/pnas.0502656102; Bischoff JL, 2007, J ARCHAEOL SCI, V34, P763, DOI 10.1016/j.jas.2006.08.003; Bischoff JL, 2003, J ARCHAEOL SCI, V30, P275, DOI 10.1006/jasc.2002.0834; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; Derevianko AP, 2008, ARCHAEOL ETHNOL ANTH, V34, P13, DOI 10.1016/j.aeae.2008.07.002; Derevianko A.P., 1998, PALAEOLITHIC SIBERIA; Derevianko A.P., 2003, PALEOENVIRONMENT PAL; DEREVIANKO AP, 1998, ARCHAEOLOGY GEOLOGY; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Lalueza-Fox C, 2006, CURR BIOL, V16, pR629, DOI 10.1016/j.cub.2006.07.044; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Morwood MJ, 2009, J HUM EVOL, V57, P437, DOI 10.1016/j.jhevol.2009.07.003; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; POPE GG, 1992, AM J PHYS ANTHR S15, V15, P243; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Rightmire GP, 2004, AM J PHYS ANTHROPOL, V124, P109, DOI 10.1002/ajpa.10346; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; WU X, 1995, HUMAN EVOLUTION ASI	40	1027	1073	24	491	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1053	1060		10.1038/nature09710	http://dx.doi.org/10.1038/nature09710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179161	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000285553800049
J	Klarenbeek, NB; Kerstens, PJSM; Huizinga, TWJ; Dijkmans, BAC; Allaart, CF				Klarenbeek, Naomi B.; Kerstens, Pit J. S. M.; Huizinga, Tom W. J.; Dijkmans, Ben A. C.; Allaart, Cornelia F.			Recent advances in the management of rheumatoid arthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MODIFYING ANTIRHEUMATIC DRUGS; LONG-TERM IMPACT; EULAR RECOMMENDATIONS; AMERICAN-COLLEGE; METHOTREXATE; CRITERIA; CLASSIFICATION; SULFASALAZINE; PROGRESSION; ANTIBODIES		[Klarenbeek, Naomi B.; Huizinga, Tom W. J.; Allaart, Cornelia F.] Leiden Univ Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Kerstens, Pit J. S. M.; Dijkmans, Ben A. C.] Jan van Breemen Inst, Dept Rheumatol, Amsterdam, Netherlands; [Dijkmans, Ben A. C.] Vrije Univ Amsterdam Med Ctr, Dept Rheumatol, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Klarenbeek, NB (corresponding author), Leiden Univ Med Ctr, Dept Rheumatol, Albinusdreef 6, Leiden, Netherlands.	n.b.klarenbeek@lumc.nl			Dutch College for Health Insurances; Scheringh Plough; Centocor	Dutch College for Health Insurances; Scheringh Plough; Centocor	All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support for the submitted work; all authors worked on the BeSt study, a study sponsored by the Dutch College for Health Insurances, Scheringh Plough, and Centocor. CFA, TWJH, and BACD received speaker fees from various drug companies that might have an interest in the submitted work in the previous three years; no non-financial interests that may be relevant to the submitted work.	Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Avouac J, 2006, ANN RHEUM DIS, V65, P845, DOI 10.1136/ard.2006.051391; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Cohen S, 2010, CURR OPIN RHEUMATOL, V22, P330, DOI 10.1097/BOR.0b013e3283378e6f; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Gaujoux-Viala C, 2010, ANN RHEUM DIS, V69, P1004, DOI 10.1136/ard.2009.127225; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Gorter SL, 2010, ANN RHEUM DIS, V69, P1010, DOI 10.1136/ard.2009.127332; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; National Institute for Health and Clinical Excellence, 2010, CG79 NICE; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS14; van der Heijde D, 1999, J RHEUMATOL, V26, P743; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380; van der Kooij SM, 2009, ANN RHEUM DIS, V68, P914, DOI 10.1136/ard.2008.092254; van der Linden MPM, 2010, ARTHRITIS RHEUM-US, V62, P3537, DOI 10.1002/art.27692; van Vollenhoven RF, 2009, LANCET, V374, P459, DOI 10.1016/S0140-6736(09)60944-2; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P1443, DOI 10.1136/ard.2007.071092; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474	29	37	38	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2010	341								c6942	10.1136/bmj.c6942	http://dx.doi.org/10.1136/bmj.c6942			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700DV	21177351				2022-12-28	WOS:000285716600017
J	Buntgen, U; Tegel, W; Nicolussi, K; McCormick, M; Frank, D; Trouet, V; Kaplan, JO; Herzig, F; Heussner, KU; Wanner, H; Luterbacher, J; Esper, J				Buentgen, Ulf; Tegel, Willy; Nicolussi, Kurt; McCormick, Michael; Frank, David; Trouet, Valerie; Kaplan, Jed O.; Herzig, Franz; Heussner, Karl-Uwe; Wanner, Heinz; Luterbacher, Juerg; Esper, Jan			2500 Years of European Climate Variability and Human Susceptibility	SCIENCE			English	Article							DROUGHT; RECONSTRUCTIONS; RECORDS	Climate variations influenced the agricultural productivity, health risk, and conflict level of preindustrial societies. Discrimination between environmental and anthropogenic impacts on past civilizations, however, remains difficult because of the paucity of high-resolution paleoclimatic evidence. We present tree ring-based reconstructions of central European summer precipitation and temperature variability over the past 2500 years. Recent warming is unprecedented, but modern hydroclimatic variations may have at times been exceeded in magnitude and duration. Wet and warm summers occurred during periods of Roman and medieval prosperity. Increased climate variability from similar to 250 to 600 C.E. coincided with the demise of the western Roman Empire and the turmoil of the Migration Period. Such historical data may provide a basis for counteracting the recent political and fiscal reluctance to mitigate projected climate change.	[Buentgen, Ulf; Frank, David; Trouet, Valerie] Swiss Fed Res Inst Forest Snow & Landscape Res WS, CH-8903 Birmensdorf, Switzerland; [Buentgen, Ulf; Frank, David; Wanner, Heinz] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Tegel, Willy] Univ Freiburg, Inst Forest Growth, D-79085 Freiburg, Germany; [Nicolussi, Kurt] Univ Innsbruck, Inst Geog, A-6020 Innsbruck, Austria; [McCormick, Michael] Harvard Univ, Dept Hist, Cambridge, MA 02138 USA; [Trouet, Valerie] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; [Kaplan, Jed O.] Ecole Polytech Fed Lausanne, Inst Environm Engn, CH-1015 Lausanne, Switzerland; [Herzig, Franz] Bavarian State Dept Cultural Heritage, D-86672 Thierhaupten, Germany; [Heussner, Karl-Uwe] German Archaeol Inst, D-14195 Berlin, Germany; [Luterbacher, Juerg] Univ Giessen, Dept Geog, D-35390 Giessen, Germany; [Esper, Jan] Johannes Gutenberg Univ Mainz, Dept Geog, D-55128 Mainz, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; University of Freiburg; University of Innsbruck; Harvard University; University of Arizona; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Justus Liebig University Giessen; Johannes Gutenberg University of Mainz	Buntgen, U (corresponding author), Swiss Fed Res Inst Forest Snow & Landscape Res WS, CH-8903 Birmensdorf, Switzerland.	buentgen@wsl.ch	buentgen, ulf/J-6952-2013; Trouet, Valerie/AAE-4888-2021; Esper, Jan/O-3127-2018; Frank, David/C-7764-2013; mahsum, masot/ABC-4546-2020; Kaplan, Jed O./P-1796-2015; Tegel, Willy/M-8187-2014	Esper, Jan/0000-0003-3919-014X; Kaplan, Jed O./0000-0001-9919-7613; Tegel, Willy/0000-0003-4707-2848; Trouet, Valerie/0000-0002-2683-8704; Frank, David/0000-0001-5463-5640; Luterbacher, Juerg/0000-0002-8569-0973; Nicolussi, Kurt/0000-0002-1737-4119	Swiss National Science Foundation (NCCR-Climate); Deutsche Forschungsgemeinschaft [62201185, 62201236]; Austrian Science Fund FWF [P15828, F3113-G02]; Institut National de Recherches Archeologiques Preventives; Andrew W. Mellon Foundation; European Union [017008, 212250, 036961]	Swiss National Science Foundation (NCCR-Climate)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Institut National de Recherches Archeologiques Preventives; Andrew W. Mellon Foundation; European Union(European Commission)	We thank E. Cook, K. Gibson, G. Haug, G. Huang, D. Johnson, M. Kuttel, N. Stenseth, E. Zorita, and two anonymous referees for comments and discussion. Supported by the Swiss National Science Foundation (NCCR-Climate), the Deutsche Forschungsgemeinschaft projects PRIME (62201185) and Paleoclimatology of the Middle East (62201236), the Austrian Science Fund FWF (P15828, F3113-G02), l'Institut National de Recherches Archeologiques Preventives, the Andrew W. Mellon Foundation, and European Union projects MILLENNIUM (017008), ACQWA (212250), and CIRCE (036961).	Brazdil R, 2005, CLIMATIC CHANGE, V70, P363, DOI 10.1007/s10584-005-5924-1; Buckley BM, 2010, P NATL ACAD SCI USA, V107, P6748, DOI 10.1073/pnas.0910827107; Buntgen U, 2010, QUATERNARY SCI REV, V29, P1005, DOI 10.1016/j.quascirev.2010.01.003; Buntgen U, 2006, J CLIMATE, V19, P5606, DOI 10.1175/JCLI3917.1; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Charman DJ, 2006, QUATERNARY SCI REV, V25, P336, DOI 10.1016/j.quascirev.2005.05.005; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cufar K, 2008, INT J BIOMETEOROL, V52, P607, DOI 10.1007/s00484-008-0153-8; deMenocal PB, 2001, SCIENCE, V292, P667, DOI 10.1126/science.1059827; Duncan-Jones R. P., 2004, APPROACHING LATE ANT, P20; Frank DC, 2010, NATURE, V463, P527, DOI 10.1038/nature08769; Friedrichs DA, 2009, TREE PHYSIOL, V29, P39, DOI 10.1093/treephys/tpn003; Haneca K, 2009, J ARCHAEOL SCI, V36, P1, DOI 10.1016/j.jas.2008.07.005; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; Kausrud KL, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-112; Kelly PM, 2002, HOLOCENE, V12, P689, DOI 10.1191/0959683602hl582rp; Larsen LB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032450; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Mann ME, 2009, NATURE, V460, P880, DOI 10.1038/nature08219; McCormick M, 2001, ORIGINS EUROPEAN EC; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Patterson WP, 2010, P NATL ACAD SCI USA, V107, P5306, DOI 10.1073/pnas.0902522107; Shanahan TM, 2009, SCIENCE, V324, P377, DOI 10.1126/science.1166352; Tegel W, 2010, QUATERNARY SCI REV, V29, P1957, DOI 10.1016/j.quascirev.2010.05.018; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; Weiss H, 2001, SCIENCE, V291, P609, DOI 10.1126/science.1058775; Witschel Christian, 2004, J ROMAN ARCHAEOL, V17, P251	30	852	896	21	494	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					578	582		10.1126/science.1197175	http://dx.doi.org/10.1126/science.1197175			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21233349	Bronze			2022-12-28	WOS:000286933600052
J	Sengupta, A; Prasad, V				Sengupta, Amit; Prasad, Vandana			Towards a truly universal Indian health system	LANCET			English	Editorial Material									[Sengupta, Amit; Prasad, Vandana] Peoples Hlth Movement India Jan Swasthya Abhiyan, L-91,Sector 25, Noida 201301, Uttar Pradesh, India		Sengupta, A (corresponding author), Peoples Hlth Movement India Jan Swasthya Abhiyan, L-91,Sector 25, Noida 201301, Uttar Pradesh, India.	chaukhat@yahoo.com		PRASAD, VANDANA/0000-0003-0640-4965				Abhiyan Jan Swasthya, 2006, GLOB HLTH NAT HLTH A; Abhiyan Jan Swasthya, 2006, HLTH SYST IND CRIS A; National Commission for Enterprises in the Unorganized Sector, 2007, REP COND WORK PROM L; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; The Hindu (New Delhi), 2009, HINDU           0923	5	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2011	377	9767					702	+		10.1016/S0140-6736(10)62043-0	http://dx.doi.org/10.1016/S0140-6736(10)62043-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729JQ	21227495				2022-12-28	WOS:000287946000009
J	Douglas, NR; Reissmann, S; Zhang, JJ; Chen, B; Jakana, J; Kumar, R; Chiu, W; Frydman, J				Douglas, Nicholai R.; Reissmann, Stefanie; Zhang, Junjie; Chen, Bo; Jakana, Joanita; Kumar, Ramya; Chiu, Wah; Frydman, Judith			Dual Action of ATP Hydrolysis Couples Lid Closure to Substrate Release into the Group II Chaperonin Chamber	CELL			English	Article							EUKARYOTIC CHAPERONIN; IN-VIVO; CONFORMATIONAL-CHANGE; FOLDING CHAMBER; CRYO-EM; PROTEIN; MECHANISM; TRIC/CCT; GROEL; THERMOSOME	Group II chaperonins are ATP-dependent ring-shaped complexes that bind nonnative polypeptides and facilitate protein folding in archaea and eukaryotes. A built-in lid encapsulates substrate proteins within the central chaperonin chamber. Here, we describe the fate of the substrate during the nucleotide cycle of group II chaperonins. The chaperonin substrate-binding sites are exposed, and the lid is open in both the ATP-free and ATP-bound prehydrolysis states. ATP hydrolysis has a dual function in the folding cycle, triggering both lid closure and substrate release into the central chamber. Notably, substrate release can occur in the absence of a lid, and lid closure can occur without substrate release. However, productive folding requires both events, so that the polypeptide is released into the confined space of the closed chamber where it folds. Our results show that ATP hydrolysis coordinates the structural and functional determinants that trigger productive folding.	[Douglas, Nicholai R.; Reissmann, Stefanie; Kumar, Ramya; Frydman, Judith] Stanford Univ, Dept Biol & BioX Program, Stanford, CA 94305 USA; [Chen, Bo; Chiu, Wah] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Zhang, Junjie; Jakana, Joanita; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA	Stanford University; Baylor College of Medicine; Baylor College of Medicine	Frydman, J (corresponding author), Stanford Univ, Dept Biol & BioX Program, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Zhang, Junjie/V-3855-2019	Zhang, Junjie/0000-0002-7912-0819; , judith/0000-0003-2302-6943	NIH [GM74074, 5PN2EY016525, P41RR002250, T32-007276, R90 DK071054, T90 DA022885]; ARCS; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. W.E. Moerner for providing Nile Red maleimide and advice on fluorescence microscopy. We also thank members of the J.F. laboratory and Raul Andino for critical reading of the manuscript; Frank DiMaio and David Baker for advice on modeling; Erik Miller for useful discussions; and Jeremy England and Erik Miller for providing PepB. This work was supported by NIH Grants GM74074 (to J.F.), 5PN2EY016525 (to J.F. and W.C.), and P41RR002250 (to W.C.). N.R.D. was a recipient of predoctoral ARCS fellowships and was supported by an NIH training grant (T32-007276). J.Z. was a recipient of NIH training grants on nanobiology (R90 DK071054 and T90 DA022885).	Baker ML, 2010, NAT PROTOC, V5, P1697, DOI 10.1038/nprot.2010.126; Bigotti MG, 2008, ARCH BIOCHEM BIOPHYS, V474, P331, DOI 10.1016/j.abb.2008.03.015; Bigotti MG, 2006, J MOL BIOL, V362, P835, DOI 10.1016/j.jmb.2006.07.064; Bigotti MG, 2005, J MOL BIOL, V348, P13, DOI 10.1016/j.jmb.2005.01.066; Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gomez-Puertas P, 2004, J MOL RECOGNIT, V17, P85, DOI 10.1002/jmr.654; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hayer-Hartl M, 2000, METH MOL B, V140, P127; Iizuka R, 2003, J BIOL CHEM, V278, P44959, DOI 10.1074/jbc.M305484200; Kanzaki T, 2008, J BIOL CHEM, V283, P34773, DOI 10.1074/jbc.M805303200; Kim SY, 2005, J PHYS CHEM B, V109, P24517, DOI 10.1021/jp0534232; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Pereira JH, 2010, J BIOL CHEM, V285, P27958, DOI 10.1074/jbc.M110.125344; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Stuart SF, 2011, J BIOL CHEM, V286, P178, DOI 10.1074/jbc.M110.166256; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Villebeck L, 2007, BIOCHEMISTRY-US, V46, P5083, DOI 10.1021/bi062093o; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701	32	68	70	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					240	252		10.1016/j.cell.2010.12.017	http://dx.doi.org/10.1016/j.cell.2010.12.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241893	Bronze, Green Accepted			2022-12-28	WOS:000286459900009
J	Vieth, R				Vieth, Reinhold			Vitamin D nutrient to treat TB begs the prevention question	LANCET			English	Editorial Material							TUBERCULOSIS		[Vieth, Reinhold] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Vieth, Reinhold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Vieth, Reinhold] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Vieth, R (corresponding author), Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada.	rvieth@mtsinai.on.ca						Abba K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006086.pub2; Aga Khan University, 2010, REPL VIT D PAT ACT T; Blumberg J, 2010, NUTR REV, V68, P478, DOI 10.1111/j.1753-4887.2010.00307.x; Christian Medical College Vellore India, 2010, CLIN TRIAL STUD EFF; Emory University, 2010, IMP VIT D SUPPL HOST; Indian Council of Medical Research, 2010, PULM TUB VIT D; Institute of Medicine, 2010, DIET REF INT CALC VI; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; [Menzies School of Health Research Indonesia Australian National University], 2010, L ARG VIT D ADJ THER; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6	13	19	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					189	190		10.1016/S0140-6736(10)62300-8	http://dx.doi.org/10.1016/S0140-6736(10)62300-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	712WG	21215444				2022-12-28	WOS:000286696400008
J	Dhuime, B; Hawkesworth, C; Cawood, P				Dhuime, Bruno; Hawkesworth, Chris; Cawood, Peter			When Continents Formed	SCIENCE			English	Editorial Material							CRUST-MANTLE EVOLUTION; SEDIMENT; ISOTOPES		[Dhuime, Bruno; Hawkesworth, Chris; Cawood, Peter] Univ St Andrews, Dept Earth Sci, St Andrews KY16 9AL, Fife, Scotland; [Dhuime, Bruno] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	University of St Andrews; University of Bristol	Dhuime, B (corresponding author), Univ St Andrews, Dept Earth Sci, North St, St Andrews KY16 9AL, Fife, Scotland.	b.dhuime@bristol.ac.uk	Dhuime, Bruno/A-6262-2016	Dhuime, Bruno/0000-0002-4146-4739; Cawood, Peter/0000-0003-1200-3826	NERC [NE/E005225/1] Funding Source: UKRI; Natural Environment Research Council [NE/E005225/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Cawood P. A., 2006, GSA TODAY, V16, P4, DOI [10.1130/GSAT01607.1, DOI 10.1130/GSAT01607.1]; Chauvel C, 2008, NAT GEOSCI, V1, P64, DOI 10.1038/ngeo.2007.51; CONDIE KC, 1995, GEOPHYS RES LETT, V22, P2215, DOI 10.1029/95GL01804; DEPAOLO DJ, 1981, NATURE, V291, P193, DOI 10.1038/291193a0; Hawkesworth CJ, 2010, J GEOL SOC LONDON, V167, P229, DOI 10.1144/0016-76492009-072; Plank T, 2005, J PETROL, V46, P921, DOI 10.1093/petrology/egi005; RUDNICK RL, 1995, NATURE, V378, P573; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; Taylor S.R., 1985, CONTINENTAL CRUST IT; WHITE WM, 1984, EARTH PLANET SC LETT, V67, P167, DOI 10.1016/0012-821X(84)90112-2	11	294	303	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2011	331	6014					154	155		10.1126/science.1201245	http://dx.doi.org/10.1126/science.1201245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233372				2022-12-28	WOS:000286433100025
J	Kiehl, J				Kiehl, Jeffrey			Lessons from Earth's Past	SCIENCE			English	Editorial Material							ATMOSPHERIC CO2; CLIMATE		Natl Ctr Atmospher Res, Boulder, CO 80305 USA	National Center Atmospheric Research (NCAR) - USA	Kiehl, J (corresponding author), Natl Ctr Atmospher Res, Boulder, CO 80305 USA.	jtkon@ucar.edu						Archer D, 2009, ANNU REV EARTH PL SC, V37, P117, DOI 10.1146/annurev.earth.031208.100206; Bijl PK, 2010, SCIENCE, V330, P819, DOI 10.1126/science.1193654; Bijl PK, 2009, NATURE, V461, P776, DOI 10.1038/nature08399; Breecker DO, 2010, P NATL ACAD SCI USA, V107, P576, DOI 10.1073/pnas.0902323106; Fletcher BJ, 2008, NAT GEOSCI, V1, P43, DOI 10.1038/ngeo.2007.29; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Lunt DJ, 2010, NAT GEOSCI, V3, P60, DOI 10.1038/NGEO706; NORTH GR, 1975, J ATMOS SCI, V32, P2033, DOI 10.1175/1520-0469(1975)032<2033:TOEBCM>2.0.CO;2; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Salzmann U, 2009, PHILOS T R SOC A, V367, P189, DOI 10.1098/rsta.2008.0200; Schwartz SE, 2011, CLIMATIC CHANGE, V106, P315, DOI 10.1007/s10584-010-9903-9; Shaffer G, 2009, NAT GEOSCI, V2, P105, DOI 10.1038/NGEO420; Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107; Solomon S., 2007, PHYS SCI BASIS WORKI	17	31	31	3	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					158	159		10.1126/science.1199380	http://dx.doi.org/10.1126/science.1199380			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233375				2022-12-28	WOS:000286433100028
J	Turner, K; Adams, E; Grant, A; Macleod, J; Bell, G; Clarke, J; Horner, P				Turner, Katy; Adams, Elisabeth; Grant, Arabella; Macleod, John; Bell, Gill; Clarke, Jan; Horner, Paddy			Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRACHOMATIS; INFECTION; POPULATION; PREVALENCE	Objectives To compare the cost, cost effectiveness, and sex equity of different intervention strategies within the English National Chlamydia Screening Programme. To develop a tool for calculating cost effectiveness of chlamydia control programmes at a local, national, or international level. Design An economic and mathematical modelling study with cost effectiveness analysis. Costs were restricted to those of screening and partner notification from the perspective of the NHS and excluded patient costs, the costs of reinfection, and costs of complications arising from initial infection. Setting England. Population Individuals eligible for the National Chlamydia Screening Programme. Main outcome measures Cost effectiveness of National Chlamydia Screening Programme in 2008-9 (as cost per individual tested, cost per positive diagnosis, total cost of screening, number screened, number infected, sex ratio of those tested and treated). Comparison of baseline programme with two different interventions-(i) increased coverage of primary screening in men and (ii) increased efficacy of partner notification. Results In 2008-9 screening was estimated to cost about 46.3m pound in total and 506 pound per infection treated. Provision for partner notification within the screening programme cost between 9 pound and 27 pound per index case, excluding treatment and testing. The model results suggest that increasing male screening coverage from 8% (baseline value) to 24% (to match female coverage) would cost an extra 22.9m pound and increase the cost per infection treated to 528 pound. In contrast, increasing partner notification efficacy from 0.4 (baseline value) to 0.8 partners per index case would cost an extra 3.3m pound and would reduce the cost per infection diagnosed to 449 pound. Increasing screening coverage to 24% in men would cost over six times as much as increasing partner notification to 0.8 but only treat twice as many additional infections. Conclusions In the English National Chlamydia Screening Programme increasing the effectiveness of partner notification is likely to cost less than increasing male coverage but also improve the ratio of women to men diagnosed. Further evaluation of the cost effectiveness of partner notification and screening is urgently needed. The spreadsheet tool developed in this study can be easily modified for use in other settings to evaluate chlamydia control programmes.	[Turner, Katy] Univ Bristol, Dept Social Med, NIHR, Bristol BS8 2PS, Avon, England; [Grant, Arabella] Pathway Analyt, London, England; [Bell, Gill] Royal Hallamshire Hosp, NHS Fdn Trust, Sheffield Teaching Hosp, Sheffield S10 2JF, S Yorkshire, England; [Clarke, Jan] Leeds Teaching Hosp Trust, Dept Genitourinary Med, Leeds LS1 3EX, W Yorkshire, England; [Horner, Paddy] Univ Hosp Bristol NHS Fdn Trust, Bristol Sexual Hlth Ctr, Bristol BS2 OJD, Avon, England	University of Bristol; Oxford University Hospitals NHS Foundation Trust; University of Sheffield; University of Leeds	Turner, K (corresponding author), Univ Bristol, Dept Social Med, NIHR, Bristol BS8 2PS, Avon, England.	katy.turner@bristol.ac.uk	Turner, Katy/R-3853-2019	Turner, Katy/0000-0002-8152-6017; Macleod, John/0000-0001-8202-1144; Horner, Paddy/0000-0003-0411-8332	Bristol Sexual Health Centre; NIHR [07/42/02]; National Institute for Health Research [07/42/02, PDF-2009-02-55] Funding Source: researchfish	Bristol Sexual Health Centre; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a grant from the Bristol Sexual Health Centre Capacity Building Research Fund. KT is supported by an NIHR PDF fellowship. KT and GB also received funding from the NIHR Health Technology Assessment programme (project number 07/42/02). All authors in this paper are independent of their funders for publication purposes. The views and opinions expressed here are those of the authors and do not necessarily reflect those of the funders.; JC, PH, and JM are board members of the National Chlamydia Screening Advisory Group of the Department of Health and receive expenses for travel to meetings. JC also receives compensation for secondment as chair on NCSAG paid directly to Leeds Hospital Teaching Hospitals Trust. AG and EA received consultancy fees from Bristol Sexual Health Centre Capacity Building Research Fund for the additional cost data analysis and travel to a meeting with the other authors. EA and AG did consultancy work for the NCSP in spring 2009 on a project to estimate the cost of chlamydia screening. KT received consultancy fees from Bristol Sexual Health Centre Capacity Building Research Fund for additional days worked to develop the model and write the paper outside funded time. KT and EA were previously employed by the Health Protection Agency to work on economic and mathematical models of the impact of chlamydia screening. PH collaborated in a multicentre evaluation of a new molecular diagnostic test for chlamydia and gonorrhoea by Siemens Healthcare Diagnostics, for which his department received funding.	Apoola A, 2007, INT J STD AIDS, V18, P493, DOI 10.1258/095646207781147238; Bilardi JE, 2010, SEX TRANSM DIS, V37, P563, DOI 10.1097/OLQ.0b013e3181d707f1; Carre H, 2008, SEX TRANSM INFECT, V84, P239, DOI 10.1136/sti.2007.028068; Cassell JA, 2003, SEX TRANSM INFECT, V79, P264, DOI 10.1136/sti.79.3.264-a; Clarke J, 2009, PARTNER NOTIFICATION; European Centre for Disease Control and Prevention (ECDC), 2008, REV CHLAM CONTR ACT; Hosenfeld CB, 2009, SEX TRANSM DIS, V36, P478, DOI 10.1097/OLQ.0b013e3181a2a933; Kretzschmar M, 2009, SEX TRANSM INFECT, V85, P359, DOI 10.1136/sti.2009.036251; Kretzschmar M, 2001, AM J EPIDEMIOL, V153, P90, DOI 10.1093/aje/153.1.90; LaMontagne DS, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.022053; Low N, 2009, INT J EPIDEMIOL, V38, P435, DOI 10.1093/ije/dyn222; Macleod J, 2005, BRIT MED J, V330, P940, DOI 10.1136/bmj.38413.663137.8F; National Audit Office, 2009, YOUNG PEOPL SEX HLTH; National Chlamydia Screening Programme, 2010, VSI DAT TABL 08 09 E; National Chlamydia Screening Programme, 2010, INV YOUNG MEN CHLAM; National Chlamydia Screening Programme, 2009, GUID COMM COSTS PROV; National Chlamydia Screening Programme, 2010, MEN TOO; National Chlamydia Screening Programme, 2009, NCSP ANN REPORT 2008; Quinn TC, 1996, JAMA-J AM MED ASSOC, V276, P1737, DOI 10.1001/jama.276.21.1737; Trelle S, 2007, BMJ-BRIT MED J, V334, P354, DOI 10.1136/bmj.39079.460741.7C; Turner KME, 2006, SEX TRANSM INFECT, V82, P496, DOI 10.1136/sti.2005.019067; van Bergen J, 2005, SEX TRANSM INFECT, V81, P17, DOI 10.1136/sti.2004.010173	22	35	35	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2011	342								c7250	10.1136/bmj.c7250	http://dx.doi.org/10.1136/bmj.c7250			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NF	21205807	hybrid, Green Submitted			2022-12-28	WOS:000286142400001
J	Nurok, M; Czeisler, CA; Lehmann, LS				Nurok, Michael; Czeisler, Charles A.; Lehmann, Lisa Soleymani			Sleep Deprivation, Elective Surgical Procedures, and Informed Consent.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nurok, Michael] Hosp Special Surg, Dept Anesthesiol, New York, NY 10021 USA; [Nurok, Michael] Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Czeisler, Charles A.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lehmann, Lisa Soleymani] Brigham & Womens Hosp, Ctr Bioeth, Boston, MA 02115 USA; [Nurok, Michael; Lehmann, Lisa Soleymani] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Czeisler, Charles A.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; [Lehmann, Lisa Soleymani] Harvard Univ, Sch Med, Div Med Eth, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Nurok, M (corresponding author), Hosp Special Surg, Dept Anesthesiol, 535 E 70th St, New York, NY 10021 USA.			Czeisler, Charles Andrew/0000-0002-7408-1849				Blum AB, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-33; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Rothschild JM, 2009, JAMA-J AM MED ASSOC, V302, P1565, DOI 10.1001/jama.2009.1423; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117	5	59	59	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2577	2579		10.1056/NEJMp1007901	http://dx.doi.org/10.1056/NEJMp1007901			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	700SD	21190452				2022-12-28	WOS:000285763700001
J	Forneris, F; Ricklin, D; Wu, J; Tzekou, A; Wallace, RS; Lambris, JD; Gros, P				Forneris, Federico; Ricklin, Daniel; Wu, Jin; Tzekou, Apostolia; Wallace, Rachel S.; Lambris, John D.; Gros, Piet			Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation	SCIENCE			English	Article							ALTERNATIVE PATHWAY CONVERTASE; CONFORMATIONAL-CHANGES; SERINE-PROTEASE; PROVIDES INSIGHTS; ACTIVATION; SYSTEM; BINDING; DOMAIN; THERAPEUTICS; THIOESTER	Activation of the complement cascade induces inflammatory responses and marks cells for immune clearance. In the central complement-amplification step, a complex consisting of surface-bound C3b and factor B is cleaved by factor D to generate active convertases on targeted surfaces. We present crystal structures of the pro-convertase C3bB at 4 angstrom resolution and its complex with factor D at 3.5 angstrom resolution. Our data show how factor B binding to C3b forms an open "activation" state of C3bB. Factor D specifically binds the open conformation of factor B through a site distant from the catalytic center and is activated by the substrate, which displaces factor D's self-inhibitory loop. This concerted proteolytic mechanism, which is cofactor-dependent and substrate-induced, restricts complement amplification to C3b-tagged target cells.	[Ricklin, Daniel; Tzekou, Apostolia; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Forneris, Federico; Wu, Jin; Wallace, Rachel S.; Gros, Piet] Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	University of Pennsylvania; Utrecht University	Lambris, JD (corresponding author), Univ Penn, Dept Pathol & Lab Med, 401 Stellar Chance, Philadelphia, PA 19104 USA.	lambris@upenn.edu; p.gros@uu.nl	Forneris, Federico/AAL-5361-2020; Mohammed, Imran/J-8271-2012; Gros, Piet/I-5569-2016; Forneris, Federico/B-1145-2011; Gros, Piet/AAD-6452-2019; Ricklin, Daniel/F-5104-2011; Lambris, John/Q-5633-2018	Forneris, Federico/0000-0002-7818-1804; Mohammed, Imran/0000-0002-8412-0768; Gros, Piet/0000-0002-7782-2585; Forneris, Federico/0000-0002-7818-1804; Gros, Piet/0000-0002-7782-2585; Ricklin, Daniel/0000-0001-6140-0233; Lambris, John/0000-0002-9370-5776	Council for Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW) [700.54.304]; NIH [AI030040, AI068730, AI072106, GM062134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030040, R01AI072106, N01AI030040, P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062134] Funding Source: NIH RePORTER	Council for Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Coordinates and structure factors of C3bB, C3bBD*, FD (S183A), and FD (R202A) have been deposited in the Protein Data Bank (PDB) with accession numbers 2XWJ, 2XWB, 2XW9, and 2XWA, respectively. We gratefully thank the European Synchrotron Radiation Facility (ESRF) and the Swiss Light source (SLS) for the provision of synchrotron radiation facilities and beamline scientists of the SLS, ESRF, and the European Molecular Biology Laboratory for assistance. This work was supported by a "Top" grant (700.54.304 to P.G.) by the Council for Chemical Sciences of the Netherlands Organization for Scientific Research (NWO-CW) and NIH grants (AI030040, AI068730, AI072106, and GM062134 to J.D.L.). Author contributions: F.F. expressed and purified all FB and FD mutants, purified C3b, generated protein complexes, performed crystallization experiments, collected diffraction data, and solved the structures; F.F. and P.G. analyzed the structures; J.W. and R.S.W. helped with cloning and optimization of protein expression and purification; F.F. performed kinetic studies; D.R. and A.T. performed the SPR binding studies and hemolytic assays; F.F., D.R., J.D.L., and P.G. conceived the experiments; F. F. prepared the figures; and F.F., D.R., and P.G. wrote the manuscript. P.G. and J.D.L. co-supervised this work. Competing financial interests: P.G., F.F., D.R., and J.D.L. are co-inventors of a patent application titled "Structure of C3bB-factor D complex and use for rational drug design."	Bhattacharya AA, 2004, STRUCTURE, V12, P371, DOI 10.1016/j.str.2004.02.012; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Campagne MV, 2007, CELL MICROBIOL, V9, P2095, DOI 10.1111/j.1462-5822.2007.00981.x; Carroll MC, 2004, MOL IMMUNOL, V41, P141, DOI 10.1016/j.molimm.2004.03.017; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; FISHELSON Z, 1982, J IMMUNOL, V129, P2603; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Haas PJ, 2007, IMMUNOL RES, V37, P161, DOI 10.1007/BF02697367; Hinshelwood J, 2000, J MOL BIOL, V298, P135, DOI 10.1006/jmbi.2000.3632; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2009, EMBO J, V28, P2469, DOI 10.1038/emboj.2009.184; Jing H, 1998, J MOL BIOL, V282, P1061, DOI 10.1006/jmbi.1998.2089; Jing H, 1999, EMBO J, V18, P804, DOI 10.1093/emboj/18.4.804; KAM CM, 1987, J BIOL CHEM, V262, P3444; KIM S, 1994, BIOCHEMISTRY-US, V33, P14393, DOI 10.1021/bi00252a004; Kim SG, 1999, JPN J APPL PHYS 2, V38, pL38; KIM SH, 1995, J IMMUNOL, V154, P6073; Law SKA, 1997, PROTEIN SCI, V6, P263; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Torreira E, 2009, J IMMUNOL, V183, P7347, DOI 10.4049/jimmunol.0902310; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x	36	183	184	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1816	1820		10.1126/science.1195821	http://dx.doi.org/10.1126/science.1195821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205667	Green Accepted			2022-12-28	WOS:000285603700039
J	Feldman, E				Feldman, Ellen			The Day the Computer Tried to Eat My Alligator	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												efeldman@altru.org							0	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2679	2679		10.1001/jama.2010.1805	http://dx.doi.org/10.1001/jama.2010.1805			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177498				2022-12-28	WOS:000285518000001
J	Graveley, BR; Brooks, AN; Carlson, J; Duff, MO; Landolin, JM; Yang, L; Artieri, CG; van Baren, MJ; Boley, N; Booth, BW; Brown, JB; Cherbas, L; Davis, CA; Dobin, A; Li, RH; Lin, W; Malone, JH; Mattiuzzo, NR; Miller, D; Sturgill, D; Tuch, BB; Zaleski, C; Zhang, DY; Blanchette, M; Dudoit, S; Eads, B; Green, RE; Hammonds, A; Jiang, LC; Kapranov, P; Langton, L; Perrimon, N; Sandler, JE; Wan, KH; Willingham, A; Zhang, Y; Zou, Y; Andrews, J; Bickel, PJ; Brenner, SE; Brent, MR; Cherbas, P; Gingeras, TR; Hoskins, RA; Kaufman, TC; Oliver, B; Celniker, SE				Graveley, Brenton R.; Brooks, Angela N.; Carlson, JosephW.; Duff, Michael O.; Landolin, Jane M.; Yang, Li; Artieri, Carlo G.; van Baren, Marijke J.; Boley, Nathan; Booth, Benjamin W.; Brown, James B.; Cherbas, Lucy; Davis, Carrie A.; Dobin, Alex; Li, Renhua; Lin, Wei; Malone, John H.; Mattiuzzo, Nicolas R.; Miller, David; Sturgill, David; Tuch, Brian B.; Zaleski, Chris; Zhang, Dayu; Blanchette, Marco; Dudoit, Sandrine; Eads, Brian; Green, Richard E.; Hammonds, Ann; Jiang, Lichun; Kapranov, Phil; Langton, Laura; Perrimon, Norbert; Sandler, Jeremy E.; Wan, Kenneth H.; Willingham, Aarron; Zhang, Yu; Zou, Yi; Andrews, Justen; Bickel, Peter J.; Brenner, Steven E.; Brent, Michael R.; Cherbas, Peter; Gingeras, Thomas R.; Hoskins, Roger A.; Kaufman, Thomas C.; Oliver, Brian; Celniker, Susan E.			The developmental transcriptome of Drosophila melanogaster	NATURE			English	Article							GENE-EXPRESSION; FUNCTIONAL ELEMENTS; BITHORAX COMPLEX; ABDOMINAL-B; IDENTIFICATION; GENOMES; TARGETS	Drosophila melanogaster is one of the most well studied genetic model organisms; nonetheless, its genome still contains unannotated coding and non-coding genes, transcripts, exons and RNA editing sites. Full discovery and annotation are pre-requisites for understanding how the regulation of transcription, splicing and RNA editing directs the development of this complex organism. Here we used RNA-Seq, tiling microarrays and cDNA sequencing to explore the transcriptome in 30 distinct developmental stages. We identified 111,195 new elements, including thousands of genes, coding and non-coding transcripts, exons, splicing and editing events, and inferred protein isoforms that previously eluded discovery using established experimental, prediction and conservation-based approaches. These data substantially expand the number of known transcribed elements in the Drosophila genome and provide a high-resolution view of transcriptome dynamics throughout development.	[Graveley, Brenton R.; Duff, Michael O.; Yang, Li] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA; [Brooks, Angela N.; Brenner, Steven E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Carlson, JosephW.; Landolin, Jane M.; Booth, Benjamin W.; Hammonds, Ann; Sandler, Jeremy E.; Wan, Kenneth H.; Hoskins, Roger A.; Celniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Artieri, Carlo G.; Li, Renhua; Malone, John H.; Mattiuzzo, Nicolas R.; Sturgill, David; Jiang, Lichun; Zhang, Yu; Oliver, Brian] NIDDK, Sect Dev Genom, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA; [van Baren, Marijke J.; Langton, Laura; Brent, Michael R.] Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA; [van Baren, Marijke J.; Langton, Laura; Brent, Michael R.] Washington Univ, Dept Comp Sci, St Louis, MO 63108 USA; [Boley, Nathan; Brown, James B.; Bickel, Peter J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Cherbas, Lucy; Zhang, Dayu; Cherbas, Peter] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Davis, Carrie A.; Dobin, Alex; Lin, Wei; Zaleski, Chris; Kapranov, Phil; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Miller, David; Eads, Brian; Andrews, Justen; Cherbas, Peter; Kaufman, Thomas C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Tuch, Brian B.] Life Technol, Res & Dev, Genet Syst Div, Foster City, CA 94404 USA; [Tuch, Brian B.] Amgen Inc, Genome Anal Unit, San Francisco, CA 94080 USA; [Blanchette, Marco] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Blanchette, Marco] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Dudoit, Sandrine] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA; [Green, Richard E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Willingham, Aarron; Brenner, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Gingeras, Thomas R.] Affymetrix, Santa Clara, CA 95051 USA	University of Connecticut; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Berkeley; Indiana University System; Indiana University Bloomington; Cold Spring Harbor Laboratory; Indiana University System; Indiana University Bloomington; Thermo Fisher Scientific; Amgen; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Affymetrix	Graveley, BR (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	graveley@neuron.uchc.edu; celniker@fruitfly.org	Lin, Wei/AAH-9924-2019; jiang, lichun/F-3776-2012; Brown, James/H-2971-2015; Brent, Michael/AAK-3702-2020	Lin, Wei/0000-0002-7506-3466; jiang, lichun/0000-0003-2462-7636; Brent, Michael/0000-0002-8689-0299; Green, Richard/0000-0003-0516-5827; Dobin, Alexander/0000-0002-4115-9128; Sturgill, David/0000-0002-7902-3605; Gingeras, Thomas/0000-0001-9106-3573; Graveley, Brenton/0000-0001-5777-5892; yang, li/0000-0001-8833-7473; Perrimon, Norbert/0000-0001-7542-472X	National Human Genome Research INstitute [U01 HB004271]; Department of Energy [DE-AC02-05CH11231]; National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER	National Human Genome Research INstitute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Energy(United States Department of Energy (DOE)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Trapnell and L. Pachter for discussions and assistance with Cufflinks, and E. Clough for comments and feedback. A.N.B. was partially supported by an NSF graduate fellowship. This work was funded by an award from the National Human Genome Research INstitute modENCODE Project (U01 HB004271) to S.E.C. (Principal Investigator) and M.R.B., P.C., T.R.G., B.R.G. and N.P. (co-Principal Investigators) under Department of Energy contract no. DE-AC02-05CH11231, and by the National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program (B.O.).	ANDRES AJ, 1992, DEVELOPMENT, V116, P865; ANDRES AJ, 1993, DEV BIOL, V160, P388, DOI 10.1006/dbio.1993.1315; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Bass BL, 2001, RNA EDITING; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; CELNIKER SE, 1990, EMBO J, V9, P4277, DOI 10.1002/j.1460-2075.1990.tb07876.x; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Costantino BFB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000102; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hild M, 2004, GENOME BIOL, V5; Ho MCW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000709; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Jepson JEC, 2007, METHOD ENZYMOL, V424, P265, DOI 10.1016/S0076-6879(07)24012-1; KARCH F, 1985, CELL, V43, P81, DOI 10.1016/0092-8674(85)90014-5; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; LOCKETT TJ, 1989, DEV BIOL, V134, P430, DOI 10.1016/0012-1606(89)90115-2; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Padgett RA, 2002, RNA, V8, P125, DOI 10.1017/S1355838202017156; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Philipps DL, 2004, RNA, V10, P1838, DOI 10.1261/rna.7136104; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; SANCHEZHERRERO E, 1989, DEVELOPMENT, V107, P321; Spradling AC, 2006, GENETICS, V174, P1; Stapleton M, 2006, RNA, V12, P1922, DOI 10.1261/rna.254306; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang JW, 2010, J NEUROGENET, V24, P67, DOI 10.3109/01677061003746341; Warren JT, 2006, DEV DYNAM, V235, P315, DOI 10.1002/dvdy.20626; Xie XH, 2006, P NATL ACAD SCI USA, V103, P11659, DOI 10.1073/pnas.0604768103; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	1035	1061	8	256	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					473	479		10.1038/nature09715	http://dx.doi.org/10.1038/nature09715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21179090	Green Accepted, Green Submitted			2022-12-28	WOS:000288702200054
J	Santos, JM; Ferguson, DJP; Blackman, MJ; Soldati-Favre, D				Santos, Joana M.; Ferguson, David J. P.; Blackman, Michael J.; Soldati-Favre, Dominique			Intramembrane Cleavage of AMA1 Triggers Toxoplasma to Switch from an Invasive to a Replicative Mode	SCIENCE			English	Article							HOST-CELL INVASION; MICRONEME PROTEINS; GONDII; PROTEASES; MEMBRANE; PARASITE; SURFACE; CYCLE	Apicomplexan parasites invade host cells and immediately initiate cell division. The extracellular parasite discharges transmembrane proteins onto its surface to mediate motility and invasion. These are shed by intramembrane cleavage, a process associated with invasion but otherwise poorly understood. Functional analysis of Toxoplasma rhomboid 4, a surface intramembrane protease, by conditional overexpression of a catalytically inactive form produced a profound block in replication. This was completely rescued by expression of the cleaved cytoplasmic tail of Toxoplasma or Plasmodium apical membrane antigen 1 (AMA1). These results reveal an unexpected function for AMA1 in parasite replication and suggest that invasion proteins help to promote parasite switch from an invasive to a replicative mode.	[Santos, Joana M.; Soldati-Favre, Dominique] Univ Geneva, Fac Med, Dept Microbiol, CH-1211 Geneva 4, Switzerland; [Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Santos, Joana M.; Blackman, Michael J.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England	University of Geneva; University of Oxford; MRC National Institute for Medical Research	Soldati-Favre, D (corresponding author), Univ Geneva, Fac Med, Dept Microbiol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Dominique.Soldati-Favre@unige.ch	; M Santos, Joana/W-4149-2018	Ferguson, David/0000-0001-5045-819X; Soldati-Favre, Dominique/0000-0003-4156-2109; M Santos, Joana/0000-0002-5411-4439	Swiss National Foundation [FN3100A0-116722]; Medical Research Council, UK [U117532063]; MalParTraining [MEST-CT-2005-02049]; Wellcome Trust; Medical Research Council [MC_U117532063] Funding Source: researchfish; MRC [MC_U117532063] Funding Source: UKRI	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MalParTraining; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Meissner for providing us with the dd system and G. Ward and F. Parussini for sharing unpublished data and inspiring discussions. We thank P. Bradley and M. Gubbels for sharing antibodies, L. Sheiner and T. Dowse for previous study of ROM4, J. Limenitakis for technical assistance, and L. Kemp for critical reading of the manuscript. This work was supported by the Swiss National Foundation (grant FN3100A0-116722) and the Medical Research Council, UK (grant U117532063). J.M.S. was funded by MalParTraining, an FP6-funded Marie Curie Initial Training Network (contract number MEST-CT-2005-020492, The Challenge of Malaria in the Post-Genomic Era). D.S.-F. is an international Howard Hughes Medical Institute scholar. D.J.P.F. is supported by an equipment grant from the Wellcome Trust.	Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Brossier F, 2008, EUKARYOT CELL, V7, P664, DOI 10.1128/EC.00331-07; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Donahue CG, 2000, MOL BIOCHEM PARASIT, V111, P15, DOI 10.1016/S0166-6851(00)00289-9; Dowse TJ, 2005, INT J PARASITOL, V35, P747, DOI 10.1016/j.ijpara.2005.04.001; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Howell SA, 2005, MOL MICROBIOL, V57, P1342, DOI 10.1111/j.1365-2958.2005.04772.x; Howell SA, 2003, J BIOL CHEM, V278, P23890, DOI 10.1074/jbc.M302160200; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Opitz C, 2002, EMBO J, V21, P1577, DOI 10.1093/emboj/21.7.1577; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Srinivasan P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000262; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3	24	75	85	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					473	477		10.1126/science.1199284	http://dx.doi.org/10.1126/science.1199284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21205639	Green Accepted			2022-12-28	WOS:000286635900056
J	Farre, JC; Subramani, S				Farre, Jean-Claude; Subramani, Suresh			Rallying the Exocyst as an Autophagy Scaffold	CELL			English	Editorial Material							RAL GTPASES		[Farre, Jean-Claude; Subramani, Suresh] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Subramani, S (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	ssubramani@ucsd.edu			NIGMS NIH HHS [R01 GM069373, R01 GM069373-06] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069373] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	10	13	13	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					172	174		10.1016/j.cell.2011.01.005	http://dx.doi.org/10.1016/j.cell.2011.01.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241888	Bronze, Green Accepted			2022-12-28	WOS:000286459900003
J	Yonehara, K; Balint, K; Noda, M; Nagel, G; Bamberg, E; Roska, B				Yonehara, Keisuke; Balint, Kamill; Noda, Masaharu; Nagel, Georg; Bamberg, Ernst; Roska, Botond			Spatially asymmetric reorganization of inhibition establishes a motion-sensitive circuit	NATURE			English	Article							SELECTIVE GANGLION-CELLS; STARBURST AMACRINE CELLS; DIRECTION SELECTIVITY; RABBIT RETINA; VISUAL EXPERIENCE; MAMMALIAN RETINA; MOUSE RETINA; CHANNELRHODOPSIN-2; ARCHITECTURE; MECHANISMS	Spatial asymmetries in neural connectivity have an important role in creating basic building blocks of neuronal processing(1,2). A key circuit module of directionally selective (DS) retinal ganglion cells is a spatially asymmetric inhibitory input from starburst amacrine cells(3-5). It is not known how and when this circuit asymmetry is established during development. Here we photostimulate mouse starburst cells targeted with channelrhodopsin-2 (refs 6-8) while recording from a single genetically labelled type of DS cell(9,10). We follow the spatial distribution of synaptic strengths between starburst and DS cells during early postnatal development before these neurons can respond to a physiological light stimulus, and confirm connectivity by monosynaptically restricted trans-synaptic rabies viral tracing. We show that asymmetry develops rapidly over a 2-day period through an intermediate state in which random or symmetric synaptic connections have been established. The development of asymmetry involves the spatially selective reorganization of inhibitory synaptic inputs. Intriguingly, the spatial distribution of excitatory synaptic inputs from starburst cells is significantly more symmetric than that of the inhibitory inputs at the end of this developmental period. Our work demonstrates a rapid developmental switch from a symmetric to asymmetric input distribution for inhibition in the neural circuit of a principal cell.	[Yonehara, Keisuke; Balint, Kamill; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland; [Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan; [Nagel, Georg] Univ Wurzburg, D-97082 Wurzburg, Germany; [Bamberg, Ernst] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Bamberg, Ernst] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany	Friedrich Miescher Institute for Biomedical Research; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; University of Wurzburg; Max Planck Society; Goethe University Frankfurt	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland.	botond.roska@fmi.ch	Noda, Masaharu/D-7146-2016; Roska, Botond/AAD-7268-2021	Noda, Masaharu/0000-0002-3796-524X; Yonehara, Keisuke/0000-0001-9541-6671; Nagel, Georg/0000-0001-8174-8712	Friedrich Miescher Institute for Biomedical Research; US Office of Naval Research; Marie Curie Excellence grant; National Centre of Competence in Research; European Research Council; European Union; EMBO	Friedrich Miescher Institute for Biomedical Research; US Office of Naval Research(Office of Naval Research); Marie Curie Excellence grant(European Commission); National Centre of Competence in Research; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); EMBO(European Molecular Biology Organization (EMBO))	We thank B. G. Scherf, S. Djaffer and J. Juttner for technical assistance, T. Szikra for helping with light intensity calibration, V. Busskamp for suggesting the use of the 2A element and the cloning strategy for the 2A-based expression system, and V. Busskamp, K. Farrow, S. Oakeley and P. King for their comments on the manuscript. We thank E. Callaway for providing the rabies viruses and K. Conzelmann and S. Arber for discussion about rabies viruses. The study was supported by the Friedrich Miescher Institute for Biomedical Research, a US Office of Naval Research Naval International Cooperative Opportunities in Science and Technology Program grant, a Marie Curie Excellence grant, a National Centre of Competence in Research Frontiers in Genetics grant, an European Research Council as well as RETICIRC, TREATRUSH and OPTONEURO grants from the European Union to B. R. and an EMBO Long-Term Fellowship to K.Y.	ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Chan YC, 2008, VISION RES, V48, P2466, DOI 10.1016/j.visres.2008.08.010; Chen MG, 2009, J PHYSIOL-LONDON, V587, P819, DOI 10.1113/jphysiol.2008.161240; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Elstrott J, 2008, NEURON, V58, P499, DOI 10.1016/j.neuron.2008.03.013; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ivanova E, 2010, NEUROSCIENCE, V165, P233, DOI 10.1016/j.neuroscience.2009.10.021; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Sun WZ, 2006, J PHYSIOL-LONDON, V576, P197, DOI 10.1113/jphysiol.2006.115857; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tian N, 2001, NEURON, V32, P439, DOI 10.1016/S0896-6273(01)00470-6; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Vaney DI, 2002, CURR OPIN NEUROBIOL, V12, P405, DOI 10.1016/S0959-4388(02)00337-9; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320	34	117	120	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					407	+		10.1038/nature09711	http://dx.doi.org/10.1038/nature09711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21170022				2022-12-28	WOS:000286385600054
J	Horton, R; Das, P				Horton, Richard; Das, Pam			Indian health: the path from crisis to progress	LANCET			English	Editorial Material									[Horton, Richard; Das, Pam] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Alkire S, INDIA COUNTRY BRIEFI; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Desiraju G. R., 2008, EC POLITICAL WKLY, V43, P37; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Guha Ramachandra, 2008, ECON POLIT WEEKLY, V43, P192; John TJ, 2011, LANCET, V377, P252, DOI 10.1016/S0140-6736(10)61265-2; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Mavalankar D, 2008, B WORLD HEALTH ORGAN, V86, P243, DOI 10.2471/BLT.07.048454; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Rama Baru, 2010, Economic and Political Weekly, V45, P49; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sakthivel Selvaraj, 2009, Economic and Political Weekly, V44, P55; Sanghavi P, 2009, LANCET, V373, P1282, DOI 10.1016/S0140-6736(09)60235-X; SRIDHAR D, 2010, HLTH POLICY PLANNING, P1; WHO, 2010, WOR HEALT REP, P1; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5	20	28	28	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					181	183		10.1016/S0140-6736(10)62179-4	http://dx.doi.org/10.1016/S0140-6736(10)62179-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	712WG	21227502				2022-12-28	WOS:000286696400004
J	John, TJ; Dandona, L; Sharma, VP; Kakkar, M				John, T. Jacob; Dandona, Lalit; Sharma, Vinod P.; Kakkar, Manish			India: Towards Universal Health Coverage 1 Continuing challenge of infectious diseases in India	LANCET			English	Article							VIBRIO-CHOLERAE O1; SEXUALLY-TRANSMITTED INFECTIONS; ANDHRA-PRADESH STATE; PUBLIC-HEALTH; TYPHOID-FEVER; VIRAL-HEPATITIS; SCRUB TYPHUS; TAMIL-NADU; CHIKUNGUNYA EPIDEMIC; TUBERCULOSIS-CONTROL	In India, the range and burden of infectious diseases are enormous. The administrative responsibilities of the health system are shared between the central (federal) and state governments. Control of diseases and outbreaks is the responsibility of the central Ministry of Health, which lacks a formal public health department for this purpose. Tuberculosis, malaria, filariasis, visceral leishmaniasis, leprosy, HIV infection, and childhood duster of vaccine-preventable diseases are given priority for control through centrally managed vertical programmes. Control of HIV infection and leprosy, but not of tuberculosis, seems to be on track. Early success of malaria control was not sustained, and visceral leishmaniasis prevalence has increased. Inadequate containment of the vector has resulted in recurrent outbreaks of dengue fever and re-emergence of Chikungunya virus disease and typhus fever. Other infectious diseases caused by faecally transmitted pathogens (enteric fevers, cholera, hepatitis A and E viruses) and zoonoses (rabies, leptospirosis, anthrax) are not in the process of being systematically controlled. Big gaps in the surveillance and response system for infectious diseases need to be addressed. Replication of the model of vertical single-disease control for all infectious diseases will not be efficient or viable. India needs to rethink and revise its health policy to broaden the agenda of disease control. A comprehensive review and redesign of the health system is needed urgently to ensure equity and quality in health care. We recommend the creation of a functional public health infrastructure that is shared between central and state governments, with professional leadership and a formally trained public health cadre of personnel who manage an integrated control mechanism of diseases in districts that includes infectious and noninfectious diseases, and injuries.	[Dandona, Lalit; Kakkar, Manish] Publ Hlth Fdn India, New Delhi 110070, India; [John, T. Jacob] Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore, Tamil Nadu, India; [John, T. Jacob] Christian Med Coll & Hosp, Dept Virol, Vellore, Tamil Nadu, India; [Dandona, Lalit] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Sharma, Vinod P.] Indian Inst Technol, Ctr Rural Dev & Technol, New Delhi, India	Public Health Foundation of India; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Dandona, L (corresponding author), Publ Hlth Fdn India, ISID Campus,4 Inst Area, New Delhi 110070, India.	lalit.dandona@phfi.org	Rivet, Catherine A/M-7978-2014		John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This report was prepared without any financial support. The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India.	Abraham M, 1999, Indian Pediatr, V36, P697; Acharya SK, 2006, NATL MED J INDIA, V19, P203; [Anonymous], HIST TB CONTR; [Anonymous], TB IND 2008RNTCP STA; [Anonymous], NAT VECT BORN DIS CO; Arankalle V A, 2006, Indian J Med Res, V123, P760; Arora P, 2008, LANCET, V372, P289, DOI 10.1016/S0140-6736(08)61105-8; Bakshi D, 2007, ACTA TROP, V104, P63, DOI 10.1016/j.actatropica.2007.07.013; BALRAJ V, 1994, J TROP MED HYG, V97, P113; Bhatla N, 2008, VACCINE, V26, P2811, DOI 10.1016/j.vaccine.2008.03.047; Bhore J, 1946, REPORT HLTH SURVEY D; BHUSHAN N, 1994, INDIAN J MED RES, V99, P195; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Brewer TF, 2004, J EPIDEMIOL COMMUN H, V58, P822, DOI 10.1136/jech.2003.008664; Chadha Mandeep S, 2003, Indian J Gastroenterol, V22, P11; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P569; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Chandy S, 2008, J BIOSCIENCES, V33, P495, DOI 10.1007/s12038-008-0068-x; Chowdhury A, 2005, J GASTROEN HEPATOL, V20, P1712, DOI 10.1111/j.1440-1746.2005.04070.x; Chu KM, 1998, J INFECT DIS, V177, P1314, DOI 10.1086/515273; Cooke FJ, 2007, T ROY SOC TROP MED H, V101, P398, DOI 10.1016/j.trstmh.2006.07.005; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; Dandona L, 2009, AIDS, V23, P233, DOI 10.1097/QAD.0b013e328320accc; Dandona L, 2008, INT J EPIDEMIOL, V37, P1274, DOI 10.1093/ije/dyn161; Dandona L, 2007, LANCET, V370, P1811, DOI 10.1016/S0140-6736(07)61756-5; Dandona Lalit, 2010, BMC Health Serv Res, V10, P117, DOI 10.1186/1472-6963-10-117; Das Gupta M, 2009, POLICY RES WORKING P; DASGUPTA PR, 1994, AIDS, V8, pS83; Datta M, 1999, INDIAN J MED RES, V110, P56; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; deBora D, 2005, J COMMUN DIS, V37, P1; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Diamond-Smith Nadia, 2009, Malar J, V8, P24, DOI 10.1186/1475-2875-8-24; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Government of India, E MAIL DIR; Grabowsky M, 2008, NATURE, V451, P1051, DOI 10.1038/4511051a; International Society for Infectious Diseases, 2009, MEN MEN IND 04 N E; International Society for Infectious Diseases, 2009, HEP B VIR IND 08 GUJ; JACOB M, 1989, INDIAN J MED RES-A, V89, P4; Jain NK, 1992, IND J TUBERC, V92, P145; Jesudason MV, 1996, LANCET, V347, P1493, DOI 10.1016/S0140-6736(96)91733-X; Jesudason MV, 2001, INDIAN J MED MICROBI, V19, P20; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; John T J, 2000, Indian Pediatr, V37, P9; John TJ, 2008, INDIAN PEDIATR, V45, P261; John TJ, 2010, INDIAN J MED RES, V132, P4; John TJ, 2010, INDIAN J MED RES, V131, P377; John TJ, 2009, INDIAN J MED RES, V130, P101; John TJ, 2009, INDIAN J MED RES, V130, P9; John TJ, 2008, INDIAN J MED RES, V128, P669; JOHN TJ, 1971, INDIAN J MED RES, V59, P1727; JOHN TJ, 1987, LANCET, V1, P160; John TJ, 2004, INDIAN J MED RES, V120, P86; JOHN TJ, 1993, INDIAN J MED RES-A, V97, P227; JOHN TJ, 1989, INDIAN J MED RES-A, V89, P1; John TJ, 1996, INDIAN J MED RES, V103, P4; John TJ, 1996, INDIAN J MED RES, V103, P62; JOHN TJ, 1974, B WORLD HEALTH ORGAN, V51, P617; John TJ, 1998, LANCET, V352, P58, DOI 10.1016/S0140-6736(97)10494-9; JOHN TJ, 1993, AIDS, V7, P421, DOI 10.1097/00002030-199303000-00018; John TJ, 2003, GLOBAL PUBLIC HLTH N, P172; John TJ., 2008, P RANB SCI FDN ROUND, P3; John TJ, 2009, TROP MED INT HEALTH, V4, P1; Kalantri SP, 2006, NATL MED J INDIA, V19, P315; Kamarasu K, 2007, INDIAN J MED RES, V126, P128; Keller A, 2008, J TRAVEL MED, V15, P248, DOI 10.1111/j.1708-8305.2008.00216.x; Khan AM, 2005, CURR SCI INDIA, V88, P1718; Khatri GR., 2000, P 7 ROUND TABL C SEP, P15; Khuroo MS, 1997, NEW ENGL J MED, V337, P881, DOI 10.1056/NEJM199709253371303; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Kingston JJ, 2009, J MICROBIOL, V47, P110, DOI 10.1007/s12275-008-0162-7; Kumar P, 2009, J MED MICROBIOL, V58, P234, DOI 10.1099/jmm.0.002089-0; Mahajan RC, 2005, INDIAN J MED RES, V121, P716; Mantur BG, 2008, J BIOSCIENCES, V33, P539, DOI 10.1007/s12038-008-0072-1; Mathai E, 2003, ANN NY ACAD SCI, V990, P359, DOI 10.1111/j.1749-6632.2003.tb07391.x; MATHAI R, 1990, INDIAN J MED RES-A, V91, P239; Mathew JL, 2009, INDIAN PEDIATR, V46, P304; Mathur P, 2008, INDIAN J MED RES, V128, P699; Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720; Ministry of Health and Family Welfare Government of India, 2009, OP MAN IMPL MAL PROG; Ministry of Health and Family Welfare Government of India, 2006, GUID SURV AC ENC SYN; Ministry of Health and Family Welfare Government of India, 1995, REP EXP COMM PLAG AU; Ministry of Health and Family Welfare Government of India, INT DIS SURV PROJ PR; Ministry of Health and Family Welfare Government of India, URB MAL SCHEM ACC UR; Mohapatra SS, 2007, J MED MICROBIOL, V56, P260, DOI 10.1099/jmm.0.46868-0; Mondal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000355; Mukhopadhya Ashis, 2006, Trop Gastroenterol, V27, P105; Nandakumar A, 2005, INT J CANCER, V116, P740, DOI 10.1002/ijc.21109; Narain JP, 2008, INDIAN J MED RES, V128, P1; Narain KL, 2003, CURR SCI INDIA, V84, P985; Narang P, 2008, INDIAN J MED MICROBI, V26, P40; National Aids Control Organisation and Government of India Ministry of Health Family Welfare, 2007, HIV SENT SURV HIV ES; National AIDS Control Organisation Ministry of Health and Family Welfare Government of India, 2006, NAT AIDS CONTR PROGR; National AIDS Control Organization, 2021, SANK STAT NAT AIDS R, V3rd; National AIDS Control Organization (NACO), 2019, IND HIV EST 2019; National Institute of Malaria Research and National Vector Borne Disease Control Programme, 2007, IN DEPTH REV MAL NAT; National Vector Borne Disease Control Programme, CHIK FEV; National Vector Borne Disease Control Programme Government of India, STAT NOT DENG FEV DE; National Vector Rome Disease Control Programme, KAL AZ VISC LEISHM; Oberoi A, 2007, Indian J Med Microbiol, V25, P75; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Pandey A, 2009, INDIAN J MED RES, V129, P50; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Pattanayak S., 1994, Indian Journal of Malariology, V31, P141; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Radha Krishna Y, 2009, LIVER INT, V29, P392, DOI 10.1111/j.1478-3231.2008.01887.x; Rajendran R, 2004, T ROY SOC TROP MED H, V98, P174, DOI 10.1016/S0035-9203(03)00042-7; Rajendran R, MASS DRUG ADM; Rajshekhar V, 2006, NEUROLOGY, V67, P2135, DOI 10.1212/01.wnl.0000249113.11824.64; Ramachandran J, 2004, J GASTROEN HEPATOL, V19, P134, DOI 10.1111/j.1440-1746.2004.03188.x; Ramaiah KD, 2000, PARASITOL TODAY, V16, P251, DOI 10.1016/S0169-4758(00)01643-4; Ramasundaram S, 2001, WG523 COMM MACR HLTH, V23; Rao BL, 2003, NATL MED J INDIA, V16, P143; Rao G Raghu Rama, 2005, Indian J Dermatol Venereol Leprol, V71, P102; Rasheeda CA, 2008, EUR J GASTROEN HEPAT, V20, P362, DOI 10.1097/MEG.0b013e3282f246d6; Raza SA, 2007, BRIT J CANCER, V96, P1127, DOI 10.1038/sj.bjc.6603649; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Reddy KS, 2006, NATL MED J INDIA, V19, P122; Reynolds SJ, 2004, LANCET, V363, P1039, DOI 10.1016/S0140-6736(04)15840-6; Richard VS, 2001, J HOSP INFECT, V47, P243, DOI 10.1053/jhin.2000.0855; Roll Back Malaria, SIT AN MAL CONTR 5 S; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Satyanarayana, EVALUATION INTEGRATE; Schneider JA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-59; Sebastian B, 1998, INDIAN J GASTROENTER, V17, pS10; Sehgal PN, 1993, J COMM DIS, V5, P175; SEHGAL SC, 1995, INDIAN J MED RES, V102, P9; Sethi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000579; Shah NK, LANCET INFE IN PRESS; Sharma NC, 2007, INDIAN J MED RES, V125, P633; Sharma PK, 2009, T ROY SOC TROP MED H, V103, P1153, DOI 10.1016/j.trstmh.2009.02.006; Sharma R, 2000, BRIT MED J, V320, P668; Sharma VP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-281; Sharma VP, 1996, INDIAN J MED RES, V103, P26; Sharma VP., 2002, CONTEXTUAL DETERMINA; Sharma VP., 2005, GETTING GRIPS MALARI; Shetty PVD, 2008, INT J TUBERC LUNG D, V12, pS26; SIMOES EAF, 1993, J ACQ IMMUN DEF SYND, V6, P1030; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335; Singh S, 2007, AIDS, V21, P2345, DOI 10.1097/QAD.0b013e3282f125c9; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Somashekar HR, 2006, J TROP PEDIATRICS, V52, P228, DOI 10.1093/tropej/fmi096; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; Sudarshan MK, 2005, INDIAN J COMMUN MED, V30, P100, DOI DOI 10.4103/0970-0218.42864; Sundaram SP, 2002, INDIAN J MED RES, V116, P258; Sur D, 2004, INDIAN J MED RES, V120, P454; Sur D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-289; Tankhiwale SS, 2003, INDIAN J MED RES, V117, P10; Tarantola A, 2008, J TRAVEL MED, V15, P273, DOI 10.1111/j.1708-8305.2008.00210.x; TBC India, DOTS EXP IND; Thakur CP, 2007, INDIAN J MED RES, V126, P447; Thakur CP, 2009, INDIAN J MED RES, V129, P102; UN Development Program, HUM DEV REP 2009 HDI; UNAIDS, 2010, REP GLOB AIDS EP 201; UNAIDS, 2006, REP GLOB AIDS EP; van den Ent M, 2009, INDIAN PEDIATR, V46, P933; VENKITARAMAN AR, 1986, INT J EPIDEMIOL, V15, P561, DOI 10.1093/ije/15.4.561; Vyas RM, 2003, INT J TUBERC LUNG D, V7, P543; WHO, 1995, MAL COUNTR PROF IND; WHO, NEW CAS DET TRENDS L; WHO, 2004, REG STRAT FRAM EL KA; WHO, 2007, NEWS LETT        JUN; WHO, 2010, GLOB TUB CONTR 2010; WHO Regional Office for South East Asia, IMM VACC DEV; WHO SEARO, COMM DIS KAL AZ; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; World Bank, 2006, IMPL COMPL RES REP I; World Health Organization, 2008, GLOB BURD DIS 2004 U; WORLDHEALTH ORGANIZATION (WHO), 2008, WORLD MAL REP 2008; Young F, 2009, INDIAN J MED RES, V130, P1	174	122	125	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					252	269		10.1016/S0140-6736(10)61265-2	http://dx.doi.org/10.1016/S0140-6736(10)61265-2			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712WG	21227500				2022-12-28	WOS:000286696400033
J	Venkatachalam, V; Yacoby, A; Pfeiffer, L; West, K				Venkatachalam, Vivek; Yacoby, Amir; Pfeiffer, Loren; West, Ken			Local charge of the v = 5/2 fractional quantum Hall state	NATURE			English	Article							LOCALIZATION	Electrons moving in two dimensions under the influence of strong magnetic fields effectively lose their kinetic energy and display exotic behaviour dominated by Coulomb forces. When the ratio of electrons to magnetic flux quanta in the system (nu) is near 5/2, the electrons are predicted to condense into a correlated phase with fractionally charged quasiparticles and a ground-state degeneracy that grows exponentially as these quasiparticles are introduced(1). The only way for electrons to transform between the many ground states would be to braid the fractional excitations around each other. This property has been proposed as the basis of a fault-tolerant quantum computer(2). Here we present observations of localized quasiparticles at nu = 5/2, confined to puddles by disorder. Using a local electrometer to compare how quasiparticles at nu = 5/2 and nu = 7/3 charge these puddles, we were able to extract the ratio of local charges for these states. Averaged over several disorder configurations and samples, we found the ratio to be 4/3, suggesting that the local charges are e(7/3)* = e/3 and e(5/2)* = e/4, where e is the charge of an electron. This is in agreement with theoretical predictions for a paired state at nu = 5/2. Confirming the existence of localized e/4 quasiparticles shows that proposed interferometry experiments to test statistics and computational ability of the state at nu = 5/2 would be possible.	[Venkatachalam, Vivek; Yacoby, Amir] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Pfeiffer, Loren; West, Ken] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	Harvard University; Princeton University	Yacoby, A (corresponding author), Harvard Univ, Dept Phys, 11 Oxford St, Cambridge, MA 02138 USA.	yacoby@physics.harvard.edu		Venkatachalam, Vivek/0000-0002-2414-7416	Microsoft Corporation; National Science Foundation	Microsoft Corporation(Microsoft); National Science Foundation(National Science Foundation (NSF))	We would like to acknowledge B. Verdene, J. Waissman and J. Nubler for technical assistance, and B. Halperin for theoretical discussions. We acknowledge financial support from Microsoft Corporation Project Q and the National Science Foundation's Graduate Research Fellowship Program.	Bid A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.236802; Bishara W, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.121302; Bonderson P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.016803; Choi HC, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.081301; Das Sarma S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.166802; Dean CR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146803; Dolev M, 2008, NATURE, V452, P829, DOI [10.1038/nature06855, 10.1038/natureO6855]; Dolev M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161303; Ilani S, 2004, NATURE, V427, P328, DOI 10.1038/nature02230; Ilani S, 2001, SCIENCE, V292, P1354, DOI 10.1126/science.1058645; Martin J, 2004, SCIENCE, V305, P980, DOI 10.1126/science.1099950; MOORE G, 1991, NUCL PHYS B, V360, P362, DOI 10.1016/0550-3213(91)90407-O; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Prange R.E., 1987, QUANTUM HALL EFFECT, V2; Stern A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.016802	16	76	77	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					185	188		10.1038/nature09680	http://dx.doi.org/10.1038/nature09680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228871	Green Submitted			2022-12-28	WOS:000286143400032
J	Aberer, E; Fingerle, V; Wutte, N; Fink-Puches, R; Cerroni, L				Aberer, Elisabeth; Fingerle, Volker; Wutte, Nora; Fink-Puches, Regina; Cerroni, Lorenzo			Within European margins	LANCET			English	Editorial Material									[Aberer, Elisabeth; Wutte, Nora; Fink-Puches, Regina; Cerroni, Lorenzo] Med Univ Graz, Dept Dermatol, A-8036 Graz, Austria; [Fingerle, Volker] Bavarian Hlth & Food Safety Author, Natl Ctr Borrelia, Oberschleissheim, Germany	Medical University of Graz; Bavarian Health & Food Safety Authority	Aberer, E (corresponding author), Med Univ Graz, Dept Dermatol, Auenbrugger Pl 8, A-8036 Graz, Austria.	elisabeth.aberer@medunigraz.at		Fingerle, Volker/0000-0002-3835-5646				Boer A, 2007, BRIT J DERMATOL, V156, P1263, DOI 10.1111/j.1365-2133.2007.07918.x; Kutting B, 1997, J AM ACAD DERMATOL, V36, P311, DOI 10.1016/S0190-9622(97)80405-7; Lenormand C, 2009, BRIT J DERMATOL, V161, P174, DOI 10.1111/j.1365-2133.2009.09100.x; Michel H, 2004, MED MICROBIOL IMMUN, V193, P219, DOI 10.1007/s00430-003-0196-8; Senff NJ, 2008, BLOOD, V112, P1600, DOI 10.1182/blood-2008-04-152850	5	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					178	178		10.1016/S0140-6736(10)62241-6	http://dx.doi.org/10.1016/S0140-6736(10)62241-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21215884				2022-12-28	WOS:000286292800030
J	Coleman, MP; Forman, D; Bryant, H; Butler, J; Rachet, B; Maringe, C; Nur, U; Tracey, E; Coory, M; Hatcher, J; McGahan, CE; Turner, D; Marrett, L; Gjerstorff, ML; Johannesen, TB; Adolfsson, J; Lambe, M; Lawrence, G; Meechan, D; Morris, EJ; Middleton, R; Steward, J; Richards, MA				Coleman, M. P.; Forman, D.; Bryant, H.; Butler, J.; Rachet, B.; Maringe, C.; Nur, U.; Tracey, E.; Coory, M.; Hatcher, J.; McGahan, C. E.; Turner, D.; Marrett, L.; Gjerstorff, M. L.; Johannesen, T. B.; Adolfsson, J.; Lambe, M.; Lawrence, G.; Meechan, D.; Morris, E. J.; Middleton, R.; Steward, J.; Richards, M. A.		ICBP Module 1 Working Grp	Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data	LANCET			English	Article							BREAST-CANCER; DEATHS; STAGE; AGE; DIAGNOSIS; ENGLAND; EUROPE; TRENDS; CARE	Background Cancer survival is a key measure of the effectiveness of health-care systems. Persistent regional and international differences in survival represent many avoidable deaths. Differences in survival have prompted or guided cancer control strategies. This is the first study in a programme to investigate international survival disparities, with the aim of informing health policy to raise standards and reduce inequalities in survival. Methods Data from population-based cancer registries in 12 jurisdictions in six countries were provided for 2.4 million adults diagnosed with primary colorectal, lung, breast (women), or ovarian cancer during 1995-2007, with follow-up to Dec 31, 2007. Data quality control and analyses were done centrally with a common protocol, overseen by external experts. We estimated 1-year and 5-year relative survival, constructing 252 complete life tables to control for background mortality by age, sex, and calendar year. We report age-specific and age-standardised relative survival at 1 and 5 years, and 5-year survival conditional on survival to the first anniversary of diagnosis. We also examined incidence and mortality trends during 1985-2005. Findings Relative survival improved during 1995-2007 for all four cancers in all jurisdictions. Survival was persistently higher in Australia, Canada, and Sweden, intermediate in Norway, and lower in Denmark, England, Northern Ireland, and Wales, particularly in the first year after diagnosis and for patients aged 65 years and older. International differences narrowed at all ages for breast cancer, from about 9% to 5% at 1 year and from about 14% to 8% at 5 years, but less or not at all for the other cancers. For colorectal cancer, the international range narrowed only for patients aged 65 years and older, by 2-6% at 1 year and by 2-3% at 5 years. Interpretation Up-to-date survival trends show increases but persistent differences between countries. Trends in cancer incidence and modality are broadly consistent with these trends in survival. Data quality and changes in classification are not likely explanations. The patterns are consistent with later diagnosis or differences in treatment, particularly in Denmark and the UK, and in patients aged 65 years and older.	[Coleman, M. P.] Univ London London Sch Hyg & Trop Med, Canc Res UK Canc Survival Grp, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Forman, D.] Int Agcy Res Canc, Sect Canc Informat, F-69372 Lyon, France; [Bryant, H.] Canadian Partnership Against Canc, Toronto, ON, Canada; [Tracey, E.] Canc Inst New S Wales, Sydney, NSW, Australia; [Coory, M.] Canc Council Victoria, Melbourne, Vic, Australia; [Hatcher, J.] Alberta Hlth Serv, Edmonton, AB, Canada; [McGahan, C. E.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Turner, D.] CancerCare Manitoba, Winnipeg, MB, Canada; [Marrett, L.] Canc Care Ontario, Toronto, ON, Canada; [Gjerstorff, M. L.] Natl Board Hlth, Danish Canc Registry, Copenhagen, Denmark; [Johannesen, T. B.] Norwegian Canc Registry, Oslo, Norway; [Adolfsson, J.] Karolinska Univ Hosp, Ctr Oncol, Stockholm, Sweden; [Adolfsson, J.] Karolinska Inst, CLINTEC Dept, Stockholm, Sweden; [Lambe, M.] Univ Uppsala Hosp, Reg Oncol Ctr, Uppsala, Sweden; [Lawrence, G.] W Midlands Canc Intelligence Unit, Birmingham, W Midlands, England; [Meechan, D.] Trent Canc Registry, Sheffield, S Yorkshire, England; [Morris, E. J.] No & Yorkshire Canc Registrat & Informat Serv, Leeds, W Yorkshire, England; [Middleton, R.] No Ireland Canc Registry, Belfast, Antrim, North Ireland; [Steward, J.] Welsh Canc Intelligence & Surveillance Unit, Cardiff, S Glam, Wales; [Richards, M. A.] Dept Hlth, Natl Canc Act Team, London SE1 6TE, England	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; International Agency for Research on Cancer (IARC); Cancer Council Victoria; Alberta Health Services (AHS); British Columbia Cancer Agency; CancerCare Manitoba Foundation; Cancer Care Ontario; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Uppsala University Hospital	Coleman, MP (corresponding author), Univ London London Sch Hyg & Trop Med, Canc Res UK Canc Survival Grp, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	michel.coleman@lshtm.ac.uk	Menon, Usha/C-4716-2008; Coleman, Michel/AAA-9543-2020	Menon, Usha/0000-0003-3708-1732; Coleman, Michel/0000-0001-8940-3807; Currow, David/0000-0003-1988-1250; Adolfsson, Jan/0000-0003-2992-1869; Bergh, Jonas/0000-0001-5526-1847; Lambe, Mats/0000-0002-4624-3767; Quaresma, Manuela/0000-0002-5290-279X; Walters, Sarah/0000-0001-9929-1917; Boyages, John/0000-0003-3208-3966; Rachet, Bernard/0000-0001-5837-7773	Department of Health; Department of Health, England (London, UK); Cancer Research UK (London, UK); Cancer Research UK [9805, 11700] Funding Source: researchfish	Department of Health; Department of Health, England (London, UK); Cancer Research UK (London, UK)(Cancer Research UK); Cancer Research UK(Cancer Research UK)	MAR is the National Cancer Director (England, funded by the Department of Health); and J Bu is Clinical Advisor to the Medical Director of the NHS (England, funded by the Department of Health). Other authors declare that they have no conflicts of interest.; This study was funded by the Department of Health, England (London, UK), and Cancer Research UK (London, UK). We thank the cancer registry staff in all jurisdictions, whose sustained efforts in data collection and quality control over many years have enabled trends in cancer patient survival to be analysed and compared in this study. We are grateful for the expert contributions from our Epidemiology Reference Group, who advised on protocol, study design, and analytical methods: Bruce Armstrong (Department of Public Health, University of Sydney, Sydney, NSW, Australia); Paul Dickman (Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden); Paul Lambert (Biostatistics Group, Department of Health Sciences, University of Leicester, Leicester, UK); Dianne O'Connell (Cancer Council New South Wales, Sydney, NSW, Australia); Milena Sant (Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy); and Hannah Weir (Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA). We also thank Jacques Ferlay (IARC, Lyon, France) for providing the incidence and mortality data for figure 3, and Max van Eijk (McKinsey) for sustained logistical support. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of any government agency.	Abdel-Rahman M, 2009, BRIT J CANCER, V101, pS115, DOI 10.1038/sj.bjc.6605401; Allemani C, 2010, EUR J CANCER, V46, P1528, DOI 10.1016/j.ejca.2010.02.016; [Anonymous], 2021, CANC INCIDENCE 5 CON; Beral V, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4112; Berrino F, 1995, IARC SCI PUBLICATION, V132; Berrino F, 1999, IARC SCI PUBLICATION, V151; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#; *CANC RES UK CANC, 2010, STREL COMP PROGR VER; Cavalli F, 2008, LANCET ONCOL, V9, P810, DOI 10.1016/S1470-2045(08)70213-4; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Coleman MP, 2000, LANCET, V356, P590, DOI 10.1016/S0140-6736(00)02593-9; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; *DEP HUM SERV, 2008, VICT CANC ACT PLAN 2; Dickman PW, 1997, J EPIDEMIOL BIOSTAT, V2, P87; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; ESTEVE J, 1990, STAT MED, V9, P529, DOI 10.1002/sim.4780090506; FERLAY J, 2010, IARC CANC BASE, V9; Fritz APC., 2013, INT CLASSIFICATION D; Gatta G, 2010, ACTA ONCOL, V49, P776, DOI 10.3109/02841861003782009; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Kaye JA, 2000, BRIT J CANCER, V83, P1556, DOI 10.1054/bjoc.2000.1493; Lavelle K, 2007, BRIT J CANCER, V96, P1197, DOI 10.1038/sj.bjc.6603709; Percy C., 1990, INT CLASSIFICATION D; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Pokhrel A, 2010, BRIT J CANCER, V103, P1109, DOI 10.1038/sj.bjc.6605861; Quaglia A, 2009, EUR J CANCER, V45, P1006, DOI 10.1016/j.ejca.2008.11.028; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Richards MA, 2000, BRIT MED J, V320, P895, DOI 10.1136/bmj.320.7239.895; Sanjoaquin MA, 2007, EUR J CANCER PREV, V16, P10, DOI 10.1097/01.cej.0000228398.30235.f5; Sant M, 2003, ANN ONCOL, V14, pV61, DOI 10.1093/annonc/mdg754; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Sant M, 2001, INT J CANCER, V93, P894, DOI 10.1002/ijc.1408; Skirnisdottir I, 2008, INT J CANCER, V123, P1897, DOI 10.1002/ijc.23724; Storm HH, 2010, ACTA ONCOL, V49, P532, DOI 10.3109/02841861003801148; Storm Hans Henrik, 2008, Ugeskr Laeger, V170, P3065; Storm HH, 1999, EUR RESPIR J, V13, P430, DOI 10.1183/09031936.99.13243099; Williams MV, 2009, CLIN ONCOL-UK, V21, P431, DOI 10.1016/j.clon.2009.05.006; World Health Organization, 2008, WHO STAT INF SYST WH; World Health Organization, 1994, INT STAT CLASS DIS R	41	865	892	0	99	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					127	138		10.1016/S0140-6736(10)62231-3	http://dx.doi.org/10.1016/S0140-6736(10)62231-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21183212	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000286292800025
J	Pollard, TD				Pollard, Thomas D.			Formin Tip Tracking	SCIENCE			English	Editorial Material							ACTIN-FILAMENT; MECHANISM; MOVEMENT		[Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM026338] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Mizuno H, 2011, SCIENCE, V331, P80, DOI 10.1126/science.1197692; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Shemesh T, 2005, J CELL BIOL, V170, P889, DOI 10.1083/jcb.200504156; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899	9	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					39	41		10.1126/science.1200773	http://dx.doi.org/10.1126/science.1200773			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212345				2022-12-28	WOS:000285974000026
J	Cocinero, EJ; Carcabal, P; Vaden, TD; Simons, JP; Davis, BG				Cocinero, Emilio J.; Carcabal, Pierre; Vaden, Timothy D.; Simons, John P.; Davis, Benjamin G.			Sensing the anomeric effect in a solvent-free environment	NATURE			English	Article							CONFORMATIONAL-ANALYSIS; GAS-PHASE; GLUCOSE; SYSTEMS; MODEL; BOND	The anomeric effect is a chemical phenomenon(1-9) that refers to an observed stabilization(10) of six-membered carbohydrate rings when they contain an electronegative substituent at the C1 position of the ring. This stereoelectronic effect influences the three-dimensional shapes of many biological molecules. It can be manifested not only in this classical manner involving interaction of the endocyclic oxygen atom (O5) found in such sugars with the C1 substituent (endo-anomeric effect) but also through a corresponding interaction of the electronegative exocyclic substituent with O5 (exoanomeric effect). However, the underlying physical origin(s) of this phenomenon is still not clear(1,3,4,11-14). Here we show, using a combination of laser spectroscopy and computational analysis, that a truncated peptide motif can engage the two anomers of an isolated sugar in the gas phase, an environment lacking extraneous factors which could confound the analysis. (Anomers are isomers that differ in the orientation of the substituent at C1.) Complexes formed between the peptide and the alpha- or beta-anomers of D-galactose are nearly identical structurally; however, the strength of the polarization of their interactions with the peptide differs greatly. Natural bond order calculations support this observation, and together they reveal the dominance of the exo- over the endo-anomeric effect. As interactions between oxygen atoms at positions C1 and C2 (O1 and O2, respectively) on the pyranose ring can alter the exo/endo ratio of a carbohydrate, our results suggest that it will be important to reevaluate the influence, and biological effects, of substituents at position C2 in sugars.	[Davis, Benjamin G.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Cocinero, Emilio J.; Carcabal, Pierre; Vaden, Timothy D.; Simons, John P.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	University of Oxford; University of Oxford	Davis, BG (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	John.Simons@chem.ox.ac.uk; Ben.Davis@chem.ox.ac.uk	Davis, Benjamin G/C-5281-2011; Cocinero, Emilio J./C-6497-2009	Davis, Benjamin G/0000-0002-5056-407X; Cocinero, Emilio J./0000-0001-7632-3728; Vaden, Timothy/0000-0002-2648-0300	EPSRC [GR/T26542]; Leverhulme Trust; Spanish Ministry (MCINN) for a Juan de la Cierva; Royal Society for a USA/Canada; Linacre College; Royal Society; Biotechnology and Biological Sciences Research Council [BB/E004350/1, BB/C510824/1, EGA17763] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G026688/1, EP/D023335/1, EP/I500200/1, EP/G03088X/1, EP/E000614/1, GR/T26542/01, EP/D023343/1] Funding Source: researchfish; BBSRC [BB/E004350/1] Funding Source: UKRI; EPSRC [EP/I500200/1, EP/G026688/1, EP/E000614/1, EP/G03088X/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Spanish Ministry (MCINN) for a Juan de la Cierva(Spanish Government); Royal Society for a USA/Canada(Royal Society of London); Linacre College; Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the EPSRC for funding (GR/T26542), the Leverhulme Trust for the award of an Emeritus Fellowship (J.P.S.), the Spanish Ministry (MCINN) for a Juan de la Cierva contract (E.J.C.), the Royal Society for a USA/Canada Research Fellowship and Linacre College for a Junior Research Fellowship (T.D.V.), the STFC for the provision of equipment from the Laser Loan Pool, and the Oxford Supercomputing Centre for their services. B.G.D. is a Royal Society Wolfson Research Merit Award recipient and is supported by an EPSRC LSI Platform grant.	BOX VGS, 1990, HETEROCYCLES, V31, P1157; BRIGGS AJ, 1984, J AM CHEM SOC, V106, P6200, DOI 10.1021/ja00333a014; Cramer CJ, 1997, CARBOHYD RES, V298, P1, DOI 10.1016/S0008-6215(96)00297-2; Deslongchamps P., 1983, STEREOELECTRONIC EFF; EDWARD JT, 1955, CHEM IND-LONDON, P1102; ELIEL EL, 1968, J ORG CHEM, V33, P3754, DOI 10.1021/jo01274a015; Eliel EL., 1994, STEREOCHEMISTRY ORGA; Gerhards M, 2004, PHYS CHEM CHEM PHYS, V6, P2682, DOI 10.1039/b316001g; Gillespie RJ, 2010, CHEM-EUR J, V16, P3663, DOI 10.1002/chem.200902599; JUARISTI E, 1992, TETRAHEDRON, V48, P5019, DOI 10.1016/S0040-4020(01)90118-8; Jungius CL, 1905, Z PHYS CHEM-STOCH VE, V52, P97; Kirby A. J., 1983, ANOMERIC EFFECT RELA; Lemieux R.U., 1971, PURE APPL CHEM, V25, P527; LEMIEUX RU, 1979, ACS SYM SER, P17; Mo YR, 2010, NAT CHEM, V2, P666, DOI [10.1038/NCHEM.721, 10.1038/nchem.721]; Robertson EG, 2001, PHYS CHEM CHEM PHYS, V3, P1, DOI 10.1039/b008225m; Romers C., 1969, TOP STEREOCHEM, V4, P39; SALZNER U, 1994, J ORG CHEM, V59, P2138, DOI 10.1021/jo00087a035; Takahashi O, 2007, CARBOHYD RES, V342, P1202, DOI 10.1016/j.carres.2007.02.032; Thatcher G. R. J., 1993, ANOMERIC EFFECT ASS; Vila A, 2007, J COMPUT CHEM, V28, P1516, DOI 10.1002/jcc.20585; WIBERG KB, 1989, J AM CHEM SOC, V111, P4821, DOI 10.1021/ja00195a038	22	124	124	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					76	U1400		10.1038/nature09693	http://dx.doi.org/10.1038/nature09693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21209661				2022-12-28	WOS:000285921600034
J	David, LA; Alm, EJ				David, Lawrence A.; Alm, Eric J.			Rapid evolutionary innovation during an Archaean genetic expansion	NATURE			English	Article							MOLECULAR FOSSILS; GENOMES; OCEAN; MODEL; SITE	The natural history of Precambrian life is still unknown because of the rarity of microbial fossils and biomarkers(1,2). However, the composition of modern-day genomes may bear imprints of ancient biogeochemical events(3-6). Here we use an explicit model of macroevolution including gene birth, transfer, duplication and loss events to map the evolutionary history of 3,983 gene families across the three domains of life onto a geological timeline. Surprisingly, we find that a brief period of genetic innovation during the Archaean eon, which coincides with a rapid diversification of bacterial lineages, gave rise to 27% of major modern gene families. A functional analysis of genes born during this Archaean expansion reveals that they are likely to be involved in electron-transport and respiratory pathways. Genes arising after this expansion show increasing use of molecular oxygen (P = 3.4 x 10(-8)) and redox-sensitive transition metals and compounds, which is consistent with an increasingly oxygenating biosphere.	[David, Lawrence A.; Alm, Eric J.] MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; [Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Alm, Eric J.] Broad Inst, Cambridge, MA 02140 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Alm, EJ (corresponding author), MIT, Computat & Syst Biol Initiat, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu	David, Lawrence Anthony/HCJ-0062-2022; David, Lawrence/B-1044-2010	David, Lawrence Anthony/0000-0002-3570-4767; David, Lawrence/0000-0002-3570-4767	US Department of Energy [DE-AC02-05CH11231]; National Science Foundation; National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank M. Polz, E. Delong, J. Waldbauer and T. Lyons for suggestions to improve this manuscript. This work is supported by the US Department of Energy ENIGMA project through contract DE-AC02-05CH11231, the National Science Foundation under an Assembling the Tree of Life Award, and a National Defense Science and Engineering Graduate Fellowship.	Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Des Marais DJ, 2000, SCIENCE, V289, P1703; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Garvin J, 2009, SCIENCE, V323, P1045, DOI 10.1126/science.1165675; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P3584, DOI 10.1128/jb.170.8.3584-3592.1988; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Konhauser KO, 2009, NATURE, V458, P750, DOI 10.1038/nature07858; Kunin V, 2003, GENOME RES, V13, P1589, DOI 10.1101/gr.1092603; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ragan MA, 2009, PHILOS T R SOC B, V364, P2241, DOI 10.1098/rstb.2009.0031; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Waldbauer JR, 2009, PRECAMBRIAN RES, V169, P28, DOI 10.1016/j.precamres.2008.10.011; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; Zerkle AL, 2005, AM J SCI, V305, P467, DOI 10.2475/ajs.305.6-8.467	28	258	266	4	121	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					93	96		10.1038/nature09649	http://dx.doi.org/10.1038/nature09649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21170026	Green Submitted			2022-12-28	WOS:000285921600038
J	Sinsky, CA				Sinsky, Christine A.			The Patient-Centered Medical Home Neighbor: A Primary Care Physician's View	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								The American College of Physicians' position paper on the patient-centered medical home neighbor (PCMH-N) extends the work of the patient-centered medical home (PCMH) as a means of improving the delivery of health care. Recognizing that the PCMH does not exist in isolation, the PCMH-N concept outlines expectations for comanagement, communication, and care coordination and broadens responsibility for safe, effective, and efficient care beyond primary care to include physicians of all specialties. As such, it is a fitting follow-up to the PCMH and moves further down the road toward improved care for complex patients. Yet, there is more work to be done. Truly transforming the U. S. health care system around personalized medical homes embedded in highly functional medical neighborhoods will require better staffing models; more robust electronic information tools; aligned incentives for quality and efficiency within payment and regulatory policies; and a culture of greater engagement of patients, their families, and communities.	Med Associates Clin, Dubuque, IA 52001 USA		Sinsky, CA (corresponding author), Med Associates Clin, 1000 Langworthy Dr, Dubuque, IA 52001 USA.	csinsky1@mahealthcare.com						American College of Physicians, 2010, PAT CTR MED HOM NEIG; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Safran DG, 2010, J GEN INTERN MED, V25, P10, DOI 10.1007/s11606-009-1134-2	4	17	18	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					61	62		10.7326/0003-4819-154-1-201101040-00010	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200041				2022-12-28	WOS:000285830900009
J	Chamberlain, JS				Chamberlain, Jeffrey S.			Duchenne Muscular Dystrophy Models Show Their Age	CELL			English	Editorial Material							DEFICIENT MICE; CELLS	The lack of appropriate animal models has hampered efforts to develop therapies for Duchenne muscular dystrophy (DMD). A new mouse model lacking both dystrophin and telomerase (Sacco et al., 2010) closely mimics the pathological progression of human DMD and shows that muscle stem cell activity is a key determinant of disease severity.	[Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chamberlain, JS (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98195 USA.	jsc5@uw.edu		Chamberlain, Jeffrey/0000-0001-5299-0059	NIA NIH HHS [R01 AG033610-03, R01 AG033610] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG033610] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Muir LA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001100; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	10	14	14	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2010	143	7					1040	1042		10.1016/j.cell.2010.12.005	http://dx.doi.org/10.1016/j.cell.2010.12.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183068	Green Accepted, Bronze			2022-12-28	WOS:000285625400001
J	Stirling, A				Stirling, Andy			Keep it complex	NATURE			English	Editorial Material							TECHNOLOGICAL RISK; APPRAISAL; SCIENCE		[Stirling, Andy] Univ Sussex, SPRU Sci & Technol Policy Res, Brighton BN1 9QE, E Sussex, England; [Stirling, Andy] Univ Sussex, Joint Ctr Social Technol & Environm Pathways Sust, Brighton BN1 9QE, E Sussex, England	University of Sussex; University of Sussex	Stirling, A (corresponding author), Univ Sussex, SPRU Sci & Technol Policy Res, Brighton BN1 9QE, E Sussex, England.	a.c.stirling@sussex.ac.uk	Stirling, Andy/G-1608-2011	Stirling, Andy/0000-0002-0650-431X	ESRC [ES/D004594/1] Funding Source: UKRI; Economic and Social Research Council [ES/D004594/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Bank of England, 2007, TREAS COMM INQ MON P; *ESRC CTR SOC TECH, 2010, NEW MAN; Farman J., 2001, LATE LESSONS EARLY W, P76; Knight, 1933, RISK UNCERTAINTY PRO; Leach M., 2010, ENV SOCIAL JUSTICE; Stirling A, 2001, ENVIRON PLANN C, V19, P529, DOI 10.1068/c8s; Stirling A, 2008, ANN NY ACAD SCI, V1128, P95, DOI 10.1196/annals.1399.011; Stirling A, 2008, SCI TECHNOL HUM VAL, V33, P262, DOI 10.1177/0162243907311265; *UK GM SCI REV PAN, 2003, UK GM SCI REV PAN 7; WYNNE B, 1992, GLOBAL ENVIRON CHANG, V2, P111, DOI 10.1016/0959-3780(92)90017-2	10	403	404	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1029	1031		10.1038/4681029a	http://dx.doi.org/10.1038/4681029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179144	Bronze			2022-12-28	WOS:000285553800032
J	Typas, A; Banzhaf, M; van Saparoea, BV; Verheul, J; Biboy, J; Nichols, RJ; Zietek, M; Beilharz, K; Kannenberg, K; von Rechenberg, M; Breukink, E; den Blaauwen, T; Gross, CA; Vollmer, W				Typas, Athanasios; Banzhaf, Manuel; van Saparoea, Bart van den Berg; Verheul, Jolanda; Biboy, Jacob; Nichols, Robert J.; Zietek, Matylda; Beilharz, Katrin; Kannenberg, Kai; von Rechenberg, Moritz; Breukink, Eefjan; den Blaauwen, Tanneke; Gross, Carol A.; Vollmer, Waldemar			Regulation of Peptidoglycan Synthesis by Outer-Membrane Proteins	CELL			English	Article							CELL-DIVISION MACHINERY; TOL-PAL COMPLEX; ESCHERICHIA-COLI; MUREIN SACCULUS; BACILLUS-SUBTILIS; SYNTHASE PBP1B; ELONGATION; BACTERIA; GROWTH; LYSIS	Growth of the mesh-like peptidoglycan (PG) sacculus located between the bacterial inner and outer membranes (OM) is tightly regulated to ensure cellular integrity, maintain cell shape, and orchestrate division. Cytoskeletal elements direct placement and activity of PG synthases from inside the cell, but precise spatiotemporal control over this process is poorly understood. We demonstrate that PG synthases are also controlled from outside of the sacculus. Two OM lipoproteins, LpoA and LpoB, are essential for the function, respectively, of PBP1A and PBP1B, the major E. coli bifunctional PG synthases. Each Lpo protein binds specifically to its cognate PBP and stimulates its transpeptidase activity, thereby facilitating attachment of new PG to the sacculus. LpoB shows partial septal localization, and our data suggest that the LpoB-PBP1B complex contributes to OM constriction during cell division. LpoA/ LpoB and their PBP-docking regions are restricted to gamma-proteobacteria, providing models for niche-specific regulation of sacculus growth.	[Typas, Athanasios; Nichols, Robert J.; Zietek, Matylda; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Gross, Carol A.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA; [Banzhaf, Manuel; Biboy, Jacob; Beilharz, Katrin; Vollmer, Waldemar] Univ Newcastle, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [van Saparoea, Bart van den Berg; Verheul, Jolanda; den Blaauwen, Tanneke] Univ Amsterdam, Swammerdam Inst Life Sci, Fac Sci, NL-1098 XH Amsterdam, Netherlands; [Nichols, Robert J.] Univ Calif San Francisco, Oral & Craniofacial Sci Grad Program, San Francisco, CA 94143 USA; [Kannenberg, Kai] Univ Tubingen, D-72076 Tubingen, Germany; [von Rechenberg, Moritz] Prolexys Pharmaceut Inc, Salt Lake City, UT 84116 USA; [Breukink, Eefjan] Univ Utrecht, Ctr Biomembranes & Lipid Enzymol, Dept Biochem Membranes, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Newcastle University - UK; University of Amsterdam; University of California System; University of California San Francisco; Eberhard Karls University of Tubingen; Utrecht University	Typas, A (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.	athanasios.typas@ucsf.edu; w.vollmer@ncl.ac.uk	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660; van den Berg van Saparoea, Bart/0000-0003-3337-5506; den Blaauwen, Tanneke/0000-0002-5403-5597; Typas, Athanasios/0000-0002-0797-9018; Banzhaf, Manuel/0000-0002-4682-1037	BBSRC [BB/F001231/1]; European Commission [LSHM-CT-2004-512138, HEALTH-F3-2009-223431]; NIH [R01 GM085697, ARRA GM085697-01S1, R01 GM036278, K99GM092984, F31 DE020206-01, T32 DE007306]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE020206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM092984, R01GM036278, R01GM085697] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F001231/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Jeff Errington, Dyche Mullins, and Monica Guo for critically reading this manuscript; H. Mori and his lab for sharing mutants of the second E. coli single-gene deletion (ASKA collection) prior to publishing; P. Born for PBP1A; N.K. Bui for PG sacculi; and Sarah Wittmer for help with the model illustration. We would like to thank T. Berhardt, D. Kahne, and their labs for communicating unpublished results. This work was supported by BBSRC BB/F001231/1 to W. V.; European Commission grants EUR-INTAFAR LSHM-CT-2004-512138 to W. V., T.d.B., and E. B. and DIVINOCELL HEALTH-F3-2009-223431 to W. V. and T.d.B.; NIH R01 GM085697, ARRA GM085697-01S1, and R01 GM036278 to C. A. G.; NIH K99GM092984 to A. T.; and NIH F31 DE020206-01 and NIH T32 DE007306 to R.J.N.	Aaron M, 2007, MOL MICROBIOL, V64, P938, DOI 10.1111/j.1365-2958.2007.05720.x; Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Born P, 2006, J BIOL CHEM, V281, P26985, DOI 10.1074/jbc.M604083200; BURMAN LG, 1984, P NATL ACAD SCI-BIOL, V81, P1844, DOI 10.1073/pnas.81.6.1844; CARBALLIDOLO PEZR, 2006, LYTE DEV CELL, V11, P399; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cayley DS, 2000, BIOPHYS J, V78, P1748, DOI 10.1016/S0006-3495(00)76726-9; Chung HS, 2009, P NATL ACAD SCI USA, V106, P21872, DOI 10.1073/pnas.0911674106; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DEJONGE BLM, 1989, J BACTERIOL, V171, P5783, DOI 10.1128/jb.171.11.5783-5794.1989; Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; GLAUNER B, 1990, J BIOL CHEM, V265, P18988; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; KOCH AL, 1992, J BACTERIOL, V174, P4811, DOI 10.1128/JB.174.14.4811-4819.1992; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003; Meisel U, 2003, J BACTERIOL, V185, P5342, DOI 10.1128/JB.185.18.5342-5348.2003; Morlot C, 2010, GENE DEV, V24, P411, DOI 10.1101/gad.1878110; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Sung MT, 2009, P NATL ACAD SCI USA, V106, P8824, DOI 10.1073/pnas.0904030106; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Vasquez-Laslop N, 2001, J BACTERIOL, V183, P2399, DOI 10.1128/JB.183.8.2399-2404.2001; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10; YOUSIF SY, 1985, J GEN MICROBIOL, V131, P2839	44	255	260	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1097	1109		10.1016/j.cell.2010.11.038	http://dx.doi.org/10.1016/j.cell.2010.11.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183073	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000285625400008
J	Reed, DA; Fletcher, KE; Arora, VM				Reed, Darcy A.; Fletcher, Kathlyn E.; Arora, Vineet M.			Systematic Review: Association of Shift Length, Protected Sleep Time, and Night Float With Patient Care, Residents' Health, and Education	ANNALS OF INTERNAL MEDICINE			English	Review							WORK HOUR RESTRICTIONS; INTERNAL-MEDICINE RESIDENTS; BLOOD-PRESSURE; CALL STRUCTURE; IMPACT; DEPRIVATION; PERFORMANCE; QUALITY; ERRORS; STAFF	Background: The Accreditation Council for Graduate Medical Education's new duty-hour standards limit interns' shifts to 16 hours and night float to 6 consecutive nights. Protected sleep time (that is, "nap") is strongly encouraged. As duty-hour reforms are implemented, examination of the quality and outcomes of the relevant literature is important. Purpose: To systematically review the literature examining shift length, protected sleep time, and night float. Data Sources: MEDLINE, PREMEDLINE, and EMBASE from January 1989 through May 2010. Study Selection: Studies examined the associations of shift length, protected sleep time, or night float with patient care, resident health, and education outcomes among residents in practice settings. Data Extraction: Study quality was measured by using the validated Medical Education Research Study Quality Instrument and the U.S. Preventive Services Task Force criteria. Two investigators independently rated study quality, and interrater agreement was calculated. Data Synthesis: Sixty-four studies met inclusion criteria. Most studies used single-group cross-sectional (19 studies [29.7%]) or prepost (41 studies [64.1%]) designs, and 4 (6.3%) were randomized, controlled trials. Five studies (7.8%) were multi-institutional. Twenty-four of 33 (72.7%) studies examining shift length reported that shorter shifts were associated with decreased medical errors, motor vehicle crashes, and percutaneous injuries. Only 2 studies assessed protected sleep time and reported that residents' adherence to naps was poor. Night floats described in 33 studies involved 5 to 7 consecutive nights. Limitations: Most studies used single-institution, observational designs. Publication bias is likely but difficult to assess in this methodologically weak and heterogeneous body of evidence. Conclusion: For the limited outcomes measured, most studies supported reducing shift length but did not adequately address the optimal shift duration. Studies had numerous methodological limitations and unclear generalizability for most outcomes. Specific recommendations about shift length, protected sleep time, and night float should acknowledge the limitations of this evidence.	[Reed, Darcy A.] Mayo Clin, Div Primary Care Internal Med, Coll Med, Rochester, MN 55905 USA; Med Coll Wisconsin, Milwaukee Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	Mayo Clinic; Medical College of Wisconsin; University of Chicago	Reed, DA (corresponding author), Mayo Clin, Div Primary Care Internal Med, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.			Arora, Vineet/0000-0002-4745-7599	Accreditation Council for Graduate Medical Education; ACGME	Accreditation Council for Graduate Medical Education; ACGME	Accreditation Council for Graduate Medical Education.; The authors thank Lisa Bellini, MD, at the University of Pennsylvania for expert review of the reference list. They also thank Jessica Schmidt and Andrea Bruckbauer at the Milwaukee Veterans Affairs Medical Center; Alexis Dye, MS, and Mark Oium at the Medical College of Wisconsin; Katya Papatla at Duke University; Patricia Erwin, MLS, and Kate Featherstone at the Mayo Clinic College of Medicine; Meryl Prochaska, BA, and Diane Daviera, BS, at the University of Chicago; and Emily Chiu at the University of Michigan for their excellent research assistance. Finally, they thank Jack Littrell, MS, for his assistance with database creation and management and DeWitt Baldwin, MD, at the ACGME for his assistance with obtaining funding.	Afessa B, 2005, CHEST, V128, P3910, DOI 10.1378/chest.128.6.3910; Akl EA, 2006, J GEN INTERN MED, V21, P494, DOI 10.1111/j.1525-1497.2006.00434.x; Amir O, 2004, AM J CARDIOL, V93, P947, DOI 10.1016/j.amjcard.2003.12.032; Antiel RM, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1008305; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Bailit JL, 2004, OBSTET GYNECOL, V103, P613, DOI 10.1097/01.AOG.0000119225.57285.c1; Barden CB, 2002, J AM COLL SURGEONS, V195, P531, DOI 10.1016/S1072-7515(02)01242-5; Barger LK, 2006, PLOS MED, V3, P2440, DOI 10.1371/journal.pmed.0030487; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; BENBARKA MM, 1995, HORM METAB RES, V27, P332, DOI 10.1055/s-2007-979972; BERKOFF K, 1991, J DEV BEHAV PEDIATR, V12, P6; Bhavsar J, 2007, AM J MED, V120, P968, DOI 10.1016/j.amjmed.2007.07.026; Blanchard MH, 2004, AM J OBSTET GYNECOL, V191, P1746, DOI 10.1016/j.ajog.2004.07.060; Brater DC, 2010, COMMUNICATION   0806; BUFF DD, 1995, J GEN INTERN MED, V10, P400, DOI 10.1007/BF02599842; Busowski JD, 1997, AM J PERINAT, V14, P177, DOI 10.1055/s-2007-994122; Cao CGL, 2008, HUM FACTORS, V50, P276, DOI 10.1518/001872008X288303; CAREY JC, 1989, OBSTET GYNECOL, V74, P668; Cavallo A, 2003, ERGONOMICS, V46, P653, DOI 10.1080/0014013031000085671; Cavallo A, 2002, CHRONOBIOL INT, V19, P893, DOI 10.1081/CBI-120014106; Cedfeldt Andrea S, 2009, J Grad Med Educ, V1, P178, DOI 10.4300/JGME-D-09-00031.1; Charap M, 2004, ANN INTERN MED, V140, P814, DOI 10.7326/0003-4819-140-10-200405180-00011; Chatterton RT, 1999, J SOC GYNECOL INVEST, V6, P50, DOI 10.1016/S1071-5576(98)00045-8; Chow KM, 2005, QJM-INT J MED, V98, P753, DOI 10.1093/qjmed/hci116; Druss BJ, 1996, ACAD PSYCHIATR, V20, P26, DOI 10.1007/BF03341958; Eastridge BJ, 2003, AM J SURG, V186, P169, DOI 10.1016/S0002-9610(03)00183-1; Ferguson Charles M, 2005, Curr Surg, V62, P535, DOI 10.1016/j.cursur.2005.04.001; Fialho G, 2006, AM J HYPERTENS, V19, P1005, DOI 10.1016/j.amjhyper.2006.03.007; Fletcher KE, 2005, JAMA-J AM MED ASSOC, V294, P1088, DOI 10.1001/jama.294.9.1088; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; Goldstein Michael J, 2005, Curr Surg, V62, P132, DOI 10.1016/j.cursur.2004.10.013; GOTTLIEB DJ, 1993, J GEN INTERN MED, V8, P146, DOI 10.1007/BF02599762; GOTTLIEB DJ, 1991, ARCH INTERN MED, V151, P2065, DOI 10.1001/archinte.151.10.2065; Griffith CH, 1997, J GEN INTERN MED, V12, P308, DOI 10.1046/j.1525-1497.1997.012005308.x; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hatala R, 2005, CAN MED ASSOC J, V172, P661, DOI 10.1503/cmaj.1031920; HAYNES DF, 1995, SOUTHERN MED J, V88, P283, DOI 10.1097/00007611-199503000-00007; Hendey GW, 2005, ACAD EMERG MED, V12, P629, DOI 10.1197/j.aem.2005.02.009; Horwitz LI, 2006, ARCH INTERN MED, V166, P1173, DOI 10.1001/archinte.166.11.1173; Institute of Medicine, 2008, RES DUT HOURS ENH SL; Izu Brent S, 2007, J Surg Educ, V64, P361, DOI 10.1016/j.jsurg.2007.08.006; Jarman Benjamin T, 2004, Curr Surg, V61, P612, DOI 10.1016/j.cursur.2004.06.016; Jasti H, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-52; Jeanmonod R, 2008, AM J EMERG MED, V26, P789, DOI 10.1016/j.ajem.2007.10.037; Kelly Robert J Jr, 2009, J Surg Educ, V66, P314, DOI 10.1016/j.jsurg.2009.07.009; Kiernan Michael, 2006, Curr Surg, V63, P237, DOI 10.1016/j.cursur.2006.03.002; Kirch DG, 2010, COMMUNICATION   0809; Kirkpatrick D. L., 1976, TRAINING DEV HDB, V2nd, P301; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Leff DR, 2008, ANN SURG, V247, P530, DOI 10.1097/SLA.0b013e3181661a99; Lefrak S, 2005, AM J SURG, V189, P639, DOI 10.1016/j.amjsurg.2004.11.034; Lehmann KS, 2010, SURGERY, V147, P246, DOI 10.1016/j.surg.2009.08.007; LIEU TA, 1992, AM J DIS CHILD, V146, P307, DOI 10.1001/archpedi.1992.02160150047018; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mann F A, 1993, Invest Radiol, V28, P92, DOI 10.1097/00004424-199301000-00032; Mautone SG, 2009, 2009 ACCR COUNC GRAD; Mcelearney ST, 2005, AM SURGEON, V71, P552; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nakayama DK, 2009, AM SURGEON, V75, P1234; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Nasca TJ, 2009, ACCREDITATION COUNCI; Nuckols TK, 2009, NEW ENGL J MED, V360, P2202, DOI 10.1056/NEJMsa0810251; Parks DK, 2000, CHRONOBIOL INT, V17, P61, DOI 10.1081/CBI-100101032; Parthasarathy S, 2007, CHEST, V131, P1685, DOI 10.1378/chest.06-1398; Petzel RA, 2010, COMMUNICATION   0805; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Pollack R, 2010, COMMUNICATION   0806; Privette AR, 2009, ANN SURG, V250, P316, DOI 10.1097/SLA.0b013e3181ae332a; Reader Douglas W, 2002, Emerg Radiol, V9, P82; Reed DA, 2008, J GEN INTERN MED, V23, P903, DOI 10.1007/s11606-008-0664-3; Reed DA, 2007, JAMA-J AM MED ASSOC, V298, P1002, DOI 10.1001/jama.298.9.1002; Richardson GS, 1996, SLEEP, V19, P718; ROSENBERG M, 1995, J GEN INTERN MED, V10, P95, DOI 10.1007/BF02600236; Roses Robert E, 2009, J Surg Educ, V66, P357, DOI 10.1016/j.jsurg.2009.07.005; Schenarts P, 2005, AM J SURG, V190, P147, DOI 10.1016/j.amjsurg.2005.03.026; SEELIG CB, 1992, SOUTH MED J, V85, P972, DOI 10.1097/00007611-199210000-00010; SEELIG CB, 1993, J GEN INTERN MED, V8, P610, DOI 10.1007/BF02599716; Short Amy C, 2006, J Matern Fetal Neonatal Med, V19, P801; Sim DJ, 2004, ANAESTHESIA, V59, P781, DOI 10.1111/j.1365-2044.2004.03808.x; STORER JS, 1989, ACAD MED, V64, P29, DOI 10.1097/00001888-198901000-00013; Suryadevara AC, 2008, LARYNGOSCOPE, V118, P1257, DOI 10.1097/MLG.0b013e31816bf52f; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; TRONTELL MC, 1991, J GEN INTERN MED, V6, P445, DOI 10.1007/BF02598169; U.S. Preventive Services Task Force Evidence Syntheses, 2010, USP STF QUAL RAT CRI; van Dongen HP, 2005, PRINCIPLES PRACTICE, P435; Vaughn DM, 2008, AM SURGEON, V74, P542; Wallach SL, 2006, SOUTH MED J, V99, P919, DOI 10.1097/01.smj.0000235501.62397.ef; Ware J Catesby, 2006, Behav Sleep Med, V4, P1, DOI 10.1207/s15402010bsm0401_1; Wayne DB, 2009, J GEN INTERN MED, V24, P1169, DOI 10.1007/s11606-009-1093-7; Welling Richard E, 2004, Curr Surg, V61, P241, DOI 10.1016/j.cursur.2003.10.009; YETMAN RJ, 1994, CHRONOBIOL INT, V11, P54, DOI 10.3109/07420529409057231; Zheng HY, 2006, JAMA-J AM MED ASSOC, V296, P1049, DOI 10.1001/jama.296.9.1049; Zucherman M, 1965, MULTIPLE AFFECT ADJE	95	103	105	2	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					829	+		10.7326/0003-4819-153-12-201012210-00010	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00010			26	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696PL	21173417				2022-12-28	WOS:000285453700007
J	Robinson, CV				Robinson, Carol V.			John Fenn (1917-2010) OBITUARY	NATURE			English	Biographical-Item									Univ Oxford, Phys & Theoret Chem Lab, Royal Soc, Oxford OX1 3QZ, England	University of Oxford	Robinson, CV (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, Royal Soc, Oxford OX1 3QZ, England.	carol.robinson@chem.ox.ac.uk		robinson, carol/0000-0001-7829-5505				FENN JB, PUBLICATION LIST	1	1	1	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					300	300		10.1038/469300a	http://dx.doi.org/10.1038/469300a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248828	Bronze			2022-12-28	WOS:000286385600028
J	Meurer, WJ				Meurer, William J.			The Canadian C-Spine Rule, used by nurses, accurately identified cervical-spine injury in patients with trauma	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Meurer, WJ (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.		Meurer, William J/A-7547-2010	Meurer, William J/0000-0002-1158-5302				Abram S, 2010, SURG-J R COLL SURG E, V8, P218, DOI 10.1016/j.surge.2010.01.002; Hauswald M, 1998, ACAD EMERG MED, V5, P214, DOI 10.1111/j.1553-2712.1998.tb02615.x; Stiell IG, 2003, NEW ENGL J MED, V349, P2510, DOI 10.1056/NEJMoa031375	3	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-13	10.7326/0003-4819-154-2-201101180-02013	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242355				2022-12-28	WOS:000286223500039
J	Ramirez, G; Beilock, SL				Ramirez, Gerardo; Beilock, Sian L.			Writing About Testing Worries Boosts Exam Performance in the Classroom	SCIENCE			English	Article							WORKING-MEMORY; STEREOTYPE THREAT; ACHIEVEMENT GAP; PRESSURE; CHOKING; SCIENCE	Two laboratory and two randomized field experiments tested a psychological intervention designed to improve students' scores on high-stakes exams and to increase our understanding of why pressure-filled exam situations undermine some students' performance. We expected that sitting for an important exam leads to worries about the situation and its consequences that undermine test performance. We tested whether having students write down their thoughts about an upcoming test could improve test performance. The intervention, a brief expressive writing assignment that occurred immediately before taking an important test, significantly improved students' exam scores, especially for students habitually anxious about test taking. Simply writing about one's worries before a high-stakes exam can boost test scores.	[Beilock, Sian L.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; Univ Chicago, Comm Educ, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Beilock, SL (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	beilock@uchicago.edu			NSF [DRL-0746970]; NSF Spatial Intelligence and Learning Center [SBE-0541957]; Institute of Educational Science [R305C050076]	NSF(National Science Foundation (NSF)); NSF Spatial Intelligence and Learning Center; Institute of Educational Science	Supported by NSF CAREER DRL-0746970 and NSF Spatial Intelligence and Learning Center SBE-0541957 to S. L. B. and Institute of Educational Science predoctoral training fellowship R305C050076 to G. R. We thank F. Spaltro for coordination of study 3 and 4 logistics and S. Goldin-Meadow for comments on a draft manuscript.	BAUMEISTER RF, 1984, J PERS SOC PSYCHOL, V46, P610, DOI 10.1037/0022-3514.46.3.610; Beilock S. L, 2010, CHOKE WHAT SECRETS B; Beilock SL, 2008, CURR DIR PSYCHOL SCI, V17, P339, DOI 10.1111/j.1467-8721.2008.00602.x; Beilock SL, 2005, PSYCHOL SCI, V16, P101, DOI 10.1111/j.0956-7976.2005.00789.x; Beilock SL, 2004, J EXP PSYCHOL GEN, V133, P584, DOI 10.1037/0096-3445.133.4.584; Cadinu M, 2005, PSYCHOL SCI, V16, P572, DOI 10.1111/j.0956-7976.2005.01577.x; Cassady JC, 2002, CONTEMP EDUC PSYCHOL, V27, P270, DOI 10.1006/ceps.2001.1094; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Cohen GL, 2009, SCIENCE, V324, P400, DOI 10.1126/science.1170769; DeCaro MS, 2010, Q J EXP PSYCHOL, V63, P1619, DOI 10.1080/17470210903474286; Hardy L, 1996, BRIT J PSYCHOL, V87, P621, DOI 10.1111/j.2044-8295.1996.tb02612.x; Hulleman CS, 2009, SCIENCE, V326, P1410, DOI 10.1126/science.1177067; Joormann J, 2009, COGNITION EMOTION, V23, P1233, DOI 10.1080/02699930802416735; Klein K, 2001, J EXP PSYCHOL GEN, V130, P520, DOI 10.1037//0096-3445.130.3.520; Miyake A, 2010, SCIENCE, V330, P1234, DOI 10.1126/science.1195996; Miyake P., 1999, MODELS WORKING MEMOR; Schmader T, 2003, J PERS SOC PSYCHOL, V85, P440, DOI 10.1037/0022-3514.85.3.440; Smyth JM, 1998, J CONSULT CLIN PSYCH, V66, P174, DOI 10.1037/0022-006X.66.1.174; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5	19	236	244	6	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					211	213		10.1126/science.1199427	http://dx.doi.org/10.1126/science.1199427			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	709JA	21233387				2022-12-28	WOS:000286433100041
J	Vivier, E; Raulet, DH; Moretta, A; Caligiuri, MA; Zitvogel, L; Lanier, LL; Yokoyama, WM; Ugolini, S				Vivier, Eric; Raulet, David H.; Moretta, Alessandro; Caligiuri, Michael A.; Zitvogel, Laurence; Lanier, Lewis L.; Yokoyama, Wayne M.; Ugolini, Sophie			Innate or Adaptive Immunity? The Example of Natural Killer Cells	SCIENCE			English	Review							MHC-CLASS-I; IMMUNOGLOBULIN-LIKE RECEPTORS; NK CELLS; INHIBITORY RECEPTORS; SELF-TOLERANCE; HEMATOPOIETIC TRANSPLANTS; PRIMARY IMMUNODEFICIENCY; ACTIVATION RECEPTOR; SIGNALING PATHWAYS; DENDRITIC CELLS	Natural killer (NK) cells were originally defined as effector lymphocytes of innate immunity endowed with constitutive cytolytic functions. More recently, a more nuanced view of NK cells has emerged. NK cells are now recognized to express a repertoire of activating and inhibitory receptors that is calibrated to ensure self-tolerance while allowing efficacy against assaults such as viral infection and tumor development. Moreover, NK cells do not react in an invariant manner but rather adapt to their environment. Finally, recent studies have unveiled that NK cells can also mount a form of antigen-specific immunologic memory. NK cells thus exert sophisticated biological functions that are attributes of both innate and adaptive immunity, blurring the functional borders between these two arms of the immune response.	[Vivier, Eric; Ugolini, Sophie] Univ Mediterranee UM 631, CIML, Campus Luminy, F-13288 Marseille, France; [Vivier, Eric; Ugolini, Sophie] INSERM, UMR S 631, F-13258 Marseille, France; [Vivier, Eric; Ugolini, Sophie] CNRS, UMR6102, Marseille, France; [Vivier, Eric] Hop Conception, AP HM, Marseille, France; [Raulet, David H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Raulet, David H.] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Moretta, Alessandro] Univ Genoa, Dept Expt Med, Genoa, Italy; [Moretta, Alessandro] Univ Genoa, CEBR, Genoa, Italy; [Caligiuri, Michael A.] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43220 USA; [Caligiuri, Michael A.] Solove Res Inst, Columbus, OH 43220 USA; [Zitvogel, Laurence] Inst Gustave Roussy, INSERM, U1015, F-94805 Villejuif, France; [Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Yokoyama, Wayne M.] Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Genoa; University of Genoa; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Washington University (WUSTL)	Vivier, E (corresponding author), Univ Mediterranee UM 631, CIML, Campus Luminy, F-13288 Marseille, France.	vivier@ciml.univ-mrs.fr; ugolini@ciml.univ-mrs.fr	Lanier, Lewis L/E-2139-2014; Vivier, Eric/F-8939-2010	Lanier, Lewis L/0000-0003-1308-3952; Vivier, Eric/0000-0001-7022-8287; Raulet, David/0000-0002-1257-8649; ZITVOGEL, laurence/0000-0003-1596-0998; Ugolini, Sophie/0000-0003-4041-0103	Agence Nationale de la Recherche (ANR); Ligue Nationale Contre le Cancer (Equipe Labellisee "La Ligue"); Fondation Del Duca; INSERM; CNRS; Universite de la Mediterranee; NIH [AI035021, AI039642, CA093678, AI068129, CA095137, AI066897, AI33903, AI34385, AI51345, AI5716]; Associazione Italiana per la Ricerca sul Cancro (AIRC); Ministero dell'Istruzione, dell'Universita e della Ricerca; U.S. National Cancer Institute [CA16058, CA95426, CA68458]; Institut National du Cancer; INFLARE EU; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R37CA068458, P01CA095426, P30CA016058, R01CA095137, R01CA068458, R01CA093678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033903, R37AI034385, R01AI051345, R01AI068129, R01AI034385, P30AI027763, R01AI039642, R37AI066897, R01AI035021, R56AI035021] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer (Equipe Labellisee "La Ligue")(Institut National du Cancer (INCA) France); Fondation Del Duca; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de la Mediterranee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institut National du Cancer(Institut National du Cancer (INCA) France); INFLARE EU; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors apologize for not having been able to quote all relevant papers due to space limitations and thank C. Beziers-Lafosse (CIML) for excellent graphic assistance as well as members of their laboratories for help and discussions. E.V. and S.U. are supported by grants from the Agence Nationale de la Recherche (ANR), Ligue Nationale Contre le Cancer (Equipe Labellisee "La Ligue"), Fondation Del Duca, and institutional grants from INSERM, CNRS, and Universite de la Mediterranee to the CIML. E.V. is a scholar from the Institut Universitaire de France and is a cofounder and shareholder of Innate-Pharma. D.H.R. is supported by NIH grants AI035021, AI039642, and CA093678 and is a scientific board member and shareholder of Innate-Pharma. A.M. is supported by grants awarded by Associazione Italiana per la Ricerca sul Cancro (AIRC), Ministero dell'Istruzione, dell'Universita e della Ricerca, and a Special Project from the AIRC and is a cofounder and shareholder of Innate-Pharma. M.A.C. is supported by U.S. National Cancer Institute grants CA16058, CA95426, and CA68458. L.Z. is supported by Institut National du Cancer, ANR, Ligue Nationale Contre le Cancer (Equipe Labellisee "La Ligue"), and INFLARE EU grants. L.L.L. is an American Cancer Society professor and is supported by NIH grants AI068129, CA095137, and AI066897 and is a consultant for Novo Nordisk and SBI Biotech Co., Ltd. W.M.Y. is supported by the Howard Hughes Medical Institute and NIH grants AI33903, AI34385, AI51345, and AI5716.	Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bottino C, 2005, TRENDS IMMUNOL, V26, P221, DOI 10.1016/j.it.2005.02.007; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Chiesa S, 2006, BLOOD, V107, P2364, DOI 10.1182/blood-2005-08-3504; Cooley S, 2007, BLOOD, V110, P578, DOI 10.1182/blood-2006-07-036228; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Eidenschenk C, 2006, AM J HUM GENET, V78, P721, DOI 10.1086/503269; Elboim M, 2010, J IMMUNOL, V184, P5637, DOI 10.4049/jimmunol.0901644; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Guia S, 2008, BLOOD, V111, P5008, DOI 10.1182/blood-2007-11-122259; HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Hoglund P, 1998, EUR J IMMUNOL, V28, P370, DOI 10.1002/(SICI)1521-4141(199801)28:01<370::AID-IMMU370>3.0.CO;2-W; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Jamieson AM, 2004, J IMMUNOL, V172, P864, DOI 10.4049/jimmunol.172.2.864; Jansen CA, 2010, DEV COMP IMMUNOL, V34, P759, DOI 10.1016/j.dci.2010.02.009; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Krebs P, 2009, BLOOD, V113, P6593, DOI 10.1182/blood-2009-01-201467; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee SH, 2007, TRENDS IMMUNOL, V28, P252, DOI 10.1016/j.it.2007.04.001; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Moretta A, 2005, TRENDS IMMUNOL, V26, P668, DOI 10.1016/j.it.2005.09.008; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Orr MT, 2010, NAT IMMUNOL, V11, P321, DOI 10.1038/ni.1849; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2003, NAT REV IMMUNOL, V3, P108, DOI 10.1038/nri999; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Pende D, 2009, BLOOD, V113, P3119, DOI 10.1182/blood-2008-06-164103; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Robbins SH, 2007, PLOS PATHOG, V3, P1152, DOI 10.1371/journal.ppat.0030123; Romagne F, 2009, BLOOD, V114, P2667, DOI 10.1182/blood-2009-02-206532; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Stewart CA, 2005, P NATL ACAD SCI USA, V102, P13224, DOI 10.1073/pnas.0503594102; Sun JC, 2008, J EXP MED, V205, P1819, DOI 10.1084/jem.20072448; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Veiga-Fernandes H, 2010, J EXP MED, V207, P269, DOI 10.1084/jem.20100105; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wang H, 2007, P NATL ACAD SCI USA, V104, P13744, DOI 10.1073/pnas.0702881104; Zimmer J, 1998, J EXP MED, V187, P117, DOI 10.1084/jem.187.1.117	78	1745	1826	7	316	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013								10.1126/science.1198687	http://dx.doi.org/10.1126/science.1198687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212348	Green Accepted, Green Submitted			2022-12-28	WOS:000285974000029
J	Greaney, TL				Greaney, Thomas L.			Accountable Care Organizations - The Fork in the Road	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Louis Univ, Sch Law, Ctr Hlth Law Studies, St Louis, MO 63103 USA	Saint Louis University	Greaney, TL (corresponding author), St Louis Univ, Sch Law, Ctr Hlth Law Studies, St Louis, MO 63103 USA.							Greaney T, 2009, U PITT LAW REV, V71, P217; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194; Pear Robert, 2010, NY TIMES        1120; WILLIAMS CH, 2006, HAS HOSP CONSOLIDATI	4	35	35	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					E1	+		10.1056/NEJMp1013404	http://dx.doi.org/10.1056/NEJMp1013404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702UY	21175305				2022-12-28	WOS:000285922600005
J	Henderson, DA				Henderson, Donald A.			Frank Fenner (1914-2010)	NATURE			English	Biographical-Item									[Henderson, Donald A.] Univ Pittsburgh, Med Ctr, Ctr Biosecur, Baltimore, MD 21202 USA; [Henderson, Donald A.] Johns Hopkins Sch Publ Hlth, Baltimore, MD 21202 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Henderson, DA (corresponding author), Univ Pittsburgh, Med Ctr, Ctr Biosecur, Baltimore, MD 21202 USA.	dahzero@aol.com							0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					35	35		10.1038/469035a	http://dx.doi.org/10.1038/469035a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21209651	Bronze			2022-12-28	WOS:000285921600020
J	Selyunin, AS; Sutton, SE; Weigele, BA; Reddick, LE; Orchard, RC; Bresson, SM; Tomchick, DR; Alto, NM				Selyunin, Andrey S.; Sutton, Sarah E.; Weigele, Bethany A.; Reddick, L. Evan; Orchard, Robert C.; Bresson, Stefan M.; Tomchick, Diana R.; Alto, Neal M.			The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold	NATURE			English	Article							STRUCTURAL BASIS; PROTEIN; ACTIVATION; SHIGELLA; MODEL; ARF; SECRETION; COATOMER; SOFTWARE; REVEALS	The fidelity and specificity of information flow within a cell is controlled by scaffolding proteins that assemble and link enzymes into signalling circuits(1,2). These circuits can be inhibited by bacterial effector proteins that post-translationally modify individual pathway components(3-6). However, there is emerging evidence that pathogens directly organize higher-order signalling networks through enzyme scaffolding(7,8), and the identity of the effectors and their mechanisms of action are poorly understood. Here we identify the enterohaemorrhagic Escherichia coli O157:H7 type III effector EspG as a regulator of endomembrane trafficking using a functional screen, and report ADP-ribosylation factor (ARF) GTPases and p21-activated kinases (PAKs) as its relevant host substrates. The 2.5 angstrom crystal structure of EspG in complex with ARF6 shows how EspG blocks GTPase-activating-protein-assisted GTP hydrolysis, revealing a potent mechanism of GTPase signalling inhibition at organelle membranes. In addition, the 2.8 angstrom crystal structure of EspG in complex with the autoinhibitory I alpha 3-helix of PAK2 defines a previously unknown catalytic site in EspG and provides an allosteric mechanism of kinase activation by a bacterial effector. Unexpectedly, ARF and PAKs are organized on adjacent surfaces of EspG, indicating its role as a 'catalytic scaffold' that effectively reprograms cellular events through the functional assembly of GTPase-kinase signalling complex.	[Selyunin, Andrey S.; Sutton, Sarah E.; Weigele, Bethany A.; Reddick, L. Evan; Orchard, Robert C.; Bresson, Stefan M.; Alto, Neal M.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Tomchick, Diana R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Alto, NM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	neal.alto@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022	Bresson, Stefan/0000-0002-0329-2243; Tomchick, Diana/0000-0002-7529-4643; Selyunin, Andrey/0000-0002-8980-0009	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NIH [5T32AI007520-12]; Welch Foundation [I-1704]; NIH (NIAID) [1RO1AI083359-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007520, R01AI083359] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank our colleagues, specifically K. Orth, M. Rosen, M. Cobb, J. Seeman, C. Brautigam and T. Fox, for helpful discussions in preparation of this manuscript, and we are particularly indebted to members of the Structural Biology Lab and mass spectrometry facilities for their efforts on this project. We would also like to thank J. Goldberg and G. Bokoch for providing valuable reagents. We would particularly like to thank J. Cherfils for providing preliminary insights into this work and for key reagents. The structure shown in this report is derived from work performed on beamlines 19-BM and 19-ID at the Structural Biology Center, Advanced Photon Source, Argonne National Laboratory. Argonne National Laboratory is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. R.C.O. was supported by a NIH Molecular Microbiology training grant (5T32AI007520-12). This work was supported by the Welch Foundation (#I-1704) and a grant from the NIH (NIAID; 1RO1AI083359-01) to N.M.A.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Borthakur A, 2006, AM J PHYSIOL-GASTR L, V290, pG30, DOI 10.1152/ajpgi.00302.2005; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis J, 2008, PROTEIN SCI, V17, P2167, DOI 10.1110/ps.037978.108; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Germane KL, 2008, BIOCHEMISTRY-US, V47, P10241, DOI 10.1021/bi801533k; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Guttman JA, 2007, CELL MICROBIOL, V9, P131, DOI 10.1111/j.1462-5822.2006.00773.x; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Isabet T, 2009, EMBO J, V28, P2835, DOI 10.1038/emboj.2009.209; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahn RA, 2009, FEBS LETT, V583, P3872, DOI 10.1016/j.febslet.2009.10.066; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shaw RK, 2005, INFECT IMMUN, V73, P4385, DOI 10.1128/IAI.73.7.4385-4390.2005; Shiba T, 2003, NAT STRUCT BIOL, V10, P386, DOI 10.1038/nsb920; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Tomson FL, 2005, MOL MICROBIOL, V56, P447, DOI 10.1111/j.1365-2958.2005.04571.x; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Winnen B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002178; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	39	85	88	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					107	U127		10.1038/nature09593	http://dx.doi.org/10.1038/nature09593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21170023	Green Accepted			2022-12-28	WOS:000285921600041
J	Kirby, T				Kirby, Tony			Profile Clare Gerada: Chair of UK's Royal College of General Practitioners	LANCET			English	Biographical-Item												tony.kirby@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 1	2011	377	9759					21	21		10.1016/S0140-6736(10)62326-4	http://dx.doi.org/10.1016/S0140-6736(10)62326-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709MQ	21195239				2022-12-28	WOS:000286445200013
J	Gingerich, O				Gingerich, Owen			Brian Marsden (1937-2010) OBITUARY	NATURE			English	Biographical-Item									Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Gingerich, O (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	ginger@cfa.harvard.edu							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1042	1042		10.1038/4681042a	http://dx.doi.org/10.1038/4681042a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179155	Bronze			2022-12-28	WOS:000285553800042
J	Wu, XY; Ruvkun, G				Wu, Xiaoyun; Ruvkun, Gary			Germ Cell Genes and Cancer	SCIENCE			English	Editorial Material							SOMATIC STEM-CELLS; C-ELEGANS; RNA INTERFERENCE; COMPLEX; ANTAGONIZE; EXPRESSION; PATHWAY; VASA		[Wu, Xiaoyun; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Wu, Xiaoyun; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wu, XY (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	wux@molbio.mgh.harvard.edu; ruvkun@molbio.mgh.harvard.edu						Andersen EC, 2006, DEVELOPMENT, V133, P2695, DOI 10.1242/dev.02444; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Extavour CG, 2005, EVOL DEV, V7, P201, DOI 10.1111/j.1525-142X.2005.05023.x; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; LEE JH, 2005, HUM MOL GENET, V15; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Rebscher N, 2007, DEV BIOL, V306, P599, DOI 10.1016/j.ydbio.2007.03.521; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Takasaki T, 2007, DEVELOPMENT, V134, P757, DOI 10.1242/dev.02771; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010	19	13	13	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1761	1762		10.1126/science.1200772	http://dx.doi.org/10.1126/science.1200772			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205660				2022-12-28	WOS:000285603700026
J	Arnold, B				Arnold, Bob			Early palliative care improved quality of life in patients with newly diagnosed metastatic NSCLC	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Arnold, B (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.								0	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12							JC6-3	10.7326/0003-4819-153-12-201012210-02003	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173404				2022-12-28	WOS:000285453700020
J	Long, EF; Brandeau, ML; Owens, DK				Long, Elisa F.; Brandeau, Margaret L.; Owens, Douglas K.			The Cost-Effectiveness and Population Outcomes of Expanded HIV Screening and Antiretroviral Treatment in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USERS; QUALITY-OF-LIFE; HETEROSEXUAL TRANSMISSION; SEXUAL-BEHAVIOR; MALE CIRCUMCISION; CHILDBEARING AGE; RISK-REDUCTION; SAN-FRANCISCO; VIRAL LOAD	Background: Although recent guidelines call for expanded routine screening for HIV, resources for antiretroviral therapy (ART) are limited, and all eligible persons are not currently receiving treatment. Objective: To evaluate the effects on the U.S. HIV epidemic of expanded ART, HIV screening, or interventions to reduce risk behavior. Design: Dynamic mathematical model of HIV transmission and disease progression and cost-effectiveness analysis. Data Sources: Published literature. Target Population: High-risk (injection drug users and men who have sex with men) and low-risk persons aged 15 to 64 years in the United States. Time Horizon: Twenty years and lifetime (costs and quality-adjusted life-years [QALYs]). Perspective: Societal. Intervention: Expanded HIV screening and counseling, treatment with ART, or both. Outcome Measures: New HIV infections, discounted costs and QALYs, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: One-time HIV screening of low-risk persons coupled with annual screening of high-risk persons could prevent 6.7% of a projected 1.23 million new infections and cost $22 382 per QALY gained, assuming a 20% reduction in sexual activity after screening. Expanding ART utilization to 75% of eligible persons prevents 10.3% of infections and costs $20 300 per QALY gained. A combination strategy prevents 17.3% of infections and costs $21 580 per QALY gained. Results of Sensitivity Analysis: With no reduction in sexual activity, expanded screening prevents 3.7% of infections. Earlier ART initiation when a CD4 count is greater than 0.350 x 10(9) cells/L prevents 20% to 28% of infections. Additional efforts to halve high-risk behavior could reduce infections by 65%. Limitation: The model of disease progression and treatment was simplified, and acute HIV screening was excluded. Conclusion: Expanding HIV screening and treatment simultaneously offers the greatest health benefit and is cost-effective. However, even substantial expansion of HIV screening and treatment programs is not sufficient to markedly reduce the U.S. HIV epidemic without substantial reductions in risk behavior.	[Long, Elisa F.] Yale Univ, Sch Management, New Haven, CT 06520 USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Yale University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Long, EF (corresponding author), Yale Univ, Sch Management, 135 Prospect St, New Haven, CT 06520 USA.	elisa.long@yale.edu	Long, Elisa/AFQ-5915-2022		Department of Veterans Affairs; National Institutes of Health [R-01-DA-15612]; National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse, National Institutes of Health, and Department of Veterans Affairs.; By the National Institute on Drug Abuse, National Institutes of Health (R-01-DA-15612), and Department of Veterans Affairs.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Anaya HD, 2008, J GEN INTERN MED, V23, P800, DOI 10.1007/s11606-008-0617-x; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P845; [Anonymous], P 13 C RETR OPP INF; [Anonymous], CDCS HIV PREV PROGR; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bacon O, 2006, SEX TRANSM DIS, V33, P228, DOI 10.1097/01.olq.0000204914.91923.ad; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Bendavid E, 2009, JAIDS-J ACQ IMM DEF, V52, P106, DOI 10.1097/QAI.0b013e3181a4f9c4; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; BRANDEAU ML, 1993, MANAGE SCI, V39, P72, DOI 10.1287/mnsc.39.1.72; BRANDEAU ML, 1992, ARCH INTERN MED, V152, P2229, DOI 10.1001/archinte.152.11.2229; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brisson M, 1999, SEX TRANSM INFECT, V75, P296, DOI 10.1136/sti.75.5.296; CACERES CF, 1994, AIDS, V8, P1051, DOI 10.1097/00002030-199408000-00004; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; *CDCP, 2010, HIV AIDS US; *CDCP, CAS HIV INF AIDS US, V18; *CDCP, HIV AIDS GAY BISEX M; Celentano DD, 1998, SCIENCE, V280, P1889, DOI 10.1126/science.280.5371.1889; *CENSUSSCOPE, 2000, US AGE DISTR; Centers for Disease Control and Prevention, 2008, EST NEW HIV INF US; Centers for Medicare and Medicaid Services, MED FEE SCHED; CLEARY PD, 1991, AM J PUBLIC HEALTH, V81, P1586, DOI 10.2105/AJPH.81.12.1586; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; DAVIS JO, GENERAL SOCIAL GENER; Desai K, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-19; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; Fryar Cheryl D, 2007, Adv Data, P1; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harawa NT, 2004, JAIDS-J ACQ IMM DEF, V35, P526, DOI 10.1097/00126334-200404150-00011; Harris ZK, 2006, HEALTH ECON, V15, P147, DOI 10.1002/hec.1021; HIGGINS DL, 1991, JAMA-J AM MED ASSOC, V266, P2419, DOI 10.1001/jama.266.17.2419; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; Honiden S, 2006, QUAL LIFE RES, V15, P69, DOI 10.1007/s11136-005-8485-x; Hutchinson AB, 2006, JAIDS-J ACQ IMM DEF, V43, P451, DOI 10.1097/01.qai.0000243090.32866.4e; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Joyce VR, 2009, JAIDS-J ACQ IMM DEF, V50, P27, DOI 10.1097/QAI.0b013e31818ce6f3; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; KAPLAN EH, 1990, J ACQ IMMUN DEF SYND, V3, P55; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; Kelly JA, 2009, AIDS BEHAV, V13, P1068, DOI 10.1007/s10461-009-9579-1; Kerndt PR, 2009, AIDS BEHAV, V13, P1037, DOI 10.1007/s10461-009-9580-8; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Kral AH, 2005, J URBAN HEALTH, V82, pI43, DOI 10.1093/jurban/jti023; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2009, VACCINE, V27, P5402, DOI 10.1016/j.vaccine.2009.06.063; MacKellar DA, 2006, AIDS, V20, P1637, DOI 10.1097/01.aids.0000238410.67700.d1; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Owens DK, 1996, ARCH INTERN MED, V156, P394, DOI 10.1001/archinte.156.4.394; Owens DK, 2007, AM J PUBLIC HEALTH, V97, P2173, DOI 10.2105/AJPH.2007.110700; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pathela P, 2006, ANN INTERN MED, V145, P416, DOI 10.7326/0003-4819-145-6-200609190-00005; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Plevritis SK, 2006, JAMA-J AM MED ASSOC, V295, P2374, DOI 10.1001/jama.295.20.2374; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rietmeijer CA, 1998, SEX TRANSM DIS, V25, P353, DOI 10.1097/00007435-199808000-00006; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Sanders GD, 2010, J GEN INTERN MED, V25, P556, DOI 10.1007/s11606-010-1265-5; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Taylor A, 2005, EPIDEMIOL INFECT, V133, P193, DOI 10.1017/S0950268804003504; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; TESHALE EH, 2005, P 12 C RETR OPP INF; Tyndall MW, 2002, SEX TRANSM INFECT, V78, pI170, DOI 10.1136/sti.78.suppl_1.i170; [U. S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents], 2009, GUID US ANT AG HIV 1; UNAIDS, 2008 REP GLOB AIDS E; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza P, 2008, LANCET, V372, P1806, DOI 10.1016/S0140-6736(08)61753-5; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; WALL SD, 1991, AM J ROENTGENOL, V157, P911, DOI 10.2214/ajr.157.5.1927808; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; World Health Organization, GLOB HLTH OBS; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100; Zetola NM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-17; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; [No title captured]	104	133	136	1	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					778	+		10.7326/0003-4819-153-12-201012210-00004	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173412	Green Accepted			2022-12-28	WOS:000285453700027
J	Grover, A; Citro, B				Grover, Anand; Citro, Brian			India: access to affordable drugs and the right to health	LANCET			English	Editorial Material									[Grover, Anand; Citro, Brian] Lawyers Collect HIV AIDS Unit, Bombay 400001, Maharashtra, India		Grover, A (corresponding author), Lawyers Collect HIV AIDS Unit, Bombay 400001, Maharashtra, India.	anandgrover@gmail.com						[Anonymous], 2004, WHO MED STRAT COUNTR; [Anonymous], 2004, WORLD MED SIT; European Commission, 2009, ANT TRAD AGR ACTA FA; *IND DEP IND POL P, 2010, DISC PAP SUBJ COMP L; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; Office of the United Nations High Commissioner for Human Rights, INT COV EC SOC CULT; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; VIVASEUGUI D, 2003, REGIONAL BILATERAL A; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; *WHO, 2004, EQ ACC ESS MED FRAM, V8	10	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					976	977		10.1016/S0140-6736(10)62042-9	http://dx.doi.org/10.1016/S0140-6736(10)62042-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	740FA	21227487				2022-12-28	WOS:000288775800008
J	Shrank, WH; Choudhry, NK				Shrank, William H.; Choudhry, Niteesh K.			Time to Fill the Doughnuts - Health Care Reform and Medicare Part D	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DRUG		[Shrank, William H.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shrank, WH (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.							*KAIS FAM FDN, EXPL HEALTHC REF KEY; Polinski JM, 2010, J AM GERIATR SOC, V58, P1764, DOI 10.1111/j.1532-5415.2010.03025.x; Polinski JM, 2010, J AM GERIATR SOC, V58, P950, DOI 10.1111/j.1532-5415.2010.02812.x; Zhang Y, 2009, NEW ENGL J MED, V361, P52, DOI 10.1056/NEJMsa0807998	4	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					598	601		10.1056/NEJMp1011625	http://dx.doi.org/10.1056/NEJMp1011625			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722BW	21247308				2022-12-28	WOS:000287406000003
J	Yanagitani, K; Kimata, Y; Kadokura, H; Kohno, K				Yanagitani, Kota; Kimata, Yukio; Kadokura, Hiroshi; Kohno, Kenji			Translational Pausing Ensures Membrane Targeting and Cytoplasmic Splicing of XBP1u mRNA	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN; TRANSLOCATION; TUNNEL; IRE1	Upon endoplasmic reticulum (ER) stress, an endoribonuclease, inositol-requiring enzyme-1 alpha, splices the precursor unspliced form of X-box-binding protein 1 messenger RNA (XBP1u mRNA) on the ER membrane to yield an active transcription factor (XBP1s), leading to the alleviation of the stress. The nascent peptide encoded by XBP1u mRNA drags the mRNA-ribosome-nascent chain (R-RNC) complex to the membrane for efficient cytoplasmic splicing. We found that translation of the XBP1u mRNA was briefly paused to stabilize the R-RNC complex. Mutational analysis of XBP1u revealed an evolutionarily conserved peptide module at the carboxyl terminus that was responsible for the translational pausing and was required for the efficient targeting and splicing of the XBP1u mRNA. Thus, translational pausing may be used for unexpectedly diverse cellular processes in mammalian cells.	[Yanagitani, Kota; Kimata, Yukio; Kadokura, Hiroshi; Kohno, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol & Cell Genet, Nara 6300192, Japan	Nara Institute of Science & Technology	Kohno, K (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol & Cell Genet, 8916-5 Takayama, Nara 6300192, Japan.	kkouno@bs.naist.jp	Yanagitani, Kota/N-4106-2018; Kadokura, Hiroshi/AAE-1645-2019; Kohno, Kenji/AAZ-6573-2020	Yanagitani, Kota/0000-0002-5905-9950; Kohno, Kenji/0000-0002-3503-6551; Kadokura, Hiroshi/0000-0001-7308-7141	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank J. Iida-Hashimoto and N. Fujimoto for technical assistance and K. Ito, S. Chiba, and H. Yoshida for discussions. This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (K.K., Y.K.) and Scientific Research B (K.K.) of KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan. K.Y. is a special postdoctoral fellow supported by Global Center of Excellence program from the Japan Society for the Promotion of Science.	Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	7	140	141	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					586	589		10.1126/science.1197142	http://dx.doi.org/10.1126/science.1197142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21233347				2022-12-28	WOS:000286933600054
J	Caronia, LM; Martin, C; Welt, CK; Sykiotis, GP; Quinton, R; Thambundit, A; Avbelj, M; Dhruvakumar, S; Plummer, L; Hughes, VA; Seminara, SB; Boepple, PA; Sidis, Y; Crowley, WF; Martin, KA; Hall, JE; Pitteloud, N				Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Quinton, Richard; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly			A Genetic Basis for Functional Hypothalamic Amenorrhea.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONADOTROPIN-RELEASING-HORMONE; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; KALLMANN-SYNDROME; LUTEINIZING-HORMONE; EATING-DISORDERS; WOMEN; MUTATIONS; RECEPTOR; DEFICIENCY; WEIGHT	Background: Functional hypothalamic amenorrhea is a reversible form of gonadotropin-releasing hormone (GnRH) deficiency commonly triggered by stressors such as excessive exercise, nutritional deficits, or psychological distress. Women vary in their susceptibility to inhibition of the reproductive axis by such stressors, but it is unknown whether this variability reflects a genetic predisposition to hypothalamic amenorrhea. We hypothesized that mutations in genes involved in idiopathic hypogonadotropic hypogonadism, a congenital form of GnRH deficiency, are associated with hypothalamic amenorrhea. Methods: We analyzed the coding sequence of genes associated with idiopathic hypogonadotropic hypogonadism in 55 women with hypothalamic amenorrhea and performed in vitro studies of the identified mutations. Results: Six heterozygous mutations were identified in 7 of the 55 patients with hypothalamic amenorrhea: two variants in the fibroblast growth factor receptor 1 gene FGFR1 (G260E and R756H), two in the prokineticin receptor 2 gene PROKR2 (R85H and L173R), one in the GnRH receptor gene GNRHR (R262Q), and one in the Kallmann syndrome 1 sequence gene KAL1 (V371I). No mutations were found in a cohort of 422 controls with normal menstrual cycles. In vitro studies showed that FGFR1 G260E, FGFR1 R756H, and PROKR2 R85H are loss-of-function mutations, as has been previously shown for PROKR2 L173R and GNRHR R262Q. Conclusions: Rare variants in genes associated with idiopathic hypogonadotropic hypogonadism are found in women with hypothalamic amenorrhea, suggesting that these mutations may contribute to the variable susceptibility of women to the functional changes in GnRH secretion that characterize hypothalamic amenorrhea. Our observations provide evidence for the role of rare variants in common multifactorial disease. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others; ClinicalTrials.gov number, NCT00494169.) N Engl J Med 2011;364:215-25.	[Sidis, Yisrael; Pitteloud, Nelly] Univ Lausanne, CHU Vaudois, Div Endocrine, CH-1011 Lausanne, Switzerland; [Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; [Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly] Massachusetts Gen Hosp, Harvard Ctr Reprod Endocrine Sci, Boston, MA 02114 USA; [Caronia, Lisa M.; Martin, Cecilia; Welt, Corrine K.; Sykiotis, Gerasimos P.; Thambundit, Apisadaporn; Avbelj, Magdalena; Dhruvakumar, Sadhana; Plummer, Lacey; Hughes, Virginia A.; Seminara, Stephanie B.; Boepple, Paul A.; Sidis, Yisrael; Crowley, William F., Jr.; Martin, Kathryn A.; Hall, Janet E.; Pitteloud, Nelly] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Quinton, Richard] Royal Victoria Infirm, Dept Endocrinol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Quinton, Richard] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Newcastle University - UK; Newcastle University - UK	Pitteloud, N (corresponding author), Univ Lausanne, CHU Vaudois, Div Endocrine, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	nelly.pitteloud@chuv.ch	Hall, Janet E/F-3516-2019; Sykiotis, Gerasimos P/E-7407-2017; PITTELOUD, Nelly/K-2709-2014	Hall, Janet E/0000-0003-4644-3061; Avbelj Stefanija, Magdalena/0000-0002-0836-5114; Sykiotis, Gerasimos/0000-0002-9565-4941; Welt, Corrine/0000-0002-8219-5504	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) [5U54HD028138, 1R01HD056264, 5R01HD015788, 5R01HD42708]; National Center for Research Resources [1 UL1 RR025758-01, M01-RR-01066]; Newcastle University Teaching Hospitals Special Trustees; Pew Latin American Fellows Program in the Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056264, U54HD028138, R01HD043341, R01HD015788] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042708] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013241] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Newcastle University Teaching Hospitals Special Trustees; Pew Latin American Fellows Program in the Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) (through cooperative agreement 5U54HD028138 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research and NICHD-NIH grants 1R01HD056264, 5R01HD015788, and 5R01HD42708), by the National Center for Research Resources (grants 1 UL1 RR025758-01 and M01-RR-01066 to the Harvard Clinical and Translational Science Center), the Newcastle University Teaching Hospitals Special Trustees, and the Pew Latin American Fellows Program in the Biomedical Sciences (grant to Dr. Martin).	Beranova M, 2001, J CLIN ENDOCR METAB, V86, P1580, DOI 10.1210/jc.86.4.1580; Bianco SDC, 2009, NAT REV ENDOCRINOL, V5, P569, DOI 10.1038/nrendo.2009.177; BOYAR RM, 1974, NEW ENGL J MED, V291, P861, DOI 10.1056/NEJM197410242911701; BULLEN BA, 1985, NEW ENGL J MED, V312, P1349, DOI 10.1056/NEJM198505233122103; Canto P, 2009, J ANDROL, V30, P41, DOI 10.2164/jandrol.108.005314; Centeno ML, 2007, J NEUROENDOCRINOL, V19, P594, DOI 10.1111/j.1365-2826.2007.01566.x; Cheng CK, 2005, ENDOCR REV, V26, P283, DOI 10.1210/er.2003-0039; Chung WCJ, 2008, ENDOCRINOLOGY, V149, P4997, DOI 10.1210/en.2007-1634; Cole LW, 2008, J CLIN ENDOCR METAB, V93, P3551, DOI 10.1210/jc.2007-2654; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Falardeau J, 2008, J CLIN INVEST, V118, P2822, DOI 10.1172/JCI34538; FRISCH RE, 1974, SCIENCE, V185, P949, DOI 10.1126/science.185.4155.949; Gardiner JV, 2010, DIABETES, V59, P397, DOI 10.2337/db09-1198; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; GILES DE, 1993, FERTIL STERIL, V60, P486; Hayes FJ, 1999, J CLIN ENDOCR METAB, V84, P1028, DOI 10.1210/jc.84.3.1028; Kim SH, 2008, J NEUROENDOCRINOL, V20, P141, DOI 10.1111/j.1365-2826.2007.01627.x; LOUCKS AB, 1989, J CLIN ENDOCR METAB, V68, P402, DOI 10.1210/jcem-68-2-402; Loucks AB, 2003, J CLIN ENDOCR METAB, V88, P297, DOI 10.1210/jc.2002-020369; Matsumoto S, 2006, P NATL ACAD SCI USA, V103, P4140, DOI 10.1073/pnas.0508881103; Mercader JM, 2007, GENES BRAIN BEHAV, V6, P706, DOI 10.1111/j.1601-183X.2007.00301.x; Mercader JM, 2008, HUM MOL GENET, V17, P1234, DOI 10.1093/hmg/ddn013; Miller KK, 1998, J CLIN ENDOCR METAB, V83, P2309, DOI 10.1210/jc.83.7.2309; Monnier C, 2009, HUM MOL GENET, V18, P75, DOI 10.1093/hmg/ddn318; Nachtigall LB, 1997, NEW ENGL J MED, V336, P410, DOI 10.1056/NEJM199702063360604; Oliveira LMB, 2001, J CLIN ENDOCR METAB, V86, P1532, DOI 10.1210/jc.86.4.1532; Perkins RB, 2001, HUM REPROD, V16, P2198, DOI 10.1093/humrep/16.10.2198; Pitteloud N, 2005, J CLIN ENDOCR METAB, V90, P1317, DOI 10.1210/jc.2004-1361; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; Raivio T, 2007, NEW ENGL J MED, V357, P863, DOI 10.1056/NEJMoa066494; Raivio T, 2009, J CLIN ENDOCR METAB, V94, P4380, DOI 10.1210/jc.2009-0179; REINDOLLAR RH, 1986, AM J OBSTET GYNECOL, V155, P531, DOI 10.1016/0002-9378(86)90274-7; SANTORO N, 1986, ENDOCR REV, V7, P11, DOI 10.1210/edrv-7-1-11; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; Sun HJD, 2007, AM J PHYSIOL-ENDOC M, V292, pE964, DOI 10.1152/ajpendo.00089.2006; Thome Jennifer L, 2007, Eat Behav, V8, P334, DOI 10.1016/j.eatbeh.2006.11.009; WARREN MP, 1980, J CLIN ENDOCR METAB, V51, P1150, DOI 10.1210/jcem-51-5-1150; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Wilfley DE, 2007, INT J EAT DISORDER, V40, pS123, DOI 10.1002/eat.20436	45	132	139	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					215	225		10.1056/NEJMoa0911064	http://dx.doi.org/10.1056/NEJMoa0911064			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21247312	Green Accepted, Bronze			2022-12-28	WOS:000286383900006
J	Dragoi, G; Tonegawa, S				Dragoi, George; Tonegawa, Susumu			Preplay of future place cell sequences by hippocampal cellular assemblies	NATURE			English	Article							RAT HIPPOCAMPUS; PYRAMIDAL CELLS; MEMORY; REPLAY; EXPERIENCE; REACTIVATION; SLEEP; CONSOLIDATION; DYNAMICS; STATE	During spatial exploration, hippocampal neurons show a sequential firing pattern in which individual neurons fire specifically at particular locations along the animal's trajectory (place cells(1,2)). According to the dominant model of hippocampal cell assembly activity, place cell firing order is established for the first time during exploration, to encode the spatial experience, and is subsequently replayed during rest(3-6) or slow-wave sleep(7-10) for consolidation of the encoded experience(11,12). Here we report that temporal sequences of firing of place cells expressed during a novel spatial experience occurred on a significant number of occasions during the resting or sleeping period preceding the experience. This phenomenon, which is called preplay, occurred in disjunction with sequences of replay of a familiar experience. These results suggest that internal neuronal dynamics during resting or sleep organize hippocampal cellular assemblies(13-15) into temporal sequences that contribute to the encoding of a related novel experience occurring in the future.	[Dragoi, George; Tonegawa, Susumu] MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Dragoi, George; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT)	Dragoi, G (corresponding author), MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gdragoi@mit.edu; tonegawa@mit.edu			NIH [R01-MH078821, P50-MH58880]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880, R01MH078821] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. A. Wilson for assistance with data acquisition, discussions and comments on an earlier version of the manuscript; J. O'Keefe, A. Siapas, F. Kloosterman, D. L. Buhl for comments on earlier versions of the manuscript; and F. Kloosterman for providing assistance with the line detection for the Bayesian decoding. This work was supported by NIH grants R01-MH078821 and P50-MH58880 to S. T., who was an HHMI Investigator in an earlier part of this study.	BLACK JE, 1986, ADV DEV PSYCHOL; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	28	342	346	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					397	+		10.1038/nature09633	http://dx.doi.org/10.1038/nature09633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21179088	Green Accepted, Green Submitted			2022-12-28	WOS:000286385600052
J	Shaikh, N; Hoberman, A; Kearney, DH; Yellon, R				Shaikh, Nader; Hoberman, Alejandro; Kearney, Diana H.; Yellon, Robert			Tympanocentesis in Children with Acute Otitis Media.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shaikh, Nader; Hoberman, Alejandro; Kearney, Diana H.] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, UPMC,Dept Pediat, Pittsburgh, PA 15224 USA; [Yellon, Robert] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, UPMC,Dept Pediat Otolaryngol, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shaikh, N (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, UPMC,Dept Pediat, 1 Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.	nader.shaikh@chp.edu						[Anonymous], 2004, PEDIATRICS, V113, P1451	1	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					E4	U8		10.1056/NEJMvcm0706756	http://dx.doi.org/10.1056/NEJMvcm0706756			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21226572				2022-12-28	WOS:000286383900011
J	Kaplan, LJ; Shaw, AD				Kaplan, Lewis J.; Shaw, Andrew D.			Standards for Education and Credentialing in Critical Care Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNIT; ILL		[Kaplan, Lewis J.] Yale Univ, Sch Med, Dept Surg, Sect Trauma Surg Crit Care & Surg Emergencies, New Haven, CT 06520 USA; [Shaw, Andrew D.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA	Yale University; Duke University	Kaplan, LJ (corresponding author), Yale Univ, Sch Med, Dept Surg, Sect Trauma Surg Crit Care & Surg Emergencies, 330 Cedar St,BB-310, New Haven, CT 06520 USA.	lewis.kaplan@yale.edu		Shaw, Andrew/0000-0002-0566-8005				Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; [Anonymous], GRADUATE MED ED DATA; Kleinpell RM, 2008, CRIT CARE MED, V36, P2888, DOI 10.1097/CCM.0b013e318186ba8c; Milbrandt EB, 2008, CRIT CARE MED, V36, P2504, DOI 10.1097/CCM.0b013e318183ef84; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; *US DEP HHS, NAT HEALTHC EXP AGGR; *US DEP HHS, CRIT CAR WORKF STUD; NEUROCRITICAL CARE C	8	23	24	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					296	297		10.1001/jama.2010.1997	http://dx.doi.org/10.1001/jama.2010.1997			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707YY	21239762				2022-12-28	WOS:000286328700026
J	Thornalley, DJR; Barker, S; Broecker, WS; Elderfield, H; McCave, IN				Thornalley, David J. R.; Barker, Stephen; Broecker, Wallace S.; Elderfield, Henry; McCave, I. Nick			The Deglacial Evolution of North Atlantic Deep Convection	SCIENCE			English	Article							SOUTHERN-OCEAN; CIRCULATION; MELTWATER; CARBON; VARIABILITY; VENTILATION; ICE	Deepwater formation in the North Atlantic by open-ocean convection is an essential component of the overturning circulation of the Atlantic Ocean, which helps regulate global climate. We use water-column radiocarbon reconstructions to examine changes in northeast Atlantic convection since the Last Glacial Maximum. During cold intervals, we infer a reduction in open-ocean convection and an associated incursion of an extremely radiocarbon (C-14)-depleted water mass, interpreted to be Antarctic Intermediate Water. Comparing the timing of deep convection changes in the northeast and northwest Atlantic, we suggest that, despite a strong control on Greenland temperature by northeast Atlantic convection, reduced open-ocean convection in both the northwest and northeast Atlantic is necessary to account for contemporaneous perturbations in atmospheric circulation.	[Thornalley, David J. R.; Barker, Stephen] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, S Glam, Wales; [Thornalley, David J. R.; Elderfield, Henry; McCave, I. Nick] Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England; [Broecker, Wallace S.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Cardiff University; University of Cambridge; Columbia University	Thornalley, DJR (corresponding author), Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, S Glam, Wales.	d.thornalley@cantab.net	McCave, I. Nick/O-3992-2018; Stephen, Barker/C-2770-2009; McCave, Nick N/G-7323-2016	McCave, I. Nick/0000-0002-4702-5489; Stephen, Barker/0000-0001-7870-6431; McCave, Nick N/0000-0002-4702-5489	NERC [NER/T/S/2002/00436, NE/F002734/1]; National Science Foundation [OCE 04-35703]; Natural Environment Research Council [NRCF010001, NE/F002734/1, NE/D001803/1] Funding Source: researchfish; NERC [NRCF010001, NE/D001803/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank L. Booth for help in picking planktic <SUP>14</SUP>C dates. D. T. thanks S. Bryan, I. Hall, L. Keigwin, G. Knorr, T. Marchitto, and L. Skinner for useful discussions. Radiocarbon dates were analyzed by Natural Environment Research Council (NERC, UK) and National Ocean Sciences Accelerator Mass Spectrometry (NOSAMS, USA) facilities. This work was funded by NERC grants NER/T/S/2002/00436 and NE/F002734/1 and National Science Foundation grant OCE 04-35703.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barker S, 2010, NAT GEOSCI, V3, P567, DOI [10.1038/ngeo921, 10.1038/NGEO921]; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Broecker W.S., 1982, TRACERS SEA; Broecker WS, 2010, QUATERNARY SCI REV, V29, P1078, DOI 10.1016/j.quascirev.2010.02.019; Broecker WS, 2009, QUATERNARY SCI REV, V28, P2557, DOI 10.1016/j.quascirev.2009.07.007; BROECKER WS, 1989, NATURE, V341, P318, DOI 10.1038/341318a0; Bryan SP, 2010, EARTH PLANET SC LETT, V298, P244, DOI 10.1016/j.epsl.2010.08.025; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; Keeling RF, 2001, PALEOCEANOGRAPHY, V16, P112, DOI 10.1029/2000PA000529; KEIGWIN LD, 1991, J GEOPHYS RES-OCEANS, V96, P16811, DOI 10.1029/91JC01624; Li C., 2010, J CLIM; LYNCHSTIEGLITZ J, 1995, GLOBAL BIOGEOCHEM CY, V9, P653, DOI 10.1029/95GB02574; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Marchitto TM, 1998, NATURE, V393, P557, DOI 10.1038/31197; Marshall J, 1999, REV GEOPHYS, V37, P1, DOI 10.1029/98RG02739; Millo C, 2006, BOREAS, V35, P50, DOI 10.1080/03009480500359244; Pahnke K, 2008, NAT GEOSCI, V1, P870, DOI 10.1038/ngeo360; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Reimer PJ, 2009, RADIOCARBON, V51, pV, DOI 10.1017/S0033822200034196; Rickaby REM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000858; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Sarnthein M., 2000, NO N ATLANTIC CHANGI, P365; SARNTHEIN M, 2007, GEOPHYS MONOGR SER, V173, P175, DOI DOI 10.1029/173GM13; Sarnthein M, 1990, PALEOCEANOGRAPHY, V5, P1041, DOI 10.1029/PA005i006p01041; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Skinner LC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000983; Stanford JD, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001340; Thornalley DJR, 2011, GLOBAL PLANET CHANGE, V79, P163, DOI 10.1016/j.gloplacha.2010.06.003; Thornalley DJR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001833; Vazquez Riveiros N., 2010, EARTH PLANET SC LETT, V298, P323, DOI [10.1016/j.epsl.2010.08.003, DOI 10.1016/J.EPSL.2010.08.003]; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618	33	117	120	1	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					202	205		10.1126/science.1196812	http://dx.doi.org/10.1126/science.1196812			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233385	Green Submitted			2022-12-28	WOS:000286433100039
J	Blackwood, B; Alderdice, F; Burns, K; Cardwell, C; Lavery, G; O'Halloran, P				Blackwood, Bronagh; Alderdice, Fiona; Burns, Karen; Cardwell, Chris; Lavery, Gavin; O'Halloran, Peter			Use of weaning protocols for reducing duration of mechanical ventilation in critically ill adult patients: Cochrane systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMPUTERIZED DECISION-SUPPORT; CONTROLLED-TRIAL; CLINICAL-OUTCOMES; RANDOMIZED-TRIAL; CARE; SEDATION; PNEUMONIA; EFFICACY; QUALITY	Objective To investigate the effects of weaning protocols on the total duration of mechanical ventilation, mortality, adverse events, quality of life, weaning duration, and length of stay in the intensive care unit and hospital. Design Systematic review. Data sources Cochrane Central Register of Controlled Trials, Medline, Embase, CINAHL, LILACS, ISI Web of Science, ISI Conference Proceedings, Cambridge Scientific Abstracts, and reference lists of articles. We did not apply language restrictions. Review methods We included randomised and quasi-randomised controlled trials of weaning from mechanical ventilation with and without protocols in critically ill adults. Data selection Three authors independently assessed trial quality and extracted data. A priori subgroup and sensitivity analyses were performed. We contacted study authors for additional information. Results Eleven trials that included 1971 patients met the inclusion criteria. Compared with usual care, the geometric mean duration of mechanical ventilation in the weaning protocol group was reduced by 25% (95% confidence interval 9% to 39%, P=0.006; 10 trials); the duration of weaning was reduced by 78% (31% to 93%, P=0.009; six trials); and stay in the intensive care unit length by 10% (2% to 19%, P=0.02; eight trials). There was significant heterogeneity among studies for total duration of mechanical ventilation (I-2=76%, P<0.01) and duration of weaning (I-2=97%, P<0.01), which could not be explained by subgroup analyses based on type of unit or type of approach. Conclusion There is evidence of a reduction in the duration of mechanical ventilation, weaning, and stay in the intensive care unit when standardised weaning protocols are used, but there is significant heterogeneity among studies and an insufficient number of studies to investigate the source of this heterogeneity. Some studies suggest that organisational context could influence outcomes, but this could not be evaluated as it was outside the scope of this review.	[Blackwood, Bronagh; Alderdice, Fiona; O'Halloran, Peter] Queens Univ Belfast, Nursing & Midwifery Res Unit, Belfast BT9 5BN, Antrim, North Ireland; [Burns, Karen] St Michaels Hosp, Interdept Div Crit Care Med, Toronto, ON M5B 1W8, Canada; [Cardwell, Chris] Queens Univ Belfast, Ctr Publ Hlth, Belfast BT9 5BN, Antrim, North Ireland; [Lavery, Gavin] Royal Victoria Hosp, Belfast Hlth & Social Care Trust, Belfast BT12 6BA, Antrim, North Ireland	Queens University Belfast; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Queens University Belfast	Blackwood, B (corresponding author), Queens Univ Belfast, Nursing & Midwifery Res Unit, Belfast BT9 5BN, Antrim, North Ireland.	b.blackwood@qub.ac.uk	Blackwood, Bronagh/GPS-9197-2022	Cardwell, Chris/0000-0002-2689-4335; Alderdice, Fiona/0000-0003-2404-5644; O'Halloran, Peter/0000-0002-0022-7331	Research and Development Office, Northern Ireland; Health Research Board, Ireland	Research and Development Office, Northern Ireland; Health Research Board, Ireland	The review was funded through a Cochrane Fellowship Award for BB from the Research and Development Office, Northern Ireland, and the Health Research Board, Ireland.	Beale R, COMP AUTOMATED WEANI; Blackwood B, 2009, COCHRANE DB SYST REV, V5; Blackwood B, 2006, J ADV NURS, V54, P612, DOI 10.1111/j.1365-2648.2006.03869.x; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; Burns KEA, 2008, INTENS CARE MED, V34, P1757, DOI 10.1007/s00134-008-1154-0; Burns KEA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1574; Butler RJ, NCT00157287; Cook D, 2000, AHRQ PUBLICATION; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Dongelmans DA, 2009, ANESTH ANALG, V108, P565, DOI 10.1213/ane.0b013e318190c49f; Dries DJ, 1997, J TRAUMA, V43, P372, DOI 10.1097/00005373-199708000-00032; East TD, 1999, J AM MED INFORM ASSN, P251; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; ESEN F, 1992, ADV EXP MED BIOL, V317, P371; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Hendrix H, 2006, EUR J CARDIO-THORAC, V29, P957, DOI 10.1016/j.ejcts.2006.01.036; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Kollef MH, 1997, CRIT CARE MED, V25, P567, DOI 10.1097/00003246-199704000-00004; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kress JP, 1996, AM J RESP CRIT CARE, V153, P1012, DOI 10.1164/ajrccm.153.3.8630539; Krishnan JA, 2004, AM J RESP CRIT CARE, V169, P673, DOI 10.1164/rccm.200306-761OC; Lawton R, 1999, SOC SCI MED, V48, P353, DOI 10.1016/S0277-9536(98)00345-1; Lellouche F, 2006, AM J RESP CRIT CARE, V174, P894, DOI 10.1164/rccm.200511-1780OC; Lellouche F, 2009, BEST PRACT RES-CLIN, V23, P81, DOI 10.1016/j.bpa.2008.08.001; Mancebo J, 1996, EUR RESPIR J, V9, P1923, DOI 10.1183/09031936.96.09091923; Marelich GP, 2000, CHEST, V118, P459, DOI 10.1378/chest.118.2.459; McKinley BA, 2001, J TRAUMA, V50, P415, DOI 10.1097/00005373-200103000-00004; Meade M O, 1995, Clin Intensive Care, V6, P166, DOI 10.1080/714028896; Meade MO, 1997, CRIT CARE MED, V25, P1915, DOI 10.1097/00003246-199711000-00034; Medical Research Council, 2008, DEV EV COMPL INT NEW; Murtagh D, 2010, PROTOCOLS PUT MORE P; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Navalesi P, 2008, CRIT CARE MED, V36, P2986, DOI 10.1097/CCM.0b013e31818b35f2; Papazian L, 1996, AM J RESP CRIT CARE, V154, P91, DOI 10.1164/ajrccm.154.1.8680705; Papirov G, 2007, COMPUTER DRIVEN MANA; Piotto RF, 2010, REV BRAS CIR CARDIOV; Polverino E, 2010, INTENS CARE MED, V36, P137, DOI 10.1007/s00134-009-1658-2; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Randolph AG, 2002, JAMA-J AM MED ASSOC, V288, P2561, DOI 10.1001/jama.288.20.2561; Reschreiter H, 2008, CRIT CARE, V12, DOI 10.1186/cc7141; Rose L, 2007, ANAESTH INTENS CARE, V35, P213, DOI 10.1177/0310057X0703500210; Rose L, 2008, INTENS CARE MED, V34, P1788, DOI 10.1007/s00134-008-1179-4; SAHN SA, 1973, CHEST, V63, P1002, DOI 10.1378/chest.63.6.1002; Scholz J, AUTOMATIC CONTROL PR; Schweickert WD, 2007, CHEST, V131, P1541, DOI 10.1378/chest.06-2065; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Simeone F, 2002, J CARDIOVASC SURG, V43, P633; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Stahl C., 2009, Intensivmedizin und Notfallmedizin, V46, P441, DOI 10.1007/s00390-009-0061-0; STRICKLAND JH, 1993, CHEST, V103, P1220, DOI 10.1378/chest.103.4.1220; STROETZ RW, 1995, AM J RESP CRIT CARE, V152, P1034, DOI 10.1164/ajrccm.152.3.7663780; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; Taniguchi C, 2009, CRIT CARE, V13, DOI 10.1186/cc7695; The Nordic Cochrane Centre The Cochrane Collaboration., 2008, REV MAN REVMAN VERS; Thompson B Taylor, 2007, Proc Am Thorac Soc, V4, P577, DOI 10.1513/pats.200706-072JK; THORENS JB, 1995, CRIT CARE MED, V23, P1807, DOI 10.1097/00003246-199511000-00004; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639	66	135	147	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2011	342								c7237	10.1136/bmj.c7237	http://dx.doi.org/10.1136/bmj.c7237			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708TG	21233157	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000286386600001
J	Ball, P				Ball, Philip			Beyond the bond	NATURE			English	Editorial Material							MO THEORY; CHEMISTRY; BORN; GOLD											Alvarez S, 2009, CHEM-EUR J, V15, P8358, DOI 10.1002/chem.200900239; Corts-Guzman F, 2005, COORDIN CHEM REV, V249, P633, DOI 10.1016/j.ccr.2004.08.022; Coulson C. A., 1953, SPIRIT APPL MATH, P20; CRIM FF, 1990, SCIENCE, V249, P1387, DOI 10.1126/science.249.4975.1387; Hoffmann R, 2003, ACCOUNTS CHEM RES, V36, P750, DOI 10.1021/ar030162a; Katz MJ, 2008, CHEM SOC REV, V37, P1884, DOI 10.1039/b709061g; Pyykko P, 2008, CHEM SOC REV, V37, P1967, DOI 10.1039/b708613j; Schmidbaur H, 2005, CHEM PHYS, V311, P151, DOI 10.1016/j.chemphys.2004.09.023; SINDELKA M, 2010, PREPRINT; Sukumar N., 2009, FDN CHEM, V11, P7; Worth GA, 2004, ANNU REV PHYS CHEM, V55, P127, DOI 10.1146/annurev.physchem.55.091602.094335; 2007, J COMPUT CHEM, V28, P1	12	48	50	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					26	28		10.1038/469026a	http://dx.doi.org/10.1038/469026a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21209641	Bronze			2022-12-28	WOS:000285921600012
J	Hall, MA				Hall, Mark A.			Rethinking Safety-Net Access for the Uninsured.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE		Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA	Wake Forest University	Hall, MA (corresponding author), Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA.			Hall, Mark A./0000-0001-6277-144X				Aaron HJ, 2010, NEW ENGL J MED, V362, P1259, DOI 10.1056/NEJMp1003394; Hall MA, 2008, J GEN INTERN MED, V23, P1257, DOI 10.1007/s11606-008-0605-1; Okie S, 2007, NEW ENGL J MED, V357, P525, DOI 10.1056/NEJMp078113; Redlener I, 2009, NEW ENGL J MED, V361, P2201, DOI 10.1056/NEJMp0910597; Saultz JW, 2010, J AM BOARD FAM MED, V23, P393, DOI 10.3122/jabfm.2010.03.090214	5	19	19	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					7	9		10.1056/NEJMp1011502	http://dx.doi.org/10.1056/NEJMp1011502			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702UY	21190449				2022-12-28	WOS:000285922600004
J	Dahabreh, IJ; Terasawa, T; Castaldi, PJ; Trikalinos, TA				Dahabreh, Issa J.; Terasawa, Teruhiko; Castaldi, Peter J.; Trikalinos, Thomas A.			Systematic Review: Anti-Epidermal Growth Factor Receptor Treatment Effect Modification by KRAS Mutations in Advanced Colorectal Cancer	ANNALS OF INTERNAL MEDICINE			English	Review							CETUXIMAB-PLUS-IRINOTECAN; PREDICT DISEASE-CONTROL; GENE COPY NUMBER; K-RAS MUTATIONS; TARGETED THERAPY; CLINICAL-TRIALS; META-REGRESSION; PUBLISHED LITERATURE; LIVER METASTASES; PUBLICATION BIAS	Background: KRAS mutations have been extensively investigated as predictive biomarkers for treatment of advanced colorectal cancer with the anti-epidermal growth factor receptor (EGFR) antibodies cetuximab and panitumumab. Purpose: To summarize whether KRAS mutation status modifies effects of anti-EGFR-based treatments for patients with advanced colorectal cancer and whether KRAS status predicts clinical outcomes among such patients. Data Sources: MEDLINE and 2 curated genetics databases (through 24 March 2010) were searched for observational studies. MEDLINE, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, and the Database of Abstracts of Reviews of Effects (through 1 September 2010) were searched for randomized, controlled trials. No search was restricted by language. Study Selection: Three reviewers screened titles and abstracts to identify published studies assessing KRAS mutations as predictors of overall and progression-free survival or treatment failure for patients who received anti-EGFR-based therapy for metastatic colorectal cancer. Data Extraction: Three investigators extracted data on population and study-design characteristics, including quality items, and on outcomes of interest. Random-effects meta-analyses were done on nonoverlapping studies. Data Synthesis: In 4 reanalyses of randomized trials of anti-EGFR-based therapy versus best supportive care or cytotoxic chemotherapy, no significant benefit was found for overall or progression-free survival from anti-EGFR-based treatment among KRAS-positive patients (hazard ratio [HR], 1.0). However, evidence favors anti-EGFR therapy among KRAS wild-type patients; the relative HR across KRAS-positive and wild-type patients was 1.30 (95% CI, 0.95 to 1.78) for overall survival and 2.22 (CI, 1.74 to 2.84) for progression-free survival by random-effects meta-analysis. In 13 cohorts of patients who received anti-EGFR antibodies, the summary HR for overall survival was 1.79 (CI, 1.48 to 2.17), with better survival in wild-type patients. The corresponding HR for progression-free survival was 2.11 (CI, 1.74 to 2.55 [16 cohorts]). In random-effects bivariate meta-analysis of 22 studies, the summary sensitivity of KRAS mutations for predicting lack of response was 0.49 (CI, 0.43 to 0.55), and summary specificity was 0.93 (CI, 0.87 to 0.97). Limitations: Limited evidence from randomized studies exists. Patient-level data are needed to assess modifiers of the mutation-by-treatment interaction. Publication bias could be a concern. Conclusion: KRAS mutations are consistently associated with reduced overall and progression-free survival and increased treatment failure rates among patients with advanced colorectal cancer treated with anti-EGFR antibodies.	[Trikalinos, Thomas A.] Tufts Med Ctr, Ctr Clin Evidence Synth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; Fujita Hlth Univ, Sch Med, Tsu, Mie, Japan	Tufts Medical Center; Fujita Health University	Trikalinos, TA (corresponding author), Tufts Med Ctr, Ctr Clin Evidence Synth, Inst Clin Res & Hlth Policy Studies, 800 Washington St,Box 63, Boston, MA 02111 USA.	TTrikalinos@tuftsmedicalcenter.org			Agency for Healthcare Research and Quality [HHSA-290-2007-100551]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By the Agency for Healthcare Research and Quality (contract HHSA-290-2007-100551).	Alberts SR, 2008, ONCOLOGIST, V13, P1063, DOI 10.1634/theoncologist.2008-0142; Allegra C, 2007, J CLIN ONCOL, V25, P3572, DOI 10.1200/JCO.2007.12.1368; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Baselga J, 2002, ONCOLOGIST, V7, P2; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; BOS JL, 1989, CANCER RES, V49, P4682; Cappuzzo F, 2008, BRIT J CANCER, V99, P83, DOI 10.1038/sj.bjc.6604439; Chu HT, 2006, J CLIN EPIDEMIOL, V59, P1331, DOI 10.1016/j.jclinepi.2006.06.011; Chung CH, 2010, CANCER EPIDEM BIOMAR, V19, P358, DOI 10.1158/1055-9965.EPI-09-0937; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deschoolmeester V, 2010, ONCOLOGIST, V15, P699, DOI 10.1634/theoncologist.2010-0025; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Freeman DJ, 2008, CLIN COLORECTAL CANC, V7, P184, DOI 10.3816/CCC.2008.n.024; Goncalves A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-169; Graziano F, 2010, PHARMACOGENOMICS J, V10, P458, DOI 10.1038/tpj.2010.9; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; Hebbar M, 2010, EUR J CANCER CARE, V19, P167, DOI 10.1111/j.1365-2354.2009.01134.x; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Jacobs B, 2009, J CLIN ONCOL, V27, P5068, DOI 10.1200/JCO.2008.21.3744; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Klump B, 2004, INT J COLORECTAL DIS, V19, P23, DOI 10.1007/s00384-003-0499-7; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Kuramochi H, 2010, CANCER CHEMOTH PHARM, V65, P825, DOI 10.1007/s00280-009-1087-5; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lin BK, 2006, AM J EPIDEMIOL, V164, P1, DOI 10.1093/aje/kwj175; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Lurje G, 2008, CLIN CANCER RES, V14, P7884, DOI 10.1158/1078-0432.CCR-07-5165; Mandrekar SJ, 2009, J CLIN ONCOL, V27, P4027, DOI 10.1200/JCO.2009.22.3701; Mayer RJ, 2009, NEW ENGL J MED, V360, P623, DOI 10.1056/NEJMe0809343; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Michiels S, 2005, INT J TECHNOL ASSESS, V21, P119, DOI 10.1017/S0266462305050154; Molinari F, 2009, BRIT J CANCER, V100, P1087, DOI 10.1038/sj.bjc.6604848; Montagut C, 2010, BRIT J CANCER, V102, P1137, DOI 10.1038/sj.bjc.6605612; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Muro K, 2009, JPN J CLIN ONCOL, V39, P321, DOI 10.1093/jjco/hyp016; Oden-Gangloff A, 2009, BRIT J CANCER, V100, P1330, DOI 10.1038/sj.bjc.6605008; Ogino S, 2009, CLIN CANCER RES, V15, P7322, DOI 10.1158/1078-0432.CCR-09-1570; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Paule B, 2009, MED ONCOL; Perkins G, 2010, INT J CANCER, V127, P1321, DOI 10.1002/ijc.25152; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Personeni N, 2008, CLIN CANCER RES, V14, P5869, DOI 10.1158/1078-0432.CCR-08-0449; Prenen H, 2009, CLIN CANCER RES, V15, P3184, DOI 10.1158/1078-0432.CCR-08-2961; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rothman KJ., 1997, MODERN EPIDEMIOLOGY, V2nd; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Savas S, 2010, HUM MUTAT, V31, P901, DOI 10.1002/humu.21285; Scartozzi M, 2010, INT J CANCER, V127, P1941, DOI 10.1002/ijc.25193; Senn SJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-10; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Simon R, 2010, CLIN TRIALS, V7, P516, DOI 10.1177/1740774510366454; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Sohn BS, 2009, ONCOLOGY-BASEL, V77, P224, DOI 10.1159/000236046; Souglakos J, 2009, BRIT J CANCER, V101, P465, DOI 10.1038/sj.bjc.6605164; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Spindler KLG, 2009, ANN ONCOL, V20, P879, DOI 10.1093/annonc/mdn712; Tabernero J, 2010, ANN ONCOL, V21, P1537, DOI 10.1093/annonc/mdp549; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; U. S. Food and Drug Administration, 2009, PAN HIGHL PRESCR INF; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yen LC, 2010, ANN SURG, V251, P254, DOI 10.1097/SLA.0b013e3181bc9d96; Yen LC, 2009, CLIN CANCER RES, V15, P4508, DOI 10.1158/1078-0432.CCR-08-3179	93	139	145	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					37	U180		10.7326/0003-4819-154-1-201101040-00006	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00006			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200037				2022-12-28	WOS:000285830900005
J	Salles, G; Seymour, JF; Offner, F; Lopez-Guillermo, A; Belada, D; Xerri, L; Feugier, P; Bouabdallah, R; Catalano, JV; Brice, P; Caballero, D; Haioun, C; Pedersen, LM; Delmer, A; Simpson, D; Leppa, S; Soubeyran, P; Hagenbeek, A; Casasnovas, O; Intragumtornchai, T; Ferme, C; da Silva, MG; Sebban, C; Lister, A; Estell, JA; Milone, G; Sonet, A; Mendila, M; Coiffier, B; Tilly, H				Salles, Gilles; Seymour, John Francis; Offner, Fritz; Lopez-Guillermo, Armando; Belada, David; Xerri, Luc; Feugier, Pierre; Bouabdallah, Reda; Catalano, John Vincent; Brice, Pauline; Caballero, Dolores; Haioun, Corinne; Pedersen, Lars Moller; Delmer, Alain; Simpson, David; Leppa, Sirpa; Soubeyran, Pierre; Hagenbeek, Anton; Casasnovas, Olivier; Intragumtornchai, Tanin; Ferme, Christophe; da Silva, Maria Gomes; Sebban, Catherine; Lister, Andrew; Estell, Jane A.; Milone, Gustavo; Sonet, Anne; Mendila, Myriam; Coiffier, Bertrand; Tilly, Herve			Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial	LANCET			English	Article							NON-HODGKINS-LYMPHOMA; TERM-FOLLOW-UP; FREE SURVIVAL; SINGLE-AGENT; INDOLENT; THERAPY; CYCLOPHOSPHAMIDE; CELL; VINCRISTINE; PREDNISONE	Patients with follicular lymphoma can have long survival times, but disease progression typically occurs 3-5 years after initial treatment. We assessed the potential benefit of 2 years of rituximab maintenance after first-line treatment in patients with follicular lymphoma receiving a rituximab plus chemotherapy regimen. Methods The randomised, open-label PRIMA study was undertaken in 223 centres in 25 countries. 1217 patients with previously untreated follicular lymphoma needing systemic therapy received one of three non-randomised immunochemotherapy induction regimens used in routine practice. 1019 patients achieving a complete or partial response were then randomly assigned to receive 2 years of rituximab maintenance therapy (375 mg/m(2) every 8 weeks) or observation. Treatment was assigned equally by centralised block randomisation, stratified by induction regimen, response, region, and centre. Neither the participants nor those giving the interventions, assessing outcomes, and analysing data were masked to group assignments. The primary endpoint was progression-free survival (PFS). Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00140582. Findings 505 patients were assigned to rituximab maintenance and 513 to observation (one patient died during randomisation). With a median follow-up of 36 months (IQR 30-42), PFS was 74.9% (95% CI 70.9-78.9) in the rituximab maintenance group (130 patients progressed) and 57.6% (53.2-62.0) in the observation group (218 progressed; hazard ratio [HR] 0.55, 95% CI 0.44-0.68, p<0.0001). 2 years after randomisation, 361 patients (71.5%) in the rituximab maintenance group were in complete or unconfirmed complete response versus 268 (52.2%) in the observation group (p=0.0001). Overall survival did not differ significantly between groups (HR 0-87, 95% CI 0.51-1.47). Grade 3 and 4 adverse events were recorded in 121 patients (24%) in the rituximab maintenance group and 84(17%) in the observation group (risk ratio 1.46, 95% CI 1.14-1.87; p=0.0026). Infections (grades 2-4) were the most common adverse event, occurring in 197 (39%) and 123 (24%) patients, respectively (risk ratio 1.62, 95% CI 1.35-1.96; p<0.0001). Interpretation 2 years of rituximab maintenance therapy after immunochemotherapy as first-line treatment for follicular lymphoma significantly improves PFS.	[Salles, Gilles; Coiffier, Bertrand] Univ Lyon 1, Ctr Hosp Lyon Sud, Hosp Civils Lyon, CNRS,UMR 5239, F-69310 Pierre Benite, France; [Seymour, John Francis] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia; [Seymour, John Francis] Univ Melbourne, Melbourne, Vic, Australia; [Offner, Fritz] Univ Ghent, B-9000 Ghent, Belgium; [Lopez-Guillermo, Armando] Hosp Clin Barcelona, Barcelona, Spain; [Belada, David] Charles Univ Prague, Fac Med, Univ Hosp Hradec Kralove, Prague, Czech Republic; [Xerri, Luc; Bouabdallah, Reda] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Feugier, Pierre] Univ Henri Poincare, CHU Nancy, Nancy, France; [Catalano, John Vincent] Frankston Hosp, Frankston, Vic, Australia; [Brice, Pauline] Hop St Louis, AP HP, Paris, France; [Caballero, Dolores] Univ Salamanca, E-37008 Salamanca, Spain; [Haioun, Corinne] Hop Henri Mondor, AP HP, F-94010 Creteil, France; [Pedersen, Lars Moller] Odense Univ Hosp, DK-5000 Odense, Denmark; [Delmer, Alain] CHU Reims, Reims, France; [Simpson, David] N Shore Hosp, Auckland, New Zealand; [Leppa, Sirpa] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Soubeyran, Pierre] Inst Bergonie, Bordeaux, France; [Soubeyran, Pierre] Univ Bordeaux 2, F-33076 Bordeaux, France; [Hagenbeek, Anton] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Casasnovas, Olivier] CHU Dijon, Dijon, France; [Intragumtornchai, Tanin] Chulalongkorn Univ, Bangkok, Thailand; [Ferme, Christophe] Inst Cancerol Gustave Roussy, Villejuif, France; [da Silva, Maria Gomes] Portuguese Inst Oncol, Lisbon, Portugal; [Sebban, Catherine] Ctr Leon Berard, F-69373 Lyon, France; [Lister, Andrew] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Med Oncol, London, England; [Estell, Jane A.] Concord Hosp, Concord, NSW, Australia; [Milone, Gustavo] Fundaleu, Buenos Aires, DF, Argentina; [Sonet, Anne] UCL, Mt Godinne, Yvoir, Belgium; [Mendila, Myriam] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland; [Tilly, Herve] Ctr Henri Becquerel, F-76038 Rouen, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Peter Maccallum Cancer Center; University of Melbourne; Ghent University; University of Barcelona; Hospital Clinic de Barcelona; Charles University Prague; University Hospital Hradec Kralove; UNICANCER; Institut Paoli-Calmette (IPC); CHU de Nancy; Universite de Lorraine; Frankston Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Salamanca; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of Southern Denmark; Odense University Hospital; CHU de Reims; University of Helsinki; Helsinki University Central Hospital; UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux; University of Amsterdam; Academic Medical Center Amsterdam; CHU Dijon Bourgogne; Chulalongkorn University; UNICANCER; Gustave Roussy; Universidade de Coimbra; UNICANCER; Centre Leon Berard; University of London; Queen Mary University London; Concord Repatriation General Hospital; Universite Catholique Louvain; Roche Holding; UNICANCER; Centre Henri Becquerel	Salles, G (corresponding author), Univ Lyon 1, Ctr Hosp Lyon Sud, Hosp Civils Lyon, CNRS,UMR 5239, F-69310 Pierre Benite, France.	gilles.salles@chu-Iyon.fr	Salles, Gilles/Z-2336-2019; Belada, David/P-9728-2017; Lopez-Guillermo, Armando/Z-5684-2019; Seymour, John/K-7326-2019; Soubeyran, Pierre-Louis/F-4523-2012	Salles, Gilles/0000-0002-9541-8666; Belada, David/0000-0002-4981-6188; Seymour, John/0000-0003-2188-6835; Soubeyran, Pierre-Louis/0000-0003-3244-7299; Gomes da Silva, Maria/0000-0002-6993-2450; Casasnovas, Rene-Olivier/0000-0002-1156-8983; Simpson, David/0000-0002-9768-7413; Delmer, Alain/0000-0002-1430-2574; Leppa, Sirpa/0000-0002-8265-511X; Haioun, Corinne/0000-0003-0095-5379	Groupe d'Etude des Lymphomes de l'Adulte (GELA); F Hoffmann-La Roche	Groupe d'Etude des Lymphomes de l'Adulte (GELA); F Hoffmann-La Roche(Hoffmann-La Roche)	Funding Groupe d'Etude des Lymphomes de l'Adulte (GELA) and F Hoffmann-La Roche.	Abes R, 2010, BLOOD, V116, P926, DOI 10.1182/blood-2009-10-248609; [Anonymous], 2008, BLOOD; Bachy E, 2010, J CLIN ONCOL, V28, P822, DOI 10.1200/JCO.2009.22.7819; Carlotti E, 2009, BLOOD, V113, P3553, DOI 10.1182/blood-2008-08-174839; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Common Terminology Criteria for Adverse Events v3.0 (CTCAE), 2006, COMMON TERMINOLOGY C; Forstpointner R, 2006, BLOOD, V108, P4003, DOI 10.1182/blood-2006-04-016725; Friedberg JW, 2008, J CLIN ONCOL, V26, P204, DOI 10.1200/JCO.2007.12.5070; GALLAGHER CJ, 1986, J CLIN ONCOL, V4, P1470, DOI 10.1200/JCO.1986.4.10.1470; Ghielmini M, 2004, BLOOD, V103, P4416, DOI 10.1182/blood-2003-10-3411; Gordan LN, 2005, J CLIN ONCOL, V23, P1096, DOI 10.1200/JCO.2005.12.171; Hainsworth JD, 2002, J CLIN ONCOL, V20, P4261, DOI 10.1200/JCO.2002.08.674; Herold M, 2007, J CLIN ONCOL, V25, P1986, DOI 10.1200/JCO.2006.06.4618; Hiddemann W, 2005, BLOOD, V106, P3725, DOI 10.1182/blood-2005-01-0016; Hilchey SP, 2009, BLOOD, V113, P3809, DOI 10.1182/blood-2008-10-185280; Hochster H, 2009, J CLIN ONCOL, V27, P1607, DOI 10.1200/JCO.2008.17.1561; JOHNSON PWM, 1995, J CLIN ONCOL, V13, P140, DOI 10.1200/JCO.1995.13.1.140; Kahl BS, 2007, BLOOD, V110, p1002A, DOI 10.1182/blood.V110.11.3420.3420; Kahl BS, 2010, CANCER-AM CANCER SOC, V116, P106, DOI 10.1002/cncr.24714; Marcus R, 2005, BLOOD, V105, P1417, DOI 10.1182/blood-2004-08-3175; Marcus R, 2008, J CLIN ONCOL, V26, P4579, DOI 10.1200/JCO.2007.13.5376; Martinelli G, 2010, J CLIN ONCOL, V28, P4480, DOI 10.1200/JCO.2010.28.4786; Pulte D, 2008, ARCH INTERN MED, V168, P469, DOI 10.1001/archinternmed.2007.125; Roulland S, 2006, J EXP MED, V203, P2425, DOI 10.1084/jem.20061292; Ruminy P, 2008, BLOOD, V112, P1951, DOI 10.1182/blood-2007-11-124560; Salles G, 2008, BLOOD, V112, P4824, DOI 10.1182/blood-2008-04-153189; Sebban C, 2008, J CLIN ONCOL, V26, P3614, DOI 10.1200/JCO.2007.15.5358; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Swenson WT, 2005, J CLIN ONCOL, V23, p595S; van Oers MHJ, 2006, BLOOD, V108, P3295, DOI 10.1182/blood-2006-05-021113; van Oers MHJ, 2010, J CLIN ONCOL, V28, P2853, DOI 10.1200/JCO.2009.26.5827; Vidal L, 2009, JNCI-J NATL CANCER I, V101, P248, DOI 10.1093/jnci/djn478	33	781	801	0	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 1	2011	377	9759					42	51		10.1016/S0140-6736(10)62175-7	http://dx.doi.org/10.1016/S0140-6736(10)62175-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709MQ	21176949				2022-12-28	WOS:000286445200030
J	Shahian, DM; Wolf, RE; Iezzoni, LI; Kirle, L; Normand, SLT				Shahian, David M.; Wolf, Robert E.; Iezzoni, Lisa I.; Kirle, Leslie; Normand, Sharon-Lise T.			Variability in the Measurement of Hospital-wide Mortality Rates.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-ADJUSTED MORTALITY; DEATH RATES; QUALITY; INDICATOR; PERFORMANCE; CARE	Background: Several countries use hospital-wide mortality rates to evaluate the quality of hospital care, although the usefulness of this metric has been questioned. Massachusetts policymakers recently requested an assessment of methods to calculate this aggregate mortality metric for use as a measure of hospital quality. Methods: The Massachusetts Division of Health Care Finance and Policy provided four vendors with identical information on 2,528,624 discharges from Massachusetts acute care hospitals from October 1, 2004, through September 30, 2007. Vendors applied their risk-adjustment algorithms and provided predicted probabilities of in-hospital death for each discharge and for hospital-level observed and expected mortality rates. We compared the numbers and characteristics of discharges and hospitals included by each of the four methods. We also compared hospitals' standardized mortality ratios and classification of hospitals with mortality rates that were higher or lower than expected, according to each method. Results: The proportions of discharges that were included by each method ranged from 28% to 95%, and the severity of patients' diagnoses varied widely. Because of their discharge-selection criteria, two methods calculated in-hospital mortality rates (4.0% and 5.9%) that were twice the state average (2.1%). Pairwise associations (Pearson correlation coefficients) of discharge-level predicted mortality probabilities ranged from 0.46 to 0.70. Hospital-performance categorizations varied substantially and were sometimes completely discordant. In 2006, a total of 12 of 28 hospitals that had higher-than-expected hospital-wide mortality when classified by one method had lower-than-expected mortality when classified by one or more of the other methods. Conclusions: Four common methods for calculating hospital-wide mortality produced substantially different results. This may have resulted from a lack of standardized national eligibility and exclusion criteria, different statistical methods, or fundamental flaws in the hypothesized association between hospital-wide mortality and quality of care. (Funded by the Massachusetts Division of Health Care Finance and Policy.) N Engl J Med 2010;363:2530-9.	[Shahian, David M.] Massachusetts Gen Hosp, Ctr Qual & Safety, Boston, MA 02114 USA; [Shahian, David M.; Wolf, Robert E.; Iezzoni, Lisa I.; Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Boston, MA USA; [Kirle, Leslie] Massachusetts Div Hlth Care Finance & Policy, Boston, MA USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Shahian, DM (corresponding author), Massachusetts Gen Hosp, Ctr Qual & Safety, 55 Fruit St, Boston, MA 02114 USA.	dshahian@partners.org		Normand, Sharon-Lise/0000-0001-7027-4769	DHCFP	DHCFP	Supported by the DHCFP.	[Anonymous], 2009, MORT MEAS; Austin PC, 2001, J EVAL CLIN PRACT, V7, P35, DOI 10.1046/j.1365-2753.2001.00261.x; Aylin P, 2010, HSMR MORTALITY INDIC; Benjamin EM, 2009, AM J MED QUAL, V24, P164, DOI 10.1177/1062860608326543; BEST WR, 1994, MED CARE, V32, P390, DOI 10.1097/00005650-199404000-00007; Black N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2066; BLUMBERG MS, 1987, HEALTH SERV RES, V21, P715; Brien Susan E, 2008, Healthc Pap, V8, P57; Crocker L, 1986, INTRO CLASSICAL MODE; DUBOIS RW, 1987, NEW ENGL J MED, V317, P1674, DOI 10.1056/NEJM198712243172626; Figler Shauna, 2008, Healthc Pap, V8, P54; Hawkes N, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2153; Hofer TP, 1996, MED CARE, V34, P737, DOI 10.1097/00005650-199608000-00002; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; Iezzoni LI, 2003, RISK ADJUSTMENT MEAS; Jarman B, 2005, BRIT MED J, V330, P329, DOI 10.1136/bmj.330.7487.329; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Jarman Brian, 2008, Healthc Pap, V8, P37; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P3611, DOI 10.1001/jama.260.24.3611; KRAKAUER H, 1992, HEALTH SERV RES, V27, P317; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Lilford R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2016; Massachusetts Division of Health Care Finance and Policy, 2009, HOSP WID MORT PROJ R; McKinley John, 2008, Healthc Pap, V8, P43; Mohammed MA, 2009, BMJ-BRIT MED J, V338, pb1348; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; PARK RE, 1990, JAMA-J AM MED ASSOC, V264, P484; Penfold Robert B, 2008, Healthc Pap, V8, P8; Pitches DW, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-91; Rothberg MB, 2008, HEALTH AFFAIR, V27, P1680, DOI 10.1377/hlthaff.27.6.1680; SHAPIRO MF, 1994, HEALTH SERV RES, V29, P95; Shojania KG, 2008, CAN MED ASSOC J, V179, P153, DOI 10.1503/cmaj.080010; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; THOMAS JW, 1993, INQUIRY-J HEALTH CAR, V30, P6; Thomas JW, 1999, MED CARE, V37, P83, DOI 10.1097/00005650-199901000-00012; Thomas JW, 1998, MED CARE RES REV, V55, P371, DOI 10.1177/107755879805500401; Wen Eugene, 2008, Healthc Pap, V8, P26; Zahn Catherine, 2008, Healthc Pap, V8, P50; Zalkind DL, 1997, HOSP HEALTH SERV ADM, V42, P3	41	165	169	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2530	2539		10.1056/NEJMsa1006396	http://dx.doi.org/10.1056/NEJMsa1006396			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697YL	21175315				2022-12-28	WOS:000285555600008
J	Sessions, SY; Detsky, AS				Sessions, Samuel Y.; Detsky, Allan S.			The "Shadow Government" in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-PRACTICE GUIDELINES; INDUSTRY		[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Sessions, Samuel Y.] Harbor UCLA Med Ctr, Dept Psychiat & Biobehav Sci, Torrance, CA 90509 USA; [Sessions, Samuel Y.] Harbor UCLA Med Ctr, LA Biomed, Torrance, CA 90509 USA; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 429-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Bankman J, 2008, FEDERAL INCOME TAX E, V46-48, P206; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Gopal AA, 2010, ACCOUNT RES, V17, P264, DOI 10.1080/08989621.2010.511568; Kaplan R. M., 2009, DIS DIAGNOSES DOLLAR; Mark TL, 2007, PSYCHIAT SERV, V58, P1041, DOI 10.1176/appi.ps.58.8.1041; Meltzer DO, 2010, JAMA-J AM MED ASSOC, V304, P2292, DOI 10.1001/jama.2010.1671; Sessions SY, 2009, JAMA-J AM MED ASSOC, V302, P2252, DOI 10.1001/jama.2009.1712; Starr P, 1982, SOCIAL TRANSFORMATIO, V23, P26; Wells DA, 2007, JAMA-J AM MED ASSOC, V298, P2785, DOI 10.1001/jama.298.23.2785	10	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2742	2743		10.1001/jama.2010.1873	http://dx.doi.org/10.1001/jama.2010.1873			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177511				2022-12-28	WOS:000285518000021
J	Zaidi, MR; Davis, S; Noonan, FP; Graff-Cherry, C; Hawley, TS; Walker, RL; Feigenbaum, L; Fuchs, E; Lyakh, L; Young, HA; Hornyak, TJ; Arnheiter, H; Trinchieri, G; Meltzer, PS; De Fabo, EC; Merlino, G				Zaidi, M. Raza; Davis, Sean; Noonan, Frances P.; Graff-Cherry, Cari; Hawley, Teresa S.; Walker, Robert L.; Feigenbaum, Lionel; Fuchs, Elaine; Lyakh, Lyudmila; Young, Howard A.; Hornyak, Thomas J.; Arnheiter, Heinz; Trinchieri, Giorgio; Meltzer, Paul S.; De Fabo, Edward C.; Merlino, Glenn			Interferon-gamma links ultraviolet radiation to melanomagenesis in mice	NATURE			English	Article							HLA-G; MOUSE; MELANOCYTES; EXPRESSION; CELLS; SEQUENCE; EXPOSURE; LEVEL; NICHE	Cutaneous malignant melanoma is a highly aggressive and frequently chemoresistant cancer, the incidence of which continues to rise. Epidemiological studies show that the major aetiological melanoma risk factor is ultraviolet (UV) solar radiation, with the highest risk associated with intermittent burning doses, especially during childhood(1,2). We have experimentally validated these epidemiological findings using the hepatocyte growth factor/scatter factor transgenic mouse model, which develops lesions in stages highly reminiscent of human melanoma with respect to biological, genetic and aetiological criteria, but only when irradiated as neonatal pups with UVB, not UVA(3,4). However, the mechanisms underlying UVB-initiated, neonatal-specific melanomagenesis remain largely unknown. Here we introduce a mouse model permitting fluorescence-aided melanocyte imaging and isolation following in vivo UV irradiation. We use expression profiling to show that activated neonatal skin melanocytes isolated following a melanomagenic UVB dose bear a distinct, persistent interferon response signature, including genes associated with immunoevasion. UVB-induced melanocyte activation, characterized by aberrant growth and migration, was abolished by antibody-mediated systemic blockade of interferon-gamma (IFN-gamma), but not type-I interferons. IFN-gamma was produced by macrophages recruited to neonatal skin by UVB-induced ligands to the chemokine receptor Ccr2. Admixed recruited skin macrophages enhanced transplanted melanoma growth by inhibiting apoptosis; notably, IFN-gamma blockade abolished macrophage-enhanced melanoma growth and survival. IFN-gamma-producing macrophages were also identified in 70% of human melanomas examined. Our data reveal an unanticipated role for IFN-gamma in promoting melanocytic cell survival/immunoevasion, identifying a novel candidate therapeutic target for a subset of melanoma patients.	[Zaidi, M. Raza; Merlino, Glenn] NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Davis, Sean; Walker, Robert L.; Meltzer, Paul S.] NCI, Genet Branch, Bethesda, MD 20892 USA; [Noonan, Frances P.; De Fabo, Edward C.] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA; [Graff-Cherry, Cari; Feigenbaum, Lionel] NCI, Lab Anim Sci Program, Frederick, MD 21702 USA; [Fuchs, Elaine] Rockefeller Univ, New York, NY 10021 USA; [Lyakh, Lyudmila; Young, Howard A.; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Hornyak, Thomas J.] NCI, Dermatol Branch, Bethesda, MD 20892 USA; [Arnheiter, Heinz] NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Merlino, G (corresponding author), NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA.	drmecd@gwumc.edu; gmerlino@helix.nih.gov	Fuchs, Elaine/G-1565-2016; Trinchieri, Giorgio/F-9369-2015; Young, Howard/R-5140-2019; Davis, Sean/AAD-1801-2021; Zaidi, M. Raza/H-1386-2016; Young, Howard/A-6350-2008	Trinchieri, Giorgio/0000-0001-5892-7464; Davis, Sean/0000-0002-8991-6458; Zaidi, M. Raza/0000-0003-0480-3188; Young, Howard/0000-0002-3118-5111; Walker, Robert/0000-0001-8235-4686; Noonan, Frances/0000-0002-3302-7280; Arnheiter, Heinz/0000-0003-2537-1134	NIH, National Cancer Institute, Center for Cancer Research; National Cancer Institute; National Institutes of Health [CA53765, CA92258]; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC010479, ZIABC010720, ZIABC010565, R01CA092258, R01CA053765, ZIABC010733, ZIABC010734, ZIABC011091, ZIABC008756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003021] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the following individuals for their support: S. Yuspa for primary keratinocytes; C. Toniatti and H. Bujard for the rtTA2sM2 construct; V. Hearing for melan-c cell line; S. Hewitt for the human melanoma tissue microarray; M. Anver for immunohistochemical staining and production/analysis of mouse melanoma tissue microarray; K. Blas and E. Vega-Valle for technical help; N. Restifo and A. Hurwitz for suggestions and discussions. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. M.R.Z. was supported by a National Cancer Institute Director's Innovation Career Development Award. E.C.D. and F.P.N. were supported by grants from the National Institutes of Health (awards CA53765 and CA92258), and the Melanoma Research Foundation.	Serrano MA, 2010, PHOTOCHEM PHOTOBIOL, V86, P716, DOI 10.1111/j.1751-1097.2009.00693.x; Aoki H, 2005, J INVEST DERMATOL, V124, P1053, DOI 10.1111/j.0022-202X.2005.23721.x; Ascierto PA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-62; BUDD PS, 1995, GENOMICS, V29, P35, DOI 10.1006/geno.1995.1212; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; Darwich L, 2009, IMMUNOLOGY, V126, P386, DOI 10.1111/j.1365-2567.2008.02905.x; De Fabo EC, 2004, CANCER RES, V64, P6372, DOI 10.1158/0008-5472.CAN-04-1454; DEFABO EC, 1990, PHOTOCHEM PHOTOBIOL, V52, P811; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Derre L, 2006, J IMMUNOL, V177, P3100, DOI 10.4049/jimmunol.177.5.3100; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Garibyan L, 2010, CURR ONCOL REP, V12, P319, DOI 10.1007/s11912-010-0119-y; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goldszmid RS, 2007, J EXP MED, V204, P2591, DOI 10.1084/jem.20070634; Gramzinski RA, 2001, INFECT IMMUN, V69, P1643, DOI 10.1128/IAI.69.3.1643-1649.2001; He YF, 2005, CANCER IMMUNOL IMMUN, V54, P891, DOI 10.1007/s00262-004-0654-1; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; MEYSKENS FL, 1995, J NATL CANCER I, V87, P1710, DOI 10.1093/jnci/87.22.1710; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Porter GA, 2001, ANN SURG ONCOL, V8, P116, DOI 10.1245/aso.2001.8.2.116; Proost P, 1996, J LEUKOCYTE BIOL, V59, P67, DOI 10.1002/jlb.59.1.67; R Development Core Team, 2009, R LANG ENV STAT COMP; Rebmann V, 2007, SEMIN CANCER BIOL, V17, P422, DOI 10.1016/j.semcancer.2007.06.010; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shah KV, 2008, J INVEST DERMATOL, V128, P2870, DOI 10.1038/jid.2008.170; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Walker GJ, 2009, J INVEST DERMATOL, V129, P184, DOI 10.1038/jid.2008.210; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928; Wischhusell J, 2007, SEMIN CANCER BIOL, V17, P459, DOI 10.1016/j.semcancer.2007.07.005; Wolnicka-Glubisz A, 2006, PHOTOCH PHOTOBIO SCI, V5, P254, DOI 10.1039/b506974b; Wolnicka-Glubisz A, 2005, J INVEST DERMATOL, V125, P383, DOI 10.1111/j.0022-202X.2005.23781.x; Wolnicka-Glubisz A, 2007, J LEUKOCYTE BIOL, V81, P1352, DOI 10.1189/jlb.1206729	43	200	210	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					548	U129		10.1038/nature09666	http://dx.doi.org/10.1038/nature09666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21248750	Green Accepted			2022-12-28	WOS:000286596500036
J	Lazich, I; Bakris, G				Lazich, Ivana; Bakris, George			Initial combination antihypertensives: let's ACCELERATE	LANCET			English	Editorial Material							HYPERTENSION; THERAPY		[Lazich, Ivana; Bakris, George] Univ Chicago, Pritzker Sch Med, Dept Med, Hypertens Dis Unit, Chicago, IL 60637 USA	University of Chicago	Bakris, G (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Med, Hypertens Dis Unit, Chicago, IL 60637 USA.	gbakris@medicine.bsd.uchicago.edu						Bakris George L, 2003, J Clin Hypertens (Greenwich), V5, P202, DOI 10.1111/j.1524-6175.2002.2041.x; Brown MJ, 2011, LANCET, V377, P312, DOI 10.1016/S0140-6736(10)62003-X; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2008, J CLIN HYPERTENS, V10, P751, DOI 10.1111/j.1751-7176.2008.00015.x; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Epstein M, 1996, ARCH INTERN MED, V156, P1969, DOI 10.1001/archinte.156.17.1969; Faria C, 2009, J AM SOC HYPERTENS, V3, P267, DOI 10.1016/j.jash.2009.03.001; Gillum RF, 1998, INT J OBESITY, V22, P127, DOI 10.1038/sj.ijo.0800554; Gradman AH, 2010, J AM SOC HYPERTENS, V4, P90, DOI [10.1016/j.jash.2010.03.001, 10.1016/j.jash.2010.02.005]; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Redon J, 2010, J HYPERTENS, V28, P1770, DOI 10.1097/HJH.0b013e32833b4953; Singer GA, 2002, HYPERTENSION, V40, P464, DOI 10.1161/01.HYP.0000035858.04434.03; Staessen JA, 2005, HYPERTENS RES, V28, P385, DOI 10.1291/hypres.28.385; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8	15	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2011	377	9762					278	279		10.1016/S0140-6736(10)62270-2	http://dx.doi.org/10.1016/S0140-6736(10)62270-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714ZO	21236482				2022-12-28	WOS:000286850400006
J	Hirschtick, RE				Hirschtick, Robert E.			Impact Factor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rober@northwestern.edu						BASTA LL, 1979, AM HEART J, V97, P96, DOI 10.1016/0002-8703(79)90120-0	1	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					230	230		10.1001/jama.2010.1996	http://dx.doi.org/10.1001/jama.2010.1996			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707YY	21245173				2022-12-28	WOS:000286328700002
J	van Bokhoven, MA; van Deursen, CTBM; Swinkels, DW				van Bokhoven, M. A.; van Deursen, C. Th B. M.; Swinkels, D. W.			Diagnosis and management of hereditary haemochromatosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HFE-RELATED HEMOCHROMATOSIS; IRON-OVERLOAD; HEPATIC-FIBROSIS; FERRITIN LEVELS; PRIMARY-CARE; LOW-RISK; C282Y; DISEASE; PHLEBOTOMY; MORBIDITY					loes.vanbokhoven@hag.unimaas.nl	Swinkels, Dorine W./H-8098-2014; Van+Deursen, Cees/AAU-2558-2021	Swinkels, Dorine W./0000-0002-1040-9446; 				Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Allen KJ, 2010, HEPATOLOGY, V52, P925, DOI 10.1002/hep.23786; Asberg A, 2001, SCAND J GASTROENTERO, V36, P1108; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Beutler E, 2007, BLOOD CELL MOL DIS, V39, P140, DOI 10.1016/j.bcmd.2007.03.009; Bryant J, 2008, J MED GENET, V45, P513, DOI 10.1136/jmg.2007.055806; Calonge N, 2006, ANN INTERN MED, V145, P204, DOI 10.7326/0003-4819-145-3-200608010-00008; Cuijpers MLH, 2010, BRIT J HAEMATOL, V149, P322, DOI 10.1111/j.1365-2141.2009.08051.x; El-Serag HB, 2000, ANN INTERN MED, V132, P261, DOI 10.7326/0003-4819-132-4-200002150-00003; Ellervik C, 2001, LANCET, V358, P1405, DOI 10.1016/S0140-6736(01)06526-6; Ellervik C, 2007, HEPATOLOGY, V46, P1071, DOI 10.1002/hep.21885; Elmberg M, 2009, GASTROENTEROLOGY, V137, P1301, DOI 10.1053/j.gastro.2009.07.038; Falize L, 2006, HEPATOLOGY, V44, P472, DOI 10.1002/hep.21260; Fischer Roland, 2009, Hematology Am Soc Hematol Educ Program, P215, DOI 10.1182/asheducation-2009.1.215; Gurrin LC, 2009, HEPATOLOGY, V50, P94, DOI 10.1002/hep.22972; Gurrin LC, 2008, GASTROENTEROLOGY, V135, P1945, DOI 10.1053/j.gastro.2008.08.056; Hicken BL, 2003, AM J GASTROENTEROL, V98, P2072, DOI 10.1016/S0002-9270(02)06014-8; Jacobs EMC, 2007, NETH J MED, V65, P425; Jacobs EMG, 2009, J HEPATOL, V50, P174, DOI 10.1016/j.jhep.2008.08.014; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Lee PL, 2009, ANNU REV PATHOL-MECH, V4, P489, DOI 10.1146/annurev.pathol.4.110807.092205; McDonnell SM, 1999, TRANSFUSION, V39, P651, DOI 10.1046/j.1537-2995.1999.39060651.x; McDonnell SM, 1998, ANN INTERN MED, V129, P962, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00007; McLaren GD, 2008, CAN J GASTROENTEROL, V22, P923, DOI 10.1155/2008/907356; Morrison ED, 2003, ANN INTERN MED, V138, P627, DOI 10.7326/0003-4819-138-8-200304150-00008; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004; Pietrangelo A, 2000, J HEPATOL, V33, P485, DOI 10.1016/S0168-8278(00)80288-3; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P805, DOI 10.1053/j.gastro.2007.01.011; Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001; Rombout-Sestrienkova E, 2007, TRANSFUS APHER SCI, V36, P261, DOI 10.1016/j.transci.2007.03.005; Seamark CJ, 2000, BMJ-BRIT MED J, V320, P1314, DOI 10.1136/bmj.320.7245.1314; Swinkels DW, 2007, NETH J MED, V65, P452; Swinkels DW, 2006, CLIN CHEM, V52, P950, DOI 10.1373/clinchem.2006.068684; van Dijk BAC, 2008, BRIT J HAEMATOL, V142, P979, DOI 10.1111/j.1365-2141.2008.07273.x; Walsh A, 2006, CLIN GASTROENTEROL H, V4, P1403, DOI 10.1016/j.cgh.2006.07.009; Weiss G, 2010, NAT REV GASTRO HEPAT, V7, P50, DOI 10.1038/nrgastro.2009.201; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009; Wood MJ, 2008, BLOOD, V111, P4456, DOI 10.1182/blood-2007-11-122374	39	55	55	3	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2011	342								c7251	10.1136/bmj.c7251	http://dx.doi.org/10.1136/bmj.c7251			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711OX	21248018	Green Submitted			2022-12-28	WOS:000286602400006
J	Witt, DM				Witt, Daniel M.			Review: Positive D-dimer results predict recurrence after first unprovoked VTE regardless of test timing or cutpoint, or patient age	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Kaiser Permanente Colorado, Aurora, CO USA	Kaiser Permanente	Witt, DM (corresponding author), Kaiser Permanente Colorado, Aurora, CO USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-5	10.7326/0003-4819-154-2-201101180-02005	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242359				2022-12-28	WOS:000286223500031
J	Miller, KM; Li, SR; Kaukinen, KH; Ginther, N; Hammill, E; Curtis, JMR; Patterson, DA; Sierocinski, T; Donnison, L; Pavlidis, P; Hinch, SG; Hruska, KA; Cooke, SJ; English, KK; Farrell, AP				Miller, Kristina M.; Li, Shaorong; Kaukinen, Karia H.; Ginther, Norma; Hammill, Edd; Curtis, Janelle M. R.; Patterson, David A.; Sierocinski, Thomas; Donnison, Louise; Pavlidis, Paul; Hinch, Scott G.; Hruska, Kimberly A.; Cooke, Steven J.; English, Karl K.; Farrell, Anthony P.			Genomic Signatures Predict Migration and Spawning Failure in Wild Canadian Salmon	SCIENCE			English	Article							SOCKEYE-SALMON; FRASER-RIVER; PHYSIOLOGICAL CONDITION; ONCORHYNCHUS-NERKA; TEMPERATURE; MORTALITY; SURVIVAL; BEHAVIOR	Long-term population viability of Fraser River sockeye salmon (Oncorhynchus nerka) is threatened by unusually high levels of mortality as they swim to their spawning areas before they spawn. Functional genomic studies on biopsied gill tissue from tagged wild adults that were tracked through ocean and river environments revealed physiological profiles predictive of successful migration and spawning. We identified a common genomic profile that was correlated with survival in each study. In ocean-tagged fish, a mortality-related genomic signature was associated with a 13.5-fold greater chance of dying en route. In river-tagged fish, the same genomic signature was associated with a 50% increase in mortality before reaching the spawning grounds in one of three stocks tested. At the spawning grounds, the same signature was associated with 3.7-fold greater odds of dying without spawning. Functional analysis raises the possibility that the mortality-related signature reflects a viral infection.	[Miller, Kristina M.; Li, Shaorong; Kaukinen, Karia H.; Ginther, Norma] Fisheries & Oceans Canada, Mol Genet Sect, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Miller, Kristina M.; Hinch, Scott G.; Hruska, Kimberly A.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1Z4, Canada; [Hammill, Edd; Curtis, Janelle M. R.] Fisheries & Oceans Canada, Conservat Biol Sect, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Patterson, David A.] Simon Fraser Univ, Sch Resource & Environm Management, Fisheries & Oceans Canada, Cooperat Resource Management Inst, Burnaby, BC V5A 1S6, Canada; [Sierocinski, Thomas; Donnison, Louise; Pavlidis, Paul] Univ British Columbia, Dept Psychiat, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Cooke, Steven J.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [English, Karl K.] LGL Ltd Environm Res Associates, Sidney, BC V8L 3Y8, Canada; [Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V6T 1Z4, Canada	Fisheries & Oceans Canada; University of British Columbia; Fisheries & Oceans Canada; Fisheries & Oceans Canada; Simon Fraser University; University of British Columbia; Carleton University; University of British Columbia; University of British Columbia	Miller, KM (corresponding author), Fisheries & Oceans Canada, Mol Genet Sect, Pacific Biol Stn, 3190 Hammond Bay Rd, Nanaimo, BC V9T 6N7, Canada.	kristi.miller@dfo-mpo.gc.ca	Pavlidis, Paul/H-8406-2013; Cooke, Steven J/F-4193-2010; Hammill, Edd/F-9030-2013	Pavlidis, Paul/0000-0002-0426-5028; Cooke, Steven J/0000-0002-5407-0659; Hammill, Edd/0000-0001-8247-6106	Pacific Salmon Commission; Department of Fisheries and Oceans; Genome British Columbia; Natural Sciences and Engineering Research Council of Canada	Pacific Salmon Commission; Department of Fisheries and Oceans; Genome British Columbia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Microarray data were deposited (according to Microarray Gene Expression Data Society Standard) in the National Center for Biotechnology Information Gene Expression Omnibus (GEO, www.ncbi.nlm.nih.gov/geo/) with the saltwater experimental accession number GSE22171, freshwater GSE22177, spawning GSE22347, and Superseries ID GSE22179. We thank the Pacific Salmon Commission Southern Endowment Fund, Department of Fisheries and Oceans Genomics Research and Development Fund, Genome British Columbia, and Natural Sciences and Engineering Research Council of Canada for research support. All procedures used were developed with approvals and guidance from the Canadian Council on Animal Care administered by the University of British Columbia and Fisheries and Oceans Canada. We thank M. Donaldson, I. Olsson, G. Crossin, K. Hanson, R. Alexander, D. Robichaud, S. Tyerman, D. Welch, and J. Hills for tagging and biopsies; L. Stenhouse and A. Schulze for RNA extractions; M. Shrimpton for gill Na<SUP>+</SUP>/K<SUP>+</SUP> ATPase activity levels; C. Wallace for figure preparation; M. Lapointe and C. McConnell for organizational assistance; and the skippers and crews of the ocean vessels Sunfisher and Belina.	Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Cooke SJ, 2008, FISHERIES, V33, P321, DOI 10.1577/1548-8446-33.7.321; Cooke SJ, 2006, CAN J FISH AQUAT SCI, V63, P1469, DOI 10.1139/F06-042; Cooperman MS, 2010, PHYSIOL BIOCHEM ZOOL, V83, P459, DOI 10.1086/650473; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Crossin GT, 2009, PHYSIOL BIOCHEM ZOOL, V82, P635, DOI 10.1086/605878; English KK, 2005, T AM FISH SOC, V134, P1342, DOI 10.1577/T04-119.1; HINCH SG, 2009, C EARL MIGR PREM MOR, P8; Irvine JR, 2005, FISHERIES, V30, P11, DOI 10.1577/1548-8446(2005)30[11:CSARA]2.0.CO;2; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; MARTINS EG, GLOBAL CHAN IN PRESS, DOI DOI 10.1111/J.1365-2486.2010.02241.X; Mathes MT, 2010, CAN J FISH AQUAT SCI, V67, P70, DOI 10.1139/F09-158; Miller KM, 2009, COMP BIOCHEM PHYS D, V4, P75, DOI 10.1016/j.cbd.2008.11.002; Portner HO, 2009, SCIENCE, V323, P876; Rand P. S., IUCN 2010 IUCN RED L; von Schalburg KR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-126; Wagner GN, 2005, CAN J FISH AQUAT SCI, V62, P2124, DOI 10.1139/F05-126	18	146	153	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					214	217		10.1126/science.1196901	http://dx.doi.org/10.1126/science.1196901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233388				2022-12-28	WOS:000286433100042
J	Freeman, WL				Freeman, William L.			The Gift: Hy'shqe Siam	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												wfreeman@nwic.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					130	131		10.1001/jama.2010.1974	http://dx.doi.org/10.1001/jama.2010.1974			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224447				2022-12-28	WOS:000286103400001
J	Piscitelli, CL; Krishnamurthy, H; Gouaux, E				Piscitelli, Chayne L.; Krishnamurthy, Harini; Gouaux, Eric			Neurotransmitter/sodium symporter orthologue LeuT has a single high-affinity substrate site	NATURE			English	Article							BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; ACID TRANSPORTER; BINDING-SITE; MECHANISM; REVEALS; PROTEINS; NA+	Neurotransmitter/sodium symporters (NSSs) couple the uptake of neurotransmitter with one or more sodium ions(1-3), removing neurotransmitter from the synaptic cleft. NSSs are essential to the function of chemical synapses, are associated with multiple neurological diseases and disorders(4), and are the targets of therapeutic and illicit drugs(5). LeuT, a prokaryotic orthologue of the NSS family, is a model transporter for understanding the relationships between molecular mechanism and atomic structure in a broad range of sodium-dependent and sodium-independent secondary transporters(6-13). At present there is a controversy over whether there are one or two high-affinity substrate binding sites in LeuT. The first-reported crystal structure of LeuT, together with subsequent functional and structural studies, provided direct evidence for a single, high-affinity, centrally located substrate-binding site, defined as the S1 site(14,15). Recent binding, flux and molecular simulation studies, however, have been interpreted in terms of a model where there are two high-affinity binding sites: the central, S1, site and a second, the S2 site, located within the extracellular vestibule(16). Furthermore, it was proposed that the S1 and S2 sites are allosterically coupled such that occupancy of the S2 site is required for the cytoplasmic release of substrate from the S1 site(16). Here we address this controversy by performing direct measurement of substrate binding to wild-type LeuT and to S2 site mutants using isothermal titration calorimetry, equilibrium dialysis and scintillation proximity assays. In addition, we perform uptake experiments to determine whether the proposed allosteric coupling between the putative S2 site and the S1 site manifests itself in the kinetics of substrate flux. We conclude that LeuT harbours a single, centrally located, high-affinity substrate-binding site and that transport is well described by a simple, single-substrate kinetic mechanism.	[Piscitelli, Chayne L.; Krishnamurthy, Harini; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Piscitelli, Chayne L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	ARCS foundation; NIH [T32 DK007680]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	ARCS foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Pan and R. Hibbs for comments and L. Vaskalis for assistance with figures. C. L. P. was supported by the ARCS foundation and NIH training grant T32 DK007680. This work was supported by the NIH. E. G. is an investigator with the Howard Hughes Medical Institute.	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; CHRISTENSEN JJ, 1971, SCIENCE, V174, P459, DOI 10.1126/science.174.4008.459; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; SEGEL IH, 1975, ENZYME KINETICS, P398; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sobczak M, 2005, CURR OPIN MICROBIOL, V8, P161, DOI 10.1016/j.mib.2005.02.005; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	25	104	104	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1129	U538		10.1038/nature09581	http://dx.doi.org/10.1038/nature09581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179170	Green Accepted			2022-12-28	WOS:000285553800064
J	Rao, M; Rao, KD; Kumar, AKS; Chatterjee, M; Sundararaman, T				Rao, Mohan; Rao, Krishna D.; Kumar, A. K. Shiva; Chatterjee, Mirai; Sundararaman, Thiagarajan			India: Towards Universal Health Coverage 5 Human resources for health in India	LANCET			English	Article							MEDICAL-EDUCATION; SERVICES; QUALITY; WORKERS; WEALTH; DELHI	India has a severe shortage of human resources for health. It has a shortage of qualified health workers and the workforce is concentrated in urban areas. Bringing qualified health workers to rural, remote, and underserved areas is very challenging. Many Indians, especially those living in rural areas, receive care from unqualified providers. The migration of qualified allopathic doctors and nurses is substantial and further strains the system. Nurses do not have much authority or say within the health system, and the resources to train them are still inadequate. Little attention is paid during medical education to the medical and public health needs of the population, and the rapid privatisation of medical and nursing education has implications for its quality and governance. Such issues are a result of underinvestment in and poor governance of the health sector two issues that the government urgently needs to address. A comprehensive national policy for human resources is needed to achieve universal health care in India. The public sector will need to redesign appropriate packages of monetary and non-monetary incentives to encourage qualified health workers to work in rural and remote areas. Such a policy might also encourage task-shifting and mainstreaming doctors and practitioners who practice traditional Indian medicine (ayurveda, yoga and naturopathy, unani, and siddha) and homoeopathy to work in these areas while adopting other innovative ways of augmenting human resources for health. At the same time, additional investments will be needed to improve the relevance, quantity, and quality of nursing, medical, and public health education in the country.	[Rao, Krishna D.] Publ Hlth Fdn India, New Delhi 110070, India; [Rao, Mohan] Jawaharlal Nehru Univ, Ctr Social Med & Community Hlth, New Delhi 110067, India; [Kumar, A. K. Shiva] UNICEF, New Delhi, India; [Chatterjee, Mirai] SEWA, Ahmadabad, Gujarat, India; [Sundararaman, Thiagarajan] Natl Hlth Syst Resource, New Delhi, India	Public Health Foundation of India; Jawaharlal Nehru University, New Delhi	Rao, KD (corresponding author), Publ Hlth Fdn India, New Delhi 110070, India.	kd.rao@phfi.org			John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	We thank Aarushi Bhatnagar and Oommen C Kurian for his assistance. The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India.	Academy for Nursing Studies, 2005, SIT AN PUBL HLTH NUR; *ALL IND I MED SCI, FEES EXP; BACH S, 2006, 200682 UNUWIDER; Banerjee A, 2004, AM ECON REV, V94, P326, DOI 10.1257/0002828041301902; BARU R, 2005, REV HEALTHCARE INDIA, P107; Buchan J., 2004, INT RECRUITMENT HLTH; Chatterjee Saha S., 2008, INTERNET J NUTR WELL, V5, P1; COUTINHO L, 2002, EC POLIT WKLY, V8, P656; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; Das J, 2007, J DEV ECON, V83, P1, DOI 10.1016/j.jdeveco.2006.05.004; DAS V, 2002, EC POLIT WKLY, V8, P625; DHAR A, 2010, HINDU           0512; DHAR A, 2010, HINDU           0206; DHAR A, 2009, HINDU           0915; DURGAPARASAD P, 1993, MANAGEMENT RURAL HLT; GAUTHAM M, 2009, HINDU           1105; GHOSH A, 2008, TIMES INDIA     0218; *GOV IND, 2007, REC MED ED; *GOV IND, NAT HLTH PROF IND 20; *GOV IND, 2009, B RUR HLTH STAT 2008; *GOV IND, 2009, 13 FIN COMM GRANTS H; *GOV IND, 2006, TASK FORC PLANN HUM; *GOV IND, 2006, TASK FORC MED ED NAT; *GOV IND, SUMM INFR FAC AYURV; *GOV IND NAT KNOWL, 2007, NAT KNOWL COMM REC M; Government of India, 1985, COMP REC VAR COMM HL; Government of India, 1975, HLTH SERV MED ED PRO; Government Of India, 2004, REV IND NAT CLASS OC; Government of India (Bhore Committee), 1946, REP HLTH SURV DEV CO, VI; Government of India (GOI), 2005, NAT RUR HLTH MISS 20; Government of India/Office of the Registrar General and Census Commissioner, 2001, CENS IND 2001; Government of India & WHO, 2009, NAT HLTH ACC 2004 05; GREENHALGH T, 1987, SOC SCI MED, V25, P307, DOI 10.1016/0277-9536(87)90233-4; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hammer J., 2007, Economic and Political Weekly, V42, P4049; HEALEY M, INT NURSE ADVISERS N; Iyer A, 1995, WOMEN HLTH CARE AUXI; Jeffery R., 1988, POLITICS HLTH INDIA; Justice J., 1989, POLICIES PLANS PEOPL; KAUL R, 2010, SEMINAR, P494; Kaushik M, 2008, B WORLD HEALTH ORGAN, V86, P40, DOI 10.2471/BLT.07.041681; Kingma M, 2007, HEALTH SERV RES, V42, P1281, DOI 10.1111/j.1475-6773.2007.00711.x; Kumari Ranjeeta, 2009, Indian J Community Med, V34, P35, DOI 10.4103/0970-0218.45372; *MAN U, ADM MAN U; *MED COUNC IND, ANN REP 2007 08; Medical Council of India, SEARCH COLL COURS; Mullan F, 2006, HEALTH AFFAIR, V25, P380, DOI 10.1377/hlthaff.25.2.380; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; MURALEEDHARAN VR, 1999, CHARACTERISTICS STRU; NANDA P, 1993, PRIVATE NURSING HOME; NANDARAJ S, 1997, PHYS STANDARDS PRIVA; Narayana K, 2006, UNQUALIFIED MED PRAC; *NAT COUNC STAT BO, 2000 NURS LIC VOL NC; *NAT COUNC STAT BO, 2007 NURS LIC VOL NC; *NAT HLTH SERV, LIST DEV COUNTR; *NAT I HLTH FAM WE, 1978, EV COMM HLTH WORK SC; *NAT I HLTH FAM WE, 1979, REP EV COMM HLTH VOL; *NAT SAMPL SURV OR, EMPL UN SIT IND 20 1; NICHTER MA, 1986, SOC SCI MED, V23, P347, DOI 10.1016/0277-9536(86)90077-8; Patel V, 2005, J Postgrad Med, V51, P9; Patro Binod Kumar, 2008, Indian J Community Med, V33, P250, DOI 10.4103/0970-0218.43232; PHADKE A, 1998, DRUG SUPPLY USE RATI; PRAKASH P, 1993, INDIAN J SOC WORK, V54, P199; *PUBL HLTH FDN IND, 2010, WHICH DOCT PRIM HLTH; Raha S, 2009, INDIA HLTH BEAT; RAHA S, 2009, HRH POLITICAL EC I A; RANA K, 2003, EC POLIT WKLY, V38, P1451; Rao K, 2009, INDIA HLTH BEAT; RAO K, 2009, HLTH BEAT; Rao KD, 2006, INT J QUAL HEALTH C, V18, P414, DOI 10.1093/intqhc/mzl049; Rao M S, 1968, Med Hist, V12, P52; RICHARDS T, 1985, BRIT MED J, V290, P1132, DOI 10.1136/bmj.290.6475.1132; Sakthivel Selvaraj, 2009, Economic and Political Weekly, V44, P55; Sharma DC, 2001, LANCET, V358, P1882, DOI 10.1016/S0140-6736(01)06935-5; SUNDARARAMAN T, 2005, REV HEALTHCARE INDIA, P107; Sundararaman T, 2007, LANCET, V369, P2058, DOI 10.1016/S0140-6736(07)60326-2; Supe A, 2006, ACAD MED, V81, P1076, DOI 10.1097/01.ACM.0000246699.94234.ab; *TNAI, 2006, NURS IND; Welfare M., 2005, INTRO NATL SMOKING P, P20; WHO Europe, 1978, DECL ALM AT; World Health Organization, 2007, NOT ENOUGH HER TOO M; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; 2010, EC POLIT WKLY, V45, P9; 2009, TIMES INDIA     0617	84	221	222	2	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					587	598		10.1016/S0140-6736(10)61888-0	http://dx.doi.org/10.1016/S0140-6736(10)61888-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724DQ	21227499				2022-12-28	WOS:000287556700029
J	Scales, DC; Dainty, K; Hales, B; Pinto, R; Fowler, RA; Adhikari, NKJ; Zwarenstein, M				Scales, Damon C.; Dainty, Katie; Hales, Brigette; Pinto, Ruxandra; Fowler, Robert A.; Adhikari, Neill K. J.; Zwarenstein, Merrick			A Multifaceted Intervention for Quality Improvement in a Network of Intensive Care Units A Cluster Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-TRIAL; SEVERE SEPSIS; PERFORMANCE; IMPLEMENTATION; MULTICENTER; MORTALITY; STATEMENT; MEDICINE; OUTCOMES; PROGRAM	Context Evidence-based practices improve intensive care unit (ICU) outcomes, but eligible patients may not receive them. Community hospitals treat most critically ill patients but may have few resources dedicated to quality improvement. Objective To determine the effectiveness of a multicenter quality improvement program to increase delivery of 6 evidence-based ICU practices. Design, Setting, and Participants Pragmatic cluster-randomized trial among 15 community hospital ICUs in Ontario, Canada. A total of 9269 admissions occurred during the trial (November 2005 to October 2006) and 7141 admissions during a decay-monitoring period (December 2006 to August 2007). Intervention We implemented a videoconference-based forum including audit and feedback, expert-led educational sessions, and dissemination of algorithms to sequentially improve delivery of 6 practices. We randomized ICUs into 2 groups. Each group received this intervention, targeting a new practice every 4 months, while acting as control for the other group, in which a different practice was targeted in the same period. Main Measure Outcomes The primary outcome was the summary ratio of odds ratios (ORs) for improvement in adoption (determined by daily data collection) of all 6 practices during the trial in intervention vs control ICUs. Results Overall, adoption of the targeted practices was greater in intervention ICUs than in controls (summary ratio of ORs, 2.79; 95% confidence interval [CI], 1.00-7.74). Improved delivery in intervention ICUs was greatest for semirecumbent positioning to prevent ventilator-associated pneumonia (90.0% of patient-days in last month vs 50.0% in first month; OR, 6.35; 95% CI, 1.85-21.79) and precautions to prevent catheter-related bloodstream infection (70.0% of patients receiving central lines vs 10.6%; OR, 30.06; 95% CI, 11.00-82.17). Adoption of other practices, many with high baseline adherence, changed little. Conclusion In a collaborative network of community ICUs, a multifaceted quality improvement intervention improved adoption of care practices.	[Scales, Damon C.; Pinto, Ruxandra; Fowler, Robert A.; Adhikari, Neill K. J.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.; Fowler, Robert A.; Adhikari, Neill K. J.] Univ Toronto, Interdept Div Crit Care, Toronto, ON, Canada; [Zwarenstein, Merrick] Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Hales, Brigette] Sunnybrook Hlth Sci Ctr, Dept Qual & Patient Safety, Toronto, ON M4N 3M5, Canada; [Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.; Fowler, Robert A.; Adhikari, Neill K. J.; Zwarenstein, Merrick] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.; Zwarenstein, Merrick] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Dainty, Katie] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Scales, DC (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave,D108, Toronto, ON M4N 3M5, Canada.	damon.scales@utoronto.ca	Dainty, Katie/AAI-8842-2020; Dainty, Katie N/P-3539-2014; Dainty, Katie/Y-7287-2019; Zwarenstein, Merrick F/P-5210-2014	Dainty, Katie N/0000-0002-2906-8813; Zwarenstein, Merrick F/0000-0003-0162-7027	Ontario Ministry of Health and Long-Term Care (MOHLTC); Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; MOHLTC Critical Care Transformation Strategy	Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); MOHLTC Critical Care Transformation Strategy	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Scales reports receiving a stipend from the Ontario Ministry of Health and Long-Term Care (MOHLTC) for his role as physician lead, MOHLTC Ontario ICU Clinical Best Practices Project, and he currently holds a New Investigator Award from the Canadian Institutes of Health Research. Ms Hales reports receiving salary support from her institution that was derived in part by the funding source for this study. Dr Fowler reports that he held a career scientist award from the Ontario Ministry of Health and Long-Term Care during the conduct of this study and is a Clinician Scientist of the Heart and Stroke Foundation of Canada. No other authors reported any financial conflicts of interest.; This study was funded by the MOHLTC Critical Care Transformation Strategy as the MOHLTC Ontario ICU Clinical Best Practices Demonstration Project.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bach PB, 1998, AM J RESP CRIT CARE, V158, P1410, DOI 10.1164/ajrccm.158.5.9804042; Berglund G, 1997, PSYCHO-ONCOL, V6, P35, DOI 10.1002/(SICI)1099-1611(199703)6:1<35::AID-PON241>3.3.CO;2-A; BERGSTROM N, 1987, NURS CLIN N AM, V22, P417; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Brindis RG, 2006, ACAD MED, V81, P802, DOI 10.1097/00001888-200609000-00007; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Center for Medicare & Medicaid Services, PHYS QUAL REP IN; Cooper H, 2009, HDB RES SYNTHESIS ME; Curtis JR, 2006, CRIT CARE MED, V34, P211, DOI 10.1097/01.CCM.0000190617.76104.AC; Doig GS, 2008, JAMA-J AM MED ASSOC, V300, P2731, DOI 10.1001/jama.2008.826; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Grimshaw JM, 2001, MED CARE, V39, pII2; Halpern NA, 2004, CRIT CARE MED, V32, P1254, DOI 10.1097/01.CCM.0000128577.31689.4C; Hauschke D, 2005, BIOMETRICAL J, V47, P782, DOI 10.1002/bimj.200510169; Haydar Z, 2008, AM J MED QUAL, V23, P252, DOI 10.1177/1062860608319814; Hedges LV, 2014, STAT METHODS META AN; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kahn JM, 2007, CURR OPIN CRIT CARE, V13, P709, DOI 10.1097/MCC.0b013e3282f1be5c; Kahn JM, 2010, AM J RESP CRIT CARE, V181, P752, DOI 10.1164/rccm.200903-0450ST; Khanduja K, 2009, CRIT CARE MED, V37, P852, DOI 10.1097/CCM.0b013e3181962b0b; Lee SK, 2009, CAN MED ASSOC J, V181, P469, DOI 10.1503/cmaj.081727; MacLehose R R, 2000, Health Technol Assess, V4, P1; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621; Murray DM, 1998, DESIGN ANAL GROUP RA; Nedza SM, 2009, ACAD MED, V84, P1645, DOI 10.1097/ACM.0b013e3181bf9c9c; O'Grady Margaret A, 2007, J Natl Compr Canc Netw, V5, P875; Ontario Critical Care LHIN Leadership Table, 2007, INV CRIT CAR SERV AN; Patel MR, 2007, AM J MED, V120, P40, DOI 10.1016/j.amjmed.2006.10.008; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2004, J CRIT CARE, V19, P158, DOI 10.1016/j.jcrc.2004.07.003; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2004, CRIT CARE MED, V32, P1289, DOI 10.1097/01.CCM.0000127266.39560.96; Scales DC, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-5; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	38	130	133	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					363	372		10.1001/jama.2010.2000	http://dx.doi.org/10.1001/jama.2010.2000			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711MH	21248161				2022-12-28	WOS:000286595200021
J	Papamichos-Chronakis, M; Watanabe, S; Rando, OJ; Peterson, CL				Papamichos-Chronakis, Manolis; Watanabe, Shinya; Rando, Oliver J.; Peterson, Craig L.			Global Regulation of H2A.Z Localization by the INO80 Chromatin-Remodeling Enzyme Is Essential for Genome Integrity	CELL			English	Article							HISTONE VARIANT H2A.Z; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; RECOMBINANT HISTONES; CELL-CYCLE; COMPLEX; ACETYLATION; REPAIR; YEAST; TRANSCRIPTION	INO80 is an evolutionarily conserved, ATP-dependent chromatin-remodeling enzyme that plays roles in transcription, DNA repair, and replication. Here, we show that yeast INO80 facilitates these diverse processes at least in part by controlling genome-wide distribution of the histone variant H2A.Z. In the absence of INO80, H2A.Z nucleosomes are mislocalized, and H2A.Z levels at promoters show reduced responsiveness to transcriptional changes, suggesting that INO80 controls H2A.Z dynamics. Additionally, we demonstrate that INO80 has a histone-exchange activity in which the enzyme can replace nucleosomal H2A.Z/H2B with free H2A/H2B dimers. Genetic interactions between ino80 and htz1 support a model in which INO80 catalyzes the removal of unacetylated H2A.Z from chromatin as a mechanism to promote genome stability.	[Papamichos-Chronakis, Manolis; Watanabe, Shinya; Peterson, Craig L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA; [Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Peterson, CL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA.	craig.peterson@umassmed.edu		Rando, Oliver/0000-0003-1516-9397; Papamichos-Chronakis, Emmanouil/0000-0002-4144-2070	National Institutes of Health [GM54096]; Burroughs Wellcome Fund; National Institute of General Medical Sciences; Human Frontier Science Program; Inserm; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054096, R01GM079205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Human Frontier Science Program(Human Frontier Science Program); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health to C.L.P. (GM54096). O.J.R. is supported in part by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund and grants from the National Institute of General Medical Sciences and Human Frontier Science Program. M.P.-C. is supported by the Avenir Program from Inserm. We thank John Holik [University of Massachusetts Medical School (UMMS)] for assistance with the tiling array studies, Jerry Workman (Stowers Institute) for yeast histone expression vectors, John Lescyz (UMMS) for mass spectrometry analysis, Nicholas Adkins (UMMS) for the western blot with Millipore alpha-Htz1 sera (Figure S7), Erica Hong (Harvard Medical School) for help with Figure 7, members of the Peterson lab for helpful discussions throughout the course of this work, and Genevieve Almouzni (Curie Institute), Angela Taddei (Curie Institute), and Valerie Borde (Curie Institute) for critical reading of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Begley TJ, 2002, MOL CANCER RES, V1, P103; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Hur SK, 2010, CELL MOL LIFE SCI, V67, P2283, DOI 10.1007/s00018-010-0337-3; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Klopf E, 2009, MOL CELL BIOL, V29, P4994, DOI 10.1128/MCB.01858-08; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kurihara LJ, 1996, MOL CELL BIOL, V16, P3990; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Logie C, 1999, METHOD ENZYMOL, V304, P726; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1999, METH MOL B, V119, P1; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Papamichos-Chronakis M, 2008, NAT STRUCT MOL BIOL, V15, P338, DOI 10.1038/nsmb.1413; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Ren QH, 2001, MOL CELL, V7, P1329, DOI 10.1016/S1097-2765(01)00269-6; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ruhl DD, 2006, BIOCHEMISTRY-US, V45, P5671, DOI 10.1021/bi060043d; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Sinha M, 2009, CELL, V138, P1109, DOI 10.1016/j.cell.2009.07.013; Svotelis A, 2010, CELL CYCLE, V9, P364, DOI 10.4161/cc.9.2.10465; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Vincent JA, 2008, NAT STRUCT MOL BIOL, V15, P477, DOI 10.1038/nsmb.1419; Wang AY, 2009, P NATL ACAD SCI USA, V106, P21573, DOI 10.1073/pnas.0906539106; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	51	287	295	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					200	213		10.1016/j.cell.2010.12.021	http://dx.doi.org/10.1016/j.cell.2010.12.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241891	Green Accepted, Bronze			2022-12-28	WOS:000286459900006
J	Small, EM; Olson, EN				Small, Eric M.; Olson, Eric N.			Pervasive roles of microRNAs in cardiovascular biology	NATURE			English	Review							NEOINTIMAL LESION FORMATION; CONGENITAL HEART-DISEASE; MUSCLE-SPECIFIC MICRORNA; CORONARY-ARTERY-DISEASE; EMBRYONIC STEM-CELLS; CHANNEL GENES HCN2; CARDIAC-HYPERTROPHY; VASCULAR INTEGRITY; FAILURE PATIENTS; DOWN-REGULATION	First recognized as regulators of development in worms and fruitflies, microRNAs are emerging as pivotal modulators of mammalian cardiovascular development and disease. Individual microRNAs modulate the expression of collections of messenger RNA targets that often have related functions, thereby governing complex biological processes. The wide-ranging functions of microRNAs in the cardiovascular system have provided new perspectives on disease mechanisms and have revealed intriguing therapeutic targets, as well as diagnostics, for a variety of cardiovascular disorders.	[Small, Eric M.; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Duarte, Graziela Biude Silva/Q-7728-2016		National Institutes of Health; Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation; Fondation Leducq's Transatlantic Network for Excellence; American Heart Association; Jon Holden DeHaan Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093039, R37HL053351, R01HL077439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation(The Welch Foundation); Fondation Leducq's Transatlantic Network for Excellence; American Heart Association(American Heart Association); Jon Holden DeHaan Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We apologize to all colleagues whose work could not be cited owing to space restrictions. We thank J. Cabrera for artwork and J. Brown for editorial assistance. E.N.O. was supported by grants from the National Institutes of Health, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the Robert A. Welch Foundation, the Fondation Leducq's Transatlantic Network for Excellence in Cardiovascular Research Program, the American Heart Association and the Jon Holden DeHaan Foundation. E. M. S. was supported by a scientist development grant from the American Heart Association.	Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Alvarez-Saavedra E, 2010, CURR BIOL, V20, P367, DOI 10.1016/j.cub.2009.12.051; Ambros V, 2010, CURR BIOL, V20, pR598, DOI 10.1016/j.cub.2010.05.054; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Brenner JL, 2010, CURR BIOL, V20, P1321, DOI 10.1016/j.cub.2010.05.062; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Cao GJ, 2010, BIOCHEM BIOPH RES CO, V396, P978, DOI 10.1016/j.bbrc.2010.05.037; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cordes KR, 2009, CIRC RES, V104, P724, DOI 10.1161/CIRCRESAHA.108.192872; Deacon DC, 2010, DEVELOPMENT, V137, P1887, DOI 10.1242/dev.050526; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fleissner F, 2010, CIRC RES, V107, P138, DOI 10.1161/CIRCRESAHA.110.216770; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Huang ZP, 2010, J CARDIOVASC TRANSL, V3, P212, DOI 10.1007/s12265-010-9165-y; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Luo XB, 2008, J BIOL CHEM, V283, P20045, DOI 10.1074/jbc.M801035200; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schipper MEI, 2008, J HEART LUNG TRANSPL, V27, P1282, DOI 10.1016/j.healun.2008.09.005; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; van Solingen C, 2009, J CELL MOL MED, V13, P1577, DOI 10.1111/j.1582-4934.2008.00613.x; Voellenkle C, 2010, PHYSIOL GENOMICS, V42, P420, DOI 10.1152/physiolgenomics.00211.2009; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Xiao JN, 2007, J CELL PHYSIOL, V212, P285, DOI 10.1002/jcp.21062; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhao GW, 2010, CURR OPIN HEMATOL, V17, P155, DOI 10.1097/MOH.0b013e328337ba6c; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	91	932	977	0	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					336	342		10.1038/nature09783	http://dx.doi.org/10.1038/nature09783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248840	Green Accepted			2022-12-28	WOS:000286385600040
J	Uzoigwe, CE; Shahid, R; Middleton, RG; Faizi, M; Maqsood, M; Baco, A				Uzoigwe, Chika E.; Shahid, Rizwan; Middleton, Rory G.; Faizi, Murtuza; Maqsood, Mohammad; Baco, Abdul			Volcanic knee	LANCET			English	Editorial Material							BRODIES ABSCESS		[Middleton, Rory G.; Faizi, Murtuza] Leicester Royal Infirm, Dept Trauma & Orthopaed, Leicester, Leics, England; [Uzoigwe, Chika E.; Shahid, Rizwan; Maqsood, Mohammad; Baco, Abdul] Lincoln Cty Hosp, Dept Trauma & Orthopaed, Lincoln, England	University of Leicester	Uzoigwe, CE (corresponding author), Gen Hosp Kettering, Rothwell Rd, Kettering NN16 8YR, England.	chika@doctors.org.uk						Brodie B C, 1832, Med Chir Trans, V17, P239; Kanoun Mohamed Lassaad, 2007, Tunis Med, V85, P857; Kornaat PR, 2010, JBR-BTR, V93, P81, DOI 10.5334/jbr-btr.145; MILLER WB, 1979, RADIOLOGY, V132, P15, DOI 10.1148/132.1.15; STEPHENS MM, 1988, CLIN ORTHOP RELAT R, P211	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 15	2011	377	9761					270	270		10.1016/S0140-6736(10)61348-7	http://dx.doi.org/10.1016/S0140-6736(10)61348-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712WG	21237401				2022-12-28	WOS:000286696400034
J	Dwyer, T; Ponsonby, AL; Ukoumunne, OC; Pezic, A; Venn, A; Dunstan, D; Barr, E; Blair, S; Cochrane, J; Zimmet, P; Shaw, J				Dwyer, T.; Ponsonby, A-L; Ukoumunne, O. C.; Pezic, A.; Venn, A.; Dunstan, D.; Barr, E.; Blair, S.; Cochrane, J.; Zimmet, P.; Shaw, J.			Association of change in daily step count over five years with insulin sensitivity and adiposity: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPAIRED GLUCOSE-TOLERANCE; PHYSICAL-ACTIVITY; LIFE-STYLE; METABOLIC SYNDROME; SEDENTARY TIME; OBESITY; INTENSITY; PEDOMETER; MODERATE; RISK	Objectives To investigate the association between change in daily step count and both adiposity and insulin sensitivity and the extent to which the association between change in daily step count and insulin sensitivity may be mediated by adiposity. Design Population based cohort study. Setting Tasmania, Australia. Participants 592 adults (men (n=267), mean age 51.4 (SD 12.2) years; women (n=325), mean age 50.3 (12.3) years) who participated in the Tasmanian component of the national AusDiab Study in 2000 and 2005. Main outcome measures Body mass index, waist to hip ratio, and HOMA insulin sensitivity at follow-up in 2005. Results Over the five year period, the daily step count decreased for 65% (n=382) of participants. Having a higher daily step count in 2005 than in 2000 was independently associated with lower body mass index (0.08 (95% confidence interval 0.04 to 0.12) lower per 1000 steps), lower waist to hip ratio (0.15 (0.07 to 0.23) lower), and greater insulin sensitivity (1.38 (0.14 to 2.63) HOMA units higher) in 2005. The mean increase in HOMA units fell to 0.34 (-0.79 to 1.47) after adjustment for body mass index in 2005. Conclusions Among community dwelling, middle aged adults, a higher daily step count at five year follow-up than at baseline was associated with better insulin sensitivity. This effect seems to be largely mediated through lower adiposity.	[Dwyer, T.; Ponsonby, A-L; Ukoumunne, O. C.; Pezic, A.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Dwyer, T.; Ponsonby, A-L; Venn, A.; Cochrane, J.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Dunstan, D.; Barr, E.; Zimmet, P.; Shaw, J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Blair, S.] Univ S Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Tasmania; Menzies Institute for Medical Research; Baker Heart and Diabetes Institute; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Dwyer, T (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	terry.dwyer@mcri.edu.au	Venn, Alison J/J-2803-2013; Zimmet, Paul/O-8486-2019; Dunstan, David Wayne/E-8473-2010; Shaw, Jonathan/E-7388-2010; Ponsonby, Anne-Louise/AAE-4351-2019	Zimmet, Paul/0000-0003-0627-0776; Dunstan, David Wayne/0000-0003-2629-9568; Shaw, Jonathan/0000-0002-6187-2203; Ponsonby, Anne-Louise/0000-0002-6581-3657	Commonwealth Department of Health and Aged Care; Abbott Australasia; Alphapharm; Aventis Pharmaceutical; AstraZeneca; Bristol-Myers Squibb Pharmaceuticals; Eli Lilly (Australia); GlaxoSmithKline; Janssen-Cilag (Australia); Merck Lipha; Merck Sharp & Dohme (Australia); Novartis Pharmaceutical (Australia); Novo Nordisk Pharmaceutical,; Pharmacia and Upjohn; Pfizer; Roche Diagnostics; Sanofi Synthelabo (Australia); Servier Laboratories (Australia); BioRad Laboratories; HITECH Pathology; Australian Kidney Foundation; Diabetes Australia; Diabetes Australia (Northern Territory); Queensland Health; South Australian Department of Human Services; Tasmanian Department of Health and Human Services; Territory Health Services; Victorian Department of Human Services; Health Department of Western Australia; Victorian Health Promotion Foundation; NHMRC [436914]	Commonwealth Department of Health and Aged Care; Abbott Australasia(Abbott Laboratories); Alphapharm; Aventis Pharmaceutical; AstraZeneca(AstraZeneca); Bristol-Myers Squibb Pharmaceuticals(Bristol-Myers Squibb); Eli Lilly (Australia)(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag (Australia)(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Lipha; Merck Sharp & Dohme (Australia)(Merck & Company); Novartis Pharmaceutical (Australia); Novo Nordisk Pharmaceutical,(Novo Nordisk); Pharmacia and Upjohn; Pfizer(Pfizer); Roche Diagnostics; Sanofi Synthelabo (Australia); Servier Laboratories (Australia); BioRad Laboratories; HITECH Pathology; Australian Kidney Foundation; Diabetes Australia; Diabetes Australia (Northern Territory); Queensland Health; South Australian Department of Human Services(Department for Environment, Food & Rural Affairs (DEFRA)); Tasmanian Department of Health and Human Services; Territory Health Services; Victorian Department of Human Services; Health Department of Western Australia; Victorian Health Promotion Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study received financial support from the Commonwealth Department of Health and Aged Care, Abbott Australasia, Alphapharm, Aventis Pharmaceutical, AstraZeneca, Bristol-Myers Squibb Pharmaceuticals, Eli Lilly (Australia), GlaxoSmithKline, Janssen-Cilag (Australia), Merck Lipha, Merck Sharp & Dohme (Australia), Novartis Pharmaceutical (Australia), Novo Nordisk Pharmaceutical, Pharmacia and Upjohn, Pfizer, Roche Diagnostics, Sanofi Synthelabo (Australia), Servier Laboratories (Australia), BioRad Laboratories, HITECH Pathology, the Australian Kidney Foundation, Diabetes Australia, Diabetes Australia (Northern Territory), Queensland Health, South Australian Department of Human Services, Tasmanian Department of Health and Human Services, Territory Health Services, Victorian Department of Human Services, and Health Department of Western Australia. DD is supported by a Victorian Health Promotion Foundation public health research fellowship. OCU is supported by NHMRC Population Health Capacity Building Grant 436914. JS is supported by an NHMRC senior research fellowship.	Ainsworth BE., 2002, COMPENDIUM PHYS ACTI; Australian Bureau of Statistics, 2001, SOC IND AR SEIFA; Australian Institute of Health and Welfare, 2003, ACT AUSTR SURV; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Cameron AJ, 2008, OBESITY, V16, P2707, DOI 10.1038/oby.2008.412; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Coke LA, 2010, J CARDIOVASC NURS, V25, P238, DOI 10.1097/JCN.0b013e3181cec814; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Dwyer T, 2007, INT J OBESITY, V31, P797, DOI 10.1038/sj.ijo.0803472; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; Hall AJ, 2002, INT J EPIDEMIOL, V31, P300, DOI 10.1093/ije/31.2.300; Hatano Y, 1993, INT COUNC HLTH PHYS, V29, P4; Hellie T, 2010, MEASURE YOUR STEP ST; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Little R. J. A., 2002, STAT ANAL MISSING DA; Magliano DJ, 2008, DIABETES CARE, V31, P267, DOI 10.2337/dc07-0912; Marshall SJ, 2009, AM J PREV MED, V36, P410, DOI 10.1016/j.amepre.2009.01.021; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Timperio A., 2002, VALIDATION ADULT PHY; Tudor-Locke C, 2002, MED SCI SPORT EXER, V34, P2045, DOI 10.1097/00005768-200212000-00027; Tudor-Locke C, 2005, PREV MED, V40, P293, DOI 10.1016/j.ypmed.2004.06.003; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wilkin TJ, 2004, J ROY SOC MED, V97, P511, DOI 10.1258/jrsm.97.11.511	30	52	52	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2011	342								c7249	10.1136/bmj.c7249	http://dx.doi.org/10.1136/bmj.c7249			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708TG	21233153	hybrid, Green Submitted			2022-12-28	WOS:000286386600002
J	Uthoff, H; Wiesli, P				Uthoff, Heiko; Wiesli, Peter			Auricular Cartilage Calcification and Adrenal Insufficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Uthoff, Heiko; Wiesli, Peter] Kantonsspital Frauenfeld, Frauenfeld, Switzerland		Uthoff, H (corresponding author), Kantonsspital Frauenfeld, Frauenfeld, Switzerland.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					157	157		10.1056/NEJMicm1000193	http://dx.doi.org/10.1056/NEJMicm1000193			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226581				2022-12-28	WOS:000286142900009
J	Trelle, S; Reichenbach, S; Wandel, S; Hildebrand, P; Tschannen, B; Villiger, PM; Egger, M; Juni, P				Trelle, Sven; Reichenbach, Stephan; Wandel, Simon; Hildebrand, Pius; Tschannen, Beatrice; Villiger, Peter M.; Egger, Matthias; Jueni, Peter			Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CYCLOOXYGENASE-2 INHIBITORS; CYCLO-OXYGENASE-2 INHIBITORS; ALZHEIMER-DISEASE; RISK; ROFECOXIB; EVENTS; TRIALS; OSTEOARTHRITIS; POPULATION; INCREASE	Objective To analyse the available evidence on cardiovascular safety of non-steroidal anti-inflammatory drugs. Design Network meta-analysis. Data sources Bibliographic databases, conference proceedings, study registers, the Food and Drug Administration website, reference lists of relevant articles, and reports citing relevant articles through the Science Citation Index (last update July 2009). Manufacturers of celecoxib and lumiracoxib provided additional data. Study selection All large scale randomised controlled trials comparing any non-steroidal anti-inflammatory drug with other non-steroidal anti-inflammatory drugs or placebo. Two investigators independently assessed eligibility. Data extraction The primary outcome was myocardial infarction. Secondary outcomes included stroke, death from cardiovascular disease, and death from any cause. Two investigators independently extracted data. Data synthesis 31 trials in 116 429 patients with more than 115 000 patient years of follow-up were included. Patients were allocated to naproxen, ibuprofen, diclofenac, celecoxib, etoricoxib, rofecoxib, lumiracoxib, or placebo. Compared with placebo, rofecoxib was associated with the highest risk of myocardial infarction (rate ratio 2.12, 95% credibility interval 1.26 to 3.56), followed by lumiracoxib (2.00, 0.71 to 6.21). Ibuprofen was associated with the highest risk of stroke (3.36, 1.00 to 11.6), followed by diclofenac (2.86, 1.09 to 8.36). Etoricoxib (4.07, 1.23 to 15.7) and diclofenac (3.98, 1.48 to 12.7) were associated with the highest risk of cardiovascular death. Conclusions Although uncertainty remains, little evidence exists to suggest that any of the investigated drugs are safe in cardiovascular terms. Naproxen seemed least harmful. Cardiovascular risk needs to be taken into account when prescribing any non-steroidal antiinflammatory drug.	[Trelle, Sven; Reichenbach, Stephan; Wandel, Simon; Tschannen, Beatrice; Egger, Matthias; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Trelle, Sven; Jueni, Peter] Inselspital Bern, CTU Bern, Bern, Switzerland; [Hildebrand, Pius] Swissmed Swiss Agcy Therapeut Prod, Bern, Switzerland; [Reichenbach, Stephan; Villiger, Peter M.] Inselspital Bern, Dept Rheumatol & Clin Immunol Allergol, Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Juni, P (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Bannuru, Raveendhara/G-2601-2011; Trelle, Sven/D-3760-2009; Villiger, Peter/AAV-8132-2021; Juni, Peter/Q-8700-2016	Bannuru, Raveendhara/0000-0002-8069-5783; Trelle, Sven/0000-0002-8162-8910; Juni, Peter/0000-0002-5985-0670; , Simon/0000-0002-1442-597X; Reichenbach, Stephan/0000-0001-8098-6567; Egger, Matthias/0000-0001-7462-5132	Swiss National Science Foundation [4053-40-104762/3, 3200-066378, 3233-066377]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	SR, ME, and PJ received grants (Nos 4053-40-104762/3 and 3200-066378) from the Swiss National Science Foundation's national research programme 53 on musculoskeletal health. PJ was a programme for social medicine, preventive and epidemiological research senior research fellow funded by the Swiss National Science Foundation (grant No 3233-066377). CTU Bern is supported by the Swiss National Science Foundation. The Swiss National Science Foundation, had no role in the study design, data collection, data analysis, data interpretation, writing of the manuscript, or decision to submit the manuscript.	Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 2006, ANN INTERN MED, V144, P943; Avorn J, 2007, NEW ENGL J MED, V357, P633, DOI 10.1056/NEJMp078134; Baron JA, 2008, LANCET, V372, P1756, DOI 10.1016/S0140-6736(08)61490-7; Borer JS, 2006, J CARDIOVASC PHARM, V47, pS87, DOI 10.1097/00005344-200605001-00016; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Cairns JA, 2007, CAN J CARDIOL, V23, P125, DOI 10.1016/S0828-282X(07)70732-8; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Chou R, 2007, J CLIN EPIDEMIOL, V60, P18, DOI 10.1016/j.jclinepi.2006.02.021; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; Dai CL, 2005, ARCH INTERN MED, V165, P171, DOI 10.1001/archinte.165.2.171; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2003, Health Technol Assess, V7, P1; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Fries JF, 2004, ARTHRITIS RHEUM, V50, P2433, DOI 10.1002/art.20440; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Harirforoosh S, 2006, CLIN EXP PHARMACOL P, V33, P917, DOI 10.1111/j.1440-1681.2006.04464.x; Hermann M, 2003, CIRCULATION, V108, P2308, DOI 10.1161/01.CIR.0000101683.30157.0B; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V302, P369, DOI 10.1001/jama.2009.1019; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Nuesch E., 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003115.PUB3; Paulose-Ram R, 2005, PHARMACOEPIDEM DR S, V14, P257, DOI 10.1002/pds.983; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Shakespeare TP, 2001, LANCET, V357, P1349, DOI 10.1016/S0140-6736(00)04522-0; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530; Sowers JR, 2005, ARCH INTERN MED, V165, P161, DOI 10.1001/archinte.165.2.161; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; van Staa TP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000194; Wolfe F, 2002, J RHEUMATOL, V29, P1015; Zhang JJ, 2006, JAMA-J AM MED ASSOC, V296, P1619, DOI 10.1001/jama.296.13.jrv60015; Zhang W, 2004, ANN RHEUM DIS, V63, P901, DOI 10.1136/ard.2003.018531	44	690	754	3	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2011	342								c7086	10.1136/bmj.c7086	http://dx.doi.org/10.1136/bmj.c7086			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SO	21224324	hybrid, Green Published			2022-12-28	WOS:000286384800006
J	Lindstrom, TM; Robinson, WH				Lindstrom, Tamsin M.; Robinson, William H.			Fishing for Biomarkers with Antigen Mimics	CELL			English	Editorial Material							PROTEIN; ANTIBODIES		[Lindstrom, Tamsin M.; Robinson, William H.] Stanford Univ, Dept Med, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA; [Lindstrom, Tamsin M.; Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Lindstrom, TM (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA.	tlind@stanford.edu; wrobins@stanford.edu		Robinson, William/0000-0003-4385-704X	NIAMS NIH HHS [RC1 AR058713-01, RC1 AR058713, RC1 AR058713-02] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC1AR058713] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Auger I, 2009, ANN RHEUM DIS, V68, P591, DOI 10.1136/ard.2008.096917; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Horn S, 2006, PROTEOMICS, V6, P605, DOI 10.1002/pmic.200401293; Reddy MM, 2011, CELL, V144, P132, DOI 10.1016/j.cell.2010.11.054; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Vacirca D, 2012, NEUROBIOL AGING, V33, P753, DOI 10.1016/j.neurobiolaging.2010.05.013; Whiting PF, 2010, ANN INTERN MED, V152, P456, DOI 10.7326/0003-4819-152-7-201004060-00010; Wu TF, 2009, AUTOIMMUN REV, V8, P595, DOI 10.1016/j.autrev.2009.01.019	10	10	13	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					13	15		10.1016/j.cell.2010.12.022	http://dx.doi.org/10.1016/j.cell.2010.12.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215365	Green Accepted, Bronze			2022-12-28	WOS:000285993600003
J	Schembri, G; Schober, P				Schembri, Gabriel; Schober, Paul			Killing two birds with one stone	LANCET			English	Editorial Material							PRIMARY BILIARY-CIRRHOSIS		[Schembri, Gabriel; Schober, Paul] Leicester Royal Infirm, Dept Genitourinary & HIV Med, Leicester, Leics, England	University of Leicester	Schembri, G (corresponding author), Hathersage Ctr, Manchester Ctr Sexual Hlth, 280 Upper Brook St, Manchester M13 0FH, Lancs, England.	gabrielschembri@gmail.com						Mason AL, 2008, CLIN LIVER DIS, V12, P445, DOI 10.1016/j.cld.2008.02.006; Montano-Loza AJ, 2010, LIVER INT, V30, P871, DOI 10.1111/j.1478-3231.2010.02257.x; Poupon R, 2004, LANCET, V363, P260, DOI 10.1016/S0140-6736(03)15418-9; XU L, 2003, PNAS, V100, P845	4	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 1	2011	377	9759					96	96		10.1016/S0140-6736(10)61343-8	http://dx.doi.org/10.1016/S0140-6736(10)61343-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709MQ	21195252				2022-12-28	WOS:000286445200035
J	Lim, LS				Lim, Lionel S.			Use of bisphosphonates was not associated with increased risk for esophageal or gastric cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Griffin Hosp, Derby, CT USA		Lim, LS (corresponding author), Griffin Hosp, Derby, CT USA.			Lim, Lionel/0000-0002-0730-8767				Anastasilakis Athanasios D, 2007, Hormones (Athens), V6, P233; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Qato DM, 2008, JAMA-J AM MED ASSOC, V300, P2867, DOI 10.1001/jama.2008.892	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12							JC6-12	10.7326/0003-4819-153-12-201012210-02012	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173401				2022-12-28	WOS:000285453700017
J	Kumar, AKS; Chen, LC; Choudhury, M; Ganju, S; Mahajan, V; Sinha, A; Sen, A				Kumar, A. K. Shiva; Chen, Lincoln C.; Choudhury, Mita; Ganju, Shiban; Mahajan, Vijay; Sinha, Amarjeet; Sen, Abhijit			India: Towards Universal Health Coverage 6 Financing health care for all: challenges and opportunities	LANCET			English	Article							INSURANCE; POOR	India's health financing system is a cause of and an exacerbating factor in the challenges of health inequity, inadequate availability and reach, unequal access, and poor-quality and costly health-care services. Low per person spending on health and insufficient public expenditure result in one of the highest proportions of private out-of-pocket expenses in the world. Citizens receive low value for money in the public and the private sectors. Financial protection against medical expenditures is far from universal with only 10% of the population having medical insurance. The Government of India has made a commitment to increase public spending on health from less than 1% to 3% of the gross domestic product during the next few years. Increased public funding combined with flexibility of financial transfers from centre to state can greatly improve the performance of state-operated public systems. Enhanced public spending can be used to introduce universal medical insurance that can help to substantially reduce the burden of private out-of-pocket expenditures on health. Increased public spending can also contribute to quality assurance in the public and private sectors through effective regulation and oversight. In addition to an increase in public expenditures on health, the Government of India will, however, need to introduce specific methods to contain costs, improve the efficiency of spending, increase accountability, and monitor the effect of expenditures on health.	[Kumar, A. K. Shiva] UNICEF India, New Delhi 110003, India; [Chen, Lincoln C.] Harvard Global Equ Initiat, Cambridge, MA USA; [Choudhury, Mita] Natl Inst Publ Finance & Policy, New Delhi, India; [Ganju, Shiban] Consultant Ingalls Hosp, Harvey, IL USA; [Mahajan, Vijay] Basix Grp, Hyderabad, Andhra Pradesh, India; [Sinha, Amarjeet] Govt India, New Delhi, India; [Sen, Abhijit] Jawaharlal Nehru Univ, Ctr Econ Studies & Planning, New Delhi 110067, India	National Institute of Public Finance & Policy (NIPFP); Jawaharlal Nehru University, New Delhi	Kumar, AKS (corresponding author), UNICEF India, 73 Lodi Estate, New Delhi 110003, India.	akshivakumar@gmail.com			John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India.	Acharya A, 2005, ECON POLIT WEEKLY, V40, P4141; Anderson GF, 2004, SPECIAL ISSUES SINGL; [Anonymous], 2008, ANN INTERN MED, V148, P55, DOI 10.7326/0003-4819-148-1-200801010-00196; [Anonymous], RES BANK IND B, P9; [Anonymous], 2009, HIGH LEVEL TASLCFORC; [Anonymous], 2004, REP 12 FIN COMM 2005; BAJPAI N, 2009, IMPROVING ACCESS SER; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; BARU RV, 1998, PRIVATE HLTH CARE IN; Berman P., 2008, Economic and Political Weekly, V43, P209; Bloom G, 2008, HEALTH AFFAIR, V27, P952, DOI 10.1377/hlthaff.27.4.952; Choudhury M, 2006, PUBLIC SPENDING LOW; Citizen's Initiative for the Rights of children under Six, 2006, FOC CHILDR 6 FOCUS; Comptroller and Auditor General of India, 2008, AUD REP CIV YEAR END; Comptroller and Auditor General of India, UN GOV CIV PERF AUD; Devadasan N., 2004, Economic and Political Weekly, V39, P3179; Development and Research Services, 2009, CONC ASS JAN SUR YOJ; Dror D, 2006, ECON POLIT WEEKLY, V41, P4541; Duggal R, 2000, PRIVATE HLTH SECTOR; Duggal R, 2007, INDIAN J MED RES, V126, P309; Ellis RP, 2000, ECON POLIT WEEKLY, V35, P207; Ganguly K., 2009, EC POLIT WKLY, V44, P65; Gottret P. E., 2006, HLTH FINANCING REVIS; Government of India. National Sample Survey Organization, 2007, HOUS CONS VAR GOODS, VI; Government of India. National Sample Survey Organization, 1997, 404 GOV IND NAT SAMP; Government of Madhya Pradesh, 2007, DET DEM GRANTS 2006; Government of Tamil Nadu, 2007, DET DEM GRANTS 2006; Gupta I, 2006, EC POLIT WKLY, V41, P2525; Hammer J., 2007, Economic and Political Weekly, V42, P4049; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; International Institute of Population Sciences, REPR CHILD HLTH 2; International Society for Equity in Health, 2006, EQ HLTH SECT REF LAT; Lagarde M, 2006, EVIDENCE SYSTEMATIC; Mills A., 2007, LIT REV COMMISSIONED; Ministry of Health and Family Welfare, 2006, REP WORK GROUP HLTH; Ministry of Health and Family Welfare Government of India, 2009, NAT HLTH PROF NHP IN; Ministry of Health and Family Welfare Government of India, 2010, M PEOPL HTLH NEEDS P; Ministry of Health and Family Welfare Government of India, 1 NRHM COMM REV MISS; Ministry of Health and Family Welfare Government of India, 2007, SEL HLTH PAR COMP AN; Ministry of Health and Family Welfare Government of India, NAT HLTH ACC 2001 02; MoHFW Government of India, 2009, 3 COMM REV IN PRESS; MoHFW Government of India, 2009, NAT HLTH ACC IND 200; Munn Jeffrey D, 2007, Benefits Q, V23, P7; Nabyonga J, 2005, HEALTH POLICY PLANN, V20, P100, DOI 10.1093/heapol/czi012; National Commission for Enterprises in the Unorganized Sector, 2007, REP COND WORK PROM L; National Commission on Macroeconomics and Health Government of India, 2005, REP NAT COMM MACR HL; Office of the Registrar General Government of India, 2006, POP PROJ IND STAT 20; Peters DH, 2008, SOC SCI MED, V66, P2133, DOI 10.1016/j.socscimed.2008.01.037; PETERS DH, 2005, REACHING POOR; Peters DH, 2002, FUNCTIONING PRIVATE, P151; Planning Commission, 2005, MID TERM APPR 10 5 Y; Planning Commission, 2006, FAST MOR INCL GROWTH; Planning Commission of India, 2008, 11 5 YEAR PLAN 2007, VII, P57; Rangarajan C., 2008, ECON POLIT WEEKLY, V43, P47; Ranson MK, 2006, SOC SCI MED, V62, P707, DOI 10.1016/j.socscimed.2005.06.037; Rao GM, 2005, RESOURCE DEVOLUTION; Rao KD, 2007, HEALTH ECON, V16, P799, DOI 10.1002/hec.1194; Rao M. G., 2008, ECON POLIT WEEKLY, V43, P41; Rao MG, 2008, INTERSTATE EQUALISAT; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; Rao S., 2004, EC POLITICAL WKLY, V39, P3835; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Reserve Bank of India, 2008, STAT FIN STUD STAT B; Tsounta E., 2009, UNIVERSAL HLTH CARE; Visaria L, 1999, IMPLEMENTING REPROD; World Bank, 2006, REF PUBL SERV IND DR; World Health Organization, WORLD HLTH STAT 2008; [No title captured]	69	91	91	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2011	377	9766					668	679		10.1016/S0140-6736(10)61884-3	http://dx.doi.org/10.1016/S0140-6736(10)61884-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	727DB	21227490				2022-12-28	WOS:000287776600037
J	Behrman, RE; Benner, JS; Brown, JS; McClellan, M; Woodcock, J; Platt, R				Behrman, Rachel E.; Benner, Joshua S.; Brown, Jeffrey S.; McClellan, Mark; Woodcock, Janet; Platt, Richard			Developing the Sentinel System - A National Resource for Evidence Development	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SAFETY		[Behrman, Rachel E.; Woodcock, Janet] US FDA, Silver Spring, MD USA; [Benner, Joshua S.; McClellan, Mark] Brookings Inst, Engelberg Ctr Hlth Care Reform, Washington, DC 20036 USA; [Brown, Jeffrey S.; Platt, Richard] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA; [Brown, Jeffrey S.; Platt, Richard] Harvard Univ, Sch Med, Boston, MA USA	US Food & Drug Administration (FDA); Brookings Institution; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Behrman, RE (corresponding author), US FDA, Silver Spring, MD USA.			Brown, Jeffrey/0000-0002-9340-7189				*BROOK I, SUMM BROOK EV ACT ME; Brown JS, 2010, MED CARE, V48, pS45, DOI 10.1097/MLR.0b013e3181d9919f; *EX OFF PRES, 2011, REAL FULL POT HLTH I; Food and Drug Administration, 2008, SENT IN NAT STRAT MO; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338	5	257	264	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					498	499		10.1056/NEJMp1014427	http://dx.doi.org/10.1056/NEJMp1014427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718QH	21226658				2022-12-28	WOS:000287139900003
J	Pavlakis, M				Pavlakis, Martha			Live Kidney Donation A 36-Year-Old Woman Hoping to Donate a Kidney to Her Mother	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							US TRANSPLANT CENTERS; BODY-MASS INDEX; STAGE RENAL-DISEASE; QUALITY-OF-LIFE; DONOR NEPHRECTOMY; LIVING-DONOR; MEDICAL OUTCOMES; RISK; PREGNANCY; METAANALYSIS	Ms D, a healthy 36-year old-woman, wishes to donate a kidney to her mother, who has diabetes and end-stage renal disease. Ms D has been evaluated as a donor at another medical center and was told to lose weight and quit smoking. Evidence from cohort studies suggests that live kidney donation is a safe procedure in the short and long terms, although donor follow-up studies have often had incomplete data on limited populations. The benefits of live donation are mostly for the recipient, but kidney donors often have improved quality of life as a result of both their generous act and the improved health of the recipient. Evaluation and eligibility of live kidney donors and their short-and long-term risks are discussed. JAMA. 2011; 305(6): 592-599	[Pavlakis, Martha] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Pavlakis, Martha] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Pavlakis, M (corresponding author), Beth Israel Deaconess Med Ctr, 110 Francis St, Boston, MA 02215 USA.	mpavlaki@bidmc.harvard.edu						Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; [Anonymous], OPTN UNOS BOARD DIR; [Anonymous], 2007, FED REGISTER, V72, P15198; BIA MJ, 1995, TRANSPLANTATION, V60, P322, DOI 10.1097/00007890-199508270-00003; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bosma RJ, 2004, KIDNEY INT, V65, P259, DOI 10.1111/j.1523-1755.2004.00351.x; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; BUSZTA C, 1985, TRANSPLANTATION, V40, P651, DOI 10.1097/00007890-198512000-00015; Davis CL, 2007, AM J TRANSPLANT, V7, P2219, DOI 10.1111/j.1600-6143.2007.01956.x; Davis CL, 2005, J AM SOC NEPHROL, V16, P2098, DOI 10.1681/ASN.2004100824; Delmonico FL, 2005, TRANSPLANTATION, V79, pS53; Dolce CJ, 2009, SURG ENDOSC, V23, P1564, DOI 10.1007/s00464-009-0340-7; Dols LFC, 2010, TRANSPL INT, V23, P121, DOI 10.1111/j.1432-2277.2009.01027.x; Ficociello LH, 2009, DIABETES CARE, V32, P889, DOI 10.2337/dc08-1560; Friedman AL, 2010, ARCH SURG-CHICAGO, V145, P356, DOI 10.1001/archsurg.2010.17; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; Ghods AJ, 2007, SAUDI J KIDNEY DIS T, V18, P648; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hippen B, 2009, HASTINGS CENT REP, V39, P4; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Ibrahim HN, 2010, AM J TRANSPLANT, V10, P331, DOI 10.1111/j.1600-6143.2009.02944.x; Ibrahim HN, 2009, AM J TRANSPLANT, V9, P825, DOI 10.1111/j.1600-6143.2009.02548.x; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; JONES JW, 1993, TRANSPLANT P, V25, P3082; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; KASISKE BL, 1995, KIDNEY INT, V48, P814, DOI 10.1038/ki.1995.355; Kranenburg LW, 2004, TRANSPLANTATION, V78, P194, DOI 10.1097/01.tp.0000129259.02340.f7; Lentine KL, 2010, NEW ENGL J MED, V363, P724, DOI 10.1056/NEJMoa1000950; Liem YS, 2007, VALUE HEALTH, V10, P390, DOI 10.1111/j.1524-4733.2007.00193.x; Lin J, 2003, J AM SOC NEPHROL, V14, P2573, DOI 10.1097/01.ASN.0000088721.98173.4B; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Mandelbrot DA, 2007, AM J TRANSPLANT, V7, P2333, DOI 10.1111/j.1600-6143.2007.01932.x; Mandelbrot DA, 2009, TRANSPLANTATION, V88, P855, DOI 10.1097/TP.0b013e3181b6dfb9; Morrissey PE, 2005, TRANSPLANTATION, V80, P1369, DOI 10.1097/01.tp.0000179153.36227.2d; Nejatisafa AA, 2008, TRANSPLANTATION, V86, P937, DOI 10.1097/TP.0b013e318186d945; Park K, 1999, TRANSPLANTATION, V67, P336, DOI 10.1097/00007890-199901270-00027; Pavlakis M, 2008, AM J TRANSPLANT, V8, P466, DOI 10.1111/j.1600-6143.2007.02067.x; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Praga M, 2000, KIDNEY INT, V58, P2111, DOI 10.1046/j.1523-1755.2000.00384.x; Praga M, 2001, NEPHROL DIAL TRANSPL, V16, P1790, DOI 10.1093/ndt/16.9.1790; Reese PP, 2009, TRANSPLANTATION, V88, P662, DOI 10.1097/TP.0b013e3181b27a17; Reisaeter AV, 2009, AM J TRANSPLANT, V9, P820, DOI 10.1111/j.1600-6143.2008.02427.x; Rodrigue JR, 2007, AM J TRANSPLANT, V7, P2326, DOI 10.1111/j.1600-6143.2007.01921.x; Rodrigue JR, 2009, AM J TRANSPLANT, V9, P2172, DOI 10.1111/j.1600-6143.2009.02741.x; Ross LF, 2010, AM J TRANSPLANT, V10, P731, DOI 10.1111/j.1600-6143.2009.03010.x; SCHAEFER G, 1968, AM J OBSTET GYNECOL, V100, P1078, DOI 10.1016/S0002-9378(15)33406-2; *SCI REG TRANSPL P, 2009 ANN REP; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Slakey Douglas R, 2002, JSLS, V6, P217; STEINER CA, 1994, NEW ENGL J MED, V330, P403, DOI 10.1056/NEJM199402103300607; Steiner R, 2008, AM J TRANSPLANT, V8, P930, DOI 10.1111/j.1600-6143.2008.02201.x; Tavakol MM, 2009, CLIN J AM SOC NEPHRO, V4, P1230, DOI 10.2215/CJN.01350209; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Transplant Living: Financing a Transplant, FIN TRANSPL; Valdez R, 2007, DIABETES CARE, V30, P2517, DOI 10.2337/dc07-0720; Wolf JS, 2000, J UROLOGY, V163, P1650, DOI 10.1016/S0022-5347(05)67513-1; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wrenshall LE, 1996, TRANSPLANTATION, V62, P1934, DOI 10.1097/00007890-199612270-00044	59	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					592	599		10.1001/jama.2011.56	http://dx.doi.org/10.1001/jama.2011.56			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717XI	21245171				2022-12-28	WOS:000287080500024
J	Lazarus, MB; Nam, YS; Jiang, JY; Sliz, P; Walker, S				Lazarus, Michael B.; Nam, Yunsun; Jiang, Jiaoyang; Sliz, Piotr; Walker, Suzanne			Structure of human O-GlcNAc transferase and its complex with a peptide substrate	NATURE			English	Article							N-ACETYLGLUCOSAMINE; CRYSTAL-STRUCTURE; PROTEIN; GLYCOSYLATION; GLCNACYLATION; NUCLEAR; GENE; REPLACEMENT; PROMOTERS; MECHANISM	The essential mammalian enzyme O-linked beta-N-acetylglucosamine transferase (O-GlcNAc transferase, here OGT) couples metabolic status to the regulation of a wide variety of cellular signalling pathways by acting as a nutrient sensor(1). OGT catalyses the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine (UDP-GlcNAc) to serines and threonines of cytoplasmic, nuclear and mitochondrial proteins(2,3), including numerous transcription factors(4), tumour suppressors, kinases(5), phosphatases(1) and histone-modifying proteins(6). Aberrant glycosylation by OGT has been linked to insulin resistance(7), diabetic complications(8), cancer(9) and neurodegenerative diseases including Alzheimer's(10). Despite the importance of OGT, the details of how it recognizes and glycosylates its protein substrates are largely unknown. We report here two crystal structures of human OGT, as a binary complex with UDP (2.8 angstrom resolution) and as a ternary complex with UDP and a peptide substrate (1.95 angstrom). The structures provide clues to the enzyme mechanism, show how OGT recognizes target peptide sequences, and reveal the fold of the unique domain between the two halves of the catalytic region. This information will accelerate the rational design of biological experiments to investigate OGT's functions; it will also help the design of inhibitors for use as cellular probes and help to assess its potential as a therapeutic target.	[Lazarus, Michael B.; Jiang, Jiaoyang; Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Lazarus, Michael B.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Nam, Yunsun; Sliz, Piotr] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Nam, Yunsun; Sliz, Piotr] Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Walker, S (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	piotr_sliz@hms.harvard.edu; suzanne_walker@hms.harvard.edu		Lazarus, Michael/0000-0002-6738-2563; Sliz, Piotr/0000-0002-6522-0835; Nam, Yunsun/0000-0002-7939-8626	US National Institutes of Health; US National Science Foundation; Harvard Biomedical Accelerator Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094263, R01GM078477, R01GM076710] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Harvard Biomedical Accelerator Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Gross and C. Drennan for advice. We also thank the US National Institutes of Health, the US National Science Foundation, and the Harvard Biomedical Accelerator Fund for financial support. This work is based on research conducted at the Advanced Photon Source (Northeastern Collaborative Access Team beamlines) and Brookhaven National Laboratory (X25 and X29 beamlines).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Boggon TJ, 2000, STRUCTURE, V8, pR143, DOI 10.1016/S0969-2126(00)00168-4; Bowers K.J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1109/SC.2006.54; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Goldberg HJ, 2006, ENDOCRINOLOGY, V147, P222, DOI 10.1210/en.2005-0523; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3	48	312	326	7	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					564	U168		10.1038/nature09638	http://dx.doi.org/10.1038/nature09638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21240259	Green Accepted			2022-12-28	WOS:000286596500039
J	Sevransky, J				Sevransky, Jonathan			48 hours of cisatracurium reduced 90-day mortality in patients with early, severe ARDS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Sevransky, J (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.							De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9	2	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-3	10.7326/0003-4819-154-2-201101180-02003	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242357				2022-12-28	WOS:000286223500029
J	Kesavan, L; Tiruvalam, R; Ab Rahim, MH; bin Saiman, MI; Enache, DI; Jenkins, RL; Dimitratos, N; Lopez-Sanchez, JA; Taylor, SH; Knight, DW; Kiely, CJ; Hutchings, GJ				Kesavan, Lokesh; Tiruvalam, Ramchandra; Ab Rahim, Mohd Hasbi; bin Saiman, Mohd Izham; Enache, Dan I.; Jenkins, Robert L.; Dimitratos, Nikolaos; Lopez-Sanchez, Jose A.; Taylor, Stuart H.; Knight, David W.; Kiely, Christopher J.; Hutchings, Graham J.			Solvent-Free Oxidation of Primary Carbon-Hydrogen Bonds in Toluene Using Au-Pd Alloy Nanoparticles	SCIENCE			English	Article							LIQUID-PHASE OXIDATION; MOLECULAR-OXYGEN; AIR OXIDATION; CATALYSTS; HYDROCARBONS; BENZALDEHYDE	Selective oxidation of primary carbon-hydrogen bonds with oxygen is of crucial importance for the sustainable exploitation of available feedstocks. To date, heterogeneous catalysts have either shown low activity and/or selectivity or have required activated oxygen donors. We report here that supported gold-palladium (Au-Pd) nanoparticles on carbon or TiO2 are active for the oxidation of the primary carbon-hydrogen bonds in toluene and related molecules, giving high selectivities to benzyl benzoate under mild solvent-free conditions. Differences between the catalytic activity of the Au-Pd nanoparticles on carbon and TiO2 supports are rationalized in terms of the particle/support wetting behavior and the availability of exposed corner/edge sites.	[Kesavan, Lokesh; Ab Rahim, Mohd Hasbi; bin Saiman, Mohd Izham; Enache, Dan I.; Jenkins, Robert L.; Dimitratos, Nikolaos; Lopez-Sanchez, Jose A.; Taylor, Stuart H.; Knight, David W.; Hutchings, Graham J.] Cardiff Univ, Sch Chem, Cardiff Catalysis Inst, Cardiff CF10 3AT, S Glam, Wales; [Tiruvalam, Ramchandra; Kiely, Christopher J.] Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA	Cardiff University; Lehigh University	Hutchings, GJ (corresponding author), Cardiff Univ, Sch Chem, Cardiff Catalysis Inst, Main Bldg,Pk Pl, Cardiff CF10 3AT, S Glam, Wales.	hutch@cardiff.ac.uk	Lopez-Sanchez, Jose A/E-4689-2011; Dimitratos, Nikolaos/O-1699-2019; Taylor, Stuart/A-3125-2011; Dimitratos, Nikolaos/B-8787-2008; Rahim, Mohd Hasbi Ab./K-8937-2012	Lopez-Sanchez, Jose A/0000-0003-3064-0140; Taylor, Stuart/0000-0002-1933-4874; Dimitratos, Nikolaos/0000-0002-6620-4335; Rahim, Mohd Hasbi Ab./0000-0002-1404-5838; Enache, Dan/0000-0002-9291-8198; Kiely, Christopher/0000-0001-5412-0970	Dow Chemical Company; EPSRC [EP/F068379/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F068379/1] Funding Source: researchfish	Dow Chemical Company; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge the support of the Dow Chemical Company through the Dow Methane Challenge.	BORGAONKAR HV, 1984, IND ENG CHEM PROD RD, V23, P455, DOI 10.1021/i300015a026; Borodzinski A, 1997, LANGMUIR, V13, P5613, DOI 10.1021/la962103u; Brutchey RL, 2005, CHEM COMMUN, P3736, DOI 10.1039/b506426k; Carrell TG, 2002, J MOL CATAL A-CHEM, V187, P3, DOI 10.1016/S1381-1169(02)00139-5; COLBY J, 1977, BIOCHEM J, V165, P395, DOI 10.1042/bj1650395; Dimitratos N, 2009, PHYS CHEM CHEM PHYS, V11, P5142, DOI 10.1039/b900151b; Edwards JK, 2009, SCIENCE, V323, P1037, DOI 10.1126/science.1168980; Enache DI, 2006, SCIENCE, V311, P362, DOI 10.1126/science.1120560; Gao J, 2007, J CHEM TECHNOL BIOT, V82, P620, DOI 10.1002/jctb.1717; Ishii Y, 2001, ADV SYNTH CATAL, V343, P393, DOI 10.1002/1615-4169(200107)343:5<393::AID-ADSC393>3.0.CO;2-K; Kantam ML, 2002, CATAL LETT, V81, P223, DOI 10.1023/A:1016537325179; Konietzni F, 1998, J CATAL, V176, P527, DOI 10.1006/jcat.1998.2076; Li X, 2006, CATAL LETT, V110, P149, DOI 10.1007/s10562-006-0103-1; Nomiya K, 2001, J MOL CATAL A-CHEM, V176, P79, DOI 10.1016/S1381-1169(01)00258-8; PARTENHEIMER W, 1995, CATAL TODAY, V23, P69, DOI 10.1016/0920-5861(94)00138-R; Saravanamurugan S, 2004, APPL CATAL A-GEN, V273, P143, DOI 10.1016/j.apcata.2004.06.023; Seddon KR, 2002, GREEN CHEM, V4, pG25, DOI 10.1039/b202711a; Sheldon R A., 1981, METAL CATALYZED OXID; Singh AP, 1996, J MOL CATAL A-CHEM, V113, P489, DOI 10.1016/S1381-1169(96)00274-9; Snia-Viscosa, 1977, HYDROCARBON P, V134, P210; Wang F, 2005, ADV SYNTH CATAL, V347, P1987, DOI 10.1002/adsc.200505107; Wittstock A, 2010, SCIENCE, V327, P319, DOI 10.1126/science.1183591; Zhu J, 2002, CHEM COMMUN, P2044, DOI 10.1039/b205673a	23	630	641	10	896	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					195	199		10.1126/science.1198458	http://dx.doi.org/10.1126/science.1198458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	709JA	21233383				2022-12-28	WOS:000286433100037
J	McMorran, BJ; Agrawal, A; Anderson, IM; Herzing, AA; Lezec, HJ; McClelland, JJ; Unguris, J				McMorran, Benjamin J.; Agrawal, Amit; Anderson, Ian M.; Herzing, Andrew A.; Lezec, Henri J.; McClelland, Jabez J.; Unguris, John			Electron Vortex Beams with High Quanta of Orbital Angular Momentum	SCIENCE			English	Article							OPTICAL VORTEX; LASER-BEAMS	Electron beams with helical wavefronts carrying orbital angular momentum are expected to provide new capabilities for electron microscopy and other applications. We used nanofabricated diffraction holograms in an electron microscope to produce multiple electron vortex beams with well-defined topological charge. Beams carrying quantized amounts of orbital angular momentum (up to 100 (h) over bar) per electron were observed. We describe how the electrons can exhibit such orbital motion in free space in the absence of any confining potential or external field, and discuss how these beams can be applied to improved electron microscopy of magnetic and biological specimens.	[McMorran, Benjamin J.; Agrawal, Amit; Lezec, Henri J.; McClelland, Jabez J.; Unguris, John] Natl Inst Stand & Technol, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA; [Agrawal, Amit] Univ Maryland, Maryland NanoCtr, College Pk, MD 20742 USA; [Anderson, Ian M.; Herzing, Andrew A.] Natl Inst Stand & Technol, Surface & Microanal Sci Div, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA	McMorran, BJ (corresponding author), Natl Inst Stand & Technol, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA.	mcmorran@nist.gov	McClelland, Jabez/A-2358-2015; McMorran, Benjamin J/G-9954-2016; Unguris, John/J-3989-2014; Herzing, Andrew/D-6239-2012; Agrawal, Amit/C-3728-2009	McClelland, Jabez/0000-0001-5672-5965; McMorran, Benjamin J/0000-0001-7207-1076; Agrawal, Amit/0000-0001-8230-4603; Agrawal, Amit/0000-0002-9619-7623	NIST-CNST NanoFab; NIST Division [637]; FIB-SEM; NIST-CNST/UMD-NanoCenter	NIST-CNST NanoFab; NIST Division; FIB-SEM; NIST-CNST/UMD-NanoCenter	We thank S. Adam, G. Gallatin, M. Stiles, and J. H. Scott for useful discussions. Supported by the NIST-CNST NanoFab, NIST Division 637 FIB-SEM, and the NIST-CNST/UMD-NanoCenter Cooperative Agreement. The authors declare no competing financial interests.	ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Andersen MF, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170406; BAZHENOV VY, 1990, JETP LETT+, V52, P429; Bliokh KY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.190404; Cronin AD, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.061602; Danev R, 2002, J BIOL PHYS, V28, P627, DOI 10.1023/A:1021234621466; Egerton R.F., 2011, ELECT ENERGY LOSS SP; Foo G, 2005, OPT LETT, V30, P3308, DOI 10.1364/OL.30.003308; Franke-Arnold S, 2008, LASER PHOTONICS REV, V2, P299, DOI 10.1002/lpor.200810007; Furhapter S, 2005, OPT LETT, V30, P1953, DOI 10.1364/OL.30.001953; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; HECKENBERG NR, 1992, OPT QUANT ELECTRON, V24, pS951, DOI 10.1007/BF01588597; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Jesacher A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.233902; Leach J, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/071; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; McMorran B, 2006, ULTRAMICROSCOPY, V106, P356, DOI 10.1016/j.ultramic.2005.11.003; McMorran B.J., 2009, THESIS U ARIZONA; McMorran BJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033021; Schultheiss K, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2179411; Uchida M, 2010, NATURE, V464, P737, DOI 10.1038/nature08904; Verbeeck J, 2010, NATURE, V467, P301, DOI 10.1038/nature09366; Volyar AV, 1999, TECH PHYS LETT+, V25, P203, DOI 10.1134/1.1262423	23	411	427	3	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					192	195		10.1126/science.1198804	http://dx.doi.org/10.1126/science.1198804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233382				2022-12-28	WOS:000286433100036
J	Ambraseys, N; Bilham, R				Ambraseys, Nicholas; Bilham, Roger			Corruption kills	NATURE			English	Editorial Material							EARTHQUAKES		[Ambraseys, Nicholas] Univ London Imperial Coll Sci Technol & Med, Dept Civil & Environm Engn, London SW5 2BU, England; [Bilham, Roger] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Bilham, Roger] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	Imperial College London; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Ambraseys, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Civil & Environm Engn, London SW5 2BU, England.	n.ambraseys@imperial.ac.uk; rogerbilham@googlemail.com		Bilham, Roger/0000-0002-5547-4102				Allen TI, 2009, SEISMOL RES LETT, V80, P57, DOI 10.1785/gssrl.80.1.57; AMBRASEYS N, 2010, P ACAD ATHENS, V85; AMBRASEYS N, 1978, ASSESSMENT MITIGATIO, P140; Bilham R, 2009, B EARTHQ ENG, V7, P839, DOI 10.1007/s10518-009-9147-0; BURTON I, 1964, NAT RESOUR J, V3, P412; Escaleras M, 2007, PUBLIC CHOICE, V132, P209, DOI 10.1007/s11127-007-9148-y; *GLOB CONSTR PERSP, 2010, GLOB CONSTR 2020 GLO; Green P, 2005, BRIT J CRIMINOL, V45, P528, DOI 10.1093/bjc/azi036; JACKSON EL, 1978, ASSESSMENT MITIGATIO, P241; Kaufmann D., 1998, POLITICAL EC CORRUPT; LEWIS J, 2005, GLOBAL CORRUPTION RE, P23; LOMNITZ C, 1970, B SEISMOL SOC AM, V60, P1309; Marano KD, 2010, NAT HAZARDS, V52, P319, DOI 10.1007/s11069-009-9372-5; The World Bank, GNI PER CAP ATL METH; Transparency International, 2010, 2010 CORR PERC IND	15	96	96	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					153	155		10.1038/469153a	http://dx.doi.org/10.1038/469153a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	705NO	21228851	Bronze			2022-12-28	WOS:000286143400014
J	Sedlak, DL; von Gunten, U				Sedlak, David L.; von Gunten, Urs			The Chlorine Dilemma	SCIENCE			English	Editorial Material							N-NITROSODIMETHYLAMINE NDMA; WATER-TREATMENT; CHEMICALS; TRICLOSAN; KINETICS		[Sedlak, David L.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [von Gunten, Urs] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [von Gunten, Urs] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Sedlak, DL (corresponding author), Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA.	sedlak@berkeley.edu; vongunten@eawag.ch	von Gunten, Urs/O-1637-2013	von Gunten, Urs/0000-0001-6852-8977				[Anonymous], 1998, FED REG, V40, P69390; Buth JM, 2010, ENVIRON SCI TECHNOL, V44, P4545, DOI 10.1021/es1001105; Deborde M, 2004, ENVIRON SCI TECHNOL, V38, P5577, DOI 10.1021/es040006e; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; Edwards M, 2004, J AM WATER WORKS ASS, V96, P69; Lee BC, 2004, WATER RES, V38, P733, DOI 10.1016/j.watres.2003.10.010; Lee Y, 2008, ENVIRON SCI TECHNOL, V42, P6333, DOI 10.1021/es7023302; Liu HZ, 2009, ENVIRON SCI TECHNOL, V43, P3278, DOI 10.1021/es803179b; Mitch WA, 2002, ENVIRON SCI TECHNOL, V36, P588, DOI 10.1021/es010684q; Park SH, 2009, ENVIRON SCI TECHNOL, V43, P1360, DOI 10.1021/es802732z; Rule KL, 2005, ENVIRON SCI TECHNOL, V39, P3176, DOI 10.1021/es048943+; Sumpter JP, 2006, ENVIRON SCI TECHNOL, V40, P5478, DOI 10.1021/es052554d	12	270	276	17	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					42	43		10.1126/science.1196397	http://dx.doi.org/10.1126/science.1196397			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212347				2022-12-28	WOS:000285974000028
J	Woo, DK; Shadel, GS				Woo, Dong Kyun; Shadel, Gerald S.			Mitochondrial Stress Signals Revise an Old Aging Theory	CELL			English	Editorial Material							ELEGANS LIFE-SPAN; RESPIRATION		[Woo, Dong Kyun; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Shadel, GS (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA.	gerald.shadel@yale.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011163] Funding Source: NIH RePORTER; NIEHS NIH HHS [P01 ES011163, ES011163] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011	10	50	51	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					11	12		10.1016/j.cell.2010.12.023	http://dx.doi.org/10.1016/j.cell.2010.12.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215364	Bronze			2022-12-28	WOS:000285993600002
J	Frye, MA				Frye, Mark A.			Bipolar Disorder - A Focus on Depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TREATMENT ENHANCEMENT PROGRAM; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; ANTIDEPRESSANT TREATMENT; LITHIUM MONOTHERAPY; RANDOMIZED-TRIAL; II DEPRESSION; MOOD; LAMOTRIGINE; QUETIAPINE		[Frye, Mark A.] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN 55901 USA	Mayo Clinic	Frye, MA (corresponding author), Mayo Clin, Dept Psychiat, 200 1st St SW, Rochester, MN 55901 USA.	mfrye@mayo.edu			Sepracor; Merck; GlaxoSmithKline; Medical Communications Media; Bristol-Myers Squibb; Abbott; Pfizer; Cephalon; Johnson Johnson; AstraZeneca; Rules-Based Medicine; American Psychiatric Association; Sanofi-Aventis	Sepracor; Merck(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Medical Communications Media; Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott(Abbott Laboratories); Pfizer(Pfizer); Cephalon; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); AstraZeneca(AstraZeneca); Rules-Based Medicine; American Psychiatric Association; Sanofi-Aventis(Sanofi-Aventis)	Dr. Frye reports receiving consulting and speaking fees from Sepracor, Merck, GlaxoSmithKline, Medical Communications Media, and Bristol-Myers Squibb, consulting and speaking fees to his institution from Abbott, Merck, Bristol-Myers Squibb, Pfizer, Cephalon, Johnson & Johnson, AstraZeneca, and GlaxoSmithKline, grant support from Cephalon, Rules-Based Medicine, and the American Psychiatric Association, and travel fees from Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported.	Altshuler LL, 2002, J CLIN PSYCHIAT, V63, P807, DOI 10.4088/JCP.v63n0910; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amsterdam JD, 2010, AM J PSYCHIAT, V167, P792, DOI 10.1176/appi.ajp.2009.09020284; Baldessarini RJ, 2007, PSYCHIAT SERV, V58, P85, DOI 10.1176/appi.ps.58.1.85-a; Bond DJ, 2010, J AFFECT DISORDERS, V124, P228, DOI 10.1016/j.jad.2009.11.008; Calabrese JR, 1999, J CLIN PSYCHIAT, V60, P79, DOI 10.4088/JCP.v60n0203; Calabrese JR, 2005, AM J PSYCHIAT, V162, P1351, DOI 10.1176/appi.ajp.162.7.1351; Frye MA, 2000, J CLIN PSYCHOPHARM, V20, P607, DOI 10.1097/00004714-200012000-00004; Frye MA, 2003, AM J PSYCHIAT, V160, P883, DOI 10.1176/appi.ajp.160.5.883; Frye MA, 2007, AM J PSYCHIAT, V164, P1242, DOI 10.1176/appi.ajp.2007.06060981; Frye MA, 2006, J CLIN PSYCHIAT, V67, P1721, DOI 10.4088/JCP.v67n1108; Frye MA, 2009, AM J PSYCHIAT, V166, P164, DOI 10.1176/appi.ajp.2008.08030322; Geddes JR, 2009, BRIT J PSYCHIAT, V194, P4, DOI 10.1192/bjp.bp.107.048504; Ghaemi SN, 2008, ACTA PSYCHIAT SCAND, V118, P347, DOI 10.1111/j.1600-0447.2008.01257.x; Goldberg JF, 2004, AM J PSYCHIAT, V161, P564, DOI 10.1176/appi.ajp.161.3.564; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Goodwin GM, 2004, J CLIN PSYCHIAT, V65, P432; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Hirschfeld RMA, 2003, AM J PSYCHIAT, V160, P178, DOI 10.1176/appi.ajp.160.1.178; Inskip HM, 1998, BRIT J PSYCHIAT, V172, P35, DOI 10.1192/bjp.172.1.35; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Kane JM, 2006, AM J PSYCHIAT, V163, P1316, DOI 10.1176/appi.ajp.163.8.1316; Kessler RC, 2006, AM J PSYCHIAT, V163, P1561, DOI 10.1176/appi.ajp.163.9.1561; McElroy SL, 2010, J CLIN PSYCHIAT, V71, P163, DOI 10.4088/JCP.08m04942gre; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Miklowitz DJ, 2007, ARCH GEN PSYCHIAT, V64, P419, DOI 10.1001/archpsyc.64.4.419; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nemeroff CB, 2001, AM J PSYCHIAT, V158, P906, DOI 10.1176/appi.ajp.158.6.906; Ostacher MJ, 2010, AM J PSYCHIAT, V167, P289, DOI 10.1176/appi.ajp.2009.09020299; Perlis RH, 2006, AM J PSYCHIAT, V163, P217, DOI 10.1176/appi.ajp.163.2.217; Sachs GS, 2007, NEW ENGL J MED, V356, P1711, DOI 10.1056/NEJMoa064135; Sidor MM, 2010, J CLIN PSYCHIAT 1005; Simon NM, 2007, J PSYCHIATR RES, V41, P255, DOI 10.1016/j.jpsychires.2006.08.004; Simon NM, 2004, AM J PSYCHIAT, V161, P2222, DOI 10.1176/appi.ajp.161.12.2222; Thase ME, 2009, J CLIN PSYCHOPHARM, V29, P38; Thase ME, 2008, J CLIN PSYCHOPHARM, V28, P13, DOI 10.1097/jcp.0b013e3181618eb4; Thase ME, 2007, J CLIN PSYCHOPHARM, V27, P51; Thase ME, 2006, J CLIN PSYCHOPHARM, V26, P600, DOI 10.1097/01.jcp.0000248603.76231.b7; Tohen M, 2004, ARCH GEN PSYCHIAT, V61, P176; Tohen M, 2003, ARCH GEN PSYCHIAT, V60, P1079, DOI 10.1001/archpsyc.60.11.1079; Tondo L, 2003, CNS DRUGS, V17, P491, DOI 10.2165/00023210-200317070-00003; Truman CJ, 2007, J CLIN PSYCHIAT, V68, P1472, DOI 10.4088/JCP.v68n1002; van der Loos MLM, 2009, J CLIN PSYCHIAT, V70, P223, DOI 10.4088/JCP.08m04152; Vieta E, 2002, J CLIN PSYCHIAT, V63, P508, DOI 10.4088/JCP.v63n0607; Yatham LN, 2009, BIPOLAR DISORD, V11, P225, DOI 10.1111/j.1399-5618.2009.00672.x; Young AH, 2010, J CLIN PSYCHIAT, V71, P150, DOI 10.4088/JCP.08m04995gre; Zarate CA, 2004, BIOL PSYCHIAT, V56, P54, DOI 10.1016/j.biopsych.2004.03.013; Zimmerman M, 2010, PSYCHIAT RES    0724; Zimmerman M, 2010, J CLIN PSYCHIAT, V71, P1212, DOI 10.4088/JCP.09m05161yel	49	92	98	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					51	59		10.1056/NEJMcp1000402	http://dx.doi.org/10.1056/NEJMcp1000402			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UY	21208108				2022-12-28	WOS:000285922600010
J	Yazdanbakhsh, M; Luty, AJF				Yazdanbakhsh, Maria; Luty, Adrian J. F.			Wormy mothers, healthy babies: case closed or conundrum?	LANCET			English	Editorial Material							PREGNANCY; MALARIA		[Yazdanbakhsh, Maria; Luty, Adrian J. F.] Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Yazdanbakhsh, M (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 Leiden, Netherlands.	M.Yazdanbakhsh@lumc.nl	Luty, Adrian/CAH-2547-2022; Yazdanbakhsh, Maria/AAI-3996-2020	Yazdanbakhsh, Maria/0000-0002-7666-1441; Luty, Adrian John Frederick/0000-0001-8830-3425				Elliott AM, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-115; Elliott AM, 2005, JAMA-J AM MED ASSOC, V294, P2032, DOI 10.1001/jama.294.16.2032-c; LaBeaud AD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000442; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Serazin Andrew C, 2010, Nat Immunol, V11, P769, DOI 10.1038/ni0910-769; Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Webb EL, 2011, LANCET, V377, P52, DOI 10.1016/S0140-6736(10)61457-2; WILLIAMSON WA, 1978, LANCET, V1, P1328	13	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 1	2011	377	9759					6	8		10.1016/S0140-6736(10)62271-4	http://dx.doi.org/10.1016/S0140-6736(10)62271-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709MQ	21176948				2022-12-28	WOS:000286445200006
J	Shen, Z; Ye, QY				Shen, Zhu; Ye, Qingyi			Ischemic Gangrene.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shen, Zhu; Ye, Qingyi] Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China	Army Medical University	Shen, Z (corresponding author), Third Mil Med Univ, Southwest Hosp, Chongqing, Peoples R China.	zhushencq@gmail.com							0	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2651	2651		10.1056/NEJMicm1001755	http://dx.doi.org/10.1056/NEJMicm1001755			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190459				2022-12-28	WOS:000285763700010
J	Chen, CA; Wang, TY; Varadharaj, S; Reyes, LA; Hemann, C; Talukder, MAH; Chen, YR; Druhan, LJ; Zweier, JL				Chen, Chun-An; Wang, Tse-Yao; Varadharaj, Saradhadevi; Reyes, Levy A.; Hemann, Craig; Talukder, M. A. Hassan; Chen, Yeong-Renn; Druhan, Lawrence J.; Zweier, Jay L.			S-glutathionylation uncouples eNOS and regulates its cellular and vascular function	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIUM-DEPENDENT RELAXATION; SUPEROXIDE GENERATION; ENDOGENOUS METHYLARGININES; TETRAHYDROBIOPTERIN; REDUCTASE; OXIDATION; CELLS; PHOSPHORYLATION; GLUTATHIOLATION	Endothelial nitric oxide synthase (eNOS) is critical in the regulation of vascular function, and can generate both nitric oxide (NO) and superoxide (O-2(center dot-)), which are key mediators of cellular signalling. In the presence of Ca2+/calmodulin, eNOS produces NO, endothelial-derived relaxing factor, from L-arginine (L-Arg) by means of electron transfer from NADPH through a flavin containing reductase domain to oxygen bound at the haem of an oxygenase domain, which also contains binding sites for tetrahydrobiopterin (BH4) and L-Arg(1-3). In the absence of BH4, NO synthesis is abrogated and instead O-2(center dot-) is generated(4-7). While NOS dysfunction occurs in diseases with redox stress, BH4 repletion only partly restores NOS activity and NOS-dependent vasodilation(7). This suggests that there is an as yet unidentified redox-regulated mechanism controlling NOS function. Protein thiols can undergo S-glutathionylation, a reversible protein modification involved in cellular signalling and adaptation(8,9). Under oxidative stress, S-glutathionylation occurs through thiol-disulphide exchange with oxidized glutathione or reaction of oxidant-induced protein thiyl radicals with reduced glutathione(10,11). Cysteine residues are critical for the maintenance of eNOS function(12,13); we therefore speculated that oxidative stress could alter eNOS activity through S-glutathionylation. Here we show that S-glutathionylation of eNOS reversibly decreases NOS activity with an increase in O-2(center dot-) generation primarily from the reductase, in which two highly conserved cysteine residues are identified as sites of S-glutathionylation and found to be critical for redox-regulation of eNOS function. We show that eNOS S-glutathionylation in endothelial cells, with loss of NO and gain of O-2(center dot-) generation, is associated with impaired endothelium-dependent vasodilation. In hypertensive vessels, eNOS S-glutathionylation is increased with impaired endothelium-dependent vasodilation that is restored by thiol-specific reducing agents, which reverse this S-glutathionylation. Thus, S-glutathionylation of eNOS is a pivotal switch providing redox regulation of cellular signalling, endothelial function and vascular tone.	[Chen, Chun-An; Wang, Tse-Yao; Varadharaj, Saradhadevi; Reyes, Levy A.; Hemann, Craig; Talukder, M. A. Hassan; Chen, Yeong-Renn; Druhan, Lawrence J.; Zweier, Jay L.] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Chen, Chun-An; Wang, Tse-Yao; Varadharaj, Saradhadevi; Reyes, Levy A.; Hemann, Craig; Talukder, M. A. Hassan; Chen, Yeong-Renn; Druhan, Lawrence J.; Zweier, Jay L.] Ohio State Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Zweier, JL (corresponding author), Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	jay.zweier@osumc.edu	Druhan, Lawrence/E-2994-2011	Hemann, Craig/0000-0002-7380-4072	National Institutes of Health [HL63744, HL65608, HL38324, HL83237, HL103846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038324, P01HL065608, R01HL063744, R01HL083237, R00HL103846, K99HL103846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank L. Zhang and K. Green-Church for support with mass spectrometric analysis. This work was supported by R01 grants HL63744, HL65608, HL38324 (J.L.Z.), HL83237 (Y.-R.C.) and HL103846 (C.-A. C.) from the National Institutes of Health.	Alzawahra WF, 2008, AM J PHYSIOL-HEART C, V295, pH499, DOI 10.1152/ajpheart.00374.2008; Berka V, 1998, BIOCHEMISTRY-US, V37, P6136, DOI 10.1021/bi980133l; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Cardounel AJ, 2005, J BIOL CHEM, V280, P7540, DOI 10.1074/jbc.M410241200; Caruso RL, 2005, TOXICOL SCI, V86, P417, DOI 10.1093/toxsci/kfi208; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen CA, 2006, BBA-GEN SUBJECTS, V1760, P1857, DOI 10.1016/j.bbagen.2006.08.002; Chen CL, 2007, BIOCHEMISTRY-US, V46, P5754, DOI 10.1021/bi602580c; Druhan LJ, 2008, BIOCHEMISTRY-US, V47, P7256, DOI 10.1021/bi702377a; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Giraldez RR, 1997, J BIOL CHEM, V272, P21420, DOI 10.1074/jbc.272.34.21420; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; Harbrecht BG, 1997, ANN SURG, V225, P76, DOI 10.1097/00000658-199701000-00009; Hill BG, 2007, IUBMB LIFE, V59, P21, DOI 10.1080/15216540701196944; HOFMANN H, 1995, BIOCHEMISTRY-US, V34, P13443, DOI 10.1021/bi00041a023; Huang AN, 2001, AM J PHYSIOL-CELL PH, V281, pC719, DOI 10.1152/ajpcell.2001.281.2.C719; Kang-Decker N, 2007, J CELL SCI, V120, P492, DOI 10.1242/jcs.03361; Kugiyama K, 1998, CIRCULATION, V97, P2299, DOI 10.1161/01.CIR.97.23.2299; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; RAPOPORT RM, 1983, NATURE, V306, P174, DOI 10.1038/306174a0; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; Roubaud V, 1997, ANAL BIOCHEM, V247, P404, DOI 10.1006/abio.1997.2067; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Sugiyama T, 2010, AM J PHYSIOL-HEART C, V298, pH194, DOI 10.1152/ajpheart.00767.2009; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Takizawa T, 2003, J HISTOCHEM CYTOCHEM, V51, P707, DOI 10.1177/002215540305100602; Vanin AF, 2000, BBA-GEN SUBJECTS, V1474, P365, DOI 10.1016/S0304-4165(00)00033-7; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vita JA, 1998, J CLIN INVEST, V101, P1408, DOI 10.1172/JCI1155; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P1283, DOI 10.1161/ATVBAHA.107.144659; Wang YM, 2006, FREE RADICAL BIO MED, V41, P775, DOI 10.1016/j.freeradbiomed.2006.05.029; Xia Y, 2000, FREE RADICAL BIO MED, V29, P793, DOI 10.1016/S0891-5849(00)00427-5; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Ying J, 2007, FREE RADICAL BIO MED, V43, P1099, DOI 10.1016/j.freeradbiomed.2007.07.014	42	418	428	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1115	U521		10.1038/nature09599	http://dx.doi.org/10.1038/nature09599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179168	Green Accepted, Green Published			2022-12-28	WOS:000285553800061
J	Coudreuse, D; Nurse, P				Coudreuse, Damien; Nurse, Paul			Driving the cell cycle with a minimal CDK control network	NATURE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; B-TYPE CYCLIN; FISSION YEAST; S-PHASE; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; DEPENDENT KINASES; GENETIC-ANALYSIS; DNA-REPLICATION; MITOTIC CONTROL	Control of eukaryotic cell proliferation involves an extended regulatory network, the complexity of which has made it difficult to understand the basic principles of the cell cycle. To investigate the core engine of the mitotic cycle we have generated a minimal control network in fission yeast that efficiently sustains cellular reproduction. Here we demonstrate that orderly progression through the major events of the cell cycle can be driven by oscillation of an engineered monomolecular cyclin-dependent protein kinase (CDK) module lacking much of the canonical regulation. We show further that the CDK oscillator acts as the primary organizer of the cell cycle, imposing timing and directionality to a system of two CDK activity thresholds that define independent cell cycle phases. We propose that this simple core architecture forms the basic control of the eukaryotic cell cycle.	[Coudreuse, Damien; Nurse, Paul] Rockefeller Univ, Lab Yeast Genet & Cell Biol, New York, NY 10065 USA	Rockefeller University	Coudreuse, D (corresponding author), Rockefeller Univ, Lab Yeast Genet & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	dcoudreuse@rockefeller.edu		Coudreuse, Damien/0000-0003-2534-1621	EMBO [ALTF 899-2007]; Human Frontier Science Program [LT00623/2008]; Breast Cancer Research Foundation; Rockefeller University; Anderson Cancer Center Research at Rockefeller University	EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Breast Cancer Research Foundation; Rockefeller University; Anderson Cancer Center Research at Rockefeller University	We thank J. Hayles, P.-Y. Wu and F. Navarro for critically reading the manuscript, and N. Rhind for the anti-Cds1 antibody. D. C. was supported by post-doctoral fellowships from EMBO (ALTF 899-2007) and the Human Frontier Science Program (LT00623/2008) and P. N. by the Breast Cancer Research Foundation, The Rockefeller University and the Anderson Cancer Center Research at Rockefeller University.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Benito J, 1998, EMBO J, V17, P482, DOI 10.1093/emboj/17.2.482; Bhaumik D, 1998, MOL BIOL CELL, V9, P2107, DOI 10.1091/mbc.9.8.2107; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; BOOHER R, 1988, EMBO J, V7, P2321, DOI 10.1002/j.1460-2075.1988.tb03075.x; BOOHER RN, 1989, CELL, V58, P485, DOI 10.1016/0092-8674(89)90429-7; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; Buck V, 1995, EMBO J, V14, P6173, DOI 10.1002/j.1460-2075.1995.tb00308.x; BUENO A, 1991, CELL, V66, P149, DOI 10.1016/0092-8674(91)90147-Q; CorreaBordes J, 1997, EMBO J, V16, P4657, DOI 10.1093/emboj/16.15.4657; CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; Decottignies A, 2001, J CELL SCI, V114, P2627; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; DENHAESE GJ, 1995, MOL BIOL CELL, V6, P371, DOI 10.1091/mbc.6.4.371; Dischinger S, 2008, J CELL SCI, V121, P843, DOI 10.1242/jcs.021584; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; FANTES PA, 1978, EXP CELL RES, V115, P317, DOI 10.1016/0014-4827(78)90286-0; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; FORSBURG SL, 1991, NATURE, V351, P245, DOI 10.1038/351245a0; FORSBURG SL, 1994, J CELL SCI, V107, P601; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; HAYLES J, 1992, ANNU REV GENET, V26, P373, DOI 10.1146/annurev.ge.26.120192.002105; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Martin-Castellanos C, 2000, MOL BIOL CELL, V11, P543, DOI 10.1091/mbc.11.2.543; Martin-Castellanos C, 1996, EMBO J, V15, P839, DOI 10.1002/j.1460-2075.1996.tb00419.x; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Mondesert O, 1996, MOL CELL BIOL, V16, P1527; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORENO S, 1994, NATURE, V367, P236, DOI 10.1038/367236a0; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Novak B, 2007, NAT CELL BIOL, V9, P724, DOI 10.1038/ncb0707-724; NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; OBARAISHIHARA T, 1994, EMBO J, V13, P1863, DOI 10.1002/j.1460-2075.1994.tb06455.x; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rhind N, 1998, MOL CELL BIOL, V18, P3782, DOI 10.1128/MCB.18.7.3782; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SAZER S, 1990, J CELL SCI, V97, P509; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Sivakumar S, 2004, METHODS, V33, P213, DOI 10.1016/j.ymeth.2003.11.016; Snaith HA, 1999, GENETICS, V152, P839; Stern B, 1996, TRENDS GENET, V12, P345; Tanaka K, 2000, MOL BIOL CELL, V11, P2845, DOI 10.1091/mbc.11.9.2845; THURIAUX P, 1980, J GEN MICROBIOL, V116, P525; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; Watt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001428; WOODS A, 1989, J CELL SCI, V93, P491; Yamano H, 1996, EMBO J, V15, P5268, DOI 10.1002/j.1460-2075.1996.tb00912.x; Yang J, 1999, TRENDS CELL BIOL, V9, P207, DOI 10.1016/S0962-8924(99)01577-9; Zarzov P, 2002, EMBO J, V21, P3370, DOI 10.1093/emboj/cdf346	67	264	269	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1074	U474		10.1038/nature09543	http://dx.doi.org/10.1038/nature09543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179163				2022-12-28	WOS:000285553800052
J	Grayson, M				Grayson, Michelle			Nutrigenomics	NATURE			English	Editorial Material																			0	15	16	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S1	S1		10.1038/468S1a	http://dx.doi.org/10.1038/468S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179075	Bronze			2022-12-28	WOS:000285553800069
J	Preudhomme, C; Guilhot, J; Nicolini, FE; Guerci-Bresler, A; Rigal-Huguet, F; Maloisel, F; Coiteux, V; Gardembas, M; Berthou, C; Vekhoff, A; Rea, D; Jourdan, E; Allard, C; Delmer, A; Rousselot, P; Legros, L; Berger, M; Corm, S; Etienne, G; Roche-Lestienne, C; Eclache, V; Mahon, FX; Guilhot, F				Preudhomme, Claude; Guilhot, Joelle; Nicolini, Franck Emmanuel; Guerci-Bresler, Agnes; Rigal-Huguet, Francoise; Maloisel, Frederic; Coiteux, Valerie; Gardembas, Martine; Berthou, Christian; Vekhoff, Anne; Rea, Delphine; Jourdan, Eric; Allard, Christian; Delmer, Alain; Rousselot, Philippe; Legros, Laurence; Berger, Marc; Corm, Selim; Etienne, Gabriel; Roche-Lestienne, Catherine; Eclache, Virginie; Mahon, Francois-Xavier; Guilhot, Francois		SPIRIT Investigators France Interg	Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; PATIENTS RECEIVING IMATINIB; HEMATOPOIETIC STEM-CELLS; ABL TYROSINE KINASE; FOLLOW-UP; INTERFERON; CYTARABINE; QUIESCENT; CML; CHROMOSOME	Background: Imatinib (400 mg daily) is considered the best initial therapy for patients with newly diagnosed chronic myeloid leukemia (CML) in the chronic phase. However, only a minority of patients treated with imatinib have a complete molecular remission. Methods: We randomly assigned 636 patients with untreated chronic-phase CML to receive imatinib alone at a dose of 400 mg daily, imatinib (400 mg daily) plus cytarabine (20 mg per square meter of body-surface area per day on days 15 through 28 of each 28-day cycle) or pegylated interferon (peginterferon) alfa-2a (90 microg weekly), or imatinib alone at a dose of 600 mg daily. Molecular and cytogenetic responses, time to treatment failure, overall and event-free survival, and adverse events were assessed. An analysis of molecular response at 12 months was planned. A superior molecular response was defined as a decrease in the ratio of transcripts of the tyrosine kinase gene BCR-ABL to transcripts of ABL of 0.01% or less, corresponding to a reduction of 4 log(sub 10) units or more from the baseline level, as assessed by means of a real-time quantitative polymerase-chain-reaction assay. Results: At 12 months, the rates of cytogenetic response were similar among the four groups. The rate of a superior molecular response was significantly higher among patients receiving imatinib and peginterferon alfa-2a (30%) than among patients receiving 400 mg of imatinib alone (14%) (P=0.001). The rate was significantly higher among patients treated for more than 12 months than among those treated for 12 months or less. Gastrointestinal events were more frequent among patients receiving cytarabine, whereas rash and depression were more frequent among patients receiving peginterferon alfa-2a. Conclusions: As compared with other treatments, the addition of peginterferon alfa-2a to imatinib therapy resulted in significantly higher rates of molecular response in patients with chronic-phase CML. (Funded by the French Ministry of Health and others; ClinicalTrials.gov number, NCT00219739.) N Engl J Med 2010;363:2511-21.	[Guilhot, Joelle; Guilhot, Francois] CHU Poitiers, INSERM, U935, CIC 802, F-86021 Poitiers, France; [Preudhomme, Claude; Roche-Lestienne, Catherine] CHU Lille, Hematol Lab, F-59037 Lille, France; [Preudhomme, Claude; Roche-Lestienne, Catherine] INSERM, U837, F-59045 Lille, France; [Nicolini, Franck Emmanuel] Hop Edouard Herriot, Hematol Clin, Lyon, France; [Guerci-Bresler, Agnes] CHU Brabois, Serv Hematol, Vandoeuvre Les Nancy, France; [Rigal-Huguet, Francoise] Hop Purpan, Serv Hematol, Toulouse, France; [Maloisel, Frederic] Clin St Anne, Serv Oncohematol, Strasbourg, France; [Coiteux, Valerie] Hop Claude Huriez, Serv Malad Sang, Lille, France; [Gardembas, Martine] CHU Angers, Serv Malad Sang, Angers, France; [Berthou, Christian] CHU Brest, Serv Hematol, F-29285 Brest, France; [Vekhoff, Anne] Hop Hotel Dieu, Serv Hematol Clin, Paris, France; [Rea, Delphine] Hop St Louis, INSERM, CIC 9504, Paris, France; [Jourdan, Eric] Grp Hosp Univ Caremeau, Nimes, France; [Allard, Christian] Ctr Hosp Meaux, Serv Hematol, Meaux, France; [Delmer, Alain] CHU Reims, Serv Hematol Clin, Reims, France; [Rousselot, Philippe] Hop Versailles, Versailles, France; [Legros, Laurence] Hop Archet 1, Serv Hematol Clin, Nice, France; [Berger, Marc] CHU Estaing, Clermont Ferrand, France; [Corm, Selim] CHU, Serv Hematol Clin, Chambery, France; [Etienne, Gabriel] Inst Bergonie, Bordeaux, France; [Eclache, Virginie] Hop Avicenne, Hematol Lab, F-93009 Bobigny, France; [Mahon, Francois-Xavier] CHU Bordeaux, Hematol Lab, Bordeaux, France; [Mahon, Francois-Xavier] CHU Bordeaux, Serv Malad Sang, Bordeaux, France; [Mahon, Francois-Xavier] Univ Victor Segalen, INSERM, U876, Bordeaux, France	CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Poitiers; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU de Nancy; CHU de Toulouse; Universite de Lille - ISITE; CHU Lille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Brest; Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Nimes; CHU de Reims; Universite de Reims Champagne-Ardenne; Centre Hospitalier de Versailles; CHU Nice; CHU Clermont Ferrand; UNICANCER; Institut Bergonie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Guilhot, F (corresponding author), CHU Poitiers, INSERM, U935, CIC 802, F-86021 Poitiers, France.	fr.guilhot@wanadoo.fr	Besson, Caroline/H-4648-2018; Giraudeau, Bruno/L-9003-2015; SAULNIER, Pierre-Jean/H-7218-2016; maury, sebastien/Q-6573-2018; Preudhomme, Claude/T-8553-2018; DECONINCK, ERIC/AAF-3647-2021; Vey, Norbert/AGE-3573-2022	Besson, Caroline/0000-0003-4364-7173; Giraudeau, Bruno/0000-0003-3031-8258; SAULNIER, Pierre-Jean/0000-0003-1862-4252; maury, sebastien/0000-0002-1170-8683; Preudhomme, Claude/0000-0002-1267-9546; DECONINCK, ERIC/0000-0002-6006-8088; Vey, Norbert/0000-0001-7027-040X; Kiladjian, Jean-Jacques/0000-0002-8121-438X; Guilhot, Francois/0000-0001-7222-487X; Roche-Lestienne, Catherine/0000-0002-7998-3817; Casasnovas, Rene-Olivier/0000-0002-1156-8983; Rea, Delphine/0000-0001-5379-7461; Delmer, Alain/0000-0002-1430-2574; moreau, philippe/0000-0003-1780-8746; Bouscary, Didier/0000-0003-3654-5064; Ojeda-Uribe, Mario/0000-0001-6881-6055; IFRAH, Norbert/0000-0003-3063-850X; GYAN, Emmanuel/0000-0002-7651-9189	French Ministry of Health; Novartis; Roche Pharma	French Ministry of Health; Novartis(Novartis); Roche Pharma	Supported by grants from the French Ministry of Health (Programme Hospitalier de Recherche Clinique 2003 and 2006), Novartis, and Roche Pharma.	Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cortes JE, 2010, J CLIN ONCOL, V28, P392, DOI 10.1200/JCO.2009.25.4896; Cortes JE, 2010, J CLIN ONCOL, V28, P398, DOI 10.1200/JCO.2009.25.4920; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gardembas M, 2003, BLOOD, V102, P4298, DOI 10.1182/blood-2003-04-1010; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Guilhot F, 2009, BEST PRACT RES CL HA, V22, P315, DOI 10.1016/j.beha.2009.10.005; Hochhaus A, 2010, LEUKEMIA, V24, P1102, DOI 10.1038/leu.2010.71; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Jiang X, 2007, LEUKEMIA, V21, P926, DOI 10.1038/sj.leu.2404609; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Lipton JH, 2007, LEUKEMIA LYMPHOMA, V48, P497, DOI 10.1080/10428190601175393; Michallet M, 2004, LEUKEMIA, V18, P309, DOI 10.1038/sj.leu.2403217; Muller MC, 2009, LEUKEMIA, V23, P1957, DOI 10.1038/leu.2009.168; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; NOWELL PC, 1960, SCIENCE, V132, P1497; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SKORSKI T, 1995, BLOOD, V86, P726, DOI 10.1182/blood.V86.2.726.bloodjournal862726; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; The Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253	32	293	310	2	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2511	2521		10.1056/NEJMoa1004095	http://dx.doi.org/10.1056/NEJMoa1004095			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697YL	21175313				2022-12-28	WOS:000285555600006
J	Wunderlich, J; Park, BG; Irvine, AC; Zarbo, LP; Rozkotova, E; Nemec, P; Novak, V; Sinova, J; Jungwirth, T				Wunderlich, Joerg; Park, Byong-Guk; Irvine, Andrew C.; Zarbo, Liviu P.; Rozkotova, Eva; Nemec, Petr; Novak, Vit; Sinova, Jairo; Jungwirth, Tomas			Spin Hall Effect Transistor	SCIENCE			English	Article							SEMICONDUCTORS; TRANSPORT; INJECTION	The field of semiconductor spintronics explores spin-related quantum relativistic phenomena in solid-state systems. Spin transistors and spin Hall effects have been two separate leading directions of research in this field. We have combined the two directions by realizing an all-semiconductor spin Hall effect transistor. The device uses diffusive transport and operates without electrical current in the active part of the transistor. We demonstrate a spin AND logic function in a semiconductor channel with two gates. Our study shows the utility of the spin Hall effect in a microelectronic device geometry, realizes the spin transistor with electrical detection directly along the gated semiconductor channel, and provides an experimental tool for exploring spin Hall and spin precession phenomena in an electrically tunable semiconductor layer.	[Wunderlich, Joerg; Park, Byong-Guk] Hitachi Cambridge Lab, Cambridge CB3 0HE, England; [Wunderlich, Joerg; Zarbo, Liviu P.; Novak, Vit; Sinova, Jairo; Jungwirth, Tomas] Inst Phys ASCR, Vvi, Prague 16253 6, Czech Republic; [Irvine, Andrew C.] Univ Cambridge, Cavendish Lab, Microelect Res Ctr, Cambridge CB3 0HE, England; [Rozkotova, Eva; Nemec, Petr] Charles Univ Prague, Fac Math & Phys, CR-12116 Prague 2, Czech Republic; [Sinova, Jairo] Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA; [Jungwirth, Tomas] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England	University of Cambridge; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; University of Cambridge; Charles University Prague; Texas A&M University System; Texas A&M University College Station; University of Nottingham	Wunderlich, J (corresponding author), Hitachi Cambridge Lab, Cambridge CB3 0HE, England.	jw526@cam.ac.uk	Wunderlich, Joerg/G-6918-2014; Schmoranzerova, Eva/F-3081-2011; Nemec, Petr/D-3063-2013; Schmoranzerova, Eva/H-1971-2017; Park, Byong Guk/B-3385-2012; Zarbo, Liviu P/O-4960-2014; Jungwirth, Tomas/G-8952-2014; Sinova, Jairo/G-9071-2014; Novak, Vit/G-6844-2014	Nemec, Petr/0000-0001-6867-5942; Schmoranzerova, Eva/0000-0002-0830-5218; Zarbo, Liviu P/0000-0001-6019-2567; Jungwirth, Tomas/0000-0002-9910-1674; Sinova, Jairo/0000-0002-9490-2333; Novak, Vit/0000-0003-2461-1685; Irvine, Andy/0000-0002-2097-3614	European Union [FP7-215368 SemiSpinNet]; Czech Republic [MSM0021620834, KAN400100652, LC510, AV0Z10100521]; Preamium Academiae; NSF-MRSEC [DMR-0820414, ONR-N000140610122, DMR-0547875]; SWAN-NRI	European Union(European Commission); Czech Republic(Czech Republic Government); Preamium Academiae; NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); SWAN-NRI	We acknowledge support from European Union grant FP7-215368 SemiSpinNet; Czech Republic grants AV0Z10100521, MSM0021620834, KAN400100652, LC510, and Preamium Academiae; and U.S. grants NSF-MRSEC DMR-0820414, ONR-N000140610122, DMR-0547875, and SWAN-NRI. J.S. is a Cottrell Scholar of Research Corporation. In connection with this work, we have two pending patent applications with the European Patent Office, patent numbers EP 2 224 500 A2 and EP 2 190 022 A.	Bernevig BA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236601; Brune C, 2010, NAT PHYS, V6, P448, DOI 10.1038/NPHYS1655; Crooker SA, 2005, SCIENCE, V309, P2191, DOI 10.1126/science.1116865; DATTA S, 1990, APPL PHYS LETT, V56, P665, DOI 10.1063/1.102730; Dietl T, 2008, SEMICONDUCT SEMIMET, V82, P371, DOI 10.1016/S0080-8784(08)00009-4; DYAKONOV MI, 1971, PHYS LETT A, VA 35, P459, DOI 10.1016/0375-9601(71)90196-4; Garlid ES, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.156602; Hammar PR, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.066806; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Huang B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.177209; Jiang X, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.056601; Kaestner B, 2007, J MOD OPTIC, V54, P431, DOI 10.1080/09500340600759605; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Kettemann S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.176808; Kikkawa JM, 1999, NATURE, V397, P139, DOI 10.1038/16420; Kiselev AA, 2000, PHYS REV B, V61, P13115, DOI 10.1103/PhysRevB.61.13115; Koo HC, 2009, SCIENCE, V325, P1515, DOI 10.1126/science.1173667; Lou XH, 2007, NAT PHYS, V3, P197, DOI 10.1038/nphys543; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Schliemann J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.146801; Schmidt G, 2002, SEMICOND SCI TECH, V17, P310, DOI 10.1088/0268-1242/17/4/304; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; Weber CP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.076604; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; Wunderlich J, 2009, NAT PHYS, V5, P675, DOI 10.1038/NPHYS1359; Zarbo LP, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205320; Zhu HJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.016601; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	29	261	264	9	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1801	1804		10.1126/science.1195816	http://dx.doi.org/10.1126/science.1195816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205664	Green Submitted			2022-12-28	WOS:000285603700034
J	Lichtenstein, MJ				Lichtenstein, Michael J.			Testosterone increased risk for adverse events in older men with mobility limitations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Lichtenstein, MJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.							Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12							JC6-7	10.7326/0003-4819-153-12-201012210-02007	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173408				2022-12-28	WOS:000285453700024
J	Michael, YL; Whitlock, EP; Lin, JS; Fu, RW; O'Connor, EA; Gold, R				Michael, Yvonne L.; Whitlock, Evelyn P.; Lin, Jennifer S.; Fu, Rongwei; O'Connor, Elizabeth A.; Gold, Rachel			Primary Care-Relevant Interventions to Prevent Falling in Older Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; HOME-BASED EXERCISE; EYE CATARACT-SURGERY; TERM VITAMIN-D; ELDERLY-PEOPLE; TAI-CHI; MULTIFACTORIAL INTERVENTION; HEALTH-STATUS; CALCIUM SUPPLEMENTATION; RISK-EVALUATION	Background: Falls among older adults are both prevalent and preventable. Purpose: To describe the benefits and harms of interventions that could be used by primary care practitioners to prevent falling among community-dwelling older adults. Data Sources: The reviewers evaluated trials from a good-quality systematic review published in 2003 and searched MEDLINE, the Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and CINAHL from the end of that review's search date to February 2010 to identify additional English-language trials. Study Selection: Two reviewers independently screened 3423 abstracts and 638 articles to identify randomized, controlled trials (RCTs) of primary care-relevant interventions among community-dwelling older adults that reported falls or fallers as an outcome. Trials were independently critically appraised to include only good-or fair-quality trials; discrepancies were resolved by a third reviewer. Data Extraction: One reviewer abstracted data from 61 articles into standardized evidence tables that were verified by a second reviewer. Data Synthesis: Overall, the included evidence was of fair quality. In 16 RCTs evaluating exercise or physical therapy, interventions reduced falling (risk ratio, 0.87 [95% CI, 0.81 to 0.94]). In 9 RCTs of vitamin D supplementation, interventions reduced falling (risk ratio, 0.83 [CI, 0.77 to 0.89]). In 19 trials involving multifactorial assessment and management, interventions with comprehensive management seemed to reduce falling, although overall pooled estimates were not statistically significant (risk ratio, 0.94 [CI, 0.87 to 1.02]). Limited evidence suggested that serious clinical harms were no more common for older adults in intervention groups than for those in control groups. Limitations: Interventions and methods of fall ascertainment were heterogeneous. Data on potential harms of interventions were scant and often not reported. Conclusion: Primary care-relevant interventions exist that can reduce falling among community-dwelling older adults.	[Michael, Yvonne L.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19102 USA; Kaiser Permanente Ctr Hlth Res, Portland, OR 97227 USA; Oregon Hlth & Sci Univ, Portland, OR 97239 USA	Drexel University; Kaiser Permanente; Oregon Health & Science University	Michael, YL (corresponding author), Drexel Univ, Sch Publ Hlth, 1505 Race St,6th Floor,MS 1033, Philadelphia, PA 19102 USA.	michaely@drexel.edu	Michael, Yvonne Louise/AAB-9995-2020		Agency for Healthcare Research and Quality; AHRQ [HHSA-290-2007-10057-I]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.; By the AHRQ (contract HHSA-290-2007-10057-I).; Potential Conflicts of Interest: Drs. Michael, Whitlock, Lin, Fu, and O'Connor: Grant (money to institution): AHRQ. Payment for writing or reviewing the manuscript (money to institution): AHRQ. Drs. Michael, Whitlock, Lin, and O'Connor: Support for travel to meetings for the study or other purposes (money to institution): AHRQ. Drs. Michael and Lin: Provision of writing assistance, medicines, equipment, or administrative support (money to institution): AHRQ. Dr. Gold: Grant (money to institution): AHRQ. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10-0104.	Ashburn A, 2007, J NEUROL NEUROSUR PS, V78, P678, DOI 10.1136/jnnp.2006.099333; Barnett A, 2003, AGE AGEING, V32, P407, DOI 10.1093/ageing/32.4.407; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Bischoff-Ferrari HA, 2006, ARCH INTERN MED, V166, P424; Buchner DM, 1997, J GERONTOL A-BIOL, V52, pM218, DOI 10.1093/gerona/52A.4.M218; Campbell AJ, 2005, BMJ-BRIT MED J, V331, P817, DOI 10.1136/bmj.38601.447731.55; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P225; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Chou R, 2009, SCREENING VISUAL IMP; Chou WC, 2006, J GEN INTERN MED, V21, P117, DOI [10.1007/s11606-006-0244-3, 10.1111/j.1525-1497.2005.00298.x]; Ciaschini PM, 2009, AGE AGEING, V38, P724, DOI 10.1093/ageing/afp176; Clemson L, 2004, J AM GERIATR SOC, V52, P1487, DOI 10.1111/j.1532-5415.2004.52411.x; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Coleman EA, 1999, J AM GERIATR SOC, V47, P775, DOI 10.1111/j.1532-5415.1999.tb03832.x; Connell BR, 1997, ARCH PHYS MED REHAB, V78, P179, DOI 10.1016/S0003-9993(97)90261-6; Cranney A., 2007, AHRQ PUBLICATION; Cumming RG, 2007, J AM GERIATR SOC, V55, P175, DOI 10.1111/j.1532-5415.2007.01046.x; Davison J, 2005, AGE AGEING, V34, P162, DOI 10.1093/ageing/afi053; Dawson-Hughes B, 2010, JAMA-J AM MED ASSOC, V303, P1861, DOI 10.1001/jama.2010.598; Day L, 2002, BRIT MED J, V325, P128, DOI 10.1136/bmj.325.7356.128; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhesi JK, 2004, AGE AGEING, V33, P589, DOI 10.1093/ageing/afh209; Dukas L, 2004, J AM GERIATR SOC, V52, P230, DOI 10.1111/j.1532-5415.2004.52060.x; Dyer CAE, 2004, AGE AGEING, V33, P596, DOI 10.1093/ageing/afh204; Elley CR, 2008, J AM GERIATR SOC, V56, P1383, DOI 10.1111/j.1532-5415.2008.01802.x; Englander F, 1996, J FORENSIC SCI, V41, P733; Fortinsky RH, 2004, J AM GERIATR SOC, V52, P1522, DOI 10.1111/j.1532-5415.2004.52416.x; Foss AJE, 2006, AGE AGEING, V35, P66, DOI 10.1093/ageing/afj005; Gallagher JC, 2001, J CLIN ENDOCR METAB, V86, P3618, DOI 10.1210/jc.86.8.3618; Gates S, 2008, BRIT MED J, V336, P130, DOI 10.1136/bmj.39412.525243.BE; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Green J, 2002, LANCET, V359, P199, DOI 10.1016/S0140-6736(02)07443-3; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; Hendriks MRC, 2008, J AM GERIATR SOC, V56, P1390, DOI 10.1111/j.1532-5415.2008.01803.x; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hogan DB, 2001, CAN MED ASSOC J, V165, P537; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Karkkainen MK, 2010, MATURITAS, V65, P359, DOI 10.1016/j.maturitas.2009.12.018; Kronhed ACG, 2009, EUR J PHYSIOTHER, V11, P154, DOI 10.1080/14038190902896659; Laird RD, 2001, AM J MANAG CARE, V7, P1133; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Li FZ, 2005, J GERONTOL A-BIOL, V60, P187, DOI 10.1093/gerona/60.2.187; Lightbody E, 2002, AGE AGEING, V31, P203, DOI 10.1093/ageing/31.3.203; Logan PA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2102; Logghe IHJ, 2009, J AM GERIATR SOC, V57, P70, DOI 10.1111/j.1532-5415.2008.02064.x; Lord SR, 2005, J AM GERIATR SOC, V53, P1296, DOI 10.1111/j.1532-5415.2005.53425.x; LORD SR, 1995, J AM GERIATR SOC, V43, P1198, DOI 10.1111/j.1532-5415.1995.tb07394.x; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Luukinen H, 2007, PREV MED, V44, P265, DOI 10.1016/j.ypmed.2006.09.011; Michael Y., 2010, AHRQ PUBLICATION; Morgan RO, 2004, J GERONTOL A-BIOL, V59, P1062; National Institute for Health and Clinical Excellence, 2004, FALLS ASS PREV FALLS; Nelson ME, 2004, J GERONTOL A-BIOL, V59, P154; Newbury JW, 2001, MED J AUSTRALIA, V175, P104, DOI 10.5694/j.1326-5377.2001.tb143541.x; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Peri K, 2008, AGE AGEING, V37, P57, DOI 10.1093/ageing/afm135; Pfeifer M, 2009, OSTEOPOROSIS INT, V20, P315, DOI 10.1007/s00198-008-0662-7; Pfeifer M, 2000, J BONE MINER RES, V15, P1113, DOI 10.1359/jbmr.2000.15.6.1113; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; Rubenstein LZ, 2000, J GERONTOL A-BIOL, V55, pM317, DOI 10.1093/gerona/55.6.M317; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Salminen M, 2009, PUBLIC HEALTH, V123, P809, DOI 10.1016/j.puhe.2009.10.018; Salminen MJ, 2009, J AM GERIATR SOC, V57, P612, DOI 10.1111/j.1532-5415.2009.02176.x; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Shumway-Cook A, 2007, J GERONTOL A-BIOL, V62, P1420, DOI 10.1093/gerona/62.12.1420; Spice CL, 2009, AGE AGEING, V38, P33, DOI 10.1093/ageing/afn192; Spivack BS, 2008, BRIT MED J, V336, P343, DOI 10.1136/bmj.39486.498866.3A; Stevens J. A., 2006, Morbidity and Mortality Weekly Report, V55, P1221; Stevens M, 2001, J AM GERIATR SOC, V49, P1448, DOI 10.1046/j.1532-5415.2001.4911236.x; Tinetti ME, 2008, J AM GERIATR SOC, V56, P1563, DOI 10.1111/j.1532-5415.2008.01800.x; Tinetti ME, 2006, GERONTOLOGIST, V46, P717, DOI 10.1093/geront/46.6.717; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; van Haastregt JCM, 2000, BMJ-BRIT MED J, V321, P994, DOI 10.1136/bmj.321.7267.994; Vind AB, 2009, J AM GERIATR SOC, V57, P971, DOI 10.1111/j.1532-5415.2009.02270.x; Voukelatos A, 2007, J AM GERIATR SOC, V55, P1185, DOI 10.1111/j.1532-5415.2007.01244.x; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x	87	203	213	0	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					815	+		10.7326/0003-4819-153-12-201012210-00008	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00008			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696PL	21173416				2022-12-28	WOS:000285453700005
J	Hodgson, JW; Brock, HW				Hodgson, Jacob W.; Brock, Hugh W.			Are Polycomb Group Bodies Gene Silencing Factories?	CELL			English	Editorial Material							DROSOPHILA		[Hodgson, Jacob W.; Brock, Hugh W.] Univ British Columbia, Dept Zool, Mol Epigenet Grp, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Brock, HW (corresponding author), Univ British Columbia, Dept Zool, Mol Epigenet Grp, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	brock@zoology.ubc.ca						Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Pirrotta V, 1999, BBA-REV CANCER, V1424, pM1; Vazquez J, 2006, MOL BIOL CELL, V17, P2158, DOI 10.1091/mbc.E06-01-0049	9	6	6	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					170	171		10.1016/j.cell.2011.01.006	http://dx.doi.org/10.1016/j.cell.2011.01.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241887	Bronze			2022-12-28	WOS:000286459900002
J	Schmidt, O; Harbauer, AB; Rao, S; Eyrich, B; Zahedi, RP; Stojanovski, D; Schonfisch, B; Guiard, B; Sickmann, A; Pfanner, N; Meisinger, C				Schmidt, Oliver; Harbauer, Angelika B.; Rao, Sanjana; Eyrich, Beate; Zahedi, Rene P.; Stojanovski, Diana; Schoenfisch, Birgit; Guiard, Bernard; Sickmann, Albert; Pfanner, Nikolaus; Meisinger, Chris			Regulation of Mitochondrial Protein Import by Cytosolic Kinases	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION SITES; RECEPTOR TOM70; COMPLEX-I; PREPROTEINS; BINDING; CK2; IDENTIFICATION; TRANSLOCATION; EVOLUTION	Mitochondria import a large number of nuclear-encoded proteins via membrane-bound transport machineries; however, little is known about regulation of the preprotein translocases. We report that the main protein entry gate of mitochondria, the translocase of the outer membrane (TOM complex), is phosphorylated by cytosolic kinases-in particular, casein kinase 2 (CK2) and protein kinase A (PKA). CK2 promotes biogenesis of the TOM complex by phosphorylation of two key components, the receptor Tom22 and the import protein Mim1, which in turn are required for import of further Tom proteins. Inactivation of CK2 decreases the levels of the TOM complex and thus mitochondrial protein import. PKA phosphorylates Tom70 under nonrespiring conditions, thereby inhibiting its receptor activity and the import of mitochondrial metabolite carriers. We conclude that cytosolic kinases exert stimulatory and inhibitory effects on biogenesis and function of the TOM complex and thus regulate protein import into mitochondria.	[Schmidt, Oliver; Harbauer, Angelika B.; Rao, Sanjana; Stojanovski, Diana; Schoenfisch, Birgit; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Schmidt, Oliver; Harbauer, Angelika B.; Schoenfisch, Birgit; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Schmidt, Oliver; Harbauer, Angelika B.; Rao, Sanjana] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Rao, Sanjana] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Eyrich, Beate; Zahedi, Rene P.; Sickmann, Albert] Leibniz Inst Analyt Wissensch ISAS eV, D-44139 Dortmund, Germany; [Stojanovski, Diana] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France; [Sickmann, Albert] Ruhr Univ Bochum, Med Proteom Ctr, D-44801 Bochum, Germany; [Meisinger, Chris] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); La Trobe University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Ruhr University Bochum; University of Bern	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de; chris.meisinger@biochemie.uni-freiburg.de	Meisinger, Chris/J-1110-2014; Sickmann, Albert/A-1010-2011; Zahedi, René/A-9148-2012; Zahedi, Rene/HGU-5710-2022; Pfanner, Nikolaus/AAV-7878-2021	Meisinger, Chris/0000-0002-8326-3548; Sickmann, Albert/0000-0002-2388-5265; Zahedi, René/0000-0002-4960-5460; Schmidt, Oliver/0000-0002-7921-4663; Stojanovski, Diana/0000-0002-0199-3222; Harbauer, Angelika/0000-0002-4568-9003	Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments; Bundesministerium fur Bildung und Forschung (Dynamo); Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen, Sonderforschungsbereich [746]; Gottfried Wilhelm Leibniz Program; Landesforschungspreis Baden-Wurttemberg	Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Dynamo)(Federal Ministry of Education & Research (BMBF)); Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen, Sonderforschungsbereich(German Research Foundation (DFG)); Gottfried Wilhelm Leibniz Program; Landesforschungspreis Baden-Wurttemberg	We thank Drs. C.V. Glover, A.P. Bidwai, K.M. Dombek, and C. Mann for strains and antisera; Drs. N. Wiedemann, K. Wagner, T. Becker, N. Gebert, M. Bohnert, M. Gebert, and D. Stroud for discussion; and C. Prinz for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft, Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS; GSC-4 Spemann Graduate School), Bundesministerium fur Bildung und Forschung (Dynamo), Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen, Sonderforschungsbereich 746, Gottfried Wilhelm Leibniz Program, and Landesforschungspreis Baden-Wurttemberg. This paper is dedicated to Klaus Paal (1955-2009), who is deeply missed.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Brix J, 2000, J MOL BIOL, V303, P479, DOI 10.1006/jmbi.2000.4120; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; De Rasmo D, 2008, CELL SIGNAL, V20, P989, DOI 10.1016/j.cellsig.2008.01.017; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Onorato TM, 2005, J BIOL CHEM, V280, P19527, DOI 10.1074/jbc.M410422200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Tripodi F, 2010, BIOCHEM BIOPH RES CO, V398, P44, DOI 10.1016/j.bbrc.2010.06.028; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	30	177	177	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					227	239		10.1016/j.cell.2010.12.015	http://dx.doi.org/10.1016/j.cell.2010.12.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21215441	Bronze			2022-12-28	WOS:000286459900008
J	Haldane, AG; May, RM				Haldane, Andrew G.; May, Robert M.			Systemic risk in banking ecosystems	NATURE			English	Article							NETWORK STRUCTURE; COMPLEX-SYSTEMS; ECOLOGY; MODEL	In the run-up to the recent financial crisis, an increasingly elaborate set of financial instruments emerged, intended to optimize returns to individual institutions with seemingly minimal risk. Essentially no attention was given to their possible effects on the stability of the system as a whole. Drawing analogies with the dynamics of ecological food webs and with networks within which infectious diseases spread, we explore the interplay between complexity and stability in deliberately simplified models of financial networks. We suggest some policy lessons that can be drawn from such models, with the explicit aim of minimizing systemic risk.	[May, Robert M.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England; [Haldane, Andrew G.] Bank England, London EC2R 8AH, England	University of Oxford; Bank of England	May, RM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	robert.may@zoo.ox.ac.uk						Alessandri P., 2009, BANKING ON THE STATE; ANDERSON R M, 1991; Arrow KJ, 1954, ECONOMETRICA, V22, P265, DOI 10.2307/1907353; Avellaneda M, 2003, QUANT FINANC, V3, P417, DOI 10.1088/1469-7688/3/6/301; Bank of England, 2009, ROL MACR POL DISC PA; Barabesi A.-L., 2002, LINKED NEW SCI NETWO; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Battiston A., 2009, LIAISONS DANGEREUSES; Brock W. A., 2008, J EC DYNAM CONT, V33, P1912; Buffet W. E., 2002, 15 BERKSH HATH INC, P15; Caccioli F, 2009, EUR PHYS J B, V71, P467, DOI 10.1140/epjb/e2009-00316-y; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Dunne JA, 2008, PLOS BIOL, V6, P693, DOI 10.1371/journal.pbio.0060102; Elton C. S., 1958, ECOLOGY INVASIONS AN; Farmer JD, 2002, IND CORP CHANGE, V11, P895, DOI 10.1093/icc/11.5.895; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; GUPTA S, 1989, AIDS, V3, P807, DOI 10.1097/00002030-198912000-00005; Haldane A. G., 2009, FIN STUD ASS AMST; Haldane A. G., 2010, 100 BILLION QUESTION; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jones C, 2010, CENT BANKING, V21, P69; Kyriakopoulos F, 2009, EUR PHYS J B, V71, P523, DOI 10.1140/epjb/e2009-00255-7; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; May R.M., 1973, STABILITY COMPLEXITY; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; May RM, 2010, J R SOC INTERFACE, V7, P823, DOI 10.1098/rsif.2009.0359; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Osler CL, 2006, INT J FINANC ECON, V11, P55, DOI 10.1002/ijfe.288; Pascuale M., 2006, ECOLOGICAL NETWORKS; Pliska S.R., 1997, INTRO MATH FINANCE D; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Sircar R., 1998, APPL MATH FINANC, V5, P45, DOI [10.1080/135048698334727, DOI 10.1080/135048698334727]; Stiglitz J., J GLOBAL DE IN PRESS; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Sugihara G, 2009, NATURE, V458, P979, DOI 10.1038/458979a; Turner P., 2009, DEBATE FINANCIAL SYS	40	699	717	22	388	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330								10.1038/nature09659	http://dx.doi.org/10.1038/nature09659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248842	Green Submitted			2022-12-28	WOS:000286385600042
J	Rosen, CJ				Rosen, Clifford J.			Vitamin D Insufficiency.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CIRCULATING 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; SERUM 25-HYDROXYVITAMIN-D; D DEFICIENCY; CONTROLLED TRIAL; FRACTURE RISK; BONE LOSS; CALCIUM; OLDER; WOMEN	A healthy 61-year-old white woman is concerned about a low vitamin D level detected during an assessment of her skeletal health. Her menopause began at 54 years of age. She has no history of falls, and there is no family history of hip fracture. She takes no medications or supplements. Her height is 157.5 cm (5 ft 2 in.), and her weight 59.1 kg (130 lb). The results of a physical examination are unremarkable, and the findings on laboratory studies are normal. The T score for bone mineral density at the hip is -1.5, and the serum level of 25-hydroxyvitamin D is 21 ng per milliliter (53 nmol per liter). What do you advise?	Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA	Maine Medical Center	Rosen, CJ (corresponding author), Maine Med Ctr, Res Inst, 81 Res Dr, Scarborough, ME 04074 USA.	rosenc@mmc.org						[Anonymous], 2010, IOM REP CALC VIT D; Avenell A, 2009, COCHRANE DB SYST REV, V2; Binkley N, 2009, J CLIN DENSITOM, V12, P417, DOI 10.1016/j.jocd.2009.06.001; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bolland MJ, 2010, AM J CLIN NUTR, V91, P82, DOI 10.3945/ajcn.2009.28424; Bunout D, 2006, EXP GERONTOL, V41, P746, DOI 10.1016/j.exger.2006.05.001; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; Cauley JA, 2010, J BONE MINER RES, V25, P545, DOI 10.1359/jbmr.090826; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chung M, 2009, VITAMIN D CALCIUM SY; Cranney A., 2007, EFFECTIVENESS SAFETY; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Dawson-Hughes B, 2008, AM J CLIN NUTR, V88, p537S, DOI 10.1093/ajcn/88.2.537S; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Ensrud KE, 2009, J CLIN ENDOCR METAB, V94, P2773, DOI 10.1210/jc.2008-2786; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Hanley DA, 2010, CAN MED ASSOC J, V182, pE610, DOI 10.1503/cmaj.080663; Heaney RP, 2005, J STEROID BIOCHEM, V97, P13, DOI 10.1016/j.jsbmb.2005.06.020; Hewison M, 2008, CURR OPIN INVEST DR, V9, P485; Holick MF, 2005, J CLIN ENDOCR METAB, V90, P3215, DOI 10.1210/jc.2004-2364; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jackson RD, 2006, NEW ENGL J MED, V354, P1102; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Kenny AM, 2003, J AM GERIATR SOC, V51, P1762, DOI 10.1046/j.1532-5415.2003.51561.x; Koch TR, 2010, GASTROENTEROL CLIN N, V39, P109, DOI 10.1016/j.gtc.2009.12.003; LeBoff MS, 1999, JAMA-J AM MED ASSOC, V281, P1505, DOI 10.1001/jama.281.16.1505; Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Melhus H, 2010, J CLIN ENDOCR METAB, V95, P2637, DOI 10.1210/jc.2009-2699; National Health and Nutrition Examination Survey, 2005, WHAT WE EAT AM; Norman AW, 2007, J STEROID BIOCHEM, V103, P204, DOI 10.1016/j.jsbmb.2006.12.071; Parker-Pope T, 2010, NY TIMES        0201; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Pittas AG, 2007, DIABETES CARE, V30, P980, DOI 10.2337/dc06-1994; Priemel M, 2010, J BONE MINER RES, V25, P305, DOI 10.1359/jbmr.090728; Salovaara K, 2010, J BONE MINER RES, V25, P1487, DOI 10.1002/jbmr.48; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P2357, DOI 10.1001/jama.2010.783; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Steingrimsdottir L, 2005, JAMA-J AM MED ASSOC, V294, P2336, DOI 10.1001/jama.294.18.2336; Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; van Schoor NM, 2008, BONE, V42, P260, DOI 10.1016/j.bone.2007.11.002; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; WHO Scientific Group on the Prevention and Management of Osteoporosis, 2003, WHO SCI GROUP PREV M	50	593	646	0	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					248	254		10.1056/NEJMcp1009570	http://dx.doi.org/10.1056/NEJMcp1009570			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21247315				2022-12-28	WOS:000286383900009
J	Houston, TK; Allison, JJ; Sussman, M; Horn, W; Holt, CL; Trobaugh, J; Salas, M; Pisu, M; Cuffee, YL; Larkin, D; Person, SD; Barton, B; Kiefe, CI; Hullett, S				Houston, Thomas K.; Allison, Jeroan J.; Sussman, Marc; Horn, Wendy; Holt, Cheryl L.; Trobaugh, John; Salas, Maribel; Pisu, Maria; Cuffee, Yendelela L.; Larkin, Damien; Person, Sharina D.; Barton, Bruce; Kiefe, Catarina I.; Hullett, Sandral			Culturally Appropriate Storytelling to Improve Blood Pressure A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							NARRATIVE COMMUNICATION; DISPARITIES; TRANSPORTATION; BEHAVIOR; DISEASE	Background: Storytelling is emerging as a powerful tool for health promotion in vulnerable populations. However, these interventions remain largely untested in rigorous studies. Objective: To test an interactive storytelling intervention involving DVDs. Design: Randomized, controlled trial in which comparison patients received an attention control DVD. Separate random assignments were performed for patients with controlled or uncontrolled hypertension. (ClinicalTrials.gov registration number: NCT00875225) Setting: An inner-city safety-net clinic in the southern United States. Patients: 230 African Americans with hypertension. Intervention: 3 DVDs that contained patient stories. Storytellers were drawn from the patient population. Measurements: The outcomes were differential change in blood pressure for patients in the intervention versus the comparison group at baseline, 3 months, and 6 to 9 months. Results: 299 African American patients were randomly assigned between December 2007 and May 2008 and 76.9% were retained throughout the study. Most patients (71.4%) were women, and the mean age was 53.7 years. Baseline mean systolic and diastolic pressures were similar in both groups. Among patients with baseline uncontrolled hypertension, reduction favored the intervention group at 3 months for both systolic (11.21 mm Hg [95% CI, 2.51 to 19.9 mm Hg]; P = 0.012) and diastolic (6.43 mm Hg [CI, 1.49 to 11.45 mm Hg]; P = 0.012) blood pressures. Patients with baseline controlled hypertension did not significantly differ over time between study groups. Blood pressure subsequently increased for both groups, but between-group differences remained relatively constant. Limitation: This was a single-site study with 23% loss to follow-up and only 6 months of follow-up. Conclusion: The storytelling intervention produced substantial and significant improvements in blood pressure for patients with baseline uncontrolled hypertension. Primary Funding Source: Finding Answers: Disparities Research for Change, a national program of the Robert Wood Johnson Foundation. Ann Intern Med. 2011;154:77-84.	[Houston, Thomas K.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; eHlth Qual Enhancement Res Initiat, Ctr Healthcare Qual Outcomes & Econ Res, Bedford, MA USA; Bedford Vet Affairs Med Ctr, Bedford, MA USA; Univ Alabama Birmingham, Birmingham, AL USA; Cooper Green Mercy Hosp, Birmingham, AL USA; Univ Maryland, College Pk, MD 20742 USA; Univ Penn, Philadelphia, PA 19104 USA; AstraZeneca, Wilmington, DE USA	University of Massachusetts System; University of Massachusetts Worcester; University of Alabama System; University of Alabama Birmingham; University System of Maryland; University of Maryland College Park; University of Pennsylvania; AstraZeneca	Houston, TK (corresponding author), Univ Massachusetts, Sch Med, 55 N Lake Ave, Worcester, MA 01605 USA.	Thomas.Houston@umassmed.edu	Houston, Thomas/F-2469-2013	Barton, Bruce/0000-0001-7878-8895; Knott, Cheryl L./0000-0002-2261-7875; Allison, Jeroan/0000-0003-4472-2112	Robert Wood Johnson Foundation [59741]; Veterans Affairs Hypertension Stories grant [I01 HX000492-01]; Agency for Healthcare Research and Quality [1R18HS019353-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS019353] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Veterans Affairs Hypertension Stories grant; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By Finding Answers: Disparities Research for Change, a national program of the Robert Wood Johnson Foundation (RWJF Finding Answers grant 59741), with direction and technical assistance provided by The University of Chicago; a Veterans Affairs Hypertension Stories grant (I01 HX000492-01; Dr. Houston); and the Agency for Healthcare Research and Quality Storyguides project (1R18HS019353-01; Dr. Allison).	Agency for Healthcare Research and Quality, 2010, AHRQ PUBL; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Ashton CM, 2010, PATIENT EDUC COUNS, V79, P245, DOI 10.1016/j.pec.2009.09.021; Borzecki AM, 2003, ARCH INTERN MED, V163, P2705, DOI 10.1001/archinte.163.22.2705; Bosworth HB, 2008, J GEN INTERN MED, V23, P692, DOI 10.1007/s11606-008-0547-7; Bruner J. S., 1990, ACTS MEANING; Dal Cin S, 2004, RESISTANCE AND PERSUASION, P175; Davis AM, 2007, MED CARE RES REV, V64, p29S, DOI 10.1177/1077558707305416; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Flack John M, 2003, J Clin Hypertens (Greenwich), V5, P5, DOI 10.1111/j.1524-6175.2003.02152.x; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Green MC, 2000, J PERS SOC PSYCHOL, V79, P701, DOI 10.1037/0022-3514.79.5.701; Green MC, 2004, DISCOURSE PROCESS, V38, P247, DOI 10.1207/s15326950dp3802_5; Hinyard LJ, 2007, HEALTH EDUC BEHAV, V34, P777, DOI 10.1177/1090198106291963; Jacobs EA, 2006, J GEN INTERN MED, V21, P642, DOI 10.1111/j.1525-1497.2006.00485.x; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kressin NR, 2010, CIRC-CARDIOVASC QUAL, V3, P173, DOI 10.1161/CIRCOUTCOMES.109.860841; Kreuter MW, 2007, ANN BEHAV MED, V33, P221, DOI 10.1007/BF02879904; Kreuter Matthew W, 2008, J Cancer Surviv, V2, P33, DOI 10.1007/s11764-007-0041-y; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McAdams D. P., 2013, REDEMPTIVE SELF STOR; Rawaf MM, 2007, J NATL MED ASSOC, V99, P1248; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; Schulz AJ, 2005, ENVIRON HEALTH PERSP, V113, P1817, DOI 10.1289/ehp.7913; Slater MD, 2002, COMMUN THEOR, V12, P173, DOI 10.1111/j.1468-2885.2002.tb00265.x; The Neilsen Company, 2009, TEL AUD 2008	26	166	171	3	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2					77	+		10.7326/0003-4819-154-2-201101180-00004	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706MW	21242364				2022-12-28	WOS:000286223500001
J	Joynt, KE; Orav, EJ; Jha, AK				Joynt, Karen E.; Orav, E. John; Jha, Ashish K.			The Association Between Hospital Volume and Processes, Outcomes, and Costs of Care for Congestive Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; PERCUTANEOUS CORONARY INTERVENTIONS; REGIONAL-VARIATIONS; MORTALITY; EXPERIENCE	Background: Congestive heart failure (CHF) is common and costly, and outcomes remain suboptimal despite pharmacologic and technical advances. Objective: To examine whether hospitals with more experience in caring for patients with CHF provide better, more efficient care. Design: Retrospective cohort study. Setting: 4095 hospitals in the United States. Patients: Medicare fee-for-service patients with a primary discharge diagnosis of CHF. Measurements: Hospital Quality Alliance CHF process measures; 30-day, risk-adjusted mortality rates; 30-day, risk-adjusted readmission rates; and costs per discharge. National Medicare claims data from 2006 to 2007 were used to examine the relationship between hospital case volume and quality, outcomes, and costs for patients with CHF. Results: Hospitals in the low-volume group had lower performance on the process measures (80.2%) than did medium-volume (87.0%) or high-volume (89.1%) hospitals (P < 0.001). In the low-volume group, being admitted to a hospital with a higher case volume was associated with lower mortality, lower readmission, and higher costs. Similar, though smaller, relationships were found between case volume and both mortality and costs in the medium- and high-volume hospital groups. Limitations: Analysis was limited to Medicare patients 65 years or older. Risk adjustment was performed by using administrative data. Conclusion: Experience with managing CHF, as measured by an institution's volume, is associated with higher quality of care and better outcomes for patients but a higher cost. Understanding which practices employed by high-volume institutions account for these advantages can help improve quality of care and clinical outcomes for all patients with CHF. Primary Funding Source: American Heart Association. Ann Intern Med. 2011;154:94-102.	[Joynt, Karen E.] Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Boston, MA 02115 USA; Vet Affairs Boston Hlth Care Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health	Joynt, KE (corresponding author), Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			American Heart Association [10CRP3780037]; National Institutes of Health [T32HL007604-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By an American Heart Association Clinical Research Program grant (10CRP3780037). Dr. Joynt was supported by a National Institutes of Health Training Grant (T32HL007604-24) held by Brigham and Women's Hospital Division of Cardiovascular Medicine.	Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; BENNETT CL, 1989, JAMA-J AM MED ASSOC, V261, P2975, DOI 10.1001/jama.261.20.2975; Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Cunningham WE, 1999, AM J MED, V107, P137, DOI 10.1016/S0002-9343(99)00195-3; Desai MM, 2009, 2009 MEASURES MAINTE; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Hannan EL, 2005, CIRCULATION, V112, P1171, DOI 10.1161/CIRCULATIONAHA.104.528455; Hannan EL, 2003, CIRCULATION, V108, P795, DOI 10.1161/01.CIR.0000084551.52010.3B; Ho V, 2008, MED CARE, V46, P718, DOI 10.1097/MLR.0b013e3181653d6b; Jha AK, 2006, HEALTH AFFAIR, V25, P844, DOI 10.1377/hlthaff.25.3.844; Jha AK, 2009, HEALTH AFFAIR, V28, P897, DOI 10.1377/hlthaff.28.3.897; Jollis JG, 1997, CIRCULATION, V95, P2485, DOI 10.1161/01.CIR.95.11.2485; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Lindenauer PK, 2006, ANN INTERN MED, V144, P894, DOI 10.7326/0003-4819-144-12-200606200-00006; Lindenauer PK, 2006, ANN INTERN MED, V144, P262, DOI 10.7326/0003-4819-144-4-200602210-00008; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; LUFT HS, 1987, HEALTH SERV RES, V22, P157; McGrath PD, 2000, JAMA-J AM MED ASSOC, V284, P3139, DOI 10.1001/jama.284.24.3139; Mechanic R, 1998, JAMA-J AM MED ASSOC, V280, P1015, DOI 10.1001/jama.280.11.1015; Medicare Payment Advisory Commission, 2009, DAT BOOK HEALTHC SPE; Mukamel DB, 1998, MED CARE, V36, P945, DOI 10.1097/00005650-199807000-00002; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Ross JS, 2008, ARCH INTERN MED, V168, P1371, DOI 10.1001/archinte.168.13.1371; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Schneider EC, 1998, JAMA-J AM MED ASSOC, V279, P1638, DOI 10.1001/jama.279.20.1638; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; STONE VE, 1992, JAMA-J AM MED ASSOC, V268, P2655, DOI 10.1001/jama.268.19.2655; Swisher SG, 2000, J THORAC CARDIOV SUR, V119, P1126, DOI 10.1067/mtc.2000.105644; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; US Department of Health and Human Services, 2010, HOSP COMP; Ward MM, 2002, J RHEUMATOL, V29, P1198; Wu CT, 2004, CIRCULATION, V110, P784, DOI 10.1161/01.CIR.0000138744.13516.B5; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566	39	124	125	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2					94	+		10.7326/0003-4819-154-2-201101180-00008	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-00008			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706MW	21242366	Green Accepted			2022-12-28	WOS:000286223500003
J	Chen, Q; Whitmer, JK; Jiang, S; Bae, SC; Luijten, E; Granick, S				Chen, Qian; Whitmer, Jonathan K.; Jiang, Shan; Bae, Sung Chul; Luijten, Erik; Granick, Steve			Supracolloidal Reaction Kinetics of Janus Spheres	SCIENCE			English	Article							CLUSTERS; GROWTH	Clusters in the form of aggregates of a small number of elemental units display structural, thermodynamic, and dynamic properties different from those of bulk materials. We studied the kinetic pathways of self-assembly of "Janus spheres" with hemispherical hydrophobic attraction and found key differences from those characteristic of molecular amphiphiles. Experimental visualization combined with theory and molecular dynamics simulation shows that small, kinetically favored isomers fuse, before they equilibrate, into fibrillar triple helices with at most six nearest neighbors per particle. The time scales of colloidal rearrangement combined with the directional interactions resulting from Janus geometry make this a prototypical system to elucidate, on a mechanistic level and with single-particle kinetic resolution, how chemical anisotropy and reaction kinetics coordinate to generate highly ordered structures.	[Luijten, Erik] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Chen, Qian; Whitmer, Jonathan K.; Jiang, Shan; Bae, Sung Chul; Granick, Steve] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Whitmer, Jonathan K.; Granick, Steve] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Luijten, Erik] Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; [Granick, Steve] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign	Luijten, E (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.	luijten@northwestern.edu; sgranick@illinois.edu	Luijten, Erik/E-3899-2010; Jiang, Shan/I-5405-2019; Chen, Qian/A-6535-2011; Jiang, Shan/A-9265-2008; Bae, Sung C/A-3423-2008; Chen, Qian/E-9624-2014	Luijten, Erik/0000-0003-2364-1866; Jiang, Shan/0000-0001-8119-9012; Jiang, Shan/0000-0001-8119-9012; Bae, Sung C/0000-0002-9765-6801; Chen, Qian/0000-0002-1968-441X	U.S. Department of Energy; Division of Materials Science through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign [DE-FG02-07ER46471]; NSF [CBET-0853737, DMR-0346914, DMR-1006430]; Directorate For Engineering [0853737] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); Division of Materials Science through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign; NSF(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank J. Yan for discussions. Supported by the U.S. Department of Energy (S. G., Q. C., S. J.); Division of Materials Science, under award DE-FG02-07ER46471 through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign (to S. G.); and by NSF grants CBET-0853737 (S. C. B.) and DMR-0346914 and DMR-1006430 (J.K.W. and E. L., to E.L.).	BOERDIJK AH, 1952, PHILIPS RES REP, V7, P303; Cacciuto A, 2004, NATURE, V428, P404, DOI 10.1038/nature02397; Campbell AI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208301; Dai HJ, 2002, SURF SCI, V500, P218, DOI 10.1016/S0039-6028(01)01558-8; ERICKSON RO, 1973, SCIENCE, V181, P705, DOI 10.1126/science.181.4101.705; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; GOODWIN JW, 2009, COLLOIDS INTERFACES, P163; Groenewold J, 2001, J PHYS CHEM B, V105, P11702, DOI 10.1021/jp011646w; Hong L, 2008, LANGMUIR, V24, P621, DOI 10.1021/la7030818; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Liu K, 2010, SCIENCE, V329, P197, DOI 10.1126/science.1189457; Mao ZW, 2010, ADV FUNCT MATER, V20, P1053, DOI 10.1002/adfm.200902076; Meng GN, 2010, SCIENCE, V327, P560, DOI 10.1126/science.1181263; Mikosch J, 2008, SCIENCE, V319, P183, DOI 10.1126/science.1150238; Miller WL, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021404; Nyrkova IA, 2005, MACROMOL THEOR SIMUL, V14, P569, DOI 10.1002/mats.200500010; Safran S. A., 1994, STAT THERMODYNAMICS; Sciortino F, 2005, J PHYS CHEM B, V109, P21942, DOI 10.1021/jp052683g; Sciortino F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.237801; Whitelam S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3316794; Yoon B, 2007, CHEMPHYSCHEM, V8, P157, DOI 10.1002/cphc.200600524	22	450	458	5	455	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2011	331	6014					199	202		10.1126/science.1197451	http://dx.doi.org/10.1126/science.1197451			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233384	Green Submitted			2022-12-28	WOS:000286433100038
J	Fausti, D; Tobey, RI; Dean, N; Kaiser, S; Dienst, A; Hoffmann, MC; Pyon, S; Takayama, T; Takagi, H; Cavalleri, A				Fausti, D.; Tobey, R. I.; Dean, N.; Kaiser, S.; Dienst, A.; Hoffmann, M. C.; Pyon, S.; Takayama, T.; Takagi, H.; Cavalleri, A.			Light-Induced Superconductivity in a Stripe-Ordered Cuprate	SCIENCE			English	Article							PHASE; PSEUDOGAP	One of the most intriguing features of some high-temperature cuprate superconductors is the interplay between one-dimensional "striped" spin order and charge order, and superconductivity. We used mid-infrared femtosecond pulses to transform one such stripe-ordered compound, nonsuperconducting La1.675Eu0.2Sr0.125CuO4, into a transient three-dimensional superconductor. The emergence of coherent interlayer transport was evidenced by the prompt appearance of a Josephson plasma resonance in the c-axis optical properties. An upper limit for the time scale needed to form the superconducting phase is estimated to be 1 to 2 picoseconds, which is significantly faster than expected. This places stringent new constraints on our understanding of stripe order and its relation to superconductivity.	[Fausti, D.; Dean, N.; Kaiser, S.; Hoffmann, M. C.; Cavalleri, A.] Univ Hamburg, Max Planck Res Dept Struct Dynam, Ctr Free Electron Laser Sci, Hamburg, Germany; [Fausti, D.; Tobey, R. I.; Dean, N.; Dienst, A.; Cavalleri, A.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Pyon, S.; Takayama, T.; Takagi, H.] Univ Tokyo, Dept Adv Mat Sci, Tokyo, Japan; [Takagi, H.] IKEN Adv Sci Inst, Wako, Saitama 3510198, Japan	Max Planck Society; University of Hamburg; University of Oxford; University of Tokyo	Fausti, D (corresponding author), Univ Trieste, Trieste, Italy.	daniele.fausti@mpsd.cfel.de; andrea.cavalleri@mpsd.cfel.de	Hoffmann, Matthias C/B-3893-2009; Kaiser, Stefan/B-7788-2008; Hoffmann, Matthias C./N-1082-2019; TAKAGI, HIDENORI/Q-1041-2019; PYON, Sunseng/B-2618-2011; Takagi, Hidenori/B-2935-2010	Hoffmann, Matthias C/0000-0002-3596-9853; Kaiser, Stefan/0000-0001-9862-2788; Hoffmann, Matthias C./0000-0002-3596-9853; TAKAGI, HIDENORI/0000-0001-5700-3761; Fausti, Daniele/0000-0002-2142-9741; Pyon, Sunseng/0000-0002-5716-1791; Dean, Nicky/0000-0002-4219-8807	Max Planck Society; University of Hamburg; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19104008]; European Young Investigator Award	Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Hamburg; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Young Investigator Award	This research was supported by a 2004 European Young Investigator Award, by core support from the Max Planck Society and the University of Hamburg, and by a Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-Aid for Scientific Research (S) (19104008).	Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Annett J.F., 2004, OXFORD MASTER SERIES; Averitt RD, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.140502; Basov DN, 2005, REV MOD PHYS, V77, P721, DOI 10.1103/RevModPhys.77.721; BASOV DN, 1994, PHYS REV B, V50, P3511, DOI 10.1103/PhysRevB.50.3511; Basov DN, 1999, SCIENCE, V283, P49, DOI 10.1126/science.283.5398.49; Berg E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.127003; CRAWFORD MK, 1991, PHYS REV B, V44, P7749, DOI 10.1103/PhysRevB.44.7749; Demsar J, 1999, PHYS REV LETT, V82, P4918, DOI 10.1103/PhysRevLett.82.4918; FERTIG HA, 1990, PHYS REV LETT, V65, P1482, DOI 10.1103/PhysRevLett.65.1482; Fink J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.100502; Fujita M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.167008; Gedik N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117005; Gedik N, 2003, SCIENCE, V300, P1410, DOI 10.1126/science.1083038; Giannetti C, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224502; Kaindl RA, 2000, SCIENCE, V287, P470, DOI 10.1126/science.287.5452.470; Klauss HH, 2000, PHYS REV LETT, V85, P4590, DOI 10.1103/PhysRevLett.85.4590; KRESIN VZ, 1988, PHYS REV B, V37, P7854, DOI 10.1103/PhysRevB.37.7854; Li Q, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.067001; NAKAMURA Y, 1992, PHYS REV B, V46, P5841, DOI 10.1103/PhysRevB.46.5841; NIEVA G, 1992, APPL PHYS LETT, V60, P2159, DOI 10.1063/1.107069; Pashkin A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.067001; Perfetti L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.197001; Rini M, 2007, NATURE, V449, P72, DOI 10.1038/nature06119; Segre GP, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137001; Suryadijaya, 2005, PHYSICA C, V426, P402, DOI 10.1016/j.physc.2005.02.052; SUZUKI T, 1989, PHYSICA C, V159, P111, DOI 10.1016/0921-4534(89)90111-1; Tajima S, 2001, PHYS REV LETT, V86, P500, DOI 10.1103/PhysRevLett.86.500; Takeshita N, 2004, J PHYS SOC JPN, V73, P1123, DOI 10.1143/JPSJ.73.1123; TAMASAKU K, 1992, PHYS REV LETT, V69, P1455, DOI 10.1103/PhysRevLett.69.1455; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Tobey RI, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197404; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Von Zimmermann M, 1998, EUROPHYS LETT, V41, P629, DOI 10.1209/epl/i1998-00204-2; Xu ZA, 2000, NATURE, V406, P486, DOI 10.1038/35020016; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391	36	748	754	12	292	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					189	191		10.1126/science.1197294	http://dx.doi.org/10.1126/science.1197294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233381				2022-12-28	WOS:000286433100035
J	Lyall, J; Irvine, RM; Sherman, A; McKinley, TJ; Nunez, A; Purdie, A; Outtrim, L; Brown, IH; Rolleston-Smith, G; Sang, H; Tiley, L				Lyall, Jon; Irvine, Richard M.; Sherman, Adrian; McKinley, Trevelyan J.; Nunez, Alejandro; Purdie, Auriol; Outtrim, Linzy; Brown, Ian H.; Rolleston-Smith, Genevieve; Sang, Helen; Tiley, Laurence			Suppression of Avian Influenza Transmission in Genetically Modified Chickens	SCIENCE			English	Article							VIRUS; TRANSCRIPTION; POLYMERASE; SYSTEM; RNAS; H5N1	Infection of chickens with avian influenza virus poses a global threat to both poultry production and human health that is not adequately controlled by vaccination or by biosecurity measures. A novel alternative strategy is to develop chickens that are genetically resistant to infection. We generated transgenic chickens expressing a short-hairpin RNA designed to function as a decoy that inhibits and blocks influenza virus polymerase and hence interferes with virus propagation. Susceptibility to primary challenge with highly pathogenic avian influenza virus and onward transmission dynamics were determined. Although the transgenic birds succumbed to the initial experimental challenge, onward transmission to both transgenic and nontransgenic birds was prevented.	[Lyall, Jon; McKinley, Trevelyan J.; Tiley, Laurence] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Irvine, Richard M.; Nunez, Alejandro; Outtrim, Linzy; Brown, Ian H.] Vet Lab Agcy, Addlestone KT15 3NB, Surrey, England; [Sherman, Adrian; Purdie, Auriol; Rolleston-Smith, Genevieve; Sang, Helen] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9PS, Midlothian, Scotland; [Sherman, Adrian; Purdie, Auriol; Rolleston-Smith, Genevieve; Sang, Helen] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9PS, Midlothian, Scotland	University of Cambridge; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Tiley, L (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	Lst21@cam.ac.uk	Castel, Alejandro Núñez/C-2560-2011; Irvine, Richard M/E-2556-2011; Brown, Ian H/E-1119-2011	Irvine, Richard M/0000-0002-1584-4076; Purdie, Auriol/0000-0003-1941-6658; Nunez, Alejandro/0000-0001-5926-7541	Biotechnology and Biological Sciences Research Council [BB/G00479X/1, BBS/B/00239, BBS/B/00301]; Cambridge Infectious Diseases Consortium Department for Environment, Food and Rural Affairs-Higher Education Funding Council for England [VT0105]; Cobb-Vantress Ltd.; BBSRC [BB/G00479X/1] Funding Source: UKRI; MRC [G0300009] Funding Source: UKRI; Medical Research Council [G0300009] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Infectious Diseases Consortium Department for Environment, Food and Rural Affairs-Higher Education Funding Council for England; Cobb-Vantress Ltd.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Lillico, F. Song, and H. Gilhooley for advice on laboratory methods and technical support; R. Mitchell, F. Thomson, and M. Hutchison for assistance in production and breeding of transgenic birds; S. Essen and W. Cox for assistance with the in vivo challenge studies at the Veterinary Laboratories Agency, Weybridge; P. Digard and W. Barclay for providing the component plasmids of the minireplicon assays; and Cobb-Vantress Ltd. for supporting part of this work. This work was supported by the Biotechnology and Biological Sciences Research Council (grants BB/G00479X/1, BBS/B/00239, and BBS/B/00301) and by the Cambridge Infectious Diseases Consortium Department for Environment, Food and Rural Affairs-Higher Education Funding Council for England (grant VT0105). Crown Copyright 2010.	Biswas SK, 1996, J VIROL, V70, P6716, DOI 10.1128/JVI.70.10.6716-6722.1996; Capua I, 2007, VACCINE, V25, P5645, DOI 10.1016/j.vaccine.2006.10.053; Chen JZ, 2008, J INFECT DIS, V197, pS25, DOI 10.1086/524987; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Howard W, 2007, AVIAN DIS, V51, P393, DOI 10.1637/7645-050906R1.1; Hunter CV, 2005, TRENDS MOL MED, V11, P293, DOI 10.1016/j.molmed.2005.04.001; Luo GX, 1997, J GEN VIROL, V78, P2329, DOI 10.1099/0022-1317-78-9-2329; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Swayne DE, 2001, AVIAN DIS, V45, P355, DOI 10.2307/1592975; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Umbach JL, 2010, MBIO, V1, DOI 10.1128/mBio.00204-10; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; WEBSTER RG, 1995, AM J RESP CRIT CARE, V152, pS25, DOI 10.1164/ajrccm/152.4_Pt_2.S25	14	127	137	6	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					223	226		10.1126/science.1198020	http://dx.doi.org/10.1126/science.1198020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233391				2022-12-28	WOS:000286433100045
J	Silk, AW; McTigue, KM				Silk, Ann Willman; McTigue, Kathleen M.			Reexamining the Physical Examination for Obese Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BODY-MASS INDEX; BREAST-CANCER; DIAGNOSIS; STAGE		[Silk, Ann Willman] Univ Pittsburgh, Sch Med, UPMC Montefiore Hosp, Internal Med Residency Program, Pittsburgh, PA 15213 USA; [McTigue, Kathleen M.] Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Silk, AW (corresponding author), Univ Pittsburgh, Sch Med, UPMC Montefiore Hosp, Internal Med Residency Program, N-713,200 Lothrop St, Pittsburgh, PA 15213 USA.	awsilk@gmail.com	Silk, Ann/J-6752-2017	Silk, Ann/0000-0003-3877-3984				Barton MB, 1999, JAMA-J AM MED ASSOC, V282, P1270, DOI 10.1001/jama.282.13.1270; Chagpar AB, 2007, AM SURGEON, V73, P555; Cooke M, 2010, NEW ENGL J MED, V362, P1253, DOI 10.1056/NEJMp0911502; Ferrante JM, 2007, AM J PREV MED, V32, P525, DOI 10.1016/j.amepre.2007.02.004; Ferrante JM, 2010, OBESITY, V18, P1153, DOI 10.1038/oby.2009.481; Fink HA, 2000, ARCH INTERN MED, V160, P833, DOI 10.1001/archinte.160.6.833; Hahn KME, 2007, AM J EPIDEMIOL, V166, P1035, DOI 10.1093/aje/kwm177; National Center for Health Statistics, 2017, HLTH US 2016 CHARTB; National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE; WILLIAMS JW, 1992, JAMA-J AM MED ASSOC, V267, P2645, DOI 10.1001/jama.267.19.2645	10	31	32	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					193	194		10.1001/jama.2010.1950	http://dx.doi.org/10.1001/jama.2010.1950			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21191004				2022-12-28	WOS:000286103400026
J	Bao, YH; Shen, XT				Bao, Yunhe; Shen, Xuetong			SnapShot: Chromatin Remodeling: INO80 and SWR1	CELL			English	Editorial Material							COMPLEXES; TRANSCRIPTION; REPAIR		[Bao, Yunhe; Shen, Xuetong] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Bao, YH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA.			Shen, Xuetong/0000-0002-4267-5298	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093104] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM093104] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altaf M, 2009, BIOCHEM CELL BIOL, V87, P35, DOI 10.1139/O08-140; Bao YH, 2007, MUTAT RES-FUND MOL M, V618, P18, DOI 10.1016/j.mrfmmm.2006.10.006; Bao Yunhe, 2007, Cell, V129, P632, DOI 10.1016/j.cell.2007.04.018; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Lu PYT, 2009, BIOCHEM CELL BIOL, V87, P799, DOI 10.1139/O09-062; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Osley MA, 2006, TRENDS GENET, V22, P671, DOI 10.1016/j.tig.2006.09.007; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001	9	36	38	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 7	2011	144	1					158	U165		10.1016/j.cell.2010.12.024	http://dx.doi.org/10.1016/j.cell.2010.12.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215376	Green Accepted, Bronze			2022-12-28	WOS:000285993600015
J	Alexandrou, MA; Oliveira, C; Maillard, M; McGill, RAR; Newton, J; Creer, S; Taylor, MI				Alexandrou, Markos A.; Oliveira, Claudio; Maillard, Marjorie; McGill, Rona A. R.; Newton, Jason; Creer, Simon; Taylor, Martin I.			Competition and phylogeny determine community structure in Mullerian co-mimics	NATURE			English	Article							POSITIVE INTERACTIONS; STABLE-ISOTOPES; DNA CONTENT; FISH; CONSPICUOUSNESS; FACILITATION; EVOLUTION	Until recently, the study of negative and antagonistic interactions (for example, competition and predation) has dominated our understanding of community structure, maintenance and assembly(1). Nevertheless, a recent theoretical model suggests that positive interactions (for example, mutualisms) may counterbalance competition, facilitating long-term coexistence even among ecologically undifferentiated species(2). Mullerian mimics are mutualists that share the costs of predator education(3) and are therefore ideally suited for the investigation of positive and negative interactions in community dynamics. The sole empirical test of this model in a Mullerian mimetic community supports the prediction that positive interactions outweigh the negative effects of spatial overlap(4) (without quantifying resource acquisition). Understanding the role of trophic niche partitioning in facilitating the evolution and stability of Mullerian mimetic communities is now of critical importance, but has yet to be formally investigated. Here we show that resource partitioning and phylogeny determine community structure and outweigh the positive effects of Mullerian mimicry in a species-rich group of neotropical catfishes. From multiple, independent reproductively isolated allopatric communities displaying convergently evolved colour patterns, 92% consist of species that do not compete for resources. Significant differences in phylogenetically conserved traits (snout morphology and body size) were consistently linked to trait-specific resource acquisition. Thus, we report the first evidence, to our knowledge, that competition for trophic resources and phylogeny are pivotal factors in the stable evolution of Mullerian mimicry rings. More generally, our work demonstrates that competition for resources is likely to have a dominant role in the structuring of communities that are simultaneously subject to the effects of both positive and negative interactions.	[Alexandrou, Markos A.; Maillard, Marjorie; Creer, Simon; Taylor, Martin I.] Bangor Univ, Coll Nat Sci, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab,Environm Ctr Wales, Bangor LL57 2UW, Gwynedd, Wales; [Oliveira, Claudio] Univ Estadual Paulista, Inst Biociencias, Dept Morfol, BR-18618970 Botucatu, SP, Brazil; [McGill, Rona A. R.; Newton, Jason] Scottish Univ Environm Res Ctr, NERC Life Sci Mass Spectrometry Facil, E Kilbride G75 0QF, Lanark, Scotland	Bangor University; Universidade Estadual Paulista; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Taylor, MI (corresponding author), Bangor Univ, Coll Nat Sci, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab,Environm Ctr Wales, Bangor LL57 2UW, Gwynedd, Wales.	m.taylor@bangor.ac.uk	Taylor, Martin I/B-4298-2013; Newton, Jason/A-9536-2009; Oliveira, Claudio/D-7713-2012; McGill, Rona/F-1793-2010; Alexandrou, Markos/E-1509-2012	Newton, Jason/0000-0001-7594-3693; Oliveira, Claudio/0000-0002-7010-8880; McGill, Rona/0000-0003-0400-7288; 	NERC [NE/C001168/1, NE/F007205/1]; UNESP, Brazil; NERC [lsmsf010002] Funding Source: UKRI; Natural Environment Research Council [NE/C001168/2] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UNESP, Brazil; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by NERC small grant (NE/C001168/1), NERC Mass Spectrometry access grant (NE/F007205/1) awarded to M.I.T., and a NERC PhD studentship (NE/F007205/1) awarded to M.A.A. Research was also supported by UNESP, Brazil. We would like to thank the staff and students of UNESP, Botucatu, Brazil for facilities and research support during fieldwork including P. Venere for helping to collect samples in the Rio Araguaia, and M. Britto for identifying samples. We would also like to thank B. Emerson and G. Ruxton for their suggestions and critical evaluation of the manuscript. We thank J. Montoya-Burgos, M. Sabaj Perez, I. Fuller, H.-G. Evers, M. Walters and K. Mathiesen for providing tissue samples and photographs, and A. Orchard for photographing preserved specimens.	Axenrot T. E., 2003, ICHTHYOL EXPLOR FRES, V14, P249; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; Drummond A. J., 2009, GENEIOUS V4 7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elias M, 2008, PLOS BIOL, V6, P2642, DOI 10.1371/journal.pbio.0060300; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; Fuller IA, 2005, IDENTIFYING CORYDORA; Genner MJ, 1999, ECOL LETT, V2, P185; Greven H., 2006, VERHANDLUNGEN GESELL, V5, P65; Gross K, 2008, ECOL LETT, V11, P929, DOI 10.1111/j.1461-0248.2008.01204.x; HINEGARDNER R, 1972, AM NAT, V106, P621, DOI 10.1086/282801; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kiehl Ernst, 2006, Verhandlungen der Gesellschaft fuer Ichthyologie (GfI) e V, V5, P111; Kovach W. L, 1999, MVSP MULTIVARIATE ST; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Luz-Agostinho KDG, 2008, HYDROBIOLOGIA, V607, P187, DOI 10.1007/s10750-008-9390-4; MAY RM, 1981, AM ZOOL, V21, P903; Merilaita S, 2007, J THEOR BIOL, V245, P268, DOI 10.1016/j.jtbi.2006.10.022; Muller F., 1878, ZOOL ANZ, V1, P54; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; NIJSSEN H, 1970, Beaufortia, V18, P1; OLIVEIRA C, 1992, J FISH BIOL, V40, P419, DOI 10.1111/j.1095-8649.1992.tb02587.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; POWER ME, 1984, ECOLOGY, V65, P523, DOI 10.2307/1941414; RAMBAUT A, 2004, TRACER V1 4; Rowland HM, 2007, NATURE, V448, P64, DOI 10.1038/nature05899; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Ruxton G. D., 2004, AVOIDING ATTACK; Sands D. D., 1994, BEHAV EVOLUTIONARY E; Stachowicz JJ, 2001, BIOSCIENCE, V51, P235, DOI 10.1641/0006-3568(2001)051[0235:MFATSO]2.0.CO;2; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Wright JJ, 2011, EVOLUTION, V65, P395, DOI 10.1111/j.1558-5646.2010.01149.x; Wright JJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-282; Wuster W, 2004, P ROY SOC B-BIOL SCI, V271, P2495, DOI 10.1098/rspb.2004.2894	42	94	101	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					84	U97		10.1038/nature09660	http://dx.doi.org/10.1038/nature09660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21209663				2022-12-28	WOS:000285921600036
J	Pimentel, M; Lembo, A; Chey, WD; Zakko, S; Ringel, Y; Yu, J; Mareya, SM; Shaw, AL; Bortey, E; Forbes, WP				Pimentel, Mark; Lembo, Anthony; Chey, William D.; Zakko, Salam; Ringel, Yehuda; Yu, Jing; Mareya, Shadreck M.; Shaw, Audrey L.; Bortey, Enoch; Forbes, William P.		TARGET Study Grp	Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTESTINAL BACTERIAL OVERGROWTH; DOUBLE-BLIND; MICROBIOTA; EFFICACY	Background: Evidence suggests that gut flora may play an important role in the pathophysiology of the irritable bowel syndrome (IBS). We evaluated rifaximin, a minimally absorbed antibiotic, as treatment for IBS. Methods: In two identically designed, phase 3, double-blind, placebo-controlled trials (TARGET 1 and TARGET 2), patients who had IBS without constipation were randomly assigned to either rifaximin at a dose of 550 mg or placebo, three times daily for 2 weeks, and were followed for an additional 10 weeks. The primary end point, the proportion of patients who had adequate relief of global IBS symptoms, and the key secondary end point, the proportion of patients who had adequate relief of IBS-related bloating, were assessed weekly. Adequate relief was defined as self-reported relief of symptoms for at least 2 of the first 4 weeks after treatment. Other secondary end points included the percentage of patients who had a response to treatment as assessed by daily self-ratings of global IBS symptoms and individual symptoms of bloating, abdominal pain, and stool consistency during the 4 weeks after treatment and during the entire 3 months of the study. Results: Significantly more patients in the rifaximin group than in the placebo group had adequate relief of global IBS symptoms during the first 4 weeks after treatment (40.8% vs. 31.2%, P=0.01, in TARGET 1; 40.6% vs. 32.2%, P=0.03, in TARGET 2; 40.7% vs. 31.7%, P<0.001, in the two studies combined). Similarly, more patients in the rifaximin group than in the placebo group had adequate relief of bloating (39.5% vs. 28.7%, P=0.005, in TARGET 1; 41.0% vs. 31.9%, P=0.02, in TARGET 2; 40.2% vs. 30.3%, P<0.001, in the two studies combined). In addition, significantly more patients in the rifaximin group had a response to treatment as assessed by daily ratings of IBS symptoms, bloating, abdominal pain, and stool consistency. The incidence of adverse events was similar in the two groups. Conclusions: Among patients who had IBS without constipation, treatment with rifaximin for 2 weeks provided significant relief of IBS symptoms, bloating, abdominal pain, and loose or watery stools. (Funded by Salix Pharmaceuticals; ClinicalTrials.gov numbers, NCT00731679 and NCT00724126.) N Engl J Med 2011;364:22-32.	[Pimentel, Mark] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Lembo, Anthony] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Lembo, Anthony] Harvard Univ, Sch Med, Boston, MA USA; [Chey, William D.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Zakko, Salam] Bristol Hosp, Connecticut Gastroenterol Inst, Bristol, Avon, England; [Ringel, Yehuda] Univ N Carolina, Chapel Hill, NC USA; [Yu, Jing; Mareya, Shadreck M.; Shaw, Audrey L.; Bortey, Enoch; Forbes, William P.] Salix Pharmaceut, Morrisville, NC USA	Cedars Sinai Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill	Forbes, WP (corresponding author), 1700 Perimeter Pk Dr, Morrisville, NC 27560 USA.		Chey, William/AAY-7766-2021; Pimentel, Mark/AAH-7073-2021	Pimentel, Mark/0000-0002-0619-5115	Salix Pharmaceuticals; Ironwood Pharmaceuticals; Prometheus; Ardelyx; Theravance; GlaxoSmithKline; AstraZeneca; Procter Gamble; Danisco; Danisco USA; General Mills; SmartPill	Salix Pharmaceuticals; Ironwood Pharmaceuticals; Prometheus; Ardelyx; Theravance; GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Procter Gamble(Procter & Gamble); Danisco; Danisco USA; General Mills; SmartPill	Supported by Salix Pharmaceuticals.; Dr. Pimentel reports receiving grant support (to his institution) and consulting fees and honoraria from Salix Pharmaceuticals and reports that Cedars-Sinai Medical Center holds patents licensed by Salix Pharmaceuticals; Dr. Lembo reports receiving consulting fees from Salix Pharmaceuticals, Ironwood Pharmaceuticals, Prometheus, Ardelyx, Theravance, GlaxoSmithKline, and AstraZeneca, receiving payment for participation in several advisory-board meetings relating to the development of rifaximin for the treatment of IBS, and receiving payment as a member of the speakers' bureau of Salix Pharmaceuticals; Dr. Chey reports receiving consulting fees and honoraria from Procter & Gamble, Ortho-McNeil, Prometheus, and Salix Pharmaceuticals, payment for the development of educational presentations, and payment or reimbursement for travel and accommodations from Procter & Gamble, Prometheus, and Salix Pharmaceuticals; Dr. Zakko reports receiving grant support (to his institution), consulting fees, payment for the development of educational presentations, and payment or reimbursement for travel and accommodations from Salix Pharmaceuticals and holding stock in Salix Pharmaceuticals; Dr. Ringel reports receiving consulting fees from Salix Pharmaceuticals, Ironwood Pharmaceuticals, Procter & Gamble, Pfizer, and Danisco, participating in several advisory-board meetings related to the development of rifaximin for the treatment of IBS, receiving payment for the development of educational presentations and as a member of the speakers' bureau of Salix Pharmaceuticals, and receiving research grants from Danisco USA, General Mills, and SmartPill. Drs. Yu, Mareya, and Bortey report being employees of and holding stock in Salix Pharmaceuticals; Dr. Shaw reports being an employee of Salix Pharmaceuticals and reports that she holds stock in the company; and Dr. Forbes reports being an officer and employee of Salix Pharmaceuticals and holding stock in the company. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2008, LOTR AL HYDR TABL; [Anonymous], 2010, GUID IND IRR BOW SYN; [Anonymous], 2007, ZELN TEG MAL TABL; [Anonymous], 2008, AM LUB CAPS; Attar A, 1999, GASTROENTEROLOGY, V117, P794, DOI 10.1016/S0016-5085(99)70336-7; Brandt LJ, 2009, AM J GASTROENTEROL, V104, pS1, DOI 10.1038/ajg.2008.122; Brigidi P, 2002, J CHEMOTHERAPY, V14, P290, DOI 10.1179/joc.2002.14.3.290; Camilleri M, 2009, DIGEST LIVER DIS, V41, P854, DOI 10.1016/j.dld.2009.07.009; Cash Brooks D, 2003, Curr Gastroenterol Rep, V5, P468, DOI 10.1007/s11894-003-0035-5; Debbia EA, 2008, J CHEMOTHERAPY, V20, P186, DOI 10.1179/joc.2008.20.2.186; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; El-Serag Hashem B, 2003, Rev Gastroenterol Disord, V3 Suppl 2, pS3; Gerard Laura, 2005, Expert Rev Anti Infect Ther, V3, P201, DOI 10.1586/14787210.3.2.201; Hammerle CW, 2008, WORLD J GASTROENTERO, V14, P2639, DOI 10.3748/wjg.14.2639; Jiang ZD, 2005, CHEMOTHERAPY, V51, P67, DOI 10.1159/000081991; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Pimentel M, 2003, AM J GASTROENTEROL, V98, P412, DOI 10.1016/S0002-9270(02)05902-6; Pimentel M, 2006, ANN INTERN MED, V145, P557, DOI 10.7326/0003-4819-145-8-200610170-00004; Pimentel M, 2009, EXPERT OPIN INV DRUG, V18, P349, DOI [10.1517/13543780902780175 , 10.1517/13543780902780175]; Posserud I, 2007, GUT, V56, P802, DOI 10.1136/gut.2006.108712; Ringel Yehuda, 2009, Gastrointest Endosc Clin N Am, V19, P141, DOI 10.1016/j.giec.2008.12.004; Schoenfeld P, 2005, GASTROENTEROL CLIN N, V34, P319, DOI 10.1016/j.gtc.2005.02.002; Sharara AI, 2006, AM J GASTROENTEROL, V101, P326, DOI 10.1111/j.1572-0241.2006.00458.x; Spiegel B, 2009, GASTROENTEROLOGY, V137, P1944, DOI 10.1053/j.gastro.2009.08.047; Thompson WG, 1999, GUT, V45, P43	25	653	689	6	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					22	32		10.1056/NEJMoa1004409	http://dx.doi.org/10.1056/NEJMoa1004409			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UY	21208106	Green Published			2022-12-28	WOS:000285922600007
J	Laine, C				Laine, Christine			Welcome to the Patient-Centered Medical Neighborhood	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PHYSICIANS VIEW; HOME NEIGHBOR		Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Laine, C (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							Sinsky CA, 2011, ANN INTERN MED, V154, P61, DOI 10.7326/0003-4819-154-1-201101040-00010; Yee HF, 2011, ANN INTERN MED, V154, P63, DOI 10.7326/0003-4819-154-1-201101040-00011	2	16	16	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					60	60		10.7326/0003-4819-154-1-201101040-00009	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200040				2022-12-28	WOS:000285830900008
J	Coovadia, H; Rollins, N				Coovadia, Hoosen; Rollins, Nigel			Tying up loose threads in delivery of a newborn care package	LANCET			English	Editorial Material									[Coovadia, Hoosen] Univ Witwatersrand, ZA-4013 Durban, Kwazulu Natal, South Africa; [Coovadia, Hoosen] Univ Kwazulu Natal, Doris Duke Med Res Inst, Nelson R Mandela Sch Med, ZA-4013 Durban, Kwazulu Natal, South Africa; [Rollins, Nigel] WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland	University of Witwatersrand; University of Kwazulu Natal; University of Geneva; World Health Organization	Coovadia, H (corresponding author), Univ Witwatersrand, ZA-4013 Durban, Kwazulu Natal, South Africa.	hcoovadia@match.org.za						Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Bahl R, 2010, SEMIN PERINATOL, V34, P477, DOI 10.1053/j.semperi.2010.09.001; Barker P, 2010, 1 GLOBS HLTH SYST RE; Bhutta ZA, 2011, LANCET          0115, DOI [10.1016/50140-6736(10)62274-X, DOI 10.1016/50140-6736(10)62274-X]; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Lassi ZS, 2010, COMMUNITY BASED INTE; Lewin S, 2010, COCHRANE DB SYST REV, V3; UNICEF, 2010, STAT WORLDS CHILDR	9	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2011	377	9763					361	363		10.1016/S0140-6736(11)60058-5	http://dx.doi.org/10.1016/S0140-6736(11)60058-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721ES	21239050				2022-12-28	WOS:000287337000008
J	Jarosz, DF; Lindquist, S				Jarosz, Daniel F.; Lindquist, Susan			Hsp90 and Environmental Stress Transform the Adaptive Value of Natural Genetic Variation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MORPHOLOGICAL EVOLUTION; PHENOTYPIC VARIATION; DRUG-RESISTANCE; CHAPERONE; PROTEIN; CAPACITOR; YEAST; ACTS	How can species remain unaltered for long periods yet also undergo rapid diversification? By linking genetic variation to phenotypic variation via environmental stress, the Hsp90 protein-folding reservoir might promote both stasis and change. However, the nature and adaptive value of Hsp90-contingent traits remain uncertain. In ecologically and genetically diverse yeasts, we find such traits to be both common and frequently adaptive. Most are based on preexisting variation, with causative polymorphisms occurring in coding and regulatory sequences alike. A common temperature stress alters phenotypes similarly. Both selective inhibition of Hsp90 and temperature stress increase correlations between genotype and phenotype. This system broadly determines the adaptive value of standing genetic variation and, in so doing, has influenced the evolution of current genomes.	[Jarosz, Daniel F.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu		Jarosz, Daniel/0000-0003-3497-5888	Broad Institute; Harold and Leila Y. Mathers Foundation; HHMI	Broad Institute; Harold and Leila Y. Mathers Foundation; HHMI(Howard Hughes Medical Institute)	We are grateful to L. Kruglyak, E. Perlstein, L. Cowen, S. Schreiber, A. Regev, I. Barassa, E. Louis, S. Dietzmann, and F. Dietrich for materials, discussion, and help. S.L. is a Howard Hughes Medical Institute (HHMI) investigator, and D.F.J. is an HHMI fellow of the Damon Runyon Cancer Research Foundation (DRG-1964-08). This work was supported by grants from the Broad Institute, the G. Harold and Leila Y. Mathers Foundation, and HHMI.	BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Hikkel I, 2003, J BIOL CHEM, V278, P11427, DOI 10.1074/jbc.M208549200; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Mitchell-Olds T, 2002, SCIENCE, V296, P2348, DOI 10.1126/science.1073846; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Ramanathan Arvind, 2007, J Biol, V6, P3, DOI 10.1186/jbiol56; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Seo BB, 2006, FEBS LETT, V580, P6105, DOI 10.1016/j.febslet.2006.10.008; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; VITOLS E, 1970, BIOCHEM BIOPH RES CO, V41, P71, DOI 10.1016/0006-291X(70)90470-5; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324	27	236	241	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1820	1824		10.1126/science.1195487	http://dx.doi.org/10.1126/science.1195487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205668	Green Accepted, Green Submitted			2022-12-28	WOS:000285603700040
J	Spence, D				Spence, Des			From the Frontline Bad medicine: general practice	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Blunt I, 2010, TRENDS EMERGENCY ADM; *DIAB UK, DIAB DRUG PRESCR RIS; NHS Information Centre, PRESCR DISP COMM ENG; *NHS PRESCR SERV, ASTHM COPD; *NHS PRESCR SERV, ACE INH ANG 2 REC AN; *NHS PRESCR SERV, CARD SYST NAT CHARTS; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182	7	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2010	341								c7336	10.1136/bmj.c7336	http://dx.doi.org/10.1136/bmj.c7336			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	700DX	21177740				2022-12-28	WOS:000285717100001
J	McDermott, J				McDermott, Jim			Harnessing Our Opportunity to Make Primary Care Sustainable	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2008, MED PAYM POL, P78; Association of American Medical Colleges, 2007, MED SCH TUIT YOUNG P; Ginsburg PB, 2011, NEW ENGL J MED, V364, P172, DOI 10.1056/NEJMhpr1004028; Kaiser Family Foundation, 2010, KAIS HLTH TRACK POLL	4	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					395	397		10.1056/NEJMp1014256	http://dx.doi.org/10.1056/NEJMp1014256			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715LL	21247309				2022-12-28	WOS:000286885900003
J	Dowell, SF; Tappero, JW; Frieden, TR				Dowell, Scott F.; Tappero, Jordan W.; Frieden, Thomas R.			Public Health in Haiti - Challenges and Progress	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dowell, Scott F.] Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA 30333 USA; [Tappero, Jordan W.] Ctr Dis Control & Prevent, Hlth Syst Reconstruct Off, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Dowell, SF (corresponding author), Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA 30333 USA.			Frieden, Thomas/0000-0002-4759-2256				Rapid establishment of an internally displaced persons disease surveillance system after an earthquake-Haiti, 2010, MMWR MORB MORTAL WKL, V59, P939; *WHO UNICEF JMP WA, PROGR SAN DRINK WAT; 2010, MMWR MORB MORTAL WKL, V59, P1372; 2011, DONNEES PRELIMINAIRE; 2010, MMWR MORB MORTAL WKL, V59, P1637	5	40	40	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					300	301		10.1056/NEJMp1100118	http://dx.doi.org/10.1056/NEJMp1100118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711LH	21219131	Bronze			2022-12-28	WOS:000286592600004
J	Afek, Y; Alon, N; Barad, O; Hornstein, E; Barkai, N; Bar-Joseph, Z				Afek, Yehuda; Alon, Noga; Barad, Omer; Hornstein, Eran; Barkai, Naama; Bar-Joseph, Ziv			A Biological Solution to a Fundamental Distributed Computing Problem	SCIENCE			English	Article							LATERAL INHIBITION; PARALLEL ALGORITHM; PATTERN-FORMATION; SET; PATHWAY	Computational and biological systems are often distributed so that processors (cells) jointly solve a task, without any of them receiving all inputs or observing all outputs. Maximal independent set (MIS) selection is a fundamental distributed computing procedure that seeks to elect a set of local leaders in a network. A variant of this problem is solved during the development of the fly's nervous system, when sensory organ precursor (SOP) cells are chosen. By studying SOP selection, we derived a fast algorithm for MIS selection that combines two attractive features. First, processors do not need to know their degree; second, it has an optimal message complexity while only using one-bit messages. Our findings suggest that simple and efficient algorithms can be developed on the basis of biologically derived insights.	[Barad, Omer; Hornstein, Eran; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Afek, Yehuda; Alon, Noga] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Afek, Yehuda; Alon, Noga] Tel Aviv Univ, Sackler Sch Math, IL-69978 Tel Aviv, Israel; [Alon, Noga] Inst Adv Study, Princeton, NJ 08544 USA; [Bar-Joseph, Ziv] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA	Weizmann Institute of Science; Tel Aviv University; Tel Aviv University; Institute for Advanced Study - USA; Carnegie Mellon University	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il; zivbj@cs.cmu.edu	Bar-Joseph, Ziv/GWN-2754-2022; Alon, Noga/GOV-5970-2022; HORNSTEIN, ERAN/K-1340-2012	Alon, Noga/0000-0003-1332-4883; HORNSTEIN, ERAN/0000-0002-5534-1924; Bar-Joseph, Ziv/0000-0003-3430-6051	European Research Council (ERC); Oswald Veblen Fund; Bell Companies Fellowship; Azrieli Foundation; Israel Science Foundation; Hellen and Martin Kimmel award for innovative investigations; NIH [1RO1 GM085022]; NSF [0448453]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085022] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)); Oswald Veblen Fund; Bell Companies Fellowship; Azrieli Foundation; Israel Science Foundation(Israel Science Foundation); Hellen and Martin Kimmel award for innovative investigations; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. W. Posakony for fly stock and D. Rosin for help in experiments. This work was supported by a European Research Council (ERC) Advanced grant, the Oswald Veblen Fund, and the Bell Companies Fellowship (N.A.), the Azrieli Foundation (O.B.), the Israel Science Foundation (E. H. and N.B.), ERC (IDEA), the Hellen and Martin Kimmel award for innovative investigations (N.B.), NIH grant 1RO1 GM085022, and NSF CAREER award 0448453 (Z.B.-J.).	ALON N, 1986, J ALGORITHM, V7, P567, DOI 10.1016/0196-6774(86)90019-2; Alon U., 2006, INTRO SYSTEMS BIOL D; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barad O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000857; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; COHEN S, 1984, THEOR COMPUT SCI, V34, P215, DOI 10.1016/0304-3975(84)90118-X; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; LUBY M, 1986, SIAM J COMPUT, V15, P1036, DOI 10.1137/0215074; Lynch N. A., 1996, DISTRIBUTED ALGORITH; Miller AC, 2009, CURR BIOL, V19, P1378, DOI 10.1016/j.cub.2009.06.042; Moscibroda T., 2005, P 24 ANN ACM S PRINC, P148; Plahte E, 2001, J MATH BIOL, V43, P411, DOI 10.1007/s002850100105; RENDEL JM, 1965, GENETICS, V52, P1137; Simpson P, 1997, CURR OPIN GENET DEV, V7, P537, DOI 10.1016/S0959-437X(97)80083-4; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; USUI K, 1993, ROUX ARCH DEV BIOL, V203, P151, DOI 10.1007/BF00365054; Valiant Leslie G., 1982, P 7 IBM S MATH FDN C; Wan PJ, 2004, MOBILE NETW APPL, V9, P141, DOI 10.1023/B:MONE.0000013625.87793.13; Yves Metivier, 2009, Structural Information and Communication Complexity. 16th International Colloquium, SIROCCO 2009. Revised Selected Papers, P323	23	89	93	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					183	185		10.1126/science.1193210	http://dx.doi.org/10.1126/science.1193210			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233379				2022-12-28	WOS:000286433100033
J	Autier, P; Boniol, M				Autier, Philippe; Boniol, Mathieu			Caution needed for country-specific cancer survival	LANCET			English	Editorial Material							BREAST-CANCER; SCREENING MAMMOGRAPHY; EUROPE; DIAGNOSIS; MORTALITY; STATISTICS; TRENDS; STAGE		[Autier, Philippe; Boniol, Mathieu] Int Prevent Res Inst, F-69006 Lyon, France		Autier, P (corresponding author), Int Prevent Res Inst, F-69006 Lyon, France.	philippe.autier@i-pri.org	Boniol, Mathieu/F-9623-2011; Autier, Philippe/A-4402-2014	Boniol, Mathieu/0000-0003-1052-5604; Autier, Philippe/0000-0003-1538-5321				Allemani C, 2010, EUR J CANCER, V46, P1528, DOI 10.1016/j.ejca.2010.02.016; Autier P, 2007, LANCET ONCOL, V8, P1050, DOI 10.1016/S1470-2045(07)70354-6; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Beral V, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4112; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Boniol M, 2010, EUR J CANCER, V46, P2534, DOI 10.1016/j.ejca.2010.07.049; Brewster DH, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5133; Ciccolallo L, 2005, GUT, V54, P268, DOI 10.1136/gut.2004.044214; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; de Vries E, 2010, NAT REV CLIN ONCOL, V7, P60, DOI 10.1038/nrclinonc.2009.184; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Olsson S, 2000, J MED SCREEN, V7, P14, DOI 10.1136/jms.7.1.14; Robinson D, 2007, EUR J CANCER, V43, P909, DOI 10.1016/j.ejca.2007.01.007; Sant M, 2004, CANCER-AM CANCER SOC, V100, P715, DOI 10.1002/cncr.20038; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Thomson CS, 2004, EUR J CANCER, V40, P743, DOI 10.1016/j.ejca.2003.08.029; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311	21	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 8	2011	377	9760					99	101		10.1016/S0140-6736(10)62347-1	http://dx.doi.org/10.1016/S0140-6736(10)62347-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707NH	21215872				2022-12-28	WOS:000286292800004
J	Blaxter, M				Blaxter, Mark			Revealing the Dark Matter of the Genome	SCIENCE			English	Editorial Material							DROSOPHILA-MELANOGASTER; FUNCTIONAL ELEMENTS; IDENTIFICATION; MODENCODE; SEQUENCE; PROJECT		Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Blaxter, M (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	mark.blaxter@ed.ac.uk	Blaxter, Mark L/B-4113-2010; Blaxter, Mark/O-2535-2019	Blaxter, Mark L/0000-0003-2861-949X; 				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Eory L, 2010, MOL BIOL EVOL, V27, P177, DOI 10.1093/molbev/msp219; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	11	43	45	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1758	1759		10.1126/science.1200700	http://dx.doi.org/10.1126/science.1200700			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698OS	21177977				2022-12-28	WOS:000285603700024
J	Lynden-Bell, D				Lynden-Bell, Donald			RETROSPECTIVE Allan Sandage (1926-2010)	SCIENCE			English	Biographical-Item									Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England	University of Cambridge	Lynden-Bell, D (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	dlb@ast.cam.ac.uk							0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1763	1763		10.1126/science.1201221	http://dx.doi.org/10.1126/science.1201221			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205661				2022-12-28	WOS:000285603700027
J	Metin, C; Luccardini, C				Metin, Christine; Luccardini, Camilla			Ubiquitination Inhibits Neuronal Exit	SCIENCE			English	Editorial Material							MIGRATION; DEGRADATION; CENTROSOME; MOVEMENT		[Metin, Christine; Luccardini, Camilla] INSERM, U839, Inst Fer Moulin, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Metin, C (corresponding author), INSERM, U839, Inst Fer Moulin, F-75005 Paris, France.	christine.metin@inserm.fr; camilla.lucca-rdini@inserm.fr	Metin, Christine/E-4995-2017	Metin, Christine/0000-0002-5936-0110				Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Famulski JK, 2010, SCIENCE, V330, P1834, DOI 10.1126/science.1198480; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Mandicourt G, 2007, J BIOL CHEM, V282, P1830, DOI 10.1074/jbc.M605666200; Metin C, 2008, J NEUROSCI, V28, P11746, DOI 10.1523/JNEUROSCI.3860-08.2008; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332	12	1	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1754	1755		10.1126/science.1200475	http://dx.doi.org/10.1126/science.1200475			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205656				2022-12-28	WOS:000285603700021
J	Stafford, N				Stafford, Ned			The changing notion of food	NATURE			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S16	S17		10.1038/468S16a	http://dx.doi.org/10.1038/468S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179078	Bronze			2022-12-28	WOS:000285553800006
J	Ngo, VN; Young, RM; Schmitz, R; Jhavar, S; Xiao, WM; Lim, KH; Kohlhammer, H; Xu, WH; Yang, YD; Zhao, H; Shaffer, AL; Romesser, P; Wright, G; Powell, J; Rosenwald, A; Muller-Hermelink, HK; Ott, G; Gascoyne, RD; Connors, JM; Rimsza, LM; Campo, E; Jaffe, ES; Delabie, J; Smeland, EB; Fisher, RI; Braziel, RM; Tubbs, RR; Cook, JR; Weisenburger, DD; Chan, WC; Staudt, LM				Ngo, Vu N.; Young, Ryan M.; Schmitz, Roland; Jhavar, Sameer; Xiao, Wenming; Lim, Kian-Huat; Kohlhammer, Holger; Xu, Weihong; Yang, Yandan; Zhao, Hong; Shaffer, Arthur L.; Romesser, Paul; Wright, George; Powell, John; Rosenwald, Andreas; Muller-Hermelink, Hans Konrad; Ott, German; Gascoyne, Randy D.; Connors, Joseph M.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Delabie, Jan; Smeland, Erlend B.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.; Weisenburger, Denny D.; Chan, Wing C.; Staudt, Louis M.			Oncogenically active MYD88 mutations in human lymphoma	NATURE			English	Article							B-CELL LYMPHOMA; NF-KAPPA-B; TNFAIP3 A20; GENE; INHIBITORS; SIGNATURES; PATHWAYS; SURVIVAL; SUBTYPES; KINASE	The activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) remains the least curable form of this malignancy despite recent advances in therapy(1). Constitutive nuclear factor (NF)-kappa B and JAK kinase signalling promotes malignant cell survival in these lymphomas, but the genetic basis for this signalling is incompletely understood. Here we describe the dependence of ABC DLBCLs on MYD88, an adaptor protein that mediates toll and interleukin (IL)-1 receptor signalling(2,3), and the discovery of highly recurrent oncogenic mutations affecting MYD88 in ABC DLBCL tumours. RNA interference screening revealed that MYD88 and the associated kinases IRAK1 and IRAK4 are essential for ABC DLBCL survival. High-throughput RNA resequencing uncovered MYD88 mutations in ABC DLBCL lines. Notably, 29% of ABC DLBCL tumours harboured the same amino acid substitution, L265P, in the MYD88 Toll/IL-1 receptor (TIR) domain at an evolutionarily invariant residue in its hydrophobic core. This mutation was rare or absent in other DLBCL subtypes and Burkitt's lymphoma, but was observed in 9% of mucosa-associated lymphoid tissue lymphomas. At a lower frequency, additional mutations were observed in the MYD88 TIR domain, occurring in both the ABC and germinal centre B-cell-like (GCB) DLBCL subtypes. Survival of ABC DLBCL cells bearing the L265P mutation was sustained by the mutant but not the wild-type MYD88 isoform, demonstrating that L265P is a gain-of-function driver mutation. The L265P mutant promoted cell survival by spontaneously assembling a protein complex containing IRAK1 and IRAK4, leading to IRAK4 kinase activity, IRAK1 phosphorylation, NF-kappa B signalling, JAK kinase activation of STAT3, and secretion of IL-6, IL-10 and interferon-beta. Hence, the MYD88 signalling pathway is integral to the pathogenesis of ABC DLBCL, supporting the development of inhibitors of IRAK4 kinase and other components of this pathway for the treatment of tumours bearing oncogenic MYD88 mutations.	[Ngo, Vu N.; Young, Ryan M.; Schmitz, Roland; Jhavar, Sameer; Lim, Kian-Huat; Kohlhammer, Holger; Xu, Weihong; Yang, Yandan; Zhao, Hong; Shaffer, Arthur L.; Romesser, Paul; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Xiao, Wenming; Powell, John] NIH, Bioinformat & Mol Anal Sect, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Romesser, Paul] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA; [Wright, George] NCI, Biometr Res Branch, DCTD, NIH, Bethesda, MD 20892 USA; [Rosenwald, Andreas; Muller-Hermelink, Hans Konrad] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Gascoyne, Randy D.; Connors, Joseph M.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Rimsza, Lisa M.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.] SW Oncol Grp, Ann Arbor, MI 48106 USA; [Campo, Elias] Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Jaffe, Elaine S.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Delabie, Jan] Univ Hosp, Rikshosp, Pathol Clin, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Hosp, Rikshosp, Inst Canc Res, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Norwegian Radium Hosp, Fac Div, Ctr Canc Biomed, N-0310 Oslo, Norway; [Fisher, Richard I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Braziel, Rita M.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Tubbs, Raymond R.; Cook, J. R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [Weisenburger, Denny D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Weisenburger, Denny D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE 68198 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; British Columbia Cancer Agency; University of Arizona; Southwest Oncology Group; University of Barcelona; Hospital Clinic de Barcelona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Rochester; Oregon Health & Science University; Cleveland Clinic Foundation; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Staudt, Louis/AAC-5324-2019; Connors, Joseph/AAF-5284-2019; Wright, George W/M-1660-2017; Smeland, Erlend/AAO-3214-2020; Campo, Elias/AAC-5593-2019; Jaffe, Elaine/G-8981-2014	Connors, Joseph/0000-0002-1361-7531; Campo, Elias/0000-0001-9850-9793; Ngo, Vu/0000-0002-9501-6990; Romesser, Paul/0000-0001-8268-2903; Delabie, Jan/0000-0001-5023-0689; Jaffe, Elaine/0000-0003-4632-0301; Lim, Kian-Huat/0000-0002-2766-200X	NIH, National Cancer Institute, Center for Cancer Research; NCI SPECS [UO1-CA 114778]; Foundation for NIH; Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe); CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748, ZIABC011007, U01CA114778] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI SPECS; Foundation for NIH; Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe)(Deutsche Krebshilfe); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant (UO1-CA 114778), and by the Foundation for NIH, through a gift from the Richard A. Lauderbaugh Memorial Fund. This study was conducted under the auspices of the Lymphoma/Leukemia Molecular Profiling Project (LLMPP). R.S. is supported by the Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe). P.R. was an HHMI-NIH Research Scholar. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, Maryland (http://biowulf.nih.gov). We thank D. Staudt for discussions, K. Meyer for help with the GEO submission, and X. Li for IRAK1 plasmids. We are grateful to B. Tran and the Center for Cancer Research Sequencing Facility for implementation of next generation RNA sequencing.	Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dierlamm J, 1997, LEUKEMIA, V11, P747, DOI 10.1038/sj.leu.2400635; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Schmidlin H, 2009, TRENDS IMMUNOL, V30, P277, DOI 10.1016/j.it.2009.03.008; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540	27	1015	1112	1	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					115	U133		10.1038/nature09671	http://dx.doi.org/10.1038/nature09671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21179087	Green Accepted			2022-12-28	WOS:000286886400045
J	Greely, HT				Greely, Henry T.			Get ready for the flood of fetal gene screening	NATURE			English	Editorial Material									Stanford Law Sch, Ctr Law & Biosci, Stanford, CA 94305 USA	Stanford University	Greely, HT (corresponding author), Stanford Law Sch, Ctr Law & Biosci, Stanford, CA 94305 USA.	hgreely@stanford.edu						Chitty LS, 2008, PRENATAL DIAG, V28, P83, DOI 10.1002/pd.1929; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Fan C, 2010, NATURE PRECEDINGS, DOI [10.1038/npre.2010.5373.1, DOI 10.1038/NPRE.2010.5373.1]; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; FUCHS F, 1956, NATURE, V177, P330, DOI 10.1038/177330a0; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Wright C., 2009, CELL FREE FETAL NUCL; RELIABLE ACCURATE PR; 2010, COM REV PREN GEN TES	10	71	85	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					289	291		10.1038/469289a	http://dx.doi.org/10.1038/469289a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	708SW	21248817				2022-12-28	WOS:000286385600018
J	Yaffe, K; Weston, A; Graff-Radford, NR; Satterfield, S; Simonsick, EM; Younkin, SG; Younkin, LH; Kuller, L; Ayonayon, HN; Ding, JZ; Harris, TB				Yaffe, Kristine; Weston, Andrea; Graff-Radford, Neill R.; Satterfield, Suzanne; Simonsick, Eleanor M.; Younkin, Steven G.; Younkin, Linda H.; Kuller, Lewis; Ayonayon, Hilsa N.; Ding, Jingzhong; Harris, Tamara B.			Association of Plasma beta-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; CARDIOVASCULAR HEALTH; OLDER PERSONS; RISK; IMPAIRMENT; DEMENTIA; PROTEIN; EDUCATION; LITERACY; MEMORY	Context Lower plasma beta-amyloid 42 and 42/40 levels have been associated with incident dementia, but results are conflicting and few have investigated cognitive decline among elders without dementia. Objective To determine if plasma beta-amyloid is associated with cognitive decline and if this association is modified by measures of cognitive reserve. Design, Setting, and Participants We studied 997 black and white community-dwelling older adults from Memphis, Tennessee, and Pittsburgh, Pennsylvania, who were enrolled in the Health ABC Study, a prospective observational study begun in 1997-1998 with 10-year follow-up in 2006-2007. Participant mean age was 74.0 (SD, 3.0) years; 55.2% (n=550) were female; and 54.0% (n=538) were black. Main Outcome Measures Association of near-baseline plasma beta-amyloid levels (42 and 42/40 measured in 2010) and repeatedly measured Modified Mini-Mental State Examination (3MS) results. Results Low beta-amyloid 42/40 level was associated with greater 9-year 3MS cognitive decline (lowest beta-amyloid tertile: mean change in 3MS score, -6.59 [95% confidence interval [CI], -5.21 to -7.67] points; middle tertile: -6.16 [95% CI, -4.92 to -7.32] points; and highest tertile: -3.60 [95% CI, -2.27 to -4.73] points; P<.001). Results were similar after multivariate adjustment for age, race, education, diabetes, smoking, and apolipoprotein E [APOE] e4 status and after excluding the 72 participants with incident dementia. Measures of cognitive reserve modified this association whereby among those with high reserve (at least a high school diploma, higher than sixth-grade literacy, or no APOE e4 allele), beta-amyloid 42/40 was less associated with multivariate adjusted 9-year decline. For example, among participants with less than a high school diploma, the 3MS score decline was -8.94 (95% CI, -6.94 to -10.94) for the lowest tertile compared with -4.45 (95% CI, -2.31 to -6.59) for the highest tertile, but for those with at least a high school diploma, 3MS score decline was -4.60 (95% CI, -3.07 to -6.13) for the lowest tertile and -2.88 (95% CI, -1.41 to -4.35) for the highest tertile (P=.004 for interaction). Interactions were also observed for literacy (P=.005) and for APOE e4 allele (P=.02). Conclusion Lower plasma beta-amyloid 42/40 is associated with greater cognitive decline among elderly persons without dementia over 9 years, and this association is stronger among those with low measures of cognitive reserve. JAMA. 2011; 305(3): 261-266	[Yaffe, Kristine; Weston, Andrea] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Yaffe, Kristine; Ayonayon, Hilsa N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94121 USA; [Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Graff-Radford, Neill R.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Younkin, Steven G.; Younkin, Linda H.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Satterfield, Suzanne] Univ Tennessee, Dept Prevent Med, Memphis, TN USA; [Simonsick, Eleanor M.] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Baltimore, MD 21224 USA; [Kuller, Lewis] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Ding, Jingzhong] Wake Forest Univ, Med Ctr, Dept Gerontol & Geriatr Med, Winston Salem, NC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Mayo Clinic; Mayo Clinic; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University	Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Psychiat, Box 181,4150 Clement St, San Francisco, CA 94121 USA.	kristine.yaffe@ucsf.edu	Simonsick, Eleanor/W-6864-2019		National Institute on Aging [N01-AG62101, N01-AG62103, N01-AG62106, K24AG031155]; NATIONAL INSTITUTE ON AGING [ZIAAG000971, ZIAAG007390, K24AG031155, N01AG062103, N01AG062101, N01AG062106] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by National Institute on Aging contracts N01-AG62101, N01-AG62103, and N01-AG62106. This research was supported in part by the Intramural Research Program of the National Institute on Aging. Dr Yaffe is supported in part by National Institute on Aging grant K24AG031155 and by an anonymous foundation.	Arvanitakis Z, 2002, ALZ DIS ASSOC DIS, V16, P187, DOI 10.1097/00002093-200207000-00009; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cosentino SA, 2010, ARCH NEUROL-CHICAGO, V67, P1485, DOI 10.1001/archneurol.2010.189; Davis T C, 1993, Fam Med, V25, P391; Davis TC, 1998, HEALTH EDUC BEHAV, V25, P613, DOI 10.1177/109019819802500508; Fukumoto H, 2003, ARCH NEUROL-CHICAGO, V60, P958, DOI 10.1001/archneur.60.7.958; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027; Innogenetics, NEW PROSP RES ALZH D; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Kemppainen NM, 2008, ANN NEUROL, V63, P112, DOI 10.1002/ana.21212; Kuller LH, 2003, NEUROEPIDEMIOLOGY, V22, P13, DOI 10.1159/000067109; Lambert JC, 2009, NEUROLOGY, V73, P847, DOI 10.1212/WNL.0b013e3181b78448; Lewczuk P, 2010, EXP NEUROL, V223, P366, DOI 10.1016/j.expneurol.2009.07.024; Lopez OL, 2008, NEUROLOGY, V70, P1664, DOI 10.1212/01.wnl.0000306696.82017.66; Mayeux R, 1999, ANN NEUROL, V46, P412, DOI 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A; Mehta KM, 2004, J AM GERIATR SOC, V52, P2120, DOI 10.1111/j.1532-5415.2004.52575.x; Pesaresi M, 2006, NEUROBIOL AGING, V27, P904, DOI 10.1016/j.neurobiolaging.2006.03.004; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Prince M, 2009, WORLD ALZHEIMER REPO; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rentz DM, 2010, ANN NEUROL, V67, P353, DOI 10.1002/ana.21904; Rothman R, 2004, DIABETES EDUCATOR, V30, P263, DOI 10.1177/014572170403000219; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Scarmeas Nikolaos, 2004, Curr Neurol Neurosci Rep, V4, P374, DOI 10.1007/s11910-004-0084-7; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4; Yaffe K, 2007, NEUROBIOL AGING, V28, P171, DOI 10.1016/j.neurobiolaging.2006.10.004; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703	33	171	180	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					261	266		10.1001/jama.2010.1995	http://dx.doi.org/10.1001/jama.2010.1995			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707YY	21245181	Green Accepted, Bronze			2022-12-28	WOS:000286328700021
J	Kurth, T; Mohamed, S; Maillard, P; Zhu, YC; Chabriat, H; Mazoyer, B; Bousser, MG; Dufouil, C; Tzourio, C				Kurth, Tobias; Mohamed, Shajahal; Maillard, Pauline; Zhu, Yi-Cheng; Chabriat, Hugues; Mazoyer, Bernard; Bousser, Marie-Germaine; Dufouil, Carole; Tzourio, Christophe			Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WHITE-MATTER HYPERINTENSITIES; CARDIOVASCULAR-DISEASE; RISK; PREVALENCE; STROKE; ABNORMALITIES; ASSOCIATION; DISABILITY; DECLINE; VOLUME	Objective To evaluate the association of overall and specific headaches with volume of white matter hyperintensities, brain infarcts, and cognition. Design Population based, cross sectional study. Setting Epidemiology of Vascular Ageing study, Nantes, France. Participants 780 participants (mean age 69, 58.5% women) with detailed headache assessment. Main outcome measures Brain scans were evaluated for volume of white matter hyperintensities (by fully automated imaging processing) and for classification of infarcts (by visual reading with a standardised assessment grid). Cognitive function was assessed by a battery of tests including the mini-mental state examination. Results 163 (20.9%) participants reported a history of severe headache and 116 had migraine, of whom 17 (14.7%) reported aura symptoms. An association was found between any history of severe headache and increasing volume of white matter hyperintensities. The adjusted odds ratio of being in the highest third for total volume of white matter hyperintensities was 2.0 (95% confidence interval 1.3 to 3.1, P for trend 0.002) for participants with any history of severe headache when compared with participants without severe headache being in the lowest third. The association pattern was similar for all headache types. Migraine with aura was the only headache type strongly associated with volume of deep white matter hyperintensities (highest third odds ratio 12.4, 1.6 to 99.4, P for trend 0.005) and with brain infarcts (3.4, 1.2 to 9.3). The location of infarcts was predominantly outside the cerebellum and brain stem. Evidence was lacking for cognitive impairment for any headache type with or without brain lesions. Conclusions In this population based study, any history of severe headache was associated with an increased volume of white matter hyperintensities. Migraine with aura was the only headache type associated with brain infarcts. Evidence that headache of any type by itself or in combination with brain lesions was associated with cognitive impairment was lacking.	[Kurth, Tobias; Mohamed, Shajahal; Zhu, Yi-Cheng; Dufouil, Carole; Tzourio, Christophe] Hop La Pitie Salpetriere, INSERM, Unit Neuroepidemiol 708, F-75651 Paris 13, France; [Kurth, Tobias; Zhu, Yi-Cheng; Dufouil, Carole; Tzourio, Christophe] Univ Paris 06, UMR S708, Paris, France; [Kurth, Tobias] Harvard Univ, Med Sch, Brigham & Womens Hosp, Div Prevent Med,Dept Med, Boston, MA 02215 USA; [Maillard, Pauline; Mazoyer, Bernard] CEA, CNRS, UMR 6194, Grp Imagerie Neurofonct, Caen, France; [Zhu, Yi-Cheng; Chabriat, Hugues; Bousser, Marie-Germaine; Tzourio, Christophe] Grp Hosp Lariboisiere Fernand Widal, AP HP, Serv Neurol, Paris, France; [Zhu, Yi-Cheng] Peking Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China; [Chabriat, Hugues; Bousser, Marie-Germaine] Univ Paris Denis Diderot, Paris, France; [Mazoyer, Bernard] Univ Caen Basse Normande, Caen, France; [Mazoyer, Bernard] Ctr Hosp & Univ Caen, Caen, France; [Mazoyer, Bernard] Inst Univ France, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Harvard University; Brigham & Women's Hospital; Harvard Medical School; CEA; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; UDICE-French Research Universities; Universite Paris Cite; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut Universitaire de France	Kurth, T (corresponding author), Hop La Pitie Salpetriere, INSERM, Unit Neuroepidemiol 708, 47 Blvd Hop, F-75651 Paris 13, France.	tobias.kurth@upmc.fr	Dufouil, Carole/J-4968-2012; Mazoyer, Bernard M/B-6303-2012; Zhu, Yi-Cheng/L-3890-2013; Maillard, Pauline/N-7600-2018; Dufouil, Carole/F-5751-2014; Tzourio, christophe/B-4015-2009; Kurth, Tobias/A-9243-2012; Tzourio, christophe/L-6344-2019; mazoyer, bernard m/A-5369-2009; Chabriat, Hugues/G-5699-2010	Mazoyer, Bernard M/0000-0003-0970-2837; Maillard, Pauline/0000-0003-3516-6345; Dufouil, Carole/0000-0003-2442-4476; Tzourio, christophe/0000-0002-6517-2984; Kurth, Tobias/0000-0001-7169-2620; Tzourio, christophe/0000-0002-6517-2984; mazoyer, bernard m/0000-0003-0970-2837; Chabriat, Hugues/0000-0001-8436-6074; Dichgans, Martin/0000-0002-0654-387X	French National Research Agency (ANR, Agence Nationale de la Recherche)	French National Research Agency (ANR, Agence Nationale de la Recherche)(French National Research Agency (ANR))	The Epidemiology of Vascular Ageing study was carried out under an agreement between INSERM (Institut National de la Sante et de la Recherche Medicale); Merck, Sharp, and Dohme-Chibret Laboratories (West Point, PA); and EISAI (Paris, France). This study was supported by a chair of excellence grant of the French National Research Agency (ANR, Agence Nationale de la Recherche) to TK. The sponsors were not involved in the design, data collection, analysis, or interpretation of the study nor were they involved in writing the manuscript.	Baars MAE, 2010, HEADACHE, V50, P176, DOI 10.1111/j.1526-4610.2009.01572.x; Bigal ME, 2010, NEUROLOGY, V74, P628, DOI 10.1212/WNL.0b013e3181d0cc8b; Buyck JF, 2009, STROKE, V40, P2327, DOI 10.1161/STROKEAHA.109.548222; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Cooney BS, 1996, HEADACHE, V36, P616, DOI 10.1046/j.1526-4610.1996.3610616.x; DEBENEDITTIS G, 1995, HEADACHE, V35, P264; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Dufouil C, 1997, AM J EPIDEMIOL, V146, P405, DOI 10.1093/oxfordjournals.aje.a009293; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; Dufouil C, 2003, ANN NEUROL, V53, P214, DOI 10.1002/ana.10440; FAZEKAS F, 1992, HEADACHE, V32, P287, DOI 10.1111/j.1526-4610.1992.hed3206287.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gruber HJ, 2010, EUR J NEUROL, V17, P419, DOI 10.1111/j.1468-1331.2009.02861.x; Gudmundsson Larus S, 2010, BMJ, V341, pc3966, DOI 10.1136/bmj.c3966; IGARASHI H, 1991, CEPHALALGIA, V11, P69, DOI 10.1046/j.1468-2982.1991.1102069.x; Intiso D, 2006, EUR J NEUROL, V13, P1364, DOI 10.1111/j.1468-1331.2006.01519.x; Inzitari D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2477; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Jongen C, 2007, DIABETOLOGIA, V50, P1509, DOI 10.1007/s00125-007-0688-y; Kruit MC, 2006, STROKE, V37, P1109, DOI 10.1161/01.STR.0000206446.26702.e9; Kruit MC, 2005, BRAIN, V128, P2068, DOI 10.1093/brain/awh542; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3659; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; Maillard P, 2008, NEURORADIOLOGY, V50, P31, DOI 10.1007/s00234-007-0312-3; Martins KM, 2006, HEADACHE, V46, P312, DOI 10.1111/j.1526-4610.2006.00343.x; Napoli R, 2009, NEUROLOGY, V72, P2111, DOI 10.1212/WNL.0b013e3181aa53ce; Nozari A, 2010, ANN NEUROL, V67, P221, DOI 10.1002/ana.21871; Olesen J, 2004, J NEUROL NEUROSUR PS, V75, P808, DOI 10.1136/jnnp.2003.031286; Paemeleire K, 2009, J NEUROL SCI, V283, P134, DOI 10.1016/j.jns.2009.02.333; Rocca MA, 2000, NEUROLOGY, V54, P507, DOI 10.1212/WNL.54.2.507; Rozen TD, 1999, NEUROLOGY, V53, P1468, DOI 10.1212/WNL.53.7.1468; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Scher AI, 2009, JAMA-J AM MED ASSOC, V301, P2563, DOI 10.1001/jama.2009.932; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Schurks M, 2008, NEUROLOGY, V71, P505, DOI 10.1212/01.wnl.0000316198.34558.e5; Schwedt TJ, 2008, CEPHALALGIA, V28, P531, DOI 10.1111/j.1468-2982.2008.01554.x; SIBERT LC, 2008, NEUROLOGY, V71, P108; Soumare A, 2009, ANN NEUROL, V65, P706, DOI 10.1002/ana.21674; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Stovner LJ, 2010, J HEADACHE PAIN, V11, P289, DOI 10.1007/s10194-010-0217-0; Swartz RH, 2004, ARCH NEUROL-CHICAGO, V61, P1366, DOI 10.1001/archneur.61.9.1366; Tietjen GE, 2007, NEUROLOGY, V68, P134, DOI 10.1212/01.wnl.0000251195.55563.02; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; Tzourio C, 2003, J NEUROL NEUROSUR PS, V74, P238, DOI 10.1136/jnnp.74.2.238; Tzourio C, 2001, NEUROLOGY, V56, P1273, DOI 10.1212/WNL.56.10.1273; Vanmolkot FH, 2007, NEUROLOGY, V68, P1563, DOI 10.1212/01.wnl.0000260964.28393.ed; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366	51	155	160	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2011	342								c7357	10.1136/bmj.c7357	http://dx.doi.org/10.1136/bmj.c7357			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711OH	21245119	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000286600800023
J	Jang, J; Ferguson, DG; Vakaryuk, V; Budakian, R; Chung, SB; Goldbart, PM; Maeno, Y				Jang, J.; Ferguson, D. G.; Vakaryuk, V.; Budakian, R.; Chung, S. B.; Goldbart, P. M.; Maeno, Y.			Observation of Half-Height Magnetization Steps in Sr2RuO4	SCIENCE			English	Article							SUPERFLUID HE-3; STATES; SUPERCONDUCTIVITY; SINGULARITIES	Spin-triplet superfluids can support exotic objects, such as half-quantum vortices characterized by the nontrivial winding of the spin structure. We present cantilever magnetometry measurements performed on mesoscopic samples of Sr2RuO4, a spin-triplet superconductor. With micrometer-sized annular-shaped samples, we observed transitions between integer fluxoid states as well as a regime characterized by "half-integer transitions"-steps in the magnetization with half the height of the ones we observed between integer fluxoid states. These half-height steps are consistent with the existence of half-quantum vortices in superconducting Sr2RuO4.	[Jang, J.; Ferguson, D. G.; Vakaryuk, V.; Budakian, R.; Goldbart, P. M.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Vakaryuk, V.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Chung, S. B.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Maeno, Y.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Argonne National Laboratory; Stanford University; Kyoto University	Budakian, R (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	budakian@illinois.edu	Jang, Joonho/E-1425-2018	Jang, Joonho/0000-0003-4380-102X; Chung, Suk Bum/0000-0002-8434-8965	U.S. Department of Energy Office of Basic Sciences through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana Champaign [DEFG02-07ER46453]; Ministry of Education, Culture, Sports, Science and Technology of Japan	U.S. Department of Energy Office of Basic Sciences through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana Champaign; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank D. Van Harlingen, M. Stone, E. Fradkin, E.-A. Kim, and H. Bluhm for valuable discussions and M. Ueda for helpful suggestions regarding the data analysis. In particular, the authors thank A. J. Leggett for his theoretical guidance. This work was supported by the U.S. Department of Energy Office of Basic Sciences, grant DEFG02-07ER46453 through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana Champaign and the grants-in-aid for the Global Centers of Excellence "Next Generation of Physics" programs from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ARUTUNIAN RM, 1983, J LOW TEMP PHYS, V52, P409, DOI 10.1007/BF00682124; Baelus BJ, 2000, PHYS REV B, V61, P9734, DOI 10.1103/PhysRevB.61.9734; Chung SB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.197002; CROSS MC, 1977, J LOW TEMP PHYS, V27, P683, DOI 10.1007/BF00655703; Das Sarma S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.220502; Ivanov DA, 2001, PHYS REV LETT, V86, P268, DOI 10.1103/PhysRevLett.86.268; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; KOPNIN NB, 1991, PHYS REV B, V44, P9667, DOI 10.1103/PhysRevB.44.9667; London F., 1961, SUPERFLUIDS; Mackenzie AP, 2003, REV MOD PHYS, V75, P657, DOI 10.1103/RevModPhys.75.657; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; VOLOVIK GE, 1976, JETP LETT+, V24, P561	13	213	217	3	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2011	331	6014					186	188		10.1126/science.1193839	http://dx.doi.org/10.1126/science.1193839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233380	Green Submitted			2022-12-28	WOS:000286433100034
J	Cauchy, E; Cheguillaume, B; Chetaille, E				Cauchy, Emmanuel; Cheguillaume, Benoit; Chetaille, Eric			A Controlled Trial of a Prostacyclin and rt-PA in the Treatment of Severe Frostbite	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							AMPUTATION		[Cauchy, Emmanuel] Hop Pays Mt Blanc, Chamonix Mt Blanc, France; [Cheguillaume, Benoit; Chetaille, Eric] IFREMMONT, Chamonix Mt Blanc, France		Cauchy, E (corresponding author), Hop Pays Mt Blanc, Chamonix Mt Blanc, France.	cauchy@ifremmont.com						Bruen KJ, 2007, ARCH SURG-CHICAGO, V142, P546, DOI 10.1001/archsurg.142.6.546; Cauchy E, 2000, J HAND SURG-AM, V25A, P969, DOI 10.1053/jhsu.2000.16357; Cauchy E, 2001, WILD ENVIRON MED, V12, P248, DOI 10.1580/1080-6032(2001)012[0248:RSOCOS]2.0.CO;2; GROECHENIG E, 1994, LANCET, V344, P1152, DOI 10.1016/S0140-6736(94)90657-2; 2009, N ENGL J MED, V361, P2654	5	74	74	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					189	190		10.1056/NEJMc1000538	http://dx.doi.org/10.1056/NEJMc1000538			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226604	Bronze			2022-12-28	WOS:000286142900034
J	Bissiere, S; Zelikowsky, M; Ponnusamy, R; Jacobs, NS; Blair, HT; Fanselow, MS				Bissiere, Stephanie; Zelikowsky, Moriel; Ponnusamy, Ravikumar; Jacobs, Nathan S.; Blair, Hugh T.; Fanselow, Michael S.			Electrical Synapses Control Hippocampal Contributions to Fear Learning and Memory	SCIENCE			English	Article							BASOLATERAL AMYGDALA; MAMMALIAN BRAIN; THETA-RHYTHM; OSCILLATIONS; CONNEXIN36; SYNCHRONIZATION; INTERNEURONS; IMPAIRMENT; MODULATION; PLASTICITY	The role of electrical synapses in synchronizing neuronal assemblies in the adult mammalian brain is well documented. However, their role in learning and memory processes remains unclear. By combining Pavlovian fear conditioning, activity-dependent immediate early gene expression, and in vivo electrophysiology, we discovered that blocking neuronal gap junctions within the dorsal hippocampus impaired context-dependent fear learning, memory, and extinction. Theta rhythms in freely moving rats were also disrupted. Our results show that gap junction-mediated neuronal transmission is a prominent feature underlying emotional memories.	[Bissiere, Stephanie; Zelikowsky, Moriel; Ponnusamy, Ravikumar; Jacobs, Nathan S.; Blair, Hugh T.; Fanselow, Michael S.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Fanselow, MS (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	fanselow@psych.ucla.edu	Zelikowsky, Moriel/GQI-0022-2022	Blair, Hugh/0000-0001-8256-5109; Jacobs, Nathan S/0000-0003-2175-6627; Zelikowsky, Moriel/0000-0002-0465-9027	NIMH [RO1-MH62122, P01NS35985, RO1-MH079511]; Swiss National Fund [PA00A-115367]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079511, R01MH062122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS035985] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swiss National Fund(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIMH grant RO1-MH62122 and P01NS35985 (M.S.F.), Swiss National Fund grant PA00A-115367 (S.B.), and NIMH grant RO1-MH079511 (H.T.B.).	Alev C, 2008, P NATL ACAD SCI USA, V105, P20964, DOI 10.1073/pnas.0805408105; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Buhl DL, 2003, J NEUROSCI, V23, P1013; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2001, NEURON, V31, P342, DOI 10.1016/S0896-6273(01)00378-6; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Evans WH, 2007, CELL COMMUN ADHES, V14, P265, DOI 10.1080/15419060801891034; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Frisch C, 2005, BEHAV BRAIN RES, V157, P177, DOI 10.1016/j.bbr.2004.06.023; Kim JJ, 2007, P NATL ACAD SCI USA, V104, P18297, DOI 10.1073/pnas.0708644104; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Muller JF, 2005, J NEUROSCI, V25, P7366, DOI 10.1523/JNEUROSCI.0899-05.2005; Placantonakis DG, 2006, J NEUROSCI, V26, P5008, DOI 10.1523/JNEUROSCI.0146-06.2006; Quinn JJ, 2008, HIPPOCAMPUS, V18, P640, DOI 10.1002/hipo.20424; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Sheth A, 2008, HIPPOCAMPUS, V18, P169, DOI 10.1002/hipo.20380; Stote DL, 2004, BEHAV NEUROSCI, V118, P253, DOI 10.1037/0735-7044.118.1.253; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004	26	92	95	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					87	91		10.1126/science.1193785	http://dx.doi.org/10.1126/science.1193785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212357	Green Accepted			2022-12-28	WOS:000285974000042
J	Hsu, YC; Pasolli, HA; Fuchs, E				Hsu, Ya-Chieh; Pasolli, H. Amalia; Fuchs, Elaine			Dynamics between Stem Cells, Niche, and Progeny in the Hair Follicle	CELL			English	Article							LABEL-RETAINING CELLS; SELF-RENEWAL; SKIN; REGENERATION; PROLIFERATION; MORPHOGENESIS; HOMEOSTASIS; ACTIVATION; EPIDERMIS; DISTINCT	Here, we exploit the hair follicle to define the point at which stem cells (SCs) become irreversibly committed along a differentiation lineage. Employing histone and nucleotide double-pulse-chase and lineage tracing, we show that the early SC descendents en route to becoming transit-amplifying cells retain stemness and slow-cycling properties and home back to the bulge niche when hair growth stops. These become the primary SCs for the next hair cycle, whereas initial bulge SCs become reserves for injury. Proliferating descendents further en route irreversibly lose their stemness, although they retain many SC markers and survive, unlike their transit-amplifying progeny. Remarkably, these progeny also home back to the bulge. Combining purification and gene expression analysis with differential ablation and functional experiments, we define critical functions for these non-SC niche residents and unveil the intriguing concept that an irreversibly committed cell in an SC lineage can become an essential contributor to the niche microenvironment.	[Hsu, Ya-Chieh; Pasolli, H. Amalia; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Pasolli, Hilda Amalia/0000-0003-3899-3530	NIH [R01AR050452]; Starr Foundation; NYSTEM [N09G074]; Empire State Stem Cell fund through NYSDOH [C023046]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; NYSTEM; Empire State Stem Cell fund through NYSDOH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to colleagues who generously donated mice, especially B. de Crombrugghe (UTMD Anderson) and H. Akiyama (Kyoto University) for sharing Sox9-CreER mice prior to publication; S. Mazel, C. Bare, and RU's FCRC for FACS sorting; A. North (Bioimaging Resource Center) for advice in image acquisition; Comparative Biology Center (AAALAC-accredited) for health care to our mice; and members of the Fuchs' lab, in particular: T. Chen, D. Devenport, E. Ezhkova, and B. Keyes for comments on the manuscript; M. Schober for advice on image analyses and quantifications; N. Stokes and D. Oristian for assistance in mouse research. Y.-C.H. is a Starr Stem Cell Scholars Postdoctoral Fellow. This work was supported by grants from NIH (R01AR050452), Starr Foundation, and NYSTEM (N09G074) to E.F., who is an HHMI Investigator. RU FCRC is supported by the Empire State Stem Cell fund through NYSDOH Contract #C023046.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Lavker RM, 2003, J INVEST DERM SYMP P, V8, P28, DOI 10.1046/j.1523-1747.2003.12169.x; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Panteleyev AA, 2001, J CELL SCI, V114, P3419; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Soeda T, 2010, GENESIS, V48, P635, DOI 10.1002/dvg.20667; Spradling AC, 2008, COLD SH Q B, V73, P49, DOI 10.1101/sqb.2008.73.023; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; UNNA PG, 1876, ARCH MIKROSK ANAT, V12, P665; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	39	420	429	4	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					92	105		10.1016/j.cell.2010.11.049	http://dx.doi.org/10.1016/j.cell.2010.11.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215372	Green Accepted, Bronze			2022-12-28	WOS:000285993600010
J	Gill, BC; Lyons, TW; Young, SA; Kump, LR; Knoll, AH; Saltzman, MR				Gill, Benjamin C.; Lyons, Timothy W.; Young, Seth A.; Kump, Lee R.; Knoll, Andrew H.; Saltzman, Matthew R.			Geochemical evidence for widespread euxinia in the Later Cambrian ocean	NATURE			English	Article							CARBON; ANOXIA; EXTINCTION; BURIAL; EVENT; SPICE; IRON	Widespread anoxia in the ocean is frequently invoked as a primary driver of mass extinction as well as a long-term inhibitor of evolutionary radiation on early Earth. In recent biogeochemical studies it has been hypothesized that oxygen deficiency was widespread in subsurface water masses of later Cambrian oceans(1,2), possibly influencing evolutionary events during this time(1-3). Physical evidence of widespread anoxia in Cambrian oceans has remained elusive and thus its potential relationship to the palaeontological record remains largely unexplored. Here we present sulphur isotope records from six globally distributed stratigraphic sections of later Cambrian marine rocks (about 499 million years old). We find a positive sulphur isotope excursion in phase with the Steptoean Positive Carbon Isotope Excursion (SPICE), a large and rapid excursion in the marine carbon isotope record, which is thought to be indicative of a global carbon cycle perturbation(4,5). Numerical box modelling of the paired carbon sulphur isotope data indicates that these isotope shifts reflect transient increases in the burial of organic carbon and pyrite sulphur in sediments deposited under large-scale anoxic and sulphidic (euxinic) conditions. Independently, molybdenum abundances in a coeval black shale point convincingly to the transient spread of anoxia. These results identify the SPICE interval as the best characterized ocean anoxic event in the pre-Mesozoic ocean and an extreme example of oxygen deficiency in the later Cambrian ocean. Thus, a redox structure similar to those in Proterozoic oceans(6-8) may have persisted or returned in the oceans of the early Phanerozoic eon. Indeed, the environmental challenges presented by widespread anoxia may have been a prevalent if not dominant influence on animal evolution in Cambrian oceans.	[Gill, Benjamin C.; Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Young, Seth A.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Kump, Lee R.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Knoll, Andrew H.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Saltzman, Matthew R.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA	University of California System; University of California Riverside; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; University System of Ohio; Ohio State University	Gill, BC (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	bgill@fas.harvard.edu	Saltzman, Matthew R/B-6769-2011; Kump, Lee/H-8287-2012; Gill, Benjamin C/B-8047-2012	Saltzman, Matthew R/0000-0001-8052-1399; Gill, Benjamin C/0000-0001-7402-0811	NSF-EAR; NASA Astrobiology	NSF-EAR(National Science Foundation (NSF)); NASA Astrobiology	NSF-EAR and NASA Astrobiology provided funding. Fieldwork and sample collection were aided by S. Bates, L. Bongers, H. Dayton, S. Mason, P. McGoldrick, J. Owens, C. Seeger and E. Starbuck. Sulphur isotope analyses were aided by S. Bates and W. Gilhooly. We thank P. Ahlberg and M. Eriksson for allowing access to the Andrarum no. 3 drill core. Discussions with G. Love, N. Hughes, D. Johnston, P. Cohen and T. Dahl improved the manuscript.	Adams DD, 2010, NAT GEOSCI, V3, P201, DOI 10.1038/NGEO743; Ahlberg P, 2009, LETHAIA, V42, P2, DOI 10.1111/j.1502-3931.2008.00127.x; Algeo TJ, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2004PA001112; Algeo TJ, 2004, GEOLOGY, V32, P1057, DOI 10.1130/G20896.1; [Anonymous], 2001, ATLAS EARTH HIST; ARTHUR MA, 1988, NATURE, V335, P714, DOI 10.1038/335714a0; Bambach RK, 2004, PALEOBIOLOGY, V30, P522, DOI 10.1666/0094-8373(2004)030<0522:OEAMDO>2.0.CO;2; BERNER RA, 1984, GEOCHIM COSMOCHIM AC, V48, P605, DOI 10.1016/0016-7037(84)90089-9; BERRY WBN, 1978, AM J SCI, V278, P257, DOI 10.2475/ajs.278.3.257; BRASIER MD, 1994, GEOLOGY, V22, P455, DOI 10.1130/0091-7613(1994)022<0455:MCESTC>2.3.CO;2; Brennan ST, 2004, GEOLOGY, V32, P473, DOI 10.1130/g20251.1; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; EMERSON SR, 1991, MAR CHEM, V34, P177, DOI 10.1016/0304-4203(91)90002-E; Gill BC, 2007, PALAEOGEOGR PALAEOCL, V256, P156, DOI 10.1016/j.palaeo.2007.02.030; Hough ML, 2006, TERRA NOVA, V18, P257, DOI 10.1111/j.1365-3121.2006.00687.x; Hurtgen MT, 2009, EARTH PLANET SC LETT, V281, P288, DOI 10.1016/j.epsl.2009.02.033; Lyons TW, 2006, GEOCHIM COSMOCHIM AC, V70, P5698, DOI 10.1016/j.gca.2006.08.021; Montanez I., 2000, GSA TODAY, V10, P1; Neretin LN, 2001, DEEP-SEA RES PT I, V48, P2569, DOI 10.1016/S0967-0637(01)00030-9; PALMER ALLISON R., 1965, J PALEONTOL, V39, P149; PALMER AR, 1984, J PALEONTOL, V58, P599; Peng SC, 2004, LETHAIA, V37, P365, DOI 10.1080/00241160410002081; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; RAISWELL R, 1988, J SEDIMENT PETROL, V58, P812; Saltzman MR, 2004, J SEDIMENT RES, V74, P366, DOI 10.1306/120203740366; Saltzman MR, 1998, GEOL SOC AM BULL, V110, P285, DOI 10.1130/0016-7606(1998)110<0285:CISOUC>2.3.CO;2; Saltzman MR, 2000, PALAEOGEOGR PALAEOCL, V162, P211, DOI 10.1016/S0031-0182(00)00128-0; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Wignall PB, 1996, SCIENCE, V272, P1155, DOI 10.1126/science.272.5265.1155; Zhuravlev AY, 1996, GEOLOGY, V24, P311, DOI 10.1130/0091-7613(1996)024<0311:AATCOT>2.3.CO;2	30	288	309	8	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					80	83		10.1038/nature09700	http://dx.doi.org/10.1038/nature09700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21209662	Green Submitted			2022-12-28	WOS:000285921600035
J	Scheel, PJ; Feeley, N; Sozio, SM				Scheel, Paul J., Jr.; Feeley, Nancy; Sozio, Stephen M.			Combined Prednisone and Mycophenolate Mofetil Treatment for Retroperitoneal Fibrosis A Case Series	ANNALS OF INTERNAL MEDICINE			English	Article							THERAPY	Background: Small case series suggest that a combination of mycophenolate mofetil and prednisone may be an effective treatment for patients with retroperitoneal fibrosis. Objective: To describe the outcomes of adults with retroperitoneal fibrosis who received a combination of prednisone and mycophenolate mofetil. Design: Prospective case series of patients followed between 1 April 2005 and 1 July 2009. Setting: Single tertiary care facility. Patients: 28 patients with retroperitoneal fibrosis. Intervention: Prednisone, 40 mg/d, tapered over 6 months, and mycophenolate mofetil, 1000 mg twice daily, for a mean of 24.3 months. Measurements: Clinical course, laboratory assessment, and measurement of periaortic mass. Mean follow-up was 1012 days, and no patients were lost to follow-up. Results: Systemic symptoms resolved in all patients; 89% had a 25% or greater reduction in periaortic mass. Elevated erythrocyte sedimentation rate and serum creatinine level and decreased hemoglobin level normalized in all patients. Disease recurred in 2 of 28 patients. Limitation: This was a small case series. Conclusion: Combined prednisone and mycophenolate mofetil therapy is a potentially effective treatment for retroperitoneal fibrosis that warrants evaluation in randomized trials.	[Scheel, Paul J., Jr.] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21205 USA	Johns Hopkins University	Scheel, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Div Nephrol, 1830 E Monument St,Room 416, Baltimore, MD 21205 USA.	PScheel1@jhmi.edu	Sozio, Stephen M./H-1214-2018	Sozio, Stephen M./0000-0002-0099-0484				Adler S, 2008, RHEUMATOLOGY, V47, P1535, DOI 10.1093/rheumatology/ken291; Goncalves RG, 2004, AM J NEPHROL, V24, P527, DOI 10.1159/000081706; Jois RN, 2007, RHEUMATOLOGY, V46, P717, DOI 10.1093/rheumatology/kel417; Kardar AH, 2002, J UROLOGY, V168, P550, DOI 10.1016/S0022-5347(05)64677-0; Khalil F, 2008, CLIN RHEUMATOL, V27, P679, DOI 10.1007/s10067-007-0826-4; Kramer S, 2005, AM J PHYSIOL-RENAL, V289, pF359, DOI 10.1152/ajprenal.00442.2004; Marcolongo R, 2004, AM J MED, V116, P194, DOI 10.1016/j.amjmed.2003.08.033; Marzano A, 2001, ANN RHEUM DIS, V60, P427, DOI 10.1136/ard.60.4.427; MCDOUGAL WS, 1991, J UROLOGY, V145, P112, DOI 10.1016/S0022-5347(17)38263-0; Moder KG, 2003, ANN ALLERG ASTHMA IM, V90, P15, DOI 10.1016/S1081-1206(10)63607-1; Morath C, 2006, CLIN TRANSPLANT, V20, P25, DOI 10.1111/j.1399-0012.2006.00597.x; Obrencevic Katarina, 2007, Vojnosanit Pregl, V64, P385, DOI 10.2298/VSP0706385O; Pescovitz MD, 2003, AM J TRANSPLANT, V3, P1581, DOI 10.1046/j.1600-6135.2003.00243.x; Plastiras SC, 2006, RHEUMATOLOGY, V45, P1572, DOI 10.1093/rheumatology/kel335; SCAVALLI AS, 1995, CLIN RHEUMATOL, V14, P481, DOI 10.1007/BF02207688; Scheel PJ, 2007, J UROLOGY, V178, P140, DOI 10.1016/j.juro.2007.03.057; Scheel PJ, 2009, MEDICINE, V88, P202, DOI 10.1097/MD.0b013e3181afc439; Swartz RD, 2008, CLIN NEPHROL, V69, P260; Vaglio A, 2006, LANCET, V367, P241, DOI 10.1016/S0140-6736(06)68035-5; van Bommel EFH, 2006, ANN INTERN MED, V144, P101, DOI 10.7326/0003-4819-144-2-200601170-00007; van Bommel EFH, 2007, AM J KIDNEY DIS, V49, P615, DOI 10.1053/j.ajkd.2007.02.268; Warnatz K, 2005, ANN RHEUM DIS, V64, P828, DOI 10.1136/ard.2004.029793; Wu Jamie, 2002, Cancer Control, V9, P432	23	67	68	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					31	U163		10.7326/0003-4819-154-1-201101040-00005	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200036				2022-12-28	WOS:000285830900004
J	Adler, NE				Adler, Nancy E.			When Separate Is More Equal	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adler, Nancy E.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Adler, Nancy E.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Adler, Nancy E.] Univ Calif San Francisco, Ctr Hlth & Community, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Adler, NE (corresponding author), Univ Calif San Francisco, Dept Psychiat, BN0844,3333 Calif St,Ste 465, San Francisco, CA 94143 USA.	nancy.adler@ucsf.edu						[Anonymous], MON ADH NIH POL INCL; [Anonymous], 2001, GAO01286R; [Anonymous], 2001, GAO01754; Gandhi M, 2005, AIDS, V19, P1885, DOI 10.1097/01.aids.0000189866.67182.f7; Grady D, 2003, Evid Rep Technol Assess (Summ), P1; Institute of Medicine, 2010, WOM HLTH RES PROGR P; Jagsi R, 2009, CANCER-AM CANCER SOC, V115, P2783, DOI 10.1002/cncr.24315; U.S. Food and Drug Administration, 1993, Fed Regist, V58, P39406; Zucker I, 2010, NATURE, V465, P690, DOI 10.1038/465690a	9	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2738	2739		10.1001/jama.2010.1865	http://dx.doi.org/10.1001/jama.2010.1865			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177509				2022-12-28	WOS:000285518000019
J	Bennett, KL; Mester, J; Eng, C				Bennett, Kristi L.; Mester, Jessica; Eng, Charis			Germline Epigenetic Regulation of KILLIN in Cowden and Cowden-like Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HAMARTOMA-TUMOR-SYNDROME; PTEN; MUTATIONS; CANCER; DISEASE; INACTIVATION; BREAST; GENES; DNA	Context Germline loss-of-function phosphatase and tensin homolog gene (PTEN) mutations cause 80% of Cowden syndrome, a rare autosomal-dominant disorder (1 in 200 000 live births), characterized by high risks of breast, thyroid, and other cancers. A large heterogeneous group of individuals with Cowden-like syndrome, who have various combinations of Cowden syndrome features but who do not meet Cowden syndrome diagnostic criteria, have PTEN mutations less than 10% of the time, making molecular diagnosis, prediction, genetic counseling, and risk management challenging. Other mechanisms of loss of function such as hypermethylation, which should result in underexpression of PTEN or of KILLIN, a novel tumor suppressor transcribed in the opposite direction, may account for the remainder of Cowden syndrome and Cowden-like syndrome. Objective To determine whether germline methylation is found in Cowden syndrome or Cowden-like syndrome in individuals lacking germline PTEN mutations. Design, Setting, and Participants Nucleic acids from prospective nested series of 123 patients with Cowden syndrome or Cowden-like syndrome and 50 unaffected individuals without PTEN variants were analyzed for germline methylation and expression of PTEN and KILLIN at the Cleveland Clinic, August 2008-June 2010. Prevalence of component cancers between groups was compared using the Fisher exact test. Main Outcome Measures Frequency of germline methylation in PTEN mutation-negative Cowden syndrome and Cowden syndrome-like individuals. Prevalence of component cancers in methylation-positive and PTEN mutation-positive individuals. Results Of 123 patients with Cowden syndrome or Cowden-like syndrome, 45 (37%; 95% confidence interval [CI], 29%-45%) showed hypermethylation upstream of PTEN but no transcriptional repression. The germline methylation was found to transcriptionally down-regulate KILLIN by 250-fold (95% CI, 45-14 286; P=.007) and exclusively disrupted TP53 activation of KILLIN by 30% (95% CI, 7%-45%; P=.008). Demethylation treatment increased only KILLIN expression 4.88-fold (95% CI, 1.4-18.1; P=.05). Individuals with KILLIN-promoter methylation had a 3-fold increased prevalence of breast cancer (35/42 vs 24/64; P<.0001) and a greater than 2-fold increase of kidney cancer (4/45 vs 6/155; P=.004) over individuals with germline PTEN mutations. Conclusions Germline KILLIN methylation is common among patients with Cowden syndrome or Cowden-like syndrome and is associated with increased risks of breast and renal cancer over PTEN mutation-positive individuals. These observations need to be replicated. JAMA. 2010;304(24):2724-2732 www.jama.com	[Bennett, Kristi L.; Mester, Jessica; Eng, Charis] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin, Taussig Canc Inst, Lerner Res Inst, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin, Stanley Shalom Zielony Nursing Inst, Cleveland, OH 44195 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, 9500 Euclid Ave,NE-50, Cleveland, OH 44195 USA.	engc@ccf.org		Eng, Charis/0000-0002-3693-5145	Breast Cancer Research Foundation; William Randolph Hearst Foundations; National Cancer Institute [P01CA124570]; FM Kirby Foundation; NATIONAL CANCER INSTITUTE [P01CA124570] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; William Randolph Hearst Foundations; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FM Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Eng reports receipt of funding for this study, in part, by the Breast Cancer Research Foundation, the William Randolph Hearst Foundations, and the National Cancer Institute (P01CA124570). Dr Eng is the Sondra J. and Stephen R. Hardis Chair of Cancer Genomic Medicine at the Cleveland Clinic, was a Doris Duke Distinguished Clinical Scientist, and is an American Cancer Society Clinical Research Professor, which is funded, in part, by the FM Kirby Foundation.	Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Cho YJ, 2008, P NATL ACAD SCI USA, V105, P5396, DOI 10.1073/pnas.0705410105; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea; Kikuno N, 2008, INT J CANCER, V123, P552, DOI 10.1002/ijc.23590; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Marsh DJ, 1998, J MED GENET, V35, P881, DOI 10.1136/jmg.35.11.881; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Ni Y, 2008, AM J HUM GENET, V83, P261, DOI 10.1016/j.ajhg.2008.07.011; Pilarski R, 2004, J MED GENET, V41, P323, DOI 10.1136/jmg.2004.018036; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; STARINK TM, 1986, CLIN GENET, V29, P222; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Teresi RE, 2007, AM J HUM GENET, V81, P756, DOI 10.1086/521051; Yu L, 2004, GENOMICS, V84, P647, DOI 10.1016/j.ygeno.2004.06.010; Zhou XP, 2003, AM J HUM GENET, V73, P1191, DOI 10.1086/379382	23	106	110	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2724	2731		10.1001/jama.2010.1877	http://dx.doi.org/10.1001/jama.2010.1877			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177507	Green Accepted, Bronze			2022-12-28	WOS:000285518000017
J	Rabl, J; Leibundgut, M; Ataide, SF; Haag, A; Ban, N				Rabl, Julius; Leibundgut, Marc; Ataide, Sandro F.; Haag, Andrea; Ban, Nenad			Crystal Structure of the Eukaryotic 40S Ribosomal Subunit in Complex with Initiation Factor 1	SCIENCE			English	Article							PROTEIN-KINASE-C; TRANSLATION INITIATION; MESSENGER-RNA; START CODON; IN-VIVO; 70S RIBOSOME; FACTOR EIF1; RACK1; S1; YEAST	Eukaryotic ribosomes are substantially larger and more complex than their bacterial counterparts. Although their core function is conserved, bacterial and eukaryotic protein synthesis differ considerably at the level of initiation. The eukaryotic small ribosomal subunit (40S) plays a central role in this process; it binds initiation factors that facilitate scanning of messenger RNAs and initiation of protein synthesis. We have determined the crystal structure of the Tetrahymena thermophila 40S ribosomal subunit in complex with eukaryotic initiation factor 1 (eIF1) at a resolution of 3.9 angstroms. The structure reveals the fold of the entire 18S ribosomal RNA and of all ribosomal proteins of the 40S subunit, and defines the interactions with eIF1. It provides insights into the eukaryotic-specific aspects of protein synthesis, including the function of eIF1 as well as signaling and regulation mediated by the ribosomal proteins RACK1 and rpS6e.	[Rabl, Julius; Leibundgut, Marc; Ataide, Sandro F.; Haag, Andrea; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch		Rabl, Julius/0000-0001-6375-852X; F Ataide, Sandro/0000-0003-1807-5708	Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR); European Research Council [250071]; European Community	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR)(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); European Community(European Commission)	All data were collected at the Swiss Light Source (SLS, Paul Scherrer Institut, Villigen). We thank C. Schulze-Briese, A. Pauluhn, R. Bingel-Erlenmeyer, M. Muller, and T. Tomizaki for their outstanding support at the SLS; B. Blattmann from the NCCR crystallization facility for screening; R. Brunisholz for help with mass spectroscopy; N. Katheder, D. Baretic, and M. Weisser for their work during the initial phase of the project; S. Arpagaus for preparation of the material; T. Maier for advice during phasing; D. Bohringer for critically reading the manuscript; all members of the Ban laboratory for suggestions and discussions; and A. Brunger for providing a prerelease version of the CNS 1.3 refinement program. Supported by the Swiss National Science Foundation (SNSF), the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF, and European Research Council grant 250071 under the European Community's Seventh Framework Programme (N.B.), and the Max Roessler prize to N.B. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession codes 2xzm and 2xzn. ETH Zurich has filed a patent application to use the crystals and the coordinates of the 40S ribosomal subunit for developing compounds that can interfere with eukaryotic translation.	Alkemar G, 2006, BIOCHEMISTRY-US, V45, P8067, DOI 10.1021/bi052149z; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Baum S, 2004, BIOCHEM J, V380, P823, DOI 10.1042/BJ20031962; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; CASTILHOVALAVICIUS B, 1990, GENETICS, V124, P483; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Dallas A, 2001, MOL CELL, V8, P855, DOI 10.1016/S1097-2765(01)00356-2; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; Gallina A, 2001, VIROLOGY, V283, P7, DOI 10.1006/viro.2001.0855; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Komarova AV, 2002, RNA, V8, P1137, DOI 10.1017/S1355838202029990; Korostelev A, 2007, P NATL ACAD SCI USA, V104, P16840, DOI 10.1073/pnas.0707850104; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Pachler K, 2004, FEMS YEAST RES, V5, P271, DOI 10.1016/j.femsyr.2004.07.009; PALM L, 1995, J BIOL CHEM, V270, P6000, DOI 10.1074/jbc.270.11.6000; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Reinhardt J, 2000, VET MICROBIOL, V74, P87, DOI 10.1016/S0378-1135(00)00169-3; Sang NL, 2001, J BIOL CHEM, V276, P27026, DOI 10.1074/jbc.M010346200; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Smith PR, 2000, J VIROL, V74, P3082, DOI 10.1128/JVI.74.7.3082-3092.2000; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Ye KQ, 2009, P NATL ACAD SCI USA, V106, P13808, DOI 10.1073/pnas.0905128106; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	54	350	355	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					730	736		10.1126/science.1198308	http://dx.doi.org/10.1126/science.1198308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21205638	Green Submitted			2022-12-28	WOS:000287205700060
J	Atarashi, K; Tanoue, T; Shima, T; Imaoka, A; Kuwahara, T; Momose, Y; Cheng, GH; Yamasaki, S; Saito, T; Ohba, Y; Taniguchi, T; Takeda, K; Hori, S; Ivanov, II; Umesaki, Y; Itoh, K; Honda, K				Atarashi, Koji; Tanoue, Takeshi; Shima, Tatsuichiro; Imaoka, Akemi; Kuwahara, Tomomi; Momose, Yoshika; Cheng, Genhong; Yamasaki, Sho; Saito, Takashi; Ohba, Yusuke; Taniguchi, Tadatsugu; Takeda, Kiyoshi; Hori, Shohei; Ivanov, Ivaylo I.; Umesaki, Yoshinori; Itoh, Kikuji; Honda, Kenya			Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species	SCIENCE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; INTESTINAL IMMUNE-RESPONSES; MICROBIOTA; INTERLEUKIN-10; HOMEOSTASIS; COLITIS; INFLAMMATION; SYSTEM; BETA	CD4(+) T regulatory cells (T-regs), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T-regs were most abundant in the colonic mucosa. The spore-forming component of indigenous intestinal microbiota, particularly clusters IV and XIVa of the genus Clostridium, promoted T-reg cell accumulation. Colonization of mice by a defined mix of Clostridium strains provided an environment rich in transforming growth factor-beta and affected Foxp3(+) T-reg number and function in the colon. Oral inoculation of Clostridium during the early life of conventionally reared mice resulted in resistance to colitis and systemic immunoglobulin E responses in adult mice, suggesting a new therapeutic approach to autoimmunity and allergy.	[Atarashi, Koji; Tanoue, Takeshi; Taniguchi, Tadatsugu; Honda, Kenya] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan; [Shima, Tatsuichiro; Imaoka, Akemi; Umesaki, Yoshinori] Yakult Cent Inst Microbiol Res, Tokyo 1868650, Japan; [Kuwahara, Tomomi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol Bacteriol, Tokushima 7708503, Japan; [Momose, Yoshika; Itoh, Kikuji] Univ Tokyo, Dept Vet Publ Hlth, Tokyo 1138657, Japan; [Cheng, Genhong] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yamasaki, Sho; Saito, Takashi] RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Kanagawa 2300045, Japan; [Ohba, Yusuke] Hokkaido Univ, Grad Sch Med, Lab Pathophysiol & Signal Transduct, Sapporo, Hokkaido 0608638, Japan; [Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Hori, Shohei] RIKEN Res Ctr Allergy & Immunol, Res Unit Immune Homeostasis, Kanagawa 2300045, Japan; [Ivanov, Ivaylo I.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Honda, Kenya] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Yakult Honsha Company, Limited; Tokushima University; University of Tokyo; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RIKEN; Hokkaido University; Osaka University; RIKEN; Columbia University; Japan Science & Technology Agency (JST)	Honda, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan.	kenya@m.u-tokyo.ac.jp	Honda, Kenya/N-5297-2015; Atarashi, Koji/I-5363-2014; Hori, Shohei/O-6163-2019; Saito, Takashi/C-9684-2009; Ohba, Yusuke/E-7944-2011	Atarashi, Koji/0000-0001-5422-0736; Hori, Shohei/0000-0001-8770-4593; Saito, Takashi/0000-0001-9495-3547; Takeda, Kiyoshi/0000-0002-1778-6332	Ministry of Education, Culture, Sports, Science and Technology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kato Memorial Bioscience Foundation; Mishima Kaiun Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; Inoue Foundation for Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056154, R01AI052359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK085329] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kato Memorial Bioscience Foundation; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; Inoue Foundation for Science(Inoue Foundation for Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Ueda, J. Nishimura, and H. Saiga for technical assistance, R. Eisenman for critically reading the manuscript, and A. Miyawaki for Venus. We thank the staff at the Sankyo Laboratories for gnotobiotic handling of the mice. The work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Kato Memorial Bioscience Foundation, the Mishima Kaiun Memorial Foundation, Kanae Foundation for the Promotion of Medical Science, and Inoue Foundation for Science. The authors have applied for a patent for use of bacteria belonging to the genus Clostridium or a physiologically active substance derived from these bacteria to induce proliferation or accumulation of regulatory T cells and suppress immune functions (patent application no. JP 2010-129134). Material transfer agreements are required for the use of the IL-10 Venus mice, SFB, Clostridium spp. 46 strains, Bacteroides spp. 16 strains, and Lactobacillus spp. 3 strains.	Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; D'Angelo M, 2001, J BIOL CHEM, V276, P11347, DOI 10.1074/jbc.M009725200; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; ITOH K, 1985, LAB ANIM, V19, P111, DOI 10.1258/002367785780942589; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Lyons A, 2010, CLIN EXP ALLERGY, V40, P811, DOI 10.1111/j.1365-2222.2009.03437.x; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Min B, 2007, EUR J IMMUNOL, V37, P1916, DOI 10.1002/eji.200737236; Momose Y, 2009, J APPL MICROBIOL, V107, P2088, DOI 10.1111/j.1365-2672.2009.04431.x; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	25	2399	2585	16	443	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					337	341		10.1126/science.1198469	http://dx.doi.org/10.1126/science.1198469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21205640	Green Accepted			2022-12-28	WOS:000286636300039
J	Moellering, RC; Abbott, GF; Ferraro, MJ				Moellering, Robert C., Jr.; Abbott, Gerald F.; Ferraro, Mary Jane			A Woman with Shock after Treatment of a Furuncle Sepsis due to community-acquired methicillinresistant Staphylococcus aureus, strain USA300-0047, PVL-positive.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRULENCE; EXPRESSION; PATHOGENESIS; ANTIBIOTICS; INFECTIONS		[Moellering, Robert C., Jr.] Beth Israel Deaconess Med Ctr, Dept Med, Div Infect Dis, Boston, MA 02215 USA; [Abbott, Gerald F.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ferraro, Mary Jane] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Moellering, Robert C., Jr.; Ferraro, Mary Jane] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Abbott, Gerald F.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Ferraro, Mary Jane] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Moellering, RC (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Infect Dis, Boston, MA 02215 USA.							Chambers HF, 2009, J INFECT DIS, V199, P291, DOI 10.1086/595983; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Gorwitz RJ, 2008, J INFECT DIS, V197, P179, DOI 10.1086/523767; Groom AV, 2001, JAMA-J AM MED ASSOC, V286, P1201, DOI 10.1001/jama.286.10.1201; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Moellering RC, 2006, ANN INTERN MED, V144, P368, DOI 10.7326/0003-4819-144-5-200603070-00014; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Stevens DL, 2006, CLIN INFECT DIS, V42, P729, DOI 10.1086/500265	12	10	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					266	275		10.1056/NEJMcpc1003886	http://dx.doi.org/10.1056/NEJMcpc1003886			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21247318				2022-12-28	WOS:000286383900014
J	Neu, J; Walker, WA				Neu, Josef; Walker, W. Allan			Medical Progress: Necrotizing Enterocolitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BIRTH-WEIGHT INFANTS; INDUCED INTERLEUKIN-8 PRODUCTION; INTESTINAL EPITHELIAL-CELLS; PERITONEAL DRAINAGE; PRETERM INFANTS; CONTROLLED-TRIAL; TERM INFANTS; DOUBLE-BLIND; FULL-TERM; CACO-2 CELLS		[Neu, Josef] Univ Florida, Dept Pediat, Gainesville, FL USA; [Walker, W. Allan] Harvard Univ, Sch Med, Boston, MA USA; [Walker, W. Allan] Massachusetts Gen Hosp Children, Dept Pediat, Charlestown, MA USA	State University System of Florida; University of Florida; Harvard University; Harvard Medical School	Walker, WA (corresponding author), Massachusetts Gen Hosp Children, Dept Pediat, Mucosal Immunol Lab, 114 16th St, Boston, MA 02129 USA.	wwalker@partners.org	Neu, Josef/AAI-2799-2020; Duarte, Graziela Biude Silva/Q-7728-2016		NICHD NIH HHS [R01 HD059143] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561, P30 DK040561-15] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu MT, 2010, GASTROENTEROLOGY, V138, P39, DOI 10.1053/j.gastro.2009.11.031; ANDERSON DM, 1991, AM J PERINAT, V8, P62, DOI 10.1055/s-2007-999344; Bedrick Alan D, 2004, J Perinatol, V24, P531, DOI 10.1038/sj.jp.7211158; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Bisquera JA, 2002, PEDIATRICS, V109, P423, DOI 10.1542/peds.109.3.423; Blakely ML, 2006, PEDIATRICS, V117, pE680, DOI 10.1542/peds.2005-1273; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; CRISSINGER K, 1994, ACTA PAEDIATR, V83, P8, DOI 10.1111/j.1651-2227.1994.tb13233.x; Dani C, 2002, BIOL NEONATE, V82, P103, DOI 10.1159/000063096; DAVEY AM, 1994, J PEDIATR-US, V124, P795, DOI 10.1016/S0022-3476(05)81376-9; Donovan SM, 2009, BRIT J NUTR, V101, P1267, DOI 10.1017/S0007114508091241; EGAN EA, 1976, J PEDIATR-US, V89, P467, DOI 10.1016/S0022-3476(76)80553-7; Epelman M, 2007, RADIOGRAPHICS, V27, P285, DOI 10.1148/rg.272055098; Erasmus HD, 2002, J PEDIATR-US, V141, P532, DOI 10.1067/mpd.2002.127499; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023; Gibson GR, 1998, BRIT J NUTR, V80, pS209, DOI 10.1017/S0007114500006048; Gordon PV, 2007, J PERINATOL, V27, P661, DOI 10.1038/sj.jp.7211782; Gordon PV, 2009, AM J PERINAT, V26, P309, DOI 10.1055/s-0028-1103514; Grave GD, 2007, PEDIATR RES, V62, P510, DOI 10.1203/PDR.0b013e318142580a; GRYLACK LJ, 1978, AM J DIS CHILD, V132, P1192, DOI 10.1001/archpedi.1978.02120370040010; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Hintz SR, 2005, PEDIATRICS, V115, P696, DOI 10.1542/peds.2004-0569; Holman RC, 2006, PAEDIATR PERINAT EP, V20, P498, DOI 10.1111/j.1365-3016.2006.00756.x; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Li N, 2009, PEDIATR RES, V66, P203, DOI 10.1203/PDR.0b013e3181aabd4f; Lin HC, 2005, PEDIATRICS, V115, pE92, DOI 10.1542/peds.2004-0924; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; LLOYD JR, 1969, J PEDIATR SURG, V4, P77, DOI 10.1016/0022-3468(69)90186-9; Lopez M, 2008, J NUTR, V138, P2264, DOI 10.3945/jn.108.093658; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lu J, 2008, AM J PHYSIOL-GASTR L, V294, pG1181, DOI 10.1152/ajpgi.00343.2007; LUCAS A, 1990, LANCET, V336, P1519, DOI 10.1016/0140-6736(90)93304-8; Mally P, 2006, AM J PERINAT, V23, P451, DOI 10.1055/s-2006-951300; Markel TA, 2006, SHOCK, V25, P329, DOI 10.1097/01.shk.0000192126.33823.87; Martin CR, 2006, SEMIN FETAL NEONAT M, V11, P369, DOI 10.1016/j.siny.2006.03.002; MartinezTallo E, 1997, BIOL NEONATE, V71, P292; Meinzen-Derr J, 2009, J PERINATOL, V29, P57, DOI 10.1038/jp.2008.117; Moro G, 2002, J PEDIATR GASTR NUTR, V34, P291, DOI 10.1097/00005176-200203000-00014; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Moss RL, 2008, J PERINATOL, V28, P665, DOI 10.1038/jp.2008.119; Moss RL, 2006, NEW ENGL J MED, V354, P2225, DOI 10.1056/NEJMoa054605; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Mukaida N, 2000, INT J HEMATOL, V72, P391; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2005, ACTA PAEDIATR, V94, P100, DOI 10.1080/08035320510043637; NOWICKI PT, 1994, CLIN PERINATOL, V21, P219, DOI 10.1016/S0095-5108(18)30342-7; Obladen M, 2009, NEONATOLOGY, V96, P203, DOI 10.1159/000215590; Oh S, 2010, J PERINATOL, V30, P701, DOI 10.1038/jp.2010.9; Otte JM, 2004, AM J PHYSIOL-GASTR L, V286, pG613, DOI 10.1152/ajpgi.00341.2003; Quigley MA, 2007, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD002971, DOI 10.1002/14651858.CD002971]; Raboei EH, 2009, EUR J PEDIATR SURG, V19, P101, DOI 10.1055/s-0029-1202771; Rees CM, 2008, ANN SURG, V248, P44, DOI 10.1097/SLA.0b013e318176bf81; Rees CM, 2010, J PEDIATR SURG, V45, P324, DOI 10.1016/j.jpedsurg.2009.10.066; Salhab Walid A, 2004, J Perinatol, V24, P534, DOI 10.1038/sj.jp.7211165; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Sharma R, 2007, J PEDIATR SURG, V42, P454, DOI 10.1016/j.jpedsurg.2006.10.038; Sherman PM, 2009, J PEDIATR-US, V155, pS61, DOI 10.1016/j.jpeds.2009.08.022; Sherman T, 2010, J PEDIATR-US, V156, P344; Sola JE, 2010, J SURG RES, V161, P95, DOI 10.1016/j.jss.2009.05.007; Spencer AU, 2008, AM J CLIN NUTR, V88, P1552, DOI 10.3945/ajcn.2008.26007; Stark AR, 2001, NEW ENGL J MED, V344, P95, DOI 10.1056/NEJM200101113440203; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Sullivan S, 2010, J PEDIAT, V156; Swanson JR, 2009, J PERINATOL, V29, P256, DOI 10.1038/jp.2008.242; Tarnow-Mordi WO, 2010, PEDIATRICS, V125, P1068, DOI 10.1542/peds.2009-2151; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Watterberg KL, 2004, PEDIATRICS, V114, P1649, DOI 10.1542/peds.2004-1159; Young C, 2009, PEDIATR RES, V65, p91R, DOI 10.1203/PDR.0b013e31819dba7d; Zhang LY, 2006, J PEDIATR GASTR NUTR, V42, P545, DOI 10.1097/01.mpg.0000221905.68781.4a; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752	80	1233	1319	7	123	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					255	264		10.1056/NEJMra1005408	http://dx.doi.org/10.1056/NEJMra1005408			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21247316	Green Accepted			2022-12-28	WOS:000286383900010
J	Martinez, RN; Sereno, PC; Alcober, OA; Colombi, CE; Renne, PR; Montanez, IP; Currie, BS				Martinez, Ricardo N.; Sereno, Paul C.; Alcober, Oscar A.; Colombi, Carina E.; Renne, Paul R.; Montanez, Isabel P.; Currie, Brian S.			A Basal Dinosaur from the Dawn of the Dinosaur Era in Southwestern Pangaea	SCIENCE			English	Article							EARLY EVOLUTION; ORIGIN; ARGENTINA; SKELETON; SAURISCHIA	Upper Triassic rocks in northwestern Argentina preserve the most complete record of dinosaurs before their rise to dominance in the Early Jurassic. Here, we describe a previously unidentified basal theropod, reassess its contemporary Eoraptor as a basal sauropodomorph, divide the faunal record of the Ischigualasto Formation with biozones, and bracket the formation with 40Ar/39Ar ages. Some 230 million years ago in the Late Triassic (mid Carnian), the earliest dinosaurs were the dominant terrestrial carnivores and small herbivores in southwestern Pangaea. The extinction of nondinosaurian herbivores is sequential and is not linked to an increase in dinosaurian diversity, which weakens the predominant scenario for dinosaurian ascendancy as opportunistic replacement.	[Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Sereno, Paul C.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Martinez, Ricardo N.; Alcober, Oscar A.; Colombi, Carina E.] Univ Nacl San Juan, Inst Ciencias Nat, RA-5400 San Juan, Argentina; [Martinez, Ricardo N.; Alcober, Oscar A.; Colombi, Carina E.] Univ Nacl San Juan, Museo Ciencias Nat, RA-5400 San Juan, Argentina; [Colombi, Carina E.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Renne, Paul R.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Renne, Paul R.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Montanez, Isabel P.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Currie, Brian S.] Miami Univ, Dept Geol, Oxford, OH 45056 USA	University of Chicago; University of Chicago; Universidad Nacional de San Juan; Universidad Nacional de San Juan; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Berkeley Geochronolgy Center; University of California System; University of California Berkeley; University of California System; University of California Davis; University System of Ohio; Miami University	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.	dinosaur@uchicago.edu		Renne, Paul/0000-0003-1769-5235; Montanez, Isabel/0000-0003-0492-3796; Currie, Brian/0000-0002-5759-3914	Whitten-Newman Foundation; New York Community Trust; Earthwatch Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Ann and Gordon Getty Foundation; National Geographic Society	Whitten-Newman Foundation; New York Community Trust; Earthwatch Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ann and Gordon Getty Foundation; National Geographic Society(National Geographic Society)	We thank C. Abraczinskas for final drafts of all figures, personnel of the Fossil Lab at the Univ. of Chicago for preparation of fossil material, personnel of the High-Resolution X-ray Computed Tomography Facility at The Univ. of Texas at Austin for assistance with computed tomography imaging, and S. Nesbitt and R. Irmis for examination of fossil material in their care. This work was supported by the Whitten-Newman Foundation, the Island Fund of the New York Community Trust, Earthwatch Institute, Consejo Nacional de Investigaciones Cientificas y Tecnicas, the Ann and Gordon Getty Foundation, and the National Geographic Society.	Alcober OA, 2010, ZOOKEYS, P55, DOI 10.3897/zookeys.63.550; Benton M. J., 2006, 3 JORN INT PAL DIN E, P11; BENTON MJ, 1994, IN THE SHADOW OF THE DINOSAURS, P366; BONAPARTE J F, 1982, Journal of Vertebrate Paleontology, V2, P362; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Charig A. J., 1984, ZOOL SOC LONDON S, V57, P597; Currie BS, 2009, J S AM EARTH SCI, V27, P74, DOI 10.1016/j.jsames.2008.10.004; Ezcurra MD, 2010, J SYST PALAEONTOL, V8, P371, DOI 10.1080/14772019.2010.484650; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Langer M. C., 2007, GLOBAL TRIASSIC; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Langer MC, 2005, J S AM EARTH SCI, V19, P219, DOI 10.1016/j.jsames.2005.04.002; Mannion PD, 2011, BIOL REV, V86, P157, DOI 10.1111/j.1469-185X.2010.00139.x; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Santa Luca A.P., 1980, Annals of the South African Museum, V79, P159; Sereno Paul C., 2007, Historical Biology, V19, P145, DOI 10.1080/08912960601167435; Sereno PC, 2007, SPEC PAP PALAEONTOL, P261; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; SERENO PC, 1992, SCIENCE, V258, P1137, DOI 10.1126/science.258.5085.1137; Tykoski R. S., 2005, THESIS U TEXAS AUSTI; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C	30	251	257	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					206	210		10.1126/science.1198467	http://dx.doi.org/10.1126/science.1198467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233386				2022-12-28	WOS:000286433100040
J	Mourou, G; Tajima, T				Mourou, Gerard; Tajima, Toshiki			More Intense, Shorter Pulses	SCIENCE			English	Editorial Material							TI-SAPPHIRE LASER; GENERATION; ULTRASHORT; OPTICS		[Mourou, Gerard] ENSTA, Inst Lumiere Extreme, F-91128 Palaiseau, France; [Tajima, Toshiki] Univ Munich, Fac Phys, D-85748 Garching, Germany	Institut Polytechnique de Paris; University of Munich	Mourou, G (corresponding author), ENSTA, Inst Lumiere Extreme, F-91128 Palaiseau, France.	gerardmourou@gmail.com	Tajima, Toshiki/G-1174-2018					[Anonymous], EXTR LIGHT INFR EUR; Antoine P, 1996, PHYS REV LETT, V77, P1234, DOI 10.1103/PhysRevLett.77.1234; BULANOV SV, 1994, PHYS PLASMAS, V1, P745, DOI 10.1063/1.870766; Bulanov SV, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.085001; Dromey B, 2006, NAT PHYS, V2, P456, DOI 10.1038/nphys338; Ell R, 2001, OPT LETT, V26, P373, DOI 10.1364/OL.26.000373; Esirkepov T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.175003; Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; MAIMAN TH, 1960, NATURE, V187, P493, DOI 10.1038/187493a0; Mourou GA, 2006, REV MOD PHYS, V78, P309, DOI 10.1103/RevModPhys.78.309; Naumova NM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.063902; Nisoli M, 1996, APPL PHYS LETT, V68, P2793, DOI 10.1063/1.116609; STINGL A, 1995, OPT LETT, V20, P602, DOI 10.1364/OL.20.000602; Sutter DH, 2000, APPL PHYS B-LASERS O, V70, pS5, DOI 10.1007/s003400000308; Tajima T, 2002, PHYS REV SPEC TOP-AC, V5, DOI 10.1103/PhysRevSTAB.5.031301; Tsakiris GD, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/1/019	16	130	135	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					41	42		10.1126/science.1200292	http://dx.doi.org/10.1126/science.1200292			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212346				2022-12-28	WOS:000285974000027
J	O'Shaughnessy, EC; Palani, S; Collins, JJ; Sarkar, CA				O'Shaughnessy, Ellen C.; Palani, Santhosh; Collins, James J.; Sarkar, Casim A.			Tunable Signal Processing in Synthetic MAP Kinase Cascades	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; SWITCH-LIKE; CELL FATE; COMPUTATIONAL DESIGN; SCAFFOLD PROTEINS; MAMMALIAN-CELLS; GENE-EXPRESSION; GLOBAL ANALYSIS; YEAST; PATHWAYS	The flexibility of MAPK cascade responses enables regulation of a vast array of cell fate decisions, but elucidating the mechanisms underlying this plasticity is difficult in endogenous signaling networks. We constructed insulated mammalian MAPK cascades in yeast to explore how intrinsic and extrinsic perturbations affect the flexibility of these synthetic signaling modules. Contrary to biphasic dependence on scaffold concentration, we observe monotonic decreases in signal strength as scaffold concentration increases. We find that augmenting the concentration of sequential kinases can enhance ultrasensitivity and lower the activation threshold. Further, integrating negative regulation and concentration variation can decouple ultrasensitivity and threshold from the strength of the response. Computational analyses show that cascading can generate ultrasensitivity and that natural cascades with different kinase concentrations are innately biased toward their distinct activation profiles. This work demonstrates that tunable signal processing is inherent to minimal MAPK modules and elucidates principles for rational design of synthetic signaling systems.	[O'Shaughnessy, Ellen C.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA; [O'Shaughnessy, Ellen C.; Collins, James J.] Boston Univ, Dept Biomed Engn, Ctr BioDynam, Boston, MA 02215 USA; [O'Shaughnessy, Ellen C.; Collins, James J.] Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Palani, Santhosh; Sarkar, Casim A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Sarkar, Casim A.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA	Boston University; Howard Hughes Medical Institute; Boston University; Boston University; University of Pennsylvania; University of Pennsylvania; Harvard University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Boston, MA 02215 USA.	jcollins@bu.edu; casarkar@seas.upenn.edu			National Institutes of Health (NIH) [DP1 OD00364]; Ellison Medical Foundation; Howard Hughes Medical Institute; American Heart Association [0835132N]; University of Pennsylvania; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Association(American Heart Association); University of Pennsylvania; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) through the NIH Director's Pioneer Award Program, grant number DP1 OD00364, and by the Ellison Medical Foundation and the Howard Hughes Medical Institute (to J.J.C.); and by the American Heart Association, grant number 0835132N, and startup funds from the University of Pennsylvania (to C.A.S.). We also thank Natalie Ahn, Lloyd Cantley, Gerald Fink, Steen Hansen, and David Levin for kindly providing cDNA.	Atienza JM, 2000, J BIOL CHEM, V275, P20638, DOI 10.1074/jbc.M910024199; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bagowski CP, 2003, CURR BIOL, V13, P315, DOI 10.1016/S0960-9822(03)00083-6; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Chen MT, 2005, NAT BIOTECHNOL, V23, P1551, DOI 10.1038/nbt1162; Chen RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-235; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Dwyer MA, 2003, P NATL ACAD SCI USA, V100, P11255, DOI 10.1073/pnas.2032284100; Elion EA, 2001, J CELL SCI, V114, P3967; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gao XD, 2004, MOL BIOL CELL, V15, P3977, DOI 10.1091/mbc.e04-01-0079; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Grunberg R, 2010, NUCLEIC ACIDS RES, V38, P2645, DOI 10.1093/nar/gkq152; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hornberg JJ, 2005, FEBS J, V272, P244, DOI 10.1111/j.1432-1033.2004.04404.x; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kiel C, 2010, CELL, V140, P33, DOI 10.1016/j.cell.2009.12.028; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McMahon M, 2001, METHOD ENZYMOL, V332, P401; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Wu JJ, 2005, MOL CELL BIOL, V25, P4792, DOI 10.1128/MCB.25.11.4792-4803.2005; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200	51	116	117	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					119	131		10.1016/j.cell.2010.12.014	http://dx.doi.org/10.1016/j.cell.2010.12.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215374	Green Accepted, Bronze			2022-12-28	WOS:000285993600012
J	Albanese, A				Albanese, Alberto			Terminology for Preparations of Botulinum Neurotoxins What a Difference a Name Makes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; ACADEMY-OF-NEUROLOGY; CERVICAL DYSTONIA; THERAPEUTICS; DISORDERS; TOXIN		Univ Cattolica Sacro Cuore, Ist Neurol Carlo Besta, I-20133 Milan, Italy	Catholic University of the Sacred Heart; IRCCS Istituto Neurologico Besta	Albanese, A (corresponding author), Univ Cattolica Sacro Cuore, Ist Neurol Carlo Besta, Via G Celoria 11, I-20133 Milan, Italy.	alberto.albanese@unicatt.it	Albanese, Alberto/K-7396-2016	Albanese, Alberto/0000-0002-5864-0006				Albanese A, 2009, TOXICON, V54, P702, DOI 10.1016/j.toxicon.2009.02.003; Benecke R, 2005, NEUROLOGY, V64, P1949, DOI 10.1212/01.WNL.0000163767.99354.C3; Bentivoglio AR, 2009, NEUROTOX RES, V15, P224, DOI 10.1007/s12640-009-9023-3; Chapman MA, 2007, CLIN THER, V29, P1325, DOI 10.1016/j.clinthera.2007.07.020; Dressler D, 2006, EUR J NEUROL, V13, P11, DOI 10.1111/j.1468-1331.2006.01439.x; Naumann M, 2008, NEUROLOGY, V70, P1707, DOI 10.1212/01.wnl.0000311390.87642.d8; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Simpson DM, 2008, NEUROLOGY, V70, P1699, DOI 10.1212/01.wnl.0000311389.26145.95; *US FDA, 2010, FDA GIV UPD BOT TOX; WHO, 1997, GUID US INT NONPR NA	10	44	49	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					89	90		10.1001/jama.2010.1937	http://dx.doi.org/10.1001/jama.2010.1937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205970				2022-12-28	WOS:000285924100029
J	Ahmed, F				Ahmed, Farooq			Tales of adversity	NATURE			English	Editorial Material																			0	23	23	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S20	S20		10.1038/468S20a	http://dx.doi.org/10.1038/468S20a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179081	Bronze			2022-12-28	WOS:000285553800008
J	Friedman, LS; Gee, MS; Misdraji, J				Friedman, Lawrence S.; Gee, Michael S.; Misdraji, Joseph			Case 39-2010: A 19-Year-Old Woman with Nausea, Jaundice, and Pruritus. Severe panlobular hepatitis, with features that were consistent with the acute onset of autoimmune hepatitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WILSONS-DISEASE; LIVER; PREGNANCY; HEPATOTOXICITY; DIAGNOSIS; FULMINANT; SERUM; RISK		[Friedman, Lawrence S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Gee, Michael S.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Misdraji, Joseph] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Friedman, Lawrence S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gee, Michael S.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Misdraji, Joseph] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Friedman, Lawrence S.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Friedman, Lawrence S.] Newton Wellesley Hosp, Dept Med, Newton, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Tufts University; Newton Wellesley Hospital	Friedman, LS (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Misdraji, Joseph/AGX-4779-2022; Misdraji, Joseph/AAD-4588-2019					Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Boberg KM, 1998, SCAND J GASTROENTERO, V33, P99; BURGART LJ, 1995, AM J SURG PATHOL, V19, P699, DOI 10.1097/00000478-199506000-00010; BURGART LJ, 1995, AM J SURG PATHOL, V19, P1341, DOI 10.1097/00000478-199511000-00024; COHEN JA, 1979, DIGEST DIS SCI, V24, P835, DOI 10.1007/BF01324898; CRAPPER RM, 1986, DIGESTION, V34, P216, DOI 10.1159/000199332; Czaja AJ, 2002, LIVER TRANSPLANT, V8, P505, DOI 10.1053/jlts.2002.33485; Czaja AJ, 2010, SLEISENGER FORDTRANS, P1461; Czaja Albert J, 2007, Expert Rev Gastroenterol Hepatol, V1, P129, DOI 10.1586/17474124.1.1.129; Czaja AJ, 2009, SEMIN LIVER DIS, V29, P315, DOI 10.1055/s-0029-1233530; Czartoski T, 2006, J CLIN MICROBIOL, V44, P1584, DOI 10.1128/JCM.44.4.1584-1586.2006; Feld JJ, 2010, SLEISENGER FORDTRANS, P1343; Ferenci P, 2005, CLIN GASTROENTEROL H, V3, P811, DOI 10.1016/S1542-3565(05)00181-3; Friedman LS, 2007, SCHIFFS DIS LIVER, P329; Hay JE, 2008, HEPATOLOGY, V47, P1067, DOI 10.1002/hep.22130; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Kaplowitz N, 2004, HEPATOLOGY, V40, P23, DOI 10.1002/hep.20312; KENNY RP, 1986, DIGEST DIS SCI, V31, P705, DOI 10.1007/BF01296447; Korman JD, 2008, HEPATOLOGY, V48, P1167, DOI 10.1002/hep.22446; Lewis JH, 2010, SLEISENGER FORDTRANS, P1447; Lewis JH, 2007, LIVER, P329; LUDWIG S, 1980, GASTROENTEROLOGY, V79, P545; Malnick SDH, 1998, J CLIN GASTROENTEROL, V26, P164, DOI 10.1097/00004836-199804000-00002; Manns MP, 2009, SEMIN LIVER DIS, V29, P239, DOI 10.1055/s-0029-1233528; Merle U, 2007, GUT, V56, P115, DOI 10.1136/gut.2005.087262; Milkiewicz P, 2000, J GASTROEN HEPATOL, V15, P570, DOI 10.1046/j.1440-1746.2000.02158.x; NIKIAS GA, 1994, J HEPATOL, V21, P866, DOI 10.1016/S0168-8278(94)80251-3; PATWARDHAN RV, 1987, ARCH INTERN MED, V147, P1249, DOI 10.1001/archinte.147.7.1249; Rautou PE, 2009, CLIN GASTROENTEROL H, V7, P1230, DOI 10.1016/j.cgh.2009.06.011; Rubio-Tapia A, 2007, HEPATOLOGY, V46, P1650, DOI 10.1002/hep.21949; Schramm C, 2006, AM J GASTROENTEROL, V101, P556, DOI 10.1111/j.1572-0241.2006.00479.x; Servoss Julie C, 2004, Clin Liver Dis, V8, P267, DOI 10.1016/j.cld.2004.02.001; Shaukat A, 2005, HEPATOL RES, V33, P24, DOI 10.1016/j.hepres.2005.06.005; Tan J, 2008, LIVER TRANSPLANT, V14, P1081, DOI 10.1002/lt.21572; Teoh NC, 2010, SLEISENGER FORDTRANS, P1413; Teschke R, 2010, JAMA-J AM MED ASSOC, V304, P2174, DOI 10.1001/jama.2010.1689; Teschke R, 2009, MATURITAS, V63, P302, DOI 10.1016/j.maturitas.2009.05.006; Werner M, 2007, SCAND J GASTROENTERO, V42, P986, DOI 10.1080/00365520601155266; Whitehead MW, 1999, GUT, V45, P129, DOI 10.1136/gut.45.1.129; Wreghitt TG, 2003, CLIN INFECT DIS, V37, P1603, DOI 10.1086/379711; Zimmerman HJ, 1995, HEPATOLOGY, V22, P1898; ZIMMERMAN HJ, 1995, HEPATOLOGY, V22, P767, DOI 10.1002/hep.1840220312	42	8	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2548	2557		10.1056/NEJMcpc1005309	http://dx.doi.org/10.1056/NEJMcpc1005309			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697YL	21175318				2022-12-28	WOS:000285555600012
J	Young, KD				Young, Kevin D.			New Ways to Make Old Walls: Bacterial Surprises	CELL			English	Editorial Material							ESCHERICHIA-COLI; CELL; SHAPE	Two papers in this issue of Cell (Paradis-Bleau et al., 2010 and Typas et al., 2010) report that the lipoproteins LpoA and LpoB are required for the synthesis of cell walls in Escherichia coli. Attached to the bacterial outer membrane, these new cell wall components regulate penicillin-binding proteins located at the inner membrane.	Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Young, KD (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	kdyoung@uams.edu	Young, Kevin/A-7954-2013	Young, Kevin/0000-0003-1760-281X	NIGMS NIH HHS [R01 GM061019] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061019] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Pichoff S, 2007, CURR OPIN MICROBIOL, V10, P601, DOI 10.1016/j.mib.2007.09.005; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038	6	3	3	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2010	143	7					1042	1044		10.1016/j.cell.2010.12.011	http://dx.doi.org/10.1016/j.cell.2010.12.011			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183069	Bronze			2022-12-28	WOS:000285625400002
J	Jafri, H; Alsheikh-Ali, AA; Karas, RH				Jafri, Haseeb; Alsheikh-Ali, Alawi A.; Karas, Richard H.			Meta-analysis: Statin Therapy Does Not Alter the Association Between Low Levels of High-Density Lipoprotein Cholesterol and Increased Cardiovascular Risk	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-HEART-DISEASE; HIGH-DOSE ATORVASTATIN; PRIMARY PREVENTION; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; CLINICAL-TRIALS; EVENTS; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN	Background: Low levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for myocardial infarction (MI). Although statins reduce the risk for MI, most cardiovascular events still occur despite statin treatment. Purpose: Using meta-analysis of large randomized, controlled trials (RCTs) of statins to determine whether statins alter the relationship between HDL-C level and MI. Data Sources: MEDLINE search to February 2010, ClinicalTrials.gov, and reference lists from eligible studies. Study Selection: English-language RCTs of statin-treated patients versus control participants with 1000 or more person-years of follow-up and reported HDL-C levels and MI. Data Extraction: Two independent investigators extracted data from eligible RCTs. Data Synthesis: Twenty eligible RCTs were identified (543 210 person-years of follow-up and 7838 MIs). After adjustment for on-treatment LDL-C levels, age, hypertension, diabetes, and tobacco use, there was a significant inverse association between HDL-C levels and risk for MI in statin-treated patients and control participants. In Poisson meta-regressions, every 0.26-mmol/L (10-mg/dL) decrease in HDL-C was associated with 7.1 (95% CI, 6.8 to 7.3) and 8.3 (CI, 8.1 to 8.5) more MIs per 1000 person-years in statin-treated patients and control participants, respectively. The inverse association between HDL-C levels and MI did not differ between statin-treated patients and control participants (P = 0.57). Limitation: The observed associations may be explained by unmeasured confounding and do not imply causality in the relationship between HDL-C level and cardiovascular risk. Conclusion: Statins do not alter the relationship between HDL-C level and cardiovascular risk, such that low levels of HDL-C remain significantly and independently associated with increased risk despite statin treatment. The remaining risk seen in statin-treated patients may be partly explained by low HDL-C levels or other factors associated with low levels of HDL-C.	[Karas, Richard H.] Tufts Med Ctr, Mol Cardiol Res Inst, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Sheikh Khalifa Med City, Inst Cardiac Sci, Abu Dhabi, U Arab Emirates	Tufts Medical Center; Tufts University	Karas, RH (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Inst Clin Res & Hlth Policy Studies, Box 80,750 Washington St, Boston, MA 02111 USA.	rkaras@tuftsmedicalcenter.org			Pfizer [M10-2091]	Pfizer(Pfizer)	Potential Conflicts of Interest: Dr. Alsheikh-Ali: Grants received: Pfizer. Grants received (money to institution): Pfizer. Dr. Karas: Consultancy: Abbott Laboratories. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10-2091.	Alsheikh-Ali AA, 2007, AM J CARDIOL, V100, P1499, DOI 10.1016/j.amjcard.2007.06.058; Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 2000, Ital Heart J, V1, P810; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Athyros VG, 2002, CURR MED RES OPIN, V18, P220, DOI 10.1185/030079902125000787; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; BRADFORD RH, 1991, ARCH INTERN MED, V151, P43, DOI 10.1001/archinte.151.1.43; Briel Matthias, 2009, BMJ, V338, pb92, DOI 10.1136/bmj.b92; Brown BG, 2006, CURR OPIN LIPIDOL, V17, P631, DOI 10.1097/MOL.0b013e32800ff750; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; Clinical trial, TREATM HDL RED INC V; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Kuvin JT, 2002, AM HEART J, V144, P165, DOI 10.1067/mhj.2002.123145; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Niacin Plus Statin to Prevent Vascular Events, NIAC PLUS STAT PREV; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sacks FM, 2000, CIRCULATION, V102, P1893, DOI 10.1161/01.CIR.102.16.1893; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; WILSON PW, 1980, AM J CARDIOL, V46, P649, DOI 10.1016/0002-9149(80)90516-0	46	80	85	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					800	808		10.7326/0003-4819-153-12-201012210-00006	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173414				2022-12-28	WOS:000285453700003
J	Simmons, S; Brown, RM; Riemann, H; Abrosimov, NV; Becker, P; Pohl, HJ; Thewalt, MLW; Itoh, KM; Morton, JJL				Simmons, Stephanie; Brown, Richard M.; Riemann, Helge; Abrosimov, Nikolai V.; Becker, Peter; Pohl, Hans-Joachim; Thewalt, Mike L. W.; Itoh, Kohei M.; Morton, John J. L.			Entanglement in a solid-state spin ensemble	NATURE			English	Article							QUANTUM; SEPARABILITY; PHASE	Entanglement is the quintessential quantum phenomenon. It is a necessary ingredient in most emerging quantum technologies, including quantum repeaters(1), quantum information processing(2) and the strongest forms of quantum cryptography(3). Spin ensembles, such as those used in liquid-state nuclear magnetic resonance(4,5), have been important for the development of quantum control methods. However, these demonstrations contain no entanglement and ultimately constitute classical simulations of quantum algorithms. Here we report the on-demand generation of entanglement between an ensemble of electron and nuclear spins in isotopically engineered, phosphorus-doped silicon. We combined high-field (3.4 T), low-temperature (2.9 K) electron spin resonance with hyperpolarization of the P-31 nuclear spin to obtain an initial state of sufficient purity to create a non-classical, inseparable state. The state was verified using density matrix tomography based on geometric phase gates, and had a fidelity of 98% relative to the ideal state at this field and temperature. The entanglement operation was performed simultaneously, with high fidelity, on 10(10) spin pairs; this fulfils one of the essential requirements for a silicon-based quantum information processor.	[Simmons, Stephanie; Brown, Richard M.; Morton, John J. L.] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Riemann, Helge; Abrosimov, Nikolai V.] Leibniz Inst Kristallzuchtung, D-12489 Berlin, Germany; [Becker, Peter] PTB Braunschweig, D-38116 Braunschweig, Germany; [Pohl, Hans-Joachim] VITCON Projectconsult GmbH, D-07743 Jena, Germany; [Thewalt, Mike L. W.] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Itoh, Kohei M.] Keio Univ, Sch Fundamental Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Morton, John J. L.] Univ Oxford, Clarendon Lab, CAESR, Oxford OX1 3PU, England	University of Oxford; Leibniz Institut fur Kristallzuchtung (IKZ); Physikalisch-Technische Bundesanstalt (PTB); Simon Fraser University; Keio University; University of Oxford	Morton, JJL (corresponding author), Univ Oxford, Dept Mat, Parks Rd, Oxford OX1 3PH, England.	john.morton@materials.ox.ac.uk	Morton, John/I-3515-2013; Itoh, Kohei/C-5738-2014		EPSRC at Oxford through CAESR [EP/D048559/1]; Oxford-Keio collaboration through the JST-EPSRC SIC [EP/H025952/1]; MEXT; JSPS; Clarendon Fund; St John's College, Oxford; Royal Society; EPSRC [EP/H025952/1, EP/D048559/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D048559/1, EP/H025952/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [18001002] Funding Source: KAKEN	EPSRC at Oxford through CAESR(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Oxford-Keio collaboration through the JST-EPSRC SIC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Clarendon Fund; St John's College, Oxford; Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Fitzsimons, S. Benjamin, A. Ardavan, A. Briggs and B. Lovett for discussions, and P. Hofer and Bruker BioSpin for support with instrumentation. Three-dimensional images were created using POV-RAY open-source software. We thank EPSRC for supporting work at Oxford through CAESR (EP/D048559/1) and the Oxford-Keio collaboration through the JST-EPSRC SIC programme (EP/H025952/1). Work at Keio has been supported by Grants-in-aid for Scientific Research by MEXT, FIRST by JSPS, Nanoquine and Keio GCOE. S.S. is supported by the Clarendon Fund, J.J.L.M. is supported by St John's College, Oxford, and the Royal Society.	Andresen SES, 2007, NANO LETT, V7, P2000, DOI 10.1021/nl070797t; Anwar MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040501; Becker P, 2010, PHYS STATUS SOLIDI A, V207, P49, DOI 10.1002/pssa.200925148; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Campbell ET, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.040302; Curty M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.217903; Hayashi H, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.045201; Horodecki M, 1996, PHYS LETT A, V223, P1, DOI 10.1016/S0375-9601(96)00706-2; Jozsa R, 2003, P ROY SOC A-MATH PHY, V459, P2011, DOI 10.1098/rspa.2002.1097; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Knill E, 1998, PHYS REV A, V57, P3348, DOI 10.1103/PhysRevA.57.3348; Mehring M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.153001; Mehring M, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.052303; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Morton J. J. L., 2009, SILICON BASED CLUSTE; Morton JJL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.200501; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Negrevergne C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.170501; Peres A, 1996, PHYS REV LETT, V77, P1413, DOI 10.1103/PhysRevLett.77.1413; Schulman LJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.120501; Simmons S, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.022330; Skinner AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.087901; SUTER D, 1988, PHYS REV LETT, V60, P1218, DOI 10.1103/PhysRevLett.60.1218; Tyryshkin AM, 2006, J PHYS-CONDENS MAT, V18, pS783, DOI 10.1088/0953-8984/18/21/S06; Tyryshkin A. M., 2010, SIL QUB WORKSH 23 24; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Verstraete F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012316; Wei TC, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.022110; WOLLAN DS, 1976, PHYS REV B, V13, P3686, DOI 10.1103/PhysRevB.13.3686	30	114	114	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					69	72		10.1038/nature09696	http://dx.doi.org/10.1038/nature09696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21248751	Green Submitted			2022-12-28	WOS:000286886400035
J	Paul, VK; Sachdev, HS; Mavalankar, D; Ramachandran, P; Sankar, MJ; Bhandari, N; Sreenivas, V; Sundararaman, T; Govil, D; Osrin, D; Kirkwood, B				Paul, Vinod Kumar; Sachdev, Harshpal Singh; Mavalankar, Dileep; Ramachandran, Prema; Sankar, Mari Jeeva; Bhandari, Nita; Sreenivas, Vishnubhatla; Sundararaman, Thiagarajan; Govil, Dipti; Osrin, David; Kirkwood, Betty			India: Towards Universal Health Coverage 2 Reproductive health, and child health and nutrition in India: meeting the challenge	LANCET			English	Article							REDUCING MATERNAL MORTALITY; IMPAIRED GLUCOSE-TOLERANCE; SEVERE ACUTE MALNUTRITION; NEONATAL-MORTALITY; MANAGEMENT; PREVALENCE; SURVIVAL; DISEASES; NEWBORN	India, with a population of more than 1 billion people, has many challenges in improving the health and nutrition of its citizens. Steady declines have been noted in fertility, maternal, infant and child mortalities, and the prevalence of severe manifestations of nutritional deficiencies, but the pace has been slow and falls short of national and Millennium Development Goal targets. The likely explanations include social inequities, disparities in health systems between and within states, and consequences of urbanisation and demographic transition. In 2005, India embarked on the National Rural Health Mission, an extraordinary effort to strengthen the health systems. However, coverage of priority interventions remains insufficient, and the content and quality of existing interventions are suboptimum. Substantial unmet need for contraception remains, adolescent pregnancies are common, and access to safe abortion is inadequate. Increases in the numbers of deliveries in institutions have not been matched by improvements in the quality of intrapartum and neonatal care. Infants and young children do not get the health care they need; access to effective treatment for neonatal illness, diarrhoea, and pneumonia shows little improvement; and the coverage of nutrition programmes is inadequate. Absence of well functioning health systems is indicated by the inadequacies related to planning, financing, human resources, infrastructure, supply systems, governance, information, and monitoring. We provide a case for transformation of health systems through effective stewardship, decentralised planning in districts, a reasoned approach to financing that affects demand for health care, a campaign to create awareness and change health and nutrition behaviour, and revision of programmes for child nutrition on the basis of evidence. This agenda needs political commitment of the highest order and the development of a people's movement.	[Paul, Vinod Kumar] All India Inst Med Sci, Dept Paediat, New Delhi 110029, India; [Sachdev, Harshpal Singh] Sitaram Bhartia Inst Sci & Res, New Delhi, India; [Mavalankar, Dileep] Indian Inst Management, Ahmadabad 380015, Gujarat, India; [Ramachandran, Prema] Nutr Fdn India, New Delhi, India; [Bhandari, Nita] Soc Appl Studies, New Delhi, India; [Sundararaman, Thiagarajan] Natl Hlth Syst Resources Ctr, New Delhi, India; [Govil, Dipti] Inst Hlth Management & Res, Jaipur, Rajasthan, India; [Osrin, David] UCL, Ctr Int Hlth & Dev, London, England; [Kirkwood, Betty] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	All India Institute of Medical Sciences (AIIMS) New Delhi; Sitaram Bhartia Institute of Science & Research; Indian Institute of Management (IIM System); Indian Institute of Management Ahmedabad; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Paul, VK (corresponding author), All India Inst Med Sci, Dept Paediat, New Delhi 110029, India.	vinodkpaul@hotmail.com	Sankar, Jeeva/Q-1007-2019; Govil, Dipti/ABC-7928-2020; Mavalankar, Dileep/AAX-6931-2020	Sankar, Jeeva/0000-0003-1474-1451; Govil, Dipti/0000-0002-0599-0045; Mavalankar, Dileep/0000-0003-0498-3799; Kirkwood, Betty/0000-0001-5274-6072; Sachdev, Harshpal Singh/0000-0002-4956-9391; Osrin, David/0000-0001-9691-9684	University College London Institute of Child Health; Wellcome Trust [081052]; John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	University College London Institute of Child Health; Wellcome Trust(Wellcome TrustEuropean Commission); John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	DO was originally a reviewer of this report and was requested to join as a co-author after the first draft; he has received payment for employment from the University College London Institute of Child Health, grants from a Wellcome Trust Fellowship, and payment for visiting lectures at the London School of Hygiene and Tropical Medicine. The other authors declare that they have no conflicts of interest.; The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India. DO is supported by Wellcome Trust Fellowship (grant number 081052). We thank Shireen J Jejeebhoy for major inputs for sections about reproductive health and Rajiv Bahl for child health; S K Bhargava for providing access to the data for the New Delhi Birth Cohort; Pavitra Mohan for highly valuable comments about the report; Armida Fernandez, Thomas Cherian, Jose Martines, and Satish Gupta for suggestions and inputs; and Manju Saksena for assistance with the research.	Agarwal RK, 2008, INDIAN PEDIATR, V45, P625; [Anonymous], 2009, REP CAUS DEATH IND 2; Arnold F, 2002, POPUL DEV REV, V28, P759, DOI 10.1111/j.1728-4457.2002.00759.x; Arun Gupta, 2007, Economic and Political Weekly, V42, P87; BAJPAI N, 2009, IMPROVING ACCESS SER; BALARAJAN Y, 2011, LANCET, DOI DOI 10.1016/S0140-6736(10)618946; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BARGE K, 1998, INT WORKSH AB FAC PO; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bhatnagar S, 2007, INDIAN PEDIATR, V44, P443; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; CHHABRA R, 1994, ABORTION INDIA OVERV; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; *DRUGS CONTR GEN I, 2006, NUMB PERM DAT ISS MF; ELUL B, 2003, UNINTENDED PREGNANCY; GANATRA B, 2000, WOMENS REPROD HLTH I; GANATRA BR, 2000, ASIA PAC POPUL J, V16, P109; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; *GOV IND, 2003, MED TERM PREGN RUL A; *GOV IND MIN HLTH, 2010, 3 COMM REV MISS REP; *GOV IND MIN WOM C, 2006, STRENGTH ICDS RED CH; Government of India Ministry of Women and Child Development, INT CHILD DEV SERV S; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *IHME, CHILD MORT GLOB; *IIPS, 2008, DISTR LEV HOUS SURV; *IIPS, 2005, IND FAC SURV; *IIPS MACR, 2007, NFHS3 IIPS MACR, V1; IIPS & ORC Macro, 2000, NATL FAMILY HLTH SUR; Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS SURV; *INT I POP SCI POP, 2009, YOUTH IND SIT NEEDS; International Institute for Population Sciences (IIPS), 2006, DISTR LEV HOUS SURV; International Institute for Population Sciences (IIPS), 1995, NAT FAM HLTH SURV NF, P199293; Jain S, 2004, J TROP PEDIATRICS, V50, P170, DOI 10.1093/tropej/50.3.170; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Jones Gareth, 2006, Indian Journal of Pediatrics, V73, P479, DOI 10.1007/BF02759891; Kalyanwala S, 2010, INT PERSPECT SEX R H, V36, P62, DOI 10.1363/ipsrh.36.062.10; Kapil U, 2010, INDIAN PEDIATR, V47, P651, DOI 10.1007/s13312-010-0099-x; Kapil U, 2009, INDIAN PEDIATR, V46, P381; Khanna SK, 1997, SOC SCI MED, V44, P171, DOI 10.1016/S0277-9536(96)00144-X; KOSH JS, 2009, IND PARTN POP STAB; Krishna U R, 1995, J Indian Med Assoc, V93, P34; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; MALHOTRA A, 2003, REALIZING REPROD CHO; Mavalankar D, 2008, LANCET, V371, P631, DOI 10.1016/S0140-6736(08)60282-2; Mavalankar DV, 2005, AM J PUBLIC HEALTH, V95, P200, DOI 10.2105/AJPH.2003.036715; *MIN HLTH FAM WELF, 2009, NRHM PROGRE SO FAR; *MIN HUM RES DEV D, 2005, NAT PLAN ACT CHILDR; *MIN WOM CHILD DEV, INT CHILD DEV SERV; MOHAN P, 1999, THESIS U N CAROLINA; *MOHFW, 2008, NAT HLTH PROF 2008; *MOHFW, 2008, NAT TRAIN STRAT INS; *MOHFW, 2000, NAT POP POL 2000; *MOHFW, 2008, NAT COLD CHAIN ASS; *MOHFW STAT DIV, 2007, B RUR HLTH STAT IND; *MOHFW STAT DIV, 2008, B RUR HLTH STAT, P26; *NCEAR, 2001, CONC EV INT CHILD DE; *NHSRC, 2008, CHILD HLTH STAT PIPS; *NNBM, 2002, NNMB MICR SURV; *NRHM, 2008, KEY FIND 2 COMM REV; Oomman N, 2002, REPROD HEALTH MATTER, V10, P184, DOI 10.1016/S0968-8080(02)00029-0; Padmanaban P, 2009, J HEALTH POPUL NUTR, V27, P202; Paul VK, 2010, LANCET, V375, P1943, DOI 10.1016/S0140-6736(10)60901-4; Prabhakaran D, 2005, NATL MED J INDIA, V18, P59; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; *REG GEN IND, 2006, MAT MORT IND 1997 20; *REG GEN IND, 1999, COMP IND FERT MORT I; *REG GEN IND, POP PROJ 2001 26; *REG GEN IND, 2009, SAMPL REG SYST SRS S; *REG GEN IND, CENS IND 2001; Registrar General of India, 2009, SPEC B MAT MORT 2004; Sachdev HPS, 2010, INDIAN PEDIATR, V47, P661, DOI 10.1007/s13312-010-0097-z; Sachdev HPS, 2004, INDIAN J MED RES, V119, pIII; SACHDEV HPS, 2003, NFI B, V24, P6; Santhya K. G., 2003, Economic and Political Weekly, V38, P4370; Santhya KG, 2010, INT PERSPECT SEX R H, V36, P132, DOI 10.1363/ipsrh.36.132.10; SANTHYA KG, 2010, TIMING 1 SEX MARRIAG; SANTHYA KG, 2005, LOOKING BACK LOOKING; SHARMA BB, 1998, 18 ANN CONV NAT NEON; Shobha Malini, 2008, Health and Population - Perspectives and Issues, V31, P126; SNTHYA KG, 2009, UNDERSTANDING PREGNA; Sundararaman T, 2007, LANCET, V369, P2058, DOI 10.1016/S0140-6736(07)60326-2; *UNFPA, 2007, ASS ASHA JAN SUR YOJ; *UNFPA, ASS ASHA JAN SUR YOJ; *UNFPA, 2005, MISS MAPP ADV CHILD; UNICEF, 2009, STATE WORLDS CHILDRE; UNICEF/WHO, 2004, LOW BIRTHW COUNTR RE; *URB HLTH RES CTR, KEY IND URB POOR IND; W.H. Organization, 2009, WORLD HLTH STAT 2009; *WHO, 2009, HOME VIS NEWB CHILD; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; *WORLD BANK, 2006, IND UND CHILDDR CALL; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; 2010, INDIAN EXPRESS  0412, P5; NAT NEONATAL PERINAT	102	167	168	1	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2011	377	9762					332	349		10.1016/S0140-6736(10)61492-4	http://dx.doi.org/10.1016/S0140-6736(10)61492-4			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714ZO	21227494	Green Accepted			2022-12-28	WOS:000286850400030
J	Fleming, TR				Fleming, Thomas R.			Addressing Missing Data in Clinical Trials	ANNALS OF INTERNAL MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TO-CHILD TRANSMISSION; FOLLOW-UP; THERAPY; INTRAPARTUM; PREVENTION; ZIDOVUDINE; PATIENT; KAMPALA; UGANDA	The reliability and interpretability of results from clinical trials can be substantially reduced by missing data. Frequently used approaches to address these concerns, such as upward adjustments in sample sizes or simplistic methods for handling missing data, including last-observation-carried-forward, complete-case, or worst-case analyses, are usually inadequate. Although rational imputation methods may be useful to treat missingness after it has occurred, these methods depend on untestable assumptions. Thus, the preferred and often only satisfactory approach to addressing missing data is to prevent it. Procedures should be in place to maximize the likelihood that outcome data will be obtained at scheduled times of evaluation for all surviving patients who have not withdrawn consent. To meaningfully reduce missing data, it is important to recognize and address many factors that commonly lead to higher levels of missingness. Ann Intern Med. 2011;154:113-117.	Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Fleming, TR (corresponding author), Univ Washington, Dept Biostat, Box 357232, Seattle, WA 98195 USA.	tfleming@u.washington.edu			National Institutes of Health/National Institute of Allergy and Infectious Disease [R37 AI 29168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029168, R37AI029168] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	By the National Institutes of Health/National Institute of Allergy and Infectious Disease (R37 AI 29168).	Cleland JGE, 2004, EUR J HEART FAIL, V6, P1, DOI 10.1016/j.eheart.2003.12.001; Faden R., 1986, HIST THEORY INFORM C; Fleming TR, 2008, NEW ENGL J MED, V359, P1400, DOI 10.1056/NEJMe0807372; Fleming TR, 2009, J CLIN ONCOL, V27, P2874, DOI 10.1200/JCO.2008.20.4107; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Gordon Elisa J, 2006, Account Res, V13, P285, DOI 10.1080/08989620600848645; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Katongole SNR, 2002, 14 INT AIDS C BARC S; Lachin JM, 2000, CONTROL CLIN TRIALS, V21, P167, DOI 10.1016/S0197-2456(00)00046-5; LAVORI PW, 1992, NEUROPSYCHOPHARMACOL, V6, P39; Levine RJ, 1986, ETHICS REGULATION CL, V2nd; Lubsen J, 2002, STAT MED, V21, P2959, DOI 10.1002/sim.1300; National Research Council, 2010, PREVENTION TREATMENT; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Wittes J, 2009, J BIOPHARM STAT, V19, P957, DOI 10.1080/10543400903239825	20	77	81	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2					113	+		10.7326/0003-4819-154-2-201101180-00010	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242367	Green Accepted			2022-12-28	WOS:000286223500005
J	Martineau, AR; Timms, PM; Bothamley, GH; Hanifa, Y; Islam, K; Claxton, AP; Packe, GE; Moore-Gillon, JC; Darmalingam, M; Davidson, RN; Milburn, HJ; Baker, LV; Barker, RD; Woodward, NJ; Venton, TR; Barnes, KE; Mullett, CJ; Coussens, AK; Rutterford, CM; Mein, CA; Davies, GR; Wilkinson, RJ; Nikolayevskyy, V; Drobniewski, FA; Eldridge, SM; Griffiths, CJ				Martineau, Adrian R.; Timms, Peter M.; Bothamley, Graham H.; Hanifa, Yasmeen; Islam, Kamrul; Claxton, Alleyna P.; Packe, Geoffrey E.; Moore-Gillon, John C.; Darmalingam, Mathina; Davidson, Robert N.; Milburn, Heather J.; Baker, Lucy V.; Barker, Richard D.; Woodward, Nicholas J.; Venton, Timothy R.; Barnes, Korina E.; Mullett, Christopher J.; Coussens, Anna K.; Rutterford, Clare M.; Mein, Charles A.; Davies, Geraint R.; Wilkinson, Robert J.; Nikolayevskyy, Vladyslav; Drobniewski, Francis A.; Eldridge, Sandra M.; Griffiths, Christopher J.			High-dose vitamin D-3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial	LANCET			English	Article							MESSENGER-RNA STABILITY; MYCOBACTERIUM-TUBERCULOSIS; CLINICAL-TRIAL; POLYMORPHISMS; CATHELICIDIN; RIFAMPICIN; SURVIVAL; OUTCOMES; DENSITY	Background Vitamin D was used to treat tuberculosis in the pre-antibiotic era, and its metabolites induce antimycobacterial immunity in vitro. Clinical trials investigating the effect of adjunctive vitamin D on sputum culture conversion are absent. Methods We undertook a multicentre randomised controlled trial of adjunctive vitamin D in adults with sputum smear-positive pulmonary tuberculosis in London, UK. 146 patients were allocated to receive 2.5 mg vitamin D-3 or placebo at baseline and 14, 28, and 42 days after starting standard tuberculosis treatment. The primary endpoint was time from initiation of antimicrobial treatment to sputum culture conversion. Patients were genotyped for TaqI and FokI polymorphisms of the vitamin D receptor, and interaction analyses were done to assess the influence of the vitamin D receptor genotype on response to vitamin D3. This trial is registered with ClinicalTrials.gov number NCT00419068. Findings 126 patients were included in the primary efficacy analysis (62 assigned to intervention, 64 assigned to placebo). Median time to sputum culture conversion was 36.0 days in the intervention group and 43.5 days in the placebo group (adjusted hazard ratio 1.39, 95% CI 0.90-2.16; p=0.14). TaqI genotype modified the effect of vitamin D supplementation on time to sputum culture conversion (p(interaction)=0.03), with enhanced response seen only in patients with the tt genotype (8.09, 95% CI 1.36-48.01; p=0.02). FokI genotype did not modify the effect of vitamin D supplementation (p(interaction)=0.85). Mean serum 25-hydroxyvitamin D concentration at 56 days was 101.4 nmol/L in the intervention group and 22.8 nmol/L in the placebo group (95% CI for difference 68.6-88.2; p<0.0001). Interpretation Administration of four doses of 2.5 mg vitamin D3 increased serum 25-hydroxyvitamin D concentrations in patients receiving intensive-phase treatment for pulmonary tuberculosis. Vitamin D did not significantly affect time to sputum culture conversion in the whole study population, but it did significantly hasten sputum culture conversion in participants with the tt genotype of the TaqI vitamin D receptor polymorphism.	[Martineau, Adrian R.; Hanifa, Yasmeen; Islam, Kamrul; Rutterford, Clare M.; Eldridge, Sandra M.; Griffiths, Christopher J.] Queen Mary Univ London, Barts & London Sch Med & Dent, London E1 2AT, England; [Nikolayevskyy, Vladyslav; Drobniewski, Francis A.] Barts & London Queen Marys Sch Med & Dent, HPA Natl Mycobacterium Reference Lab, London, England; [Mein, Charles A.] Barts & London Queen Marys Sch Med & Dent, Genome Ctr, London, England; [Martineau, Adrian R.; Coussens, Anna K.; Wilkinson, Robert J.] Natl Inst Med Res, Div Mycobacterial Res, London NW7 1AA, England; [Timms, Peter M.; Bothamley, Graham H.; Claxton, Alleyna P.; Venton, Timothy R.; Barnes, Korina E.; Mullett, Christopher J.] Homerton Univ NHS Fdn Trust, London, England; [Packe, Geoffrey E.] Newham Chest Clin, London, England; [Moore-Gillon, John C.] St Bartholomews Hosp, Dept Resp Med, London, England; [Moore-Gillon, John C.] Royal London Hosp, Dept Resp Med, London E1 1BB, England; [Darmalingam, Mathina] Whipps Cross Univ Hosp, Dept Resp Med, London, England; [Davidson, Robert N.] Northwick Pk Hosp & Clin Res Ctr, TB Clin, Harrow HA1 3UJ, Middx, England; [Milburn, Heather J.] Guys & St Thomas NHS Fdn Trust, Dept Resp Med, London, England; [Baker, Lucy V.] Lewisham Hosp, Dept Resp Med, London, England; [Barker, Richard D.] Kings Coll London, Dept Resp Med, London WC2R 2LS, England; [Woodward, Nicholas J.] Royal Free Hosp, Dept Radiol, London NW3 2QG, England; [Davies, Geraint R.] Univ Liverpool, Sch Clin Sci, Liverpool L69 3BX, Merseyside, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; MRC National Institute for Medical Research; University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Liverpool	Martineau, AR (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, London E1 2AT, England.	a.martineau@qmul.ac.uk	Martineau, Adrian R/A-3083-2010; Nikolayevskyy, Vladyslav/HFZ-7738-2022; Coussens, Anna Kathleen/AAN-2949-2021	Nikolayevskyy, Vladyslav/0000-0002-9502-0332; Coussens, Anna Kathleen/0000-0002-7086-2621; Mein, Charles/0000-0003-0811-9658; HANIFA, YASMEEN/0000-0002-1677-0697; Davies, Geraint/0000-0002-3819-490X; Wilkinson, Robert/0000-0002-2753-1800; Robinson, Clare/0000-0002-2673-2205	British Lung Foundation [TB05/11]; MRC [MC_U117588499] Funding Source: UKRI; Medical Research Council [G1000758B, MC_U117588499, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	British Lung Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	British Lung Foundation.; The study was funded by the British Lung Foundation (ref TB05/11). Merck Serono donated Vigantol and Miglyol oils, and assayed vitamin D, concentrations in vials of placebo and active study preparations. We thank the members of our Data Monitoring Committee, Guy E Thwaites (Chair), Brenda E Jones, and Tuan Q Phung. We also thank Denis A Mitchison for advice on trial design; Thomas C Stokes, and Stefan Lozewicz for acting as principal investigators; June Parris, Olubisi Tunde-Adebayo, and Wai-Yee James for assistance with recruitment and follow-up of patients; Leena Bhaw-Rosun and Rosamond Nuamah for assistance with genotyping assays; pharmacy staff at Homerton University NHS Trust and Northwick Park Hospital for overseeing dispensing of the study preparations; all tuberculosis nurses and administrative staff who referred patients to the study, and all the patients who participated in the trial.	ALOIA JR, 2007, EPIDEMIOL INFECT, V12, P1; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Breen RAM, 2004, THORAX, V59, P704, DOI 10.1136/thx.2003.019224; Coussens AK, 2009, IMMUNOLOGY, V127, P539, DOI 10.1111/j.1365-2567.2008.03024.x; Durrin LK, 1999, BBA-MOL BASIS DIS, V1453, P311, DOI 10.1016/S0925-4439(99)00007-1; GONZALEZMONTANER LJ, 1994, TUBERCLE LUNG DIS, V75, P341, DOI 10.1016/0962-8479(94)90079-5; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; GWINUP G, 1981, ACTA ENDOCRINOL-COP, V97, P114, DOI 10.1530/acta.0.0970114; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Martineau AR, 2009, INT J TUBERC LUNG D, V13, P119; Martineau AR, 2007, J STEROID BIOCHEM, V103, P793, DOI 10.1016/j.jsbmb.2006.12.052; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; Morcos M M, 1998, Boll Chim Farm, V137, P157; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; Narang N K, 1984, J Assoc Physicians India, V32, P185; Nursyam Elly Wijaya, 2006, Acta Med Indones, V38, P3; Phillips PJ, 2008, INT J TUBERC LUNG D, V12, pS146; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Rockett KA, 1998, INFECT IMMUN, V66, P5314, DOI 10.1128/IAI.66.11.5314-5321.1998; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; Roth DE, 2004, J INFECT DIS, V190, P920, DOI 10.1086/423212; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Sabin FR, 1926, T 22 ANN M NAT TUB A, V22, P252; SCHOENFELD DA, 1982, BIOMETRICS, V38, P163, DOI 10.2307/2530299; Selvaraj P, 2004, J CLIN IMMUNOL, V24, P523, DOI 10.1023/B:JOCI.0000040923.07879.31; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; Su WJ, 2011, EUR RESPIR J, V37, P376, DOI 10.1183/09031936.00007410; Verbeek W, 1997, BIOCHEM BIOPH RES CO, V238, P77, DOI 10.1006/bbrc.1997.7239; Vieth R, 2001, AM J CLIN NUTR, V73, P288; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; *WHO, 2009, GLOB TUB CONTR SHORT; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	36	437	457	1	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 15	2011	377	9761					242	250		10.1016/S0140-6736(10)61889-2	http://dx.doi.org/10.1016/S0140-6736(10)61889-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712WG	21215445	Green Accepted			2022-12-28	WOS:000286696400031
J	Poland, GA; Jacobson, RM				Poland, Gregory A.; Jacobson, Robert M.			The Age-Old Struggle against the Antivaccinationists	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Poland, Gregory A.; Jacobson, Robert M.] Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA; [Poland, Gregory A.] Mayo Clin, Dept Med, Rochester, MN USA; [Poland, Gregory A.; Jacobson, Robert M.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA.			Jacobson, Robert/0000-0002-6355-8752				Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Jacobson RA, 2007, VACCINE, V25, P3146, DOI 10.1016/j.vaccine.2007.01.046; McBrien J, 2003, PEDIATR INFECT DIS J, V22, P580, DOI 10.1097/00006454-200307000-00002; Wakefield AJ, 2010, LANCET, V375, P445, DOI 10.1016/S0140-6736(10)60175-4; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wolfe RM, 2002, BMJ-BRIT MED J, V325, P430, DOI 10.1136/bmj.325.7361.430	6	147	151	0	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					97	99		10.1056/NEJMp1010594	http://dx.doi.org/10.1056/NEJMp1010594			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	705NJ	21226573				2022-12-28	WOS:000286142900001
J	Braun, S; Garcia, JF; Rowley, M; Rougemaille, M; Shankar, S; Madhani, HD				Braun, Sigurd; Garcia, Jennifer F.; Rowley, Margot; Rougemaille, Mathieu; Shankar, Smita; Madhani, Hiten D.			The Cul4-Ddb1(Cdt2) Ubiquitin Ligase Inhibits Invasion of a Boundary-Associated Antisilencing Factor into Heterochromatin	CELL			English	Article							JMJC DOMAIN PROTEIN; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; DNA-DAMAGE; S-PHASE; TRANSCRIPTION FACTOR; CHROMATIN DOMAINS; BINDING-PROTEIN; H3 METHYLATION; DDB1	Partitioning of chromosomes into euchromatic and heterochromatic domains requires mechanisms that specify boundaries. The S. pombe JmjC family protein Epe1 prevents the ectopic spread of heterochromatin and is itself concentrated at boundaries. Paradoxically, Epe1 is recruited to heterochromatin by HP1 silencing factors that are distributed throughout heterochromatin. We demonstrate here that the selective enrichment of Epe1 at boundaries requires its regulation by the conserved Cul4-Ddb1(Cdt2) ubiquitin ligase, which directly recognizes Epe1 and promotes its polyubiquitylation and degradation. Strikingly, in cells lacking the ligase, Epe1 persists in the body of heterochromatin thereby inducing a defect in gene silencing. Epe1 is the sole target of the Cul4-Ddb1(Cdt2) complex whose destruction is necessary for the preservation of heterochromatin. This mechanism acts parallel with phosphorylation of HP1/Swi6 by CK2 to restrict Epe1. We conclude that the ubiquitin-dependent sculpting of the chromosomal distribution of an antisilencing factor is critical for heterochromatin boundaries to form correctly.	[Braun, Sigurd; Garcia, Jennifer F.; Rowley, Margot; Rougemaille, Mathieu; Shankar, Smita; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St,GH-N372C, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com	Garcia, Jennifer/HDN-4569-2022	Braun, Sigurd/0000-0001-6399-8574; Rougemaille, Mathieu/0000-0002-9675-3888; Garcia, Jennifer/0000-0002-0620-0594; Madhani, Hiten/0000-0001-7400-6657	German Research Foundation [BR 3511/1-1]; Human Frontier Science Program; Leukemia and Lymphoma Society; NIH/NIGMS IMSD [R25-GM56847]; National Institutes of Health [GM071801]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847, R01GM071801] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH/NIGMS IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael Rape, Stefan Jentsch, Geeta Narlikar, David Morgan, members of their labs, and Ulrike Boettcher for critical reading of the manuscript. We are grateful to Danesh Moazed, Karl Ekwall, and Takashi Toda for strains, plasmids, and protocols. S.B., M. Rougemaille, and S.S. were supported by postdoctoral fellowships of the German Research Foundation (BR 3511/1-1), the Human Frontier Science Program, and the Leukemia and Lymphoma Society, respectively. J.F.G. was supported by an NIH/NIGMS IMSD predoctoral fellowship (R25-GM56847). This work was supported by a grant to H.D.M. from the National Institutes of Health (GM071801) and a scholar's award to H.D.M. from the Leukemia and Lymphoma Society.	Appelgren H, 2003, J CELL SCI, V116, P4035, DOI 10.1242/jcs.00707; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; Ekwall K, 1999, GENETICS, V153, P1153; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Golemis EA, 2009, CURR PROTOC PROTEIN; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Ishii K, 2003, MOL CELL, V11, P237, DOI 10.1016/S1097-2765(03)00010-8; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Liu C, 2005, EMBO J, V24, P3940, DOI 10.1038/sj.emboj.7600854; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Rougemaille M, 2008, J BIOL CHEM, V283, P25770, DOI 10.1074/jbc.C800140200; Sacher M, 2005, METHOD ENZYMOL, V399, P392, DOI 10.1016/S0076-6879(05)99027-7; Sadaie M, 2008, MOL CELL BIOL, V28, P6973, DOI 10.1128/MCB.00791-08; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Shimada A, 2009, GENE DEV, V23, P18, DOI 10.1101/gad.1708009; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	46	71	71	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 7	2011	144	1					41	54		10.1016/j.cell.2010.11.051	http://dx.doi.org/10.1016/j.cell.2010.11.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215368	Bronze, Green Accepted			2022-12-28	WOS:000285993600006
J	Nichols, RJ; Sen, S; Choo, YJ; Beltrao, P; Zietek, M; Chaba, R; Lee, S; Kazmierczak, KM; Lee, KJ; Wong, A; Shales, M; Lovett, S; Winkler, ME; Krogan, NJ; Typas, A; Gross, CA				Nichols, Robert J.; Sen, Saunak; Choo, Yoe Jin; Beltrao, Pedro; Zietek, Matylda; Chaba, Rachna; Lee, Sueyoung; Kazmierczak, Krystyna M.; Lee, Karis J.; Wong, Angela; Shales, Michael; Lovett, Susan; Winkler, Malcolm E.; Krogan, Nevan J.; Typas, Athanasios; Gross, Carol A.			Phenotypic Landscape of a Bacterial Cell	CELL			English	Article							SYSTEMATIC GENETIC-ANALYSIS; TRANSPOSON MUTANT LIBRARY; ANTIBIOTIC-RESISTANCE MAR; ESCHERICHIA-COLI; MARA/SOXS/ROB REGULON; MEMBRANE-PROTEINS; DRUG-INTERACTIONS; FISSION YEAST; E. COLI; GENOME	The explosion of sequence information in bacteria makes developing high-throughput, cost-effective approaches to matching genes with phenotypes imperative. Using E. coli as proof of principle, we show that combining large-scale chemical genomics with quantitative fitness measurements provides a high-quality data set rich in discovery. Probing growth profiles of a mutant library in hundreds of conditions in parallel yielded > 10,000 phenotypes that allowed us to study gene essentiality, discover leads for gene function and drug action, and understand higher-order organization of the bacterial chromosome. We highlight new information derived from the study, including insights into a gene involved in multiple antibiotic resistance and the synergy between a broadly used combinatory antibiotic therapy, trimethoprim and sulfonamides. This data set, publicly available at http://ecoliwiki.net/tools/chemgen/, is a valuable resource for both the microbiological and bioinformatic communities, as it provides high-confidence associations between hundreds of annotated and uncharacterized genes as well as inferences about the mode of action of several poorly understood drugs.	[Nichols, Robert J.; Choo, Yoe Jin; Zietek, Matylda; Chaba, Rachna; Lee, Sueyoung; Lee, Karis J.; Wong, Angela; Typas, Athanasios; Gross, Carol A.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Nichols, Robert J.] Univ Calif San Francisco, Oral & Craniofacial Sci Grad Program, San Francisco, CA 94143 USA; [Sen, Saunak] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Beltrao, Pedro; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Beltrao, Pedro; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Kazmierczak, Krystyna M.; Winkler, Malcolm E.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Lovett, Susan] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Lovett, Susan] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Gross, Carol A.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington; Brandeis University; Brandeis University; University of California System; University of California San Francisco	Typas, A (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, 600 16th St, San Francisco, CA 94158 USA.	athanasios.typas@ucsf.edu; cgrossucsf@gmail.com	Beltrao, Pedro/B-3342-2010; Lovett, Susan/AAC-1810-2021	Beltrao, Pedro/0000-0002-2724-7703; Lovett, Susan/0000-0003-2792-1857; Typas, Athanasios/0000-0002-0797-9018	NIH [R01 GM085697, R01 GM036278, K99GM092984, AI060744, GM078338, F31 DE020206-01, T32 DE007306]; ARRA [GM085697-01S1]; European Molecular Biology Organization; Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE020206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085697, R01GM078338, K99GM092984, R01GM036278] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Kishony, J. Weissman, A. Hochschild, and R.G. Martin for critically reading this manuscript; J. Hu and P. Thomas for hosting these data on E. coli Wiki; C. Raetz for CHIR-090 and M. Gottesman for Bicyclomycin; H. Mori for the Keio Collection; G. Storz for sharing the sRNA deletion library prior to publication; J. Greenblatt and A. Emili for SPA-tagged alleles; W. Margolin, R. Misra, T. Silhavy, and B. Palsson for mutants; and T. Baker and R. Sauer for controllable degradation plasmids. This work was supported by NIH R01 GM085697 and ARRA GM085697-01S1 to C.A.G. and N.J.K.; NIH R01 GM036278 to C.A.G.; NIH K99GM092984 to A.T.; NIH AI060744 to M.E.W.; NIH GM078338 to S.S.; NIH F31 DE020206-01 and NIH T32 DE007306 (R.J.N. support); European Molecular Biology Organization long-term fellowship (to A.T.); and Human Frontier Science Program Long-Term Postdoctoral Fellowship (to P.B.). In loving memory of S.R. Bartlett and J.T. Blair.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barker CA, 2010, CHEM BIOL, V17, P624, DOI 10.1016/j.chembiol.2010.05.010; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Carpentier AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-84; Couturier E, 2006, MOL MICROBIOL, V59, P1506, DOI 10.1111/j.1365-2958.2006.05046.x; D'Elia MA, 2009, TRENDS MICROBIOL, V17, P433, DOI 10.1016/j.tim.2009.08.005; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Field MS, 2006, J BIOL CHEM, V281, P4215, DOI 10.1074/jbc.M510624200; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; GILONI L, 1981, J BIOL CHEM, V256, P8608; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Griffith KL, 2004, MOL MICROBIOL, V51, P1801, DOI 10.1046/j.1365-2958.2003.03952.x; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hobbs EC, 2010, J BACTERIOL, V192, P59, DOI 10.1128/JB.00873-09; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Jeanguenin L, 2010, J BIOL CHEM, V285, P41557, DOI 10.1074/jbc.M110.190504; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; Kwon YK, 2010, ACS CHEM BIOL, V5, P787, DOI 10.1021/cb100096f; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Martin RG, 2002, MOL MICROBIOL, V44, P1611, DOI 10.1046/j.1365-2958.2002.02985.x; Martin RG, 2008, J MOL BIOL, V380, P278, DOI 10.1016/j.jmb.2008.05.015; MCOSKER CC, 1994, J ANTIMICROB CHEMOTH, V33, P23, DOI 10.1093/jac/33.suppl_A.23; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nicoloff H, 2007, ANTIMICROB AGENTS CH, V51, P1293, DOI 10.1128/AAC.01128-06; Nicoloff H, 2006, J BACTERIOL, V188, P4413, DOI 10.1128/JB.01502-05; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; SCHIRCH V, 1985, J BACTERIOL, V163, P1; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; STOVER P, 1993, TRENDS BIOCHEM SCI, V18, P102, DOI 10.1016/0968-0004(93)90162-G; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; TU Y, 1975, BIOCHIM BIOPHYS ACTA, V402, P142, DOI 10.1016/0005-2787(75)90032-5; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Warner DM, 2010, MICROBIOL-SGM, V156, P570, DOI 10.1099/mic.0.033415-0; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133	70	458	466	1	93	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 7	2011	144	1					143	156		10.1016/j.cell.2010.11.052	http://dx.doi.org/10.1016/j.cell.2010.11.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21185072	Green Accepted, Bronze			2022-12-28	WOS:000285993600014
J	Higgins, GL				Higgins, George L., III			Donor Diary	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												higgig@mmc.org							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					20	21		10.1001/jama.2010.1860	http://dx.doi.org/10.1001/jama.2010.1860			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205956				2022-12-28	WOS:000285924100001
J	Studenski, S; Perera, S; Patel, K; Rosano, C; Faulkner, K; Inzitari, M; Brach, J; Chandler, J; Cawthon, P; Connor, EB; Nevitt, M; Visser, M; Kritchevsky, S; Badinelli, S; Harris, T; Newman, AB; Cauley, J; Ferrucci, L; Guralnik, J				Studenski, Stephanie; Perera, Subashan; Patel, Kushang; Rosano, Caterina; Faulkner, Kimberly; Inzitari, Marco; Brach, Jennifer; Chandler, Julie; Cawthon, Peggy; Connor, Elizabeth Barrett; Nevitt, Michael; Visser, Marjolein; Kritchevsky, Stephen; Badinelli, Stefania; Harris, Tamara; Newman, Anne B.; Cauley, Jane; Ferrucci, Luigi; Guralnik, Jack			Gait Speed and Survival in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL PERFORMANCE-MEASURES; LOWER-EXTREMITY FUNCTION; LOWER-BODY FUNCTION; WALKING SPEED; MUSCLE STRENGTH; MOBILITY LIMITATIONS; 5-YEAR MORTALITY; LIFE EXPECTANCY; ELDERLY PERSONS; HEALTH	Context Survival estimates help individualize goals of care for geriatric patients, but life tables fail to account for the great variability in survival. Physical performance measures, such as gait speed, might help account for variability, allowing clinicians to make more individualized estimates. Objective To evaluate the relationship between gait speed and survival. Design, Setting, and Participants Pooled analysis of 9 cohort studies (collected between 1986 and 2000), using individual data from 34 485 community-dwelling older adults aged 65 years or older with baseline gait speed data, followed up for 6 to 21 years. Participants were a mean (SD) age of 73.5 (5.9) years; 59.6%, women; and 79.8%, white; and had a mean (SD) gait speed of 0.92 (0.27) m/s. Main Outcome Measures Survival rates and life expectancy. Results There were 17 528 deaths; the overall 5-year survival rate was 84.8% (confidence interval [CI], 79.6%-88.8%) and 10-year survival rate was 59.7% (95% CI, 46.5%-70.6%). Gait speed was associated with survival in all studies (pooled hazard ratio per 0.1 m/s, 0.88; 95% CI, 0.87-0.90; P<.001). Survival increased across the full range of gait speeds, with significant increments per 0.1 m/s. At age 75, predicted 10-year survival across the range of gait speeds ranged from 19% to 87% in men and from 35% to 91% in women. Predicted survival based on age, sex, and gait speed was as accurate as predicted based on age, sex, use of mobility aids, and self-reported function or as age, sex, chronic conditions, smoking history, blood pressure, body mass index, and hospitalization. Conclusion In this pooled analysis of individual data from 9 selected cohorts, gait speed was associated with survival in older adults. JAMA. 2011;305(1):50-58 www.jama.com	[Studenski, Stephanie; Perera, Subashan] Univ Pittsburgh, Sch Med, Dept Med, Div Geriatr Med, Pittsburgh, PA 15260 USA; [Rosano, Caterina; Newman, Anne B.; Cauley, Jane] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Brach, Jennifer] Univ Pittsburgh, Sch Hlth & Rehabil, Dept Phys Therapy, Pittsburgh, PA 15260 USA; [Faulkner, Kimberly] Natl Personal Protect Technol Lab, Pittsburgh, PA USA; [Patel, Kushang; Harris, Tamara; Guralnik, Jack] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Ferrucci, Luigi] NIA, Clin Res Branch, Intramural Res Program, Bethesda, MD 20892 USA; [Inzitari, Marco] Autonomous Univ Barcelona, Pere Virgili Hosp, Barcelona, Spain; [Inzitari, Marco] Autonomous Univ Barcelona, Inst Aging, Barcelona, Spain; [Chandler, Julie] Merck Res Labs, N Wales, PA USA; [Nevitt, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Connor, Elizabeth Barrett] Univ Calif San Diego, La Jolla, CA 92093 USA; [Kritchevsky, Stephen] Wake Forest Univ, Winston Salem, NC 27109 USA; [Badinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, Florence, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Autonomous University of Barcelona; Autonomous University of Barcelona; Merck & Company; University of California System; University of California San Francisco; University of California System; University of California San Diego; Wake Forest University; Azienda Sanitaria di Firenze	Studenski, S (corresponding author), Kaufmann Bldg,Ste 500,3471 5th Ave, Pittsburgh, PA 15143 USA.	sas33@pitt.edu	Inzitari, Marco/ABC-1529-2021; Perera, Subashan/D-7603-2014; Newman, Anne B./C-6408-2013; Visser, Marjolein/AAP-3224-2020; Brach, Jennifer/A-6912-2009	Newman, Anne B./0000-0002-0106-1150; Kritchevsky, Stephen/0000-0003-3336-6781; Rosano, Caterina/0000-0002-4271-6010; Visser, Marjolein/0000-0002-5136-298X; Cauley, Jane A/0000-0003-0752-4408; Rosano, Caterina/0000-0002-0909-1506; Brach, Jennifer/0000-0002-7793-2004; Inzitari, Marco/0000-0002-3796-0625	Merck; Novartis; GTX; Merck Research Lab; Amgen; National Institute on Aging, NIH NIA Professional Services Contract Health and Human Services [11200800292P];  [AG023641];  [AG024827]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827, K07AG023641, P30AG021332] Funding Source: NIH RePORTER	Merck(Merck & Company); Novartis(Novartis); GTX; Merck Research Lab; Amgen(Amgen); National Institute on Aging, NIH NIA Professional Services Contract Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Studenski reported receiving institutional grant support, travel expenses, and consultancy fees from Merck; consultlancy fees from Novartis and GTX; and royalties from Hazzart Text McGraw Hill. Dr Perera reported receiving institutional grant support from Merck Research Lab. Dr Inzitari reported receiving insitutional grant support from Merck. Dr Brach reported receiving institutional grant support from Merck. Dr Cawthon reported receiving consultancy fees from Amgen and Merck. Dr Cauley reported receiving consultancy fees and institutional grant support from Novartis. Drs Patel, Faulkner, Barett-Connor, Nevitt, Visser, Bandellini, Harris, Newman, Ferrucci, and Gurlanik reported no disclosures.; Additional support for the pooled analyses was provided by grants AG023641, AG024827 and the Intramural Research Program, National Institute on Aging, NIH NIA Professional Services Contract Health and Human Services number 11200800292P. Dr Studenski received grant support from Merck to perform this work.	Apfel CC, 2001, BRIT J ANAESTH, V86, P822, DOI 10.1093/bja/86.6.822; Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; Baezner H, 2008, NEUROLOGY, V70, P935, DOI 10.1212/01.wnl.0000305959.46197.e6; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Buchman Aron S, 2009, Proc Am Thorac Soc, V6, P581, DOI 10.1513/pats.200905-030RM; Callisaya ML, 2009, AGE AGEING, V38, P290, DOI 10.1093/ageing/afp017; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari Matteo, 2008, BMC Geriatr, V8, P34, DOI 10.1186/1471-2318-8-34; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; Cham R, 2008, EXP BRAIN RES, V185, P391, DOI 10.1007/s00221-007-1161-3; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; Cuoco A, 2004, J GERONTOL A-BIOL, V59, P1200, DOI 10.1093/gerona/59.11.1200; DEAR KBG, 1994, BIOMETRICS, V50, P989, DOI 10.2307/2533438; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Fitzpatrick AL, 2007, J GERONTOL A-BIOL, V62, P1244, DOI 10.1093/gerona/62.11.1244; Fried LF, 2006, J AM GERIATR SOC, V54, P750, DOI 10.1111/j.1532-5415.2006.00727.x; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gill TM, 2010, J AM GERIATR SOC, V58, pS308, DOI 10.1111/j.1532-5415.2010.02914.x; Graham JE, 2008, ARCH PHYS MED REHAB, V89, P865, DOI 10.1016/j.apmr.2007.11.029; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hall WJ, 2006, ANN INTERN MED, V145, P538, DOI 10.7326/0003-4819-145-7-200610030-00012; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Jones LM, 2009, J PHYS ACT HEALTH, V6, P327, DOI 10.1123/jpah.6.3.327; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Katsahian S, 2008, CONTEMP CLIN TRIALS, V29, P220, DOI 10.1016/j.cct.2007.08.002; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; Kerrigan DC, 2001, ARCH PHYS MED REHAB, V82, P26, DOI 10.1053/apmr.2001.18584; Klein JP., 2003, SURVIVAL ANAL TECHNI; Kuo Chen-Ko, 2009, BMC Geriatr, V9, P49, DOI 10.1186/1471-2318-9-49; LAVSKYSHULAN M, 1985, J AM GERIATR SOC, V33, P23, DOI 10.1111/j.1532-5415.1985.tb02855.x; Lawless J. F., 2002, STAT MODELS METHODS, V2nd, DOI DOI 10.1002/9781118033005; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Lubitz J, 2003, NEW ENGL J MED, V349, P1048, DOI 10.1056/NEJMsa020614; Markides KS, 1999, SERVING MINORITY ELDERS IN THE 21ST CENTURY, P72; Markides KS, 2001, J GERONTOL A-BIOL, V56, pM243, DOI 10.1093/gerona/56.4.M243; Martin FC, 2005, AGE AGEING, V34, P281, DOI 10.1093/ageing/afi074; Mazzaglia G, 2007, J AM GERIATR SOC, V55, P1955, DOI 10.1111/j.1532-5415.2007.01446.x; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; Nebes RD, 2007, J GERONTOL A-BIOL, V62, P83, DOI 10.1093/gerona/62.1.83; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Ostbye T, 1999, J AM GERIATR SOC, V47, P1249, DOI 10.1111/j.1532-5415.1999.tb05207.x; Ostir GV, 2007, AM J EPIDEMIOL, V166, P599, DOI 10.1093/aje/kwm121; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; Rolland Y, 2006, EUR J EPIDEMIOL, V21, P113, DOI 10.1007/s10654-005-5458-x; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Rosano C, 2007, J GERONTOL A-BIOL, V62, P1048, DOI 10.1093/gerona/62.9.1048; Schonberg MA, 2009, J GEN INTERN MED, V24, P1115, DOI 10.1007/s11606-009-1073-y; Simonsick EM, 2008, J GERONTOL A-BIOL, V63, P841, DOI 10.1093/gerona/63.8.841; Solway S, 2001, CHEST, V119, P256, DOI 10.1378/chest.119.1.256; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Thernau TM, 2000, MODELING SURVIVAL DA; *US DEP HHS, 2004, 941308 PHS US DEP HL; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Visser M, 2000, J AM GERIATR SOC, V48, P381, DOI 10.1111/j.1532-5415.2000.tb04694.x; Volpato S, 2002, DIABETES CARE, V25, P678, DOI 10.2337/diacare.25.4.678; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Woo J, 1999, J AM GERIATR SOC, V47, P1257, DOI 10.1111/j.1532-5415.1999.tb05209.x; 2010, US LIFE TABLES	67	2559	2606	9	235	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					50	58		10.1001/jama.2010.1923	http://dx.doi.org/10.1001/jama.2010.1923			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702VN	21205966	Green Accepted, Bronze			2022-12-28	WOS:000285924100024
J	Picado, A; Singh, SP; Rijal, S; Sundar, S; Ostyn, B; Chappuis, F; Uranw, S; Gidwani, K; Khanal, B; Rai, M; Paudel, IS; Das, ML; Kumar, R; Srivastava, P; Dujardin, JC; Vanlerberghe, V; Andersen, EW; Davies, CR; Boelaert, M				Picado, Albert; Singh, Shri Prakash; Rijal, Suman; Sundar, Shyam; Ostyn, Bart; Chappuis, Francois; Uranw, Surendra; Gidwani, Kamlesh; Khanal, Basudha; Rai, Madhukar; Paudel, Ishwari Sharma; Das, Murari Lal; Kumar, Rajiv; Srivastava, Pankaj; Dujardin, Jean Claude; Vanlerberghe, Veerle; Andersen, Elisabeth Wreford; Davies, Clive Richard; Boelaert, Marleen			Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIRECT AGGLUTINATION-TEST; HIGH-TRANSMISSION FOCI; VISCERAL LEISHMANIASIS; PHLEBOTOMUS-ARGENTIPES; KALA-AZAR; IMPREGNATED BEDNETS; BIHAR; RISK; EPIDEMIOLOGY; SUBCONTINENT	Objective To test the effectiveness of large scale distribution of longlasting nets treated with insecticide in reducing the incidence of visceral leishmaniasis in India and Nepal. Design Paired cluster randomised controlled trial designed to detect a 50% reduction in incidence of Leishmania donovani infection. Setting Villages in Muzaffarpur district in India and Saptari, Sunsari, and Morang districts in Nepal. Participants 13 intervention and 13 control clusters. 12 691 people were included in the analysis of the main outcome (infection), and 19 810 were enrolled for the secondary (disease) end point. Intervention Longlasting insecticidal nets (treated with deltamethrin) were distributed in the intervention clusters in December 2006. Main outcome measures Infection was determined by direct agglutination test at 12 and 24 months after the intervention in those who had negative results (titre <1:1600) at baseline. The effect estimate was computed as the geometric mean of the risk ratios for seroconversion for each cluster pair (net/no net), with its 95% confidence interval. Formal tests of effect of no intervention were obtained with a paired t test. Results There was no significant difference in the risk of seroconversion over 24 months in intervention (5.4%; 347/6372) compared with control (5.5%; 345/6319 people) clusters (risk ratio 0.90, 95% confidence interval 0.49 to 1.65) nor in the risk of clinical visceral leishmaniasis (0.99, 0.46 to 1.40). Adjustment for covariates did not alter these conclusions. Conclusions There is no evidence that large scale distribution of longlasting insecticidal nets provides additional protection against visceral leishmaniasis compared with existing control practice in the Indian subcontinent. The observed effect was small and not significant, though the confidence intervals did not exclude a 50% change in either direction.	[Ostyn, Bart; Dujardin, Jean Claude; Vanlerberghe, Veerle; Boelaert, Marleen] Inst Trop Med, B-2000 Antwerp, Belgium; [Picado, Albert; Andersen, Elisabeth Wreford; Davies, Clive Richard] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Singh, Shri Prakash; Sundar, Shyam; Gidwani, Kamlesh; Rai, Madhukar; Kumar, Rajiv; Srivastava, Pankaj] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India; [Rijal, Suman; Uranw, Surendra; Khanal, Basudha; Paudel, Ishwari Sharma; Das, Murari Lal] BP Koirala Inst Hlth Sci, Kathmandu, Nepal; [Chappuis, Francois] Univ Hosp Geneva, Geneva, Switzerland	Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine; Banaras Hindu University (BHU); B.P. Koirala Institute of Health Sciences; University of Geneva	Boelaert, M (corresponding author), Inst Trop Med, B-2000 Antwerp, Belgium.	mboelaert@itg.be	Kumar, Rajiv/GSE-5530-2022; Boelaert, Marleen/E-2698-2012; Dujardin, Jean-Claude/AAO-1783-2021; Das, Murari/AAK-9157-2021	Boelaert, Marleen/0000-0001-8051-6776; Das, Murari/0000-0001-6816-2389; Kumar, Rajiv/0000-0003-2338-1494; Chappuis, Francois/0000-0003-0442-7610; Gidwani, Kamlesh/0000-0002-9014-0618; Picado, Albert/0000-0001-7344-628X; Vanlerberghe, Veerle/0000-0002-6531-0793	European Union [015374]; European Commission [INCO-CT 2005-01537]	European Union(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	The KALANET community trial was part of a large project conducted by the KALANET consortium funded by the European Union under its 6<SUP>th</SUP> Framework Program (INCODEV/Project 015374). We are grateful to the co-investigators in the KALANET consortium who conducted the socioeconomic, biological, or technological studies that generated extremely valuable information for interpretation of the trial data. We thank the members of the scientific advisory board (C Lengeler (chair), A Kroeger, M Maroli, C Prasittisuk, J Alvar, B Mahendra, and S Bhattacharya) for their comments; A Huys and C Albrecht for administrative support; J Menten for statistical support; F Meheus for computation of the socioeconomic index; V Lejon, D Jacquet, I Wouters, and J Swiers for the quality control of the laboratory activities; B Greenwood and P Milligan for their comments on the manuscript; V K Dubey, B Pathak, and all field workers of the KALANET consortium and the population of the villages who took part in the trial. Vestergaard-Frandsen provided free PermaNets for distribution in control clusters at the end of the trial. Dedicated to the memory of Clive Richard Davies, who died in March 2009.; This study was funded by the European Union under its 6th Framework Program (INCODEV/Project 015374). The funder of the study had no role in the study design, data collection and analysis, interpretation or reporting of this work, or the decision to submit the work for publication. European Commission: Contract no INCO-CT 2005-01537, KALANET project.	[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2000, AM J TROP MED HYG, V63, P184, DOI 10.4269/ajtmh.2000.63.184; Bhattacharya SK, 2006, INDIAN J MED RES, V123, P195; Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x; Boelaert M, 1999, TROP MED INT HEALTH, V4, P31, DOI 10.1046/j.1365-3156.1999.00348.x; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chappuis F, 2006, BMJ-BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; CHOWDHURY MS, 1993, PARASITOL RES, V79, P444, DOI 10.1007/BF00931580; Chowdhury R, ANN TROP ME IN PRESS; Courtenay O, 2007, MED VET ENTOMOL, V21, P168, DOI 10.1111/j.1365-2915.2007.00678.x; Davies CR, 1999, PARASITOLOGY, V119, P247, DOI 10.1017/S0031182099004680; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x; Dinesh DS, 2009, ENTOMOL NEWS, V120, P496, DOI 10.3157/021.120.0505; Dinesh DS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000859; Dinesh DS, 2001, ANN TROP MED PARASIT, V95, P197, DOI 10.1080/00034980120041071; Gidwani K, 2009, AM J TROP MED HYG, V80, P566, DOI 10.4269/ajtmh.2009.80.566; Hayes RJ, 2009, INTERD STAT, P3; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Jacquet D, 2006, TROP MED INT HEALTH, V11, P1777, DOI 10.1111/j.1365-3156.2006.01743.x; Joshi AB, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-54; Koirala S, 2004, TROP MED INT HEALTH, V9, P533, DOI 10.1111/j.1365-3156.2004.01212.x; Ostyn B, 2009, TROP MED INT HEALTH, V14, P60; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; Picado A, 2009, MEM I OSWALDO CRUZ, V104, P1183, DOI 10.1590/S0074-02762009000800018; Picado A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000587; Rijal S, 2010, TROP MED INT HEALTH, V15, P21, DOI 10.1111/j.1365-3156.2010.02518.x; Ritmeijer K, 2007, TROP MED INT HEALTH, V12, P404, DOI 10.1111/j.1365-3156.2006.01807.x; Saha S, 2009, T ROY SOC TROP MED H, V103, P737, DOI 10.1016/j.trstmh.2008.10.006; Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x; Singh R, 2008, ACTA TROP, V107, P117, DOI 10.1016/j.actatropica.2008.04.025; Singh SP, 2010, TROP MED INT HEALTH, V15, P12, DOI 10.1111/j.1365-3156.2010.02519.x; Sundar S, 2006, J CLIN MICROBIOL, V44, P251, DOI 10.1128/JCM.44.1.251-253.2006; Swaminath CS, 2006, INDIAN J MED RES, V123, pA473; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P60, DOI 10.1111/j.1365-3156.2009.02433.x; *WHO, 2009, MED EL CRIT CONTR US, P1	38	74	75	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2010	341								c6760	10.1136/bmj.c6760	http://dx.doi.org/10.1136/bmj.c6760			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UZ	21190965	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000285922700001
J	Phelps, J; Webb, EL; Bickford, D; Nijman, V; Sodhi, NS				Phelps, Jacob; Webb, Edward L.; Bickford, David; Nijman, Vincent; Sodhi, Navjot S.			Boosting CITES	SCIENCE			English	Editorial Material							INTERNATIONAL WILDLIFE TRADE; CONSERVATION; DYNAMICS		[Phelps, Jacob; Webb, Edward L.; Bickford, David; Sodhi, Navjot S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Nijman, Vincent] Oxford Brookes Univ, Sch Social Sci & Law, Oxford OX3 0BP, England	National University of Singapore; Oxford Brookes University	Phelps, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	jacob.phelps@gmail.com; dbsbdp@nus.edu.sg	Nijman, Vincent/AHD-8685-2022; Bickford, David P/A-5306-2011; Webb, Edward L/E-8343-2011	Bickford, David P/0000-0003-1478-3387; Webb, Edward L/0000-0001-5554-9955; Nijman, Vincent/0000-0002-5600-4276; Phelps, Jacob/0000-0001-6489-1103				Amir O. G., 2006, WILDLIFE TRADE SOMAL; [Anonymous], WILDLIFE TRADE POLIC; [Anonymous], RESOLUTION FINANCING; [Anonymous], GATHERING ANAL DATA; Blundell AG, 2004, ORYX, V38, P84, DOI 10.1017/S0030605304000134; Brito D, 2010, BIOL CONSERV, V143, P1154, DOI 10.1016/j.biocon.2010.02.015; Carpenter AI, 2004, BIOL CONSERV, V120, P291, DOI 10.1016/j.biocon.2004.03.002; CITES, NOND FIND; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davenport TRB, 2003, ORYX, V37, P55, DOI 10.1017/S0030605303000127; Dickson B, 2008, ORYX, V42, P548, DOI 10.1017/S0030605307000786; Gehring T, 2008, GLOBAL ENVIRON POLIT, V8, P123, DOI 10.1162/glep.2008.8.2.123; Gerson H, 2008, CONSERV BIOL, V22, P4, DOI 10.1111/j.1523-1739.2007.00857.x; Giles BG, 2006, BIODIVERS CONSERV, V15, P2497, DOI 10.1007/s10531-005-2432-6; Green EP, 1999, CORAL REEFS, V18, P403, DOI 10.1007/s003380050218; IUCN Species Survival Commission, 2009, ORCH SPEC GROUP GEN; Li YM, 1998, BIODIVERS CONSERV, V7, P895, DOI 10.1023/A:1008873119651; Milius S., 2010, SCI NEWS        0326; Mohneke M., 2010, Traffic Bulletin, V22, P117; Moyle B, 2009, GLOB CRIME, V10, P124, DOI 10.1080/17440570902783921; Nguyen Van Song, 2008, Journal of Environment & Development, V17, P145, DOI 10.1177/1070496508316220; Nijman V., 2010, WILDLIFE TRADE ASEAN; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; Olsen CS, 2005, MT RES DEV, V25, P37, DOI 10.1659/0276-4741(2005)025[0037:ATOEAI]2.0.CO;2; Parsons ECM, 2010, MAR POLICY, V34, P384, DOI 10.1016/j.marpol.2009.08.008; Pistoni Juliana, 2010, South American Journal of Herpetology, V5, P51, DOI 10.2994/057.005.0106; Reeve R, 2006, INT AFF, V82, P881, DOI 10.1111/j.1468-2346.2006.00576.x; RENCTAS (Rede Nacional de Combate ao Trafico de Animais, 2001, 1 REL NAC TRAF FAUN; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Sand P H, 1997, EUR J INT LAW, V8, P29, DOI [10.1093/oxfordjournals.ejil.a015561, DOI 10.1093/OXFORDJOURNALS.EJIL.A015561]; Shepherd CR, 2008, BIODIVERS CONSERV, V17, P35, DOI 10.1007/s10531-007-9228-9; *SING MIN ED HS TR, R154000400133 SING M; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Sodhi NS., 2007, TROPICAL CONSERVATIO; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; United Nations Environment Programme-World Conservation Monitoring Centre (UNEP-WCMC), 2010, THREAT SPEC DAT; Veith M, 2000, BIODIVERS CONSERV, V9, P333, DOI 10.1023/A:1008906918236; Vitousek PM, 1996, AM SCI, V84, P468; Warkentin IG, 2009, CONSERV BIOL, V23, P1056, DOI 10.1111/j.1523-1739.2008.01165.x; Wilson-Wilde L, 2010, FORENSIC SCI MED PAT, V6, P221, DOI 10.1007/s12024-010-9167-8	41	79	82	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1752	1753		10.1126/science.1195558	http://dx.doi.org/10.1126/science.1195558			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698OS	21205655				2022-12-28	WOS:000285603700020
J	Humphrey, JH; Marinda, E; Mutasa, K; Moulton, LH; Iliff, PJ; Ntozini, R; Chidawanyika, H; Nathoo, KJ; Tavengwa, N; Jenkins, A; Piwoz, EG; Van de Perre, P; Ward, BJ				Humphrey, Jean H.; Marinda, Edmore; Mutasa, Kuda; Moulton, Lawrence H.; Iliff, Peter J.; Ntozini, Robert; Chidawanyika, Henry; Nathoo, Kusum J.; Tavengwa, Naume; Jenkins, Alison; Piwoz, Ellen G.; Van de Perre, Philippe; Ward, Brian J.		ZVITAMBO Study Grp	Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RISK-FACTORS; TYPE-1; LYMPHOCYTES; INFECTION; INFANT; RATES; CELLS	Objectives To estimate the rates and timing of mother to infant transmission of HIV associated with breast feeding in mothers who seroconvert postnatally, and their breast milk and plasma HIV loads during and following seroconversion, compared with women who tested HIV positive at delivery. Design Prospective cohort study. Setting Urban Zimbabwe. Participants 14 110 women and infants enrolled in the Zimbabwe Vitamin A for Mothers and Babies (ZVITAMBO) trial (1997-2001). Main outcome measures Mother to child transmission of HIV, and breast milk and maternal plasma HIV load during the postpartum period. Results Among mothers who tested HIV positive at baseline and whose infant tested HIV negative with polymerase chain reaction (PCR) at six weeks (n=2870), breastfeeding associated transmission was responsible for an average of 8.96 infant infections per 100 child years of breast feeding (95% CI 7.92 to 10.14) and varied little over the breastfeeding period. Breastfeeding associated transmission for mothers who seroconverted postnatally (n=334) averaged 34.56 infant infections per 100 child years (95% CI 26.60 to 44.91) during the first nine months after maternal infection, declined to 9.50 (95% CI 3.07 to 29.47) during the next three months, and was zero thereafter. Among women who seroconverted postnatally and in whom the precise timing of infection was known (<= 90 days between last negative and first positive test; n=51), 62% (8/13) of transmissions occurred in the first three months after maternal infection and breastfeeding associated transmission was 4.6 times higher than in mothers who tested HIV positive at baseline and whose infant tested HIV negative with PCR at six weeks. Median plasma HIV concentration in all mothers who seroconverted postnatally declined from 5.0 log(10) copies/mL at the last negative enzyme linked immunosorbent assay (ELISA) to 4.1 log(10) copies/mL at 9-12 months after infection. Breast milk HIV load in this group was 4.3 log(10) copies/mL 0-30 days after infection, but rapidly declined to 2.0 log(10) copies/mL and <1.5 log(10) copies/mL by 31-90 days and more than 90 days, respectively. Among women whose plasma sample collected soon after delivery tested negative for HIV with ELISA but positive with PCR (n=17), 75% of their infants were infected or had died by 12 months. An estimated 18.6% to 20.4% of all breastfeeding associated transmission observed in the ZVITAMBO trial occurred among mothers who seroconverted postnatally. Conclusions Breastfeeding associated transmission is high during primary maternal HIV infection and is mirrored by a high but transient peak in breast milk HIV load. Around two thirds of breastfeeding associated transmission by women who seroconvert postnatally may occur while the mother is still in the "window period" of an antibody based test, when she would test HIV negative using one of these tests.	[Humphrey, Jean H.; Marinda, Edmore; Mutasa, Kuda; Iliff, Peter J.; Ntozini, Robert; Chidawanyika, Henry; Tavengwa, Naume; Jenkins, Alison] ZVITAMBO Project, Harare, Zimbabwe; [Humphrey, Jean H.; Moulton, Lawrence H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Marinda, Edmore; Nathoo, Kusum J.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Iliff, Peter J.] Univ Zimbabwe, Dept Paediat & Child Hlth, Harare, Zimbabwe; [Jenkins, Alison] Populat Serv Int, Kigali, Rwanda; [Piwoz, Ellen G.] Acad Educ Dev, Ctr Nutr, Washington, DC USA; [Piwoz, Ellen G.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Van de Perre, Philippe] Montpellier Univ Hosp, Lab Bacteriol Virol, Montpellier, France; [Ward, Brian J.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Witwatersrand; University of Zimbabwe; Bill & Melinda Gates Foundation; Universite de Montpellier; CHU de Montpellier; McGill University	Humphrey, JH (corresponding author), ZVITAMBO Project, 1 Borrowdale Rd, Harare, Zimbabwe.	jhumphrey@zvitambo.co.zw	Ntozini, Robert/AAD-8403-2020; Ntozini, Robert/AFU-4878-2022; Van de Perre, Philippe/B-9692-2008	Ntozini, Robert/0000-0002-8543-2835; Van de Perre, Philippe/0000-0002-3912-0427; Moulton, Lawrence/0000-0001-7041-7387	Canadian International Development Agency [690/M3688]; United States Agency for International Development (USAID) [HRN-A-00-97-00015-00]; Bill and Melinda Gates Foundation, Seattle, WA; SARA Project; Department for International Development, United Kingdom [AG 4996, 073-555-013 CA 007]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	Canadian International Development Agency; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Bill and Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation); SARA Project; Department for International Development, United Kingdom; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The ZVITAMBO Project was supported by the Canadian International Development Agency (R/C Project 690/M3688); United States Agency for International Development (USAID; cooperative agreement number HRN-A-00-97-00015-00 between Johns Hopkins University and the Office of Health and Nutrition-USAID); a grant from the Bill and Melinda Gates Foundation, Seattle, WA; the SARA Project, operated by the Academy for Educational Development, Washington, DC; and the Department for International Development, United Kingdom ("Saving Maternal and Newborn Lives in the Context of HIV and AIDS in Zimbabwe" Grant No AG 4996 (MIS code 073-555-013 CA 007)). The sponsors of the study had no role in the study design, recruitment of participants, data collection, data analysis, data interpretation, writing of the report, or the decision to submit for publication. The corresponding author had full access to all data and had final responsibility for the decision to submit for publication.	BERTOTTO A, 1990, EUR J IMMUNOL, V20, P1877, DOI 10.1002/eji.1830200838; BERTOTTO A, 1991, ACTA PAEDIATR SCAND, V80, P98, DOI 10.1111/j.1651-2227.1991.tb11738.x; BERTOTTO A, 1992, EUR J PEDIATR, V151, P150, DOI 10.1007/BF01958967; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; COLEBUNDERS R, 1988, LANCET, V2, P1487; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; HIRA SK, 1990, J PEDIATR-US, V117, P421, DOI 10.1016/S0022-3476(05)81084-4; Humphrey JH, 2007, EPIDEMIOL INFECT, V135, P933, DOI 10.1017/S0950268806007709; Humphrey JH, 2006, AIDS, V20, P1437, DOI 10.1097/01.aids.0000233578.72091.09; Humphrey JH, 2006, J INFECT DIS, V193, P960; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Insoft RM, 1996, PEDIATR CLIN N AM, V43, P551, DOI 10.1016/S0031-3955(05)70420-X; KIEFFER MP, 2009, 5 C HIV PATH TREATM; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Liang K, 2009, J INFECT DIS, V200, P682, DOI 10.1086/605123; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; PALASANTHIRAN P, 1993, J INFECT DIS, V167, P441, DOI 10.1093/infdis/167.2.441; Piwoz EG, 2005, J NUTR, V135, P950; Tavengwa NV, 2007, TROP MED INT HEALTH, V12, P97, DOI 10.1111/j.1365-3156.2006.01758.x; Tuaillon E, 2009, J IMMUNOL, V182, P7155, DOI 10.4049/jimmunol.0803107; VANDEPERRE P, 1992, LANCET, V339, P1490; VANDEPERRE P, 1991, NEW ENGL J MED, V325, P593, DOI 10.1056/NEJM199108293250901; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; *WHO, 2006, HIV INF FEED NEW EV; WIRT DP, 1992, CYTOMETRY, V13, P282, DOI 10.1002/cyto.990130310; World Health Organization, 2009, RAP ADV ANT THER HIV	29	70	71	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2010	341								c6580	10.1136/bmj.c6580	http://dx.doi.org/10.1136/bmj.c6580			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700DX	21177735	Green Published, hybrid			2022-12-28	WOS:000285717100002
J	Kharchenko, PV; Alekseyenko, AA; Schwartz, YB; Minoda, A; Riddle, NC; Ernst, J; Sabo, PJ; Larschan, E; Gorchakov, AA; Gu, TT; Linder-Basso, D; Plachetka, A; Shanower, G; Tolstorukov, MY; Luquette, LJ; Xi, RB; Jung, YL; Park, RW; Bishop, EP; Canfield, TK; Sandstrom, R; Thurman, RE; MacAlpine, DM; Stamatoyannopoulos, JA; Kellis, M; Elgin, SCR; Kuroda, MI; Pirrotta, V; Karpen, GH; Park, PJ				Kharchenko, Peter V.; Alekseyenko, Artyom A.; Schwartz, Yuri B.; Minoda, Aki; Riddle, Nicole C.; Ernst, Jason; Sabo, Peter J.; Larschan, Erica; Gorchakov, Andrey A.; Gu, Tingting; Linder-Basso, Daniela; Plachetka, Annette; Shanower, Gregory; Tolstorukov, Michael Y.; Luquette, Lovelace J.; Xi, Ruibin; Jung, Youngsook L.; Park, Richard W.; Bishop, Eric P.; Canfield, Theresa K.; Sandstrom, Richard; Thurman, Robert E.; MacAlpine, David M.; Stamatoyannopoulos, John A.; Kellis, Manolis; Elgin, Sarah C. R.; Kuroda, Mitzi I.; Pirrotta, Vincenzo; Karpen, Gary H.; Park, Peter J.			Comprehensive analysis of the chromatin landscape in Drosophila melanogaster	NATURE			English	Article							HISTONE MODIFICATIONS; GENE-EXPRESSION; HUMAN GENOME; SHORT RNAS; DNASE-I; TRANSCRIPTION; POLYCOMB; SEQUENCE; ENHANCERS; COHESIN	Chromatin is composed of DNA and a variety of modified histones and non-histone proteins, which have an impact on cell differentiation, gene regulation and other key cellular processes. Here we present a genome-wide chromatin landscape for Drosophila melanogaster based on eighteen histone modifications, summarized by nine prevalent combinatorial patterns. Integrative analysis with other data (non-histone chromatin proteins, DNase I hypersensitivity, GRO-Seq reads produced by engaged polymerase, short/long RNA products) reveals discrete characteristics of chromosomes, genes, regulatory elements and other functional domains. We find that active genes display distinct chromatin signatures that are correlated with disparate gene lengths, exon patterns, regulatory functions and genomic contexts. We also demonstrate a diversity of signatures among Polycomb targets that include a subset with paused polymerase. This systematic profiling and integrative analysis of chromatin signatures provides insights into how genomic elements are regulated, and will serve as a resource for future experimental investigations of genome structure and function.	[Kharchenko, Peter V.; Tolstorukov, Michael Y.; Luquette, Lovelace J.; Xi, Ruibin; Jung, Youngsook L.; Park, Richard W.; Bishop, Eric P.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Kharchenko, Peter V.; Tolstorukov, Michael Y.; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Alekseyenko, Artyom A.; Larschan, Erica; Gorchakov, Andrey A.; Plachetka, Annette; Jung, Youngsook L.; Kuroda, Mitzi I.; Park, Peter J.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Alekseyenko, Artyom A.; Larschan, Erica; Gorchakov, Andrey A.; Plachetka, Annette; Kuroda, Mitzi I.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Schwartz, Yuri B.; Linder-Basso, Daniela; Shanower, Gregory; Pirrotta, Vincenzo] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Minoda, Aki; Karpen, Gary H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Minoda, Aki; Karpen, Gary H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Riddle, Nicole C.; Gu, Tingting; Elgin, Sarah C. R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Ernst, Jason; Kellis, Manolis] MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ernst, Jason; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sabo, Peter J.; Canfield, Theresa K.; Sandstrom, Richard; Thurman, Robert E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Larschan, Erica] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02906 USA; [Park, Richard W.; Bishop, Eric P.] Boston Univ, Grad Program Bioinformat, Boston, MA 02115 USA; [MacAlpine, David M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Rutgers State University New Brunswick; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Washington; University of Washington Seattle; Brown University; Boston University; Duke University; University of Washington; University of Washington Seattle	Park, PJ (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA.	karpen@fruitfly.org; peter_park@harvard.edu	Kellis, Manolis/ABE-7385-2020; Minoda, Aki/D-5335-2017; Gorchakov, Andrey A/N-5840-2015; Minoda, Aki/Q-4454-2019	Kellis, Manolis/0000-0001-7113-9630; Minoda, Aki/0000-0002-2927-5791; Gorchakov, Andrey A/0000-0003-2830-4236; Minoda, Aki/0000-0002-2927-5791; Xi, Ruibin/0000-0001-7545-7361; Elgin, Sarah C. R./0000-0002-5176-2510; Riddle, Nicole/0000-0003-1827-9145; Sandstrom, Richard/0000-0002-3356-1547; Park, Peter/0000-0001-9378-960X	modENCODE [U01HG004258]; Department of Energy [DE-AC02-05CH11231];  [RC2 HG005639];  [U01 HG004279];  [R01 GM082798];  [R37 GM45744];  [RC1 HG005334];  [R01 GM071923];  [U54 HG004592];  [NSF 0905968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004258, RC1HG005334, U54HG004592, R01HG004037, U01HG004279, RC2HG005639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045744, R01GM071923, R01GM082798] Funding Source: NIH RePORTER	modENCODE; Department of Energy(United States Department of Energy (DOE)); ; ; ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our technicians D. Acevedo, S. Gadel, C. Kennedy, O.-K. Lee, S. Marchetti, S. Vong and M. Weaver, and Rutgers BRTC. We also thank our colleagues who donated antibodies: J. Kadonaga (H1), A. L. Greenleaf (RNA pol II), G. Reuter (SU(VAR)3-9), G. Cavalli (GAF) and I. F. Zhimulev/H. Saumweber (Chromator). The major support for this work came from the modENCODE grant U01HG004258 to G.H.K. (Principal Investigator) and S.C.R.E., M.I.K., P.J.P. and V.P. (co-Principal Investigators), administered under Department of Energy contract no. DE-AC02-05CH11231. Additional funding came from RC2 HG005639, U01 HG004279, R01 GM082798, R37 GM45744, RC1 HG005334, R01 GM071923, U54 HG004592 and NSF 0905968.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Anders S, 2009, BIOINFORMATICS, V25, P1231, DOI 10.1093/bioinformatics/btp152; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blumenthal AB, 1974, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/sqb.1974.038.01.024; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	46	606	622	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					480	+		10.1038/nature09725	http://dx.doi.org/10.1038/nature09725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21179089	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000288702200055
J	Carter, JA; Fabrycky, DC; Ragozzine, D; Holman, MJ; Quinn, SN; Latham, DW; Buchhave, LA; Van Cleve, J; Cochran, WD; Cote, MT; Endl, M; Ford, EB; Haas, MR; Jenkins, JM; Koch, DG; Li, J; Lissauer, JJ; MacQueen, PJ; Middour, CK; Orosz, JA; Rowe, JF; Steffen, JH; Welsh, WF				Carter, Joshua A.; Fabrycky, Daniel C.; Ragozzine, Darin; Holman, Matthew J.; Quinn, Samuel N.; Latham, David W.; Buchhave, Lars A.; Van Cleve, Jeffrey; Cochran, William D.; Cote, Miles T.; Endl, Michael; Ford, Eric B.; Haas, Michael R.; Jenkins, Jon M.; Koch, David G.; Li, Jie; Lissauer, Jack J.; MacQueen, Phillip J.; Middour, Christopher K.; Orosz, Jerome A.; Rowe, Jason F.; Steffen, Jason H.; Welsh, William F.			KOI-126: A Triply Eclipsing Hierarchical Triple with Two Low-Mass Stars	SCIENCE			English	Article							MAGNETIC ACTIVITY; BINARY; EVOLUTION; MODELS	The Kepler spacecraft has been monitoring the light from 150,000 stars in its primary quest to detect transiting exoplanets. Here, we report on the detection of an eclipsing stellar hierarchical triple, identified in the Kepler photometry. KOI-126 [A, (B, C)], is composed of a low-mass binary [masses M-B = 0.2413 +/- 0.0030 solar mass (M-circle dot), M-C = 0.2127 +/- 0.0026 M-circle dot; radii R-B = 0.2543 +/- 0.0014 solar radius (R-circle dot), R-C = 0.2318 +/- 0.0013 R-circle dot; orbital period P-1 = 1.76713 +/- 0.00019 days] on an eccentric orbit about a third star (mass M-A = 1.347 +/- 0.032 M-circle dot; radius R-A = 2.0254 +/- 0.0098 R-circle dot; period of orbit around the low-mass binary P-2 = 33.9214 +/- 0.0013 days; eccentricity of that orbit e(2) = 0.3043 +/- 0.0024). The low-mass pair probe the poorly sampled fully convective stellar domain offering a crucial benchmark for theoretical stellar models.	[Carter, Joshua A.; Ragozzine, Darin; Holman, Matthew J.; Quinn, Samuel N.; Latham, David W.; Buchhave, Lars A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Fabrycky, Daniel C.] Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Van Cleve, Jeffrey; Cote, Miles T.; Haas, Michael R.; Jenkins, Jon M.; Koch, David G.; Li, Jie; Lissauer, Jack J.; Middour, Christopher K.; Rowe, Jason F.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Cochran, William D.; Endl, Michael; MacQueen, Phillip J.] Univ Texas Austin, Austin, TX 78712 USA; [Ford, Eric B.] Univ Florida, Gainesville, FL 32611 USA; [Van Cleve, Jeffrey; Jenkins, Jon M.; Li, Jie; Rowe, Jason F.] SETI Inst, Mountain View, CA 94043 USA; [Lissauer, Jack J.] Stanford Univ, Stanford, CA 94305 USA; [Orosz, Jerome A.; Welsh, William F.] San Diego State Univ, San Diego, CA 92182 USA; [Steffen, Jason H.] Fermilab Ctr Particle Astrophys, Batavia, IL 60510 USA; [Middour, Christopher K.] Orbital Sci Corp, Dulles, VA 20166 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Santa Cruz; University of Copenhagen; Niels Bohr Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Texas System; University of Texas Austin; State University System of Florida; University of Florida; Stanford University; California State University System; San Diego State University	Carter, JA (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	jacarter@cfa.harvard.edu	Steffen, Jason H./A-4320-2013; Buchhave, Lars A./ABF-2000-2020; Ford, Eric B./AAB-5479-2019; Welsh, William/AAS-3445-2021; Cochran, William D/M-4421-2014; Carter, Joshua A/A-8280-2013; Ragozzine, Darin/C-4926-2013	Buchhave, Lars A./0000-0003-1605-5666; Ford, Eric B./0000-0001-6545-639X; Cochran, William D/0000-0001-9662-3496; Fabrycky, Daniel/0000-0003-3750-0183; Rowe, Jason/0000-0002-5904-1865; Latham, David/0000-0001-9911-7388; Steffen, Jason/0000-0003-2202-3847	NASA's Science Mission Directorate; NASA [HF-51267.01-A, HF-51272.01-A, NAS 5-26555]	NASA's Science Mission Directorate; NASA(National Aeronautics & Space Administration (NASA))	Funding for this Discovery mission is provided by NASA's Science Mission Directorate. J.A.C. and D. C. F. are Hubble Fellows and acknowledge support for this work by NASA through Hubble Fellowship grants HF-51267.01-A and HF-51272.01-A awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA under contract NAS 5-26555. J.A.C. is grateful for helpful discussions with P. Podsiadlowski, S. Rappaport, G. Torres, A. Levine, J. Winn, S. Seager, and T. Dupuy. J. F. R. is a NASA Postdoctoral Program Fellow.	Baraffe I, 1998, ASTRON ASTROPHYS, V337, P403; Cakirli O, 2010, REV MEX ASTRON ASTR, V46, P355; Morales JC, 2010, ASTROPHYS J, V718, P502, DOI 10.1088/0004-637X/718/1/502; Morales JC, 2009, ASTROPHYS J, V691, P1400, DOI 10.1088/0004-637X/691/2/1400; CLARET A, 1993, ASTRON ASTROPHYS, V277, P487; Demarque P, 2004, ASTROPHYS J SUPPL S, V155, P667, DOI 10.1086/424966; Demory BO, 2009, ASTRON ASTROPHYS, V505, P205, DOI 10.1051/0004-6361/200911976; Ford EB, 2000, ASTROPHYS J, V535, P385, DOI 10.1086/308815; Gilliland RL, 2010, ASTROPHYS J LETT, V713, pL160, DOI 10.1088/2041-8205/713/2/L160; Jenkins JM, 2010, P SPIE, V7740; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL87, DOI 10.1088/2041-8205/713/2/L87; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Kopal Z., 1978, DYNAMICS CLOSE BINAR, DOI DOI 10.1007/978-94-009-9780-6; Kovacs G, 2002, ASTRON ASTROPHYS, V391, P369, DOI 10.1051/0004-6361:20020802; LACY CH, 1977, ASTROPHYS J, V218, P444, DOI 10.1086/155698; Lopez-Morales M, 2007, ASTROPHYS J, V660, P732, DOI 10.1086/513142; Mardling RA, 2002, ASTROPHYS J, V573, P829, DOI 10.1086/340752; Metcalfe TS, 1996, ASTROPHYS J, V456, P356, DOI 10.1086/176657; Morales JC, 2008, ASTRON ASTROPHYS, V478, P507, DOI 10.1051/0004-6361:20078324; Ragozzine D., 2010, ASTROPHYS J; Siess L, 2000, ASTRON ASTROPHYS, V358, P593; SODERHJELM S, 1984, ASTRON ASTROPHYS, V141, P232; Soffel M. H, 1989, RELATIVITY ASTROMETR; Torres G, 2006, ASTROPHYS J, V640, P1018, DOI 10.1086/500188; Vida K, 2009, ASTRON ASTROPHYS, V504, P1021, DOI 10.1051/0004-6361/200912326	26	167	168	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					562	565		10.1126/science.1201274	http://dx.doi.org/10.1126/science.1201274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21224439	Green Submitted			2022-12-28	WOS:000286933600047
J	Vann, RD; Butler, FK; Mitchell, SJ; Moon, RE				Vann, Richard D.; Butler, Frank K.; Mitchell, Simon J.; Moon, Richard E.			Decompression illness	LANCET			English	Article							PATENT FORAMEN OVALE; ARTERIAL GAS EMBOLISM; TO-LEFT SHUNT; HYPERBARIC-OXYGEN THERAPY; INNER-EAR; BUBBLE FORMATION; PULMONARY-EDEMA; AIR-EMBOLISM; SCUBA-DIVERS; CEREBRAL PROTECTION	Decompression illness is caused by intravascular or extravascular bubbles that are formed as a result of reduction in environmental pressure (decompression). The term covers both arterial gas embolism, in which alveolar gas or venous gas emboli (via cardiac shunts or via pulmonary vessels) are introduced into the arterial circulation, and decompression sickness, which is caused by in-situ bubble formation from dissolved inert gas. Both syndromes can occur in divers, compressed air workers, aviators, and astronauts, but arterial gas embolism also arises from iatrogenic causes unrelated to decompression. Risk of decompression illness is affected by immersion, exercise, and heat or cold. Manifestations range From itching and minor pain to neurological symptoms, cardiac collapse, and death. First-aid treatment is 100% oxygen and definitive treatment is recompression to increased pressure, breathing 100% oxygen. Adjunctive treatment, including fluid administration and prophylaxis against venous thromboembolism in paralysed patients, is also recommended. Treatment is, in most cases, effective although residual deficits can remain in serious cases, even after several recompressions.	[Vann, Richard D.; Moon, Richard E.] Duke Univ, Med Ctr, Ctr Hyperbar Med & Environm Physiol, Durham, NC 27710 USA; [Vann, Richard D.; Moon, Richard E.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Butler, Frank K.] USA, Inst Surg Res, San Antonio, TX USA; [Mitchell, Simon J.] Univ Auckland, Dept Anaesthesiol, Auckland 1, New Zealand	Duke University; Duke University; University of Auckland	Vann, RD (corresponding author), Duke Univ, Med Ctr, Ctr Hyperbar Med & Environm Physiol, Box 3823, Durham, NC 27710 USA.	richard.vann@duke.edu	Moon, Richard/AAF-2170-2019	Moon, Richard/0000-0003-4432-0332; Mitchell, Simon/0000-0002-5149-6371	US Navy; Divers Alert Network	US Navy(United States Department of Defense); Divers Alert Network	The authors received no revenue in support for this manuscript. RDV and REM received research grant funding from the US Navy. A portion of RDV's salary is paid by the Divers Alert Network. All other authors declare that they have no conflicts of interest.	ACOTT CJ, 1992, ANAESTH INTENS CARE, V20, P249; Adir Y, 2004, CHEST, V126, P394, DOI 10.1378/chest.126.2.394; BALL R, 1993, UNDERSEA HYPERBAR M, V20, P133; BALLDIN UI, 1972, AEROSPACE MED, V43, P1101; BALLDIN UI, 1971, AEROSPACE MED, V42, P489; BARRY PD, 1984, UNDERSEA BIOMED RES, V11, P387; BASON R, 1991, AVIAT SPACE ENVIR MD, V62, P994; BASON R, 1991, AVIAT SPACE ENVIR MD, V62, P1180; Bendrick GA, 1996, AVIAT SPACE ENVIR MD, V67, P199; Bennell P., 1989, Proceedings of the SACCAR/ISNAR regional workshop on human resource management in National Agricultural Research Systems., P29; Bennett M, 2003, UNDERSEA HYPERBAR M, V30, P195; Bennett M., 2005, MANAGEMENT MIND MARG, P125; Bennett MH, 2007, COCHRANE DB SYST REV, V2; Benson J, 2003, UNDERSEA HYPERBAR M, V30, P117; Benton PJ, 1996, AVIAT SPACE ENVIR MD, V67, P63; Berghage T.E.D., 1980, US NAVY AIR DECOMPRE; Blatteau JE, 2005, AVIAT SPACE ENVIR MD, V76, P666; Blatteau JE, 2007, BRIT J SPORT MED, V41, P375, DOI 10.1136/bjsm.2006.032359; BOND JG, 1990, AVIAT SPACE ENVIR MD, V61, P738; Bosco G, 2001, UNDERSEA HYPERBAR M, V28, P207; Boussuges A, 1996, INT J SPORTS MED, V17, P351, DOI 10.1055/s-2007-972859; Boussuges A, 1996, UNDERSEA HYPERBAR M, V23, P151; Bove AA, 1998, UNDERSEA HYPERBAR M, V25, P175; Boycott AE, 1908, J HYG-CAMBRIDGE, V8, P342, DOI 10.1017/S0022172400003399; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; BRUNNER FP, 1964, LANCET, V1, P1071; BUTLER FK, 1986, ANN EMERG MED, V15, P738, DOI 10.1016/S0196-0644(86)80439-5; BUTLER FK, 1991, AVIAT SPACE ENVIR MD, V62, P346; Butler FK, 1999, UNDERSEA HYPERBAR M, V26, P257; Butler FK, 2001, UNDERSEA HYPERBAR M, V28, P31; Cantais E, 2003, CRIT CARE MED, V31, P84, DOI 10.1097/00003246-200301000-00013; Cianci P, 2006, AVIAT SPACE ENVIR MD, V77, P1003; Cooper PD, 2009, DIVING HYPERB MED, V39, P71; Dainer H, 2007, J APPL PHYSIOL, V102, P1099, DOI 10.1152/japplphysiol.01539.2005; DICK APK, 1985, NEUROLOGY, V35, P667, DOI 10.1212/WNL.35.5.667; Doolette DJ, 2004, SPUMS J, V34, P63; Doolette DJ, 2005, MANAGEMENT MILD MARG, P10; Dowse MS, 2002, AVIAT SPACE ENVIR MD, V73, P743; Dromsky DM, 2003, AVIAT SPACE ENVIR MD, V74, P21; Dujic E, 2004, J PHYSIOL-LONDON, V555, P637, DOI 10.1113/jphysiol.2003.059360; Dujic Z, 2006, AVIAT SPACE ENVIR MD, V77, P592; Dujic Z, 2008, EXERC SPORT SCI REV, V36, P38, DOI 10.1097/jes.0b013e31815ddb02; Dunford RG, 2002, UNDERSEA HYPERBAR M, V29, P247; EASTAUGH J, 1989, ARCH INTERN MED, V149, P1735, DOI 10.1001/archinte.149.8.1735; ECKENHOFF RG, 1990, J APPL PHYSIOL, V69, P914, DOI 10.1152/jappl.1990.69.3.914; Fahlman A, 2006, AVIAT SPACE ENVIR MD, V77, P102; FARMER JC, 1977, ANN OTO RHINOL LARYN, V86, P1; Flynn ET, 2004, BOVE DAVIS DIVING ME, P343; FRANCIS TJR, 1988, UNDERSEA BIOMED RES, V15, P403; Francis TJR, 1991, DESCRIBING DECOMPRES; Francis TJR, 2003, BENNETT ELLIOTTS PHY, V5th, P578; Freiberger JJ, 2004, AVIAT SPACE ENVIR MD, V75, P1023; Freiberger JJ, 2002, AVIAT SPACE ENVIR MD, V73, P980; Gempp E, 2009, BRIT J SPORT MED, V43, P224, DOI 10.1136/bjsm.2007.043240; Gempp E, 2009, INT J SPORTS MED, V30, P150, DOI 10.1055/s-2008-1038844; Gempp E, 2010, J CRIT CARE, V25, P236, DOI 10.1016/j.jcrc.2009.05.011; Gempp E, 2009, CLIN J SPORT MED, V19, P512, DOI 10.1097/JSM.0b013e3181bd1df9; Gempp E, 2008, AVIAT SPACE ENVIR MD, V79, P1112, DOI 10.3357/ASEM.2376.2008; Germonpre P, 1998, J APPL PHYSIOL, V84, P1622, DOI 10.1152/jappl.1998.84.5.1622; Gerth WA, 2007, TR0607 NEDU; GOLDING F C, 1960, Br J Ind Med, V17, P167; Gorman DF, 1987, UNDERWAWTER HYPERBAR, P1031; Grover I, 2007, UNDERSEA HYPERBAR M, V34, P199; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Hampson NB, 1997, UNDERSEA HYPERBAR M, V24, P29; Harrah JD, 2008, UNDERSEA HYPERBAR M, V35, P207; Holley T., 2000, SPUMS J, V30, P75; Howle LE, 2009, J APPL PHYSIOL, V107, P1539, DOI 10.1152/japplphysiol.00185.2009; HYLDEGAARD O, 1991, UNDERSEA BIOMED RES, V18, P361; Ito M, 1999, AVIAT SPACE ENVIR MD, V70, P141; Jallul S, 2007, SPINAL CORD, V45, P116, DOI 10.1038/sj.sc.3101923; Jersey SL, 2010, AVIAT SPACE ENVIR MD, V81, P64, DOI 10.3357/ASEM.2303.2010; Kelleher PC, 1996, AVIAT SPACE ENVIR MD, V67, P654; Kerut EK, 2001, J AM COLL CARDIOL, V38, P613, DOI 10.1016/S0735-1097(01)01427-9; KIZER KW, 1982, JAMA-J AM MED ASSOC, V247, P2555, DOI 10.1001/jama.247.18.2555; Klingmann C, 2003, LARYNGOSCOPE, V113, P1356, DOI 10.1097/00005537-200308000-00017; Klingmann C, 2007, OTOL NEUROTOL, V28, P447, DOI 10.1097/MAO.0b013e318030d356; Krause KM, 2000, AVIAT SPACE ENVIR MD, V71, P115; Ladd G, 2002, S PACIFIC UNDERW MED, V32, P124; LEITCH DR, 1985, UNDERSEA BIOMED RES, V12, P291; LEITCH DR, 1984, UNDERSEA BIOMED RES, V11, P221; Longphre JM, 2007, UNDERSEA HYPERBAR M, V34, P43; LOWE VJ, 1994, UNDERSEA HYPERBAR M, V21, P103; Martin JD, 2002, AVIAT SPACE ENVIR MD, V73, P565; Mathew JP, 2009, STROKE, V40, P880, DOI 10.1161/STROKEAHA.108.531236; MELLEM H, 1990, AVIAT SPACE ENVIR MD, V61, P559; Mitchell SJ, 2009, ANN THORAC SURG, V87, P820, DOI 10.1016/j.athoracsur.2008.12.042; Mitchell SJ, 2009, J APPL PHYSIOL, V106, P298, DOI 10.1152/japplphysiol.90915.2008; Mitchell SJ, 1999, ANN THORAC SURG, V67, P1117, DOI 10.1016/S0003-4975(99)00057-0; Mitchell SJ, 2001, UNDERSEA HYPERBAR M, V28, P165; Mitchell SJ, 2009, TECHN DIV P DIV AL N, P178; Mitchell SJ, 1998, SPUMS J, V28, P89; Mitchell SJ., 2005, MANAGEMENT MILD MARG; MOLVAER OI, 1988, UNDERSEA BIOMED RES, V15, P271; MOON RE, 1989, LANCET, V1, P513; Moon RE, 2004, UNDERSEA HYPERBAR M, V31, P271; Moon RE, 1997, AVIAT SPACE ENVIR MD, V68, P234; Moon RE., 2003, ADJUNCTIVE THERAPY D; Navy Department, 2008, US NAV DIV MAN REV 6; NEUMAN TS, 1990, UNDERSEA BIOMED RES, V17, P429; Newton HB, 2007, UNDERSEA HYPERBAR M, V34, P349; Nossum V, 2002, EUR J APPL PHYSIOL, V86, P209, DOI 10.1007/s00421-001-0531-y; Ozyigit T, 2010, AVIAT SPACE ENVIR MD, V81, P3, DOI 10.3357/ASEM.2495.2010; Pickard BJ, 2003, AVIAT SPACE ENVIR MD, V74, P357; Pitkin AD, 1999, AVIAT SPACE ENVIR MD, V70, P517; Pollock NW, 2008, DAN ANN DIVING REPOR; Randsoe T, 2009, J APPL PHYSIOL, V107, P1857, DOI 10.1152/japplphysiol.00785.2009; RIVERA JC, 1964, MIL MED, V129, P314, DOI 10.1093/milmed/129.4.314; Ross JAS., 2000, CLIN AUDIT OUTCOME M; Schoen SP, 2008, HEART, V94, P844, DOI 10.1136/hrt.2007.132662; SHUPAK A, 1991, LARYNGOSCOPE, V101, P173; Slade JB, 2001, CHEST, V120, P1686, DOI 10.1378/chest.120.5.1686; Smerz RW, 2005, UNDERSEA HYPERBAR M, V32, P363; SMITH RM, 1994, NEW ENGL J MED, V330, P19, DOI 10.1056/NEJM199401063300104; Soliman OII, 2007, EUR J ECHOCARDIOGR, V8, pS2, DOI 10.1016/j.euje.2007.03.006; SPENCER MP, 1976, J APPL PHYSIOL, V40, P229, DOI 10.1152/jappl.1976.40.2.229; Spiess BD, 2009, J APPL PHYSIOL, V106, P1444, DOI 10.1152/japplphysiol.90995.2008; Steigleman A, 2003, AVIAT SPACE ENVIR MD, V74, P985; Temple DJ, 1999, DIVE PROFILES MANIFE, VI; Thalmann E, 1996, TREATMENT DECOMPRESS; Thalmann ED, 1990, DIVING ACCIDENT MANA, P194; TOko B, 2005, SPUMS J, V35, P23; Torti SR, 2004, EUR HEART J, V25, P1014, DOI 10.1016/j.ehj.2004.04.028; Van der Aue OE, 1949, EFFECT EXERCISE DURI, P8; Van Liew HD, 2005, UNDERSEA HYPERBAR M, V32, P409; Van Liew HD, 2005, UNDERSEA HYPERBAR M, V32, P187; Vann R., 2004, BOVE DAVIS DIVING ME, P53, DOI 10.1016/b978-0-7216-9424-5.50010-1; Vann RD, 2007, UNDERSEA HYPERBAR M, V34, P211; Vann R.D., 2004, BOVE DAVIS DIVING ME, V4th ed., P127, DOI DOI 10.1016/B978-0-7216-9424-5.X5001-1; Vann RD, 2004, UNDERSEA HYPERBAR M, V31, P431; Vann RD, 2000, DANS ANN REV RECREAT; Vann RD, 2008, AVIAT SPACE ENVIR MD, V79, P797, DOI 10.3357/ASEM.2316.2008; Vann RD, 2007, UNDERSEA HYPERBAR M, V34, P311; VIK A, 1990, J APPL PHYSIOL, V69, P237, DOI 10.1152/jappl.1990.69.1.237; Weaver LK, 2006, UNDERSEA HYPERBAR M, V33, P85; Webb JT, 2003, AVIAT SPACE ENVIR MD, V74, P2; WEIEN RW, 1990, AVIAT SPACE ENVIR MD, V61, P833; Weisher DD, 2008, UNDERSEA HYPERBAR M, V35, P159; WEISS LD, 1995, CHEST, V107, P1653, DOI 10.1378/chest.107.6.1653; Williams STB, 2007, WILD ENVIRON MED, V18, P48, DOI 10.1580/06-WEME-BR-009R.1; Wilmshurst P, 2000, CLIN SCI, V99, P65, DOI 10.1042/CS19990338; WILMSHURST PT, 1989, LANCET, V2, P1302; WILMSHURST PT, 1986, BRIT MED J, V293, P1277, DOI 10.1136/bmj.293.6557.1277; Zhu J, 2007, UNDERSEA HYPERBAR M, V34, P7; ZWIREWICH CV, 1987, RADIOLOGY, V163, P81, DOI 10.1148/radiology.163.1.3823462	145	368	391	1	76	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					153	164		10.1016/S0140-6736(10)61085-9	http://dx.doi.org/10.1016/S0140-6736(10)61085-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707NH	21215883				2022-12-28	WOS:000286292800028
J	Lima, MD; Fang, SL; Lepro, X; Lewis, C; Ovalle-Robles, R; Carretero-Gonzalez, J; Castillo-Martinez, E; Kozlov, ME; Oh, JY; Rawat, N; Haines, CS; Haque, MH; Aare, V; Stoughton, S; Zakhidov, AA; Baughman, RH				Lima, Marcio D.; Fang, Shaoli; Lepro, Xavier; Lewis, Chihye; Ovalle-Robles, Raquel; Carretero-Gonzalez, Javier; Castillo-Martinez, Elizabeth; Kozlov, Mikhail E.; Oh, Jiyoung; Rawat, Neema; Haines, Carter S.; Haque, Mohammad H.; Aare, Vaishnavi; Stoughton, Stephanie; Zakhidov, Anvar A.; Baughman, Ray H.			Biscrolling Nanotube Sheets and Functional Guests into Yarns	SCIENCE			English	Article							CARBON NANOTUBES; OXYGEN REDUCTION; ELECTROCATALYTIC ACTIVITY; GRAPHENE NANORIBBONS; MAGNESIUM DIBORIDE; FIBERS; ARRAYS; NANOFIBERS; BATTERIES	Multifunctional applications of textiles have been limited by the inability to spin important materials into yarns. Generically applicable methods are demonstrated for producing weavable yarns comprising up to 95 weight percent of otherwise unspinnable particulate or nanofiber powders that remain highly functional. Scrolled 50-nanometer-thick carbon nanotube sheets confine these powders in the galleries of irregular scroll sacks whose observed complex structures are related to twist-dependent extension of Archimedean spirals, Fermat spirals, or spiral pairs into scrolls. The strength and electronic connectivity of a small weight fraction of scrolled carbon nanotube sheet enables yarn weaving, sewing, knotting, braiding, and charge collection. This technology is used to make yarns of superconductors, lithium-ion battery materials, graphene ribbons, catalytic nanofibers for fuel cells, and titanium dioxide for photocatalysis.	[Lima, Marcio D.; Fang, Shaoli; Lepro, Xavier; Lewis, Chihye; Ovalle-Robles, Raquel; Carretero-Gonzalez, Javier; Castillo-Martinez, Elizabeth; Kozlov, Mikhail E.; Oh, Jiyoung; Rawat, Neema; Haines, Carter S.; Haque, Mohammad H.; Aare, Vaishnavi; Stoughton, Stephanie; Zakhidov, Anvar A.; Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Baughman, RH (corresponding author), Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Castillo-Martinez, Elizabeth/D-1776-2013; Baughman, Ray/A-8628-2018; Lepro, Xavier/G-1021-2012; Gonzalez, Javier Carretero/H-3105-2017; Lima, Marcio/G-4634-2012	Castillo-Martinez, Elizabeth/0000-0002-8577-9572; Baughman, Ray/0000-0001-5845-5137; Lepro, Xavier/0000-0002-0166-3127; Gonzalez, Javier Carretero/0000-0002-6265-9746; Carretero Gonzalez, Javier/0000-0002-8008-5715; Zakhidov, Anvar/0000-0003-3983-2229	Air Force Grant [AOARD-10-4067]; Air Force Office of Scientific Research [FA9550-09-1-0384, FA9550-09-1-0537]; Office of Naval Research Multidisciplinary University Research Initiative [N00014-08-1-0654]; NSF [DMI-0609115]; Robert A. Welch Foundation [AT-0029]	Air Force Grant(United States Department of DefenseUS Air Force Research Laboratory); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research Multidisciplinary University Research Initiative(MURIOffice of Naval Research); NSF(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation)	We thank A. L. Elias and M. Terrones for N-doped MWNTs; D. Goldberg and Y. Bando for boron nitride nanotubes; E. J. Kneeland, A. E. Nabinger, S. Y. Yoon, and M. J. de Andrade for help with experiments; and A. E. Aliev and D. M. Rogers for useful comments. Supported by Air Force Grant AOARD-10-4067, Air Force Office of Scientific Research grants FA9550-09-1-0384 and FA9550-09-1-0537, Office of Naval Research Multidisciplinary University Research Initiative grant N00014-08-1-0654, NSF grant DMI-0609115, and Robert A. Welch Foundation grant AT-0029. Some of the authors have filed patent application PCT/US2010/36378 (27 May 2010).	Aliev AE, 2009, SCIENCE, V323, P1575, DOI 10.1126/science.1168312; Bhardwaj T, 2010, J AM CHEM SOC, V132, P12556, DOI 10.1021/ja106162f; Castano VM, 2005, JPN J APPL PHYS 1, V44, P5009, DOI 10.1143/JJAP.44.5009; Chen JJ, 2006, ELECTROCHEM COMMUN, V8, P855, DOI 10.1016/j.elecom.2006.03.021; Dalton AB, 2003, NATURE, V423, P703, DOI 10.1038/423703a; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Dou SX, 2006, ADV MATER, V18, P785, DOI 10.1002/adma.200501617; Golberg D, 2007, ADV MATER, V19, P2413, DOI 10.1002/adma.200700179; Gong KP, 2009, SCIENCE, V323, P760, DOI 10.1126/science.1168049; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Kozlov ME, 2005, ADV MATER, V17, P614, DOI 10.1002/adma.200401130; Kundu S, 2009, J PHYS CHEM C, V113, P14302, DOI 10.1021/jp811320d; Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719; Li QW, 2006, ADV MATER, V18, P3160, DOI 10.1002/adma.200601344; Li XL, 2007, ELECTROCHEM COMMUN, V9, P663, DOI 10.1016/j.elecom.2006.10.050; Maldonado S, 2005, J PHYS CHEM B, V109, P4707, DOI 10.1021/jp044442z; Nagamatsu J, 2001, NATURE, V410, P63, DOI 10.1038/35065039; Nakayama Y, 2008, JPN J APPL PHYS, V47, P8149, DOI 10.1143/JJAP.47.8149; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Shao YY, 2008, APPL CATAL B-ENVIRON, V79, P89, DOI 10.1016/j.apcatb.2007.09.047; Terrones M, 2000, CHEM COMMUN, P2335, DOI 10.1039/b008253h; Uddin MJ, 2008, J PHOTOCH PHOTOBIO A, V199, P64, DOI 10.1016/j.jphotochem.2008.05.004; Vigolo B, 2000, SCIENCE, V290, P1331, DOI 10.1126/science.290.5495.1331; Xiao L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2909593; Ye HH, 2004, APPL PHYS LETT, V85, P1775, DOI 10.1063/1.1787892; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhang XB, 2006, ADV MATER, V18, P1505, DOI 10.1002/adma.200502528; Zhang XF, 2007, SMALL, V3, P244, DOI 10.1002/smll.200600368	29	275	291	11	541	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					51	55		10.1126/science.1195912	http://dx.doi.org/10.1126/science.1195912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212350				2022-12-28	WOS:000285974000031
J	O'Connor, PG; Nyquist, JG; McLellan, AT				O'Connor, Patrick G.; Nyquist, Julie G.; McLellan, A. Thomas			Integrating Addiction Medicine Into Graduate Medical Education in Primary Care: The Time Has Come	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG-USE; ALCOHOL; INTERVENTIONS; PREVALENCE; CURRICULUM; DISORDERS	Substance use disorders create an enormous burden of medical, behavioral, and social problems and pose a major and costly public health challenge. Despite the high prevalence of substance use and its consequences, physicians often do not recognize these conditions and, as a result, provide inadequate patient care. At the center of this failure is insufficient training for physicians about substance use disorders. To address this deficit, the Betty Ford Institute convened a meeting of experts who developed the following 5 recommendations focused on improving training in substance abuse in primary care residency programs in internal medicine and family medicine: 1) integrating substance abuse competencies into training, 2) assigning substance abuse teaching the same priority as teaching about other chronic diseases, 3) enhancing faculty development, 4) creating addiction medicine divisions or programs in academic medical centers, and 5) making substance abuse screening and management routine care in new models of primary care practice. This enhanced primary care residency training should represent a major step forward in improving patient care.	[O'Connor, Patrick G.] Yale Univ, Sch Med, New Haven, CT 06520 USA; Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; White House Off Natl Drug Control Policy, Washington, DC USA	Yale University; University of Southern California	O'Connor, PG (corresponding author), Yale Univ, Sch Med, POB 208093, New Haven, CT 06520 USA.	patrick.oconnor@yale.edu			The Betty Ford Institute; Norlien Foundation	The Betty Ford Institute; Norlien Foundation	The Betty Ford Institute and the Norlien Foundation provided funding for this article and the conference that generated the recommendations.	Accreditation Council for Graduate Medical Education, 2007, COMM PROGR REQ GEN C; Berg AO, 2004, ANN INTERN MED, V140, P554, DOI 10.7326/0003-4819-140-7-200404060-00016; Bernstein Edward, 2007, Subst Abus, V28, P79, DOI 10.1300/J465v28n04_01; Bowen JL, 2005, J GEN INTERN MED, V20, P1181, DOI 10.1111/j.1525-1497.2005.0248.x; Croghan T. W, 2010, INTEGRATING MENTAL H; D'Amico EJ, 2005, MED CARE, V43, P229, DOI 10.1097/00005650-200503000-00005; Epstein RM, 2007, NEW ENGL J MED, V356, P387, DOI 10.1056/NEJMra054784; Fiellin David A, 2002, Subst Abus, V23, P207; Harwood H. J., 2000, UPDATING ESTIMATES E; Huang BJ, 2006, J CLIN PSYCHIAT, V67, P1062, DOI 10.4088/JCP.v67n0708; Institute of Medicine, 2005, IMPR QUAL HLTH CAR M; Jackson AH, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-22; Kirkpatrick D.L., 2007, IMPLEMENTING 4 LEVEL; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P1868, DOI 10.1001/jama.300.16.1868; Madras BK, 2009, DRUG ALCOHOL DEPEN, V99, P280, DOI 10.1016/j.drugalcdep.2008.08.003; Marcus Marianne T, 2005, Subst Abus, V26, P5; Mertens JR, 2005, ALCOHOL CLIN EXP RES, V29, P989, DOI 10.1097/01.ALC.0000167958.68586.3D; Miller NS, 2001, ACAD MED, V76, P410, DOI 10.1097/00001888-200105000-00007; National Center on Addiction and Substance Abuse at Columbia University, MISS OPP NAT SURV PR; O'Malley SS, 2003, ARCH INTERN MED, V163, P1695, DOI 10.1001/archinte.163.14.1695; Ramani S, 2008, MED TEACH, V30, P347, DOI 10.1080/01421590802061613; Ring JM, 2008, CURRICULUM CULTURALL; Seale JP, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-33; Substance Abuse and Mental Health Services Administration, 2010, RES 2009 NAT SURV DR, VI; Sullivan LE, 2008, ANN INTERN MED, V148, P662, DOI 10.7326/0003-4819-148-9-200805060-00006	25	82	83	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					56	U192		10.7326/0003-4819-154-1-201101040-00008	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200039				2022-12-28	WOS:000285830900007
J	Bostrom, P; Mann, N; Wu, J; Quintero, PA; Plovie, ER; Panakova, D; Gupta, RK; Xiao, CY; MacRae, CA; Rosenzweig, A; Spiegelman, BM				Bostroem, Pontus; Mann, Nina; Wu, Jun; Quintero, Pablo A.; Plovie, Eva R.; Panakova, Daniela; Gupta, Rana K.; Xiao, Chunyang; MacRae, Calum A.; Rosenzweig, Anthony; Spiegelman, Bruce M.			C/EBP beta Controls Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling	CELL			English	Article							SERUM RESPONSE FACTOR; HEART; MUSCLE; ROLES	The heart has the ability to growin size in response to exercise, but little is known about the transcriptional mechanisms underlying physiological hypertrophy. Adult cardiomyocytes have also recently been proven to hold the potential for proliferation, a process that could be of great importance for regenerative medicine. Using a unique RT-PCR-based screen against all transcriptional components, we showed that C/EBP beta was downregulated with exercise, whereas the expression of CITED4 was increased. Reduction of C/EBP beta in vitro and in vivo resulted in a phenocopy of endurance exercise with cardiomyocyte hypertrophy and proliferation. This proliferation was mediated, at least in part, by the increased CITED4. Importantly, mice with reduced cardiac C/EBP beta levels displayed substantial resistance to cardiac failure upon pressure overload. These data indicate that C/EBP beta represses cardiomyocyte growth and proliferation in the adult mammalian heart and that reduction in C/EBP beta is a central signal in physiologic hypertrophy and proliferation.	[Mann, Nina; Quintero, Pablo A.; Xiao, Chunyang; Rosenzweig, Anthony] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; [Mann, Nina; Quintero, Pablo A.; Xiao, Chunyang; Rosenzweig, Anthony] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Bostroem, Pontus; Wu, Jun; Gupta, Rana K.; Spiegelman, Bruce M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bostroem, Pontus; Wu, Jun; Gupta, Rana K.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Plovie, Eva R.; Panakova, Daniela; MacRae, Calum A.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Rosenzweig, A (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc, 330 Brookline Ave, Boston, MA 02215 USA.	arosenzw@bidmc.harvard.edu; bruce_spiegelman@dfci.harvard.edu	Rosenzweig, Anthony/AAD-7893-2019	Gupta, Rana/0000-0002-9001-4531; Panakova, Daniela/0000-0002-8739-6225	NIH [R01 HL085593]; Swedish Heart and Lung foundation; SSMF; Wenner-Gren Foundation; American Heart Association [09POST2010078]; Howard Hughes Postdoctoral Fellowship; T32 training grant; Leducq Foundation Network of Research Excellence; Maxwell Hurston Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109264, K08HL076361, R01HL085593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); SSMF; Wenner-Gren Foundation; American Heart Association(American Heart Association); Howard Hughes Postdoctoral Fellowship; T32 training grant; Leducq Foundation Network of Research Excellence(Leducq Foundation); Maxwell Hurston Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Shingo Kajimura for valuable discussion during the progression of the manuscript. This project was supported by NIH grant R01 HL085593. P. B. was supported by the Swedish Heart and Lung foundation, SSMF, and the Wenner-Gren Foundation. J.W. was supported by a postdoctoral fellowship from the American Heart Association (Founders Affiliate #09POST2010078). N.M. is a trainee the Harvard/MIT Health Sciences and Technology Program and is supported by a Howard Hughes Postdoctoral Fellowship. P. A. Q. is supported by a T32 training grant. This research was supported in part by a Leducq Foundation Network of Research Excellence (B. M. S. and A. R.) and grants from the NIH (A. R. and B. W. S.). A. R. also gratefully acknowledges support from Judith and David Ganz and the Maxwell Hurston Charitable Foundation. A. R. is a principal faculty member of the Harvard Stem Cell Institute.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Aoyama T, 2005, CIRCULATION, V111, P1652, DOI 10.1161/01.CIR.0000160352.58142.06; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bostrom P, 2010, DIABETES, V59, pA12; Braganca J, 2002, J BIOL CHEM, V277, P8559, DOI 10.1074/jbc.M110850200; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hanlon M, 1999, J BIOL CHEM, V274, P14224, DOI 10.1074/jbc.274.20.14224; Hulten LM, 2010, EUR J CLIN INVEST, V40, P11, DOI 10.1111/j.1365-2362.2009.02223.x; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Liao Ronglih, 2007, V139, P251; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Taniike M, 2008, CIRCULATION, V117, P545, DOI 10.1161/CIRCULATIONAHA.107.710434; Yahata T, 2002, GENOMICS, V80, P601, DOI 10.1006/geno.2002.7005	27	285	301	2	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1072	1083		10.1016/j.cell.2010.11.036	http://dx.doi.org/10.1016/j.cell.2010.11.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183071	Green Accepted, Bronze			2022-12-28	WOS:000285625400006
J	Egan, DF; Shackelford, DB; Mihaylova, MM; Gelino, S; Kohnz, RA; Mair, W; Vasquez, DS; Joshi, A; Gwinn, DM; Taylor, R; Asara, JM; Fitzpatrick, J; Dillin, A; Viollet, B; Kundu, M; Hansen, M; Shaw, RJ				Egan, Daniel F.; Shackelford, David B.; Mihaylova, Maria M.; Gelino, Sara; Kohnz, Rebecca A.; Mair, William; Vasquez, Debbie S.; Joshi, Aashish; Gwinn, Dana M.; Taylor, Rebecca; Asara, John M.; Fitzpatrick, James; Dillin, Andrew; Viollet, Benoit; Kundu, Mondira; Hansen, Malene; Shaw, Reuben J.			Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy	SCIENCE			English	Article							CATALYTIC SUBUNIT; AUTOPHAGY; COMPLEX; ROLES; METABOLISM; DOMAINS; TARGET; LIVER	Adenosine monophosphate-activated protein kinase (AMPK) is a conserved sensor of intracellular energy activated in response to low nutrient availability and environmental stress. In a screen for conserved substrates of AMPK, we identified ULK1 and ULK2, mammalian orthologs of the yeast protein kinase Atg1, which is required for autophagy. Genetic analysis of AMPK or ULK1 in mammalian liver and Caenorhabditis elegans revealed a requirement for these kinases in autophagy. In mammals, loss of AMPK or ULK1 resulted in aberrant accumulation of the autophagy adaptor p62 and defective mitophagy. Reconstitution of ULK1-deficient cells with a mutant ULK1 that cannot be phosphorylated by AMPK revealed that such phosphorylation is required for mitochondrial homeostasis and cell survival during starvation. These findings uncover a conserved biochemical mechanism coupling nutrient status with autophagy and cell survival.	[Egan, Daniel F.; Shackelford, David B.; Mihaylova, Maria M.; Kohnz, Rebecca A.; Mair, William; Vasquez, Debbie S.; Gwinn, Dana M.; Taylor, Rebecca; Dillin, Andrew; Shaw, Reuben J.] Salk Inst Biol Studies, Dulbecco Ctr Canc Res, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Mihaylova, Maria M.; Dillin, Andrew; Shaw, Reuben J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Fitzpatrick, James] Salk Inst Biol Studies, Waitt Adv Biophoton Ctr, La Jolla, CA 92037 USA; [Gelino, Sara; Hansen, Malene] Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, Grad Sch Biomed Sci, La Jolla, CA 92037 USA; [Joshi, Aashish; Kundu, Mondira] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Viollet, Benoit] Univ Paris 05, CNRS, Inst Cochin, INSERM,U1016,UMR 8104, Paris, France	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute; Sanford Burnham Prebys Medical Discovery Institute; St Jude Children's Research Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Dulbecco Ctr Canc Res, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu	Fitzpatrick, James/C-2268-2009; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; Mihaylova, Maria M./ACZ-4949-2022; Kundu, Mondira/N-8139-2018	Fitzpatrick, James/0000-0002-7907-3602; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Mihaylova, Maria M./0000-0002-2725-767X; Kundu, Mondira/0000-0001-9946-2472; Taylor, Rebecca/0000-0003-3429-3123; Mair, William/0000-0002-0661-1342	CMG; NIH [R01 DK080425, 1P01CA120964]; National Cancer Institute [P30CA014195]; American Cancer Society; American Diabetes Association [1-08-JF-47]; Howard Hughes Medical Institute; NHBLI [K08]; Burroughs Welcome Fund; American Lebanese Syrian Association; Agence Nationale de la Recherche (ANR); Ellison Medical Foundation; Helmsley Charitable Trust;  [T32 CA009370];  [5P30CA006516-43];  [1P01CA120964-01A]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA014195, T32CA009370, P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425] Funding Source: NIH RePORTER	CMG; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); American Diabetes Association(American Diabetes Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHBLI; Burroughs Welcome Fund(Burroughs Wellcome Fund); American Lebanese Syrian Association; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ellison Medical Foundation(Lawrence Ellison Foundation); Helmsley Charitable Trust; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Gerken for mouse colony assistance, F. Esterman for confocal assistance, C. Chu for assistance in scoring LGG-1 assays, M. Wood at The Scripps Research Institute EM facility, X. Yang in the Beth Israel Deaconess Medical Center mass spectometry facility, R. Chitta from St. Jude's proteomic core, and K. Lamia for comments on the manuscript. D.F.E., D.M.G., and M.M.M. were supported through the T32 CMG training grant to the UCSD-Salk Biological Sciences Graduate Program. D.B.S. was funded by T32 CA009370 to the Salk Institute Center for Cancer Research. R.J.S. is funded by the NIH grants R01 DK080425 and 1P01CA120964, National Cancer Institute grant P30CA014195, an American Cancer Society Research Scholar Award, the American Diabetes Association Junior Faculty Award 1-08-JF-47, and a Howard Hughes Medical Institute Early Career Scientist Award. J.M.A. is supported by grants 5P30CA006516-43 and 1P01CA120964-01A. M.K. is funded by grant NHBLI K08, Burroughs Welcome Fund, and the American Lebanese Syrian Association. B.V. is supported by Agence Nationale de la Recherche (ANR). M.H. is an Ellison Medical Foundation New Scholar in Aging. We also thank the Leona M. and Harry B. Helmsley Charitable Trust for their generous support. Several of the authors (D.F.E., D.B.S., M.M.M, and R.J.S.) have filed a patent related to this work (U.S. patent application 61/325361).	Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hars ES, 2007, AUTOPHAGY, V3, P93, DOI 10.4161/auto.3636; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5, P1099, DOI 10.4161/auto.5.8.9825; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781	32	1756	1841	14	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					456	461		10.1126/science.1196371	http://dx.doi.org/10.1126/science.1196371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21205641	Green Accepted			2022-12-28	WOS:000286635900052
J	Horie, T; Shinki, R; Ogura, Y; Kusakabe, TG; Satoh, N; Sasakura, Y				Horie, Takeo; Shinki, Ryoko; Ogura, Yosuke; Kusakabe, Takehiro G.; Satoh, Nori; Sasakura, Yasunori			Ependymal cells of chordate larvae are stem-like cells that form the adult nervous system	NATURE			English	Article							ASCIDIAN CIONA-INTESTINALIS; ORIGIN; EXPRESSION; PLACODES; GENES; BRAIN; IDENTIFICATION; TRANSGENESIS; NETWORKS; INSIGHTS	In ascidian tunicates, the metamorphic transition from larva to adult is accompanied by dynamic changes in the body plan. For instance, the central nervous system (CNS) is subjected to extensive rearrangement because its regulating larval organs are lost and new adult organs are created(1). To understand how the adult CNS is reconstructed, we traced the fate of larval CNS cells during ascidian metamorphosis by using transgenic animals and imaging technologies with photoconvertible fluorescent proteins(2). Here we show that most parts of the ascidian larval CNS, except for the tail nerve cord, are maintained during metamorphosis and recruited to form the adult CNS. We also show that most of the larval neurons disappear and only a subset of cholinergic motor neurons and glutamatergic neurons are retained. Finally, we demonstrate that ependymal cells of the larval CNS contribute to the construction of the adult CNS and that some differentiate into neurons in the adult CNS. An unexpected role of ependymal cells highlighted by this study is that they serve as neural stem-like cells to reconstruct the adult nervous network during chordate metamorphosis. Consequently, the plasticity of non-neuronal ependymal cells and neuronal cells in chordates should be re-examined by future studies(3,4).	[Horie, Takeo; Shinki, Ryoko; Ogura, Yosuke; Sasakura, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan; [Kusakabe, Takehiro G.] Konan Univ, Dept Biol, Kobe, Hyogo 6588501, Japan; [Satoh, Nori] Sci & Technol Promot Corp, Okinawa Inst, Marine Genom Unit, Okinawa 9040412, Japan	University of Tsukuba; Konan University	Horie, T (corresponding author), Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan.	horie@kurofune.shimoda.tsukuba.ac.jp	Satoh, Nori/C-4123-2009; Horie, Takeo/AAN-6967-2020; Kusakabe, Takehiro/H-7178-2012	Satoh, Nori/0000-0002-4480-3572; Horie, Takeo/0000-0002-4843-3775; Kusakabe, Takehiro/0000-0002-8325-3665; Ogura, Yosuke/0000-0002-5251-9176	Japan Society for the Promotion of Science; MEXT; National Institute of Genetics; Grants-in-Aid for Scientific Research [22310120] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Genetics; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge the members of the Shimoda Marine Research Center at the University of Tsukuba for their cooperation with our study. We also thank National Bio-resource Project, Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), S. Fujiwara and all members of the Maizuru Fishery Research Station of Kyoto University and the Education and Research Center of Marine Bioresources of Tohoku University for providing us with Ciona adults, and C. Savakis for providing Minos. This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and MEXT to T.H., T.G.K., N.S. and Y.S. Y.S. was supported by the National Institute of Genetics Cooperative Research Program.	Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Cole AG, 2004, DEV BIOL, V271, P239, DOI 10.1016/j.ydbio.2004.04.001; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Dufour HD, 2006, P NATL ACAD SCI USA, V103, P8727, DOI 10.1073/pnas.0600805103; Gilbert SF, 2006, DEV BIOL; Horie T, 2008, J COMP NEUROL, V508, P249, DOI 10.1002/cne.21678; Horie T, 2010, ZOOL SCI, V27, P181, DOI 10.2108/zsj.27.181; Horie T, 2009, DEV GROWTH DIFFER, V51, P207, DOI 10.1111/j.1440-169X.2009.01105.x; Hozumi A, 2010, DEV DYNAM, V239, P1076, DOI 10.1002/dvdy.22254; Ikuta T, 2007, DEV BIOL, V312, P631, DOI 10.1016/j.ydbio.2007.10.005; Imai KS, 2009, DEVELOPMENT, V136, P285, DOI 10.1242/dev.026419; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Joly JS, 2007, DEV DYNAM, V236, P1832, DOI 10.1002/dvdy.21124; KATZ MJ, 1983, BIOL BULL-US, V164, P1, DOI 10.2307/1541186; Konno A, 2010, DEV BIOL, V337, P42, DOI 10.1016/j.ydbio.2009.10.012; Kusakabe T, 2004, DEV BIOL, V276, P563, DOI 10.1016/j.ydbio.2004.09.037; Manni L, 2005, J EXP ZOOL PART B, V304B, P324, DOI 10.1002/jez.b.21039; Manni L, 2004, J EXP ZOOL PART B, V302B, P483, DOI 10.1002/jez.b.21013; Matsuoka T, 2005, GENESIS, V41, P67, DOI 10.1002/gene.20096; Moret F, 2005, DEV BIOL, V277, P567, DOI 10.1016/j.ydbio.2004.11.004; NICOL D, 1991, J COMP NEUROL, V309, P415, DOI 10.1002/cne.903090402; Nielsen C, 2005, EVOL DEV, V7, P483, DOI 10.1111/j.1525-142X.2005.05051.x; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Satoh N., 1994, DEV BIOL ASCIDIANS; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Takamura K, 2002, DEV GENES EVOL, V212, P50, DOI 10.1007/s00427-001-0205-0; Tarallo R, 2004, DEV DYNAM, V230, P251, DOI 10.1002/dvdy.20055; Tsuda M, 2003, VISION RES, V43, P3045, DOI 10.1016/j.visres.2003.09.012; Wada H, 1998, DEVELOPMENT, V125, P1113; Yoshida R, 2004, GENESIS, V39, P130, DOI 10.1002/gene.20032	33	62	63	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					525	U256		10.1038/nature09631	http://dx.doi.org/10.1038/nature09631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21196932				2022-12-28	WOS:000286596500031
J	Anderson, WA; Banerjee, U; Drennan, CL; Elgin, SCR; Epstein, IR; Handelsman, J; Hatfull, GF; Losick, R; O'Dowd, DK; Olivera, BM; Strobel, SA; Walker, GC; Warner, IM				Anderson, W. A.; Banerjee, U.; Drennan, C. L.; Elgin, S. C. R.; Epstein, I. R.; Handelsman, J.; Hatfull, G. F.; Losick, R.; O'Dowd, D. K.; Olivera, B. M.; Strobel, S. A.; Walker, G. C.; Warner, I. M.			Changing the Culture of Science Education at Research Universities	SCIENCE			English	Editorial Material							BIOLOGY		[Losick, R.] Harvard Univ, Cambridge, MA 02138 USA; [Anderson, W. A.] Howard Univ, Washington, DC 20059 USA; [Banerjee, U.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Drennan, C. L.; Walker, G. C.] MIT, Cambridge, MA 02139 USA; [Elgin, S. C. R.] Washington Univ, St Louis, MO 63130 USA; [Epstein, I. R.] Brandeis Univ, Waltham, MA 02453 USA; [Handelsman, J.; Strobel, S. A.] Yale Univ, New Haven, CT 06520 USA; [Hatfull, G. F.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [O'Dowd, D. K.] Univ Calif Irvine, Irvine, CA 92697 USA; [Olivera, B. M.] Univ Utah, Salt Lake City, UT 84112 USA; [Warner, I. M.] Lousiana State Univ, Baton Rouge, LA 70803 USA	Harvard University; Howard University; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Brandeis University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Irvine; Utah System of Higher Education; University of Utah; Louisiana State University System; Louisiana State University	Losick, R (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	losick@mcb.harvard.edu; dkodowd@uci.edu	kistner, kharol/E-6849-2010	Elgin, Sarah C. R./0000-0002-5176-2510; /0000-0001-7243-8261				[Anonymous], 2007, RISING GATHERING STO; [Anonymous], 1995, CHANGE, DOI DOI 10.1080/00091383.1995.10544672; Bok D., 2005, OUR UNDERACHIEVING C; Duschl R. A., 2007, TAKING SCI SCH LEARN, DOI DOI 10.17226/11625; Fairweather J., 2010, LINKING EVIDENCE PRO; Hake R. R., 2007, LATIN AM J PHYS ED, V1, P24; Handelsman J, 2007, SCI TEACHING; Johnson A. L., 1931, J CHEM EDUC, V8, P115; Klymkowsky Michael W, 2003, Cell Biol Educ, V2, P155, DOI 10.1187/cbe.03-03-0014; Koos L. V., 1919, ADJUSTMENT TEACHING; Labov JB, 2010, CBE-LIFE SCI EDUC, V9, P10, DOI 10.1187/cbe.09-12-0092; Lasry N, 2008, AM J PHYS, V76, P1066, DOI 10.1119/1.2978182; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; Marsh HW, 2002, J HIGH EDUC, V73, P603, DOI 10.1353/jhe.2002.0047; McDaniel M. A., 2008, LEARNING MEMORY COMP; Pashler H., 2007, ORG INSTRUCTION STUD; Pfund C, 2009, SCIENCE, V324, P470, DOI 10.1126/science.1170015; Physics Education Research at Colorado University-Boulder, PHYS ED RES COL U; Savkar V., 2010, TIME DECIDE AMBIVALE; Seymour E, 2004, SCI EDUC, V88, P493, DOI 10.1002/sce.10131; STEM at North Carolina State University, STEM N CARL STAT U; Taraban R., 2008, CREATING EFFECTIVE U; Taylor M. C., 2010, CHRON HIGH ED, V56, pA22; Wieman C., 2010, CHANGE           MAR; Wilson R., 2010, CHRON HIGH ED, V57, pA1; Wood WB, 2009, ANNU REV CELL DEV BI, V25, P93, DOI 10.1146/annurev.cellbio.24.110707.175306	26	149	158	1	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					152	153		10.1126/science.1198280	http://dx.doi.org/10.1126/science.1198280			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	709JA	21233371	Green Published			2022-12-28	WOS:000286433100024
J	Brittenham, GM				Brittenham, Gary M.			Iron-Chelating Therapy for Transfusional Iron Overload	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THALASSEMIA MAJOR; MYELODYSPLASTIC SYNDROMES; DEPENDENT THALASSEMIA; DEFERASIROX ICL670; DEFEROXAMINE; SICKLE; DESFERRIOXAMINE; GUIDELINES; HEMOCHROMATOSIS; METABOLISM	A 16-year-old boy with sickle cell anemia undergoes routine screening with transcranial Doppler ultrasonography to assess the risk of stroke. This examination shows an abnormally elevated blood-flow velocity in the middle cerebral artery. The hemoglobin level is 7.2 g per deciliter, the reticulocyte count is 12.5%, and the fetal hemoglobin level is 8.0%. Long-term treatment with red-cell transfusion is initiated to prevent stroke. A hematologist recommends prophylactic iron-chelating therapy.	[Brittenham, Gary M.] Columbia Univ Coll Phys & Surg, Dept Pediat, Div Pediat Hematol, New York, NY 10032 USA	Columbia University	Brittenham, GM (corresponding author), Columbia Univ, Med Ctr, Dept Pediat, Div Pediat Hematol, Rm CHN 10-08,3959 Broadway, New York, NY 10032 USA.	gmb31@columbia.edu	Noce, Annalisa/B-5558-2019		St. Giles Foundation; Food and Drug Administration [R01 FD003702]; National Institutes of Health [R37 DK049108, R01 DK066251]; FOOD AND DRUG ADMINISTRATION [R01FD003702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049108, R01DK066251] Funding Source: NIH RePORTER	St. Giles Foundation; Food and Drug Administration(United States Department of Health & Human Services); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the St. Giles Foundation, the Food and Drug Administration (R01 FD003702), and the National Institutes of Health (R37 DK049108; R01 DK066251).	Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Aessopos A., 2008, GUIDELINES CLIN MANA, P33; Anderson LJ, 2004, BRIT J HAEMATOL, V127, P348, DOI 10.1111/j.1365-2141.2004.05202.x; Angelucci E, 2008, HAEMATOLOGICA, V93, P741, DOI 10.3324/haematol.12413; BARRY M, 1974, BMJ-BRIT MED J, V2, P16, DOI 10.1136/bmj.2.5909.16; Beau-Salinas F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2319; Bennett JM, 2008, AM J HEMATOL, V83, P858, DOI 10.1002/ajh.21269; Borgna-Pignatti C, 2006, BLOOD, V107, P3733, DOI 10.1182/blood-2005-07-2933; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Borgna-Pignatti C, 2004, BRIT J HAEMATOL, V124, P114, DOI 10.1046/j.1365-2141.2003.04732.x; Breuer W, 2000, TRANSFUS SCI, V23, P185, DOI 10.1016/S0955-3886(00)00087-4; Cappellini MD, 2010, HAEMATOL-HEMATOL J, V95, P557, DOI 10.3324/haematol.2009.014696; Cappellini MD, 2006, BLOOD, V107, P3455, DOI 10.1182/blood-2005-08-3430; Chan YL, 2002, PEDIATR RADIOL, V32, P492, DOI 10.1007/s00247-002-0664-0; Claster S, 2009, AM J HEMATOL, V84, P344, DOI 10.1002/ajh.21416; COHEN A, 1990, J PEDIATR-US, V117, P326, DOI 10.1016/S0022-3476(05)80556-6; Cohen AR, COMPASSIONATE USE DE; Darbari DS, 2006, AM J HEMATOL, V81, P858, DOI 10.1002/ajh.20685; Davis BA, 2000, BLOOD, V95, P1229, DOI 10.1182/blood.V95.4.1229.004k32_1229_1236; De Domenico I, 2009, BLOOD, V114, P4546, DOI 10.1182/blood-2009-05-224188; De Sanctis V, 2006, J PEDIATR ENDOCR MET, V19, P471; Delea TE, 2007, TRANSFUSION, V47, P1919, DOI 10.1111/j.1537-2995.2007.01416.x; Delea TE, 2007, PHARMACOECONOMICS, V25, P329, DOI 10.2165/00019053-200725040-00005; Division of Blood Diseases and Resources NHLBI, 2002, MAN SICKL CELL DIS; European Medicines Agency, 2009, FERR DEF SUMM PROD C, P14; FILLET G, 1989, BLOOD, V74, P844; FINCH CA, 1982, ARCH INTERN MED, V142, P279, DOI 10.1001/archinte.142.2.279; Gattermann N, 2008, INT J HEMATOL, V88, P24, DOI 10.1007/s12185-008-0118-z; Jensen PD, 1996, BRIT J HAEMATOL, V94, P288, DOI 10.1046/j.1365-2141.1996.d01-1795.x; Ko C, 2007, LIVER INT, V27, P1394, DOI 10.1111/j.1478-3231.2007.01596.x; Leitch HA, 2010, BLOOD REV       1026; Marsh JCW, 2009, BRIT J HAEMATOL, V147, P43, DOI 10.1111/j.1365-2141.2009.07842.x; MODELL B, 1982, BRIT MED J, V284, P1081, DOI 10.1136/bmj.284.6322.1081; Novartis Pharmaceuticals, 2010, DESF DEF MES PRESCR; Novartis Pharmaceuticals, MYEL PLAST SYNDR MDS; Novartis Pharmaceuticals, 2010, EXJ DEF PRESCR INF; Olivieri, 1997, BLOOD, V89, P2621; Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739; OLIVIERI NF, 1986, NEW ENGL J MED, V314, P869, DOI 10.1056/NEJM198604033141402; Piga A, 2006, HAEMATOL-HEMATOL J, V91, P873; Porter J, 2008, EUR J HAEMATOL, V80, P168, DOI 10.1111/j.1600-0609.2007.00985.x; Roberts D., 2007, COCHRANE DB SYST REV, V3; Sickle Cell Society, 2008, STANDARDS CLIN CARE; Vichinsky E, 2005, AM J HEMATOL, V80, P70, DOI 10.1002/ajh.20402; Vichinsky E, 2007, BRIT J HAEMATOL, V136, P501, DOI 10.1111/j.1365-2141.2006.06455.x; Vichinsky EP, 2005, PEDIATRICS, V116, pE818, DOI 10.1542/peds.2005-0843; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Waldmeier F, 2010, DRUG METAB DISPOS, V38, P808, DOI 10.1124/dmd.109.030833; Walter PB, 2006, BRIT J HAEMATOL, V135, P254, DOI 10.1111/j.1365-2141.2006.06277.x; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Weatherall DJ., 2001, THALASSAEMIA SYNDROM, V4th ed	51	228	236	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					146	156		10.1056/NEJMct1004810	http://dx.doi.org/10.1056/NEJMct1004810			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226580	Green Accepted			2022-12-28	WOS:000286142900008
J	Jefferson, T; Doshi, P; Thompson, M; Heneghan, C				Jefferson, Tom; Doshi, Peter; Thompson, Matthew; Heneghan, Carl		Cochrane Acute Resp Infections Grp	Ensuring safe and effective drugs: who can do what it takes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE INFLUENZA; OSELTAMIVIR; EFFICACY; ROSIGLITAZONE		[Doshi, Peter] MIT, Program Hist Anthropol Sci Technol & Soc, Cambridge, MA 02139 USA; [Jefferson, Tom] Cochrane Collaborat, Acute Resp Infect Grp, Rome, Italy; [Thompson, Matthew; Heneghan, Carl] Univ Oxford, Dept Primary Hlth Care, Oxford, England; [Thompson, Matthew] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA	Massachusetts Institute of Technology (MIT); University of Oxford; Oregon Health & Science University	Doshi, P (corresponding author), MIT, Program Hist Anthropol Sci Technol & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pnd@mit.edu			National Institute for Health Research [10/80/01] Funding Source: researchfish; Department of Health [HTA/10/80/01, 10/80/01] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		COCHR ED UN, NEUR INH INFL HTA; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Godlee F, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5405; Higgins J.P.T., 2021, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Ioannidis JPA, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4875; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Li LY, 2003, CHINESE MED J-PEKING, V116, P44; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Monto AS, 1999, J ANTIMICROB CHEMOTH, V44, P23, DOI 10.1093/jac/44.suppl_2.23; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nissen S, 2010, ROSIGLITAZONE CRITIC; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; van Driel ML, 2009, J CLIN EPIDEMIOL, V62, P838, DOI 10.1016/j.jclinepi.2008.09.010	20	33	33	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2011	342								c7258	10.1136/bmj.c7258	http://dx.doi.org/10.1136/bmj.c7258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708SO	21224325				2022-12-28	WOS:000286384800009
J	Antonangeli, D; Siebert, J; Aracne, CM; Farber, DL; Bosak, A; Hoesch, M; Krisch, M; Ryerson, FJ; Fiquet, G; Badro, J				Antonangeli, Daniele; Siebert, Julien; Aracne, Chantel M.; Farber, Daniel L.; Bosak, A.; Hoesch, M.; Krisch, M.; Ryerson, Frederick J.; Fiquet, Guillaume; Badro, James			Spin Crossover in Ferropericlase at High Pressure: A Seismologically Transparent Transition?	SCIENCE			English	Article							EARTHS LOWER MANTLE; MGSIO3 PEROVSKITE; SOUND-VELOCITY; IRON; ELASTICITY; (MG,FE)O; MAGNESIOWUSTITE; ANISOTROPY	Seismic discontinuities in Earth typically arise from structural, chemical, or temperature variations with increasing depth. The pressure-induced iron spin state transition in the lower mantle may influence seismic wave velocities by changing the elasticity of iron-bearing minerals, but no seismological evidence of an anomaly exists. Inelastic x-ray scattering measurements on (Mg0.83Fe0.17)O-ferropericlase at pressures across the spin transition show effects limited to the only shear moduli of the elastic tensor. This explains the absence of deviation in the aggregate seismic velocities and, thus, the lack of a one-dimensional seismic signature of the spin crossover. The spin state transition does, however, influence shear anisotropy of ferropericlase and should contribute to the seismic shear wave anisotropy of the lower mantle.	[Antonangeli, Daniele; Siebert, Julien; Fiquet, Guillaume; Badro, James] Univ Paris Diderot, Univ Paris 06, Inst Phys Globe Paris, Inst Mineral & Phys Milieux Condenses,CNRS,UMR 75, F-75005 Paris, France; [Antonangeli, Daniele; Siebert, Julien; Aracne, Chantel M.; Farber, Daniel L.; Ryerson, Frederick J.; Badro, James] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Farber, Daniel L.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Bosak, A.; Hoesch, M.; Krisch, M.] European Synchrotron Radiat Facil, F-38043 Grenoble, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Santa Cruz; European Synchrotron Radiation Facility (ESRF)	Antonangeli, D (corresponding author), Univ Paris Diderot, Univ Paris 06, Inst Phys Globe Paris, Inst Mineral & Phys Milieux Condenses,CNRS,UMR 75, F-75005 Paris, France.	daniele.antonangeli@impmc.upmc.fr	BOSAK, Alexei/J-7895-2013; Ryerson, Frederick J/A-2105-2012; Fiquet, Guillaume/O-7077-2019; Fiquet, Guillaume/M-6934-2014; Fiquet, Guillaume M/H-1219-2011; Siebert, Julien/A-8336-2014; Farber, Daniel L/F-9237-2011; Krisch, Michael H/U-5662-2018; Badro, James/A-6003-2011; Hoesch, Moritz/AAJ-6574-2020	Fiquet, Guillaume/0000-0001-8961-3281; Siebert, Julien/0000-0001-9972-6239; Krisch, Michael H/0000-0001-7423-1715; Badro, James/0000-0001-9337-4789; Hoesch, Moritz/0000-0002-0114-2110	U.S. Department of Energy; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Office of Basic Energy Sciences; European Research Council (ERC) under the European Community [207467]; French National Research Agency [ANR-07-BLAN-0124-01]; ERC [207467]	U.S. Department of Energy(United States Department of Energy (DOE)); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); European Research Council (ERC) under the European Community(European Research Council (ERC)); French National Research Agency(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission)	We thank F. Occelli, G. Le Marchand, P. Munsch, P. Bouvier, M. Hanfland, M. Mezouar, and A. L. Auzende for experimental help. This work was performed under the auspices of the U.S. Department of Energy and Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344 and was supported by the Office of Basic Energy Sciences-Geosciences Research Program (F.J.R.). D.A., J.B., and J.S. acknowledge financial support from the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 207467. This work was supported by the French National Research Agency grant no. ANR-07-BLAN-0124-01 and ERC grant agreement no. 207467.	Antonangeli D, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.134303; Antonangeli D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.215505; Antonangeli D, 2004, EARTH PLANET SC LETT, V225, P243, DOI 10.1016/j.epsl.2004.06.004; Antonangeli D, 2010, EARTH PLANET SC LETT, V295, P292, DOI 10.1016/j.epsl.2010.04.018; Antonangeli D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.085501; Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Badro J, 2004, SCIENCE, V305, P383, DOI 10.1126/science.1098840; Cammarano F, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041583; Catalli K, 2010, EARTH PLANET SC LETT, V289, P68, DOI 10.1016/j.epsl.2009.10.029; Crowhurst JC, 2008, SCIENCE, V319, P451, DOI 10.1126/science.1149606; Crowhurst JC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2220537; Decremps F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.157204; Fei YW, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030712; Goncharov AF, 2006, SCIENCE, V312, P1205, DOI 10.1126/science.1125622; Jackson JM, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004052; Jackson JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023522; Jacobsen SD, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000490; Kiefer B, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014683; Lin JF, 2005, NATURE, V436, P377, DOI 10.1038/nature03825; Lin JF, 2007, SCIENCE, V317, P1740, DOI 10.1126/science.1144997; Lin JF, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028099; Lin JF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029880; Madi K, 2005, EARTH PLANET SC LETT, V237, P223, DOI 10.1016/j.epsl.2005.06.027; Marquardt H, 2009, EARTH PLANET SC LETT, V287, P345, DOI 10.1016/j.epsl.2009.08.017; Marquardt H, 2009, SCIENCE, V324, P224, DOI 10.1126/science.1169365; Masters G., 2008, EOS T AGU S, V89; Murakami M, 2007, EARTH PLANET SC LETT, V256, P47, DOI 10.1016/j.epsl.2007.01.011; Nataf L, 2006, ULTRASONICS, V44, pE555, DOI 10.1016/j.ultras.2006.05.188; Oganov AR, 2001, EARTH PLANET SC LETT, V184, P555, DOI 10.1016/S0012-821X(00)00363-0; Poirier J.-P., 2000, INTRO PHYS EARTHS IN; Speziale S, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004730; Tommaseo CE, 2006, PHYS CHEM MINER, V33, P84, DOI 10.1007/s00269-005-0054-x; Wentzcovitch RM, 2009, P NATL ACAD SCI USA, V106, P8447, DOI 10.1073/pnas.0812150106	33	92	99	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					64	67		10.1126/science.1198429	http://dx.doi.org/10.1126/science.1198429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212352				2022-12-28	WOS:000285974000035
J	Al-Khatib, SM; Hellkamp, A; Curtis, J; Mark, D; Peterson, E; Sanders, GD; Heidenreich, PA; Hernandez, AF; Curtis, LH; Hammill, S				Al-Khatib, Sana M.; Hellkamp, Anne; Curtis, Jeptha; Mark, Daniel; Peterson, Eric; Sanders, Gillian D.; Heidenreich, Paul A.; Hernandez, Adrian F.; Curtis, Lesley H.; Hammill, Stephen			Non-Evidence-Based ICD Implantations in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVERTER-DEFIBRILLATOR; MYOCARDIAL-INFARCTION; PROPHYLACTIC USE; HEART-FAILURE	Context Practice guidelines do not recommend use of an implantable cardioverter-defibrillator (ICD) for primary prevention in patients recovering from a myocardial infarction or coronary artery bypass graft surgery and those with severe heart failure symptoms or a recent diagnosis of heart failure. Objective To determine the number, characteristics, and in-hospital outcomes of patients who receive a non-evidence-based ICD and examine the distribution of these implants by site, physician specialty, and year of procedure. Design, Setting, and Patients Retrospective cohort study of cases submitted to the National Cardiovascular Data Registry-ICD Registry between January 1, 2006, and June 30, 2009. Main Outcome Measure In-hospital outcomes. Results Of 111 707 patients, 25 145 received non-evidence-based ICD implants (22.5%). Patients who received a non-evidence-based ICD compared with those who received an evidence-based ICD had a significantly higher risk of in-hospital death (0.57% [95% confidence interval {CI}, 0.48%-0.66%] vs 0.18% [95% CI, 0.15%-0.20%]; P<.001) and any postprocedure complication (3.23% [95% CI, 3.01%-3.45%] vs 2.41% [95% CI, 2.31%-2.51%]; P<.001). There was substantial variation in non-evidence-based ICDs by site. The rate of non-evidence-based ICD implants was significantly lower for electrophysiologists (20.8%; 95% CI, 20.5%-21.1%) than nonelectrophysiologists (24.8% [95% CI, 24.2%-25.3%] for nonelectrophysiologist cardiologists; 36.1% [95% CI, 34.3%-38.0%] for thoracic surgeons; and 24.9% [95% CI, 23.8%-25.9%] for other specialties) (P<.001 for all comparisons). There was no clear decrease in the rate of non-evidence-based ICDs over time (24.5% [6908/28 233] in 2006, 21.8% [7395/33 965] in 2007, 22.0% [7245/32 960] in 2008, and 21.7% [3597/16 549] in 2009; P<.001 for trend from 2006-2009 and P=.94 for trend from 2007-2009). Conclusion Among patients with ICD implants in this registry, 22.5% did not meet evidence-based criteria for implantation. JAMA. 2011;305(1):43-49 www.jama.com	[Al-Khatib, Sana M.; Hellkamp, Anne; Mark, Daniel; Peterson, Eric; Sanders, Gillian D.; Hernandez, Adrian F.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; [Curtis, Lesley H.] Duke Univ, Sch Med, Ctr Clin & Genet Econ, Durham, NC 27715 USA; [Al-Khatib, Sana M.; Peterson, Eric; Hernandez, Adrian F.] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27715 USA; Duke Univ, Sch Med, Dept Med, Div Gen Internal Med, Durham, NC 27715 USA; [Curtis, Jeptha] Yale Univ, Dept Med, Div Cardiovasc Med, New Haven, CT 06520 USA; [Heidenreich, Paul A.] VA Palo Alto Healthcare Syst, Div Cardiol, Palo Alto, CA USA; [Hammill, Stephen] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Duke University; Duke University; Duke University; Duke University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Mayo Clinic	Al-Khatib, SM (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	alkha001@mc.duke.edu	Heidenreich, Paul/AAU-6864-2021; Hernandez, Adrian F/A-7818-2016; Peterson, Eric David/ABF-5033-2021	Heidenreich, Paul/0000-0001-7730-8490; Hernandez, Adrian F/0000-0003-3387-9616; Mark, Daniel/0000-0001-6340-8087	Medtronic; Biotronik; American College of Cardiology; Eli Lilly Company; Proctor and Gamble; Pfizer; Alexion Pharmaceuticals; Medicure; Innocoll; St Judes Medical; Boston Scientific; Johnson Johnson; Merck Co; Allergan Pharmaceuticals; GlaxoSmithKline; OSI Eyetech; Sanofi-Aventis; National Heart, Lung, and Blood Institute [1R01-HL093071-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093071] Funding Source: NIH RePORTER	Medtronic(Medtronic); Biotronik; American College of Cardiology(General Electric); Eli Lilly Company(Eli Lilly); Proctor and Gamble(Procter & Gamble); Pfizer(Pfizer); Alexion Pharmaceuticals; Medicure; Innocoll; St Judes Medical(St. Jude Medical); Boston Scientific(Boston Scientific); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck Co(Merck & Company); Allergan Pharmaceuticals(AbbVieAllergan); GlaxoSmithKline(GlaxoSmithKline); OSI Eyetech; Sanofi-Aventis(Sanofi-Aventis); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Al-Khatib reported receiving research support and honoraria for presentations from Medtronic and Biotronik. Dr J. Curtis reported owning stock in Medtronic and receiving salary support from the American College of Cardiology. Dr Mark reported having consulted for Novartis and Sanofi-Aventis and receiving research grants from Eli Lilly & Company, Proctor and Gamble, Pfizer, Medtronic, Alexion Pharmaceuticals, Medicure, Innocoll, and St Judes Medical. Dr Sanders reported receiving research support from Medtronic. Dr Heidenreich reported receiving research support from Medtronic and consultancy fees from Boston Scientific. Dr Hernandez reported receiving research support from Johnson & Johnson, Medtronic, and Merck & Co; serving on the speakers' bureau for Novartis; and receiving honoraria from Amgen, AstraZeneca, and Medtronic. Dr L. Curtis reported receiving research and salary support from Allergan Pharmaceuticals, GlaxoSmithKline, Medtronic, OSI Eyetech, and Sanofi-Aventis (a detailed listing of her financial disclosures is available at https://www.dcri.org/about-us/conflict-of-interest/Curtis-COI.pdf). None of the other authors reported financial disclosures.; This analysis was funded by grant 1R01-HL093071-01A1 from the National Heart, Lung, and Blood Institute.	Al-Khatib SM, 2008, CIRC-ARRHYTHMIA ELEC, V1, P240, DOI 10.1161/CIRCEP.108.777888; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; Curtis JP, 2009, JAMA-J AM MED ASSOC, V301, P1661, DOI 10.1001/jama.2009.547; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Farmer SA, 2009, HEART RHYTHM, V6, P325, DOI 10.1016/j.hrthm.2008.12.018; Hammill SC, 2009, HEART RHYTHM, V6, P1397, DOI 10.1016/j.hrthm.2009.07.015; *HEART RHYTHM SOC, ICD REG PROGR; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; *NAT CARD DAT REG, ICD REG; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	15	184	186	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					43	49		10.1001/jama.2010.1915	http://dx.doi.org/10.1001/jama.2010.1915			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205965	Green Accepted			2022-12-28	WOS:000285924100023
J	Bawaskar, HS; Bawaskar, PH				Bawaskar, Himmatrao Saluba; Bawaskar, Pramodini Himmatrao			Efficacy and safety of scorpion antivenom plus prazosin compared with prazosin alone for venomous scorpion (Mesobuthus tamulus) sting: randomised open label clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR MANIFESTATIONS; ENVENOMATION; MANAGEMENT; SEROTHERAPY; CHILDREN; EXPERIENCE; CONCANESIS; THERAPY; STUNG; HEART	Objective Envenomation by Mesobuthus tamulus scorpion sting can result in serious cardiovascular effects. Scorpion antivenom is a specific treatment for scorpion sting. Evidence for the benefit of scorpion antivenom and its efficacy compared with that of commonly used vasodilators, such as prazosin, is scarce. We assessed the efficacy of prazosin combined with scorpion antivenom, compared with prazosin alone, in individuals with autonomic storm caused by scorpion sting. Design Prospective, open label randomised controlled trial. Setting General hospital inpatients (Bawaskar Hospital and Research Centre Mahad Dist-Raigad Maharashtra, India). Participants Seventy patients with grade 2 scorpion envenomation, older than six months, with no cardiorespiratory or central nervous system abnormalities. Intervention Scorpion antivenom plus prazosin (n=35) or prazosin alone (n=35) assigned by block randomisation. Treatment was not masked. Analysis was by intention to treat. Main outcome measures The primary end point was the proportion of patients achieving resolution of the clinical syndrome (sweating, salivation, cool extremities, priapism, hypertension or hypotension, tachycardia) 10 hours after administration of study drugs. Secondary end points were time required for complete resolution of clinical syndrome, prevention of deterioration to higher grade, doses of prazosin required overall and within 10 hours, and adverse events. The study protocol was approved by the independent ethics committee of Mumbai. Results Mean (SD) recovery times in hours for the prazosin plus scorpion antivenom group compared with the prazosin alone groups were: sweating 3 (1.1) v 6.6 (2.6); salivation 1.9 (0.9) v 3 (1.9); priapism 4.7 (1.5) v 9.4 (1.5). Mean (SD) doses of prazosin in the groups were 2 (2.3) and 4 (3.5), respectively. 32 patients (91.4%, 95% confidence interval 76.9% to 97.8%) in the prazosin plus antivenom group showed complete resolution of the clinical syndrome within 10 hours of administration of treatment compared with eight patients in the prazosin group (22.9%, 11.8% to 39.3%). Patients from the antivenom plus prazosin group recovered earlier (mean 8 hours, 95% CI 6.5 to 9.5) than those in the control group (17.7 hours, 15.4 to 19.9; mean difference -9.7 hours, -6.9 to -12.4). The number of patients whose condition deteriorated to a higher grade was similar in both groups (antivenom plus prazosin four of 35, prazosin alone five of 35). Hypotension was reported in fewer patients in the antivenom plus prazosin group (12 of 35, 34.3%) than in the prazosin group (19 of 35, 54.3%), but the difference was not statistically significant. No difference was noted in change in blood pressure and pulse rate over time between two groups. Conclusion Recovery from scorpion sting is hastened by simultaneous administration of scorpion antivenom plus prazosin compared with prazosin alone.	[Bawaskar, Himmatrao Saluba; Bawaskar, Pramodini Himmatrao] Bawaskar Hosp & Res Ctr, Mahad 402301, Maharashtra, India		Bawaskar, HS (corresponding author), Bawaskar Hosp & Res Ctr, Mahad 402301, Maharashtra, India.	himmatbawaskar@rediffmail.com						Abroug F, 1999, LANCET, V354, P906, DOI 10.1016/S0140-6736(98)12083-4; Al-Asmari AK, 2008, SAUDI MED J, V29, P299; AMARAL CFS, 1994, TOXICON, V32, P211, DOI 10.1016/0041-0101(94)90110-4; Bawaskar H S, 2007, J Assoc Physicians India, V55, P14; Bawaskar H S, 2000, J Assoc Physicians India, V48, P1175; BAWASKAR HS, 1992, BRIT HEART J, V68, P478, DOI 10.1136/hrt.68.11.478; BAWASKAR HS, 1994, TOXICON, V32, P1031, DOI 10.1016/0041-0101(94)90386-7; BAWASKAR HS, 1991, J TROP MED HYG, V94, P156; BAWASKAR HS, 1986, LANCET, V1, P510; Bawaskar HS, 2000, TROP DOCT, V30, P23, DOI 10.1177/004947550003000112; BAWASKAR HS, 1982, LANCET, V1, P552; BLUM A, 1992, CLIN CARDIOL, V15, P377, DOI 10.1002/clc.4960150514; Bosnak M, 2009, HUM EXP TOXICOL, V28, P721, DOI 10.1177/0960327109350667; Boyer LV, 2009, NEW ENGL J MED, V360, P2090, DOI 10.1056/NEJMoa0808455; Cupo P, 2002, TOXICON, V40, P823, DOI 10.1016/S0041-0101(02)00080-6; de Davila CAM, 2002, TOXICON, V40, P1339; DEHESADAVILA M, 1994, TOXICON, V32, P1015, DOI 10.1016/0041-0101(94)90383-2; DEREZENDE NA, 1995, AM J TROP MED HYG, V52, P277, DOI 10.4269/ajtmh.1995.52.277; Deshpande SB, 2010, J POSTGRAD MED, V56, P253, DOI 10.4103/0022-3859.70927; FREIREMAIA L, 1994, TOXICON, V32, P1009, DOI 10.1016/0041-0101(94)90382-4; Ghalim N, 2000, AM J TROP MED HYG, V62, P277, DOI 10.4269/ajtmh.2000.62.277; Gupta V, 2006, J TROP PEDIATRICS, V52, P150, DOI 10.1093/tropej/fmi097; Gwee MC, 2002, CLIN EXP PHARMACOL P, V29, P795, DOI 10.1046/j.1440-1681.2002.03726.x; ISMAIL M, 1994, TOXICON, V32, P1019, DOI 10.1016/0041-0101(94)90384-0; ISMAIL M, 1995, TOXICON, V33, P825, DOI 10.1016/0041-0101(95)00005-7; Kankonkar R C, 1998, J Postgrad Med, V44, P85; Karnad DR, 1998, HEART, V79, P485, DOI 10.1136/hrt.79.5.485; KARNAD DR, 1989, BRIT MED J, V298, P1430, DOI 10.1136/bmj.298.6685.1430; Keegan HL, 1980, SCORPIONS MED IMPORT, P17; Koseoglu Zikret, 2006, Am J Ther, V13, P285, DOI 10.1097/01.mjt.0000182269.71689.32; Mahadevan S, 1981, Indian J Pediatr, V48, P757, DOI 10.1007/BF02758544; MILLER RR, 1977, NEW ENGL J MED, V297, P303, DOI 10.1056/NEJM197708112970604; MUNDLE PM, 1961, BRIT MED J, V1, P1042, DOI 10.1136/bmj.1.5231.1042-a; MURTHY KRK, 1991, ANN TROP MED PARASIT, V85, P651, DOI 10.1080/00034983.1991.11812621; Natu VS, 2010, J POSTGRAD MED, V56, P275, DOI 10.4103/0022-3859.70938; Natu V S, 2006, J Assoc Physicians India, V54, P283; Peker E, 2010, HUM EXP TOXICOL, V29, P231, DOI 10.1177/0960327109359639; RAMACHANDRAN LK, 1986, INDIAN J BIOCHEM BIO, V23, P355; Singh SK, 2009, NEUROSCI LETT, V464, P199, DOI 10.1016/j.neulet.2009.08.052; SOFER S, 1994, J PEDIATR-US, V124, P973, DOI 10.1016/S0022-3476(05)83196-8; Tiwari AK, 1994, P 1 NAT S VEN TOX IN, P37; WARRELL DA, 1993, SAUDI MED J, V14, P196; Warrell DA, 1997, TROP DOCT, V27, P1	43	46	49	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2011	342								c7136	10.1136/bmj.c7136	http://dx.doi.org/10.1136/bmj.c7136			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NH	21209062	Green Published, hybrid			2022-12-28	WOS:000286142700003
J	Reilly, MP; Li, MY; He, J; Ferguson, JF; Stylianou, IM; Mehta, NN; Burnett, MS; Devaney, JM; Knouff, CW; Thompson, JR; Horne, BD; Stewart, AFR; Assimes, TL; Wild, PS; Allayee, H; Nitschke, PL; Patel, RS; Martinelli, N; Girelli, D; Quyyumi, AA; Anderson, JL; Erdmann, J; Hall, AS; Schunkert, H; Quertermous, T; Blankenberg, S; Hazen, SL; Roberts, R; Kathiresan, S; Samani, NJ; Epstein, SE; Rader, DJ				Reilly, Muredach P.; Li, Mingyao; He, Jing; Ferguson, Jane F.; Stylianou, Ioannis M.; Mehta, Nehal N.; Burnett, Mary Susan; Devaney, Joseph M.; Knouff, Christopher W.; Thompson, John R.; Horne, Benjamin D.; Stewart, Alexandre F. R.; Assimes, Themistocles L.; Wild, Philipp S.; Allayee, Hooman; Nitschke, Patrick Linsel; Patel, Riyaz S.; Martinelli, Nicola; Girelli, Domenico; Quyyumi, Arshed A.; Anderson, Jeffrey L.; Erdmann, Jeanette; Hall, Alistair S.; Schunkert, Heribert; Quertermous, Thomas; Blankenberg, Stefan; Hazen, Stanley L.; Roberts, Robert; Kathiresan, Sekar; Samani, Nilesh J.; Epstein, Stephen E.; Rader, Daniel J.		Myocardial Infarction Genetics Con; Wellcome Trust Case Control Consor	Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies	LANCET			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; VON-WILLEBRAND-FACTOR; SUSCEPTIBILITY LOCUS; CHROMOSOME 9P21; ARTERY-DISEASE; LINKAGE; METAANALYSIS; IMPUTATION; EFFICIENT; SELECTIN	Background We tested whether genetic factors distinctly contribute to either development of coronary atherosclerosis or, specifically, to myocardial infarction in existing coronary atherosclerosis. Methods We did two genome-wide association studies (GWAS) with coronary angiographic phenotyping in participants of European ancestry. To identify loci that predispose to angiographic coronary artery disease (CAD), we compared individuals who had this disorder (n=12393) with those who did not (controls, n=7383). To identify loci that predispose to myocardial infarction, we compared patients who had angiographic CAD and myocardial infarction (n=5783) with those who had angiographic CAD but no myocardial infarction (n=3644). Findings In the comparison of patients with angiographic CAD versus controls, we identified a novel locus, ADAMTS7 (p=4.98x10(-13)). In the comparison of patients with angiographic CAD who had myocardial infarction versus those with angiographic CAD but no myocardial infarction, we identified a novel association at the ABO locus (p=7.62x10(-9)). The ABO association was attributable to the glycotransferase-deficient enzyme that encodes the ABO blood group 0 phenotype previously proposed to protect against myocardial infarction. Interpretation Our findings indicate that specific genetic predispositions promote the development of coronary atherosclerosis whereas others lead to myocardial infarction in the presence of coronary atherosclerosis. The relation to specific CAD phenotypes might modify how novel loci are applied in personalised risk assessment and used in the development of novel therapies for CAD.	[Reilly, Muredach P.; Ferguson, Jane F.; Mehta, Nehal N.; Rader, Daniel J.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Reilly, Muredach P.; Stylianou, Ioannis M.; Mehta, Nehal N.; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Burnett, Mary Susan; Devaney, Joseph M.; Epstein, Stephen E.] Washington Hosp Ctr, MedStar Hlth Res Inst, Cardiovasc Res Inst, Washington, DC 20010 USA; [Knouff, Christopher W.] GlaxoSmithKline, Div Genet, King Of Prussia, PA USA; [Knouff, Christopher W.] GlaxoSmithKline, Drug Discovery, King Of Prussia, PA USA; [Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Horne, Benjamin D.; Anderson, Jeffrey L.] Intermt Med Ctr, Cardiovasc Dept, Salt Lake City, UT USA; [Horne, Benjamin D.] Univ Utah, Genet Epidemiol Div, Salt Lake City, UT USA; [Anderson, Jeffrey L.] Univ Utah, Div Cardiol, Salt Lake City, UT 84112 USA; [Stewart, Alexandre F. R.; Roberts, Robert] Univ Ottawa, Inst Heart, Dept Med, Ottawa, ON, Canada; [Assimes, Themistocles L.; Quertermous, Thomas] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Wild, Philipp S.; Blankenberg, Stefan] Univ Med Ctr Mainz, Dept Med 2, Mainz, Germany; [Allayee, Hooman] Univ So Calif, Keck Sch Med, Inst Med Genet, Dept Prevent Med, Los Angeles, CA 90033 USA; [Nitschke, Patrick Linsel; Erdmann, Jeanette; Schunkert, Heribert] Univ Lubeck, Med Klin 2, Lubeck, Germany; [Patel, Riyaz S.; Quyyumi, Arshed A.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; [Martinelli, Nicola; Girelli, Domenico] Univ Verona, Dept Med, I-37100 Verona, Italy; [Hall, Alistair S.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Hall, Alistair S.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England; [Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44106 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kathiresan, Sekar] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02139 USA; [Kathiresan, Sekar] Harvard Univ, Cambridge, MA 02138 USA; [Samani, Nilesh J.] Glenfield Hosp, Leicester Natl Inst Hlth Res, Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; MedStar Health Research Institute; MedStar Washington Hospital Center; GlaxoSmithKline; GlaxoSmithKline; University of Leicester; University of Leicester; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Ottawa; University of Ottawa Heart Institute; Stanford University; Johannes Gutenberg University of Mainz; University of Southern California; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Emory University; University of Verona; University of Leeds; University of Leeds; Cleveland Clinic Foundation; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Reilly, MP (corresponding author), Univ Penn, Cardiovasc Inst, 609 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	muredach@mail.med.upenn.edu	Munzel, Thomas/A-2912-2014; Horne, Benjamin/GQP-7851-2022; eyre, stephen/K-3776-2017; Assimes, Themistocles Leonard/D-9696-2015; Mehta, Nehal N/W-4669-2019; Dominiczak, Anna F/P-9390-2017; Tang, Wai Hong Wilson/I-1238-2013; Ramos, Rafel/D-9627-2016; Duga, Stefano/F-8173-2014; Wild, Philipp S./M-2106-2019; Willenborg, Christina/D-2668-2012; Erdmann, Jeanette/A-4417-2009; Breen, Gerome/Y-2706-2019; Erdmann, Jeanette/P-7513-2014; Hall, Alistair/K-1953-2019; Peters, Annette/A-6117-2011; Stewart, Alexandre F.R./A-5677-2011; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Ferguson, Jane/C-7154-2011; Collier, David A/D-1649-2011; Girelli, Domenico/B-1183-2008; Ramos, Rafel/P-2083-2019; Breen, Gerome D/A-5540-2010; Martinelli, Nicola/J-5622-2016; He, Jing/E-5316-2012; Lucas, Gavin/D-4346-2012; Hazen, Stanley L/ABD-5845-2021; Asselta, Rosanna/AAC-2367-2019	Munzel, Thomas/0000-0001-5503-4150; eyre, stephen/0000-0002-1251-6974; Assimes, Themistocles Leonard/0000-0003-2349-0009; Mehta, Nehal N/0000-0003-4939-5130; Dominiczak, Anna F/0000-0003-4913-3608; Ramos, Rafel/0000-0001-7970-5537; Duga, Stefano/0000-0003-3457-1410; Willenborg, Christina/0000-0001-5217-6882; Breen, Gerome/0000-0003-2053-1792; Erdmann, Jeanette/0000-0002-4486-6231; Peters, Annette/0000-0001-6645-0985; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Ferguson, Jane/0000-0001-6896-1025; Collier, David A/0000-0003-4087-1559; Girelli, Domenico/0000-0001-9684-1899; Ramos, Rafel/0000-0001-7970-5537; Breen, Gerome D/0000-0003-2053-1792; Martinelli, Nicola/0000-0001-6465-5119; Reilly, Muredach/0000-0002-3035-9386; Weedon, Michael/0000-0002-6174-6135; Melander, Olle/0000-0002-2581-484X; Lees, Charlie/0000-0002-0732-8215; Quertermous, Thomas/0000-0002-7645-9067; Wallace, Chris/0000-0001-9755-1703; Munroe, Patricia/0000-0002-4176-2947; Zeggini, Eleftheria/0000-0003-4238-659X; Lindgren, Cecilia/0000-0002-4903-9374; Asselta, Rosanna/0000-0001-5351-0619; Lango Allen, Hana/0000-0002-7803-8688; Zeller, Tanja/0000-0003-3379-2641; Stewart, Alexandre/0000-0003-2673-9164; Wild, Philipp/0000-0003-4413-9752; Iles, Mark/0000-0002-2603-6509; Marrugat, Jaume/0000-0003-3320-554X; Dunger, Professor David/0000-0002-2566-9304; Hattersley, Andrew/0000-0001-5620-473X; Berzuini, Carlo/0000-0001-6056-0489; Ouwehand, Willem/0000-0002-7744-1790; Piazza, Alberto/0000-0002-2355-4183; Hall, Alistair/0000-0003-0306-7887	Cardiovascular Institute of the University of Pennsylvania; MedStar Health Research Institute at Washington Hospital Center; GlaxoSmithKline; MRC [G0800759, G0600329, G0800675] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278, KL2RR024132] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676, P01HL076491, P01HL098055, K23HL097151, R01HL087647, R01HL071878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071224] Funding Source: NIH RePORTER; Medical Research Council [G9817803B, G0600329, G0801418B, G0800675, G0800759] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish	Cardiovascular Institute of the University of Pennsylvania; MedStar Health Research Institute at Washington Hospital Center; GlaxoSmithKline(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The PennCath and MedStar studies were supported by the Cardiovascular Institute of the University of Pennsylvania, by the MedStar Health Research Institute at Washington Hospital Center and by a research grant from GlaxoSmithKline. The funding and support for the other cohorts contributing to the paper are described in the webappendix.	Assimes TL, 2008, HUM MOL GENET, V17, P2320, DOI 10.1093/hmg/ddn132; Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; BRONTESTEWART B, 1962, BRIT MED J, P1646, DOI 10.1136/bmj.1.5293.1646; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Dandona S, 2010, HUM GENET, V127, P101, DOI 10.1007/s00439-009-0761-3; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Horne BD, 2008, CIRC-CARDIOVASC GENE, V1, P85, DOI 10.1161/CIRCGENETICS.108.793158; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Ketch TR, 2008, THROMB RES, V123, P200, DOI 10.1016/j.thromres.2008.02.003; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martinelli N, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-41; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pare G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000118; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; Somerville RPT, 2004, J BIOL CHEM, V279, P35159, DOI 10.1074/jbc.M402380200; Storry J R, 2009, Immunohematology, V25, P48; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tiret L, 2005, CIRCULATION, V112, P643, DOI 10.1161/CIRCULATIONAHA.104.519702; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389; Wang L, 2009, CIRC RES, V104, P688, DOI 10.1161/CIRCRESAHA.108.188425; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu O, 2008, J THROMB HAEMOST, V6, P62; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	39	378	398	0	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2011	377	9763					383	392		10.1016/S0140-6736(10)61996-4	http://dx.doi.org/10.1016/S0140-6736(10)61996-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721ES	21239051	Green Accepted			2022-12-28	WOS:000287337000028
J	Baron, N				Baron, Nancy			Stand up for science	NATURE			English	Editorial Material									[Baron, Nancy] Natl Ctr Ecol Anal & Synth, COMPASS, Santa Barbara, CA 93101 USA; [Baron, Nancy] Natl Ctr Ecol Anal & Synth, Aldo Leopold Leadership Program, Santa Barbara, CA 93101 USA	National Center for Ecological Analysis & Synthesis; National Center for Ecological Analysis & Synthesis	Baron, N (corresponding author), Natl Ctr Ecol Anal & Synth, COMPASS, Santa Barbara, CA 93101 USA.	baron@nceas.ucsb.edu						*AGU, 2010, 1037 AGU; Bowman TE, 2010, SCIENCE, V330, P1044, DOI 10.1126/science.330.6007.1044; Lubchenco J, 1998, SCIENCE, V279, P491, DOI 10.1126/science.279.5350.491; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Palmer MA, 2010, SCIENCE, V327, P148, DOI 10.1126/science.1180543; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	7	15	15	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1032	1033		10.1038/4681032a	http://dx.doi.org/10.1038/4681032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21170025	Bronze			2022-12-28	WOS:000285553800033
J	Paradis-Bleau, C; Markovski, M; Uehara, T; Lupoli, TJ; Walker, S; Kahne, DE; Bernhardt, TG				Paradis-Bleau, Catherine; Markovski, Monica; Uehara, Tsuyoshi; Lupoli, Tania J.; Walker, Suzanne; Kahne, Daniel E.; Bernhardt, Thomas G.			Lipoprotein Cofactors Located in the Outer Membrane Activate Bacterial Cell Wall Polymerases	CELL			English	Article							PENICILLIN-BINDING PROTEINS; ESCHERICHIA-COLI; HAEMOPHILUS-INFLUENZAE; PEPTIDOGLYCAN BIOSYNTHESIS; PBP1B; IDENTIFICATION; MORPHOGENESIS; COMPLEXES; MUTANTS; DIMERS	Most bacteria surround themselves with a peptidoglycan (PG) exoskeleton synthesized by polysaccharide polymerases called penicillin-binding proteins (PBPs). Because they are the targets of penicillin and related antibiotics, the structure and biochemical functions of the PBPs have been extensively studied. Despite this, we still know surprisingly little about how these enzymes build the PG layer in vivo. Here, we identify the Escherichia coli outermembrane lipoproteins LpoA and LpoB as essential PBP cofactors. We show that LpoA and LpoB form specific trans-envelope complexes with their cognate PBP and are critical for PBP function in vivo. We further show that LpoB promotes PG synthesis by its partner PBP in vitro and that it likely does so by stimulating glycan chain polymerization. Overall, our results indicate that PBP accessory proteins play a central role in PG biogenesis, and like the PBPs they work with, these factors are attractive targets for antibiotic development.	[Paradis-Bleau, Catherine; Markovski, Monica; Uehara, Tsuyoshi; Walker, Suzanne; Bernhardt, Thomas G.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Kahne, Daniel E.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lupoli, Tania J.; Walker, Suzanne; Kahne, Daniel E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Bernhardt, TG (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	thomas_bernhardt@hms.harvard.edu		Uehara, Tsuyoshi/0000-0001-6994-4286	Massachusetts Life Science Center; Burroughs Wellcome Fund; National Institutes of Health [R01 AI083365-01A1, GM066174, GM076710]; FRSQ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066174, R01GM076710] Funding Source: NIH RePORTER	Massachusetts Life Science Center; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRSQ(Fonds de la Recherche en Sante du Quebec); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank D. Rudner, M. Waldor, and members of our laboratories for critical reading of the manuscript. We would also like to thank A. Typas, C. Gross, W. Vollmer, and coworkers for communicating their results in advance of publication. Special thanks to K. Suefuji and J.T. Park for generously providing the UDP-M-pep5. This work was supported by the Massachusetts Life Science Center (T. G. B.), the Burroughs Wellcome Fund (T. G. B.), and the National Institutes of Health (R01 AI083365-01A1 for T. G. B, GM066174 for D. E. K., and GM076710 for D. E. K and S. W.). T. G. B. holds a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund. C.P.-B. was supported in part by a fellowship from FRSQ.	Alaedini A, 1999, BIOCHEM BIOPH RES CO, V264, P191, DOI 10.1006/bbrc.1999.1509; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Charpentier X, 2002, J BACTERIOL, V184, P3749, DOI 10.1128/JB.184.13.3749-3752.2002; DELPORTILLO FG, 1990, J BACTERIOL, V172, P5863; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; DENBLAAUWEN T, 1990, J BACTERIOL, V172, P71, DOI 10.1128/JB.172.1.71-79.1990; Dougherty TJ, 1996, J BACTERIOL, V178, P6110, DOI 10.1128/jb.178.21.6110-6115.1996; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; GOODELL EW, 1975, J GEN MICROBIOL, V86, P201, DOI 10.1099/00221287-86-2-201; KATO J, 1985, MOL GEN GENET, V200, P272, DOI 10.1007/BF00425435; Lewenza S, 2006, J BACTERIOL, V188, P3516, DOI 10.1128/JB.188.10.3516-3524.2006; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; MIRELMAN D, 1976, BIOCHEMISTRY-US, V15, P1781, DOI 10.1021/bi00654a001; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; SCHMIDT LS, 1981, J BACTERIOL, V145, P632, DOI 10.1128/JB.145.1.632-637.1981; SCHWARZ U, 1971, J BACTERIOL, V106, P588, DOI 10.1128/JB.106.2.588-595.1971; SPRATT BG, 1975, NATURE, V254, P516, DOI 10.1038/254516a0; TAMAKI S, 1977, P NATL ACAD SCI USA, V74, P5472, DOI 10.1073/pnas.74.12.5472; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Vijayalakshmi J, 2008, PROTEINS, V73, P204, DOI 10.1002/prot.22033; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Wong SM, 2003, GENE, V316, P177, DOI 10.1016/S0378-1119(03)00762-5; YOUSIF SY, 1985, J GEN MICROBIOL, V131, P2839	32	222	227	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1110	1120		10.1016/j.cell.2010.11.037	http://dx.doi.org/10.1016/j.cell.2010.11.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183074	Bronze, Green Accepted			2022-12-28	WOS:000285625400009
J	Sengupta, S; Peterson, TR; Laplante, M; Oh, S; Sabatini, DM				Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.			mTORC1 controls fasting-induced ketogenesis and its modulation by ageing	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; FATTY-ACID OXIDATION; RAT-LIVER; MICE; IDENTIFICATION; GENES	The multi-component mechanistic target of rapamycin complex 1 (mTORC1) kinase is the central node of a mammalian pathway that coordinates cell growth with the availability of nutrients, energy and growth factors(1). Progress has been made in the identification of mTORC1 pathway components and in understanding their functions in cells, but there is relatively little known about the role of the pathway in vivo. Specifically, we have little knowledge regarding the role mTOCR1 has in liver physiology. In fasted animals, the liver performs numerous functions that maintain whole-body homeostasis, including the production of ketone bodies for peripheral tissues to use as energy sources. Here we show that mTORC1 controls ketogenesis in mice in response to fasting. We find that liver-specific loss of TSC1 (tuberous sclerosis 1), an mTORC1 inhibitor(1), leads to a fasting-resistant increase in liver size, and to a pronounced defect in ketone body production and ketogenic gene expression on fasting. The loss of raptor (regulatory associated protein of mTOR, complex 1) an essential mTORC1 component(1), has the opposite effects. In addition, we find that the inhibition of mTORC1 is required for the fasting-induced activation of PPAR alpha (peroxisome proliferator activated receptor alpha), the master transcriptional activator of ketogenic genes(2), and that suppression of NCoR1 (nuclear receptor co-repressor 1), a co-repressor of PPAR alpha(3), reactivates ketogenesis in cells and livers with hyperactive mTORC1 signalling. Like livers with activated mTORC1, livers from aged mice have a defect in ketogenesis(4,5), which correlates with an increase in mTORC1 signalling. Moreover, we show that the suppressive effects of mTORC1 activation and ageing on PPAR alpha activity and ketone production are not additive, and that mTORC1 inhibition is sufficient to prevent the ageing-induced defect in ketogenesis. Thus, our findings reveal that mTORC1 is a key regulator of PPAR alpha function and hepatic ketogenesis and suggest a role for mTORC1 activity in promoting the ageing of the liver.	[Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256; Oh, Stephanie/0000-0002-6287-9116	American Diabetes Association; Ludwig Cancer Fund; Canadian Institutes of Health Research; NIH [CA103866, CA129105]; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Ludwig Cancer Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Biddinger and C. R. Kahn for providing the Ir<SUP>loxP/loxP</SUP> and Li-Ir<SUP>KO</SUP> mice; D. Kwiatkowski for the Tsc1<SUP>loxP/loxP</SUP> mice; R. Zoncu for assistance with imaging experiments and image analysis; F. Reinhardt for assistance in animal virus injections; and T. Jacks, L. Guarente, V. Mootha and members of the Sabatini laboratory for support and discussions. This research was supported by fellowships from the American Diabetes Association and Ludwig Cancer Fund to T. R. P.; a fellowship from the Canadian Institutes of Health Research to M. L.; and NIH grants CA103866 and CA129105 to D. M. S. D. M. S. is an investigator of the Howard Hughes Medical Institute.	Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Faraj M, 2004, AM J PHYSIOL-ENDOC M, V287, pE150, DOI 10.1152/ajpendo.00398.2003; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Glass CK, 2000, GENE DEV, V14, P121; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Hoch RV, 2006, DEVELOPMENT, V133, P663, DOI 10.1242/dev.02242; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; MCGARRY JD, 1973, J BIOL CHEM, V248, P270; MCGARRY JD, 1971, J BIOL CHEM, V246, P1149; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Osoegawa K, 2000, GENOME RES, V10, P116; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283	30	439	447	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1100	U502		10.1038/nature09584	http://dx.doi.org/10.1038/nature09584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179166				2022-12-28	WOS:000285553800058
J	Aronow, HD				Aronow, Herbert D.			Adding clopidogrel to proton-pump inhibitors was not associated with increased CV risk after MI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Michigan Heart & Vasc Inst, Ann Arbor, MI USA		Aronow, HD (corresponding author), Michigan Heart & Vasc Inst, Ann Arbor, MI USA.							Allen Christopher, 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P66; Bhatt DL, 2010, N ENGL J MED; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Yusuf S, 2001, NEW ENGL J MED, V345, P494	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12							JC6-13	10.7326/0003-4819-153-12-201012210-02013	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173402				2022-12-28	WOS:000285453700018
J	Kirshner, HS				Kirshner, Howard S.			A biobehavioral intervention improved caregiver well-being and some measures of functioning in patients with dementia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA	Vanderbilt University	Kirshner, HS (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA.							[Anonymous], 2010, PFIZ MED ANN RES 2 P; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Hogan DB, 2008, CAN MED ASSOC J, V179, P1019, DOI 10.1503/cmaj.081103	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12							JC6-4	10.7326/0003-4819-153-12-201012210-02004	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173405				2022-12-28	WOS:000285453700021
J	Leipzig, RM; Whitlock, EP; Wolff, TA; Barton, MB; Michael, YL; Harris, R; Petitti, D; Wilt, T; Siu, A				Leipzig, Rosanne M.; Whitlock, Evelyn P.; Wolff, Tracy A.; Barton, Mary B.; Michael, Yvonne L.; Harris, Russell; Petitti, Diana; Wilt, Timothy; Siu, Al		US Preventive Serv Task Force Geri	Reconsidering the Approach to Prevention Recommendations for Older Adults	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES-TASK-FORCE; RISK-FACTORS; ELDERLY-PEOPLE; COMMUNITY; INTERVENTION; FALLS	The U.S. Preventive Services Task Force (USPSTF) bases its recommendations on an evidence-based model of clinical prevention that focuses on specific diseases, well-defined preventive interventions, and evidence of improved health outcomes. Applying this model to prevention for very old patients has been problematic for several reasons: Many geriatric disorders have multiple risk factors, interventions, and expected outcomes; older adults are not often represented in clinical trials; and important outcomes may not be measured and reported in ways that are conducive to evidence synthesis and interpretation. In 2005, the USPSTF convened a geriatrics workgroup to refine USPSTF methodology and processes to better address the preventive needs of older adults. The USPSTF has begun to apply these new approaches to the review and recommendation on interventions to prevent falls in older adults.	[Leipzig, Rosanne M.] Mt Sinai Sch Med, Brookdale Dept Geriatr & Adult Dev, New York, NY 10029 USA; Kaiser Permanente NW, Ctr Hlth Res, Oregon Evidence Based Practice Ctr, Portland, OR USA; Agcy Healthcare Res & Qual, Rockville, MD 20850 USA; Univ N Carolina, Chapel Hill, NC 27599 USA; Arizona State Univ, Phoenix, AZ 85004 USA; Minneapolis Vet Affairs Med Ctr, Minneapolis, MN 55417 USA; Univ Minnesota, Minneapolis, MN 55417 USA	Icahn School of Medicine at Mount Sinai; Kaiser Permanente; Agency for Healthcare Research & Quality; University of North Carolina; University of North Carolina Chapel Hill; Arizona State University; Arizona State University-Downtown Phoenix; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Leipzig, RM (corresponding author), Mt Sinai Sch Med, Brookdale Dept Geriatr & Adult Dev, 1468 Madison Ave,Box 1070, New York, NY 10029 USA.		Michael, Yvonne Louise/AAB-9995-2020		Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The general work of the USPSTF is supported by the Agency for Healthcare Research and Quality. This specific manuscript did not receive separate funding.	[Anonymous], 2007, FUT DIS AM; Berg AO, 2003, ANN INTERN MED, V138, P925, DOI 10.7326/0003-4819-138-11-200306030-00014; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; Guirguis-Blake J, 2007, ANN INTERN MED, V147, P117, DOI 10.7326/0003-4819-147-2-200707170-00170; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Whitlock EP, 2008, ANN INTERN MED, V148, P776, DOI 10.7326/0003-4819-148-10-200805200-00010	13	33	33	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					809	+		10.7326/0003-4819-153-12-201012210-00007	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173415				2022-12-28	WOS:000285453700004
J	Haigo, SL; Bilder, D				Haigo, Saori L.; Bilder, David			Global Tissue Revolutions in a Morphogenetic Movement Controlling Elongation	SCIENCE			English	Article							DROSOPHILA FOLLICULAR EPITHELIUM; OVARIAN FOLLICLES; PLANAR POLARITY; CELL-MIGRATION; AXIS; INTERCALATION; MECHANISMS; EXTENSION; INTEGRIN; PATHWAY	Polarized cell behaviors drive axis elongation in animal embryos, but the mechanisms underlying elongation of many tissues remain unknown. Eggs of Drosophila undergo elongation from a sphere to an ellipsoid during oogenesis. We used live imaging of follicles (developing eggs) to elucidate the cellular basis of egg elongation. We find that elongating follicles undergo repeated rounds of circumferential rotation around their long axes. Follicle epithelia mutant for integrin or collagen IV fail to rotate and elongate, which results in round eggs. We present evidence that polarized rotation is required to build a polarized, fibrillar extracellular matrix (ECM) that constrains tissue shape. Thus, global tissue rotation is a morphogenetic behavior that uses planar polarity information in the ECM to control tissue elongation.	[Haigo, Saori L.; Bilder, David] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bilder, D (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 379 Life Sci Addit 3200, Berkeley, CA 94720 USA.	bilder@berkeley.edu		Bilder, David/0000-0002-1842-4966	Berkeley Graduate Fellowship; American Heart Association; NIH [R01 GM068675]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068675] Funding Source: NIH RePORTER	Berkeley Graduate Fellowship; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kimbrell, L. Cooley, A. Spradling, M. Buszczak, J. Lipsick, and the Bloomington Drosophila Stock Center for kindly providing fly stocks and M. Welch for providing reagents. We thank members of the Bilder laboratory, I. Hariharan, and R. Harland for providing feedback and S. Windler for comments on the manuscript. We apologize to those whose work could only be cited in review articles. This work is supported by a Berkeley Graduate Fellowship and an American Heart Association Predoctoral Fellowship to S.L.H. and by NIH grant R01 GM068675 to D.B.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Bastock R, 2007, DEVELOPMENT, V134, P3055, DOI 10.1242/dev.010447; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; Becam IE, 2005, NAT CELL BIOL, V7, P510, DOI 10.1038/ncb1253; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Conder R, 2007, DEV BIOL, V305, P470, DOI 10.1016/j.ydbio.2007.02.034; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; GUTZEIT HO, 1990, EUR J CELL BIOL, V53, P349; GUTZEIT HO, 1991, J CELL SCI, V100, P781; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; King R. C., 1970, OVARIAN DEV DROSOPHI; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Mirouse V, 2009, DEV CELL, V16, P83, DOI 10.1016/j.devcel.2008.11.006; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; SHIH J, 1992, DEVELOPMENT, V116, P901; Spradling Allan C., 1993, P1; Viktorinova I, 2009, DEVELOPMENT, V136, P4123, DOI 10.1242/dev.039099; Wallingford JB, 2005, AM J MED GENET C, V135C, P59, DOI 10.1002/ajmg.c.30054; WENT DF, 1978, J EXP ZOOL, V205, P149, DOI 10.1002/jez.1402050118	30	210	213	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1071	1074		10.1126/science.1199424	http://dx.doi.org/10.1126/science.1199424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21212324	Green Accepted			2022-12-28	WOS:000287699000065
J	Raj, A				Raj, Anita			Gender equity and universal health coverage in India	LANCET			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA	Boston University	Raj, A (corresponding author), Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA.	anitaraj@bu.edu						Balarajan Y, 2011, LANCET; Hausmann R., 2010, GLOBAL GENDER GAP RE; International Institute for Population Sciences & Macro International, 2007, NAT FAM HLTH SURV NF, V1; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; RAJ A, 2010, GYNECOL OBSTET, V110, P35; Raj A, 2009, LANCET, V373, P1883, DOI 10.1016/S0140-6736(09)60246-4; REDDY KS, 2011, LANCET; SILVERMAN JG, ARCH PEDIAT IN PRESS; United Nations Development Programme (UNDP), 2010, HUMAN DEV REPORT 201	9	19	19	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 19	2011	377	9766					618	619		10.1016/S0140-6736(10)62112-5	http://dx.doi.org/10.1016/S0140-6736(10)62112-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	727DB	21227498				2022-12-28	WOS:000287776600007
J	Walport, M; Brest, P				Walport, Mark; Brest, Paul			Sharing research data to improve public health	LANCET			English	Editorial Material									[Walport, Mark] Wellcome Trust Res Labs, London NW1 2BE, England; [Brest, Paul] Hewlett Fdn, Menlo Pk, CA USA	Hewlett-Packard	Walport, M (corresponding author), Wellcome Trust Res Labs, London NW1 2BE, England.	m.walport@wellcome.ac.uk		Walport, Mark/0000-0001-7220-5273				Cochrane GR, 2010, NUCLEIC ACIDS RES, V38, pD1, DOI 10.1093/nar/gkp1077; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Pisani E, 2010, LANCET, V375, P703, DOI 10.1016/S0140-6736(09)61486-0; Wellcome Trust, 2011, SHAR RES DAT IMPR PU	4	146	148	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 12	2011	377	9765					537	539		10.1016/S0140-6736(10)62234-9	http://dx.doi.org/10.1016/S0140-6736(10)62234-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724DQ	21216456				2022-12-28	WOS:000287556700008
J	Balarajan, Y; Selvaraj, S; Subramanian, SV				Balarajan, Y.; Selvaraj, S.; Subramanian, S. V.			India: Towards Universal Health Coverage 4 Health care and equity in India	LANCET			English	Article							DEVELOPING-COUNTRIES; SYSTEM REFORM; DEMAND-SIDE; INEQUALITIES; SERVICES; ACCESS; BARRIERS; POVERTY; CHALLENGES; EDUCATION	In India, despite improvements in access to health care, inequalities are related to socioeconomic status, geography, and gender, and are compounded by high out-of-pocket expenditures, with more than three-quarters of the increasing financial burden of health care being met by households. Health-care expenditures exacerbate poverty, with about 39 million additional people falling into poverty every year as a result of such expenditures. We identify key challenges for the achievement of equity in service provision, and equity in financing and financial risk protection in India. These challenges include an imbalance in resource allocation, inadequate physical access to high-quality health services and human resources for health, high out-of-pocket health expenditures, inflation in health spending, and behavioural Factors that affect the demand for appropriate health care. Use of equity metrics in monitoring, assessment, and strategic planning; investment in development of a rigorous knowledge base of health-systems research; development of a refined equity-focused process of deliberative decision making in health reform; and redefinition of the specific responsibilities and accountabilities of key actors are needed to try to achieve equity in health care in India. The implementation of these principles with strengthened public health and primary-care services will help to ensure a more equitable health care for India's population.	[Balarajan, Y.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Selvaraj, S.] Publ Hlth Fdn India, New Delhi, India	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Public Health Foundation of India	Balarajan, Y (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.		Selvaraj, Sakthivel/ABD-5873-2021; Selvaraj, Sakthivel/ABE-6897-2020	Selvaraj, Sakthivel/0000-0001-5940-1958	National Institutes of Health [NHLBI K25 HL081275]; John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	YB, SS, and SVS received no funding support to undertake this study. SVS is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275). The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India.	Acharya LB, 2000, HEALTH POLICY PLANN, V15, P223, DOI 10.1093/heapol/15.2.223; [Anonymous], 2010, HLTH NUTR POPUL SER; [Anonymous], 2010, WORLD HLTH STAT 2010; [Anonymous], 1998, NFHS2 IIPS MACR INT; [Anonymous], 1992, NATL FAM HLTH SURV M; [Anonymous], THEORY JUSTICE; BAJPAI N, 2009, IMPROVING ACCESS SER; Banerjee A, 2006, J ECON PERSPECT, V20, P117, DOI 10.1257/089533006776526139; Banerjee A, 2003, EC POLIT WKLY, V39, P944; Baru R., 2005, REV HEALTHCARE INDIA; Bhat R, 1996, HEALTH POLICY PLANN, V11, P265, DOI 10.1093/heapol/11.3.265; Bonu S, 2009, HEALTH POLICY PLANN, V24, P445, DOI 10.1093/heapol/czp032; Burd-Sharps S, 2008, MEAS AM AM HUM DEV R; CBHI, 2008, INFR NAT HLTH PROF I; Chan M, PLOS MED, pe1000223; Chaudhury N, 2006, J ECON PERSPECT, V20, P91, DOI 10.1257/089533006776526058; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; Daniels Norman, 2008, JUST HLTH M HLTH NEE; Daniels Norman, 1996, BENCHMARKS FAIRNESS; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; Das J, 2007, J DEV ECON, V83, P1, DOI 10.1016/j.jdeveco.2006.05.004; Dasgupta M, 2009, WORLD BANK POLICY RE; Day Gupta M, 2004, INDIAS PUBLIC HLTH S; De Costa A, 2009, HEALTH POLICY, V93, P41, DOI 10.1016/j.healthpol.2009.03.015; Devadasan N, 2006, HEALTH POLICY, V78, P224, DOI 10.1016/j.healthpol.2005.10.005; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Evans T., 2001, CHALLENGING INEQUITI; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; Frenk J, PLOS MED, V7, pe1000089; Frenk J, 2006, LANCET, V368, P3, DOI 10.1016/S0140-6736(06)68942-3; Fryatt R, 2010, LANCET, V375, P419, DOI 10.1016/S0140-6736(09)61833-X; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Gaudin S, 2006, SOC SCI MED, V62, P694, DOI 10.1016/j.socscimed.2005.06.042; Gill K., 2009, 1 PLANN COMM IND; Gilson L, 2007, WHO COMM SOC DET HLT; Gita Sen, 2002, Economic and Political Weekly, V37, P1342; Goddard M, 2001, SOC SCI MED, V53, P1149, DOI 10.1016/S0277-9536(00)00415-9; Government of India, 2009, NAT HLTH ACC IND 200; Government of India, 2009, STAT DOM PROD; Government of India Planning Commission, 2008, 11 5 YEAR PLAN 2007, VII; Griffiths P, 2001, J BIOSOC SCI, V33, P339, DOI 10.1017/S002193200100339X; Gupta I, 2000, I EC GROWTH, V14, P1; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; Hammer J. S., 2004, STRAINED MERCY QUALI; Harper S, 2010, MILBANK Q, V88, P4, DOI 10.1111/j.1468-0009.2010.00587.x; Hart JT, 2000, BRIT MED J, V320, P18; *IIPS MACR INT, 2007, NFHS3 IIPS MACR INT; Kawachi I, 2002, J EPIDEMIOL COMMUN H, V56, P647, DOI 10.1136/jech.56.9.647; Krishna A, 2004, WORLD DEV, V32, P121, DOI 10.1016/j.worlddev.2003.08.002; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Lavy V, 1994, WORLD BANK QUAL COST; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Lewis M., 2006, GOVERNANCE CORRUPTIO; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; MAHAL A, 2001, POOR HLTH SERVICE US; Manager of Publications, 1946, REPORT HLTH SURVEY D; MoHFW, 2009, NATL RUR HLTH MISS; MoHFW, 2005, NATL HLTH ACC INDIA; MoHFW, 1983, NATL HLTH POLICY; MoHFW, 2009, NATL HLTH BILL; MoHFW, 2005, M PEOPLES HLTH NEEDS; MoHFW, 2002, NATL HLTH POLICY; National Sample Survey Organisation (NSSO), 2006, MORB HLTH CAR COND A; NSSO, 2006, HOUS CONS EXP; NSSO, 2000, HOUS CONS EXP; NSSO, 1998, MORB HLTH CAR COND A; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; O'Donnell O, 2007, CAD SAUDE PUBLICA, V23, P2820, DOI 10.1590/S0102-311X2007001200003; Office of the Registrar General and Census Commissioner, 2008, CENS ATL IND 2001; OLSON M., 1971, LOGIC COLLECTIVE ACT; Peters D.H., 2002, BETTER HLTH SYSTEMS; Peters DH, 2008, SOC SCI MED, V66, P2133, DOI 10.1016/j.socscimed.2008.01.037; Peters DH, 2003, HEALTH POLICY PLANN, V18, P249, DOI 10.1093/heapol/czg031; Planning Commission Government of India, 2008, 11 5 YEAR PLAN 2007; Pritchett L, 2009, INDIA FLAILING STATE; Ranson MK, 2002, REPROD HEALTH MATTER, V10, P70, DOI 10.1016/S0968-8080(02)00086-1; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; Rao S, 2005, FINANCING HLH INDIA; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; Roberts M., 2008, GETTING HLTH REFORM, DOI DOI 10.1093/ACPROF:OSO/9780195371505.001.0001; Rohde J, 1994, Health Millions, V2, P13; Selvaraj S, 2009, EC POLIT WKLY, V40, P55; Selvaraj S, 2010, INDIA HLTH REPORT 20, P83; Sengupta A, 2008, EC CONSTRAINTS ACCES; Siddiqi S, 2009, HEALTH POLICY, V90, P13, DOI 10.1016/j.healthpol.2008.08.005; Singh C H, 2009, Indian J Public Health, V53, P6; Sreevidya S, 2003, BJOG-INT J OBSTET GY, V110, P106, DOI 10.1046/j.1471-0528.2003.02006.x; Subramanian SV, 2006, PLOS MED, V3, P1794, DOI 10.1371/journal.pmed.0030421; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; Subramanian SV., 2008, BROWN J WORLD AFF, V14, P127; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Tangcharoensathien V, 2007, ECONOMICS OF HEALTH EQUITY, P222, DOI 10.1017/CBO9780511544460.012; Thampi GK, 2002, CORRUPTION S ASIA IN; UNICEF, 2009, STATE WORLDS CHILDRE; UNICEF & WHO, 1978, DECL ALM AT INT C PR; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Vissandjee B, 1997, PUBLIC HEALTH, V111, P135, DOI 10.1016/S0033-3506(97)00572-6; Whitehead M, 1990, CONCEPTS PRINCIPLES; WHO, 2009, DIS INJ COUNTR EST D; WHO, 2000, WORLD HLTH REP 2000; WHO, 2008, PHARMAFORUM 0121; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; Yip W, 2008, HEALTH AFFAIR, V27, P921, DOI 10.1377/hlthaff.27.4.921	107	494	497	4	89	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2011	377	9764					505	515		10.1016/S0140-6736(10)61894-6	http://dx.doi.org/10.1016/S0140-6736(10)61894-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721TX	21227492	Green Accepted			2022-12-28	WOS:000287381800032
J	Macilwain, C				Macilwain, Colin			Funding in 2011: East Heats Up as West Cools Down	CELL			English	Editorial Material																		[Anonymous], EUROSTAT; *EUR MED RES COUNC, EUR MED RES COUNC 20; UNITED NATIONS EDUCATIONAL SCIENTIFIC AND CULTURAL ORGANIZATION, UNESCO SCI REP 2010	3	4	4	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 21	2011	144	2					167	169		10.1016/j.cell.2011.01.002	http://dx.doi.org/10.1016/j.cell.2011.01.002			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241886	Bronze			2022-12-28	WOS:000286459900001
J	Rosenbeck, L; Kiel, PJ				Rosenbeck, Lindsay; Kiel, Patrick J.			Palmar-Plantar Rash with Cytarabine Therapy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbeck, Lindsay; Kiel, Patrick J.] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Rosenbeck, L (corresponding author), Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA.	lrosenb1@clarian.org							0	10	10	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					E5	E5		10.1056/NEJMicm1006530	http://dx.doi.org/10.1056/NEJMicm1006530			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21247311				2022-12-28	WOS:000286383900013
J	Shetty, P				Shetty, Priya			Rani and Abhay Bang-pioneers of health care in rural India	LANCET			English	Editorial Material												priya4876@googlemail.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 15	2011	377	9761					199	199		10.1016/S0140-6736(11)60034-2	http://dx.doi.org/10.1016/S0140-6736(11)60034-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	712WG	21237388				2022-12-28	WOS:000286696400012
J	Wawer, MJ; Tobian, AAR; Kigozi, G; Kong, XR; Gravitt, PE; Serwadda, D; Nalugoda, F; Makumbi, F; Ssempiija, V; Sewankambo, N; Watya, S; Eaton, KP; Oliver, AE; Chen, MZ; Reynolds, SJ; Quinn, TC; Gray, RH				Wawer, Maria J.; Tobian, Aaron A. R.; Kigozi, Godfrey; Kong, Xiangrong; Gravitt, Patti E.; Serwadda, David; Nalugoda, Fred; Makumbi, Frederick; Ssempiija, Victor; Sewankambo, Nelson; Watya, Stephen; Eaton, Kevin P.; Oliver, Amy E.; Chen, Michael Z.; Reynolds, Steven J.; Quinn, Thomas C.; Gray, Ronald H.			Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda	LANCET			English	Article							RISK HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; FEMALE PARTNERS; YOUNG MEN; PREVENTION; INFECTION; METAANALYSIS; PREVALENCE; DNA; ACQUISITION	Background Randomised trials show that male circumcision reduces the prevalence and incidence of high-risk human papillomavirus (HPV) infection in men. We assessed the efficacy of male circumcision to reduce prevalence and incidence of high-risk HPV in female partners of circumcised men. Methods In two parallel but independent randomised controlled trials of male circumcision, we enrolled HIV-negative men and their female partners between 2003 and 2006, in Rakai, Uganda. With a computer-generated random number sequence in blocks of 20, men were assigned to undergo circumcision immediately (intervention) or after 24 months (control). HIV-uninfected female partners (648 of men from the intervention group, and 597 of men in the control group) were simultaneously enrolled and provided interview information and self-collected vaginal swabs at baseline, 12 months, and 24 months. Vaginal swabs were tested for high-risk HPV by Roche HPV Linear Array. Female HPV infection was a secondary endpoint of the trials, assessed as the prevalence of high-risk HPV infection 24 months after intervention and the incidence of new infections during the trial. Analysis was by intention-to-treat. An as-treated analysis was also done to account for study-group crossovers. The trials were registered, numbers NCT00425984 and NCT00124878. Findings During the trial, 18 men in the control group underwent circumcision elsewhere, and 31 in the intervention group did not undergo circumcision. At 24-month follow-up, data were available for 544 women in the intervention group and 488 in the control group; 151 (27.8%) women in the intervention group and 189 (38.7%) in the control group had high-risk HPV infection (prevalence risk ratio=0.72, 95% CI 0.60-0.85, p=0.001). During the trial, incidence of high-risk HPV infection in women was lower in the intervention group than in the control group (20.7 infections vs 26.9 infections per 100 person-years; incidence rate ratio=0.77, 0.63-0.93, p=0.008). Interpretation Our findings indicate that male circumcision should now be accepted as an efficacious intervention for reducing the prevalence and incidence of HPV infections in female partners. However, protection is only partial; the promotion of safe sex practices is also important.	[Tobian, Aaron A. R.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21287 USA; [Wawer, Maria J.; Tobian, Aaron A. R.; Kong, Xiangrong; Chen, Michael Z.; Gray, Ronald H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21287 USA; [Eaton, Kevin P.; Oliver, Amy E.; Reynolds, Steven J.; Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; [Kong, Xiangrong] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21287 USA; [Gravitt, Patti E.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21287 USA; [Wawer, Maria J.; Kigozi, Godfrey; Serwadda, David; Nalugoda, Fred; Makumbi, Frederick; Ssempiija, Victor; Sewankambo, Nelson; Gray, Ronald H.] Rakai Hlth Sci Program, Entebbe, Uganda; [Serwadda, David; Nalugoda, Fred; Makumbi, Frederick] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Sewankambo, Nelson] Makerere Univ, Sch Allied Med Sci, Kampala, Uganda; [Sewankambo, Nelson] Makerere Univ, Dept Med, Kampala, Uganda; [Watya, Stephen] Makerere Univ, Dept Urol, Kampala, Uganda; [Reynolds, Steven J.; Quinn, Thomas C.] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Rakai Health Sciences Program; Makerere University; Makerere University; Makerere University; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tobian, AAR (corresponding author), Johns Hopkins Univ, Dept Pathol, Carnegie 667,600 N Wolfe St, Baltimore, MD 21287 USA.	atobian1@jhmi.edu	Hug, Balthasar L./G-1568-2010	Sewankambo, Nelson/0000-0001-9362-053X; Reynolds, Steven/0000-0002-5403-2759	The Bill & Melinda Gates Foundation [22006.02]; National Institutes of Health [U1AI51171]; Fogarty International Center [5D43TW001508, 2D43TW00001049-AITRP]; National Institute of Allergy and Infectious Diseases (NIAID), NIH [U01-A1-068613, 3U01-AI075115-03S1]; NIAID; Johns Hopkins University; FOGARTY INTERNATIONAL CENTER [D43TW001508, T22TW000015, D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000361, U01AI075115, U01AI068613, ZIAAI001040, U01AI051171] Funding Source: NIH RePORTER	The Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases (NIAID), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins University(Johns Hopkins University); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Bill & Melinda Gates Foundation, National Institutes of Health, and Fogarty International Center.; The study was funded by the Bill & Melinda Gates Foundation (22006.02) and the National Institutes of Health (U1AI51171). The Fogarty International Center (5D43TW001508 and 2D43TW00001049-AITRP) contributed to training. National Institute of Allergy and Infectious Diseases (NIAID), NIH grants (U01-A1-068613 and 3U01-AI075115-03S1) and NIAID Intramural Program provided laboratory support. AART was supported by the Johns Hopkins University Clinician Scientist Award. We thank the study participants and the Rakai Community Advisory Board whose commitment and cooperation made this study possible. We thank Edward M'bidde, Director, Uganda Virus Research Institute, for his continuing support, and Renee Ridzon of the Bill & Melinda Gates Foundation and Melanie Bacon of National Institutes of Health for their assistance with the trial.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BRINTON LA, 1989, INT J CANCER, V44, P199, DOI 10.1002/ijc.2910440202; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Dickson NP, 2009, CANCER EPIDEM BIOMAR, V18, P177, DOI 10.1158/1055-9965.EPI-08-0353; Drain PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-172; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giuliano AR, 2009, INT J CANCER, V124, P1251, DOI 10.1002/ijc.24097; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2010, J INFECT DIS, V201, P1455, DOI 10.1086/652184; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Kigozi G, 2008, PLOS MED, V5, P911, DOI 10.1371/journal.pmed.0050116; KJAER SK, 1991, INT J CANCER, V48, P39; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mbulawa ZZA, 2009, J INFECT DIS, V199, P1514, DOI 10.1086/598220; MOSCICKI AB, 1993, J INFECT DIS, V167, P723, DOI 10.1093/infdis/167.3.723; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nielson CM, 2009, J INFECT DIS, V199, P7, DOI 10.1086/595567; Ogilvie GS, 2005, SEX TRANSM INFECT, V81, P207, DOI 10.1136/sti.2004.011858; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Serwadda D, 1999, J INFECT DIS, V180, P1316, DOI 10.1086/315026; Tobian AAR, 2010, ARCH PEDIAT ADOL MED, V164, P78, DOI 10.1001/archpediatrics.2009.232; Tobian AAR, 2009, AIDS, V23, P1589, DOI 10.1097/QAD.0b013e32832d4042; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weaver BA, 2004, J INFECT DIS, V189, P677, DOI 10.1086/381395	30	129	137	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 15	2011	377	9761					209	218		10.1016/S0140-6736(10)61967-8	http://dx.doi.org/10.1016/S0140-6736(10)61967-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	712WG	21216000	Green Accepted			2022-12-28	WOS:000286696400028
J	Aguilera, C; Nakagawa, K; Sancho, R; Chakraborty, A; Hendrich, B; Behrens, A				Aguilera, Cristina; Nakagawa, Kentaro; Sancho, Rocio; Chakraborty, Atanu; Hendrich, Brian; Behrens, Axel			c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex	NATURE			English	Article							BINDING DOMAIN; MAP KINASES; STEM-CELLS; MBD3; NURD; TUMORIGENESIS; ACTIVATION; COMPONENT; MI-2/NURD; COLON	AP-1 (activator protein 1) activity is strongly induced in response to numerous signals, including growth factors, cytokines and extracellular stresses(1). The proto-oncoprotein c-Jun belongs to the AP-1 group of transcription factors and it is a crucial regulator of intestinal progenitor proliferation and tumorigenesis(2-4). An important mechanism of AP-1 stimulation is phosphorylation of c-Jun by the Jun amino-terminal kinases (JNKs)(1). N-terminal phosphorylation of the c-Jun transactivation domain increases target gene transcription(5,6), but a molecular explanation was elusive. Here we show that unphosphorylated, but not N-terminally phosphorylated c-Jun, interacts with Mbd3 and thereby recruits the nucleosome remodelling and histone deacetylation (NuRD) repressor complex. Mbd3 depletion in colon cancer cells increased histone acetylation at AP-1-dependent promoters, which resulted in increased target gene expression. The intestinal stem cell marker lgr5 was identified as a novel target gene controlled by c-Jun/Mbd3. Gut-specific conditional deletion of mbd3 (mbd3(Delta G/Delta G) mice) stimulated c-Jun activity and increased progenitor cell proliferation. In response to inflammation, mdb3 deficiency resulted in colonic hyperproliferation and mbd3(Delta G/Delta G) mice showed markedly increased susceptibility to colitis-induced tumorigenesis. Notably, concomitant inactivation of a single allele of c-jun reverted physiological and pathological hyperproliferation, as well as the increased tumorigenesis in mbd3(Delta G/Delta G) mice. Thus the transactivation domain of c-Jun recruits Mbd3/NuRD to AP-1 target genes to mediate gene repression, and this repression is relieved by JNK-mediated c-Jun N-terminal phosphorylation.	[Aguilera, Cristina; Nakagawa, Kentaro; Sancho, Rocio; Chakraborty, Atanu; Behrens, Axel] Canc Res UK London Res Inst, Mammalian Genet Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England; [Nakagawa, Kentaro] Tokyo Med & Dent Univ, Grad Sch Med, Dept Med Biochem, Bunkyo Ku, Tokyo 1138519, Japan; [Hendrich, Brian] Univ Cambridge, Dept Biochem, MRC,Wellcome Trust Ctr Stem Cell Res, Ctr Stem Cell Biol & Regenerat Med, Cambridge CB2 1QR, England	Cancer Research UK; Tokyo Medical & Dental University (TMDU); University of Cambridge	Behrens, A (corresponding author), Canc Res UK London Res Inst, Mammalian Genet Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	axel.behrens@cancer.org.uk	Hendrich, Brian/AAG-5898-2020	Hendrich, Brian/0000-0002-0231-3073; Sancho, Rocio/0000-0002-4894-5391; Behrens, Axel/0000-0002-1557-1143	Marie Curie Intraeuropean Fellowships [PIEF-GA-2008-220566, MEIF-CT-2006-041119]; Cancer Research UK; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish	Marie Curie Intraeuropean Fellowships(European Commission); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the LRI Animal Unit, Equipment Park, FACS, Peptide synthesis and the Experimental Histopathology unit for technical help and O. S. Gabrielsen for reagents. We thank C. Hill and H. Van Dam for critical reading of the manuscript. C. A. and R. S. were funded by Marie Curie Intraeuropean Fellowships (PIEF-GA-2008-220566 and MEIF-CT-2006-041119). The London Research Institute is funded by Cancer Research UK.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BAICHWAL VR, 1992, GENE DEV, V6, P1493, DOI 10.1101/gad.6.8.1493; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; D'Orazio D, 1997, GENE, V201, P179, DOI 10.1016/S0378-1119(97)00445-9; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364	28	92	99	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					231	235		10.1038/nature09607	http://dx.doi.org/10.1038/nature09607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21196933				2022-12-28	WOS:000286143400042
J	Macilwain, C				Macilwain, Colin			University cuts show science is far from saved	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					133	133		10.1038/469133a	http://dx.doi.org/10.1038/469133a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	705NO	21228831	Bronze			2022-12-28	WOS:000286143400004
J	Poste, G				Poste, George			Bring on the biomarkers	NATURE			English	Editorial Material							MEDICINE		[Poste, George] Complex Adapt Syst Initiat, Scottsdale, AZ 85257 USA; [Poste, George] Arizona State Univ, Scottsdale, AZ 85257 USA	Arizona State University	Poste, G (corresponding author), Complex Adapt Syst Initiat, Scottsdale, AZ 85257 USA.	george.poste@asu.edu						Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Davis JC, 2009, NAT REV DRUG DISCOV, V8, P279, DOI 10.1038/nrd2825; Javitt G, 2010, NATURE, V466, P817, DOI 10.1038/466817a; Meckley LM, 2010, HEALTH POLICY, V94, P91, DOI 10.1016/j.healthpol.2009.09.006; Moore Helen M, 2009, Cancer Res, V69, P6770, DOI 10.1158/0008-5472.CAN-09-1795; Ransohoff DF, 2010, J CLIN ONCOL, V28, P698, DOI 10.1200/JCO.2009.25.6065; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Vaught J., 2009, RES POLICY INITIATIV	9	386	393	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					156	157		10.1038/469156a	http://dx.doi.org/10.1038/469156a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228852				2022-12-28	WOS:000286143400015
J	Luco, RF; Allo, M; Schor, IE; Kornblihtt, AR; Misteli, T				Luco, Reini F.; Allo, Mariano; Schor, Ignacio E.; Kornblihtt, Alberto R.; Misteli, Tom			Epigenetics in Alternative Pre-mRNA Splicing	CELL			English	Review							CARBOXY-TERMINAL DOMAIN; SR PROTEIN FAMILY; POLYMERASE-II; DNA METHYLATION; INTRON REMOVAL; TRANSCRIPTION; RECRUITMENT; BINDING; POLYADENYLATION; YEAST	Alternative splicing plays critical roles in differentiation, development, and disease and is a major source for protein diversity in higher eukaryotes. Analysis of alternative splicing regulation has traditionally focused on RNA sequence elements and their associated splicing factors, but recent provocative studies point to a key function of chromatin structure and histone modifications in alternative splicing regulation. These insights suggest that epigenetic regulation determines not only what parts of the genome are expressed but also how they are spliced.	[Luco, Reini F.; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA; [Allo, Mariano; Schor, Ignacio E.; Kornblihtt, Alberto R.] Univ Buenos Aires, Fac Ciencias Exactas Nat, LFBM, Dept Fisiol Biol Mol, Buenos Aires, DF, Argentina; [Allo, Mariano; Schor, Ignacio E.; Kornblihtt, Alberto R.] Univ Buenos Aires, Fac Ciencias Exactas Nat, IFIBYNE CONICET, Buenos Aires, DF, Argentina	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Schor, Ignacio/M-6793-2019; Luco, Reini/E-9855-2018	Schor, Ignacio/0000-0002-8566-6471; Luco, Reini/0000-0002-9086-6507; Kornblihtt, Alberto/0000-0003-4322-0831; Allo, Mariano/0000-0002-3617-6126	Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina; Universidad de Buenos Aires; European Alternative Splicing Network (EURASNET); Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET); National Institutes of Health (NIH), NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires); European Alternative Splicing Network (EURASNET)(European Commission); Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institutes of Health (NIH), NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to A.R.K. from the Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina, the Universidad de Buenos Aires, and the European Alternative Splicing Network (EURASNET). I.E.S. is a recipient of a postdoctoral fellowships, and A.R.K. is a career investigator from the Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (CONICET). A.R.K. is an international research scholar of the Howard Hughes Medical Institute. Work in the Misteli laboratory is supported by the Intramural Research Program of the National Institutes of Health (NIH), NCI, Center for Cancer Research.	AEBI M, 1987, TRENDS GENET, V3, P102, DOI 10.1016/0168-9525(87)90193-4; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Attanasio C, 2003, BLOOD, V101, P1851, DOI 10.1182/blood-2002-03-0853; Auboeuf D, 2004, P NATL ACAD SCI USA, V101, P2270, DOI 10.1073/pnas.0308133100; Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; BAUREN G, 1994, CELL, V76, P183, DOI 10.1016/0092-8674(94)90182-1; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; Bird G, 2004, MOL CELL BIOL, V24, P8963, DOI 10.1128/MCB.24.20.8963-8969.2004; BRODSKY AS, 2004, MOL CELL BIOL, V24, P10505; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Chasin LA, 2007, ADV EXP MED BIOL, V623, P85, DOI 10.1007/978-0-387-77374-2_6; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Das R, 2006, GENE DEV, V20, P1100, DOI 10.1101/gad.1397406; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; de la Mata M, 2010, RNA, V16, P904, DOI 10.1261/rna.1993510; Dhami P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012339; Dower K, 2002, RNA, V8, P686, DOI 10.1017/S1355838202024068; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Fox-Walsh KL, 2009, P NATL ACAD SCI USA, V106, P1766, DOI 10.1073/pnas.0813128106; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Gunderson FQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000682; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hanamura A, 1998, RNA, V4, P430; Hicks MJ, 2006, PLOS BIOL, V4, P943, DOI 10.1371/journal.pbio.0040147; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; KESSLER O, 1993, MOL CELL BIOL, V13, P6211, DOI 10.1128/MCB.13.10.6211; Khanna A, 2010, RNA BIOL, V7, P480, DOI 10.4161/rna.7.4.12746; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Kotovic KM, 2003, MOL CELL BIOL, V23, P5768, DOI 10.1128/MCB.23.16.5768-5779.2003; Lacadie SA, 2005, MOL CELL, V19, P65, DOI 10.1016/j.molcel.2005.05.006; Lazarev D, 2007, RNA, V13, P1546, DOI 10.1261/rna.595907; LEMAIRE MF, 1990, MOL CELL BIOL, V10, P6059, DOI 10.1128/MCB.10.11.6059; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; McCracken S, 1998, COLD SPRING HARB SYM, V63, P301, DOI 10.1101/sqb.1998.63.301; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nahkuri S, 2009, CELL CYCLE, V8, P3420, DOI 10.4161/cc.8.20.9916; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; OKEEFE RT, 1994, J CELL BIOL, V124, P249, DOI 10.1083/jcb.124.3.249; Pagani F, 2003, J BIOL CHEM, V278, P1511, DOI 10.1074/jbc.M209676200; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Piacentini L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000670; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Roberts GC, 1998, NUCLEIC ACIDS RES, V26, P5568, DOI 10.1093/nar/26.24.5568; Sapra AK, 2009, MOL CELL, V34, P179, DOI 10.1016/j.molcel.2009.02.031; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; SMALE ST, 1985, MOL CELL BIOL, V5, P352, DOI 10.1128/MCB.5.2.352; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tardiff DF, 2006, MOL CELL, V24, P917, DOI 10.1016/j.molcel.2006.12.002; TENNYSON CN, 1995, NAT GENET, V9, P184, DOI 10.1038/ng0295-184; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Wagner EJ, 2007, MOL CELL, V28, P692, DOI 10.1016/j.molcel.2007.10.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	94	542	569	3	189	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					16	26		10.1016/j.cell.2010.11.056	http://dx.doi.org/10.1016/j.cell.2010.11.056			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215366	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000285993600004
J	Prudic, KL; Jeon, C; Cao, H; Monteiro, A				Prudic, Kathleen L.; Jeon, Cheonha; Cao, Hui; Monteiro, Antonia			Developmental Plasticity in Sexual Roles of Butterfly Species Drives Mutual Sexual Ornamentation	SCIENCE			English	Article							BICYCLUS-ANYNANA; ROLE REVERSAL; PHENOTYPIC PLASTICITY; SELECTION; MALES; PATTERN; POLYPHENISM; INVESTMENT; INSECTS; CHOICE	Current explanations for why sexual ornaments are found in both sexes include genetic correlation, same sex competition, and mutual mate choice. In this study, we report developmental plasticity in mating behavior as induced by temperature during development in the butterfly Bicyclus anynana. Males and females reciprocally change their sexual roles depending on their larval rearing temperatures. This switch is correlated with a change in mating benefits to females and costs to males. The discrete seasonal environments, wet season and dry season, are known to produce the two developmental forms and as a consequence impose alternating, symmetrical patterns of sexual selection, one season on male ornaments, the following season on female ornaments. Thus, reciprocal selection through time may result in mutual sexual ornamentation.	[Prudic, Kathleen L.] Yale Univ, Yale Inst Biospher Studies, New Haven, CT 06511 USA; [Monteiro, Antonia] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06511 USA	Yale University; Yale University	Prudic, KL (corresponding author), Yale Univ, Yale Inst Biospher Studies, 165 Prospect St, New Haven, CT 06511 USA.	Kathleen.prudic@yale.edu; antonia.monteiro@yale.edu	Cao, Hui/F-4815-2012; Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; Prudic, Kathleen/0000-0001-8242-7769	American Association of University Women; Yale Institute of Biospheric Studies; Yale University; Yale NSF-MRSEC [DMR-0520495]	American Association of University Women; Yale Institute of Biospheric Studies; Yale University; Yale NSF-MRSEC	Visual recordings of O. anynana courtship displays are available online at www.youtube.com/watch?v=_1AjNkJuyX0. We thank A. Alonzo, H. Kindsvater, J. Oliver, D. Papaj, E. Snell-Rood, A. Stoehr, and three anonymous reviewers for comments and R. Rak and C. Bolick for rearing host plants. Funding was provided by the American Association of University Women and Yale Institute of Biospheric Studies to K.L.P., Yale University to A.M., and the Yale NSF-MRSEC (DMR-0520495) to H.C.	Berglund A, 2005, BEHAV ECOL, V16, P649, DOI 10.1093/beheco/ari038; Billing AM, 2007, BEHAV ECOL, V18, P535, DOI 10.1093/beheco/arm007; BOGGS CL, 1990, AM NAT, V136, P598, DOI 10.1086/285118; BRAKEFIELD PM, 1995, J EVOLUTION BIOL, V8, P559, DOI 10.1046/j.1420-9101.1995.8050559.x; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1998, AM NAT, V152, P853, DOI 10.1086/286213; Brakefield PM, 2008, PHENOTYPIC PLASTICIT, P121; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Friberg M, 2007, BEHAV ECOL, V18, P758, DOI 10.1093/beheco/arm037; GWYNNE DT, 1984, EVOLUTION, V38, P1011, DOI 10.1111/j.1558-5646.1984.tb00371.x; GWYNNE DT, 1990, NATURE, V346, P172, DOI 10.1038/346172a0; KAITALA A, 1994, BEHAV ECOL SOCIOBIOL, V35, P385, DOI 10.1007/s002650050110; Karlsson B, 1998, ECOLOGY, V79, P2931, DOI 10.1890/0012-9658(1998)079[2931:NGRBAR]2.0.CO;2; KINGSOLVER JG, 1995, EVOLUTION, V49, P932, DOI [10.2307/2410415, 10.1111/j.1558-5646.1995.tb02328.x]; Kooi RE, 1999, J INSECT PHYSIOL, V45, P201, DOI 10.1016/S0022-1910(98)00093-6; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; Lewis Z, 2007, J INSECT BEHAV, V20, P201, DOI 10.1007/s10905-007-9075-2; Molleman F, 2004, BEHAV ECOL SOCIOBIOL, V56, P404, DOI 10.1007/s00265-004-0789-2; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Obara Y, 2008, ZOOL SCI, V25, P1, DOI 10.2108/zsj.25.1; Oliver JC, 2009, P ROY SOC B-BIOL SCI, V276, P2369, DOI 10.1098/rspb.2009.0182; Ritchie MG, 1998, J INSECT BEHAV, V11, P481, DOI 10.1023/A:1022359228537; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; SHAPIRO A.M., 1976, EVOL BIOL, V9, P259, DOI DOI 10.1007/978-1-4615-6950-3_6; SIMMONS LW, 1992, NATURE, V358, P61, DOI 10.1038/358061a0; West-Eberhard Mary Jane, 2003, pi; Wiklund C, 2004, ANIM BEHAV, V68, P621, DOI 10.1016/j.anbehav.2003.12.008	30	101	101	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					73	75		10.1126/science.1197114	http://dx.doi.org/10.1126/science.1197114			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212355				2022-12-28	WOS:000285974000038
J	Smyth, RMD; Kirkham, JJ; Jacoby, A; Altman, DG; Gamble, C; Williamson, PR				Smyth, R. M. D.; Kirkham, J. J.; Jacoby, A.; Altman, D. G.; Gamble, C.; Williamson, P. R.			Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED-TRIALS; PUBLICATION; PROTOCOLS	Objectives To provide information on the frequency and reasons for outcome reporting bias in clinical trials. Design Trial protocols were compared with subsequent publication(s) to identify any discrepancies in the outcomes reported, and telephone interviews were conducted with the respective trialists to investigate more extensively the reporting of the research and the issue of unreported outcomes. Participants Chief investigators, or lead or coauthors of trials, were identified from two sources: trials published since 2002 covered in Cochrane systematic reviews where at least one trial analysed was suspected of being at risk of outcome reporting bias (issue 4, 2006; issue 1, 2007, and issue 2, 2007 of the Cochrane library); and a random sample of trial reports indexed on PubMed between August 2007 and July 2008. Setting Australia, Canada, Germany, the Netherlands, New Zealand, the United Kingdom, and the United States. Main outcome measures Frequency of incomplete outcome reporting-signified by outcomes that were specified in a trial's protocol but not fully reported in subsequent publications-and trialists' reasons for incomplete reporting of outcomes. Results 268 trials were identified for inclusion (183 from the cohort of Cochrane systematic reviews and 85 from PubMed). Initially, 161 respective investigators responded to our requests for interview, 130 (81%) of whom agreed to be interviewed. However, failure to achieve subsequent contact, obtain a copy of the study protocol, or both meant that final interviews were conducted with 59 (37%) of the 161 trialists. Sixteen trial investigators failed to report analysed outcomes at the time of the primary publication, 17 trialists collected outcome data that were subsequently not analysed, and five trialists did not measure a prespecified outcome over the course of the trial. In almost all trials in which prespecified outcomes had been analysed but not reported (15/16, 94%), this under-reporting resulted in bias. In nearly a quarter of trials in which prespecified outcomes had been measured but not analysed (4/17, 24%), the "direction" of the main findings influenced the investigators' decision not to analyse the remaining data collected. In 14 (67%) of the 21 randomly selected PubMed trials, there was at least one unreported efficacy or harm outcome. More than a quarter (6/21, 29%) of these trials were found to have displayed outcome reporting bias. Conclusion The prevalence of incomplete outcome reporting is high. Trialists seemed generally unaware of the implications for the evidence base of not reporting all outcomes and protocol changes. A general lack of consensus regarding the choice of outcomes in particular clinical settings was evident and affects trial design, conduct, analysis, and reporting.	[Smyth, R. M. D.; Kirkham, J. J.; Gamble, C.; Williamson, P. R.] Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England; [Smyth, R. M. D.; Jacoby, A.] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England; [Altman, D. G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of Liverpool; University of Liverpool; University of Oxford	Williamson, PR (corresponding author), Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England.	prw@liv.ac.uk	Gamble, Carrol/AAE-9895-2019; Altman, Douglas G/A-9714-2012; Kirkham, Jamie/AAD-4490-2019; Smyth, Rebecca MD/P-5124-2014; Williamson, Paula R/B-6425-2016	Gamble, Carrol/0000-0002-3021-1955; Kirkham, Jamie/0000-0003-2579-9325; Smyth, Rebecca MD/0000-0002-2108-1503; Williamson, Paula R/0000-0001-9802-6636	Medical Research Council [G0500952]; Cancer Research UK; Medical Research Council [G0800792] Funding Source: researchfish; MRC [G0800792, G0500952] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The ORBIT (Outcome Reporting Bias In Trials) project was funded by the Medical Research Council (grant number G0500952). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript. DGA is supported by Cancer Research UK.	Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chan AW, 2006, BMJ-BRIT MED J, V332, P1086, DOI 10.1136/bmj.332.7549.1086; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; Cooney RM, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-17; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Ewart R, 2009, ANN FAM MED, V7, P542, DOI 10.1370/afm.1017; Fanelli Daniele, 2009, PLoS One, V4, pe5738, DOI 10.1371/journal.pone.0005738; GHERSI D, 2006, THESIS U SYDNEY; Hahn S, 2002, J EVAL CLIN PRACT, V8, P353, DOI 10.1046/j.1365-2753.2002.00314.x; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; Ioannidis JPA, 2009, ARCH INTERN MED, V169, P1737, DOI 10.1001/archinternmed.2009.313; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Moher D, 2007, CAN J ANAESTH, V54, P331, DOI 10.1007/BF03022653; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Sinha I, 2008, PLOS MED, V5, P569, DOI 10.1371/journal.pmed.0050096; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa	28	120	123	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2011	342								c7153	10.1136/bmj.c7153	http://dx.doi.org/10.1136/bmj.c7153			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NK	21212122	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000286143000002
J	Whitesides, GM; Deutch, J				Whitesides, George M.; Deutch, John			Let's get practical	NATURE			English	Editorial Material									[Whitesides, George M.] Harvard Univ, Woodford L & Ann A Flowers Inst, Cambridge, MA 02138 USA; [Deutch, John] MIT, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Whitesides, GM (corresponding author), Harvard Univ, Woodford L & Ann A Flowers Inst, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu							0	37	39	0	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					21	22		10.1038/469021a	http://dx.doi.org/10.1038/469021a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	702UO	21209639				2022-12-28	WOS:000285921600010
J	Leichsenring, F; Leibing, E; Kruse, J; New, AS; Leweke, F				Leichsenring, Falk; Leibing, Eric; Kruse, Johannes; New, Antonia S.; Leweke, Frank			Borderline personality disorder	LANCET			English	Article							DIALECTICAL BEHAVIOR-THERAPY; POSTTRAUMATIC-STRESS-DISORDER; DSM-IV CRITERIA; RANDOMIZED CONTROLLED-TRIAL; TRANSFERENCE-FOCUSED PSYCHOTHERAPY; SEROTONIN TRANSPORTER GENE; CHILDHOOD SEXUAL-ABUSE; DELIBERATE SELF-HARM; DOUBLE-BLIND; FOLLOW-UP	Recent research findings have contributed to an improved understanding and treatment of borderline personality disorder. This disorder is characterised by severe functional impairments, a high risk of suicide, a negative effect on the course of depressive disorders, extensive use of treatment, and high costs to society. The course of this disorder is less stable than expected for personality disorders. The causes are not yet clear, but genetic factors and adverse life events seem to interact to lead to the disorder. Neurobiological research suggests that abnormalities in the frontolimbic networks are associated with many of the symptoms. Data for the effectiveness of pharmacotherapy vary and evidence is not yet robust. Specific forms of psychotherapy seem to be beneficial for at least some of the problems frequently reported in patients with borderline personality disorder. At present, there is no evidence to suggest that one specific form of psychotherapy is more effective than another. Further research is needed on the diagnosis, neurobiology, and treatment of borderline personality disorder.	[Leichsenring, Falk; Kruse, Johannes; Leweke, Frank] Univ Giessen, Dept Psychosomat & Psychotherapy, D-35392 Giessen, Germany; [Leibing, Eric] Univ Goettingen, Dept Psychosomat Med & Psychotherapy, Gottingen, Germany; [New, Antonia S.] James J Peters VA Med Ctr, Dept Vet Affairs, Mental Illness Res Educ & Clin Ctr, New York, NY USA; [New, Antonia S.] Mt Sinai Sch Med, New York, NY USA	Justus Liebig University Giessen; University of Gottingen; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai	Leichsenring, F (corresponding author), Univ Giessen, Dept Psychosomat & Psychotherapy, Ludwigstr 76, D-35392 Giessen, Germany.	falk.leichsenring@psycho.med.uni-giessen.de	Leweke, Frank/B-5300-2012	New, Antonia S/0000-0002-8993-6467				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; American Psychiatric Association, DSM 5 FUT PSYCH DIAG; [Anonymous], NICE GUID TREATM MAN, P218; [Anonymous], 1959, AM HDB PSY CHIATRY; Bateman A, 1999, AM J PSYCHIAT, V156, P1563, DOI 10.1176/ajp.156.10.1563; Bateman A, 2001, AM J PSYCHIAT, V158, P36, DOI 10.1176/appi.ajp.158.1.36; Bateman A, 2008, AM J PSYCHIAT, V165, P631, DOI 10.1176/appi.ajp.2007.07040636; Bateman A, 2009, AM J PSYCHIAT, V166, P1355, DOI 10.1176/appi.ajp.2009.09040539; Beblo T, 2006, PSYCHOL MED, V36, P845, DOI 10.1017/S0033291706007227; Bellino S, 2006, CAN J PSYCHIAT, V51, P453, DOI 10.1177/070674370605100707; Bender DS, 2001, AM J PSYCHIAT, V158, P295, DOI 10.1176/appi.ajp.158.2.295; Binks CA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005653; Binks CA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005652; Blum N, 2008, AM J PSYCHIAT, V165, P468, DOI 10.1176/appi.ajp.2007.07071079; Bogenschutz MP, 2004, J CLIN PSYCHIAT, V65, P104; Bohus M, 2004, BEHAV RES THER, V42, P487, DOI 10.1016/S0005-7967(03)00174-8; Brazier J, 2006, HEALTH TECHNOL ASSES, V10, P1; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Brunner R, 2010, NEUROIMAGE, V49, P114, DOI 10.1016/j.neuroimage.2009.07.070; CARPENTER WT, 1977, COMPR PSYCHIAT, V18, P567, DOI 10.1016/S0010-440X(97)90007-9; Chanen AM, 2008, PSYCHIAT RES-NEUROIM, V163, P116, DOI 10.1016/j.pscychresns.2007.08.007; Clarkin JF, 2007, AM J PSYCHIAT, V164, P922, DOI 10.1176/appi.ajp.164.6.922; Cloninger CR, 2005, TXB PERSONALITY DISO, P143; COCCARO EF, 2005, TXB PERSONALITY DISO, P155; Cottraux J, 2009, PSYCHOTHER PSYCHOSOM, V78, P307, DOI 10.1159/000229769; Davidson K, 2006, J PERS DISORD, V20, P450, DOI 10.1521/pedi.2006.20.5.450; DELAFUENTE JM, 1994, EUR NEUROPSYCHOPHARM, V4, P479, DOI 10.1016/0924-977X(94)90296-8; Doering S, 2010, BRIT J PSYCHIAT, V196, P389, DOI 10.1192/bjp.bp.109.070177; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Farrell JM, 2009, J BEHAV THER EXP PSY, V40, P317, DOI 10.1016/j.jbtep.2009.01.002; Fossati A, 1999, J PERS DISORD, V13, P268, DOI 10.1521/pedi.1999.13.3.268; Frankenburg FR, 2002, J CLIN PSYCHIAT, V63, P442, DOI 10.4088/JCP.v63n0511; Gabbard GO, 2005, AM J PSYCHIAT, V162, P648, DOI 10.1176/appi.ajp.162.4.648; Gabbard GO, 2001, AM J PSYCHIAT, V158, P1, DOI 10.1176/appi.ajp.158.1.1; Garner B, 2005, BIOL PSYCHIAT, V58, P417, DOI 10.1016/j.biopsych.2005.04.018; Garner B, 2007, PSYCHIAT RES-NEUROIM, V156, P257, DOI 10.1016/j.pscychresns.2007.05.001; Giesen-Bloo J, 2006, ARCH GEN PSYCHIAT, V63, P649, DOI 10.1001/archpsyc.63.6.649; GOLDBERG SC, 1986, ARCH GEN PSYCHIAT, V43, P680; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Gregory RJ, 2008, PSYCHOTHERAPY, V45, P28, DOI 10.1037/0033-3204.45.1.28; Grilo CM, 2007, CAN J PSYCHIAT, V52, P357, DOI 10.1177/070674370705200604; Grilo CM, 2004, J CONSULT CLIN PSYCH, V72, P126, DOI 10.1037/0022-006X.72.1.126; Gross R, 2002, ARCH INTERN MED, V162, P53, DOI 10.1001/archinte.162.1.53; Grossman R, 1997, ANN NY ACAD SCI, V821, P459, DOI 10.1111/j.1749-6632.1997.tb48305.x; Gunderson JG, 2004, J CLIN PSYCHIAT, V65, P1049; Gunderson JG, 2003, PSYCHIATRY, V66, P111, DOI 10.1521/psyc.66.2.111.20614; Gunderson JG, 2009, AM J PSYCHIAT, V166, P530, DOI 10.1176/appi.ajp.2009.08121825; Harned MS, 2008, J CONSULT CLIN PSYCH, V76, P1068, DOI 10.1037/a0014044; Herpertz SC, 2001, BIOL PSYCHIAT, V50, P292, DOI 10.1016/S0006-3223(01)01075-7; Hollander E, 2005, AM J PSYCHIAT, V162, P621, DOI 10.1176/appi.ajp.162.3.621; Hollander E, 2001, J CLIN PSYCHIAT, V62, P199, DOI 10.4088/JCP.v62n0311; Hopwood CJ, 2009, J ABNORM PSYCHOL, V118, P806, DOI 10.1037/a0016954; Irle E, 2005, BIOL PSYCHIAT, V57, P173, DOI 10.1016/j.biopsych.2004.10.004; Irle E, 2007, PSYCHIAT RES-NEUROIM, V156, P139, DOI 10.1016/j.pscychresns.2007.01.007; Jovev M, 2008, PSYCHIAT RES-NEUROIM, V162, P273, DOI 10.1016/j.pscychresns.2007.12.003; Juengling FD, 2003, J PSYCHIAT RES, V37, P109, DOI 10.1016/S0022-3956(02)00084-5; Kendall T, 2010, BRIT J PSYCHIAT, V196, P158, DOI 10.1192/bjp.196.2.158; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Koenigsberg HW, 2009, BIOL PSYCHIAT, V66, P854, DOI 10.1016/j.biopsych.2009.06.010; Koenigsberg HW, 2009, PSYCHIAT RES-NEUROIM, V172, P192, DOI 10.1016/j.pscychresns.2008.07.010; Koons CR, 2001, BEHAV THER, V32, P371, DOI 10.1016/S0005-7894(01)80009-5; Kraus A, 2009, BIOL PSYCHIAT, V65, P819, DOI 10.1016/j.biopsych.2008.10.028; LAHMEYER HW, 1989, J CLIN PSYCHIAT, V50, P217; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; LEONE NF, 1982, J CLIN PSYCHIAT, V43, P148; Levy KN, 2006, J CONSULT CLIN PSYCH, V74, P1027, DOI 10.1037/0022-006X.74.6.1027; Lewis KL, 2009, HARVARD REV PSYCHIAT, V17, P322, DOI 10.3109/10673220903271848; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Lieb K, 2010, BRIT J PSYCHIAT, V196, P4, DOI 10.1192/bjp.bp.108.062984; Linehan MM, 2008, J CLIN PSYCHIAT, V69, P999, DOI 10.4088/JCP.v69n0617; Linehan MM, 2006, ARCH GEN PSYCHIAT, V63, P757, DOI 10.1001/archpsyc.63.7.757; Linehan MM, 1999, AM J ADDICTION, V8, P279; LINEHAN MM, 1993, ARCH GEN PSYCHIAT, V50, P971; Linehan MM, 2002, DRUG ALCOHOL DEPEN, V67, P13, DOI 10.1016/S0376-8716(02)00011-X; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; McGlashan TH, 2005, AM J PSYCHIAT, V162, P883, DOI 10.1176/appi.ajp.162.5.883; McMain SF, 2009, AM J PSYCHIAT, V166, P1365, DOI 10.1176/appi.ajp.2009.09010039; Minzenberg MJ, 2008, J PSYCHIATR RES, V42, P727, DOI 10.1016/j.jpsychires.2007.07.015; Minzenberg MJ, 2007, PSYCHIAT RES-NEUROIM, V155, P231, DOI 10.1016/j.pscychresns.2007.03.006; MUNROEBLUM H, 1995, J PERS DISORD, V9, P190, DOI 10.1521/pedi.1995.9.3.190; Nadort M, 2009, BEHAV RES THER, V47, P961, DOI 10.1016/j.brat.2009.07.013; New AS, 2008, PSYCHIAT CLIN N AM, V31, P441, DOI 10.1016/j.psc.2008.03.011; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; New AS, 2009, BIOL PSYCHIAT, V66, P1107, DOI 10.1016/j.biopsych.2009.07.015; Ni XQ, 2007, PSYCHIAT GENET, V17, P153, DOI 10.1097/YPG.0b013e328016831c; Ni XQ, 2006, J PSYCHIATR RES, V40, P448, DOI 10.1016/j.jpsychires.2006.03.010; Ni XQ, 2009, PROG NEURO-PSYCHOPH, V33, P128, DOI 10.1016/j.pnpbp.2008.10.022; Nose M, 2006, INT CLIN PSYCHOPHARM, V21, P345; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; Oldham JM, 2006, AM J PSYCHIAT, V163, P20, DOI 10.1176/appi.ajp.163.1.20; Paris J, 2007, J PERS DISORD, V21, P457, DOI 10.1521/pedi.2007.21.5.457; Paris J, 2007, COMPR PSYCHIAT, V48, P145, DOI 10.1016/j.comppsych.2006.10.001; Pascual JC, 2008, J CLIN PSYCHIAT, V69, P603, DOI 10.4088/JCP.v69n0412; Pascual JC, 2008, J PSYCHIATR RES, V42, P87, DOI 10.1016/j.jpsychires.2006.10.005; Reich DB, 2009, INT CLIN PSYCHOPHARM, V24, P270, DOI 10.1097/YIC.0b013e32832d6c2f; Rinne T, 2002, AM J PSYCHIAT, V159, P2048, DOI 10.1176/appi.ajp.159.12.2048; SALZMAN C, 1995, J CLIN PSYCHOPHARM, V15, P23, DOI 10.1097/00004714-199502000-00005; Sanislow CA, 2002, AM J PSYCHIAT, V159, P284, DOI 10.1176/appi.ajp.159.2.284; Sanislow CA, 2009, J ABNORM PSYCHOL, V118, P507, DOI 10.1037/a0016478; Schmahl CG, 2003, PSYCHIAT RES-NEUROIM, V122, P193, DOI 10.1016/S0925-4927(03)00023-4; Schmahl C, 2009, J PSYCHIATR NEUROSCI, V34; Schulz SC, 2008, BRIT J PSYCHIAT, V193, P485, DOI 10.1192/bjp.bp.107.037903; Shafti SS, 2010, J CLIN PSYCHOPHARM, V30, P44, DOI 10.1097/JCP.0b013e3181c826ff; Siever LJ, 2002, BIOL PSYCHIAT, V51, P964, DOI 10.1016/S0006-3223(02)01326-4; Silva H, 2007, ACTAS ESP PSIQUIATRI, V35, P387; Simpson EB, 2004, J CLIN PSYCHIAT, V65, P379; Skodol AE, 2005, AM J PSYCHIAT, V162, P1919, DOI 10.1176/appi.ajp.162.10.1919; Skodol AE, 2005, PSYCHOL MED, V35, P443, DOI 10.1017/S003329170400354X; Skodol AE, 2005, J PERS DISORD, V19, P487, DOI 10.1521/pedi.2005.19.5.487; Skodol AE, 2002, AM J PSYCHIAT, V159, P276, DOI 10.1176/appi.ajp.159.2.276; Skodol AE, 2002, BIOL PSYCHIAT, V51, P936, DOI 10.1016/S0006-3223(02)01324-0; Skodol AE, 2002, BIOL PSYCHIAT, V51, P951, DOI 10.1016/S0006-3223(02)01325-2; Soler J, 2005, AM J PSYCHIAT, V162, P1221, DOI 10.1176/appi.ajp.162.6.1221; Soler J, 2009, BEHAV RES THER, V47, P353, DOI 10.1016/j.brat.2009.01.013; SOLOFF PH, 1989, J CLIN PSYCHOPHARM, V9, P238, DOI 10.1097/00004714-198908000-00002; SOLOFF PH, 1993, ARCH GEN PSYCHIAT, V50, P377; Tadic A, 2009, AM J MED GENET B, V150B, P487, DOI 10.1002/ajmg.b.30843; Torgersen S, 2008, PSYCHOL MED, V38, P1617, DOI 10.1017/S0033291708002924; Torgersen S, 2001, ARCH GEN PSYCHIAT, V58, P590, DOI 10.1001/archpsyc.58.6.590; Torgersen S., 2005, EPIDEMIOLOGY AM PSYC, P129; Turner RM, 2000, COGN BEHAV PRACT, V7, P413, DOI 10.1016/S1077-7229(00)80052-8; Tyrer P, 2003, PSYCHOL MED, V33, P969, DOI 10.1017/S0033291703008171; Tyrer P, 2007, BRIT J PSYCHIAT, V190, pS51, DOI 10.1192/bjp.190.5.s51; van den Bosch LMC, 2002, ADDICT BEHAV, V27, P911, DOI 10.1016/S0306-4603(02)00293-9; Verheul R, 2003, BRIT J PSYCHIAT, V182, P135, DOI 10.1192/bjp.182.2.135; Wagner S, 2010, GENES BRAIN BEHAV, V9, P97, DOI 10.1111/j.1601-183X.2009.00539.x; Wagner S, 2009, J PSYCHIATR RES, V43, P1067, DOI 10.1016/j.jpsychires.2009.03.004; Warner MB, 2004, J ABNORM PSYCHOL, V113, P217, DOI 10.1037/0021-843X.113.2.217; Weinberg I, 2006, J PERS DISORD, V20, P482, DOI 10.1521/pedi.2006.20.5.482; Weniger G, 2009, J PSYCHIATR NEUROSCI, V34, P383; Widiger TA, 2007, PSYCHIAT ANN, V37, P93; Yen S, 2002, J NERV MENT DIS, V190, P510, DOI 10.1097/00005053-200208000-00003; Zanarini MC, 2010, ACTA PSYCHIAT SCAND, V122, P103, DOI 10.1111/j.1600-0447.2010.01543.x; Zanarini MC, 2009, ACTA PSYCHIAT SCAND, V120, P373, DOI 10.1111/j.1600-0447.2009.01448.x; Zanarini MC, 2007, AM J PSYCHIAT, V164, P929, DOI 10.1176/appi.ajp.164.6.929; Zanarini MC, 2006, AM J PSYCHIAT, V163, P827, DOI 10.1176/appi.ajp.163.5.827; Zanarini MC, 2002, J NERV MENT DIS, V190, P381, DOI 10.1097/00005053-200206000-00006; Zanarini MC, 2004, ACTA PSYCHIAT SCAND, V110, P416, DOI 10.1111/j.1600-0447.2004.00362.x; Zanarini MC, 2004, J CLIN PSYCHIAT, V65, P903; Zanarini MC, 2003, AM J PSYCHIAT, V160, P167, DOI 10.1176/appi.ajp.160.1.167; Zanarini MC, 2001, J CLIN PSYCHIAT, V62, P849, DOI 10.4088/JCP.v62n1103; Ziegenhorn AA, 2009, J CLIN PSYCHOPHARM, V29, P170, DOI 10.1097/JCP.0b013e31819a4bae; Zimmerman DJ, 2009, HARVARD REV PSYCHIAT, V17, P167, DOI 10.1080/10673220902996734	143	573	588	4	167	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2011	377	9759					74	84		10.1016/S0140-6736(10)61422-5	http://dx.doi.org/10.1016/S0140-6736(10)61422-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	709MQ	21195251				2022-12-28	WOS:000286445200033
J	Webb, EL; Mawa, PA; Ndibazza, J; Kizito, D; Namatovu, A; Kyosiimire-Lugemwa, J; Nanteza, B; Nampijja, M; Muhangi, L; Woodburn, PW; Akurut, H; Mpairwe, H; Akello, M; Lyadda, N; Bukusuba, J; Kihembo, M; Kizza, M; Kizindo, R; Nabulime, J; Ameke, C; Namujju, PB; Tweyongyere, R; Muwanga, M; Whitworth, JAG; Elliott, AM				Webb, Emily L.; Mawa, Patrice A.; Ndibazza, Juliet; Kizito, Dennison; Namatovu, Alice; Kyosiimire-Lugemwa, Jacqueline; Nanteza, Bridget; Nampijja, Margaret; Muhangi, Lawrence; Woodburn, Patrick W.; Akurut, Hellen; Mpairwe, Harriet; Akello, Miriam; Lyadda, Nancy; Bukusuba, Joseph; Kihembo, Macklyn; Kizza, Moses; Kizindo, Robert; Nabulime, Juliet; Ameke, Christine; Namujju, Proscovia B.; Tweyongyere, Robert; Muwanga, Moses; Whitworth, James A. G.; Elliott, Alison M.			Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							SCHISTOSOMA-MANSONI; IMMUNE-RESPONSES; TUBERCULOSIS; UGANDA; HELMINTH; EPIDEMIOLOGY; FILARIASIS; MORTALITY; CHILDREN; TETANUS	Background Helminth infections affect the human immune response. We investigated whether prenatal exposure to and treatment of maternal helminth infections affects development of an infant's immune response to immunisations and unrelated infections. Methods In this randomised, double-blind, placebo-controlled trial, we enrolled 2507 women in the second or third trimester of pregnancy who were planning to deliver in Entebbe General Hospital, Entebbe, Uganda. With a computer-generated random number sequence in blocks of 100, we assigned patients to 440 mg albendazole and 40 mg/kg praziquantel (n=628), 440 mg albendazole and a praziquantel-matching placebo (n=625), 40 mg/kg praziquantel and an albendazole-matching placebo (n=626), or an albendazole-matching placebo and praziquantel-matching placebo (n=628). All participants and hospital staff were masked to allocation. Primary outcomes were immune response at age 1 year to BCG, tetanus, and measles immunisation; incidence of infectious diseases during infancy; and vertical HIV transmission. Analysis was by intention-to-treat. This trial is registered, number ISRCTN32849447. Findings Data were available at delivery for 2356 women, with 2345 livebirths; 2115 (90%) of liveborn infants remained in follow-up at 1 year of age. Neither albendazole nor praziquantel treatments affected infant response to BCG, tetanus, or measles immunisation. However, in infants of mothers with hookworm infection, athendazole treatment reduced interleukin-5 (geometric mean ratio 0.50, 95% CI 0.30-0.81, interaction p=0.02) and interleukin-13 (0.52,. 34-0.82, 0.0005) response to tetanus toxoid. The rate per 100 person-years of malaria was 40.9 (95% CI 38.3-43. 7), of diarrhoea was 134.1 (129.2-139.2), and of pneumonia was 22.3 (20.4-24.4). We noted no effect on infectious disease incidence for albendazole treatment (malaria [hazard ratio 0.95, 95% CI 0.79-1.14], diarrhoea [1.06, 0.96-1.16], pneumonia 11.11,. 90-1.38]) or praziquantel treatment (malaria [1.00, 0.84-1.20], diarrhoea [1.07, 0.98-1.18], pneumonia [1.00, 0.80-1.24]). In HIV-exposed infants, 39 (18%) were infected at 6 weeks; vertical transmission was not associated with albendazole (odds ratio 0.70, 95% CI 0.35-1.42) or praziquantel (0.60, 0.29-1.23) treatment. Interpretation These results do not accord with the recently advocated policy of routine antenatal anthelmintic treatment, and the value of such a policy may need to be reviewed.	[Webb, Emily L.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Mawa, Patrice A.; Ndibazza, Juliet; Kizito, Dennison; Kyosiimire-Lugemwa, Jacqueline; Nanteza, Bridget; Muhangi, Lawrence; Woodburn, Patrick W.; Akurut, Hellen; Mpairwe, Harriet; Bukusuba, Joseph; Kihembo, Macklyn; Kizza, Moses; Kizindo, Robert; Nabulime, Juliet; Ameke, Christine; Namujju, Proscovia B.; Tweyongyere, Robert; Whitworth, James A. G.; Elliott, Alison M.] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Akello, Miriam; Lyadda, Nancy; Muwanga, Moses] Entebbe Hosp, Entebbe, Uganda; [Namatovu, Alice] Makerere Univ, Fac Vet Med, Kampala, Uganda	University of London; London School of Hygiene & Tropical Medicine; Makerere University	Webb, EL (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	emily.webb@lshtm.ac.uk		Webb, Emily/0000-0002-4019-7456; Mawa, Akusa Patrice/0000-0002-4819-8904; Mpairwe, Harriet/0000-0003-1199-4859; Nampijja, Margaret/0000-0002-1200-6042; Elliott, Alison/0000-0003-2818-9549; Kyosiimire-Lugemwa, Jacqueline/0000-0001-7868-9504	Wellcome Trust [064693, 079110, 074791]; MRC [E743]; UK MRC; National Institutes of Health [NOI-AI-25147]; MRC [G0700837] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025147] Funding Source: NIH RePORTER; Medical Research Council [G0700837] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding Wellcome Trust.; The study was funded by Wellcome Trust grant numbers 064693 and 079110; Medical Research Council (MRC) staff were supported by MRC programme grant E743; ELW was supported by the UK MRC; and HM was supported in part by a Wellcome Trust PhD studentship, grant number 074791. Mycobacterial antigens were provided through the National Institutes of Health contract NOI-AI-25147 We thank all staff and participants of the Entebbe Mother and Baby Study, the midwives of the Entebbe Hospital Maternity Department, the community field team in Entebbe and Katabi, and the staff of the Clinical Diagnostic Services Laboratory at the MRC/UVRI Uganda Research Unit on AIDS. We thank Richard Hayes for helpful comments on the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Allen Henrietta E., 2002, Trends in Parasitology, V18, P381, DOI 10.1016/S1471-4922(02)02386-3; Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Bundy D, 2000, PARASITOL TODAY, V16, P273, DOI 10.1016/S0169-4758(00)01689-6; Christian P, 2004, LANCET, V364, P981, DOI 10.1016/S0140-6736(04)17023-2; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Cousens S, 1988, WHOCDDEDP882; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Elliott AM, 2007, CLIN TRIALS, V4, P42, DOI 10.1177/1740774506075248; Elliott AM, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-115; Elliott AM, 1999, INT J TUBERC LUNG D, V3, P239; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; FRIEND J, 1996, MACKIE MCCARTNEY PRA, P757; GILL TJ, 1983, J CLIN INVEST, V72, P987, DOI 10.1172/JCI111071; GREENWOOD B, 1992, J INFECT DIS, V165, pS26, DOI 10.1093/infdis/165-Supplement_1-S26; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; KHAN EA, 1995, EMERG INFECT DIS, V1, P115, DOI 10.3201/eid0104.950402; Knopp S, 2009, T ROY SOC TROP MED H, V103, P347, DOI 10.1016/j.trstmh.2008.11.013; LaBeaud AD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000442; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Malhotra I, 1999, J IMMUNOL, V162, P6843; Malhotra I, 2003, INFECT IMMUN, V71, P5231, DOI 10.1128/IAI.71.9.5231-5237.2003; McGuinness D, 1997, J IMMUNOL METHODS, V201, P99, DOI 10.1016/S0022-1759(96)00216-5; Melrose WD, 2000, T ROY SOC TROP MED H, V94, P176, DOI 10.1016/S0035-9203(00)90266-9; Morley D, 1973, PAEDIAT PRIORITIES D, P207; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Muhangi L, 2007, T ROY SOC TROP MED H, V101, P899, DOI 10.1016/j.trstmh.2007.03.017; Ndibazza J, 2010, CLIN INFECT DIS, V50, P531, DOI 10.1086/649924; Nookala S, 2004, INFECT IMMUN, V72, P2598, DOI 10.1128/IAI.72.5.2598-2604.2004; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; Sabin EA, 1996, J INFECT DIS, V173, P269, DOI 10.1093/infdis/173.1.269; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Tann Carolyn J, 2007, BMC Pregnancy Childbirth, V7, P23, DOI 10.1186/1471-2393-7-23; UBOS, 2007, UG DEM HLTH SURV 200; Utzinger J, 2001, PARASITOLOGY, V122, P537, DOI 10.1017/S0031182001007752; WHO, 2009, WKLY EPIDEMIOL REC, V84, P509; WHO Programme for the Control of Acute Respiratory Infections, 1990, WHOARI905; Woodburn PW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000473	44	87	87	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 1	2011	377	9759					52	62		10.1016/S0140-6736(10)61457-2	http://dx.doi.org/10.1016/S0140-6736(10)61457-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709MQ	21176950	Green Accepted, Green Published			2022-12-28	WOS:000286445200031
J	Bosworth, AM; Steuer, A				Bosworth, Ailsa M.; Steuer, Alan			A Patient's Journey Rheumatoid arthritis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bosworth, Ailsa M.] Natl Rheumatoid Arthrit Soc, Maidenhead SL6 3RT, Berks, England; [Steuer, Alan] Wexham Pk Hosp, Slough SL2 4HL, Berks, England		Bosworth, AM (corresponding author), Natl Rheumatoid Arthrit Soc, Westacott Business Ctr, Maidenhead SL6 3RT, Berks, England.	Ailsa@nras.org.uk							0	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 31	2010	341								c7095	10.1136/bmj.c7095	http://dx.doi.org/10.1136/bmj.c7095			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702VB	21196483				2022-12-28	WOS:000285922900008
J	Laursen, L				Laursen, Lucas			Big science at the table	NATURE			English	Editorial Material																			0	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S2	S4		10.1038/468S2a	http://dx.doi.org/10.1038/468S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179080	Bronze			2022-12-28	WOS:000285553800001
J	Thomas, L; Moriya, R; Rettner, C; Parkin, SSP				Thomas, Luc; Moriya, Rai; Rettner, Charles; Parkin, Stuart S. P.			Dynamics of Magnetic Domain Walls Under Their Own Inertia	SCIENCE			English	Article							MOTION; FERROMAGNETS; NANOWIRES; SHIFT	The motion of magnetic domain walls induced by spin-polarized current has considerable potential for use in magnetic memory and logic devices. Key to the success of these devices is the precise positioning of individual domain walls along magnetic nanowires, using current pulses. We show that domain walls move surprisingly long distances of several micrometers and relax over several tens of nanoseconds, under their own inertia, when the current stimulus is removed. We also show that the net distance traveled by the domain wall is exactly proportional to the current pulse length because of the lag derived from its acceleration at the onset of the pulse. Thus, independent of its inertia, a domain wall can be accurately positioned using properly timed current pulses.	[Thomas, Luc; Moriya, Rai; Rettner, Charles; Parkin, Stuart S. P.] IBM Almaden Res Ctr, San Jose, CA USA	International Business Machines (IBM)	Thomas, L (corresponding author), IBM Almaden Res Ctr, 650 Harry Rd, San Jose, CA USA.	lucthom@us.ibm.com; parkin@almaden.ibm.com	Parkin, Stuart/D-2521-2012; Moriya, Rai/P-1460-2016	Parkin, Stuart/0000-0003-4702-6139; Moriya, Rai/0000-0001-7471-7432				Barnes SE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.107204; Bedau D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.146601; BERGER L, 1986, PHYS REV B, V33, P1572, DOI 10.1103/PhysRevB.33.1572; Bocklage L, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.180405; Eltschka M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.056601; Grollier J, 2003, APPL PHYS LETT, V83, P509, DOI 10.1063/1.1594841; Hayashi M, 2008, SCIENCE, V320, P209, DOI 10.1126/science.1154587; Hayashi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.037204; Hayashi M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.207205; Klaui M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.026601; Li Z, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207203; Malozemoff A.P., 1979, MAGNETIC DOMAIN WALL; Meier G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.187202; Miron IM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.137202; Moore TA, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.132403; Moriya R, 2008, NAT PHYS, V4, P368, DOI 10.1038/nphys936; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Ravelosona D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117203; Saitoh E, 2004, NATURE, V432, P203, DOI 10.1038/nature03009; Tatara G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.086601; Thiaville A, 2005, EUROPHYS LETT, V69, P990, DOI 10.1209/epl/i2004-10452-6; Thomas L, 2007, SCIENCE, V315, P1553, DOI 10.1126/science.1137662; Thomas L, 2006, NATURE, V443, P197, DOI 10.1038/nature05093; Vernier N, 2004, EUROPHYS LETT, V65, P526, DOI 10.1209/epl/i2003-10112-5; Vlaminck V, 2008, SCIENCE, V322, P410, DOI 10.1126/science.1162843; Yamanouchi M, 2004, NATURE, V428, P539, DOI 10.1038/nature02441; Yang SQ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.220403; Zhang S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.127204	29	174	175	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1810	1813		10.1126/science.1197468	http://dx.doi.org/10.1126/science.1197468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205666				2022-12-28	WOS:000285603700037
J	Willett, LR				Willett, Laura Rees			Review: Steroids, US, electromagnetic field therapy, and splinting have moderate, short-term effectiveness for the carpal tunnel syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Willett, LR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA.								0	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12							JC6-10	10.7326/0003-4819-153-12-201012210-02010	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173399				2022-12-28	WOS:000285453700015
J	Bonell, C; McKee, M; Fletcher, A; Haines, A; Wilkinson, P				Bonell, Chris; McKee, Martin; Fletcher, Adam; Haines, Andrew; Wilkinson, Paul			Nudge smudge: UK Government misrepresents "nudge"	LANCET			English	Editorial Material									[Bonell, Chris; McKee, Martin; Fletcher, Adam; Haines, Andrew; Wilkinson, Paul] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Bonell, C (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England.	chris.bonell@lshtm.ac.uk	McKee, Marc D/E-2187-2011; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Wilkinson, Paul/0000-0001-7456-259X; McKee, Martin/0000-0002-0121-9683; Haines, Andy/0000-0002-8053-4605				BROWNE JI, 2011, DISTRIBUTIONAL EFFEC; Cabinet Office and Behavioural Insights Team, 2010, APPL BEH INS HLTH BE; Channel 4 News, 2010, CHANNEL 4 NEWS; DAVEY-SMITH G, 2003, HLTH INEQUALITIES LI; Department of Health and Social Security England, 1980, IN HLTH REP RES WORK; Dolan P., 2010, MINDSPACE INFLUENCIN; Healthy People 2020, 2010, FDN HLTH MEAS REP HE; Marmot M, 2010, FAIR SOC HLTH LIVES; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Roberts, 2010, ENERGY GLUT; Wilkinson Richard, 2009, SPIRIT LEVEL WHY MOR	12	24	24	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2011	377	9784					2158	2159		10.1016/S0140-6736(11)60063-9	http://dx.doi.org/10.1016/S0140-6736(11)60063-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	786XI	21244864				2022-12-28	WOS:000292340800007
J	Narayan, R				Narayan, Ravi			Universal health care in India: missing core determinants	LANCET			English	Editorial Material									Ctr Publ Hlth & Equ, Soc Community Hlth Awareness Res & Act, Bangalore 560034, Karnataka, India		Narayan, R (corresponding author), Ctr Publ Hlth & Equ, Soc Community Hlth Awareness Res & Act, Bangalore 560034, Karnataka, India.	chcravi@gmail.com						ABHIYAN JS, 2009, HLTH SERVICES NATL R; Banerji D, 1985, HLTH FAMILY PLANNING; Health Survey and Development Committee, 1946, REP HLTH DEV COMM SU; *IND COUNC SOC SCI, 1981, HLTH ALL ALT STRAT R; Ministry of Health and Family Welfare Government of India, NAT RUR HLTH MISS M; *NAT COORD COMM, 2004, JAN SWASTH ABH HLTH; *PEOPL HLTH MOV IN, 2000, IND PEOPL HLTH CHART; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; *S E AS REG ORG WH, REG M APPL EP PRINC; World Health Organization, WORLD HLTH REP 2008; 2010, GLOBAL HLTH WATC OCT	11	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					883	885		10.1016/S0140-6736(10)62045-4	http://dx.doi.org/10.1016/S0140-6736(10)62045-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GR	21227491				2022-12-28	WOS:000288628800008
J	Itzhaki, I; Maizels, L; Huber, I; Zwi-Dantsis, L; Caspi, O; Winterstern, A; Feldman, O; Gepstein, A; Arbel, G; Hammerman, H; Boulos, M; Gepstein, L				Itzhaki, Ilanit; Maizels, Leonid; Huber, Irit; Zwi-Dantsis, Limor; Caspi, Oren; Winterstern, Aaron; Feldman, Oren; Gepstein, Amira; Arbel, Gil; Hammerman, Haim; Boulos, Monther; Gepstein, Lior			Modelling the long QT syndrome with induced pluripotent stem cells	NATURE			English	Article							CARDIOMYOCYTES; INDUCTION; RANOLAZINE; MECHANISM; MYOCYTES; BLOCK	The ability to generate patient-specific human induced pluripotent stem cells (iPSCs)(1-3) offers a new paradigm for modelling human disease and for individualizing drug testing(4). Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death(5-7). Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I-Kr. Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K-ATP-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.	[Itzhaki, Ilanit; Maizels, Leonid; Huber, Irit; Zwi-Dantsis, Limor; Caspi, Oren; Winterstern, Aaron; Feldman, Oren; Gepstein, Amira; Arbel, Gil; Gepstein, Lior] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis Family Res Lab Cardiac Electrophysiol & Re, IL-31096 Haifa, Israel; [Hammerman, Haim; Boulos, Monther; Gepstein, Lior] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Gepstein, L (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Sohnis Family Res Lab Cardiac Electrophysiol & Re, POB9649, IL-31096 Haifa, Israel.	mdlior@techunix.technion.ac.il	Gepstein, Lior/H-9458-2012	Maizels, Leonid/0000-0001-6993-2808	Israel Science Foundation; Legacy Heritage Foundation [1225/09]; Yad Hanadiv Foundation; Lorry Lokey research fund; Nancy and Stephen Grand Philanthropic Fund	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Foundation; Yad Hanadiv Foundation; Lorry Lokey research fund; Nancy and Stephen Grand Philanthropic Fund	This study was supported in part by the Israel Science Foundation and Legacy Heritage Foundation (no. 1225/09), by the Yad Hanadiv Foundation Bruno Award, by the Lorry Lokey research fund, and by the Nancy and Stephen Grand Philanthropic Fund. We thank E. Suss-Toby and O. Shenker (from the multidisciplinary laboratory unit) and M. Tzukerman for their valuable help, A. Zamir for writing the MEA analysis software and I. Laevsky and T. Falik-Zaccai for the karyotype analysis.	Antoons G, 2010, J AM COLL CARDIOL, V55, P801, DOI 10.1016/j.jacc.2009.10.033; Antzelevitch C, 2004, CIRCULATION, V110, P904, DOI 10.1161/01.CIR.0000139333.83620.5D; Arbel G, 2010, METHODS MOL BIOL, V660, P85, DOI 10.1007/978-1-60761-705-1_6; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Fermini B, 2003, NAT REV DRUG DISCOV, V2, P439, DOI 10.1038/nrd1108; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P2291, DOI 10.1016/j.jacc.2008.02.068; Halbach MD, 2003, CELL PHYSIOL BIOCHEM, V13, P271, DOI 10.1159/000074542; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; Kehat I, 2002, CIRC RES, V91, P659, DOI 10.1161/01.RES.0000039084.30342.9B; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Luo S, 2004, J ELECTROCARDIOL, V37, P81, DOI 10.1016/j.jelectrocard.2004.08.030; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Nakajima T, 1998, CIRC RES, V83, P415, DOI 10.1161/01.RES.83.4.415; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patel C, 2008, PHARMACOL THERAPEUT, V118, P138, DOI 10.1016/j.pharmthera.2008.02.001; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tenenbaum M, 2008, ISR MED ASSOC J, V10, P809; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	28	727	750	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					225	U113		10.1038/nature09747	http://dx.doi.org/10.1038/nature09747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21240260				2022-12-28	WOS:000288170200039
J	Dandona, L; Katoch, VM; Dandona, R				Dandona, Lalit; Katoch, V. M.; Dandona, Rakhi			Research to achieve health care for all in India	LANCET			English	Editorial Material									[Dandona, Lalit; Dandona, Rakhi] Publ Hlth Fdn India, New Delhi 110070, India; [Dandona, Lalit] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Katoch, V. M.] Govt India, Dept Hlth Res, New Delhi, India; [Katoch, V. M.] Govt India, Minist Hlth & Family Welf, Indian Council Med Res, New Delhi, India	Public Health Foundation of India; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Indian Council of Medical Research (ICMR)	Dandona, L (corresponding author), Publ Hlth Fdn India, New Delhi 110070, India.	lalit.dandona@phfi.org		Dandona, Rakhi/0000-0003-0926-788X				*AUSTR GOV NAT HLT, 2009, REP REV PUBL HLTH RE; *CAN I HLTH RES, 2002, CHART COURS PAN CAN; DANDONA L, 2010, 1 GLOB S HLTH SYST R; Dandona L, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-59; Health Metrics Network, 2008, FRAM STAND COUNTR HL; *MIN HLTH FAM WELF, MAND; Ministry of Health and Family Welfare Govt of India, 2002, NAT HLTH POL; Raban MZ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-208; Reddy KS, 2006, NATL MED J INDIA, V19, P122; *WELLC TRUST DBT I, BIOM RES CAR PROGR I; World Health Organization, 2004, WORLD REP KNOWL BETT; World Health Organization, 2008, GLOB BURD DIS 2004 U	12	21	21	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1055	1057		10.1016/S0140-6736(10)62034-X	http://dx.doi.org/10.1016/S0140-6736(10)62034-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	743QY	21227496				2022-12-28	WOS:000289035000008
J	den Camp, RO; Streng, A; De Mita, S; Cao, QQ; Polone, E; Liu, W; Ammiraju, JSS; Kudrna, D; Wing, R; Untergasser, A; Bisseling, T; Geurts, R				den Camp, Rik Op; Streng, Arend; De Mita, Stephane; Cao, Qingqin; Polone, Elisa; Liu, Wei; Ammiraju, Jetty S. S.; Kudrna, Dave; Wing, Rod; Untergasser, Andreas; Bisseling, Ton; Geurts, Rene			LysM-Type Mycorrhizal Receptor Recruited for Rhizobium Symbiosis in Nonlegume Parasponia	SCIENCE			English	Article							MEDICAGO-TRUNCATULA; NODULATION; EVOLUTION; LEGUME; BACTERIA; KINASES; CELLS	Rhizobium-root nodule symbiosis is generally considered to be unique for legumes. However, there is one exception, and that is Parasponia. In this nonlegume, the rhizobial nodule symbiosis evolved independently and is, as in legumes, induced by rhizobium Nod factors. We used Parasponia andersonii to identify genetic constraints underlying evolution of Nod factor signaling. Part of the signaling cascade, downstream of Nod factor perception, has been recruited from the more-ancient arbuscular endomycorrhizal symbiosis. However, legume Nod factor receptors that activate this common signaling pathway are not essential for arbuscular endomycorrhizae. Here, we show that in Parasponia a single Nod factor-like receptor is indispensable for both symbiotic interactions. Therefore, we conclude that the Nod factor perception mechanism also is recruited from the widespread endomycorrhizal symbiosis.	[den Camp, Rik Op; Streng, Arend; De Mita, Stephane; Cao, Qingqin; Polone, Elisa; Liu, Wei; Untergasser, Andreas; Bisseling, Ton; Geurts, Rene] Wageningen Univ, Dept Plant Sci, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands; [Polone, Elisa] Univ Padua, Dept Agr Biotechnol, I-35020 Padua, Italy; [Liu, Wei] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Ammiraju, Jetty S. S.; Wing, Rod] Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; [Bisseling, Ton] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia	Wageningen University & Research; University of Padua; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of Arizona; King Saud University	Bisseling, T (corresponding author), Wageningen Univ, Dept Plant Sci, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands.	ton.bisseling@wur.nl	Wing, Rod A/Z-2885-2019; poinssot, benoit/B-2569-2009; Untergasser, Andreas/AAA-7452-2022; Liu, Wei/J-6317-2013; Op den Camp, Rik/F-4308-2011; cao, qingqin/W-5009-2019; Bisseling, Ton/A-2421-2013	Wing, Rod A/0000-0001-6633-6226; poinssot, benoit/0000-0001-5890-4318; Liu, Wei/0000-0003-4653-0448; 	Dutch Science Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) [VIDI 864.06.007]	Dutch Science Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek)(Netherlands Organization for Scientific Research (NWO))	We thank W. Broughton for NGR234; E. James, P. Hadobas, and T. J. Higgens for Parasponia seeds; P. van Dijk for flow cytometry; and J. Talag and W. Golser for BAC library construction. This research is funded by the Dutch Science Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) (VIDI 864.06.007).	AKKERMANS ADL, 1978, NATURE, V274, P190, DOI 10.1038/274190c0; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Cannon SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011630; Gewin V, 2010, NATURE, V466, P552, DOI 10.1038/466552a; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lohmann GV, 2010, MOL PLANT MICROBE IN, V23, P510, DOI 10.1094/MPMI-23-4-0510; Markmann K, 2009, TRENDS PLANT SCI, V14, P77, DOI 10.1016/j.tplants.2008.11.009; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Pawlowski K, 1996, PLANT CELL, V8, P1899, DOI 10.1105/tpc.8.10.1899; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Sytsma KJ, 2002, AM J BOT, V89, P1531, DOI 10.3732/ajb.89.9.1531; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; TRINICK MJ, 1973, NATURE, V244, P459, DOI 10.1038/244459a0; WEBSTER G, 1995, J EXP BOT, V46, P1131, DOI 10.1093/jxb/46.9.1131; Zhang XC, 2007, PLANT PHYSIOL, V144, P623, DOI 10.1104/pp.107.097097; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183; Zhu HY, 2006, GENETICS, V172, P2491, DOI 10.1534/genetics.105.051185	23	183	188	5	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					909	912		10.1126/science.1198181	http://dx.doi.org/10.1126/science.1198181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21205637				2022-12-28	WOS:000287455100057
J	Frank, RD; Velden, J				Frank, Rolf Dario; Velden, Joachim			Cholesterol Emboli after Coronary Bypass Surgery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Frank, Rolf Dario] St Antonius Hosp, Eschweiler, Germany; [Velden, Joachim] Univ Krankenhaus Eppendorf, Hamburg, Germany	Saint Antonius Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Frank, RD (corresponding author), St Antonius Hosp, Eschweiler, Germany.	dario.frank@sah-eschweiler.de							0	1	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					265	265		10.1056/NEJMicm1003750	http://dx.doi.org/10.1056/NEJMicm1003750			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21247317				2022-12-28	WOS:000286383900012
J	Swing, K				Swing, Kelly			Day of reckoning for Ecuador's biodiversity	NATURE			English	Editorial Material									Univ San Francisco Quito, Tiputini Biodivers Stn, Quito, Ecuador		Swing, K (corresponding author), Univ San Francisco Quito, Tiputini Biodivers Stn, Quito, Ecuador.	kswing@usfq.edu.ec							0	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					267	267		10.1038/469267a	http://dx.doi.org/10.1038/469267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	708SW	21248795	Bronze			2022-12-28	WOS:000286385600004
J	Visvader, JE				Visvader, Jane E.			Cells of origin in cancer	NATURE			English	Review							GENE-EXPRESSION PROFILES; NEURAL STEM-CELL; ACUTE MYELOID-LEUKEMIA; SELF-RENEWAL; COLORECTAL-CANCER; TUMOR-DEVELOPMENT; MOUSE MODEL; LINEAGE; TRANSFORMATION; PROGENITORS	Both solid tumours and leukaemias show considerable histological and functional heterogeneity. It is widely accepted that genetic lesions have a major role in determining tumour phenotype, but evidence is also accumulating that cancers of distinct subtypes within an organ may derive from different 'cells of origin'. These cells acquire the first genetic hit or hits that culminate in the initiation of cancer. The identification of these crucial target cell populations may allow earlier detection of malignancies and better prediction of tumour behaviour, and ultimately may lead to preventive therapies for individuals at high risk of developing cancer.	[Visvader, Jane E.] Walter & Eliza Hall Inst Med Res, Stem Cells & Canc Div, Parkville, Vic 3052, Australia; [Visvader, Jane E.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Visvader, JE (corresponding author), Walter & Eliza Hall Inst Med Res, Stem Cells & Canc Div, Parkville, Vic 3052, Australia.	visvader@wehi.edu.au			National Health and Medical Research Council; Victorian Breast Cancer Research Consortium	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Breast Cancer Research Consortium	I am grateful to J. Adams, G. Lindeman and A. Strasser for critical review of the manuscript, P. Dirks for discussion and P. Maltezos for preparation of figures. I apologize to authors whose work could not be cited owing to space limitations. J.E.V. is supported by the National Health and Medical Research Council and the Victorian Breast Cancer Research Consortium.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Ashworth A, 2008, CANCER RES, V68, P10021, DOI 10.1158/0008-5472.CAN-08-2287; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; FIALKOW PJ, 1978, J CLIN INVEST, V62, P815, DOI 10.1172/JCI109193; Foulkes WD, 2004, J MED GENET, V41, P1, DOI 10.1136/jmg.2003.013805; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hewish M, 2010, NAT REV CLIN ONCOL, V7, P197, DOI 10.1038/nrclinonc.2010.18; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Korsten H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005662; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lee CW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2200; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Martin SA, 2010, CANCER CELL, V17, P235, DOI 10.1016/j.ccr.2009.12.046; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang L, 2010, NATURE, V464, P1058, DOI 10.1038/nature08871; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	85	973	1015	4	255	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					314	322		10.1038/nature09781	http://dx.doi.org/10.1038/nature09781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248838				2022-12-28	WOS:000286385600038
J	Marcovitch, H				Marcovitch, Harvey			MMR and scientific fraud Is research safe in their hands?	BRITISH MEDICAL JOURNAL			English	Editorial Material							MISCONDUCT					h.marcovitch@btinternet.com						Angell M., NEW YORK REV BOOKS; Deer B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7001; Dillner L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d185; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Marcovitch H, 2006, MED J AUSTRALIA, V185, P616, DOI 10.5694/j.1326-5377.2006.tb00730.x; MARCUS A, FRAUD CASE ROCKS ANE; Nylenna M, 2006, LANCET, V367, P1882, DOI 10.1016/S0140-6736(06)68821-1; PINCOCK S, SCIENTIST; Shafer SL, 2010, ANESTH ANALG, V111, P1567, DOI [10.1213/ANE.0b013e3182040b99, 10.1213/ANE.0b013e3182009a22]; Steen RG, 2011, J MED ETHICS, V37, P249, DOI 10.1136/jme.2010.040923; *UK RES INT OFF, PROC INV MISC RES	11	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2011	342								d284	10.1136/bmj.d284	http://dx.doi.org/10.1136/bmj.d284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OX	21248020				2022-12-28	WOS:000286602400013
J	Gonzalez, EB				Gonzalez, Emilio B.			Celecoxib reduced GI events more than diclofenac plus omeprazole in patients with osteoarthritis or rheumatoid arthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DOUBLE-BLIND; HIGH-RISK; TRIAL		Univ Texas Med Branch, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston	Gonzalez, EB (corresponding author), Univ Texas Med Branch, Galveston, TX USA.							Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; Rahme E, 2007, ARTHRIT RHEUM-ARTHR, V57, P748, DOI 10.1002/art.22764; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-9	10.7326/0003-4819-154-2-201101180-02009	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242363				2022-12-28	WOS:000286223500035
J	Karchmer, AW; MacGillivray, TE; Healey, TT; Stone, JR				Karchmer, Adolf W.; MacGillivray, Thomas E.; Healey, Terrance T.; Stone, James R.			Case 1-2011: A 35-Year-Old Man with Fever, Bacteremia, and a Mass in the Left Atrium A foreign body in the left atrium that was consistent with an inhaled or ingested wire bristle, and polymicrobial sepsis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STREPTOCOCCUS-MILLERI; ENDOCARDITIS; ADULT; BODIES		[Karchmer, Adolf W.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [MacGillivray, Thomas E.] Massachusetts Gen Hosp, Cardiac Surg Div, Boston, MA 02114 USA; [Healey, Terrance T.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Karchmer, Adolf W.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [MacGillivray, Thomas E.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Healey, Terrance T.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Stone, James R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Karchmer, AW (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.				Taser International; GlaxoSmithKline; Merck; Proteon Therapeutics; Alternatives Research and Development Foundation	Taser International; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Proteon Therapeutics; Alternatives Research and Development Foundation	Dr. Stone reports receiving consulting fees from Taser International, GlaxoSmithKline, Merck, and Proteon Therapeutics, and grant support from Alternatives Research and Development Foundation. No other potential conflict of interest relevant to this article was reported.	Bert F, 1998, CLIN INFECT DIS, V27, P385, DOI 10.1086/514658; Bisharat N, 2001, EUR J CLIN MICROBIOL, V20, P651; BUCHBINDER NA, 1972, ARCH PATHOL, V93, P435; Clarridge JE, 2001, J CLIN MICROBIOL, V39, P1549, DOI 10.1128/JCM.39.4.1549-1552.2001; Dogan K, 1999, SCAND CARDIOVASC J, V33, P309; Koji T, 2002, CIRC J, V66, P305, DOI 10.1253/circj.66.305; Lefort A, 2002, ARCH INTERN MED, V162, P2450, DOI 10.1001/archinte.162.21.2450; MARKOWITZ SM, 1976, AM J MED, V60, P571, DOI 10.1016/0002-9343(76)90725-7; Ngaage DL, 2001, EMERG MED J, V18, P500, DOI 10.1136/emj.18.6.500; PETERS GL, 2006, J AM SOC ECHOCARDIOG, V19; PRICE DL, 1970, ARCH NEUROL-CHICAGO, V23, P558, DOI 10.1001/archneur.1970.00480300080011; Vedire S, 2007, AM J MED SCI, V334, P125, DOI 10.1097/MAJ.0b013e31812f5ad1; Woo PCY, 2004, DIAGN MICR INFEC DIS, V48, P81, DOI 10.1016/j.diagmicrobio.2003.09.011; Yang L, 2007, CHINESE MED J-PEKING, V120, P437, DOI 10.1097/00029330-200703010-00019; 1972, N ENGL J MED, V286, P1309	15	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					158	166		10.1056/NEJMcpc1004362	http://dx.doi.org/10.1056/NEJMcpc1004362			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226582				2022-12-28	WOS:000286142900011
J	Olzscha, H; Schermann, SM; Woerner, AC; Pinkert, S; Hecht, MH; Tartaglia, GG; Vendruscolo, M; Hayer-Hartl, M; Hartl, FU; Vabulas, RM				Olzscha, Heidi; Schermann, Sonya M.; Woerner, Andreas C.; Pinkert, Stefan; Hecht, Michael H.; Tartaglia, Gian G.; Vendruscolo, Michele; Hayer-Hartl, Manajit; Hartl, F. Ulrich; Vabulas, R. Martin			Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions	CELL			English	Article							MOLECULAR CHAPERONES; IN-VIVO; PREDICTION; DISEASE; OLIGOMERS; TOXICITY; REGIONS; STRESS	Protein aggregation is linked with neurodegeneration and numerous other diseases by mechanisms that are not well understood. Here, we have analyzed the gain-of-function toxicity of artificial beta sheet proteins that were designed to form amyloid-like fibrils. Using quantitative proteomics, we found that the toxicity of these proteins in human cells correlates with the capacity of their aggregates to promote aberrant protein interactions and to deregulate the cytosolic stress response. The endogenous proteins that are sequestered by the aggregates share distinct physicochemical properties: They are relatively large in size and significantly enriched in predicted unstructured regions, features that are strongly linked with multifunctionality. Many of the interacting proteins occupy essential hub positions in cellular protein networks, with key roles in chromatin organization, transcription, translation, maintenance of cell architecture and protein quality control. We suggest that amyloidogenic aggregation targets a metastable subproteome, thereby causing multifactorial toxicity and, eventually, the collapse of essential cellular functions.	[Olzscha, Heidi; Schermann, Sonya M.; Woerner, Andreas C.; Pinkert, Stefan; Hayer-Hartl, Manajit; Hartl, F. Ulrich; Vabulas, R. Martin] Max Planck Inst Biochem, Dept Cellular Biochem, D-82159 Martinsried, Germany; [Hecht, Michael H.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Tartaglia, Gian G.; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Max Planck Society; Princeton University; University of Cambridge	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82159 Martinsried, Germany.	mhartl@biochem.mpg.de; uhartl@biochem.mpg.de; vabulas@biochem.mpg.de	Olzscha, Heidi/AAU-1296-2020; Hayer-Hartl, Manajit/V-8078-2017; Pinkert, Stefan/A-5534-2009; Vabulas, R. Martin/D-3506-2011; Hartl, F. Ulrich/Y-8206-2019; Vendruscolo, Michele/F-5901-2012; Tartaglia, Gian Gaetano/K-1229-2014	Olzscha, Heidi/0000-0002-1929-1384; Hayer-Hartl, Manajit/0000-0001-8213-6742; Vendruscolo, Michele/0000-0002-3616-1610; Hecht, Michael/0000-0002-5538-9813; Tartaglia, Gian Gaetano/0000-0001-7524-6310	EU; Deutsche Forschungsgemeinschaft [SFB 596]; Ernst-Jung Foundation; Korber Foundation; Fonds der Chemischen Industrie; Elite Graduate Network of Bavaria	EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst-Jung Foundation; Korber Foundation; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Elite Graduate Network of Bavaria	We thank C.G. Glabe for providing the A11 antibody and H. Wagner for plasmids HSP70-Luc and NF-kappa B-Luc. We acknowledge the help of H. Engelhardt with FTIR measurements, technical assistance by O. Mihalache and V. Marcus with electron microscopy, and R. Zenke (MPIB core facility) for confocal microscopy. Financial support from EU Framework 7 Integrated Project PROSPECTS, the Deutsche Forschungsgemeinschaft (SFB 596), the Ernst-Jung Foundation, and the Korber Foundation is acknowledged. H.O. and A.W. have a fellowship from the Fonds der Chemischen Industrie, and H.O. is supported by the Elite Graduate Network of Bavaria.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Erkina TY, 2010, NUCLEIC ACIDS RES, V38, P1441, DOI 10.1093/nar/gkp1130; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim W, 2006, ACS CHEM BIOL, V1, P461, DOI 10.1021/cb600135w; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lee EK, 2006, BIOCHEM BIOPH RES CO, V344, P471, DOI 10.1016/j.bbrc.2006.03.166; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Nesterov EE, 2005, ANGEW CHEM INT EDIT, V44, P5452, DOI 10.1002/anie.200500845; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pentony MM, 2010, PROTEINS, V78, P212, DOI 10.1002/prot.22504; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Shearman MS, 1999, METHOD ENZYMOL, V309, P716; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; TATZELT J, 1995, P NATL ACAD SCI USA, V92, P2944, DOI 10.1073/pnas.92.7.2944; Wei YN, 2003, PROTEIN SCI, V12, P92, DOI 10.1110/ps.0228003; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; WILLIAMS GT, 1989, MOL CELL BIOL, V9, P2574, DOI 10.1128/MCB.9.6.2574; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	43	488	494	2	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					67	78		10.1016/j.cell.2010.11.050	http://dx.doi.org/10.1016/j.cell.2010.11.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215370	Green Submitted, Bronze			2022-12-28	WOS:000285993600008
J	Stephens, PJ; Greenman, CD; Fu, BY; Yang, FT; Bignell, GR; Mudie, LJ; Pleasance, ED; Lau, KW; Beare, D; Stebbings, LA; McLaren, S; Lin, ML; McBride, DJ; Varela, I; Nik-Zainal, S; Leroy, C; Jia, MM; Menzies, A; Butler, AP; Teague, JW; Quail, MA; Burton, J; Swerdlow, H; Carter, NP; Morsberger, LA; Iacobuzio-Donahue, C; Follows, GA; Green, AR; Flanagan, AM; Stratton, MR; Futreal, PA; Campbell, PJ				Stephens, Philip J.; Greenman, Chris D.; Fu, Beiyuan; Yang, Fengtang; Bignell, Graham R.; Mudie, Laura J.; Pleasance, Erin D.; Lau, King Wai; Beare, David; Stebbings, Lucy A.; McLaren, Stuart; Lin, Meng-Lay; McBride, David J.; Varela, Ignacio; Nik-Zainal, Serena; Leroy, Catherine; Jia, Mingming; Menzies, Andrew; Butler, Adam P.; Teague, Jon W.; Quail, Michael A.; Burton, John; Swerdlow, Harold; Carter, Nigel P.; Morsberger, Laura A.; Iacobuzio-Donahue, Christine; Follows, George A.; Green, Anthony R.; Flanagan, Adrienne M.; Stratton, Michael R.; Futreal, P. Andrew; Campbell, Peter J.			Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development	CELL			English	Article							CELL LUNG-CANCER; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; MUTATIONS; EVOLUTION; INSTABILITY; SIGNATURES; RESOLUTION; SEQUENCE	Cancer is driven by somatically acquired point mutations and chromosomal rearrangements, conventionally thought to accumulate gradually over time. Using next-generation sequencing, we characterize a phenomenon, which we term chromothripsis, whereby tens to hundreds of genomic rearrangements occur in a one-off cellular crisis. Rearrangements involving one or a few chromosomes crisscross back and forth across involved regions, generating frequent oscillations between two copy number states. These genomic hallmarks are highly improbable if rearrangements accumulate over time and instead imply that nearly all occur during a single cellular catastrophe. The stamp of chromothripsis can be seen in at least 2%-3% of all cancers, across many subtypes, and is present in similar to 25% of bone cancers. We find that one, or indeed more than one, cancer-causing lesion can emerge out of the genomic crisis. This phenomenon has important implications for the origins of genomic remodeling and temporal emergence of cancer.	[Stephens, Philip J.; Greenman, Chris D.; Fu, Beiyuan; Yang, Fengtang; Bignell, Graham R.; Mudie, Laura J.; Pleasance, Erin D.; Lau, King Wai; Beare, David; Stebbings, Lucy A.; McLaren, Stuart; Lin, Meng-Lay; McBride, David J.; Varela, Ignacio; Nik-Zainal, Serena; Leroy, Catherine; Jia, Mingming; Menzies, Andrew; Butler, Adam P.; Teague, Jon W.; Quail, Michael A.; Burton, John; Swerdlow, Harold; Carter, Nigel P.; Stratton, Michael R.; Futreal, P. Andrew; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; [Morsberger, Laura A.; Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA; [Morsberger, Laura A.; Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA; [Follows, George A.; Green, Anthony R.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Green, Anthony R.; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Flanagan, Adrienne M.] UCL, Inst Canc, London WC1E 6BT, England; [Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	University of Cambridge; Wellcome Trust Sanger Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; University College London; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; Institute of Cancer Research - UK	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England.	pc8@sanger.ac.uk	Iacobuzio-Donahue, Christine/ABF-1295-2020; Nik-Zainal, Serena/ABD-4437-2020; Varela, Ignacio/AAA-7680-2021; Califano, Andrea/F-7239-2012; Pillay, Nischalan/F-9536-2012; Yang, Fan/GYU-4249-2022; Varela, Ignacio/G-1699-2016; Quail, michael/ABE-6131-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Nik-Zainal, Serena/0000-0001-5054-1727; Yang, Fengtang/0000-0002-3573-2354; Flanagan, Adrienne/0000-0002-2832-1303; Swerdlow, Harold/0000-0002-9510-160X; Green, Anthony/0000-0002-9795-0218	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Chordoma Foundation; International Human Frontier Science Program Organization	Wellcome Trust(Wellcome TrustEuropean Commission); Chordoma Foundation; International Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by the Wellcome Trust (grant reference 077012/Z/05/Z) and the Chordoma Foundation. P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant reference WT088340MA). I.V. is supported by a fellowship from The International Human Frontier Science Program Organization. We also acknowledge support for sample banking and processing from the Cambridge and UCL/UCLH NIHR Biomedical Research Centres and Skeletal Action Cancer Trust (SCAT), especially Dr. Anthony Bench, Dr. Wendy Erber, and Miss Dina Halai. We would like to thank George Vassiliou for the neologism "chromothripsis.''	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chen JM, 2009, HUM MUTAT, V30, P1435, DOI 10.1002/humu.21088; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Geigl JB, 2006, NAT PROTOC, V1, P1172, DOI 10.1038/nprot.2006.160; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; McClintock B, 1941, GENETICS, V26, P234; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Pampalona J, 2010, MUTAT RES-FUND MOL M, V683, P16, DOI 10.1016/j.mrfmmm.2009.10.001; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104	36	1513	1550	5	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					27	40		10.1016/j.cell.2010.11.055	http://dx.doi.org/10.1016/j.cell.2010.11.055			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215367	Green Published, hybrid			2022-12-28	WOS:000285993600005
J	Chahal, HS; Stals, K; Unterlander, M; Balding, DJ; Thomas, MG; Kumar, AV; Besser, GM; Atkinson, AB; Morrison, PJ; Howlett, TA; Levy, MJ; Orme, SM; Akker, SA; Abel, RL; Grossman, AB; Burger, J; Ellard, S; Korbonits, M				Chahal, Harvinder S.; Stals, Karen; Unterlander, Martina; Balding, David J.; Thomas, Mark G.; Kumar, Ajith V.; Besser, G. Michael; Atkinson, A. Brew; Morrison, Patrick J.; Howlett, Trevor A.; Levy, Miles J.; Orme, Steve M.; Akker, Scott A.; Abel, Richard L.; Grossman, Ashley B.; Burger, Joachim; Ellard, Sian; Korbonits, Marta			Brief Report: AIP Mutation in Pituitary Adenomas in the 18th Century and Today.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERACTING-PROTEIN GENE; YOUNG-PATIENTS; LARGE COHORT; IRISH GIANT; ADOLESCENTS; FAMILIES; CHILDREN; COMPLEX	Gigantism results when a growth hormone-secreting pituitary adenoma is present before epiphyseal fusion. In 1909, when Harvey Cushing examined the skeleton of an Irish patient who lived from 1761 to 1783, *RF 1-3* he noted an enlarged pituitary fossa. We extracted DNA from the patient's teeth and identified a germline mutation in the aryl hydrocarbon-interacting protein gene (AIP). Four contemporary Northern Irish families who presented with gigantism, acromegaly, or prolactinoma have the same mutation and haplotype associated with the mutated gene. Using coalescent theory, we infer that these persons share a common ancestor who lived about 57 to 66 generations earlier.	[Chahal, Harvinder S.; Besser, G. Michael; Akker, Scott A.; Grossman, Ashley B.; Korbonits, Marta] Queen Mary Univ London, Barts & London Sch Med, Dept Endocrinol, London EC1A 6BQ, England; [Balding, David J.] UCL, Inst Genet, London, England; [Thomas, Mark G.] UCL, Res Dept Genet Evolut & Environm, London, England; [Kumar, Ajith V.] Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London, England; [Abel, Richard L.] Nat Hist Museum, Dept Mineral, London SW7 5BD, England; [Stals, Karen; Ellard, Sian] Royal Devon & Exeter Fdn Trust, Dept Mol Genet, Exeter, Devon, England; [Ellard, Sian] Univ Exeter, Peninsula Med Sch, Exeter, Devon, England; [Atkinson, A. Brew] Royal Victoria Hosp, Reg Ctr Endocrinol & Diabet, Belfast BT12 6BA, Antrim, North Ireland; [Morrison, Patrick J.] Belfast HSC Trust, Dept Med Genet, Belfast, Antrim, North Ireland; [Morrison, Patrick J.] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Howlett, Trevor A.; Levy, Miles J.] Univ Hosp Leicester, Dept Endocrinol, Leicester, Leics, England; [Orme, Steve M.] St James Univ Hosp, Dept Endocrinol, Leeds, W Yorkshire, England; [Unterlander, Martina; Burger, Joachim] Johannes Gutenberg Univ Mainz, Inst Anthropol, Mainz, Germany; [Thomas, Mark G.] Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Uppsala, Sweden	University of London; Queen Mary University London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Natural History Museum London; University of Exeter; Ulster University; University Hospitals of Leicester NHS Trust; University of Leicester; Saint James's University Hospital; Johannes Gutenberg University of Mainz; Uppsala University	Korbonits, M (corresponding author), Queen Mary Univ London, Barts & London Sch Med, Dept Endocrinol, Charterhouse Sq, London EC1A 6BQ, England.	m.korbonits@qmul.ac.uk	Abel, Richard/C-9913-2011; Thomas, Mark G/A-2219-2012; Balding, David/G-9898-2011	Thomas, Mark G/0000-0002-2452-981X; Balding, David/0000-0002-1480-6115; Korbonits, Marta/0000-0002-4101-9432; Ellard, Sian/0000-0002-7620-5526	Medical Research Council; National Institute for Health Research (United Kingdom); Barts; London Charity; MRC [G0701307] Funding Source: UKRI; Medical Research Council [G0701307] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (United Kingdom)(National Institute for Health Research (NIHR)); Barts; London Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a Medical Research Council Training Fellowship (to Dr. Chahal) and by grants from the National Institute for Health Research (United Kingdom) and from Barts and the London Charity.	BERGLAND RM, 1965, J NEUROSURG, V23, P265, DOI 10.3171/jns.1965.23.3.0265; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Cazabat L, 2007, EUR J ENDOCRINOL, V157, P1, DOI 10.1530/EJE-07-0181; Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007; Cushing H, 1912, PITUITARY BODY ITS D; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Donnelly P, 1996, SCIENCE, V272, P1357, DOI 10.1126/science.272.5266.1357; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Georgitsi M, 2008, CLIN ENDOCRINOL, V69, P621, DOI 10.1111/j.1365-2265.2008.03266.x; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; J Wier, 1567, VIRGO GYGANTEA EX QU, V1567, P7; Jennings JE, 2009, EUR J ENDOCRINOL, V161, P799, DOI 10.1530/EJE-09-0406; Keith A, 1911, LANCET, V1, P993; Kingman JFC., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; LANDOLT AM, 1980, LANCET, V1, P1311; Langer K, 1872, WACHSTUM MENSCHLICHE, P31; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Livi Bacci M, 2001, CONCISE HIST WORLD P; Marie P., 1986, REV MED LIEGE, V6, P297; Massalongo R, 1892, RIFORMA MED, V8, P74; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; Melmed S, 2007, NEW ENGL J MED, V356, P879; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Melmed S, 2009, J CLIN INVEST, V119, P3189, DOI 10.1172/JCI39375; Minkowski O, 1887, BERLINER KLIN WOCHEN, V21, P371; Myers CS, 1901, MAN LOND, V127, P152; Naves LA, 2007, EUR J ENDOCRINOL, V157, P383, DOI 10.1530/EJE-07-0533; Nordborg M., 2007, HDB STAT GENETICS, P843; Occhi G, 2010, J ENDOCRINOL IN 0330; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; Stratakis CA, 2010, CLIN GENET, V78, P457, DOI 10.1111/j.1399-0004.2010.01406.x; Thomas MG, 2006, P ROY SOC B-BIOL SCI, V273, P2651, DOI 10.1098/rspb.2006.3627; Verga A, 1864, SCI LETT BENDICONTI, V1, P111; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100	35	91	94	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					43	50		10.1056/NEJMoa1008020	http://dx.doi.org/10.1056/NEJMoa1008020			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UY	21208107	Green Published			2022-12-28	WOS:000285922600009
J	O'Sullivan, MC; Sprafke, JK; Kondratuk, DV; Rinfray, C; Claridge, TDW; Saywell, A; Blunt, MO; O'Shea, JN; Beton, PH; Malfois, M; Anderson, HL				O'Sullivan, Melanie C.; Sprafke, Johannes K.; Kondratuk, Dmitry V.; Rinfray, Corentin; Claridge, Timothy D. W.; Saywell, Alex; Blunt, Matthew O.; O'Shea, James N.; Beton, Peter H.; Malfois, Marc; Anderson, Harry L.			Vernier templating and synthesis of a 12-porphyrin nano-ring	NATURE			English	Article							CRYSTAL-STRUCTURE; ENERGY-TRANSFER; PI CONJUGATION; PORPHYRIN; GIANT; ASSEMBLIES; ANTENNA; COMPLEX; ARRAYS	Templates are widely used to arrange molecular components so they can be covalently linked into complex molecules that are not readily accessible by classical synthetic methods(1-7). Nature uses sophisticated templates such as the ribosome, whereas chemists use simple ions or small molecules. But as we tackle the synthesis of larger targets, we require larger templates-which themselves become synthetically challenging. Here we show that Vernier complexes can solve this problem: if the number of binding sites on the template, n(T), is not a multiple of the number of binding sites on the molecular building blocks, n(B), then small templates can direct the assembly of relatively large Vernier complexes where the number of binding sites in the product, n(P), is the lowest common multiple of n(B) and n(T) (refs 8, 9). We illustrate the value of this concept for the covalent synthesis of challenging targets by using a simple six-site template to direct the synthesis of a 12-porphyrin nano-ring with a diameter of 4.7 nm, thus establishing Vernier templating as a powerful new strategy for the synthesis of large monodisperse macromolecules.	[O'Sullivan, Melanie C.; Sprafke, Johannes K.; Kondratuk, Dmitry V.; Rinfray, Corentin; Claridge, Timothy D. W.; Anderson, Harry L.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Saywell, Alex; Blunt, Matthew O.; O'Shea, James N.; Beton, Peter H.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Malfois, Marc] Diamond Light Source Ltd, Didcot OX11 0DE, Oxon, England	University of Oxford; University of Nottingham; Diamond Light Source	Anderson, HL (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	harry.anderson@chem.ox.ac.uk	Claridge, Tim/A-8324-2018; Saywell, Alex/M-5004-2015; Malfois, Marc/L-2974-2014; O'Shea, James/B-5881-2016; Blunt, Matthew O/A-4133-2015; Beton, Peter/M-5303-2014; Anderson, Harry Laurence/E-7843-2011	Claridge, Tim/0000-0001-5583-6460; Saywell, Alex/0000-0002-2242-3149; Malfois, Marc/0000-0001-5231-1896; O'Shea, James/0000-0003-4687-7257; Blunt, Matthew O/0000-0001-9877-4183; Beton, Peter/0000-0002-2120-8033; Anderson, Harry Laurence/0000-0002-1801-8132; O'Sullivan, Melanie/0000-0001-8689-1059	Engineering and Physical Sciences Research Council (EPSRC); Diamond Light Source; European Commission [MRTN-CT-2006-036040, THREADMILL]; Clarendon Fund; Engineering and Physical Sciences Research Council [EP/D076552/1] Funding Source: researchfish; EPSRC [EP/D076552/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Diamond Light Source; European Commission(European CommissionEuropean Commission Joint Research Centre); Clarendon Fund; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the Engineering and Physical Sciences Research Council (EPSRC), the Diamond Light Source, the European Commission (EU-contract: MRTN-CT-2006-036040, THREADMILL) and the Clarendon Fund for support; the EPSRC mass spectrometry service (Swansea) for mass spectra; and B. Odell for help with NMR spectroscopy.	ANDERSON S, 1993, ACCOUNTS CHEM RES, V26, P469, DOI 10.1021/ar00033a003; Bleszynski-Jayich AC, 2009, SCIENCE, V326, P272, DOI 10.1126/science.1178139; Chang MH, 2008, J AM CHEM SOC, V130, P10171, DOI 10.1021/ja711222c; Chichak KS, 2004, SCIENCE, V304, P1308, DOI 10.1126/science.1096914; Crowley JD, 2010, J AM CHEM SOC, V132, P6243, DOI 10.1021/ja101121j; Diederich F., 1999, TEMPLATED ORGANIC SY; Hajjaj F, 2006, J AM CHEM SOC, V128, P4612, DOI 10.1021/ja0583214; Hoffmann M, 2008, ANGEW CHEM INT EDIT, V47, P4993, DOI 10.1002/anie.200801188; Hoffmann M, 2007, ANGEW CHEM INT EDIT, V46, P3122, DOI 10.1002/anie.200604601; Hunter CA, 2006, J AM CHEM SOC, V128, P8975, DOI 10.1021/ja061928f; Jung SH, 2006, ANGEW CHEM INT EDIT, V45, P4685, DOI 10.1002/anie.200601131; Kelley RF, 2008, J AM CHEM SOC, V130, P4277, DOI 10.1021/ja075494f; Kelly TR, 1998, TETRAHEDRON LETT, V39, P3675; LINDSEY JS, 1991, NEW J CHEM, V15, P153; Mayor M, 2003, ANGEW CHEM INT EDIT, V42, P3176, DOI 10.1002/anie.200250763; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; Nakamura Y, 2007, CHEM SOC REV, V36, P831, DOI 10.1039/b618854k; Nakao K, 2006, J AM CHEM SOC, V128, P16740, DOI 10.1021/ja067077t; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Saywell A, 2010, ANGEW CHEM INT EDIT, V49, P9136, DOI 10.1002/anie.201004896; Taylor PN, 1999, J AM CHEM SOC, V121, P11538, DOI 10.1021/ja992821d; Zhang F, 2009, ANGEW CHEM INT EDIT, V48, P6632, DOI 10.1002/anie.200900101	22	322	323	8	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					72	75		10.1038/nature09683	http://dx.doi.org/10.1038/nature09683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21209660				2022-12-28	WOS:000285921600033
J	Wender, P; Cummins, CC; Poliakoff, M; Kiessling, L; Meijer, EW; Alivisatos, P; Wooley, K; King, D; Aizenberg, J; Fleming, G				Wender, Paul; Cummins, Christopher C.; Poliakoff, Martyn; Kiessling, Laura; Meijer, E. W. 'Bert'; Alivisatos, Paul; Wooley, Karen; King, David; Aizenberg, Joanna; Fleming, Graham			What lies ahead	NATURE			English	Editorial Material									[Wender, Paul] Stanford Univ, Stanford, CA 94305 USA; [Cummins, Christopher C.] MIT, Cambridge, MA 02139 USA; [Poliakoff, Martyn] Univ Nottingham, Nottingham NG7 2RD, England; [Kiessling, Laura] Univ Wisconsin, Madison, WI 53706 USA; [Meijer, E. W. 'Bert'] Eindhoven Univ Technol, NL-5600 MB Eindhoven, Netherlands; [Alivisatos, Paul] Lawrence Berkeley Natl Lab, Berkeley, CA USA; [Wooley, Karen] Texas A&M Univ, College Stn, TX USA; [King, David] Smith Sch Enterprise & Environm, Oxford, England; [Aizenberg, Joanna] Harvard Univ, Cambridge, MA 02138 USA; [Fleming, Graham] Univ Calif Berkeley, Berkeley, CA 94720 USA	Stanford University; Massachusetts Institute of Technology (MIT); University of Nottingham; University of Wisconsin System; University of Wisconsin Madison; Eindhoven University of Technology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Texas A&M University System; Texas A&M University College Station; University of Oxford; Harvard University; University of California System; University of California Berkeley	Wender, P (corresponding author), Stanford Univ, Stanford, CA 94305 USA.		Meijer, E.W./K-7632-2013; Chen, Yao/AAJ-2409-2020; Wooley, Karen/AAX-2259-2020; Wooley, Karen L/D-4399-2015	Meijer, E.W./0000-0003-4126-7492; Wooley, Karen/0000-0003-4086-384X; Wooley, Karen L/0000-0003-4086-384X					0	11	11	0	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					23	25		10.1038/469023a	http://dx.doi.org/10.1038/469023a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	702UO	21209640				2022-12-28	WOS:000285921600011
J	Kahn, BB; McGraw, TE				Kahn, Barbara B.; McGraw, Timothy E.			Rosiglitazone, PPAR(gamma), and Type 2 Diabetes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GAMMA; DRUGS		[Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kahn, Barbara B.] Harvard Univ, Sch Med, Boston, MA USA; [McGraw, Timothy E.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cornell University	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052852, R37DK043051] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK052852, R37 DK043051, R01 DK043051] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; DeSouza C, 2009, NAT REV DRUG DISCOV, V8, P361, DOI 10.1038/nrd2872; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; McGuire DK, 2008, CIRCULATION, V117, P440, DOI 10.1161/CIRCULATIONAHA.107.704080; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512	6	49	58	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2667	2669		10.1056/NEJMcibr1012075	http://dx.doi.org/10.1056/NEJMcibr1012075			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190462	Green Accepted			2022-12-28	WOS:000285763700015
J	Ahmed, F				Ahmed, Farooq			Edible advice	NATURE			English	Editorial Material																		Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Matsuo T, 2009, OBESITY, V17, P1924, DOI 10.1038/oby.2009.199; Tripathy S, 2010, J LIPID RES, V51, P2642, DOI 10.1194/jlr.M006080; Wise Carolyn, 2009, J Diabetes Sci Technol, V3, P710	5	5	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					S10	S12		10.1038/468S10a	http://dx.doi.org/10.1038/468S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179076	Bronze			2022-12-28	WOS:000285553800004
J	Cruikshank, DP				Cruikshank, Dale P.			Generating an Atmosphere	SCIENCE			English	Editorial Material							OXYGEN; WATER		NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Cruikshank, DP (corresponding author), NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA.	dale.p.cruikshank@nasa.gov						Campins H, 2010, NATURE, V464, P1320, DOI 10.1038/nature09029; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Dalton JB, 2010, SPACE SCI REV, V153, P113, DOI 10.1007/s11214-010-9665-8; Hall DT, 1998, ASTROPHYS J, V499, P475, DOI 10.1086/305604; Kaltenegger L, 2010, ASTROPHYS J LETT, V712, pL125, DOI 10.1088/2041-8205/712/2/L125; Teolis BD, 2010, SCIENCE, V330, P1813, DOI 10.1126/science.1198366; Vidal-Madjar A, 2004, ASTROPHYS J, V604, pL69, DOI 10.1086/383347	7	3	3	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1755	1756		10.1126/science.1200473	http://dx.doi.org/10.1126/science.1200473			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205657				2022-12-28	WOS:000285603700022
J	Eisenstein, M				Eisenstein, Michael			More than meets the mouth	NATURE			English	Editorial Material																			0	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S18	S19		10.1038/468S18a	http://dx.doi.org/10.1038/468S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179079	Bronze			2022-12-28	WOS:000285553800007
J	Niehrs, C; Acebron, SP				Niehrs, Christof; Acebron, Sergio P.			Wnt Signaling: Multivesicular Bodies Hold GSK3 Captive	CELL			English	Editorial Material							PHOSPHORYLATION; ENDOCYTOSIS; RECEPTOR	Two key events in Wnt signal transduction, receptor endocytosis and inactivation of Glycogen Synthase Kinase 3 (GSK3), remain incompletely understood. Taelman et al. (2010) discover that Wnt signaling inactivates GSK3 by sequestering the enzyme in multivesicular bodies, thus linking these two events and providing a new framework for understanding Wnt signaling.	[Niehrs, Christof; Acebron, Sergio P.] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Div Mol Embryol, Heidelberg, Germany; [Niehrs, Christof] IMB, D-55128 Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Institute of Molecular Biology (IMB)	Niehrs, C (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Div Mol Embryol, Neuenheimer Feld 581, Heidelberg, Germany.	niehrs@dkfz.de						Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Kikuchi A, 2007, J BIOCHEM, V141, P443, DOI 10.1093/jb/mvm061; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	10	26	26	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 23	2010	143	7					1044	1046		10.1016/j.cell.2010.12.003	http://dx.doi.org/10.1016/j.cell.2010.12.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183070	Bronze			2022-12-28	WOS:000285625400003
J	Lesser, CS; Lucey, CR; Egener, B; Braddock, CH; Linas, SL; Levinson, W				Lesser, Cara S.; Lucey, Catherine R.; Egener, Barry; Braddock, Clarence H., III; Linas, Stuart L.; Levinson, Wendy			A Behavioral and Systems View of Professionalism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE; MEDICINE	Professionalism may not be sufficient to drive the profound and far-reaching changes needed in the US health care system, but without it, the health care enterprise is lost. Formal statements defining professionalism have been abstract and principle based, without a clear description of what professional behaviors look like in practice. This article proposes a behavioral and systems view of professionalism that provides a practical approach for physicians and the organizations in which they work. A more behaviorally oriented definition makes the pursuit of professionalism in daily practice more accessible and attainable. Professionalism needs to evolve from being conceptualized as an innate character trait or virtue to sophisticated competencies that can and must be taught and refined over a lifetime of practice. Furthermore, professional behaviors are profoundly influenced by the organizational and environmental context of contemporary medical practice, and these external forces need to be harnessed to support-not inhibit-professionalism in practice. This perspective on professionalism provides an opportunity to improve the delivery of health care through education and system-level reform. JAMA. 2010;304(24):2732-2737 www.jama.com	[Lesser, Cara S.] Amer Board Internal Med Fdn, Fdn Programs, Philadelphia, PA USA; [Lucey, Catherine R.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Egener, Barry] Fdn Med Excellence, Portland, OR USA; [Braddock, Clarence H., III] Stanford Univ, Palo Alto, CA 94304 USA; [Linas, Stuart L.] Univ Colorado, Denver Sch Med, Dept Med, Denver, CO 80202 USA; [Levinson, Wendy] Univ Toronto, Dept Med, Toronto, ON, Canada	American Board of Internal Medicine; University System of Ohio; Ohio State University; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Toronto	Lesser, CS (corresponding author), US Dept HHS, Off Planning & Evaluat, Off Consumer & Informat & Insurance Oversight, 2000 Independence Ave SW, Washington, DC 20201 USA.	cara.lesser@hhs.gov						Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Cohen JJ, 2007, JAMA-J AM MED ASSOC, V298, P670, DOI 10.1001/jama.298.6.670; Durant William, 1991, STORY PHILOS LIVES O; Freidson E., 2001, PROFESSIONALISM 3 LO; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Ginsburg S, 2000, ACAD MED, V75, pS6, DOI 10.1097/00001888-200010001-00003; Gruen RL, 2004, JAMA-J AM MED ASSOC, V291, P94, DOI 10.1001/jama.291.1.94; Hafferty FW, 2010, ACAD MED, V85, P288, DOI 10.1097/ACM.0b013e3181c85b43; Hall MA, 2001, J HEALTH POLIT POLIC, V26, P1131, DOI 10.1215/03616878-26-5-1131; Hibbard JH, 2008, ANN INTERN MED, V148, P160, DOI 10.7326/0003-4819-148-2-200801150-00011; Leach DC, 2004, AM J BIOETHICS, V4, P11, DOI 10.1162/152651604323097619; Lucey C, 2010, ACAD MED, V85, P1018, DOI 10.1097/ACM.0b013e3181dbe51f; National Alliance for Physician Competence, 2008, GUID GOOD MED PRACT; Pink D.H., 2010, DRIVE SURPRISING TRU; Relman AS, 2007, JAMA-J AM MED ASSOC, V298, P2668, DOI 10.1001/jama.298.22.2668; Rosenthal MB, 2008, NEW ENGL J MED, V359, P1197, DOI 10.1056/NEJMp0804658; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Swensen SJ, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0911199	18	149	153	7	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2732	2737		10.1001/jama.2010.1864	http://dx.doi.org/10.1001/jama.2010.1864			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177508				2022-12-28	WOS:000285518000018
J	Phizackerley, D				Phizackerley, David			Commentary: Achieving savings will not be straightforward	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Phizackerley, David] Drug & Therapeut Bulletin, London WC1H 9JR, England		Phizackerley, D (corresponding author), Drug & Therapeut Bulletin, London WC1H 9JR, England.	dphizackerley@bmjgroup.com	Phizackerley, David/V-4769-2019	Phizackerley, David/0000-0002-1795-6127				*AUD COMM, 1994, PRESCR IMPR MOR RAT; Audit Commission, 2001, SPOONF SUG MED MAN N; Department of Health, 2010, STRAT ACH COST EFF P; National Audit Office, 2007, PRESCR COSTS PRIM CA	4	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2010	341								c7161	10.1136/bmj.c7161	http://dx.doi.org/10.1136/bmj.c7161			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	697XO	21169322				2022-12-28	WOS:000285553300003
J	Carlson, D				Carlson, David			A lesson in sharing	NATURE			English	Editorial Material											Carlson, D (corresponding author), Nonprofit Geodesy Consortium UNAVCO, Boulder, CO USA.	ipy.djc@gmail.com							0	17	18	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					293	293		10.1038/469293a	http://dx.doi.org/10.1038/469293a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	708SW	21248818	Bronze			2022-12-28	WOS:000286385600019
J	Mariner, WK; Annas, GJ; Glantz, LH				Mariner, Wendy K.; Annas, George J.; Glantz, Leonard H.			Can Congress Make You Buy Broccoli? And Why That's a Hard Question.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mariner, Wendy K.; Annas, George J.; Glantz, Leonard H.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Mariner, WK (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831; Glantz, Leonard/0000-0003-4591-2305; Mariner, Wendy/0000-0001-5176-5917				Hall MA, 2011, NEW ENGL J MED, V364, P295, DOI 10.1056/NEJMp1013234; Mariner WK, 2010, NEW ENGL J MED, V363, P1300, DOI 10.1056/NEJMp1009054; Rosenbaum S, 2010, NEW ENGL J MED, V363, P1881, DOI 10.1056/NEJMp1010850	3	14	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					201	203		10.1056/NEJMp1014367	http://dx.doi.org/10.1056/NEJMp1014367			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708SF	21175307				2022-12-28	WOS:000286383900004
J	Witt, DM				Witt, Daniel M.			Weekly INR self-testing did not reduce stroke, major bleeding, or death more than monthly clinic testing	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Kaiser Permanente Colorado, Aurora, CO USA	Kaiser Permanente	Witt, DM (corresponding author), Kaiser Permanente Colorado, Aurora, CO USA.							Cundiff David Keith, 2008, Medscape J Med, V10, P258; Garcia-Alamino JM, 2010, COCHRANE DB SYST REV; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-4	10.7326/0003-4819-154-2-201101180-02004	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242358				2022-12-28	WOS:000286223500030
J	Muddiman, DC				Muddiman, David C.			John Bennett Fenn (1917-2010)	SCIENCE			English	Biographical-Item									N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Muddiman, DC (corresponding author), N Carolina State Univ, Dept Chem, Box 8204, Raleigh, NC 27695 USA.	dcmuddim@ncsu.edu		Muddiman, David/0000-0003-2216-499X					0	0	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2011	331	6014					160	160		10.1126/science.1201766	http://dx.doi.org/10.1126/science.1201766			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233376				2022-12-28	WOS:000286433100029
J	Stewart, MP; Helenius, J; Toyoda, Y; Ramanathan, SP; Muller, DJ; Hyman, AA				Stewart, Martin P.; Helenius, Jonne; Toyoda, Yusuke; Ramanathan, Subramanian P.; Muller, Daniel J.; Hyman, Anthony A.			Hydrostatic pressure and the actomyosin cortex drive mitotic cell rounding	NATURE			English	Article							ATOMIC-FORCE MICROSCOPE; SHAPE; FLOW; MORPHOGENESIS; OSCILLATIONS; RETRACTION; MEMBRANE; RIGIDITY; DIVISION; MOESIN	During mitosis, adherent animal cells undergo a drastic shape change, from essentially flat to round(1-3). Mitotic cell rounding is thought to facilitate organization within the mitotic cell and be necessary for the geometric requirements of division(4-7). However, the forces that drive this shape change remain poorly understood in the presence of external impediments, such as a tissue environment(2). Here we use cantilevers to track cell rounding force and volume. We show that cells have an outward rounding force, which increases as cells enter mitosis. We find that this mitotic rounding force depends both on the actomyosin cytoskeleton and the cells' ability to regulate osmolarity. The rounding force itself is generated by an osmotic pressure. However, the actomyosin cortex is required to maintain this rounding force against external impediments. Instantaneous disruption of the actomyosin cortex leads to volume increase, and stimulation of actomyosin contraction leads to volume decrease. These results show that in cells, osmotic pressure is balanced by inwardly directed actomyosin cortex contraction. Thus, by locally modulating actomyosin-cortex-dependent surface tension and globally regulating osmotic pressure, cells can control their volume, shape and mechanical properties.	[Toyoda, Yusuke; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-1307 Dresden, Germany; [Stewart, Martin P.; Helenius, Jonne; Ramanathan, Subramanian P.; Muller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Stewart, Martin P.] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technische Universitat Dresden	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-1307 Dresden, Germany.	daniel.muller@bsse.ethz.ch	Hyman, Anthony A/B-3917-2017; Ramanathan, Subramanian/AAE-9817-2020; Müller, Daniel J./A-5967-2010; Stewart, Martin Philip/E-8059-2011; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Müller, Daniel J./0000-0003-3075-0665; Stewart, Martin Philip/0000-0003-4112-6622; Ramanathan, Subu/0000-0002-2876-0322; Toyoda, Yusuke/0000-0003-0534-6898	DFG; BMBF; SNF; JSPS; Max Planck Society	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); SNF; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Max Planck Society(Max Planck SocietyFoundation CELLEX)	DFG, BMBF and SNF supported this project. JSPS supported Y.T. A. A. H. is funded by the Max Planck Society. We thank S. Bhakdi for toxins and advice on their use, T. J. Mitchison for extensive discussions on osmotic pressure and critical reading of the manuscript, M. Krieg for valuable insights into cell blebbing, and B. Baum, C. Brangwynne, S. Grill, A. Helenius, J. Howard, F. Julicher, Z. Maliga and E. Paluch for discussions and critical reading of the manuscript.	Bereiter-Hahn J, 2005, MED ENG PHYS, V27, P743, DOI 10.1016/j.medengphy.2005.04.021; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cramer LP, 1997, MOL BIOL CELL, V8, P109, DOI 10.1091/mbc.8.1.109; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; Fujibuchi T, 2005, BIOCHEM BIOPH RES CO, V327, P268, DOI 10.1016/j.bbrc.2004.11.156; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; HAROLD FM, 1990, MICROBIOL REV, V54, P381, DOI 10.1128/MMBR.54.4.381-431.1990; HARRIS A, 1973, DEV BIOL, V35, P97, DOI 10.1016/0012-1606(73)90009-2; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; HIRAMOTO Y, 1963, EXP CELL RES, V32, P59, DOI 10.1016/0014-4827(63)90069-7; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Koschinski A, 2006, FASEB J, V20, P973, DOI 10.1096/fj.05-4561fje; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lang F., 2006, MECH SIGNIFICANCE CE; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Matzke R, 2001, NAT CELL BIOL, V3, P607, DOI 10.1038/35078583; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6; RUTA M, 1986, MOL CELL BIOL, V6, P1706, DOI 10.1128/MCB.6.5.1706; Salbreux G, 2007, PHYS BIOL, V4, P268, DOI 10.1088/1478-3975/4/4/004; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Valeva A, 2000, MOL MICROBIOL, V36, P467, DOI 10.1046/j.1365-2958.2000.01865.x; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x	35	441	449	1	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					226	230		10.1038/nature09642	http://dx.doi.org/10.1038/nature09642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21196934				2022-12-28	WOS:000286143400041
J	Meyerson, M; Pellman, D				Meyerson, Matthew; Pellman, David			Cancer Genomes Evolve by Pulverizing Single Chromosomes	CELL			English	Editorial Material							MAMMALIAN-CELL FUSION; TELOMERES		[Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Pellman, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Meyerson, Matthew] Broad Inst, Cambridge, MA 02142 USA; [Pellman, David] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Pellman, David] Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; [Pellman, David] Childrens Hosp, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012	Meyerson, Matthew/0000-0002-9133-8108				Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; McClintock B, 1941, GENETICS, V26, P234; Murnane JP, 2006, DNA REPAIR, V5, P1082, DOI 10.1016/j.dnarep.2006.05.030; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pampalona J, 2010, MUTAT RES-FUND MOL M, V683, P16, DOI 10.1016/j.mrfmmm.2009.10.001; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; SPERLING K, 1974, CHROMOSOMA, V45, P121, DOI 10.1007/BF00362306; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943	10	77	81	2	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 7	2011	144	1					9	10		10.1016/j.cell.2010.12.025	http://dx.doi.org/10.1016/j.cell.2010.12.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215363	Bronze			2022-12-28	WOS:000285993600001
J	Netea, MG; van der Meer, JWM				Netea, Mihai G.; van der Meer, Jos W. M.			MECHANISMS OF DISEASE Immunodeficiency and Genetic Defects of Pattern-Recognition Receptors	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INNATE-IMMUNE-SYSTEM; MANNOSE-BINDING LECTIN; TOLL-LIKE RECEPTORS; CHRONIC MUCOCUTANEOUS CANDIDIASIS; RECURRENT BACTERIAL-INFECTIONS; HERPES-SIMPLEX ENCEPHALITIS; PERIODIC FEVER SYNDROMES; GENOME-WIDE ASSOCIATION; STOP CODON POLYMORPHISM; CROHNS-DISEASE	The susceptibility of adopted children to infection correlates more with the susceptibility of their biologic parents than with that of their adoptive parents.(1) This suggests that genetic factors can increase the risk of infection. These factors are often genetic polymorphisms, but in a few cases monogenic defects underlie vulnerability to repeated infections. Genetic studies of susceptibility to infection have typically focused on defects of antibody production, or a lack of T cells, phagocytes, natural killer cells, or complement, each of which can cause a classic immunodeficiency syndrome. Recently, genetic defects have been identified that impair recognition of pathogens by the innate immune system, increasing susceptibility to specific classes of microorganisms. For example, defects in the interferon-gamma pathway have been implicated in recalcitrant infections by intracellular pathogens such as mycobacteria and salmonella.(2,3) In this review, we focus on types of immunodeficiencies in which defects in pattern-recognition receptors and their downstream intracellular pathways predominate.	Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Netea, MG (corresponding author), Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med 463, POB 9101, NL-6500 HB Nijmegen, Netherlands.	m.netea@aig.umcn.nl	van der Meer, Jos W.M./C-8521-2013; Netea, Mihai/N-5155-2014	van der Meer, Jos W.M./0000-0001-5120-3690; 	Netherlands Organization of Scientific Research	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO))	Supported by a Vici grant from the Netherlands Organization of Scientific Research (to Dr. Netea).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029; Bousfiha A, 2010, CLIN IMMUNOL, V135, P204, DOI 10.1016/j.clim.2010.02.001; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Bugarcic A, 2008, GLYCOBIOLOGY, V18, P679, DOI 10.1093/glycob/cwn046; Cardenes M, 2006, J PEDIATR-US, V148, P549, DOI 10.1016/j.jpeds.2005.12.012; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chapel H, 2005, CLIN INFECT DIS, V40, P1227, DOI 10.1086/428733; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Comeau JL, 2008, PEDIATR INFECT DIS J, V27, P170, DOI 10.1097/INF.0b013e318157ad01; Davidson DJ, 2006, J IMMUNOL, V177, P8202, DOI 10.4049/jimmunol.177.11.8202; De Tiege X, 2008, EUR J PAEDIATR NEURO, V12, P72, DOI 10.1016/j.ejpn.2007.07.007; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dunstan SJ, 2005, J INFECT DIS, V191, P1068, DOI 10.1086/428593; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Etzioni A, 2009, CURR OPIN IMMUNOL, V21, P481, DOI 10.1016/j.coi.2009.07.005; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hawn TR, 2005, P NATL ACAD SCI USA, V102, P10593, DOI 10.1073/pnas.0501165102; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jack DL, 2003, BIOCHEM SOC T, V31, P753, DOI 10.1042/BST0310753; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Jeru I, 2008, P NATL ACAD SCI USA, V105, P1614, DOI 10.1073/pnas.0708616105; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P401, DOI 10.1016/S0304-4165(02)00321-5; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Kuhns DB, 1997, J IMMUNOL, V158, P3959; Kullberg BJ, 2008, IMMUNOLOGY, V123, P600, DOI 10.1111/j.1365-2567.2007.02735.x; Lamkanfi M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000510; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lilic D, 2003, INFECT IMMUN, V71, P5690, DOI 10.1128/IAI.71.10.5690-5699.2003; Marks D, 2007, LANCET, V370, P318; Marks DJB, 2010, CLIN REV ALLERG IMMU, V38, P20, DOI 10.1007/s12016-009-8133-2; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Netea MG, 2004, J LEUKOCYTE BIOL, V75, P749, DOI 10.1189/jlb.1103543; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Notarangelo LD, 2009, J LEUKOCYTE BIOL, V85, P335, DOI 10.1189/jlb.0808474; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Saegusa S, 2004, FEMS IMMUNOL MED MIC, V41, P227, DOI 10.1016/j.femsim.2004.03.006; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Sewell GW, 2009, CURR OPIN IMMUNOL, V21, P506, DOI 10.1016/j.coi.2009.06.003; Simon A, 2007, AM J PHYSIOL-REG I, V292, pR86, DOI 10.1152/ajpregu.00504.2006; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Sprong T, 2008, CLIN INFECT DIS, V47, P517, DOI 10.1086/590007; Szabo J, 2007, J MED MICROBIOL, V56, P863, DOI 10.1099/jmm.0.47046-0; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; van Bruggen R, 2009, MOL IMMUNOL, V47, P575, DOI 10.1016/j.molimm.2009.09.018; van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Wlasiuk G, 2009, MOL BIOL EVOL, V26, P937, DOI 10.1093/molbev/msp018; Worthley DL, 2005, INTERN MED J, V35, P548, DOI 10.1111/j.1445-5994.2005.00908.x; Yadav M, 2006, BLOOD, V108, P3168, DOI 10.1182/blood-2006-05-024406; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	94	63	65	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					60	70		10.1056/NEJMra1001976	http://dx.doi.org/10.1056/NEJMra1001976			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UY	21208109	Green Published			2022-12-28	WOS:000285922600011
J	Anothaisintawee, T; Attia, J; Nickel, JC; Thammakraisorn, S; Numthavaj, P; McEvoy, M; Thakkinstian, A				Anothaisintawee, Thunyarat; Attia, John; Nickel, J. Curtis; Thammakraisorn, Sangsuree; Numthavaj, Pawin; McEvoy, Mark; Thakkinstian, Ammarin			Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome A Systematic Review and Network Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLACEBO-CONTROLLED MULTICENTER; DOUBLE-BLIND; MEN; SYMPTOMS; THERAPY; CIPROFLOXACIN; LEVOFLOXACIN; FINASTERIDE; TAMSULOSIN; DIAGNOSIS	Context Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is common, but trial evidence is conflicting and therapeutic options are controversial. Objective To conduct a systematic review and network meta-analysis comparing mean symptom scores and treatment response among alpha-blockers, antibiotics, antiinflammatory drugs, other active drugs (phytotherapy, glycosaminoglycans, finasteride, and neuromodulators), and placebo. Data Sources We searched MEDLINE from 1949 and EMBASE from 1974 to November 16, 2010, using the PubMed and Ovid search engines. Study Selection Randomized controlled trials comparing drug treatments in CP/CPPS patients. Data Extraction Two reviewers independently extracted mean symptom scores, quality-of-life measures, and response to treatment between treatment groups. Standardized mean difference and random-effects methods were applied for pooling continuous and dichotomous outcomes, respectively. A longitudinal mixed regression model was used for network meta-analysis to indirectly compare treatment effects. Data Synthesis Twenty-three of 262 studies identified were eligible. Compared with placebo, alpha-blockers were associated with significant improvement in symptoms with standardized mean differences in total symptom, pain, voiding, and quality-of-life scores of -1.7 (95% confidence interval [CI], -2.8 to -0.6), -1.1 (95% CI, -1.8 to -0.3), -1.4 (95% CI, -2.3 to -0.5), and -1.0 (95% CI, -1.8 to -0.2), respectively. Patients receiving alpha-blockers or anti-inflammatory medications had a higher chance of favorable response compared with placebo, with pooled RRs of 1.6 (95% CI, 1.1-2.3) and 1.8 (95% CI, 1.2-2.6), respectively. Contour-enhanced funnel plots suggested the presence of publication bias for smaller studies of alpha-blocker therapies. The network meta-analysis suggested benefits of antibiotics in decreasing total symptom scores (-9.8; 95% CI, -15.1 to -4.6), pain scores (-4.4; 95% CI, -7.0 to -1.9), voiding scores (-2.8; 95% CI, -4.1 to -1.6), and quality-of-life scores (-1.9; 95% CI, -3.6 to -0.2) compared with placebo. Combining alpha-blockers and antibiotics yielded the greatest benefits compared with placebo, with corresponding decreases of -13.8 (95% CI, -17.5 to -10.2) for total symptom scores, -5.7 (95% CI, -7.8 to -3.6) for pain scores, -3.7 (95% CI, -5.2 to -2.1) for voiding, and -2.8 (95% CI, -4.7 to -0.9) for quality-of-life scores. Conclusions alpha-Blockers, antibiotics, and combinations of these therapies appear to achieve the greatest improvement in clinical symptom scores compared with placebo. Antiinflammatory therapies have a lesser but measurable benefit on selected outcomes. However, beneficial effects of alpha-blockers may be overestimated because of publication bias. JAMA. 2011;305(1):78-86 www.jama.com	[Anothaisintawee, Thunyarat; Numthavaj, Pawin; Thakkinstian, Ammarin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Sect Clin Epidemiol & Biostat, Bangkok 10400, Thailand; [Anothaisintawee, Thunyarat; Thammakraisorn, Sangsuree] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Family Med, Bangkok 10400, Thailand; [Attia, John; McEvoy, Mark] Univ Newcastle, Sch Med & Publ Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2308, Australia; [Attia, John] Hunter Med Res Inst, Newcastle, NSW, Australia; [Nickel, J. Curtis] Queens Univ, Dept Urol, Kingston, ON, Canada	Mahidol University; Mahidol University; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Queens University - Canada	Thakkinstian, A (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Sect Clin Epidemiol & Biostat, Rama VI Rd, Bangkok 10400, Thailand.	raatk@mahidol.ac.th	Attia, John R/F-5376-2013; Thakkinstian, Ammarin/J-4788-2019	Attia, John R/0000-0001-9800-1308; McEvoy, Mark/0000-0002-5505-5557	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; Canada Institute for Health Research; Canada Research Chair Program	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Canada Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Program(Canada Research Chairs)	Dr Nickel's research in CP/CPPS is funded in part by the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, the Canada Institute for Health Research, and the Canada Research Chair Program.	Alexander RB, 2004, ANN INTERN MED, V141, P581, DOI 10.7326/0003-4819-141-8-200410190-00005; [Anonymous], 2009, STAT COMP PROGR REL; Bates SM, 2007, BJU INT, V99, P355, DOI 10.1111/j.1464-410X.2007.06667.x; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Cheah PY, 2003, J UROLOGY, V169, P592, DOI 10.1016/S0022-5347(05)63960-2; Cockett ATK, 1994, 2 INT CONS BEN PROST, P624; Collins MM, 2000, ANN INTERN MED, V133, P367, DOI 10.7326/0003-4819-133-5-200009050-00013; Collins MM, 2001, J GEN INTERN MED, V16, P656; Collins MM, 1998, J UROLOGY, V159, P1224, DOI 10.1016/S0022-5347(01)63564-X; DELAROSETTE JJMCH, 1993, UROLOGY, V41, P301, DOI 10.1016/0090-4295(93)90584-W; Elist J, 2006, UROLOGY, V67, P60, DOI 10.1016/j.urology.2005.07.035; Evliyaoglu Yalcin, 2002, International Urology and Nephrology, V34, P351, DOI 10.1023/A:1024487604631; Galley HF, 1997, CRIT CARE MED, V25, P1392, DOI 10.1097/00003246-199708000-00029; Goldmeier D, 2005, INT J STD AIDS, V16, P196, DOI 10.1258/0956462053420239; Gul Osman, 2001, International Urology and Nephrology, V32, P433, DOI 10.1023/A:1017504830834; Hetrick DC, 2003, J UROLOGY, V170, P828, DOI 10.1097/01.ju.0000080513.13968.56; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hochreiter WW, 2000, UROLOGY, V56, P1025, DOI 10.1016/S0090-4295(00)00844-X; Jeong CW, 2008, UROL INT, V80, P157, DOI 10.1159/000112606; Kaplan SA, 2004, J UROLOGY, V171, P284, DOI 10.1097/01.ju.0000101487.83730.80; Katsuno G, 2006, CLIN IMMUNOL, V119, P110, DOI 10.1016/j.clim.2005.12.004; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Krieger JN, 1996, UROLOGY, V48, P715, DOI 10.1016/S0090-4295(96)00421-9; Kulovac B, 2007, BOSNIAN J BASIC MED, V7, P245, DOI 10.17305/bjbms.2007.3053; Leskinen M, 1999, UROLOGY, V53, P502, DOI 10.1016/S0090-4295(98)00540-8; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Mehik A, 2003, UROLOGY, V62, P425, DOI 10.1016/S0090-4295(03)00466-7; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Nickel JC, 2008, J UROLOGY, V179, P1391, DOI 10.1016/j.juro.2007.11.081; Nickel JC, 2008, INT J ANTIMICROB AG, V31, pS112, DOI 10.1016/j.ijantimicag.2007.07.028; Nickel JC, 2010, BJU INT, V106, P1252, DOI 10.1111/j.1464-410X.2010.09701.x; Nickel JC, 2008, NEW ENGL J MED, V359, P2663, DOI 10.1056/NEJMoa0803240; Nickel JC, 2005, UROLOGY, V66, P2, DOI 10.1016/j.urology.2004.12.028; Nickel JC, 2005, J UROLOGY, V173, P1252, DOI 10.1097/01.ju.0000159198.83103.01; Nickel JC, 2004, BJU INT, V93, P991, DOI 10.1111/j.1464-410X.2003.04766.x; Nickel JC, 2004, J UROLOGY, V171, P1594, DOI 10.1097/01.ju.0000117811.40279.19; Nickel JC, 2003, UROLOGY, V62, P614, DOI 10.1016/S0090-4295(03)00583-1; Nickel JC, 2003, J UROLOGY, V169, P1401, DOI 10.1097/01.ju.0000054983.45096.16; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Pontari MA, 2010, ARCH INTERN MED, V170, P1586, DOI 10.1001/archinternmed.2010.319; Roberts RO, 1998, UROLOGY, V51, P578, DOI 10.1016/S0090-4295(98)00034-X; Shoskes DA, 1999, UROLOGY, V54, P960, DOI 10.1016/S0090-4295(99)00358-1; Shoskes DA, 2010, UROLOGY, V75, P1249, DOI 10.1016/j.urology.2010.01.021; Shoskes DA, 2009, UROLOGY, V73, P538, DOI 10.1016/j.urology.2008.09.074; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Tugcu V, 2007, EUR UROL, V51, P1113, DOI 10.1016/j.eururo.2006.09.036; Wagenlehner FME, 2009, EUR UROL, V56, P544, DOI 10.1016/j.eururo.2009.05.046; Yang G, 2006, J ANDROL, V27, P847, DOI 10.2164/jandrol.106.000661; Ye ZQ, 2008, J INT MED RES, V36, P244, DOI 10.1177/147323000803600205; Yoshimura T, 1996, CHEMOTHERAPY, V42, P459, DOI 10.1159/000239480; Zhao WP, 2009, BRAZ J MED BIOL RES, V42, P963, DOI 10.1590/S0100-879X2009005000021; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041	54	152	183	4	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					78	86		10.1001/jama.2010.1913	http://dx.doi.org/10.1001/jama.2010.1913			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205969	Bronze			2022-12-28	WOS:000285924100027
J	Frio, TR; Bahubeshi, A; Kanellopoulou, C; Hamel, N; Niedziela, M; Sabbaghian, N; Pouchet, C; Gilbert, L; O'Brien, PK; Serfas, K; Broderick, P; Houlston, RS; Lesueur, F; Bonora, E; Muljo, S; Schimke, RN; Bouron-Dal Soglio, D; Arseneau, J; Schultz, KA; Priest, JR; Nguyen, VH; Harach, HR; Livingston, DM; Foulkes, WD; Tischkowitz, M				Frio, Thomas Rio; Bahubeshi, Amin; Kanellopoulou, Chryssa; Hamel, Nancy; Niedziela, Marek; Sabbaghian, Nelly; Pouchet, Carly; Gilbert, Lucy; O'Brien, Paul K.; Serfas, Kim; Broderick, Peter; Houlston, Richard S.; Lesueur, Fabienne; Bonora, Elena; Muljo, Stefan; Schimke, R. Neil; Bouron-Dal Soglio, Dorothee; Arseneau, Jocelyne; Schultz, Kris Ann; Priest, John R.; Nguyen, Van-Hung; Ruben Harach, H.; Livingston, David M.; Foulkes, William D.; Tischkowitz, Marc			DICER1 Mutations in Familial Multinodular Goiter With and Without Ovarian Sertoli-Leydig Cell Tumors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLEUROPULMONARY BLASTOMA; THYROID-CARCINOMA; DOMINANT FORM; CANCER; GERMLINE; DISEASE; ARRHENOBLASTOMA; DISORDERS; MICRORNAS; FEMALE	Context Nontoxic multinodular goiter (MNG) is frequently observed in the general population, but little is known about the underlying genetic susceptibility to this disease. Familial cases of MNG have been reported, and published reports describe 5 families that also contain at least 1 individual with a Sertoli-Leydig cell tumor of the ovary (SLCT). Germline mutations in DICER1, a gene that codes for an RNase III endoribonuclease, have been identified in families affected by pleuropulmonary blastoma (PPB), some of whom include cases of MNG and gonadal tumors such as SLCTs. Objective To determine whether familial MNG with or without SLCT in the absence of PPB was associated with mutations in DICER1. Design, Setting, and Patients From September 2009 to September 2010, we screened 53 individuals from 2 MNG and 3 MNG/SLCT families at McGill University for mutations in DICER1. We investigated blood lymphocytes and MNG and SLCT tissue from family members for loss of the wild-type DICER1 allele (loss of heterozygosity), DICER1 expression, and microRNA (miRNA) dysregulation. Main Outcome Measure Detection of germline DICER1 gene mutations in familial MNG with and without SLCT. Results We identified and characterized germline DICER1 mutations in 37 individuals from 5 families. Two mutations were predicted to be protein truncating, 2 resulted in inframe deletions, and 1 was a missense mutation. Molecular analysis of the 3 SLCTs showed no loss of heterozygosity of DICER1, and immunohistochemical analysis in 2 samples showed strong expression of DICER1 in Sertoli cells but weak staining of Leydig cells. miRNA profiling of RNA from lymphoblastoid cell lines from both affected and unaffected members of the familial MNG cases revealed miRNA perturbations in DICER1 mutation carriers. Conclusions DICER1 mutations are associated with both familial MNG and MNG with SLCT, independent of PPB. These germline DICER1 mutations are associated with dysregulation of miRNA expression patterns. JAMA. 2011;305(1):68-77 www.jama.com	[Foulkes, William D.] McGill Univ, Ctr Hlth, Gerald Bronfman Ctr Clin Res Oncol, Program Canc Genet,Dept Oncol, Montreal, PQ H2W 1S6, Canada; [Gilbert, Lucy] McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H2W 1S6, Canada; [Arseneau, Jocelyne; Nguyen, Van-Hung] McGill Univ, Ctr Hlth, Dept Pathol, Montreal, PQ H2W 1S6, Canada; [Frio, Thomas Rio; Hamel, Nancy; Foulkes, William D.] McGill Univ, Ctr Hlth, Dept Med Genet, Montreal, PQ H2W 1S6, Canada; [Frio, Thomas Rio; Hamel, Nancy; Foulkes, William D.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H2W 1S6, Canada; [Bahubeshi, Amin; Sabbaghian, Nelly; Pouchet, Carly; Foulkes, William D.; Tischkowitz, Marc] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Segal Canc Ctr, Montreal, PQ H2W 1S6, Canada; [Kanellopoulou, Chryssa; Livingston, David M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Niedziela, Marek] Poznan Univ Med Sci, Dept Pediat Endocrinol & Rheumatol, Poznan, Poland; [O'Brien, Paul K.] Etobicoke Gen Hosp, Dept Pathol, Toronto, ON, Canada; [Serfas, Kim] Hlth Sci Ctr Winnipeg, Hereditary Breast Hlth Clin, Winnipeg, MB, Canada; [Broderick, Peter; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Surrey, England; [Lesueur, Fabienne] Int Agcy Res Canc, Genet Canc Susceptibil Grp, F-69372 Lyon, France; [Bonora, Elena] Univ Bologna, S Orsola M Malpighi Hosp, Dept Gynaecol, Med Genet Unit, Bologna, Italy; [Muljo, Stefan] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Schimke, R. Neil] Univ Kansas, Med Ctr, Dept Internal Med, Div Endocrinol Metab & Genet, Kansas City, KS 66103 USA; [Bouron-Dal Soglio, Dorothee] CHU St Justine, Dept Pathol, Montreal, PQ, Canada; [Schultz, Kris Ann] Childrens Hosp & Clin Minnesota, St Paul, MN USA; [Priest, John R.] Int Pleuropulm Blastoma Registry, St Paul, MN USA; [Ruben Harach, H.] Hosp Dr A Onativia, Sector Patol, Salta, Argentina; [Frio, Thomas Rio; Bahubeshi, Amin; Hamel, Nancy; Sabbaghian, Nelly; Pouchet, Carly; Foulkes, William D.; Tischkowitz, Marc] McGill Univ, Ctr Hlth, Program Canc Genet, Dept Human Genet, Montreal, PQ H2W 1S6, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Harvard University; Dana-Farber Cancer Institute; Poznan University of Medical Sciences; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of London; Institute of Cancer Research - UK; World Health Organization; International Agency for Research on Cancer (IARC); IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Kansas; University of Kansas Medical Center; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Children's Hospitals & Clinics of Minnesota; McGill University	Foulkes, WD (corresponding author), McGill Univ, Ctr Hlth, Gerald Bronfman Ctr Clin Res Oncol, Program Canc Genet,Dept Oncol, 546 Ave Pins, Montreal, PQ H2W 1S6, Canada.	william.foulkes@mcgill.ca	Niedziela, Marek/A-1155-2011; Tischkowitz, Marc/O-4452-2018; Gilbert, Lucy/M-6879-2019; Hamel, Nancy/L-5122-2016; Foulkes, William D./AAR-9586-2021; Lesueur, Fabienne/R-2178-2017; Muljo, Stefan A/F-5671-2015	Niedziela, Marek/0000-0001-8862-6937; Tischkowitz, Marc/0000-0002-7880-0628; Gilbert, Lucy/0000-0001-8605-5472; Hamel, Nancy/0000-0001-8971-0428; Foulkes, William D./0000-0001-7427-4651; Lesueur, Fabienne/0000-0001-7404-4549; Muljo, Stefan A/0000-0003-1013-446X; Broderick, Peter/0000-0002-8348-5829; Nguyen, Van-Hung/0000-0001-5318-2416; Houlston, Richard/0000-0002-5268-0242; Bonora, Elena/0000-0001-6132-7734	Jewish General Hospital; Turner Family Cancer Research Fund; Fonds de la Recherche en Sante du Quebec (FRSQ); Canadian Institutes of Health Research/FRSQ [FRN53888]; Research Institute of the McGill University Health Centre; Cedars Cancer Institute; Pine Tree Apple Tennis Classic; Theodora H. Lang Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001131] Funding Source: NIH RePORTER	Jewish General Hospital(General Electric); Turner Family Cancer Research Fund; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research/FRSQ(Fonds de la Recherche en Sante du QuebecCanadian Institutes of Health Research (CIHR)); Research Institute of the McGill University Health Centre; Cedars Cancer Institute; Pine Tree Apple Tennis Classic; Theodora H. Lang Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by the Jewish General Hospital Weekend to End Women's Cancers, the Turner Family Cancer Research Fund, and les Fonds de la Recherche en Sante du Quebec (FRSQ). Mr Bahubeshi is funded by the Canadian Institutes of Health Research/FRSQ training grant in cancer research (FRN53888) of the McGill Integrated Cancer Research Training Program. Dr Rio Frio was funded by the Research Institute of the McGill University Health Centre and by the Henry R. Shibata Fellowship of the Cedars Cancer Institute. Dr Priest receives funding support from the Pine Tree Apple Tennis Classic and the Theodora H. Lang Charitable trust. Dr Foulkes holds an FRSQ national scientist award and Dr Tischkowitz holds an FRSQ clinician-scientist award.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bahubeshi A, 2010, J MED GENET, V47, P863, DOI 10.1136/jmg.2010.081216; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bignell GR, 1997, AM J HUM GENET, V61, P1123, DOI 10.1086/301610; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Capon F, 2000, AM J HUM GENET, V67, P1004, DOI 10.1086/303095; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; COUCH RM, 1986, AM J HUM GENET, V39, P811; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Druker HA, 1997, AM J MED GENET, V72, P30, DOI 10.1002/(SICI)1096-8628(19971003)72:1<30::AID-AJMG6>3.0.CO;2-Z; Frio TR, 2008, J CLIN INVEST, V118, P1519, DOI 10.1172/JCI34211; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hill DA, 2010, LAB INVEST, V90, P311; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; JENSEN RD, 1974, CANCER, V33, P218, DOI 10.1002/1097-0142(197401)33:1<218::AID-CNCR2820330132>3.0.CO;2-Z; Knobel M, 2003, THYROID, V13, P771, DOI 10.1089/105072503768499671; KOONINGS PP, 1989, OBSTET GYNECOL, V74, P921; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lau PW, 2009, STRUCTURE, V17, P1326, DOI 10.1016/j.str.2009.08.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Ngan ESW, 2009, JNCI-J NATL CANCER I, V101, P162, DOI 10.1093/jnci/djn471; Niedziela M, 2008, PEDIATR BLOOD CANCER, V51, P543, DOI 10.1002/pbc.21675; OBRIEN PK, 1981, AM J CLIN PATHOL, V75, P578; Pinchera A., 1996, Annali Italiani di Chirurgia, V67, P317; Priest JR, 2009, PEDIATR PULM, V44, P14, DOI 10.1002/ppul.20917; Priest JR, 1996, J PEDIATR-US, V128, P220, DOI 10.1016/S0022-3476(96)70393-1; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schultz K, 2010, AM SOC PED ONC HEM M; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; WHITCOMB RW, 1986, OBSTET GYNECOL, V67, pS89, DOI 10.1097/00006250-198603001-00026; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Young RH, 2005, MODERN PATHOL, V18, pS81, DOI 10.1038/modpathol.3800311; YOUNG RH, 1985, AM J SURG PATHOL, V9, P543, DOI 10.1097/00000478-198508000-00001; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	41	191	194	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					68	77		10.1001/jama.2010.1910	http://dx.doi.org/10.1001/jama.2010.1910			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205968	Green Accepted, Bronze			2022-12-28	WOS:000285924100026
J	Polyzos, NP; Polyzos, IP; Zavos, A; Valachis, A; Mauri, D; Papanikolaou, EG; Tzioras, S; Weber, D; Messinis, IE				Polyzos, Nikolaos P.; Polyzos, Ilias P.; Zavos, Apostolos; Valachis, Antonis; Mauri, Davide; Papanikolaou, Evangelos G.; Tzioras, Spyridon; Weber, Daniel; Messinis, Ioannis E.			Obstetric outcomes after treatment of periodontal disease during pregnancy: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LOW-BIRTH-WEIGHT; PRETERM BIRTH; EMPIRICAL-EVIDENCE; PUBLICATION BIAS; THERAPY; QUALITY; WOMEN; RISK; TRIALS; ANTIBIOTICS	Objective To examine whether treatment of periodontal disease with scaling and root planing during pregnancy is associated with a reduction in the preterm birth rate. Design Systematic review and meta-analysis of randomised controlled trials. Data sources Cochrane Central Trials Registry, ISI Web of Science, Medline, and reference lists of relevant studies to July 2010; hand searches in key journals. Study selection Randomised controlled trials including pregnant women with documented periodontal disease randomised to either treatment with scaling and root planing or no treatment. Data extraction Data were extracted by two independent investigators, and a consensus was reached with the involvement a third. Methodological quality of the studies was assessed with the Cochrane's risk of bias tool, and trials were considered either high or low quality. The primary outcome was preterm birth (<37 weeks). Secondary outcomes were low birthweight infants (<2500 g), spontaneous abortions/stillbirths, and overall adverse pregnancy outcome (preterm birth <37 weeks and spontaneous abortions/stillbirths). Results 11 trials (with 6558 women) were included. Five trials were considered to be of high methodological quality (low risk of bias), whereas the rest were low quality (high or unclear risk of bias). Results among low and high quality trials were consistently diverse; low quality trials supported a beneficial effect of treatment, and high quality trials provided clear evidence that no such effect exists. Among high quality studies, treatment had no significant effect on the overall rate of preterm birth (odds ratio 1.15, 95% confidence interval 0.95 to 1.40; P=0.15). Furthermore, treatment did not reduce the rate of low birthweight infants (odds ratio 1.07, 0.85 to 1.36; P=0.55), spontaneous abortions/stillbirths (0.79, 0.51 to 1.22; P=0.28), or overall adverse pregnancy outcome (preterm births <37 weeks and spontaneous abortions/stillbirths) (1.09, 0.91 to 1.30; P=0.34). Conclusion Treatment of periodontal disease with scaling and root planing cannot be considered to be an efficient way of reducing the incidence of preterm birth. Women may be advised to have periodical dental examinations during pregnancy to test their dental status and may have treatment for periodontal disease. However, they should be told that such treatment during pregnancy is unlikely to reduce the risk of preterm birth or low birthweight infants.	[Polyzos, Nikolaos P.; Tzioras, Spyridon] Panhellen Assoc Continual Med Res PACMeR, Sect Obstet & Gynaecol, Athens, Greece; [Polyzos, Nikolaos P.; Zavos, Apostolos; Messinis, Ioannis E.] Univ Thessalia, Dept Obstet & Gynaecol, Larisa, Greece; [Polyzos, Ilias P.] Univ Manchester, Sch Dent, Dept Oral & Maxillofacial Surg, Manchester, Lancs, England; [Valachis, Antonis] Panhellen Assoc Continual Med Res PACMeR, Sect Publ Hlth, Athens, Greece; [Papanikolaou, Evangelos G.] Biogenesis Med Ctr, Thessaloniki, Greece; [Weber, Daniel] Lancaster Gen Hlth, Dept Obstet & Gynecol, Lancaster, PA USA	University of Thessaly; University of Manchester	Polyzos, NP (corresponding author), Panhellen Assoc Continual Med Res PACMeR, Sect Obstet & Gynaecol, Athens, Greece.	n.polyzos@gmail.com	Polyzos, Nikolaos P/O-5130-2014					Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M, 2001, SYSTEMATIC REV HLTH; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hopewell S, 2009, COCHRANE DATABASE SY, V1; Hopewell S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c723; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Jeffcoat MK, 2003, J PERIODONTOL, V74, P1214, DOI 10.1902/jop.2003.74.8.1214; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lafaurie GI, 2007, J CLIN PERIODONTOL, V34, P873, DOI 10.1111/j.1600-051X.2007.01125.x; Laine MA, 2002, ACTA ODONTOL SCAND, V60, P257, DOI 10.1080/00016350260248210; Leroy R, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-8; Lopez NJ, 2005, J PERIODONTOL, V76, P2144, DOI 10.1902/jop.2005.76.11-S.2144; Lopez NJ, 2002, J PERIODONTOL, V73, P911, DOI 10.1902/jop.2002.73.8.911; Macones GA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.892; Manau C, 2008, J CLIN PERIODONTOL, V35, P385, DOI 10.1111/j.1600-051X.2008.01222.x; McDonald H, 2007, COCHRANE DB SYST REV, V1; MCQUEEN MP, 2006, WALL STREET J   0919; Mercer BM, 2000, AM J OBSTET GYNECOL, V183, P738, DOI 10.1067/mob.2000.106766; Michalowicz BS, 2008, J AM DENT ASSOC, V139, P685, DOI 10.14219/jada.archive.2008.0250; Michalowicz BS, 2006, NEW ENGL J MED, V355, P1885, DOI 10.1056/NEJMoa062249; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Newnham JP, 2009, OBSTET GYNECOL, V114, P1239, DOI 10.1097/AOG.0b013e3181c15b40; Offenbacher S, 1998, Ann Periodontol, V3, P233, DOI 10.1902/annals.1998.3.1.233; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Offenbacher S, 2006, J PERIODONTOL, V77, P2011, DOI 10.1902/jop.2006.060047; Offenbacher S, 2009, OBSTET GYNECOL, V114, P551, DOI 10.1097/AOG.0b013e3181b1341f; Okun N, 2005, OBSTET GYNECOL, V105, P857, DOI 10.1097/01.AOG.0000157108.32059.8f; OLIVEIRA AM, 2010, CLIN ORAL INVES 0522; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Polyzos NP, 2009, AM J OBSTET GYNECOL, V200, P225, DOI 10.1016/j.ajog.2008.09.020; Radnai M, 2009, J DENT RES, V88, P280, DOI 10.1177/0022034508330229; Sadatmansouri S, 2006, J Indian Soc Pedod Prev Dent, V24, P23; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Simcox R, 2007, AUST NZ J OBSTET GYN, V47, P368, DOI 10.1111/j.1479-828X.2007.00759.x; Tarannum F, 2007, J PERIODONTOL, V78, P2095, DOI 10.1902/jop.2007.060388; van Nieuwenhoven CA, 2001, JAMA-J AM MED ASSOC, V286, P335, DOI 10.1001/jama.286.3.335; Vergnes Jean-Noel, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.028; VERGNES JN, 2007, AM J OBSTET GYNECOL, V196, pE1, DOI DOI 10.1016/J.AJ0G.2006.09.028; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	45	101	104	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2010	341								c7017	10.1136/bmj.c7017	http://dx.doi.org/10.1136/bmj.c7017			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UZ	21190966	Green Published, hybrid			2022-12-28	WOS:000285922700002
J	Huttlin, EL; Jedrychowski, MP; Elias, JE; Goswami, T; Rad, R; Beausoleil, SA; Villen, J; Haas, W; Sowa, ME; Gygi, SP				Huttlin, Edward L.; Jedrychowski, Mark P.; Elias, Joshua E.; Goswami, Tapasree; Rad, Ramin; Beausoleil, Sean A.; Villen, Judit; Haas, Wilhelm; Sowa, Mathew E.; Gygi, Steven P.			A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression	CELL			English	Article							KINASE; PREDICTION; LIPOLYSIS; DATABASE	Although most tissues in an organism are genetically identical, the biochemistry of each is optimized to fulfill its unique physiological roles, with important consequences for human health and disease. Each tissue's unique physiology requires tightly regulated gene and protein expression coordinated by specialized, phosphorylation-dependent intracellular signaling. To better understand the role of phosphorylation in maintenance of physiological differences among tissues, we performed proteomic and phosphoproteomic characterizations of nine mouse tissues. We identified 12,039 proteins, including 6296 phosphoproteins harboring nearly 36,000 phosphorylation sites. Comparing protein abundances and phosphorylation levels revealed specialized, interconnected phosphorylation networks within each tissue while suggesting that many proteins are regulated by phosphorylation independently of their expression. Our data suggest that the "typical'' phosphoprotein is widely expressed yet displays variable, often tissue-specific phosphorylation that tunes protein activity to the specific needs of each tissue. We offer this dataset as an online resource for the biological research community.	[Huttlin, Edward L.; Jedrychowski, Mark P.; Elias, Joshua E.; Goswami, Tapasree; Beausoleil, Sean A.; Villen, Judit; Haas, Wilhelm; Sowa, Mathew E.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Rad, Ramin; Gygi, Steven P.] Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; [Sowa, Mathew E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu		Huttlin, Edward/0000-0002-1822-1173; Villen, Judit/0000-0002-1005-1739	NIH [HG3456]; ThermoFisher Scientific; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ThermoFisher Scientific; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank Xue Li and Abir Mukherjee for help with phosphorylation studies and acknowledge Julian Mintseris, Deepak Kolippikam, Noah Dephoure, Younghao Yu, and other Gygi lab members for insightful discussions. This work was funded in part by a grant from the NIH to S. P. G. (HG3456) and by an industry-sponsored research project with ThermoFisher Scientific.	Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Castellanos-Serra L, 2002, ELECTROPHORESIS, V23, P1745, DOI 10.1002/1522-2683(200206)23:11<1745::AID-ELPS1745>3.0.CO;2-A; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Dehmelt L, 2005, GENOME BIOL, V6; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Duta F, 2006, HISTOCHEM CELL BIOL, V126, P495, DOI 10.1007/s00418-006-0188-z; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Itoh TJ, 1997, BIOCHEMISTRY-US, V36, P12574, DOI 10.1021/bi962606z; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Lienhard GE, 2008, TRENDS BIOCHEM SCI, V33, P351, DOI 10.1016/j.tibs.2008.05.004; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Pasini EM, 2008, MOL CELL PROTEOMICS, V7, P1317, DOI 10.1074/mcp.M700458-MCP200; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; *ROCH APPL SCI, 2004, COMPL GUID PROT INH; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Timm T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S9; Ulanova M, 2005, AM J PHYSIOL-LUNG C, V288, pL497, DOI 10.1152/ajplung.00246.2004; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Watt MJ, 2008, BIOCHEM J, V414, P313, DOI 10.1042/BJ20080305; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Wu CH, 2003, NUCLEIC ACIDS RES, V31, P345, DOI 10.1093/nar/gkg040	51	1152	10079	17	383	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1174	1189		10.1016/j.cell.2010.12.001	http://dx.doi.org/10.1016/j.cell.2010.12.001			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183079	Green Accepted, Bronze			2022-12-28	WOS:000285625400014
J	Kovacs, AM; Teglas, E; Endress, AD				Kovacs, Agnes Melinda; Teglas, Erno; Endress, Ansgar Denis			The Social Sense: Susceptibility to Others' Beliefs in Human Infants and Adults	SCIENCE			English	Article							FALSE-BELIEF; ATTRIBUTION; MIND	Human social interactions crucially depend on the ability to represent other agents' beliefs even when these contradict our own beliefs, leading to the potentially complex problem of simultaneously holding two conflicting representations in mind. Here, we show that adults and 7-month-olds automatically encode others' beliefs, and that, surprisingly, others' beliefs have similar effects as the participants' own beliefs. In a visual object detection task, participants' beliefs and the beliefs of an agent (whose beliefs were irrelevant to performing the task) both modulated adults' reaction times and infants' looking times. Moreover, the agent's beliefs influenced participants' behavior even after the agent had left the scene, suggesting that participants computed the agent's beliefs online and sustained them, possibly for future predictions about the agent's behavior. Hence, the mere presence of an agent automatically triggers powerful processes of belief computation that may be part of a "social sense" crucial to human societies.	[Kovacs, Agnes Melinda; Teglas, Erno] Hungarian Acad Sci, Inst Psychol, H-1132 Budapest, Hungary; [Kovacs, Agnes Melinda; Teglas, Erno] Cent European Univ, Cognit Dev Ctr, H-1015 Budapest, Hungary; [Kovacs, Agnes Melinda; Teglas, Erno; Endress, Ansgar Denis] Int Sch Adv Studies SISSA, Cognit Neurosci Sector, I-34014 Trieste, Italy; [Endress, Ansgar Denis] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Central European University; International School for Advanced Studies (SISSA); Massachusetts Institute of Technology (MIT)	Kovacs, AM (corresponding author), Hungarian Acad Sci, Inst Psychol, H-1132 Budapest, Hungary.	agneskovacs@mtapi.hu		Endress, Ansgar/0000-0003-4086-5167; Kovacs, Agnes Melinda/0000-0003-3452-7727; Teglas, Erno/0000-0003-4502-3639	New and Emerging Science and Technology PATHFINDER initiative CALACEI; Marie Curie Disorders and Coherence of the Embodied Self Research Training Network	New and Emerging Science and Technology PATHFINDER initiative CALACEI; Marie Curie Disorders and Coherence of the Embodied Self Research Training Network	This research was supported by the New and Emerging Science and Technology PATHFINDER initiative CALACEI and the Marie Curie Disorders and Coherence of the Embodied Self Research Training Network. We thank G. Csibra, G. Gergely, J. Perner, H. Wellman, M. Hauser, P. Jacob, L. Bonatti, and J. Mehler for comments.	BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; Csibra G, 2008, COGNITION, V107, P705, DOI 10.1016/j.cognition.2007.08.001; FODOR JA, 1992, COGNITION, V44, P283, DOI 10.1016/0010-0277(92)90004-2; HERRMANN E, 2007, Behav Brain Sci, V317, P1; Kovacs AM, 2009, DEVELOPMENTAL SCI, V12, P48, DOI 10.1111/j.1467-7687.2008.00742.x; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Perner J, 1991, UNDERSTANDING REPRES; Scholl BJ, 2001, CHILD DEV, V72, P696, DOI 10.1111/1467-8624.00308; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x	11	480	489	5	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1830	1834		10.1126/science.1190792	http://dx.doi.org/10.1126/science.1190792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698OS	21205671				2022-12-28	WOS:000285603700043
J	Petsko, G				Petsko, Gregory			Save university arts from the bean counters	NATURE			English	Editorial Material									Brandeis Univ, Waltham, MA 02454 USA	Brandeis University	Petsko, G (corresponding author), Brandeis Univ, Waltham, MA 02454 USA.	petsko@brandeis.edu							0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1003	1003		10.1038/4681003a	http://dx.doi.org/10.1038/4681003a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179122	Bronze			2022-12-28	WOS:000285553800013
J	Christian, P; Murray-Kolb, LE; Khatry, SK; Katz, J; Schaefer, BA; Cole, PM; LeClerq, SC; Tielsch, JM				Christian, Parul; Murray-Kolb, Laura E.; Khatry, Subarna K.; Katz, Joanne; Schaefer, Barbara A.; Cole, Pamela M.; LeClerq, Steven C.; Tielsch, James M.			Prenatal Micronutrient Supplementation and Intellectual and Motor Function in Early School-aged Children in Nepal	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IRON-DEFICIENCY ALTERS; PLACEBO-CONTROLLED TRIAL; ZINC SUPPLEMENTATION; FOLIC-ACID; FOLLOW-UP; PSYCHOMOTOR DEVELOPMENT; MENTAL-DEVELOPMENT; INFANT DEVELOPMENT; RANDOMIZED-TRIAL; PREGNANT-WOMEN	Context Iron and zinc are important for the development of both intellectual and motor skills. Few studies have examined whether iron and zinc supplementation during gestation, a critical period of central nervous system development, affects children's later functioning. Objective To examine intellectual and motor functioning of children whose mothers received micronutrient supplementation during pregnancy. Design, Setting, and Participants Cohort follow-up of 676 children aged 7 to 9 years in June 2007-April 2009 who had been born to women in 4 of 5 groups of a community-based, double-blind, randomized controlled trial of prenatal micronutrient supplementation between 1999 and 2001 in rural Nepal. Study children were also in the placebo group of a subsequent preschool iron and zinc supplementation trial. Interventions Women whose children were followed up had been randomly assigned to receive daily iron/folic acid, iron/folic acid/zinc, or multiple micronutrients containing these plus 11 other micronutrients, all with vitamin A, vs a control group of vitamin A alone from early pregnancy through 3 months postpartum. These children did not receive additional micronutrient supplementation other than biannual vitamin A supplementation. Main Outcome Measures Children's intellectual functioning, assessed using the Universal Nonverbal Intelligence Test (UNIT); tests of executive function, including go/no-go, the Stroop test, and backward digit span; and motor function, assessed using the Movement Assessment Battery for Children (MABC) and finger-tapping test. Results The difference across outcomes was significant (Bonferroni-adjusted P<.001) for iron/folic acid vs control but not for other supplement groups. The mean UNIT T score in the iron/folic acid group was 51.7 (SD, 8.5) and in the control group was 48.2 (SD, 10.2), withanadjustedmeandifference of 2.38 (95% confidence interval [CI], 0.06-4.70; P=.04). Differences were not significant between the control group and either the iron/folic acid/zinc (0.73; 95% CI, -0.95 to 2.42) or multiple micronutrient (1.00; 95% CI, -0.55 to 2.56) groups. In tests of executive function, scores were better in the iron/folic acid group relative to the control group for the Stroop test (adjusted mean difference in proportion who failed, -0.14; 95% CI, -0.23 to -0.04) and backward digit span (adjusted mean difference, 0.36; 95% CI, 0.01-0.71) but not for the go/no-go test. The MABC score was lower (better) in the iron/folic acid group compared with the control group but not after adjustment for confounders (mean difference, -1.47; 95% CI, -3.06 to 0.12; P=.07). Finger-tapping test scores were higher (mean difference, 2.05; 95% CI, 0.87-3.24; P=.001) in the iron/folic acid group. Conclusion Aspects of intellectual functioning including working memory, inhibitory control, and fine motor functioning among offspring were positively associated with prenatal iron/folic acid supplementation in an area where iron deficiency is prevalent.	[Christian, Parul; Murray-Kolb, Laura E.; Katz, Joanne; LeClerq, Steven C.; Tielsch, James M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD USA; [Murray-Kolb, Laura E.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Schaefer, Barbara A.] Penn State Univ, Dept Educ, University Pk, PA 16802 USA; [Schaefer, Barbara A.] Penn State Univ, Sch Psychol & Special Educ, University Pk, PA 16802 USA; [Khatry, Subarna K.; LeClerq, Steven C.] Nepal Eye Hosp Complex, Nepal Nutr Intervent Project Sarlahi, Kathmandu, Nepal	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Christian, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, 615 N Wolfe St,Room W2041, Baltimore, MD 21205 USA.	pchristi@jhsph.edu	Mireku, Michael/D-5262-2016	Tielsch, James/0000-0002-1151-060X; Katz, Joanne/0000-0002-5997-7823	National Institutes of Health [R01 HD050254-01, HD 38753]; Bill and Melinda Gates Foundation, Seattle, Washington; Johns Hopkins University [HRN-A-00-97-00015-00, GHS-A-00-03-00019-00]; Office of Health, Infectious Diseases, and Nutrition, US Agency for International Development, Washington, DC [HRN-A-00-97-00015-00, GHS-A-00-03-00019-00]; Bill and Melinda Gates Foundation; US Agency for International Development [HRN-A-00-97-00015-00]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050254, R01HD038753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation, Seattle, Washington(Bill & Melinda Gates Foundation); Johns Hopkins University(Johns Hopkins University); Office of Health, Infectious Diseases, and Nutrition, US Agency for International Development, Washington, DC(United States Agency for International Development (USAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Agency for International Development(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was carried out by the Center for Human Nutrition, Department of International Health of the Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, in collaboration with the National Society for the Prevention of Blindness, Kathmandu, Nepal, with funding from National Institutes of Health grant R01 HD050254-01 and the Bill and Melinda Gates Foundation, Seattle, Washington. The antenatal micronutrient supplementation study was conducted under Micronutrients for Health Cooperative Agreement HRN-A-00-97-00015-00 and Global Research Activity Cooperative Agreement GHS-A-00-03-00019-00 between Johns Hopkins University and the Office of Health, Infectious Diseases, and Nutrition, US Agency for International Development, Washington, DC. Bill and Melinda Gates Foundation and Sight and Life Research Institute, Baltimore, Maryland, provided additional support for the study. The preschool child iron and zinc supplementation study was funded by the National Institutes of Health (HD 38753), the Bill and Melinda Gates Foundation, and a cooperative agreement between Johns Hopkins University and the Office of Health, Infectious Diseases, and Nutrition, US Agency for International Development (HRN-A-00-97-00015-00).	Beard JL, 2008, J NUTR, V138, P2534, DOI 10.1093/jn/138.12.2534; Bracken B.A., 1998, UNIVERSAL NONVERBAL; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Caldwell B., 1984, HOME OBSERVATION MEA; Carlson ES, 2007, HIPPOCAMPUS, V17, P679, DOI 10.1002/hipo.20307; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Christian P, 2003, J NUTR, V133, p1969S, DOI 10.1093/jn/133.6.1969S; Christian P, 2003, BMJ-BRIT MED J, V326, P571, DOI 10.1136/bmj.326.7389.571; Clardy SL, 2006, J NEURAL TRANSM-SUPP, P173; Connor J., 1997, METALS OXIDATIVE DAM, P23; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; deUngria M, 2000, PEDIATR RES, V48, P169, DOI 10.1203/00006450-200008000-00009; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Dreyfuss ML, 2000, J NUTR, V130, P2527, DOI 10.1093/jn/130.10.2527; Georgieff MK, 2008, BIOCHEM SOC T, V36, P1267, DOI 10.1042/BST0361267; Gillian BJ, 2009, THESIS J HOPKINS U B; Golub MS, 2006, NEUROTOXICOL TERATOL, V28, P3, DOI 10.1016/j.ntt.2005.10.005; Hamadani JD, 2002, LANCET, V360, P290, DOI 10.1016/S0140-6736(02)09551-X; Henderson S., 1992, MOVEMENT ASSESSMENT; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Li Q, 2009, PEDIATRICS, V123, pE685, DOI 10.1542/peds.2008-3007; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Malouf M, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004514; McCallum S, 2001, ESSENTIALS NONVERBAL; McGrath N, 2006, PEDIATRICS, V117, pE216, DOI 10.1542/peds.2004-1668; Merialdi M, 1999, AM J OBSTET GYNECOL, V180, P483, DOI 10.1016/S0002-9378(99)70236-X; Olivares M, 2007, NUTRITION, V23, P292, DOI 10.1016/j.nut.2007.01.006; Ortiz E, 2004, J NEUROSCI RES, V77, P681, DOI 10.1002/jnr.20207; Rao R, 2003, J NUTR, V133, P3215, DOI 10.1093/jn/133.10.3215; Raven JC., 1992, MANUAL RAVENS PROGR; Roza SJ, 2010, BRIT J NUTR, V103, P445, DOI 10.1017/S0007114509991954; Siddappa AM, 2004, PEDIATR RES, V55, P1034, DOI 10.1203/01.pdr.0000127021.38207.62; Snedecor GW, 1980, STAT METHODS; Tamura T, 2003, AM J CLIN NUTR, V77, P1512, DOI 10.1093/ajcn/77.6.1512; Tielsch JM, 2007, LANCET, V370, P1230, DOI 10.1016/S0140-6736(07)61539-6; Tielsch JM, 2006, LANCET, V367, P144, DOI 10.1016/S0140-6736(06)67963-4; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Tofail F, 2008, AM J CLIN NUTR, V87, P704, DOI 10.1093/ajcn/87.3.704; Ward KL, 2007, J NUTR, V137, P1043, DOI 10.1093/jn/137.4.1043; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wehby GL, 2008, MATERN CHILD HLTH J, V12, P180, DOI 10.1007/s10995-007-0230-3; Whittaker P, 1998, AM J CLIN NUTR, V68, p442S, DOI 10.1093/ajcn/68.2.442S; Zhou SJ, 2006, AM J CLIN NUTR, V83, P1112, DOI 10.1093/ajcn/83.5.1112	44	169	174	0	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2716	2723		10.1001/jama.2010.1861	http://dx.doi.org/10.1001/jama.2010.1861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177506				2022-12-28	WOS:000285518000016
J	Gentles, AJ; Plevritis, SK; Majeti, R; Alizadeh, AA				Gentles, Andrew J.; Plevritis, Sylvia K.; Majeti, Ravindra; Alizadeh, Ash A.			Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INITIATING CELLS; PROGENITOR CELLS; BREAST-CANCER; MUTATIONS; SURVIVAL; AML; HETEROGENEITY; PROLIFERATION; INDUCTION; FREQUENCY	Context In many cancers, specific subpopulations of cells appear to be uniquely capable of initiating and maintaining tumors. The strongest support for this cancer stem cell model comes from transplantation assays in immunodeficient mice, which indicate that human acute myeloid leukemia (AML) is driven by self-renewing leukemic stem cells (LSCs). This model has significant implications for the development of novel therapies, but its clinical relevance has yet to be determined. Objective To identify an LSC gene expression signature and test its association with clinical outcomes in AML. Design, Setting, and Patients Retrospective study of global gene expression (microarray) profiles of LSC-enriched subpopulations from primary AML and normal patient samples, which were obtained at a US medical center between April 2005 and July 2007, and validation data sets of global transcriptional profiles of AML tumors from 4 independent cohorts (n=1047). Main Outcome Measures Identification of genes discriminating LSC-enriched populations from other subpopulations in AML tumors; and association of LSC-specific genes with overall, event-free, and relapse-free survival and with therapeutic response. Results Expression levels of 52 genes distinguished LSC-enriched populations from other subpopulations in cell-sorted AML samples. An LSC score summarizing expression of these genes in bulk primary AML tumor samples was associated with clinical outcomes in the 4 independent patient cohorts. High LSC scores were associated with worse overall, event-free, and relapse-free survival among patients with either normal karyotypes or chromosomal abnormalities. For the largest cohort of patients with normal karyotypes (n=163), the LSC score was significantly associated with overall survival as a continuous variable (hazard ratio [HR], 1.15; 95% confidence interval [CI], 1.08-1.22; log-likelihood P<.001). The absolute risk of death by 3 years was 57% (95% CI, 43%-67%) for the low LSC score group compared with 78% (95% CI, 66%-86%) for the high LSC score group (HR, 1.9 [95% CI, 1.3-2.7]; log-rank P=.002). In another cohort with available data on event-free survival for 70 patients with normal karyotypes, the risk of an event by 3 years was 48% (95% CI, 27%-63%) in the low LSC score group vs 81% (95% CI, 60%-91%) in the high LSC score group (HR, 2.4 [95% CI, 1.3-4.5]; log-rank P=.006). In multivariate Cox regression including age, mutations in FLT3 and NPM1, and cytogenetic abnormalities, the HRs for LSC score in the 3 cohorts with data on all variables were 1.07 (95% CI, 1.01-1.13; P=.02), 1.10 (95% CI, 1.03-1.17; P=.005), and 1.17 (95% CI, 1.05-1.30; P=.005). Conclusion High expression of an LSC gene signature is independently associated with adverse outcomes in patients with AML. JAMA. 2010;304(24):2706-2715 www.jama.com	[Majeti, Ravindra; Alizadeh, Ash A.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94305 USA; [Gentles, Andrew J.; Plevritis, Sylvia K.] Stanford Univ, Lucas Ctr MR Spect & Imaging, Dept Radiol, Palo Alto, CA 94305 USA; [Alizadeh, Ash A.] Stanford Univ, Ctr Canc, Dept Internal Med, Div Oncol, Palo Alto, CA 94305 USA; [Majeti, Ravindra; Alizadeh, Ash A.] Stanford Univ, Ctr Canc, Dept Internal Med, Div Hematol, Palo Alto, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Alizadeh, AA (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94305 USA.	rmajeti@stanford.edu; arasha@stanford.edu	Alizadeh, Ash A/C-5594-2009	Alizadeh, Ash A/0000-0002-5153-5625; Majeti, Ravindra/0000-0002-5814-0984	National Institutes of Health [1U54CA149145, U56-CA112973]; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [U54CA149145, U56CA112973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Integrative Cancer Biology Program through National Institutes of Health awards 1U54CA149145 and U56-CA112973 (Dr Plevritis). Dr Majeti holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. Dr Alizadeh holds a Career Development Award from the Leukemia and Lymphoma Society.	Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Cleary ML, 2009, BEST PRACT RES CL HA, V22, P483, DOI 10.1016/j.beha.2009.08.005; Costello RT, 1999, LEUKEMIA, V13, P1513, DOI 10.1038/sj.leu.2401519; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Dufour A, 2010, J CLIN ONCOL, V28, P570, DOI 10.1200/JCO.2008.21.6010; Ellis L, 2008, CLIN CANCER RES, V14, P4500, DOI 10.1158/1078-0432.CCR-07-4262; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gentles AJ, 2009, BLOOD, V114, P3158, DOI 10.1182/blood-2009-02-202465; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade David, 2009, Hematology Am Soc Hematol Educ Program, P385, DOI 10.1182/asheducation-2009.1.385; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2007, BLOOD, V110, P4436, DOI 10.1182/blood-2007-05-088815; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Langer C, 2008, BLOOD, V111, P5371, DOI 10.1182/blood-2007-11-124958; LEE EJ, 1987, BLOOD, V70, P1400; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Lodygin D, 2002, J CLIN INVEST, V110, P1717, DOI 10.1172/JCI200216588; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McWeeney SK, 2010, BLOOD, V115, P315, DOI 10.1182/blood-2009-03-210732; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; OSHITA AK, 1977, BLOOD, V49, P585; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Wilson CS, 2006, BLOOD, V108, P685, DOI 10.1182/blood-2004-12-4633; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895	55	256	273	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 22	2010	304	24					2706	2715		10.1001/jama.2010.1862	http://dx.doi.org/10.1001/jama.2010.1862			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697MP	21177505	Green Accepted, Bronze			2022-12-28	WOS:000285518000015
J	Johnson, KS				Johnson, Kimberly S.			Save the Children BMJ Christmas Appeal Free healthcare in Sierra Leone	BRITISH MEDICAL JOURNAL			English	Editorial Material												kimberlysj@gmail.com							0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2010	341								c7268	10.1136/bmj.c7268	http://dx.doi.org/10.1136/bmj.c7268			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	700DV	21177354				2022-12-28	WOS:000285716600011
J	Vazquez, S; Rondina, MT				Vazquez, Sara; Rondina, Matthew T.			Review: Graduated compression stockings reduce deep venous thrombosis in hospitalized patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Vazquez, Sara; Rondina, Matthew T.] Univ Utah, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Vazquez, S (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.			Rondina, Matthew/0000-0003-3455-3730	NHLBI NIH HHS [K23 HL092161-02, K23 HL092161] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL092161] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656	1	1	1	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12							JC6-6	10.7326/0003-4819-153-12-201012210-02006	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173407	Green Accepted			2022-12-28	WOS:000285453700023
J	Sen, B				Sen, Binayak			Securing the right to health for all in India	LANCET			English	Editorial Material									Christian Med Coll & Hosp, Curriculum Off, Vellore 632004, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore	Sen, B (corresponding author), Christian Med Coll & Hosp, Curriculum Off, Vellore 632004, Tamil Nadu, India.	sbinayak60@gmail.com						BHORE S, 1946, REPORT HLTH SURVEY D, V1; DUGGAL R, REGULATING PRIVATE H; GHOSH J, 2009, FRONTLINE       0818, V26; *MIN HLTH FAM WELF, 2009, NAT HLTH BILL GOI WO; Patnaik U., 2007, REPUBLIC HUNGER OTHE; PRASAD S, 2006, SECURING HLTH ALL DI; SEN B, LITTLE MAGA IN PRESS; 1949, CONSTITUTION INDIA 4	8	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 12	2011	377	9765					532	533		10.1016/S0140-6736(10)62182-4	http://dx.doi.org/10.1016/S0140-6736(10)62182-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724DQ	21227497				2022-12-28	WOS:000287556700005
J	Capak, PL; Riechers, D; Scoville, NZ; Carilli, C; Cox, P; Neri, R; Robertson, B; Salvato, M; Schinnerer, E; Yan, L; Wilson, GW; Yun, M; Civano, F; Elvis, M; Karim, A; Mobasher, B; Staguhn, JG				Capak, Peter L.; Riechers, Dominik; Scoville, Nick Z.; Carilli, Chris; Cox, Pierre; Neri, Roberto; Robertson, Brant; Salvato, Mara; Schinnerer, Eva; Yan, Lin; Wilson, Grant W.; Yun, Min; Civano, Francesca; Elvis, Martin; Karim, Alexander; Mobasher, Bahram; Staguhn, Johannes G.			A massive protocluster of galaxies at a redshift of z approximate to 5.3	NATURE			English	Article							LYMAN-BREAK GALAXIES; MOLECULAR GAS; SUBMILLIMETER GALAXIES; COSMOS SURVEY; EVOLUTION; QUASARS; Z-SIMILAR-TO-6; POPULATION; CLUSTER; FIELD	Massive clusters of galaxies have been found that date from as early as 3.9 billion years(1) (3.9 Gyr; z = 1.62) after the Big Bang, containing stars that formed at even earlier epochs(2,3). Cosmological simulations using the current cold dark matter model predict that these systems should descend from 'protoclusters'-early overdensities of massive galaxies that merge hierarchically to form a cluster(4,5). These protocluster regions themselves are built up hierarchically and so are expected to contain extremely massive galaxies that can be observed as luminous quasars and starbursts(4-6). Observational evidence for this picture, however, is sparse because high-redshift protoclusters are rare and difficult to observe(6,7). Here we report a protocluster region that dates from 1 Gyr (z = 55.3) after the Big Bang. This cluster of massive galaxies extends over more than 13 megaparsecs and contains a luminous quasar as well as a system rich in molecular gas(8). These massive galaxies place a lower limit of more than 4 x 10(11) solar masses of dark and luminous matter in this region, consistent with that expected from cosmological simulations for the earliest galaxy clusters(4,5,7).	[Capak, Peter L.; Yan, Lin] CALTECH, Spitzer Sci Ctr, Pasadena, CA 91125 USA; [Riechers, Dominik; Scoville, Nick Z.; Robertson, Brant] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Carilli, Chris] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Cox, Pierre; Neri, Roberto] Inst Radio Astron Millimetr, F-38406 St Martin Dheres, France; [Salvato, Mara] Max Planck Inst Plasma Phys, D-85748 Garching, Germany; [Schinnerer, Eva; Karim, Alexander] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Wilson, Grant W.; Yun, Min] Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA; [Civano, Francesca; Elvis, Martin] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Mobasher, Bahram] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA; [Staguhn, Johannes G.] Johns Hopkins Univ, Lab Observat Cosmol, NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	California Institute of Technology; California Institute of Technology; National Radio Astronomy Observatory (NRAO); Max Planck Society; Max Planck Society; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Riverside; Johns Hopkins University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Capak, PL (corresponding author), CALTECH, Spitzer Sci Ctr, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	capak@astro.caltech.edu	Robertson, Brant/AAA-6124-2022; Capak, Peter/AAK-4282-2020; Salvato, Mara/AAD-7397-2019	Robertson, Brant/0000-0002-4271-0364; Capak, Peter/0000-0003-3578-6843; Salvato, Mara/0000-0001-7116-9303; Schinnerer, Eva/0000-0002-3933-7677	NASA; NSF; Division Of Astronomical Sciences [0907952] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	These results are based on observations with: the W. M. Keck Observatory, the IRAM Plateau de Bure Interferometer, the IRAM 30-m telescope with the GISMO 2-mm camera, the Chandra X-ray Observatory, the Subaru Telescope, the Hubble Space Telescope, the Canada-France-Hawaii Telescope with WIRCam and MegaPrime, the United Kingdom Infrared Telescope, the Spitzer Space Telescope, the Smithsonian Submillimeter Array Telescope, the James Clerk Maxwell Telescope with the AzTEC 1.1 mm camera, and the National Radio Astronomy Observatory's Very Large Array. D. R. and B. R. acknowledge support from NASA through Hubble Fellowship grants awarded by the Space Telescope Science Institute. P. L. C. and N.Z.S. acknowledge grant support from NASA. G. W. W., M.Y. and J.G.S. acknowledge grant support from the NSF.	Bouwens RJ, 2007, ASTROPHYS J, V670, P928, DOI 10.1086/521811; Brusa M, 2009, ASTROPHYS J, V693, P8, DOI 10.1088/0004-637X/693/1/8; Calzetti D, 1996, ASTROPHYS J, V458, P132, DOI 10.1086/176797; Capak P, 2007, ASTROPHYS J SUPPL S, V172, P99, DOI 10.1086/519081; Elvis M, 2009, ASTROPHYS J SUPPL S, V184, P158, DOI 10.1088/0067-0049/184/1/158; Hildebrandt H, 2009, ASTRON ASTROPHYS, V498, P725, DOI 10.1051/0004-6361/200811042; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; LARSON D, 2010, ASTROPHYS J IN PRESS; Li YL, 2007, ASTROPHYS J, V665, P187, DOI 10.1086/519297; Maraston C, 1998, MON NOT R ASTRON SOC, V300, P872, DOI 10.1046/j.1365-8711.1998.01947.x; Mei S, 2009, ASTROPHYS J, V690, P42, DOI 10.1088/0004-637X/690/1/42; Miley GK, 2004, NATURE, V427, P47, DOI 10.1038/nature02125; Overzier RA, 2009, ASTROPHYS J, V704, P548, DOI 10.1088/0004-637X/704/1/548; Overzier RA, 2009, MON NOT R ASTRON SOC, V394, P577, DOI 10.1111/j.1365-2966.2008.14264.x; Papovich C, 2010, ASTROPHYS J, V716, P1503, DOI 10.1088/0004-637X/716/2/1503; Pettini M, 2000, ASTROPHYS J, V528, P96, DOI 10.1086/308176; Riechers DA, 2010, ASTROPHYS J LETT, V720, pL131, DOI 10.1088/2041-8205/720/2/L131; Robertson B, 2007, ASTROPHYS J, V667, P60, DOI 10.1086/520057; Schinnerer E, 2007, ASTROPHYS J SUPPL S, V172, P46, DOI 10.1086/516587; Scott KS, 2008, MON NOT R ASTRON SOC, V385, P2225, DOI 10.1111/J.1365-2966.2008.12989.x; Scoville N, 2007, ASTROPHYS J SUPPL S, V172, P1, DOI 10.1086/516585; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Stark DP, 2009, ASTROPHYS J, V697, P1493, DOI 10.1088/0004-637X/697/2/1493; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; Tacconi LJ, 2010, NATURE, V463, P781, DOI 10.1038/nature08773; Walter F, 2003, NATURE, V424, P406, DOI 10.1038/nature01821; Wang R, 2010, ASTROPHYS J, V714, P699, DOI 10.1088/0004-637X/714/1/699; Younger JD, 2007, ASTROPHYS J, V671, P1531, DOI 10.1086/522776	28	222	223	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					233	235		10.1038/nature09681	http://dx.doi.org/10.1038/nature09681			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21228776	Green Accepted, Green Submitted			2022-12-28	WOS:000287144200038
J	Clausen, C; Usmani, I; Bussieres, F; Sangouard, N; Afzelius, M; de Riedmatten, H; Gisin, N				Clausen, Christoph; Usmani, Imam; Bussieres, Felix; Sangouard, Nicolas; Afzelius, Mikael; de Riedmatten, Hugues; Gisin, Nicolas			Quantum storage of photonic entanglement in a crystal	NATURE			English	Article							SINGLE-PHOTON; ATOMIC ENSEMBLES; TRAPPED ATOM; COMMUNICATION; LIGHT; MATTER	Entanglement is the fundamental characteristic of quantum physics-much experimental effort is devoted to harnessing it between various physical systems. In particular, entanglement between light and material systems is interesting owing to their anticipated respective roles as 'flying' and stationary qubits in quantum information technologies (such as quantum repeaters(1-3) and quantum networks(4)). Here we report the demonstration of entanglement between a photon at a telecommunication wavelength (1,338 nm) and a single collective atomic excitation stored in a crystal. One photon from an energy-time entangled pair(5) is mapped onto the crystal and then released into a well-defined spatial mode after a predetermined storage time. The other (telecommunication wavelength) photon is sent directly through a 50-metre fibre link to an analyser. Successful storage of entanglement in the crystal is proved by a violation of the Clauser-Horne-Shimony-Holt inequality(6) by almost three standard deviations (S=2.64 +/- 0.23). These results represent an important step towards quantum communication technologies based on solid-state devices. In particular, our resources pave the way for building multiplexed quantum repeaters(7) for long-distance quantum networks.	[Clausen, Christoph; Usmani, Imam; Bussieres, Felix; Sangouard, Nicolas; Afzelius, Mikael; de Riedmatten, Hugues; Gisin, Nicolas] Univ Geneva, Appl Phys Grp, CH-1211 Geneva 4, Switzerland; [de Riedmatten, Hugues] ICFO Inst Ciencies Foton, Barcelona 08860, Spain; [de Riedmatten, Hugues] ICREA, Barcelona 08015, Spain	University of Geneva; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); ICREA	Afzelius, M (corresponding author), Univ Geneva, Appl Phys Grp, CH-1211 Geneva 4, Switzerland.	mikael.afzelius@unige.ch	de Riedmatten, Hugues/P-7563-2017; Bussieres, Felix/E-5384-2011; Afzelius, Mikael/N-5825-2016	Bussieres, Felix/0000-0003-0234-175X; Afzelius, Mikael/0000-0001-8367-6820; de Riedmatten, Hugues/0000-0002-4418-0723	Swiss NCCR Quantum Photonics; Science and Technology Cooperation Program Switzerland-Russia; QuRep; ERC-Qore; FQRNT; ICREA Funding Source: Custom	Swiss NCCR Quantum Photonics(Swiss National Science Foundation (SNSF)); Science and Technology Cooperation Program Switzerland-Russia; QuRep; ERC-Qore; FQRNT(FQRNT); ICREA(ICREA)	We thank R. Locher for help during the early stages of the experiment. We are grateful to A. Beveratos and W. Tittel for lending us avalanche photodiodes. This work was supported by the Swiss NCCR Quantum Photonics, the Science and Technology Cooperation Program Switzerland-Russia, as well as by the European projects QuRep and ERC-Qore. F.B. was supported in part by FQRNT.	Afzelius M, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.022310; Afzelius M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.040503; Afzelius M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.052329; Akiba K, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013049; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Chaneliere T, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/2/023025; Chen S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.180505; de Riedmatten H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.113603; de Riedmatten H, 2008, NATURE, V456, P773, DOI 10.1038/nature07607; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; FRANSON JD, 1989, PHYS REV LETT, V62, P2205, DOI 10.1103/PhysRevLett.62.2205; Hedges MP, 2010, NATURE, V465, P1052, DOI 10.1038/nature09081; Jin X.-M., 2010, QUANTUM INTERFACE FR; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Longdell JJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063601; Matsukevich DN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040405; Moiseev SA, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.022311; Sabooni M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.060501; Sangouard N., 2009, QUANTUM REPEATERS BA; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Simon C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190503; Tittel W, 2010, LASER PHOTONICS REV, V4, P244, DOI 10.1002/lpor.200810056; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Usmani I, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1010; Volz J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030404	28	349	359	1	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					508	U79		10.1038/nature09662	http://dx.doi.org/10.1038/nature09662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21228774	Green Accepted, Green Submitted			2022-12-28	WOS:000286596500027
J	Lamont, T; Watts, F; Panesar, S; MacFie, J; Matthew, D				Lamont, Tara; Watts, Fran; Panesar, Sukhmeet; MacFie, John; Matthew, Dinah			Safety Alerts Early detection of complications after laparoscopic surgery: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHOLECYSTECTOMY; ENGLAND; AUDIT					tara.lamont@npsa.nhs.uk						Alkhaffaf B, 2010, ANN SURG, V251, P682, DOI 10.1097/SLA.0b013e3181cc99fd; Chitre VV, 1999, BRIT J SURG, V86, P185, DOI 10.1046/j.1365-2168.1999.00989.x; Dexter F, 1999, J CLIN MONITOR COMP, V15, P153, DOI 10.1023/A:1009941214632; DUNN D, 1994, ANN ROY COLL SURG, V76, P269; Ferriman A, 2000, BRIT MED J, V321, P784, DOI 10.1136/bmj.321.7264.784; MCMAHON M, 2009, RECOGNITION MANAGEME; Solly J, 2007, J ONE DAY SURG, V17, P15; Survey of injuries associated with laparoscopic surgery, 2010, SURV INJ ASS LAP SUR; Tang B, 2004, ARCH SURG-CHICAGO, V139, P1215, DOI 10.1001/archsurg.139.11.1215	9	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2011	342								c7221	10.1136/bmj.c7221	http://dx.doi.org/10.1136/bmj.c7221			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OX	21248017				2022-12-28	WOS:000286602400008
J	Gilbert, NC; Bartlett, SG; Waight, MT; Neau, DB; Boeglin, WE; Brash, AR; Newcomer, ME				Gilbert, Nathaniel C.; Bartlett, Sue G.; Waight, Maria T.; Neau, David B.; Boeglin, William E.; Brash, Alan R.; Newcomer, Marcia E.			The Structure of Human 5-Lipoxygenase	SCIENCE			English	Article							PURIFIED HUMAN 5-LIPOXYGENASE; CRYSTAL-STRUCTURE; SOYBEAN LIPOXYGENASE-1; C2-LIKE DOMAIN; PROTEIN; SPECIFICITY; OXYGENATION; 8R-LIPOXYGENASE; BIOSYNTHESIS; DETERMINANTS	The synthesis of both proinflammatory leukotrienes and anti-inflammatory lipoxins requires the enzyme 5-lipoxygenase (5-LOX). 5-LOX activity is short-lived, apparently in part because of an intrinsic instability of the enzyme. We identified a 5-LOX-specific destabilizing sequence that is involved in orienting the carboxyl terminus, which binds the catalytic iron. Here, we report the crystal structure at 2.4 angstrom resolution of human 5-LOX stabilized by replacement of this sequence.	[Gilbert, Nathaniel C.; Bartlett, Sue G.; Waight, Maria T.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Neau, David B.] Argonne Natl Lab, NE Collaborat Access Team, Argonne, IL 60439 USA; [Boeglin, William E.; Brash, Alan R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Louisiana State University System; Louisiana State University; United States Department of Energy (DOE); Argonne National Laboratory; Vanderbilt University	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu	Gilbert, Nathaniel/I-8223-2018	Gilbert, Nathaniel/0000-0002-6706-811X	American Heart Association [MCB 08553920E]; NSF [0818387]; NIH [GM-15431]; Louisiana Governors' Biotechnology Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Governors' Biotechnology Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by grants from the American Heart Association (MCB 08553920E) and NSF (0818387) to M.E.N. and from NIH (GM-15431) to A. R. B. Preliminary work was performed at the Center for Advanced Microstructures and Devices (Baton Rouge), funded in part by the Louisiana Governors' Biotechnology Initiative. X-ray data were collected at Beam Line 24-ID-E of NE-CAT at the Advanced Photon Source. Atomic coordinates and structure factors have been deposited in the Protein Data Bank under accession number 3O8Y. M.E.N., N.C.G., and S. G. B, have applied for a patent on the modified enzyme (Stable-5-LOX). For noncommercial use, the construct will be supplied subject to a material transfer agreement.	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; AHARONY D, 1986, J BIOL CHEM, V261, P1512; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Chen XS, 1998, J BIOL CHEM, V273, P31237, DOI 10.1074/jbc.273.47.31237; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Hammarberg T, 2002, ADV EXP MED BIOL, V507, P117; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Kuhn H, 2003, ARTERIOSCL THROM VAS, V23, P1072, DOI 10.1161/01.ATV.0000074167.01184.48; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Neau DB, 2007, ACTA CRYSTALLOGR F, V63, P972, DOI 10.1107/S1744309107050993; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; PERCIVAL MD, 1992, EUR J BIOCHEM, V210, P109, DOI 10.1111/j.1432-1033.1992.tb17397.x; Radmark O, 2009, J LIPID RES, V50, pS40, DOI 10.1194/jlr.R800062-JLR200; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; SHIMIZU T, 1984, P NATL ACAD SCI-BIOL, V81, P689, DOI 10.1073/pnas.81.3.689; Walther M, 2001, CHEM BIOL, V8, P779, DOI 10.1016/S1074-5521(01)00050-3; ZHANG YY, 1994, ANAL BIOCHEM, V220, P28, DOI 10.1006/abio.1994.1294	29	301	309	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 14	2011	331	6014					217	219		10.1126/science.1197203	http://dx.doi.org/10.1126/science.1197203			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233389	Green Accepted, Green Submitted			2022-12-28	WOS:000286433100043
J	Khera, AV; Cuchel, M; de la Llera-Moya, M; Rodrigues, A; Burke, MF; Jafri, K; French, BC; Phillips, JA; Mucksavage, ML; Wilensky, RL; Mohler, ER; Rothblat, GH; Rader, DJ				Khera, Amit V.; Cuchel, Marina; de la Llera-Moya, Margarita; Rodrigues, Amrith; Burke, Megan F.; Jafri, Kashif; French, Benjamin C.; Phillips, Julie A.; Mucksavage, Megan L.; Wilensky, Robert L.; Mohler, Emile R.; Rothblat, George H.; Rader, Daniel J.			Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; PHOSPHOLIPID TRANSFER PROTEIN; APOLIPOPROTEIN-A-I; METABOLIC SYNDROME; MACROPHAGE ABCA1; HDL; PLASMA; ABCG1; SERUM; ABILITY	BACKGROUND High-density lipoprotein (HDL) may provide cardiovascular protection by promoting reverse cholesterol transport from macrophages. We hypothesized that the capacity of HDL to accept cholesterol from macrophages would serve as a predictor of atherosclerotic burden. METHODS We measured cholesterol efflux capacity in 203 healthy volunteers who underwent assessment of carotid artery intima-media thickness, 442 patients with angiographically confirmed coronary artery disease, and 351 patients without such angiographically confirmed disease. We quantified efflux capacity by using a validated ex vivo system that involved incubation of macrophages with apolipoprotein B-depleted serum from the study participants. RESULTS The levels of HDL cholesterol and apolipoprotein A-I were significant determinants of cholesterol efflux capacity but accounted for less than 40% of the observed variation. An inverse relationship was noted between efflux capacity and carotid intima-media thickness both before and after adjustment for the HDL cholesterol level. Furthermore, efflux capacity was a strong inverse predictor of coronary disease status (adjusted odds ratio for coronary disease per 1-SD increase in efflux capacity, 0.70; 95% confidence interval [CI], 0.59 to 0.83; P<0.001). This relationship was attenuated, but remained significant, after additional adjustment for the HDL cholesterol level (odds ratio per 1-SD increase, 0.75; 95% CI, 0.63 to 0.90; P = 0.002) or apolipoprotein A-I level (odds ratio per 1-SD increase, 0.74; 95% CI, 0.61 to 0.89; P = 0.002). Additional studies showed enhanced efflux capacity in patients with the metabolic syndrome and low HDL cholesterol levels who were treated with pioglitazone, but not in patients with hypercholesterolemia who were treated with statins. CONCLUSIONS Cholesterol efflux capacity from macrophages, a metric of HDL function, has a strong inverse association with both carotid intima-media thickness and the likelihood of angiographic coronary artery disease, independently of the HDL cholesterol level.	[Cuchel, Marina; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Khera, Amit V.; Rodrigues, Amrith; Burke, Megan F.; Jafri, Kashif; French, Benjamin C.; Mucksavage, Megan L.; Wilensky, Robert L.; Mohler, Emile R.; Rader, Daniel J.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [French, Benjamin C.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Mucksavage, Megan L.; Rothblat, George H.] Childrens Hosp Philadelphia, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; [Phillips, Julie A.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08903 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Rutgers State University New Brunswick	Cuchel, M (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, 654 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	mcuchel@mail.med.upenn.edu; rader@mail.med.upenn.edu			National Heart, Lung, and Blood Institute (NHLBI) [HL22633, P50 HL70128, HL077146]; National Center for Research Resources [M01 RR00040, UL1-RR-024134]; Doris Duke Charitable Foundation; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000040, UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633, P50HL070128, K23HL077146] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (HL22633 and P50 HL70128) and the National Center for Research Resources (M01 RR00040 and UL1-RR-024134) and a Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation. Dr. Khera was supported by a medical student research fellowship from the Howard Hughes Medical Institute, and Dr. Cuchel by a K23 award (HL077146) from the NHLBI.	Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Calabresi L, 2009, CIRCULATION, V120, P628, DOI 10.1161/CIRCULATIONAHA.108.818143; Chirinos JA, 2005, CIRCULATION, V112, P2446, DOI 10.1161/CIRCULATIONAHA.104.521815; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Cui D, 2007, J LEUKOCYTE BIOL, V82, P1040, DOI 10.1189/jlb.0307192; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; de Vries R, 2008, ATHEROSCLEROSIS, V196, P733, DOI 10.1016/j.atherosclerosis.2006.12.027; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Dullaart RPF, 2008, EUR J ENDOCRINOL, V158, P53, DOI 10.1530/EJE-07-0451; Fournier N, 1997, ARTERIOSCL THROM VAS, V17, P2685, DOI 10.1161/01.ATV.17.11.2685; FRANCESCHINI G, 1980, J CLIN INVEST, V66, P892, DOI 10.1172/JCI109956; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; GLOMSET JA, 1968, J LIPID RES, V9, P155; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Khera AV, 2010, CURR ATHEROSCLER REP, V12, P73, DOI 10.1007/s11883-009-0080-0; Ky B, 2008, J AM COLL CARDIOL, V51, P1653, DOI 10.1016/j.jacc.2008.01.026; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; Mikkola TS, 2003, ATHEROSCLEROSIS, V170, P31, DOI 10.1016/S0021-9150(03)00247-8; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Pajunen P, 2001, SCAND CARDIOVASC J, V35, P96; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P1516; Singh IM, 2007, JAMA-J AM MED ASSOC, V298, P786, DOI 10.1001/jama.298.7.786; Syvanne M, 1996, ATHEROSCLEROSIS, V127, P245, DOI 10.1016/S0021-9150(96)05962-X; Szapary PO, 2006, ARTERIOSCL THROM VAS, V26, P182, DOI 10.1161/01.ATV.0000195790.24531.4f; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van Dam MJ, 2002, LANCET, V359, P37, DOI 10.1016/S0140-6736(02)07277-X; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang LH, 2010, J LIPID RES, V51, P2211, DOI 10.1194/jlr.M004481; Zhou HL, 2008, DIABETES-METAB RES, V24, P617, DOI 10.1002/dmrr.895	39	1462	1516	5	168	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					127	135		10.1056/NEJMoa1001689	http://dx.doi.org/10.1056/NEJMoa1001689			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226578	Green Accepted			2022-12-28	WOS:000286142900006
J	Warne, T; Moukhametzianov, R; Baker, JG; Nehme, R; Edwards, PC; Leslie, AGW; Schertler, GFX; Tate, CG				Warne, Tony; Moukhametzianov, Rouslan; Baker, Jillian G.; Nehme, Rony; Edwards, Patricia C.; Leslie, Andrew G. W.; Schertler, Gebhard F. X.; Tate, Christopher G.			The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-ADRENERGIC-RECEPTORS; HIGH-AFFINITY BINDING; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; LIGAND-BINDING; AMINO-ACID; ACTIVATION; CRYSTALLOGRAPHY; CRYSTALLIZATION	beta-adrenergic receptors (beta ARs) are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins upon binding catecholamine agonist ligands such as adrenaline and noradrenaline(1,2). Synthetic ligands have been developed that either activate or inhibit beta ARs for the treatment of asthma, hypertension or cardiac dysfunction. These ligands are classified as either full agonists, partial agonists or antagonists, depending on whether the cellular response is similar to that of the native ligand, reduced or inhibited, respectively. However, the structural basis for these different ligand efficacies is unknown. Here we present four crystal structures of the thermo-stabilized turkey (Meleagris gallopavo) beta(1)-adrenergic receptor (beta(1)AR-m23) bound to the full agonists carmoterol and isoprenaline and the partial agonists salbutamol and dobutamine. In each case, agonist binding induces a 1 angstrom contraction of the catecholamine-binding pocket relative to the antagonist bound receptor. Full agonists can form hydrogen bonds with two conserved serine residues in transmembrane helix 5 (Ser(5.42) and Ser(5.46)), but partial agonists only interact with Ser(5.42) (superscripts refer to Ballesteros-Weinstein numbering(3)). The structures provide an understanding of the pharmacological differences between different ligand classes, illuminating how GPCRs function and providing a solid foundation for the structure-based design of novel ligands with predictable efficacies.	[Warne, Tony; Moukhametzianov, Rouslan; Nehme, Rony; Edwards, Patricia C.; Leslie, Andrew G. W.; Schertler, Gebhard F. X.; Tate, Christopher G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Baker, Jillian G.] Univ Nottingham, Sch Med, Inst Cell Signalling, Queens Med Ctr, Nottingham NG7 2UH, England	MRC Laboratory Molecular Biology; University of Nottingham	Tate, CG (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	gebhard.schertler@psi.ch; cgt@mrc-lmb.cam.ac.uk	Schertler, Gebhard/M-9512-2014	Schertler, Gebhard F.X./0000-0002-5846-6810; Warne, Tony/0000-0001-9646-6080; Tate, Christopher/0000-0002-2008-9183	MRC; BBSRC [BB/G003653/1]; Human Frontier Science Project (HFSP) [RG/0052]; European Commission [LSH-2003-1.1.0-1]; ESRF; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/G003653/1] Funding Source: researchfish; Medical Research Council [MC_U105184325, MC_U105197215] Funding Source: researchfish; MRC [MC_U105197215, MC_U105184325] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontier Science Project (HFSP)(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); ESRF; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by core funding from the MRC and the BBSRC grant (BB/G003653/1). Financial support for G. F. X. S was also from a Human Frontier Science Project (HFSP) programme grant (RG/0052), a European Commission FP6 specific targeted research project (LSH-2003-1.1.0-1) and an ESRF long-term proposal. J.G.B. was funded by a Wellcome Trust Clinician Scientist Fellowship. We are grateful to P. Coli and A. Rizzi for the supply of (R,R)-carmoterol. F. Gorrec is thanked for his help with crystallisation robotics. We would also like to thank beamline staff at the European Synchrotron Radiation Facility, particularly D. Flot and A. Popov at ID23-2 and F. Marshall, M. Weir, M. Congreve and R. Henderson for comments on the manuscript.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Baker JG, 2003, MOL PHARMACOL, V63, P1312, DOI 10.1124/mol.63.6.1312; Balaraman GS, 2010, BIOPHYS J, V99, P568, DOI 10.1016/j.bpj.2010.04.075; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelhardt S, 2001, MOL PHARMACOL, V60, P712; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Green SA, 2001, EUR J PHARMACOL, V421, P141, DOI 10.1016/S0014-2999(01)01049-4; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Isogaya M, 1998, MOL PHARMACOL, V54, P616; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Kikkawa H, 1998, MOL PHARMACOL, V53, P128, DOI 10.1124/mol.53.1.128; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Piscione F, 2008, J AM COLL CARDIOL, V52, P1381, DOI 10.1016/j.jacc.2008.07.034; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sato T, 1999, BRIT J PHARMACOL, V128, P272, DOI 10.1038/sj.bjp.0702813; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Serrano-Vega MJ, 2009, MOL MEMBR BIOL, V26, P385, DOI 10.3109/09687680903208239; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, J BIOL CHEM, V264, P13572; SURYANARAYANA S, 1993, MOL PHARMACOL, V44, P111; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2009, PROTEIN EXPRES PURIF, V65, P204, DOI 10.1016/j.pep.2009.01.014; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; WILLIAMS RS, 1981, J CLIN INVEST, V67, P1703, DOI 10.1172/JCI110208	42	489	500	5	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					241	244		10.1038/nature09746	http://dx.doi.org/10.1038/nature09746			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228877	Green Accepted			2022-12-28	WOS:000286143400044
J	Goldman, S; Sethi, GK; Holman, W; Thai, H; McFalls, E; Ward, HB; Kelly, RF; Rhenman, B; Tobler, GH; Bakaeen, FG; Huh, J; Soltero, E; Moursi, M; Haime, M; Crittenden, M; Kasirajan, V; Ratliff, M; Pett, S; Irimpen, A; Gunnar, W; Thomas, D; Fremes, S; Moritz, T; Reda, D; Harrison, L; Wagner, TH; Wang, YJ; Planting, L; Miller, M; Rodriguez, Y; Juneman, E; Morrison, D; Pierce, MK; Kreamer, S; Shih, MC; Lee, K				Goldman, Steven; Sethi, Gulshan K.; Holman, William; Thai, Hoang; McFalls, Edward; Ward, Herbert B.; Kelly, Rosemary F.; Rhenman, Birger; Tobler, Gareth H.; Bakaeen, Faisal G.; Huh, Joseph; Soltero, Ernesto; Moursi, Mohammed; Haime, Miguel; Crittenden, Michael; Kasirajan, Vigneshwar; Ratliff, Michelle; Pett, Stewart; Irimpen, Anand; Gunnar, William; Thomas, Donald; Fremes, Stephen; Moritz, Thomas; Reda, Domenic; Harrison, Lynn; Wagner, Todd H.; Wang, Yajie; Planting, Lori; Miller, Meredith; Rodriguez, Yvette; Juneman, Elizabeth; Morrison, Douglass; Pierce, Mary Kaye; Kreamer, Sandra; Shih, Mei-Chiung; Lee, Kelvin			Radial Artery Grafts vs Saphenous Vein Grafts in Coronary Artery Bypass Surgery A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIPLATELET THERAPY; PATENCY; CONDUIT; IMPACT	Context Arterial grafts are thought to be better conduits than saphenous vein grafts for coronary artery bypass grafting (CABG) based on experience with using the left internal mammary artery to bypass the left anterior descending coronary artery. The efficacy of the radial artery graft is less clear. Objective To compare 1-year angiographic patency of radial artery grafts vs saphenous vein grafts in patients undergoing elective CABG. Design, Setting, and Participants Multicenter, randomized controlled trial conducted from February 2003 to February 2009 at 11 Veterans Affairs medical centers among 757 participants (99% men) undergoing first-time elective CABG. Interventions The left internal mammary artery was used to preferentially graft the left anterior descending coronary artery whenever possible; the best remaining recipient vessel was randomized to radial artery vs saphenous vein graft. Main Outcome Measures The primary end point was angiographic graft patency at 1 year after CABG. Secondary end points included angiographic graft patency at 1 week after CABG, myocardial infarction, stroke, repeat revascularization, and death. Results Analysis included 733 patients (366 in the radial artery group, 367 in the saphenous vein group). There was no significant difference in study graft patency at 1 year after CABG (radial artery, 238/266; 89%; 95% confidence interval [CI], 86%-93%; saphenous vein, 239/269; 89%; 95% CI, 85%-93%; adjusted OR, 0.99; 95% CI, 0.56-1.74; P=.98). There were no significant differences in the secondary end points. Conclusion Among Veterans Affairs patients undergoing first-time elective CABG, the use of a radial artery graft compared with saphenous vein graft did not result in greater 1-year patency.	[Goldman, Steven] So Arizona VA Hlth Care Syst, Cardiol Sect 1 111C, Tucson, AZ 85723 USA; [Goldman, Steven; Sethi, Gulshan K.; Thai, Hoang; Rhenman, Birger; Juneman, Elizabeth] Univ Arizona Sarver Heart Ctr, Tucson, AZ USA; [Holman, William] Vet Affairs Med Ctr, Birmingham, AL USA; [McFalls, Edward; Ward, Herbert B.; Kelly, Rosemary F.] Vet Affairs Med Ctr, Minneapolis, MN USA; [Tobler, Gareth H.; Moursi, Mohammed] Vet Affairs Hlth Care Syst, Little Rock, AR USA; [Bakaeen, Faisal G.; Huh, Joseph; Soltero, Ernesto] Vet Affairs Med Ctr, Houston, TX 77030 USA; [Huh, Joseph] Baylor Coll Med, Texas Heart Inst, Houston, TX 77030 USA; [Soltero, Ernesto] Hosp Damas, Ponce, PR USA; [Haime, Miguel] Vet Affairs Hlth Care Ctr, W Roxbury, MA USA; [Crittenden, Michael] Vet Affairs Med Ctr, St Louis, MO USA; [Kasirajan, Vigneshwar] Vet Affairs Med Ctr, Richmond, VA USA; [Ratliff, Michelle; Pett, Stewart] Vet Affairs Med Ctr, Albuquerque, NM USA; [Irimpen, Anand] Vet Affairs Med Ctr, New Orleans, LA USA; [Gunnar, William; Thomas, Donald; Moritz, Thomas; Reda, Domenic] Hines VA Hosp, Cooperat Studies Program Coordinating Ctr, Hines, IL USA; [Fremes, Stephen] Univ Toronto, Sunnybrooke & Womens Coll Hlth Sci Ctr, Toronto, ON M5S 1A1, Canada; [Harrison, Lynn] Baptist Hlth S Florida, Miami, FL USA; [Harrison, Lynn] Florida Int Univ, Miami, FL 33199 USA; [Wagner, Todd H.] VA Palo Alto Hlth Econ Resource Ctr, Menlo Pk, CA USA; [Wang, Yajie; Planting, Lori; Miller, Meredith; Shih, Mei-Chiung; Lee, Kelvin] Vet Affairs Hlth Care Syst, Cooperat Studies Program Coordinating Ctr, Palo Alto, CA USA; [Morrison, Douglass] Yakima Heart Ctr, Yakima, WA USA; [Shih, Mei-Chiung] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System; University of Arizona; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; Texas Heart Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Hunter Holmes McGuire Veterinary Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; State University System of Florida; Florida International University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University	Goldman, S (corresponding author), So Arizona VA Hlth Care Syst, Cardiol Sect 1 111C, 3601 S 6th Ave, Tucson, AZ 85723 USA.	steven.goldman@va.gov	Fremes, Stephen E/P-7928-2015	Fremes, Stephen E/0000-0003-1723-3049; , Domenic/0000-0003-1831-4270; Haime, Miguel/0000-0003-4774-0113; Wagner, Todd/0000-0001-7625-3504	Department of Veterans Affairs Clinical Science Research & Development Service, Washington, DC; Department of Veterans Affairs [474]	Department of Veterans Affairs Clinical Science Research & Development Service, Washington, DC; Department of Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the Cooperative Studies Program of the Department of Veterans Affairs Clinical Science Research & Development Service, Washington, DC, and by the Department of Veterans Affairs Cooperative Studies Program (CSP No. 474).	Collins P, 2008, CIRCULATION, V117, P2859, DOI 10.1161/CIRCULATIONAHA.107.736215; Desai ND, 2004, NEW ENGL J MED, V351, P2302, DOI 10.1056/NEJMoa040982; Desai ND, 2007, CIRCULATION, V115, P684, DOI 10.1161/CIRCULATIONAHA.105.567495; GOLDMAN S, 1989, CIRCULATION, V80, P1190, DOI 10.1161/01.CIR.80.5.1190; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; GOLDMAN S, 1994, CIRCULATION, V89, P1138, DOI 10.1161/01.CIR.89.3.1138; GOLDMAN S, 1988, CIRCULATION, V77, P1324, DOI 10.1161/01.CIR.77.6.1324; Hayward PAR, 2008, EUR J CARDIO-THORAC, V34, P113, DOI 10.1016/j.ejcts.2008.03.027; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lopes RD, 2009, NEW ENGL J MED, V361, P235, DOI 10.1056/NEJMoa0900708; Miwa S, 2006, ANN THORAC SURG, V81, P112, DOI 10.1016/j.athoracsur.2005.06.076; Schwann TA, 2008, EUR J CARDIO-THORAC, V33, P914, DOI 10.1016/j.ejcts.2008.01.062; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Singh SK, 2008, CIRCULATION, V118, pS222, DOI 10.1161/CIRCULATIONAHA.107.757161; Zacharias A, 2009, ANN THORAC SURG, V87, P19, DOI 10.1016/j.athoracsur.2008.09.050	15	175	193	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					167	174		10.1001/jama.2010.1976	http://dx.doi.org/10.1001/jama.2010.1976			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224458				2022-12-28	WOS:000286103400022
J	Goode, PS; Burgio, KL; Johnson, TM; Clay, OJ; Roth, DL; Markland, AD; Burkhardt, JH; Issa, MM; Lloyd, LK				Goode, Patricia S.; Burgio, Kathryn L.; Johnson, Theodore M., II; Clay, Olivio J.; Roth, David L.; Markland, Alayne D.; Burkhardt, Jeffrey H.; Issa, Muta M.; Lloyd, L. Keith			Behavioral Therapy With or Without Biofeedback and Pelvic Floor Electrical Stimulation for Persistent Postprostatectomy Incontinence A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION SYMPTOM INDEX; QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; URINARY-INCONTINENCE; EXERCISES; VALIDATION; OUTCOMES; CANCER; MEN	Context Although behavioral therapy has been shown to improve postoperative recovery of continence, there have been no controlled trials of behavioral therapy for postprostatectomy incontinence persisting more than 1 year. Objective To evaluate the effectiveness of behavioral therapy for reducing persistent postprostatectomy incontinence and to determine whether the technologies of biofeedback and pelvic floor electrical stimulation enhance the effectiveness of behavioral therapy. Design, Setting, and Participants A prospective randomized controlled trial involving 208 community-dwelling men aged 51 through 84 years with incontinence persisting 1 to 17 years after radical prostatectomy was conducted at a university and 2 Veterans Affairs continence clinics (2003-2008) and included a 1-year follow-up after active treatment. Twenty-four percent of the men were African American; 75%, white. Interventions After stratification by type and frequency of incontinence, participants were randomized to 1 of 3 groups: 8 weeks of behavioral therapy (pelvic floor muscle training and bladder control strategies); behavioral therapy plus in-office, dual-channel electromyograph biofeedback and daily home pelvic floor electrical stimulation at 20 Hz, current up to 100 mA (behavior plus); or delayed treatment, which served as the control group. Main Outcome Measure Percentage reduction in mean number of incontinence episodes after 8 weeks of treatment as documented in 7-day bladder diaries. Results Mean incontinence episodes decreased from 28 to 13 per week (55% reduction; 95% confidence interval [CI], 44%-66%) after behavioral therapy and from 26 to 12 (51% reduction; 95% CI, 37%-65%) after behavior plus therapy. Both reductions were significantly greater than the reduction from 25 to 21 (24% reduction; 95% CI, 10%-39%) observed among controls (P=.001 for both treatment groups). However, there was no significant difference in incontinence reduction between the treatment groups (P=.69). Improvements were durable to 12 months in the active treatment groups: 50% reduction (95% CI, 39.8%-61.1%; 13.5 episodes per week) in the behavioral group and 59% reduction (95% CI, 45.0%-73.1%; 9.1 episodes per week) in the behavior plus group (P=.32). Conclusions Among patients with postprostatectomy incontinence for at least 1 year, 8 weeks of behavioral therapy, compared with a delayed-treatment control, resulted in fewer incontinence episodes. The addition of biofeedback and pelvic floor electrical stimulation did not result in greater effectiveness.	[Goode, Patricia S.] Univ Alabama Birmingham, Ctr Aging, Dept Med, Div Gerontol Geriatr & Palliat Care, Birmingham, AL 35294 USA; [Goode, Patricia S.; Burgio, Kathryn L.; Johnson, Theodore M., II; Roth, David L.; Markland, Alayne D.] Univ Alabama Birmingham, Dept Vet Affairs, Birmingham Atlanta Geriatr Res Educ & Clin Ctr, Birmingham, AL 35294 USA; [Clay, Olivio J.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Roth, David L.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Burkhardt, Jeffrey H.] Univ Alabama Birmingham, Dept Hlth Serv Adm, Birmingham, AL 35294 USA; [Lloyd, L. Keith] Univ Alabama Birmingham, Dept Surg, Div Urol, Birmingham, AL 35294 USA; [Johnson, Theodore M., II] Emory Univ, Dept Med, Div Geriatr Med & Gerontol, Atlanta, GA 30322 USA; [Issa, Muta M.] Emory Univ, Dept Vet Affairs, Atlanta VA Med Ctr, Atlanta, GA 30322 USA; [Issa, Muta M.] Emory Univ, Dept Urol, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; Geriatric Research Education & Clinical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University	Goode, PS (corresponding author), Univ Alabama Birmingham, Ctr Aging, Dept Med, Div Gerontol Geriatr & Palliat Care, 933 19th St S, Birmingham, AL 35294 USA.	pgoode@uab.edu	Clay, Olivio/AAF-8952-2020; , Theodore M. Johnson/A-6374-2014	Clay, Olivio/0000-0002-7529-6120; , Theodore M. Johnson/0000-0001-8332-5369	Pfizer; Astellas; Vantia; Allergan; Indevus; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK60044]; Department of Veterans Affairs Birmingham-Atlanta Geriatric Research, Education, and Clinical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060044] Funding Source: NIH RePORTER	Pfizer(Pfizer); Astellas(Astellas Pharmaceuticals); Vantia; Allergan(AbbVieAllergan); Indevus; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs Birmingham-Atlanta Geriatric Research, Education, and Clinical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Goode reported receiving a research grant from Pfizer. Dr Burgio reported serving on the advisory board of Astellas, as a consultant to GlaxoSmithKline, and as receiving research grants and serving as a consultant to Pfizer. Dr Johnson reported receiving grant support from Astellas, Pfizer and Vantia and serving as a consultant for Boehringer-Ingelheim, Ferring, Johnson & Johnson, Pfizer, and Vantia. Dr Issa reported serving as a consultant for and on the speakers bureau and receiving honoraria from GlaxoSmithKline. Dr Lloyd reported receiving research support from Allergan, Indevus, and Pfizer; serving as a consultant to and on the speakers bureau of Astellas, Boehringer-Ingelheim, GlaxoSmithKline, Novartis, and Pfizer. No other authors reported having a financial conflict of interest.; This study was supported by grant R01 DK60044 from the National Institute of Diabetes and Digestive and Kidney Diseases and by the Department of Veterans Affairs Birmingham-Atlanta Geriatric Research, Education, and Clinical Center.	Abrams P, 2017, INCONTINENCE 6 INT C; *AM CANC SOC, CANC FACTS FIG 2008; Barber MD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.007; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Burgio KL, 2006, NEUROUROL URODYNAM, V25, P411, DOI 10.1002/nau.20243; Burgio KL, 2006, J UROLOGY, V175, P196, DOI 10.1016/S0022-5347(05)00047-9; Cockett ATK, 1991, P 1 INT CONS BEN PRO; ERIKSEN BC, 1987, BRIT J UROL, V59, P45, DOI 10.1111/j.1464-410X.1987.tb04577.x; Ficazzola MA, 1998, J UROLOGY, V160, P1317, DOI 10.1016/S0022-5347(01)62525-4; Filocamo MT, 2005, EUR UROL, V48, P734, DOI 10.1016/j.eururo.2005.06.004; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hunter KF, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001843.pub3; Locher JL, 2001, J GERONTOL A-BIOL, V56, pM32, DOI 10.1093/gerona/56.1.M32; Lynn Stothers L, URINARY INCONTINENCE; Manassero F, 2007, NEUROUROL URODYNAM, V26, P985, DOI 10.1002/nau.20442; Mariotti G, 2009, J UROLOGY, V181, P1788, DOI 10.1016/j.juro.2008.11.104; Migliari R, 2006, J UROLOGY, V176, P2114, DOI 10.1016/j.juro.2006.07.027; Moore K N, 2000, J Wound Ostomy Continence Nurs, V27, P304, DOI 10.1067/mjw.2000.110623; Moore KN, 1999, BJU INT, V83, P57, DOI 10.1046/j.1464-410X.1999.00894.x; Moore KN, 1999, J ADV NURS, V29, P1121, DOI 10.1046/j.1365-2648.1999.00995.x; Penson DF, 2005, J UROLOGY, V173, P1701, DOI 10.1097/01.ju.0000154637.38262.3a; Romano SV, 2009, ACTAS UROL ESP, V33, P309; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; US Food and Drug Administration, AMS SPHINCT 800 UR P; Van Kampen M, 2000, LANCET, V355, P98, DOI 10.1016/S0140-6736(99)03473-X; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wei JT, 2000, UROLOGY, V56, P899, DOI 10.1016/S0090-4295(00)00858-X; Wille S, 2003, J UROLOGY, V170, P490, DOI 10.1097/01.ju.0000076141.33973.75; Yalcin I, 2010, NEUROUROL URODYNAM, V29, P344, DOI 10.1002/nau.20744	30	94	101	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					151	159		10.1001/jama.2010.1972	http://dx.doi.org/10.1001/jama.2010.1972			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	705BM	21224456	Green Accepted, Bronze			2022-12-28	WOS:000286103400020
J	Bastviken, D; Tranvik, LJ; Downing, JA; Crill, PM; Enrich-Prast, A				Bastviken, David; Tranvik, Lars J.; Downing, John A.; Crill, Patrick M.; Enrich-Prast, Alex			Freshwater Methane Emissions Offset the Continental Carbon Sink	SCIENCE			English	Article							LAKES		[Bastviken, David] Linkoping Univ, Dept Themat Studies Water & Environm Studies, SE-58183 Linkoping, Sweden; [Tranvik, Lars J.] Uppsala Univ, Evolutionary Biol Ctr, Dept Limnol, SE-75236 Uppsala, Sweden; [Downing, John A.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Crill, Patrick M.] Stockholm Univ, Dept Geol Sci, SE-10691 Stockholm, Sweden; [Enrich-Prast, Alex] Univ Fed Rio de Janeiro, Dept Ecol, BR-68020 Rio De Janeiro, Brazil	Linkoping University; Uppsala University; Iowa State University; Stockholm University; Universidade Federal do Rio de Janeiro	Bastviken, D (corresponding author), Linkoping Univ, Dept Themat Studies Water & Environm Studies, SE-58183 Linkoping, Sweden.	david.bastviken@liu.se	Crill, Patrick/ABC-1357-2021; Magaña, Felipe/B-6966-2013; Tranvik, Lars J/H-2222-2011; Enrich-Prast, Alex/H-5391-2012; Prast, Alex Enrich/AAL-4722-2021	Prast, Alex Enrich/0000-0003-3561-0936; Bastviken, David/0000-0003-0038-2152; Downing, John/0000-0001-8547-0789; Tranvik, Lars J./0000-0003-3509-8266; Crill, Patrick/0000-0003-1110-3059	Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (Formas); NSF [DEB-94-21535]; University of California at Santa Barbara; state of California	Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (Formas)(Swedish Research Council Formas); NSF(National Science Foundation (NSF)); University of California at Santa Barbara; state of California	We thank J. Cole, N. Than Duc, and H. Marotta for valuable input. This study was supported by the Swedish Research Council (VR) and the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (Formas). Analyses of global surface water area come from the ITAC (Integrating the Terrestrial and Aquatic Carbon Cycle) Working Group supported by the National Center for Ecological Analysis and Synthesis, a center funded by NSF (grant DEB-94-21535), the University of California at Santa Barbara, and the state of California.	Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Benoy G, 2007, ENVIRON REV, V15, P175, DOI 10.1139/A07-006; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Downing J. A., 2009, ENCY INLAND WATERS, V1; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Guerin F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027929; International Commission on Large Dams, 2006, DAMS NEWSL       MAY, P2; Kemenes A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029479; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Melack JM, 2004, GLOBAL CHANGE BIOL, V10, P530, DOI 10.1111/j.1365-2486.2004.00763.x; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298	13	904	968	70	846	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					50	50		10.1126/science.1196808	http://dx.doi.org/10.1126/science.1196808			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212349	Green Submitted			2022-12-28	WOS:000285974000030
J	Fabbri, M; Bottoni, A; Shimizu, M; Spizzo, R; Nicoloso, MS; Rossi, S; Barbarotto, E; Cimmino, A; Adair, B; Wojcik, SE; Valeri, N; Calore, F; Sampath, D; Fanini, F; Vannini, I; Musuraca, G; Dell'Aquila, M; Alder, H; Davuluri, RV; Rassenti, LZ; Negrini, M; Nakamura, T; Amadori, D; Kay, NE; Rai, KR; Keating, MJ; Kipps, TJ; Calin, GA; Croce, CM				Fabbri, Muller; Bottoni, Arianna; Shimizu, Masayoshi; Spizzo, Riccardo; Nicoloso, Milena S.; Rossi, Simona; Barbarotto, Elisa; Cimmino, Amelia; Adair, Brett; Wojcik, Sylwia E.; Valeri, Nicola; Calore, Federica; Sampath, Deepa; Fanini, Francesca; Vannini, Ivan; Musuraca, Gerardo; Dell'Aquila, Marie; Alder, Hansjuerg; Davuluri, Ramana V.; Rassenti, Laura Z.; Negrini, Massimo; Nakamura, Tatsuya; Amadori, Dino; Kay, Neil E.; Rai, Kanti R.; Keating, Michael J.; Kipps, Thomas J.; Calin, George A.; Croce, Carlo M.			Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROGRESSION; SURVIVAL; DISEASE; ZAP-70	Context Chromosomal abnormalities (namely 13q, 17p, and 11q deletions) have prognostic implications and are recurrent in chronic lymphocytic leukemia (CLL), suggesting that they are involved in a common pathogenetic pathway; however, the molecular mechanism through which chromosomal abnormalities affect the pathogenesis and outcome of CLL is unknown. Objective To determine whether the microRNA miR-15a/miR-16-1 cluster (located at 13q), tumor protein p53 (TP53, located at 17p), and miR-34b/miR-34c cluster (located at 11q) are linked in a molecular pathway that explains the pathogenetic and prognostic implications (indolent vs aggressive form) of recurrent 13q, 17p, and 11q deletions in CLL. Design, Setting, and Patients CLL Research Consortium institutions provided blood samples from untreated patients (n=206) diagnosed with B-cell CLL between January 2000 and April 2008. All samples were evaluated for the occurrence of cytogenetic abnormalities as well as the expression levels of the miR-15a/miR-16-1 cluster, miR-34b/miR-34c cluster, TP53, and zeta-chain (TCR)-associated protein kinase 70kDa (ZAP70), a surrogate prognostic marker of CLL. The functional relationship between these genes was studied using in vitro gain-and loss-of-function experiments in cell lines and primary samples and was validated in a separate cohort of primary CLL samples. Main Outcome Measures Cytogenetic abnormalities; expression levels of the miR15a/miR-16-1 cluster, miR-34 family, TP53 gene, downstream effectors cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A) and B-cell CLL/lymphoma 2 binding component 3 (BBC3), and ZAP70 gene; genetic interactions detected by chromatin immunoprecipitation. Results In CLLs with 13q deletions the miR-15a/miR-16-1 cluster directly targeted TP53 (mean luciferase activity for miR-15a vs scrambled control, 0.68 relative light units (RLU) [95% confidence interval {CI}, 0.63-0.73]; P=.02; mean for miR-16 vs scrambled control, 0.62 RLU [95% CI, 0.59-0.65]; P=.02) and its downstream effectors. In leukemic cell lines and primary CLL cells, TP53 stimulated the transcription of miR-15/miR-16-1 as well as miR-34b/miR-34c clusters, and the miR-34b/miR-34c cluster directly targeted the ZAP70 kinase(mean luciferase activity for miR-34a vs scrambled control, 0.33 RLU [95% CI, 0.30-0.36]; P=.02; mean for miR-34b vs scrambled control, 0.31 RLU [95% CI, 0.30-0.32]; P=.01; and mean for miR-34c vs scrambled control, 0.35 RLU [95% CI, 0.33-0.37]; P=.02). Conclusions A microRNA/TP53 feedback circuitry is associated with CLL pathogenesis and outcome. This mechanism provides a novel pathogenetic model for the association of 13q deletions with the indolent form of CLL that involves microRNAs, TP53, and ZAP70. JAMA. 2011;305(1):59-67 www.jama.com	[Shimizu, Masayoshi; Spizzo, Riccardo; Nicoloso, Milena S.; Rossi, Simona; Barbarotto, Elisa; Sampath, Deepa; Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Shimizu, Masayoshi; Spizzo, Riccardo; Nicoloso, Milena S.; Rossi, Simona; Barbarotto, Elisa; Sampath, Deepa; Calin, George A.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Keating, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Fabbri, Muller; Bottoni, Arianna; Adair, Brett; Wojcik, Sylwia E.; Valeri, Nicola; Calore, Federica; Alder, Hansjuerg; Nakamura, Tatsuya; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Barbarotto, Elisa] Univ Ferrara, Dept Morphol & Embryol, Human Anat Sect, I-44100 Ferrara, Italy; [Negrini, Massimo] Univ Ferrara, Dept Expt & Diagnost Med, Interdept Ctr Canc Res, I-44100 Ferrara, Italy; [Cimmino, Amelia] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Fabbri, Muller; Fanini, Francesca; Vannini, Ivan; Musuraca, Gerardo; Amadori, Dino] Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy; [Dell'Aquila, Marie; Rassenti, Laura Z.; Kipps, Thomas J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Davuluri, Ramana V.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Kay, Neil E.] Mayo Clin, Coll Med, Dept Internal Med, Div Hematol, Rochester, MN USA; [Rai, Kanti R.] Long Isl Jewish Med Ctr, New Hyde Pk, NY 11042 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Ferrara; University of Ferrara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Meldola (IRST); University of California System; University of California San Diego; The Wistar Institute; Mayo Clinic; Northwell Health	Calin, GA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gcalin@mdanderson.org; carlo.croce@osumc.edu	Sampath, Deepa/J-3298-2016; Musuraca, Gerardo/ADK-9808-2022; Davuluri, Ramana/D-7348-2011; Spizzo, Riccardo/V-1057-2019; Young, Richard A/F-6495-2012; Fanini, Francesca/H-6973-2019; Nicoloso, Milena S/K-6411-2012; Calin, George/E-9390-2011; Negrini, Massimo/J-2377-2016; Sampath, Deepa/T-5069-2019; Vannini, Ivan/T-7226-2019	Musuraca, Gerardo/0000-0003-1947-1032; Spizzo, Riccardo/0000-0001-7772-0960; Young, Richard A/0000-0001-8855-8647; Nicoloso, Milena S/0000-0003-4231-9303; Negrini, Massimo/0000-0002-0007-1920; Vannini, Ivan/0000-0002-9279-1801; valeri, nicola/0000-0002-5426-5683; Calin, George/0000-0001-6704-5615; Cimmino, Amelia/0000-0002-0004-9299; Sampath, Deepa/0000-0002-4366-8436	Kimmel Scholar Award; FIRC (Federazione Italiana Ricerca sul Cancro); University of Texas M. D. Anderson Research Trust; University of Texas; CLL Global Research Foundation; National Institutes of Health; US Department of Defense; Leukemia SPORE Developmental Research Award; National Institutes of Health [R01 CA111953]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA151319, P01CA129242, P30CA010815, R01CA111953] Funding Source: NIH RePORTER	Kimmel Scholar Award; FIRC (Federazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); University of Texas M. D. Anderson Research Trust; University of Texas; CLL Global Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Leukemia SPORE Developmental Research Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Fabbri is supported by a 2009 Kimmel Scholar Award. Dr Cimmino is supported by a fellowship from FIRC (Federazione Italiana Ricerca sul Cancro). Dr Calin is supported by a fellowship from the University of Texas M. D. Anderson Research Trust, a fellowship from The University of Texas System Regents Research Scholar Program, and a grant from the CLL Global Research Foundation. Dr Calin's laboratory is supported in part by the National Institutes of Health, the US Department of Defense, and a Leukemia SPORE Developmental Research Award. Drs Kay and Croce are supported by National Institutes of Health grant R01 CA111953.	Ambros Victor, 2004, Methods Mol Biol, V265, P131; Auer RL, 2007, BRIT J HAEMATOL, V137, P443, DOI 10.1111/j.1365-2141.2007.06600.x; BINET JL, 1977, CANCER-AM CANCER SOC, V40, P855, DOI 10.1002/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; CALL TG, 1994, MAYO CLIN PROC, V69, P323, DOI 10.1016/S0025-6196(12)62215-0; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Dewald GW, 2003, BRIT J HAEMATOL, V121, P287, DOI 10.1046/j.1365-2141.2003.04265.x; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Rossi S, 2010, BLOOD, V116, P945, DOI 10.1182/blood-2010-01-263889	18	216	233	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					59	67		10.1001/jama.2010.1919	http://dx.doi.org/10.1001/jama.2010.1919			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21205967	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000285924100025
J	Brenner, H; Chang-Claude, J; Seiler, CM; Rickert, A; Hoffmeister, M				Brenner, Hermann; Chang-Claude, Jenny; Seiler, Christoph M.; Rickert, Alexander; Hoffmeister, Michael			Protection From Colorectal Cancer After Colonoscopy A Population-Based, Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							SIDED COLON-CANCER; SCREENING COLONOSCOPY; OUTPATIENT COLONOSCOPY; UNITED-STATES; RISK-FACTORS; PREVENTION; SIGMOIDOSCOPY; SURVEILLANCE; POLYPECTOMY; ENDOSCOPY	Background: Colonoscopy with detection and removal of adenomas is considered a powerful tool to reduce colorectal cancer (CRC) incidence. However, the degree of protection achievable in a population setting with high-quality colonoscopy resources remains to be quantified. Objective: To assess the association between previous colonoscopy and risk for CRC. Design: Population-based case-control study. Setting: Rhine-Neckar region of Germany. Patients: A total of 1688 case patients with colorectal cancer and 1932 control participants aged 50 years or older. Measurements: A detailed lifetime history of CRC risk factors and preventive factors, including history and results of previous colonoscopies, and of medical data obtained by self-reports and medical records. Odds ratios of CRC associated with colonoscopy in the preceding 10 years were estimated, after adjustment for sex, age, education level, participation in a general health screening examination, family history of CRC, smoking status, body mass index, and use of nonsteroidal anti-inflammatory drugs or hormone replacement therapy. Results: Overall, colonoscopy in the preceding 10 years was associated with 77% lower risk for CRC. Adjusted odds ratios for any CRC, right-sided CRC, and left-sided CRC were 0.23 (95% CI, 0.19 to 0.27), 0.44 (CI, 0.35 to 0.55), and 0.16 (CI, 0.12 to 0.20), respectively. Strong risk reduction was observed for all cancer stages and all ages, except for right-sided cancer in persons aged 50 to 59 years. Risk reduction increased over the years in both the right and the left colon. Limitation: The study was observational, with potential for residual confounding and selection bias. Conclusion: Colonoscopy with polypectomy can be associated with strongly reduced risk for CRC in the population setting. Aside from strong risk reduction with respect to left-sided CRC, risk reduction of more than 50% was also seen for right-sided colon cancer.	[Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; Heidelberg Univ, Univ Clin Heidelberg, Heidelberg, Germany; Univ Hosp Mannheim, Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	h.brenner@Dkfz-Heidelberg.de	Hoffmeister, Michael/T-7187-2019; Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Hoffmeister, Michael/AAB-2321-2022; Hoffmeister, Michael/B-5745-2012; Seiler, Christoph/AAG-7056-2021	Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; 	German Research Council [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]	German Research Council(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Grant Support: By the German Research Council (BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, and CH 117/1-1) and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814).	Ahmadi AA, 2007, SURG CLIN N AM, V87, P743, DOI 10.1016/j.suc.2007.03.013; Arain MA, 2010, AM J GASTROENTEROL, V105, P1189, DOI 10.1038/ajg.2009.699; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2010, J NATL CANCER I, V102, P70, DOI 10.1093/jnci/djp469; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Brenner H, 2006, GUT, V55, P1145, DOI [10.1136/gut.2005.087130, 10.1136/gut.2005087130]; Brenner H, 2001, BRIT J CANCER, V85, P972, DOI 10.1038/sj.bjc.6692023; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Brenner H, 2007, AM J GASTROENTEROL, V102, P1739, DOI 10.1111/j.1572-0241.2007.01231.x; Brenner H, 2007, CANCER EPIDEM BIOMAR, V16, P494, DOI 10.1158/1055-9965.EPI-06-0460; Brenner H, 2010, ANN INTERN MED, V152, P697, DOI 10.7326/0003-4819-152-11-201006010-00002; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Bressler B, 2004, GASTROENTEROLOGY, V127, P452, DOI 10.1053/j.gastro.2004.05.032; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Gondos A, 2007, INT J CANCER, V121, P395, DOI 10.1002/ijc.22683; Hoffmeister M, 2007, AM J EPIDEMIOL, V166, P130, DOI 10.1093/aje/kwm062; Hosokawa O, 2003, ENDOSCOPY, V35, P506; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Kahi CJ, 2009, CLIN GASTROENTEROL H, V7, P770, DOI 10.1016/j.cgh.2008.12.030; Karlitz JJ, 2009, ANN INTERN MED, V150, P816, DOI 10.7326/0003-4819-150-11-200906020-00012; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Mulder SA, 2010, EUR J GASTROEN HEPAT, V22, P437, DOI 10.1097/MEG.0b013e328333fc6a; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Nawa T, 2008, J GASTROEN HEPATOL, V23, P418, DOI 10.1111/j.1440-1746.2007.04923.x; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; Ning Y, 2010, OBES REV, V11, P19, DOI 10.1111/j.1467-789X.2009.00613.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pox C, 2008, Z GASTROENTEROL, V46, pS31, DOI 10.1055/s-2007-963563; Pox C, 2007, ENDOSCOPY, V39, P168, DOI 10.1055/s-2007-966182; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Schmiegel W, 2008, Z GASTROENTEROL, V46, P799, DOI 10.1055/s-2008-1027726; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Taylor DP, 2010, GASTROENTEROLOGY, V138, P877, DOI 10.1053/j.gastro.2009.11.044; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	42	587	602	1	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					22	U156		10.7326/0003-4819-154-1-201101040-00004	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200035				2022-12-28	WOS:000285830900003
J	Lee, YK; Mazmanian, SK				Lee, Yun Kyung; Mazmanian, Sarkis K.			Has the Microbiota Played a Critical Role in the Evolution of the Adaptive Immune System?	SCIENCE			English	Review							REGULATORY T-CELLS; SEGMENTED FILAMENTOUS BACTERIA; INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; GERM-FREE MICE; GUT FLORA; LYMPHOID-TISSUE; LAMINA PROPRIA; COLONIZATION; EXPANSION; DRIVES	Although microbes have been classically viewed as pathogens, it is now well established that the majority of host-bacterial interactions are symbiotic. During development and into adulthood, gut bacteria shape the tissues, cells, and molecular profile of our gastrointestinal immune system. This partnership, forged over many millennia of coevolution, is based on a molecular exchange involving bacterial signals that are recognized by host receptors to mediate beneficial outcomes for both microbes and humans. We explore how specific aspects of the adaptive immune system are influenced by intestinal commensal bacteria. Understanding the molecular mechanisms that mediate symbiosis between commensal bacteria and humans may redefine how we view the evolution of adaptive immunity and consequently how we approach the treatment of numerous immunologic disorders.	[Lee, Yun Kyung; Mazmanian, Sarkis K.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Mazmanian, SK (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	sarkis@caltech.edu	Mazmanian, Sarkis/ABD-7729-2021	Mazmanian, Sarkis/0000-0003-2713-1513	NIH [DK078938, DK083633, AI088626]; Damon Runyon Cancer Research Foundation; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK083633, R56DK078938, R01DK078938] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Mazmanian laboratory for their critical review of the manuscript. Supported by NIH grants DK078938, DK083633, and AI088626; the Damon Runyon Cancer Research Foundation; and the Crohn's and Colitis Foundation of America (S.K.M.).	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Baranzini SE, 2009, CURR OPIN IMMUNOL, V21, P596, DOI 10.1016/j.coi.2009.09.014; Battaglia M, 2006, SEMIN IMMUNOL, V18, P120, DOI 10.1016/j.smim.2006.01.007; BAUER H, 1963, AM J PATHOL, V42, P471; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boirivant M, 2007, CURR OPIN GASTROEN, V23, P679, DOI 10.1097/MOG.0b013e3282f0cffc; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coombes JL, 2007, SEMIN IMMUNOL, V19, P116, DOI 10.1016/j.smim.2007.01.001; Dobber R, 1992, Dev Immunol, V2, P141, DOI 10.1155/1992/57057; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Foussat A, 2003, J IMMUNOL, V171, P5018, DOI 10.4049/jimmunol.171.10.5018; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; GLAISTER JR, 1973, INT ARCH ALLER A IMM, V45, P719, DOI 10.1159/000231071; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; HOSHI H, 1992, TOHOKU J EXP MED, V166, P297, DOI 10.1620/tjem.166.297; Imaoka A, 1996, EUR J IMMUNOL, V26, P945, DOI 10.1002/eji.1830260434; Inagaki H, 1996, INFECT IMMUN, V64, P3280, DOI 10.1128/IAI.64.8.3280-3287.1996; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; MATSUMOTO S, 1992, GASTROENTEROLOGY, V103, P1777, DOI 10.1016/0016-5085(92)91434-6; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; Min B, 2007, EUR J IMMUNOL, V37, P1916, DOI 10.1002/eji.200737236; Niess JH, 2008, J IMMUNOL, V180, P559, DOI 10.4049/jimmunol.180.1.559; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ostman S, 2006, EUR J IMMUNOL, V36, P2336, DOI 10.1002/eji.200535244; POLLARD M, 1970, Infection and Immunity, V2, P96; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Snel J, 1998, CAN J MICROBIOL, V44, P1177, DOI 10.1139/cjm-44-12-1177; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Talham GL, 1999, INFECT IMMUN, V67, P1992; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; UMESAKI Y, 1993, IMMUNOLOGY, V79, P32; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720	62	729	777	4	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1768	1773		10.1126/science.1195568	http://dx.doi.org/10.1126/science.1195568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205662	Green Accepted			2022-12-28	WOS:000285603700029
J	Boers, KE; Vijgen, SMC; Bijlenga, D; van der Post, JAM; Bekedam, DJ; Kwee, A; van der Salm, PCM; van Pampus, MG; Spaanderman, MEA; de Boer, K; Duvekot, JJ; Bremer, HA; Hasaart, THM; Delemarre, FMC; Bloemenkamp, KWM; van Meir, CA; Willekes, C; Wijnen, EJ; Rijken, M; le Cessie, S; Roumen, FJME; Thornton, JG; van Lith, JMM; Mol, BWJ; Scherjon, SA				Boers, K. E.; Vijgen, S. M. C.; Bijlenga, D.; van der Post, J. A. M.; Bekedam, D. J.; Kwee, A.; van der Salm, P. C. M.; van Pampus, M. G.; Spaanderman, M. E. A.; de Boer, K.; Duvekot, J. J.; Bremer, H. A.; Hasaart, T. H. M.; Delemarre, F. M. C.; Bloemenkamp, K. W. M.; van Meir, C. A.; Willekes, C.; Wijnen, E. J.; Rijken, M.; le Cessie, S.; Roumen, F. J. M. E.; Thornton, J. G.; van Lith, J. M. M.; Mol, B. W. J.; Scherjon, S. A.		DIGITAT Study Grp	Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL-AGE INFANTS; FETAL-GROWTH; INTERVENTION TRIAL; CEREBRAL-PALSY; BIRTH-WEIGHT; PRETERM; RETARDATION; SCORE; LABOR; RISK	Objective To compare the effect of induction of labour with a policy of expectant monitoring for intrauterine growth restriction near term. Design Multicentre randomised equivalence trial (the Disproportionate Intrauterine Growth Intervention Trial At Term (DIGITAT)). Setting Eight academic and 44 non-academic hospitals in the Netherlands between November 2004 and November 2008. Participants Pregnant women who had a singleton pregnancy beyond 36+0 weeks' gestation with suspected intrauterine growth restriction. Interventions Induction of labour or expectant monitoring. Main outcome measures The primary outcome was a composite measure of adverse neonatal outcome, defined as death before hospital discharge, five minute Apgar score of less than 7, umbilical artery pH of less than 7.05, or admission to the intensive care unit. Operative delivery (vaginal instrumental delivery or caesarean section) was a secondary outcome. Analysis was by intention to treat, with confidence intervals calculated for the differences in percentages or means. Results 321 pregnant women were randomly allocated to induction and 329 to expectant monitoring. Induction group infants were delivered 10 days earlier (mean difference -9.9 days, 95% CI -11.3 to -8.6) and weighed 130 g less (mean difference -130 g, 95% CI -188 g to -71 g) than babies in the expectant monitoring group. A total of 17 (5.3%) infants in the induction group experienced the composite adverse neonatal outcome, compared with 20 (61%) in the expectant monitoring group (difference -0.8%, 95% CI -4.3% to 3.2%). Caesarean sections were performed on 45 (14.0%) mothers in the induction group and 45 (13.7%) in the expectant monitoring group (difference 0.3%, 95% CI -5.0% to 5.6%). Conclusions In women with suspected intrauterine growth restriction at term, we found no important differences in adverse outcomes between induction of labour and expectant monitoring. Patients who are keen on non-intervention can safely choose expectant management with intensive maternal and fetal monitoring; however, it is rational to choose induction to prevent possible neonatal morbidity and stillbirth.	[Boers, K. E.; Bloemenkamp, K. W. M.; Rijken, M.; le Cessie, S.; van Lith, J. M. M.; Scherjon, S. A.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Vijgen, S. M. C.; Bijlenga, D.; van der Post, J. A. M.; Mol, B. W. J.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Bekedam, D. J.; van Pampus, M. G.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Kwee, A.] Univ Med Ctr, Utrecht, Netherlands; [van der Salm, P. C. M.] Meander Med Ctr, Amersfoort, Netherlands; [Spaanderman, M. E. A.] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [de Boer, K.] Hosp Rijnstate, Arnhem, Netherlands; [Duvekot, J. J.] Univ Med Ctr, Erasmus MC, Rotterdam, Netherlands; [Bremer, H. A.] Reinier de Graaf Hosp, Delft, Netherlands; [Hasaart, T. H. M.] Catharina Hosp, Eindhoven, Netherlands; [Delemarre, F. M. C.] Elkerliek Hosp, Helmond, Netherlands; [van Meir, C. A.] Groene Hart Hosp, Gouda, Netherlands; [Willekes, C.] Univ Hosp Maastricht, Maastricht, Netherlands; [Wijnen, E. J.] VieCuri Med Ctr, Venlo, Netherlands; [Roumen, F. J. M. E.] Atrium Med Ctr, Heerlen, Netherlands; [Thornton, J. G.] City Hosp Nottingham, Nottingham, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; Utrecht University; Utrecht University Medical Center; Meander Medisch Centrum; Radboud University Nijmegen; Rijnstate Hospital; Erasmus University Rotterdam; Erasmus MC; Reinier de Graaf Hospital; Catharina Hospital; Maastricht University; Maastricht University Medical Centre (MUMC); VieCuri Medical Center; Atrium Medical Center; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Boers, KE (corresponding author), Bronovo Hosp, Hague Dept Obstet & Gynaecol, Bronovolaan 5, NL-2597 AX The Hague, Netherlands.	k.e.boers@lumc.nl	le+Cessie, Saskia/HGC-8966-2022; Mol, Ben/I-4526-2012; Willekes, Christine/GWZ-1205-2022; van der Post, Joris A M/A-8991-2008; Thornton, Jim/B-8336-2008	Thornton, Jim/0000-0001-9764-6876; van Pampus, Maria/0000-0002-3020-8908; van der Post, Joris/0000-0003-3311-2116; le Cessie, Saskia/0000-0003-2154-4923; Delemarre, Friso/0000-0001-8512-8107; Roumen, Frans JME/0000-0003-2319-4808	ZonMw, the Netherlands Organisation for Health Research and Development [945-04-558]; MRC [G9533539] Funding Source: UKRI; Medical Research Council [G9533539] Funding Source: researchfish	ZonMw, the Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by ZonMw, the Netherlands Organisation for Health Research and Development healthcare efficiency programme (grant number 945-04-558). The funder had no role in study design; collection, analysis, and interpretation of data; writing of the report; or the decision to submit the paper for publication. The corresponding author had full access to all data and final responsibility for the decision to submit for publication.	Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; BARKER DJP, 1992, BRIT J OBSTET GYNAEC, V99, P275, DOI 10.1111/j.1471-0528.1992.tb13719.x; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Bijlenga Denise, 2007, BMC Pregnancy Childbirth, V7, P10, DOI 10.1186/1471-2393-7-10; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; Boulet SL, 2006, AM J OBSTET GYNECOL, V195, P1571, DOI 10.1016/j.ajog.2006.03.069; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chauhan SP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.025; Chien PFW, 2000, OBSTET GYNECOL, V95, P856, DOI 10.1016/S0029-7844(00)00828-0; Clausson B, 1998, BRIT J OBSTET GYNAEC, V105, P1011, DOI 10.1111/j.1471-0528.1998.tb10266.x; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; DIJXHOORN MJ, 1987, BRIT J OBSTET GYNAEC, V94, P873, DOI 10.1111/j.1471-0528.1987.tb03758.x; Engle WA, 2008, CLIN PERINATOL, V35, P325, DOI 10.1016/j.clp.2008.03.003; Hershkovitz R, 2001, EUR J OBSTET GYN R B, V97, P141, DOI 10.1016/S0301-2115(00)00517-0; Jacobsson B, 2008, BJOG-INT J OBSTET GY, V115, P1250, DOI 10.1111/j.1471-0528.2008.01827.x; Jahn A, 1998, ACTA OBSTET GYN SCAN, V77, P643, DOI 10.1034/j.1600-0412.1998.770611.x; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Kelly AJ, 2009, COCHRANE DB SYST REV, V4; KLOOSTERMAN GJ, 1970, INT J GYNECOL OBSTET, V8, P895, DOI DOI 10.1002/J.1879-3479.1970.TB00313.X; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; KRAMER MS, 1990, PEDIATRICS, V86, P707; LOW JA, 1978, AM J OBSTET GYNECOL, V130, P534, DOI 10.1016/0002-9378(78)90072-8; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; NVOGnet voorlichting & richtlijnen, 2009, IND BAR; Ohel G, 1996, INT J GYNECOL OBSTET, V55, P29, DOI 10.1016/0020-7292(96)02730-0; Pulver LS, 2009, PEDIATRICS, V123, pE1072, DOI 10.1542/peds.2008-3288; Roth S, 1999, EARLY HUM DEV, V55, P39, DOI 10.1016/S0378-3782(99)00002-X; SOOTHILL PW, 1993, BRIT J OBSTET GYNAEC, V100, P742, DOI 10.1111/j.1471-0528.1993.tb14265.x; The Netherlands Perinatal Registry Foundation, 2005, PER CAR NETH 2005; Thornton JG, 2004, LANCET, V364, P513, DOI 10.1016/S0140-6736(04)16809-8; Van Bulck B, 2003, BJOG-INT J OBSTET GY, V110, P27; van den Hove MML, 2006, EUR J OBSTET GYN R B, V125, P54, DOI 10.1016/j.ejogrb.2005.06.018; van Gemund N, 2003, GYNECOL OBSTET INVES, V56, P133, DOI 10.1159/000073771; Vrouenraets FPJM, 2005, OBSTET GYNECOL, V105, P690, DOI 10.1097/01.AOG.0000152338.76759.38	35	238	245	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2010	341								c7087	10.1136/bmj.c7087	http://dx.doi.org/10.1136/bmj.c7087			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700DV	21177352	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000285716600006
J	Sultan, S; Moshiree, B				Sultan, Shahnaz; Moshiree, Baharak			Review: Polyethylene glycol is more effective than lactulose for chronic constipation in children and adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sultan, Shahnaz; Moshiree, Baharak] Univ Florida, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Sultan, S (corresponding author), Univ Florida, Gainesville, FL 32611 USA.			Sultan, Shahnaz/0000-0002-5867-8741				Faigel Douglas O, 2002, Clin Cornerstone, V4, P11, DOI 10.1016/S1098-3597(02)90002-5; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x	3	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12							JC6-5	10.7326/0003-4819-153-12-201012210-02005	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173406				2022-12-28	WOS:000285453700022
J	Chandra, A; Gruber, J; McKnight, R				Chandra, Amitabh; Gruber, Jonathan; McKnight, Robin			The Importance of the Individual Mandate - Evidence from Massachusetts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chandra, Amitabh] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Gruber, Jonathan] MIT, Cambridge, MA 02139 USA; [McKnight, Robin] Wellesley Coll, Wellesley, MA 02181 USA	Harvard University; Massachusetts Institute of Technology (MIT); Wellesley College	Chandra, A (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.							Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Rosenbaum S, 2010, NEW ENGL J MED, V363, P401, DOI 10.1056/NEJMp1005897	2	44	44	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					293	295		10.1056/NEJMp1013067	http://dx.doi.org/10.1056/NEJMp1013067			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711LH	21226568				2022-12-28	WOS:000286592600001
J	Song, MS; Carracedo, A; Salmena, L; Song, SJ; Egia, A; Malumbres, M; Pandolfi, PP				Song, Min Sup; Carracedo, Arkaitz; Salmena, Leonardo; Song, Su Jung; Egia, Ainara; Malumbres, Marcos; Pandolfi, Pier Paolo			Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner	CELL			English	Article							SMALL-MOLECULE INHIBITOR; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; GROWTH IN-VIVO; AURORA KINASES; CELLULAR SENESCENCE; MUTATIONAL SPECTRA; CHROMOSOME-10 PTEN; GENOMIC STABILITY; EXPRESSION; GENE	PTEN is a frequently mutated tumor suppressor gene that opposes the PI3K/AKT pathway through dephosphorylation of phosphoinositide-3,4,5-triphosphate. Recently, nuclear compartmentalization of PTEN was found as a key component of its tumor-suppressive activity; however its nuclear function remains poorly defined. Here we show that nuclear PTEN interacts with APC/C, promotes APC/C association with CDH1, and thereby enhances the tumor-suppressive activity of the APC-CDH1 complex. We find that nuclear exclusion but not phosphatase inactivation of PTEN impairs APC-CDH1. This nuclear function of PTEN provides a straightforward mechanistic explanation for the fail-safe cellular senescence response elicited by acute PTEN loss and the tumor-suppressive activity of catalytically inactive PTEN. Importantly, we demonstrate that PTEN mutant and PTEN null states are not synonymous as they are differentially sensitive to pharmacological inhibition of APC-CDH1 targets such as PLK1 and Aurora kinases. This finding identifies a strategy for cancer patient stratification and, thus, optimization of targeted therapies.	[Song, Min Sup; Carracedo, Arkaitz; Salmena, Leonardo; Song, Su Jung; Egia, Ainara; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA; [Malumbres, Marcos] CNIO, Cell Div & Canc Grp, Mol Oncol Programme, Madrid 28029, Spain	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Centro Nacional de Investigaciones Oncologicas (CNIO)	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Canc Genet Program,Sch Med, Beth Israel Deaconess Canc Ctr,Dept Med & Pathol, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Carracedo, Arkaitz/F-7029-2011; Malumbres, Marcos/E-8834-2011	Carracedo, Arkaitz/0000-0001-5957-1260; Malumbres, Marcos/0000-0002-0829-6315; Salmena, Leonardo/0000-0003-4023-658X; Pandolfi, Pier Paolo/0000-0002-5352-5295	NIH; European Molecular Biology Organization; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R01CA082328] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to former and present members of the Pandolfi lab for experimental support, advice, or discussion. We are thankful to Drs. Manuel Serrano, Pumin Zhang, Wenyi Wei, and Hongtao Yu for providing reagents. We thank Dr. John Asara for mass-spectrometric analysis. This work was supported by NIH grants to P.P.P. A.C. is supported by a Long-Term Fellowship Award from the European Molecular Biology Organization, and L.S. is supported by a Fellowship from the Canadian Institutes of Health Research.	Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Cairns P, 1997, CANCER RES, V57, P4997; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Fridberg M, 2007, LEUKEMIA LYMPHOMA, V48, P2221, DOI 10.1080/10428190701636443; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Georgescu MM, 2000, CANCER RES, V60, P7033; Gildea JJ, 2004, ONCOGENE, V23, P6788, DOI 10.1038/sj.onc.1207599; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Ginn-Pease ME, 2003, CANCER RES, V63, P282; Gray IC, 1998, BRIT J CANCER, V78, P1296, DOI 10.1038/bjc.1998.674; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Huot TJ, 2002, MOL CELL BIOL, V22, P8135, DOI 10.1128/MCB.22.23.8135-8143.2002; Koul D, 2002, ONCOGENE, V21, P2357, DOI 10.1038/sj/onc/1205296; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Lai JP, 2007, BRIT J PHARMACOL, V152, P1172, DOI 10.1038/sj.bjp.0707501; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li DM, 1997, CANCER RES, V57, P2124; Li M, 2008, NAT CELL BIOL, V10, P1083, DOI 10.1038/ncb1768; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Liu JL, 2005, MOL CELL BIOL, V25, P6211, DOI 10.1128/MCB.25.14.6211-6224.2005; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maier D, 1999, CANCER RES, V59, P5479; Manchado E, 2010, BIOCHEM SOC T, V38, P65, DOI 10.1042/BST0380065; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Okumura K, 2005, CELL CYCLE, V4, P540, DOI 10.4161/cc.4.4.1614; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; RUBIN SJ, 1991, J SURG ONCOL, V46, P31, DOI 10.1002/jso.2930460108; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Wang CX, 2000, BLOOD, V96, P259, DOI 10.1182/blood.V96.1.259.013k36_259_263; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9	56	276	301	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					187	199		10.1016/j.cell.2010.12.020	http://dx.doi.org/10.1016/j.cell.2010.12.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241890	Green Accepted, Bronze			2022-12-28	WOS:000286459900005
J	Hankey, GJ				Hankey, Graeme J.			Carotid artery stenting increased short-term risk for stroke or death more than endarterectomy in symptomatic carotid stenosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Royal Perth Hosp, Perth, WA, Australia	Royal Perth Hospital; University of Western Australia	Hankey, GJ (corresponding author), Royal Perth Hosp, Perth, WA, Australia.		Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328; Brown, Martin M/0000-0002-3273-1356				Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Meier P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c467; Rothwell PM, 2009, LANCET NEUROL, V8, P871, DOI 10.1016/S1474-4422(09)70230-3; Rothwell PM, 2005, LANCET, V365, P256	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-8	10.7326/0003-4819-154-2-201101180-02008	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242362				2022-12-28	WOS:000286223500034
J	Dunn, RA; Martinez, F				Dunn, Robert A.; Martinez, Fernando			Contrasting crustal production and rapid mantle transitions beneath back-arc ridges	NATURE			English	Article							LAU BASIN; MIDOCEAN RIDGE; MARIANA TROUGH; MORPHOLOGY; EVOLUTION; PACIFIC	The opening of back-arc basins behind subduction zones progresses from initial rifting near the volcanic arc to seafloor spreading(1). During this process, the spreading ridge and the volcanic arc separate and lavas erupted at the ridge are predicted to evolve away from being heavily subduction influenced (with high volatile contents derived from the subducting plate)(2-5). Current models(4,6-8) predict gradational, rather than abrupt, changes in the crust formed along the ridge as the inferred broad melting region beneath it migrates away from heavily subduction-influenced mantle. In contrast, here we show that across-strike and along-strike changes in crustal properties at the Eastern Lau spreading centre are large and abrupt, implying correspondingly large discontinuities in the nature of the mantle supplying melt to the ridge axes. With incremental separation of the ridge axis from the volcanic front of as little as 5 km, seafloor morphology changes from shallower complex volcanic landforms to deeper flat sea floor dominated by linear abyssal hills, upper crustal seismic velocities abruptly increase by over 20%, and gravity anomalies and isostasy indicate crustal thinning of more than 1.9 km. We infer that the abrupt changes in crustal properties reflect rapid evolution of the mantle entrained by the ridge, such that stable, broad triangular upwelling regions, as inferred for mid-ocean ridges(9,10), cannot form near the mantle wedge corner. Instead, the observations imply a dynamic process in which the ridge upwelling zone preferentially captures water-rich low-viscosity mantle when it is near the arc. As the ridge moves away from the arc, a tipping point is reached at which that material is rapidly released from the upwelling zone, resulting in rapid changes in the character of the crust formed at the ridge.	[Dunn, Robert A.] Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Martinez, Fernando] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii System	Dunn, RA (corresponding author), Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA.	dunn@soest.hawaii.edu	Dunn, Robert A/L-9892-2014	Dunn, Robert A/0000-0003-1434-5512	NSF [OCE0426428, OCE0732536, OCE0727138]; Directorate For Geosciences [0426428] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the captain, crew, and science parties of the R/V Langseth leg MGL0903 and R/V Kilo Moana leg KM0804. This work was funded as part of the NSF Ridge 2000 Program by grants OCE0426428 (R. A. D.) and OCE0732536 & OCE0727138 (F. M.). We thank J. Hammer, G. Ito, J. Sinton, B. Taylor and C. Wolfe for comments on an early version of the manuscript.	CARLSON RL, 1990, J GEOPHYS RES-SOLID, V95, P9153, DOI 10.1029/JB095iB06p09153; Conder JA, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000807; DAVIES JH, 1991, PHILOS T ROY SOC A, V335, P355, DOI 10.1098/rsta.1991.0051; Dunn RA, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003473; Dunn RA, 2009, J ACOUST SOC AM, V126, P1084, DOI 10.1121/1.3158929; Escrig S, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002281; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; Gerya TV, 2003, EARTH PLANET SC LETT, V212, P47, DOI 10.1016/S0012-821X(03)00265-6; GILL JB, 1976, GEOL SOC AM BULL, V87, P1384, DOI 10.1130/0016-7606(1976)87<1384:CAAOLB>2.0.CO;2; Hawkins J.W., 1995, BACKARC BASINS, P63; HAWKINS JW, 1985, J GEOPHYS RES-SOLID, V90, P1431, DOI 10.1029/JB090iB13p11431; Hirth G., 2003, INSIDE SUBDUCTION FA, V138, P83, DOI [10.1029/138GM06, DOI 10.1029/138GM06]; Jacobs AM, 2007, EARTH PLANET SC LETT, V259, P239, DOI 10.1016/j.epsl.2007.04.021; KARIG DE, 1970, J GEOPHYS RES, V75, P239, DOI 10.1029/JB075i002p00239; Kincaid C, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001174; Langmuir CH, 2006, GEOPHYS MONOGR SER, V166, P87; Ma Y, 1996, J GEOPHYS RES-SOL EA, V101, P15849, DOI 10.1029/95JB03038; MARSH BD, 1979, J GEOL, V87, P687, DOI 10.1086/628460; Martinez F, 2002, NATURE, V416, P417, DOI 10.1038/416417a; Martinez F, 2006, EARTH PLANET SC LETT, V245, P655, DOI 10.1016/j.epsl.2006.03.049; MORGAN JP, 1993, NATURE, V364, P706, DOI 10.1038/364706a0; Nishi K, 2001, EARTH PLANETS SPACE, V53, P101, DOI 10.1186/BF03352367; PARSON LM, 1990, GEOLOGY, V18, P470, DOI 10.1130/0091-7613(1990)018<0470:RORJAR>2.3.CO;2; Pearce J.A., 1994, GEOL SOC LOND SPEC P, V81, P53, DOI [10.1144/GSL.SP.1994.081.01.04, DOI 10.1144/GSL.SP.1994.081.01.04]; Pearce JA, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000895; SMALL C, 1994, GEOPHYS J INT, V116, P64, DOI 10.1111/j.1365-246X.1994.tb02128.x; STOLPER E, 1994, EARTH PLANET SC LETT, V121, P293, DOI 10.1016/0012-821X(94)90074-4; Taylor B, 2003, EARTH PLANET SC LETT, V210, P481, DOI 10.1016/S0012-821X(03)-00167-5; Turner IM, 1999, GEOPHYS J INT, V138, P495, DOI 10.1046/j.1365-246X.1999.00883.x; Zellmer KE, 2001, GEOCHEM GEOPHY GEOSY, V2	30	51	50	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					198	202		10.1038/nature09690	http://dx.doi.org/10.1038/nature09690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228874				2022-12-28	WOS:000286143400035
J	Rider, LG; Miller, FW				Rider, Lisa G.; Miller, Frederick W.			Deciphering the Clinical Presentations, Pathogenesis, and Treatment of the Idiopathic Inflammatory Myopathies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOSITIS-SPECIFIC AUTOANTIBODIES; ULTRAVIOLET-RADIATION INTENSITY; INTERSTITIAL LUNG-DISEASE; INCLUSION-BODY MYOSITIS; JUVENILE DERMATOMYOSITIS; POLYMYOSITIS-DERMATOMYOSITIS; ENVIRONMENTAL-FACTORS; RITUXIMAB; THERAPY; RISK	The idiopathic inflammatory myopathies or myositis syndromes (the most common forms are polymyositis, dermatomyositis, and inclusion body myositis) are systemic autoimmune diseases defined by chronic muscle weakness and inflammation of unknown etiology and result in significant morbidity and mortality. Research suggests that categorizing heterogeneous myositis syndromes into mutually exclusive and stable phenotypes by using clinical and immune response features is useful for predicting clinical signs and symptoms, associated genetic and environmental risk factors, and responses to therapy and prognosis. Knowledge of myositis phenotypes should enhance clinicians' ability to recognize and manage these rare disorders. JAMA. 2011; 305(2): 183-190	[Rider, Lisa G.; Miller, Frederick W.] Natl Inst Environm Hlth Sci, Environm Autoimmun Grp, Program Clin Res, NIH,US Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Rider, LG (corresponding author), Natl Inst Environm Hlth Sci, Environm Autoimmun Grp, Program Clin Res, NIH,US Dept Hlth & Human Serv, CRC 4-2352,MSC 1301,10 Ctr Dr, Bethesda, MD 20892 USA.	riderl@mail.nih.gov	Rider, Lisa G/C-7083-2018; Miller, Frederick/D-2431-2019	Rider, Lisa G/0000-0002-6912-2458; Miller, Frederick/0000-0003-2831-9593	National Institute of Environmental Health Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101081] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health.	BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Chinoy H, 2009, CURR OPIN RHEUMATOL, V21, P588, DOI 10.1097/BOR.0b013e3283315a22; Dalakas MC, 2009, BRAIN, V132, P1536, DOI 10.1093/brain/awp104; Dalakas MC, 2006, NAT CLIN PRACT RHEUM, V2, P219, DOI 10.1038/ncprheum0140; Dalakas MC, 2002, RHEUM DIS CLIN N AM, V28, P779, DOI 10.1016/S0889-857X(02)00030-3; Dastmalchi M, 2008, ANN RHEUM DIS, V67, P1670, DOI 10.1136/ard.2007.077974; Feldman BM, 2008, LANCET, V371, P2201, DOI 10.1016/S0140-6736(08)60955-1; Figarella-Branger D, 2003, MUSCLE NERVE, V28, P659, DOI 10.1002/mus.10462; Fischer A, 2009, RESP MED, V103, P1719, DOI 10.1016/j.rmed.2009.05.001; Goebels N, 1996, J CLIN INVEST, V97, P2905, DOI 10.1172/JCI118749; Gourley M, 2007, NAT CLIN PRACT RHEUM, V3, P172, DOI 10.1038/ncprheum0435; Gunawardena H, 2009, RHEUMATOLOGY, V48, P607, DOI 10.1093/rheumatology/kep078; Hengstman GJD, 2009, EXPERT OPIN PHARMACO, V10, P1183, DOI [10.1517/14656560902913815, 10.1517/14656560902913815 ]; Hill CL, 2001, LANCET, V357, P96, DOI 10.1016/S0140-6736(00)03540-6; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Huber AM, 2010, ARTHRIT CARE RES, V62, P219, DOI 10.1002/acr.20071; Kao AH, 2004, ARTHRITIS RHEUM, V50, P209, DOI 10.1002/art.11484; Klein R, 2010, ARCH DERMATOL, V146, P780, DOI 10.1001/archdermatol.2010.142; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; Love LA, 2009, ARTHRITIS RHEUM-US, V60, P2499, DOI 10.1002/art.24702; Lundberg IE, 2008, CLIN EXP RHEUMATOL, V26, pS109; LYON MG, 1989, J RHEUMATOL, V16, P1218; Madan V, 2009, CLIN EXP DERMATOL, V34, P451, DOI 10.1111/j.1365-2230.2009.03216.x; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; Majmudar S, 2009, JCR-J CLIN RHEUMATOL, V15, P338, DOI 10.1097/RHU.0b013e3181bb8e70; Mendez EP, 2003, ARTHRIT RHEUM-ARTHR, V49, P300, DOI 10.1002/art.11122; Miller FW, 2005, ARTHRITIS ALLIED CON, V15, P1593; Morganroth PA, 2010, ARTHRIT CARE RES, V62, P1496, DOI 10.1002/acr.20212; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0; O'Hanlon TP, 2008, ARTHRITIS RHEUM, V58, P3239, DOI 10.1002/art.23899; O'Hanlon Terrance P, 2009, Curr Rheumatol Rep, V11, P287; O'Hanlon TP, 2006, MEDICINE, V85, P111, DOI 10.1097/01.md.0000217525.82287.eb; Oddis CV, 2005, ARTHRITIS RHEUM, V52, P2607, DOI 10.1002/art.21291; ODDIS CV, 1990, J RHEUMATOL, V17, P1329; Okada S, 2003, ARTHRITIS RHEUM-US, V48, P2285, DOI 10.1002/art.11090; Reed AM, 2002, RHEUM DIS CLIN N AM, V28, P891, DOI 10.1016/S0889-857X(02)00029-7; Rider LG, 2010, RHEUMATOLOGY, V49, P2381, DOI 10.1093/rheumatology/keq277; Rider LG, 2009, ARTHRITIS RHEUM-US, V60, P3425, DOI 10.1002/art.24904; Riley P, 2008, RHEUMATOLOGY, V47, P877, DOI 10.1093/rheumatology/ken074; Riley P, 2004, RHEUMATOLOGY, V43, P491, DOI 10.1093/rheumatology/keh082; Fernandez RR, 2009, CLIN EXP RHEUMATOL, V27, P1009; Sarkar K, 2005, ARTHRITIS RHEUM-US, V52, P2433, DOI 10.1002/art.21198; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Trieu EP, 2009, METHODS MOL BIOL, V536, P259, DOI 10.1007/978-1-59745-542-8_28; Valiyil R, 2010, ARTHRIT CARE RES, V62, P1328, DOI 10.1002/acr.20219; Wedderburn LR, 2009, BEST PRACT RES CL RH, V23, P665, DOI 10.1016/j.berh.2009.07.007; Wilkes MR, 2005, ARTHRITIS RHEUM-US, V52, P2439, DOI 10.1002/art.21240; Wilson FC, 2008, J RHEUMATOL, V35, P445	49	88	92	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					183	190		10.1001/jama.2010.1977	http://dx.doi.org/10.1001/jama.2010.1977			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224460	Green Accepted			2022-12-28	WOS:000286103400024
J	Tseng, HF; Smith, N; Harpaz, R; Bialek, SR; Sy, LS; Jacobsen, SJ				Tseng, Hung Fu; Smith, Ning; Harpaz, Rafael; Bialek, Stephanie R.; Sy, Lina S.; Jacobsen, Steven J.			Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLUENZA VACCINE; VARICELLA; EFFICACY; HOSPITALIZATIONS; EPIDEMIOLOGY; OPHTHALMICUS; MANAGEMENT; ACCURACY; CHILDREN; HISTORY	Context Approximately 1 million episodes of herpes zoster occur annually in the United States. Although prelicensure data provided evidence that herpes zoster vaccine works in a select study population under idealized circumstances, the vaccine needs to be evaluated in field conditions. Objective To evaluate risk of herpes zoster after receipt of herpes zoster vaccine among individuals in general practice settings. Design, Setting, and Participants A retrospective cohort study from January 1, 2007, through December 31, 2009, of individuals enrolled in the Kaiser Permanente Southern California health plan. Participants were immunocompetent community-dwelling adults aged 60 years or older. The 75 761 members in the vaccinated cohort were age matched (1:3) to 227 283 unvaccinated members. Main Outcome Measure Incidence of herpes zoster. Results Herpes zoster vaccine recipients were more likely to be white, women, with more outpatient visits, and fewer chronic diseases. The number of herpes zoster cases among vaccinated individuals was 828 in 130 415 person-years (6.4 per 1000 person-years; 95% confidence interval [CI], 5.9-6.8), and for unvaccinated individuals it was 4606 in 355 659 person-years (13.0 per 1000 person-years; 95% CI, 12.6-13.3). In adjusted analysis, vaccination was associated with a reduced risk of herpes zoster (hazard ratio [HR], 0.45; 95% CI, 0.42-0.48); this reduction occurred in all age strata and among individuals with chronic diseases. Risk of herpes zoster differed by vaccination status to a greater magnitude than the risk of unrelated acute medical conditions, suggesting results for herpes zoster were not due to bias. Ophthalmic herpes zoster (HR, 0.37; 95% CI, 0.23-0.61) and hospitalizations coded as herpes zoster (HR, 0.35; 95% CI, 0.24-0.51) were less likely among vaccine recipients. Conclusions Among immunocompetent community-dwelling adults aged 60 years or older, receipt of the herpes zoster vaccine was associated with a lower incidence of herpes zoster. The risk was reduced among all age strata and among individuals with chronic diseases. JAMA. 2011; 305(2): 160-166	[Tseng, Hung Fu; Smith, Ning; Sy, Lina S.; Jacobsen, Steven J.] So Calif Kaiser Permanente, Dept Res & Evaluat, Pasadena, CA USA; [Harpaz, Rafael; Bialek, Stephanie R.] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Kaiser Permanente; Centers for Disease Control & Prevention - USA	Tseng, HF (corresponding author), Kaiser Permanente, So Calif Med Grp, Dept Res & Evaluat, 100 S Los Robles Ave,2nd Floor, Pasadena, CA 91101 USA.	Hung-Fu.x.Tseng@kp.org	Sy, Lina/AFM-9458-2022	Sy, Lina/0000-0003-2762-9266; Jacobsen, Steven/0000-0002-8174-8533	Merck	Merck(Merck & Company)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Tseng, Smith, and Jacobsen and Ms Sy report having received research funding from Merck for other vaccine studies. Dr Jacobsen reports having served as an unpaid consultant for Merck Research Laboratories. Drs Harpaz and Bialek report no disclosures.	BROOME CV, 1980, NEW ENGL J MED, V303, P549, DOI 10.1056/NEJM198009043031003; Clemens J, 1996, JAMA-J AM MED ASSOC, V275, P390, DOI 10.1001/jama.275.5.390; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Hicks LD, 2008, ARCH DERMATOL, V144, P603, DOI 10.1001/archderm.144.5.603; Hurley LP, 2010, ANN INTERN MED, V152, P555, DOI 10.7326/0003-4819-152-9-201005040-00005; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2008, CLIN INFECT DIS, V47, P754, DOI 10.1086/591132; Jumaan AO, 2005, J INFECT DIS, V191, P2002, DOI 10.1086/430325; Leung J, ANN INTERN IN PRESS; Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696; Liesegang TJ, 2008, OPHTHALMOLOGY, V115, pS3, DOI 10.1016/j.ophtha.2007.10.009; Lin F, 2000, J INFECT DIS, V181, P1897, DOI 10.1086/315492; Lindley M, 2010, 44 NAT IMM C APR 19; Lua PJ, 2009, VACCINE, V27, P882, DOI 10.1016/j.vaccine.2008.11.077; Merck & Co, MERCK CO ZOSTAVAX ZO; Merck Research Laboratories, 2005, MERCK RES LAB VACC R; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Nelson JC, 2009, J CLIN EPIDEMIOL, V62, P687, DOI 10.1016/j.jclinepi.2008.06.014; Okamoto S, 2009, J INFECT DIS, V200, P1606, DOI 10.1086/644646; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Schiller JS, 2008, VACCINATION COVERAGE; Schmader K, 1998, J INFECT DIS, V178, pS67, DOI 10.1086/514254; Schmader K, 1999, CLIN INFECT DIS, V28, P736, DOI 10.1086/515205; Severson EA, 2003, ARCH OPHTHALMOL-CHIC, V121, P386, DOI 10.1001/archopht.121.3.386; Shaikh S, 2002, AM FAM PHYSICIAN, V66, P1723; Sy LS, 2010, VACCINE, V28, P5254, DOI 10.1016/j.vaccine.2010.05.061; Tate JE, 2009, PEDIATRICS, V123, P744, DOI 10.1542/peds.2008-1200; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Tseng HF, 2010, PEDIATR INFECT DIS J, V29, P205, DOI 10.1097/INF.0b013e3181bc379b; Weinberg GA, 2010, J INFECT DIS, V201, P1607, DOI 10.1086/652404; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341	36	151	157	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					160	166		10.1001/jama.2010.1983	http://dx.doi.org/10.1001/jama.2010.1983			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224457	Bronze			2022-12-28	WOS:000286103400021
J	Deer, B				Deer, Brian			Secrets of the MMR scare How the vaccine crisis was meant to make money	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	43	44	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2011	342								c5258	10.1136/bmj.c5258	http://dx.doi.org/10.1136/bmj.c5258			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SO	21224310				2022-12-28	WOS:000286384800029
J	Robinson, KA; Goodman, SN				Robinson, Karen A.; Goodman, Steven N.			A Systematic Examination of the Citation of Prior Research in Reports of Randomized, Controlled Trials	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINE; GENERAL MEDICAL JOURNALS; LOW-BACK-PAIN; RELEVANT EVIDENCE; REFERENCE BIAS; REVIEWS; SURGERY; PUBLICATION; SECTIONS; ARTICLES	Background: A randomized, controlled trial (RCT) should not be started or interpreted without accounting for evidence from preceding RCTs addressing the same question. Research has suggested that evidence from prior trials is often not accounted for in reports of subsequent RCTs. Objective: To assess the extent to which reports of RCTs cite prior trials studying the same interventions. Design: Meta-analyses published in 2004 that combined 4 or more trials were identified; within each meta-analysis, the extent to which each trial report cited the trials that preceded it by more than 1 year was assessed. Measurements: The proportion of prior trials that were cited (prior research citation index), the proportion of the total participants from prior trials that were in the cited trials (sample size citation index), and the absolute number of trials cited were calculated. Results: 227 meta-analyses were identified, comprising 1523 trials published from 1963 to 2004. The median prior research citation index was 0.21 (95% CI, 0.18 to 0.24), meaning that less than one quarter of relevant reports were cited. The median sample size citation index (0.24 [CI, 0.21 to 0.27]) was similar, suggesting that larger trials were not selectively cited. Of the 1101 RCTs that had 5 or more prior trials to cite, 254 (23%) cited no prior RCTs and 257 (23%) cited only 1. The median number of prior cited trials was 2, which did not change as the number of citable trials increased. The mean number of preceding trials cited by trials published after 2000 was 2.4, compared with 1.5 for those published before 2000 (P < 0.001). Limitation: The investigators could not ascertain why prior trials were not cited, and noncited trials may have been taken into account in the trial design and proposal stages. Conclusion: In reports of RCTs published over 4 decades, fewer than 25% of preceding trials were cited, comprising fewer than 25% of the participants enrolled in all relevant prior trials. A median of 2 trials was cited, regardless of the number of prior trials that had been conducted. Research is needed to explore the explanations for and consequences of this phenomenon. Potential implications include ethically unjustifiable trials, wasted resources, incorrect conclusions, and unnecessary risks for trial participants.	Johns Hopkins Sch Med, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Robinson, KA (corresponding author), Johns Hopkins Univ, Div Gen Internal Med, Dept Med, 1830 E Monument St,Room 8069, Baltimore, MD 21287 USA.	krobin@jhmi.edu						Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; BAUM ML, 1981, NEW ENGL J MED, V305, P795, DOI 10.1056/NEJM198110013051404; Bhandari M, 2007, CAN J SURG, V50, P119; Boissel JP, 2001, EUROPEAN SCI FDN POL; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Centers for Medicare & Medicaid Services, 2007, NCD ROUT COSTS CLIN; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2009, SPINE, V34, P1094, DOI 10.1097/BRS.0b013e3181a105fc; Clark S, 2010, LANCET, V376, P10, DOI 10.1016/S0140-6736(10)61001-X; Clarke M, 1998, JAMA-J AM MED ASSOC, V280, P280, DOI 10.1001/jama.280.3.280; Clarke M, 2002, JAMA-J AM MED ASSOC, V287, P2799, DOI 10.1001/jama.287.21.2799; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Cooper NJ, 2005, CLIN TRIALS, V2, P260, DOI 10.1191/1740774505cn090oa; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; Garfield E, 2002, SCIENTIST, V16, P6; GOTZSCHE PC, 1987, BRIT MED J, V295, P654, DOI 10.1136/bmj.295.6599.654; Gould WW, 1992, STATA TECHNICAL B, P19, DOI DOI 10.1201/9781315120256-; Hayden JA, 2009, J CLIN EPIDEMIOL, V62, P781, DOI 10.1016/j.jclinepi.2008.09.004; HUTCHISON BG, 1995, CAN FAM PHYSICIAN, V41, P1356; Hyett M, 2009, AUST NZ J PSYCHIAT, V43, P173, DOI 10.1080/00048670802607246; International Committee of Medical Journal Editors, BIOM J WRIT ED UNPUB; Joyce J, 1998, JAMA-J AM MED ASSOC, V280, P264, DOI 10.1001/jama.280.3.264; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; Lokker C, 2008, BMJ-BRIT MED J, V336, P655, DOI 10.1136/bmj.39482.526713.BE; MERTON RK, 1988, ISIS, V79, P606, DOI 10.1086/354848; Nieminen Pentti, 2006, BMC Med Res Methodol, V6, P42, DOI 10.1186/1471-2288-6-42; RAVNSKOV U, 1992, BMJ-BRIT MED J, V305, P15, DOI 10.1136/bmj.305.6844.15; RAVNSKOV U, 1995, J CLIN EPIDEMIOL, V48, P713, DOI 10.1016/0895-4356(94)00222-C; Savulescu J, 1996, BMJ-BRIT MED J, V313, P1390, DOI 10.1136/bmj.313.7069.1390; Schmidt LM, 2005, J FAM PRACTICE, V54, P334; Song F, 1997, BRIT DENT J, V182, P339, DOI 10.1038/sj.bdj.4809378; West R, 2002, ADDICTION, V97, P501, DOI 10.1046/j.1360-0443.2002.00104.x; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	36	98	101	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					50	U187		10.7326/0003-4819-154-1-201101040-00007	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	701OT	21200038				2022-12-28	WOS:000285830900006
J	Miyamichi, K; Amat, F; Moussavi, F; Wang, C; Wickersham, I; Wall, NR; Taniguchi, H; Tasic, B; Huang, ZJ; He, ZG; Callaway, EM; Horowitz, MA; Luo, LQ				Miyamichi, Kazunari; Amat, Fernando; Moussavi, Farshid; Wang, Chen; Wickersham, Ian; Wall, Nicholas R.; Taniguchi, Hiroki; Tasic, Bosiljka; Huang, Z. Josh; He, Zhigang; Callaway, Edward M.; Horowitz, Mark A.; Luo, Liqun			Cortical representations of olfactory input by trans-synaptic tracing	NATURE			English	Article							PIRIFORM CORTEX; RABIES VIRUS; TOPOGRAPHIC ORGANIZATION; GENE-EXPRESSION; MOSAIC ANALYSIS; BULB GLOMERULI; DOUBLE MARKERS; PARS EXTERNA; DROSOPHILA; NUCLEUS	In the mouse, each class of olfactory receptor neurons expressing a given odorant receptor has convergent axonal projections to two specific glomeruli in the olfactory bulb, thereby creating an odour map. However, it is unclear how this map is represented in the olfactory cortex. Here we combine rabies-virus-dependent retrograde mono-trans-synaptic labelling with genetics to control the location, number and type of 'starter' cortical neurons, from which we trace their presynaptic neurons. We find that individual cortical neurons receive input from multiple mitral cells representing broadly distributed glomeruli. Different cortical areas represent the olfactory bulb input differently. For example, the cortical amygdala preferentially receives dorsal olfactory bulb input, whereas the piriform cortex samples the whole olfactory bulb without obvious bias. These differences probably reflect different functions of these cortical areas in mediating innate odour preference or associative memory. The trans-synaptic labelling method described here should be widely applicable to mapping connections throughout the mouse nervous system.	[Miyamichi, Kazunari; Tasic, Bosiljka; Luo, Liqun] Stanford Univ, Dept Biol, HHMI, Stanford, CA 94305 USA; [Amat, Fernando; Moussavi, Farshid; Horowitz, Mark A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Wang, Chen; He, Zhigang] Childrens Hosp, Dept Neurosci, Boston, MA 02115 USA; [Wickersham, Ian; Wall, Nicholas R.; Callaway, Edward M.] Univ Calif San Diego, Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Wickersham, Ian; Wall, Nicholas R.; Callaway, Edward M.] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92037 USA; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor Lab, New York, NY 11724 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Harvard University; Boston Children's Hospital; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory	Luo, LQ (corresponding author), Stanford Univ, Dept Biol, HHMI, Stanford, CA 94305 USA.	lluo@stanford.edu	Callaway, Edward/D-4336-2011; Miyamichi, Kazunari/AAO-3705-2021	Callaway, Edward/0000-0002-6366-5267; Wall, Nicholas/0000-0003-2039-8258; Huang, Z. Josh/0000-0003-0592-028X; Luo, Liqun/0000-0001-5467-9264	JSPS; NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Stanford Transgenic Facility for help in generating transgenic mice, F. Zhang and K. Deisseroth for teaching us stereotactic injection, Y. Yoshihara and H. Zeng for reagents, C. Manalac and M. Shu for technical assistance, R. Axel, L. Buck, and L. Stryer, R. Yuste and members of the L.L. laboratory for discussion and critical reading of the manuscript. K.M. was supported by the JSPS program for Research Abroad and Human Frontier Science Program. K.M. is currently a research associate and L.L. is an investigator of the Howard Hughes Medical Institute. This work was also supported by an NIH grant.	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Brunjes PC, 2005, BRAIN RES REV, V50, P305, DOI 10.1016/j.brainresrev.2005.08.005; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CONG G, 1998, P 4 IEEE WORKSH APPL, V140; Cowan WM, 1998, NEURON, V20, P413, DOI 10.1016/S0896-6273(00)80985-X; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lei HM, 2006, J NEUROSCI, V26, P12023, DOI 10.1523/JNEUROSCI.2598-06.2006; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011503; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; LUSKIN MB, 1982, J COMP NEUROL, V209, P249, DOI 10.1002/cne.902090304; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; NEVELLE KR, 2004, SYNAPTIC ORG BRAIN; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; Schaefer ML, 2001, J COMP NEUROL, V436, P351; SCHOENFELD TA, 1984, J COMP NEUROL, V227, P121, DOI 10.1002/cne.902270113; Schroeder W., 1997, VISUALIZATION TOOLKI; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; SCOTT JW, 1985, J COMP NEUROL, V242, P415, DOI 10.1002/cne.902420309; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P669, DOI 10.1016/0361-9230(84)90148-5; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Stokes CCA, 2010, NEURON, V67, P452, DOI 10.1016/j.neuron.2010.06.029; Suzuki N, 2010, J COMP NEUROL, V518, P1670, DOI 10.1002/cne.22295; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; ZHANG ZY, 1994, INT J COMPUT VISION, V13, P119, DOI 10.1007/BF01427149; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	58	344	350	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					191	196		10.1038/nature09714	http://dx.doi.org/10.1038/nature09714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21179085	Green Accepted			2022-12-28	WOS:000289469100036
J	Bernardini, E				Bernardini, Elisa			Astronomy in the Time Domain	SCIENCE			English	Editorial Material							CRAB-NEBULA		DESY, D-15738 Zeuthen, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Bernardini, E (corresponding author), DESY, Platanen Allee 6, D-15738 Zeuthen, Germany.	elisa.bernardini@desy.de	Bernardini, Elisa/AAA-4810-2020	Bernardini, Elisa/0000-0003-3108-1141				Abdo AA, 2011, SCIENCE, V331, P739, DOI 10.1126/science.1199705; Atoyan AM, 1996, MON NOT R ASTRON SOC, V278, P525, DOI 10.1093/mnras/278.2.525; Hester JJ, 2008, ANNU REV ASTRON ASTR, V46, P127, DOI 10.1146/annurev.astro.45.051806.110608; Tavani M, 2011, SCIENCE, V331, P736, DOI 10.1126/science.1200083	4	5	6	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					686	687		10.1126/science.1201365	http://dx.doi.org/10.1126/science.1201365			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21212319				2022-12-28	WOS:000287205700036
J	Saglamyurek, E; Sinclair, N; Jin, J; Slater, JA; Oblak, D; Bussieres, F; George, M; Ricken, R; Sohler, W; Tittel, W				Saglamyurek, Erhan; Sinclair, Neil; Jin, Jeongwan; Slater, Joshua A.; Oblak, Daniel; Bussieres, Felix; George, Mathew; Ricken, Raimund; Sohler, Wolfgang; Tittel, Wolfgang			Broadband waveguide quantum memory for entangled photons	NATURE			English	Article								The reversible transfer of quantum states of light into and out of matter constitutes an important building block for future applications of quantum communication: it will allow the synchronization of quantum information(1), and the construction of quantum repeaters(2) and quantum networks(3). Much effort has been devoted to the development of such quantum memories(1), the key property of which is the preservation of entanglement during storage. Here we report the reversible transfer of photon-photon entanglement into entanglement between a photon and a collective atomic excitation in a solid-state device. Towards this end, we employ a thulium-doped lithium niobate waveguide in conjunction with a photon-echo quantum memory protocol(4), and increase the spectral acceptance from the current maximum(5) of 100 megahertz to 5 gigahertz. We assess the entanglement-preserving nature of our storage device through Bell inequality violations(6) and by comparing the amount of entanglement contained in the detected photon pairs before and after the reversible transfer. These measurements show, within statistical error, a perfect mapping process. Our broadband quantum memory complements the family of robust, integrated lithium niobate devices(7). It simplifies frequency-matching of light with matter interfaces in advanced applications of quantum communication, bringing fully quantum-enabled networks a step closer.	[Saglamyurek, Erhan; Sinclair, Neil; Jin, Jeongwan; Slater, Joshua A.; Oblak, Daniel; Bussieres, Felix; Tittel, Wolfgang] Univ Calgary, Inst Quantum Informat Sci, Calgary, AB T2N 1N4, Canada; [Saglamyurek, Erhan; Sinclair, Neil; Jin, Jeongwan; Slater, Joshua A.; Oblak, Daniel; Bussieres, Felix; Tittel, Wolfgang] Univ Calgary, Dept Phys & Astron, Calgary, AB T2N 1N4, Canada; [George, Mathew; Ricken, Raimund; Sohler, Wolfgang] Univ Paderborn, Dept Phys Appl Phys, D-33095 Paderborn, Germany	University of Calgary; University of Calgary; University of Paderborn	Tittel, W (corresponding author), Univ Calgary, Inst Quantum Informat Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	wtittel@ucalgary.ca	Slater, Joshua A/F-2523-2011; Tittel, Wolfgang/AAW-7332-2020; Bussieres, Felix/E-5384-2011; Tittel, Wolfgang/A-1600-2011	Tittel, Wolfgang/0000-0003-3136-8919; Bussieres, Felix/0000-0003-0234-175X; Oblak, Daniel/0000-0002-0277-3360	NSERC; QuantumWorks; General Dynamics Canada; iCORE (now part of Alberta Innovates); CFI; AAET; FQRNT	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); QuantumWorks; General Dynamics Canada; iCORE (now part of Alberta Innovates); CFI(Canada Foundation for Innovation); AAET; FQRNT(FQRNT)	This work is supported by NSERC, QuantumWorks, General Dynamics Canada, iCORE (now part of Alberta Innovates), CFI, AAET and FQRNT. We thank C. La Mela, T. Chaneliere, T. Stuart, V. Kiselyov and C. Dascollas for help during various stages of the experiment, C. Simon, K. Rupavatharam and N. Gisin for discussions, and A. Lvovsky for lending us a single-photon detector.	Akiba K, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013049; Altepeter JB, 2005, ADV ATOM MOL OPT PHY, V52, P105, DOI 10.1016/S1049-250X(05)52003-2; Appel J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093602; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Boozer AD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.193601; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Choi KS, 2008, NATURE, V452, P67, DOI 10.1038/nature06670; de Riedmatten H, 2008, NATURE, V456, P773, DOI 10.1038/nature07607; Eisaman MD, 2005, NATURE, V438, P837, DOI 10.1038/nature04327; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; Hedges MP, 2010, NATURE, V465, P1052, DOI 10.1038/nature09081; Honda K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093601; Jin X.-M., 2010, QUANTUM INTERFACE FR; Julsgaard B, 2004, NATURE, V432, P482, DOI 10.1038/nature03064; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Longdell JJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063601; Lvovsky AI, 2009, NAT PHOTONICS, V3, P706, DOI 10.1038/nphoton.2009.231; Marcikic I, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.062308; Matsukevich DN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040405; Pan J.-W., 2008, MULTIPHOTON ENTANGLE; Plenio MB, 2007, QUANTUM INF COMPUT, V7, P1; Sangouard N., 2009, QUANTUM REPEATERS BA; Sinclair N, 2010, J LUMIN, V130, P1586, DOI 10.1016/j.jlumin.2009.12.022; Sohler W, 2008, OPT PHOTONICS NEWS, V19, P24, DOI 10.1364/OPN.19.1.000024; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Usmani I, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1010; Yuan ZS, 2008, NATURE, V454, P1098, DOI 10.1038/nature07241	28	404	413	5	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					512	515		10.1038/nature09719	http://dx.doi.org/10.1038/nature09719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21228775	Green Submitted			2022-12-28	WOS:000286596500028
J	Bantignies, F; Roure, V; Comet, I; Leblanc, B; Schuettengruber, B; Bonnet, J; Tixier, V; Mas, A; Cavalli, G				Bantignies, Frederic; Roure, Virginie; Comet, Itys; Leblanc, Benjamin; Schuettengruber, Bernd; Bonnet, Jerome; Tixier, Vanessa; Mas, Andre; Cavalli, Giacomo			Polycomb-Dependent Regulatory Contacts between Distant Hox Loci in Drosophila	CELL			English	Article							BITHORAX COMPLEX; NUCLEAR-ORGANIZATION; RESPONSE ELEMENTS; HOMEOTIC MUTATION; MCP ELEMENT; GENE; DOMAIN; EXPRESSION; EVOLUTION; LADYBIRD	In Drosophila melanogaster, Hox genes are organized in an anterior and a posterior cluster, called Antennapedia complex and bithorax complex, located on the same chromosome arm and separated by 10 Mb of DNA. Both clusters are repressed by Polycomb group (PcG) proteins. Here, we show that genes of the two Hox complexes can interact within nuclear PcG bodies in tissues where they are corepressed. This colocalization increases during development and depends on PcG proteins. Hox gene contacts are conserved in the distantly related Drosophila virilis species and they are part of a large gene interaction network that includes other PcG target genes. Importantly, mutations on one of the loci weaken silencing of genes in the other locus, resulting in the exacerbation of homeotic phenotypes in sensitized genetic backgrounds. Thus, the three-dimensional organization of Polycomb target genes in the cell nucleus stabilizes the maintenance of epigenetic gene silencing.	[Bantignies, Frederic; Roure, Virginie; Comet, Itys; Leblanc, Benjamin; Schuettengruber, Bernd; Bonnet, Jerome; Tixier, Vanessa; Cavalli, Giacomo] CNRS, Inst Genet Humaine, UPR 1142, F-34396 Montpellier 5, France; [Mas, Andre] Univ Montpellier 2, Inst Modelisat Math Montpellier, CNRS, UMR 5149, F-34095 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Montpellier	Bantignies, F (corresponding author), CNRS, Inst Genet Humaine, UPR 1142, 141 Rue Cardonille, F-34396 Montpellier 5, France.	frederic.bantignies@igh.cnrs.fr; giacomo.cavalli@igh.cnrs.fr	Bonnet, Jerome/D-3041-2014; Bonnet, Jerome/AAT-5600-2020; Cavalli, Giacomo/A-7958-2008; cavalli, giacomo/Z-2754-2019	Bonnet, Jerome/0000-0002-8420-9359; Bonnet, Jerome/0000-0002-8420-9359; Cavalli, Giacomo/0000-0003-3709-3469; cavalli, giacomo/0000-0003-3709-3469; Leblanc, Benjamin/0000-0002-8657-2821; Schuettengruber, Bernd/0000-0001-7338-4648; Comet, Itys/0000-0001-7265-2284	CNRS; Ministere de l'Enseignement Superieur; Association pour la Recherche sur le Cancer; Agence Nationale de la Recherche; Fondation de la Recherche Medicale; Human Frontier Science Program Organization; European Union; European Research Council [ERC-2008-AdG No 232947]; Indo-French Centre for Promotion of Advanced Research; Ministere de l'Enseignement Superieur, ACI BCMS	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Human Frontier Science Program Organization(Human Frontier Science Program); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Indo-French Centre for Promotion of Advanced Research(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur, ACI BCMS	We would like to thank W. Gehring, F. Karch, H. Gyurkovics, J.M. Dura, and Alain Pelisson for fly lines and plasmids. We also thank T. Sexton and D. Cribbs for stimulating discussions; B. Pfeiffer and S. Celniker for sharing the D. virilis BX-C sequence before publication; Chantal Cazevieille for electron microscopy at the Centre de Ressources en Imagerie Cellulaire of Montpellier. F.B. is supported by the CNRS; V.R. and I.C. were supported by the Ministere de l'Enseignement Superieur, the Association pour la Recherche sur le Cancer, and the Agence Nationale de la Recherche. B.L. was supported by the Ministere de l'Enseignement Superieur. B.S. was supported by the Fondation de la Recherche Medicale. G.C. was supported by grants of the CNRS, the Human Frontier Science Program Organization, the European Union FP6 (Network of Excellence, The Epigenome, and STREP 3D Genome), the European Research Council (ERC-2008-AdG No 232947), by the Indo-French Centre for Promotion of Advanced Research, by the Agence Nationale de la Recherche, and by the Ministere de l'Enseignement Superieur, ACI BCMS.	Alkema MJ, 1997, GENE DEV, V11, P226, DOI 10.1101/gad.11.2.226; Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Castelli-Gair J, 1998, INT J DEV BIOL, V42, P437; Cavalli G, 2007, CURR OPIN GENET DEV, V17, P443, DOI 10.1016/j.gde.2007.08.013; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; Fedorova E, 2008, CHROMOSOME RES, V16, P649, DOI 10.1007/s10577-008-1218-6; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; GALLONI M, 1993, EMBO J, V12, P1087, DOI 10.1002/j.1460-2075.1993.tb05750.x; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; GYURKOVICS H, 1990, EMBO J, V9, P2579, DOI 10.1002/j.1460-2075.1990.tb07439.x; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Jagla K, 1997, DEVELOPMENT, V124, P3471; Jagla K, 1997, DEVELOPMENT, V124, P91; Jagla T, 1998, DEVELOPMENT, V125, P3699; KARCH F, 1994, NUCLEIC ACIDS RES, V22, P3138, DOI 10.1093/nar/22.15.3138; Kaufman T C, 1990, Adv Genet, V27, P309; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; KUZIORA MA, 1993, MECH DEVELOP, V42, P125, DOI 10.1016/0925-4773(93)90002-F; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lewis EB, 2003, CURR BIOL, V13, pR587, DOI 10.1016/S0960-9822(03)00520-7; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Merdes G, 2009, DEV CELL, V17, P440, DOI 10.1016/j.devcel.2009.10.001; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Miele Adriana, 2008, V464, P105; Mihaly J, 1997, DEVELOPMENT, V124, P1809; MORATA P, 1994, CANCER LETT, V81, P209, DOI 10.1016/0304-3835(94)90204-6; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Muller M, 1999, GENETICS, V153, P1333; Negre B, 2003, MOL BIOL EVOL, V20, P2042, DOI 10.1093/molbev/msg238; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; PATTATUCCI AM, 1991, GENETICS, V129, P423; PIRROTTA V, 1995, GENETICS, V141, P1439; Ranz JM, 1997, GENETICS, V145, P281; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Sexton T, 2007, SEMIN CELL DEV BIOL, V18, P691, DOI 10.1016/j.semcdb.2007.08.008; Sexton T, 2009, SEMIN CELL DEV BIOL, V20, P849, DOI 10.1016/j.semcdb.2009.06.004; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Southworth JW, 2002, GENETICS, V161, P733; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; TALBERT PB, 1994, GENETICS, V138, P709; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Vazquez J, 2006, MOL BIOL CELL, V17, P2158, DOI 10.1091/mbc.E06-01-0049; Vazquez M, 1999, DEVELOPMENT, V126, P733; VonAllmen G, 1996, NATURE, V380, P116, DOI 10.1038/380116a0; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007	56	298	308	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					214	226		10.1016/j.cell.2010.12.026	http://dx.doi.org/10.1016/j.cell.2010.12.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241892	Bronze			2022-12-28	WOS:000286459900007
J	Kessler, JD; Valentine, DL; Redmond, MC; Du, MR; Chan, EW; Mendes, SD; Quiroz, EW; Villanueva, CJ; Shusta, SS; Werra, LM; Yvon-Lewis, SA; Weber, TC				Kessler, John D.; Valentine, David L.; Redmond, Molly C.; Du, Mengran; Chan, Eric W.; Mendes, Stephanie D.; Quiroz, Erik W.; Villanueva, Christie J.; Shusta, Stephani S.; Werra, Lindsay M.; Yvon-Lewis, Shari A.; Weber, Thomas C.			A Persistent Oxygen Anomaly Reveals the Fate of Spilled Methane in the Deep Gulf of Mexico	SCIENCE			English	Article							OXIDATION; HYDRATE; CARBON; DISSOCIATION; INPUT	Methane was the most abundant hydrocarbon released during the 2010 Deepwater Horizon oil spill in the Gulf of Mexico. Beyond relevancy to this anthropogenic event, this methane release simulates a rapid and relatively short-term natural release from hydrates into deep water. Based on methane and oxygen distributions measured at 207 stations throughout the affected region, we find that within similar to 120 days from the onset of release similar to 3.0 x 10(10) to 3.9 x 10(10) moles of oxygen were respired, primarily by methanotrophs, and left behind a residual microbial community containing methanotrophic bacteria. We suggest that a vigorous deepwater bacterial bloom respired nearly all the released methane within this time, and that by analogy, large-scale releases of methane from hydrate in the deep ocean are likely to be met by a similarly rapid methanotrophic response.	[Kessler, John D.; Du, Mengran; Chan, Eric W.; Yvon-Lewis, Shari A.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Valentine, David L.; Redmond, Molly C.; Mendes, Stephanie D.; Villanueva, Christie J.; Shusta, Stephani S.; Werra, Lindsay M.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Valentine, David L.; Redmond, Molly C.; Mendes, Stephanie D.; Villanueva, Christie J.; Shusta, Stephani S.; Werra, Lindsay M.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Quiroz, Erik W.] Texas A&M Univ, Geochem & Environm Res Grp, College Stn, TX 77843 USA; [Weber, Thomas C.] Univ New Hampshire, Ctr Coastal & Ocean Mapping, Durham, NH 03824 USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Texas A&M University System; Texas A&M University College Station; University System Of New Hampshire; University of New Hampshire	Kessler, JD (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	jkessler@ocean.tamu.edu; valentine@geol.ucsb.edu	du, mengran/AAO-7295-2021; Valentine, David/E-5594-2012; Kessler, John/U-6398-2017; Weber, Thomas C/H-2428-2012; Yvon-Lewis, Shari/E-4108-2012	Kessler, John/0000-0003-1097-6800; Weber, Thomas C/0000-0001-8320-361X; Yvon-Lewis, Shari/0000-0003-1378-8434; du, meng ran/0000-0001-8862-5256; Redmond, Molly/0000-0003-4227-394X; Valentine, David/0000-0001-5914-9107	NSF [OCE 1042650, OCE 0849246, OCE 1042097, OCE 0961725]; U.S. Department of Energy [DE-NT0005667]; NOAA; Consolidated Safety Services, Incorporated; Direct For Education and Human Resources [0806926] Funding Source: National Science Foundation; Division Of Human Resource Development [0929836] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Consolidated Safety Services, Incorporated; Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); Division Of Human Resource Development(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	J.D.K. and D.L.V. contributed equally to this work. This research was supported by the NSF through grants OCE 1042650 and OCE 0849246 to J.D.K. and OCE 1042097 and OCE 0961725 to D.L.V. and by the U.S. Department of Energy (DE-NT0005667) to D.L.V. The August, September, and October expeditions were funded by NOAA through a contract with Consolidated Safety Services, Incorporated. We thank the officers and crew of the NOAA ship Pisces, as well as S. Joye, M. Heintz, C. Farwell, F. Kinnaman, K. Mouyard, T. Bryant, B. Pierce, A. Lee, R. Hansman, S. Socolofsky, L. Hu, F. Garcia Tigreros, T. Bianchi, X. Li, S. DiMarco, S. Bagby, G. Paradis, and the staff at Picarro Incorporated and Los Gatos Research Incorporated for valuable technical assistance and discussions. Sequences are available on GenBank, accession numbers HQ738556 to HQ733567, HQ433363 to HQ433432, and HQ652514 to HQ652537.	Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; Brooks J. M., 1975, THESIS TEXAS A M U C; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; DEANGELIS MA, 1993, DEEP-SEA RES PT I, V40, P1169, DOI 10.1016/0967-0637(93)90132-M; Dickens, 2001, GEOPHYS MONOGR SER, V124, P19, DOI DOI 10.1029/GM124P0019; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Judd AG, 2002, GEOFLUIDS, V2, P109, DOI 10.1046/j.1468-8123.2002.00027.x; Katz ME, 1999, SCIENCE, V286, P1531, DOI 10.1126/science.286.5444.1531; Kessler JD, 2006, EARTH PLANET SC LETT, V243, P366, DOI 10.1016/j.epsl.2006.01.006; McGinnis DF, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003183; REEBURGH WS, 1991, DEEP-SEA RES, V38, pS1189; REEBURGH WS, 2003, TREATISE GEOCHEMISTR, V4, P65, DOI DOI 10.1016/B0-08-043751-6/04036-6; Rehder G, 2009, MAR CHEM, V114, P19, DOI 10.1016/j.marchem.2009.03.004; Rothman LS, 2005, J QUANT SPECTROSC RA, V96, P139, DOI 10.1016/j.jqsrt.2004.10.008; Socolofsky SA, 2005, J HYDRAUL ENG, V131, P273, DOI 10.1061/(ASCE)0733-9429(2005)131:4(273); Tavormina PL, 2008, APPL ENVIRON MICROB, V74, P3985, DOI 10.1128/AEM.00069-08; U. S. Department of Energy, DEEPW HOR RESP; U. S. Geological Survey, 2010, DEEPW HOR MC252 GULF; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Valentine DL, 2001, GEOCHIM COSMOCHIM AC, V65, P2633, DOI 10.1016/S0016-7037(01)00625-1; WARD BB, 1987, NATURE, V327, P226, DOI 10.1038/327226a0; Yvon-Lewis SA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045928	24	343	351	6	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					312	315		10.1126/science.1199697	http://dx.doi.org/10.1126/science.1199697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21212320				2022-12-28	WOS:000286636300031
J	Hopkins, R; Rausher, MD				Hopkins, Robin; Rausher, Mark D.			Identification of two genes causing reinforcement in the Texas wildflower Phlox drummondii	NATURE			English	Article							CHARACTER DISPLACEMENT; REPRODUCTIVE ISOLATION; SPECIATION GENETICS; HYBRIDIZATION; EVOLUTION	Species formation generates biological diversity and occurs when traits evolve that prevent gene flow between populations. Discerning the number and distribution of genes underlying these traits and, in a few cases, identifying the genes involved, has greatly enhanced our understanding over the past 15 years of species formation (reviewed by Noor and Feder(1) and Wolf et al.(2)). However, this work has almost exclusively focused on traits that restrict gene flow between populations that have evolved as a by-product of genetic divergence between geographically isolated populations. By contrast, little is known about the characteristics of genes associated with reinforcement, the process by which natural selection directly favours restricted gene flow during the formation of species. Here we identify changes in two genes that appear to cause a flower colour change in Phlox drummondii, which previous work has shown contributes to reinforcement. Both changes involve cis-regulatory mutations to genes in the anthocyanin biosynthetic pathway (ABP). Because one change is recessive whereas the other is dominant, hybrid offspring produce an intermediate flower colour that is visited less by pollinators, and is presumably maladaptive. Thus genetic change selected to increase prezygotic isolation also appears to result in increased postzygotic isolation.	[Hopkins, Robin; Rausher, Mark D.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Hopkins, R (corresponding author), Duke Univ, Dept Biol, Box 90338, Durham, NC 27708 USA.	robin.hopkins@duke.edu; mrausher@duke.edu			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	We thank D. Des Marais, J. Tung, S. Johnsen and T. Juenger for technical advice, D. Levin for assistance in locating natural populations, and M. Noor for comments on the manuscript. This work was supported by a National Science Foundation grant to M. D. R. and a National Science Foundation Doctoral Dissertation Research Improvement Grant to R. H. R. H. was supported in part by the National Science Foundation Graduate Research Fellowship Program.	Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; Dambroski HR, 2005, EVOLUTION, V59, P1953, DOI 10.1111/j.0014-3820.2005.tb01065.x; Des Marais DL, 2010, EVOLUTION, V64, P2044, DOI 10.1111/j.1558-5646.2010.00972.x; Dobzhansky T., 1937; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; GONNET JF, 1993, J HORTIC SCI, V68, P499, DOI 10.1080/00221589.1993.11516378; Haldane J. B. S., 1924, Trans Phil Soc Cambridge U K, V23, P19; Hoballah ME, 2007, PLANT CELL, V19, P779, DOI 10.1105/tpc.106.048694; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; HOWARD DJ, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P46; Kelly AJ, 1998, MOL ECOL, V7, P769, DOI 10.1046/j.1365-294x.1998.00328.x; Kirkpatrick M, 2000, P ROY SOC B-BIOL SCI, V267, P1649, DOI 10.1098/rspb.2000.1191; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; LEVIN DA, 1970, EVOLUTION, V24, P367, DOI 10.1111/j.1558-5646.1970.tb01768.x; LEVIN DA, 1975, EVOLUTION, V29, P37, DOI 10.1111/j.1558-5646.1975.tb00812.x; LEVIN DA, 1967, AM J BOT, V54, P1122, DOI 10.2307/2440537; LEVIN DA, 1985, EVOLUTION, V39, P1275, DOI 10.1111/j.1558-5646.1985.tb05693.x; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Mouritzen P, 2004, BIOTECHNIQUES, V37, P492, DOI 10.2144/04373AF02; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Nosil P, 2005, EVOLUTION, V59, P705; Orr HA, 2001, GENETICS, V157, P875; Ortiz-Barrientos D, 2004, PLOS BIOL, V2, P2256, DOI 10.1371/journal.pbio.0020416; Ortiz-Barrientos D, 2009, ANN NY ACAD SCI, V1168, P156, DOI 10.1111/j.1749-6632.2009.04919.x; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Ruane LG, 2008, EVOL ECOL, V22, P229, DOI 10.1007/s10682-007-9174-8; Saether SA, 2007, SCIENCE, V318, P95, DOI 10.1126/science.1141506; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023	34	130	132	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					411	+		10.1038/nature09641	http://dx.doi.org/10.1038/nature09641			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21217687				2022-12-28	WOS:000286385600055
J	Iglehart, JK				Iglehart, John K.			Assessing an ACO Prototype - Medicare's Physician Group Practice Demonstration.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Berenson RA, 2010, AM J MANAG CARE, V16, P721; Ginsburg PB, 2011, NEW ENGL J MED, V364, P172, DOI 10.1056/NEJMhpr1004028; Kautter J, 2007, HEALTH CARE FINANC R, V29, P15; Kocher R, 2010, NEW ENGL J MED, V363, P2579, DOI 10.1056/NEJMp1011712; Sebelius Kathleen, 2009, REPORT C PHYS GROUP	5	35	36	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					198	200		10.1056/NEJMp1013896	http://dx.doi.org/10.1056/NEJMp1013896			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708SF	21175306				2022-12-28	WOS:000286383900003
J	Kane, RL				Kane, Robert L.			Finding the Right Level of Posthospital Care "We Didn't Realize There Was Any Other Option for Him"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM-CARE; INPATIENT REHABILITATION FACILITIES; NURSING-HOME RESIDENTS; OUTCOMES; QUALITY; TRANSITIONS; FRACTURE; STROKE; REIMBURSEMENT; REPLACEMENT	Many families considering posthospital care options are ill-prepared and in need of guidance. They may not know the range of available options, the relative benefits of each, or have considered their therapeutic goals. Physicians should be informants, advocates, and facilitators of this big leap for their patients. Making a good long-term care decision requires information and structure, but such decisions are often made under great time pressure as part of a hospital discharge. Professional intervention and guidance by an informed but disinterested facilitator may be needed, but hospital discharge planners may not be well suited for this role because their mandate is a rapid discharge. Physicians have 2 crucial roles in these transitions: to ensure the seamless delivery of primary care and to advocate for and facilitate, however possible, better decision making. Physicians need at least a rudimentary knowledge of the array of options and the implications of each. Even if the physician cannot serve as the planning facilitator, the physician should ensure that this task is done well. This review describes the range of options and the implications of each option for long-term care in the United States. It suggests the need for evaluating each patient's care goals, family circumstances and resources, and clinical status to determine if more aggressive medical care might improve an individual's clinical trajectory. JAMA. 2011; 305(3): 284-293	Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kane, RL (corresponding author), Univ Minnesota, Sch Publ Hlth, D351 Mayo MMC 197,420 Delaware St SE, Minneapolis, MN 55455 USA.	kanex001@umn.edu			SCAN Foundation	SCAN Foundation	The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	[Anonymous], DOES MED COV HOM CAR; [Anonymous], NURS HOM REP CARD; [Anonymous], AD FOST CAR OV; [Anonymous], MED STAT WALV PROGR; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Bostick JE, 2006, J AM MED DIR ASSOC, V7, P366, DOI 10.1016/j.jamda.2006.01.024; Buntin MB, 2010, MED CARE, V48, P776, DOI 10.1097/MLR.0b013e3181e359df; Chudyk AM, 2009, ARCH PHYS MED REHAB, V90, P246, DOI 10.1016/j.apmr.2008.06.036; Coleman E. A., 2003, ANN LONG TERM CARE, V11, P33; Coleman EA, 2005, ARCH INTERN MED, V165, P1842, DOI 10.1001/archinte.165.16.1842; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; Coleman EA, 2004, J AM GERIATR SOC, V52, pS1; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Collier E, 2008, RES GERONTOL NURS, V1, P157, DOI 10.3928/00220124-20091301-03; Comondore VR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2732; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1306, DOI 10.1016/j.apmr.2009.04.003; Deutsch A, 2005, MED CARE, V43, P892, DOI 10.1097/01.mlr.0000173591.23310.d5; Deutsch A, 2006, STROKE, V37, P1477, DOI 10.1161/01.STR.0000221172.99375.5a; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukuda Y, 2008, GERIATR GERONTOL INT, V8, P166, DOI 10.1111/j.1447-0594.2008.00466.x; Golant S, 2008, ASSISTED LIVING RESI; Hilliard JL, 2005, J LEGAL MED, V26, P41, DOI 10.1080/01947640590917945; Hillmer MP, 2005, MED CARE RES REV, V62, P139, DOI 10.1177/1077558704273769; Hunt R, 2004, CASE MANAGING LONG T; Jarman Brian, 2004, BMJ, V328, P605, DOI 10.1136/bmj.328.7440.605; Kane RL, 2003, J AM GERIATR SOC, V51, P1427, DOI 10.1046/j.1532-5415.2003.51461.x; Kane RL, 1998, J AM GERIATR SOC, V46, P1525, DOI 10.1111/j.1532-5415.1998.tb01537.x; Kane RL, 2011, GOOD CAREGIVER; Kane RL, 2009, ESSENTIALS CLIN GERI; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; Kane RL, 2006, GERONTOLOGIST, V46, P474, DOI 10.1093/geront/46.4.474; Kane RA, 2007, GERONTOLOGIST, V47, P125, DOI 10.1093/geront/47.Supplement_1.125; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kramer AM, 1997, JAMA-J AM MED ASSOC, V277, P396, DOI 10.1001/jama.277.5.396; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; MAHONEY F I, 1965, Md State Med J, V14, P61; *MED, NURS HOM COMP; Mor V, 2007, HEALTH AFFAIR, V26, P1762, DOI 10.1377/hlthaff.26.6.1762; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; Naylor M, 2008, AM J NURS, V108, P58, DOI 10.1097/01.NAJ.0000336420.34946.3a; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Ouslander JG, 2010, J AM GERIATR SOC, V58, P760; Ouslander JG, 2010, J AM GERIATR SOC, V58, P627, DOI 10.1111/j.1532-5415.2010.02768.x; Spillman BC, 2002, MED CARE, V40, P965, DOI 10.1097/00005650-200210000-00013; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stevenson DG, 2010, HEALTH AFFAIR, V29, P35, DOI 10.1377/hlthaff.2009.0527; Stone RI, 2007, GERONTOLOGIST, V47, P23, DOI 10.1093/geront/47.Supplement_1.23; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; Wiener JM, 1999, J AGING HEALTH, V11, P417, DOI 10.1177/089826439901100308; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zimmerman S, 2007, GERONTOLOGIST, V47, P33, DOI 10.1093/geront/47.Supplement_1.33	57	71	71	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					284	293		10.1001/jama.2010.2015	http://dx.doi.org/10.1001/jama.2010.2015			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707YY	21245184				2022-12-28	WOS:000286328700024
J	Deer, B				Deer, Brian			Secrets of the MMR scare The Lancet's two days to bury bad news	BRITISH MEDICAL JOURNAL			English	Editorial Material							STATEMENT											BARR R, 1996, PROPOSED PROTO UNPUB; CORRIGAN S, 2006, MAIL SUNDAY     0716; DEER B, IS WAKEFIELD CLUSTER; Deer B., 2006, SUNDAY TIMES 1231; DEER B, ROYAL FREE D HULL IN; DEER B, WALKERSMITH EXPLAINS; DEER B, 2004, SUNDAY TIMES    0222; Deer B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c5258; Deer B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c5347; FILIPEK PA, 1999, PEDIAT NEUROLOGY PRI; *GMC, A WAK DET SER PROF M; *GMC, J WALK DET SER PROF; *GMC, 2010, FITN PRACT PAN FIND; Hodgson H, 2004, LANCET, V363, P824, DOI 10.1016/S0140-6736(04)15711-5; Horton R, 2004, LANCET, V363, P820, DOI 10.1016/S0140-6736(04)15699-7; HORTON R, 2010, PRESS GAZETTE    MAR, P19; Horton Richard C., 2003, 2 OPINION DOCTORS DI; LAURANCE J, 2004, INDEPENDENT     0229; *LEG AID BOARD, 1996, AUTH DO CONTR WORK; MEIKLE J, 2004, GUARDIAN        0224; Murch S, 2004, LANCET, V363, P821, DOI 10.1016/S0140-6736(04)15708-5; *U COLL LOND, 2010, FREED INF REQ 10045; Wakefield A, 2004, LANCET, V363, P823, DOI 10.1016/S0140-6736(04)15710-3; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Walker-Smith J, 2004, LANCET, V363, P822, DOI 10.1016/S0140-6736(04)15709-7; [No title captured]	26	32	34	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2011	342								c7001	10.1136/bmj.c7001	http://dx.doi.org/10.1136/bmj.c7001			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711OH	21245118				2022-12-28	WOS:000286600800018
J	Eikelboom, JW; Weitz, JI				Eikelboom, John W.; Weitz, Jeffrey I.			Therapeutics New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENOUS THROMBOEMBOLISM; DABIGATRAN ETEXILATE; DOUBLE-BLIND; ENOXAPARIN; RIVAROXABAN; PREVENTION; REPLACEMENT; THROMBIN					eikelbj@mcmaster.ca	Eikelboom, John/AAG-6117-2019; Weitz, Jeffrey/AAD-1929-2019	Eikelboom, John/0000-0003-4126-1285; Weitz, Jeffrey/0000-0002-1092-7550				[Anonymous], 2010, PROD MON PRAD; [Anonymous], 2008, PROD MON XAR; Apostolakis S, 2009, PHARMACOECONOMICS, V27, P793, DOI 10.2165/11313780-000000000-00000; Eikelboom JW, 2010, CIRCULATION, V121, P1523, DOI 10.1161/CIRCULATIONAHA.109.853119; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Eriksson BI, 2009, CLIN PHARMACOKINET, V48, P1, DOI 10.2165/0003088-200948010-00001; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ginsberg JS, 2009, J ARTHROPLASTY, V24, P1, DOI 10.1016/j.arth.2008.01.132; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; McCullagh L, 2009, PHARMACOECONOMICS, V27, P829, DOI 10.2165/11313800-000000000-00000; National Institute for Health and Clinical Excellence, 2010, 92 NAT I HLTH CLIN E; Trkulja V, 2010, CROAT MED J, V51, P113, DOI 10.3325/cmj.2010.51.113; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; van Ryn J, 2010, THROMB HAEMOSTASIS, V103, P1116, DOI 10.1160/TH09-11-0758	17	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2011	342								c7270	10.1136/bmj.c7270	http://dx.doi.org/10.1136/bmj.c7270			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711OH	21245113				2022-12-28	WOS:000286600800014
J	Rosenbaum, DM; Zhang, C; Lyons, JA; Holl, R; Aragao, D; Arlow, DH; Rasmussen, SGF; Choi, HJ; DeVree, BT; Sunahara, RK; Chae, PS; Gellman, SH; Dror, RO; Shaw, DE; Weis, WI; Caffrey, M; Gmeiner, P; Kobilka, BK				Rosenbaum, Daniel M.; Zhang, Cheng; Lyons, Joseph A.; Holl, Ralph; Aragao, David; Arlow, Daniel H.; Rasmussen, Soren G. F.; Choi, Hee-Jung; DeVree, Brian T.; Sunahara, Roger K.; Chae, Pil Seok; Gellman, Samuel H.; Dror, Ron O.; Shaw, David E.; Weis, William I.; Caffrey, Martin; Gmeiner, Peter; Kobilka, Brian K.			Structure and function of an irreversible agonist-beta(2) adrenoceptor complex	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTALLIZING MEMBRANE-PROTEINS; MOLECULAR-DYNAMICS SIMULATIONS; LIPIDIC MESOPHASES; ADRENERGIC-RECEPTOR; BINDING-SITE; FORCE-FIELDS; RHODOPSIN; ACTIVATION; AGONISTS	G-protein-coupled receptors (GPCRs) are eukaryotic integral membrane proteins that modulate biological function by initiating cellular signalling in response to chemically diverse agonists. Despite recent progress in the structural biology of GPCRs(1), the molecular basis for agonist binding and allosteric modulation of these proteins is poorly understood. Structural knowledge of agonist-bound states is essential for deciphering the mechanism of receptor activation, and for structure-guided design and optimization of ligands. However, the crystallization of agonist-bound GPCRs has been hampered by modest affinities and rapid off-rates of available agonists. Using the inactive structure of the human beta(2) adrenergic receptor (beta(2)AR) as a guide, we designed a beta(2)AR agonist that can be covalently tethered to a specific site on the receptor through a disulphide bond. The covalent beta(2)AR-agonist complex forms efficiently, and is capable of activating a heterotrimeric G protein. We crystallized a covalent agonist-bound beta(2)AR-T4L fusion protein in lipid bilayers through the use of the lipidic mesophase method(2), and determined its structure at 3.5 angstrom resolution. A comparison to the inactive structure and an antibody-stabilized active structure (companion paper(3)) shows how binding events at both the extracellular and intracellular surfaces are required to stabilize an active conformation of the receptor. The structures are in agreement with long-timescale (up to 30 mu s) molecular dynamics simulations showing that an agonist-bound active conformation spontaneously relaxes to an inactive-like conformation in the absence of a G protein or stabilizing antibody.	[Rosenbaum, Daniel M.; Zhang, Cheng; Rasmussen, Soren G. F.; Choi, Hee-Jung; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lyons, Joseph A.] Univ Limerick, Dept Chem & Environm Sci, Limerick, Ireland; [Lyons, Joseph A.; Aragao, David; Caffrey, Martin] Trinity Coll Dublin, Sch Biochem & Immunol, Membrane Struct & Funct Biol Grp, Dublin 2, Ireland; [Holl, Ralph; Gmeiner, Peter] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91052 Erlangan, Germany; [Arlow, Daniel H.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Choi, Hee-Jung; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [DeVree, Brian T.; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chae, Pil Seok; Gellman, Samuel H.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	Stanford University; University of Limerick; Trinity College Dublin; University of Erlangen Nuremberg; D. E. Shaw Research; Stanford University; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	martin.caffrey@tcd.ie; peter.gmeiner@medchem.uni-erlangen.de; kobilka@stanford.edu	Weis, William I/G-1437-2011; Gmeiner, Peter/N-5275-2015; Lyons, Joseph/AAA-2528-2020; Aragao, David/A-1695-2012; Sunahara, Roger/AAJ-8667-2020; Aragao, David/AAV-5514-2021; DeVree, Brian T/F-6205-2011; Zhang, Cheng/O-4372-2015	Weis, William I/0000-0002-5583-6150; Aragao, David/0000-0002-6551-4657; Aragao, David/0000-0002-6551-4657; Zhang, Cheng/0000-0001-9042-4007; DeVree, Brian/0000-0003-0582-8125; Rasmussen, Soren/0000-0002-1853-1841; Choi, Hee-Jung/0000-0002-1167-1526; Gmeiner, Peter/0000-0002-4127-197X; Dror, Ron/0000-0002-6418-2793; Kobilka, Brian/0000-0001-5958-3990; Lyons, Joseph/0000-0003-0218-4862	National Institutes of Health [NS028471, GM083118, GM56169, P01 GM75913, GM75915, P50GM073210, P60DK-20572]; Mathers Foundation; Lundbeck Foundation; Science Foundation Ireland [07/IN.1/B1836]; FP7 COST Action [CM0902]; Bavaria California Technology Center; University of Michigan; Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075915, P50GM073210, P01GM075913, R01GM056169, R01GM068603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Lundbeck Foundation(Lundbeckfonden); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); FP7 COST Action; Bavaria California Technology Center; University of Michigan(University of Michigan System); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health Grants NS028471 and GM083118 (B. K. K.), GM56169 (W. I. W.), P01 GM75913 (S. H. G), GM75915 and P50GM073210 (M. C), and P60DK-20572 (R. K. S.), the Mathers Foundation (B. K. K and W. I. W), the Lundbeck Foundation (Junior Group Leader Fellowship, S. G. F. R.), Science Foundation Ireland (07/IN.1/B1836) and FP7 COST Action CM0902 (M. C.), the Bavaria California Technology Center (P. G.), and the University of Michigan Biomedical Sciences Scholars Program(R. K. S). We thank Stefan Lober, Harald Hubner, Albert Pan and Paul Maragakis for discussion and suggestions. We thank Foon Sun Thian for help with insect cell expression.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; Buck E, 2005, P NATL ACAD SCI USA, V102, P2719, DOI 10.1073/pnas.0500016102; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen AH, 1998, CHEM PHYS LIPIDS, V95, P11, DOI 10.1016/S0009-3084(98)00060-7; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; DOHLMAN HG, 1988, BIOCHEMISTRY-US, V27, P1813, DOI 10.1021/bi00406a002; Dror RO, 2009, P C HIGH PERF COMP N; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liapakis G, 2004, MOL PHARMACOL, V65, P1181, DOI 10.1124/mol.65.5.1181; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinelli MJ, 2002, J AM CHEM SOC, V124, P3578, DOI 10.1021/ja016031r; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; RUBENSTEIN RC, 1987, J BIOL CHEM, V262, P16655; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; TOTA MR, 1991, TRENDS PHARMACOL SCI, V12, P4, DOI 10.1016/0165-6147(91)90479-C; TU T, 2008, P 2008 ACM IEEE C SU; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanni S, 2010, J MOL BIOL, V397, P1339, DOI 10.1016/j.jmb.2010.01.060; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801	52	624	644	1	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 13	2011	469	7329					236	240		10.1038/nature09665	http://dx.doi.org/10.1038/nature09665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228876	Green Accepted			2022-12-28	WOS:000286143400043
J	Bai, G; Chivatakarn, O; Bonanomi, D; Lettieri, K; Franco, L; Xia, CH; Stein, E; Ma, L; Lewcock, JW; Pfaff, SL				Bai, Ge; Chivatakarn, Onanong; Bonanomi, Dario; Lettieri, Karen; Franco, Laura; Xia, Caihong; Stein, Elke; Ma, Le; Lewcock, Joseph W.; Pfaff, Samuel L.			Presenilin-Dependent Receptor Processing Is Required for Axon Guidance	CELL			English	Article							SONIC HEDGEHOG; SLIT PROTEINS; MICE LACKING; NETRIN-1; CHEMOATTRACTANT; CHEMOREPELLENTS; ATTRACTION; MECHANISMS; OUTGROWTH; BIOLOGY	The Alzheimer's disease-linked gene presenilin is required for intramembrane proteolysis of amyloid-beta precursor protein, contributing to the pathogenesis of neurodegeneration that is characterized by loss of neuronal connections, but the role of Presenilin in establishing neuronal connections is less clear. Through a forward genetic screen in mice for recessive genes affecting motor neurons, we identified the Columbus allele, which disrupts motor axon projections from the spinal cord. We mapped this mutation to the Presenilin-1 gene. Motor neurons and commissural interneurons in Columbus mutants lacking Presenilin-1 acquire an inappropriate attraction to Netrin produced by the floor plate because of an accumulation of DCC receptor fragments within the membrane that are insensitive to Slit/Robo silencing. Our findings reveal that Presenilin-dependent DCC receptor processing coordinates the interplay between Netrin/DCC and Slit/Robo signaling. Thus, Presenilin is a key neural circuit builder that gates the spatiotemporal pattern of guidance signaling, thereby ensuring neural projections occur with high fidelity.	[Bai, Ge; Chivatakarn, Onanong; Bonanomi, Dario; Lettieri, Karen; Franco, Laura; Lewcock, Joseph W.; Pfaff, Samuel L.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Bai, Ge; Chivatakarn, Onanong; Bonanomi, Dario; Lettieri, Karen; Franco, Laura; Lewcock, Joseph W.; Pfaff, Samuel L.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Xia, Caihong; Ma, Le] Univ So Calif, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Keck Sch Med, Los Angeles, CA 90089 USA; [Stein, Elke] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of Southern California; Yale University	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu	Ma, Le/A-3733-2013; Bai, Ge/K-2608-2014; Stein, Elke/E-8107-2013; Bonanomi, Dario/K-3450-2016	Stein, Elke/0000-0001-8965-5692; Bonanomi, Dario/0000-0003-4517-1244; Ma, Le/0000-0003-2769-9416	National Institutes of Health through National Institute of Neurological Disorders and Stroke [R37NS037116]; Howard Hughes Medical Institute; NINDS [R37NS037116, P01NS031249]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031249, R01NS054172, R01NS062047, R37NS037116] Funding Source: NIH RePORTER	National Institutes of Health through National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Edward Koo for critical reading of the manuscript, Shane Andrews for assistance with imaging, and members of the Pfaff lab for advice and discussions on the experiments and manuscript. We are also grateful to Marc Tessier-Lavigne and Jie Shen for providing Netrin-1, DCC and PS1<SUP>fl/fl</SUP> mutant mice. We thank Roman Giger and Geetha Suresh for plasmids and Developmental Studies Hybridoma Bank for antibodies. These experiments were supported by National Institutes of Health Grant R37NS037116 through National Institute of Neurological Disorders and Stroke and the Howard Hughes Medical Institute. G.B., D.B., and K.L. are supported by the Howard Hughes Medical Institute. O.C. is supported by NINDS Grant R37NS037116. L.F. is supported by NINDS Grant P01NS031249. S.L.P. is a Howard Hughes Medical Institute Investigator.	Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Kandel E., 2000, PRINCIPLES NEURAL SC; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kim SK, 2005, FASEB J, V19, P157, DOI 10.1096/fj.05-4055fje; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Lourenco FC, 2009, CELL DEATH DIFFER, V16, P655, DOI 10.1038/cdd.2008.191; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; O'Donnell M, 2009, ANNU REV NEUROSCI, V32, P383, DOI 10.1146/annurev.neuro.051508.135614; Parent AT, 2005, J NEUROSCI, V25, P1540, DOI 10.1523/JNEUROSCI.3850-04.2005; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Patel K, 2001, DEVELOPMENT, V128, P5031; Puschel AW, 1999, MECH DEVELOP, V83, P65, DOI 10.1016/S0925-4773(99)00035-0; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Shirasaki R, 2006, NEURON, V50, P841, DOI 10.1016/j.neuron.2006.04.030; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Taniguchi Y, 2003, J BIOL CHEM, V278, P30425, DOI 10.1074/jbc.C300239200; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	38	89	90	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					106	118		10.1016/j.cell.2010.11.053	http://dx.doi.org/10.1016/j.cell.2010.11.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215373	Green Accepted, Bronze			2022-12-28	WOS:000285993600011
J	Moynihan, R				Moynihan, Ray			Reality Check Beware the fortune tellers peddling genetic tests	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH		Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					*AG HEALTHC RES QU, PUBL AG HEALTHC RES; Berg AO, 2010, GENET MED, V12, P839, DOI 10.1097/GIM.0b013e3181f872c0; Government Accountability Office, 2011, DIR TO CONS GEN TEST; Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; MANNING J, HLTH HUMANITY JUSTIC; Melzer D, 2008, BRIT MED J, V336, P590, DOI 10.1136/bmj.39506.601053.BE; Nuffield Council on Bioethics, 2010, MED PROF ONL MED ETH; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; *PHG FDN, PUBL HLTH EAR ER GEN	9	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 6	2011	342								c7233	10.1136/bmj.c7233	http://dx.doi.org/10.1136/bmj.c7233			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NK	21212125				2022-12-28	WOS:000286143000001
J	Tonelli, M; Muntner, P; Lloyd, A; Manns, BJ; James, MT; Klarenbach, S; Quinn, RR; Wiebe, N; Hemmelgarn, BR				Tonelli, Marcello; Muntner, Paul; Lloyd, Anita; Manns, Braden J.; James, Matthew T.; Klarenbach, Scott; Quinn, Robert R.; Wiebe, Natasha; Hemmelgarn, Brenda R.		Alberta Kidney Dis Network	Using Proteinuria and Estimated Glomerular Filtration Rate to Classify Risk in Patients With Chronic Kidney Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; SERUM CREATININE; ADMINISTRATIVE DATA; GENERAL-POPULATION; PREVALENCE; MORTALITY; ALBERTA; INSUFFICIENCY; HYPERTENSION; PREDICTION	Background: The staging system for chronic kidney disease relies almost exclusively on estimated glomerular filtration rate (eGFR), although proteinuria is also associated with adverse outcomes. Objective: To validate a 5-category system for risk stratification based on the combination of eGFR and proteinuria. Design: Retrospective cohort study. Setting: A provincial laboratory registry in Alberta, Canada, and a representative sample of noninstitutionalized U.S. adults. Patients: A derivation data set of 474 521 adult outpatients, 2 independent internal validation cohorts with 51 356 and 460 623 patients, and an external validation cohort of 14 358 patients. Measurements: Glomerular filtration rate, estimated by using the Modification of Diet in Renal Disease Study equation, and proteinuria, measured by using urine albumin-to-creatinine ratio or dipstick urinalysis. Outcomes included all-cause mortality and a composite renal outcome of kidney failure or doubling of serum creatinine level. Results: Over a median follow-up of 38 months in the internal validation cohorts, higher risk categories (indicating lower eGFR or more proteinuria) were associated with a graded increase in the risk for the composite renal outcome. The projected number of U. S. adults assigned to risk categories 3 and 4 in the alternate system was 3.9 million, compared with 16.3 million assigned to stage 3 and 4 in the current staging system. The alternate system was more likely to correctly reclassify persons who did not develop the renal outcome than those who did, although some persons developed the renal outcome despite reclassification to a lower category. However, all analyses of patients reclassified to a lower category showed that substantially fewer such patients developed the renal outcome than did not. Correct reclassification by the alternate system was more likely when proteinuria was measured by using albumin-to-creatinine ratio than with dipstick testing, and also more likely for the composite renal outcome than for mortality. Limitation: The study had a short follow-up time. Conclusion: Using proteinuria in combination with eGFR may reduce unnecessary referrals for care at the cost of not referring or delaying referral for some patients who go on to develop kidney failure.	Univ Alberta, Edmonton, AB, Canada; Univ Alabama Birmingham, Birmingham, AL USA; Univ Calgary, Calgary, AB, Canada	University of Alberta; University of Alabama System; University of Alabama Birmingham; University of Calgary	Tonelli, M (corresponding author), 7-129 Clin Sci Bldg,8440 112 St, Edmonton, AB T6B 2G3, Canada.		Manns, Braden J/I-8942-2012; Hemmelgarn, Brenda R./I-6894-2012; Wiebe, Natasha/V-7803-2019; Quinn, Robert R/E-7017-2011; Tonelli, Marcello/B-3028-2009; Klarenbach, Scott/E-7731-2013	Wiebe, Natasha/0000-0002-5613-1582; Tonelli, Marcello/0000-0002-0846-3187; Klarenbach, Scott/0000-0002-8611-1056	Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes of Health Research; Shire Biochem-KRESCENT	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Shire Biochem-KRESCENT	Primary Funding Source: Alberta Heritage Foundation for Medical Research interdisciplinary research team grant.; Grant Support: By an interdisciplinary research team grant from the Alberta Heritage Foundation for Medical Research (AHFMR), career salary awards from the AHFMR (Drs. Hemmelgarn, Tonelli, and Klarenbach), New Investigator Awards from the Canadian Institutes of Health Research (Drs. Hemmelgarn, Tonelli, and Manns), a joint initiative between Alberta Health and Wellness and the Universities of Alberta and Calgary (Drs. Hemmelgarn, Klarenbach, Manns, and Tonelli), and a Shire Biochem-KRESCENT Joint Fellowship and an AHFMR research Award (Dr. James).	[Anonymous], 1994, VITAL HLTH STAT, P1; Chen MLW, 2003, AM J KIDNEY DIS, V42, P623, DOI 10.1016/S0272-6386(03)00870-9; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Gansevoort RT, 2010, CURR OPIN NEPHROL HY, V19, P308, DOI 10.1097/MNH.0b013e328337bbbe; Gao S, 2007, J AM SOC NEPHROL, V18, P2953, DOI 10.1681/ASN.2007030360; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hsu C, 2000, AM J KIDNEY DIS, V36, P415, DOI 10.1053/ajkd.2000.8996; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Sin DD, 2003, CHEST, V124, P51, DOI 10.1378/chest.124.1.51; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Winearls CG, 2009, KIDNEY INT, V75, P1009, DOI 10.1038/ki.2009.49; 2002, AM J KIDNEY DIS S1, V39, pS76	30	131	134	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					12	U146		10.7326/0003-4819-154-1-201101040-00003	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-00003			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200034				2022-12-28	WOS:000285830900002
J	Bevilacqua, L; Doly, S; Kaprio, J; Yuan, QP; Tikkanen, R; Paunio, T; Zhou, ZF; Wedenoja, J; Maroteaux, L; Diaz, S; Belmer, A; Hodgkinson, CA; Dell'Osso, L; Suvisaari, J; Coccaro, E; Rose, RJ; Peltonen, L; Virkkunen, M; Goldman, D				Bevilacqua, Laura; Doly, Stephane; Kaprio, Jaakko; Yuan, Qiaoping; Tikkanen, Roope; Paunio, Tiina; Zhou, Zhifeng; Wedenoja, Juho; Maroteaux, Luc; Diaz, Silvina; Belmer, Arnaud; Hodgkinson, Colin A.; Dell'Osso, Liliana; Suvisaari, Jaana; Coccaro, Emil; Rose, Richard J.; Peltonen, Leena; Virkkunen, Matti; Goldman, David			A population-specific HTR2B stop codon predisposes to severe impulsivity	NATURE			English	Article							MONOAMINE-OXIDASE; MOLECULAR-GENETICS; SEROTONIN; VULNERABILITY; DOPAMINE; MUTATION; POLYMORPHISM; AGGRESSION; MECHANISMS; RECEPTORS	Impulsivity, describing action without foresight, is an important feature of several psychiatric diseases, suicidality and violent behaviour. The complex origins of impulsivity hinder identification of the genes influencing it and the diseases with which it is associated. Here we perform exon-focused sequencing of impulsive individuals in a founder population, targeting fourteen genes belonging to the serotonin and dopamine domain. A stop codon in HTR2B was identified that is common (minor allele frequency >1%) but exclusive to Finnish people. Expression of the gene in the human brain was assessed, as well as the molecular functionality of the stop codon, which was associated with psychiatric diseases marked by impulsivity in both population and family-based analyses. Knockout of Htr2b increased impulsive behaviours in mice, indicative of predictive validity. Our study shows the potential for identifying and tracing effects of rare alleles in complex behavioural phenotypes using founder populations, and indicates a role for HTR2B in impulsivity.	[Bevilacqua, Laura; Yuan, Qiaoping; Zhou, Zhifeng; Hodgkinson, Colin A.; Goldman, David] NIAAA, Neurogenet Lab, NIH, Rockville, MD 20852 USA; [Doly, Stephane; Maroteaux, Luc; Diaz, Silvina; Belmer, Arnaud] INSERM, UMR S 839, F-75654 Paris, France; [Doly, Stephane; Maroteaux, Luc; Diaz, Silvina; Belmer, Arnaud] Univ Paris 06, Inst du Fer Moulin, F-75654 Paris, France; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, FI-00014 Helsinki, Finland; [Kaprio, Jaakko] Inst Mol Med, FI-00014 Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Unit Child & Adolescent Psychiat, FI-00271 Helsinki, Finland; [Tikkanen, Roope; Virkkunen, Matti] Univ Helsinki, Inst Clin Med, Dept Psychiat, FI-00014 Helsinki, Finland; [Paunio, Tiina; Suvisaari, Jaana] Univ Helsinki, Dept Psychiat, Cent Hosp, FI-00014 Helsinki, Finland; [Wedenoja, Juho] Univ Helsinki, Dept Med Genet, FI-00014 Helsinki, Finland; [Wedenoja, Juho] Univ Helsinki, Inst Mol Med Finland, FI-00014 Helsinki, Finland; [Wedenoja, Juho] Natl Inst Hlth & Welf, FI-00014 Helsinki, Finland; [Dell'Osso, Liliana] Univ Pisa, Dept Psychiat, I-56100 Pisa, Italy; [Coccaro, Emil] Univ Chicago, Pritzker Sch Med, Dept Psychiat, Chicago, IL 60637 USA; [Rose, Richard J.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Virkkunen, Matti] Kellokoski Psychiat Hosp, FI-04500 Kellokoski, Finland	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Pisa; University of Chicago; Indiana University System; Indiana University Bloomington	Goldman, D (corresponding author), NIAAA, Neurogenet Lab, NIH, Rockville, MD 20852 USA.	davidgoldman@mail.nih.gov	Belmer, Arnauld/AAE-2554-2019; Kaprio, Jaakko/A-1820-2008; Maroteaux, Luc/H-4585-2019; Majid, Salma/AAT-2616-2020; Goldman, David/F-9772-2010; doly, stephane/Y-2318-2019; Wedenoja, Juho/AAX-7008-2020	Belmer, Arnauld/0000-0001-6640-5631; Kaprio, Jaakko/0000-0002-3716-2455; Maroteaux, Luc/0000-0002-9499-8603; Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; doly, stephane/0000-0002-3517-8605; Wedenoja, Juho/0000-0002-6155-0378; Yuan, Qiaoping/0000-0002-5880-8702; Suvisaari, Jaana/0000-0001-7167-0990; , Laura/0000-0002-6460-0852	National Institute on Alcohol Abuse and Alcoholism, NIH; Academy of Finland Centre of Excellence in Complex Disease Genetics; National Institute on Alcohol Abuse and Alcoholism [AA-12502, AA-09203]; Academy of Finland [100499, 205585, 118555]; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Fondation de France; Fondation pour la Recherche Medicale; French Ministry of Research (Agence Nationale pour la Recherche); European Union; IBRO; Region Ile de France DIM STEM; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301, R01AA012502, R01AA009203, R37AA012502] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Academy of Finland Centre of Excellence in Complex Disease Genetics(Academy of Finland); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Academy of Finland(Academy of Finland); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministry of Research (Agence Nationale pour la Recherche)(French National Research Agency (ANR)Ministry of Research, France); European Union(European Commission); IBRO; Region Ile de France DIM STEM(Region Ile-de-France); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study is dedicated to the memory of L.P. and M. Linnoila. We thank L. Akhtar for assistance with tissue culture, C. Marietta for assistance with measurement of receptor protein levels, V. Srivastava and G. Yamini for discussions, and P.-H. Shen for contributions to ancestry analyses. M. Eggert and L. Brown assisted with clinical ascertainment and assessment of the University of Helsinki sample. We thank M. Linnoila for his contributions to the collection of the University of Helsinki sample. E. Kempas assisted with genotyping. J.-M. Launay measured plasma testosterone levels in Htr2b<SUP>-/-</SUP> mice. We also thank A. Tuulio-Henriksson, E. Vuoksimaa, A. Happola and L. Arala. This work was supported by the Intramural Research Program of the National Institute on Alcohol Abuse and Alcoholism, NIH and the Academy of Finland Centre of Excellence in Complex Disease Genetics. The FinnTwin12 and FinnTwin16 studies were supported by the National Institute on Alcohol Abuse and Alcoholism (AA-12502 and AA-09203 to R.J.R.), and by the Academy of Finland (100499, 205585 and 118555 to J.K.). The studies on Htr2b<SUP>-/-</SUP> mice were supported by the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie, and by grants from the Fondation de France, the Fondation pour la Recherche Medicale, the French Ministry of Research (Agence Nationale pour la Recherche), and the European Union. L.M.'s team is an "Equipe Fondation pour la Recherche Medicale''. S. Diaz is supported by a fellowship from IBRO and Region Ile de France DIM STEM.	Abel L, 1998, GENET EPIDEMIOL, V15, P371, DOI 10.1002/(SICI)1098-2272(1998)15:4<371::AID-GEPI4>3.0.CO;2-5; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Blanpain C, 2003, CARDIOVASC RES, V60, P518, DOI 10.1016/j.cardiores.2003.09.015; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Cases O, 1998, J NEUROSCI, V18, P6914; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chiavegatto S, 2010, GENES BRAIN BEHAV, V9, P110, DOI 10.1111/j.1601-183X.2009.00544.x; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; COCCARO EF, 1993, PSYCHIAT RES, V48, P229, DOI 10.1016/0165-1781(93)90074-Q; DEJONG J, 1992, J NERV MENT DIS, V180, P543, DOI 10.1097/00005053-199209000-00001; Doly S, 2008, J NEUROSCI, V28, P2933, DOI 10.1523/JNEUROSCI.5723-07.2008; Ducci F, 2008, MOL PSYCHIATR, V13, P334, DOI 10.1038/sj.mp.4002034; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; EYSENCK SBG, 1977, BRIT J SOC CLIN PSYC, V16, P57, DOI 10.1111/j.2044-8260.1977.tb01003.x; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Gustavsson JP, 2000, ACTA PSYCHIAT SCAND, V102, P217, DOI 10.1034/j.1600-0447.2000.102003217.x; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hodgkinson CA, 2008, ALCOHOL ALCOHOLISM, V43, P505, DOI 10.1093/alcalc/agn032; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P1438, DOI 10.1001/archpsyc.65.12.1438; Kim SJ, 2000, MOL CELL PROBE, V14, P47, DOI 10.1006/mcpr.1999.0281; Launay JM, 2006, FASEB J, V20, P1843, DOI 10.1096/fj.06-5724com; Lin ZC, 2004, PHARMACOGENETICS, V14, P805, DOI 10.1097/00008571-200412000-00003; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; Misener VL, 2004, MOL PSYCHIATR, V9, P500, DOI 10.1038/sj.mp.4001440; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Roy A, 2007, NEUROPSYCHOPHARMACOL, V32, P2046, DOI 10.1038/sj.npp.1301331; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P1092, DOI 10.1111/1469-7610.00194; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Sjoberg RL, 2008, NEUROPSYCHOPHARMACOL, V33, P425, DOI 10.1038/sj.npp.1301417; VIRKKUNEN M, 1994, ARCH GEN PSYCHIAT, V51, P20; VIRKKUNEN M, 1993, J STUD ALCOHOL, P163, DOI 10.15288/jsas.1993.s11.163; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; Winstanley CA, 2006, CEREB CORTEX, V16, P106, DOI 10.1093/cercor/bhi088; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001	39	173	187	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 23	2010	468	7327					1061	U460		10.1038/nature09629	http://dx.doi.org/10.1038/nature09629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179162	Green Accepted			2022-12-28	WOS:000285553800050
J	Gerstein, MB; Lu, ZJ; Van Nostrand, EL; Cheng, C; Arshinoff, BI; Liu, T; Yip, KY; Robilotto, R; Rechtsteiner, A; Ikegami, K; Alves, P; Chateigner, A; Perry, M; Morris, M; Auerbach, RK; Feng, X; Leng, J; Vielle, A; Niu, W; Rhrissorrakrai, K; Agarwal, A; Alexander, RP; Barber, G; Brdlik, CM; Brennan, J; Brouillet, JJ; Carr, A; Cheung, MS; Clawson, H; Contrino, S; Dannenberg, LO; Dernburg, AF; Desai, A; Dick, L; Dose, AC; Du, JA; Egelhofer, T; Ercan, S; Euskirchen, G; Ewing, B; Feingold, EA; Gassmann, R; Good, PJ; Green, P; Gullier, F; Gutwein, M; Guyer, MS; Habegger, L; Han, T; Henikoff, JG; Henz, SR; Hinrichs, A; Holster, H; Hyman, T; Iniguez, AL; Janette, J; Jensen, M; Kato, M; Kent, WJ; Kephart, E; Khivansara, V; Khurana, E; Kim, JK; Kolasinska-Zwierz, P; Lai, EC; Latorre, I; Leahey, A; Lewis, S; Lloyd, P; Lochovsky, L; Lowdon, RF; Lubling, Y; Lyne, R; MacCoss, M; Mackowiak, SD; Mangone, M; Mckay, S; Mecenas, D; Merrihew, G; Miller, DM; Muroyama, A; Murray, JI; Ooi, SL; Pham, H; Phippen, T; Preston, EA; Rajewsky, N; Ratsch, G; Rosenbaum, H; Rozowsky, J; Rutherford, K; Ruzanov, P; Sarov, M; Sasidharan, R; Sboner, A; Scheid, P; Segal, E; Shin, HJ; Shou, C; Slack, FJ; Slightam, C; Smith, R; Spencer, WC; Stinson, EO; Taing, S; Takasaki, T; Vafeados, D; Voronina, K; Wang, GL; Washington, NL; Whittle, CM; Wu, BJ; Yan, KK; Zeller, G; Zha, Z; Zhong, M; Zhou, XL; Ahringer, J; Strome, S; Gunsalus, KC; Micklem, G; Liu, XS; Reinke, V; Kim, SK; Hillier, LW; Henikoff, S; Piano, F; Snyder, M; Stein, L; Lieb, JD; Waterston, RH				Gerstein, Mark B.; Lu, Zhi John; Van Nostrand, Eric L.; Cheng, Chao; Arshinoff, Bradley I.; Liu, Tao; Yip, Kevin Y.; Robilotto, Rebecca; Rechtsteiner, Andreas; Ikegami, Kohta; Alves, Pedro; Chateigner, Aurelien; Perry, Marc; Morris, Mitzi; Auerbach, Raymond K.; Feng, Xin; Leng, Jing; Vielle, Anne; Niu, Wei; Rhrissorrakrai, Kahn; Agarwal, Ashish; Alexander, Roger P.; Barber, Galt; Brdlik, Cathleen M.; Brennan, Jennifer; Brouillet, Jeremy Jean; Carr, Adrian; Cheung, Ming-Sin; Clawson, Hiram; Contrino, Sergio; Dannenberg, Luke O.; Dernburg, Abby F.; Desai, Arshad; Dick, Lindsay; Dose, Andrea C.; Du, Jiang; Egelhofer, Thea; Ercan, Sevinc; Euskirchen, Ghia; Ewing, Brent; Feingold, Elise A.; Gassmann, Reto; Good, Peter J.; Green, Phil; Gullier, Francois; Gutwein, Michelle; Guyer, Mark S.; Habegger, Lukas; Han, Ting; Henikoff, Jorja G.; Henz, Stefan R.; Hinrichs, Angie; Holster, Heather; Hyman, Tony; Iniguez, A. Leo; Janette, Judith; Jensen, Morten; Kato, Masaomi; Kent, W. James; Kephart, Ellen; Khivansara, Vishal; Khurana, Ekta; Kim, John K.; Kolasinska-Zwierz, Paulina; Lai, Eric C.; Latorre, Isabel; Leahey, Amber; Lewis, Suzanna; Lloyd, Paul; Lochovsky, Lucas; Lowdon, Rebecca F.; Lubling, Yaniv; Lyne, Rachel; MacCoss, Michael; Mackowiak, Sebastian D.; Mangone, Marco; Mckay, Sheldon; Mecenas, Desirea; Merrihew, Gennifer; Miller, David M., III; Muroyama, Andrew; Murray, John I.; Ooi, Siew-Loon; Pham, Hoang; Phippen, Taryn; Preston, Elicia A.; Rajewsky, Nikolaus; Raetsch, Gunnar; Rosenbaum, Heidi; Rozowsky, Joel; Rutherford, Kim; Ruzanov, Peter; Sarov, Mihail; Sasidharan, Rajkumar; Sboner, Andrea; Scheid, Paul; Segal, Eran; Shin, Hyunjin; Shou, Chong; Slack, Frank J.; Slightam, Cindie; Smith, Richard; Spencer, William C.; Stinson, E. O.; Taing, Scott; Takasaki, Teruaki; Vafeados, Dionne; Voronina, Ksenia; Wang, Guilin; Washington, Nicole L.; Whittle, Christina M.; Wu, Beijing; Yan, Koon-Kiu; Zeller, Georg; Zha, Zheng; Zhong, Mei; Zhou, Xingliang; Ahringer, Julie; Strome, Susan; Gunsalus, Kristin C.; Micklem, Gos; Liu, X. Shirley; Reinke, Valerie; Kim, Stuart K.; Hillier, LaDeana W.; Henikoff, Steven; Piano, Fabio; Snyder, Michael; Stein, Lincoln; Lieb, Jason D.; Waterston, Robert H.		modENCODE Consortium	Integrative Analysis of the Caenorhabditis elegans Genome by the modENCODE Project	SCIENCE			English	Article							TRANSCRIPTION; REVEALS; DNA; MOTIFS; ROLES; IDENTIFICATION; ORGANIZATION; EXPRESSION; LANDSCAPE; GERMLINE	We systematically generated large-scale data sets to improve genome annotation for the nematode Caenorhabditis elegans, a key model organism. These data sets include transcriptome profiling across a developmental time course, genome-wide identification of transcription factor-binding sites, and maps of chromatin organization. From this, we created more complete and accurate gene models, including alternative splice forms and candidate noncoding RNAs. We constructed hierarchical networks of transcription factor-binding and microRNA interactions and discovered chromosomal locations bound by an unusually large number of transcription factors. Different patterns of chromatin composition and histone modification were revealed between chromosome arms and centers, with similarly prominent differences between autosomes and the X chromosome. Integrating data types, we built statistical models relating chromatin, transcription factor binding, and gene expression. Overall, our analyses ascribed putative functions to most of the conserved genome.	[Gerstein, Mark B.; Lu, Zhi John; Cheng, Chao; Yip, Kevin Y.; Robilotto, Rebecca; Alves, Pedro; Auerbach, Raymond K.; Leng, Jing; Alexander, Roger P.; Habegger, Lukas; Lochovsky, Lucas; Rozowsky, Joel; Sboner, Andrea; Shou, Chong; Yan, Koon-Kiu] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, Mark B.; Lu, Zhi John; Cheng, Chao; Yip, Kevin Y.; Agarwal, Ashish; Alexander, Roger P.; Rozowsky, Joel; Sasidharan, Rajkumar; Sboner, Andrea; Yan, Koon-Kiu] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark B.; Agarwal, Ashish; Du, Jiang] Yale Univ, Dept Comp Sci, New Haven, CT 06511 USA; [Van Nostrand, Eric L.; Brdlik, Cathleen M.; Brouillet, Jeremy Jean; Kim, Stuart K.; Snyder, Michael] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; [Arshinoff, Bradley I.; Perry, Marc; Feng, Xin; Kephart, Ellen; Lloyd, Paul; Ruzanov, Peter; Zha, Zheng; Stein, Lincoln] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Arshinoff, Bradley I.; Stein, Lincoln] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Liu, Tao; Shin, Hyunjin; Taing, Scott; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Tao; Shin, Hyunjin; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Ikegami, Kohta; Brennan, Jennifer; Ercan, Sevinc; Jensen, Morten; Whittle, Christina M.; Zhou, Xingliang; Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Ikegami, Kohta; Brennan, Jennifer; Ercan, Sevinc; Jensen, Morten; Whittle, Christina M.; Zhou, Xingliang; Lieb, Jason D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Chateigner, Aurelien; Carr, Adrian; Contrino, Sergio; Gullier, Francois; Lyne, Rachel; Rutherford, Kim; Smith, Richard; Micklem, Gos] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Chateigner, Aurelien; Carr, Adrian; Contrino, Sergio; Gullier, Francois; Lyne, Rachel; Rutherford, Kim; Smith, Richard; Micklem, Gos] Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Morris, Mitzi; Rhrissorrakrai, Kahn; Gutwein, Michelle; Khurana, Ekta; Mangone, Marco; Mecenas, Desirea; Scheid, Paul; Gunsalus, Kristin C.; Piano, Fabio] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Vielle, Anne; Cheung, Ming-Sin; Kolasinska-Zwierz, Paulina; Latorre, Isabel; Ahringer, Julie] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Niu, Wei; Euskirchen, Ghia; Zhong, Mei; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06824 USA; [Niu, Wei; Janette, Judith; Wang, Guilin; Reinke, Valerie] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Dannenberg, Luke O.; Holster, Heather; Iniguez, A. Leo; Rosenbaum, Heidi] Roche NimbleGen, Madison, WI 53719 USA; [Dernburg, Abby F.; Dose, Andrea C.; Pham, Hoang] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dernburg, Abby F.; Dose, Andrea C.; Pham, Hoang] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Desai, Arshad; Gassmann, Reto; Muroyama, Andrew; Voronina, Ksenia] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, San Diego, CA 92093 USA; [Ewing, Brent; Green, Phil; Leahey, Amber; MacCoss, Michael; Merrihew, Gennifer; Murray, John I.; Preston, Elicia A.; Vafeados, Dionne; Hillier, LaDeana W.; Waterston, Robert H.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Feingold, Elise A.; Good, Peter J.; Guyer, Mark S.; Lowdon, Rebecca F.] NHGRI, Div Extramural Res, NIH, Bethesda, MD 20892 USA; [Feng, Xin] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Han, Ting; Khivansara, Vishal; Kim, John K.] Univ Michigan, Inst Life Sci, Dept Human Genet, Ann Arbor, MI 48109 USA; [Henikoff, Jorja G.; Ooi, Siew-Loon; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Raetsch, Gunnar; Zeller, Georg] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Hyman, Tony; Sarov, Mihail] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Miller, David M., III; Spencer, William C.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Kato, Masaomi; Slack, Frank J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Henz, Stefan R.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Lai, Eric C.] Sloan Kettering Inst, New York, NY 10065 USA; [Lewis, Suzanna; Stinson, E. O.; Washington, Nicole L.] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Lubling, Yaniv; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Mackowiak, Sebastian D.; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Div Syst Biol, D-13125 Berlin, Germany; [Mckay, Sheldon; Stein, Lincoln] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11542 USA; [Slightam, Cindie; Wu, Beijing; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Zeller, Georg] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Gunsalus, Kristin C.; Piano, Fabio] NYU, Abu Dhabi, U Arab Emirates; [Dick, Lindsay] Rockefeller Univ, David Rockefeller Grad Program, New York, NY 10065 USA	Yale University; Yale University; Yale University; Stanford University; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge; University of Cambridge; New York University; University of Cambridge; Yale University; Yale University; University of California System; University of California Santa Cruz; Roche Holding; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Michigan System; University of Michigan; Fred Hutchinson Cancer Center; Eberhard Karls University of Tubingen; Max Planck Society; Max Planck Society; Vanderbilt University; Yale University; Max Planck Society; Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Weizmann Institute of Science; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Cold Spring Harbor Laboratory; Stanford University; European Molecular Biology Laboratory (EMBL); Rockefeller University	Gerstein, MB (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, Bass 432,266 Whitney Ave, New Haven, CT 06520 USA.	modencode.worm.pi@gersteinlab.org	Spencer, William/E-8529-2010; Zeller, Georg/M-6484-2013; Yan, Koon-Kiu/A-5940-2009; Hyman, Anthony A/B-3917-2017; Mackowiak, Sebastian D/S-3266-2017; Segal, Eran/AAF-4855-2019; Chateigner, Aurelien/AAC-9143-2020; Yip, Kevin/AAT-4771-2020; Alexander, Roger/A-8643-2008; Lai, Eric C/A-3412-2008; Liu, Tao/AAO-6310-2021; Rutherford, Kim/Y-7995-2018; Lai, Eric/AAO-1143-2021; Khurana, Ekta/C-4933-2013; Sboner, Andrea/C-6487-2008; Hinrichs, Angie S./H-9159-2019; Lyne, Rachel/AAE-2189-2020; Hyman, Tony/F-1923-2011; NUI, WEI/B-8300-2011; Clawson, Hiram/ABE-6101-2020; KHIVANSARA, VISHAL/P-7702-2019; Gassmann, Reto/M-6488-2013; Liu, Tao/G-3585-2010; Mangone, Marco/H-2462-2016	Zeller, Georg/0000-0003-1429-7485; Hyman, Anthony A/0000-0003-3664-154X; Mackowiak, Sebastian D/0000-0003-1673-5389; Yip, Kevin/0000-0001-5516-9944; Alexander, Roger/0000-0002-2967-7395; Liu, Tao/0000-0002-8818-8313; Rutherford, Kim/0000-0001-6277-726X; Lai, Eric/0000-0002-8432-5851; Sboner, Andrea/0000-0001-6915-3070; Hinrichs, Angie S./0000-0002-1697-1130; Lyne, Rachel/0000-0001-8050-402X; KHIVANSARA, VISHAL/0000-0003-2574-5298; Gassmann, Reto/0000-0002-0360-2977; Liu, Tao/0000-0002-8818-8313; Rechtsteiner, Andreas/0000-0001-6031-1087; Clawson, Hiram/0000-0002-0480-0545; Ratsch, Gunnar/0000-0001-5486-8532; Slack, Frank/0000-0001-8263-0409; Dernburg, Abby/0000-0001-8037-1079; Ahringer, Julie/0000-0002-7074-4051; contrino, sergio/0000-0003-3409-5231; Snyder, Michael/0000-0003-0784-7987; Henikoff, Steven/0000-0002-7621-8685; Lloyd, Paul/0000-0003-3508-5553; Van Nostrand, Eric/0000-0002-5188-0082; Muroyama, Andrew/0000-0003-0701-212X; Micklem, Gos/0000-0002-6883-6168; Rozowsky, Joel/0000-0002-3565-0762; Rajewsky, Nikolaus/0000-0002-4785-4332; Lubling, Yaniv/0000-0003-3461-9621; Mangone, Marco/0000-0001-7551-8793; McKay, Sheldon/0000-0002-4011-3160; Segal, Eran/0000-0002-6859-1164; Latorre, Isabel/0000-0003-0638-1783; Liu, Tao/0000-0003-0446-9001; Lewis, Suzanna/0000-0002-8343-612X	NHGRI of the NIH [R01GM088565]; Muscular Dystrophy Association; Pew Charitable Trusts; Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network); Wellcome Trust; William H. Gates III Endowed Chair of Biomedical Sciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088565] Funding Source: NIH RePORTER	NHGRI of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Muscular Dystrophy Association(Muscular Dystrophy Association); Pew Charitable Trusts; Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network); Wellcome Trust(Wellcome TrustEuropean Commission); William H. Gates III Endowed Chair of Biomedical Sciences; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work came from the NHGRI of the NIH as part of the modENCODE project, NIH (grant R01GM088565), Muscular Dystrophy Association, and the Pew Charitable Trusts (J.K.K.); the Helmholtz-Alliance on Systems Biology (Max Delbruck Centrum Systems Biology Network) (S.D.M.); the Wellcome Trust (J.A.); the William H. Gates III Endowed Chair of Biomedical Sciences (R.H.W.); and the A. L. Williams Professorship (M.B.G.). M. Snyder has an advisory role with DNANexus, a DNA sequence storage and analysis company. Transfer of GFP-tagged fosmids requires a Materials Transfer Agreement with the Max Planck Institute of Molecular Cell Biology and Genetics. Raw microarray data are available from the Gene Expression Omnibus archive, and raw sequencing data are available from the SRA archive (accessions are in table S18). We appreciate help from S. Anthony, K. Bell, C. Davis, C. Dieterich, Y. Field, A. S. Hammonds, J. Jo, N. Kaplan, A. Manrai, B. Mathey-Prevot, R. McWhirter, S. Mohr, S. Von Stetina, J. Watson, K. Watkins, C. Xue, and Y. Zhang, and B. Carpenter. We thank C. Jan and D. Bartel for sharing data on poly(A) sites before publication, WormBase curator G. Williams for assistance in quality checking and preparing the transcriptomics data sets for publication, as well as his fellow curator P. Davis for reviewing and hand-checking the list of pseudogenes.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARNES TM, 1995, GENETICS, V141, P159; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bickel P. J., 2010, ANN APPL STAT, V0, P1; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chung WJ, 2011, GENOME RES, V21, P286, DOI 10.1101/gr.113050.110; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; EDGAR LG, 1994, DEVELOPMENT, V120, P443; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Ercan S, 2011, GENOME RES, V21, P237, DOI 10.1101/gr.115931.110; Ercan S, 2009, CURR BIOL, V19, P1777, DOI 10.1016/j.cub.2009.09.047; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Guoping S, 2010, CHROMOSOMA, V119, P73, DOI 10.1007/s00412-009-0235-3; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Ikegami K., GENOME RES, DOI [10.1186/gb-2010-11-12-r120, DOI 10.1186/GB-2010-11-12-R120]; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jans J, 2009, GENE DEV, V23, P602, DOI 10.1101/gad.1751109; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Kelly WG, 2002, DEVELOPMENT, V129, P479; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lamesch P, 2004, GENOME RES, V14, P2064, DOI 10.1101/gr.2496804; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Lu ZJ, 2011, GENOME RES, V21, P276, DOI 10.1101/gr.110189.110; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Meyer BJ., 2005, WORMBOOK, P1, DOI [10.1895/wormbook.1.8.1, DOI 10.1895/WORMBOOK.1.8.1]; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Ooi SL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1090; Phillips CM, 2009, NAT CELL BIOL, V11, P934, DOI 10.1038/ncb1904; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Riddle D. L, 1997, C ELEGANS, P47; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Stoeckius M, 2009, NAT METHODS, V6, P745, DOI [10.1038/nmeth.1370, 10.1038/NMETH.1370]; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103	76	685	691	0	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1775	1787		10.1126/science.1196914	http://dx.doi.org/10.1126/science.1196914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21177976	Green Accepted, Green Submitted			2022-12-28	WOS:000285603700031
J	Kapoor, A; Goldberg, MS; Cumberland, LK; Ratnakumar, K; Segura, MF; Emanuel, PO; Menendez, S; Vardabasso, C; LeRoy, G; Vidal, CI; Polsky, D; Osman, I; Garcia, BA; Hernando, E; Bernstein, E				Kapoor, Avnish; Goldberg, Matthew S.; Cumberland, Lara K.; Ratnakumar, Kajan; Segura, Miguel F.; Emanuel, Patrick O.; Menendez, Silvia; Vardabasso, Chiara; LeRoy, Gary; Vidal, Claudia I.; Polsky, David; Osman, Iman; Garcia, Benjamin A.; Hernando, Eva; Bernstein, Emily			The histone variant macroH2A suppresses melanoma progression through regulation of CDK8	NATURE			English	Article							INACTIVE X-CHROMOSOME; CORE HISTONE; CANCER; METASTASIS; EXPRESSION; GENE; TRANSCRIPTION; STAGE; LINES	Cancer is a disease consisting of both genetic and epigenetic changes. Although increasing evidence demonstrates that tumour progression entails chromatin-mediated changes such as DNA methylation, the role of histone variants in cancer initiation and progression currently remains unclear. Histone variants replace conventional histones within the nucleosome and confer unique biological functions to chromatin(1-3). Here we report that the histone variant macroH2A (mH2A) suppresses tumour progression of malignant melanoma. Loss of mH2A isoforms, histone variants generally associated with condensed chromatin and fine-tuning of developmental gene expression programs(1,4-6), is positively correlated with increasing malignant phenotype of melanoma cells in culture and human tissue samples. Knockdown of mH2A isoforms in melanoma cells of low malignancy results in significantly increased proliferation and migration in vitro and growth and metastasis in vivo. Restored expression of mH2A isoforms rescues these malignant phenotypes in vitro and in vivo. We demonstrate that the tumour-promoting function of mH2A loss is mediated, at least in part, through direct transcriptional upregulation of CDK8. Suppression of CDK8, a colorectal cancer oncogene(7,8), inhibits proliferation of melanoma cells, and knockdown of CDK8 in cells depleted of mH2A suppresses the proliferative advantage induced by mH2A loss. Moreover, a significant inverse correlation between mH2A and CDK8 expression levels exists in melanoma patient samples. Taken together, our results demonstrate that mH2A is a critical component of chromatin that suppresses the development of malignant melanoma, a highly intractable cutaneous neoplasm.	[Kapoor, Avnish; Goldberg, Matthew S.; Cumberland, Lara K.; Ratnakumar, Kajan; Vardabasso, Chiara; Bernstein, Emily] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Kapoor, Avnish; Goldberg, Matthew S.; Cumberland, Lara K.; Ratnakumar, Kajan; Emanuel, Patrick O.; Vardabasso, Chiara; Vidal, Claudia I.; Bernstein, Emily] Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USA; [Emanuel, Patrick O.; Vidal, Claudia I.] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; [Segura, Miguel F.; Menendez, Silvia; Polsky, David; Hernando, Eva] NYU, Dept Pathol, Langone Med Ctr, New York, NY 10016 USA; [Polsky, David; Osman, Iman] NYU, Dept Dermatol, Langone Med Ctr, New York, NY 10016 USA; [Segura, Miguel F.; Menendez, Silvia; Polsky, David; Osman, Iman; Hernando, Eva] NYU, Interdisciplinary Melanoma Cooperat Grp, Langone Med Ctr, New York, NY 10016 USA; [LeRoy, Gary; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Princeton University	Bernstein, E (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, 1425 Madison Ave, New York, NY 10029 USA.	emily.bernstein@mssm.edu	Polsky, David/AAO-6254-2020; Segura, Miguel F/J-4749-2013; Grieshaber-Bouyer, Ricardo/R-7512-2016	Polsky, David/0000-0001-9554-5289; Segura, Miguel F/0000-0003-0916-3618; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Hernando, Eva/0000-0003-1023-0312	American Skin Association; American Society for Mass Spectrometry; New Jersey Commission on Cancer Research; National Science Foundation [CBET-0941143]; National Institutes of Health [CA109388]; Sergei S. Zlinkoff Fund for Medical Education; New York University Cancer Institute Cancer Center [5P30CA016087-27]; Marc Jacobs Campaign; NYSTEM IDEA [C024291]; Harry L. Lloyd Charitable Trust; Ellison Medical Foundation; Tisch Cancer Institute; NCI [R21CA150117]; NATIONAL CANCER INSTITUTE [P30CA016087, R21CA109388, R21CA150117] Funding Source: NIH RePORTER	American Skin Association; American Society for Mass Spectrometry; New Jersey Commission on Cancer Research; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sergei S. Zlinkoff Fund for Medical Education; New York University Cancer Institute Cancer Center; Marc Jacobs Campaign; NYSTEM IDEA; Harry L. Lloyd Charitable Trust; Ellison Medical Foundation(Lawrence Ellison Foundation); Tisch Cancer Institute; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Hannon, S. Hake and M. Wirtz for reading this manuscript; J. Doucette for statistical support; the laboratories of S. Aaronson, J. Aguirre-Ghiso, D. Burstein and M. O'Connell for discussions and advice; M. Lebwohl, S. Mercer, J. Emer and G. Singer for dermatology and pathology support. We also thank N. Mall, L. Murray, S. Malu and S. Mungamuri for technical assistance; J. Pehrson, M. Narita, A. Aplin, H. Wei, A. Ting, S. Young Kim, M. Herlyn and J. Espinosa for reagents; T. Chu (Mount Sinai School of Medicine Microarray SRF) for data analysis; Q. Yu, the New York University Interdisciplinary Melanoma Cooperative Group and Mount Sinai Biorepository Cooperative for melanoma specimens. This work was supported by an American Skin Association Medical Student Grant to M. S. G., American Society for Mass Spectrometry Award, New Jersey Commission on Cancer Research Seed Grant, and National Science Foundation CBET-0941143 to B. A. G., National Institutes of Health CA109388 and the Sergei S. Zlinkoff Fund for Medical Education to D. P., New York University Cancer Institute Cancer Center Support Grant (5P30CA016087-27) and Marc Jacobs Campaign to I.O., NYSTEM IDEA C024291 and Harry L. Lloyd Charitable Trust to E. H., and an American Skin Association Research Scholar Award, Ellison Medical Foundation New Scholar Award, Tisch Cancer Institute Developmental Funds and NCI R21CA150117 to E.B.	Bernstein E, 2008, P NATL ACAD SCI USA, V105, P1533, DOI 10.1073/pnas.0711632105; Bernstein E, 2006, BIOCHEM CELL BIOL, V84, P505, DOI 10.1139/O06-085; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Costanzi C, 2001, J BIOL CHEM, V276, P21776, DOI 10.1074/jbc.M010919200; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; QIAN F, 1994, CELL, V77, P335, DOI 10.1016/0092-8674(94)90149-X; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Thambirajah AA, 2009, BIOCHEM CELL BIOL, V87, P7, DOI 10.1139/O08-103; Yancovitz M, 2007, J MOL DIAGN, V9, P178, DOI 10.2353/jmoldx.2007.060135; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	30	284	299	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1105	U509		10.1038/nature09590	http://dx.doi.org/10.1038/nature09590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179167	Green Accepted			2022-12-28	WOS:000285553800059
J	Mozaffarian, D; Cao, HM; King, IB; Lemaitre, RN; Song, XL; Siscovick, DS; Hotamisligil, GS				Mozaffarian, Dariush; Cao, Haiming; King, Irena B.; Lemaitre, Rozenn N.; Song, Xiaoling; Siscovick, David S.; Hotamisligil, Goekhan S.			Trans-Palmitoleic Acid, Metabolic Risk Factors, and New-Onset Diabetes in U.S. Adults A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CONJUGATED LINOLEIC-ACID; DE-NOVO LIPOGENESIS; NONFATAL MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE SYNDROME; SERUM-CHOLESTEROL ESTERS; ISCHEMIC-HEART-DISEASE; C-REACTIVE PROTEIN; DAIRY FAT INTAKE; ADIPOSE-TISSUE; HIGH-CARBOHYDRATE	Background: Palmitoleic acid (cis-16:1n-7), which is produced by endogenous fat synthesis, has been linked to both beneficial and deleterious metabolic effects, potentially confounded by diverse determinants and tissue sources of endogenous production. Trans-palmitoleate (trans-16:1n-7) represents a distinctly exogenous source of 16:1n-7, unconfounded by endogenous synthesis or its determinants, that may be uniquely informative. Objective: To investigate whether circulating trans-palmitoleate is independently related to lower metabolic risk and incident type 2 diabetes. Design: Prospective cohort study from 1992 to 2006. Setting: Four U.S. communities. Patients: 3736 adults in the Cardiovascular Health Study. Measurements: Anthropometric characteristics and levels of plasma phospholipid fatty acids, blood lipids, inflammatory markers, and glucose-insulin measured at baseline in 1992 and dietary habits measured 3 years earlier. Multivariate-adjusted models were used to investigate how demographic, clinical, and lifestyle factors independently related to plasma phospholipid trans-palmitoleate; how trans-palmitoleate related to major metabolic risk factors; and how trans-palmitoleate related to new-onset diabetes (304 incident cases). Findings were validated for metabolic risk factors in an independent cohort of 327 women. Results: In multivariate analyses, whole-fat dairy consumption was most strongly associated with higher trans-palmitoleate levels. Higher trans-palmitoleate levels were associated with slightly lower adiposity and, independently, with higher high-density lipoprotein cholesterol levels (1.9% across quintiles; P = 0.040), lower triglyceride levels (-19.0%; P < 0.001), a lower total cholesterol-HDL cholesterol ratio (-4.7%; P < 0.001), lower C-reactive protein levels (-13.8%; P = 0.05), and lower insulin resistance (-16.7%, P < 0.001). Trans-palmitoleate was also associated with a substantially lower incidence of diabetes, with multivariate hazard ratios of 0.41 (95% CI, 0.27 to 0.64) and 0.38 (CI, 0.24 to 0.62) in quintiles 4 and 5 versus quintile 1 (P for trend < 0.001). Findings were independent of estimated dairy consumption or other fatty acid dairy biomarkers. Protective associations with metabolic risk factors were confirmed in the validation cohort. Limitation: Results could be affected by measurement error or residual confounding. Conclusion: Circulating trans-palmitoleate is associated with lower insulin resistance, presence of atherogenic dyslipidemia, and incident diabetes. Our findings may explain previously observed metabolic benefits of dairy consumption and support the need for detailed further experimental and clinical investigation.	[Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; NIH, Bethesda, MD 20892 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; University of New Mexico; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Cao, Haiming/P-4634-2016; Mozaffarian, Dariush/B-2276-2008		National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01-HL085710, DK064360, DK71507-04, N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079, -85086, N01-HC-15103, N01-HC-55222, U01-HL080295]; Searle Scholar Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC075150, N01HC045133, N01HC085084, N01HC085079, N01HC085085, N01HC035129, N01HC055222, N01HC085083, N01HC015103, N01HC085080, N01HC085082, N01HC085086, N01HC085081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL085710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064360, R01DK064360, R90DK071507] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Searle Scholar Award; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.; By the National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (grants R01-HL085710, DK064360, and DK71507-04 and grants N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079 through -85086, N01-HC-15103, N01-HC-55222, and U01-HL080295 for the CHS), with additional contributions from the National Institutes of Health Office of Dietary Supplements and National Institute of Neurological Disorders and Stroke. A subset of additional fatty acid measurements was supported by a Searle Scholar Award.	Azadbakht L, 2005, AM J CLIN NUTR, V82, P523, DOI 10.1093/ajcn/82.3.523; Barazzoni R, 2003, DIABETES, V52, P1851, DOI 10.2337/diabetes.52.7.1851; Baumgard LH, 2002, J DAIRY SCI, V85, P2155, DOI 10.3168/jds.S0022-0302(02)74294-X; Beydoun MA, 2008, AM J CLIN NUTR, V87, P1914, DOI 10.1093/ajcn/87.6.1914; Brevik A, 2005, EUR J CLIN NUTR, V59, P1417, DOI 10.1038/sj.ejcn.1602256; CAMBIEN F, 1988, AM J EPIDEMIOL, V127, P75, DOI 10.1093/oxfordjournals.aje.a114793; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chardigny JM, 2008, AM J CLIN NUTR, V87, P558, DOI 10.1093/ajcn/87.3.558; Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; Devaraj S, 2009, CURR OPIN LIPIDOL, V20, P182, DOI 10.1097/MOL.0b013e32832ac03e; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Elwood PC, 2008, J AM COLL NUTR, V27, p723S, DOI 10.1080/07315724.2008.10719750; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gertow K, 2006, EUR J CLIN NUTR, V60, P1406, DOI 10.1038/sj.ejcn.1602471; Harvatine KJ, 2009, J NUTR, V139, P849, DOI 10.3945/jn.108.099994; Harvey-Berino J, 2005, OBES RES, V13, P1720, DOI 10.1038/oby.2005.210; Hodgson JM, 1996, ATHEROSCLEROSIS, V120, P147, DOI 10.1016/0021-9150(95)05696-3; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Hudgins LC, 2008, J NUTR BIOCHEM, V19, P237, DOI 10.1016/j.jnutbio.2007.02.013; Iggman D, 2010, DIABETOLOGIA, V53, P850, DOI 10.1007/s00125-010-1669-0; King IB, 2006, AM J CLIN NUTR, V83, P227; Kumanyika SK, 1997, AM J CLIN NUTR, V65, P1123; Kusunoki Masataka, 2007, J Med Invest, V54, P243, DOI 10.2152/jmi.54.243; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; Lemaitre RN, 2006, CIRCULATION, V114, P209, DOI 10.1161/CIRCULATIONAHA.106.620336; LEPAGE G, 1986, J LIPID RES, V27, P114; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Lindgarde F, 2006, AM J CLIN NUTR, V84, P1009, DOI 10.1093/ajcn/84.5.1009; Liu SM, 2006, DIABETES CARE, V29, P1579, DOI 10.2337/dc06-0256; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maguire LS, 2004, INT J FOOD SCI NUTR, V55, P171, DOI 10.1080/09637480410001725175; Marques-Lopes I, 2001, AM J CLIN NUTR, V73, P253; Micha R, 2010, AM J CLIN NUTR, V91, P883, DOI 10.3945/ajcn.2009.28877; Mirmiran P, 2005, INT J OBESITY, V29, P115, DOI 10.1038/sj.ijo.0802838; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Motard-Belanger A, 2008, AM J CLIN NUTR, V87, P593, DOI 10.1093/ajcn/87.3.593; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2010, AM J CLIN NUTR  1013; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Okada T, 2005, AM J CLIN NUTR, V82, P747, DOI 10.1093/ajcn/82.4.747; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Petersson H, 2009, ATHEROSCLEROSIS, V203, P298, DOI 10.1016/j.atherosclerosis.2008.06.020; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Riserus U, 2004, AM J CLIN NUTR, V79, p1146S; Rosell M, 2006, AM J CLIN NUTR, V84, P1481, DOI 10.1093/ajcn/84.6.1481; ROSNER B, 1977, AM J EPIDEMIOL, V106, P306, DOI 10.1093/oxfordjournals.aje.a112466; ROSSNER S, 1989, INT J OBESITY, V13, P603; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; SALOMAA V, 1990, METABOLISM, V39, P1285, DOI 10.1016/0026-0495(90)90185-F; Sarabi M, 2001, ATHEROSCLEROSIS, V156, P349, DOI 10.1016/S0021-9150(00)00658-4; Sauma L, 2006, NUTRITION, V22, P60, DOI 10.1016/j.nut.2005.04.011; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Simon JA, 1996, HYPERTENSION, V27, P303, DOI 10.1161/01.HYP.27.2.303; SOMMERFELD M, 1983, PROG LIPID RES, V22, P221, DOI 10.1016/0163-7827(83)90010-3; Stefan N, 2010, DIABETES CARE, V33, P405, DOI [10.2337/dc10-0002, 10.2337/dc09-0544]; Sun Q, 2008, AM J CLIN NUTR, V88, P216, DOI 10.1093/ajcn/88.1.216; Tremblay A, 2009, J AM COLL NUTR, V28, p91S, DOI 10.1080/07315724.2009.10719809; Vergnaud AC, 2008, AM J CLIN NUTR, V88, P1248, DOI 10.3945/ajcn.2007.25151; VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/s001250050215; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Willett W, 2008, AM J CLIN NUTR, V87, P515, DOI 10.1093/ajcn/87.3.515; Wolk A, 1998, AM J CLIN NUTR, V68, P291, DOI 10.1093/ajcn/68.2.291; Wolk A, 2001, J NUTR, V131, P828, DOI 10.1093/jn/131.3.828; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67	69	265	285	1	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					790	+		10.7326/0003-4819-153-12-201012210-00005	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173413	Green Accepted			2022-12-28	WOS:000285453700002
J	Thomas, R				Thomas, Roger			A promotional, educational intervention increased staff influenza vaccination in primary care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calgary, Calgary, AB, Canada	University of Calgary	Thomas, R (corresponding author), Univ Calgary, Calgary, AB, Canada.							Thomas RE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub3; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12							JC6-2	10.7326/0003-4819-153-12-201012210-02002	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173403				2022-12-28	WOS:000285453700019
J	Reines, AE; Sivakoff, GR; Johnson, KE; Brogan, CL				Reines, Amy E.; Sivakoff, Gregory R.; Johnson, Kelsey E.; Brogan, Crystal L.			An actively accreting massive black hole in the dwarf starburst galaxy Henize 2-10	NATURE			English	Article							LARGE-MAGELLANIC-CLOUD; SUPER-STAR-CLUSTERS; RADIO; LUMINOSITY; EMISSION; DIFFUSE	Supermassive black holes are now thought to lie at the heart of every giant galaxy with a spheroidal component, including our own Milky Way(1,2). The birth and growth of the first 'seed' black holes in the earlier Universe, however, is observationally unconstrained(3) and we are only beginning to piece together a scenario for their subsequent evolution(4). Here we report that the nearby dwarf starburst galaxy Henize 2-10 (refs 5 and 6) contains a compact radio source at the dynamical centre of the galaxy that is spatially coincident with a hard X-ray source. From these observations, we conclude that Henize 2-10 harbours an actively accreting central black hole with a mass of approximately one million solar masses. This nearby dwarf galaxy, simultaneously hosting a massive black hole and an extreme burst of star formation, is analogous in many ways to galaxies in the infant Universe during the early stages of black-hole growth and galaxy mass assembly. Our results confirm that nearby star-forming dwarf galaxies can indeed form massive black holes, and that by implication so can their primordial counterparts. Moreover, the lack of a substantial spheroidal component in Henize 2-10 indicates that supermassive black-hole growth may precede the build-up of galaxy spheroids.	[Reines, Amy E.; Sivakoff, Gregory R.; Johnson, Kelsey E.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Johnson, Kelsey E.; Brogan, Crystal L.] Natl Radio Astron Observ, Charlottesville, VA 22904 USA	University of Virginia; National Radio Astronomy Observatory (NRAO)	Reines, AE (corresponding author), Univ Virginia, Dept Astron, 530 McCormick Rd, Charlottesville, VA 22904 USA.	areines@virginia.edu	Sivakoff, Gregory R/G-9602-2011	Sivakoff, Gregory R/0000-0001-6682-916X; Reines, Amy/0000-0001-7158-614X; Brogan, Crystal/0000-0002-6558-7653	NASA; University of Virginia; NASA through the Chandra X-ray Observatory Center; NSF; David and Lucile Packard Foundation; NASA through Space Telescope Science Institute	NASA(National Aeronautics & Space Administration (NASA)); University of Virginia; NASA through the Chandra X-ray Observatory Center; NSF(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NASA through Space Telescope Science Institute(Space Telescope Science Institute)	A.E.R. is grateful for many discussions on this work, in particular with M. Whittle, J. Ulvestad, M. Goss, S. Kannappan, J. Greene, R. Hickox, A. Evens, R. O'Connell, R. Chevalier, A. Seth, E. Gallo, S. Ransom, L. Hunt and J. Simon. A.E.R. acknowledges support from a NASA Earth and Space Science Fellowship, and the University of Virginia through a Governor's Fellowship and a Dissertation Acceleration Fellowship. G.R.S. acknowledges support for this work by NASA through the Chandra X-ray Observatory Center, which is operated by the Smithsonian Astrophysical Observatory for and on behalf of NASA. K.E.J. acknowledges support from the NSF through a CAREER award and the David and Lucile Packard Foundation through a Packard Fellowship. Support was provided by NASA through a grant from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. This research has made use of data obtained from the Hubble Space Telescope and Chandra X-ray Observatory Data Archives.	ALLEN DA, 1976, MON NOT R ASTRON SOC, V177, P91, DOI 10.1093/mnras/177.1.91; Barth AJ, 2008, ASTRON J, V136, P1179, DOI 10.1088/0004-6256/136/3/1179; Barth AJ, 2004, ASTROPHYS J, V607, P90, DOI 10.1086/383302; Bell EF, 2003, ASTROPHYS J SUPPL S, V149, P289, DOI 10.1086/378847; Calzetti D, 2007, ASTROPHYS J, V666, P870, DOI 10.1086/520082; Engelbracht CW, 2005, ASTROPHYS J, V628, pL29, DOI 10.1086/432613; FILIPPENKO AV, 1989, ASTROPHYS J, V342, pL11, DOI 10.1086/185472; Greene JE, 2008, ASTROPHYS J, V688, P159, DOI 10.1086/592078; Greene JE, 2007, ASTROPHYS J, V670, P92, DOI 10.1086/522082; Heckman TM, 2010, IAU SYMP P SERIES, P3, DOI 10.1017/S1743921310005508; Henry AL, 2007, ASTRON J, V133, P757, DOI 10.1086/510358; Ho LC, 2008, ANNU REV ASTRON ASTR, V46, P475, DOI 10.1146/annurev.astro.45.051806.110546; Johnson KE, 2003, ASTROPHYS J, V597, P923, DOI 10.1086/378585; Johnson KE, 2000, ASTRON J, V120, P1273, DOI 10.1086/301541; Kim S, 1998, ASTROPHYS J, V503, P674, DOI 10.1086/306030; KOBULNICKY HA, 1995, ASTRON J, V110, P116, DOI 10.1086/117500; Kobulnicky HA, 2010, ASTROPHYS J, V718, P724, DOI 10.1088/0004-637X/718/2/724; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Mendez DI, 1999, ASTRON ASTROPHYS, V349, P801; Merloni A, 2003, MON NOT R ASTRON SOC, V345, P1057, DOI 10.1046/j.1365-2966.2003.07017.x; Orienti M, 2010, MON NOT R ASTRON SOC, V401, P2599, DOI 10.1111/j.1365-2966.2009.15837.x; Reines AE, 2008, ASTRON J, V136, P1415, DOI 10.1088/0004-6256/136/4/1415; Reines AE, 2008, ASTRON J, V135, P2222, DOI 10.1088/0004-6256/135/6/2222; Reines AE, 2010, ASTROPHYS J, V708, P26, DOI 10.1088/0004-637X/708/1/26; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Ulvestad JS, 2007, ASTRON J, V133, P1868, DOI 10.1086/512190; Volonteri M, 2010, ASTRON ASTROPHYS REV, V18, P279, DOI 10.1007/s00159-010-0029-x; Whitney BA, 2008, ASTRON J, V136, P18, DOI 10.1088/0004-6256/136/1/18	30	172	172	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					66	68		10.1038/nature09724	http://dx.doi.org/10.1038/nature09724			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21217688	Green Submitted			2022-12-28	WOS:000286886400034
J	Reddy, KS; Patel, V; Jha, P; Paul, VK; Kumar, AKS; Dandona, L				Reddy, K. Srinath; Patel, Vikram; Jha, Prabhat; Paul, Vinod K.; Kumar, A. K. Shiva; Dandona, Lalit		Lancet India Grp Universal Healthc	India: Towards Universal Health Coverage 7 Towards achievement of universal health care in India by 2020: a call to action	LANCET			English	Article								To sustain the positive economic trajectory that India has had during the past decade, and to honour the fundamental right of all citizens to adequate health care, the health of all Indian people has to be given the highest priority in public policy. We propose the creation of the Integrated National Health System in India through provision of universal health insurance, establishment of autonomous organisations to enable accountable and evidence-based good-quality health-care practices and development of appropriately trained human resources, the restructuring of health governance to make it coordinated and decentralised, and legislation of health entitlement for all Indian people. The key characteristics of our proposal are to strengthen the public health system as the primary provider of promotive, preventive, and curative health services in India, to improve quality and reduce the out-of-pocket expenditure on health care through a well regulated integration of the private sector within the national health-care system. Dialogue and consensus building among the stakeholders in the government, civil society, and private sector are the next steps to formalise the actions needed and to monitor their achievement. In our call to action, we propose that India must achieve health care for all by 2020.	[Reddy, K. Srinath; Dandona, Lalit] Publ Hlth Fdn India, New Delhi, India; [Patel, Vikram] London Sch Hyg & Trop Med, London WC1, England; [Jha, Prabhat] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Paul, Vinod K.] All India Inst Med Sci, New Delhi, India; [Kumar, A. K. Shiva] UNICEF India, New Delhi, India; [Dandona, Lalit] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; All India Institute of Medical Sciences (AIIMS) New Delhi; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Reddy, KS (corresponding author), Publ Hlth Fdn India, New Delhi, India.		Prabhakaran, Dorairaj/B-4147-2011	Prabhakaran, Dorairaj/0000-0002-3172-834X; Patel, Vikram/0000-0003-1066-8584; Reddy, K Srinath/0000-0003-3416-3548	John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation	John T and Catherine D MacArthur Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	The Lancet Series on India: Towards Universal Health Coverage was supported by grants from the John T and Catherine D MacArthur Foundation and the David and Lucile Packard Foundation to the Public Health Foundation of India.	Bajpai N, 2009, MIDTERM EVALUATION N; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Dandona L, 2011, LANCET, V377, P1055, DOI 10.1016/S0140-6736(10)62034-X; Das Gupta M, 2009, IMPROVE PUBLIC HLTH; Government of India, 1946, REP HLTH SURV DEV CO; Grover A, 2011, LANCET, V377, P976, DOI 10.1016/S0140-6736(10)62042-9; Health and Family Welfare Department Government of Gujarat, CHIR YOJ; ICHDI, 2009, REP 2009 ICHDI; Jha P., 2009, CHOOSING HLTH ENTITL; John TJ, 2011, LANCET, V377, P252, DOI 10.1016/S0140-6736(10)61265-2; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Mavalankar D, 2009, INT J GYNECOL OBSTET, V107, P271, DOI 10.1016/j.ijgo.2009.09.008; Ministry of Labour and Employment Government of India, RASHTR SWASTH BIM YO; MOHFW, 2005, JAN SUR YOJ GUID IMP; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Press information Bureau Government of India, 2010, AZ OUTL PRIOR HLTH S; Raj A, 2011, LANCET, V377, P618, DOI 10.1016/S0140-6736(10)62112-5; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; Sen B, 2011, LANCET, V377, P532, DOI 10.1016/S0140-6736(10)62182-4; Sudarshan H, 2011, LANCET, V377, P790, DOI 10.1016/S0140-6736(10)62041-7; UNDP (United Nations Development Programme), 2009, HUM DEV REP 2009; UNPF-India, 2009, CONC ASS JAN SUR YOJ; WHO, 2007, EV BUS STRENGTH HLTH	25	200	202	1	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2011	377	9767					760	768		10.1016/S0140-6736(10)61960-5	http://dx.doi.org/10.1016/S0140-6736(10)61960-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729JQ	21227489	Green Accepted			2022-12-28	WOS:000287946000033
J	Castillo, LS; Williams, BA; Hooper, SM; Sabatino, CP; Weithorn, LA; Sudore, RL				Castillo, Lesley S.; Williams, Brie A.; Hooper, Sarah M.; Sabatino, Charles P.; Weithorn, Lois A.; Sudore, Rebecca L.			Lost in Translation: The Unintended Consequences of Advance Directive Law on Clinical Care	ANNALS OF INTERNAL MEDICINE			English	Article							OF-LIFE CARE; SURROGATE DECISION-MAKING; HEALTH LITERACY; END; DEATH; COMMUNICATION; PREFERENCES; BARRIERS; SHE	Background: Advance directive law may compromise the clinical effectiveness of advance directives. Purpose: To identify unintended legal consequences of advance directive law that may prevent patients from communicating end-of-life preferences. Data Sources: Advance directive legal statutes for all 50 U. S. states and the District of Columbia and English-language searches of LexisNexis, Westlaw, and MEDLINE from 1966 to August 2010. Study Selection: Two independent reviewers selected 51 advance directive statutes and 20 articles. Three independent legal reviewers selected 105 legal proceedings. Data Extraction: Two reviewers independently assessed data sources and used critical content analysis to determine legal barriers to the clinical effectiveness of advance directives. Disagreements were resolved by consensus. Data Synthesis: Legal and content-related barriers included poor readability (that is, laws in all states were written above a 12th-grade reading level), health care agent or surrogate restrictions (for example, 40 states did not include same-sex or domestic partners as default surrogates), and execution requirements needed to make forms legally valid (for example, 35 states did not allow oral advance directives, and 48 states required witness signatures, a notary public, or both). Vulnerable populations most likely to be affected by these barriers included patients with limited literacy, limited English proficiency, or both who cannot read or execute advance directives; same-sex or domestic partners who may be without legally valid and trusted surrogates; and unbefriended, institutionalized, or homeless patients who may be without witnesses and suitable surrogates. Limitation: Only appellate-level legal cases were available, which may have excluded relevant cases. Conclusion: Unintended negative consequences of advance directive legal restrictions may prevent all patients, and particularly vulnerable patients, from making and communicating their end-of-life wishes and having them honored. These restrictions have rendered advance directives less clinically useful. Recommendations include improving readability, allowing oral advance directives, and eliminating witness or notary requirements. Primary Funding Source: U.S. Department of Veterans Affairs and the Pfizer Foundation. Ann Intern Med. 2011;154:121-128.	[Sudore, Rebecca L.] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA; Amer Bar Assoc, Washington, DC 20013 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Sudore, RL (corresponding author), Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, 4150 Clement St,151R, San Francisco, CA 94121 USA.	Rebecca.Sudore@ucsf.edu	Sudore, Rebecca/AAF-1635-2021		Veterans Affairs Career Development Award; Pfizer; University of California, Hastings College of the Law; U.S. Department of Veterans Affairs; Pfizer Foundation; National Institutes of Health; University of California, San Francisco; Hartford Foundation Center of Excellence; NATIONAL INSTITUTE ON AGING [K23AG033102] Funding Source: NIH RePORTER	Veterans Affairs Career Development Award; Pfizer(Pfizer); University of California, Hastings College of the Law(University of California System); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Pfizer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco(University of California System); Hartford Foundation Center of Excellence; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Ms. Castillo and Dr. Sudore are supported by a Veterans Affairs Career Development Award and a Pfizer Fellowship in Clear Health Communication. Ms. Hooper is supported by the University of California, Hastings College of the Law.r U.S. Department of Veterans Affairs and the Pfizer Foundation.r Dr. Williams: Grants received (money to institution): National Institutes of Health and University of California, San Francisco, Hartford Foundation Center of Excellence; Consultancy: Independent Medical Monitor of Michigan and Disability Legal Rights Center of Southern California; Expert testimony: University of Denver Student Law Office, Hunton & Williams LLP, and Holland & Knight LLP. Ms. Hooper: Consulting fee or honorarium (money to institution): Department of Veterans Affairs; Payment for writing or reviewing the manuscript (money to institution): Department of Veterans Affairs. Dr. Sudore: Grants received (money to institution): Pfizer Foundation. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOf InterestForms.do?msNum=M10-1985.	Ache KA, 2009, PALLIATIVE MED, V23, P545, DOI 10.1177/0269216309106313; Aging with Dignity, 5 WISH; [Anonymous], MASS GEN LAWAS ANN; [Anonymous], FLA STAT ANN; [Anonymous], KY REV STAT; Arnold RM, 2003, CRIT CARE MED, V31, pS347, DOI 10.1097/01.CCM.0000065123.23736.12; Beltran Joseph E, 1996, Bioethics Forum, V12, P17; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; California Department of Developmental Services, 2008, THINKING AHEAD MY WA; California Government Code Section 8200-8230, NOT PUBL CAL; Crawley Lavera M, 2002, J Palliat Med, V5, P775, DOI 10.1089/109662102320880697; Davis TC, 2002, CA-CANCER J CLIN, V52, P134, DOI 10.3322/canjclin.52.3.134; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Fagerlin A, 2007, AM J HEALTH BEHAV, V31, pS47; Furlong EB, 2005, BIFOCAL BAR ASS FOCU, V27, P21; Giger Joyce Newman, 2006, J Cult Divers, V13, P3; Gill CJ, 2005, J DISABIL POLICY STU, V16, P6; Gillick Muriel R, 1995, J Ethics Law Aging, V1, P87; Gillick Muriel R, 2006, Nutr Clin Pract, V21, P126, DOI 10.1177/0115426506021002126; Gillick MR, 2009, J PALLIAT MED, V12, P121, DOI 10.1089/jpm.2008.0240; Gostin LO, 1997, JAMA-J AM MED ASSOC, V278, P1523, DOI 10.1001/jama.278.18.1523; Gunter-Hunt G, 2002, GERONTOLOGIST, V42, P51, DOI 10.1093/geront/42.1.51; Hanson LC, 1996, ARCH INTERN MED, V156, P1018, DOI 10.1001/archinte.156.9.1018; Hawkins NA, 2005, GERONTOLOGIST, V45, P107, DOI 10.1093/geront/45.1.107; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; *I MED, 2004, HLTH LIT PRESCR END; Karp N, 2004, INCAPACITATED ALONE; Kemp Charles, 2005, Semin Oncol Nurs, V21, P44, DOI 10.1053/j.soncn.2004.10.007; Kushel MB, 2006, JAMA-J AM MED ASSOC, V296, P2959, DOI 10.1001/jama.296.24.2959; Kusmin B, 2006, AM J LAW MED, V32, P93, DOI 10.1177/009885880603200103; Kwak J, 2005, GERONTOLOGIST, V45, P634, DOI 10.1093/geront/45.5.634; Lo B, 2004, ARCH INTERN MED, V164, P1501, DOI 10.1001/archinte.164.14.1501; Lo B, 2009, RESOLVING ETHICAL DI, V4th; Longmore PK, 2005, J DISABILITY POLICY, P38; Meisel A, 2000, JAMA-J AM MED ASSOC, V284, P2495, DOI 10.1001/jama.284.19.2495; Mueller LA, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-6; Murray TH, 2005, HASTINGS CENT REP, V35, pS52, DOI 10.1353/hcr.2005.0098; National Conference of Commissioners on Uniform State Laws, 1993, UN HLTH CAR DEC ACT; National Law Center on Homelessness and Poverty, 2007, 2007 ANN REP NAT LAW; Perkins HS, 2007, ANN INTERN MED, V147, P51, DOI 10.7326/0003-4819-147-1-200707030-00008; Rosenfeld KE, 2000, J GEN INTERN MED, V15, P620, DOI 10.1046/j.1525-1497.2000.06289.x; Sabatino CP, 2010, MILBANK Q, V88, P211, DOI 10.1111/j.1468-0009.2010.00596.x; Sabatino Charles P., 2005, NAELA J, V1, P131; Sabatino CP, 2003, BIFOCAL BAR ASS FOCU, V25, P5; Schickedanz AD, 2009, J AM GERIATR SOC, V57, P31, DOI 10.1111/j.1532-5415.2008.02093.x; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; Searight HR, 2005, AM FAM PHYSICIAN, V71, P515; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; Sethi M, 2007, BIFOCAL BAR ASS FOCU, V29, p[21, vi]; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Smith AK, 2009, JAMA-J AM MED ASSOC, V301, P1047, DOI 10.1001/jama.2009.308; Song J, 2007, J GEN INTERN MED, V22, P435, DOI 10.1007/s11606-006-0046-7; Sudore RL, 2007, PATIENT EDUC COUNS, V69, P165, DOI 10.1016/j.pec.2007.08.015; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Sulmasy DP, 1998, ANN INTERN MED, V128, P621, DOI 10.7326/0003-4819-128-8-199804150-00002; Teno JM, 1998, J GEN INTERN MED, V13, P439, DOI 10.1046/j.1525-1497.1998.00132.x; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x; Tolle SW, 1998, J AM GERIATR SOC, V46, P1097, DOI 10.1111/j.1532-5415.1998.tb06647.x; US Census Bureau, 2008, 2006 2008 AM COMM SU; US Census Bureau, LANG US; Volandes AE, 2008, J PALLIAT MED, V11, P754, DOI 10.1089/jpm.2007.0224; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Wisconsin Secretary of State, 2007, NOTARY PUBLIC GEN IN	64	79	79	0	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2					121	+		10.7326/0003-4819-154-2-201101180-00012	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-00012			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706MW	21242368	Green Accepted			2022-12-28	WOS:000286223500007
J	Montzka, SA; Krol, M; Dlugokencky, E; Hall, B; Jockel, P; Lelieveld, J				Montzka, S. A.; Krol, M.; Dlugokencky, E.; Hall, B.; Joeckel, P.; Lelieveld, J.			Small Interannual Variability of Global Atmospheric Hydroxyl	SCIENCE			English	Article							CARBON-MONOXIDE; METHYL CHLOROFORM; TROPOSPHERIC OH; CHEMISTRY; EMISSIONS; (CO)-C-14; CAPACITY; RADICALS; OZONE	The oxidizing capacity of the global atmosphere is largely determined by hydroxyl (OH) radicals and is diagnosed by analyzing methyl chloroform (CH3CCl3) measurements. Previously, large year-to-year changes in global mean OH concentrations have been inferred from such measurements, suggesting that the atmospheric oxidizing capacity is sensitive to perturbations by widespread air pollution and natural influences. We show how the interannual variability in OH has been more precisely estimated from CH3CCl3 measurements since 1998, when atmospheric gradients of CH3CCl3 had diminished as a result of the Montreal Protocol. We infer a small interannual OH variability as a result, indicating that global OH is generally well buffered against perturbations. This small variability is consistent with measurements of methane and other trace gases oxidized primarily by OH, as well as global photochemical model calculations.	[Montzka, S. A.; Dlugokencky, E.; Hall, B.] NOAA Earth Syst Res Lab, Boulder, CO 80305 USA; [Krol, M.] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3584 CC Utrecht, Netherlands; [Krol, M.] Wageningen Univ, Meteorol & Air Qual Grp, NL-6708 PB Wageningen, Netherlands; [Joeckel, P.; Lelieveld, J.] Max Planck Inst Chem, Dept Atmospher Chem, D-55128 Mainz, Germany; [Lelieveld, J.] Cyprus Inst, CY-1645 Nicosia, Cyprus	National Oceanic Atmospheric Admin (NOAA) - USA; Utrecht University; Wageningen University & Research; Max Planck Society	Montzka, SA (corresponding author), NOAA Earth Syst Res Lab, Boulder, CO 80305 USA.	stephen.a.montzka@noaa.gov	Jöckel, Patrick/C-3687-2009; Dlugokencky, Edward/AAN-8746-2020; Lelieveld, Jos/A-1986-2013; Krol, Maarten C./E-3414-2013; montzka, stephen/V-6162-2019	Jöckel, Patrick/0000-0002-8964-1394; Dlugokencky, Edward/0000-0003-0612-6985; Lelieveld, Jos/0000-0001-6307-3846; Krol, Maarten C./0000-0002-3506-2477; montzka, stephen/0000-0002-9396-0400	NOAA's Climate Program Office; Stichting Nationale Computerfaciliteiten (National Computing Facilities Foundation)	NOAA's Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); Stichting Nationale Computerfaciliteiten (National Computing Facilities Foundation)	We thank C. Siso, B. Miller, L. Miller, D. Mondeel, L. Bruhwiler, P. Novelli, B. Weatherhead, J. W. Elkins, J. H. Butler, station personnel involved with sampling flasks, C. M. Spivakovsky, R. G. Prinn, and other AGAGE scientists, P. Bergamaschi, and J.-F. Meirink. Supported in part by the Atmospheric Composition and Climate Program of NOAA's Climate Program Office and by the Stichting Nationale Computerfaciliteiten (National Computing Facilities Foundation).	Bousquet P, 2005, ATMOS CHEM PHYS, V5, P2635, DOI 10.5194/acp-5-2635-2005; BRENNINKMEIJER CAM, 1992, NATURE, V356, P50, DOI 10.1038/356050a0; Dalsoren SB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027295; Dentener F, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002916; Dlugokencky EJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039780; Duncan BN, 2008, ATMOS CHEM PHYS, V8, P7389, DOI 10.5194/acp-8-7389-2008; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Jockel P, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001324; Jockel P, 2006, ATMOS CHEM PHYS, V6, P5067; Krol M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002423; Krol MC, 2008, ATMOS CHEM PHYS, V8, P5033, DOI 10.5194/acp-8-5033-2008; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Lelieveld J, 2006, ATMOS ENVIRON, V40, P5741, DOI 10.1016/j.atmosenv.2006.04.008; Lelieveld J, 2004, ATMOS CHEM PHYS, V4, P2337, DOI 10.5194/acp-4-2337-2004; LEVY H, 1971, SCIENCE, V173, P141, DOI 10.1126/science.173.3992.141; LOGAN JA, 1981, J GEOPHYS RES-OCEANS, V86, P7210, DOI 10.1029/JC086iC08p07210; LOVELOCK JE, 1977, NATURE, V267, P32, DOI 10.1038/267032a0; MAK JE, 1992, GEOPHYS RES LETT, V19, P1467, DOI 10.1029/92GL01611; Manning MR, 2005, NATURE, V436, P1001, DOI 10.1038/nature03900; Montzka SA, 2000, SCIENCE, V288, P500, DOI 10.1126/science.288.5465.500; Prinn RG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022228; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; SINGH HB, 1977, GEOPHYS RES LETT, V4, P453, DOI 10.1029/GL004i010p00453; Spivakovsky CM, 2000, J GEOPHYS RES-ATMOS, V105, P8931, DOI 10.1029/1999JD901006; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34189, DOI 10.1029/2001JD900165; Wang YH, 1998, J GEOPHYS RES-ATMOS, V103, P31123, DOI 10.1029/1998JD100004; WEINSTOCK B, 1972, SCIENCE, V176, P290, DOI 10.1126/science.176.4032.290	29	219	222	0	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					67	69		10.1126/science.1197640	http://dx.doi.org/10.1126/science.1197640			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212353				2022-12-28	WOS:000285974000036
J	Blau, HM; Pomerantz, JH				Blau, Helen M.; Pomerantz, Jason H.			Re"evolutionary" Regenerative Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELL-CYCLE; INK4A/ARF; RB		[Blau, Helen M.] Stanford Univ, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Pomerantz, Jason H.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Blau, HM (corresponding author), Stanford Univ, Sch Med, Baxter Lab Stem Cell Biol, 269 Campus Dr,CCSR 4215, Stanford, CA 94305 USA.	hblau@stanford.edu; jason.pomerantz@ucsfmedctr.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R43AR059565, F32AR051678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020961, R37AG009521, R01AG009521] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL096113, U01 HL100397-03, R01 HL096113, U01 HL100397, HL100397, R01 HL096113-03] Funding Source: Medline; NIAMS NIH HHS [AR059565, R43 AR059565, F32 AR051678] Funding Source: Medline; NIA NIH HHS [AG009521, R37 AG009521, R01 AG009521, AG020961, R01 AG020961, R01 AG009521-25, R01 AG020961-08] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; del Arroyo AG, 2005, ADV EXP MED BIOL, V570, P227; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	10	17	19	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	2011	305	1					87	88		10.1001/jama.2010.1938	http://dx.doi.org/10.1001/jama.2010.1938			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702VN	21177496	Green Accepted			2022-12-28	WOS:000285924100028
J	Cucchiara, B; Kasner, SE				Cucchiara, Brett; Kasner, Scott E.			Transient Ischemic Attack	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SYMPTOMATIC CAROTID STENOSIS; ATRIAL-FIBRILLATION; ABCD(2) SCORE; VASCULAR EVENTS; STROKE RISK; ENDARTERECTOMY; PREVENTION; ASPIRIN; CLOPIDOGREL; PREDICTORS	An estimated 200 000 to 500 000 people in the United States receive a diagnosis of transient ischemic attack (TIA) each year (1). TIA is as an important warning that a person is at increased short-term risk for stroke, and early recognition and rapid treatment may significantly reduce this risk. Assessment of a patient with suspected TIA is challenging because the physical examination is often normal, and there are no easy methods to confirm the diagnosis at the bedside. However, the recent development of clinical risk scores and an increasing amount of data on the prognostic value of early magnetic resonance imaging (MRI) now provide an evidence-based foundation for clinical decision making in TIA.										Amarenco P, 2006, NEW ENGL J MED, V355, P549; Asimos AW, 2010, ANN EMERG MED, V55, P201, DOI 10.1016/j.annemergmed.2009.05.002; BANGALORE S, 2010, ARCH NEUROL; Bonati LH, 2010, LANCET, V376, P1062, DOI 10.1016/S0140-6736(10)61009-4; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Calvet D, 2007, CEREBROVASC DIS, V24, P80, DOI 10.1159/000103120; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Chandratheva A, 2010, STROKE, V41, P851, DOI 10.1161/STROKEAHA.109.570010; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cucchiara BL, 2009, J STROKE CEREBROVASC, V18, P367, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.006; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; FURIE KL, 2010, GUIDELINES PREVENT S; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Giles MF, 2010, STROKE, V41, P1907, DOI 10.1161/STROKEAHA.110.578971; Giles MF, 2010, STROKE, V41, P667, DOI 10.1161/STROKEAHA.109.571174; Gulli G, 2009, STROKE, V40, P2732, DOI 10.1161/STROKEAHA.109.553859; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Johnston SC, 2003, NEUROLOGY, V60, P280; Johnston SC, 2002, NEW ENGL J MED, V347, P1687, DOI 10.1056/NEJMcp020891; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; KIM AS, 2010, ANN EMERG MED 0918; Krol AL, 2005, STROKE, V36, P2487, DOI 10.1161/01.STR.0000185936.05516.fc; LEVY DE, 1988, NEUROLOGY, V38, P674, DOI 10.1212/WNL.38.5.674; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Merwick A, 2010, LANCET NEUROL, V9, P1060, DOI 10.1016/S1474-4422(10)70240-4; Ois A, 2008, STROKE, V39, P1717, DOI 10.1161/STROKEAHA.107.505438; Purroy F, 2007, STROKE, V38, P3225, DOI 10.1161/STROKEAHA.107.488833; Rashid P, 2003, STROKE, V34, P2741, DOI 10.1161/01.STR.0000092488.40085.15; Redgrave JNE, 2007, STROKE, V38, P1482, DOI 10.1161/STROKEAHA.106.477380; Ringleb PA, 2008, J VASC SURG, V47, P350, DOI 10.1016/j.jvs.2007.10.035; Robinson TG, 2010, LANCET NEUROL, V9, P767, DOI 10.1016/S1474-4422(10)70163-0; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Sandercock P, 1997, LANCET, V349, P1569; Sherman DG, 2007, LANCET, V369, P1347, DOI 10.1016/S0140-6736(07)60633-3; Tayal AH, 2008, NEUROLOGY, V71, P1696, DOI 10.1212/01.wnl.0000325059.86313.31; Turan TN, 2009, STROKE, V40, P2257, DOI 10.1161/STROKEAHA.108.537589; Wu CM, 2007, ARCH INTERN MED, V167, P2417, DOI 10.1001/archinte.167.22.2417	45	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 4	2011	154	1					ITC11	ITC15	ITC1	10.7326/0003-4819-154-1-201101040-01001	http://dx.doi.org/10.7326/0003-4819-154-1-201101040-01001			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701OT	21200033				2022-12-28	WOS:000285830900019
J	Katon, WJ; Lin, EHB; Von Korff, M; Ciechanowski, P; Ludman, EJ; Young, B; Peterson, D; Rutter, CM; McGregor, M; McCulloch, D				Katon, Wayne J.; Lin, Elizabeth H. B.; Von Korff, Michael; Ciechanowski, Paul; Ludman, Evette J.; Young, Bessie; Peterson, Do; Rutter, Carolyn M.; McGregor, Mary; McCulloch, David			Collaborative Care for Patients with Depression and Chronic Illnesses.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY IMPROVEMENT STRATEGIES; DIABETES SELF-CARE; MICROVASCULAR COMPLICATIONS; SECONDARY PREVENTION; RANDOMIZED-TRIALS; GLYCEMIC CONTROL; BLOOD-PRESSURE; ASSOCIATION; ADHERENCE; OUTCOMES	Background: Patients with depression and poorly controlled diabetes, coronary heart disease, or both have an increased risk of adverse outcomes and high health care costs. We conducted a study to determine whether coordinated care management of multiple conditions improves disease control in these patients. Methods: We conducted a single-blind, randomized, controlled trial in 14 primary care clinics in an integrated health care system in Washington State, involving 214 participants with poorly controlled diabetes, coronary heart disease, or both and coexisting depression. Patients were randomly assigned to the usual-care group or to the intervention group, in which a medically supervised nurse, working with each patient's primary care physician, provided guideline-based, collaborative care management, with the goal of controlling risk factors associated with multiple diseases. The primary outcome was based on simultaneous modeling of glycated hemoglobin, low-density lipoprotein (LDL) cholesterol, and systolic blood-pressure levels and Symptom Checklist-20 (SCL-20) depression outcomes at 12 months; this modeling allowed estimation of a single overall treatment effect. Results: As compared with controls, patients in the intervention group had greater overall 12-month improvement across glycated hemoglobin levels (difference, 0.58%), LDL cholesterol levels (difference, 6.9 mg per deciliter [0.2 mmol per liter]), systolic blood pressure (difference, 5.1 mm Hg), and SCL-20 depression scores (difference, 0.40 points) (P<0.001). Patients in the intervention group also were more likely to have one or more adjustments of insulin (P=0.006), antihypertensive medications (P<0.001), and antidepressant medications (P<0.001), and they had better quality of life (P<0.001) and greater satisfaction with care for diabetes, coronary heart disease, or both (P<0.001) and with care for depression (P<0.001). Conclusions: As compared with usual care, an intervention involving nurses who provided guideline-based, patient-centered management of depression and chronic disease significantly improved control of medical disease and depression. (Funded by the National Institute of Mental Health; ClinicalTrials.gov number, NCT00468676.) N Engl J Med 2010;363:2611-20.	[Katon, Wayne J.; Ciechanowski, Paul] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Young, Bessie] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Lin, Elizabeth H. B.; Von Korff, Michael; Ludman, Evette J.; Peterson, Do; Rutter, Carolyn M.; McGregor, Mary; McCulloch, David] Grp Hlth Res Inst, Seattle, WA USA; [Rutter, Carolyn M.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Katon, WJ (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Box 356560,1959 NE Pacific St, Seattle, WA 98195 USA.	wkaton@u.washington.edu	Young, Lucky\\1234/GNH-2046-2022; Rutter, Carolyn/AAZ-3677-2021	VonKorff, Michael/0000-0001-5386-8477	Services Division of the National Institute of Mental Health [MH041739, MH069741]; Wyeth; Eli Lilly; Forest; Pfizer; HealthSTAR Communications (Eli Lilly); World Psychiatry Association; John A. Hartford Foundation; Roche Diagnostics; Rewarding Health; Group Health Cooperative; Johnson Johnson; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH069741, R01MH041739] Funding Source: NIH RePORTER	Services Division of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wyeth(Wyeth); Eli Lilly(Eli Lilly); Forest; Pfizer(Pfizer); HealthSTAR Communications (Eli Lilly)(Eli Lilly); World Psychiatry Association; John A. Hartford Foundation; Roche Diagnostics; Rewarding Health; Group Health Cooperative; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants (MH041739 and MH069741) from the Services Division of the National Institute of Mental Health (to Dr. Katon) and by institutional support from Group Health Cooperative.; Dr. Katon reports receiving support as an advisor to Wyeth and Eli Lilly and lecture fees from Wyeth, Eli Lilly, Forest, and Pfizer; Dr. Lin, serving on an advisory board for Physicians Postgraduate Press and receiving payment for a manuscript from Prescott Medical, lecture fees from HealthSTAR Communications (Eli Lilly), travel fees from the World Psychiatry Association, and a grant from the John A. Hartford Foundation; Dr. Von Korff, having a grant pending with Johnson & Johnson; Dr. Ciechanowski, serving on the editorial boards of Diabetic Living and Diabetes Forecast, owning Samepage, receiving lecture fees from Rewarding Health, having a patent for Samepage, and receiving travel fees from Roche Diagnostics; and Ms. McGregor, receiving travel and lecture fees from Group Health Cooperative. No other potential conflict of interest relevant to this article was reported.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Anderson G, 2002, CHRONIC CONDITIONS M; [Anonymous], 2001, PARTN SOL PROJ J HOP; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Bodenheimer T., 2009, CARE MANAGEMENT PATI; Bush D E, 2005, Evid Rep Technol Assess (Summ), P1; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Guy W, 1976, BCDEU ASSESSMENT MAN; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Institute of Medicine, 2001, CROSSING QUALITY CHA; Katon W, 2003, DEPRESSION HELPBOOK; Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668; Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Lippi G, 2009, SEMIN THROMB HEMOST, V35, P325, DOI 10.1055/s-0029-1222611; McAlister FA, 2001, BRIT MED J, V323, P957, DOI 10.1136/bmj.323.7319.957; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rollnick S, 1995, BEHAV COGN PSYCHOTH, V23, P325, DOI DOI 10.1017/S135246580001643X; Roy J, 2003, BIOSTATISTICS, V4, P371, DOI 10.1093/biostatistics/4.3.371; Schmittdiel JA, 2008, J GEN INTERN MED, V23, P588, DOI 10.1007/s11606-008-0554-8; Schneider KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-82; SHERBOURNE CD, 1992, J BEHAV MED, V15, P447, DOI 10.1007/BF00844941; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Simon GE, 2005, GEN HOSP PSYCHIAT, V27, P344, DOI 10.1016/j.genhosppsych.2005.04.008; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Smith Jr SC, 2006, CIRCULATION, V113, pe847; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Walsh JME, 2006, MED CARE, V44, P646, DOI 10.1097/01.mlr.0000220260.30768.32	36	1054	1064	1	226	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2611	2620		10.1056/NEJMoa1003955	http://dx.doi.org/10.1056/NEJMoa1003955			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	700SD	21190455	Green Accepted			2022-12-28	WOS:000285763700006
J	Bridson, R; Batty, C				Bridson, Robert; Batty, Christopher			Computational Physics in Film	SCIENCE			English	Editorial Material									[Bridson, Robert; Batty, Christopher] Univ British Columbia, Dept Comp Sci, Vancouver, BC V6T 1Z4, Canada; [Bridson, Robert] Exot Matter AB, S-18233 Danderyd, Sweden; [Bridson, Robert] Weta Digital Ltd, Wellington 6022, New Zealand	University of British Columbia	Bridson, R (corresponding author), Univ British Columbia, Dept Comp Sci, 201-2366 Main Mall, Vancouver, BC V6T 1Z4, Canada.	rbridson@cs.ubc.ca						Brochu T, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778784; English E, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360665; Horvath C, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1531326.1531347; Kaldor JM, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778842; Kaufman DM, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1409060.1409117; Kaufmann P, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1531326.1531356; Lee SH, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1559755.1559756; McAdams A, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1531326.1531368; Molino N, 2004, ACM T GRAPHIC, V23, P385, DOI 10.1145/1015706.1015734; OBRIEN J, 1999, P SIGGRAPH 99, V18, P137; Zhu YN, 2005, ACM T GRAPHIC, V24, P965, DOI 10.1145/1073204.1073298	11	6	9	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1756	1757		10.1126/science.1198769	http://dx.doi.org/10.1126/science.1198769			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698OS	21205658				2022-12-28	WOS:000285603700023
J	Sudarshan, H; Prashanth, NS				Sudarshan, Hanumappa; Prashanth, N. S.			Good governance in health care: the Karnataka experience	LANCET			English	Editorial Material									[Prashanth, N. S.] Inst Publ Hlth, Bangalore 560085, Karnataka, India; [Sudarshan, Hanumappa] Karuna Trust, Bengaluru, Karnataka, India		Prashanth, NS (corresponding author), Inst Publ Hlth, Bangalore 560085, Karnataka, India.	prashanthns@iphindia.org	Srinivas, Prashanth Nuggehalli/H-3061-2019	Srinivas, Prashanth Nuggehalli/0000-0003-0968-0826				Azfar O., 2008, ECON GOV, V9, P197, DOI [DOI 10.1007/S10101-006-0031-Y, DOI 10.1007/s10101-006-0031-y]; Centre for Media Studies, 2005, IND CORR STUD IMPR G; Centre for Media Studies, 2008, IND CORR STUD SPEC F; Coombes R, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1794; ECTA, 2005, SETT VIG CELL HLTH S; Government of India, 2005, EQ DEV HLTH FUT REP; Government of Karnataka, 2001, KARN EQ QUAL INT HLT; Gupta S., 2001, POLITICAL EC CORRUPT, P111; Laughton T, 2005, DETAILS REFORM OPTIO; Lewis M., 2006, GOVERNANCE CORRUPTIO; Ministry of Health and Family Welfare, 2010, NRHM PROGR SO FAR; Ministry of Health and Family Welfare, 2010, COMM BAS MON HLTH SE; National Rural Health Mission, 2009, PROGR PROC DOC COMM; Rose R, 2006, GLOBAL CORRUPTION RE; Solberg KE, 2008, LANCET, V371, P464, DOI 10.1016/S0140-6736(08)60220-2; Srinivas C, 2004, PROGR RATIONAL USE D; Sudarshan H., 2010, GOOD GOVERNANCE HLTH; Sudarshan H, 2003, EPIDEMIC CORRUPTION; Taneja D K, 2005, Indian J Public Health, V49, P152; Zinnbauer D., 2009, GLOBAL CORRUPTION RE	20	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2011	377	9768					790	792		10.1016/S0140-6736(10)62041-7	http://dx.doi.org/10.1016/S0140-6736(10)62041-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GO	21227488				2022-12-28	WOS:000288628500007
J	Eden, E; Geva-Zatorsky, N; Issaeva, I; Cohen, A; Dekel, E; Danon, T; Cohen, L; Mayo, A; Alon, U				Eden, Eran; Geva-Zatorsky, Naama; Issaeva, Irina; Cohen, Ariel; Dekel, Erez; Danon, Tamar; Cohen, Lydia; Mayo, Avi; Alon, Uri			Proteome Half-Life Dynamics in Living Human Cells	SCIENCE			English	Article							ASSISTED LIGHT INACTIVATION; UBIQUITIN; OVEREXPRESSION; PROTEASOME; LIBRARY; CANCER; GENES; YEAST	Cells remove proteins by two processes: degradation and dilution due to cell growth. The balance between these basic processes is poorly understood. We addressed this by developing an accurate and noninvasive method for measuring protein half-lives, called "bleach-chase," that is applicable to fluorescently tagged proteins. Assaying 100 proteins in living human cancer cells showed half-lives that ranged between 45 minutes and 22.5 hours. A variety of stresses that stop cell division showed the same general effect: Long-lived proteins became longer-lived, whereas short-lived proteins remained largely unaffected. This effect is due to the relative strengths of degradation and dilution and suggests a mechanism for differential killing of rapidly growing cells by growth-arresting drugs. This approach opens a way to understand proteome half-life dynamics in living cells.	[Eden, Eran; Geva-Zatorsky, Naama; Issaeva, Irina; Cohen, Ariel; Dekel, Erez; Danon, Tamar; Cohen, Lydia; Mayo, Avi; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Eden, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	eraneden@gmail.com; urialon@weizmann.ac.il	mayo, avi/N-3756-2019; Geva-Zatorsky, Naama/AAP-9176-2021; MAYO, AVI E/K-1736-2012	mayo, avi/0000-0002-4479-3423; Geva-Zatorsky, Naama/0000-0002-7303-854X; 	European Research Council; Israel Science Foundation; Kahn Family Foundation	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Kahn Family Foundation	We thank Z. Yakhini, Z. Kam, R. Milo, S. Sela, and A. Ciechanover for discussions and P. Choukroun for technical assistance. We acknowledge support by the European Research Council, the Israel Science Foundation, and the Kahn Family Foundation. The Weizmann Institute of Science has filed for a patent on the technology described in this report for measuring protein half-lives.	Alon U., 2007, INTRO SYSTEMS BIOL; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; LIU HP, 1992, GENETICS, V132, P665; MONOD J, 1952, BIOCHIM BIOPHYS ACTA, V9, P648, DOI 10.1016/0006-3002(52)90227-8; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; SCHIMKE RT, 1970, ANNU REV BIOCHEM, V39, P929, DOI 10.1146/annurev.bi.39.070170.004433; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; Tour O, 2003, NAT BIOTECHNOL, V21, P1505, DOI 10.1038/nbt914; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	17	219	220	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					764	768		10.1126/science.1199784	http://dx.doi.org/10.1126/science.1199784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21233346				2022-12-28	WOS:000287205700069
J	Varela, I; Tarpey, P; Raine, K; Huang, D; Ong, CK; Stephens, P; Davies, H; Jones, D; Lin, ML; Teague, J; Bignell, G; Butler, A; Cho, J; Dalgliesh, GL; Galappaththige, D; Greenman, C; Hardy, C; Jia, MM; Latimer, C; Lau, KW; Marshall, J; McLaren, S; Menzies, A; Mudie, L; Stebbings, L; Largaespada, DA; Wessels, LFA; Richard, S; Kahnoski, RJ; Anema, J; Tuveson, DA; Perez-Mancera, PA; Mustonen, V; Fischer, A; Adams, DJ; Rust, A; Chan-on, W; Subimerb, C; Dykema, K; Furge, K; Campbell, PJ; Teh, BT; Stratton, MR; Futreal, PA				Varela, Ignacio; Tarpey, Patrick; Raine, Keiran; Huang, Dachuan; Ong, Choon Kiat; Stephens, Philip; Davies, Helen; Jones, David; Lin, Meng-Lay; Teague, Jon; Bignell, Graham; Butler, Adam; Cho, Juok; Dalgliesh, Gillian L.; Galappaththige, Danushka; Greenman, Chris; Hardy, Claire; Jia, Mingming; Latimer, Calli; Lau, King Wai; Marshall, John; McLaren, Stuart; Menzies, Andrew; Mudie, Laura; Stebbings, Lucy; Largaespada, David A.; Wessels, L. F. A.; Richard, Stephane; Kahnoski, Richard J.; Anema, John; Tuveson, David A.; Perez-Mancera, Pedro A.; Mustonen, Ville; Fischer, Andrej; Adams, David J.; Rust, Alistair; Chan-on, Waraporn; Subimerb, Chutima; Dykema, Karl; Furge, Kyle; Campbell, Peter J.; Teh, Bin Tean; Stratton, Michael R.; Futreal, P. Andrew			Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma	NATURE			English	Article							TUMOR-SUPPRESSOR GENE; CELL CARCINOMA; CANCER; MUTAGENESIS; BAF180; ARID1A; MOUSE; INACTIVATION; SENESCENCE; INDUCTION	The genetics of renal cancer is dominated by inactivation of the VHL tumour suppressor gene in clear cell carcinoma (ccRCC), the commonest histological subtype. A recent large-scale screen of similar to 3,500 genes by PCR-based exon re-sequencing identified several new cancer genes in ccRCC including UTX (also known as KDM6A)(1), JARID1C (also known as KDM5C) and SETD2 (ref. 2). These genes encode enzymes that demethylate (UTX, JARID1C) or methylate (SETD2) key lysine residues of histone H3. Modification of the methylation state of these lysine residues of histone H3 regulates chromatin structure and is implicated in transcriptional control(3). However, together these mutations are present in fewer than 15% of ccRCC, suggesting the existence of additional, currently unidentified cancer genes. Here, we have sequenced the protein coding exome in a series of primary ccRCC and report the identification of the SWI/SNF chromatin remodelling complex gene PBRM1 (ref. 4) as a second major ccRCC cancer gene, with truncating mutations in 41% (92/227) of cases. These data further elucidate the somatic genetic architecture of ccRCC and emphasize the marked contribution of aberrant chromatin biology.	[Huang, Dachuan; Ong, Choon Kiat; Chan-on, Waraporn; Subimerb, Chutima; Teh, Bin Tean] Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, Singapore 169610, Singapore; [Varela, Ignacio; Tarpey, Patrick; Raine, Keiran; Stephens, Philip; Davies, Helen; Jones, David; Lin, Meng-Lay; Teague, Jon; Bignell, Graham; Butler, Adam; Cho, Juok; Dalgliesh, Gillian L.; Galappaththige, Danushka; Greenman, Chris; Hardy, Claire; Jia, Mingming; Latimer, Calli; Lau, King Wai; Marshall, John; McLaren, Stuart; Menzies, Andrew; Mudie, Laura; Stebbings, Lucy; Campbell, Peter J.; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Largaespada, David A.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Wessels, L. F. A.] Netherlands Canc Inst, Dept Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Richard, Stephane] Fac Med Paris Sud, INSERM, U753, Genet Oncol EPHE, F-94805 Villejuif, France; [Richard, Stephane] Inst Cancerol Gustave Roussy, F-94805 Villejuif, France; [Richard, Stephane] Hop Bicetre, AP HP, Serv Urol, Ctr Expert Natl Canc Rares INCa PREDIR, F-94276 Le Kremlin Bicetre, France; [Kahnoski, Richard J.; Anema, John] Spectrum Hlth Hosp, Dept Urol, Grand Rapids, MI 49503 USA; [Tuveson, David A.; Perez-Mancera, Pedro A.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Mustonen, Ville; Fischer, Andrej; Adams, David J.; Rust, Alistair] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Fischer, Andrej] Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany; [Dykema, Karl; Furge, Kyle] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI 49503 USA; [Teh, Bin Tean] DUKE NUS Grad Med Sch, Lab Canc Therapeut, Singapore, Singapore; [Teh, Bin Tean] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	National Cancer Centre Singapore (NCCS); Wellcome Trust Sanger Institute; University of Minnesota System; University of Minnesota Twin Cities; Netherlands Cancer Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Paris Saclay; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of Cologne; Van Andel Institute; National University of Singapore; Van Andel Institute; University of London; Institute of Cancer Research - UK	Teh, BT (corresponding author), Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, 11 Hosp Dr, Singapore 169610, Singapore.	Bin.Teh@vai.org; mrs@sanger.ac.uk; paf@sanger.ac.uk	Largaespada, David/C-9832-2014; Mustonen, Ville/X-1599-2019; Mustonen, Ville/J-1155-2018; Varela, Ignacio/AAA-7680-2021; Varela, Ignacio/G-1699-2016; Dalgliesh, Gillian/B-7799-2008	Mustonen, Ville/0000-0002-7270-1792; Mustonen, Ville/0000-0002-7270-1792; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Raine, Keiran/0000-0002-5634-1539; Teh, Bin Tean/0000-0003-1514-1124; Dalgliesh, Gillian/0000-0001-8526-5064; HUANG, DACHUAN/0000-0002-7518-4081; Adams, David/0000-0001-9490-0306; Ong, Choon Kiat/0000-0001-6402-4288; Rust, Alistair/0000-0001-7287-192X	Wellcome Trust [077012/Z/05/Z]; Lee Foundation; International Human Frontier Science Program Organization; Cancer Research UK; University of Cambridge; Van Andel Research Institute; NATIONAL CANCER INSTITUTE [R01CA113636, R01CA134759] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Lee Foundation; International Human Frontier Science Program Organization(Human Frontier Science Program); Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); Van Andel Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	P.A.F. and M.R.S. would like to acknowledge the Wellcome Trust for support under grant reference 077012/Z/05/Z and A. Coffey, D. Turner and L. Mamanova for assistance with the exon capture. K.F., K.D. and B.T.T. acknowledge the support of the Van Andel Research Institute. B.T.T. would like to acknowledge support from the Lee Foundation. I.V. is supported by a fellowship from The International Human Frontier Science Program Organization. D.J.A. acknowledges the support of Cancer Research UK. D.A.T. and P.A.P.-M. acknowledge the support of the University of Cambridge, Cancer Research UK and Hutchison Whampo and thank W. Howatt, A. Hazelhurst and colleagues in the CRI core facilities for their support. B.T.T. would like to dedicate this work to Tat Hock Teh.	Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107; Chandrasekaran R, 2007, BIOCHEM BIOPH RES CO, V355, P661, DOI 10.1016/j.bbrc.2007.01.193; Clifford SC, 1998, GENE CHROMOSOME CANC, V22, P200, DOI 10.1002/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kenneth NS, 2009, J BIOL CHEM, V284, P4123, DOI 10.1074/jbc.M808491200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Sekine I, 2005, ONCOGENE, V24, P2735, DOI 10.1038/sj.onc.1207694; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Thompson M, 2009, BIOCHIMIE, V91, P309, DOI 10.1016/j.biochi.2008.10.019; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Vries RGJ, 2005, GENE DEV, V19, P665, DOI 10.1101/gad.335805; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wong AKC, 2000, CANCER RES, V60, P6171; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	30	914	1029	0	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					539	542		10.1038/nature09639	http://dx.doi.org/10.1038/nature09639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21248752	Green Submitted, Green Accepted			2022-12-28	WOS:000286596500034
J	Kasten, MM; Clapier, CR; Cairns, BR				Kasten, Margaret M.; Clapier, Cedric R.; Cairns, Bradley R.			SnapShot: Chromatin Remodeling: SWI/SNF	CELL			English	Editorial Material							NUCLEOSOME COMPLEX		[Kasten, Margaret M.; Clapier, Cedric R.; Cairns, Bradley R.] Univ Utah, HHMI, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Kasten, MM (corresponding author), Univ Utah, HHMI, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060415] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060415] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Leschziner AE, 2005, STRUCTURE, V13, P267, DOI 10.1016/j.str.2004.12.008; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Skiniotis G, 2007, J BIOL CHEM, V282, P20804, DOI 10.1074/jbc.C700081200; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3	10	34	38	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2								10.1016/j.cell.2011.01.007	http://dx.doi.org/10.1016/j.cell.2011.01.007			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241897	Bronze			2022-12-28	WOS:000286459900014
J	Novershtern, N; Subramanian, A; Lawton, LN; Mak, RH; Haining, WN; McConkey, ME; Habib, N; Yosef, N; Chang, CY; Shay, T; Frampton, GM; Drake, ACB; Leskov, I; Nilsson, B; Preffer, F; Dombkowski, D; Evans, JW; Liefeld, T; Smutko, JS; Chen, JZ; Friedman, N; Young, RA; Golub, TR; Regev, A; Ebert, BL				Novershtern, Noa; Subramanian, Aravind; Lawton, Lee N.; Mak, Raymond H.; Haining, W. Nicholas; McConkey, Marie E.; Habib, Naomi; Yosef, Nir; Chang, Cindy Y.; Shay, Tal; Frampton, Garrett M.; Drake, Adam C. B.; Leskov, Ilya; Nilsson, Bjorn; Preffer, Fred; Dombkowski, David; Evans, John W.; Liefeld, Ted; Smutko, John S.; Chen, Jianzhu; Friedman, Nir; Young, Richard A.; Golub, Todd R.; Regev, Aviv; Ebert, Benjamin L.			Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELLS; ERYTHROID-DIFFERENTIATION; EXPRESSION PROFILES; MODULE NETWORKS; T-CELLS; GENE; BINDING; LINE; ERYTHROPOIESIS	Though many individual transcription factors are known to regulate hematopoietic differentiation, major aspects of the global architecture of hematopoiesis remain unknown. Here, we profiled gene expression in 38 distinct purified populations of human hematopoietic cells and used probabilistic models of gene expression and analysis of cis-elements in gene promoters to decipher the general organization of their regulatory circuitry. We identified modules of highly coexpressed genes, some of which are restricted to a single lineage but most of which are expressed at variable levels across multiple lineages. We found densely interconnected cis-regulatory circuits and a large number of transcription factors that are differentially expressed across hematopoietic states. These findings suggest a more complex regulatory system for hematopoiesis than previously assumed.	[Novershtern, Noa; Subramanian, Aravind; Mak, Raymond H.; Yosef, Nir; Chang, Cindy Y.; Shay, Tal; Nilsson, Bjorn; Liefeld, Ted; Golub, Todd R.; Regev, Aviv; Ebert, Benjamin L.] Broad Inst, Cambridge, MA 02142 USA; [Novershtern, Noa; Frampton, Garrett M.; Drake, Adam C. B.; Leskov, Ilya; Chen, Jianzhu; Young, Richard A.; Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA; [Novershtern, Noa; Habib, Naomi; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci, IL-91904 Jerusalem, Israel; [Lawton, Lee N.; Frampton, Garrett M.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Haining, W. Nicholas; Evans, John W.; Golub, Todd R.; Ebert, Benjamin L.] Dana Farber Canc Inst, Boston, MA 02115 USA; [McConkey, Marie E.; Chang, Cindy Y.; Nilsson, Bjorn; Ebert, Benjamin L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Drake, Adam C. B.; Leskov, Ilya; Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Dombkowski, David] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Smutko, John S.] Nugen Technol, San Carlos, CA 94070 USA; [Golub, Todd R.; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Regev, A (corresponding author), Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; bebert@partners.org	Friedman, Nir/H-9692-2012; Young, Richard A/F-6495-2012; Shay, Tal/J-4028-2016; Habib, Naomi/AAA-8937-2020	Friedman, Nir/0000-0002-9678-3550; Young, Richard A/0000-0001-8855-8647; Shay, Tal/0000-0003-0755-1350; Frampton, Garrett/0000-0002-2361-2750; Mak, Raymond/0000-0002-8754-0565; Novershtern, Noa/0000-0002-2244-6877	NIH [R01 HL082945, P01 CA108631]; Burroughs-Wellcome Fund; Landon and Lavinia Clay; HHMI; NATIONAL CANCER INSTITUTE [P01CA108631, P01CA066996, RC1CA145229] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL082448, R01HL082945] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Landon and Lavinia Clay; HHMI(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Lander, I. Amit, and I. Gat-Viks for critical review of the manuscript; D. Scadden for helpful discussions; L. Gaffney and S. Hart for assistance with figure generation; and D. Peck, J. Lamb, R. Onofrio, and the Broad Genetic Analysis Platform for assistance with expression arrays. The work was funded by the NIH (grants R01 HL082945 and P01 CA108631 to B.L.E. and the PIONEER award to A.R.), the Burroughs-Wellcome Fund (CAMS to B.L.E. and CASI to A.R.), funds from Landon and Lavinia Clay (R.A.Y.) and HHMI (T.R.G. and A.R.). A.R. is an investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute. J.S.S. is an employee of NuGEN Technologies, Inc.	Akashi K, 2005, ANN NY ACAD SCI, V1044, P125, DOI 10.1196/annals.1349.016; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; APLAN PD, 1992, EMBO J, V11, P4073, DOI 10.1002/j.1460-2075.1992.tb05500.x; ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Bakker WJ, 2007, MOL CELL BIOL, V27, P3839, DOI 10.1128/MCB.01662-06; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Davidson E. H., 2001, DEV EVOLUTION; Ebert BL, 2004, BLOOD, V104, P923, DOI 10.1182/blood-2004-01-0274; Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Lee HM, 2010, BLOOD, V116, P720, DOI 10.1182/blood-2009-11-253872; Li QZ, 1998, BLOOD, V92, P3841, DOI 10.1182/blood.V92.10.3841.422k02_3841_3847; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mitelman F, 2010, MITELMAN DATABASE CH; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; QUESENBERRY PJ, 2005, WILLIAMS HEMATOLOGY, P153; Rincon-Arano H, 2005, J MOL BIOL, V349, P961, DOI 10.1016/j.jmb.2005.04.040; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Segal E, 2005, J MACH LEARN RES, V6, P557; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	56	624	640	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					296	309		10.1016/j.cell.2011.01.004	http://dx.doi.org/10.1016/j.cell.2011.01.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241896	Bronze, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000286459900013
J	Margueron, R; Reinberg, D				Margueron, Raphael; Reinberg, Danny			The Polycomb complex PRC2 and its mark in life	NATURE			English	Review							EMBRYONIC STEM-CELLS; H3 LYSINE 27; METHYLTRANSFERASE GENE EZH2; RNA-POLYMERASE-II; TARGET GENES; CHROMATIN-STRUCTURE; GROUP PROTEINS; DEVELOPMENTAL REGULATORS; DNA METHYLATION; NONCODING RNA	Polycomb group proteins maintain the gene-expression pattern of different cells that is set during early development by regulating chromatin structure. In mammals, two main Polycomb group complexes exist - Polycomb repressive complex 1 (PRC1) and 2 (PRC2). PRC1 compacts chromatin and catalyses the monoubiquitylation of histone H2A. PRC2 also contributes to chromatin compaction, and catalyses the methylation of histone H3 at lysine 27. PRC2 is involved in various biological processes, including differentiation, maintaining cell identity and proliferation, and stem-cell plasticity. Recent studies of PRC2 have expanded our perspectives on its function and regulation, and uncovered a role for non-coding RNA in the recruitment of PRC2 to target genes.	[Reinberg, Danny] NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA; [Margueron, Raphael] Inst Curie, F-75005 Paris, France; [Margueron, Raphael] CNRS, UMR3215, F-75005 Paris, France; [Margueron, Raphael] INSERM, U934, F-75005 Paris, France	Howard Hughes Medical Institute; New York University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Reinberg, D (corresponding author), NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, 522 1st Ave, New York, NY 10016 USA.	danny.reinberg@nyumc.org	Margueron, Raphael F/B-9996-2015	Margueron, Raphael F/0000-0002-9093-7977; Reinberg, Danny/0000-0003-4288-2016	Institut Nationale du Cancer; Fondation pour la Recherche Medicale; US National Institutes of Health [RO1GM064844, 4R37GM037120]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037120, R01GM064844] Funding Source: NIH RePORTER	Institut Nationale du Cancer; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to L. Vales, E. Heard and R. Bonasio for crucial reading of this manuscript and active discussions. We apologize to authors whose studies could not be cited owing to space limitations. Work in the laboratory of R. M. is supported by the Institut Nationale du Cancer and Fondation pour la Recherche Medicale. Work in the laboratory of D.R. is funded by the US National Institutes of Health (grants RO1GM064844 and 4R37GM037120) and the Howard Hughes Medical Institute.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hennig L, 2009, TRENDS GENET, V25, P414, DOI 10.1016/j.tig.2009.07.002; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Karanikolas BDW, 2010, PROSTATE, V70, P675, DOI 10.1002/pros.21112; Karanikolas BDW, 2009, MOL CANCER RES, V7, P1456, DOI 10.1158/1541-7786.MCR-09-0121; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lewis PH., 1947, DROS INFORM SERV, V21, P69; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ohno K, 2008, MECH DEVELOP, V125, P527, DOI 10.1016/j.mod.2008.01.002; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Savla U, 2008, DEVELOPMENT, V135, P813, DOI 10.1242/dev.016006; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shaver S, 2010, EPIGENETICS-US, V5, P301, DOI 10.4161/epi.5.4.11608; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wang SW, 2004, GENE, V343, P69, DOI 10.1016/j.gene.2004.09.006; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	98	2117	2189	12	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					343	349		10.1038/nature09784	http://dx.doi.org/10.1038/nature09784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248841	Green Accepted			2022-12-28	WOS:000286385600041
J	Clark, CM; Schneider, JA; Bedell, BJ; Beach, TG; Bilker, WB; Mintun, MA; Pontecorvo, MJ; Hefti, F; Carpenter, AP; Flitter, ML; Krautkramer, MJ; Kung, HF; Coleman, RE; Doraiswamy, PM; Fleisher, AS; Sabbagh, MN; Sadowsky, CH; Reiman, PEM; Zehntner, SP; Skovronsky, DM				Clark, Christopher M.; Schneider, Julie A.; Bedell, Barry J.; Beach, Thomas G.; Bilker, Warren B.; Mintun, Mark A.; Pontecorvo, Michael J.; Hefti, Franz; Carpenter, Alan P.; Flitter, Matthew L.; Krautkramer, Michael J.; Kung, Hank F.; Coleman, R. Edward; Doraiswamy, P. Murali; Fleisher, Adam S.; Sabbagh, Marwan N.; Sadowsky, Carl H.; Reiman, P. Eric M.; Zehntner, Simone P.; Skovronsky, Daniel M.		AV45-A07 Study Grp	Use of Florbetapir-PET for Imaging beta-Amyloid Pathology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MILD COGNITIVE IMPAIRMENT; PITTSBURGH COMPOUND-B; PRECLINICAL ALZHEIMERS-DISEASE; BRAIN; DIAGNOSIS; DECLINE; NEUROPATHOLOGY; INDIVIDUALS; RADIOLIGAND; PREDICTION	Context The ability to identify and quantify brain beta-amyloid could increase the accuracy of a clinical diagnosis of Alzheimer disease. Objective To determine if florbetapir F 18 positron emission tomographic (PET) imaging performed during life accurately predicts the presence of beta-amyloid in the brain at autopsy. Design, Setting, and Participants Prospective clinical evaluation conducted February 2009 through March 2010 of florbetapir-PET imaging performed on 35 patients from hospice, long-term care, and community health care facilities near the end of their lives (6 patients to establish the protocol and 29 to validate) compared with immunohistochemistry and silver stain measures of brain beta-amyloid after their death used as the reference standard. PET images were also obtained in 74 young individuals (18-50 years) presumed free of brain amyloid to better understand the frequency of a false-positive interpretation of a florbetapir-PET image. Main Outcome Measures Correlation of florbetapir-PET image interpretation (based on the median of 3 nuclear medicine physicians' ratings) and semiautomated quantification of cortical retention with postmortem beta-amyloid burden, neuritic amyloid plaque density, and neuropathological diagnosis of Alzheimer disease in the first 35 participants autopsied (out of 152 individuals enrolled in the PET pathological correlation study). Results Florbetapir-PET imaging was performed a mean of 99 days (range, 1-377 days) before death for the 29 individuals in the primary analysis cohort. Fifteen of the 29 individuals (51.7%) met pathological criteria for Alzheimer disease. Both visual interpretation of the florbetapir-PET images and mean quantitative estimates of cortical uptake were correlated with presence and quantity of beta-amyloid pathology at autopsy as measured by immunohistochemistry (Bonferroni rho, 0.78 [95% confidence interval, 0.58-0.89]; P<.001]) and silver stain neuritic plaque score (Bonferroni rho, 0.71 [95% confidence interval, 0.47-0.86]; P<.001). Florbetapir-PET images and postmortem results rated as positive or negative for beta-amyloid agreed in 96% of the 29 individuals in the primary analysis cohort. The florbetapir-PET image was rated as amyloid negative in the 74 younger individuals in the nonautopsy cohort. Conclusions Florbetapir-PET imaging was correlated with the presence and density of beta-amyloid. These data provide evidence that a molecular imaging procedure can identify beta-amyloid pathology in the brains of individuals during life. Additional studies are required to understand the appropriate use of florbetapir-PET imaging in the clinical diagnosis of Alzheimer disease and for the prediction of progression to dementia. JAMA. 2011; 305(3): 275-283	[Clark, Christopher M.; Mintun, Mark A.; Pontecorvo, Michael J.; Hefti, Franz; Carpenter, Alan P.; Flitter, Matthew L.; Krautkramer, Michael J.; Skovronsky, Daniel M.] Avid Radiopharmaceut, Philadelphia, PA USA; [Clark, Christopher M.; Bilker, Warren B.; Kung, Hank F.; Skovronsky, Daniel M.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Schneider, Julie A.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Bedell, Barry J.; Zehntner, Simone P.] Biospective Inc, Montreal, PQ, Canada; [Bedell, Barry J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Beach, Thomas G.; Sabbagh, Marwan N.] Banner Sun Hlth Res Inst, Phoenix, AZ USA; [Mintun, Mark A.] Washington Univ, Sch Med, St Louis, MO USA; [Coleman, R. Edward; Doraiswamy, P. Murali] Duke Univ, Med Ctr, Durham, NC USA; [Fleisher, Adam S.; Reiman, P. Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA; [Fleisher, Adam S.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Sadowsky, Carl H.] Nova SE Univ, Dept Med, Div Neurol, Ft Lauderdale, FL 33314 USA; [Reiman, P. Eric M.] Arizona Alzheimers Consortium, Phoenix, AZ USA; [Reiman, P. Eric M.] Univ Arizona, Coll Med, Dept Psychiat, Phoenix, AZ USA	University of Pennsylvania; Rush University; McGill University; Banner Research; Banner Health; Banner Sun Health Research Institute; Washington University (WUSTL); Duke University; Banner Research; Banner Health; Banner Alzheimer's Institute; University of California System; University of California San Diego; Nova Southeastern University; University of Arizona	Clark, CM (corresponding author), 3711 Market St, Philadelphia, PA 19104 USA.	clark@avidrp.com	Kennedy, Kristen M/B-4699-2008; Bilker, Warren/AAS-3515-2021	Kennedy, Kristen M/0000-0001-5373-9026; 	National Institute on Aging [P30 AG19610, R01AG031581, AG-0222559]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; National Institutes of Health [AG-0222559]; Molecular Insights Pharmaceuticals; Avid; Avid Radiopharmaceuticals; Eli Lilly; Baxter; Bayer; General Electric Healthcare; Bristol-Myers Squibb; Eisai; Janssen; Wyeth/Elan; Medivation; AstraZeneca; Kronos Life Sciences; National Institute for Mental Health; Nomis Foundation; Banner Alzheimer's Foundation; State of Arizona; Avid Radiopharmaceuticals Inc; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING [R01AG031581, P30AG019610] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Insights Pharmaceuticals; Avid; Avid Radiopharmaceuticals; Eli Lilly(Eli Lilly); Baxter; Bayer(Bayer AG); General Electric Healthcare(General ElectricGE Healthcare); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Wyeth/Elan(Wyeth); Medivation; AstraZeneca(AstraZeneca); Kronos Life Sciences; National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Nomis Foundation; Banner Alzheimer's Foundation; State of Arizona; Avid Radiopharmaceuticals Inc; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Clark, Mintun, Pontecorvo, Hefti, Carpenter, and Skovronsky and Messrs Flitter and Krautkramer reported owning Avid stock and/or stock options and being employed by Avid Radiopharmaceuticals Inc. Dr Schneider reported being a consultant for Avid Radiopharmaceuticals and receiving compensation for services. Drs Bedell and Zehntner reported receiving compensation and shares from Biospective Inc. Dr Beach reported receiving funding related to the topic of this article from the National Institute on Aging (grant P30 AG19610), the Arizona Department of Health Services (contract 211002 awarded to the Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001), Avid Radiopharmaceuticals, Bayer Healthcare Inc, and GE Healthcare. Dr Bilker reported working as consultant for Avid Radiopharmaceuticals on issues related to this study. Dr Kung reported receiving financial support from National Institutes of Health grant AG-0222559; serving on the Avid Scientific Advisory board; participating in the formation of Avid; and being an Avid stockholder. Dr Coleman reported being on the medical advisory board for General Electric Healthcare from 2003-2008; being a consultant for General Electric Healthcare from 2003-2008; receiving a research grant from General Electric Healthcare in 2010; receiving funding for a clinical trial from Molecular Insights Pharmaceuticals in 2010; serving on a medical advisory board for Molecular Insights Pharmaceuticals from 2004-2009; and receiving a grant from Avid to support his participation in this study. Dr Doraiswamy reported receiving research grants (awarded to Duke University); currently or previously serving as an advisor to Forest, Bristol-Myers Squibb, Avid Radiopharmaceuticals, Lundbeck, Medivation, Pfizer, Elan, Eli Lilly, Bayer, Neuroptix, Neuronetrix, Sonexa, Accera, TauRx, Myriad, National Institute on Aging, AstraZeneca, Labopharm, Clarimedix, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, Alzheimer's Association, Alzheimer's Foundation, Rutgers University, and the University of California; owning stock in Sonexa; and receiving a grant from Avid (awarded to Duke University) for his participation in this study. Dr Fleisher reported receiving research contracts from Avid Radiopharmaceuticals to the Banner Alzheimer's Institute, from which he receives no personal compensation; being a consultant on a scientific advisory board for Eli Lilly; serving on an advisory board for Elan Pharmaceuticals; and having a pending investigator-initiated grant from Avid Radiopharmaceuticals. Dr Sabbagh reported working as a consultant for Eisai, Pfizer, Amerisciences, Takeda, and GlaxoSmithKline; receiving royalties from Wiley, FT Pearson Press, and Amerisciences; and having grants and contracts with Eli Lilly, Baxter, Bayer, General Electric Healthcare, Bristol-Myers Squibb, Eisai, Janssen, Wyeth/Elan, Avid, and Medivation. Dr Sadowsky reported being on the speaker's bureau and receiving honoraria from Novartis, Forrest, Accera, and Pamlab; and serving on the advisory board for Novartis.; Dr Reiman reported serving as a scientific advisor to Amnestix/Sygnis, AstraZeneca, Elan, Eli Lilly, GlaxoSmithKline, Intellect, Siemens, Bayer, Takeda, and Eisai; having research contracts with the National Institute on Aging, Arizona Department of Health Services, AstraZeneca, Avid Radiopharmaceuticals, and Kronos Life Scienes; receiving research grants from the National Institute on Aging, National Institute for Mental Health, the Anonymous Foundation, Nomis Foundation, Banner Alzheimer's Foundation, and the State of Arizona; holding patents for imaging strategy for the screening of AD treatments in laboratory animals (active), biomarker strategy for the evaluation of presymptomatic AD treatments (pending, through Banner Health), statistical strategy for the analysis of complementary complex data sets (pending, through Banner Health), and GAB2 testing in clinical assessment of AD (pending, through Translational Genomics Research Institute); and serving as the executive director for the Banner Alzheimer's Institute and the director of the Arizona Alzheimer's Consortium.; This study was funded by Avid Radiopharmaceuticals Inc and by grants R01AG031581, P30AG19610, and AG-0222559 from the National Institute on Aging, contract 211002 from the Arizona Department of Health Services, contracts 4001, 0011, 1001, and 05-901 from the Arizona Biomedical Research Commission, and funding from the Michael J. Fox Foundation for Parkinson's Research.	Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bourgeat P, 2010, NEUROLOGY, V74, P121, DOI 10.1212/WNL.0b013e3181c918b5; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Hulette CM, 1998, J NEUROPATH EXP NEUR, V57, P1168, DOI 10.1097/00005072-199812000-00009; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; Jobst K A, 1998, Int Psychogeriatr, V10, P271, DOI 10.1017/S1041610298005389; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Klunk WE, 2001, LIFE SCI, V69, P1471, DOI 10.1016/S0024-3205(01)01232-2; Koole M, 2009, J NUCL MED, V50, P818, DOI 10.2967/jnumed.108.060756; Kung HF, 2010, J MED CHEM, V53, P933, DOI 10.1021/jm901039z; Lin KJ, 2010, NUCL MED BIOL, V37, P497, DOI 10.1016/j.nucmedbio.2010.02.003; Lopponen M, 2003, AGE AGEING, V32, P606, DOI 10.1093/ageing/afg097; Mathis CA, 2007, NUCL MED BIOL, V34, P809, DOI 10.1016/j.nucmedbio.2007.06.015; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Ranginwala NA, 2008, AM J GERIAT PSYCHIAT, V16, P384, DOI 10.1097/JGP.0b013e3181629971; Resnick SM, 2010, NEUROLOGY, V74, P807, DOI 10.1212/WNL.0b013e3181d3e3e9; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Storandt M, 2009, ARCH NEUROL-CHICAGO, V66, P1476, DOI 10.1001/archneurol.2009.272; Thal LJ, 2006, ALZ DIS ASSOC DIS, V20, P6, DOI 10.1097/01.wad.0000191420.61260.a8; Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088	34	769	787	0	116	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					275	283		10.1001/jama.2010.2008	http://dx.doi.org/10.1001/jama.2010.2008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707YY	21245183	Green Accepted, Bronze			2022-12-28	WOS:000286328700023
J	Davila, JA; Henderson, L; Kramer, JR; Kanwal, F; Richardson, PA; Duan, ZG; El-Serag, HB				Davila, Jessica A.; Henderson, Louise; Kramer, Jennifer R.; Kanwal, Fasiha; Richardson, Peter A.; Duan, Zhigang; El-Serag, Hashem B.			Utilization of Surveillance for Hepatocellular Carcinoma Among Hepatitis C Virus-Infected Veterans in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							INCREASING INCIDENCE; VIRAL-HEPATITIS; CIRRHOSIS; SURVIVAL; CANCER; MANAGEMENT; IMPROVE; STAGE	Background: Surveillance for hepatocellular carcinoma (HCC) is recommended for patients with hepatitis C virus (HCV) infection and cirrhosis. However, whether surveillance is being done as recommended is unknown. Objective: To examine the prevalence and determinants of HCC surveillance among HCV-infected patients with cirrhosis in Veterans Affairs (VA) health care facilities in the United States. Design: Retrospective cohort study of HCV-infected patients using data obtained from the national VA Hepatitis C Clinical Case Registry. Setting: 128 VA medical centers. Patients: HCV-infected patients with cirrhosis diagnosed between fiscal years 1998 and 2005. Measurements: Abdominal ultrasonography and measurement of alpha-fetoprotein for HCC surveillance were identified from administrative data by using a previously validated algorithm. Patients were categorized as having routine (tests done during at least 2 consecutive years in the 4 years after cirrhosis diagnosis), inconsistent (at least 1 test, but not routine), or no surveillance in the 4 years after cirrhosis diagnosis. Predictors of surveillance were identified by using hierarchical random-effects regression. Results: 126 670 patients with HCV were identified; 13 002 (10.1%) had cirrhosis. Approximately 42.0% of patients with cirrhosis received 1 or more HCC surveillance tests within the first year after the cirrhosis index date; however, a decline in receipt of surveillance was observed in the following 2 to 4 years. Among patients with cirrhosis and at least 2 years of follow-up, routine surveillance occurred in 12.0%, inconsistent surveillance in 58.5%, and no surveillance in 29.5%. Lower medical and psychological comorbid conditions, presence of varices, and the absence of decompensated liver disease were associated with a higher likelihood of receiving routine surveillance. Limitations: Hepatocellular carcinoma surveillance tests were indirectly identified from registry data. Physician recommendations could not be captured. Conclusion: Few HCV-infected veterans with cirrhosis received routine HCC surveillance. New strategies are needed to improve the implementation of HCC surveillance in clinical practice. Primary Funding Source: Houston Veterans Affairs Health Services Research and Development Center of Excellence and the National Cancer Institute. Ann Intern Med. 2011;154:85-93.	[Davila, Jessica A.] Michael E DeBakey VA Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; Univ N Carolina, Chapel Hill, NC USA; St Louis Univ, Sch Med, St Louis, MO USA	Baylor College of Medicine; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Saint Louis University	Davila, JA (corresponding author), Michael E DeBakey VA Med Ctr, Houston Ctr Qual Care & Utilizat Studies, 2002 Holcombe Blvd 152, Houston, TX 77030 USA.	jdavila@bcm.tmc.edu			Houston Veterans Affairs Health Services Research and Development Center of Excellence [HFP90-020]; National Cancer Institute [R01-CA-125487]; NATIONAL CANCER INSTITUTE [R01CA125487] Funding Source: NIH RePORTER	Houston Veterans Affairs Health Services Research and Development Center of Excellence; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the Houston Veterans Affairs Health Services Research and Development Center of Excellence (HFP90-020) and the National Cancer Institute (R01-CA-125487).	Backus LI, 2009, J AM MED INFORM ASSN, V16, P775, DOI 10.1197/jamia.M3203; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Chalasani N, 1999, AM J GASTROENTEROL, V94, P2988, DOI 10.1016/S0002-9270(99)00504-3; Colombo M, 1998, DIGESTION, V59, P70, DOI 10.1159/000051428; Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020; Davila JA, 2007, J CLIN GASTROENTEROL, V41, P777, DOI 10.1097/MCG.0b013e3180381560; Davila JA, 2010, HEPATOLOGY, V52, P132, DOI 10.1002/hep.23615; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; El-Serag HB, 2000, ARCH INTERN MED, V160, P3227, DOI 10.1001/archinte.160.21.3227; Harman H. H., 1976, MODERN FACTOR ANAL; Hassan MM, 2002, J CLIN GASTROENTEROL, V35, P266, DOI 10.1097/00004836-200209000-00013; Kramer JR, 2008, ALIMENT PHARM THERAP, V27, P274, DOI 10.1111/j.1365-2036.2007.03572.x; Kulkarni K, 2004, ALIMENT PHARM THER, V20, P445, DOI 10.1111/j.1365-2036.2004.02090.x; Leykum LK, 2007, CLIN GASTROENTEROL H, V5, P508, DOI 10.1016/j.cgh.2007.01.014; Liu JH, 2004, ANN SURG ONCOL, V11, P298, DOI 10.1245/ASO.2004.03.042; LIVRAGHI T, 1995, J HEPATOL, V22, P522, DOI 10.1016/0168-8278(95)80445-5; MCMAHON BJ, 1991, J NATL CANCER I, V83, P916, DOI 10.1093/jnci/83.13.916; Nguyen MH, 2002, J CLIN GASTROENTEROL, V35, pS86, DOI 10.1097/00004836-200211002-00004; Richardson P, 2010, DIGEST DIS SCI, V55, P3241, DOI 10.1007/s10620-010-1387-y; Ryder SD, 2003, GUT, V52; Sherman M, 1999, BEST PRACT RES CL GA, V13, P623, DOI 10.1053/bega.1999.0052; Tong MJ, 2001, J GASTROEN HEPATOL, V16, P553, DOI 10.1046/j.1440-1746.2001.02470.x; Trevisani F, 2004, AM J GASTROENTEROL, V99, P1470, DOI 10.1111/j.1572-0241.2004.30137.x; Trevisani F, 2002, AM J GASTROENTEROL, V97, P734; Trevisani F, 2007, AM J GASTROENTEROL, V102, P2448, DOI 10.1111/j.1572-0241.2007.01395.x; United Network for Organ Sharing, 2010, MELD PELD CALC; VA Information Resource Center, 2010, VA CMS DAT RES; Wong LL, 2000, LIVER TRANSPLANT, V6, P320, DOI 10.1053/lv.2000.4875; Yang BH, 1997, J CANCER RES CLIN, V123, P357, DOI 10.1007/s004320050070; Yu EWR, 2004, CANCER J, V10, P317, DOI 10.1097/00130404-200409000-00009; Yuen MF, 2000, HEPATOLOGY, V31, P330, DOI 10.1002/hep.510310211; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	35	234	235	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2					85	+		10.7326/0003-4819-154-2-201101180-00006	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242365				2022-12-28	WOS:000286223500002
J	Rawlins, M				Rawlins, Michael			A new era for UK clinical research?	LANCET			English	Editorial Material									Acad Med Sci, London WC1B 1QH, England		Rawlins, M (corresponding author), Acad Med Sci, London WC1B 1QH, England.	Robert.Frost@acmedsci.ac.uk						*AG MED SCI, 2011, NEW PATHW REG GOV HL; [Anonymous], 2003, LANCET, V361, P2167; Department of Health, 2010, LIB NHS REP ARMS LEN; 2001, OFFICIAL J EUROPEA L, V121	4	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 15	2011	377	9761					190	192		10.1016/S0140-6736(10)62315-X	http://dx.doi.org/10.1016/S0140-6736(10)62315-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	712WG	21227501				2022-12-28	WOS:000286696400009
J	Levy, O; Kaniewska, P; Alon, S; Eisenberg, E; Karako-Lampert, S; Bay, LK; Reef, R; Rodriguez-Lanetty, M; Miller, DJ; Hoegh-Guldberg, O				Levy, O.; Kaniewska, P.; Alon, S.; Eisenberg, E.; Karako-Lampert, S.; Bay, L. K.; Reef, R.; Rodriguez-Lanetty, M.; Miller, D. J.; Hoegh-Guldberg, O.			Complex Diel Cycles of Gene Expression in Coral-Algal Symbiosis	SCIENCE			English	Article							ACROPORA-MILLEPORA; LIGHT		[Bay, L. K.; Miller, D. J.; Hoegh-Guldberg, O.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Levy, O.; Karako-Lampert, S.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Levy, O.; Kaniewska, P.; Reef, R.; Rodriguez-Lanetty, M.; Hoegh-Guldberg, O.] Univ Queensland, Global Change Inst, St Lucia, Qld 4072, Australia; [Alon, S.] Tel Aviv Univ, Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Eisenberg, E.] Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Reef, R.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Rodriguez-Lanetty, M.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA	James Cook University; Bar Ilan University; University of Queensland; Tel Aviv University; Tel Aviv University; University of Queensland; University of Louisiana Lafayette	Miller, DJ (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	David.Miller@jcu.edu.au; oveh@uq.edu.au	Hoegh-Guldberg, Ove/H-6169-2011; Eisenberg, Eli/D-2587-2009; Bay, Line/D-4037-2009; Hoegh-Guldberg, Ove/ABA-5420-2020	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Eisenberg, Eli/0000-0001-8681-3202; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Reef, Ruth/0000-0001-6639-520X	Australian Research Council; Israel Science Foundation [699/06]; Division Of Ocean Sciences [1321500] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); Israel Science Foundation(Israel Science Foundation); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank Y. Gothilf for critical discussions and N. Simon-Blecher for assistance in collecting coral samples. This work was supported by the Australian Research Council (O.H.-G. and D.J.M.) and Israel Science Foundation grant no. 699/06. Microarray data are Minimum Information About a Microarray Experiment (MIAME)-compliant and deposited under accession number GSE21658 (National Center for Biotechnology Information GEO). HIF ortholog present in A. millepora (GenBank identification EZ037157).	Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; CHALKER BE, 1975, PROC R SOC SER B-BIO, V190, P323, DOI 10.1098/rspb.1975.0096; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241	9	97	97	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 14	2011	331	6014					175	175		10.1126/science.1196419	http://dx.doi.org/10.1126/science.1196419			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709JA	21233378				2022-12-28	WOS:000286433100031
J	Murry, CE; Pu, WT				Murry, Charles E.; Pu, William T.			Reprogramming Fibroblasts into Cardiomyocytes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Murry, Charles E.] Univ Washington, Dept Pathol, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Pu, William T.] Harvard Stem Cell Inst, Cambridge, MA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard University	Murry, CE (corresponding author), Univ Washington, Dept Pathol, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Seattle, WA 98195 USA.		Pu, William/AAJ-8301-2020	Pu, William/0000-0002-4551-8079	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094683, R01HL084642, RC1HL099618, U01HL100401] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL084642, U01 HL100401, R01 HL094683, RC1 HL099618] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Murry CE, 1996, J CLIN INVEST, V98, P2209, DOI 10.1172/JCI119030; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	4	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 13	2011	364	2					177	178		10.1056/NEJMcibr1013069	http://dx.doi.org/10.1056/NEJMcibr1013069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705NJ	21226585	Green Accepted			2022-12-28	WOS:000286142900015
J	Frio, TR; Lavoie, J; Hamel, N; Geyer, FC; Kushner, YB; Novak, DJ; Wark, L; Capelli, C; Reis, JS; Mai, S; Pastinen, T; Tischkowitz, MD; Marcus, VA; Foulkes, WD				Frio, Thomas Rio; Lavoie, Josee; Hamel, Nancy; Geyer, Felipe C.; Kushner, Yael B.; Novak, David J.; Wark, Landon; Capelli, Cristian; Reis-Filho, Jorge S.; Mai, Sabine; Pastinen, Tomi; Tischkowitz, Marc D.; Marcus, Victoria A.; Foulkes, William D.			Brief Report: Homozygous BUB1B Mutation and Susceptibility to Gastrointestinal Neoplasia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOSAIC VARIEGATED ANEUPLOIDY; HUMAN MITOTIC MUTANT; COLORECTAL CANCERS; CHROMATID SEPARATION; SPINDLE CHECKPOINT; BUBR1; PROTEIN; INSTABILITY; INHIBITION; EXPRESSION	A patient received a diagnosis of adenocarcinoma of the ampulla of Vater at 34 years of age. Two decades later, adenomatous polyps were found, followed by multiple primary invasive adenocarcinomas of both the colon and the stomach. Premature chromatid separation and mosaic variegated aneuploidy, combined with structural chromosomal abnormalities, were detected in his cells. We identified a germline homozygous intronic mutation, c.2386-11A(rightarrow)G, in the spindle-assembly checkpoint gene BUB1B, which creates a de novo splice site that is favored over the authentic (i.e., preferentially used) site. Our findings expand the phenotype associated with BUB1B mutations and the mosaic variegated aneuploidy syndrome to include common adult-onset cancers and provide evidence for the interdependency of the APC protein (encoded by the adenomatous polyposis coli gene) and the BUBR1 protein (encoded by BUB1B) in humans. (Funded by the Turner Family Cancer Research Fund and others.).	[Frio, Thomas Rio; Hamel, Nancy; Novak, David J.; Tischkowitz, Marc D.; Foulkes, William D.] McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada; [Frio, Thomas Rio; Hamel, Nancy; Novak, David J.; Tischkowitz, Marc D.; Foulkes, William D.] McGill Univ, Dept Human Genet, Program Canc Genet, Montreal, PQ, Canada; [Frio, Thomas Rio; Hamel, Nancy; Pastinen, Tomi; Foulkes, William D.] McGill Univ, Ctr Hlth, Dept Med Genet, Montreal, PQ, Canada; [Frio, Thomas Rio; Hamel, Nancy; Pastinen, Tomi; Foulkes, William D.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Novak, David J.; Tischkowitz, Marc D.; Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Dept Med Genet, Montreal, PQ H3T 1E2, Canada; [Novak, David J.; Tischkowitz, Marc D.; Foulkes, William D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Pastinen, Tomi] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ H3T 1E2, Canada; [Geyer, Felipe C.; Reis-Filho, Jorge S.] Breakthrough Breast Canc Res Ctr, Inst Canc Res, London, England; [Wark, Landon; Mai, Sabine] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada; [Capelli, Cristian] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; McGill University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Manitoba; University of Oxford	Foulkes, WD (corresponding author), Montreal Gen Hosp, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	william.foulkes@mcgill.ca	Foulkes, William D./AAR-9586-2021; Hamel, Nancy/L-5122-2016; Tischkowitz, Marc/O-4452-2018; Mai, Sabine/E-5667-2017	Foulkes, William D./0000-0001-7427-4651; Hamel, Nancy/0000-0001-8971-0428; Tischkowitz, Marc/0000-0002-7880-0628; Mai, Sabine/0000-0002-5797-2201; Capelli, Cristian/0000-0001-9348-9084	Turner Family Cancer Research Fund; Les Fonds de la Recherche en Sante du Quebec; Research Institute of the McGill University Health Centre; Cedars Cancer Institute; Breakthrough Breast Cancer Research Centre; Research Councils UK	Turner Family Cancer Research Fund; Les Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Research Institute of the McGill University Health Centre; Cedars Cancer Institute; Breakthrough Breast Cancer Research Centre; Research Councils UK(UK Research & Innovation (UKRI))	Supported by grants from the Turner Family Cancer Research Fund; les Fonds de la Recherche en Sante du Quebec; the Research Institute of the McGill University Health Centre and the Henry R. Shibata Fellowship of the Cedars Cancer Institute (to Dr. Rio Frio); the Breakthrough Breast Cancer Research Centre (to Drs. Geyer and Reis-Filho); and the Research Councils UK (to Dr. Capelli).	Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bohers E, 2008, HUM GENET, V124, P473, DOI 10.1007/s00439-008-0572-y; Burum-Auensen E, 2008, CELL PROLIFERAT, V41, P645, DOI 10.1111/j.1365-2184.2008.00539.x; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Callier P, 2005, AM J MED GENET A, V137A, P204, DOI 10.1002/ajmg.a.30783; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Garcia-Castillo H, 2008, AM J MED GENET A, V146A, P1687, DOI 10.1002/ajmg.a.32315; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lynch HT, 1999, J MED GENET, V36, P801; Matsuura S, 2006, AM J MED GENET A, V140A, P358, DOI 10.1002/ajmg.a.31069; Micale MA, 2007, AM J MED GENET A, V143A, P1890, DOI 10.1002/ajmg.a.31848; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; RUDD NL, 1983, HUM GENET, V65, P117, DOI 10.1007/BF00286646; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Su Li-Kuo, 2003, Methods Mol Biol, V223, P135; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; TOLMIE JL, 1988, HUM GENET, V80, P197, DOI 10.1007/BF00702872; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang Q, 2004, BLOOD, V103, P1278, DOI 10.1182/blood-2003-06-2158; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; WARBURTON D, 1991, ANN GENET-PARIS, V34, P287; Zhang JY, 2007, J CELL BIOL, V178, P773, DOI 10.1083/jcb.200702138	27	61	61	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2628	2637		10.1056/NEJMoa1006565	http://dx.doi.org/10.1056/NEJMoa1006565			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190457	Bronze			2022-12-28	WOS:000285763700008
J	Chell, JM; Brand, AH				Chell, James M.; Brand, Andrea H.			Nutrition-Responsive Glia Control Exit of Neural Stem Cells from Quiescence	CELL			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; DROSOPHILA INSULIN-RECEPTOR; ADULT MAMMALIAN BRAIN; PHOSPHOINOSITIDE 3-KINASE; LARVAL BRAIN; POSTEMBRYONIC NEUROBLASTS; PROLIFERATION ACTIVATION; TRANSCRIPTION FACTORS; TEMPORAL IDENTITY	The systemic regulation of stem cells ensures that they meet the needs of the organism during growth and in response to injury. A key point of regulation is the decision between quiescence and proliferation. During development, Drosophila neural stem cells (neuroblasts) transit through a period of quiescence separating distinct embryonic and postembryonic phases of proliferation. It is known that neuroblasts exit quiescence via a hitherto unknown pathway in response to a nutrition-dependent signal from the fat body. We have identified a population of glial cells that produce insulin/IGF-like peptides in response to nutrition, and we show that the insulin/IGF receptor pathway is necessary for neuroblasts to exit quiescence. The forced expression of insulin/IGF-like peptides in glia, or activation of PI3K/Akt signaling in neuroblasts, can drive neuroblast growth and proliferation in the absence of dietary protein and thus uncouple neuroblasts from systemic control.	[Chell, James M.; Brand, Andrea H.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Chell, James M.; Brand, Andrea H.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Brand, AH (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ahb@mole.bio.cam.ac.uk	Brand, Andrea H/F-8220-2014	Brand, Andrea H/0000-0002-2089-6954	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank H. Stocker, E. Hafen, S. Bray, S. Leevers, T. Xu, E. Rulifson, C. Doe, J. Skeath, S. Baumgartner, Y. Bellaiche, S. Gronke, L. Partridge, L. Cooley, I. Miguel-Aliaga, the DSHB, and the Bloomington Drosophila Stock Center for reagents. We thank K. Edoff for assistance with confocal microscopy, T. Southall for assistance with microinjection, and Pao-Shu Wu for Q-PCR wisdom. This work was funded by a Wellcome Trust four-year PhD studentship to J. M. C. and a Wellcome Trust Programme Grant to A.H.B.	Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alam S, 2004, BIOTECHNOL BIOENG, V88, P332, DOI 10.1002/bit.20246; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Barrett AL, 2008, DEV BIOL, V317, P234, DOI 10.1016/j.ydbio.2008.02.025; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Cho KS, 2001, P NATL ACAD SCI USA, V98, P6144, DOI 10.1073/pnas.101596998; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; DATTA S, 1995, DEVELOPMENT, V121, P1173; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244; Dumstrei K, 2003, J NEUROSCI, V23, P3325; EBENS AJ, 1993, CELL, V74, P15, DOI 10.1016/0092-8674(93)90291-W; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Friedrich MVK, 2000, EUR J BIOCHEM, V267, P3149, DOI 10.1046/j.1432-1327.2000.01337.x; GARCIAESTRADA J, 1992, BRAIN RES, V592, P343, DOI 10.1016/0006-8993(92)91695-B; GAROFALO RS, 1988, MOL CELL BIOL, V8, P1638, DOI 10.1128/MCB.8.4.1638; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871; Huang H, 1999, DEVELOPMENT, V126, P5365; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lindner JR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-121; Lizcano JM, 2003, BIOCHEM J, V374, P297, DOI 10.1042/BJ20030577; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mairet-Coello G, 2009, J NEUROSCI, V29, P775, DOI 10.1523/JNEUROSCI.1700-08.2009; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miron M, 2003, MOL CELL BIOL, V23, P9117, DOI 10.1128/MCB.23.24.9117-9126.2003; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nern C, 2006, STEM CELL REV, V2, P233, DOI 10.1007/s12015-006-0051-6; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Oldham S, 2002, DEVELOPMENT, V129, P4103; Park Y, 2003, DEV BIOL, V253, P247, DOI 10.1016/S0012-1606(02)00019-2; PROKOP A, 1991, DEVELOPMENT, V111, P79; Prokop A, 1998, MECH DEVELOP, V74, P99, DOI 10.1016/S0925-4773(98)00068-9; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Shetty AK, 2005, GLIA, V51, P173, DOI 10.1002/glia.20187; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189; Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Voigt A, 2002, DEV DYNAM, V224, P403, DOI 10.1002/dvdy.10120; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Yan YP, 2006, EUR J NEUROSCI, V24, P45, DOI 10.1111/j.1460-9568.2006.04872.x; Ye P, 2004, J NEUROSCI RES, V78, P472, DOI 10.1002/jnr.20288; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu CC, 2008, DEVELOPMENT, V135, P513, DOI 10.1242/dev.010876	79	256	261	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1161	1173		10.1016/j.cell.2010.12.007	http://dx.doi.org/10.1016/j.cell.2010.12.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183078	Green Published, hybrid			2022-12-28	WOS:000285625400013
J	Fakhri, N; MacKintosh, FC; Lounis, B; Cognet, L; Pasquali, M				Fakhri, Nikta; MacKintosh, Frederick C.; Lounis, Brahim; Cognet, Laurent; Pasquali, Matteo			Brownian Motion of Stiff Filaments in a Crowded Environment	SCIENCE			English	Article							WALLED CARBON NANOTUBES; SEMIFLEXIBLE POLYMERS; AGAROSE GELS; DYNAMICS; DIFFUSION; MICROSCOPY; CHAIN; FLUORESCENCE; REPTATION; ROD	The thermal motion of stiff filaments in a crowded environment is highly constrained and anisotropic; it underlies the behavior of such disparate systems as polymer materials, nanocomposites, and the cell cytoskeleton. Despite decades of theoretical study, the fundamental dynamics of such systems remains a mystery. Using near-infrared video microscopy, we studied the thermal diffusion of individual single-walled carbon nanotubes (SWNTs) confined in porous agarose networks. We found that even a small bending flexibility of SWNTs strongly enhances their motion: The rotational diffusion constant is proportional to the filament-bending compliance and is independent of the network pore size. The interplay between crowding and thermal bending implies that the notion of a filament's stiffness depends on its confinement. Moreover, the mobility of SWNTs and other inclusions can be controlled by tailoring their stiffness.	[Fakhri, Nikta; Pasquali, Matteo] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Dept Chem, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [MacKintosh, Frederick C.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Lounis, Brahim; Cognet, Laurent] Univ Bordeaux, CNRS, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France	Rice University; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Pasquali, M (corresponding author), Rice Univ, Smalley Inst Nanoscale Sci & Technol, Dept Chem, Dept Chem & Biomol Engn, Houston, TX 77005 USA.	mp@rice.edu	MacKintosh, Frederick/AAB-9332-2021; Cognet, Laurent/M-4505-2019; Fakhri, Nikta/B-4657-2008; MacKintosh, Fred C/A-9450-2008; Cognet, Laurent/F-4163-2011; Pasquali, Matteo/A-2489-2008; Lounis, Brahim/I-7862-2016	MacKintosh, Frederick/0000-0002-2607-9541; Fakhri, Nikta/0000-0003-1261-7465; MacKintosh, Fred C/0000-0002-2607-9541; Cognet, Laurent/0000-0002-3573-5387; Pasquali, Matteo/0000-0001-5951-395X; Lounis, Brahim/0000-0001-7501-0236	NSF Center for Biological and Environmental Nanotechnology [EEC-0118007, EEC-0647452]; Welch Foundation [C-1668]; Advanced Energy Consortium; Region Aquitaine; Agence Nationale pour la Recherche (ANR PNANO); European Research Council [232942]; Foundation for Fundamental Research on Matter (FOM); Netherlands Organisation for Scientific Research (NWO)	NSF Center for Biological and Environmental Nanotechnology(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); Advanced Energy Consortium; Region Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale pour la Recherche (ANR PNANO)(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the NSF Center for Biological and Environmental Nanotechnology (EEC-0118007 and EEC-0647452), the Welch Foundation (grant C-1668), the Advanced Energy Consortium (www.beg.utexas.edu/aec), the Region Aquitaine, the Agence Nationale pour la Recherche (ANR PNANO), the European Research Council (grant n 232942), and the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organisation for Scientific Research (NWO).	ATTWOOD TK, 1988, BIOPOLYMERS, V27, P201, DOI 10.1002/bip.360270204; Cognet L, 2007, SCIENCE, V316, P1465, DOI 10.1126/science.1141316; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; Dogic Z, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.125503; DOI M, 1985, J POLYM SCI POL SYM, P93; DOI M, 1978, J CHEM SOC FARAD T 2, V74, P1789, DOI 10.1039/f29787401789; Doi M., 1988, THEORY POLYM DYNAMIC; Duggal R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.246104; Duque JG, 2008, J AM CHEM SOC, V130, P2626, DOI 10.1021/ja0777234; EDWARDS SF, 1967, P PHYS SOC LOND, V92, pR1; Fakhri N, 2009, P NATL ACAD SCI USA, V106, P14219, DOI 10.1073/pnas.0904148106; FARGE E, 1993, MACROMOLECULES, V26, P5041, DOI 10.1021/ma00071a009; Gittes F, 1998, PHYS REV E, V58, pR1241, DOI 10.1103/PhysRevE.58.R1241; Granek R, 1997, J PHYS II, V7, P1761, DOI 10.1051/jp2:1997214; Green MJ, 2009, POLYMER, V50, P4979, DOI 10.1016/j.polymer.2009.07.044; Han Y, 2006, SCIENCE, V314, P626, DOI 10.1126/science.1130146; Hofling F, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.060904; Munk T, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/30003; ODIJK T, 1983, MACROMOLECULES, V16, P1340, DOI 10.1021/ma00242a015; PERKINS TT, 1994, SCIENCE, V264, P819, DOI 10.1126/science.8171335; Pernodet N, 1997, ELECTROPHORESIS, V18, P55, DOI 10.1002/elps.1150180111; Ramanathan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.010501; SATO T, 1991, MACROMOLECULES, V24, P6220, DOI 10.1021/ma00023a025; TRACY MA, 1992, ANNU REV PHYS CHEM, V43, P525, DOI 10.1146/annurev.physchem.43.1.525; Tsyboulski DA, 2005, NANO LETT, V5, P975, DOI 10.1021/nl050366f; WIJMENGA SS, 1986, BIOPOLYMERS, V25, P2173, DOI 10.1002/bip.360251110; ZERO KM, 1982, MACROMOLECULES, V15, P87, DOI 10.1021/ma00229a017	27	97	97	1	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1804	1807		10.1126/science.1197321	http://dx.doi.org/10.1126/science.1197321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205665				2022-12-28	WOS:000285603700035
J	Frood, A				Frood, Arran			A flavour of the future	NATURE			English	Editorial Material																			0	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					S21	S22		10.1038/468S21a	http://dx.doi.org/10.1038/468S21a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21179082	Bronze			2022-12-28	WOS:000285553800009
J	Kavanagh, BP; McCowen, KC				Kavanagh, Brian P.; McCowen, Karen C.			Glycemic Control in the ICU.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE INSULIN THERAPY; BLOOD-GLUCOSE; NUTRITION SUPPORT; CRITICAL ILLNESS; GUIDELINES; MORTALITY; STRESS; CARE; HYPERGLYCEMIA; HYPOGLYCEMIA		[Kavanagh, Brian P.] Univ Toronto, Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; [Kavanagh, Brian P.] Univ Toronto, Hosp Sick Children, Dept Anesthesia, Toronto, ON M5G 1X8, Canada; [McCowen, Karen C.] Harvard Univ, Sch Med, Harvard Vanguard Med Associates, Boston, MA USA; [McCowen, Karen C.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Harvard Medical School; Harvard Vanguard Medical Associates; Harvard University; Beth Israel Deaconess Medical Center	Kavanagh, BP (corresponding author), Univ Toronto, Hosp Sick Children, Dept Crit Care Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	brian.kavanagh@sickkids.ca						American Diabetes Association, 2010, Diabetes Care, V33 Suppl 1, pS11, DOI 10.2337/dc10-S011; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P1698; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P341, DOI 10.1001/jama.2010.2; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Corstjens AM, 2006, CRIT CARE, V10, DOI 10.1186/cc5048; Davidson PC, 2005, DIABETES CARE, V28, P2418, DOI 10.2337/diacare.28.10.2418; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Egi M, 2008, CRIT CARE MED, V36, P2249, DOI 10.1097/CCM.0b013e318181039a; Egi M, 2010, MAYO CLIN PROC, V85, P217, DOI 10.4065/mcp.2009.0394; Erickson SE, 2009, CRIT CARE MED, V37, P1, DOI 10.1097/CCM.0b013e31819292ea; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P349, DOI 10.1136/jnnp.2003.034819; Garber Alan J, 2004, Endocr Pract, V10, P77; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Ingels C, 2006, EUR HEART J, V27, P2716, DOI 10.1093/eurheartj/ehi855; Juhl CB, 2010, DIABETES RES CLIN PR, V88, P22, DOI 10.1016/j.diabres.2010.01.007; Kosiborod M, 2009, JAMA-J AM MED ASSOC, V301, P1556, DOI 10.1001/jama.2009.496; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Louie K, 2010, QUAL SAF HLTH C 0804; Malhotra A, 2006, NEW ENGL J MED, V354, P516, DOI 10.1056/NEJMe058304; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Moghissi ES, 2010, CURR MED RES OPIN, V26, P589, DOI 10.1185/03007990903566822; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Rabiee Atoosa, 2009, J Diabetes Sci Technol, V3, P951; Rood E, 2005, J AM MED INFORM ASSN, V12, P172, DOI 10.1197/jamia.M1598; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Treggiari MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6807; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wiener RS, 2009, JAMA-J AM MED ASSOC, V301, P936; Worthley MI, 2007, AM J MED, V120, p643e1	39	118	136	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2540	2546		10.1056/NEJMcp1001115	http://dx.doi.org/10.1056/NEJMcp1001115			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697YL	21175316				2022-12-28	WOS:000285555600009
J	Wang, AT; Smith, SA				Wang, Amy T.; Smith, Steven A.			In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Wang, Amy T.; Smith, Steven A.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Wang, AT (corresponding author), Mayo Clin, Rochester, MN 55905 USA.		amy.tu.wang, amy.tu.wang/F-8331-2014; Smith, Steven/HDM-9496-2022	amy.tu.wang, amy.tu.wang/0000-0002-0929-1399; 				ClinicalTrials.gov, 2010, THIAZ INT VIT D EV T; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Woodcock J., 2010, DECISION CONTINUED M	5	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12							JC6-11	10.7326/0003-4819-153-12-201012210-02011	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173400				2022-12-28	WOS:000285453700016
J	Baker, WL; Colby, JA; Tongbram, V; Talati, R; Silverman, IE; White, CM; Kluger, J; Coleman, CI				Baker, William L.; Colby, Jennifer A.; Tongbram, Vanita; Talati, Ripple; Silverman, Isaac E.; White, C. Michael; Kluger, Jeffrey; Coleman, Craig I.			Neurothrombectomy Devices for the Treatment of Acute Ischemic Stroke: State of the Evidence	ANNALS OF INTERNAL MEDICINE			English	Review							MERCI CLOT RETRIEVER; MECHANICAL THROMBECTOMY; INTERVENTIONAL MANAGEMENT; PENUMBRA SYSTEM; POOLED ANALYSIS; AB DEVICE; RECANALIZATION; REVASCULARIZATION; OCCLUSION; THROMBOLYSIS	Background: Acute ischemic strokes are associated with poor outcomes and high health care burden. Evidence exists evaluating the use of neurothrombectomy devices in patients receiving currently recommended treatments that may have limited efficacy. Purpose: To describe the state of the evidence supporting use of neurothrombectomy devices in the treatment of acute ischemic stroke. Data Sources: MEDLINE, SCOPUS, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, and Web of Science were searched, without language restrictions, from their inception through May 2010. The MEDLINE and Cochrane Central Register of Controlled Trials searches were updated through November 2010. Study Selection: Two independent investigators screened citations for human studies of any design or case series or case reports of patients with an acute ischemic stroke that evaluated a neurothrombectomy device and reported at least 1 clinical effectiveness outcome or harm. Data Extraction: Using standardized protocols, 2 independent investigators extracted information about study characteristics and outcomes, and a third reviewer resolved disagreement. Data Synthesis: 87 articles met eligibility criteria, including 18 prospective single-group studies, 7 noncomparative retrospective studies, and 62 case series or case reports. Two U. S. Food and Drug Administration (FDA)-cleared devices, the MERCI Retriever (Concentric Medical, Mountain View, California) (40%) and the Penumbra System (Penumbra, Alameda, California) (9%), represented a large portion of the available data. All prospective and retrospective studies provided data on successful recanalization with widely varying rates (43% to 78% with the MERCI Retriever and 83% to 100% with the Penumbra System). Rates of harms, including symptomatic (16 studies; 0% to 10% with the MERCI Retriever and 0% to 11% with the Penumbra System) or asymptomatic (13 studies; 28% to 43% and 1% to 30%, respectively) intracranial hemorrhage and vessel perforation or dissection (11 studies; 0% to 7% and 0% to 5%, respectively), also varied by device. Predictors of harm included older age, history of stroke, and higher baseline stroke severity scores, whereas successful recanalization was the sole predictor of good outcomes. Limitations: Most available data are from single-group, noncomparative studies. In addition, the patient population most likely to benefit from these devices is undetermined. Conclusion: Currently available neurothrombectomy devices offer intriguing treatment options in patients with acute ischemic stroke. Future trials should use a randomized design, with adequate power to show equivalency or noninferiority between competing strategies or devices, and strive to identify populations that are most likely to benefit from use of neurothrombectomy devices.	[Baker, William L.; Colby, Jennifer A.; Tongbram, Vanita; Talati, Ripple; Silverman, Isaac E.; White, C. Michael; Kluger, Jeffrey; Coleman, Craig I.] Univ Connecticut, Hartford Hosp, Evidence Based Practice Ctr, Hartford, CT 06102 USA	Hartford Hospital; University of Connecticut	Coleman, CI (corresponding author), Univ Connecticut, Hartford Hosp, Evidence Based Practice Ctr, 80 Seymour St, Hartford, CT 06102 USA.	ccolema@harthosp.org	Baker, William L./H-7977-2016	Baker, William L./0000-0003-2172-0931; Coleman, Craig/0000-0003-4868-7158	University of Connecticut/Hartford Hospital Evidence-based Practice Center, Agency for Healthcare Research and Quality [290-2007-10067-I]; Agency for Healthcare Research and Quality, Boston Scientific, Astellas; Agency for Healthcare Research and Quality	University of Connecticut/Hartford Hospital Evidence-based Practice Center, Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality, Boston Scientific, Astellas(United States Department of Health & Human ServicesAgency for Healthcare Research & QualityBoston ScientificAstellas Pharmaceuticals); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: This article is based on research conducted by the University of Connecticut/Hartford Hospital Evidence-based Practice Center under contract 290-2007-10067-I with the Agency for Healthcare Research and Quality.; Drs. Baker, Colby, Tongbram, Talati, White, and Coleman: Grant (money to institution): Agency for Healthcare Research and Quality. Dr. Silverman: Payment for writing or reviewing the manuscript: Agency for Healthcare Research and Quality. Dr. Kluger: Grant (money to institution): Agency for Healthcare Research and Quality, Boston Scientific, Astellas; Consultancy: Sanofi-Aventis; Payment for lectures including service on speakers' bureaus: Medtronic, Sanofi-Aventis. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10-2218.	Alexandrov AV, 2002, NEUROLOGY, V59, P862, DOI 10.1212/WNL.59.6.862; BAKER WL, 2010, NEUROTHROMBECTOMY DE; Becker KJ, 2005, STROKE, V36, P400, DOI 10.1161/01.STR.0000153056.25397.ff; Berlis A, 2004, STROKE, V35, P1112, DOI 10.1161/01.STR.0000124126.17508.d3; Bose A, 2008, AM J NEURORADIOL, V29, P1409, DOI 10.3174/ajnr.A1110; Castano C, 2009, INTERV NEURORADIOL, V15, P209, DOI 10.1177/159101990901500212; Castano C, 2010, STROKE, V41, P1836, DOI 10.1161/STROKEAHA.110.584904; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Connors JJ, 2009, J VASC INTERV RADIOL, V20, P1507, DOI 10.1016/j.jvir.2009.10.005; Devlin TG, 2007, NEUROCRIT CARE, V6, P11, DOI 10.1385/NCC:6:1:11; Fischer U, 2005, STROKE, V36, P2121, DOI 10.1161/01.STR.0000182099.04994.fc; Frei D, 2009, STROKE, V40, pE250; Gobin YP, 2004, STROKE, V35, P2848, DOI 10.1161/01.STR.0000147718.12954.60; Gonzalez A, 2007, NEURORADIOLOGY, V49, P365, DOI 10.1007/s00234-006-0207-8; Gralla J, 2006, STROKE, V37, P3019, DOI 10.1161/01.STR.0000248457.55493.85; Grunwald IQ, 2009, EUR J NEUROL, V16, P1210, DOI 10.1111/j.1468-1331.2009.02750.x; Gupta R, 2009, J NEUROIMAGING, V19, P61, DOI 10.1111/j.1552-6569.2008.00197.x; Hauck EF, 2009, AM J NEURORADIOL, V30, P1532, DOI 10.3174/ajnr.A1536; Henkes H, 2009, STROKE, V40, pE247; Jo KD, 2008, STROKE, V39, P599; Josephson SA, 2009, NEUROCRIT CARE, V10, P43, DOI 10.1007/s12028-008-9167-7; Kelly ME, 2008, STROKE, V39, P1770, DOI 10.1161/STROKEAHA.107.506212; Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847; Khatri P, 2008, INT J STROKE, V3, P130, DOI 10.1111/j.1747-4949.2008.00151.x; Kidwell CS, 2008, CEREBROVASC DIS, V25, P338, DOI 10.1159/000118379; Kim D, 2006, AM J NEURORADIOL, V27, P2048; Kulcsar Z, 2010, AM J NEURORADIOL, V31, P628, DOI 10.3174/ajnr.A1924; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Liebig T, 2008, STROKE, V39, P608; Lin R, 2009, STROKE, V40, P2092, DOI 10.1161/STROKEAHA.108.544783; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Loh Y, 2010, AM J NEURORADIOL, V31, P935, DOI 10.3174/ajnr.A1958; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lutsep HL, 2008, CURR OPIN NEUROL, V21, P70, DOI 10.1097/WCO.0b013e3282f35564; Madison MT, 2008, STROKE, V39, P547; Mahon BR, 2003, AM J NEURORADIOL, V24, P534; Mauldin PD, 2008, INT J STROKE, V3, P138, DOI 10.1111/j.1747-4949.2008.00190.x; Mayer TE, 2005, AM J NEURORADIOL, V26, P1389; Mayer TE, 2002, STROKE, V33, P2232, DOI 10.1161/01.STR.0000024524.71680.C6; McNeil JM, 2001, JAMA-J AM MED ASSOC, V285, P1571; Meyers PM, 2010, J NEUROSURG, V113, P149, DOI 10.3171/2009.12.JNS091813; Nichols C, 2010, J NEUROINTERV SURG, V2, P67, DOI 10.1136/jnis.2009.001768; Nogueira RG, 2009, AM J NEURORADIOL, V30, P859, DOI 10.3174/ajnr.A1604; Nogueira RG, 2009, AM J NEURORADIOL, V30, P649, DOI 10.3174/ajnr.A1486; Nogueira RG, 2009, STROKE, V40, pE131; Nogueira RG, 2009, STROKE, V40, P516, DOI 10.1161/STROKEAHA.108.525089; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Smith WS, 2008, STROKE, V39, P1205, DOI 10.1161/STROKEAHA.107.497115; Smith WS, 2006, NEUROCRIT CARE, V4, P14, DOI 10.1385/NCC:4:1:014; Smith WS, 2009, STROKE, V40, P3834, DOI 10.1161/STROKEAHA.109.561787; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Stead LG, 2008, ARCH NEUROL-CHICAGO, V65, P1024, DOI 10.1001/archneur.65.8.1024; Struffert T, 2009, EUR RADIOL, V19, P2286, DOI 10.1007/s00330-009-1390-x; Suh SH, 2009, NEURORADIOLOGY, V51, P541, DOI 10.1007/s00234-009-0530-y; Tarr R, 2009, STROKE, V40, pE151; Thomassen L, 2007, ACTA NEUROL SCAND, V115, P22, DOI 10.1111/j.1600-0404.2007.00842.x; Tomsick T, 2008, AM J NEURORADIOL, V29, P582, DOI 10.3174/ajnr.A0843; *US FDA, 2007, GUID IND FDA STAFF P; US Food and Drug Administration, 510 K PREM NOT; WOLPERT SM, 1993, AM J NEURORADIOL, V14, P3; Xie J., 2007, Morbidity and Mortality Weekly Report, V56, P504; Zangerle A, 2007, NEUROLOGY, V68, P39, DOI 10.1212/01.wnl.0000250341.38014.d2	62	64	67	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					243	252		10.7326/0003-4819-154-4-201102150-00306	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00306			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21242342				2022-12-28	WOS:000287310000016
J	Ting, DT; Lipson, D; Paul, S; Brannigan, BW; Akhavanfard, S; Coffman, EJ; Contino, G; Deshpande, V; Iafrate, AJ; Letovsky, S; Rivera, MN; Bardeesy, N; Maheswaran, S; Haber, DA				Ting, David T.; Lipson, Doron; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Letovsky, Stan; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.			Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial Cancers	SCIENCE			English	Article							PERVASIVE TRANSCRIPTION; DIFFERENTIATION; ELEMENTS; DATABASE; RNAS	Satellite repeats in heterochromatin are transcribed into noncoding RNAs that have been linked to gene silencing and maintenance of chromosomal integrity. Using digital gene expression analysis, we showed that these transcripts are greatly overexpressed in mouse and human epithelial cancers. In 8 of 10 mouse pancreatic ductal adenocarcinomas (PDACs), pericentromeric satellites accounted for a mean 12% (range 1 to 50%) of all cellular transcripts, a mean 40-fold increase over that in normal tissue. In 15 of 15 human PDACs, alpha satellite transcripts were most abundant and HSATII transcripts were highly specific for cancer. Similar patterns were observed in cancers of the lung, kidney, ovary, colon, and prostate. Derepression of satellite transcripts correlated with overexpression of the long interspersed nuclear element 1 (LINE-1) retrotransposon and with aberrant expression of neuroendocrine-associated genes proximal to LINE-1 insertions. The overexpression of satellite transcripts in cancer may reflect global alterations in heterochromatin silencing and could potentially be useful as a biomarker for cancer detection.	[Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA; [Ting, David T.; Paul, Suchismita; Brannigan, Brian W.; Akhavanfard, Sara; Coffman, Erik J.; Contino, Gianmarco; Deshpande, Vikram; Iafrate, A. John; Rivera, Miguel N.; Bardeesy, Nabeel; Maheswaran, Shyamala; Haber, Daniel A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02114 USA; [Lipson, Doron; Letovsky, Stan] Helicos BioSci Corp, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Haber, DA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	haber@helix.mgh.harvard.edu	Akhavanfard, Sara/R-2032-2017; Akhavanfard, Sara/AAP-6475-2020; Ting, David/F-4389-2017	Akhavanfard, Sara/0000-0003-1659-8185; Akhavanfard, Sara/0000-0003-1659-8185; Contino, Gianmarco/0000-0001-5874-0405; Ting, David/0000-0002-3261-2322	Pancreatic Cancer Action Network-American Association for Cancer Research; Warshaw Institute for Pancreatic Cancer Research; Fond. Veronesi; Howard Hughes Medical Institute; National Cancer Institute [CA129933]; NATIONAL CANCER INSTITUTE [R01CA129933, R01CA133557, P01CA117969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010023] Funding Source: NIH RePORTER	Pancreatic Cancer Action Network-American Association for Cancer Research; Warshaw Institute for Pancreatic Cancer Research; Fond. Veronesi(Fondazione Umberto Veronesi); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a Pancreatic Cancer Action Network-American Association for Cancer Research Fellowship and the Warshaw Institute for Pancreatic Cancer Research (D.T.T.); Fond. Veronesi (G.C.); Howard Hughes Medical Institute (D.A.H. and M.N.R.); and National Cancer Institute CA129933 (D.A.H). We thank T. Raz, P. Kapranov, E. Giladi, and J. Whetstine for helpful discussions and K. Haigis and K. Wong for providing mouse colon and lung tumors, respectively. Massachusetts General Hospital and the authors (D.A.H., D.L., S.M., D.T.T.) have filed a patent application relating to detection of satellite and LINE sequences in human cancers.	Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Carone DM, 2009, CHROMOSOMA, V118, P113, DOI 10.1007/s00412-008-0181-5; Cindolo L, 2007, UROL INT, V79, P287, DOI 10.1159/000109711; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Montoya-Durango DE, 2009, MUTAT RES-FUND MOL M, V665, P20, DOI 10.1016/j.mrfmmm.2009.02.011; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Tezel E, 2000, CANCER, V89, P2230, DOI 10.1002/1097-0142(20001201)89:11<2230::AID-CNCR11>3.0.CO;2-X; Ugarkovic D, 2005, EMBO REP, V6, P1035, DOI 10.1038/sj.embor.7400558; Valgardsdottir R, 2008, NUCLEIC ACIDS RES, V36, P423, DOI 10.1093/nar/gkm1056	23	337	368	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					593	596		10.1126/science.1200801	http://dx.doi.org/10.1126/science.1200801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21233348	Green Accepted			2022-12-28	WOS:000286933600056
J	Weber, RC; Lin, PY; Garnero, EJ; Williams, Q; Lognonne, P				Weber, Renee C.; Lin, Pei-Ying; Garnero, Edward J.; Williams, Quentin; Lognonne, Philippe			Seismic Detection of the Lunar Core	SCIENCE			English	Article							MELTING RELATIONS; PLANETARY BODIES; METALLIC CORES; HIGH-PRESSURE; PROSPECTOR; MANTLE; MOON; CONSTRAINTS; EVOLUTION; STATE	Despite recent insight regarding the history and current state of the Moon from satellite sensing and analyses of limited Apollo-era seismic data, deficiencies remain in our understanding of the deep lunar interior. We reanalyzed Apollo lunar seismograms using array-processing methods to search for the presence of reflected and converted seismic energy from the core. Our results suggest the presence of a solid inner and fluid outer core, overlain by a partially molten boundary layer. The relative sizes of the inner and outer core suggest that the core is similar to 60% liquid by volume. Based on phase diagrams of iron alloys and the presence of partial melt, the core probably contains less than 6 weight % of lighter alloying components, which is consistent with a volatile-depleted interior.	[Weber, Renee C.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35805 USA; [Lin, Pei-Ying; Garnero, Edward J.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Williams, Quentin] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Lognonne, Philippe] Univ Paris Diderot, Inst Phys Globe, Sorbonne Paris Cite, St Maur Des Fosses, France	National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Arizona State University; Arizona State University-Tempe; University of California System; University of California Santa Cruz; UDICE-French Research Universities; Universite Paris Cite	Weber, RC (corresponding author), NASA, George C Marshall Space Flight Ctr, 320 Sparkman Dr, Huntsville, AL 35805 USA.	renee.c.weber@nasa.gov	Lognonne, Philippe/F-8846-2010	Lognonne, Philippe/0000-0002-1014-920X; Lin, Pei-Ying/0000-0001-6732-4163	NASA [NNH09AK41I]; Division Of Earth Sciences [0732741] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by NASA Planetary Geology and Geophysics grant NNH09AK41I to R.C.W. The authors thank four reviewers, and Y. Nakamura for helpful comments and discussions.	Balog PS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001646; BRETT R, 1969, EARTH PLANET SC LETT, V6, P479, DOI 10.1016/0012-821X(69)90119-8; Bulow RC, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002414; Canup RM, 2004, ICARUS, V168, P433, DOI 10.1016/j.icarus.2003.09.028; Chen B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033311; Dasgupta R, 2009, GEOCHIM COSMOCHIM AC, V73, P6678, DOI 10.1016/j.gca.2009.08.001; Gagnepain-Beyneix J, 2006, PHYS EARTH PLANET IN, V159, P140, DOI 10.1016/j.pepi.2006.05.009; Goossens S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031960; GREEN DH, 1971, EARTH PLANET SC LETT, V13, P85, DOI 10.1016/0012-821X(71)90109-9; Hood LL, 1999, GEOPHYS RES LETT, V26, P2327, DOI 10.1029/1999GL900487; Khan A, 2007, GEOPHYS J INT, V168, P243, DOI 10.1111/j.1365-246X.2006.03200.x; Konopliv AS, 1998, SCIENCE, V281, P1476, DOI 10.1126/science.281.5382.1476; Konopliv AS, 2001, ICARUS, V150, P1, DOI 10.1006/icar.2000.6573; Lognonne P, 2003, EARTH PLANET SC LETT, V211, P27, DOI 10.1016/S0012-821X(03)00172-9; Lognonne P., 2007, TREATISE GEOPHYS, V10, P69, DOI DOI 10.1016/B978-044452748-6.00154-1; Longhi J, 2006, GEOCHIM COSMOCHIM AC, V70, P5919, DOI 10.1016/j.gca.2006.09.023; Nakamura Y, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002332; NAKAMURA Y, 1983, J GEOPHYS RES, V88, P677, DOI 10.1029/JB088iB01p00677; Nakamura Y., 1978, P LUN PLAN SCI C 9, V3, P3589; Nakamura Y, 1974, GEOPHYS RES LETT, V1, P137, DOI 10.1029/GL001i003p00137; Righter K, 1996, ICARUS, V124, P513, DOI 10.1006/icar.1996.0227; Rost S, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000100; Sanloup C, 2000, GEOPHYS RES LETT, V27, P811, DOI 10.1029/1999GL008431; Wieczorek MA, 2006, REV MINERAL GEOCHEM, V60, P221, DOI 10.2138/rmg.2006.60.3; Williams J. G., 2010, 41 LUN PLAN SCI C WO; Williams JG, 2001, J GEOPHYS RES-PLANET, V106, P27933, DOI 10.1029/2000JE001396; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528; Williams Q, 2009, EARTH PLANET SC LETT, V284, P564, DOI 10.1016/j.epsl.2009.05.019; WYATT BA, 1977, CONTRIB MINERAL PETR, V61, P1, DOI 10.1007/BF00375941	29	314	329	6	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					309	312		10.1126/science.1199375	http://dx.doi.org/10.1126/science.1199375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21212323	Green Published			2022-12-28	WOS:000286636300030
J	Stone, GW; Maehara, A; Lansky, AJ; de Bruyne, B; Cristea, E; Mintz, GS; Mehran, R; McPherson, J; Farhat, N; Marso, SP; Parise, H; Templin, B; White, R; Zhang, Z; Serruys, PW				Stone, Gregg W.; Maehara, Akiko; Lansky, Alexandra J.; de Bruyne, Bernard; Cristea, Ecaterina; Mintz, Gary S.; Mehran, Roxana; McPherson, John; Farhat, Naim; Marso, Steven P.; Parise, Helen; Templin, Barry; White, Roseann; Zhang, Zhen; Serruys, Patrick W.		PROSPECT Investigators	A Prospective Natural-History Study of Coronary Atherosclerosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVASCULAR ULTRASOUND ASSESSMENT; RISK-ASSESSMENT STRATEGIES; ARTERY-DISEASE; REGRESSION-ANALYSIS; VULNERABLE PATIENT; PLAQUE; DEFINITIONS; PROGRESSION; CALL	Background: Atherosclerotic plaques that lead to acute coronary syndromes often occur at sites of angiographically mild coronary-artery stenosis. Lesion-related risk factors for such events are poorly understood. Methods: In a prospective study, 697 patients with acute coronary syndromes underwent three-vessel coronary angiography and gray-scale and radiofrequency intravascular ultrasonographic imaging after percutaneous coronary intervention. Subsequent major adverse cardiovascular events (death from cardiac causes, cardiac arrest, myocardial infarction, or rehospitalization due to unstable or progressive angina) were adjudicated to be related to either originally treated (culprit) lesions or untreated (nonculprit) lesions. The median follow-up period was 3.4 years. Results: The 3-year cumulative rate of major adverse cardiovascular events was 20.4%. Events were adjudicated to be related to culprit lesions in 12.9% of patients and to nonculprit lesions in 11.6%. Most nonculprit lesions responsible for follow-up events were angiographically mild at baseline (mean [+/-SD] diameter stenosis, 32.3+/-20.6%). However, on multivariate analysis, nonculprit lesions associated with recurrent events were more likely than those not associated with recurrent events to be characterized by a plaque burden of 70% or greater (hazard ratio, 5.03; 95% confidence interval [CI], 2.51 to 10.11; P<0.001) or a minimal luminal area of 4.0 mm(sup 2) or less (hazard ratio, 3.21; 95% CI, 1.61 to 6.42; P=0.001) or to be classified on the basis of radiofrequency intravascular ultrasonography as thin-cap fibroatheromas (hazard ratio, 3.35; 95% CI, 1.77 to 6.36; P<0.001). Conclusions: In patients who presented with an acute coronary syndrome and underwent percutaneous coronary intervention, major adverse cardiovascular events occurring during follow-up were equally attributable to recurrence at the site of culprit lesions and to nonculprit lesions. Although nonculprit lesions that were responsible for unanticipated events were frequently angiographically mild, most were thin-cap fibroatheromas or were characterized by a large plaque burden, a small luminal area, or some combination of these characteristics, as determined by gray-scale and radiofrequency intravascular ultrasonography. (Funded by Abbott Vascular and Volcano; ClinicalTrials.gov number, NCT00180466.) N Engl J Med 2011;364:226-35.	[Stone, Gregg W.; Maehara, Akiko; Lansky, Alexandra J.; Cristea, Ecaterina; Mintz, Gary S.; Mehran, Roxana; Parise, Helen] Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA; [Stone, Gregg W.; Maehara, Akiko; Lansky, Alexandra J.; Cristea, Ecaterina; Mintz, Gary S.; Mehran, Roxana; Parise, Helen] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10022 USA; [de Bruyne, Bernard] Onze Lieve Vrouw Hosp, Ctr Cardiovasc, Aalst, Belgium; [McPherson, John] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Farhat, Naim] Elyria Mem Hosp, Reg Med Ctr, N Ohio Heart Ctr, Elyria, OH USA; [Marso, Steven P.] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Templin, Barry; White, Roseann; Zhang, Zhen] Abbott Vasc, Santa Clara, CA USA; [Serruys, Patrick W.] Erasmus Univ, Thoraxctr, NL-3000 DR Rotterdam, Netherlands	Cardiovascular Research Foundation (CRF); Columbia University; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Center Aalst; Vanderbilt University; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; Erasmus University Rotterdam; Erasmus MC	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St,11th Fl, New York, NY 10022 USA.	gs2184@columbia.edu	Mehran, Roxana/ABF-4160-2021	Zhang, Zhen/0000-0002-0804-8741; Botker, Hans Erik/0000-0001-6358-8962; Parise, Helen/0000-0001-7761-4973; McPherson, John/0000-0003-3371-7481	Abbott Vascular; Volcano; TherOx; Medicines Company; Atrium Medical; Boston Scientific; Osprey; Reva Systems; Merck; InfraReDx; CoreValve; Xtent; Edwards Lifesciences; Bioabsorbable Therapeutics; Asten BioPharma; Accelerated Technologies; S. B. Medical; Evalve; AstraZeneca; Prescient; Eli Lilly; Bristol-Myers Squibb; Sanofi-Aventis; Biosensors International; Otsuka; Cappella; Cardiva Medical; Regado BioSciences; Cordis; Terumo; Novo Nordisk; Amylin Pharmaceuticals	Abbott Vascular(Abbott Laboratories); Volcano; TherOx; Medicines Company; Atrium Medical; Boston Scientific(Boston Scientific); Osprey; Reva Systems; Merck(Merck & Company); InfraReDx; CoreValve; Xtent; Edwards Lifesciences; Bioabsorbable Therapeutics; Asten BioPharma; Accelerated Technologies; S. B. Medical; Evalve; AstraZeneca(AstraZeneca); Prescient; Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis); Biosensors International; Otsuka(Otsuka Pharmaceutical); Cappella; Cardiva Medical; Regado BioSciences; Cordis; Terumo; Novo Nordisk(Novo Nordisk); Amylin Pharmaceuticals(Bristol-Myers Squibb)	Supported by Abbott Vascular and by Volcano.; Dr. Stone reports receiving grant support from Abbott Vascular, TherOx, the Medicines Company, Atrium Medical, Boston Scientific, and Volcano, being a board member for Devax, receiving consulting fees from Osprey, Reva Systems, Merck, InfraReDx, CoreValve, Boston Scientific, Abbott Vascular, Xtent, Edwards Lifesciences, Bioabsorbable Therapeutics, Asten BioPharma, Accelerated Technologies, S. B. Medical, Evalve, AstraZeneca, Prescient, Eli Lilly, Bristol-Myers Squibb, Sanofi-Aventis, Biosensors International, Otsuka, the Medicines Company, and Ortho-McNeil, receiving lecture fees from Edwards Lifesciences, Boston Scientific, and Abbott Vascular, and owning stock or stock options in Devax, CoreValve, Savacor, Biostar I and II funds, MedFocus I, II, and Accelerator funds, Xtent, Caliber, FlowCardia, Ovalum Vascular, MediGuide, Guided Delivery Systems, Arstasis, MiCardia, and AccessClosure; Dr. Maehara, receiving grant support from Boston Scientific and lecture fees from Volcano; Dr. Mintz, receiving grant support from Boston Scientific and Volcano, consultancy fees and lecture fees from Boston Scientific and Volcano, and travel or meeting expenses from Cappella; Dr. Mehran, receiving institutional grant support from Bristol-Myers Squibb and Sanofi-Aventis and consulting fees from Abbott Vascular, Cardiva Medical, the Medicines Company, and Regado BioSciences, and institutional grant support to her spouse from AstraZeneca and Cordis; Dr. McPherson, receiving consulting fees from Abbott Vascular and CardioDx and lecture fees from Volcano and CardioDx; Dr. Marso, receiving grant support from Volcano, Terumo, Novo Nordisk, the Medicines Company, and Amylin Pharmaceuticals, consulting fees from Volcano, Abbott Vascular, and Novo Nordisk, lecture fees from the Medicines Company, and payment for manuscript preparation from Novo Nordisk; Mr. Templin and Ms. White report being employees of Abbott Vascular. No other potential conflict of interest relevant to this article was reported.	Abizaid AS, 1999, J AM COLL CARDIOL, V34, P707, DOI 10.1016/S0735-1097(99)00261-2; AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56, DOI 10.1016/0735-1097(88)90356-7; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Anderson SD, 2008, CIRCULATION, V117, pE174, DOI 10.1161/CIRCULATIONAHA.107.737551; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cannon CP, 2006, NEW ENGL J MED, V354, P778; Diethrich EB, 2007, J ENDOVASC THER, V14, P676, DOI 10.1583/1545-1550(2007)14[676:VHIUAO]2.0.CO;2; Garcia-Garcia HM, 2009, EUROINTERVENTION, V5, P177, DOI 10.4244/EIJV5I2A29; Glaser R, 2005, CIRCULATION, V111, P143, DOI 10.1161/01.CIR.0000150335.01285.12; Kubo T, 2010, J AM COLL CARDIOL, V55, P1590, DOI 10.1016/j.jacc.2009.07.078; Kushner, 2010, CIRCULATION, V121, pE257, DOI 10.1161/CIR.0b013e3181d7a65e; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lansky AJ, 2002, J AM COLL CARDIOL, V39, P274, DOI 10.1016/S0735-1097(01)01745-4; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nair Anuja, 2007, EuroIntervention, V3, P113; Nishioka T, 1999, J AM COLL CARDIOL, V33, P1870, DOI 10.1016/S0735-1097(99)00100-X; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084	22	2105	2201	7	156	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					226	235		10.1056/NEJMoa1002358	http://dx.doi.org/10.1056/NEJMoa1002358			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21247313				2022-12-28	WOS:000286383900007
J	Luckmann, R				Luckmann, Roger			Review: Prostate cancer screening using PSA does not decrease mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Luckmann, R (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.							Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084	2	0	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-2	10.7326/0003-4819-154-2-201101180-02002	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242356				2022-12-28	WOS:000286223500028
J	Fewtrell, M; Wilson, DC; Booth, I; Lucas, A				Fewtrell, Mary; Wilson, David C.; Booth, Ian; Lucas, Alan			Six months of exclusive breast feeding: how good is the evidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IRON-DEFICIENCY; DURATION; RISK; HOSPITALIZATION; INFANTS; HEALTH; CONSUMPTION; INFECTION; EXPOSURE; CHILDREN		[Fewtrell, Mary; Lucas, Alan] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London WC1N 1EH, England; [Wilson, David C.] Univ Edinburgh, Coll Med & Vet Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Booth, Ian] Univ Birmingham, Inst Child Hlth, Birmingham B15 2TT, W Midlands, England	University of London; University College London; University of Edinburgh; University of Birmingham	Fewtrell, M (corresponding author), UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London WC1N 1EH, England.	m.fewtrell@ich.ucl.ac.uk			Medical Research Council [G1002033] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Agostoni C, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1423; Bolling K, 2007, INFANT FEEDING SURVE; British Dietetic Association, 2010, BDA PAED GROUP POS S; Chantry CJ, 2007, BREASTFEED MED, V2, P63, DOI 10.1089/bfm.2007.0002; Chantry CJ, 2006, PEDIATRICS, V117, P425, DOI 10.1542/peds.2004-2283; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; Garza C, 2002, NUTRIENT ADEQUACY EX; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Kramer MS, 2009, AM J CLIN NUTR, V90, P1070, DOI 10.3945/ajcn.2009.28021; Kramer MS, 2003, AM J CLIN NUTR, V78, P291, DOI 10.1093/ajcn/78.2.291; KRAMER MS, 2002, OPTIMAL DURATION EXC; Lanigan JA, 2001, EUR J CLIN NUTR, V55, P309, DOI 10.1038/sj.ejcn.1601168; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; Lucas A, 1998, J NUTR, V128, p401S, DOI 10.1093/jn/128.2.401S; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; [OECD Directorate for Employment Labour and Social Affairs Social Policy Division], 2009, OECD FAM DAT CO1 5 B; Olsson C, 2008, PEDIATRICS, V122, P528, DOI 10.1542/peds.2007-2989; Talayero JMP, 2006, PEDIATRICS, V118, pE92, DOI 10.1542/peds.2005-1629; Platt MPW, 2009, ARCH DIS CHILD, V94, P79, DOI 10.1136/adc.2008.150011; Poole JA, 2006, J ALLERGY CLIN IMMUN, V117, pS42, DOI 10.1016/j.jaci.2005.12.174; Prescott SL, 2008, PEDIAT ALLERG IMM-UK, V19, P375, DOI 10.1111/j.1399-3038.2008.00718.x; Quigley MA, 2009, ARCH DIS CHILD, V94, P148, DOI 10.1136/adc.2008.146126; Quigley MA, 2007, PEDIATRICS, V119, pE837, DOI 10.1542/peds.2006-2256; Rebhan B, 2009, ACTA PAEDIATR, V98, P974, DOI 10.1111/j.1651-2227.2009.01281.x; Reilly JJ, 2005, BRIT J NUTR, V94, P56, DOI 10.1079/BJN20051464; Reilly JJ, 2005, BRIT J NUTR, V94, P869, DOI 10.1079/BJN20051601; Schack-Nielsen L, 2010, AM J CLIN NUTR, V91, P619, DOI 10.3945/ajcn.2008.27078; [Scientific Advisory Committee on Nutrition (SACN) Subgroup on Maternal and Child Nutrition (SMCN)], 2003, SMCN0308 SACN; [Scientific Advisory Committee on Nutrition (SACN) Subgroup on Maternal and Child Nutrition (SMCN)], 2003, 2 M SUBGR MAT CHILD; WHO, 1998, WHONUT981; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; World Health Organization (WHO), 2002, 55 WORLD HLTH ASS IN	34	79	80	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2011	342								c5955	10.1136/bmj.c5955	http://dx.doi.org/10.1136/bmj.c5955			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708TG	21233152	Green Published			2022-12-28	WOS:000286386600005
J	Brook, RH				Brook, Robert H.			Is Choice of Physician and Hospital an Essential Benefit?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									RAND Corp, Santa Monica, CA 90407 USA	RAND Corporation	Brook, RH (corresponding author), RAND Corp, POB 2138, Santa Monica, CA 90407 USA.	robert_brook@rand.org						Eibner C, 2010, NEW ENGL J MED, V363, P1393, DOI 10.1056/NEJMp1008047; *EUR OBS HLTH CAR, 2009, HLTH CAR SYST TRANS; Newhouse JP, 1993, RAND CORPORATION INS; *OFF STAT HLTH PLA, 2009, REP COR ART BYP GRAF; 2010, PROJECT DEFINING REV	5	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					195	196		10.1001/jama.2010.1987	http://dx.doi.org/10.1001/jama.2010.1987			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224462				2022-12-28	WOS:000286103400027
J	Tanabe, K				Tanabe, Kazushige			The Feeding Habits of Ammonites	SCIENCE			English	Editorial Material									Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan	University of Tokyo	Tanabe, K (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan.	tanabe@eps.s.u-tokyo.ac.jp			Grants-in-Aid for Scientific Research [23340157] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ALLDREDGE AL, 1985, MAR BIOL, V84, P253, DOI 10.1007/BF00392494; Doguzhaeva Larisa A., 1992, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V223, P167; HOUSE MR, 1993, AMMONOIDEA ENV ECOLO, V47, P13; Huber BT, 2002, GEOL SOC AM SPEC PAP, V356, P277; HUNT S, 1981, COMP BIOCHEM PHYS B, V68, P535, DOI 10.1016/0305-0491(81)90071-7; Kruta I, 2011, SCIENCE, V331, P70, DOI 10.1126/science.1198793; Landman N. H., 1988, CEPHALOPODS PRESENT, P215; LANDMAN NH, 1996, AMMONOID PALEOBIOLOG, P343; Lehmann U., 1981, AMMONITES THEIR LIFE; NIXON M, 1988, MOLLUSCA PALEONTOLOG, V12, P103; TANABE K, 1980, LETHAIA, V13, P157, DOI 10.1111/j.1502-3931.1980.tb01046.x; Tanabe Kazushige, 2002, Abhandlungen der Geologischen Bundesanstalt (Vienna), V57, P157; Tanabe Kazushige, 1999, P245	13	23	25	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 7	2011	331	6013					37	38		10.1126/science.1201002	http://dx.doi.org/10.1126/science.1201002			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	703JK	21212343				2022-12-28	WOS:000285974000024
J	Nichols, D				Nichols, David			Legal highs: the dark side of medicinal chemistry	NATURE			English	Editorial Material									Purdue Univ, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Nichols, D (corresponding author), Purdue Univ, W Lafayette, IN 47907 USA.	drdave@purdue.edu							0	15	15	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 6	2011	469	7328					7	7		10.1038/469007a	http://dx.doi.org/10.1038/469007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	702UO	21209630	Bronze			2022-12-28	WOS:000285921600002
J	Jacobs, EJ				Jacobs, Eric J.			Will an aspirin a day help keep fatal cancer away?	LANCET			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOW-DOSE ASPIRIN; COLORECTAL-CANCER; RISK; COHORT		Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30303 USA	American Cancer Society	Jacobs, EJ (corresponding author), Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30303 USA.	eric.jacobs@cancer.org						Abnet CC, 2009, BRIT J CANCER, V100, P551, DOI 10.1038/sj.bjc.6604880; Bosetti C, 2006, CANCER CAUSE CONTROL, V17, P871, DOI 10.1007/s10552-006-0033-7; Calonge N, 2009, ANN INTERN MED, V150, P396; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Feskanich D, 2007, BRIT J CANCER, V97, P1295, DOI 10.1038/sj.bjc.6603996; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Hernandez-Diaz S, 2007, INT J CANCER, V120, P1565, DOI 10.1002/ijc.22514; Laine L, 2006, ALIMENT PHARM THER, V24, P897, DOI 10.1111/j.1365-2036.2006.03077.x; Larsson SC, 2006, CANCER EPIDEM BIOMAR, V15, P2561, DOI 10.1158/1055-9965.EPI-06-0574; Mahmud SM, 2010, INT J CANCER, V127, P1680, DOI 10.1002/ijc.25186; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; US Preventive Services Task Force, 2007, ANN INTERN MED, V146, P361, DOI 10.7326/0003-4819-146-5-200703060-00008	14	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2011	377	9759					3	4		10.1016/S0140-6736(10)62301-X	http://dx.doi.org/10.1016/S0140-6736(10)62301-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709MQ	21195237				2022-12-28	WOS:000286445200004
J	Lassen, MR; Gallus, A; Raskob, GE; Pineo, G; Chen, D; Ramirez, LM				Lassen, Michael Rud; Gallus, Alexander; Raskob, Gary E.; Pineo, Graham; Chen, Dalei; Ramirez, Luz Margarita		ADVANCE-3 Investigators	Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; TOTAL KNEE ARTHROPLASTY; FACTOR XA INHIBITOR; VENOUS THROMBOEMBOLISM; DABIGATRAN ETEXILATE; ELECTIVE HIP; DOUBLE-BLIND; RANDOMIZED-TRIAL; PREVENTION; RIVAROXABAN	Background: There are various regimens for thromboprophylaxis after hip replacement. Low-molecular-weight heparins such as enoxaparin predominantly inhibit factor Xa but also inhibit thrombin to some degree. Orally active, specific factor Xa inhibitors such as apixaban may provide effective thromboprophylaxis with a lower risk of bleeding and improved ease of use. Methods: In this double-blind, double-dummy study, we randomly assigned 5407 patients undergoing total hip replacement to receive apixaban at a dose of 2.5 mg orally twice daily or enoxaparin at a dose of 40 mg subcutaneously every 24 hours. Apixaban therapy was initiated 12 to 24 hours after closure of the surgical wound; enoxaparin therapy was initiated 12 hours before surgery. Prophylaxis was continued for 35 days after surgery, followed by bilateral venographic studies. The primary efficacy outcome was the composite of asymptomatic or symptomatic deep-vein thrombosis, nonfatal pulmonary embolism, or death from any cause during the treatment period. Patients were followed for an additional 60 days after the last intended dose of study medication. Results: A total of 1949 patients in the apixaban group (72.0%) and 1917 patients in the enoxaparin group (71.0%) could be evaluated for the primary efficacy analysis. The primary efficacy outcome occurred in 27 patients in the apixaban group (1.4%) and in 74 patients in the enoxaparin group (3.9%) (relative risk with apixaban, 0.36; 95% confidence interval [CI], 0.22 to 0.54; P<0.001 for both noninferiority and superiority; absolute risk reduction, 2.5 percentage points; 95% CI, 1.5 to 3.5). The composite outcome of major and clinically relevant nonmajor bleeding occurred in 129 of 2673 patients assigned to apixaban (4.8%) and 134 of 2659 assigned to enoxaparin (5.0%) (absolute difference in risk, -0.2 percentage points; 95% CI, -1.4 to 1.0). Conclusions: Among patients undergoing hip replacement, thromboprophylaxis with apixaban, as compared with enoxaparin, was associated with lower rates of venous thromboembolism, without increased bleeding. (Funded by Bristol-Myers Squibb and Pfizer; ClinicalTrials.gov number, NCT00423319.) N Engl J Med 2010;363:2487-98.	[Lassen, Michael Rud] Univ Copenhagen, Horsholm Hosp, Dept Orthoped, Spine Clin,Clin Trial Unit, DK-2970 Horsholm, Denmark; [Gallus, Alexander] Flinders Med Ctr, SA Pathol, Adelaide, SA, Australia; [Gallus, Alexander] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA; [Pineo, Graham] Univ Calgary, Dept Med, Calgary, AB, Canada; [Pineo, Graham] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Chen, Dalei; Ramirez, Luz Margarita] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ USA	University of Copenhagen; Flinders Medical Centre; SA Pathology; Flinders University South Australia; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Calgary; University of Calgary; Bristol-Myers Squibb	Lassen, MR (corresponding author), Univ Copenhagen, Horsholm Hosp, Dept Orthoped, Spine Clin,Clin Trial Unit, Usserod Kongevej 102, DK-2970 Horsholm, Denmark.	mirula@noh.regionh.dk	Schulman, Sam/I-7559-2019; Bohatyrewicz, Andrzej/J-4658-2014	Schulman, Sam/0000-0002-8512-9043; Bohatyrewicz, Andrzej/0000-0002-4773-0970; Borris, Lars/0000-0002-0527-1518; Gallus, Alexander/0000-0001-7347-9989	Bristol-Myers Squibb; Pfizer; Sanofi-Aventis; Astellas Pharma Europe; GlaxoSmithKline; Bayer HealthCare; Astellas; Bayer; Progen Pharmaceuticals; Boehringer Ingelheim; Johnson Johnson; Daiichi Sankyo; Takeda Global Research and Development	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Astellas Pharma Europe(Astellas Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Astellas(Astellas Pharmaceuticals); Bayer(Bayer AG); Progen Pharmaceuticals; Boehringer Ingelheim(Boehringer Ingelheim); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Daiichi Sankyo(Daiichi Sankyo Company Limited); Takeda Global Research and Development	Dr. Lassen reports receiving consulting fees from Bristol-Myers Squibb, Pfizer, Sanofi-Aventis, Astellas Pharma Europe, GlaxoSmithKline, and Bayer HealthCare and payment for development of educational materials from Bayer HealthCare; Dr. Gallus, receiving compensation for advisory-board membership from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, and Sanofi-Aventis, consulting fees from Astellas, Bayer, Sanofi-Aventis, and Progen Pharmaceuticals, lecture fees from Boehringer Ingelheim, Bristol-Myers Squibb, and Pfizer, and payment for manuscript preparation from Bayer and Sanofi-Aventis; Dr. Raskob (and his institution), receiving consulting fees from Bristol-Myers Squibb, Boehringer Ingelheim, Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Sanofi-Aventis, and Daiichi Sankyo, payment for manuscript preparation from Sanofi-Aventis, Daiichi Sankyo, GlaxoSmithKline, and Takeda Global Research and Development, and compensation for travel, accommodations, or meeting expenses from Boehringer Ingelheim, Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Sanofi-Aventis, and Daiichi Sankyo; Dr. Pineo, receiving consulting fees from Bayer, Boehringer Ingelheim, Sanofi-Aventis, Bristol-Myers Squibb, and Pfizer, payment for lectures as part of speakers bureaus and for paper or poster presentations from Boehringer Ingelheim, Bayer, and Sanofi-Aventis, payment for manuscript preparation from Bristol-Myers Squibb, Pfizer, and Sanofi-Aventis, payment for development of educational materials from Boehringer Ingelheim, Bayer, and Sanofi-Aventis, and compensation for travel, accommodations, or meeting expenses from Boehringer Ingelheim and Bayer; and Drs. Ramirez and Chen, being full-time employees of Bristol-Myers Squibb. No other potential conflict of interest relevant to this article was reported.	Eriksson BI, 2007, LANCET, V370, P2004; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2009, J BONE JOINT SURG BR, V91B, P1120; Eriksson BI, 2009, J BONE JOINT SURG BR, V91B, P636, DOI 10.1302/0301-620X.91B5.21691; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Geerts WH, 2008, CLIN PRACTICE, V133, p381S; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ginsberg JS, 2009, J ARTHROPLASTY, V24, P1, DOI 10.1016/j.arth.2008.01.132; Gogarten W, 2010, EUR J ANAESTH, V27, P999, DOI 10.1097/EJA.0b013e32833f6f6f; Hull RD, 1999, ARCH INTERN MED, V159, P137, DOI 10.1001/archinte.159.2.137; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; Lassen MR, 2007, J THROMB HAEMOST, V5, P2368, DOI 10.1111/j.1538-7836.2007.02764.x; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lassen MR, 2010, LANCET, V375, P807, DOI 10.1016/S0140-6736(09)62125-5; Lassen MR, 2009, NEW ENGL J MED, V361, P594, DOI 10.1056/NEJMoa0810773; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Strebel N, 2002, ARCH INTERN MED, V162, P1451, DOI 10.1001/archinte.162.13.1451; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; Wong PC, 2008, J THROMB HAEMOST, V6, P820, DOI 10.1111/j.1538-7836.2008.02939.x	22	552	582	2	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					2487	2498		10.1056/NEJMoa1006885	http://dx.doi.org/10.1056/NEJMoa1006885			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697YL	21175312	Bronze			2022-12-28	WOS:000285555600004
J	Li, WT; Chetelat, RT				Li, Wentao; Chetelat, Roger T.			A Pollen Factor Linking Inter- and Intraspecific Pollen Rejection in Tomato	SCIENCE			English	Article							SELF-INCOMPATIBILITY; S-RNASE; LYCOPERSICON-ESCULENTUM; UNILATERAL INCOMPATIBILITY; SOLANUM-LYCOPERSICOIDES; IDENTIFICATION; COMPATIBILITY; EXPRESSION; INCONGRUITY; PERUVIANUM	Self-incompatibility (SI)-intraspecific pollen recognition systems that allow plants to avoid inbreeding-in the Solanaceae (the nightshade family) is controlled by a polymorphic S locus where "self" pollen is rejected on pistils with matching S alleles. In contrast, unilateral interspecific incompatibility (UI) prevents hybridization between related species, most commonly when the pollen donor is self-compatible (SC) and the recipient is SI. We observed that in Solanum, a pollen-expressed Cullin1 gene with high similarity to Petunia SI factors interacts genetically with a gene at or near the S locus to control UI. Cultivated tomato and related red-or orange-fruited species (all SC) exhibit the same loss-of-function mutation in this gene, whereas the green-fruited species (mostly SI) contain a functional allele; hence, similar biochemical mechanisms underlie the rejection of both "self" and interspecific pollen.	[Li, Wentao; Chetelat, Roger T.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Chetelat, RT (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	trchetelat@ucdavis.edu			NSF [DBI 0605200]	NSF(National Science Foundation (NSF))	We thank J. DeVerna, P. March, K. Smith, and the C. M. Rick Tomato Genetics Resource Center (TGRC) staff for providing seed or cuttings of key genotypes; P. March for photos of fruit; B. McClure and P. Bedinger for comments on the manuscript; and S. Tanksley for providing seed of S. habrochaites introgression lines. Supported by NSF grant DBI 0605200. Sequence data have been deposited in GenBank under accession numbers HQ610200 and HQ610201. Seed requests submitted to the TGRC are subject to a material transfer agreement (http://tgrc.ucdavis.edu/MTA/TGRC-MTA.pdf).	Bernacchi D, 1997, GENETICS, V147, P861; Canady MA, 2005, GENOME, V48, P685, DOI 10.1139/G05-032; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; CHETELAT RT, 1991, THEOR APPL GENET, V82, P704, DOI 10.1007/BF00227314; Covey PA, 2010, PLANT J, V64, P367, DOI 10.1111/j.1365-313X.2010.04340.x; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; HO JY, 1992, PLANT J, V2, P971; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; LEWIS D., 1958, HEREDITY, V12, P233, DOI 10.1038/hdy.1958.26; Li WT, 2010, GENETICS, V185, P1069, DOI 10.1534/genetics.110.116343; Liedl BE, 1996, SEX PLANT REPROD, V9, P299, DOI 10.1007/BF02152705; MCCLURE BA, 1989, NATURE, V342, P955, DOI 10.1038/342955a0; McClure B, 2009, J EXP BOT, V60, P1069, DOI 10.1093/jxb/erp024; Monforte AJ, 2000, GENOME, V43, P803, DOI 10.1139/gen-43-5-803; Murfett J, 1996, PLANT CELL, V8, P943, DOI 10.1105/tpc.8.6.943; Mutschler M. A., 1994, Genetic control of self-incompatibility and reproductive development in flowering plants., P164; Qiao H, 2004, PLANT CELL, V16, P582, DOI 10.1105/tpc.017673; Rick C.M., 1988, PLANT EVOLUTIONARY B, P133, DOI DOI 10.1007/978-94-009-1207-6_6; RICK CM, 1986, P NATL ACAD SCI USA, V83, P3580, DOI 10.1073/pnas.83.11.3580; RICK CM, 1986, SOLANACEAE BIOL SYST, P475; ROYO J, 1994, P NATL ACAD SCI USA, V91, P6511, DOI 10.1073/pnas.91.14.6511; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; TWELL D, 1990, DEVELOPMENT, V109, P705; van Heusden AW, 1999, THEOR APPL GENET, V99, P1068, DOI 10.1007/s001220051416; Zhao L, 2010, PLANT J, V62, P52, DOI 10.1111/j.1365-313X.2010.04123.x; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	27	81	85	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1827	1830		10.1126/science.1197908	http://dx.doi.org/10.1126/science.1197908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205670				2022-12-28	WOS:000285603700042
J	Nadj-Perge, S; Frolov, SM; Bakkers, EPAM; Kouwenhoven, LP				Nadj-Perge, S.; Frolov, S. M.; Bakkers, E. P. A. M.; Kouwenhoven, L. P.			Spin-orbit qubit in a semiconductor nanowire	NATURE			English	Article							SINGLE-ELECTRON SPIN; QUANTUM-DOT; MANIPULATION; FIELD	Motion of electrons can influence their spins through a fundamental effect called spin-orbit interaction. This interaction provides a way to control spins electrically and thus lies at the foundation of spintronics(1). Even at the level of single electrons, the spin-orbit interaction has proven promising for coherent spin rotations(2). Here we implement a spin-orbit quantum bit (qubit) in an indium arsenide nanowire, where the spin-orbit interaction is so strong that spin and motion can no longer be separated(3,4). In this regime, we realize fast qubit rotations and universal single-qubit control using only electric fields; the qubits are hosted in single-electron quantum dots that are individually addressable. We enhance coherence by dynamically decoupling the qubits from the environment. Nanowires offer various advantages for quantum computing: they can serve as one-dimensional templates for scalable qubit registers, and it is possible to vary the material even during wire growth(5). Such flexibility can be used to design wires with suppressed decoherence and to push semiconductor qubit fidelities towards error correction levels. Furthermore, electrical dots can be integrated with optical dots in p-n junction nanowires(6). The coherence times achieved here are sufficient for the conversion of an electronic qubit into a photon, which can serve as a flying qubit for long-distance quantum communication.	[Nadj-Perge, S.; Frolov, S. M.; Bakkers, E. P. A. M.; Kouwenhoven, L. P.] Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; [Bakkers, E. P. A. M.] Eindhoven Univ Technol, Dept Appl Phys, NL-5600 MB Eindhoven, Netherlands	Delft University of Technology; Eindhoven University of Technology	Kouwenhoven, LP (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands.	l.p.kouwenhoven@tudelft.nl	Nadj-Perge, Stevan/G-4115-2013	Nadj-Perge, Stevan/0000-0002-2916-360X; Nadj-Perge, Stevan/0000-0002-2394-9070	NWO/FOM (the Netherlands Organization for Scientific Research); ERC; DARPA	NWO/FOM (the Netherlands Organization for Scientific Research)(FOM (The Netherlands)Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We thank K. Nowack, R. Schouten, M. Laforest, K. Zuo, M. Hocevar, R. Algra, J. van Tilburg, M. Scheffler, G. de Lange, V. Dobrovitski, J. Danon, R. Hanson, R. Liu, Yu. V. Nazarov and L. Vandersypen for their help. This work has been supported by NWO/FOM (the Netherlands Organization for Scientific Research), an ERC Advanced Grant and through the DARPA program QUEST.	BARTHEL C, 2010, INTERLACED DYNAMICAL; Berezovsky J, 2008, SCIENCE, V320, P349, DOI 10.1126/science.1154798; BLUHM H, 2010, LONG COHERENCE ELECT; Danon J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.041301; DATTA S, 1990, APPL PHYS LETT, V56, P665, DOI 10.1063/1.102730; Fasth C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.266801; Foletti S, 2009, NAT PHYS, V5, P903, DOI 10.1038/NPHYS1424; Golovach VN, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165319; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Johnson AC, 2005, NATURE, V435, P925, DOI 10.1038/nature03815; Kato Y, 2003, SCIENCE, V299, P1201, DOI 10.1126/science.1080880; Koppens FHL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236802; Koppens FHL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.106803; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Koppens FHL, 2005, SCIENCE, V309, P1346, DOI 10.1126/science.1113719; Laird EA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.246601; Minot ED, 2007, NANO LETT, V7, P367, DOI 10.1021/nl062483w; Nadj-Perge S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.201305; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Obata T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.085317; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Pfund A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.161308; Pfund A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.036801; Pioro-Ladriere M, 2008, NAT PHYS, V4, P776, DOI 10.1038/nphys1053; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Pryor CE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.026804; Rashba EI, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.126405; van Weert MHM, 2009, NANO LETT, V9, P1989, DOI 10.1021/nl900250g	30	518	524	2	248	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1084	1087		10.1038/nature09682	http://dx.doi.org/10.1038/nature09682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	697XT	21179164	Green Accepted, Green Submitted			2022-12-28	WOS:000285553800054
J	Palmer, J; Pini, P				Palmer, Joanna; Pini, Pia			Winner of the Wakley prize 2010	LANCET			English	Editorial Material									[Palmer, Joanna; Pini, Pia] The Lancet, London NW1 7BY, England		Palmer, J (corresponding author), The Lancet, London NW1 7BY, England.							*OLD AG WORK GROUP, 2010, FORG AG UND POV SOC; Palmer J, 2010, LANCET, V375, P2131, DOI 10.1016/S0140-6736(10)60969-5	2	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 18	2010	376	9758					2053	2053		10.1016/S0140-6736(10)62277-5	http://dx.doi.org/10.1016/S0140-6736(10)62277-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702LA	21188760				2022-12-28	WOS:000285895000009
J	Patel, V; Kumar, AKS; Paul, VK; Rao, KD; Reddy, KS				Patel, Vikram; Kumar, A. K. Shiva; Paul, Vinod K.; Rao, Krishna D.; Reddy, K. Srinath			Universal health care in India: the time is right	LANCET			English	Editorial Material									[Patel, Vikram] London Sch Hyg & Trop Med, London WC1, England; [Patel, Vikram] Sangath Ctr, Alto Porvorim 403521, Goa, India; [Kumar, A. K. Shiva] UNICEF India, New Delhi, India; [Paul, Vinod K.] All India Inst Med Sci, New Delhi, India; [Rao, Krishna D.; Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	University of London; London School of Hygiene & Tropical Medicine; All India Institute of Medical Sciences (AIIMS) New Delhi; Public Health Foundation of India	Patel, V (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	vikram.patel@lshtm.ac.uk		Patel, Vikram/0000-0003-1066-8584; Reddy, K Srinath/0000-0003-3416-3548	Wellcome Trust [091834] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2008, WORLD HLTH STAT 2008; BALARAJAN Y, 2011, LANCET          0112, DOI DOI 10.1016/50140-6736(10)61894-6; Bhore Committee, 1946, REP HLTH SURV DEV CO; JOHN TJ, 2011, LANCET          0112; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; PATEL V, 2011, LANCET          0112, DOI DOI 10.1016/S0140-6736(10)61188-9; PAUL VK, 2011, LANCET          0112, DOI DOI 10.1016/50140-6736(10)61492-4; REDDY KS, 2011, LANCET          0112, DOI DOI 10.1016/50140-6736(10)61492-4.7; World Health Organization, 2000, WORLD HLTH REP 2000	9	17	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					448	449		10.1016/S0140-6736(10)62044-2	http://dx.doi.org/10.1016/S0140-6736(10)62044-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721TX	21227493	Green Accepted			2022-12-28	WOS:000287381800008
J	Zhang, ZH; Pugh, BF				Zhang, Zhenhai; Pugh, B. Franklin			High-Resolution Genome-wide Mapping of the Primary Structure of Chromatin	CELL			English	Review							POSITIONS IN-VIVO; NUCLEOSOME POSITIONS; SACCHAROMYCES-CEREVISIAE; HISTONE MODIFICATIONS; DNA INTERACTIONS; GENE-EXPRESSION; STEM-CELLS; LIFE-SPAN; YEAST; IDENTIFICATION		[Zhang, Zhenhai; Pugh, B. Franklin] Penn State Univ, Ctr Comparat Genom & Bioinformat, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	bfp2@psu.edu	Zhang, Zhenhai/GRX-5887-2022	Zhang, Zhenhai/0000-0002-4310-0525	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG004160, R01 HG004160-04, R01 HG004160, R01 HG004160-05] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; Fragoso G, 1997, METHODS, V11, P246, DOI 10.1006/meth.1996.0411; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; GEOCKS J, 2010, GENOME BIOL, V11, P86; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Guarente L, 2000, GENE DEV, V14, P1021; Gundersen BB, 2009, NEUROPHARMACOLOGY, V57, P67, DOI 10.1016/j.neuropharm.2009.04.008; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Pardo CE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq716; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Rando OJ, 2010, METHOD ENZYMOL, V470, P105, DOI 10.1016/S0076-6879(10)70005-7; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	51	112	117	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					175	186		10.1016/j.cell.2011.01.003	http://dx.doi.org/10.1016/j.cell.2011.01.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21241889	Green Accepted, Bronze			2022-12-28	WOS:000286459900004
J	O'Shaughnessy, J; Osborne, C; Pippen, JE; Yoffe, M; Patt, D; Rocha, C; Koo, IC; Sherman, BM; Bradley, C				O'Shaughnessy, Joyce; Osborne, Cynthia; Pippen, John E.; Yoffe, Mark; Patt, Debra; Rocha, Christine; Koo, Ingrid Chou; Sherman, Barry M.; Bradley, Charles			Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-II TRIAL; GENE-EXPRESSION; DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE; SPORADIC BREAST; SUBTYPES; TUMORS; GEMCITABINE/CARBOPLATIN; TRASTUZUMAB; CARCINOMAS	Background: Triple-negative breast cancers have inherent defects in DNA repair, making this cancer a rational target for therapy based on poly(adenosine diphosphate-ribose) polymerase (PARP) inhibition. Methods: We conducted an open-label, phase 2 study to compare the efficacy and safety of gemcitabine and carboplatin with or without iniparib, a small molecule with PARP-inhibitory activity, in patients with metastatic triple-negative breast cancer. A total of 123 patients were randomly assigned to receive gemcitabine (1000 mg per square meter of body-surface area) and carboplatin (at a dose equivalent to an area under the concentration-time curve of 2) on days 1 and 8 -- with or without iniparib (at a dose of 5.6 mg per kilogram of body weight) on days 1, 4, 8, and 11 -- every 21 days. Primary end points were the rate of clinical benefit (i.e., the rate of objective response [complete or partial response] plus the rate of stable disease for greater/equal 6 months) and safety. Additional end points included the rate of objective response, progression-free survival, and overall survival. Results: The addition of iniparib to gemcitabine and carboplatin improved the rate of clinical benefit from 34% to 56% (P=0.01) and the rate of overall response from 32% to 52% (P=0.02). The addition of iniparib also prolonged the median progression-free survival from 3.6 months to 5.9 months (hazard ratio for progression, 0.59; P=0.01) and the median overall survival from 7.7 months to 12.3 months (hazard ratio for death, 0.57; P=0.01). The most frequent grade 3 or 4 adverse events in either treatment group included neutropenia, thrombocytopenia, anemia, fatigue or asthenia, leukopenia, and increased alanine aminotransferase level. No significant difference was seen between the two groups in the rate of adverse events. Conclusions: The addition of iniparib to chemotherapy improved the clinical benefit and survival of patients with metastatic triple-negative breast cancer without significantly increased toxic effects. On the basis of these results, a phase 3 trial adequately powered to evaluate overall survival and progression-free survival is being conducted. (Funded by BiPar Sciences [now owned by Sanofi-Aventis]; ClinicalTrials.gov number, NCT00540358.) N Engl J Med 2011;364:205-14.	[O'Shaughnessy, Joyce; Osborne, Cynthia; Pippen, John E.] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA; [O'Shaughnessy, Joyce; Osborne, Cynthia; Pippen, John E.; Yoffe, Mark; Patt, Debra] US Oncol, Dallas, TX USA; [O'Shaughnessy, Joyce; Osborne, Cynthia; Pippen, John E.] Texas Oncol, Dallas, TX USA; [Yoffe, Mark] Canc Ctr N Carolina, Raleigh, NC USA; [Patt, Debra] Texas Oncol Canc Ctr, Austin, TX USA; [Rocha, Christine; Koo, Ingrid Chou; Sherman, Barry M.; Bradley, Charles] BiPar Sci, San Francisco, CA USA	Baylor University Medical Center; Texas Oncology-Baylor Charles A Sammons Cancer Center; US Oncology Network; Texas Oncology	O'Shaughnessy, J (corresponding author), Baylor Charles A Sammons Canc Ctr, Dallas, TX USA.	joyce.oshaughnessy@usoncology.com			BiPar Sciences; Sanofi-Aventis	BiPar Sciences; Sanofi-Aventis(Sanofi-Aventis)	Supported by BiPar Sciences (now owned by Sanofi-Aventis).; Dr. O'Shaughnessy reports receiving speaking fees and consulting fees from Sanofi-Aventis; Dr. Osborne, receiving travel support from Sanofi-Aventis; Dr. Yoffe, owning stock in Sanofi-Aventis; and Ms. Rocha and Drs. Koo, Sherman, and Bradley, being employees of and owning stock or stock options in BiPar Sciences. No other potential conflict of interest relevant to this article was reported.	Alli E, 2009, CANCER RES, V69, P3589, DOI 10.1158/0008-5472.CAN-08-4016; Baldassarre G, 2003, MOL CELL BIOL, V23, P2225, DOI 10.1128/MCB.23.7.2225-2238.2003; Bartkova J, 2008, MOL ONCOL, V2, P296, DOI 10.1016/j.molonc.2008.09.007; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chew HK, 2009, J CLIN ONCOL, V27, P2163, DOI 10.1200/JCO.2008.17.4839; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; HASTAK K, CANC RES IN PRESS; Heikkinen T, 2009, CLIN CANCER RES, V15, P3214, DOI 10.1158/1078-0432.CCR-08-3128; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Loesch D, 2008, CLIN BREAST CANCER, V8, P178, DOI 10.3816/CBC.2008.n.019; MAHANY JJ, 2008, J CLIN ONCOL S, V26, pS172; Mok I., 2008, J CLIN ONCOL S, V26, p172S; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Osborne CR, 2005, SAN ANT BREAST CANC; OSSOVSKAYA V, 2009, AM ASS CANC RES ANN, P5552; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Swain SM, 2008, AM SOC CLIN ONC ANN; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tommiska J, 2008, ONCOGENE, V27, P2501, DOI 10.1038/sj.onc.1210885; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Yardley DA, 2008, CLIN BREAST CANCER, V8, P425, DOI 10.3816/CBC.2008.n.051	30	638	664	2	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	2011	364	3					205	214		10.1056/NEJMoa1011418	http://dx.doi.org/10.1056/NEJMoa1011418			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708SF	21208101	Bronze			2022-12-28	WOS:000286383900005
J	Djulbegovic, M; Djulbegovic, B				Djulbegovic, Mia; Djulbegovic, Benjamin			Implications of the Principle of Question Propagation for Comparative-Effectiveness and "Data Mining" Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Djulbegovic, Mia] Univ Florida, Gainesville, FL USA; [Djulbegovic, Benjamin] Univ S Florida, Dept Med, Tampa, FL USA; [Djulbegovic, Benjamin] Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL USA; [Djulbegovic, Benjamin] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol, Tampa, FL USA; [Djulbegovic, Benjamin] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Djulbegovic, B (corresponding author), Univ S Florida Hlth, 12901 Bruce B Downs Blvd,MDC27,Room 3127-3126, Tampa, FL 33612 USA.	bdjulbeg@health.usf.edu	Djulbegovic, Benjamin/I-3661-2012	Djulbegovic, Benjamin/0000-0003-0671-1447				Brassey J, 2007, NUMBER CLIN QUESTION; Commitee on Comparative Research Prioritization, 2009, I MED IN NAT PRIOR C; Djulbegovic B, 2009, CANCER CONTROL, V16, P158, DOI 10.1177/107327480901600208; LaValley MP, 2002, ANN INTERN MED, V137, P932, DOI 10.7326/0003-4819-137-11-200212030-00016; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; Popper K., 1959, LOGIC SCI DISCOVERY; Rescher, 1999, LIMITS SCI, DOI 10.2307/j.ctt9qh79p; Sox HC, 2010, MED CARE, V48, pS7, DOI 10.1097/MLR.0b013e3181da3709	8	10	11	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					298	299		10.1001/jama.2010.2013	http://dx.doi.org/10.1001/jama.2010.2013			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707YY	21245185				2022-12-28	WOS:000286328700027
J	McNeely, J; Sherman, S				McNeely, Jennifer; Sherman, Scott			Review: Acamprosate increases abstinence in patients with alcohol dependence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONTROLLED-TRIAL		[McNeely, Jennifer; Sherman, Scott] NYU, Sch Med, New York, NY 10003 USA	New York University	McNeely, J (corresponding author), NYU, Sch Med, New York, NY 10003 USA.			Sherman, Scott/0000-0003-1752-7303; McNeely, Jennifer/0000-0003-4601-6940				Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Mason BJ, 2006, J PSYCHIATR RES, V40, P383, DOI 10.1016/j.jpsychires.2006.02.002; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Substance Abuse and Mental Health Services Administration, 2008, RES 2007 NAT SURV DR	4	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-10	10.7326/0003-4819-154-2-201101180-02010	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242352				2022-12-28	WOS:000286223500036
J	Moliterno, DJ				Moliterno, David J.			Increased doses of clopidogrel or aspirin did not prevent cardiovascular events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Kentucky, Lexington, KY 40506 USA	University of Kentucky	Moliterno, DJ (corresponding author), Univ Kentucky, Lexington, KY 40506 USA.							King Spencer B 3rd, 2008, J Am Coll Cardiol, V51, P172, DOI 10.1016/j.jacc.2007.10.002; Mehta S, 2009, HOTL SESS ESC C 30 A; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; PRICE MJ, 2010, AM HEART ASS SCI SES; Von Beckerath N, 2007, EUR HEART J, V28, P1814, DOI 10.1093/eurheartj/ehl489	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-7	10.7326/0003-4819-154-2-201101180-02007	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242361				2022-12-28	WOS:000286223500033
J	Wyithe, JSB; Yan, HJ; Windhorst, RA; Mao, SD				Wyithe, J. Stuart B.; Yan, Haojing; Windhorst, Rogier A.; Mao, Shude			A distortion of very-high-redshift galaxy number counts by gravitational lensing	NATURE			English	Article							DIGITAL SKY SURVEY; ULTRA-DEEP-FIELD; LUMINOSITY FUNCTION; LENSED GALAXIES; HUBBLE; DISTRIBUTIONS; MAGNIFICATION; REIONIZATION; STATISTICS; SCIENCE	The observed number counts of high-redshift galaxy candidates(1-8) have been used to build up a statistical description of star-forming activity at redshift z greater than or similar to 7, when galaxies reionized the Universe(1,2,9,10). Standard models(11) predict that a high incidence of gravitational lensing will probably distort measurements of flux and number of these earliest galaxies. The raw probability of this happening has been estimated to be similar to 0.5 per cent (refs 11, 12), but can be larger owing to observational biases. Here we report that gravitational lensing is likely to dominate the observed properties of galaxies with redshifts of z greater than or similar to 12, when the instrumental limiting magnitude is expected to be brighter than the characteristic magnitude of the galaxy sample. The number counts could be modified by an order of magnitude, with most galaxies being part of multiply imaged systems, located less than 1 arcsec from brighter foreground galaxies at z approximate to 2. This lens-induced association of high-redshift and foreground galaxies has perhaps already been observed among a sample of galaxy candidates identified at z approximate to 10.6. Future surveys will need to be designed to account for a significant gravitational lensing bias in high-redshift galaxy samples.	[Wyithe, J. Stuart B.] Univ Melbourne, Sch Phys, Parkville, Vic 3010, Australia; [Yan, Haojing] Ohio State Univ, Ctr Cosmol & AstroParticle Phys, Columbus, OH 43210 USA; [Windhorst, Rogier A.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Mao, Shude] Univ Manchester, Ctr Astrophys, Jodrell Bank, Manchester M13 9PL, Lancs, England; [Mao, Shude] Chinese Acad Sci, Natl Astron Observ China, Beijing 100012, Peoples R China	University of Melbourne; University System of Ohio; Ohio State University; Arizona State University; Arizona State University-Tempe; University of Manchester; Jodrell Bank Centre for Astrophysics; Chinese Academy of Sciences; National Astronomical Observatory, CAS	Wyithe, JSB (corresponding author), Univ Melbourne, Sch Phys, Parkville, Vic 3010, Australia.	swyithe@unimelb.edu.au		Wyithe, Stuart/0000-0001-7956-9758; Mao, Shude/0000-0001-8317-2788	Australian Research Council; Center for Cosmology and AstroParticle Physics (CCAPP) at The Ohio State University; Space Telescope Science Institute; NASA; QE-II fellowship	Australian Research Council(Australian Research Council); Center for Cosmology and AstroParticle Physics (CCAPP) at The Ohio State University(Ohio State University); Space Telescope Science Institute(Space Telescope Science Institute); NASA(National Aeronautics & Space Administration (NASA)); QE-II fellowship	We thank K.-H. Chae for discussing results of his lensing calculations. J.S.B.W. was supported in part by a QE-II fellowship and grants from the Australian Research Council. H.Y. acknowledges support from the long-term fellow-ship programme of the Center for Cosmology and AstroParticle Physics (CCAPP) at The Ohio State University. H.Y. and R. A. W. were supported by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc. R. A. W. was supported by a NASA JWST Interdisciplinary Scientist grant.	Barkana R, 2000, ASTROPHYS J, V531, P613, DOI 10.1086/308503; Bouwens R. J., 2010, UV LUMINOSITY FUNCTI; Bouwens RJ, 2004, ASTROPHYS J, V606, pL25, DOI 10.1086/421016; BOUWENS RJ, 2009, CONSTRAINTS 1 GALAXI; Bouwens RJ, 2009, ASTROPHYS J, V690, P1764, DOI 10.1088/0004-637X/690/2/1764; Bradley LD, 2008, ASTROPHYS J, V678, P647, DOI 10.1086/533519; Choi YY, 2007, ASTROPHYS J, V658, P884, DOI 10.1086/511060; Comerford JM, 2002, ASTROPHYS J, V580, P63, DOI 10.1086/343116; Greif TH, 2007, ASTROPHYS J, V670, P1, DOI 10.1086/522028; Hathi NP, 2010, ASTROPHYS J, V720, P1708, DOI 10.1088/0004-637X/720/2/1708; Huterer D, 2005, ASTROPHYS J, V624, P34, DOI 10.1086/429153; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; LORENZONI S, 2010, CANDIDATE Z 8 9 GALA; Nollenberg JG, 2005, ASTROPHYS J, V634, P793, DOI 10.1086/497103; Oguri M, 2008, ASTRON J, V135, P512, DOI 10.1088/0004-6256/135/2/512; PEI YCC, 1995, ASTROPHYS J, V440, P485, DOI 10.1086/175290; Richard J, 2008, ASTROPHYS J, V685, P705, DOI 10.1086/591312; SCHECHTER P, 1976, ASTROPHYS J, V203, P297, DOI 10.1086/154079; Scranton R, 2005, ASTROPHYS J, V633, P589, DOI 10.1086/431358; Trenti M, 2010, ASTROPHYS J LETT, V714, pL202, DOI 10.1088/2041-8205/714/2/L202; TURNER EL, 1984, ASTROPHYS J, V284, P1, DOI 10.1086/162379; WEBSTER RL, 1988, NATURE, V336, P358, DOI 10.1038/336358a0; WILKINS SM, 2010, SPACE TELESCOPE, V403, P938; Windhorst RA, 2008, ADV SPACE RES, V41, P1965, DOI 10.1016/j.asr.2007.07.005; Windhorst RA, 2006, NEW ASTRON REV, V50, P113, DOI 10.1016/j.newar.2005.11.018; Yan HJ, 2010, RES ASTRON ASTROPHYS, V10, P867, DOI 10.1088/1674-4527/10/9/003; Yan HJ, 2004, ASTROPHYS J, V612, pL93, DOI 10.1086/424690; Yan HJ, 2004, ASTROPHYS J, V600, pL1, DOI 10.1086/381573; Zheng W, 2009, ASTROPHYS J, V697, P1907, DOI 10.1088/0004-637X/697/2/1907	30	51	51	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					181	184		10.1038/nature09619	http://dx.doi.org/10.1038/nature09619			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228870	Green Submitted			2022-12-28	WOS:000286143400031
J	Francesconi, F; Francesconi, V				Francesconi, Fabio; Francesconi, Valeska			Lobomycosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Francesconi, Fabio] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Francesconi, Valeska] Univ Estado Amazonas, Manaus, Amazonas, Brazil	Universidade Federal de Amazonas; Universidade do Estado do Amazonas	Francesconi, F (corresponding author), Univ Fed Amazonas, Manaus, Amazonas, Brazil.	fabiofrancesconi@globo.com	Francesconi, Fabio/AAF-2150-2019	Francesconi, Fabio/0000-0001-6381-3584					0	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 6	2011	364	1					E2	E2		10.1056/NEJMicm1002082	http://dx.doi.org/10.1056/NEJMicm1002082			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UY	21208104				2022-12-28	WOS:000285922600013
J	Brown, EN; Lydic, R; Schiff, ND				Brown, Emery N.; Lydic, Ralph; Schiff, Nicholas D.			Mechanisms of Disease: General Anesthesia, Sleep, and Coma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LESS-THAN-1 HZ OSCILLATION; ACETYLCHOLINE-RELEASE; EMERGENCE DELIRIUM; PROPOFOL; ELECTROENCEPHALOGRAM; MIDAZOLAM; CONSCIOUSNESS; KETAMINE; EEG; RECOVERY		[Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Emery N.] Harvard Univ, Sch Med, Boston, MA USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Lydic, Ralph] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Schiff, Nicholas D.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); University of Michigan System; University of Michigan; Cornell University	Brown, EN (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St,GRJ 4, Boston, MA 02114 USA.	enb@neurostat.mit.edu	Lydic, Ralph/O-9396-2014	Lydic, Ralph/0000-0002-2686-251X	Massachusetts General Hospital Department of Anesthesia, Critical Care, and Pain Medicine; National Institutes of Health (NIH) [DP1OD003646, HL40881, HL65272, HD51912]; University of Michigan, Department of Anesthesiology; James S. McDonnell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD051912] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040881, R01HL065272] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003646] Funding Source: NIH RePORTER	Massachusetts General Hospital Department of Anesthesia, Critical Care, and Pain Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan, Department of Anesthesiology(University of Michigan System); James S. McDonnell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the Massachusetts General Hospital Department of Anesthesia, Critical Care, and Pain Medicine and by the National Institutes of Health (NIH) Director's Pioneer Award (DP1OD003646, to Dr. Brown); by the University of Michigan, Department of Anesthesiology, and by NIH grants (HL40881 and HL65272, to Dr. Lydic); and by grants from the James S. McDonnell Foundation (to Dr. Schiff) and the NIH (HD51912, to Dr. Schiff).	ALDRETE JA, 1995, J CLIN ANESTH, V7, P89, DOI 10.1016/0952-8180(94)00001-K; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2007, ANESTHESIOLOGY, V107, P264, DOI 10.1097/01.anes.0000270741.33766.24; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, pA27; ANGEL A, 1991, EXP PHYSIOL, V76, P1; [Anonymous], 1995, Neurology, V45, P1012; [Anonymous], 2006, PONT MED MED LAT RET; Bai DL, 1999, J NEUROSCI, V19, P10635, DOI 10.1523/JNEUROSCI.19-24-10635.1999; Bedford OH, 2008, PROP; Bergey Gregory K, 2006, Epilepsy Curr, V6, P119, DOI 10.1111/j.1535-7511.2006.00117.x; Bevan JC, 1997, ANESTH ANALG, V85, P50, DOI 10.1097/00000539-199707000-00009; Blumenfeld H, 2003, NEUROSCIENTIST, V9, P301, DOI 10.1177/1073858403255624; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; CESSELIN F, 1999, OPIOIDS PAIN CONTROL, P70; Chase MH, 2008, SLEEP, V31, P1487, DOI 10.1093/sleep/31.11.1487; Chen L, 2004, EXP NEUROL, V186, P212, DOI 10.1016/j.expneurol.2003.11.003; Ching S, 2010, P NATL ACAD IN PRESS; Claassen J, 2002, EPILEPSIA, V43, P146, DOI 10.1046/j.1528-1157.2002.28501.x; CLARK DL, 1973, ANESTHESIOLOGY, V38, P564, DOI 10.1097/00000542-197306000-00011; CORREASALES C, 1992, ANESTHESIOLOGY, V76, P948, DOI 10.1097/00000542-199206000-00013; COTE CJ, 1981, ANESTHESIOLOGY, V55, P703, DOI 10.1097/00000542-198155060-00023; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Devor M, 2001, PAIN, V94, P101, DOI 10.1016/S0304-3959(01)00345-1; Doyle PW, 1999, BRIT J ANAESTH, V83, P580, DOI 10.1093/bja/83.4.580; DURRANI Z, 1991, ANESTH ANALG, V72, P249, DOI 10.1213/00000539-199102000-00020; DUTTON RP, 1994, ANESTHESIOLOGY, V80, P939, DOI 10.1097/00000542-199404000-00028; Evers A., 2006, CLIN ANESTH, P95; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Feshchenko VA, 2004, NEUROPSYCHOBIOLOGY, V50, P257, DOI 10.1159/000079981; Fiset P, 1999, J NEUROSCI, V19, P5506; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Fulton SA, 2000, AM J GASTROENTEROL, V95, P809; Funk W, 2008, EUR J ANAESTH, V25, P37, DOI 10.1017/S0265021507001159; Gawande A, 2008, NEW ENGL J MED, V358, P448, DOI 10.1056/NEJMp0800378; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gibbs FA, 1937, ARCH INTERN MED, V60, P154, DOI 10.1001/archinte.1937.00180010159012; Gray AT, 1997, ARCH NEUROL-CHICAGO, V54, P579, DOI 10.1001/archneur.1997.00550170055014; HEINRICHER MM, 1999, OPIOIDS PAIN CONTROL, P46; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; HILGENBERG JC, 1981, ANESTHESIOLOGY, V54, P341, DOI 10.1097/00000542-198104000-00018; HUG CC, 1990, ANESTHESIOLOGY, V73, P1, DOI 10.1097/00000542-199007000-00001; Huupponen E, 2008, ACTA ANAESTH SCAND, V52, P289, DOI 10.1111/j.1399-6576.2007.01537.x; JORM CM, 1993, BRIT J ANAESTH, V71, pP317; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kennedy D, 2005, SCIENCE, V309, P75, DOI 10.1126/science.309.5731.75; KIERSEY D K, 1951, Br J Anaesth, V23, P141, DOI 10.1093/bja/23.3.141; Koenig MA, 2006, NEUROL CLIN, V24, P89, DOI 10.1016/j.ncl.2005.11.003; Kryger M.H., 2010, PRINCIPLES PRACTICE, V5th ed., DOI [10.1016/B0-7216-0797-7/X5001-0, DOI 10.1016/B0-7216-0797-7/X5001-0]; Kungys G, 2009, ANESTH ANALG, V108, P1531, DOI 10.1213/ane.0b013e31819d9308; Lavigne G, 2007, SLEEP AND PAIN; Lepouse C, 2006, BRIT J ANAESTH, V96, P747, DOI 10.1093/bja/ael094; Lydic R, 2005, ANESTHESIOLOGY, V103, P1268; Lydic R, 2002, SLEEP, V25, P617; Maksimow A, 2006, CLIN NEUROPHYSIOL, V117, P1660, DOI 10.1016/j.clinph.2006.05.011; McCarley RW, 2007, SLEEP MED, V8, P302, DOI 10.1016/j.sleep.2007.03.005; McCarthy Michelle M, 2008, J Neurosci, V28, P13488, DOI 10.1523/JNEUROSCI.3536-08.2008; Meuret P, 2000, ANESTHESIOLOGY, V93, pU190; Mhuircheartaigh RN, 2010, J NEUROSCI, V30, P9095, DOI 10.1523/JNEUROSCI.5516-09.2010; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Morairty S, 2004, NEUROSCIENCE, V123, P451, DOI 10.1016/j.neuroscience.2003.08.066; Mourisse J, 2003, ACTA ANAESTH SCAND, V47, P593, DOI 10.1034/j.1399-6576.2003.00100.x; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Osman NI, 2005, ANESTHESIOLOGY, V103, P779, DOI 10.1097/00000542-200510000-00016; OYE I, 1992, J PHARMACOL EXP THER, V260, P1209; Palanca BA, 2009, CURR OPIN ANESTHESIO, V22, P553, DOI 10.1097/ACO.0b013e3283304032; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Posner JB, 2007, PLUM POSNERS DIAGNOS; PRYSROBERTS C, 1987, BRIT J ANAESTH, V59, P1341, DOI 10.1093/bja/59.11.1341; Purdon PL, 2009, ANN NY ACAD SCI, V1157, P61, DOI 10.1111/j.1749-6632.2008.04119.x; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Reboso Morales J A, 1999, Rev Esp Anestesiol Reanim, V46, P111; Ren J, 2009, ANESTHESIOLOGY, V110, P1364, DOI 10.1097/ALN.0b013e31819faa2a; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2000, J CLIN NEUROPHYSIOL, V17, P438, DOI 10.1097/00004691-200009000-00002; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2007, ANN NEUROL, V62, P5, DOI 10.1002/ana.21158; Seamans J, 2008, NAT CHEM BIOL, V4, P91, DOI 10.1038/nchembio0208-91; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; Stecker MM, 2001, ANN THORAC SURG, V71, P14, DOI 10.1016/S0003-4975(00)01592-7; Stein C, 2001, Curr Opin Pharmacol, V1, P62, DOI 10.1016/S1471-4892(01)00005-4; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1994, ELECTROEN CLIN NEURO, V90, P1, DOI 10.1016/0013-4694(94)90108-2; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; The Joint Commission, 2004, SENT EV AL PREV MAN; TINKER JH, 1977, ANESTHESIOLOGY, V46, P252, DOI 10.1097/00000542-197704000-00005; Tsuda N, 2007, ACTA ANAESTH SCAND, V51, P472, DOI 10.1111/j.1399-6576.2006.01246.x; Tung A, 2001, J CLIN ANESTH, V13, P24, DOI 10.1016/S0952-8180(00)00237-3; Velly LJ, 2007, ANESTHESIOLOGY, V107, P202, DOI 10.1097/01.anes.0000270734.99298.b4; Velly LJ, 2007, ANESTHESIOLOGY, V107, p[202, 175]; Watson CJ, 2010, SUPPRESSING THE MIND: ANESTHETIC MODULATION OF MEMORY AND CONSCIOUSNESS, P33, DOI 10.1007/978-1-60761-462-3_3; Watson SL, 2010, J PAIN, V11, P535, DOI 10.1016/j.jpain.2009.09.010; Yamatogi Y, 2002, BRAIN DEV-JPN, V24, P13, DOI 10.1016/S0387-7604(01)00392-8; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006	101	653	680	7	174	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2638	2650		10.1056/NEJMra0808281	http://dx.doi.org/10.1056/NEJMra0808281			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190458	Green Published, Green Accepted			2022-12-28	WOS:000285763700009
J	Sinha, S; Peach, AHS				Sinha, Shiba; Peach, A. Howard S.			Diagnosis and management of soft tissue sarcoma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POSTOPERATIVE RADIOTHERAPY; CHEMOTHERAPY; GUIDELINES; RADIATION; EXTREMITY; OUTCOMES; SURGERY; TRIAL		[Sinha, Shiba] OBrien Inst Microsurg, St Vincent Hosp Dept Plast Surg, Melbourne, Vic 3065, Australia; [Peach, A. Howard S.] Gen Infirm Leeds, Leeds, England	St Vincent's Hospital Melbourne; Leeds General Infirmary	Sinha, S (corresponding author), OBrien Inst Microsurg, St Vincent Hosp Dept Plast Surg, Melbourne, Vic 3065, Australia.	shibasinha@gmail.com						Al-Absi E, 2010, ANN SURG ONCOL, V17, P1367, DOI 10.1245/s10434-009-0885-7; Bhangu A. A., 2004, Sarcoma, V8, P1, DOI 10.1080/13577140410001679185; Canter RJ, 2010, J AM COLL SURGEONS, V210, P191, DOI 10.1016/j.jamcollsurg.2009.10.007; Casali PG, 2010, ANN ONCOL, V21, pv198, DOI 10.1093/annonc/mdq209; Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; Davis AM, 2002, J CLIN ONCOL, V20, P4472, DOI 10.1200/JCO.2002.03.084; Demetri GD, 2010, J NATL COMPR CANC NE, V8, P630, DOI 10.6004/jnccn.2010.0049; Enneking WF, 2003, CLIN ORTHOP RELAT R, P4, DOI 10.1097/01.blo.0000093891.12372.0f; Gortzak E, 2001, EUR J CANCER, V37, P1096, DOI 10.1016/S0959-8049(01)00083-1; Grimer Robert, 2010, Sarcoma, V2010, P1, DOI 10.1155/2010/506182; Hussein R, 2005, ANN ROY COLL SURG, V87, P171, DOI 10.1308/1478708051658; Kattan MW, 2002, J CLIN ONCOL, V20, P791, DOI 10.1200/JCO.2002.20.3.791; Kogevinas M, 1997, AM J EPIDEMIOL, V145, P1061, DOI 10.1093/oxfordjournals.aje.a009069; Lakkaraju A, 2009, CLIN RADIOL, V64, P615, DOI 10.1016/j.crad.2009.01.012; LAWRENCE W, 1987, ANN SURG, V205, P349, DOI 10.1097/00000658-198704000-00003; Mendenhall WM, 2009, AM J CLIN ONCOL-CANC, V32, P436, DOI 10.1097/COC.0b013e318173a54f; National Institute for Health and Clinical Excellence, 2006, IMPR OUTC PEOPL SARC; O'Sullivan B, 2002, LANCET, V359, P2235, DOI 10.1016/S0140-6736(02)09292-9; Panicek DM, 1997, RADIOLOGY, V202, P237, DOI 10.1148/radiology.202.1.8988217; Pencavel TD, 2010, ANN ROY COLL SURG, V92, P417, DOI 10.1308/003588410X12664192075972; Pervaiz N, 2008, CANCER-AM CANCER SOC, V113, P573, DOI 10.1002/cncr.23592; Pisters PWT, 2007, ANN SURG, V246, P675, DOI 10.1097/SLA.0b013e318155a9ae; Pisters PWT, 1996, J CLIN ONCOL, V14, P1679, DOI 10.1200/JCO.1996.14.5.1679; ROSENBERG SA, 1982, ANN SURG, V196, P305, DOI 10.1097/00000658-198209000-00009; Rougraff BT, 2009, CLIN ORTHOP RELAT R, V467, P2783, DOI 10.1007/s11999-009-0965-9; Rydholm A, 1998, BMJ-BRIT MED J, V317, P93, DOI 10.1136/bmj.317.7151.93; Stojadinovic A, 2002, J CLIN ONCOL, V20, P4344, DOI 10.1200/JCO.2002.07.154; Strauss DC, 2010, J SURG ONCOL, V102, P523, DOI 10.1002/jso.21600; Taylor W. St. J., 2010, Sarcoma, V2010, P312648, DOI 10.1155/2010/312648; Tierney JF, 1997, LANCET, V350, P1647; Wibmer C, 2010, ANN ONCOL, V21, P1106, DOI 10.1093/annonc/mdp415; Woll PJ, 2007, J CLIN ONCOL, V25	32	42	48	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2010	341								c7170	10.1136/bmj.c7170	http://dx.doi.org/10.1136/bmj.c7170			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702UZ	21190968				2022-12-28	WOS:000285922700005
J	Chueh, WC; Falter, C; Abbott, M; Scipio, D; Furler, P; Haile, SM; Steinfeld, A				Chueh, William C.; Falter, Christoph; Abbott, Mandy; Scipio, Danien; Furler, Philipp; Haile, Sossina M.; Steinfeld, Aldo			High-Flux Solar-Driven Thermochemical Dissociation of CO2 and H2O Using Nonstoichiometric Ceria	SCIENCE			English	Article							CARBON-DIOXIDE; PHOTOCATALYTIC CONVERSION; THERMAL-DISSOCIATION; HYDROGEN-PRODUCTION; H-2 GENERATION; TEMPERATURE; REDUCTION; WATER; ENERGY; ZNO	Because solar energy is available in large excess relative to current rates of energy consumption, effective conversion of this renewable yet intermittent resource into a transportable and dispatchable chemical fuel may ensure the goal of a sustainable energy future. However, low conversion efficiencies, particularly with CO2 reduction, as well as utilization of precious materials have limited the practical generation of solar fuels. By using a solar cavity-receiver reactor, we combined the oxygen uptake and release capacity of cerium oxide and facile catalysis at elevated temperatures to thermochemically dissociate CO2 and H2O, yielding CO and H-2, respectively. Stable and rapid generation of fuel was demonstrated over 500 cycles. Solar-to-fuel efficiencies of 0.7 to 0.8% were achieved and shown to be largely limited by the system scale and design rather than by chemistry.	[Chueh, William C.; Abbott, Mandy; Scipio, Danien; Haile, Sossina M.] CALTECH, Pasadena, CA 91125 USA; [Falter, Christoph; Furler, Philipp; Steinfeld, Aldo] ETH, Dept Mech & Proc Engn, CH-8092 Zurich, Switzerland; [Steinfeld, Aldo] Paul Scherrer Inst, Solar Technol Lab, CH-5232 Villigen, Switzerland	California Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Haile, SM (corresponding author), CALTECH, MC 309-81, Pasadena, CA 91125 USA.	smhaile@caltech.edu; aldo.steinfeld@ethz.ch	Haile, Sossina M/I-3448-2015; Steinfeld, Aldo/B-8869-2008	Steinfeld, Aldo/0000-0001-7797-686X; Falter, Christoph/0000-0002-8860-7100	NSF [CBET-0829114, DMR 08-43934]; Initiative for Renewable Energy and the Environment under University of Minnesota; Swiss National Science Foundation [200021-126512]	NSF(National Science Foundation (NSF)); Initiative for Renewable Energy and the Environment under University of Minnesota(University of Minnesota System); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded in part by NSF (CBET-0829114), the Initiative for Renewable Energy and the Environment (under subcontract from the University of Minnesota), and the Swiss National Science Foundation (contract no. 200021-126512). Additional travel support was provided by the International Materials Institutes program of NSF under award no. DMR 08-43934. We thank the technical staff of the Solar Technology Laboratory of the Paul Scherrer Institute for supporting the experimental activities at the High-Flux Solar Simulator. W.C.C. designed the experiments, and C.F. designed the solar reactor. Samples were prepared by M.A. and D.S. W.C.C, C.F., P.F., and D.S. executed the experiments. S.M.H. and A.S. supervised the project.	Abanades S, 2010, J MATER SCI, V45, P4163, DOI 10.1007/s10853-010-4506-4; Chambon M, 2010, CHEM ENG SCI, V65, P3671, DOI 10.1016/j.ces.2010.03.005; Chueh WC, 2010, PHILOS T R SOC A, V368, P3269, DOI 10.1098/rsta.2010.0114; Chueh WC, 2009, CHEMSUSCHEM, V2, P735, DOI 10.1002/cssc.200900138; Fletcher EA, 2001, J SOL ENERG-T ASME, V123, P63, DOI 10.1115/1.1349552; Gstoehl D, 2008, J MATER SCI, V43, P4729, DOI 10.1007/s10853-007-2351-x; Haile S., 2009, US Patent Application, Patent No. [20,090,107,044, 20090107044]; Haxel G., 2002, RARE EARTH ELEMENTS; HORI Y, 1985, CHEM LETT, P1695, DOI 10.1246/cl.1985.1695; Indrakanti VP, 2009, ENERG ENVIRON SCI, V2, P745, DOI 10.1039/b822176f; INOUE T, 1979, NATURE, V277, P637, DOI 10.1038/277637a0; Kaneko H, 2007, ENERGY, V32, P656, DOI 10.1016/j.energy.2006.05.002; Khaselev O, 1998, SCIENCE, V280, P425, DOI 10.1126/science.280.5362.425; Kodama T, 2007, CHEM REV, V107, P4048, DOI 10.1021/cr050188a; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Li C, 1998, J CATAL, V178, P275, DOI 10.1006/jcat.1998.2135; Miller JE, 2008, J MATER SCI, V43, P4714, DOI 10.1007/s10853-007-2354-7; Perkins C, 2009, AICHE J, V55, P286, DOI 10.1002/aic.11810; Roeb M, 2009, INT J HYDROGEN ENERG, V34, P4537, DOI 10.1016/j.ijhydene.2008.08.049; Roy SC, 2010, ACS NANO, V4, P1259, DOI 10.1021/nn9015423; Schunk LO, 2009, CHEM ENG J, V150, P502, DOI 10.1016/j.cej.2009.03.012; Schunk LO, 2009, AICHE J, V55, P1497, DOI 10.1002/aic.11765; Singh P, 2010, CHEM MATER, V22, P762, DOI 10.1021/cm9013305; Steinfeld A, 2005, SOL ENERGY, V78, P603, DOI 10.1016/j.solener.2003.12.012; Takeda H, 2008, J AM CHEM SOC, V130, P2023, DOI 10.1021/ja077752e; THAMPI KR, 1987, NATURE, V327, P506, DOI 10.1038/327506a0; Varghese OK, 2009, NANO LETT, V9, P731, DOI 10.1021/nl803258p	27	1078	1099	49	1103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1797	1801		10.1126/science.1197834	http://dx.doi.org/10.1126/science.1197834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205663				2022-12-28	WOS:000285603700033
J	Coureuil, M; Lecuyer, H; Scott, MGH; Boularan, C; Enslen, H; Soyer, M; Mikaty, G; Bourdoulous, S; Nassif, X; Marullo, S				Coureuil, Mathieu; Lecuyer, Herve; Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Soyer, Magali; Mikaty, Guillain; Bourdoulous, Sandrine; Nassif, Xavier; Marullo, Stefano			Meningococcus Hijacks a beta 2-Adrenoceptor/beta-Arrestin Pathway to Cross Brain Microvasculature Endothelium	CELL			English	Article							ARRESTIN-DEPENDENT ENDOCYTOSIS; NEISSERIA-MENINGITIDIS; TYROSINE-KINASE; BETA-ARRESTINS; IV PILI; ACTIVATION; BARRIER; ADHESION; INVASION; CELLS	Following pilus-mediated adhesion to human brain endothelial cells, meningococcus (N. meningitidis), the bacterium causing cerebrospinal meningitis, initiates signaling cascades, which eventually result in the opening of intercellular junctions, allowing meningeal colonization. The signaling receptor activated by the pathogen remained unknown. We report that N. meningitidis specifically stimulates a biased beta 2-adrenoceptor/beta-arrestin signaling pathway in endothelial cells, which ultimately traps beta-arrestin-interacting partners, such as the Src tyrosine kinase and junctional proteins, under bacterial colonies. Cytoskeletal reorganization mediated by beta-arrestinactivated Src stabilizes bacterial adhesion to endothelial cells, whereas beta-arrestin-dependent delocalization of junctional proteins results in anatomical gaps used by bacteria to penetrate into tissues. Activation of beta-adrenoceptor endocytosis with specific agonists prevents signaling events downstream of N. meningitidis adhesion and inhibits bacterial crossing of the endothelial barrier. The identification of the mechanism used for hijacking host cell signaling machineries opens perspectives for treatment and prevention of meningococcal infection.	[Coureuil, Mathieu; Lecuyer, Herve; Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Soyer, Magali; Mikaty, Guillain; Bourdoulous, Sandrine; Nassif, Xavier; Marullo, Stefano] Univ Paris 05, Fac Med, F-75006 Paris, France; [Coureuil, Mathieu; Lecuyer, Herve; Mikaty, Guillain; Nassif, Xavier] INSERM, U1002, Paris, France; [Lecuyer, Herve; Nassif, Xavier] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France; [Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Bourdoulous, Sandrine; Marullo, Stefano] CNRS, Inst Cochin, UMR 8104, F-75014 Paris, France; [Scott, Mark G. H.; Boularan, Cedric; Enslen, Herve; Bourdoulous, Sandrine; Marullo, Stefano] INSERM, U1016, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Marullo, S (corresponding author), Univ Paris 05, Fac Med, F-75006 Paris, France.	stefano.marullo@inserm.fr	Marullo, Stefano/C-6142-2008; Enslen, Hervé/M-3400-2017; Coureuil, Mathieu/D-4793-2017; Enslen, Hervé/AAH-4492-2021; Scott, Mark/R-3521-2019	Marullo, Stefano/0000-0001-9604-9973; Enslen, Hervé/0000-0001-9741-5293; Coureuil, Mathieu/0000-0001-7655-9685; Enslen, Hervé/0000-0001-9741-5293; Nassif, Xavier/0000-0003-2855-3240; Scott, Mark G.H./0000-0002-1557-1856	Fondation pour la Recherche Medicale; AXA; Association pour la Recherche contre le Cancer [ARC-4954];  [ANR-09-BLAN-0137-03];  [ANR-07-BLAN-0072-01]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); AXA; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ; 	We thank Drs P.O. Couraud, R. Jockers, A. Benmerah, G. Bismuth, and G. Dumenil (Institut Cochin and Cardiovascular Research Center [G. D.], Paris) for reviewing the manuscript; M. Garfa-Traore, N. Goudin, and O. Duc of the Necker Institute imaging facility for their technical support; and G. Guilbaud for advice and technical assistance. M. C. was supported by fellowships of the Fondation pour la Recherche Medicale and of the AXA Research Fund. This work was supported by a collaboration study grant (ANR-09-BLAN-0137-03) to S. B., X. N., and S. M., the ANR-07-BLAN-0072-01 grant to S. M., and a grant from the Association pour la Recherche contre le Cancer (ARC-4954) to M.G.H.S.	Audet M, 2008, NAT CHEM BIOL, V4, P397, DOI 10.1038/nchembio.97; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Benmerah A, 1999, J CELL SCI, V112, P1303; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Eugene E, 2002, J CELL SCI, V115, P1231; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Lambotin M, 2005, J CELL SCI, V118, P3805, DOI 10.1242/jcs.02514; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mairey E, 2006, J EXP MED, V203, P1939, DOI 10.1084/jem.20060482; Martin MC, 2008, EMERG INFECT DIS, V14, P1672, DOI 10.3201/eid1410.080118; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Pron B, 1997, J INFECT DIS, V176, P1285, DOI 10.1086/514124; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje	36	138	145	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 23	2010	143	7					1149	1160		10.1016/j.cell.2010.11.035	http://dx.doi.org/10.1016/j.cell.2010.11.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	698WO	21183077	Green Submitted, Bronze			2022-12-28	WOS:000285625400012
J	Janic, A; Mendizabal, L; Llamazares, S; Rossell, D; Gonzalez, C				Janic, Ana; Mendizabal, Leire; Llamazares, Salud; Rossell, David; Gonzalez, Cayetano			Ectopic Expression of Germline Genes Drives Malignant Brain Tumor Growth in Drosophila	SCIENCE			English	Article							TRANSCRIPTIONAL REPRESSOR; CANCER/TESTIS ANTIGENS; STEM-CELLS; COMPLEX; PROTEIN; IDENTIFICATION; MELANOGASTER; INTERACTS; DIVISION; MUTANTS	Model organisms such as the fruit fly Drosophila melanogaster can help to elucidate the molecular basis of complex diseases such as cancer. Mutations in the Drosophila gene lethal (3) malignant brain tumor cause malignant growth in the larval brain. Here we show that l(3)mbt tumors exhibited a soma-to-germline transformation through the ectopic expression of genes normally required for germline stemness, fitness, or longevity. Orthologs of some of these genes were also expressed in human somatic tumors. In addition, inactivation of any of the germline genes nanos, vasa, piwi, or aubergine suppressed l(3) mbt malignant growth. Our results demonstrate that germline traits are necessary for tumor growth in this Drosophila model and suggest that inactivation of germline genes might have tumor-suppressing effects in other species.	[Janic, Ana; Mendizabal, Leire; Llamazares, Salud; Gonzalez, Cayetano] PCB, IRB Barcelona, Cell Div Grp, Barcelona, Spain; [Rossell, David] PCB, IRB Barcelona, Bioinformat & Biostat Unit, Barcelona, Spain; [Gonzalez, Cayetano] Passeig Lluis Co 23, ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; ICREA	Gonzalez, C (corresponding author), PCB, IRB Barcelona, Cell Div Grp, C Baldiri Reixac 10-12, Barcelona, Spain.	gonzalez@irbbarcelona.org	Gonzalez, Cayetano/K-3055-2019; Janic, Ana/AAR-4783-2020; Gonzalez, Cayetano/K-3933-2019; Rossell, David/AAM-4292-2021	Gonzalez, Cayetano/0000-0002-5259-3608; Janic, Ana/0000-0002-4200-2560; Rossell, David/0000-0002-7104-5789; Llamazares, Salud/0000-0002-8771-2312	Consolider-Ingenio [CSD2006-23]; Ministerio de Ciencia e Innovacion Formacion de Personal;  [ONCASYM-037398];  [BFU2006-05813];  [BFU2009-07975];  [SGR2005];  [SRG200];  [CEN-20091016]; ICREA Funding Source: Custom	Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion Formacion de Personal; ; ; ; ; ; ; ICREA(ICREA)	We thank E. Gateff, R. Lehmann, P. Zamore, A. Spradling, F. Azorin, P. Lasko, S. Hawley, M. Siomi, T. Kai, T. Orr-Weaver, H. White-Cooper, D. McKearin, T. Schupbach, Hybridoma Bank, and Bloomington and Tubingen Drosophila Stock centers for antibodies and fly stocks; H. Auer, the IRB Functional Genomics Facility, and the European Molecular Biology Laboratory Genomics Core Facility for invaluable technical guidance; J. Januschke and members of our laboratory for discussions; and M. Llamazares for proofreading. Work in our laboratory is supported by ONCASYM-037398, BFU2006-05813, BFU2009-07975, SGR2005, SRG200, CEN-20091016, and Consolider-Ingenio CSD2006-23. A.J. is a recipient of a Ministerio de Ciencia e Innovacion Formacion de Personal Investigador fellowship. Array data sets are deposited at Gene Expression Omnibus (accession no. GSE24917).	Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Bonnomet A, 2008, ONCOGENE, V27, P3692, DOI 10.1038/sj.onc.1211035; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Grochola LF, 2008, BRIT J CANCER, V99, P1083, DOI 10.1038/sj.bjc.6604653; Jager E, 2002, CURR OPIN IMMUNOL, V14, P178, DOI 10.1016/S0952-7915(02)00318-7; Joyce EF, 2009, GENETICS, V181, P335, DOI 10.1534/genetics.108.093104; Kai T, 2005, DEV BIOL, V283, P486, DOI 10.1016/j.ydbio.2005.04.018; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Lee LA, 2003, GENE DEV, V17, P2979, DOI 10.1101/gad.1132603; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Old Lloyd J, 2008, Cancer Immun, V8 Suppl 1, P1; Page SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000194; Patil VS, 2010, CURR BIOL, V20, P724, DOI 10.1016/j.cub.2010.02.046; Perezgasga L, 2004, DEVELOPMENT, V131, P1691, DOI 10.1242/dev.01032; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smulders-Srinivasan TK, 2003, GENETICS, V165, P1971; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Svensson MJ, 2003, CHROMOSOMA, V112, P133, DOI 10.1007/s00412-003-0253-5; Taubert H, 2007, ONCOGENE, V26, P1098, DOI 10.1038/sj.onc.1209880; Tavosanis G, 1997, EMBO J, V16, P1809, DOI 10.1093/emboj/16.8.1809; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Tureci O, 1998, P NATL ACAD SCI USA, V95, P5211, DOI 10.1073/pnas.95.9.5211; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Yohn CB, 2003, GENETICS, V165, P1889	32	195	199	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1824	1827		10.1126/science.1195481	http://dx.doi.org/10.1126/science.1195481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21205669				2022-12-28	WOS:000285603700041
J	Lai-Cheong, J; McGrath, J				Lai-Cheong, Joey; McGrath, John			Tinea.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lai-Cheong, Joey; McGrath, John] Guys & St Thomas Hosp, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Lai-Cheong, J (corresponding author), Guys & St Thomas Hosp, London SE1 9RT, England.	joey.lai-cheong@kcl.ac.uk	McGrath, John/N-3529-2019						0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 23	2010	363	26					E39	E39		10.1056/NEJMicm1003685	http://dx.doi.org/10.1056/NEJMicm1003685			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	697YL	21175309				2022-12-28	WOS:000285555600011
J	Barrett, B; Brown, R; Rakel, D; Mundt, M; Bone, K; Barlow, S; Ewers, T				Barrett, Bruce; Brown, Roger; Rakel, Dave; Mundt, Marlon; Bone, Kerry; Barlow, Shari; Ewers, Tola			Echinacea for Treating the Common Cold A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SUFFICIENTLY IMPORTANT DIFFERENCE; EXPERIMENTAL RHINOVIRUS COLDS; RESPIRATORY-TRACT INFECTIONS; PLACEBO-CONTROLLED TRIAL; TUMOR-NECROSIS-FACTOR; DOUBLE-BLIND; PURPUREA PREPARATIONS; ALKAMIDES; PREVENTION; PHARMACOKINETICS	Background: Echinacea is widely used to treat the common cold. Objective: To assess the potential benefits of echinacea as a treatment of common cold. Design: Randomized, controlled trial. (ClinicalTrials.gov registration number: NCT00065715) Setting: Dane County, Wisconsin. Patients: 719 patients, aged 12 to 80 years, with new-onset common cold. Intervention: Patients were assigned to 1 of 4 parallel groups: no pills, placebo pills (blinded), echinacea pills (blinded), or echinacea pills (unblinded, open-label). Echinacea groups received the equivalent of 10.2 g of dried echinacea root during the first 24 hours and 5.1 g during each of the next 4 days. Indistinguishable placebo tablets contained only inert ingredients. Measurements: The primary outcome was the area under the curve for global severity, with severity assessed twice daily by self-report using the Wisconsin Upper Respiratory Symptom Survey, short version. Secondary outcomes included interleukin-8 levels and neutrophil counts from nasal wash, assessed at intake and 2 days later. Results: Of the 719 patients enrolled, 713 completed the protocol. Mean age was 33.7 years, 64% were female, and 88% were white. Mean global severity was 236 and 258 for the blinded and unblinded echinacea groups, respectively; 264 for the blinded placebo group; and 286 for the no-pill group. A comparison of the 2 blinded groups showed a 28-point trend (95% CI, -69 to 13 points) toward benefit for echinacea (P = 0.089). Mean illness duration in the blinded and unblinded echinacea groups was 6.34 and 6.76 days, respectively, compared with 6.87 days in the blinded placebo group and 7.03 days in the no-pill group. A comparison of the blinded groups showed a nonsignificant 0.53-day (CI, -1.25 to 0.19 days) benefit (P = 0.075). Median change in interleukin-8 levels and neutrophil counts were also not statistically significant (30 ng/L and 1 cell/high-power field [hpf] in the no-pill group, 39 ng/L and 1 cell/hpf in the blinded placebo group, 58 ng/L and 2 cells/hpf in the blinded echinacea group, and 70 ng/L and 1 cell/hpf in the open-label echinacea group). Limitation: Higher-than-expected variability limited power to detect small benefits. Conclusion: Illness duration and severity were not statistically significant with echinacea compared with placebo. These results do not support the ability of this dose of the echinacea formulation to substantively change the course of the common cold.	[Barrett, Bruce] Univ Wisconsin, Dept Family Med, Madison, WI 53715 USA; MediHerb, Warwick, Qld 4370, Australia; Univ New England, Armidale, NSW, Australia	University of Wisconsin System; University of Wisconsin Madison; University of New England	Barrett, B (corresponding author), Univ Wisconsin, Dept Family Med, 1100 Delaplaine Court, Madison, WI 53715 USA.				National Center for Complementary and Alternative Medicine, National Institutes of Health [R01AT001428, K23 AT00051]; Robert Wood Johnson Foundation; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F32AT000051, K23AT000051, R01AT001428] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [T32AT000051] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Center for Complementary and Alternative Medicine, National Institutes of Health.; By the National Center for Complementary and Alternative Medicine at the National Institutes of Health (grant R01AT001428 and a Patient-Oriented Career Development Grant [K23 AT00051] to Dr. Barrett) and the Robert Wood Johnson Foundation Generalist Physician Faculty Scholars Program (Dr. Barrett). MediHerb (Queensland, Australia) provided the placebo and echinacea tablets used in this trial and conducted the phytochemical assays, all free of charge. When the National Institutes of Health funds ran out before data collection had been completed, Deans Robert Golden and Paul DeLuca of the UW School of Medicine and Public Health facilitated financial support to allow the project to reach enrollment goals.	American Herbal Pharmacopoeia, 2004, ECH PURP ROOT STAND; American Herbal Pharmacopoeia, 2010, ECH ANG ROOT STAND A; Barrett B, 2005, J CLIN EPIDEMIOL, V58, P609, DOI 10.1016/j.jclinepi.2004.11.019; Barrett B, 2005, MED DECIS MAKING, V25, P47, DOI 10.1177/0272989X04273147; Barrett B, 1999, J FAM PRACTICE, V48, P628; Barrett B, 2003, PHYTOMEDICINE, V10, P66, DOI 10.1078/094471103321648692; Barrett B, 2006, PHARMACOLOGYONLINE, V3, P392; Barrett BP, 2002, ANN INTERN MED, V137, P939, DOI 10.7326/0003-4819-137-12-200212170-00006; Barrett B, 2008, QUAL LIFE RES, V17, P75, DOI 10.1007/s11136-007-9277-2; Barrett B, 2007, EXPLORE-NY, V3, P561, DOI 10.1016/j.explore.2007.08.001; Barrett B, 2007, ANN FAM MED, V5, P216, DOI 10.1370/afm.698; Barrett B, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-76; Bauer R., 1991, EC MED PLANT RES, V5, P253; Bauer R, 1999, IMMUNOMODULATORY AGE, P41, DOI DOI 10.1007/978-3-0348-8763-22; BECKER S, 1993, AM J RESP CELL MOL, V8, P20, DOI 10.1165/ajrcmb/8.1.20; Bernath J, 2001, FASEB J, V15, pA1228; Block Keith I, 2003, Integr Cancer Ther, V2, P247, DOI 10.1177/1534735403256419; Bukovsky Marian, 1995, Polish Journal of Pharmacology, V47, P175; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Caruso TJ, 2005, CLIN INFECT DIS, V40, P807, DOI 10.1086/428061; Cohen HA, 2004, ARCH PEDIAT ADOL MED, V158, P217, DOI 10.1001/archpedi.158.3.217; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 1998, HEALTH PSYCHOL, V17, P214, DOI 10.1037/0278-6133.17.3.214; Cohen S., 1988, SOCIAL PSYCHOL HLTH; Eccles R, 2005, LANCET INFECT DIS, V5, P718, DOI 10.1016/S1473-3099(05)70270-X; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Flannery M A, 1999, Pharm Hist, V41, P52; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Gertsch J, 2004, FEBS LETT, V577, P563, DOI 10.1016/j.febslet.2004.10.064; Giles JT, 2000, PHARMACOTHERAPY, V20, P690, DOI 10.1592/phco.20.7.690.35173; Goel V, 2002, INT IMMUNOPHARMACOL, V2, P381, DOI 10.1016/S1567-5769(01)00163-1; Goel V, 2004, J CLIN PHARM THER, V29, P75, DOI 10.1111/j.1365-2710.2003.00542.x; Gorski JC, 2004, CLIN PHARMACOL THER, V75, P89, DOI 10.1016/j.clpt.2003.09.013; Guiotto P, 2008, PHYTOMEDICINE, V15, P547, DOI 10.1016/j.phymed.2008.05.003; GWALTNEY J M JR, 1985, Rhinology (Utrecht), V23, P265; Hinz B, 2007, BIOCHEM BIOPH RES CO, V360, P441, DOI 10.1016/j.bbrc.2007.06.073; Huntley AL, 2005, DRUG SAFETY, V28, P387, DOI 10.2165/00002018-200528050-00003; JACKSON GG, 1962, AM J PUBLIC HEALTH N, V56, P940, DOI 10.2105/AJPH.52.6.940; Jager H, 2002, PLANTA MED, V68, P469, DOI 10.1055/s-2002-32076; Lalone CA, 2007, J AGR FOOD CHEM, V55, P7314, DOI 10.1021/jf063711a; Linde K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000530.pub2; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Llach XB, 1999, MED CARE, V37, P671, DOI 10.1097/00005650-199907000-00007; Matthias A, 2005, LIFE SCI, V77, P2018, DOI 10.1016/j.lfs.2005.04.009; Matthias A, 2005, CHEM-BIOL INTERACT, V155, P62, DOI 10.1016/j.cbi.2005.04.003; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Melchart D, 1994, Phytomedicine, V1, P245, DOI 10.1016/S0944-7113(11)80072-3; Monto AS, 1995, AM J MED, V99, pS24, DOI 10.1016/S0002-9343(99)80307-6; NOAH TL, 1995, J INFECT DIS, V171, P584, DOI 10.1093/infdis/171.3.584; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1; Ryff CD, 1996, PSYCHOTHER PSYCHOSOM, V65, P14, DOI 10.1159/000289026; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schoop R, 2006, CLIN THER, V28, P174, DOI 10.1016/j.clinthera.2006.02.001; Senchina DS, 2005, CLIN CHIM ACTA, V355, P67, DOI 10.1016/j.cccn.2004.12.013; Shah SA, 2007, LANCET INFECT DIS, V7, P473, DOI 10.1016/S1473-3099(07)70160-3; Sperber SJ, 2004, CLIN INFECT DIS, V38, P1367, DOI 10.1086/386324; Taylor JA, 2003, JAMA-J AM MED ASSOC, V290, P2824, DOI 10.1001/jama.290.21.2824; Teran LM, 1997, AM J RESP CRIT CARE, V155, P1362, DOI 10.1164/ajrccm.155.4.9105080; Turner RB, 2005, NEW ENGL J MED, V353, P341, DOI 10.1056/NEJMoa044441; Turner RB, 2000, ANTIMICROB AGENTS CH, V44, P1708, DOI 10.1128/AAC.44.6.1708-1709.2000; Turner RB, 2005, PEDIATR ANN, V34, P53, DOI 10.3928/0090-4481-20050101-12; WAGNER H, 1988, PHYTOCHEMISTRY, V27, P119, DOI 10.1016/0031-9422(88)80601-0; Ware JE Jr, 2001, SCORE INTERPRET SING; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Woelkart K, 2006, INT J CLIN PHARM TH, V44, P401; Woelkart K, 2005, PLANTA MED, V71, P701, DOI 10.1055/s-2005-871290; Woelkart K, 2008, PLANTA MED, V74, P651, DOI 10.1055/s-2008-1034284; Woelkart K, 2007, PLANTA MED, V73, P615, DOI 10.1055/s-2007-981531; Yale SH, 2004, ARCH INTERN MED, V164, P1237, DOI 10.1001/archinte.164.11.1237; Zhai Z, 2007, FOOD AGR IMMUNOL, V18, P221, DOI 10.1080/09540100701797363	72	52	53	2	55	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					769	+		10.7326/0003-4819-153-12-201012210-00003	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	21173411	Green Accepted			2022-12-28	WOS:000285453700001
J	Laurance, J				Laurance, Jeremy			The Medical Year 2010: a nudge in the wrong direction	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Laurance, Jeremy] Independent, London W8 5HF, England		Laurance, J (corresponding author), Independent, London W8 5HF, England.	J.Laurance@independent.co.uk							0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 21	2010	341								c7248	10.1136/bmj.c7248	http://dx.doi.org/10.1136/bmj.c7248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	700DV	21177353				2022-12-28	WOS:000285716600002
J	Bloss, CS; Schork, NJ; Topol, EJ				Bloss, Cinnamon S.; Schork, Nicholas J.; Topol, Eric J.			Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROPHYLACTIC SURGERY; ALZHEIMERS-DISEASE; IMPACT	Background: The use of direct-to-consumer genomewide profiling to assess disease risk is controversial, and little is known about the effect of this technology on consumers. We examined the psychological, behavioral, and clinical effects of risk scanning with the Navigenics Health Compass, a commercially available test of uncertain clinical validity and utility. Methods: We recruited subjects from health and technology companies who elected to purchase the Health Compass at a discounted rate. Subjects reported any changes in symptoms of anxiety, intake of dietary fat, and exercise behavior at a mean (+/-SD) of 5.6+/-2.4 months after testing, as compared with baseline, along with any test-related distress and the use of health-screening tests. Results: From a cohort of 3639 enrolled subjects, 2037 completed follow-up. Primary analyses showed no significant differences between baseline and follow-up in anxiety symptoms (P=0.80), dietary fat intake (P=0.89), or exercise behavior (P=0.61). Secondary analyses revealed that test-related distress was positively correlated with the average estimated lifetime risk among all the assessed conditions ((beta)=0.117, P<0.001). However, 90.3% of subjects who completed follow-up had scores indicating no test-related distress. There was no significant increase in the rate of use of screening tests associated with genomewide profiling, most of which are not considered appropriate for screening asymptomatic persons in any case. Conclusions: In a selected sample of subjects who completed follow-up after undergoing consumer genomewide testing, such testing did not result in any measurable short-term changes in psychological health, diet or exercise behavior, or use of screening tests. Potential effects of this type of genetic testing on the population at large are not known. (Funded by the National Institutes of Health and Scripps Health.) N Engl J Med 2011;364:524-34.	[Bloss, Cinnamon S.; Schork, Nicholas J.; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Bloss, Cinnamon S.; Schork, Nicholas J.; Topol, Eric J.] Scripps Hlth, La Jolla, CA USA; [Schork, Nicholas J.; Topol, Eric J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Topol, Eric J.] Scripps Clin, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Topol, EJ (corresponding author), Scripps Translat Sci Inst, 3344 N Torrey Pines Ct,Suite 300, La Jolla, CA 92037 USA.	etopol@scripps.edu		Topol, Eric/0000-0002-1478-4729; Schork, Nicholas/0000-0003-0920-5013	National Center for Research Resources of the National Institutes of Health (NIH) [1UL1RR025774-01]; NIH's National Human Genome Research Institute [1R21HG005747-01]; Scripps Genomic Medicine Division of Scripps Health; National Institutes of Health and Scripps Health; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005747] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH's National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Scripps Genomic Medicine Division of Scripps Health; National Institutes of Health and Scripps Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported in part by grants from the National Center for Research Resources of the National Institutes of Health (NIH) (1UL1RR025774-01, to Dr. Topol) and the NIH's National Human Genome Research Institute (1R21HG005747-01, to Dr. Bloss) and by the Scripps Genomic Medicine Division of Scripps Health.; Funded by the National Institutes of Health and Scripps Health.	Block G, 2000, AM J PREV MED, V18, P284, DOI 10.1016/S0749-3797(00)00119-7; Bloss CS, 2010, GENET MED, V12, P556, DOI 10.1097/GIM.0b013e3181eb51c6; Botkin JR, 2003, AM J MED GENET A, V118A, P201, DOI 10.1002/ajmg.a.10102; Collins VR, 2007, GENET MED, V9, P290, DOI 10.1097/GIM.0b013e31804b45db; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Healy M, 2009, LOS ANGELES TIM 1024, P4; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Lerman C, 2000, PREV MED, V31, P75, DOI 10.1006/pmed.2000.0684; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; Pollack A, 2010, NY TIMES        0611, pB2; Roberts JS, 2005, J GERIATR PSYCH NEUR, V18, P250, DOI 10.1177/0891988705281883; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Weiss Daniel S., 1997, P399	18	382	382	0	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					524	534		10.1056/NEJMoa1011893	http://dx.doi.org/10.1056/NEJMoa1011893			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21226570	Green Accepted			2022-12-28	WOS:000287139900006
J	Weaver, DL; Ashikaga, T; Krag, DN; Skelly, JM; Anderson, SJ; Harlow, SP; Julian, TB; Mamounas, EP; Wolmark, N				Weaver, Donald L.; Ashikaga, Takamaru; Krag, David N.; Skelly, Joan M.; Anderson, Stewart J.; Harlow, Seth P.; Julian, Thomas B.; Mamounas, Eleftherios P.; Wolmark, Norman			Effect of Occult Metastases on Survival in Node-Negative Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SENTINEL LYMPH-NODES; MICROMETASTASES; CARCINOMA; RECOMMENDATIONS	BACKGROUND Retrospective and observational analyses suggest that occult lymph-node metastases are an important prognostic factor for disease recurrence or survival among patients with breast cancer. Prospective data on clinical outcomes from randomized trials according to sentinel-node involvement have been lacking. METHODS We randomly assigned women with breast cancer to sentinel-lymph-node biopsy plus axillary dissection or sentinel-lymph-node biopsy alone. Paraffin-embedded tissue blocks of sentinel lymph nodes obtained from patients with pathologically negative sentinel lymph nodes were centrally evaluated for occult metastases deeper in the blocks. Both routine staining and immunohistochemical staining for cytokeratin were used at two widely spaced additional tissue levels. Treating physicians were unaware of the findings, which were not used for clinical treatment decisions. The initial evaluation at participating sites was designed to detect all macrometastases larger than 2 mm in the greatest dimension. RESULTS Occult metastases were detected in 15.9% (95% confidence interval [CI], 14.7 to 17.1) of 3887 patients. Log-rank tests indicated a significant difference between patients in whom occult metastases were detected and those in whom no occult metastases were detected with respect to overall survival (P = 0.03), disease-free survival (P = 0.02), and distant-disease-free interval (P = 0.04). The corresponding adjusted hazard ratios for death, any outcome event, and distant disease were 1.40 (95% CI, 1.05 to 1.86), 1.31 (95% CI, 1.07 to 1.60), and 1.30 (95% CI, 1.02 to 1.66), respectively. Five-year Kaplan-Meier estimates of overall survival among patients in whom occult metastases were detected and those without detectable metastases were 94.6% and 95.8%, respectively. CONCLUSIONS Occult metastases were an independent prognostic variable in patients with sentinel nodes that were negative on initial examination; however, the magnitude of the difference in outcome at 5 years was small (1.2 percentage points). These data do not indicate a clinical benefit of additional evaluation, including immunohistochemical analysis, of initially negative sentinel nodes in patients with breast cancer.	[Weaver, Donald L.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Weaver, Donald L.; Ashikaga, Takamaru; Krag, David N.; Skelly, Joan M.; Harlow, Seth P.] Vermont Canc Ctr, Dept Pathol, Burlington, VT USA; [Weaver, Donald L.; Ashikaga, Takamaru; Krag, David N.; Skelly, Joan M.; Harlow, Seth P.] Vermont Canc Ctr, Dept Surg, Burlington, VT USA; [Weaver, Donald L.; Ashikaga, Takamaru; Krag, David N.; Skelly, Joan M.; Harlow, Seth P.] Vermont Canc Ctr, Dept Med Biostat, Burlington, VT USA; [Weaver, Donald L.; Ashikaga, Takamaru; Krag, David N.; Anderson, Stewart J.; Harlow, Seth P.; Julian, Thomas B.; Mamounas, Eleftherios P.; Wolmark, Norman] Natl Surg Adjuvant Breast & Bowel Project NSABP, Pittsburgh, PA USA; [Anderson, Stewart J.] NSABP Biostat Ctr, Pittsburgh, PA USA; [Anderson, Stewart J.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Julian, Thomas B.; Wolmark, Norman] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA	University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Allegheny General Hospital	Weaver, DL (corresponding author), Univ Vermont, Coll Med, Dept Pathol, 89 Beaumont Ave, Burlington, VT 05405 USA.	donald.weaver@vtmednet.org		Anderson, Stewart/0000-0001-8948-0650	Public Health Service of the National Cancer Institute [UO1-CA65121, P30-CA22435, U10CA-12027, U10CA-69974, U10CA-37377, U10CA-69651]; National Cancer Institute; NATIONAL CANCER INSTITUTE [U01CA065121, U10CA012027, U10CA069651, P30CA022435, U10CA069974, U10CA037377, R01CA074137] Funding Source: NIH RePORTER	Public Health Service of the National Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants (UO1-CA65121, P30-CA22435, U10CA-12027, U10CA-69974, U10CA-37377, and U10CA-69651) from the Public Health Service of the National Cancer Institute.; Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT00003830.	CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chen SL, 2007, ANN SURG ONCOL, V14, P3378, DOI 10.1245/s10434-007-9513-6; COTE R, 2010, J CLIN ONCOL S, V28, P18; COX DR, 1972, J R STAT SOC B, V34, P187; de Boer M, 2010, J NATL CANCER I, V102, P410, DOI 10.1093/jnci/djq008; Dowlatshahi K, 1997, CANCER, V80, P1188, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO;2-H; Gibbons J.D., 1985, NONPARAMETRIC STAT I, DOI 10.2307/2531272; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; MANTEL N, 1959, J NATL CANCER I, V22, P719; SAPHIR O, 1948, CANCER, V1, P238, DOI 10.1002/1097-0142(194807)1:2<238::AID-CNCR2820010208>3.0.CO;2-U; Weaver DL, 2000, CANCER, V88, P1099, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1099::AID-CNCR22>3.3.CO;2-Z; Weaver DL, 2003, AM J SURG PATHOL, V27, P842, DOI 10.1097/00000478-200306000-00018; Weaver DL, 2010, MODERN PATHOL, V23, pS26, DOI 10.1038/modpathol.2010.36; Weaver DL, 2009, AM J SURG PATHOL, V33, P1583, DOI 10.1097/PAS.0b013e3181b274e7	18	298	301	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					412	421		10.1056/NEJMoa1008108	http://dx.doi.org/10.1056/NEJMoa1008108			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21247310	Bronze, Green Accepted			2022-12-28	WOS:000286885900006
J	Ukai-Tadenuma, M; Yamada, RG; Xu, HY; Ripperger, JA; Liu, AC; Ueda, HR				Ukai-Tadenuma, Maki; Yamada, Rikuhiro G.; Xu, Haiyan; Ripperger, Juergen A.; Liu, Andrew C.; Ueda, Hiroki R.			Delay in Feedback Repression by Cryptochrome 1 Is Required for Circadian Clock Function	CELL			English	Article							GENE-EXPRESSION; TRANSCRIPTION; PROTEINS; CRY1; PAR; COMPONENTS; BINDING; LIMB	Direct evidence for the requirement of delay in feedback repression in the mammalian circadian clock has been elusive. Cryptochrome 1 (Cry1), an essential clock component, displays evening-time expression and serves as a strong repressor at morning-time elements (E box/E' box). In this study, we reveal that a combination of day-time elements (D box) within the Cry1-proximal promoter and night-time elements (RREs) within its intronic enhancer gives rise to evening-time expression. A synthetic composite promoter produced evening-time expression, which was further recapitulated by a simple phase-vector model. Of note, coordination of day-time with night-time elements can modulate the extent of phase delay. A genetic complementation assay in Cry1(-/-):Cry2(-/-) cells revealed that substantial delay of Cry1 expression is required to restore circadian rhythmicity, and its prolonged delay slows circadian oscillation. Taken together, our data suggest that phase delay in Cry1 transcription is required for mammalian clock function.	[Ukai-Tadenuma, Maki; Yamada, Rikuhiro G.; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Funct Genom Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ueda, Hiroki R.] RIKEN Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Xu, Haiyan; Liu, Andrew C.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Ripperger, Juergen A.] Univ Fribourg, Dept Med, Biochem Unit, CH-1700 Fribourg, Switzerland; [Ueda, Hiroki R.] Osaka Univ, Grad Sch Sci, Osaka 5600043, Japan; [Ueda, Hiroki R.] Kyoto Univ, Dept Math, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	RIKEN; RIKEN; RIKEN; University of Memphis; University of Fribourg; Osaka University; Kyoto University	Ueda, HR (corresponding author), RIKEN Ctr Dev Biol, Lab Syst Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	uedah-tky@umin.ac.jp	Liu, Andrew C/B-3548-2009; Ueda, Hiroki R/C-5037-2014	Liu, Andrew C/0000-0003-1927-0900; Ueda, Hiroki R/0000-0001-8342-9176	RIKEN Center for Developmental Biology (CDB); Uehara Memorial Foundation; Mitsubishi Foundation; RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Science Foundation [IOS-0920417]; SNF/FNS; Direct For Biological Sciences [0920417] Funding Source: National Science Foundation	RIKEN Center for Developmental Biology (CDB); Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Science Foundation(National Science Foundation (NSF)); SNF/FNS(Swiss National Science Foundation (SNSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by an intramural Grant-in-Aid from the RIKEN Center for Developmental Biology (CDB) (H.R.U.), Uehara Memorial Foundation (H.R.U.), The Mitsubishi Foundation (H.R.U.), the President's Fund from RIKEN (H.R.U.), KAKENHI (Grant-in-Aid for Scientific Research) on Priority Areas "Systems Genomics'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan (H.R.U.), the National Science Foundation (IOS-0920417) (A.C.L.), and the SNF/FNS (J.A.R.). We thank Ueli Schibler, Urs Albrecht, and Frederic Gachon for their valuable reagents; Akira Yasui and Gijsbertus T.J. van der Horst for Cry1<SUP>-/-</SUP>:Cry2<SUP>-/-</SUP> double-knockout mice; Hideki Ukai and Koh-hei Masumoto for technical support in establishment of Cry1<SUP>-/-</SUP>:Cry2<SUP>-/-</SUP> cells; Yohei Koyama for critical comments on the theoretical analysis of delayed negative feedback loop; Hajime Tei for Cry1 and Cry2 expression vectors; and David K. Welsh for critical reading of the manuscript.	Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Bernard S, 2006, PHILOS T R SOC A, V364, P1155, DOI 10.1098/rsta.2006.1761; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Falvey E, 1996, BIOL CHEM, V377, P797; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; Fustin JM, 2009, J BIOL RHYTHM, V24, P16, DOI 10.1177/0748730408329267; Gachon F, 2004, GENE DEV, V18, P1397, DOI 10.1101/gad.301404; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	39	183	188	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 21	2011	144	2					268	281		10.1016/j.cell.2010.12.019	http://dx.doi.org/10.1016/j.cell.2010.12.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	709RU	21236481	Green Submitted, Bronze			2022-12-28	WOS:000286459900011
J	Coutinho, JM; Stam, J				Coutinho, Jonathan M; Stam, Jan			Case Report A rare cause of thunderclap headache Cerebral venous thrombosis is the most likely diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SINUS THROMBOSIS					j.coutinho@amc.uva.nl	Coutinho, Jonathan/AAN-4546-2020	Coutinho, Jonathan/0000-0002-8284-982X				Canhao P, 2003, CEREBROVASC DIS, V15, P159, DOI 10.1159/000068833; Coutinho JM, 2009, STROKE, V40, P2356, DOI 10.1161/STROKEAHA.108.543884; Coutinho JM, 2009, STROKE, V40, P2233, DOI 10.1161/STROKEAHA.108.543421; deBruijn SFTM, 1996, LANCET, V348, P1623, DOI 10.1016/S0140-6736(96)07294-7; Einhaupl K, 2010, EUR J NEUROL, V17, P1229, DOI 10.1111/j.1468-1331.2010.03011.x; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; Ozsvath RR, 1997, AM J ROENTGENOL, V169, P1699, DOI 10.2214/ajr.169.6.9393193; Richard S, 2010, INFLAMM BOWEL DIS, V16, P366, DOI 10.1002/ibd.20996; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; STAM J, 2002, CD002005 COCHRANE DA, V4; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; VIRAPONGSE C, 1987, RADIOLOGY, V162, P779, DOI 10.1148/radiology.162.3.3809494	14	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2011	342								c6054	10.1136/bmj.c6054	http://dx.doi.org/10.1136/bmj.c6054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711OX	21248016				2022-12-28	WOS:000286602400028
J	Krist, AH; Woolf, SH				Krist, Alex H.; Woolf, Steven H.			A Vision for Patient-Centered Health Information Systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMMUNICATION		[Krist, Alex H.; Woolf, Steven H.] Virginia Commonwealth Univ, Dept Family Med, Richmond, VA 23298 USA; [Woolf, Steven H.] Virginia Commonwealth Univ, Ctr Human Needs, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Krist, AH (corresponding author), Virginia Commonwealth Univ, Dept Family Med, POB 980251, Richmond, VA 23298 USA.	ahkrist@vcu.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R21HS018811, R18HS017046] Funding Source: NIH RePORTER; AHRQ HHS [R21 HS018811-01, R21 HS018811, R18 HS017046, R18 HS17046-01] Funding Source: Medline; PHS HHS [RFTO 17, 290-07-100113] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Connecting for Health, 2008, AM OV BEL EL PERS HL; KRIST AH, IMPROVING CARE AHRQ; O'Connor AM, 2003, BMJ-BRIT MED J, V327, P736, DOI 10.1136/bmj.327.7417.736; Ralston JD, 2010, HEALTH AFFAIR, V29, P607, DOI 10.1377/hlthaff.2010.0113; Robinson TN, 1998, JAMA-J AM MED ASSOC, V280, P1264, DOI 10.1001/jama.280.14.1264; Silvestre AL, 2009, HEALTH AFFAIR, V28, P334, DOI 10.1377/hlthaff.28.2.334; Tang PC, 2009, NEW ENGL J MED, V360, P1276, DOI 10.1056/NEJMp0810264; Tang PC, 2006, J AM MED INFORM ASSN, V13, P121, DOI 10.1197/jamia.M2025	8	104	104	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					300	301		10.1001/jama.2010.2011	http://dx.doi.org/10.1001/jama.2010.2011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707YY	21245186	Green Accepted			2022-12-28	WOS:000286328700028
J	Biancari, F; Juvonen, T				Biancari, Fausto; Juvonen, Tatu			Review: Contrast-enhanced MRA is highly accurate for diagnosing steno-occlusions in peripheral arterial disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANGIOGRAPHY		[Biancari, Fausto; Juvonen, Tatu] Oulu Univ Hosp, Oulu, Finland	University of Oulu	Biancari, F (corresponding author), Oulu Univ Hosp, Oulu, Finland.		Biancari, Fausto/A-1039-2008	Biancari, Fausto/0000-0001-5028-8186				Biancari F, 2010, AM HEART J, V159, P518, DOI 10.1016/j.ahj.2009.12.027; Collins R, 2007, BMJ-BRIT MED J, V334, P1257, DOI 10.1136/bmj.39217.473275.55; Willmann JK, 2005, RADIOLOGY, V236, P1083, DOI 10.1148/radiol.2362040895	3	1	1	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 18	2011	154	2							JC1-11	10.7326/0003-4819-154-2-201101180-02011	http://dx.doi.org/10.7326/0003-4819-154-2-201101180-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706MW	21242353				2022-12-28	WOS:000286223500037
J	Santander-Syro, AF; Copie, O; Kondo, T; Fortuna, F; Pailhes, S; Weht, R; Qiu, XG; Bertran, F; Nicolaou, A; Taleb-Ibrahimi, A; Le Fevre, P; Herranz, G; Bibes, M; Reyren, N; Apertet, Y; Lecoeur, P; Barthelemy, A; Rozenberg, MJ				Santander-Syro, A. F.; Copie, O.; Kondo, T.; Fortuna, F.; Pailhes, S.; Weht, R.; Qiu, X. G.; Bertran, F.; Nicolaou, A.; Taleb-Ibrahimi, A.; Le Fevre, P.; Herranz, G.; Bibes, M.; Reyren, N.; Apertet, Y.; Lecoeur, P.; Barthelemy, A.; Rozenberg, M. J.			Two-dimensional electron gas with universal subbands at the surface of SrTiO3	NATURE			English	Article							STRONTIUM TITANATE; INSULATOR; HETEROSTRUCTURES; TEMPERATURE; TRANSITION; INTERFACE; OXIDES; BANDS	As silicon is the basis of conventional electronics, so strontium titanate (SrTiO3) is the foundation of the emerging field of oxide electronics(1,2). SrTiO3 is the preferred template for the creation of exotic, two-dimensional (2D) phases of electron matter at oxide interfaces(3-5) that have metal-insulator transitions(6,7), superconductivity(8,9) or large negative magnetoresistance(10). However, the physical nature of the electronic structure underlying these 2D electron gases (2DEGs), which is crucial to understanding their remarkable properties(11,12), remains elusive. Here we show, using angle-resolved photoemission spectroscopy, that there is a highly metallic universal 2DEG at the vacuum-cleaved surface of SrTiO3 (including the non-doped insulating material) independently of bulk carrier densities over more than seven decades. This 2DEG is confined within a region of about five unit cells and has a sheet carrier density of similar to 0.33 electrons per square lattice parameter. The electronic structure consists of multiple subbands of heavy and light electrons. The similarity of this 2DEG to those reported in SrTiO3-based heterostructures(6,8,13) and field-effect transistors(9,14) suggests that different forms of electron confinement at the surface of SrTiO3 lead to essentially the same 2DEG. Our discovery provides a model system for the study of the electronic structure of 2DEGs in SrTiO3-based devices and a novel means of generating 2DEGs at the surfaces of transition-metal oxides.	[Santander-Syro, A. F.; Fortuna, F.] CNRS, IN2P3, CSNSM, F-91405 Orsay, France; [Apertet, Y.; Lecoeur, P.] Univ Paris 11, Inst Elect Fondamentale, F-91405 Orsay, France; [Santander-Syro, A. F.] UPMC, CNRS, ESPCI, Lab Phys & Etud Mat,UMR 8213, F-75231 Paris 5, France; [Copie, O.; Bibes, M.; Reyren, N.; Barthelemy, A.] Unite Mixte Phys CNRS Thales, F-91767 Palaiseau, France; [Copie, O.] Univ Wurzburg, D-97074 Wurzburg, Germany; [Kondo, T.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Kondo, T.] Iowa State Univ, Ames Lab, Ames, IA 50011 USA; [Pailhes, S.] CEA Saclay, CNRS, CEA, Lab Leon Brillouin, F-91191 Gif Sur Yvette, France; [Weht, R.] Univ Nacl San Martin, Inst Sabato, CNEA, RA-1650 San Martin, Argentina; [Qiu, X. G.] Chinese Acad Sci, Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Qiu, X. G.] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Bertran, F.; Nicolaou, A.; Taleb-Ibrahimi, A.; Le Fevre, P.] CEA, CNRS, Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France; [Herranz, G.] ICMAB CSIC, Inst Ciencia Mat Barcelona, Bellaterra 08193, Catalonia, Spain; [Rozenberg, M. J.] Univ Paris 11, Phys Solides Lab, F-91405 Orsay, France; [Rozenberg, M. J.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); University of Wurzburg; Iowa State University; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Comision Nacional de Energia Atomica (CNEA); Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Physics, CAS; CEA; Centre National de la Recherche Scientifique (CNRS); SOLEIL Synchrotron; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Barcelona (ICMAB); UDICE-French Research Universities; Universite Paris Saclay; University of Buenos Aires	Santander-Syro, AF (corresponding author), CNRS, IN2P3, CSNSM, Batiment 104 & 108, F-91405 Orsay, France.	andres.santander@csnsm.in2p3.fr	Santander-Syro, Andrés Felipe/P-4470-2019; Herranz, Gervasi/G-2770-2014; Reyren, Nicolas/AAA-4984-2022; Copie, Olivier/N-1398-2014; Bibes, Manuel/AAC-5764-2019; pailhès, stéphane/AAA-5774-2021; BARTHELEMY, Agnès/ABB-5522-2020; BERTRAN, François/B-7515-2008; Kondo, Takeshi/H-2680-2016; Santander-Syro, Andres Felipe/D-7017-2012; Bibes, Manuel/C-5899-2013	Santander-Syro, Andrés Felipe/0000-0003-3966-2485; Herranz, Gervasi/0000-0003-4633-4367; Reyren, Nicolas/0000-0002-7745-7282; Copie, Olivier/0000-0002-4261-433X; Bibes, Manuel/0000-0002-6704-3422; pailhès, stéphane/0000-0002-9221-7092; BERTRAN, François/0000-0002-2416-0514; Santander-Syro, Andres Felipe/0000-0003-3966-2485; Bibes, Manuel/0000-0002-6704-3422; Rozenberg, Marcelo/0000-0001-9161-0370; Fortuna, Franck/0000-0002-7063-1890	ANR OXITRONICS; CNRS-CSIC [PICS2008FR1]; National Science Foundation [DMR-0537588]; US DOE [W-7405-ENG-82]; CONICET [PIP 112-200801-00047]; ANPCyT [PICT 837/07]; MOST and NSF of China; Spanish Government [MAT2008-06761-C03, NANOSELECT CSD2007-00041]	ANR OXITRONICS(French National Research Agency (ANR)); CNRS-CSIC; National Science Foundation(National Science Foundation (NSF)); US DOE(United States Department of Energy (DOE)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); MOST and NSF of China; Spanish Government(Spanish GovernmentEuropean Commission)	We are grateful to N. Bontemps, R. Claessen, Y. Fagot-Revurat, M. Gabay, I. C. Infante, D. Malterre, A. J. Millis and F. Reinert for discussions, to E. Jacquet for help with the sample preparation and to R. Guerrero for help with the transport measurements. This work was supported by the ANR OXITRONICS and the CNRS-CSIC PICS 'POSTIT' project under grant number PICS2008FR1. The Synchrotron Radiation Center, University of Wisconsin-Madison, is supported by the National Science Foundation under award no. DMR-0537588. The Ames Laboratory is operated for the US DOE by Iowa State University under contract number W-7405-ENG-82. R. W. is a research fellow of CONICET-Argentina, supported by CONICET (grant PIP 112-200801-00047) and ANPCyT grant PICT 837/07. X. G. Q. is supported by the MOST and NSF of China, and G. H. is supported by the Spanish Government under project numbers MAT2008-06761-C03 and NANOSELECT CSD2007-00041.	Ahn CH, 2003, NATURE, V424, P1015, DOI 10.1038/nature01878; Aiura Y, 2002, SURF SCI, V515, P61, DOI 10.1016/S0039-6028(02)01784-3; BARRETT HH, 1964, J APPL PHYS, V35, P1420, DOI 10.1063/1.1713643; Basletic M, 2008, NAT MATER, V7, P621, DOI 10.1038/nmat2223; Brinkman A, 2007, NAT MATER, V6, P493, DOI 10.1038/nmat1931; Caviglia AD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.126803; Cen C, 2008, NAT MATER, V7, P298, DOI 10.1038/nmat2136; Cen C, 2009, SCIENCE, V323, P1026, DOI 10.1126/science.1168294; Chang YJ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.235109; Copie O, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.216804; FUJIMORI A, 1992, PHYS REV B, V46, P9841, DOI 10.1103/PhysRevB.46.9841; Hsieh D, 2009, NATURE, V460, P1101, DOI 10.1038/nature08234; Ishida Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.056401; LYTLE FW, 1964, J APPL PHYS, V35, P2212, DOI 10.1063/1.1702820; MATTHEISS LF, 1972, PHYS REV B, V6, P4740, DOI 10.1103/PhysRevB.6.4740; MATTHEISS LF, 1972, PHYS REV B, V6, P4718, DOI 10.1103/PhysRevB.6.4718; Nakamura H, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.083713; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Okamoto S, 2004, NATURE, V428, P630, DOI 10.1038/nature02450; Pentcheva R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.205106; Popovic ZS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.256801; Ramirez AP, 2007, SCIENCE, V315, P1377, DOI 10.1126/science.1138578; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Salluzzo M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.166804; Seo SSA, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3213390; Sing M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176805; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; XIE Y, 2010, NANO LETT, V10	30	572	574	14	523	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 13	2011	469	7329					189	193		10.1038/nature09720	http://dx.doi.org/10.1038/nature09720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	705NO	21228872	Green Submitted			2022-12-28	WOS:000286143400033
J	Gostin, LO; Kim, SC				Gostin, Lawrence O.; Kim, Susan C.			Ethical Allocation of Preexposure HIV Prophylaxis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Kim, Susan C.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Dabis F, 2005, AIDS, V19, P309; Gostin LO, 2010, JAMA-J AM MED ASSOC, V304, P789, DOI 10.1001/jama.2010.1164; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; MCNEILL DG, 2010, NY TIMES        0510, pA10; Obengo T.J., 2020, UTILITARIAN ASSESSME; The Global Fund, 2022, BMJ, DOI DOI 10.1136/BMJ.O2320; *UNAIDS, REP G UNAIDS REP GLO; *US CDCP, PREL RES 1 SAF STUD; *US PRES EM PLAN A, EX SUMM PEPFARS STRA	10	18	18	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 12	2011	305	2					191	192		10.1001/jama.2010.1975	http://dx.doi.org/10.1001/jama.2010.1975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705BM	21224461	Green Published			2022-12-28	WOS:000286103400025
J	Dillner, L				Dillner, Luisa			Interview with Michael Rawlins Regulating research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Dillner, L (corresponding author), BMJ, London, England.	ldillner@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2011	342								c7461	10.1136/bmj.c7461	http://dx.doi.org/10.1136/bmj.c7461			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708SO	21224327				2022-12-28	WOS:000286384800019
J	Leonard, TA; Rozycki, B; Saidi, LF; Hummer, G; Hurley, JH				Leonard, Thomas A.; Rozycki, Bartosz; Saidi, Layla F.; Hummer, Gerhard; Hurley, James H.			Crystal Structure and Allosteric Activation of Protein Kinase C beta II	CELL			English	Article							MEMBRANE-BINDING; CATALYTIC DOMAIN; BIOLOGICAL MACROMOLECULES; INDUCED TRANSLOCATION; SOLUTION SCATTERING; PKC; ALPHA; PHOSPHORYLATION; ROLES; SIMULATIONS	Protein kinase C (PKC) isozymes are the paradigmatic effectors of lipid signaling. PKCs translocate to cell membranes and are allosterically activated upon binding of the lipid diacylglycerol to their C1A and C1B domains. The crystal structure of full-length protein kinase C beta II was determined at 4.0 angstrom, revealing the conformation of an unexpected intermediate in the activation pathway. Here, the kinase active site is accessible to substrate, yet the conformation of the active site corresponds to a low-activity state because the ATP-binding side chain of Phe629 of the conserved NFD motif is displaced. The C1B domain clamps the NFD helix in a low-activity conformation, which is reversed upon membrane binding. A low-resolution solution structure of the closed conformation of PKC beta II was derived from small-angle X-ray scattering. Together, these results show how PKC beta II is allosterically regulated in two steps, with the second step defining a novel protein kinase regulatory mechanism.	[Leonard, Thomas A.; Saidi, Layla F.; Hurley, James H.] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Rozycki, Bartosz; Hummer, Gerhard] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Leonard, Thomas/A-5143-2013; Hummer, Gerhard/A-2546-2013; Rozycki, Bartosz/B-7005-2009	Leonard, Thomas/0000-0001-6853-666X; Hummer, Gerhard/0000-0001-7768-746X; Rozycki, Bartosz/0000-0001-5938-7308	NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; EMBO; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036127, ZIADK029033] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Chang for technical assistance, J. Lloyd and D. E. Anderson for assistance with mass spectrometry, J. F. Mushinski and A. Toker for DNAs, E. Boura for assistance with SAXS data collection, H. Tsuruta and T. Weiss for user support at BL4-2, SSRL, M. Becker for user support at GM/CA-CAT, APS, H. Mischak and M. Pearson for early efforts, A. Newton for discussions, and A. Brunger for a prerelease version of CNS 1.3. GM/CA-CAT has been funded in whole or in part with Federal funds from the NCI (Y1-CO-1020) and the NIGMS (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract No. DE-AC02-06CH11357. SAXS data were collected at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. T.A.L. was supported in part by an EMBO long term fellowship. B.R. was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme. This research was supported by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health to J.H.H. and G.H.	Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bogi K, 1999, FEBS LETT, V456, P27, DOI 10.1016/S0014-5793(99)00927-8; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; HOMMEL U, 1994, NAT STRUCT BIOL, V1, P383, DOI 10.1038/nsb0694-383; Hurley JH, 1997, CURR OPIN STRUC BIOL, V7, P557, DOI 10.1016/S0959-440X(97)80122-4; Hurley JH, 1997, PROTEIN SCI, V6, P477; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Kim YC, 2008, J MOL BIOL, V375, P1416, DOI 10.1016/j.jmb.2007.11.063; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Littler DR, 2006, BIOCHEM BIOPH RES CO, V349, P1182, DOI 10.1016/j.bbrc.2006.08.160; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P13216, DOI 10.1021/bi010761u; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ochoa WF, 2001, J MOL BIOL, V311, P837, DOI 10.1006/jmbi.2001.4910; ORR JW, 1994, J BIOL CHEM, V269, P8383; Pappa H, 1998, STRUCT FOLD DES, V6, P885, DOI 10.1016/S0969-2126(98)00090-2; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639; TSUTAKAWA SE, 1995, J BIOL CHEM, V270, P26807, DOI 10.1074/jbc.270.45.26807; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	56	148	149	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 7	2011	144	1					55	66		10.1016/j.cell.2010.12.013	http://dx.doi.org/10.1016/j.cell.2010.12.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	703QF	21215369	Green Accepted, Bronze			2022-12-28	WOS:000285993600007
J	Cederwall, B; Moradi, FG; Back, T; Johnson, A; Blomqvist, J; Clement, E; de France, G; Wadsworth, R; Andgren, K; Lagergren, K; Dijon, A; Jaworski, G; Liotta, R; Qi, C; Nyako, BM; Nyberg, J; Palacz, M; Al-Azri, H; Algora, A; de Angelis, G; Atac, A; Bhattacharyya, S; Brock, T; Brown, JR; Davies, P; Di Nitto, A; Dombradi, Z; Gadea, A; Gal, J; Hadinia, B; Johnston-Theasby, F; Joshi, P; Juhasz, K; Julin, R; Jungclaus, A; Kalinka, G; Kara, SO; Khaplanov, A; Kownacki, J; La Rana, G; Lenzi, SM; Molnar, J; Moro, R; Napoli, DR; Singh, BSN; Persson, A; Recchia, F; Sandzelius, M; Scheurer, JN; Sletten, G; Sohler, D; Soderstrom, PA; Taylor, MJ; Timar, J; Valiente-Dobon, JJ; Vardaci, E; Williams, S				Cederwall, B.; Moradi, F. Ghazi; Back, T.; Johnson, A.; Blomqvist, J.; Clement, E.; de France, G.; Wadsworth, R.; Andgren, K.; Lagergren, K.; Dijon, A.; Jaworski, G.; Liotta, R.; Qi, C.; Nyako, B. M.; Nyberg, J.; Palacz, M.; Al-Azri, H.; Algora, A.; de Angelis, G.; Atac, A.; Bhattacharyya, S.; Brock, T.; Brown, J. R.; Davies, P.; Di Nitto, A.; Dombradi, Zs.; Gadea, A.; Gal, J.; Hadinia, B.; Johnston-Theasby, F.; Joshi, P.; Juhasz, K.; Julin, R.; Jungclaus, A.; Kalinka, G.; Kara, S. O.; Khaplanov, A.; Kownacki, J.; La Rana, G.; Lenzi, S. M.; Molnar, J.; Moro, R.; Napoli, D. R.; Singh, B. S. Nara; Persson, A.; Recchia, F.; Sandzelius, M.; Scheurer, J. -N.; Sletten, G.; Sohler, D.; Soderstrom, P. -A.; Taylor, M. J.; Timar, J.; Valiente-Dobon, J. J.; Vardaci, E.; Williams, S.			Evidence for a spin-aligned neutron-proton paired phase from the level structure of Pd-92	NATURE			English	Article							SHELL-MODEL DESCRIPTION; GENERALIZED SENIORITY; SPECTROMETER; STATES	Shell structure and magic numbers in atomic nuclei were generally explained by pioneering work(1) that introduced a strong spin-orbit interaction to the nuclear shell model potential. However, knowledge of nuclear forces and the mechanisms governing the structure of nuclei, in particular far from stability, is still incomplete. In nuclei with equal neutron and proton numbers (N = Z), enhanced correlations arise between neutrons and protons (two distinct types of fermions) that occupy orbitals with the same quantum numbers. Such correlations have been predicted to favour an unusual type of nuclear superfluidity, termed isoscalar neutron-proton pairing(2-6), in addition to normal isovector pairing. Despite many experimental efforts, these predictions have not been confirmed. Here we report the experimental observation of excited states in the N = Z = 46 nucleus Pd-92. Gamma rays emitted following the Ni-58(Ar-36,2n)Pd-92 fusion-evaporation reaction were identified using a combination of state-of-the-art high-resolution c-ray, charged-particle and neutron detector systems. Our results reveal evidence for a spin-aligned, isoscalar neutron-proton coupling scheme, different from the previous prediction(2-6). We suggest that this coupling scheme replaces normal superfluidity (characterized by seniority coupling(7,8)) in the ground and low-lying excited states of the heaviest N = Z nuclei. Such strong, isoscalar neutron-proton correlations would have a considerable impact on the nuclear level structure and possibly influence the dynamics of rapid proton capture in stellar nucleosynthesis.	[Cederwall, B.; Moradi, F. Ghazi; Back, T.; Johnson, A.; Blomqvist, J.; Andgren, K.; Lagergren, K.; Liotta, R.; Qi, C.; Hadinia, B.; Khaplanov, A.; Persson, A.; Sandzelius, M.] Royal Inst Technol, Dept Phys, SE-10691 Stockholm, Sweden; [Clement, E.; de France, G.; Dijon, A.; Bhattacharyya, S.] CNRS, IN2P3, CEA, DSM,GANIL, F-14076 Caen 5, France; [Wadsworth, R.; Al-Azri, H.; Brock, T.; Brown, J. R.; Davies, P.; Johnston-Theasby, F.; Joshi, P.; Singh, B. S. Nara; Taylor, M. J.] Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England; [Lagergren, K.] Holifield Radioact Ion Beam Facil, Joint Inst Heavy Ion Res, Oak Ridge, TN 37831 USA; [Jaworski, G.; Palacz, M.; Kownacki, J.] Univ Warsaw, Heavy Ion Lab, PL-02093 Warsaw, Poland; [Jaworski, G.] Warsaw Univ Technol, Fac Phys, PL-00662 Warsaw, Poland; [Nyako, B. M.; Dombradi, Zs.; Gal, J.; Kalinka, G.; Molnar, J.; Sohler, D.; Timar, J.] Hungarian Acad Sci, Inst Nucl Res, H-4001 Debrecen, Hungary; [Nyberg, J.; Soderstrom, P. -A.] Uppsala Univ, Dept Phys & Astron, SE-75121 Uppsala, Sweden; [Algora, A.; Gadea, A.] Univ Valencia, CSIC, IFIC, E-46071 Valencia, Spain; [de Angelis, G.; Napoli, D. R.; Valiente-Dobon, J. J.] Inst Nazl Fis Nucl, Lab Nazl Legnaro, I-35020 Legnaro, Italy; [Atac, A.; Kara, S. O.] Ankara Univ, Dept Phys, TR-06100 Tandogan, Turkey; [Di Nitto, A.; La Rana, G.; Moro, R.; Vardaci, E.] Univ Naples Federico II, Dipartimento Sci Fis, I-80126 Naples, Italy; [Di Nitto, A.; La Rana, G.; Moro, R.; Vardaci, E.] Inst Nazl Fis Nucl, I-80126 Naples, Italy; [Juhasz, K.] Univ Debrecen, Dept Informat Technol, H-4010 Debrecen, Hungary; [Julin, R.] Univ Jyvaskyla, Dept Phys, FIN-40014 Jyvaskyla, Finland; [Jungclaus, A.] CSIC, Inst Estruct Mat, E-28006 Madrid, Spain; [Lenzi, S. M.; Recchia, F.] Univ Padua, Dipartimento Fis, I-35122 Padua, Italy; [Lenzi, S. M.; Recchia, F.] Inst Nazl Fis Nucl, Sez Padova, I-35122 Padua, Italy; [Scheurer, J. -N.] Univ Bordeaux 1, CNRS, IN2P3, Ctr Etud Nucl Bordeaux Gradignan, F-33175 Gradignan, France; [Sletten, G.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Williams, S.] TRIUMF, Vancouver, BC V6T 2A3, Canada	Royal Institute of Technology; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); University of York - UK; University of Warsaw; Warsaw University of Technology; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Nuclear Research; Uppsala University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia; Istituto Nazionale di Fisica Nucleare (INFN); Ankara University; University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); University of Debrecen; University of Jyvaskyla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Estructura de la Materia (IEM); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; University of Copenhagen; Niels Bohr Institute; University of British Columbia	Cederwall, B (corresponding author), Royal Inst Technol, Dept Phys, SE-10691 Stockholm, Sweden.	cederwall@nuclear.kth.se	Dombradi, Zsolt/B-3743-2012; Jaworski, Grzegorz/R-6640-2016; de France, Gilles/AAS-5059-2021; Di+Nitto, Antonio/AAK-4033-2021; Di Nitto, Antonio/C-5069-2011; Algora, Alejandro/E-2960-2015; Qi, Chong/B-1741-2008; La Rana, Giovanni/D-3753-2017; Jungclaus, Andrea/AAB-1906-2020; Palacz, Marcin/H-3713-2012; Napoli, Daniel Ricardo/D-9863-2012; Khaplanov, Anton/HDN-5813-2022; Di Nitto, Antonio/Q-8071-2019; Cederwall, Bo W/M-3337-2014; Taylor, Michael/N-1725-2015; Gadea, Andres/L-8529-2014; Soderstrom, Par-Anders/E-2983-2017	Jaworski, Grzegorz/0000-0003-2241-0329; de France, Gilles/0000-0002-7439-1759; Di Nitto, Antonio/0000-0002-9319-366X; Algora, Alejandro/0000-0002-5199-1794; Qi, Chong/0000-0002-1406-5695; La Rana, Giovanni/0000-0003-2814-4113; Napoli, Daniel Ricardo/0000-0002-8154-6958; Di Nitto, Antonio/0000-0002-9319-366X; Cederwall, Bo W/0000-0003-1771-2656; Taylor, Michael/0000-0002-8718-3684; Gadea, Andres/0000-0002-4233-1970; Jungclaus, Andrea/0000-0002-8559-0331; Nyberg, Johan/0000-0001-6996-7605; Back, Torbjorn/0000-0003-1996-0805; Bondili, S Nara Singh/0000-0002-4096-2429; Clement, Emmanuel/0000-0003-1887-717X; Soderstrom, Par-Anders/0000-0002-9504-2814; Recchia, Francesco/0000-0002-8428-0112; AL-Azri, Harith/0000-0002-5361-6605	Swedish Research Council [2007-4067, 2008-5793]; Goran Gustafsson Foundation; European Union [506065]; Hungarian Scientific Research Fund, OTKA [K72566, K68801]; UK Science and Technology Facilities Council (STFC); Polish Ministry of Science and Higher Education [N N202 073935]; Spanish Ministerio de Ciencia e Innovacion [FPA2007-66069]; Spanish Consolider-Ingenio 2010 Programme CPAN [CSD2007-00042]; Ankara University [DPT 2005120140]; STFC [ST/F012071/1, ST/J000124/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F012071/1, ST/J000124/1] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Goran Gustafsson Foundation; European Union(European Commission); Hungarian Scientific Research Fund, OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); UK Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Consolider-Ingenio 2010 Programme CPAN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ankara University(Ankara University); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the Swedish Research Council (contract nos 2007-4067 and 2008-5793), the Goran Gustafsson Foundation, the European Union Sixth Framework Programme 'Integrating Infrastructure Initiative-Transnational Access' (no. 506065; EURONS), the Hungarian Scientific Research Fund, OTKA (contract nos. K72566 and K68801), the UK Science and Technology Facilities Council (STFC), the Polish Ministry of Science and Higher Education (grant no. N N202 073935), the Spanish Ministerio de Ciencia e Innovacion (contract no. FPA2007-66069), the Spanish Consolider-Ingenio 2010 Programme CPAN (CSD2007-00042), and Ankara University BIYEP project no. DPT 2005120140. We thank the EXOGAM collaboration for use of the germanium detector system, the DIAMANT collaboration for use of the charged particle detector system, the European gamma-Ray Spectroscopy Pool for use of the neutron detector system, L. Einarsson and R. Seppala for providing some of the targets used in this experiment and the GANIL staff for technical support and for providing the <SUP>36</SUP>Ar beam.	Afanasjev AV, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.064318; ALBER D, 1989, Z PHYS A-HADRON NUCL, V332, P129, DOI 10.1007/BF01289767; Azaiez F, 1999, NUCL PHYS A, V654, p1003C, DOI 10.1016/S0375-9474(00)88588-7; Civitarese O, 1997, PHYS REV C, V56, P1840, DOI 10.1103/PhysRevC.56.1840; Clement RRC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.172502; DANOS M, 1967, PHYS REV, V161, P1034, DOI 10.1103/PhysRev.161.1034; Engel J, 1996, PHYS LETT B, V389, P211, DOI 10.1016/S0370-2693(96)01294-4; Engel J, 1997, PHYS REV C, V55, P1781, DOI 10.1103/PhysRevC.55.1781; Gal J, 2004, NUCL INSTRUM METH A, V516, P502, DOI 10.1016/j.nima.2003.08.158; Goodman A. L., 1979, ADV NUCL PHYS, V11, P260; HEESE J, 1994, PHYS REV C, V49, P1896, DOI 10.1103/PhysRevC.49.1896; Lenzi SM, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.021303; Macchiavelli AO, 2000, PHYS REV C, V61, DOI 10.1103/PhysRevC.61.041303; Marginean N, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.061301; Marginean N, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.014302; MAYER MG, 1949, PHYS REV, V75, P1969, DOI 10.1103/PhysRev.75.1969; O'Leary CD, 1999, PHYS LETT B, V459, P73, DOI 10.1016/S0370-2693(99)00656-5; Satula W, 1997, PHYS LETT B, V393, P1, DOI 10.1016/S0370-2693(96)01603-6; Schatz H, 2001, PHYS REV LETT, V86, P3471, DOI 10.1103/PhysRevLett.86.3471; Scheurer JN, 1997, NUCL INSTRUM METH A, V385, P501, DOI 10.1016/S0168-9002(96)01038-8; Simpson J, 2000, ACTA PHYS HUNG NS-H, V11, P159; Skeppstedt O, 1999, NUCL INSTRUM METH A, V421, P531, DOI 10.1016/S0168-9002(98)01208-X; TALMI I, 1971, NUCL PHYS A, VA172, P1, DOI 10.1016/0375-9474(71)90112-6; Talmi I, 2001, NUCL PHYS A, V686, P217, DOI 10.1016/S0375-9474(00)00565-0	24	135	140	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 6	2011	469	7328					68	71		10.1038/nature09644	http://dx.doi.org/10.1038/nature09644			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702UO	21179086	Green Submitted			2022-12-28	WOS:000285921600032
J	Picard, MH; Rosenfield, K; Digumarthy, S; Smith, RN; Harris, NL				Picard, Michael H.; Rosenfield, Kenneth; Digumarthy, Subba; Smith, R. Neal; Harris, Nancy Lee			A Woman with Chest Pain during an Airplane Flight Myocardial infarction and rupture of the free wall of the left ventricle.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOGENIC-SHOCK		[Picard, Michael H.; Rosenfield, Kenneth] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [Digumarthy, Subba] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Smith, R. Neal] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Picard, Michael H.; Rosenfield, Kenneth] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Digumarthy, Subba] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Smith, R. Neal] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Picard, MH (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA.		Picard, Michael/F-1567-2013	Picard, Michael/0000-0002-9264-3243	Abbott Vascular; Boston Scientific; Boston Biomedical; Baxter Healthcare; Harvard Clinical Research Institute; Micell Technologies; Complete Conference Management; Cordis; IDev Technologies; Medtronic/Invatec; Bard; Lutonix; Atrium	Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Boston Biomedical; Baxter Healthcare; Harvard Clinical Research Institute; Micell Technologies; Complete Conference Management; Cordis; IDev Technologies; Medtronic/Invatec(Medtronic); Bard; Lutonix; Atrium	Dr. Rosenfield reports being a member of the board of VIVA Physicians (a not-for-profit educational organization with support from commercial and private donors; www.vivapvd.com); receiving consulting fees from Abbott Vascular, Boston Scientific, Boston Biomedical, Baxter Healthcare, Harvard Clinical Research Institute, Micell Technologies, and Complete Conference Management; receiving royalties from Angioguard; and holding stock in Micell Technologies, Icon Medical Corp., Contego, Lumen Biomedical, and Medical Simulation Corp. Dr. Rosenfield also reports that Massachusetts General Hospital has received grant support from Abbott Vascular, Boston Scientific, Baxter Healthcare, Cordis, IDev Technologies, Medtronic/Invatec, Bard, Lutonix, and Atrium on his behalf. No other potential conflict of interest relevant to this article was reported.	Antman EM, 2008, J AM COLL CARDIOL, V51, P977, DOI 10.1016/j.jacc.2008.01.007; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Chockalingam A, 2007, CIRCULATION, V116, pE110, DOI 10.1161/CIRCULATIONAHA.107.711697; DAVIDOFF R, 1994, AM HEART J, V127, P1231, DOI 10.1016/0002-8703(94)90041-8; Douglas PS, 2007, J AM SOC ECHOCARDIOG, V20, P787, DOI 10.1016/j.echo.2007.06.011; Dowdall N, 2000, BRIT MED J, V321, P1336, DOI 10.1136/bmj.321.7272.1336; Figueras J, 1996, AM HEART J, V131, P861, DOI 10.1016/S0002-8703(96)90165-9; Figueras J, 1998, J AM COLL CARDIOL, V32, P135, DOI 10.1016/S0735-1097(98)00180-6; Figueras J, 2000, HEART, V83, P499, DOI 10.1136/heart.83.5.499; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Markowicz-Pawlus Ewa, 2007, Cardiol J, V14, P538; Menon V, 2000, J AM COLL CARDIOL, V36, P1110, DOI 10.1016/S0735-1097(00)00878-0; Menon V, 2002, HEART, V88, P531, DOI 10.1136/heart.88.5.531; Sand M, 2009, CRIT CARE, V13, DOI 10.1186/cc7690; Stein PD, 2007, AM J MED, V120, P871, DOI 10.1016/j.amjmed.2007.03.024; Takada A, 2009, PATHOL RES PRACT, V205, P241, DOI 10.1016/j.prp.2008.10.006	16	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 30	2010	363	27					2652	2661		10.1056/NEJMcpc1011317	http://dx.doi.org/10.1056/NEJMcpc1011317			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	700SD	21190460	Green Published			2022-12-28	WOS:000285763700012
J	Roy, S; Ernst, J; Kharchenko, PV; Kheradpour, P; Negre, N; Eaton, ML; Landolin, JM; Bristow, CA; Ma, LJ; Lin, MF; Washietl, S; Arshinoff, BI; Ay, F; Meyer, PE; Robine, N; Washington, NL; Di Stefano, L; Berezikov, E; Brown, CD; Candeias, R; Carlson, JW; Carr, A; Jungreis, I; Marbach, D; Sealfon, R; Tolstorukov, MY; Will, S; Alekseyenko, AA; Artieri, C; Booth, BW; Brooks, AN; Dai, Q; Davis, CA; Duff, MO; Feng, X; Gorchakov, AA; Gu, TT; Henikoff, JG; Kapranov, P; Li, RH; MacAlpine, HK; Malone, J; Minoda, A; Nordman, J; Okamura, K; Perry, M; Powell, SK; Riddle, NC; Sakai, A; Samsonova, A; Sandler, JE; Schwartz, YB; Sher, N; Spokony, R; Sturgill, D; van Baren, M; Wan, KH; Yang, L; Yu, C; Feingold, E; Good, P; Guyer, M; Lowdon, R; Ahmad, K; Andrews, J; Berger, B; Brenner, SE; Brent, MR; Cherbas, L; Elgin, SCR; Gingeras, TR; Grossman, R; Hoskins, RA; Kaufman, TC; Kent, W; Kuroda, MI; Orr-Weaver, T; Perrimon, N; Pirrotta, V; Posakony, JW; Ren, B; Russell, S; Cherbas, P; Graveley, BR; Lewis, S; Micklem, G; Oliver, B; Park, PJ; Celniker, SE; Henikoff, S; Karpen, GH; Lai, EC; MacAlpine, DM; Stein, LD; White, KP; Kellis, M				Roy, Sushmita; Ernst, Jason; Kharchenko, Peter V.; Kheradpour, Pouya; Negre, Nicolas; Eaton, Matthew L.; Landolin, Jane M.; Bristow, Christopher A.; Ma, Lijia; Lin, Michael F.; Washietl, Stefan; Arshinoff, Bradley I.; Ay, Ferhat; Meyer, Patrick E.; Robine, Nicolas; Washington, Nicole L.; Di Stefano, Luisa; Berezikov, Eugene; Brown, Christopher D.; Candeias, Rogerio; Carlson, Joseph W.; Carr, Adrian; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Tolstorukov, Michael Y.; Will, Sebastian; Alekseyenko, Artyom A.; Artieri, Carlo; Booth, Benjamin W.; Brooks, Angela N.; Dai, Qi; Davis, Carrie A.; Duff, Michael O.; Feng, Xin; Gorchakov, Andrey A.; Gu, Tingting; Henikoff, Jorja G.; Kapranov, Philipp; Li, Renhua; MacAlpine, Heather K.; Malone, John; Minoda, Aki; Nordman, Jared; Okamura, Katsutomo; Perry, Marc; Powell, Sara K.; Riddle, Nicole C.; Sakai, Akiko; Samsonova, Anastasia; Sandler, Jeremy E.; Schwartz, Yuri B.; Sher, Noa; Spokony, Rebecca; Sturgill, David; van Baren, Marijke; Wan, Kenneth H.; Yang, Li; Yu, Charles; Feingold, Elise; Good, Peter; Guyer, Mark; Lowdon, Rebecca; Ahmad, Kami; Andrews, Justen; Berger, Bonnie; Brenner, Steven E.; Brent, Michael R.; Cherbas, Lucy; Elgin, Sarah C. R.; Gingeras, Thomas R.; Grossman, Robert; Hoskins, Roger A.; Kaufman, Thomas C.; Kent, William; Kuroda, Mitzi I.; Orr-Weaver, Terry; Perrimon, Norbert; Pirrotta, Vincenzo; Posakony, James W.; Ren, Bing; Russell, Steven; Cherbas, Peter; Graveley, Brenton R.; Lewis, Suzanna; Micklem, Gos; Oliver, Brian; Park, Peter J.; Celniker, Susan E.; Henikoff, Steven; Karpen, Gary H.; Lai, Eric C.; MacAlpine, David M.; Stein, Lincoln D.; White, Kevin P.; Kellis, Manolis		modENCODE Consortium	Identification of Functional Elements and Regulatory Circuits by Drosophila modENCODE	SCIENCE			English	Article							PREDICTIVE CHROMATIN SIGNATURES; TRANSCRIPTION FACTORS; SOMATIC-CELLS; HUMAN GENOME; DNA-BINDING; RNA PATHWAY; MELANOGASTER; SEQUENCE; REGIONS; NETWORK	To gain insight into how genomic information is translated into cellular and developmental programs, the Drosophila model organism Encyclopedia of DNA Elements (modENCODE) project is comprehensively mapping transcripts, histone modifications, chromosomal proteins, transcription factors, replication proteins and intermediates, and nucleosome properties across a developmental time course and in multiple cell lines. We have generated more than 700 data sets and discovered protein-coding, noncoding, RNA regulatory, replication, and chromatin elements, more than tripling the annotated portion of the Drosophila genome. Correlated activity patterns of these elements reveal a functional regulatory network, which predicts putative new functions for genes, reveals stage-and tissue-specific regulators, and enables gene-expression prediction. Our results provide a foundation for directed experimental and computational studies in Drosophila and related species and also a model for systematic data integration toward comprehensive genomic and functional annotation.	[Roy, Sushmita; Ernst, Jason; Kheradpour, Pouya; Bristow, Christopher A.; Lin, Michael F.; Washietl, Stefan; Ay, Ferhat; Meyer, Patrick E.; Di Stefano, Luisa; Candeias, Rogerio; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Will, Sebastian; Berger, Bonnie; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Roy, Sushmita; Ernst, Jason; Kheradpour, Pouya; Bristow, Christopher A.; Lin, Michael F.; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Berger, Bonnie; Kellis, Manolis] MIT, Broad Inst, Cambridge, MA 02140 USA; [Roy, Sushmita; Ernst, Jason; Kheradpour, Pouya; Bristow, Christopher A.; Lin, Michael F.; Jungreis, Irwin; Marbach, Daniel; Sealfon, Rachel; Berger, Bonnie; Kellis, Manolis] Harvard Univ, Cambridge, MA 02140 USA; [Kharchenko, Peter V.; Tolstorukov, Michael Y.; Schwartz, Yuri B.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Negre, Nicolas; Ma, Lijia; Brown, Christopher D.; Spokony, Rebecca; Grossman, Robert; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, Chicago, IL 60637 USA; [Eaton, Matthew L.; MacAlpine, Heather K.; Powell, Sara K.; MacAlpine, David M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Landolin, Jane M.; Carlson, Joseph W.; Booth, Benjamin W.; Minoda, Aki; Sandler, Jeremy E.; Wan, Kenneth H.; Yu, Charles; Hoskins, Roger A.; Celniker, Susan E.; Karpen, Gary H.] Lawrence Berkeley Natl Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Arshinoff, Bradley I.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Robine, Nicolas; Dai, Qi; Henikoff, Jorja G.; Okamura, Katsutomo; Lai, Eric C.] Sloan Kettering Inst, New York, NY 10065 USA; [Washington, Nicole L.; Lewis, Suzanna] LBNL, Genome Sci Div, Berkeley, CA 94720 USA; [Carr, Adrian; Russell, Steven; Micklem, Gos] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Carr, Adrian; Russell, Steven; Micklem, Gos] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 3EH, England; [Alekseyenko, Artyom A.; Gorchakov, Andrey A.; Kuroda, Mitzi I.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Alekseyenko, Artyom A.; Gorchakov, Andrey A.; Kuroda, Mitzi I.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Genet, Boston, MA 02115 USA; [Artieri, Carlo; Malone, John; Sturgill, David; Oliver, Brian] NIDDK, Sect Dev Genom, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Davis, Carrie A.; Feng, Xin; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Duff, Michael O.; Yang, Li; Graveley, Brenton R.] Univ Connecticut, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Gu, Tingting; Riddle, Nicole C.; Elgin, Sarah C. R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Kapranov, Philipp; Gingeras, Thomas R.] Affymetrix, Santa Clara, CA 95051 USA; [Li, Renhua; Feingold, Elise; Good, Peter; Guyer, Mark; Lowdon, Rebecca] NHGRI, Div Extramural Res, NIH, Bethesda, MD 20892 USA; [Arshinoff, Bradley I.; Feng, Xin; Perry, Marc; Stein, Lincoln D.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Samsonova, Anastasia; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Samsonova, Anastasia; Perrimon, Norbert] Harvard Univ, Sch Med, Drosophila RNAi Screening Ctr, Boston, MA 02115 USA; [van Baren, Marijke; Brent, Michael R.] Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA; [Andrews, Justen; Cherbas, Lucy; Kaufman, Thomas C.; Cherbas, Peter] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Nordman, Jared; Sher, Noa; Orr-Weaver, Terry] Whitehead Inst, Cambridge, MA 02142 USA; [Berezikov, Eugene] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Berezikov, Eugene] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Cherbas, Lucy; Cherbas, Peter] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Posakony, James W.; Ren, Bing] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Pirrotta, Vincenzo] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Brooks, Angela N.; Brenner, Steven E.; Karpen, Gary H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Sakai, Akiko; Ahmad, Kami] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Meyer, Patrick E.] Univ Libre Bruxelles, Machine Learning Grp, B-1050 Brussels, Belgium; [Di Stefano, Luisa] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Brenner, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ay, Ferhat] Univ Florida, Gainesville, FL 32611 USA; [Kent, William] Univ Calif Santa Cruz, Sch Engn, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Kent, William] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Feng, Xin] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; University of Chicago; Duke University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Toronto; Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Cambridge; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cold Spring Harbor Laboratory; University of Connecticut; Washington University (WUSTL); Affymetrix; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Massachusetts Institute of Technology (MIT); Whitehead Institute; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Indiana University System; Indiana University Bloomington; Fred Hutchinson Cancer Center; University of California System; University of California San Diego; Rutgers State University New Brunswick; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Universite Libre de Bruxelles; Harvard University; Massachusetts General Hospital; University of California System; University of California Berkeley; State University System of Florida; University of Florida; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kellis, M (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	celniker@fruitfly.org; steveh@fhcrc.org; karpen@fruitfly.org; laie@mskcc.org; david.macalpine@duke.edu; lincoln.stein@gmail.com; kpwhite@uchicago.edu; manoli@mit.edu	Sakai, Akiko/A-8929-2010; Lai, Eric C/A-3412-2008; Rutherford, Kim/Y-7995-2018; Venken, Koen/B-9909-2013; Gorchakov, Andrey A/N-5840-2015; Kellis, Manolis/ABE-7385-2020; White, Rob A H/G-4835-2012; Minoda, Aki/Q-4454-2019; Brent, Michael/AAK-3702-2020; Brenner, Steven E/A-8729-2008; Graveley, Brenton R/C-3108-2013; jiang, lichun/F-3776-2012; Berezikov, Eugene/D-3363-2013; Chateigner, Aurelien/AAC-9143-2020; Samsonova, Anastasia/Q-7591-2016; Eaton, Matthew/C-4408-2011; Spokony, Rebecca/AAD-3014-2020; Hirst, Martin/B-7684-2016; dai, qi/AAB-6637-2020; Russell, Steve/A-4072-2011; Marra, Marco A/B-5987-2008; Brooks, Angela/B-6173-2011; Hinrichs, Angie S./H-9159-2019; Samsonova, Anastasia/AAU-7269-2021; Lai, Eric/AAO-1143-2021; Eng, Thomas/AAV-5157-2020; Minoda, Aki/D-5335-2017; Hansen, Kasper D/E-6094-2011; Di Stefano, Luisa/ABB-6457-2020; Ay, Ferhat/J-7800-2019; Grossman, Robert/B-1865-2009	Sakai, Akiko/0000-0003-3120-0104; Rutherford, Kim/0000-0001-6277-726X; Venken, Koen/0000-0003-0741-4698; Gorchakov, Andrey A/0000-0003-2830-4236; Kellis, Manolis/0000-0001-7113-9630; Minoda, Aki/0000-0002-2927-5791; Brent, Michael/0000-0002-8689-0299; Brenner, Steven E/0000-0001-7559-6185; jiang, lichun/0000-0003-2462-7636; Berezikov, Eugene/0000-0002-1145-2884; Samsonova, Anastasia/0000-0002-9353-9173; Russell, Steve/0000-0003-0546-3031; Marra, Marco A/0000-0001-7146-7175; Hinrichs, Angie S./0000-0002-1697-1130; Samsonova, Anastasia/0000-0002-9353-9173; Lai, Eric/0000-0002-8432-5851; Eng, Thomas/0000-0002-4974-3863; Minoda, Aki/0000-0002-2927-5791; Hansen, Kasper D/0000-0003-0086-0687; Di Stefano, Luisa/0000-0003-3437-9066; Ay, Ferhat/0000-0002-0708-6914; Lewis, Suzanna/0000-0002-8343-612X; Elgin, Sarah C. R./0000-0002-5176-2510; Perrimon, Norbert/0000-0001-7542-472X; Bellen, Hugo/0000-0001-5992-5989; Dobin, Alexander/0000-0002-4115-9128; Negre, Nicolas/0000-0001-9727-3416; contrino, sergio/0000-0003-3409-5231; Graveley, Brenton/0000-0001-5777-5892; Lloyd, Paul/0000-0003-3508-5553; Sturgill, David/0000-0002-7902-3605; Henikoff, Steven/0000-0002-7621-8685; Lin, Wei/0000-0002-7506-3466; Meyer, Folker/0000-0003-1112-2284; Fagegaltier, Delphine/0000-0001-9154-6786; Park, Peter/0000-0001-9378-960X; Washington, Nicole/0000-0001-8936-9143; Clawson, Hiram/0000-0002-0480-0545; Robine, Nicolas/0000-0001-5698-8183; Gingeras, Thomas/0000-0001-9106-3573; Micklem, Gos/0000-0002-6883-6168; yang, li/0000-0001-8833-7473; Kapranov, Philipp/0000-0003-2647-4856; McKay, Sheldon/0000-0002-4011-3160; Brown, Christopher/0000-0002-3785-5008; Zieba, Jennifer/0000-0003-1650-1830; Dai, Qi/0000-0002-2082-0693; Grossman, Robert/0000-0003-3741-5739	National Human Genome Research Institute [RC2HG005639, U01HG004271, U01HG004258, U01HG004264, U01HG004279, U01HG004261, U01HG004274, U41HG004269]; LBNL [DE-AC02-05CH11231]; NSF [0937060, 0905968, 0644282]; Natural Sciences and Engineering Research Council of Canada (NSERC); Japan Society for the Promotion of Science; Swedish Research Council; NIH National Research Service; National Defense Science and Engineering; Austrian Fonds zur Forderung der wissenschaftlichen Forschung; Leukemia and Lymphoma Society; Lilly-Life Sciences Research Foundation; Affymetrix; Swiss National Science Foundation; German Research Foundation [WI 3628/1-1]; HHMI; Indiana Genomics Initiative; NIDDK genomics core laboratory; NIH [R01HG004037]; Sloan Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004279, RC2HG005639, U01HG004264, U01HG004274, U01HG004258, R01HG004037, U41HG004269, U01HG004261, U01HG004271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081871] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); LBNL; NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering; Austrian Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Lilly-Life Sciences Research Foundation; Affymetrix; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG)); HHMI(Howard Hughes Medical Institute); Indiana Genomics Initiative; NIDDK genomics core laboratory; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Human Genome Research Institute as part of the modENCODE project under RC2HG005639 (M.K.), U01HG004271 (S.E.C.), U01HG004258 (G.H.K.), U01HG004264 (K.P.W.), U01HG004279 (D.M.M.), U01HG004261 (E.L.), U01HG004274 (S.H.), and U41HG004269 (L.S.). Awards to S.E.C. and G.H.K. were carried out at LBNL under contract no. DE-AC02-05CH11231. Additional support was provided by the NSF under grant 0937060 to the Computing Research Association for the CIFellows Project (S.R.) and under award no. 0905968 (J.E.), a Natural Sciences and Engineering Research Council of Canada (NSERC) fellowship (B.A.), T. Kahveci (F.A.), the Japan Society for the Promotion of Science (K.O.), the Swedish Research Council (Q.D.), a NIH National Research Service Award postdoctoral fellowship (C.A.B.), a National Defense Science and Engineering Graduate Fellowship (R.S.), an Erwin Schrodinger Fellowship of the Austrian Fonds zur Forderung der wissenschaftlichen Forschung (S.W.), a Leukemia and Lymphoma Society fellowship (S.W.), a Lilly-Life Sciences Research Foundation fellowship (C.D.B.), a NSERC postdoctoral fellowship (C. G. A.), Affymetrix (T.G.R.), a fellowship from the Swiss National Science Foundation (D.M.), a German Research Foundation grant WI 3628/1-1 (S.W.), a HHMI Damon Runyon Cancer Research fellowship (J.T.N.), the Indiana Genomics Initiative (T.C.K.), H. Smith and the NIDDK genomics core laboratory (B.O.), NIH R01HG004037, NSF CAREER award 0644282, and the Sloan Foundation (M.K.). A full list of author contributions is available in the SOM.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; [Anonymous], 2008, COMP FLYB REL 5 12, DOI http://fb2008_09.flybase.org/; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Berbenetz NM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001092; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Chung WJ, 2011, GENOME RES, V21, P286, DOI 10.1101/gr.113050.110; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Flynt AS, 2010, MOL CELL, V38, P900, DOI 10.1016/j.molcel.2010.06.014; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; GRAVELEY BR, 2010, NATURE, V471, P473, DOI DOI 10.1038/NATURE09715; HARRISON DA, 1993, GENE DEV, V7, P1966, DOI 10.1101/gad.7.10.1966; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Lee LA, 2003, ANNU REV GENET, V37, P545, DOI 10.1146/annurev.genet.37.110801.143149; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Scott KS, 1995, EMBO J, V14, P6258, DOI 10.1002/j.1460-2075.1995.tb00316.x; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spradling AC, 2006, GENETICS, V174, P1; STAPLETON M, 2002, GENOME BIOL, V0003; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Wan KH, 2006, NAT PROTOC, V1, P624, DOI 10.1038/nprot.2006.90; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	69	854	864	1	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 23	2010	330	6012					1787	1797		10.1126/science.1198374	http://dx.doi.org/10.1126/science.1198374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698OS	21177974	Green Accepted, Green Published			2022-12-28	WOS:000285603700032
J	Schenkel, R				Schenkel, Roland			The Challenge of Feeding Scientific Advice into Policy-Making	SCIENCE			English	Editorial Material									[Schenkel, Roland] European Commiss, Joint Res Ctr, B-1049 Brussels, Belgium	European Commission Joint Research Centre		roland.schenkel@t-online.de						[Anonymous], GROSS DOMESTIC EXPEN; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; *EC, 2010, EU EN TRANSP FIG, P80; *EC, 2005, SPEC EUR 227 RAD WAS, P26; Edwards R, 2010, INDIRECT LAND USE CH, DOI 10.2788/54137; *EU, EU ANN GUID BIOF SUS; *EUR OP FOR, 2010, REC EUR COMM JOINT R; *EUR PROGR, INT EN; *NUCL EN AG, 2010, PUBL ATT NUCL POW, P45; RANKIN J, 2010, EUROPEAN VOICE  0903; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; *SKB, 2006, TR0609 SKB SR CAN PR; *SKB, 2009, ANN REP 2009 SKB; *SKB, PUBL CONS REP SKB; *SKB SWED NUCL FUE, 2009, FIN REP SPENT FUEL F; 2009, WORLD NUCL NEWS 0603	16	20	23	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 23	2010	330	6012					1749	1751		10.1126/science.1197503	http://dx.doi.org/10.1126/science.1197503			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698OS	21205654				2022-12-28	WOS:000285603700019
J	Kaplan, K				Kaplan, Karen			EMPLOYMENT TRENDS Drawn to academia	NATURE			English	Editorial Material																			0	27	27	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1135	1135		10.1038/nj7327-1135a	http://dx.doi.org/10.1038/nj7327-1135a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	697XT	21157983	Bronze			2022-12-28	WOS:000285553800067
